"status","label","pos tag","length","corpus-ngram w","^length","doc list","corp list","db ID","corpora ID"
"w","group p with unit","NN  IN NN",4,18,104976,"16511277 16511264 16511266 16511267 16511272 16511291 16511268 16511294 16511269 16511286 16511287 16511249 16511285 16511280 16511255 16511256 16511288 16511252",2,4.54E+018,"testalpha"
"w","p with unit cell"," IN NN NN",4,16,65536,"16511277 16511267 16511272 16511291 16511268 16511294 16511269 16511286 16511287 16511285 16511282 16511288 16511281 16511256 16511249 16511252",2,2.03E+018,"testalpha"
"w","c h n o","NN   ",4,7,2401,"16397334 16456285 16456295 16456265 16456292 16456282 16456283",2,6.18E+018,"testalpha"
"w","title compound c h","NN NN NN ",4,7,2401,"16397344 16456275 16456289 16397330 16456285 16456296 16456295",2,3.93E+018,"testalpha"
"w","hanging drop vapour diffusion","VBG NN JJ NN",4,7,2401,"16511264 16511276 16511291 16511286 16511284 16511255 16511252",2,3.14E+018,"testalpha"
"w","x ray diffraction data","NN  NN NNS",4,5,625,"16511287 16511275 16511285 16369094 16511253",2,9.18E+018,"testalpha"
"w","p with unit cellparameters"," IN NN NNS",4,5,625,"16511264 16511255 16511266 16511274 16511280",2,1.04E+018,"testalpha"
"w","patients with atopic dermatitis","NNS IN NN NN",4,4,256,"16955181 16648919 16648913 16648910",2,1.02E+018,"testalpha"
"w","diffusion method at k","NN NN IN ",4,4,256,"16511286 16511264 16511255 16511269",2,8.69E+018,"testalpha"
"w","c withunit cell parameters","NN JJ NN NNS",4,4,256,"16511276 16511275 16511253 16511289",2,5.81E+018,"testalpha"
"w","group c withunit cell","NN NN JJ NN",4,4,256,"16511276 16511275 16511253 16511289",2,1.01E+018,"testalpha"
"w","compound c h n","NN NN  ",4,4,256,"16456285 16456295 16456275 16397330",2,4.63E+018,"testalpha"
"w","fine needle aspiration fna","JJ NN NN ",4,4,256,"16514847 16514836 16514845 16514850",2,1.47E+017,"testalpha"
"w","group c with unit","NN NN IN NN",4,4,256,"16511293 16511261 16511288 16511250",2,2.23E+017,"testalpha"
"w","drop vapour diffusion method","NN JJ NN NN",4,4,256,"16511286 16511264 16511255 16511252",2,6.29E+018,"testalpha"
"w","cells of undetermined significance","NNS IN JJ NN",4,4,256,"16514835 16514839 16514841 16514840",2,4.68E+018,"testalpha"
"w","nausea and vomiting ponv","NNP CC VBG ",4,3,81,"17236637 16451147 16451145","pubmed1",4.86E+018,"testalpha"
"w","split thickness skin grafts","NN NN NN NNS",4,3,81,"16999269 17165596 17165599",2,6.06E+017,"testalpha"
"w","monoclinic space group c","JJ NN NN NN",4,3,81,"16511275 16511288 16511289",2,5.91E+018,"testalpha"
"w","cd cd and cd","  CC ",4,3,81,"17016035 17119322 16256177",2,8.65E+018,"testalpha"
"w","c with unit cell","NN IN NN NN",4,3,81,"16511261 16511288 16511250",2,8.88E+018,"testalpha"
"w","cell nuclear antigen pcna","NN JJ NN ",4,3,81,"17013509 17013510 17013511",2,6.30E+017,"testalpha"
"w","human umbilical cord blood","JJ JJ NN NN",4,3,81,"17265690 16404477 17265691","pubmed1 2",5.81E+018,"testalpha"
"w","hanging dropvapour diffusion method","NN JJ NN NN",4,3,81,"16511272 16511253 16511281",2,4.90E+018,"testalpha"
"w","patients with rectal cancer","NNS IN NN NN",4,3,81,"17139895 17139896 17139900",2,1.82E+018,"testalpha"
"w","p withunit cell parameters"," JJ NN NNS",4,3,81,"16511273 16511259 16511278",2,4.75E+018,"testalpha"
"w","hanging drop vapour diffusionmethod","NN NN JJ NN",4,3,81,"16511287 16511268 16511254",2,8.06E+018,"testalpha"
"w","h o c h","  NN ",4,3,81,"16397334 16456265 16456276",2,5.31E+018,"testalpha"
"w","cd cd cd cd","   ",4,3,81,"16733557 17119322 16256177","pubmed1 2",2.22E+018,"testalpha"
"w","high index of suspicion","JJ NN IN NN",4,3,81,"16612930 16462410 16612928","pubmed1",7.84E+016,"testalpha"
"w","year old female patient","NN JJ NN NN",4,2,16,"16603099 16859616",2,6.10E+018,"testalpha"
"w","graft versus host disease","NN IN NN NN",4,2,16,"17311739 17016038",2,2.29E+018,"testalpha"
"w","sialic acid specific topo","JJ NN JJ ",4,2,16,"16714048 16542712",2,7.25E+017,"testalpha"
"w","high pressure homogenization technique","JJ NN NN NN",4,2,16,"17285742 16584150","pubmed1",5.44E+018,"testalpha"
"w","short chain fatty acids","JJ NN JJ NNS",4,2,16,"16491218 17293957",2,2.97E+018,"testalpha"
"w","significant number of patients","JJ NN IN NNS",4,2,16,"16377190 16462406","pubmed1",6.29E+018,"testalpha"
"w","scanning electron microscopy sem","VBG NN  ",4,2,16,"16701867 16584166","pubmed1",8.44E+018,"testalpha"
"w","methods wistar rats n","NNS NN NNS ",4,2,16,"17013509 17293962",2,3.45E+018,"testalpha"
"w","mean age of years","NN NN IN NNS",4,2,16,"16377190 16436792","pubmed1",4.43E+018,"testalpha"
"w","topo optical reaction toluidine"," JJ NN NN",4,2,16,"16714048 16542712",2,1.92E+017,"testalpha"
"w","n o c h","  NN ",4,2,16,"16456265 16456283",2,3.54E+017,"testalpha"
"w","h n c h","  NN ",4,2,16,"16397333 16456283",2,8.68E+017,"testalpha"
"w","cutaneous adverse drug reactions","JJ JJ NN NNS",4,2,16,"17106599 17106600",2,4.19E+018,"testalpha"
"w","cell cell and cell","NN NN CC NN",4,2,16,"16713618 17049369",2,3.44E+018,"testalpha"
"w","g protein coupled receptors"," NN VBN NNS",4,2,16,"16594640 16594639","pubmed1",3.93E+018,"testalpha"
"w","o c h n"," NN  ",4,2,16,"16397334 16456276",2,4.82E+018,"testalpha"
"w","idiopathic thrombocytopenic purpura itp","JJ JJ NNP ",4,2,16,"17016035 16424648",2,6.48E+018,"testalpha"
"w","h o hydrogen bonds","  NN NNS",4,2,16,"16397330 16456283",2,5.21E+018,"testalpha"
"w","polymerase chain reaction pcr","NN NN NN ",4,2,16,"16514834 16951742","pubmed1 2",8.01E+017,"testalpha"
"w","b l amb ambisome","NN   NN",4,2,16,"16918060 17370566","pubmed1",3.02E+018,"testalpha"
"w","transforming growth factor beta","VBG NN NN NN",4,2,16,"16762404 16733556","pubmed1 2",8.98E+018,"testalpha"
"w","il beta and il"," NN CC ",4,2,16,"17293958 17293960",2,2.44E+018,"testalpha"
"w","chronic health evaluation apache","JJ NN NN NNP",4,2,16,"16365336 17117607","pubmed1 2",1.72E+018,"testalpha"
"w","central nervous system cns","JJ JJ NN ",4,2,16,"16956113 17370568","pubmed1 2",6.63E+018,"testalpha"
"w","h n o h","   ",4,2,16,"16456285 16456292",2,8.68E+017,"testalpha"
"w","patients with high risk","NNS IN JJ NN",4,2,16,"16424645 17236637","pubmed1 2",5.22E+018,"testalpha"
"w","diagnoses were compared withthe","NNS VBD VBN NNP",4,2,16,"16514836 16514837",2,3.74E+018,"testalpha"
"w","vascular endothelial growth factor","JJ JJ NN NN",4,2,16,"16317488 17139902","pubmed1 2",7.64E+018,"testalpha"
"w","volume per protein weight","NN IN NN NN",4,2,16,"16511276 16511285",2,4.03E+018,"testalpha"
"w","limited number of case","VBN NN IN NN",4,2,16,"16612924 16983449","pubmed1 2",4.87E+018,"testalpha"
"w","transforming growthfactor beta tgf","VBG NN NN ",4,2,16,"16395524 16874413","pubmed1 2",5.93E+017,"testalpha"
"w","patients and healthy controls","NNS CC JJ NNS",4,2,16,"16603095 16874421",2,9.65E+015,"testalpha"
"w","c h n pf","NN   ",4,2,16,"16397333 16456276",2,2.36E+018,"testalpha"
"w","hepatic ischemia and reperfusion","JJ NN CC NN",4,2,16,"16491220 17013507",2,2.99E+018,"testalpha"
"w","h n and c","  CC NN",4,2,16,"16456284 16456295",2,3.34E+018,"testalpha"
"w","growth factor vegf expression","NN NN  NN",4,2,16,"16317488 17139902","pubmed1 2",8.10E+018,"testalpha"
"w","length of hospital stay","NN IN NN NN",4,2,16,"17165597 16956118",2,7.93E+018,"testalpha"
"w","activation of protein kinase","NN IN NN NN",4,2,16,"16395521 16479030","pubmed1 2",2.60E+018,"testalpha"
"w","c h o c","NN   NN",4,2,16,"16456265 16456276",2,6.18E+018,"testalpha"
"w","fas ligand fas l"," NN  ",4,2,16,"16330085 16919708",2,2.38E+018,"testalpha"
"w","high performance liquid chromatography","JJ NN JJ NN",4,2,16,"16701856 16874416","pubmed1 2",8.81E+018,"testalpha"
"w","total mesorectal excision tme","JJ NN NN ",4,2,16,"17139896 16612911",2,5.16E+018,"testalpha"
"w","drop vapour diffusion technique","NN JJ NN NN",4,2,16,"16511291 16511284",2,6.43E+018,"testalpha"
"w","crystal volume per protein","NN NN IN NN",4,2,16,"16511276 16511285",2,6.26E+018,"testalpha"
"w","c h n c","NN   NN",4,2,16,"16397333 16456283",2,6.18E+018,"testalpha"
"w","molecule per asymmetric unit","NN IN JJ NN",4,2,16,"16511289 16511252",2,8.01E+018,"testalpha"
"w","fatality analysis reporting system","NN NN NN NN",4,2,16,"16171767 16405857","pubmed1",8.64E+018,"testalpha"
"w","group p withunit cell","NN  JJ NN",4,2,16,"16511273 16511278",2,1.53E+018,"testalpha"
"w","endothelial growth factor vegf","JJ NN NN ",4,2,16,"16317488 17139902","pubmed1 2",5.37E+018,"testalpha"
"w","tomography and magnetic resonance","NN CC JJ NN",4,2,16,"16918065 16333706","pubmed1",5.87E+018,"testalpha"
"w","active antiretroviral therapy haart","JJ JJ NN NN",4,2,16,"16462404 16462406","pubmed1",3.79E+018,"testalpha"
"w","toluidine bluetopo optical reaction","NN  JJ NN",4,2,16,"16714048 16542712",2,4.19E+018,"testalpha"
"w","n and c h"," CC NN ",4,2,16,"16456284 16456295",2,5.02E+018,"testalpha"
"w","year old male patient","NN JJ JJ NN",4,2,16,"16809891 16612928","pubmed1 2",6.58E+018,"testalpha"
"w","area and severity index","NN CC NN NN",4,2,16,"16585987 16585983",2,5.61E+018,"testalpha"
"w","children with chronic itp","NNS IN JJ ",4,2,16,"16424649 16424648",2,8.81E+018,"testalpha"
"w","diffusion method using peg","NN NN VBG ",4,2,16,"16511260 16511281",2,4.15E+018,"testalpha"
"w","were male and female","VBD NN CC NN",4,2,16,"17688033 17338205",2,5.37E+018,"testalpha"
"w","end stage liver disease","NN NN NN NN",4,2,16,"17013520 17013505",2,9.62E+017,"testalpha"
"w","sensory and motor block","NN CC NN NN",4,2,16,"16451159 16617756","pubmed1",2.54E+018,"testalpha"
"w","positive patch test reaction","JJ NN NN NN",4,2,16,"17106597 16874422",2,6.99E+018,"testalpha"
"w","accreditation council for graduate","NN NN IN NN",4,2,16,"16377825 16377812","pubmed1",7.75E+018,"testalpha"
"w","n h o hydrogen","   NN",4,2,16,"16456284 16456283",2,8.94E+017,"testalpha"
"w","growthfactor beta tgf beta","NN NN  NN",4,2,16,"16395524 16874413","pubmed1 2",9.29E+017,"testalpha"
"w","emergency medical services ems","NN JJ NNS ",4,2,16,"16365324 16365334","pubmed1",7.65E+017,"testalpha"
"w","topo optical staining reactions"," JJ VBG NNS",4,2,16,"16542712 16714051",2,3.37E+018,"testalpha"
"w","number of cell divisions","NN IN NN NNS",4,2,16,"17106513 17106512","pubmed1",1.24E+018,"testalpha"
"w","peroxisome proliferator activated receptor","NN NN VBN NN",4,2,16,"16395520 16809887","pubmed1 2",3.76E+018,"testalpha"
"w","group p or p","NN  CC ",4,2,16,"16511274 16511259",2,5.96E+018,"testalpha"
"w","differential scanning calorimetry dsc","JJ VBG NN ",4,2,16,"16584150 17285745","pubmed1",4.36E+018,"testalpha"
"w","n o h o","   ",4,2,16,"16456285 16456292",2,3.54E+017,"testalpha"
"w","group i with unit","NN  IN NN",4,2,16,"16511257 16511292",2,2.94E+018,"testalpha"
"w","h n hydrogen bonds","  NN NNS",4,2,16,"16456284 16456283",2,5.85E+018,"testalpha"
"w","partial hepatectomy in rats","JJ NN IN NNS",4,2,16,"17013510 17013511",2,8.35E+018,"testalpha"
"w","h n o c","   NN",4,2,16,"16456265 16456283",2,8.68E+017,"testalpha"
"w","median age of years","JJ NN IN NNS",4,2,16,"16424647 16549900",2,3.18E+018,"testalpha"
"w","molecules in theasymmetric unit","NNS IN JJ NN",4,2,16,"16511287 16511279",2,2.30E+018,"testalpha"
"w","specific topo optical reaction","JJ  JJ NN",4,2,16,"16714048 16542712",2,4.05E+017,"testalpha"
"w","c h n os","NN   ",4,2,16,"16397328 16397330",2,2.36E+018,"testalpha"
"w","number of cd cd","NN IN  ",4,2,16,"17016036 17119322",2,4.36E+017,"testalpha"
"w","i with unit cell"," IN NN NN",4,2,16,"16511257 16511292",2,5.83E+018,"testalpha"
"w","growing body of literature","VBG NN IN NN",4,2,16,"16596897 16596899","pubmed1",9.03E+018,"testalpha"
"w","intramolecular n h o","JJ   ",4,2,16,"16397328 16456295",2,6.67E+018,"testalpha"
"w","epidermal growth factor receptor","JJ NN NN NN",4,2,16,"16673564 16874412",2,9.21E+018,"testalpha"
"w","proliferating cell nuclear antigen","VBG NN JJ NN",4,2,16,"17013510 17013511",2,2.22E+018,"testalpha"
"w","skin prick test spt","NN NNP NN ",4,2,16,"16859613 16859611",2,2.06E+018,"testalpha"
"w","optical reaction toluidine bluetopo","JJ NN NN ",4,2,16,"16714048 16542712",2,7.83E+018,"testalpha"
"w","residency review committee rrc","NN NN NN ",4,2,16,"16473996 16473998","pubmed1",6.12E+018,"testalpha"
"w","chronic myeloid leukemia cml","JJ VB NN ",4,2,16,"16914906 16424660",2,3.92E+018,"testalpha"
"w","mg kg body weight","  NN NN",4,2,16,"17007911 16549901",2,7.17E+018,"testalpha"
"w","generation of reactiveoxygen species","NN IN NN NN",4,2,16,"17160142 16999986","pubmed1 2",4.64E+018,"testalpha"
"w","sitting dropvapour diffusion method","VBG JJ NN NN",4,2,16,"16511260 16511269",2,8.96E+018,"testalpha"
"w","cleft lip and palate","NN NN CC NN",4,2,16,"16722348 17165598",2,6.63E+018,"testalpha"
"w","patients male and female","NNS NN CC NN",4,2,16,"16859613 16989147",2,3.17E+018,"testalpha"
"w","amino acid side chains","NNP NN NN NNS",4,2,16,"16421453 16511248",2,9.01E+018,"testalpha"
"w","models for cannabinoid receptors","NNS IN VB NNS",4,1,1,16808046,"pubmed1",7.32E+018,"testalpha"
"w","lr in cervical cancer"," IN JJ NN",4,1,1,16514834,2,6.24E+018,"testalpha"
"w","immunogenicity and greater flexibility","NN CC JJR NN",4,1,1,17285739,"pubmed1",3.80E+018,"testalpha"
"w","month of standard therapy","NN IN JJ NN",4,1,1,17370569,"pubmed1",2.15E+017,"testalpha"
"w","consecutive sample of edpatients","JJ NN IN NNS",4,1,1,16365337,"pubmed1",1.90E+017,"testalpha"
"w","conditioning regimen of aml","VBG NN IN ",4,1,1,17119322,2,4.15E+018,"testalpha"
"w","contrast enhancement pattern equivalent","NN NN NN NN",4,1,1,16333704,"pubmed1",5.37E+018,"testalpha"
"w","treatment modality of iron","NN NN IN NN",4,1,1,17117609,2,4.91E+018,"testalpha"
"w","inverselyon opposed phase t","NNP VBN NN ",4,1,1,16317488,"pubmed1",5.37E+017,"testalpha"
"w","expression of ppargamma protein","NN IN NN NN",4,1,1,16809887,2,1.59E+018,"testalpha"
"w","epigastric pain eructation pyrosis","JJ NN NN NN",4,1,1,16424650,2,6.93E+018,"testalpha"
"w","irregular nuclear contours uniform","JJ JJ NNS NN",4,1,1,16514847,2,3.47E+018,"testalpha"
"w","forperceived exaggeration of symptoms","VBN NN IN NNS",4,1,1,16436793,"pubmed1",1.61E+018,"testalpha"
"w","subunitoxidizes nadh and transfers","VBZ  CC NNS",4,1,1,16511277,2,5.15E+018,"testalpha"
"w","face and upper extremities","NN CC JJ NNS",4,1,1,16617761,"pubmed1",1.17E+018,"testalpha"
"w","todetermine product dry layer","NN NN JJ NN",4,1,1,17285744,"pubmed1",8.71E+017,"testalpha"
"w","intensive chemotherapy and radiotherapy","JJ NN CC NN",4,1,1,16914909,2,8.29E+018,"testalpha"
"w","apoptosis or programmed cell","NN CC VBN NN",4,1,1,16919708,2,7.73E+018,"testalpha"
"w","protein antigens for immunotherapy","NN NNS IN NN",4,1,1,16404477,"pubmed1",3.35E+018,"testalpha"
"w","aspartylglucosaminidases with alphabeta oligomericstructure","NNS IN NN NN",4,1,1,17143335,"pubmed1",2.68E+018,"testalpha"
"w","inter and intramolecular hydrogen","NN CC JJ NN",4,1,1,16397330,2,6.44E+018,"testalpha"
"w","mu n n bis","   ",4,1,1,16456265,2,1.17E+018,"testalpha"
"w","au lait spots cases","  NNS NNS",4,1,1,17010267,2,1.39E+018,"testalpha"
"w","rearrangement of gliomac cells","NN IN NNP NNS",4,1,1,17115079,"pubmed1",1.81E+018,"testalpha"
"w","withmarked differences in pregnancy","VBD NNS IN NN",4,1,1,16603098,2,9.19E+018,"testalpha"
"w","c gg d klaklak","NN   NNP",4,1,1,17143339,"pubmed1",1.34E+018,"testalpha"
"w","rash and internal organ","NN CC JJ NN",4,1,1,16710584,2,6.80E+018,"testalpha"
"w","other useful research training","JJ JJ NN NN",4,1,1,16473989,"pubmed1",7.04E+018,"testalpha"
"w","termeffects of regular exercise","NNS IN JJ NN",4,1,1,16921608,"pubmed1",4.98E+018,"testalpha"
"w","patients with oral lichen","NNS IN JJ NNP",4,1,1,16710580,2,8.76E+018,"testalpha"
"w","frequency of crash involvement","NN IN NN NN",4,1,1,16122689,"pubmed1",5.21E+018,"testalpha"
"w","general pattern significant differences","JJ NN JJ NNS",4,1,1,16949651,2,8.36E+018,"testalpha"
"w","ligament fibroblasts cementocytes andodontoblasts","NN NNS NNS NNS",4,1,1,17049369,2,3.59E+018,"testalpha"
"w","inlga infants of non"," NNS IN ",4,1,1,17438837,2,7.15E+018,"testalpha"
"w","group reported higher satisfaction","NN VBD JJR NN",4,1,1,16365322,"pubmed1",8.59E+018,"testalpha"
"w","student education in psychiatry","NN NN IN NN",4,1,1,16473991,"pubmed1",1.20E+017,"testalpha"
"w","culture medium without cells","NN NN IN NNS",4,1,1,16970980,2,3.09E+017,"testalpha"
"w","focal dilatation of fluid","JJ NN IN NN",4,1,1,16333701,"pubmed1",6.37E+017,"testalpha"
"w","pericardium and anticalcification treatments","NN CC NN NNS",4,1,1,16701880,"pubmed1",7.51E+018,"testalpha"
"w","mean percent changes ofheart","VB NN NNS NN",4,1,1,17067136,"pubmed1",6.89E+018,"testalpha"
"w","effectiveness of court actions","NN IN NN NNS",4,1,1,16112068,"pubmed1",6.28E+018,"testalpha"
"w","risk factor surveillance system","NN NN NN NN",4,1,1,16596900,"pubmed1",5.81E+018,"testalpha"
"w","indicators and iron deficiency","NNS CC NN NN",4,1,1,16809889,2,2.85E+018,"testalpha"
"w","cell adhesion related proteins","NN NN VBN NNS",4,1,1,16951744,"pubmed1",6.48E+018,"testalpha"
"w","dermatitis and normal healthyvolunteers","NN CC JJ NNS",4,1,1,16955181,2,3.81E+018,"testalpha"
"w","thefollowing categories lymphocytic group","VBG NNS JJ NN",4,1,1,17311739,2,4.02E+018,"testalpha"
"w","feces and use oflaxatives","NNS CC NN NNS",4,1,1,16424650,2,1.75E+018,"testalpha"
"w","bladder outlet obstruction pboo","NN NN NN ",4,1,1,16253314,2,6.09E+017,"testalpha"
"w","ray source of choice"," NN IN NN",4,1,1,16369095,2,2.45E+018,"testalpha"
"w","cell lines g csf","NN NNS  ",4,1,1,16809884,2,8.72E+018,"testalpha"
"w","folded prokaryotic proteins yield","VBD JJ NNS NN",4,1,1,16369101,2,6.02E+018,"testalpha"
"w","fas expressing germ cells"," VBG NN NNS",4,1,1,16330085,2,4.84E+018,"testalpha"
"w","laboratory tests revealed pancytopenia","NN NNS VBD NNP",4,1,1,16914905,2,5.01E+018,"testalpha"
"w","intothe inferior vena cava","NNP JJ  ",4,1,1,16447097,"pubmed1",5.19E+018,"testalpha"
"w","tests and skin tests","NNS CC NN NNS",4,1,1,17106599,2,3.23E+018,"testalpha"
"w","time allelic discrimination assay","NN JJ NN NN",4,1,1,16929381,"pubmed1",5.26E+018,"testalpha"
"w","conclusions implementation of resident","NNS NN IN NN",4,1,1,16377822,"pubmed1",4.90E+018,"testalpha"
"w","synthesis of virus likesystems","NN IN NN NNS",4,1,1,17285739,"pubmed1",3.43E+018,"testalpha"
"w","long term low concentrationexposures","JJ NN JJ NNS",4,1,1,16808045,"pubmed1",2.37E+018,"testalpha"
"w","study that followed consort","NN IN VBD NN",4,1,1,16436796,"pubmed1",1.72E+017,"testalpha"
"w","negative acute phase variablesare","JJ JJ NN NN",4,1,1,16714050,2,6.71E+018,"testalpha"
"w","conformational freedom of sidechains","JJ NN IN NNS",4,1,1,16369101,2,1.42E+018,"testalpha"
"w","significant increase in distensibility","JJ NN IN NN",4,1,1,16874414,2,4.26E+018,"testalpha"
"w","body for occupational health","NN IN JJ NN",4,1,1,16438092,"pubmed1",6.44E+017,"testalpha"
"w","momentum andconservation of energy","NN NN IN NN",4,1,1,16054101,"pubmed1",3.37E+018,"testalpha"
"w","children showedimprovements in iron","NNS NNS IN NN",4,1,1,16809890,2,2.53E+018,"testalpha"
"w","initial oral n acetylcysteine","JJ JJ  NN",4,1,1,17106603,2,2.82E+018,"testalpha"
"w","hemochromatosis and severe iron","NN CC JJ NN",4,1,1,16424658,2,5.07E+018,"testalpha"
"w","affected hemisphere after h","VBN NN IN ",4,1,1,17265689,2,7.20E+018,"testalpha"
"w","fruits among different nuts","NNS IN JJ ",4,1,1,16673562,2,1.25E+018,"testalpha"
"w","bisphosphatase and pfkfb andpfkfb","NN CC  ",4,1,1,17143338,"pubmed1",7.40E+018,"testalpha"
"w","inflammatory effect of corticosteroids","JJ NN IN NNS",4,1,1,16612917,"pubmed1",4.20E+018,"testalpha"
"w","ultrastructural level numerous endocrine","JJ NN JJ NN",4,1,1,16569423,2,9.64E+017,"testalpha"
"w","x ray crystal structure","NN  NN NN",4,1,1,16421448,2,6.32E+018,"testalpha"
"w","emission and iv self","NN CC  NN",4,1,1,16411740,"pubmed1",6.01E+018,"testalpha"
"w","significant difference in meanadc","JJ NN IN ",4,1,1,16399034,"pubmed1",5.12E+018,"testalpha"
"w","least additional patients withfvii","JJS JJ NNS ",4,1,1,16424651,2,2.68E+017,"testalpha"
"w","urethra intact elastic fibers"," JJ JJ NNS",4,1,1,16962646,2,5.45E+018,"testalpha"
"w","presence of hpv dna","NN IN  ",4,1,1,17019439,"pubmed1",3.31E+018,"testalpha"
"w","crystal structure of i","NN NN IN ",4,1,1,16456293,2,1.08E+018,"testalpha"
"w","bacterial vaginosis and candidiasis","JJ NN CC NN",4,1,1,16603098,2,5.85E+018,"testalpha"
"w","cells towards h o","NNS IN  ",4,1,1,17046053,2,8.04E+017,"testalpha"
"w","pressure management brain protection","NN NN NN NN",4,1,1,17067134,"pubmed1",1.22E+018,"testalpha"
"w","determine post operativecognitive dysfunction","VB NN JJ NN",4,1,1,16451151,"pubmed1",6.07E+018,"testalpha"
"w","vomiting epigastric pain eructation","VBG JJ NN NN",4,1,1,16424650,2,4.14E+018,"testalpha"
"w","distributions ofthe multiple cam","NNS NNP JJ ",4,1,1,16949651,2,7.97E+018,"testalpha"
"w","application bath puva cream","NN NN  NN",4,1,1,16585984,2,9.36E+017,"testalpha"
"w","therapyfor psoriasis in children","JJ NN IN NNS",4,1,1,17311742,2,5.75E+018,"testalpha"
"w","cancer patients treated withintensity","NN NNS VBN NN",4,1,1,17117605,2,5.65E+018,"testalpha"
"w","expressed egfp but transfectionefficiency","VBN  CC NN",4,1,1,16404477,"pubmed1",7.84E+018,"testalpha"
"w","groupc with unit cell"," IN NN NN",4,1,1,16511271,2,1.93E+018,"testalpha"
"w","stimulate achange in patient","NN NN IN NN",4,1,1,16710573,2,1.89E+018,"testalpha"
"w","subunits betaa or betab","NNS  CC ",4,1,1,16423381,2,5.10E+016,"testalpha"
"w","patient with neurosyphilistested venereal","NN IN VBN NN",4,1,1,16874420,2,2.35E+018,"testalpha"
"w","endocervical component epithelial cell","JJ NN JJ NN",4,1,1,16514841,2,8.57E+018,"testalpha"
"w","head injury ratesare p","NN NN NN ",4,1,1,16223468,"pubmed1",4.15E+018,"testalpha"
"w","withambisome and surgical debridement","NN CC JJ NN",4,1,1,16918059,"pubmed1",6.92E+018,"testalpha"
"w","professional logistical power differentials","JJ JJ NN NNS",4,1,1,16209925,"pubmed1",7.43E+018,"testalpha"
"w","division differentiation growth arrest","NN NN NN NN",4,1,1,16569423,2,5.88E+018,"testalpha"
"w","class i major histocompatibility","NN  JJ NN",4,1,1,16511266,2,6.44E+018,"testalpha"
"w","ontreatments of chronic ulcers","NNS IN JJ NNS",4,1,1,17293973,2,7.59E+018,"testalpha"
"w","percentage of themonomeric form","NN IN JJ NN",4,1,1,16528413,"pubmed1",1.41E+018,"testalpha"
"w","soluble fas ligand secretion","JJ  NN NN",4,1,1,16710577,2,1.83E+018,"testalpha"
"w","structure shows strong connections","NN VBZ JJ NNS",4,1,1,16823609,"pubmed1",3.07E+016,"testalpha"
"w","carrier havingcontrolled drug release","NN VBN NN NN",4,1,1,17285742,"pubmed1",3.49E+018,"testalpha"
"w","l t g f","   NN",4,1,1,16333710,"pubmed1",2.22E+018,"testalpha"
"w","extensive total body surface","JJ NN NN NN",4,1,1,17165599,2,3.57E+018,"testalpha"
"w","target plasma anti xa","NN NNP IN ",4,1,1,16549902,2,4.74E+018,"testalpha"
"w","vascular relationship andportal hypertension","JJ NN NN NN",4,1,1,17013515,2,3.06E+018,"testalpha"
"w","vegf expression index vegf"," NN NN ",4,1,1,16317488,"pubmed1",4.18E+018,"testalpha"
"w","n or remifentanil n"," CC  ",4,1,1,16451148,"pubmed1",3.28E+018,"testalpha"
"w","efficacious diagnosis and management","JJ NN CC NN",4,1,1,16859618,2,3.33E+018,"testalpha"
"w","positivity onfollicular epithelial cells","NN JJ JJ NNS",4,1,1,16720036,2,2.67E+018,"testalpha"
"w","available treatments including drugs","JJ NNS VBG NNS",4,1,1,16479031,2,7.08E+018,"testalpha"
"w","kda protein in dermalextract"," NN IN NN",4,1,1,16955192,2,2.54E+018,"testalpha"
"w","inpatients with ongoing atopic","NNS IN JJ NN",4,1,1,16648916,2,2.15E+018,"testalpha"
"w","previous experience with novelty","JJ NN IN NN",4,1,1,17133955,2,6.27E+018,"testalpha"
"w","monitor different membrane properties","NN JJ NN NNS",4,1,1,16964324,"pubmed1",1.01E+018,"testalpha"
"w","old man with non","JJ NN IN ",4,1,1,16603100,2,3.32E+018,"testalpha"
"w","suitable carriers in agriculture","JJ NNS IN NN",4,1,1,16584150,"pubmed1",2.78E+018,"testalpha"
"w","simultaneous integrated boost sib","JJ VBN NN ",4,1,1,17117605,2,1.06E+018,"testalpha"
"w","metabolic variables were ph","JJ NNS VBD ",4,1,1,16491220,2,7.27E+018,"testalpha"
"w","twisting ankle or foot","VBG NN CC NN",4,1,1,16436790,"pubmed1",2.69E+018,"testalpha"
"w","cerebralartery mca thread occlusion","NN  NN NN",4,1,1,17265689,2,4.30E+018,"testalpha"
"w","safe alternative systemic form","JJ NN JJ NN",4,1,1,16955187,2,3.52E+018,"testalpha"
"w","examination revealed urolithiasis n","NN VBD NN ",4,1,1,16956119,2,4.05E+018,"testalpha"
"w","tosupport hematopoiesis in culture","NN NN IN NN",4,1,1,17016038,2,2.42E+018,"testalpha"
"w","syndrome was diagnosed sonography","NN VBD VBN NN",4,1,1,16603099,2,2.61E+017,"testalpha"
"w","thevalues of dna damage","NNS IN  NN",4,1,1,16582984,"pubmed1",7.23E+017,"testalpha"
"w","blood loss and dextran","NN NN CC NN",4,1,1,16762404,2,3.30E+018,"testalpha"
"w","deep burns in humans","JJ NNS IN NNS",4,1,1,16999270,2,1.67E+018,"testalpha"
"w","framework of soft tissuemechanics","NN IN JJ NNS",4,1,1,16399039,"pubmed1",6.20E+018,"testalpha"
"w","inhibitorof soluble guanylate cyclase"," JJ NN NN",4,1,1,17068635,"pubmed1",3.90E+018,"testalpha"
"w","compound c h fno","NN NN  ",4,1,1,16456296,2,2.48E+018,"testalpha"
"w","groupand males and females","NN NNS CC NNS",4,1,1,16424647,2,3.03E+018,"testalpha"
"w","hospital morbidity data system","NN NN NNS NN",4,1,1,16221468,"pubmed1",7.29E+018,"testalpha"
"w","channel blockers affectedmyocardial apoptosis","NN NNS JJ NN",4,1,1,16566960,2,2.58E+017,"testalpha"
"w","vlsat dktnv laawg kvggn","   ",4,1,1,16770447,"pubmed1",3.46E+018,"testalpha"
"w","chronicallergic diseases in children","JJ NNS IN NNS",4,1,1,17438830,2,3.90E+018,"testalpha"
"w","unfolded peptide backbone insolution","VBN VB NN NN",4,1,1,16388314,"pubmed1",9.20E+018,"testalpha"
"w","hydrophobic mounting medium canada","JJ VBG NN NNP",4,1,1,16714051,2,4.56E+018,"testalpha"
"w","progress in understanding suchreactions","NN IN NN NNS",4,1,1,16594644,"pubmed1",1.82E+018,"testalpha"
"w","inhibitor treatment during weeks","NN NN IN NNS",4,1,1,16253314,2,5.56E+018,"testalpha"
"w","igg anti basement membrane"," IN NN NN",4,1,1,16955192,2,6.42E+018,"testalpha"
"w","metastases further gains insurvival","NNS JJ NNS NN",4,1,1,17139885,2,6.42E+018,"testalpha"
"w","fold increase in modulus","NN NN IN NN",4,1,1,16701863,"pubmed1",5.22E+018,"testalpha"
"w","attention concentration memory changes","NN NN NN NNS",4,1,1,16479025,2,1.11E+018,"testalpha"
"w","drug following intranasal administration","NN VBG NN NN",4,1,1,16584167,"pubmed1",7.09E+018,"testalpha"
"w","thestructural requirements for catalysis","JJ NNS IN NN",4,1,1,16421444,2,6.29E+018,"testalpha"
"w","showed arestoration of microcirculation","VBD NN IN NN",4,1,1,17438835,2,7.61E+017,"testalpha"
"w","uptake of plasmid dna","NN IN JJ ",4,1,1,16701879,"pubmed1",1.48E+018,"testalpha"
"w","iu t i d","   ",4,1,1,16859614,2,5.56E+018,"testalpha"
"w","nosignificant difference in serum","JJ NN IN NN",4,1,1,17010262,2,3.75E+018,"testalpha"
"w","t cell leukemia virus"," NN NN NN",4,1,1,16421452,2,1.37E+017,"testalpha"
"w","programs in general surgery","NNS IN JJ NN",4,1,1,16377820,"pubmed1",9.58E+017,"testalpha"
"w","biologicalsamples including exonuclease enzyme","NNS VBG NN ",4,1,1,17285740,"pubmed1",5.33E+018,"testalpha"
"w","themonomer and associate bands","NN CC JJ NNS",4,1,1,16528413,"pubmed1",4.16E+018,"testalpha"
"w","cdcbehavioral risk factor surveillance","JJ NN NN NN",4,1,1,16596900,"pubmed1",2.77E+018,"testalpha"
"w","area of high attenuation","NN IN JJ NN",4,1,1,16333701,"pubmed1",6.92E+017,"testalpha"
"w","disorders treated showmarked variations","NNS VBN VBD NNS",4,1,1,17318328,"pubmed1",8.40E+018,"testalpha"
"w","properties ofvarious cell types","NNS JJ NN NNS",4,1,1,16414103,2,3.39E+018,"testalpha"
"w","index developing standards guidelines","NN VBG NNS NNS",4,1,1,16438093,"pubmed1",6.38E+018,"testalpha"
"w","cases ofmucous extravasation phenomenon","NNS JJ NN NN",4,1,1,16899283,2,3.42E+018,"testalpha"
"w","secretionby activated mouse t"," VBN NN ",4,1,1,17117211,"pubmed1",4.86E+018,"testalpha"
"w","themediterranean sea and food","JJ NN CC NN",4,1,1,16696439,2,8.86E+017,"testalpha"
"w","mood disturbances during internship","NN NNS IN NN",4,1,1,16377826,"pubmed1",2.73E+018,"testalpha"
"w","old g body weight","JJ  NN NN",4,1,1,17133954,2,7.11E+018,"testalpha"
"w","bone pain and fractures","NN NN CC NNS",4,1,1,16714048,2,6.77E+018,"testalpha"
"w","dna binding peptides proteins"," VBG NNS NNS",4,1,1,16411739,"pubmed1",7.99E+018,"testalpha"
"w","crystal structures bymolecular replacement","NN NNS JJ NN",4,1,1,16511279,2,7.55E+018,"testalpha"
"w","endocrine cells for cytoprotection","NN NNS IN NN",4,1,1,16569423,2,4.38E+018,"testalpha"
"w","pathogenesis of hypertension type","NN IN NN NN",4,1,1,16479031,2,1.53E+018,"testalpha"
"w","hadthrombotic progression and recurrence","JJ NN CC NN",4,1,1,16549893,2,1.47E+018,"testalpha"
"w","entropy deltaso of binding","  IN NN",4,1,1,17019442,"pubmed1",5.37E+018,"testalpha"
"w","free split skin grafts","JJ NN NN NNS",4,1,1,16612932,"pubmed1",7.85E+018,"testalpha"
"w","onychomycosis and age p","NN CC NN ",4,1,1,16955188,2,1.32E+018,"testalpha"
"w","inflammation in arthritic animals","NN IN JJ NNS",4,1,1,16399028,"pubmed1",2.17E+018,"testalpha"
"w","hypothesis that transforming growthfactor","NN IN VBG NN",4,1,1,16395524,"pubmed1",1.49E+018,"testalpha"
"w","kj mol and activationentropy","  CC ",4,1,1,17117212,"pubmed1",8.48E+018,"testalpha"
"w","triage of mechanical ventilation","NN IN JJ NN",4,1,1,16400088,"pubmed1",5.86E+018,"testalpha"
"w","competitive inhibition of angiotensin","JJ NN IN NNP",4,1,1,16479034,2,3.04E+018,"testalpha"
"w","skin graftsand skin extension","NN NN NN NN",4,1,1,17165596,2,7.31E+018,"testalpha"
"w","blood pressure pulse rate","NN NN NN NN",4,1,1,16612915,"pubmed1",7.44E+018,"testalpha"
"w","lines mkn and nugc","NNS  CC ",4,1,1,17143338,"pubmed1",2.01E+017,"testalpha"
"w","serum iron si concentration","NN NN  NN",4,1,1,16809889,2,3.07E+018,"testalpha"
"w","advantages disadvantages and consensus","NNS NNS CC NN",4,1,1,16918067,"pubmed1",9.90E+017,"testalpha"
"w","chemotherapy and systemicchemotherapy prolongs","NN CC NN NNS",4,1,1,17139879,2,7.08E+018,"testalpha"
"w","true malignant histiocytosis associatedwith","JJ JJ NN NN",4,1,1,16809892,2,6.31E+018,"testalpha"
"w","umbilical cord blood bone","JJ NN NN NN",4,1,1,17269167,2,7.00E+018,"testalpha"
"w","redundant cells atthe end","JJ NNS NNP NN",4,1,1,16919708,2,5.13E+018,"testalpha"
"w","epithelial cells growth hormone","JJ NNS NN NN",4,1,1,16564564,2,5.44E+018,"testalpha"
"w","ofchange including nicotine dependence","NN IN NN NN",4,1,1,16365327,"pubmed1",6.79E+018,"testalpha"
"w","types in serial sections","NNS IN JJ NNS",4,1,1,16919313,2,2.23E+018,"testalpha"
"w","arterialpressure and heart rate","NN CC NN NN",4,1,1,16762404,2,8.21E+018,"testalpha"
"w","betterbut maculopapular erythematous rash","NN JJ JJ NN",4,1,1,16603101,2,5.23E+018,"testalpha"
"w","long termhematological response morbidity","JJ JJ NN NN",4,1,1,16424648,2,2.66E+018,"testalpha"
"w","storage particle size analysis","NN NN NN NN",4,1,1,17285747,"pubmed1",8.21E+018,"testalpha"
"w","inhibitor of hif alphahydroxylase","NN IN  NN",4,1,1,17143338,"pubmed1",5.02E+018,"testalpha"
"w","sitearchitecture and solvent network","NN CC NN NN",4,1,1,16511248,2,8.08E+018,"testalpha"
"w","sensitivity of food sige","NN IN NN ",4,1,1,16673562,2,2.86E+018,"testalpha"
"w","spectrophotometer model e celm","NN NN  ",4,1,1,17013510,2,3.06E+018,"testalpha"
"w","thedistal common bile duct","NN JJ NN ",4,1,1,16333694,"pubmed1",6.26E+018,"testalpha"
"w","czech gypsy and non","NN NN CC ",4,1,1,17165598,2,8.55E+018,"testalpha"
"w","chain lengths c c","NN NNS NN NN",4,1,1,16594645,"pubmed1",3.39E+018,"testalpha"
"w","secundum atrial septal defect","NN JJ NN NN",4,1,1,16612922,"pubmed1",7.33E+018,"testalpha"
"w","toluidineblue reaction sialic acid","NN NN JJ NN",4,1,1,16542712,2,2.54E+017,"testalpha"
"w","cd t cell expansion","  NN NN",4,1,1,16511253,2,5.36E+018,"testalpha"
"w","units alsu doctor andfiremen","NNS  NN NNS",4,1,1,16491215,2,3.40E+018,"testalpha"
"w","faculty more frequent skill","NN JJR JJ NN",4,1,1,16377820,"pubmed1",6.25E+018,"testalpha"
"w","temperature difference deltat degrees","NN NN NN NNS",4,1,1,17285744,"pubmed1",6.51E+018,"testalpha"
"w","combine police reported crash","VB NN VBD NN",4,1,1,16430844,"pubmed1",6.41E+018,"testalpha"
"w","patients with ischemic stroke","NNS IN JJ NN",4,1,1,16549894,2,8.63E+018,"testalpha"
"w","low viscosity guluronic acid","JJ NN JJ NN",4,1,1,16701881,"pubmed1",2.86E+018,"testalpha"
"w","byundue concern of non","JJ NN IN ",4,1,1,16424650,2,3.03E+018,"testalpha"
"w","tyr asn asn thr","   ",4,1,1,16511248,2,4.94E+016,"testalpha"
"w","morbidityafter extended laryngeal surgery","NN VBD NN NN",4,1,1,16989147,2,2.13E+018,"testalpha"
"w","lateral displacement in response","JJ NN IN NN",4,1,1,16426558,"pubmed1",5.69E+018,"testalpha"
"w","thesubsequent high rhepo phase","NN JJ  NN",4,1,1,17119327,2,4.36E+018,"testalpha"
"w","genomes of related organisms","NNS IN VBN NNS",4,1,1,16770443,"pubmed1",1.38E+018,"testalpha"
"w","radiation damage in cryocooledcrystals","NN NN IN NNS",4,1,1,16369092,2,2.69E+018,"testalpha"
"w","normal thyroid function patients","JJ NN NN NNS",4,1,1,16479025,2,4.28E+018,"testalpha"
"w","atp production in hela"," NN IN ",4,1,1,16951738,"pubmed1",1.52E+017,"testalpha"
"w","dimensions of x x","NNS IN NN NN",4,1,1,16511277,2,2.17E+018,"testalpha"
"w","hp and laser application"," CC NN NN",4,1,1,17013509,2,3.04E+017,"testalpha"
"w","acute myeloidleukemia aml patients","JJ NN  NNS",4,1,1,17119322,2,7.56E+018,"testalpha"
"w","antigen specific ige asige","NN JJ  NN",4,1,1,16603096,2,6.62E+018,"testalpha"
"w","h middle cerebralartery mca"," NN NN ",4,1,1,17265689,2,3.02E+018,"testalpha"
"w","early goal directed therapy","JJ NN VBN NN",4,1,1,16365336,"pubmed1",2.43E+018,"testalpha"
"w","dangerous situations because ofothers","JJ NNS IN NNS",4,1,1,16157285,"pubmed1",7.45E+018,"testalpha"
"w","stages of acute blood","NNS IN JJ NN",4,1,1,16762404,2,1.09E+018,"testalpha"
"w","transcription pcr rt pcr","NN   ",4,1,1,17019440,"pubmed1",5.05E+018,"testalpha"
"w","year old female patientwith","NN JJ NN NN",4,1,1,16612934,"pubmed1",4.86E+018,"testalpha"
"w","primers according topatients groups","NNS IN NNS NNS",4,1,1,16696442,2,1.16E+018,"testalpha"
"w","storage theyshowed convenient physico","NN VBN JJ NNP",4,1,1,16970980,2,8.94E+018,"testalpha"
"w","females thrice flail thrombus","NNS NN NN NNP",4,1,1,16696443,2,6.50E+018,"testalpha"
"w","egfp packaging cell line"," NN NN NN",4,1,1,17160143,"pubmed1",8.51E+018,"testalpha"
"w","n h n hydrogen","   NN",4,1,1,16456283,2,3.28E+018,"testalpha"
"w","cold water memory testing","JJ NN NN NN",4,1,1,17236636,"pubmed1",2.56E+018,"testalpha"
"w","prototypecolonization factor antigen i","NN NN NN ",4,1,1,16511280,2,4.21E+017,"testalpha"
"w","human cell types ccl","JJ NN NNS ",4,1,1,16414103,2,3.62E+018,"testalpha"
"w","fimbrial assembly and mediates","JJ NN CC NNS",4,1,1,16511280,2,4.97E+018,"testalpha"
"w","sulfate co h o","NN   ",4,1,1,16397335,2,2.21E+018,"testalpha"
"w","calcium and ct concentrations","NN CC  NNS",4,1,1,16762403,2,6.25E+018,"testalpha"
"w","moderate exercise and achievement","JJ NN CC NN",4,1,1,16549898,2,1.38E+018,"testalpha"
"w","dependence self efficacy presence","NN NN NN NN",4,1,1,16365327,"pubmed1",5.31E+018,"testalpha"
"w","risk of severe injuries","NN IN JJ NNS",4,1,1,16197912,"pubmed1",1.34E+018,"testalpha"
"w","nag in children boys"," IN NNS NNS",4,1,1,16956119,2,2.42E+018,"testalpha"
"w","decrease in plasma gsh","NN IN NNP ",4,1,1,17160142,"pubmed1",6.74E+018,"testalpha"
"w","causes of abdominal infections","NNS IN JJ NNS",4,1,1,16612906,2,5.78E+018,"testalpha"
"w","areas withprior allergic contact","NNS JJ JJ NN",4,1,1,16585981,2,1.72E+018,"testalpha"
"w","subsequent resection ofthe parotid","JJ NN NNP ",4,1,1,16514848,2,6.22E+018,"testalpha"
"w","doubling of baseline pc","NN IN NN ",4,1,1,16424649,2,4.06E+017,"testalpha"
"w","theright internal iliac artery","NN JJ JJ NN",4,1,1,16612928,"pubmed1",2.84E+018,"testalpha"
"w","isolated fromthe random library","VBN NNP JJ NN",4,1,1,16369090,2,6.83E+018,"testalpha"
"w","formationof new blood vessels"," JJ NN NNS",4,1,1,16733559,"pubmed1",4.81E+018,"testalpha"
"w","lesionformation lipid filled macrophages","NN NN VBN NNS",4,1,1,17007910,2,5.47E+018,"testalpha"
"w","cancermetastasis for general readers","NN IN JJ NNS",4,1,1,16730054,2,6.77E+018,"testalpha"
"w","deficiency anemia ida inchildren","NN NN  NNS",4,1,1,16809889,2,8.57E+018,"testalpha"
"w","values of thekinetic parameters","NNS IN JJ NNS",4,1,1,16770446,"pubmed1",6.15E+018,"testalpha"
"w","studies with other patients","NNS IN JJ NNS",4,1,1,16451147,"pubmed1",8.97E+018,"testalpha"
"w","quantitative errors in transcription","JJ NNS IN NN",4,1,1,17294912,2,3.20E+018,"testalpha"
"w","number of muscle fibers","NN IN NN NNS",4,1,1,16893562,2,9.00E+018,"testalpha"
"w","pure form by crystallization","JJ NN IN NN",4,1,1,16456281,2,8.16E+017,"testalpha"
"w","serum and urine eosinophil","NN CC NN ",4,1,1,16859611,2,8.77E+018,"testalpha"
"w","transformation of stromal cells","NN IN JJ NNS",4,1,1,16443258,2,7.92E+018,"testalpha"
"w","whole mind and body","JJ NN CC NN",4,1,1,17139889,2,2.01E+018,"testalpha"
"w","laser application hpl hpl","NN NN  ",4,1,1,17013509,2,5.51E+018,"testalpha"
"w","injuries in san diego","NNS IN  NNP",4,1,1,16223468,"pubmed1",7.52E+018,"testalpha"
"w","soluble b immunoglobuling fusion","JJ NN VBG NN",4,1,1,17117211,"pubmed1",4.00E+018,"testalpha"
"w","iodinated contrast and water","VBN NN CC NN",4,1,1,16252139,"pubmed1",7.37E+018,"testalpha"
"w","imaging option for screening","VBG NN IN NN",4,1,1,16317492,"pubmed1",7.62E+018,"testalpha"
"w","intranasal andintravenous iv administrations","NN JJ  NNS",4,1,1,16584167,"pubmed1",7.48E+017,"testalpha"
"w","adequate surgery or drainage","JJ NN CC NN",4,1,1,16612906,2,5.92E+018,"testalpha"
"w","worldwide public health problem","VB JJ NN NN",4,1,1,16479031,2,6.27E+018,"testalpha"
"w","time teen driver fatalities","NN  NN NNS",4,1,1,16171767,"pubmed1",6.29E+017,"testalpha"
"w","orthorhombicp with unit cell"," IN NN NN",4,1,1,16511260,2,2.29E+018,"testalpha"
"w","trimedoxime hi and bi","JJ  CC ",4,1,1,17438836,2,9.39E+017,"testalpha"
"w","musculoskeletalinjuries and workplace ergonomics","NNS CC NN NNS",4,1,1,16438094,"pubmed1",7.83E+018,"testalpha"
"w","estimated number of fatalities","VBN NN IN NNS",4,1,1,16221468,"pubmed1",5.19E+018,"testalpha"
"w","days in manugel capsules","NNS IN NNP NNS",4,1,1,16701881,"pubmed1",2.49E+018,"testalpha"
"w","dividedinto groups of n","NNP NNS IN ",4,1,1,16612919,"pubmed1",7.27E+018,"testalpha"
"w","human prostatic acid phosphatase","JJ JJ NN NN",4,1,1,16511256,2,4.75E+018,"testalpha"
"w","life quality by improvement","NN NN IN NN",4,1,1,16956120,2,6.71E+018,"testalpha"
"w","detecting cin or worsewas","VBG  CC ",4,1,1,16514835,2,2.06E+018,"testalpha"
"w","rattus norvegicus rn genomes","NN NN  NNS",4,1,1,16733558,"pubmed1",3.02E+018,"testalpha"
"w","triglycerides increased high density","NNS VBN JJ NN",4,1,1,16918068,"pubmed1",5.43E+018,"testalpha"
"w","holders with driver education","NNS IN NN NN",4,1,1,16112070,"pubmed1",2.82E+018,"testalpha"
"w","onactivated antigen presenting cells","VBN NN VBG NNS",4,1,1,16511253,2,6.58E+018,"testalpha"
"w","ii derivatizedcalixarenes for f"," NNS IN NN",4,1,1,16411740,"pubmed1",1.62E+018,"testalpha"
"w","main enzyme in purinedegradation","JJ  IN NN",4,1,1,16956117,2,1.78E+018,"testalpha"
"w","parameters drug targetingefficiency dte","NNS NN NN ",4,1,1,16584167,"pubmed1",8.08E+018,"testalpha"
"w","small bowel wall thickness","JJ NN NN NN",4,1,1,16447095,"pubmed1",1.40E+018,"testalpha"
"w","anddevelopment of practical standards","NN IN JJ NNS",4,1,1,17265690,2,3.68E+018,"testalpha"
"w","mean arterial pressure map","VB JJ NN NN",4,1,1,16491220,2,8.80E+018,"testalpha"
"w","physicochemical properties of aminoacids","JJ NNS IN NNS",4,1,1,16823609,"pubmed1",8.01E+017,"testalpha"
"w","clinical andsurgical re evaluation","JJ JJ  NN",4,1,1,17370569,"pubmed1",4.12E+018,"testalpha"
"w","timethan full time staff","NNP JJ NN NN",4,1,1,16438093,"pubmed1",6.56E+018,"testalpha"
"w","andmoderate hepatic impairment child","NN JJ NN NN",4,1,1,16584121,"pubmed1",5.19E+018,"testalpha"
"w","work related injuries wri","NN VBN NNS ",4,1,1,16438093,"pubmed1",4.15E+018,"testalpha"
"w","observations oral contraceptive therapy","NNS JJ JJ NN",4,1,1,16424651,2,6.40E+018,"testalpha"
"w","nodes liver spleen lung","NNS NN IN NN",4,1,1,17293960,2,4.32E+018,"testalpha"
"w","agram positive bacillus erysipelothrix","NN JJ NN NNP",4,1,1,16859614,2,8.28E+018,"testalpha"
"w","cancer undergoing total mesorectal","NN VBG JJ NN",4,1,1,17139896,2,8.91E+018,"testalpha"
"w","sectionsof thyroid and lungs"," NN CC NNS",4,1,1,16762403,2,2.51E+018,"testalpha"
"w","model numerous amino acid","VB JJ NNP NN",4,1,1,16421453,2,2.73E+018,"testalpha"
"w","result inhypercortisolemia and hypocortisolemia","VB NN CC NN",4,1,1,16462408,"pubmed1",4.92E+018,"testalpha"
"w","permanent strain and hysteresis","JJ NN CC NN",4,1,1,16701859,"pubmed1",2.30E+018,"testalpha"
"w","increase indiastolic blood pressure","NN JJ NN NN",4,1,1,16874421,2,5.87E+017,"testalpha"
"w","formal evaluation between june","JJ NN IN ",4,1,1,16696444,2,7.89E+018,"testalpha"
"w","medium preparation cytyc corp","NN NN  ",4,1,1,16514835,2,2.17E+018,"testalpha"
"w","ncs dimer in space"," NN IN NN",4,1,1,16511271,2,8.42E+017,"testalpha"
"w","c o h c","NN   NN",4,1,1,16456276,2,7.82E+018,"testalpha"
"w","lactate release profiles werefound","NN NN NNS NN",4,1,1,17285750,"pubmed1",8.19E+018,"testalpha"
"w","use and alcohol use","NN CC NN NN",4,1,1,16436792,"pubmed1",5.55E+017,"testalpha"
"w","sizesof bp bp bp","   ",4,1,1,16951742,"pubmed1",1.97E+018,"testalpha"
"w","phospholipids glycoproteins and adenosine","NNS NNS CC NN",4,1,1,16523217,"pubmed1",6.23E+018,"testalpha"
"w","reduction of cell growth","NN IN NN NN",4,1,1,16951738,"pubmed1",2.57E+018,"testalpha"
"w","therisk factors for catheter","JJ NNS IN NN",4,1,1,16549897,2,9.22E+016,"testalpha"
"w","endocrine diseases histological evaluation","NN NNS JJ NN",4,1,1,16720036,2,3.42E+018,"testalpha"
"w","o h o hydrogen","   NN",4,1,1,16456283,2,2.03E+017,"testalpha"
"w","limiting factor for expression","VBG NN IN NN",4,1,1,16951738,"pubmed1",6.13E+018,"testalpha"
"w","examination and laboratory tests","NN CC NN NNS",4,1,1,16673615,2,6.33E+018,"testalpha"
"w","local reorganization of protein","JJ NN IN NN",4,1,1,16770442,"pubmed1",2.34E+018,"testalpha"
"w","controlled cross over study","VBN NN IN NN",4,1,1,16874418,2,2.67E+018,"testalpha"
"w","flow and saline drop","NN CC NN NN",4,1,1,16491219,2,2.11E+018,"testalpha"
"w","contractility and synthesis ofcollagen","NN CC NN NN",4,1,1,17013515,2,3.26E+017,"testalpha"
"w","measures including increased use","NNS IN VBN NN",4,1,1,16377816,"pubmed1",6.48E+018,"testalpha"
"w","segmentation of breast lesions","NN IN NN NNS",4,1,1,16399033,"pubmed1",3.82E+018,"testalpha"
"w","deltas j mol k","NNS   ",4,1,1,17117212,"pubmed1",7.72E+018,"testalpha"
"w","decreasing ponv in breast","VBG  IN NN",4,1,1,16451147,"pubmed1",1.00E+018,"testalpha"
"w","soft tissuemechanics and air","JJ NNS CC NN",4,1,1,16399039,"pubmed1",6.43E+018,"testalpha"
"w","componentsto train competent physicians","NNP NN JJ NNS",4,1,1,16377823,"pubmed1",8.87E+018,"testalpha"
"w","cytoplasm of primary spermatocytes","NN IN JJ NNS",4,1,1,16325891,2,3.74E+016,"testalpha"
"w","ultra low rectal resections","JJ JJ NN NNS",4,1,1,17139887,2,4.35E+018,"testalpha"
"w","bipolar affective disorder patients","JJ JJ NN NNS",4,1,1,16733555,"pubmed1",4.02E+017,"testalpha"
"w","dermatitis research group icdrg","NN NN NN ",4,1,1,17010264,2,4.27E+018,"testalpha"
"w","c atom and c","NN NN CC NN",4,1,1,16456293,2,8.81E+018,"testalpha"
"w","memantine oramantadine and mpep","NN NN CC ",4,1,1,17265692,2,1.98E+018,"testalpha"
"w","dihydrate c h brn","NN NN  ",4,1,1,16456284,2,6.11E+018,"testalpha"
"w","acquiredinfections and increased mortality","NNS CC VBN NN",4,1,1,16462412,"pubmed1",6.74E+018,"testalpha"
"w","renalfunction and calcium levels","NN CC NN NNS",4,1,1,17016034,2,1.36E+018,"testalpha"
"w","evaluation including assessmentof depression","NN IN  NN",4,1,1,17013512,2,4.58E+018,"testalpha"
"w","strength and modulus ofelasticity","NN CC NN NN",4,1,1,16701863,"pubmed1",4.11E+018,"testalpha"
"w","colonicanastomosis was performed cm","NN VBD VBN ",4,1,1,16612917,"pubmed1",8.65E+018,"testalpha"
"w","were iga and igg","VBD  CC ",4,1,1,16874419,2,6.35E+018,"testalpha"
"w","capabilities ofpharmaceutical dry powders","NNS JJ JJ NNS",4,1,1,17285749,"pubmed1",5.50E+018,"testalpha"
"w","l lactoside c h"," VB NN ",4,1,1,16456293,2,5.08E+017,"testalpha"
"w","pseudopelade brocq n mucinosis","NN   NN",4,1,1,17311739,2,1.07E+018,"testalpha"
"w","tsv lv volume stroke","  NN NN",4,1,1,16989140,2,9.07E+018,"testalpha"
"w","generate day fatality adjustment","VB NN NN NN",4,1,1,16430844,"pubmed1",8.05E+018,"testalpha"
"w","iv self assembly processes"," NN NN NNS",4,1,1,16411740,"pubmed1",2.37E+017,"testalpha"
"w","compare tissue preservation efficiency","VB NN NN NN",4,1,1,16950501,2,1.84E+018,"testalpha"
"w","behavioural factors mightexplain differences","JJ NNS VB NNS",4,1,1,16874417,2,8.51E+018,"testalpha"
"w","consideringage inflammation iron adequacy","NN NN NN NN",4,1,1,17119323,2,4.63E+018,"testalpha"
"w","diseased leg in comparison","VBN NN IN NN",4,1,1,16919313,2,1.19E+018,"testalpha"
"w","thisclinical risk assessment score","JJ NN NN NN",4,1,1,17236637,"pubmed1",6.34E+018,"testalpha"
"w","developed costs per victim","VBD NNS IN NN",4,1,1,16426556,"pubmed1",1.53E+018,"testalpha"
"w","mds fab subtype raeb","  JJ ",4,1,1,16914909,2,8.97E+018,"testalpha"
"w","police reporting time standards","NN NN NN NNS",4,1,1,16430844,"pubmed1",5.27E+018,"testalpha"
"w","practical scale up rules","JJ NN IN NNS",4,1,1,17285748,"pubmed1",9.08E+018,"testalpha"
"w","woman with resistant asthma","NN IN JJ NN",4,1,1,16612936,"pubmed1",3.84E+018,"testalpha"
"w","ada and dppiv cd"," CC  ",4,1,1,16929383,"pubmed1",7.35E+018,"testalpha"
"w","english classification by race","JJ NN IN NN",4,1,1,16436792,"pubmed1",1.12E+018,"testalpha"
"w","groups pure ad n","NNS JJ NN ",4,1,1,16859613,2,8.44E+018,"testalpha"
"w","space group p bar","NN NN  NN",4,1,1,16434797,2,5.56E+018,"testalpha"
"w","inproteins of e coli","NNS IN  ",4,1,1,17019443,"pubmed1",9.21E+018,"testalpha"
"w","reduced ifcenterline rumble strips","VBN NN NN NNS",4,1,1,16423319,"pubmed1",2.45E+018,"testalpha"
"w","theactivity and changing dynamics","NN CC VBG NNS",4,1,1,16762403,2,8.31E+018,"testalpha"
"w","tests revealed pancytopenia andhyperferritinemia","NNS VBD NNP NN",4,1,1,16914905,2,2.91E+018,"testalpha"
"w","plasmid patf cre luc","JJ   ",4,1,1,16395528,"pubmed1",2.45E+018,"testalpha"
"w","purpose of thepresent study","NN IN NN NN",4,1,1,16648912,2,5.70E+018,"testalpha"
"w","n carbamylated beta amino"," VBN NN NNP",4,1,1,16511257,2,1.37E+018,"testalpha"
"w","mentored ci of difference","VBN  IN NN",4,1,1,16436795,"pubmed1",5.83E+018,"testalpha"
"w","association oflow power laser","NN VB NN NN",4,1,1,17293969,2,5.25E+018,"testalpha"
"w","focal lesions containinghyperechoic images","JJ NNS JJ NNS",4,1,1,16447096,"pubmed1",3.18E+018,"testalpha"
"w","casesof normal anal epithelium"," JJ  NN",4,1,1,17139883,2,5.15E+018,"testalpha"
"w","patient with unrecognized adrenocorticotropic","NN IN JJ NN",4,1,1,16603099,2,8.64E+018,"testalpha"
"w","cells and thatboth genes","NNS CC JJ NNS",4,1,1,17143338,"pubmed1",5.21E+018,"testalpha"
"w","manufacturing process of cell","NN NN IN NN",4,1,1,16696437,2,3.80E+018,"testalpha"
"w","door for noveltherapeutic procedures","NN IN JJ NNS",4,1,1,16395523,"pubmed1",7.72E+018,"testalpha"
"w","protein kinases and phosphatases","NN NNS CC NNS",4,1,1,16410836,"pubmed1",6.64E+018,"testalpha"
"w","group b hemodynamic data","NN NN JJ NN",4,1,1,16989140,2,5.01E+018,"testalpha"
"w","dutch travel survey data","NN NN NN NNS",4,1,1,16426560,"pubmed1",5.17E+018,"testalpha"
"w","d cys phe cys","   ",4,1,1,16496038,"pubmed1",3.77E+018,"testalpha"
"w","submitted immunohistochemical results representedmisdiagnoses","VBN JJ NNS NNS",4,1,1,16790262,2,2.75E+018,"testalpha"
"w","reliablydetected small vehicles berms","VBN JJ NNS NNS",4,1,1,16129405,"pubmed1",7.77E+018,"testalpha"
"w","containing bovine islet equivalents","VBG NN NN NNS",4,1,1,16701881,"pubmed1",8.32E+018,"testalpha"
"w","tovarious diseases e g","JJ NNS  ",4,1,1,16956116,2,9.09E+018,"testalpha"
"w","oncogenichuman papillomavirus hpv dna","NN NN  ",4,1,1,16514835,2,8.46E+018,"testalpha"
"w","general temporal fluorescence intensity","JJ JJ NN NN",4,1,1,16399028,"pubmed1",4.61E+018,"testalpha"
"w","french road crash data","JJ NN NN NNS",4,1,1,16126153,"pubmed1",3.18E+018,"testalpha"
"w","inmaanshan city of anhui","NNP NN IN ",4,1,1,16236234,"pubmed1",5.54E+018,"testalpha"
"w","complications after rfa risk","NNS IN  NN",4,1,1,16696443,2,8.27E+018,"testalpha"
"w","patientcare and medical education","NN CC JJ NN",4,1,1,16377823,"pubmed1",5.10E+018,"testalpha"
"w","cannabinoid receptors endocannabinoid ligands","VB NNS VB NNS",4,1,1,16808046,"pubmed1",6.80E+018,"testalpha"
"w","lung injury gas exchange","NN NN NN NN",4,1,1,16451155,"pubmed1",1.18E+017,"testalpha"
"w","receivedintramuscular injections of desferrioxamine","JJ NNS IN NN",4,1,1,16612918,"pubmed1",1.51E+018,"testalpha"
"w","first description of mscs","JJ NN IN ",4,1,1,16696440,2,3.14E+018,"testalpha"
"w","esmolol n or remifentanil","  CC ",4,1,1,16451148,"pubmed1",7.17E+017,"testalpha"
"w","n naja and d","  CC ",4,1,1,16436788,"pubmed1",7.69E+018,"testalpha"
"w","free skin margins reconstruction","JJ NN NNS NN",4,1,1,16612932,"pubmed1",5.18E+018,"testalpha"
"w","measures included complete historyand","NNS VBD JJ NN",4,1,1,16479028,2,3.33E+018,"testalpha"
"w","lipid soluble calcium channel","NN JJ NN NN",4,1,1,16436797,"pubmed1",4.84E+018,"testalpha"
"w","cm specialty examination blueprint"," NN NN NN",4,1,1,16438092,"pubmed1",6.95E+018,"testalpha"
"w","data after necessary corrections","NNS IN JJ NNS",4,1,1,16404478,"pubmed1",1.80E+018,"testalpha"
"w","surveyed internal medicine residents","VBN JJ NN NNS",4,1,1,16377825,"pubmed1",2.93E+018,"testalpha"
"w","tetraphenylborate mniimniii c h","NN  NN ",4,1,1,16456265,2,9.05E+018,"testalpha"
"w","meaningful effect on driver","JJ NN IN NN",4,1,1,16171767,"pubmed1",6.56E+018,"testalpha"
"w","hypo and hyperglycemic effects"," CC JJ NNS",4,1,1,16918069,"pubmed1",1.57E+018,"testalpha"
"w","siberian hamster phodopus sungorus","JJ NN NN NN",4,1,1,17133952,2,7.28E+018,"testalpha"
"w","ofserum antigen specific ige","NN NN JJ ",4,1,1,16603096,2,1.81E+018,"testalpha"
"w","female heavy vehicle drivers","NN JJ NN NNS",4,1,1,16221468,"pubmed1",5.93E+018,"testalpha"
"w","features with hereditaryangioedema hae","NNS IN NN ",4,1,1,16451161,"pubmed1",3.31E+018,"testalpha"
"w","hand held mobile phone","NN VBN JJ NN",4,1,1,16157285,"pubmed1",7.21E+018,"testalpha"
"w","inch vector hi coaters","NN NN  NNS",4,1,1,17285748,"pubmed1",2.60E+018,"testalpha"
"w","unchangedhalf life or elimination","NN NN CC NN",4,1,1,17067137,"pubmed1",1.73E+017,"testalpha"
"w","residues ofhuman histone h","NNS NN NN ",4,1,1,17117212,"pubmed1",6.15E+018,"testalpha"
"w","aggregation of min beta","NN IN  NN",4,1,1,16701853,"pubmed1",1.55E+018,"testalpha"
"w","trucks at asurface mine","NNS IN NN NN",4,1,1,16129405,"pubmed1",4.76E+017,"testalpha"
"w","individual researcher theresearch group","JJ NN NN NN",4,1,1,16377817,"pubmed1",7.18E+018,"testalpha"
"w","hps pathogenesis inkidney transplants"," NN NN NNS",4,1,1,16914905,2,3.25E+018,"testalpha"
"w","kappab in pathological processes"," IN JJ NNS",4,1,1,17068636,"pubmed1",7.09E+018,"testalpha"
"w","months recallfor major injuries","NNS JJ JJ NNS",4,1,1,16412373,"pubmed1",7.16E+017,"testalpha"
"w","ubiquinone oxidoreductase succinate dehydrogenaseand","NN NN NN NN",4,1,1,17068635,"pubmed1",5.49E+018,"testalpha"
"w","inhibitors of mitochondrial genome","NNS IN JJ NN",4,1,1,16951738,"pubmed1",6.53E+018,"testalpha"
"w","tgf beta induces transdifferentiation"," NN NNS NN",4,1,1,16395524,"pubmed1",5.43E+018,"testalpha"
"w","secondary scars skin contractures","JJ NNS NN NNS",4,1,1,17293973,2,1.33E+018,"testalpha"
"w","held electronic record datix","VBN JJ NN ",4,1,1,16321534,"pubmed1",6.75E+018,"testalpha"
"w","inobserved seat belt use","VBN NN NN NN",4,1,1,16236235,"pubmed1",3.80E+018,"testalpha"
"w","ligand for haemoglobin scavengerreceptor","NN IN NNP NN",4,1,1,16770444,"pubmed1",2.09E+018,"testalpha"
"w","dispersion in isopropyl alcohol","NN IN  NN",4,1,1,17285743,"pubmed1",2.90E+018,"testalpha"
"w","timespent accomplishing responsibilities dio","NN VBG NNS ",4,1,1,16377812,"pubmed1",5.38E+018,"testalpha"
"w","aeds aeroallergens and food"," NNS CC NN",4,1,1,17438830,2,8.25E+018,"testalpha"
"w","specimens were studied results","NNS VBD VBN NNS",4,1,1,16612917,"pubmed1",5.11E+018,"testalpha"
"w","n methyl d aspartate","   NN",4,1,1,16451144,"pubmed1",5.60E+018,"testalpha"
"w","ii tetraaquadiglycinatocobalt ii bis"," NN  ",4,1,1,16397335,2,2.00E+017,"testalpha"
"w","euglycemia normalization of blood","NN NN IN NN",4,1,1,16436794,"pubmed1",6.06E+018,"testalpha"
"w","negative experiences of awarenessare","JJ NNS IN NN",4,1,1,17236646,"pubmed1",5.13E+018,"testalpha"
"w","m tc labeled st","  VBD ",4,1,1,16584167,"pubmed1",2.43E+018,"testalpha"
"w","o c h o"," NN  ",4,1,1,16456265,2,4.82E+018,"testalpha"
"w","higher dose ofl amb","JJR NN  ",4,1,1,17370566,"pubmed1",2.39E+018,"testalpha"
"w","enhancement on computed tomography","NN IN VBN NN",4,1,1,16333694,"pubmed1",8.47E+018,"testalpha"
"w","butyrate propionate and acetate","NN NN CC NN",4,1,1,16491218,2,3.59E+018,"testalpha"
"w","sperm quality and influences","JJ NN CC NNS",4,1,1,16325891,2,8.08E+018,"testalpha"
"w","patf cre luc bearing","   NN",4,1,1,16395528,"pubmed1",1.63E+018,"testalpha"
"w","h o and n","  CC ",4,1,1,16397328,2,6.17E+018,"testalpha"
"w","pressure and centralvenous oxygen","NN CC JJ NN",4,1,1,16365336,"pubmed1",3.31E+018,"testalpha"
"w","ofthe input plasma power","NNP NN NNP NN",4,1,1,16701874,"pubmed1",5.90E+018,"testalpha"
"w","h and c nmr"," CC NN ",4,1,1,16496039,"pubmed1",3.46E+018,"testalpha"
"w","improve growth and development","VB NN CC NN",4,1,1,16918068,"pubmed1",2.88E+018,"testalpha"
"w","component epithelial cell abnormalities","NN JJ NN NNS",4,1,1,16514841,2,7.86E+018,"testalpha"
"w","stg using diffusion tensor"," VBG NN NN",4,1,1,16399034,"pubmed1",2.65E+018,"testalpha"
"w","leukaemia and long periods","NN CC JJ NNS",4,1,1,17370567,"pubmed1",4.04E+018,"testalpha"
"w","detectable onac fixed samples","JJ  VBN NNS",4,1,1,16950501,2,7.13E+018,"testalpha"
"w","hivdisease hiv treatment modalities","NN  NN NNS",4,1,1,16462405,"pubmed1",6.17E+018,"testalpha"
"w","higher levels inyounger faculty","JJR NNS NN NN",4,1,1,16377815,"pubmed1",7.64E+018,"testalpha"
"w","standard methylated phenylalanine residues","JJ VBN NN NNS",4,1,1,16523218,"pubmed1",4.28E+018,"testalpha"
"w","radiofrequency for various ano","NN IN JJ ",4,1,1,17139880,2,2.76E+018,"testalpha"
"w","gradesquamous intraepithelial lesion hsil","JJ JJ NN ",4,1,1,16514835,2,3.12E+018,"testalpha"
"w","atypia nuclear grade apocrine","NNP JJ NN NN",4,1,1,16514838,2,7.44E+018,"testalpha"
"w","represents thetreatment of choice","VBZ NN IN NN",4,1,1,16859612,2,2.83E+018,"testalpha"
"w","manuscript theposterior injection technique","NN JJ NN NN",4,1,1,16916183,"pubmed1",6.60E+018,"testalpha"
"w","thromboses in pediatric cases","NNS IN JJ NNS",4,1,1,16549901,2,9.01E+018,"testalpha"
"w","effective geno and immunotherapy","JJ  CC NN",4,1,1,16733557,"pubmed1",3.67E+018,"testalpha"
"w","grades ofcolloidal silicon dioxide","NNS NN NN NN",4,1,1,17285749,"pubmed1",8.98E+018,"testalpha"
"w","dermatology publications andpatient support","NN NNS NN NN",4,1,1,17106594,2,5.88E+017,"testalpha"
"w","december and september patients","NN CC NN NNS",4,1,1,17117605,2,7.81E+018,"testalpha"
"w","ldl cholesterol did notdemonstrate"," NN VBD NN",4,1,1,16479026,2,2.40E+018,"testalpha"
"w","px sod cat activities","  NN NNS",4,1,1,16999986,2,4.60E+017,"testalpha"
"w","exon g d mutation","   NN",4,1,1,16585980,2,1.34E+018,"testalpha"
"w","ofacademic medical centers amcs","JJ JJ NNS ",4,1,1,16377814,"pubmed1",8.57E+018,"testalpha"
"w","bone and metastatic tumorwith","NN CC JJ NN",4,1,1,16514850,2,2.98E+018,"testalpha"
"w","temperature measurement mtm procedure","NN NN  NN",4,1,1,17285744,"pubmed1",2.50E+018,"testalpha"
"w","specimens patches of hyaluronate","NNS NNS IN NN",4,1,1,16713618,2,5.69E+018,"testalpha"
"w","pteronyssinus in atopic dermatitis","NN IN NN NN",4,1,1,16859613,2,5.85E+018,"testalpha"
"w","infiltration of neoplastic cells","NN IN JJ NNS",4,1,1,16983449,2,7.80E+018,"testalpha"
"w","iron catalysed oxidative demethylation","NN VBN JJ NN",4,1,1,16733554,"pubmed1",4.15E+018,"testalpha"
"w","tissue section and theslides","NN NN CC NNS",4,1,1,17049369,2,6.02E+018,"testalpha"
"w","enhancementof capacitative calcium entry"," JJ NN NN",4,1,1,17115079,"pubmed1",6.30E+018,"testalpha"
"w","derivatives for such purposes","NNS IN JJ NNS",4,1,1,17265690,2,4.07E+018,"testalpha"
"w","glutathione portion of substrate","NN NN IN NN",4,1,1,16421451,2,8.12E+018,"testalpha"
"w","child turcotte pugh score","NN NNP  NN",4,1,1,17013505,2,2.04E+018,"testalpha"
"w","introns of different lengths","NNS IN JJ NNS",4,1,1,16365637,"pubmed1",3.46E+018,"testalpha"
"w","artificial saliva containing f","JJ  VBG NN",4,1,1,16701867,"pubmed1",6.66E+018,"testalpha"
"w","effect of thedisulfide replacements","NN IN VB NNS",4,1,1,16496038,"pubmed1",6.53E+018,"testalpha"
"w","crystals in fine needle","NNS IN JJ NN",4,1,1,16514850,2,3.12E+018,"testalpha"
"w","debridement intravenous liposomal amphotericin","NN JJ JJ NNP",4,1,1,17370565,"pubmed1",5.63E+018,"testalpha"
"w","hematology oncology department children","NN NN NN NNS",4,1,1,16918061,"pubmed1",5.27E+018,"testalpha"
"w","level inserum deprived mk","NN NN VBN ",4,1,1,17265688,2,1.34E+018,"testalpha"
"w","tothe slow binding inhibition","NNP JJ VBG NN",4,1,1,16505899,"pubmed1",2.07E+018,"testalpha"
"w","factor antigen i cfa","NN NN  ",4,1,1,16511280,2,9.02E+018,"testalpha"
"w","rigid volume or pressure","JJ NN CC NN",4,1,1,16451155,"pubmed1",8.23E+018,"testalpha"
"w","urinary nag creatinine ratio","JJ  NN NN",4,1,1,16956119,2,7.10E+018,"testalpha"
"w","aim ofthe present study","NN NNP JJ NN",4,1,1,17016037,2,3.32E+018,"testalpha"
"w","cytochromec independent nitration oftyrosine","NNP JJ NN NN",4,1,1,16951741,"pubmed1",2.13E+018,"testalpha"
"w","solid lipid nanoparticles sln","JJ NN NNS ",4,1,1,17285742,"pubmed1",4.43E+018,"testalpha"
"w","methylene analogue with d","NN NN IN ",4,1,1,16496038,"pubmed1",1.15E+018,"testalpha"
"w","expected sizesof bp bp","VBN   ",4,1,1,16951742,"pubmed1",5.48E+017,"testalpha"
"w","granulomas cases of hpv","NNP NNS IN ",4,1,1,17139883,2,6.54E+018,"testalpha"
"w","leiomyosarcomas of adrenal origin","NNP IN NN NN",4,1,1,16177871,"pubmed1",5.09E+018,"testalpha"
"w","methotrexate was added skin","NN VBD VBN NN",4,1,1,16955192,2,2.46E+018,"testalpha"
"w","behaviors infrequent seat belt","NNS JJ NN NN",4,1,1,16426559,"pubmed1",7.08E+018,"testalpha"
"w","stimulation with gm csf","NN IN  ",4,1,1,16404477,"pubmed1",5.98E+018,"testalpha"
"w","tablets formulated using combination","NNS VBD VBG NN",4,1,1,16584139,"pubmed1",4.32E+018,"testalpha"
"w","leiomyomas and completeendoscopic removal","NNP CC NN NN",4,1,1,16989154,2,5.78E+018,"testalpha"
"w","efficient predictor of future","JJ NN IN NN",4,1,1,16405859,"pubmed1",1.58E+018,"testalpha"
"w","correlation spectroscopy pcs andlaser","NN   NN",4,1,1,16584150,"pubmed1",6.83E+017,"testalpha"
"w","algorithmfor breast lesion segmentation","JJ NN NN NN",4,1,1,16399033,"pubmed1",4.64E+018,"testalpha"
"w","enhancement patterns in liverhemangiomas","NN NNS IN NNP",4,1,1,16333704,"pubmed1",4.83E+018,"testalpha"
"w","mg gradients effective valve"," NNS JJ NN",4,1,1,16989140,2,4.59E+017,"testalpha"
"w","heat transfer coefficient error","NN VB NN NN",4,1,1,17285746,"pubmed1",6.85E+018,"testalpha"
"w","substrate analogues in otherstructures","NN NNS IN NNS",4,1,1,16421451,2,7.66E+017,"testalpha"
"w","different types of measures","JJ NNS IN NNS",4,1,1,16406188,"pubmed1",5.81E+018,"testalpha"
"w","predominant symptom regardlessof etiology","JJ NN  NN",4,1,1,16462406,"pubmed1",8.54E+018,"testalpha"
"w","gitrl expressing cells inatopic"," VBG NNS NN",4,1,1,16955181,2,3.44E+018,"testalpha"
"w","post legislation serious head","NN NN JJ NN",4,1,1,16223468,"pubmed1",7.37E+018,"testalpha"
"w","surgical results and complications","JJ NNS CC NNS",4,1,1,17139896,2,8.21E+018,"testalpha"
"w","committeesare under increasing pressure","NN IN VBG NN",4,1,1,16399035,"pubmed1",5.47E+018,"testalpha"
"w","withacceptable morbidity and mortality","JJ NN CC NN",4,1,1,17139879,2,3.29E+018,"testalpha"
"w","acute lymphoblastic leukemia b","JJ JJ NN NN",4,1,1,16809887,2,8.00E+018,"testalpha"
"w","behavior therapy dbt training","NN NN  NN",4,1,1,16473997,"pubmed1",2.79E+018,"testalpha"
"w","more positiveentropies of activation","JJR NNS IN NN",4,1,1,16929382,"pubmed1",5.31E+018,"testalpha"
"w","psi and psii activities"," CC  NNS",4,1,1,17106510,"pubmed1",4.66E+018,"testalpha"
"w","increased density of nf","VBN NN IN ",4,1,1,16919707,2,6.90E+017,"testalpha"
"w","high voltage electrical injuries","JJ NN JJ NNS",4,1,1,17294910,2,6.37E+018,"testalpha"
"w","histology including benign endometrium","NN IN JJ NN",4,1,1,16514840,2,2.88E+018,"testalpha"
"w","procedures of lateral canthoplastyas","NNS IN JJ ",4,1,1,17165595,2,5.10E+018,"testalpha"
"w","infusion requirements and recovery","NN NNS CC NN",4,1,1,17236635,"pubmed1",4.23E+018,"testalpha"
"w","herpes oro genital sex","NNS  NN NN",4,1,1,16648915,2,9.20E+017,"testalpha"
"w","multiple cam mrna species","JJ   NN",4,1,1,16949651,2,8.92E+018,"testalpha"
"w","candidates during lead selection","NNS IN NN NN",4,1,1,16584115,"pubmed1",8.60E+018,"testalpha"
"w","include sex of driver","VBP NN IN NN",4,1,1,16112070,"pubmed1",2.53E+018,"testalpha"
"w","years ml of blood","NNS  IN NN",4,1,1,17117609,2,3.50E+018,"testalpha"
"w","had lower arrest rates","VBD JJR NN NNS",4,1,1,16202465,"pubmed1",6.34E+018,"testalpha"
"w","severity of escalator ridingaccidents","NN IN NN NNS",4,1,1,16434013,"pubmed1",3.24E+018,"testalpha"
"w","nutritional deficits andreactive processes","JJ NNS JJ NNS",4,1,1,16714050,2,1.12E+018,"testalpha"
"w","hexaaquacobalt ii tetraaquadiglycinatocobalt ii","NN  NN ",4,1,1,16397335,2,8.72E+018,"testalpha"
"w","rigid work hour restrictions","JJ NN NN NNS",4,1,1,16377823,"pubmed1",3.00E+018,"testalpha"
"w","adult patients undergoing surgicalresection","NN NNS VBG NN",4,1,1,17236639,"pubmed1",6.79E+018,"testalpha"
"w","intubatinglaryngeal mask ilma laryngeal","NN   NN",4,1,1,16451149,"pubmed1",7.96E+018,"testalpha"
"w","variant revealed increased efficiency","NN VBD VBN NN",4,1,1,16549895,2,8.14E+018,"testalpha"
"w","complained ofheadache and diplopia","VBD NNP CC NNP",4,1,1,16612920,"pubmed1",3.03E+018,"testalpha"
"w","bipolar affective disorder susceptibility","JJ JJ NN NN",4,1,1,16733555,"pubmed1",1.29E+018,"testalpha"
"w","temperature anddry layer resistance","NN JJ NN NN",4,1,1,17285744,"pubmed1",4.11E+018,"testalpha"
"w","locomotor hyperactivity and latencyin","NN NN CC ",4,1,1,17265693,2,1.20E+018,"testalpha"
"w","provide rapid pain relief","VB JJ NN NN",4,1,1,16613748,2,8.13E+018,"testalpha"
"w","pharmacological differences between bupivacaine","JJ NNS IN NN",4,1,1,16617757,"pubmed1",6.48E+018,"testalpha"
"w","much cost being involvedsuggest","NN VBD VBG NN",4,1,1,16424652,2,6.23E+018,"testalpha"
"w","tbo laser vs control"," NN  NN",4,1,1,17293963,2,4.70E+018,"testalpha"
"w","mean radial outgrowth rate","NN JJ NN NN",4,1,1,16874412,2,6.36E+018,"testalpha"
"w","highest increase in p","JJT NN IN ",4,1,1,16733561,"pubmed1",2.90E+018,"testalpha"
"w","sonographers in rural manitoba","NNS IN JJ NNP",4,1,1,16438094,"pubmed1",8.35E+018,"testalpha"
"w","change of particle charge","NN IN NN NN",4,1,1,16584150,"pubmed1",1.62E+018,"testalpha"
"w","aspects of hepatitis cand","NNS IN NN ",4,1,1,17013506,2,6.55E+018,"testalpha"
"w","early surgery within day","JJ NN IN NN",4,1,1,16613748,2,5.65E+018,"testalpha"
"w","opinions on curricular reform","NNS IN JJ NN",4,1,1,16473990,"pubmed1",1.10E+018,"testalpha"
"w","theinfluence of alcohol drugs","NN IN NN NNS",4,1,1,16191426,"pubmed1",7.78E+018,"testalpha"
"w","n with homogeneouscontrast enhancement"," IN JJS NN",4,1,1,16333694,"pubmed1",7.62E+018,"testalpha"
"w","ofnuclear encoded rnas co","JJ VBN  ",4,1,1,16496041,"pubmed1",7.89E+018,"testalpha"
"w","hocl modified low density"," VBN JJ NN",4,1,1,17128291,"pubmed1",1.26E+018,"testalpha"
"w","inflammatory changes of periappendicealtissue","JJ NNS IN NN",4,1,1,16612913,"pubmed1",7.13E+018,"testalpha"
"w","study of quantum rate","NN IN NN NN",4,1,1,16411736,"pubmed1",6.81E+018,"testalpha"
"w","gly hepaticglycogen gh pyruvate"," NN  NN",4,1,1,17013507,2,2.26E+018,"testalpha"
"w","initiate thepre metastatic niche","VBP  JJ NN",4,1,1,16730054,2,1.11E+018,"testalpha"
"w","months after successful bone","NNS IN JJ NN",4,1,1,16918065,"pubmed1",9.15E+018,"testalpha"
"w","psh differentiation of sinus"," NN IN NN",4,1,1,16256177,2,6.36E+018,"testalpha"
"w","context of neurodegenerative diseases","NN IN JJ NNS",4,1,1,16733558,"pubmed1",9.22E+018,"testalpha"
"w","group required additional localanesthetics","NN VBN JJ NNS",4,1,1,16617756,"pubmed1",1.26E+017,"testalpha"
"w","quantitative energy dispersive spectrometry","JJ NN JJ NN",4,1,1,16648911,2,7.05E+018,"testalpha"
"w","scheme of thespatial localization","NN IN JJ NN",4,1,1,16770442,"pubmed1",2.98E+018,"testalpha"
"w","scintigraphy endorsed higher uptake","NN VBN JJR NN",4,1,1,16584167,"pubmed1",6.37E+018,"testalpha"
"w","terms of cell attachment","NNS IN NN NN",4,1,1,16701866,"pubmed1",6.80E+018,"testalpha"
"w","anegative correlation between apache","JJ NN IN NNP",4,1,1,17117607,2,1.59E+018,"testalpha"
"w","ab initio structure determination"," NN NN NN",4,1,1,16421448,2,1.97E+017,"testalpha"
"w","treatment ofconnective tissue diseases","NN JJ NN NNS",4,1,1,17106602,2,6.87E+018,"testalpha"
"w","mitochondrial translocation of bax","JJ NN IN ",4,1,1,16424655,2,4.39E+018,"testalpha"
"w","cytomegalovirus hcmv in leukocytes","NN  IN NNS",4,1,1,17019440,"pubmed1",2.46E+018,"testalpha"
"w","month old rat hearts","NN JJ NN NNS",4,1,1,17046052,2,7.67E+018,"testalpha"
"w","treatment of displaced fractures","NN IN VBN NNS",4,1,1,16613748,2,5.86E+016,"testalpha"
"w","support units provided medicalreports","NN NNS VBN NNS",4,1,1,16491215,2,5.84E+018,"testalpha"
"w","results of total cholesterol","NNS IN JJ NN",4,1,1,16479026,2,2.48E+017,"testalpha"
"w","heart and liver tissue","NN CC NN NN",4,1,1,16950501,2,5.73E+018,"testalpha"
"w","th th and st","  CC ",4,1,1,17293969,2,5.90E+018,"testalpha"
"w","diameterand area of spindles","NN NN IN NNS",4,1,1,16730053,2,1.56E+018,"testalpha"
"w","demands of patient care","NNS IN NN NN",4,1,1,16377823,"pubmed1",7.93E+018,"testalpha"
"w","short term immunosuppressionprolong islet","JJ NN IN NN",4,1,1,16701881,"pubmed1",1.79E+018,"testalpha"
"w","technique in inguinalhernia repairs","NN IN NNP NNS",4,1,1,16612912,"pubmed1",1.11E+018,"testalpha"
"w","level was measured withthe","NN VBD VBN NNP",4,1,1,16956116,2,5.66E+018,"testalpha"
"w","substitutions and cc cc","NNS CC  ",4,1,1,16733554,"pubmed1",5.00E+018,"testalpha"
"w","mortality in theindustrialized world","NN IN VBN NN",4,1,1,17014894,2,8.90E+018,"testalpha"
"w","favor endometrial origin agc","VB JJ NN ",4,1,1,16514840,2,1.53E+018,"testalpha"
"w","amulti substrate growth potential"," NN NN NN",4,1,1,17019438,"pubmed1",2.10E+017,"testalpha"
"w","serine aspartic cysteine andmetalloproteinases","NN JJ NN NNS",4,1,1,16410836,"pubmed1",7.74E+018,"testalpha"
"w","treatedgroups showed cytoplasmic vacuolization","NNS VBD JJ NN",4,1,1,16574202,2,7.33E+018,"testalpha"
"w","basis for fvii deficiency","NN IN  NN",4,1,1,16914903,2,7.00E+017,"testalpha"
"w","e levels hightriglyceride levels"," NNS VB NNS",4,1,1,16673555,2,8.28E+018,"testalpha"
"w","method for matching ambulancerecords","NN IN VBG NNS",4,1,1,16365326,"pubmed1",2.93E+018,"testalpha"
"w","positive mac technique test","JJ  NN NN",4,1,1,16365333,"pubmed1",6.36E+018,"testalpha"
"w","c terminal purification tag","NN NN NN NN",4,1,1,16511285,2,6.83E+018,"testalpha"
"w","novel delta fatty aciddesaturase","NN NN JJ NN",4,1,1,17063209,"pubmed1",5.66E+017,"testalpha"
"w","x exon nt c","NN   NN",4,1,1,16424658,2,1.67E+018,"testalpha"
"w","fatalities among young drivers","NNS IN JJ NNS",4,1,1,16171767,"pubmed1",6.65E+018,"testalpha"
"w","elisa against rhoa gdp"," IN  ",4,1,1,17019437,"pubmed1",8.24E+017,"testalpha"
"w","lower leg withseveral satellite","JJR NN JJ NN",4,1,1,16603099,2,4.47E+018,"testalpha"
"w","discs for different time","NNS IN JJ NN",4,1,1,16701866,"pubmed1",3.42E+018,"testalpha"
"w","cip kip family ofcdk","  NN ",4,1,1,17115080,"pubmed1",7.15E+018,"testalpha"
"w","sucralfate gel in relation","NN  IN NN",4,1,1,16584168,"pubmed1",7.09E+018,"testalpha"
"w","time of hospital admission","NN IN NN NN",4,1,1,16710574,2,6.32E+018,"testalpha"
"w","light scattering andelectron microscopy","NN VBG NNP ",4,1,1,17285741,"pubmed1",7.94E+018,"testalpha"
"w","premise supporting such practice","NN VBG JJ NN",4,1,1,16399035,"pubmed1",3.00E+018,"testalpha"
"w","frequent cause of death","JJ NN IN NN",4,1,1,16859619,2,4.18E+018,"testalpha"
"w","expression by smoothmuscle cells","NN IN NN NNS",4,1,1,16395522,"pubmed1",7.84E+018,"testalpha"
"w","origin ofthe deposited amyloids","NN NNP VBN NNS",4,1,1,16790262,2,2.63E+018,"testalpha"
"w","endometrial stromal sarcomas ess","JJ JJ NNP ",4,1,1,17338203,2,3.12E+018,"testalpha"
"w","markers epidermal growth factor","NNS JJ NN NN",4,1,1,16673564,2,7.96E+018,"testalpha"
"w","vwd patients type type"," NNS NN NN",4,1,1,16424652,2,1.74E+018,"testalpha"
"w","majority of parenteral dmstudies","NN IN JJ NNS",4,1,1,16451144,"pubmed1",4.51E+018,"testalpha"
"w","related lipid transfer start","VBN NN VB NN",4,1,1,16951743,"pubmed1",7.68E+018,"testalpha"
"w","number of drug candidates","NN IN NN NNS",4,1,1,16584115,"pubmed1",7.90E+017,"testalpha"
"w","national institutes of healthcriteria","JJ NNS IN NNP",4,1,1,17010267,2,1.35E+018,"testalpha"
"w","follicularmucinosis from follicular mf","NN IN JJ ",4,1,1,16859615,2,1.40E+018,"testalpha"
"w","psychiatry residency within theparameters","NN NN IN NNS",4,1,1,16473996,"pubmed1",5.63E+018,"testalpha"
"w","complex ofthe wild type","JJ NNP JJ NN",4,1,1,16421451,2,5.71E+018,"testalpha"
"w","differentiation mitosesand apoptotic cells","NN NN JJ NNS",4,1,1,17311737,2,3.95E+018,"testalpha"
"w","count and colonyforming units","NN CC VBG NNS",4,1,1,17293960,2,4.96E+018,"testalpha"
"w","inisolated platelet membrane fraction","VBN NN NN NN",4,1,1,16523217,"pubmed1",1.86E+018,"testalpha"
"w","forthe identification and determination","NNP NN CC NN",4,1,1,16970980,2,6.20E+018,"testalpha"
"w","day end point conclusions","NN NN NN NNS",4,1,1,16365321,"pubmed1",8.13E+018,"testalpha"
"w","crp patients demonstrated dyslipidaemia"," NNS VBN NN",4,1,1,16479028,2,4.10E+018,"testalpha"
"w","n pf c h","  NN ",4,1,1,16397333,2,1.71E+018,"testalpha"
"w","c andgroup v pretreatment","NN NN  NN",4,1,1,17067136,"pubmed1",8.72E+018,"testalpha"
"w","including developmental disordersinvolving chromosome","VBG NN VBG NN",4,1,1,16582985,"pubmed1",2.67E+018,"testalpha"
"w","high number of crashes","JJ NN IN NNS",4,1,1,16126153,"pubmed1",7.25E+018,"testalpha"
"w","tothe active site cys","NNP JJ NN ",4,1,1,16421453,2,4.01E+018,"testalpha"
"w","intestinal adaptation of rats","JJ NN IN NNS",4,1,1,17293957,2,7.51E+018,"testalpha"
"w","resuscitation radiological evaluation monitoring","NN JJ NN NN",4,1,1,17067134,"pubmed1",6.77E+018,"testalpha"
"w","non competitive nmda glutamate"," JJ  NN",4,1,1,17133953,2,7.77E+018,"testalpha"
"w","ligand secretion after stimulation","NN NN IN NN",4,1,1,16710577,2,1.55E+018,"testalpha"
"w","patients with cushing syndrome","NNS IN VBG NN",4,1,1,16603099,2,2.89E+018,"testalpha"
"w","study oxidative proteinmodification characterization","VB JJ NN NN",4,1,1,17063208,"pubmed1",3.88E+018,"testalpha"
"w","purificationwith protein g affinity","NN NN  NN",4,1,1,17117211,"pubmed1",4.16E+018,"testalpha"
"w","collagen stimulated platelets onoo","NN VBN NNS ",4,1,1,17068635,"pubmed1",5.24E+018,"testalpha"
"w","alphavbeta receptors and whetherit","NN NNS CC NN",4,1,1,17143339,"pubmed1",4.23E+018,"testalpha"
"w","cells following beta interferon","NNS VBG NN NNP",4,1,1,16505900,"pubmed1",6.41E+018,"testalpha"
"w","differentiate from primary thyroid","NN IN JJ NN",4,1,1,16514846,2,7.60E+018,"testalpha"
"w","dna fragments identified twomulticopy"," NNS VBN ",4,1,1,17146497,"pubmed1",5.61E+018,"testalpha"
"w","methods data from transplants","NNS NNS IN NNS",4,1,1,17013513,2,1.42E+018,"testalpha"
"w","tests of small bowel","NNS IN JJ NN",4,1,1,16673560,2,7.60E+018,"testalpha"
"w","branch msec right branch","NN  NN NN",4,1,1,17139884,2,7.65E+018,"testalpha"
"w","myeloperoxidase mpo anca titres","NN   NNS",4,1,1,16648918,2,6.71E+017,"testalpha"
"w","neurotoxic effects of dex","JJ NNS IN ",4,1,1,17133953,2,3.95E+018,"testalpha"
"w","mostextensive saccharide inhibitor list","JJ VB NN NN",4,1,1,16730370,2,4.84E+018,"testalpha"
"w","patients with negative crp","NNS IN JJ ",4,1,1,16479028,2,7.45E+018,"testalpha"
"w","drivers regarding driving safety","NNS IN VBG NN",4,1,1,16061188,"pubmed1",3.34E+018,"testalpha"
"w","andunder cell culture conditions","NN NN NN NNS",4,1,1,16713618,2,6.22E+018,"testalpha"
"w","agreement betweenmtm and vial","NN  CC ",4,1,1,17285744,"pubmed1",1.64E+018,"testalpha"
"w","first classification offemoral neck","JJ NN JJ NN",4,1,1,16613748,2,7.59E+018,"testalpha"
"w","soil habitat indicated lack","NN NN VBD NN",4,1,1,17019438,"pubmed1",8.55E+018,"testalpha"
"w","glutamineenhanced serum antioxidant capacity","VBN NN JJ NN",4,1,1,17293970,2,1.86E+018,"testalpha"
"w","proliferation rate of jejunum","NN NN IN NN",4,1,1,16491217,2,9.00E+018,"testalpha"
"w","cytokines and growth factors","NNS CC NN NNS",4,1,1,17013516,2,5.70E+018,"testalpha"
"w","vis cd epr results","   NNS",4,1,1,16496037,"pubmed1",3.73E+018,"testalpha"
"w","comparative atopy patch testing","JJ  NN NN",4,1,1,16648919,2,1.55E+018,"testalpha"
"w","transglutaminase antibodies in patients","NN NNS IN NNS",4,1,1,16874419,2,7.31E+017,"testalpha"
"w","reactivity index and themaslach","NN NN CC NN",4,1,1,16377826,"pubmed1",8.55E+018,"testalpha"
"w","albuminproduction mitochondrial membrane potential","NN JJ NN NN",4,1,1,16696445,2,3.62E+018,"testalpha"
"w","model of autocatalytic zymogen","NN IN JJ NN",4,1,1,16770446,"pubmed1",2.62E+017,"testalpha"
"w","fatality risk and thetotal","NN NN CC NN",4,1,1,16061188,"pubmed1",9.05E+018,"testalpha"
"w","university hospital and hours","NN NN CC NNS",4,1,1,16365324,"pubmed1",1.90E+018,"testalpha"
"w","ssri therapy does notimpair"," NN VBZ NN",4,1,1,16549890,2,2.80E+018,"testalpha"
"w","responsive element atf cre","JJ NN  ",4,1,1,16395528,"pubmed1",8.82E+018,"testalpha"
"w","meanerythrocyte hb concentration serum","NNP  NN NN",4,1,1,16809890,2,4.47E+018,"testalpha"
"w","effect on nmda inducedrespiratory","NN IN  NN",4,1,1,17133957,2,3.40E+018,"testalpha"
"w","andits correlations with iron","NNS NNS IN NN",4,1,1,17119323,2,7.51E+017,"testalpha"
"w","requirements on gme practice","NNS IN  NN",4,1,1,16377812,"pubmed1",3.55E+018,"testalpha"
"w","ofmental illness in television","NN NN IN NN",4,1,1,16474001,"pubmed1",1.39E+018,"testalpha"
"w","risk of fulminant sepsisremains","NN IN JJ NNS",4,1,1,16424648,2,5.46E+018,"testalpha"
"w","theproliferation of blast cells","NN IN NN NNS",4,1,1,16809884,2,2.68E+018,"testalpha"
"w","fine needle aspirationcytology fnac","JJ NN NN ",4,1,1,16514846,2,8.54E+018,"testalpha"
"w","apoptosis p p mdm","NN   ",4,1,1,17117604,2,3.40E+018,"testalpha"
"w","year after mitral valve","NN IN JJ NN",4,1,1,16916185,"pubmed1",8.74E+018,"testalpha"
"w","suggest asan optimal model","VB  JJ NN",4,1,1,16696445,2,2.76E+018,"testalpha"
"w","zone of blood stasis","NN IN NN NN",4,1,1,17294912,2,8.79E+018,"testalpha"
"w","lectins as search models","NNS IN NN NNS",4,1,1,16511291,2,5.05E+018,"testalpha"
"w","linked fluorescence at nm","VBN NN IN ",4,1,1,16696441,2,5.90E+018,"testalpha"
"w","working personnel and emergency","VBG NNS CC NN",4,1,1,16365330,"pubmed1",1.83E+018,"testalpha"
"w","experimental observations are inagreement","JJ NNS VBP NN",4,1,1,16410837,"pubmed1",3.01E+017,"testalpha"
"w","ofreactions involving quantum particles","NNS VBG NN NNS",4,1,1,16411736,"pubmed1",7.10E+018,"testalpha"
"w","centrosymmetric c c space","JJ NN NN NN",4,1,1,16456295,2,5.85E+018,"testalpha"
"w","different nonneuronal cell types","JJ JJ NN NNS",4,1,1,16594641,"pubmed1",4.62E+018,"testalpha"
"w","sacs showed lesser score"," VBD JJR NN",4,1,1,16491218,2,6.53E+018,"testalpha"
"w","circulatory shock and livertransplantation","JJ NN CC NN",4,1,1,17013514,2,8.90E+018,"testalpha"
"w","adjuvant treatment for gastroenteritis","JJ NN IN NN",4,1,1,17293961,2,2.76E+018,"testalpha"
"w","postgraduate year pgy residents","NN NN  NNS",4,1,1,16377825,"pubmed1",2.84E+018,"testalpha"
"w","homeostasis and development andcaspases","NN CC NN NNS",4,1,1,17034836,2,1.74E+018,"testalpha"
"w","arranged cup shaped structures","VBN NN VBN NNS",4,1,1,16733562,"pubmed1",1.59E+018,"testalpha"
"w","cellular fluid and thenonquiescent","JJ NN CC NN",4,1,1,16988902,"pubmed1",6.22E+018,"testalpha"
"w","joints hours after dyeapplication","NNS NNS IN NN",4,1,1,16399028,"pubmed1",8.94E+018,"testalpha"
"w","diagnosis of myelodysplastic syndrome","NN IN JJ NN",4,1,1,17016041,2,1.52E+017,"testalpha"
"w","using anilino naphthalene sulfonate","VBG NNP NN NN",4,1,1,16714053,2,7.97E+018,"testalpha"
"w","wide adipo fascial peduncle","JJ  JJ NN",4,1,1,16722345,2,7.64E+018,"testalpha"
"w","surgicalcorrection of medial patella","NN IN JJ NNP",4,1,1,17293971,2,6.66E+018,"testalpha"
"w","support from healthcare providers","NN IN NN NNS",4,1,1,16710575,2,3.94E+018,"testalpha"
"w","extensive pseudosymmetry andsignificant deviations","JJ NN JJ NNS",4,1,1,16421452,2,1.97E+018,"testalpha"
"w","crystals of human t","NNS IN JJ ",4,1,1,16421452,2,9.69E+016,"testalpha"
"w","cora from thermotoga maritima"," IN NNP NN",4,1,1,16511288,2,8.44E+018,"testalpha"
"w","young single high school","JJ NN JJ NN",4,1,1,16405857,"pubmed1",1.63E+018,"testalpha"
"w","mg kg of body","  IN NN",4,1,1,17293967,2,3.09E+018,"testalpha"
"w","isa need for intervention"," NN IN NN",4,1,1,16710573,2,6.22E+018,"testalpha"
"w","g and radioactivity count"," CC NN NN",4,1,1,17293960,2,6.60E+018,"testalpha"
,"support units blsu firemen","NN NNS  NNS",4,1,1,16491215,2,2.15E+018,"testalpha"
,"hospital results and patients","NN NNS CC NNS",4,1,1,16673554,2,8.84E+018,"testalpha"
,"province in eastern china","NN IN JJ NN",4,1,1,16236234,"pubmed1",8.94E+018,"testalpha"
,"potential use in plant","JJ NN IN NN",4,1,1,16395526,"pubmed1",7.35E+018,"testalpha"
,"requiring majoramputations patients men","VBG NNS NNS NNS",4,1,1,16612914,"pubmed1",5.03E+018,"testalpha"
,"factor receptor inhibitor pki","NN NN NN ",4,1,1,16874412,2,3.33E+018,"testalpha"
,"concurrence with hcc months","NN IN  NNS",4,1,1,17119328,2,1.31E+018,"testalpha"
,"tumours and clark level","NNS CC NN NN",4,1,1,16710578,2,8.51E+018,"testalpha"
,"positive bacillus erysipelothrix rhusiopathiae","JJ NN NNP ",4,1,1,16859614,2,4.59E+018,"testalpha"
,"experimentaldesigns and clinical applications","NNS CC JJ NNS",4,1,1,17016038,2,3.17E+018,"testalpha"
,"patients men with psoriasis","NNS NNS IN NN",4,1,1,16710574,2,3.30E+018,"testalpha"
,"stomadiameter intraperitoneal or extraperitoneal","NN NN CC NN",4,1,1,17139894,2,5.58E+018,"testalpha"
,"alkyl chain lengths c"," NN NNS NN",4,1,1,16594645,"pubmed1",3.32E+018,"testalpha"
,"thecytochrome c catalyzed nitrotyrosine","NN NN VBN NN",4,1,1,16951741,"pubmed1",9.94E+017,"testalpha"
,"typicalbasic leucine zipper domain","NN NN NN NN",4,1,1,16325892,2,8.68E+018,"testalpha"
,"resistance ie mtm determinedresistance","NN   NN",4,1,1,17285746,"pubmed1",2.67E+018,"testalpha"
,"adjacent negative patch tests","JJ JJ NN NNS",4,1,1,16874422,2,2.04E+018,"testalpha"
,"precurarization of vecuroni um","NN IN NNP ",4,1,1,17067136,"pubmed1",4.95E+018,"testalpha"
,"hour periods consecutive patients","NN NNS JJ NNS",4,1,1,16365327,"pubmed1",1.74E+018,"testalpha"
,"treatment in plants nt","NN IN NNS ",4,1,1,16395523,"pubmed1",7.95E+017,"testalpha"
,"use of thebiomechanical software","NN IN JJ NN",4,1,1,16438094,"pubmed1",6.45E+017,"testalpha"
,"loopof small bowel cm"," JJ NN ",4,1,1,16612930,"pubmed1",6.54E+018,"testalpha"
,"new techniqueincludes several improvements","JJ NNS JJ NNS",4,1,1,16730369,2,7.20E+017,"testalpha"
,"eczema area and severity","NN NN CC NN",4,1,1,16585987,2,4.40E+018,"testalpha"
,"inhibitors showed certain properties","NNS VBD JJ NNS",4,1,1,16505899,"pubmed1",3.61E+018,"testalpha"
,"vaccination in males male","NN IN NNS NN",4,1,1,17010274,2,8.90E+018,"testalpha"
,"crashes of older drivers","NNS IN JJR NNS",4,1,1,16122689,"pubmed1",1.41E+018,"testalpha"
,"cryomicroscopy and low temperature"," CC JJ NN",4,1,1,17285745,"pubmed1",8.72E+018,"testalpha"
,"markers of apoptosis p","NNS IN NN ",4,1,1,17117604,2,1.18E+018,"testalpha"
,"cell tumor of theparotid","NN NN IN ",4,1,1,16514845,2,3.06E+017,"testalpha"
,"sex of driver months","NN IN NN NNS",4,1,1,16112070,"pubmed1",4.17E+018,"testalpha"
,"different patterns of binding","JJ NNS IN NN",4,1,1,16496040,"pubmed1",9.01E+018,"testalpha"
,"percentage of thesporadic colon","NN IN JJ NN",4,1,1,17139886,2,3.06E+018,"testalpha"
,"ii iii tetraphenylborate mniimniii","  NN ",4,1,1,16456265,2,3.18E+018,"testalpha"
,"training inpsychiatry and neurosciences","NN NN CC NNS",4,1,1,16473989,"pubmed1",1.11E+018,"testalpha"
,"eradication oftenincreases platelet counts","NN NNS NN NNS",4,1,1,16809885,2,8.38E+017,"testalpha"
,"f element separation iii","NN NN NN ",4,1,1,16411740,"pubmed1",3.75E+018,"testalpha"
,"forelective operations requiring blood","JJ NNS VBG NN",4,1,1,16809890,2,7.62E+018,"testalpha"
,"hydantoin calcium sulfate dihydrate","VB NN NN NN",4,1,1,17285749,"pubmed1",4.79E+018,"testalpha"
,"neuroscienceresearch and primary care","NN CC JJ NN",4,1,1,16473990,"pubmed1",8.66E+018,"testalpha"
,"surface area samples shows","NN NN NNS NNS",4,1,1,17293968,2,1.05E+018,"testalpha"
,"medium sized congenital naevi","JJ VBN NN ",4,1,1,16710582,2,2.14E+018,"testalpha"
,"diffusion capacity dl co","NN NN  ",4,1,1,16809886,2,8.59E+018,"testalpha"
,"reactivators with oxime group","NNS IN JJ NN",4,1,1,17438836,2,8.29E+018,"testalpha"
,"alternativeantithrombotic use in children","JJ NN IN NNS",4,1,1,16549902,2,3.63E+018,"testalpha"
,"hinge regions by theproduction","NN NNS IN NN",4,1,1,16733064,2,1.91E+018,"testalpha"
,"infarction mi and revascularization","NN  CC NN",4,1,1,16365321,"pubmed1",5.38E+017,"testalpha"
,"agnor expression and lung","NN NN CC NN",4,1,1,17293964,2,6.06E+018,"testalpha"
,"narrowband ultraviolet b uvb","NN NN NN ",4,1,1,16585987,2,3.00E+018,"testalpha"
,"release test in media","VB NN IN NNS",4,1,1,17285750,"pubmed1",9.00E+018,"testalpha"
,"ourdepartment with fulminant vasculitis","NN IN JJ NN",4,1,1,16424662,2,8.48E+018,"testalpha"
,"scales suggesting theirinsufficient tissue","NNS VBG NN NN",4,1,1,16585983,2,8.57E+018,"testalpha"
,"colorectal cancer involving microsatelliteinstability","NN NN VBG NN",4,1,1,16673564,2,5.18E+018,"testalpha"
,"risk of thrombosis anaesthesiologists","NN IN NN NNS",4,1,1,17236644,"pubmed1",6.80E+018,"testalpha"
,"growth factorbeta tgf beta","NN NN  NN",4,1,1,17293967,2,2.28E+018,"testalpha"
,"evaluate theconcentrations of serum","VB NNS IN NN",4,1,1,16956116,2,6.69E+018,"testalpha"
,"omentum spleen oesophagus adrenal","NN IN JJ NN",4,1,1,17338205,2,8.94E+018,"testalpha"
,"difference inpoints of view","NN NNS IN NN",4,1,1,17486414,"pubmed1",6.08E+018,"testalpha"
,"treatments with estradiol dipropionate","NNS IN  NN",4,1,1,16714054,2,4.76E+018,"testalpha"
,"interleukin secretionby activated mouse","NNP  VBN NN",4,1,1,17117211,"pubmed1",9.14E+018,"testalpha"
,"lsi ms and esi","  CC ",4,1,1,16496039,"pubmed1",1.91E+018,"testalpha"
,"patientswith cc dukes c","NN  VBZ NN",4,1,1,17139902,2,6.97E+018,"testalpha"
,"ongoing eczema at examination","JJ NN IN NN",4,1,1,16648916,2,4.55E+018,"testalpha"
,"lhcb lhcb and lhcb","  CC ",4,1,1,17106511,"pubmed1",8.00E+018,"testalpha"
,"deans ofacademic medical centers","NNS JJ JJ NNS",4,1,1,16377814,"pubmed1",7.24E+018,"testalpha"
,"unique measure of biodiversity","JJ NN IN NN",4,1,1,16988906,"pubmed1",5.73E+018,"testalpha"
,"disulfide exchanges between dsba","VB NNS IN ",4,1,1,17019443,"pubmed1",6.43E+016,"testalpha"
,"encapsulated beta cell survival","VBN NN NN NN",4,1,1,16701853,"pubmed1",3.61E+018,"testalpha"
,"administration of distilled water","NN IN VBN NN",4,1,1,17013511,2,6.20E+018,"testalpha"
,"theprobability of serious injury","NN IN JJ NN",4,1,1,16054101,"pubmed1",6.26E+018,"testalpha"
,"asingle centre with patients","NN NN IN NNS",4,1,1,16424653,2,5.81E+018,"testalpha"
,"decreased apoptosis in psoriaticepidermis","VBD NN IN NN",4,1,1,17034836,2,8.90E+018,"testalpha"
,"reportedmethyltransferase from sinorhizobium meliloti","NN IN NN NNP",4,1,1,16511261,2,1.76E+018,"testalpha"
,"blood urea nitrogen bun","NN  NN ",4,1,1,16999986,2,1.69E+018,"testalpha"
,"injury and abbreviated injuryscale","NN CC VBN NN",4,1,1,16223468,"pubmed1",5.09E+018,"testalpha"
,"generallypresent with thicker tumours","NN IN JJR NNS",4,1,1,16585990,2,7.39E+018,"testalpha"
,"optical reactions with thiazine","JJ NNS IN NN",4,1,1,16542712,2,2.80E+018,"testalpha"
,"care in different countries","NN IN JJ NNS",4,1,1,16451154,"pubmed1",6.66E+018,"testalpha"
,"spherical diamond tipped drill","JJ NN VBD NN",4,1,1,17293969,2,9.63E+017,"testalpha"
,"filter based pcr screening","NN VBD  NN",4,1,1,16951742,"pubmed1",1.70E+018,"testalpha"
,"obtaining diffraction quality crystals","VBG NN NN NNS",4,1,1,16511266,2,8.44E+018,"testalpha"
,"arterial pressure map mmhg","JJ NN NN ",4,1,1,16491220,2,8.14E+018,"testalpha"
,"impairment in albinowistar rats","NN IN NN NNS",4,1,1,16956120,2,3.67E+018,"testalpha"
,"year old man presentedwith","NN JJ NN NN",4,1,1,16514847,2,3.48E+018,"testalpha"
,"naja naja indian cobra","  JJ NNP",4,1,1,16436788,"pubmed1",8.30E+018,"testalpha"
,"cognitive outcome after concussion","JJ NN IN NN",4,1,1,16436787,"pubmed1",7.84E+017,"testalpha"
,"retrospective study patients male","JJ NN NNS NN",4,1,1,16989147,2,1.38E+017,"testalpha"
,"eachinjection rate formulation combination","NN NN NN NN",4,1,1,16584164,"pubmed1",7.44E+017,"testalpha"
,"design oral controlled release","NN JJ VBN NN",4,1,1,16584161,"pubmed1",5.21E+018,"testalpha"
,"several problems in hepaticsurgery","JJ NNS IN NN",4,1,1,17013507,2,4.83E+018,"testalpha"
,"fluid was minimal forair","NN VBD JJ NN",4,1,1,16594643,"pubmed1",4.88E+018,"testalpha"
,"disease new treatment modalities","NN JJ NN NNS",4,1,1,16733557,"pubmed1",7.66E+018,"testalpha"
,"early tracheostomy improved survival","JJ NN VBN NN",4,1,1,16451156,"pubmed1",6.42E+018,"testalpha"
,"use of theveress needle","NN IN NN NN",4,1,1,16491219,2,9.01E+018,"testalpha"
,"population were observed inspecimens","NN VBD VBN NNS",4,1,1,16612917,"pubmed1",3.66E+018,"testalpha"
,"based sural artery flap","VBN JJ NN ",4,1,1,16722345,2,5.91E+018,"testalpha"
,"alkaline phosphatase alp activity","NN NN  NN",4,1,1,16701866,"pubmed1",2.83E+018,"testalpha"
,"extracellular matrix ecm molecules","JJ NNP  NNS",4,1,1,16414104,2,5.32E+018,"testalpha"
,"fresh inputs from biology","JJ NNS IN NN",4,1,1,17318328,"pubmed1",6.46E+018,"testalpha"
,"inflammatory cytokines during bowelischemia","JJ NNS IN NN",4,1,1,17293960,2,5.09E+018,"testalpha"
,"volume expansion maycause coagulation","NN NN IN NN",4,1,1,16451158,"pubmed1",5.53E+018,"testalpha"
,"fas ligand on t"," NN IN ",4,1,1,17016035,2,5.95E+018,"testalpha"
,"bloodpressure body mass index","NN NN NN NN",4,1,1,16479027,2,2.91E+018,"testalpha"
,"males youngadults binge drinkers","NNS NNS NN NNS",4,1,1,16434012,"pubmed1",3.13E+018,"testalpha"
,"cancer detection and control","NN NN CC NN",4,1,1,16596900,"pubmed1",2.28E+018,"testalpha"
,"length integral membrane protein","NN JJ NN NN",4,1,1,16511288,2,6.57E+016,"testalpha"
,"artery bypass grafting cabg","NN VB VBG ",4,1,1,16451153,"pubmed1",8.36E+018,"testalpha"
,"liver and muscle glycogen","NN CC NN NN",4,1,1,16921609,"pubmed1",6.17E+018,"testalpha"
,"topographyand recognition of target","NN NN IN NN",4,1,1,16411737,"pubmed1",4.07E+018,"testalpha"
,"activitypresent in total cell","NN IN JJ NN",4,1,1,16404475,"pubmed1",1.39E+018,"testalpha"
,"more practicalmodels are penicillamine","JJR NNS VBP NN",4,1,1,16594644,"pubmed1",2.68E+018,"testalpha"
,"pss physiologic saline solution"," JJ NN NN",4,1,1,16491220,2,1.09E+018,"testalpha"
,"vp gene inthe baculovirus","  NNP NN",4,1,1,16733562,"pubmed1",5.36E+018,"testalpha"
,"prototypes of amyloid fibril","NNS IN VB NNP",4,1,1,16790262,2,2.46E+018,"testalpha"
,"parent non gypsy andone","NN  NN NN",4,1,1,17165598,2,2.27E+018,"testalpha"
,"generation in cord plasma","NN IN NN NNP",4,1,1,16549888,2,5.25E+018,"testalpha"
,"themechanisms and risk factors","NNS CC NN NNS",4,1,1,16808045,"pubmed1",7.03E+018,"testalpha"
,"teaching relationships between housestaff","VBG NNS IN NN",4,1,1,16377816,"pubmed1",2.73E+018,"testalpha"
,"plasma donors duringthe period","NNP NNS NNP NN",4,1,1,16956121,2,1.41E+018,"testalpha"
,"industrial oxidizing conditions e","JJ VBG NNS ",4,1,1,16411734,"pubmed1",7.38E+018,"testalpha"
,"human igg stbetarii fc","JJ   ",4,1,1,16733563,"pubmed1",3.14E+018,"testalpha"
,"arg locus leading tosynthesis"," NN VBG NN",4,1,1,16389406,"pubmed1",8.28E+018,"testalpha"
,"agglutinate human group erythrocytes","NN JJ NN NNS",4,1,1,16733562,"pubmed1",1.29E+018,"testalpha"
,"human vertebral body bone","JJ JJ NN NN",4,1,1,16696440,2,2.51E+018,"testalpha"
,"deprived mk treated neurons","VBN  VBN NNS",4,1,1,17265688,2,6.40E+018,"testalpha"
,"hormone release by way","NN NN IN NN",4,1,1,16395521,"pubmed1",8.90E+018,"testalpha"
,"chargeability of dry powders","NN IN JJ NNS",4,1,1,17285749,"pubmed1",8.55E+018,"testalpha"
,"possible cultural bias byphysicians","JJ JJ NN NNS",4,1,1,16436792,"pubmed1",4.46E+018,"testalpha"
,"rats were bled ml","NNS VBD VBD ",4,1,1,16762404,2,4.00E+018,"testalpha"
,"main chain hydrogen bonds","JJS NN NN NNS",4,1,1,16365636,"pubmed1",7.04E+018,"testalpha"
,"useful tool for risk","JJ NN IN NN",4,1,1,16365321,"pubmed1",4.96E+018,"testalpha"
,"acute attacks of migraine","JJ NNS IN NN",4,1,1,16584167,"pubmed1",9.11E+018,"testalpha"
,"calcium and phosphorus concentrations","NN CC NN NNS",4,1,1,16424647,2,1.57E+018,"testalpha"
,"standards education and compliance","NNS NN CC NN",4,1,1,16770860,"pubmed1",7.21E+018,"testalpha"
,"stranded beta sheet structure","VBN NN NN NN",4,1,1,16421453,2,8.73E+017,"testalpha"
,"ofthe subjects were atopic","NNP NNS VBD NN",4,1,1,16648917,2,5.89E+018,"testalpha"
,"stratifiedby county of residence","JJ NN IN NN",4,1,1,16202465,"pubmed1",9.11E+018,"testalpha"
,"initial pressure was mm","JJ NN VBD ",4,1,1,16491219,2,3.56E+018,"testalpha"
,"microemulsion developed inthis investigation","NN VBD NNP NN",4,1,1,16584167,"pubmed1",3.09E+018,"testalpha"
,"monthsin patients with cc","NNP NNS IN ",4,1,1,17139879,2,1.32E+018,"testalpha"
,"head injury and brain","NN NN CC NN",4,1,1,16417901,"pubmed1",6.26E+018,"testalpha"
,"thetoxicity profile of bortezomib","NN NN IN ",4,1,1,17016040,2,4.69E+018,"testalpha"
,"histogenetic type breslow thickness","JJ NN VB NN",4,1,1,16585990,2,3.06E+018,"testalpha"
,"characteristics of deployed healthywarriors","NNS IN VBN NNS",4,1,1,16405857,"pubmed1",7.61E+018,"testalpha"
,"topical therapy includes corticosteroids","JJ NN VBZ NNS",4,1,1,17010269,2,5.82E+018,"testalpha"
,"reconstructive surgery university hospital","JJ NN NN NN",4,1,1,16722345,2,4.98E+018,"testalpha"
,"transfections of baby hamster","NNS IN NN NN",4,1,1,16914903,2,4.73E+018,"testalpha"
,"fiveplexiform neurofibromas and pruritus","NN NNP CC NN",4,1,1,17010267,2,1.79E+018,"testalpha"
,"strategies toprevent chronic diseases","NNS NN JJ NNS",4,1,1,16918068,"pubmed1",6.58E+018,"testalpha"
,"includes early detection soit","VBZ JJ NN ",4,1,1,16859619,2,7.59E+018,"testalpha"
,"complete response and patient","JJ NN CC NN",4,1,1,17119326,2,8.77E+018,"testalpha"
,"i e human phenylalanine","  JJ NN",4,1,1,16823609,"pubmed1",8.69E+018,"testalpha"
,"amplitude voltages fluorescence microscopy","VB NNS NN ",4,1,1,16701857,"pubmed1",6.59E+018,"testalpha"
,"height perioperative blood loss","NN JJ NN NN",4,1,1,17139896,2,5.49E+018,"testalpha"
,"local sites of tissue","JJ NNS IN NN",4,1,1,16770444,"pubmed1",3.78E+018,"testalpha"
,"states and iatrogenic factors","NNS CC JJ NNS",4,1,1,16462409,"pubmed1",5.77E+018,"testalpha"
,"effect on rnase p","NN IN NN ",4,1,1,16648912,2,5.52E+018,"testalpha"
,"pkautophosphorylation sites abcde casette","NN NNS  NNP",4,1,1,16404475,"pubmed1",6.66E+018,"testalpha"
,"included patients with hodgkin","VBD NNS IN NNP",4,1,1,16914904,2,1.83E+018,"testalpha"
,"patients with sporadic colorectal","NNS IN JJ NN",4,1,1,17139886,2,5.25E+018,"testalpha"
,"iron deficiency anemia ida","NN NN NN ",4,1,1,16809889,2,7.86E+018,"testalpha"
,"patency ofthe affected vessel","NN NNP VBN NN",4,1,1,16549901,2,3.81E+018,"testalpha"
,"result than laser application","NN IN NN NN",4,1,1,17293969,2,1.71E+018,"testalpha"
,"geographic socialand economic conditions","JJ NN JJ NNS",4,1,1,16696444,2,9.03E+018,"testalpha"
,"intervention month ems diversion","NN NN  NN",4,1,1,16365324,"pubmed1",3.21E+018,"testalpha"
,"barium enteroclysis and findings","NN NN CC NNS",4,1,1,16447095,"pubmed1",8.02E+018,"testalpha"
,"level ofselectivity is characteristic","NN NN VBZ NN",4,1,1,16411734,"pubmed1",1.99E+018,"testalpha"
,"stromal cells into osteoblasts","JJ NNS IN NNS",4,1,1,16443258,2,2.19E+018,"testalpha"
,"angiogenesis and tumour growth","NN CC JJ NN",4,1,1,16388313,"pubmed1",5.11E+018,"testalpha"
,"myosin ii activity influences","NNP  NN NNS",4,1,1,17115079,"pubmed1",1.82E+017,"testalpha"
,"surviving normal muscle fibers","VBG JJ NN NNS",4,1,1,16965805,2,2.33E+018,"testalpha"
,"determines theunit cell parameters","VBZ JJ NN NNS",4,1,1,16369093,2,4.80E+018,"testalpha"
,"were selected age gender","VBD VBN NN NN",4,1,1,16585990,2,8.65E+018,"testalpha"
,"exploration of theunderlying pathologies","NN IN VBG NNS",4,1,1,16549895,2,4.70E+018,"testalpha"
,"mesophyll and bundle sheath","NN CC NN NN",4,1,1,17106510,"pubmed1",2.81E+018,"testalpha"
,"wrong opinion of therespondent","JJ NN IN NN",4,1,1,16434013,"pubmed1",5.90E+018,"testalpha"
,"data mtm resistance data","NN  NN NNS",4,1,1,17285744,"pubmed1",4.58E+018,"testalpha"
,"etiology during late ards","NN IN JJ ",4,1,1,16451155,"pubmed1",4.61E+018,"testalpha"
,"ischemia and reperfusion i","NN CC NN ",4,1,1,17013514,2,6.50E+018,"testalpha"
,"women attendingselected primary care","NNS VBN JJ NN",4,1,1,16514839,2,3.47E+018,"testalpha"
,"goal forseveral research laboratories","NN JJ NN NNS",4,1,1,16411739,"pubmed1",6.62E+018,"testalpha"
,"creb family oftranscription factors"," NN NN NNS",4,1,1,16395528,"pubmed1",5.38E+017,"testalpha"
,"practical scale up model","JJ NN IN NN",4,1,1,17285748,"pubmed1",2.90E+017,"testalpha"
,"concentration and critical perinatalperiods","NN CC JJ NNS",4,1,1,16808045,"pubmed1",7.22E+018,"testalpha"
,"th age dependent percentiles"," NN JJ NNS",4,1,1,16549894,2,7.68E+018,"testalpha"
,"poly diaqua mu glycinato"," NNP  NN",4,1,1,16397335,2,1.42E+018,"testalpha"
,"pe case enhancement ratios"," NN NN NNS",4,1,1,16399029,"pubmed1",1.48E+018,"testalpha"
,"heat on thehuman organism","NN IN NN NN",4,1,1,17294912,2,2.47E+018,"testalpha"
,"g sil r il","  NN ",4,1,1,16603096,2,2.55E+018,"testalpha"
,"gen induced kidney damage"," VBN NN NN",4,1,1,16999986,2,2.69E+018,"testalpha"
,"tests were used toassess","NNS VBD VBN NN",4,1,1,17265691,2,4.57E+018,"testalpha"
,"found foralcohol related motor","VBN NN VBN NN",4,1,1,16169506,"pubmed1",8.37E+018,"testalpha"
,"dermis tothe subcutaneous fat","NN NNP JJ NN",4,1,1,16648918,2,4.59E+018,"testalpha"
,"stimulated p and p","VBN  CC ",4,1,1,16733561,"pubmed1",3.67E+018,"testalpha"
,"method of stapled ileo","NN IN VBN ",4,1,1,17139887,2,5.53E+018,"testalpha"
,"treatment for urinary tractinfections","NN IN JJ NNS",4,1,1,16365328,"pubmed1",1.36E+018,"testalpha"
,"chronic myelogenous leukaemia cml","JJ JJ NN ",4,1,1,16809884,2,7.05E+018,"testalpha"
,"reports case series abstracts","NNS NN NN NNS",4,1,1,16365335,"pubmed1",1.03E+018,"testalpha"
,"age male sex dependency","NN NN NN NN",4,1,1,16451146,"pubmed1",2.69E+018,"testalpha"
,"license programs on teen","NN NNS IN ",4,1,1,16171767,"pubmed1",1.32E+018,"testalpha"
,"artery aneurysm with occlusion","NN  IN NN",4,1,1,16612927,"pubmed1",3.70E+018,"testalpha"
,"directed ambulance destination control","VBN NN NN NN",4,1,1,16365324,"pubmed1",7.42E+017,"testalpha"
,"sections from patientswith cc","NNS IN NN ",4,1,1,17139902,2,8.76E+018,"testalpha"
,"polarization colors of picrosirius","NN NNS IN NNP",4,1,1,16899283,2,6.63E+018,"testalpha"
,"posttraumaticstress syndrome or parts","NN NN CC NNS",4,1,1,17236646,"pubmed1",8.70E+018,"testalpha"
,"globule size and size","NN NN CC NN",4,1,1,16584167,"pubmed1",3.98E+018,"testalpha"
,"prenataldevelopment early postnatal maturation","NN JJ NN NN",4,1,1,16808045,"pubmed1",6.84E+018,"testalpha"
,"old man with hepatitis","JJ NN IN NN",4,1,1,17119328,2,8.89E+018,"testalpha"
,"thetreatment of pediatric patients","NN IN JJ NNS",4,1,1,16421443,2,7.47E+017,"testalpha"
,"patients withchronic idiopathic myelofibrosis","NNS JJ JJ NN",4,1,1,16424657,2,2.45E+018,"testalpha"
,"medical records of allpatients","JJ NNS IN NNS",4,1,1,16436791,"pubmed1",1.62E+018,"testalpha"
,"groups was acute hepatitis","NNS VBD JJ NN",4,1,1,16696442,2,7.14E+018,"testalpha"
,"pharyngectomy and total laryngectomy","NN CC JJ NN",4,1,1,16989147,2,6.53E+018,"testalpha"
,"clinical features laboratory parameters","JJ NNS NN NNS",4,1,1,17117607,2,4.69E+017,"testalpha"
,"asfollows grade normal liver","VBZ NN JJ NN",4,1,1,16673610,2,4.33E+018,"testalpha"
,"structures of isolated nbds","NNS IN VBN ",4,1,1,16511258,2,2.75E+018,"testalpha"
,"viaenzyme linked immunosorbent assay"," VBN NN NN",4,1,1,16594642,"pubmed1",7.89E+018,"testalpha"
,"cd dr andcd cd","   ",4,1,1,17119322,2,4.04E+018,"testalpha"
,"non crystallographic symmetry ncs"," JJ NN ",4,1,1,16511271,2,1.63E+018,"testalpha"
,"g l methanol g","  NN ",4,1,1,17019438,"pubmed1",4.64E+017,"testalpha"
,"driver months of licensureand","NN NNS IN NN",4,1,1,16112070,"pubmed1",8.93E+018,"testalpha"
,"areas have occurred conclusion","NNS VBP VBD NN",4,1,1,16473988,"pubmed1",6.66E+018,"testalpha"
,"gm csf stem cell","  VB NN",4,1,1,16404477,"pubmed1",3.12E+018,"testalpha"
,"indicator ofgastrointestinal interstitial microcirculation","NN JJ JJ NN",4,1,1,17438835,2,7.36E+018,"testalpha"
,"researcher theresearch group leader","NN NN NN NN",4,1,1,16377817,"pubmed1",1.02E+018,"testalpha"
,"liverhemangiomas with atypical appearance","NNP IN JJ NN",4,1,1,16333704,"pubmed1",8.76E+018,"testalpha"
,"diameter and pore area","NN CC  NN",4,1,1,16701855,"pubmed1",1.50E+018,"testalpha"
,"effort related upper extremity","NN VBN JJ NN",4,1,1,16549899,2,7.62E+018,"testalpha"
,"methods forty sixhd patients","NNS NN  NNS",4,1,1,17119323,2,7.09E+018,"testalpha"
,"incompetent vein and ablationwith","JJ NN CC NN",4,1,1,16612909,2,3.82E+018,"testalpha"
,"limiting step in catalysis","VBG NN IN NN",4,1,1,16511248,2,2.60E+018,"testalpha"
,"pyruvate diffracted x rays","NN VBN NN NNS",4,1,1,16511261,2,9.30E+015,"testalpha"
,"serum uric acid ua","NN JJ NN ",4,1,1,17338197,2,3.54E+018,"testalpha"
,"improved cellular interaction andsubsequent","VBN JJ NN NN",4,1,1,16701855,"pubmed1",1.45E+018,"testalpha"
,"vr apple computer inc"," NNS NN ",4,1,1,16399038,"pubmed1",1.82E+018,"testalpha"
,"novelgjb mutation p gly"," NN  ",4,1,1,17106596,2,2.65E+018,"testalpha"
,"unstable allergens in fruits","JJ NNS IN NNS",4,1,1,16673562,2,6.04E+018,"testalpha"
,"acid and glutamic acidresidues","NN CC JJ NNS",4,1,1,16496040,"pubmed1",3.53E+018,"testalpha"
,"increasing ebpadma tegdma ratio","VBG NN NN NN",4,1,1,16701862,"pubmed1",6.40E+018,"testalpha"
,"fragments of protein chains","NNS IN NN NNS",4,1,1,16365636,"pubmed1",3.65E+018,"testalpha"
,"decisions or implicitperceptual processes","NNS CC JJ NNS",4,1,1,16426558,"pubmed1",7.82E+018,"testalpha"
,"independent plant type l","JJ NN NN ",4,1,1,17143335,"pubmed1",5.74E+018,"testalpha"
,"atrx fos dnmt dnmt","   ",4,1,1,16914901,2,7.39E+018,"testalpha"
,"enhanced prospects of lymph","VBN NNS IN NN",4,1,1,16603102,2,3.84E+018,"testalpha"
,"patients men and women","NNS NNS CC NNS",4,1,1,16612911,2,7.50E+018,"testalpha"
,"excise or coagulate tissues","NN CC NN NNS",4,1,1,17139880,2,5.82E+018,"testalpha"
,"correlation between liver echogenicity","NN IN NN NN",4,1,1,16673610,2,2.19E+018,"testalpha"
,"proteins than ad cases","NNS IN NN NNS",4,1,1,16859611,2,1.20E+018,"testalpha"
,"ii activity byblocking rho"," NN VBG ",4,1,1,17115079,"pubmed1",4.26E+018,"testalpha"
,"age sex andcalendar year","NN NN NN NN",4,1,1,16139232,"pubmed1",6.93E+018,"testalpha"
,"specific inhibitor of hif","JJ NN IN ",4,1,1,17143338,"pubmed1",6.70E+017,"testalpha"
,"main chain and refines","JJ NN CC NNS",4,1,1,16421450,2,2.37E+018,"testalpha"
,"non ischemic myocardium alongwith"," JJ NN NN",4,1,1,16451157,"pubmed1",1.72E+018,"testalpha"
,"post operative transfusion requirements","NN JJ NN NNS",4,1,1,16451158,"pubmed1",6.98E+018,"testalpha"
,"assay enabling detection ofthe","NN VBG NN NNP",4,1,1,16929381,"pubmed1",8.26E+018,"testalpha"
,"grass and mugwort pollen","NN CC NN NN",4,1,1,17328144,2,8.87E+017,"testalpha"
,"initial lesion of atherosclerosis","JJ NN IN NN",4,1,1,16479030,2,8.29E+017,"testalpha"
,"adaptation with reduced speeds","NN IN VBN NNS",4,1,1,16426558,"pubmed1",2.10E+018,"testalpha"
,"binding protein c bp","VBG NN NN ",4,1,1,16964325,"pubmed1",3.29E+018,"testalpha"
,"last month intravenous iron","JJ NN JJ NN",4,1,1,17119323,2,8.96E+017,"testalpha"
,"modalities of biological pulp","NNS IN JJ NN",4,1,1,16919707,2,8.37E+018,"testalpha"
,"patients with thrombotic complications","NNS IN JJ NNS",4,1,1,16696443,2,2.02E+017,"testalpha"
,"ku and k cell"," CC  NN",4,1,1,16809884,2,5.77E+018,"testalpha"
,"undergoing surgicalresection of rectal","VBG NN IN NN",4,1,1,17236639,"pubmed1",3.85E+018,"testalpha"
,"association with injury rates","NN IN NN NNS",4,1,1,16430845,"pubmed1",8.31E+017,"testalpha"
,"history skintests biological tests","NN NNS JJ NNS",4,1,1,16673561,2,6.39E+017,"testalpha"
,"demonstrated dyslipidaemia in patients","VBN NN IN NNS",4,1,1,16479028,2,9.07E+018,"testalpha"
,"reduces bp and i","VBZ  CC ",4,1,1,16764913,2,4.37E+018,"testalpha"
,"common bile duct resection","JJ NN  NN",4,1,1,16612931,"pubmed1",8.88E+018,"testalpha"
,"human common type acylphosphatase","JJ JJ NN NN",4,1,1,16511269,2,5.71E+018,"testalpha"
,"found torepair cytotoxic dna","VBD NN JJ ",4,1,1,16733554,"pubmed1",3.74E+017,"testalpha"
,"agonist evoked strong calcium","NN VBD JJ NN",4,1,1,17115079,"pubmed1",8.32E+018,"testalpha"
,"inthe treatment of diabetes","NNP NN IN NN",4,1,1,16918071,"pubmed1",2.71E+018,"testalpha"
,"foreducation in anatomy training","NN IN NN NN",4,1,1,16399038,"pubmed1",9.58E+017,"testalpha"
,"dermalextract on western immunoblot","NN IN JJ NN",4,1,1,16955192,2,7.17E+018,"testalpha"
,"societal factors bear consideration","NN NNS VB NN",4,1,1,16473991,"pubmed1",5.79E+018,"testalpha"
,"methods patients with nafld","NNS NNS IN ",4,1,1,16673555,2,7.05E+018,"testalpha"
,"average age percentof postmenopausal","NN NN  NN",4,1,1,17338203,2,4.76E+018,"testalpha"
,"good agreement with values","JJ NN IN NNS",4,1,1,17133956,2,1.22E+018,"testalpha"
,"expression using quantitative pcr","NN VBG JJ ",4,1,1,16914901,2,1.64E+018,"testalpha"
,"endpoint for populationbased studies","NN IN VBN NNS",4,1,1,17010274,2,6.91E+018,"testalpha"
,"crystallization and ultimate structure","NN CC JJ NN",4,1,1,16511271,2,4.76E+018,"testalpha"
,"infusions of ibandronate mg","NNS IN NN ",4,1,1,17016034,2,6.63E+018,"testalpha"
,"patients with hs n","NNS IN  ",4,1,1,17016037,2,5.72E+017,"testalpha"
,"solution with various ph","NN IN JJ ",4,1,1,16701857,"pubmed1",3.22E+018,"testalpha"
,"conservative day fatalityadjustment factor","JJ NN NN NN",4,1,1,16430844,"pubmed1",9.09E+018,"testalpha"
,"focal adhesion kinase p","JJ NN NN ",4,1,1,17106595,2,6.39E+018,"testalpha"
,"human colon cancer ht","JJ NN NN ",4,1,1,16733561,"pubmed1",3.71E+018,"testalpha"
,"ofed patients with chest","VBD NNS IN NN",4,1,1,16365321,"pubmed1",8.78E+018,"testalpha"
,"naja and d polylepsis"," CC  NN",4,1,1,16436788,"pubmed1",4.96E+018,"testalpha"
,"anticipated cessation relatedhealth improvement","VBN NN NN NN",4,1,1,16365327,"pubmed1",8.02E+017,"testalpha"
,"altered connective tissue properties","VBN JJ NN NNS",4,1,1,16962646,2,5.62E+018,"testalpha"
,"type andmutant codons approach","NN JJ NNS NN",4,1,1,16823609,"pubmed1",5.10E+018,"testalpha"
,"constant kapp of thisreaction","JJ  IN NN",4,1,1,17019443,"pubmed1",3.29E+018,"testalpha"
,"showed thickened bowel wall","VBD VBN NN NN",4,1,1,16447095,"pubmed1",1.94E+018,"testalpha"
,"subsequent database search identification","JJ NN NN NN",4,1,1,16710579,2,7.47E+017,"testalpha"
,"indications results and pitfallsof","NNS NNS CC ",4,1,1,17139898,2,3.55E+018,"testalpha"
,"initiate intramolecular signal transduction","VBP JJ NN NN",4,1,1,16411738,"pubmed1",2.69E+018,"testalpha"
,"theendonucleolytic cleavage of trna","JJ NN IN ",4,1,1,16648912,2,2.49E+018,"testalpha"
,"borborygmi colicpain flatulence constipation"," VB NN NN",4,1,1,16424650,2,2.11E+018,"testalpha"
,"series common radiologic findings","NN JJ JJ NNS",4,1,1,16333694,"pubmed1",6.36E+017,"testalpha"
,"balance and circulatory function","NN CC JJ NN",4,1,1,16462411,"pubmed1",6.32E+018,"testalpha"
,"gal for d gal"," IN  ",4,1,1,16456293,2,8.30E+018,"testalpha"
,"bicycle related head injuries","NN VBN NN NNS",4,1,1,16223468,"pubmed1",4.66E+018,"testalpha"
,"sensory and motor axons","NN CC NN NNS",4,1,1,16414104,2,3.89E+018,"testalpha"
,"initiation of cfa i","NN IN  ",4,1,1,16511280,2,9.06E+018,"testalpha"
,"diminishes infiltration of neutrophilsto","VBZ NN IN NNP",4,1,1,16491218,2,4.31E+018,"testalpha"
,"ofgrowth of horny scutes","NN IN JJ NNS",4,1,1,16733064,2,1.73E+018,"testalpha"
,"effect onblood sugar response","NN NN NN NN",4,1,1,16918071,"pubmed1",8.87E+018,"testalpha"
,"case of asige measurements","NN IN NN NNS",4,1,1,16603096,2,2.06E+018,"testalpha"
,"providesan increase of survival","JJ NN IN NN",4,1,1,17013518,2,2.48E+018,"testalpha"
,"i deletion of part"," NN IN NN",4,1,1,16511258,2,2.75E+018,"testalpha"
,"iii causes nostructural perturbations"," NNS JJ NNS",4,1,1,16421446,2,6.18E+018,"testalpha"
,"propofol propce and remice","  CC NN",4,1,1,17067138,"pubmed1",5.03E+018,"testalpha"
,"congenital prothrombin complex factor","NN NNP JJ NN",4,1,1,16424651,2,5.51E+018,"testalpha"
,"inflammation and expel theparasites","NN CC VB NNS",4,1,1,16410836,"pubmed1",4.78E+018,"testalpha"
,"trends towards less complications","NNS IN JJR NNS",4,1,1,16613748,2,5.29E+018,"testalpha"
,"remission withbreast cancer n","NN JJS NN ",4,1,1,17016036,2,5.54E+018,"testalpha"
,"acute abdomen or intestinalobstruction","JJ NN CC NN",4,1,1,16612930,"pubmed1",7.26E+018,"testalpha"
,"decision of g csfadministration","NN IN  NN",4,1,1,16809884,2,7.92E+018,"testalpha"
,"clips of driving rating","NNS IN VBG NN",4,1,1,16427019,"pubmed1",1.90E+018,"testalpha"
,"ofintroduction absorption and utilization","NN NN CC NN",4,1,1,16918067,"pubmed1",7.75E+018,"testalpha"
,"progenitor ora liver trunk","NN  NN NN",4,1,1,17013517,2,7.76E+018,"testalpha"
,"ongoing medicinal chemistry projects","JJ JJ NN NNS",4,1,1,16369099,2,3.57E+018,"testalpha"
,"areas of statistical significance","NNS IN JJ NN",4,1,1,16252139,"pubmed1",7.55E+018,"testalpha"
,"technology associates fta filter","NN NNS  NN",4,1,1,16951742,"pubmed1",7.20E+018,"testalpha"
,"age matched general population","NN VBN JJ NN",4,1,1,16451146,"pubmed1",7.47E+016,"testalpha"
,"septic shock in hospital","JJ NN IN NN",4,1,1,16365336,"pubmed1",7.25E+018,"testalpha"
,"questionnaire on proctology practice","NN IN NN NN",4,1,1,16673559,2,7.35E+018,"testalpha"
,"c catalyzed nitrotyrosine formation","NN VBN NN NN",4,1,1,16951741,"pubmed1",3.86E+018,"testalpha"
,"data and vital registration","NNS CC JJ NN",4,1,1,16430844,"pubmed1",8.83E+018,"testalpha"
,"surface treatmentpresented more deposition","NN VBN JJR NN",4,1,1,17293968,2,7.50E+018,"testalpha"
,"higher risk of vulvo","JJR NN IN ",4,1,1,16955190,2,5.80E+018,"testalpha"
,"theperiimplantation embryo uterine dialog","NN  NN NN",4,1,1,16808046,"pubmed1",2.33E+018,"testalpha"
,"useful foran adequate tracking","JJ NN JJ NN",4,1,1,17285747,"pubmed1",5.62E+018,"testalpha"
,"demonstration of monosodiumurate msu","NN IN NN ",4,1,1,16514850,2,4.46E+017,"testalpha"
,"exanthema and eczematous eruptions","NN CC JJ NNS",4,1,1,17106599,2,6.71E+018,"testalpha"
,"gly leu val phe","   ",4,1,1,16496040,"pubmed1",4.80E+018,"testalpha"
,"neurologic injury in humans","JJ NN IN NNS",4,1,1,16436787,"pubmed1",1.01E+017,"testalpha"
,"invasion and extracellular proteindigestion","NN CC JJ NN",4,1,1,16410836,"pubmed1",3.31E+018,"testalpha"
,"laser treatment in therabbits","NN NN IN NNS",4,1,1,16648911,2,4.24E+018,"testalpha"
,"different hormones and growth","JJ NNS CC NN",4,1,1,16714054,2,1.23E+018,"testalpha"
,"nucleus and cytoplasm condensation","NN CC NN NN",4,1,1,17133953,2,4.97E+018,"testalpha"
,"ami and e plasma"," CC  NNP",4,1,1,16594642,"pubmed1",1.69E+018,"testalpha"
,"hyperechogenicity on ultrasound hyperdensity","NN IN NN NN",4,1,1,16314989,"pubmed1",6.70E+018,"testalpha"
,"evaluation of coronary arteries","NN IN NN NNS",4,1,1,16399037,"pubmed1",4.03E+018,"testalpha"
,"cc score and monthsin"," NN CC NNP",4,1,1,17139879,2,8.08E+018,"testalpha"
,"benefit in os andpfs","NN IN  ",4,1,1,16424643,2,6.01E+018,"testalpha"
,"ofthe transcription start site","NNP NN NN NN",4,1,1,16964327,"pubmed1",9.15E+018,"testalpha"
,"generalemergency medicine em journals","NN NN  NNS",4,1,1,16365335,"pubmed1",8.90E+017,"testalpha"
,"albino rats following intranasal","NNP NNS VBG NN",4,1,1,16584167,"pubmed1",3.89E+018,"testalpha"
,"anova and covariance analysis","NNP CC NN NN",4,1,1,16491220,2,3.78E+018,"testalpha"
,"ii technique hcii digene"," NN  NN",4,1,1,16514835,2,4.47E+017,"testalpha"
,"distribution of inh beta","NN IN  NN",4,1,1,16423381,2,2.05E+016,"testalpha"
,"tissue preservation efficiency ofacetone","NN NN NN NN",4,1,1,16950501,2,7.72E+018,"testalpha"
,"substrate specificity for catechol","NN NN IN NN",4,1,1,16511281,2,3.86E+018,"testalpha"
,"f ser ile lys","NN   ",4,1,1,16496040,"pubmed1",3.59E+018,"testalpha"
,"ala thr towardscopper ii","  NN ",4,1,1,16496037,"pubmed1",4.28E+018,"testalpha"
,"ahuman liver cdna library","NN NN  NN",4,1,1,16951743,"pubmed1",4.51E+018,"testalpha"
,"process and increase throughput","NN CC VB NN",4,1,1,16369099,2,2.26E+017,"testalpha"
,"hasapparent support from crash","NN NN IN NN",4,1,1,16426560,"pubmed1",2.77E+018,"testalpha"
,"directed transfer function sdtf","VBN VB NN ",4,1,1,17133951,2,5.94E+018,"testalpha"
,"cml patients with differentbcr"," NNS IN ",4,1,1,16914906,2,7.42E+018,"testalpha"
,"colour word naming test","JJ NN VBG NN",4,1,1,16874421,2,4.34E+018,"testalpha"
,"inhibition ofnf kappab activity","NN   NN",4,1,1,17068636,"pubmed1",6.47E+018,"testalpha"
,"f cyclins cip kip","NN NNS  ",4,1,1,17115080,"pubmed1",1.41E+018,"testalpha"
,"mode atomic force microscopy","NN JJ NN ",4,1,1,16701857,"pubmed1",3.78E+018,"testalpha"
,"exon nt c t","  NN ",4,1,1,16424658,2,3.12E+018,"testalpha"
,"maze performance by cd","NN NN IN ",4,1,1,17265691,2,5.59E+018,"testalpha"
,"outcomes following abuse patterns","NNS VBG NN NNS",4,1,1,16808045,"pubmed1",8.97E+018,"testalpha"
,"best practices constitute a''snapshot'","JJS NNS VB ",4,1,1,16377817,"pubmed1",1.16E+018,"testalpha"
,"withwomen within acute care","NNS IN JJ NN",4,1,1,16596895,"pubmed1",5.36E+018,"testalpha"
,"cardiacindex vascular resistance system","NN JJ NN NN",4,1,1,16491220,2,9.95E+017,"testalpha"
,"membrane receptor of mk","NN NN IN ",4,1,1,16965805,2,4.81E+018,"testalpha"
,"transplants or temporary skinreplacements","NNS CC JJ NNS",4,1,1,16999270,2,7.50E+018,"testalpha"
,"variance anova and student","NN NNP CC NN",4,1,1,17293959,2,1.40E+018,"testalpha"
,"saline ns d polylepsis","NN   NN",4,1,1,16436788,"pubmed1",8.86E+018,"testalpha"
,"atpiii criteria asia pacific"," NNS  NNP",4,1,1,16479027,2,4.35E+018,"testalpha"
,"diffraction and low selenium","NN CC JJ NN",4,1,1,16369100,2,2.12E+018,"testalpha"
,"em in tertiary care"," IN JJ NN",4,1,1,16514840,2,1.33E+018,"testalpha"
,"surgeon general surgeon gynaecologist","NN JJ NN NN",4,1,1,17139877,2,1.16E+018,"testalpha"
,"more hours slept orfewer","JJR NNS VBD NN",4,1,1,16377826,"pubmed1",4.88E+018,"testalpha"
,"treatmentof minor liver injuries"," JJ NN NNS",4,1,1,17013521,2,5.01E+018,"testalpha"
,"patients with rheumatic stenosis","NNS IN JJ NN",4,1,1,16989140,2,2.65E+018,"testalpha"
,"r group minute ischemia","NN NN NN NN",4,1,1,17013508,2,2.68E+018,"testalpha"
,"productanalyses of ribosomal dna","NNS IN JJ ",4,1,1,17019438,"pubmed1",2.03E+018,"testalpha"
,"ttv infection in slovakia"," NN IN NNP",4,1,1,16696442,2,9.35E+016,"testalpha"
,"significantsymptomatic protection against ap","JJ NN IN ",4,1,1,17007911,2,5.97E+018,"testalpha"
,"potentialproblem with device closure","NN IN NN NN",4,1,1,16612922,"pubmed1",6.56E+018,"testalpha"
,"fak expression on melanocytes"," NN IN NNS",4,1,1,17106595,2,8.08E+018,"testalpha"
,"effects of radiation damage","NNS IN NN NN",4,1,1,16369100,2,7.78E+018,"testalpha"
,"hybrid capture ii technique","JJ VB  NN",4,1,1,16514835,2,5.13E+018,"testalpha"
,"liver transplantation fromcadaveric donors","NN NN JJ NNS",4,1,1,17013513,2,9.99E+016,"testalpha"
,"visits forsledding related injuries","NNS VBG VBN NNS",4,1,1,16436798,"pubmed1",9.00E+018,"testalpha"
,"morphological rearrangement of gliomac","JJ NN IN NNP",4,1,1,17115079,"pubmed1",2.18E+018,"testalpha"
,"verbal memory and executivefunction","JJ NN CC NN",4,1,1,16479025,2,7.37E+018,"testalpha"
,"pain level blood pressure","NN NN NN NN",4,1,1,16365322,"pubmed1",1.08E+018,"testalpha"
,"different areas ofprimary colorectal","JJ NNS JJ NN",4,1,1,16430945,2,7.48E+018,"testalpha"
,"aim of linking computedtomography","NN IN VBG NN",4,1,1,16399039,"pubmed1",7.97E+018,"testalpha"
,"etiology of nasal defects","NN IN NN NNS",4,1,1,17165594,2,1.66E+018,"testalpha"
,"safety and medical fallibilitycurriculum","NN CC JJ NN",4,1,1,16377828,"pubmed1",4.38E+018,"testalpha"
,"weighted imaging sequences perfusionmeasurements","JJ VBG NNS NNS",4,1,1,16447077,"pubmed1",2.74E+018,"testalpha"
,"differences in resource use","NNS IN NN NN",4,1,1,16451154,"pubmed1",7.62E+018,"testalpha"
,"initial workup and monitoring","JJ NN CC NN",4,1,1,16317492,"pubmed1",4.01E+018,"testalpha"
,"progesterone p for days","NN  IN NNS",4,1,1,16584758,2,4.96E+018,"testalpha"
,"c with unit cellparameters","NN IN NN NNS",4,1,1,16511293,2,7.54E+018,"testalpha"
,"rnai silences gene expression"," NNS  NN",4,1,1,16395523,"pubmed1",5.63E+018,"testalpha"
,"sufficientquality for structure determination","NN IN NN NN",4,1,1,16369100,2,4.02E+018,"testalpha"
,"diagnosed dependence on alcoholwas","VBN NN IN ",4,1,1,16236233,"pubmed1",8.07E+018,"testalpha"
,"was development of vacuolization","VBD NN IN NN",4,1,1,16956122,2,7.57E+018,"testalpha"
,"molecular mechanism of inositolhexaphosphate","JJ NN IN NN",4,1,1,16733561,"pubmed1",5.20E+018,"testalpha"
,"deoxynucleotidyltransferase mediated deoxyuridine triphosphate","NN VBN NN NN",4,1,1,16395522,"pubmed1",2.34E+018,"testalpha"
,"monomer bis phenyl glycidyl","NN  NN ",4,1,1,16701856,"pubmed1",8.89E+018,"testalpha"
,"killing activity against wehi","VBG NN IN ",4,1,1,17117211,"pubmed1",1.61E+018,"testalpha"
,"cis acting element plays"," VBG NN NNS",4,1,1,16395526,"pubmed1",9.50E+017,"testalpha"
,"london teaching hospitaland report","NNP VBG NN NN",4,1,1,16321534,"pubmed1",6.63E+018,"testalpha"
,"aesthetic improvement in patients","JJ NN IN NNS",4,1,1,16722347,2,2.03E+018,"testalpha"
,"examination of rat skin","NN IN NN NN",4,1,1,16574202,2,8.82E+018,"testalpha"
,"rate ofhydrolysis yielded activation","NN NN VBD NN",4,1,1,17117212,"pubmed1",1.40E+018,"testalpha"
,"neutrophils lymphocytes and eosinophils","NNS NNS CC NNS",4,1,1,17293958,2,8.60E+018,"testalpha"
,"patients with aplacebo group","NNS IN  NN",4,1,1,16479024,2,7.08E+018,"testalpha"
,"v and dimethylarsenate dma"," CC NN ",4,1,1,17019444,"pubmed1",1.36E+018,"testalpha"
,"addressed stamped return envelope","VBN VBN NN NN",4,1,1,16377812,"pubmed1",2.54E+018,"testalpha"
,"validate software for assessment","VB NN IN NN",4,1,1,16648914,2,4.43E+017,"testalpha"
,"disease with demonstrable neurologicpathology","NN IN JJ NN",4,1,1,16436787,"pubmed1",1.76E+018,"testalpha"
,"caucasian female at weeks","JJ NN IN NNS",4,1,1,16916187,"pubmed1",6.45E+018,"testalpha"
,"nih t and ct","  CC ",4,1,1,16701879,"pubmed1",1.83E+018,"testalpha"
,"dyes indocyanine green icg"," NN JJ ",4,1,1,16399028,"pubmed1",2.00E+017,"testalpha"
,"skin heart colon lung","NN NN NN NN",4,1,1,16514845,2,6.15E+018,"testalpha"
,"involving spinal analgesics andantihyperalgesic","VBG JJ NNS NN",4,1,1,17236639,"pubmed1",6.84E+018,"testalpha"
,"cortex were group pss","NNP VBD NN ",4,1,1,16491220,2,4.57E+017,"testalpha"
,"inthe structure function relationship","NNP NN NN NN",4,1,1,16929383,"pubmed1",4.23E+018,"testalpha"
,"d and r p"," CC NN ",4,1,1,16585980,2,8.32E+018,"testalpha"
,"e g dle lichen","   NNP",4,1,1,17311739,2,3.81E+018,"testalpha"
,"health consequences because ofits","NN NNS IN NNS",4,1,1,17013520,2,8.60E+018,"testalpha"
,"anddetermination of extracellular saccharase","NN IN JJ NN",4,1,1,16970980,2,2.84E+018,"testalpha"
,"attention from vital driving","NN IN JJ NN",4,1,1,16427019,"pubmed1",1.11E+018,"testalpha"
,"ischemia reperfusion injury iri","NN NN NN ",4,1,1,16491218,2,2.01E+018,"testalpha"
,"polarizing microscopy gelation gel","VBG  NN ",4,1,1,17285743,"pubmed1",7.03E+018,"testalpha"
,"episode and tertiary prevention","NN CC JJ NN",4,1,1,16462410,"pubmed1",6.95E+018,"testalpha"
,"critical roles inmitochondrion biogenesis","JJ NNS NN NN",4,1,1,16511294,2,1.22E+018,"testalpha"
,"borrelia induced lyme arthritis","NNP VBN  NN",4,1,1,16399028,"pubmed1",9.58E+017,"testalpha"
,"evidence for intracellular targets","NN IN JJ NNS",4,1,1,17265696,2,4.57E+018,"testalpha"
,"rateand c reactive protein","NN NN JJ NN",4,1,1,16809889,2,8.76E+018,"testalpha"
,"investigatedthe expression of ppargamma","NNP NN IN NN",4,1,1,16809887,2,1.04E+018,"testalpha"
,"thatthey had atopic dermatitis","NNP VBD NN NN",4,1,1,16648913,2,2.97E+018,"testalpha"
,"sub classes of 'process","NN NNS IN NN",4,1,1,17486414,"pubmed1",4.03E+018,"testalpha"
,"gel filtration and velocity"," NN CC NN",4,1,1,17019436,"pubmed1",1.49E+018,"testalpha"
,"year period consecutive children","NN NN JJ NNS",4,1,1,16549893,2,7.73E+018,"testalpha"
,"inner membrane tim complexes","JJ NN  NNS",4,1,1,16511294,2,6.64E+018,"testalpha"
,"patients females thrice flail","NNS NNS NN NN",4,1,1,16696443,2,3.28E+018,"testalpha"
,"clinical suspicion of sarcoidosis","JJ NN IN NN",4,1,1,16256177,2,3.58E+018,"testalpha"
,"group of ad patients","NN IN NN NNS",4,1,1,17328144,2,2.94E+018,"testalpha"
,"dfr dbr and positivecorrelation","  CC NN",4,1,1,16479025,2,6.91E+018,"testalpha"
,"theearliest publication on patch","NN NN IN NN",4,1,1,17438830,2,4.57E+016,"testalpha"
,"o andc h n","   ",4,1,1,16397334,2,6.23E+018,"testalpha"
,"clinical score w azs","JJ NN  ",4,1,1,16603096,2,8.76E+017,"testalpha"
,"haemorrhage and abdominal surgery","NN CC JJ NN",4,1,1,16916181,"pubmed1",2.62E+018,"testalpha"
,"observational study of patients","JJ NN IN NNS",4,1,1,16436793,"pubmed1",8.44E+018,"testalpha"
,"retroviral vector packaging celllines","JJ NN NN NNS",4,1,1,17160143,"pubmed1",1.79E+018,"testalpha"
,"ratio ofaligned lung volumes","NN VBN NN NNS",4,1,1,16399029,"pubmed1",3.86E+017,"testalpha"
,"correlated withthe neutrophil r","VBN NNP  NN",4,1,1,17119322,2,7.34E+018,"testalpha"
,"urethra and bladder neck"," CC NN NN",4,1,1,16962646,2,4.62E+018,"testalpha"
,"induces transdifferentiation of fibroblasts","NNS NN IN NNS",4,1,1,16395524,"pubmed1",9.09E+018,"testalpha"
,"nervous system cns cryptococcosis","JJ NN  NN",4,1,1,17370568,"pubmed1",1.14E+017,"testalpha"
,"l serum than inthe"," NN IN NNP",4,1,1,16764913,2,4.15E+018,"testalpha"
,"structures of vascular plants","NNS IN JJ NNS",4,1,1,17486414,"pubmed1",4.81E+018,"testalpha"
,"mimics theshort range protein","VBZ NN NN NN",4,1,1,16365636,"pubmed1",8.43E+018,"testalpha"
,"theorthorhombic space group p","JJ NN NN ",4,1,1,16511267,2,4.89E+017,"testalpha"
,"normalrange in intermediate patients","NN IN JJ NNS",4,1,1,16809886,2,8.26E+017,"testalpha"
,"intra acinar pulmonary arteries","JJ NN JJ NNS",4,1,1,16395524,"pubmed1",2.93E+018,"testalpha"
,"secondary leukemia afterconsolidation therapy","JJ NN NN NN",4,1,1,16914902,2,3.27E+018,"testalpha"
,"termhematological response morbidity mortality","JJ NN NN NN",4,1,1,16424648,2,1.15E+018,"testalpha"
,"country area and race","NN NN CC NN",4,1,1,16696444,2,6.07E+016,"testalpha"
,"performedusing fibroblast cell lines","VBG JJS NN NNS",4,1,1,16874413,2,7.62E+018,"testalpha"
,"pathogenic protein such asbeta","JJ NN JJ NN",4,1,1,16701860,"pubmed1",7.78E+018,"testalpha"
,"higher white blood cell","JJR JJ NN NN",4,1,1,16914906,2,1.43E+018,"testalpha"
,"radiology in detecting recurrentdisease","NN IN VBG NN",4,1,1,16514843,2,4.58E+017,"testalpha"
,"risk drivers kentucky data","NN NNS JJ NN",4,1,1,16405858,"pubmed1",4.87E+018,"testalpha"
,"createdynamic incident duration estimation","JJ NN NN NN",4,1,1,16426557,"pubmed1",3.04E+018,"testalpha"
,"bsa and pathogenic protein"," CC JJ NN",4,1,1,16701860,"pubmed1",6.93E+018,"testalpha"
,"beta expression in right","NN NN IN NN",4,1,1,17293967,2,1.50E+018,"testalpha"
,"extremity digital arteries embolization","NN NN NNS NN",4,1,1,16696443,2,3.32E+018,"testalpha"
,"activity in ckd patients","NN IN  NNS",4,1,1,17160142,"pubmed1",7.21E+018,"testalpha"
,"native andsemet substituted afcora","NN VB VBN NNP",4,1,1,16511288,2,2.81E+018,"testalpha"
,"causal factors related tothe","NN NNS VBN NNP",4,1,1,16122689,"pubmed1",6.35E+018,"testalpha"
,"follicular neoplasms hurthle cell","JJ NNS  NN",4,1,1,16514836,2,5.20E+018,"testalpha"
,"magnetic resonance imaging findings","JJ NN VBG NNS",4,1,1,16252140,"pubmed1",6.06E+018,"testalpha"
,"min of coronary artery"," IN JJ NN",4,1,1,16566960,2,7.45E+018,"testalpha"
,"toimprove organizational safety performance","VB JJ NN NN",4,1,1,16442068,"pubmed1",6.63E+018,"testalpha"
,"achieved complete remissions partialremissions","VBN JJ NNS NNS",4,1,1,16424645,2,7.41E+018,"testalpha"
,"afflicts young healthy individuals","NNS JJ JJ NNS",4,1,1,16549899,2,4.66E+018,"testalpha"
,"programs on teen driverfatalities","NNS IN  NNS",4,1,1,16171767,"pubmed1",3.95E+018,"testalpha"
,"hours cum from tablets","NNS  IN NNS",4,1,1,17285748,"pubmed1",7.14E+018,"testalpha"
,"h tyr c d","  NN ",4,1,1,16496038,"pubmed1",6.56E+018,"testalpha"
,"risk standardized mortality ratio","NN VBN NN NN",4,1,1,16710578,2,4.83E+018,"testalpha"
,"dc and water sorption"," CC NN NN",4,1,1,16701862,"pubmed1",5.40E+018,"testalpha"
,"non polyposis colorectal cancer"," NN NN NN",4,1,1,16673564,2,8.15E+018,"testalpha"
,"pain scores blood pressure","NN NNS NN NN",4,1,1,16612915,"pubmed1",8.53E+018,"testalpha"
,"cells of protaminobacter rubrum","NNS IN NN NN",4,1,1,16511267,2,6.94E+018,"testalpha"
,"filling on theselected object","NN IN VBN NN",4,1,1,16399033,"pubmed1",6.86E+018,"testalpha"
,"mesylate for advanced stage","NN IN VBN NN",4,1,1,16809884,2,8.42E+018,"testalpha"
,"measured withthe warren method","VBN NNP NNS NN",4,1,1,16956116,2,6.73E+018,"testalpha"
,"absence ofassociated health problems","NN VBN NN NNS",4,1,1,16808045,"pubmed1",4.83E+018,"testalpha"
,"dosing regimens comparing dmtreatment","VBG NNS VBG NN",4,1,1,16451144,"pubmed1",7.39E+018,"testalpha"
,"atp induced calcium responsepresents"," VBN NN NNS",4,1,1,17115079,"pubmed1",3.08E+018,"testalpha"
,"aboutprogress and upcoming modifications","NN CC VBG NNS",4,1,1,17285738,"pubmed1",8.33E+018,"testalpha"
,"resection ofthe parotid mass","NN NNP  NN",4,1,1,16514848,2,6.64E+018,"testalpha"
,"industrystandards and greater collaboration","NNS CC JJR NN",4,1,1,16438094,"pubmed1",2.21E+018,"testalpha"
,"betterbowel distention wall visualization","NN NN NN NN",4,1,1,16252139,"pubmed1",2.48E+018,"testalpha"
,"number of shortenmers thekidneys","NN IN NNS NNS",4,1,1,17285740,"pubmed1",7.91E+018,"testalpha"
,"therapeutic options of fusariosis","JJ NNS IN NN",4,1,1,16918066,"pubmed1",6.08E+018,"testalpha"
,"therapeutic approaches inmany situations","JJ NNS NN NNS",4,1,1,17068636,"pubmed1",3.31E+016,"testalpha"
,"exchange column chromatographic methods","NN NN JJ NNS",4,1,1,16511253,2,8.61E+018,"testalpha"
,"gap familycommittee proposes recommendations","NN NN VBZ NNS",4,1,1,16473998,"pubmed1",6.30E+018,"testalpha"
,"tissue growth factor ctgf","NN NN NN ",4,1,1,16395527,"pubmed1",7.31E+017,"testalpha"
,"celladhesion cell migration proteases","NN NN NN NNS",4,1,1,16730054,2,5.73E+018,"testalpha"
,"total resection of thislesion","NN NN IN NN",4,1,1,16612936,"pubmed1",8.63E+018,"testalpha"
,"treatedwith liposomal amphotericin b","NN JJ NNP NN",4,1,1,16918065,"pubmed1",2.50E+018,"testalpha"
,"accomplish rapid delivery ofdrug","VB JJ NN NN",4,1,1,16584167,"pubmed1",3.75E+018,"testalpha"
,"stem cells pb sc","VB NNS  ",4,1,1,16914909,2,8.79E+018,"testalpha"
,"hip subluxation and dislocation","NN NN CC NN",4,1,1,17438833,2,4.63E+018,"testalpha"
,"significant advances in science","JJ NNS IN NN",4,1,1,16596899,"pubmed1",1.44E+018,"testalpha"
,"range underwent elective cabg","VBP NN JJ ",4,1,1,17338197,2,9.13E+018,"testalpha"
,"surgery laparoscopic cholecystectomy laparotomy","NN NN NN NN",4,1,1,16914908,2,9.35E+017,"testalpha"
,"factors for eczematous skin","NNS IN JJ NN",4,1,1,16648919,2,8.65E+018,"testalpha"
,"year actuarial overall survival","NN JJ JJ NN",4,1,1,16424644,2,6.63E+018,"testalpha"
,"combination of varioustopical therapies","NN IN JJ NNS",4,1,1,17010269,2,5.44E+018,"testalpha"
,"days at mg kg","NNS IN  ",4,1,1,17013510,2,7.51E+018,"testalpha"
,"adiagnosis of mediastinal germ","NN IN JJ NN",4,1,1,16809892,2,4.16E+018,"testalpha"
,"afterhemorrhagic shock and fluid","JJ NN CC NN",4,1,1,16365323,"pubmed1",2.02E+017,"testalpha"
,"celiac artery occlusion cao","JJ NN NN ",4,1,1,17438835,2,1.81E+018,"testalpha"
,"gee and logistic models"," CC JJ NNS",4,1,1,16126153,"pubmed1",1.28E+018,"testalpha"
,"plywood patterned collagen bundles","NN VBN NN NNS",4,1,1,16733064,2,6.72E+018,"testalpha"
,"medial incision and resection","JJ NN CC NN",4,1,1,16956118,2,5.95E+017,"testalpha"
,"onychomycosis among diabetic patients","NN IN JJ NNS",4,1,1,16955188,2,1.77E+018,"testalpha"
,"peptide levels in type","VB NNS IN NN",4,1,1,16673610,2,2.66E+016,"testalpha"
,"approach is toenable predictions","NN VBZ JJ NNS",4,1,1,16399039,"pubmed1",1.69E+018,"testalpha"
,"children years of age","NNS NNS IN NN",4,1,1,16436798,"pubmed1",7.98E+018,"testalpha"
,"hdac atrx fos dnmt","   ",4,1,1,16914901,2,7.82E+018,"testalpha"
,"cyto screen system seroa"," NN NN ",4,1,1,16514835,2,7.80E+018,"testalpha"
,"containing domain of nqrf","VBG NN IN ",4,1,1,16511277,2,8.47E+018,"testalpha"
,"afterhes infusion in comparison","NNS NN IN NN",4,1,1,16451158,"pubmed1",2.27E+018,"testalpha"
,"conclusion nonalcoholic fatty liver","NN JJ JJ NN",4,1,1,17013519,2,3.88E+018,"testalpha"
,"hybrid capture andpu m","JJ VB  ",4,1,1,17019439,"pubmed1",1.56E+018,"testalpha"
,"enos gene inisolated human","  VBN NN",4,1,1,16733564,"pubmed1",5.47E+017,"testalpha"
,"tattoo ink after nd"," NN IN ",4,1,1,16648911,2,6.00E+018,"testalpha"
,"minimal handling of wash","JJ NN IN NN",4,1,1,16951742,"pubmed1",7.65E+018,"testalpha"
,"dioxide magnesium stearate grades","NN NN NN NNS",4,1,1,17285749,"pubmed1",6.38E+018,"testalpha"
,"amyloid deposits i e","VB NNS  ",4,1,1,16714051,2,6.59E+017,"testalpha"
,"defect by anal ultrasound","NN IN  NN",4,1,1,17139884,2,2.79E+018,"testalpha"
,"induction of g cell","NN IN  NN",4,1,1,16809887,2,3.19E+018,"testalpha"
,"coli at nucleotide resolution"," IN VB NN",4,1,1,16582987,"pubmed1",6.50E+018,"testalpha"
,"thealtered properties of tsr","VBN NNS IN ",4,1,1,16505899,"pubmed1",2.55E+018,"testalpha"
,"zinc bound solvent h","NN VBN NN ",4,1,1,16511248,2,2.18E+018,"testalpha"
,"enzymatic inventions and alltypes","JJ NNS CC NNS",4,1,1,17347785,"pubmed1",6.44E+018,"testalpha"
,"ano rectal pathologies namelyhemorrhoids"," NN NNS NNS",4,1,1,17139880,2,8.79E+018,"testalpha"
,"period ina contact clinic","NN  NN NN",4,1,1,16710586,2,3.22E+018,"testalpha"
,"molecular diagnostics and therapy","JJ NNS CC NN",4,1,1,16596744,"pubmed1",7.08E+018,"testalpha"
,"n and ahypoxia l"," CC  ",4,1,1,16395522,"pubmed1",6.65E+018,"testalpha"
,"showed marginal moderatedirect correlation","VBD JJ NN NN",4,1,1,16317488,"pubmed1",9.67E+016,"testalpha"
,"kvggn apafg aeale rm","  NN ",4,1,1,16770447,"pubmed1",1.69E+018,"testalpha"
,"cpa and postnatal complications"," CC NN NNS",4,1,1,16549889,2,5.56E+018,"testalpha"
,"e coli lacz mutants","   NNS",4,1,1,16733554,"pubmed1",6.93E+018,"testalpha"
,"cirrhosis andsimultaneous hepatic relapse","NN JJ JJ NN",4,1,1,17119328,2,6.45E+018,"testalpha"
,"fordrug content globule size","NN JJ NN NN",4,1,1,16584167,"pubmed1",5.85E+017,"testalpha"
,"prognosis and therapeutic options","NN CC JJ NNS",4,1,1,16918066,"pubmed1",4.44E+018,"testalpha"
,"fluoridecontent on osteoblastic cell","NN IN JJ NN",4,1,1,16701866,"pubmed1",4.33E+018,"testalpha"
,"immune deposits for fn","JJ NNS IN ",4,1,1,16430945,2,2.08E+018,"testalpha"
,"patients receivedbroad spectrum antibiotics","NNS NN NN NNS",4,1,1,16365336,"pubmed1",7.43E+018,"testalpha"
,"correlation with plasma timp","NN IN NNP ",4,1,1,16585983,2,4.69E+018,"testalpha"
,"actingdrugs have profound effects","NNS VBP JJ NNS",4,1,1,16594639,"pubmed1",2.16E+018,"testalpha"
,"findings suggest thattubular impairment","NNS VBP JJ NN",4,1,1,16956119,2,8.27E+018,"testalpha"
,"studyconsiders as crash predictors","NNS IN NN NNS",4,1,1,16405858,"pubmed1",6.48E+018,"testalpha"
,"activity by fluorimetric detection","NN IN JJ NN",4,1,1,16733564,"pubmed1",7.97E+018,"testalpha"
,"ameliorating toxicity from lipid","VBG NN IN NN",4,1,1,16436797,"pubmed1",3.69E+018,"testalpha"
,"infiltrates and thebrain abscess","NNS CC VB NN",4,1,1,16918065,"pubmed1",1.27E+018,"testalpha"
,"based protein specific potentials","VBN NN JJ NNS",4,1,1,16365636,"pubmed1",1.67E+018,"testalpha"
,"young adults with t","JJ NNS IN ",4,1,1,16918068,"pubmed1",3.14E+018,"testalpha"
,"skin rash in rats","NN NN IN NNS",4,1,1,16594644,"pubmed1",2.80E+018,"testalpha"
,"valproate after carbamazepine intake","NN IN NN NN",4,1,1,16710584,2,3.49E+018,"testalpha"
,"middle cerebralartery mca thread","NN NN  NN",4,1,1,17265689,2,1.01E+018,"testalpha"
,"associated proteins i e","VBN NNS  ",4,1,1,17265696,2,4.39E+018,"testalpha"
,"risk factors of transmission","NN NNS IN NN",4,1,1,16696442,2,8.93E+018,"testalpha"
,"etiology in late ards","NN IN JJ ",4,1,1,16451155,"pubmed1",1.41E+018,"testalpha"
,"intensified dex induced neurotoxicity","VBN  VBN NN",4,1,1,17133953,2,8.88E+018,"testalpha"
,"relation to measured dissolution","NN IN VBN NN",4,1,1,16594638,"pubmed1",2.03E+018,"testalpha"
,"basal and squamous cell","NN CC JJ NN",4,1,1,16603102,2,8.50E+018,"testalpha"
,"educational materials and study","JJ NNS CC NN",4,1,1,16596896,"pubmed1",4.10E+018,"testalpha"
,"need for education outreach","NN IN NN NN",4,1,1,16596897,"pubmed1",9.14E+018,"testalpha"
,"patients with recurrentaphthous stomatitis","NNS IN JJ NN",4,1,1,16874419,2,6.82E+018,"testalpha"
,"clinical assessment and pft","JJ NN CC ",4,1,1,16809886,2,5.85E+018,"testalpha"
,"severe sepsis after surgery","JJ NN IN NN",4,1,1,16914908,2,4.17E+018,"testalpha"
,"namelyhemorrhoids anal fistula anal","NNS  NN ",4,1,1,17139880,2,3.40E+018,"testalpha"
,"mechanism and anatomic injuries","NN CC JJ NNS",4,1,1,16491215,2,6.69E+018,"testalpha"
,"pediatric intensive care unit","JJ JJ NN NN",4,1,1,16549896,2,3.24E+018,"testalpha"
,"data on diagnosis andmanagement","NN IN NN NN",4,1,1,17139885,2,3.84E+018,"testalpha"
,"time assessment and therapy","VB NN CC NN",4,1,1,16955182,2,3.07E+018,"testalpha"
,"bladder urine andileal conduit","NN NN NN NN",4,1,1,16514843,2,1.43E+018,"testalpha"
,"conduction secretion vasodilation proliferation","NN NN NN NN",4,1,1,16770441,"pubmed1",5.67E+018,"testalpha"
,"successionalseres and taxonomic trajectories","NNS CC JJ NNS",4,1,1,16988904,"pubmed1",2.90E+018,"testalpha"
,"major pathogen of rabbits","JJ NN IN NNS",4,1,1,16733562,"pubmed1",5.55E+018,"testalpha"
,"new ward team call","JJ NN NN NN",4,1,1,16377824,"pubmed1",5.44E+018,"testalpha"
,"low morbidity and mortality","JJ NN CC NN",4,1,1,16424648,2,7.94E+018,"testalpha"
,"amino acid r p","NNP NN NN ",4,1,1,16585980,2,2.73E+018,"testalpha"
,"murine monoclonalanti methotrexate igg","NN  NN ",4,1,1,16594642,"pubmed1",5.08E+018,"testalpha"
,"prevalence of toe nailonychomycosis","NN IN NN NN",4,1,1,16955188,2,2.18E+018,"testalpha"
,"indication of liver transplantation","NN IN NN NN",4,1,1,17013506,2,8.63E+017,"testalpha"
,"distraction upon driving performance","NN IN VBG NN",4,1,1,16226211,"pubmed1",9.00E+018,"testalpha"
,"expressing cells inatopic dermatitis","VBG NNS NN NN",4,1,1,16955181,2,3.08E+018,"testalpha"
,"transmission of ttv infection","NN IN  NN",4,1,1,16696442,2,7.85E+018,"testalpha"
,"aziridination rearrangement process startingwith","NN NN NN NN",4,1,1,16456281,2,7.21E+018,"testalpha"
,"respiratory and general symptoms","NN CC JJ NNS",4,1,1,16612936,"pubmed1",2.27E+017,"testalpha"
,"l interactionstimulates b cells"," NNS NN NNS",4,1,1,16733557,"pubmed1",1.92E+018,"testalpha"
,"cm h o multidetector","   NN",4,1,1,16399039,"pubmed1",8.09E+018,"testalpha"
,"copper zinc and selenium","NN NN CC NN",4,1,1,17160142,"pubmed1",2.78E+018,"testalpha"
,"labelled tissue using confocalmicroscopy","VBN NN VBG ",4,1,1,16730369,2,8.42E+018,"testalpha"
,"urticaria and local reactions","NNP CC JJ NNS",4,1,1,17106600,2,3.59E+018,"testalpha"
,"intercellulardysjunctions and increased quantities","NNS CC VBN NNS",4,1,1,16574202,2,8.30E+018,"testalpha"
,"withchop cyclophosphamide doxorubicin vincristine","NN VB NNP NN",4,1,1,16424646,2,7.23E+018,"testalpha"
,"totallyreliable low cost diagnostic","JJ JJ NN NN",4,1,1,17139883,2,4.56E+018,"testalpha"
,"plants nt antiviral treatment","NNS  JJ NN",4,1,1,16395523,"pubmed1",9.02E+018,"testalpha"
,"regulatory t cells treg","JJ  NNS ",4,1,1,16955181,2,1.49E+018,"testalpha"
,"selective mitokatp channelblocker hydroxydecanoate","JJ  NN NN",4,1,1,16566960,2,4.87E+018,"testalpha"
,"n and hsil n"," CC  ",4,1,1,16514835,2,7.07E+018,"testalpha"
,"barr requiringrevision in patients"," NN IN NNS",4,1,1,16956118,2,6.55E+018,"testalpha"
,"development of carbohydrate drugs","NN IN NN NNS",4,1,1,16730370,2,5.93E+018,"testalpha"
,"theexistence of carbohydrate residues","NN IN NN NNS",4,1,1,16714048,2,2.89E+018,"testalpha"
,"feasible option for testing","JJ NN IN NN",4,1,1,16549889,2,8.39E+018,"testalpha"
,"previous allergic contact dermatitis","JJ JJ NN NN",4,1,1,16585981,2,1.52E+018,"testalpha"
,"innateimmune system of complement","NN NN IN NN",4,1,1,16964325,"pubmed1",6.17E+018,"testalpha"
,"patients with malignanthematological disorders","NNS IN JJ NNS",4,1,1,16914909,2,8.31E+018,"testalpha"
,"strain mapshowed functional changes","NN VBN JJ NNS",4,1,1,16399029,"pubmed1",3.75E+018,"testalpha"
,"tuberculosis n celiac disease","NN  JJ NN",4,1,1,16447095,"pubmed1",3.37E+018,"testalpha"
,"application and gen tech","NN CC  ",4,1,1,17293969,2,6.48E+018,"testalpha"
,"transient or permanent occlusion","NN CC JJ NN",4,1,1,17265691,2,2.43E+018,"testalpha"
,"patients with perhyp p","NNS IN  ",4,1,1,16436794,"pubmed1",9.05E+018,"testalpha"
,"non cirrhotic liver disease"," JJ NN NN",4,1,1,17013518,2,5.13E+018,"testalpha"
,"crystallizesin long hexagonal needles","NNP JJ JJ NNS",4,1,1,16511277,2,6.27E+018,"testalpha"
,"thepatients reported adverse impact","NNS VBD JJ NN",4,1,1,16710574,2,1.04E+018,"testalpha"
,"group of pulmonary tuberculosis","NN IN JJ NN",4,1,1,16479024,2,7.12E+018,"testalpha"
,"experimental unilateral cryptorchidism model","JJ JJ NN NN",4,1,1,16395525,"pubmed1",2.57E+018,"testalpha"
,"adverse impact on qol","JJ NN IN ",4,1,1,16710574,2,4.13E+017,"testalpha"
,"results on positive leadership","NNS IN JJ NN",4,1,1,16377814,"pubmed1",7.72E+018,"testalpha"
,"contact withany exterior environment","NN NN JJ NN",4,1,1,16701857,"pubmed1",4.00E+018,"testalpha"
,"particular histopathologic finding weconsider","JJ JJ NN NN",4,1,1,16859615,2,6.54E+018,"testalpha"
,"function ofworkload than hours","NN NN IN NNS",4,1,1,16377825,"pubmed1",3.26E+018,"testalpha"
,"patients with acutegastrointestinal gi","NNS IN JJ ",4,1,1,16333701,"pubmed1",1.53E+017,"testalpha"
,"importantdevelopments in healthcare policy","NNS IN NN NN",4,1,1,16473988,"pubmed1",7.05E+018,"testalpha"
,"antithrombotic medication and risk","JJ NN CC NN",4,1,1,17236644,"pubmed1",2.44E+018,"testalpha"
,"treatment for gastroenteritis indogs","NN IN NN NNS",4,1,1,17293961,2,5.60E+018,"testalpha"
,"affective disorder susceptibility locus","JJ NN NN NN",4,1,1,16733555,"pubmed1",8.43E+018,"testalpha"
,"educational principles and opinions","JJ NNS CC NNS",4,1,1,16473990,"pubmed1",6.07E+018,"testalpha"
,"metabolic enzymes with rna","JJ NNS IN ",4,1,1,16410835,"pubmed1",5.49E+018,"testalpha"
,"failed perineal or trans","VBD NN CC NNS",4,1,1,17139891,2,2.31E+017,"testalpha"
,"male patient fingernail onychomycosis","NN NN NN NN",4,1,1,16603097,2,8.40E+018,"testalpha"
,"belong tospace group p","VB NN NN ",4,1,1,16511256,2,3.85E+018,"testalpha"
,"lipids and nucleic acids","NNS CC JJ NNS",4,1,1,17160142,"pubmed1",3.63E+017,"testalpha"
,"drivingskills inventory lajunen t","NNS NN NN ",4,1,1,16443186,"pubmed1",8.51E+018,"testalpha"
,"pain after emergency physicians","NN IN NN NNS",4,1,1,16436792,"pubmed1",8.66E+018,"testalpha"
,"risk factors non medicateddiabetes","NN NNS  NNS",4,1,1,16054104,"pubmed1",1.32E+018,"testalpha"
,"extra nodal non hodgkinlymphomas","JJ NN  NNP",4,1,1,16612936,"pubmed1",5.21E+018,"testalpha"
,"antiangiogenic drug dosing schedule","JJ NN VBG NN",4,1,1,16388313,"pubmed1",9.02E+017,"testalpha"
,"industrial research groups development","JJ NN NNS NN",4,1,1,16369099,2,7.61E+018,"testalpha"
,"patients were included intothe","NNS VBD VBN NNP",4,1,1,17139899,2,7.40E+018,"testalpha"
,"asses if increased levels","NNS IN VBN NNS",4,1,1,17338197,2,4.83E+018,"testalpha"
,"elements andfour w boxes","NNS JJ  NNS",4,1,1,16395526,"pubmed1",9.04E+018,"testalpha"
,"polarimetric study of thecompound","JJ NN IN NN",4,1,1,16456295,2,5.54E+018,"testalpha"
,"traffic volume horizontal alignment","NN NN NN NN",4,1,1,16442487,"pubmed1",3.16E+018,"testalpha"
,"assayed byenzyme linked immunosorbent","VBN  VBN NN",4,1,1,16549888,2,6.04E+018,"testalpha"
,"inflammation coagulation and site","NN NN CC NN",4,1,1,16730054,2,8.81E+018,"testalpha"
,"collectinformation on school injuries","NN IN NN NNS",4,1,1,16236234,"pubmed1",3.87E+018,"testalpha"
,"beta lactam antibiotics extracts","NN  NNS NNS",4,1,1,17106600,2,7.20E+018,"testalpha"
,"absolute contraindications for salvage","JJ NNS IN NN",4,1,1,17139900,2,4.80E+018,"testalpha"
,"patterns and anisotropic effects","NNS CC NN NNS",4,1,1,16542712,2,1.33E+018,"testalpha"
,"abu nme in carbon","  IN NN",4,1,1,16528413,"pubmed1",3.56E+018,"testalpha"
,"abnormalities and miscellaneous findings","NNS CC JJ NNS",4,1,1,16514841,2,7.63E+018,"testalpha"
,"days afterthe initial symptoms","NNS NNP JJ NNS",4,1,1,16918065,"pubmed1",1.51E+018,"testalpha"
,"demographic information anxietylevel pain","JJ NN NN NN",4,1,1,16365322,"pubmed1",8.35E+018,"testalpha"
,"leds light emitting diodes"," NN VBG NNS",4,1,1,17013504,2,2.25E+018,"testalpha"
,"b ns protease complexes","NN  NN NNS",4,1,1,16511290,2,3.48E+018,"testalpha"
,"andbi achieved sufficient reactivation"," VBN JJ NN",4,1,1,17438836,2,7.26E+018,"testalpha"
,"doppler ultrasound in check","NN NN IN NN",4,1,1,17438838,2,3.60E+018,"testalpha"
,"ft ir raman andx","  NN ",4,1,1,16701876,"pubmed1",3.57E+018,"testalpha"
,"induced hemolysis by glutathione","VBN NN IN NN",4,1,1,16395529,"pubmed1",3.74E+018,"testalpha"
,"oxygen in decreasing ponv","NN IN VBG ",4,1,1,16451147,"pubmed1",8.14E+018,"testalpha"
,"aprospective study with cases","JJ NN IN NNS",4,1,1,16956117,2,8.55E+017,"testalpha"
,"better predictor of escitalopram","JJR NN IN NN",4,1,1,16584121,"pubmed1",2.11E+018,"testalpha"
,"fibrogenic form and suppression","JJ NN CC NN",4,1,1,16256175,2,1.31E+018,"testalpha"
,"interaction betweenbax and bax","NN  CC ",4,1,1,16424655,2,6.44E+018,"testalpha"
,"residing withinthis rural tennessee","VBG NNP JJ NN",4,1,1,16596901,"pubmed1",3.24E+017,"testalpha"
,"colleague attrition and otherwork","NN NN CC NN",4,1,1,16377815,"pubmed1",2.54E+018,"testalpha"
,"low molecular mass rnas","JJ JJ NN ",4,1,1,16505901,"pubmed1",4.46E+018,"testalpha"
,"antiviral lectins small proteins","JJ NNS JJ NNS",4,1,1,17128290,"pubmed1",6.26E+018,"testalpha"
,"accidents in eachtraffic zone","NNS IN NNP NN",4,1,1,16414003,"pubmed1",6.11E+018,"testalpha"
,"infarct volumes and detection","NN NNS CC NN",4,1,1,17265691,2,1.04E+017,"testalpha"
,"onoo reduces platelet aggregation"," VBZ NN NN",4,1,1,17068635,"pubmed1",5.59E+018,"testalpha"
,"specificallyinhibit interleukin b il","NN NNP NN ",4,1,1,17019444,"pubmed1",1.75E+018,"testalpha"
,"reconceptualisation and application ofdeterrence","NN CC NN NN",4,1,1,16405859,"pubmed1",5.82E+017,"testalpha"
,"stimulus was applied hand","NN VBD VBN NN",4,1,1,17236636,"pubmed1",5.15E+018,"testalpha"
,"grade orlarge b cell","NN JJ NN NN",4,1,1,16612936,"pubmed1",5.87E+018,"testalpha"
,"concerns about road rage","NNS IN NN NN",4,1,1,16434012,"pubmed1",5.30E+018,"testalpha"
,"american college of rheumatology","JJ NN IN NN",4,1,1,16479028,2,7.73E+018,"testalpha"
,"kluyveri expression of pp","NN NN IN ",4,1,1,17063209,"pubmed1",1.15E+018,"testalpha"
,"conserved family of gtp","VBN NN IN ",4,1,1,16511282,2,4.50E+018,"testalpha"
,"thedifferent gene expression profile","NN  NN NN",4,1,1,16951744,"pubmed1",7.58E+018,"testalpha"
,"study using b f","NN VBG NN NN",4,1,1,16388313,"pubmed1",6.72E+018,"testalpha"
,"change reticulocyte counts reticulocyte","NN NNP NNS NNP",4,1,1,17117609,2,9.12E+017,"testalpha"
,"micromolar range and thatr","JJ NN CC ",4,1,1,17019437,"pubmed1",2.32E+018,"testalpha"
,"liquid flow and saline","JJ NN CC NN",4,1,1,16491219,2,4.80E+018,"testalpha"
,"hpv hr hpv detection","   NN",4,1,1,16514834,2,9.60E+017,"testalpha"
,"injury trend over time","NN NN IN NN",4,1,1,16430844,"pubmed1",7.28E+018,"testalpha"
,"using nested pcr npcr","VBG VBN  ",4,1,1,17019440,"pubmed1",8.54E+018,"testalpha"
,"poor predictor of rr","JJ NN IN ",4,1,1,16399035,"pubmed1",6.09E+018,"testalpha"
,"mg multiple mm pustules"," JJ  NNS",4,1,1,16696448,2,5.66E+018,"testalpha"
,"beta blocker containing eye","NN NN VBG NN",4,1,1,17106597,2,3.90E+017,"testalpha"
,"cells for therapeutic purposes","NNS IN JJ NNS",4,1,1,16696440,2,6.09E+018,"testalpha"
,"low nmol l range","JJ   NN",4,1,1,16594645,"pubmed1",1.06E+018,"testalpha"
,"predictor of injury occurrence","NN IN NN NN",4,1,1,16442068,"pubmed1",8.01E+018,"testalpha"
,"microscopy of fna smears"," IN  NNS",4,1,1,16514850,2,2.56E+018,"testalpha"
,"t variant of exon"," NN IN ",4,1,1,16733564,"pubmed1",6.18E+018,"testalpha"
,"expression levels in patientswith","NN NNS IN NN",4,1,1,16424642,2,8.27E+017,"testalpha"
,"l d h h","   ",4,1,1,17133952,2,4.92E+018,"testalpha"
,"st microemulsion developed inthis"," NN VBD NNP",4,1,1,16584167,"pubmed1",4.32E+018,"testalpha"
,"possibility of using capsaicin","NN IN VBG NNP",4,1,1,16955183,2,2.15E+018,"testalpha"
,"thesingularities of paediatric head","NNS IN JJ NN",4,1,1,17067134,"pubmed1",9.64E+017,"testalpha"
,"mannanoligosacharides on dogs showinggastroenteritis","NNS IN NNS NN",4,1,1,17293961,2,6.50E+018,"testalpha"
,"tohigher average gloss values","JJ NN IN NNS",4,1,1,16584166,"pubmed1",5.27E+018,"testalpha"
,"negligible changes of ph","JJ NNS IN ",4,1,1,16701876,"pubmed1",2.13E+018,"testalpha"
,"efficiency and fluorescenceemission characteristic","NN CC NN NN",4,1,1,17106510,"pubmed1",8.13E+018,"testalpha"
,"andwaterborne diarrheal disease threat","NNP NN NN NN",4,1,1,16511280,2,2.47E+017,"testalpha"
,"dt images using orientations"," NNS VBG NNS",4,1,1,16399034,"pubmed1",6.20E+018,"testalpha"
,"corticosteroid administration and rhapcadministration","VB NN CC NN",4,1,1,16365336,"pubmed1",8.47E+016,"testalpha"
,"analysis oftssr sequence motifs","NN  NN ",4,1,1,16733558,"pubmed1",3.98E+018,"testalpha"
,"infants and mg kg","NNS CC  ",4,1,1,16549901,2,8.05E+018,"testalpha"
,"anincreased risk of death","VBN NN IN NN",4,1,1,16426561,"pubmed1",8.78E+018,"testalpha"
,"hyperactivity and latencyin nest","NN CC  NN",4,1,1,17265693,2,1.20E+018,"testalpha"
,"differentmolecular weight chitosan edta","JJ NN JJ ",4,1,1,17285741,"pubmed1",4.84E+018,"testalpha"
,"background osteoclastomalike giant cell","NN NN NN NN",4,1,1,16514845,2,8.63E+018,"testalpha"
,"tissues proofof product microbiology","NNS  NN NN",4,1,1,16999268,2,5.66E+018,"testalpha"
,"results incomparisons between g","NNS NNS IN ",4,1,1,17293969,2,8.63E+018,"testalpha"
,"cells of c maf","NNS IN NN ",4,1,1,16325892,2,5.63E+018,"testalpha"
,"km and vmax oflada"," CC  NNP",4,1,1,16929383,"pubmed1",5.33E+018,"testalpha"
,"use of various types","NN IN JJ NNS",4,1,1,16999270,2,3.47E+018,"testalpha"
,"first post operative hours","JJ NN JJ NNS",4,1,1,16451147,"pubmed1",7.54E+018,"testalpha"
,"blue ink contained highamounts","NN NN VBD NNS",4,1,1,16648911,2,7.15E+018,"testalpha"
,"havepermanent release of contractures","NN NN IN NNS",4,1,1,16999266,2,2.09E+018,"testalpha"
,"egg white lysozyme hewl","NN JJ  ",4,1,1,16770442,"pubmed1",8.26E+018,"testalpha"
,"head and neck cancer","NN CC NN NN",4,1,1,17117605,2,1.03E+018,"testalpha"
,"introduction total mesorectal excision","NN JJ NN NN",4,1,1,16612911,2,3.75E+018,"testalpha"
,"phase of partial hematologicalremission","NN IN JJ NN",4,1,1,16914909,2,2.69E+018,"testalpha"
,"report presents magnetic resonance","NN VBZ JJ NN",4,1,1,16177871,"pubmed1",5.04E+018,"testalpha"
,"l arg group n","  NN ",4,1,1,16395522,"pubmed1",7.38E+018,"testalpha"
,"arterial phase of contrast","JJ NN IN NN",4,1,1,17119328,2,7.03E+018,"testalpha"
,"patient day in uk","NN NN IN ",4,1,1,16451154,"pubmed1",5.31E+018,"testalpha"
,"men mean age years","NNS VBP NN NNS",4,1,1,16874420,2,1.58E+017,"testalpha"
,"used classes of vectors","VBN NNS IN NNS",4,1,1,17285739,"pubmed1",5.40E+018,"testalpha"
,"ultrasound findings in aseries","NN NNS IN NNS",4,1,1,16333710,"pubmed1",2.79E+018,"testalpha"
,"flow with combined effects","NN IN VBN NNS",4,1,1,16549898,2,1.71E+018,"testalpha"
,"droplets during storage particle","NNS IN NN NN",4,1,1,17285747,"pubmed1",4.85E+018,"testalpha"
,"re implantation offingers hand"," NN NNS NN",4,1,1,16451159,"pubmed1",4.03E+018,"testalpha"
,"molecular mechanics force fields","JJ NNS VBP NNS",4,1,1,16388314,"pubmed1",8.72E+018,"testalpha"
,"rate causes ofroad accidents","NN VBZ NN NNS",4,1,1,16191426,"pubmed1",1.45E+018,"testalpha"
,"vial after thetp slide"," IN  NN",4,1,1,16514842,2,1.55E+018,"testalpha"
,"cancerfatalism and breast cancer","NN CC NN NN",4,1,1,16596899,"pubmed1",7.32E+018,"testalpha"
,"increase in pressureand volume","NN IN NN NN",4,1,1,16491219,2,6.24E+018,"testalpha"
,"groups of patientswith colorectal","NNS IN NN NN",4,1,1,17139895,2,3.99E+018,"testalpha"
,"induced rhdv specific antibodies","VBN  JJ NNS",4,1,1,16733562,"pubmed1",6.94E+018,"testalpha"
,"associations between sleep deprivation","NNS IN NN NN",4,1,1,16377826,"pubmed1",6.16E+018,"testalpha"
,"size nm and zeta","NN  CC ",4,1,1,16584167,"pubmed1",4.57E+018,"testalpha"
,"participate inregular breast cancer","VB JJ NN NN",4,1,1,16596899,"pubmed1",6.91E+018,"testalpha"
,"available techniques and tools","JJ NNS CC NNS",4,1,1,16612907,2,9.04E+018,"testalpha"
,"supporting staff of auditors","VBG NN IN NNS",4,1,1,16770860,"pubmed1",5.22E+018,"testalpha"
,"stratum corneum withimproved skin","NN NN VBN NN",4,1,1,17285742,"pubmed1",8.01E+018,"testalpha"
,"components of traffic safety","NNS IN NN NN",4,1,1,16406188,"pubmed1",5.54E+018,"testalpha"
,"emphasis on incontinent women","NN IN NN NNS",4,1,1,16962646,2,7.80E+017,"testalpha"
,"caspase and specific dff","NN CC JJ ",4,1,1,16951739,"pubmed1",2.64E+018,"testalpha"
,"annual incidence of hospitalisation","JJ NN IN NN",4,1,1,16162331,"pubmed1",3.73E+017,"testalpha"
,"administration of pooled polyvalent","NN IN VBN NN",4,1,1,16594642,"pubmed1",5.06E+016,"testalpha"
,"mrna decay after thiamphenicoltreatment"," NN IN NN",4,1,1,16389406,"pubmed1",1.35E+018,"testalpha"
,"children age range years","NNS VBP NN NNS",4,1,1,16710582,2,2.40E+018,"testalpha"
,"proinflammatory haemoglobin fromthe circulation","NN NNP NNP NN",4,1,1,16770444,"pubmed1",3.21E+018,"testalpha"
,"synthesis or technique c","NN CC NN NN",4,1,1,17293966,2,5.20E+018,"testalpha"
,"night time young driver","NN NN JJ NN",4,1,1,16171767,"pubmed1",6.64E+018,"testalpha"
,"dose intensified double chop","NN VBN JJ ",4,1,1,16914902,2,5.18E+017,"testalpha"
,"virus tmv rna accumulation","NN   NN",4,1,1,16395523,"pubmed1",6.92E+018,"testalpha"
,"increase in p mrna","NN IN  ",4,1,1,16733561,"pubmed1",5.73E+017,"testalpha"
,"influence and explainthe process","NN CC NNP NN",4,1,1,16209925,"pubmed1",5.34E+018,"testalpha"
,"concernfor completeness and consistency","JJ NN CC NN",4,1,1,16988904,"pubmed1",5.62E+017,"testalpha"
,"asteep fracture line pauwels","JJ NN NN NNS",4,1,1,16613748,2,5.43E+018,"testalpha"
,"rupture of aneurysmsor masses","NN IN NN NNS",4,1,1,16317492,"pubmed1",8.33E+018,"testalpha"
,"health evaluation apache iii","NN NN NNP ",4,1,1,17117607,2,7.65E+018,"testalpha"
,"atp c on chromosome"," NN IN NN",4,1,1,17311740,2,7.18E+017,"testalpha"
,"rhapc administration in patients"," NN IN NNS",4,1,1,16365336,"pubmed1",8.46E+018,"testalpha"
,"dimerization constant k d","NN JJ  ",4,1,1,16528413,"pubmed1",7.34E+018,"testalpha"
,"h after surgery i"," IN NN ",4,1,1,16451153,"pubmed1",8.45E+018,"testalpha"
,"peoplewith multiple co morbidity","NN JJ  NN",4,1,1,16613748,2,2.54E+018,"testalpha"
,"manifestations of reversible ischemiccolitis","NNS IN JJ NN",4,1,1,16333702,"pubmed1",2.27E+016,"testalpha"
,"melanogaster mirnas and others","NN NNP CC NNS",4,1,1,16770443,"pubmed1",3.50E+018,"testalpha"
,"storage time and temperature","NN NN CC NN",4,1,1,17285747,"pubmed1",6.93E+018,"testalpha"
,"r exon nt g","NN   ",4,1,1,16424658,2,1.08E+018,"testalpha"
,"survival and early tracheostomy","NN CC JJ NN",4,1,1,16451156,"pubmed1",6.04E+018,"testalpha"
,"media were harvested followingstarvation","NNS VBD VBN NN",4,1,1,16395527,"pubmed1",5.13E+018,"testalpha"
,"hydroxyproline concentrations were measuredand","NN NNS VBD NN",4,1,1,16612916,"pubmed1",8.28E+017,"testalpha"
,"received oral tyrosine kinase","VBD JJ NN NN",4,1,1,16914906,2,8.29E+018,"testalpha"
,"arepetitive occlusive patch test","JJ JJ NN NN",4,1,1,16648917,2,5.00E+018,"testalpha"
,"arr arr sheep years","  NN NNS",4,1,1,16770445,"pubmed1",6.07E+018,"testalpha"
,"heat transfer coefficients kv","NN VB NNS ",4,1,1,17285746,"pubmed1",5.20E+018,"testalpha"
,"clinical cases virtual body","JJ NNS JJ NN",4,1,1,16399038,"pubmed1",8.40E+018,"testalpha"
,"ad cases withnegative spt","NN NNS JJ ",4,1,1,16859611,2,5.23E+018,"testalpha"
,"values of tgf beta","NNS IN  NN",4,1,1,17293967,2,4.28E+018,"testalpha"
,"polylepsisvenom ns and csav","NN  CC ",4,1,1,16436788,"pubmed1",3.12E+018,"testalpha"
,"product of complete dephosphorylation","NN IN JJ NN",4,1,1,16770441,"pubmed1",4.84E+018,"testalpha"
,"vinyl chloride metabolite caa","NN NN JJ ",4,1,1,16582987,"pubmed1",3.04E+018,"testalpha"
,"affective disorder and acontrol","JJ NN CC NN",4,1,1,16733555,"pubmed1",7.86E+018,"testalpha"
,"long term outcome withregard","JJ NN NN NN",4,1,1,16451156,"pubmed1",2.30E+018,"testalpha"
,"relations between pkc activity","NNS IN  NN",4,1,1,17016035,2,7.12E+018,"testalpha"
,"traditional research record keepingpractices","JJ NN NN NNS",4,1,1,16377817,"pubmed1",4.58E+017,"testalpha"
,"images and visualize changes","NNS CC VB NNS",4,1,1,16399029,"pubmed1",6.28E+018,"testalpha"
,"pediatric center in argentina","JJ NN IN NNP",4,1,1,16549893,2,4.26E+018,"testalpha"
,"myocardial inducible nos inos","JJ JJ NNS ",4,1,1,16566960,2,2.21E+018,"testalpha"
,"numbers of sexual partners","NNS IN JJ NNS",4,1,1,16874417,2,6.95E+018,"testalpha"
,"mg dl on hospitaladmission","  IN NN",4,1,1,16436794,"pubmed1",3.72E+018,"testalpha"
,"phenylalanine hydroxylase human beta","NN NN JJ NN",4,1,1,16823609,"pubmed1",6.22E+018,"testalpha"
,"afull quantum mechanical treatment","NN NN JJ NN",4,1,1,16411736,"pubmed1",7.45E+018,"testalpha"
,"greater radioactivity than background","JJR NN IN NN",4,1,1,16491216,2,7.36E+018,"testalpha"
,"increased volume of distribution","VBN NN IN NN",4,1,1,17067137,"pubmed1",1.15E+018,"testalpha"
,"groups development of technology","NNS NN IN NN",4,1,1,16369099,2,7.52E+018,"testalpha"
,"common type of skin","JJ NN IN NN",4,1,1,17106599,2,5.77E+018,"testalpha"
,"expression of costimulatory molecules","NN IN NN NNS",4,1,1,16733557,"pubmed1",3.42E+018,"testalpha"
,"curves auc during hes","NNS  IN ",4,1,1,17067137,"pubmed1",3.58E+018,"testalpha"
,"changes in structural support","NNS IN JJ NN",4,1,1,16962646,2,2.40E+018,"testalpha"
,"hemodynamics were assessed pressure","NNS VBD VBN NN",4,1,1,16451155,"pubmed1",7.82E+018,"testalpha"
,"temporal effects and space","JJ NNS CC NN",4,1,1,16451795,"pubmed1",7.77E+018,"testalpha"
,"residency programs method questionnaires","NN NNS NN NNS",4,1,1,16377820,"pubmed1",2.20E+018,"testalpha"
,"increased number of arrhythmias","VBN NN IN NNP",4,1,1,16451157,"pubmed1",1.52E+018,"testalpha"
,"right and left ear","NN CC NN NN",4,1,1,16955182,2,2.08E+018,"testalpha"
,"single stranded dna ssdna","JJ VBN  ",4,1,1,16569423,2,8.77E+018,"testalpha"
,"radiologicfindings of autoimmune pancreatitis","NNS IN NN NN",4,1,1,16333694,"pubmed1",2.29E+018,"testalpha"
,"example havehigher rejection rates","NN JJ NN NNS",4,1,1,16399035,"pubmed1",9.21E+018,"testalpha"
,"more application site skin","JJR NN NN NN",4,1,1,16585986,2,4.94E+018,"testalpha"
,"aerobic organisms possess specialsystems","JJ NNS VB NNS",4,1,1,17063208,"pubmed1",2.59E+018,"testalpha"
,"discovered rna binding protein","VBD  VBG NN",4,1,1,16410835,"pubmed1",7.85E+018,"testalpha"
,"address theshortage of assistance","VB NN IN NN",4,1,1,16612907,2,2.38E+018,"testalpha"
,"various storage temperaturesduring months","JJ NN VBG NNS",4,1,1,16584150,"pubmed1",2.23E+018,"testalpha"
,"oxygen consumption accelerated lactateproduction","NN NN VBD NN",4,1,1,17068635,"pubmed1",7.71E+018,"testalpha"
,"n naja venom csav","  NN ",4,1,1,16436788,"pubmed1",6.12E+018,"testalpha"
,"phosphate binding protein hpbp","NN VBG NN ",4,1,1,16511265,2,5.26E+018,"testalpha"
,"individual estimates of effect","NN NNS IN NN",4,1,1,16427020,"pubmed1",5.05E+018,"testalpha"
,"workers compensation data forthe","NNS NN NNS NNP",4,1,1,16043107,"pubmed1",1.80E+018,"testalpha"
,"abuse disorders and participation","NN NNS CC NN",4,1,1,16426559,"pubmed1",5.27E+018,"testalpha"
,"manifestations of svc syndrome","NNS IN  NN",4,1,1,16617761,"pubmed1",6.05E+018,"testalpha"
,"averageblood loss was ml","NN NN VBD ",4,1,1,16956118,2,8.45E+018,"testalpha"
,"trigger factor in adpatients","VB NN IN NNS",4,1,1,16859613,2,6.74E+018,"testalpha"
,"ventricle plusseptum weight ratio","NN NN NN NN",4,1,1,16537087,2,7.61E+018,"testalpha"
,"carbohydrates found onviral envelopes","NNS VBD JJ NNS",4,1,1,17128290,"pubmed1",4.40E+018,"testalpha"
,"includinggrowth differentiation cell migration","NN NN NN NN",4,1,1,16713618,2,8.52E+018,"testalpha"
,"gene expression oxygen nitrogen"," NN NN NN",4,1,1,17143336,"pubmed1",3.86E+018,"testalpha"
,"sites of tissue damage","NNS IN NN NN",4,1,1,16770444,"pubmed1",6.38E+018,"testalpha"
,"used desflurane or sevoflurane","VBD NN CC NN",4,1,1,16916184,"pubmed1",7.82E+018,"testalpha"
,"vp gene of strainsgm","  IN ",4,1,1,16733562,"pubmed1",6.69E+018,"testalpha"
,"presented withhigher mean levels","VBN JJ NN NNS",4,1,1,16859611,2,8.85E+017,"testalpha"
,"patients as markers ofdisease","NNS IN NNS NN",4,1,1,16859611,2,5.48E+018,"testalpha"
,"acute andchronic sleep deprivation","JJ JJ NN NN",4,1,1,16377826,"pubmed1",4.63E+018,"testalpha"
,"majority of thehereditary nonpolyposis","NN IN JJ NN",4,1,1,17139886,2,8.09E+018,"testalpha"
,"n bis pyridylmethyl aminomethyl","   ",4,1,1,16456265,2,7.20E+018,"testalpha"
,"resp of chronic hepatitis"," IN JJ NN",4,1,1,16696442,2,2.87E+018,"testalpha"
,"patients had higher serum","NNS VBD JJR NN",4,1,1,17119323,2,7.48E+018,"testalpha"
,"vehicles with ontariolicence plates","NNS IN NN NNS",4,1,1,16169506,"pubmed1",8.58E+018,"testalpha"
,"agrobacteriumtumefaciens mediated transient expression","NNS VBN NN NN",4,1,1,16395523,"pubmed1",9.04E+018,"testalpha"
,"movement on noxious stimulation","NN IN JJ NN",4,1,1,17236636,"pubmed1",8.68E+017,"testalpha"
,"amyloid deposits and tissue","VB NNS CC NN",4,1,1,16764914,2,4.18E+018,"testalpha"
,"matching program radiology fellowship","VBG NN NN NN",4,1,1,16399040,"pubmed1",2.78E+018,"testalpha"
,"treatment with gtnand nifedipine","NN IN NN NN",4,1,1,16612915,"pubmed1",3.57E+018,"testalpha"
,"indicates time dependent change","VBZ NN JJ NN",4,1,1,17133956,2,1.85E+018,"testalpha"
,"important differences in perceptions","JJ NNS IN NNS",4,1,1,16191426,"pubmed1",2.13E+018,"testalpha"
,"maximize continuity of care","VB NN IN NN",4,1,1,16365324,"pubmed1",2.39E+018,"testalpha"
,"plasma for intravascular volume","NNP IN JJ NN",4,1,1,16451158,"pubmed1",4.37E+018,"testalpha"
,"helmet laws with u","VB NNS IN ",4,1,1,16202466,"pubmed1",3.19E+017,"testalpha"
,"lipid and enzyme levels","NN CC  NNS",4,1,1,16523217,"pubmed1",6.81E+018,"testalpha"
,"cell carcinomas in situ","NN NNP IN ",4,1,1,17311737,2,1.27E+018,"testalpha"
,"cdna of humanp gene"," IN  ",4,1,1,16582987,"pubmed1",3.89E+018,"testalpha"
,"delta delta ct method","NN NN  NN",4,1,1,16733561,"pubmed1",2.15E+018,"testalpha"
,"alcohol dependence and trafficaccidents","NN NN CC NNS",4,1,1,16236233,"pubmed1",6.28E+018,"testalpha"
,"mm and harmful effects"," CC JJ NNS",4,1,1,17046053,2,2.34E+018,"testalpha"
,"control and sham group","NN CC  NN",4,1,1,16612916,"pubmed1",8.24E+018,"testalpha"
,"addition of further polypeptidechains","NN IN JJ NNS",4,1,1,16714052,2,6.84E+018,"testalpha"
,"thisantioxidative system and point","JJ NN CC NN",4,1,1,17046053,2,3.97E+018,"testalpha"
,"displacement of airway bifurcations","NN IN NN NNS",4,1,1,16399039,"pubmed1",3.93E+018,"testalpha"
,"department ofa major city","NN  JJ NN",4,1,1,16330213,"pubmed1",2.14E+018,"testalpha"
,"lymph nodes brain bone","NN NNS NN NN",4,1,1,17139900,2,2.62E+018,"testalpha"
,"reform in medicalstudent education","NN IN NN NN",4,1,1,16473990,"pubmed1",9.08E+018,"testalpha"
,"concentrations in rat blood","NNS IN NN NN",4,1,1,16762403,2,2.29E+018,"testalpha"
,"grade b cell lymphomas","NN NN NN NNP",4,1,1,16612936,"pubmed1",4.29E+018,"testalpha"
,"d couldmaintain pc k"," VB  ",4,1,1,16424649,2,8.73E+018,"testalpha"
,"give higher crash severities","VB JJR NN NNS",4,1,1,16423319,"pubmed1",1.89E+018,"testalpha"
,"good agreement with imageddisplacements","JJ NN IN NNS",4,1,1,16399039,"pubmed1",6.62E+018,"testalpha"
,"values within hourafter e","NNS IN NN ",4,1,1,16594642,"pubmed1",1.28E+018,"testalpha"
,"restrictions with loweredfaculty expectations","NNS IN NN NNS",4,1,1,16377820,"pubmed1",8.00E+018,"testalpha"
,"adequateantibiotics for bacteria infection","NNS IN NNS NN",4,1,1,16424648,2,3.39E+018,"testalpha"
,"poor prognosis accompanying c","JJ NN VBG NN",4,1,1,16809887,2,4.67E+018,"testalpha"
,"dependence of suchni ii","NN IN  ",4,1,1,17117212,"pubmed1",2.20E+018,"testalpha"
,"range of possibilitiesfor diagnosis","NN IN JJ NN",4,1,1,17013504,2,3.28E+018,"testalpha"
,"associated antigens on b","VBN NNS IN NN",4,1,1,16424654,2,3.31E+018,"testalpha"
,"complement c inhibitorconcentrate units","NN NN NN NNS",4,1,1,16451161,"pubmed1",2.68E+017,"testalpha"
,"cornerstones ofintra abdominal infection","NNS JJ JJ NN",4,1,1,16612906,2,1.82E+018,"testalpha"
,"stable psoriasis andpsoriatic arthritis","JJ NN JJ NN",4,1,1,17311738,2,8.80E+017,"testalpha"
,"withprior allergic contact dermatitis","JJ JJ NN NN",4,1,1,16585981,2,7.75E+018,"testalpha"
,"lipid transfer start domain","NN VB NN NN",4,1,1,16951743,"pubmed1",6.45E+018,"testalpha"
,"cerevisiae cells and fibroblasts"," NNS CC NNS",4,1,1,17106512,"pubmed1",8.65E+018,"testalpha"
,"forms of viral spread","NNS IN JJ NN",4,1,1,17311741,2,5.81E+018,"testalpha"
,"secretors of soluble fas","NNS IN JJ ",4,1,1,16710577,2,1.08E+018,"testalpha"
,"th and th year"," CC  NN",4,1,1,16722348,2,3.42E+018,"testalpha"
,"control control beta d","NN NN NN ",4,1,1,16612917,"pubmed1",7.18E+018,"testalpha"
,"marginallyreduced errors on ay","VBN NNS IN ",4,1,1,16436796,"pubmed1",2.04E+018,"testalpha"
,"inhibits stromal layer generation","NNS JJ NN NN",4,1,1,17016038,2,2.31E+018,"testalpha"
,"serial ct lung studies","JJ  NN NNS",4,1,1,16399029,"pubmed1",8.08E+017,"testalpha"
,"median follow upof months","JJ VB  NNS",4,1,1,16549900,2,8.20E+018,"testalpha"
,"dysfunction with bortezomib dexamethasone","NN IN  NN",4,1,1,17119326,2,8.61E+018,"testalpha"
,"groups acute group n","NNS JJ NN ",4,1,1,16491217,2,4.43E+018,"testalpha"
,"activity of atf creb","NN IN  ",4,1,1,16395528,"pubmed1",1.37E+018,"testalpha"
,"withconventional marketed tablet zidovir","JJ VBN NN ",4,1,1,16584139,"pubmed1",8.92E+018,"testalpha"
,"ncep atpiii criteria asia","  NNS ",4,1,1,16479027,2,1.51E+018,"testalpha"
,"cryptorchidism model ofthe adult","NN NN NNP NN",4,1,1,16395525,"pubmed1",6.92E+018,"testalpha"
,"blepharitis keratoconjunctivitis keratoconus uveitis","NN NN NN NN",4,1,1,17106598,2,8.01E+018,"testalpha"
,"axis bridgesthe carboxylate group"," NNP NN NN",4,1,1,16456283,2,4.62E+018,"testalpha"
,"computedtomographic findings of hyperdense","JJ NNS IN NN",4,1,1,16447096,"pubmed1",3.73E+018,"testalpha"
,"promising method ofcontrolling skin","JJ NN VBG NN",4,1,1,17328144,2,4.18E+018,"testalpha"
,"temporal subtraction ofregistered images","JJ NN VBN NNS",4,1,1,16399029,"pubmed1",6.31E+018,"testalpha"
,"dosage and improve temporalresolution","NN CC VB NN",4,1,1,16399032,"pubmed1",2.53E+018,"testalpha"
,"concentrations and gsh px","NNS CC  ",4,1,1,17160142,"pubmed1",2.97E+018,"testalpha"
,"mu glycinato mu thiosulfato"," NN  NN",4,1,1,16397335,2,2.04E+018,"testalpha"
,"acid sodium carbonate sodium","NN NN NN NN",4,1,1,17285749,"pubmed1",2.29E+018,"testalpha"
,"possible pathogenesis for therapeuticconsideration","JJ NN IN NN",4,1,1,16790262,2,9.16E+018,"testalpha"
,"inhibitors for heart failure","NNS IN NN NN",4,1,1,16377816,"pubmed1",4.16E+018,"testalpha"
,"ml min injection rate","  NN NN",4,1,1,16584164,"pubmed1",9.13E+018,"testalpha"
,"infectious complications after endoscopic","JJ NNS IN NN",4,1,1,16673611,2,4.93E+018,"testalpha"
,"kidney heart and liver","NN NN CC NN",4,1,1,16950501,2,7.65E+018,"testalpha"
,"foralcohol related motor vehicle","NN VBN NN NN",4,1,1,16169506,"pubmed1",4.84E+018,"testalpha"
,"present work involve adult","JJ NN VB NN",4,1,1,17236639,"pubmed1",2.78E+018,"testalpha"
,"magneticresonance mr imaging mri","NN  VBG ",4,1,1,16399033,"pubmed1",5.34E+018,"testalpha"
,"receive stem cell transplantation","VB VB NN NN",4,1,1,16914906,2,5.09E+018,"testalpha"
,"factors including lesion location","NNS IN NN NN",4,1,1,16722347,2,3.94E+018,"testalpha"
,"removal ofthe pineal gland","NN NNP NN NN",4,1,1,16491217,2,2.01E+018,"testalpha"
,"presence of astroglial elements","NN IN JJ NNS",4,1,1,16514849,2,2.69E+018,"testalpha"
,"complication ofinflammatory bowel disease","NN NN NN NN",4,1,1,16673554,2,1.03E+018,"testalpha"
,"meanarterial pressure map alanine","JJ NN NN NN",4,1,1,17013507,2,3.23E+018,"testalpha"
,"todefine efficient protein crystallization","NN JJ NN NN",4,1,1,16369090,2,2.99E+018,"testalpha"
,"system orthe cytotoxic activity","NN NNP JJ NN",4,1,1,16919708,2,8.65E+018,"testalpha"
,"laser scanning confocal microscopic","NN VBG JJ NN",4,1,1,16955192,2,2.86E+018,"testalpha"
,"tissue and consequent local","NN CC NN NN",4,1,1,16603102,2,2.09E+018,"testalpha"
,"delivery of nucleic acids","NN IN JJ NNS",4,1,1,17285739,"pubmed1",1.97E+018,"testalpha"
,"circulation and local sites","NN CC JJ NNS",4,1,1,16770444,"pubmed1",7.82E+017,"testalpha"
,"levelsthan teenagers or adults","NNP NNS CC NNS",4,1,1,16549902,2,1.51E+018,"testalpha"
,"differences in hazard acrossindustries","NNS IN NN NNS",4,1,1,16430845,"pubmed1",4.04E+018,"testalpha"
,"term complete remission rate","NN JJ NN NN",4,1,1,16955185,2,6.63E+018,"testalpha"
,"prescription rates in germany","NN NNS IN NN",4,1,1,17106597,2,4.78E+018,"testalpha"
,"secondary reagents for theidentification","JJ NNS IN NN",4,1,1,16730369,2,3.23E+018,"testalpha"
,"prp in dental pulp"," IN JJ NN",4,1,1,16919707,2,2.52E+018,"testalpha"
,"stimulated pi kinase activity","VBN  NN NN",4,1,1,16964326,"pubmed1",3.29E+018,"testalpha"
,"complete hematologicaland cytogenetic remissions","JJ NN JJ NNS",4,1,1,16424660,2,1.02E+017,"testalpha"
,"internal medicine and pediatrics","JJ NN CC NNS",4,1,1,16377822,"pubmed1",1.51E+018,"testalpha"
,"cytologic findings of osteoclastomalike","JJ NNS IN NN",4,1,1,16514845,2,6.18E+018,"testalpha"
,"months of licensureand kilometers","NNS IN NN NNS",4,1,1,16112070,"pubmed1",5.71E+018,"testalpha"
,"telephone calls or home","NN NNS CC NN",4,1,1,16696444,2,1.19E+018,"testalpha"
,"recent upsurge of interest","JJ NN IN NN",4,1,1,16411740,"pubmed1",3.18E+018,"testalpha"
,"dimethacrylate tegdma hydroxyethylmethacrylate hema","NN NN NN ",4,1,1,16701862,"pubmed1",1.66E+018,"testalpha"
,"observation that thehaemoglobin scavenger","NN IN NNP NN",4,1,1,16770444,"pubmed1",4.66E+018,"testalpha"
,"statistical significance included averagebowel","JJ NN VBD NN",4,1,1,16252139,"pubmed1",5.65E+018,"testalpha"
,"cohort of chest pain","NN IN NN NN",4,1,1,16365321,"pubmed1",3.31E+018,"testalpha"
,"delivery of st microemulsion","NN IN  NN",4,1,1,16584167,"pubmed1",8.19E+018,"testalpha"
,"protein crp andhematocrit hct","NN  NN ",4,1,1,17119323,2,1.01E+018,"testalpha"
,"sites of thehighest sensitivity","NNS IN NN NN",4,1,1,16582987,"pubmed1",4.95E+018,"testalpha"
,"remission rate offractionated ala","NN NN VBN ",4,1,1,16955185,2,5.88E+018,"testalpha"
,"best benefit from pkc","VB NN IN ",4,1,1,16424642,2,7.28E+018,"testalpha"
,"ns infusion and ml"," NN CC ",4,1,1,17067137,"pubmed1",6.30E+018,"testalpha"
,"saturation monitoring antibiotics fluid","NN NN NNS NN",4,1,1,16365336,"pubmed1",5.88E+017,"testalpha"
,"observed dose rate effect","VBN NN NN NN",4,1,1,16421442,2,2.07E+018,"testalpha"
,"short axillary plexus catheter","JJ JJ NN NN",4,1,1,16451159,"pubmed1",9.17E+018,"testalpha"
,"o bound h atoms"," VBN  NNS",4,1,1,16456282,2,7.18E+018,"testalpha"
,"protease andhiv reverse transcriptase","NN  VB NN",4,1,1,16823609,"pubmed1",7.98E+018,"testalpha"
,"review oxidation of proteins","NN NN IN NNS",4,1,1,17063208,"pubmed1",2.38E+018,"testalpha"
,"vascular anomalies in children","JJ NNS IN NNS",4,1,1,16722347,2,7.34E+018,"testalpha"
,"twosplenectomized siblings with congenital","VBN NNS IN NN",4,1,1,17117609,2,9.33E+017,"testalpha"
,"children with cerebral palsy","NNS IN JJ NN",4,1,1,17438833,2,1.53E+018,"testalpha"
,"including aortic wall repairs","VBG JJ NN NNS",4,1,1,16714053,2,6.86E+018,"testalpha"
,"tbiwhen accurate case ascertainment","NNP JJ NN NN",4,1,1,16365331,"pubmed1",3.62E+018,"testalpha"
,"mutation nt g deletion","NN   NN",4,1,1,16424663,2,1.05E+018,"testalpha"
,"d in sheep tissues"," IN NN NNS",4,1,1,16770445,"pubmed1",1.31E+018,"testalpha"
,"markedstimulary effect on rat","JJ NN IN NN",4,1,1,16770447,"pubmed1",3.64E+017,"testalpha"
,"laue group and point"," NN CC NN",4,1,1,16369096,2,7.67E+018,"testalpha"
,"forl phenylalanyl l serine"," NN  NN",4,1,1,16397334,2,4.38E+018,"testalpha"
,"protective effects on adherens","JJ NNS IN NNS",4,1,1,16253314,2,5.58E+018,"testalpha"
,"t weighted spoiled gradient"," JJ VBN NN",4,1,1,16317488,"pubmed1",6.85E+018,"testalpha"
,"forms extended stem loop","NNS VBN VB NN",4,1,1,16770443,"pubmed1",6.35E+018,"testalpha"
,"acid bindinglectins tritrichomonas mobilensis","NN NNS NNP NN",4,1,1,16720036,2,5.49E+017,"testalpha"
,"patients with radical resection","NNS IN JJ NN",4,1,1,17139895,2,8.49E+018,"testalpha"
,"images equilibrium phase gre","NNS NN NN ",4,1,1,16317488,"pubmed1",1.93E+017,"testalpha"
,"new products usp expectsthe","JJ NNS  NNP",4,1,1,17285738,"pubmed1",5.48E+018,"testalpha"
,"sleep deprivation and mood","NN NN CC NN",4,1,1,16377826,"pubmed1",1.22E+018,"testalpha"
,"antibodies in right colonsamples","NNS IN JJ NNS",4,1,1,17293967,2,2.39E+018,"testalpha"
,"tube upon thoracostomy tube","NN IN NN NN",4,1,1,16365333,"pubmed1",2.93E+018,"testalpha"
,"induction in rat liver","NN IN NN NN",4,1,1,16951743,"pubmed1",2.50E+018,"testalpha"
,"hourrestrictions on patient care","NNS IN NN NN",4,1,1,16377823,"pubmed1",6.88E+018,"testalpha"
,"focus on stimulating angiogenesis","NN IN VBG NN",4,1,1,17014894,2,2.63E+018,"testalpha"
,"ribonuclease p rnase p","NN  NN ",4,1,1,16648912,2,5.48E+018,"testalpha"
,"approach thechain length dependence","NN VB NN NN",4,1,1,16411735,"pubmed1",1.92E+018,"testalpha"
,"abuse patterns of exposure","NN NNS IN NN",4,1,1,16808045,"pubmed1",4.33E+018,"testalpha"
,"overview of common endocrine","NN IN JJ NN",4,1,1,16462411,"pubmed1",1.47E+018,"testalpha"
,"bowel disease ibd patients","NN NN  NNS",4,1,1,16673554,2,9.63E+017,"testalpha"
,"expression andintracellular fos protein","NN JJ  NN",4,1,1,17007911,2,3.03E+018,"testalpha"
,"complex form using synchrotronradiation","NN NN VBG NN",4,1,1,16511293,2,5.69E+018,"testalpha"
,"promise cellular tissue engineeredproducts","NN JJ NN NNS",4,1,1,17010268,2,6.00E+018,"testalpha"
,"evaluated using annexin v","VBN VBG  ",4,1,1,17016038,2,3.50E+018,"testalpha"
,"ofpatients with benign colon","NNS IN JJ NN",4,1,1,17139878,2,6.64E+017,"testalpha"
,"high rates of nadh","JJ NNS IN ",4,1,1,16511277,2,5.62E+018,"testalpha"
,"evaluate attention concentration memory","VB NN NN NN",4,1,1,16479025,2,1.47E+018,"testalpha"
,"including bodyplethysmography and gas","VBG NN CC NN",4,1,1,16809886,2,6.20E+018,"testalpha"
,"tissuemechanics and air flow","NNS CC NN NN",4,1,1,16399039,"pubmed1",7.10E+018,"testalpha"
,"frequency versusthe other tssr","NN NNP JJ ",4,1,1,16733558,"pubmed1",1.65E+018,"testalpha"
,"injury triggers spontaneous plasticity","NN NNS JJ NN",4,1,1,17133958,2,4.19E+018,"testalpha"
,"divider method significantlyoverestimates fractal","NN NN NNS NN",4,1,1,16823606,"pubmed1",6.18E+018,"testalpha"
,"process design and control","NN NN CC NN",4,1,1,17285746,"pubmed1",7.81E+018,"testalpha"
,"forinjuries among finnish conscripts","NNS IN JJ NNS",4,1,1,16162331,"pubmed1",4.66E+018,"testalpha"
,"solutions containing aha week","NNS VBG  NN",4,1,1,16574202,2,4.67E+018,"testalpha"
,"t dm because hyperglycemia","  IN NN",4,1,1,16918068,"pubmed1",4.89E+018,"testalpha"
,"appearance of membrane protrusions","NN IN NN NNS",4,1,1,16956122,2,5.55E+018,"testalpha"
,"compensation effect of intrinsic","NN NN IN NN",4,1,1,17019442,"pubmed1",4.48E+018,"testalpha"
,"ls and cancer development"," CC NN NN",4,1,1,17311737,2,5.00E+018,"testalpha"
,"provided medicalreports from victims","VBN NNS IN NNS",4,1,1,16491215,2,2.96E+018,"testalpha"
,"fissure abscess and fistula","NN NN CC NN",4,1,1,16673559,2,3.33E+018,"testalpha"
,"catalyzesthe double bond isomerization","NNP JJ NN NN",4,1,1,16511289,2,4.00E+018,"testalpha"
,"largest number of studies","JJS NN IN NNS",4,1,1,16365335,"pubmed1",7.56E+018,"testalpha"
,"binds native tgf beta","NNS JJ  NN",4,1,1,16733563,"pubmed1",4.01E+018,"testalpha"
,"studies and negative immunofluorescence","NNS CC JJ NN",4,1,1,17311740,2,5.85E+018,"testalpha"
,"teaching correlation of x","NN NN IN NN",4,1,1,16399038,"pubmed1",1.10E+018,"testalpha"
,"fat mass and body","NN NN CC NN",4,1,1,16921608,"pubmed1",6.27E+018,"testalpha"
,"different grades of microcrystalline","JJ NNS IN NN",4,1,1,17285749,"pubmed1",2.54E+018,"testalpha"
,"non arterial chronic ulcers"," JJ JJ NNS",4,1,1,17293973,2,4.22E+018,"testalpha"
,"inthe regulation of testosterone","NNP NN IN NN",4,1,1,16325891,2,7.31E+018,"testalpha"
,"sample and enable integration","NN CC VB NN",4,1,1,16714050,2,4.57E+018,"testalpha"
,"ribosomal rna processing factor","JJ  NN NN",4,1,1,16511260,2,7.89E+018,"testalpha"
,"methods of ad treatment","NNS IN NN NN",4,1,1,17328144,2,2.05E+018,"testalpha"
,"determination of circulating ox","NN IN VBG ",4,1,1,17106515,"pubmed1",8.18E+018,"testalpha"
,"allergen in maize pollen","NN IN VB NN",4,1,1,16963110,2,8.86E+018,"testalpha"
,"distance between plant organs","NN IN NN NNS",4,1,1,17486414,"pubmed1",1.71E+017,"testalpha"
,"anasojejunal tube modified billbao","JJ NN VBN ",4,1,1,16447095,"pubmed1",6.29E+018,"testalpha"
,"orthorhombic space group c","JJ NN NN NN",4,1,1,16511261,2,5.48E+018,"testalpha"
,"extracellular space of hippocampus","JJ NN IN NN",4,1,1,17133953,2,7.66E+018,"testalpha"
,"theestablished prevalence of ttv","VBN NN IN ",4,1,1,16696442,2,7.28E+018,"testalpha"
,"death in patientswith colorectal","NN IN NN NN",4,1,1,17139885,2,1.44E+018,"testalpha"
,"signs of vlp underwentbiopsy","NNS IN  NN",4,1,1,16955190,2,6.95E+017,"testalpha"
,"duct carcinoid tumours surgicalresection"," VB NNS NN",4,1,1,16612931,"pubmed1",1.36E+018,"testalpha"
,"r xy intensive chemotherapy","NN  JJ NN",4,1,1,16914909,2,6.58E+017,"testalpha"
,"pruritus sedation and respiratory","NN NN CC NN",4,1,1,16916180,"pubmed1",5.55E+018,"testalpha"
,"prevents futureproblems with pain","VBZ NNS IN NN",4,1,1,17438833,2,5.92E+018,"testalpha"
,"admission for psa relatedcomplications","NN IN  NNS",4,1,1,16365337,"pubmed1",3.10E+018,"testalpha"
,"therapeutic factors displayantiangiogenic capabilities","JJ NNS JJ NNS",4,1,1,16733559,"pubmed1",1.73E+018,"testalpha"
,"atf and patf cre"," CC  ",4,1,1,16395528,"pubmed1",6.13E+018,"testalpha"
,"grade squamous intraepitheliallesion hsil","NN JJ NN ",4,1,1,16514839,2,6.32E+018,"testalpha"
,"celldeath showing morphological features","NN VBG JJ NNS",4,1,1,16956122,2,1.83E+018,"testalpha"
,"physical activity beneficial inthe","JJ NN JJ NNP",4,1,1,16918071,"pubmed1",8.36E+018,"testalpha"
,"mass with air bronchograms","NN IN NN NNS",4,1,1,16612936,"pubmed1",7.25E+018,"testalpha"
,"simple tool for stratification","JJ NN IN NN",4,1,1,17236637,"pubmed1",4.30E+018,"testalpha"
,"significant variation in emergency","JJ NN IN NN",4,1,1,16365329,"pubmed1",2.28E+018,"testalpha"
,"system takes advantage ofthe","NN VBZ NN NNP",4,1,1,16733563,"pubmed1",2.44E+018,"testalpha"
,"objectives prehospital lead electrocardiogram","NNS NN NN NN",4,1,1,16365334,"pubmed1",3.41E+018,"testalpha"
,"x including doctors nursesand","NN IN NNS NN",4,1,1,16710575,2,3.92E+018,"testalpha"
,"offormulating independent double readings","VBG JJ NN NNS",4,1,1,16399036,"pubmed1",4.18E+018,"testalpha"
,"scf fl and tumor","  CC NN",4,1,1,16404477,"pubmed1",4.63E+018,"testalpha"
,"positive patients had episodes","JJ NNS VBD NNS",4,1,1,16874419,2,3.22E+018,"testalpha"
,"picture of eeg activity","NN IN  NN",4,1,1,17133951,2,1.23E+018,"testalpha"
,"energy liquefies sweat glands","NN NNS NN NNS",4,1,1,16710583,2,4.82E+018,"testalpha"
,"activation of glycid metabolism","NN IN NN NN",4,1,1,17013507,2,8.77E+018,"testalpha"
,"main pancreatic duct andit","JJS JJ  NN",4,1,1,16333694,"pubmed1",4.04E+018,"testalpha"
,"describe cases of b","VB NNS IN NN",4,1,1,16424654,2,7.47E+017,"testalpha"
,"following gross total resection","VBG JJ NN NN",4,1,1,16612936,"pubmed1",4.42E+017,"testalpha"
,"key regulator of apoptosis","JJ NN IN NN",4,1,1,17115080,"pubmed1",8.47E+018,"testalpha"
,"biological properties andspontaneous differentiation","JJ NNS JJ NN",4,1,1,16696440,2,6.96E+018,"testalpha"
,"chemical carcinogen n acetoxy","NN NN  NN",4,1,1,17143337,"pubmed1",6.84E+018,"testalpha"
,"hospital ambulance diversion hours","NN NN NN NNS",4,1,1,16365324,"pubmed1",2.97E+018,"testalpha"
,"histological technique of agnor","JJ NN IN NN",4,1,1,17293964,2,9.03E+017,"testalpha"
,"theglyoxylate cycle in yeast","NN NN IN NN",4,1,1,17146497,"pubmed1",8.21E+018,"testalpha"
,"frompyrobaculum calidifontis and afest","NN NN CC NN",4,1,1,16511287,2,5.10E+018,"testalpha"
,"ultrasound images with d","NN NNS IN ",4,1,1,16399038,"pubmed1",5.73E+017,"testalpha"
,"multiple linear regression analysis","JJ JJ NN NN",4,1,1,17119323,2,8.16E+017,"testalpha"
,"conjunction with bone fixation","NN IN NN NN",4,1,1,16701863,"pubmed1",6.76E+018,"testalpha"
,"ratio u nag cr","NN   ",4,1,1,16956119,2,8.34E+018,"testalpha"
,"high molecular weight kda","JJ JJ NN ",4,1,1,16733556,"pubmed1",3.90E+018,"testalpha"
,"whereasdifferent domains require recognition","NN NNS VBP NN",4,1,1,16988904,"pubmed1",5.79E+018,"testalpha"
,"subjects were used totest","NNS VBD VBN NN",4,1,1,16365330,"pubmed1",5.74E+018,"testalpha"
,"hsv in primary genital"," IN JJ NN",4,1,1,16648915,2,4.73E+018,"testalpha"
,"abnormal indicator irondeficiency idef","JJ NN NN ",4,1,1,16809889,2,6.45E+018,"testalpha"
,"association between chronic sleepdeprivation","NN IN JJ NN",4,1,1,16377826,"pubmed1",7.71E+018,"testalpha"
,"merit in reviewing publication","NN IN VBG NN",4,1,1,16399035,"pubmed1",3.54E+018,"testalpha"
,"differences in industry hazards","NNS IN NN NNS",4,1,1,16430845,"pubmed1",7.63E+017,"testalpha"
,"blind placebo controlled cross","JJ  VBN NN",4,1,1,16874418,2,3.83E+018,"testalpha"
,"patients in complete remission","NNS IN JJ NN",4,1,1,17016036,2,4.49E+018,"testalpha"
,"countries france uk germany","NNS NN  NN",4,1,1,16451154,"pubmed1",3.48E+018,"testalpha"
,"carbon dioxide and bicarbonate","NN NN CC NN",4,1,1,16511248,2,5.68E+018,"testalpha"
,"epr spin labeling methods"," VB VBG NNS",4,1,1,16964324,"pubmed1",8.29E+018,"testalpha"
,"switch from low flux","NN IN JJ NN",4,1,1,17106603,2,6.13E+018,"testalpha"
,"thatthe transferred models yield","NNP VBN NNS NN",4,1,1,16414003,"pubmed1",7.47E+018,"testalpha"
,"ddexma and ddexma vinyl"," CC  NN",4,1,1,16701854,"pubmed1",8.86E+018,"testalpha"
,"cytoplasmic organelles of malassezia","JJ NNS IN NNP",4,1,1,16874415,2,5.61E+018,"testalpha"
,"employee safety control mediates","NN NN NN NNS",4,1,1,16442068,"pubmed1",1.43E+018,"testalpha"
,"dppiv cd bound form","  VBN NN",4,1,1,16929383,"pubmed1",8.71E+018,"testalpha"
,"following ami pretreatment nadir","VBG  NN NN",4,1,1,16594642,"pubmed1",3.71E+018,"testalpha"
,"senescence and growth arrest","NN CC NN NN",4,1,1,16505900,"pubmed1",3.96E+018,"testalpha"
,"causes of reperfusion injury","NNS IN NN NN",4,1,1,17338197,2,4.73E+018,"testalpha"
,"adults with t dm","NNS IN  ",4,1,1,16918068,"pubmed1",5.61E+017,"testalpha"
,"transfection efficiencyinto caco cells","NN NNP  NNS",4,1,1,17285741,"pubmed1",7.70E+018,"testalpha"
,"abolished rhbfgf induced melanocytemigration","VBN  VBN NN",4,1,1,17106595,2,6.16E+018,"testalpha"
,"quantity of residual monomer","NN IN JJ NN",4,1,1,16701856,"pubmed1",7.66E+018,"testalpha"
,"majority of fellowship directorsfavor","NN IN NN NN",4,1,1,16399040,"pubmed1",1.08E+018,"testalpha"
,"various fields of surgery","JJ NNS IN NN",4,1,1,17139892,2,5.49E+018,"testalpha"
,"analysistechniques x ray photoelectron","NNS NN  NNP",4,1,1,16701874,"pubmed1",6.68E+018,"testalpha"
,"study performed using confirmatory","NN VBN VBG NN",4,1,1,16584161,"pubmed1",4.86E+018,"testalpha"
,"standardbattery of neurological tests","NN IN JJ NNS",4,1,1,17688033,2,9.08E+018,"testalpha"
,"quantitative stepcolorimetric sandwich elisa","JJ JJ NN ",4,1,1,16603096,2,6.64E+018,"testalpha"
,"allpatients achieved rapid improvement","NNS VBN JJ NN",4,1,1,17119326,2,8.58E+018,"testalpha"
,"visual imagery of themedium","JJ NN IN NN",4,1,1,16474001,"pubmed1",7.34E+018,"testalpha"
,"offull thickness skin grafts","NN NN NN NNS",4,1,1,17165596,2,4.74E+018,"testalpha"
,"proportion of falsenegatives fn","NN IN NNS ",4,1,1,16436791,"pubmed1",6.89E+018,"testalpha"
,"cells and nih t","NNS CC  ",4,1,1,16770447,"pubmed1",1.88E+018,"testalpha"
,"hereditary non polyposis colorectal","JJ  NN NN",4,1,1,16673564,2,7.66E+018,"testalpha"
,"regulated mechanisms in signal","VBN NNS IN NN",4,1,1,17016035,2,9.00E+018,"testalpha"
,"mitochondrial membrane potential activity","JJ NN NN NN",4,1,1,16696445,2,4.28E+018,"testalpha"
,"definedactive site solvent network","JJ NN NN NN",4,1,1,16511248,2,2.71E+018,"testalpha"
,"paste of gen tech","NN IN  ",4,1,1,17293969,2,4.56E+017,"testalpha"
,"abnormal glycosylation of cell","JJ NN IN NN",4,1,1,16720036,2,8.03E+018,"testalpha"
,"calcipotriol tars and dithranol","  CC NN",4,1,1,17311742,2,1.70E+018,"testalpha"
,"perfusionmeasurements and dedicated contrast","NNS CC VBN NN",4,1,1,16447077,"pubmed1",2.83E+018,"testalpha"
,"different cell types mscs","JJ NN NNS ",4,1,1,16696440,2,1.62E+018,"testalpha"
,"acute blood loss inmale","JJ NN NN NN",4,1,1,16762404,2,9.41E+017,"testalpha"
,"merging fusion and incorporation","VBG NN CC NN",4,1,1,16988903,"pubmed1",7.26E+018,"testalpha"
,"tool for retrospective determination","NN IN JJ NN",4,1,1,16710577,2,1.49E+018,"testalpha"
,"volume and replicative life","NN CC JJ NN",4,1,1,17106513,"pubmed1",1.62E+018,"testalpha"
,"due toimmunologic reactions allergy","JJ JJ NNS NN",4,1,1,16673561,2,8.02E+018,"testalpha"
,"little change in thesupervision","JJ NN IN NN",4,1,1,16377820,"pubmed1",2.66E+018,"testalpha"
,"provide betterbowel distention wall","VB NN NN NN",4,1,1,16252139,"pubmed1",7.08E+018,"testalpha"
,"intersection fatal disabling injury","NN JJ VBG NN",4,1,1,16426556,"pubmed1",5.53E+018,"testalpha"
,"albicans fromcardiovascular system samples","NNS JJ NN NNS",4,1,1,17311736,2,3.94E+018,"testalpha"
,"hema and methacryloxyethyl phthalate"," CC  NN",4,1,1,16701862,"pubmed1",6.71E+018,"testalpha"
,"named g n control","VBN   NN",4,1,1,17293959,2,2.03E+018,"testalpha"
,"increased lengths of stay","JJ NNS IN NN",4,1,1,16462412,"pubmed1",4.60E+018,"testalpha"
,"mitochondrial transcripts nd nd","JJ NNS  ",4,1,1,16389406,"pubmed1",8.01E+018,"testalpha"
,"ignore nonconfirmatory data clinicians","VB NN NNS NNS",4,1,1,16365325,"pubmed1",3.22E+018,"testalpha"
,"induced c fos expression","VBN NN  NN",4,1,1,17007911,2,4.83E+018,"testalpha"
,"recombinant particles induced rhdv","JJ NNS VBN ",4,1,1,16733562,"pubmed1",1.17E+018,"testalpha"
,"use compliance site severity","NN NN NN NN",4,1,1,16223468,"pubmed1",5.81E+018,"testalpha"
,"development of atherosclerotic lesions","NN IN JJ NNS",4,1,1,17007910,2,4.98E+017,"testalpha"
,"postoperative morbidity and hospitalization","JJ NN CC NN",4,1,1,16989147,2,6.78E+018,"testalpha"
,"complete remission using flow","JJ NN VBG NN",4,1,1,17016036,2,4.62E+018,"testalpha"
,"p and p waf"," CC  ",4,1,1,16733561,"pubmed1",7.28E+018,"testalpha"
,"coagulation activity in thepatients","NN NN IN NNS",4,1,1,16914903,2,5.40E+018,"testalpha"
,"epid group combination ofbupicavaine"," NN NN NN",4,1,1,17236639,"pubmed1",7.05E+018,"testalpha"
,"matched placebo in adults","VBN  IN NNS",4,1,1,16874418,2,3.02E+018,"testalpha"
,"physiological significance and metabolism","JJ NN CC NN",4,1,1,16389406,"pubmed1",4.00E+018,"testalpha"
,"nutritionalsupplements other ergogenic aids","NNS JJ JJ NNS",4,1,1,16918070,"pubmed1",7.33E+018,"testalpha"
,"individuals with atopic dermatitis","NNS IN NN NN",4,1,1,16648913,2,5.85E+018,"testalpha"
,"cervicovaginal smears vaginal pool","JJ NNS JJ NN",4,1,1,16514840,2,4.30E+018,"testalpha"
,"rnai technique and agrobacterium"," NN CC NN",4,1,1,16395523,"pubmed1",2.87E+018,"testalpha"
,"skin homing t cells","NN VBG  NNS",4,1,1,16955181,2,6.85E+018,"testalpha"
,"antifungal treatment in life","JJ NN IN NN",4,1,1,16918062,"pubmed1",3.94E+018,"testalpha"
,"noveltytook place after habituation","NN NN IN NN",4,1,1,17133955,2,6.54E+017,"testalpha"
,"resolution over wax sections","NN IN  NNS",4,1,1,17007910,2,8.03E+017,"testalpha"
,"conventionalsplit thickness skin grafts","NN NN NN NNS",4,1,1,16999269,2,3.23E+018,"testalpha"
,"anegative fragrance patch test","JJ NN NN NN",4,1,1,16874422,2,1.93E+018,"testalpha"
,"h hardness and h"," NN CC ",4,1,1,16701865,"pubmed1",2.37E+018,"testalpha"
,"analysis of nd mrna","NN IN  ",4,1,1,16389406,"pubmed1",6.15E+018,"testalpha"
,"conformations of amino acid","NNS IN NNP NN",4,1,1,16523218,"pubmed1",1.77E+018,"testalpha"
,"torsionangles phi o gal","NNS   ",4,1,1,16456293,2,8.63E+018,"testalpha"
,"recovery return ofcognitive function","NN NN JJ NN",4,1,1,16451145,"pubmed1",4.80E+018,"testalpha"
,"conservative management exceptions canbe","JJ NN NNS ",4,1,1,17013521,2,7.57E+018,"testalpha"
,"seat belt use drinking","NN NN NN NN",4,1,1,16426559,"pubmed1",6.69E+018,"testalpha"
,"significant increases in activation","JJ NNS IN NN",4,1,1,17133958,2,8.50E+018,"testalpha"
,"granulocyte colony stimulating factors","NNP NN JJ NNS",4,1,1,16424645,2,8.23E+017,"testalpha"
,"year in surface mines","NN IN NN NNS",4,1,1,16129405,"pubmed1",2.04E+018,"testalpha"
,"analysis using theproliferating cell","NN VBG VBG NN",4,1,1,17013509,2,4.92E+018,"testalpha"
,"diagnosis of agc em","NN IN  ",4,1,1,16514840,2,2.78E+017,"testalpha"
,"time grant funded researchers","NN NN VBN NNS",4,1,1,16473996,"pubmed1",1.11E+018,"testalpha"
,"wavelength and pulse duration","NN CC NN NN",4,1,1,16722347,2,2.63E+018,"testalpha"
,"microscopic findings of skinbiopsy","NN NNS IN NN",4,1,1,16603099,2,9.21E+018,"testalpha"
,"radiation therapy oncology group","NN NN NN NN",4,1,1,17117605,2,6.48E+018,"testalpha"
,"allpropofol related psa events"," VBN  NNS",4,1,1,16365337,"pubmed1",2.97E+018,"testalpha"
,"sp from mycobacterium tuberculosis"," IN NN NN",4,1,1,16256177,2,7.04E+018,"testalpha"
,"genetic information of cells","JJ NN IN NNS",4,1,1,17294912,2,8.65E+018,"testalpha"
,"cancer with published rate","NN IN VBN NN",4,1,1,17139900,2,4.71E+018,"testalpha"
,"regulates anti microbial responses","NNS IN JJ NNS",4,1,1,16648910,2,4.49E+018,"testalpha"
,"bowel wall with lossof","NN NN IN ",4,1,1,16447095,"pubmed1",2.07E+018,"testalpha"
,"different species of chelonians","JJ NN IN NNS",4,1,1,16733064,2,7.25E+018,"testalpha"
,"indicators were monthly motor","NNS VBD JJ NN",4,1,1,16169506,"pubmed1",3.97E+018,"testalpha"
,"dried sucralfate gel powders","VBN NN  NNS",4,1,1,16584168,"pubmed1",7.89E+018,"testalpha"
,"weeks with oral celecoxib","NNS IN JJ ",4,1,1,16253314,2,1.78E+018,"testalpha"
,"atopic and non atopic","NN CC  NN",4,1,1,16648917,2,1.83E+018,"testalpha"
,"ai total cholesterol hdl"," NN NN ",4,1,1,17106515,"pubmed1",4.33E+018,"testalpha"
,"receptors on cell proliferation","NNS IN NN NN",4,1,1,17115080,"pubmed1",1.19E+018,"testalpha"
,"source of abdominal problems","NN IN JJ NNS",4,1,1,16132430,"pubmed1",8.85E+018,"testalpha"
,"value of visual analogue","NN IN JJ NN",4,1,1,16955183,2,3.92E+018,"testalpha"
,"gcs or prolonged treatment"," CC VBN NN",4,1,1,17133953,2,6.33E+018,"testalpha"
,"activity of gsh r","NN IN  NN",4,1,1,16404476,"pubmed1",6.05E+018,"testalpha"
,"sex matched healthycontrol individuals","NN VBN NN NNS",4,1,1,17034836,2,6.49E+017,"testalpha"
,"divisions of yeast cells","NNS IN NN NNS",4,1,1,17106513,"pubmed1",6.45E+017,"testalpha"
,"co localization of twoor"," NN IN NN",4,1,1,16730369,2,4.59E+017,"testalpha"
,"tigrinum immunoreactivity for isoforms","NN NN IN NNS",4,1,1,16824585,2,9.15E+018,"testalpha"
,"phage displayed random mer","NN VBN JJ ",4,1,1,17019437,"pubmed1",6.13E+018,"testalpha"
,"reliable method for assessment","JJ NN IN NN",4,1,1,16491215,2,2.54E+018,"testalpha"
,"paperinvestigates median barrier crash","NNS JJ NN NN",4,1,1,16442487,"pubmed1",2.99E+018,"testalpha"
,"mechanism for iron absorption","NN IN NN NN",4,1,1,17119325,2,4.82E+018,"testalpha"
,"ml vs ng ml","   ",4,1,1,17067137,"pubmed1",1.83E+018,"testalpha"
,"annual cost of police","JJ NN IN NN",4,1,1,16426556,"pubmed1",5.43E+018,"testalpha"
,"measures variables and components","NNS NNS CC NNS",4,1,1,16406188,"pubmed1",1.29E+017,"testalpha"
,"response induced e coli","NN VBN  ",4,1,1,16582987,"pubmed1",7.82E+017,"testalpha"
,"degrees c data showeda","NNS NN NNS NNP",4,1,1,16584150,"pubmed1",1.03E+016,"testalpha"
,"patient registry cancer registry","NN NN NN NN",4,1,1,16710578,2,1.47E+018,"testalpha"
,"band nse immunoreactive nerve","NN  JJ NN",4,1,1,16919707,2,4.52E+018,"testalpha"
,"reports of myocardial infarction","NNS IN JJ NN",4,1,1,16914907,2,7.58E+018,"testalpha"
,"nuclear volumes in tsh","JJ NNS IN ",4,1,1,16714054,2,6.30E+018,"testalpha"
,"mistakes and producepathological collagen","NNS CC JJ NN",4,1,1,17294912,2,8.45E+018,"testalpha"
,"beneficial effect ofspecific immunotherapy","JJ NN NNP NN",4,1,1,16603103,2,9.95E+017,"testalpha"
,"interactions play arelevant role","NNS VB JJ NN",4,1,1,17019436,"pubmed1",6.85E+018,"testalpha"
,"determining host response totumor","VBG NN NN NN",4,1,1,16951739,"pubmed1",8.55E+017,"testalpha"
,"hope of cure emergeson","NN IN VB NN",4,1,1,16673565,2,4.94E+018,"testalpha"
,"antibiotic antihemetic vermifuge vitamins","JJ JJ NNP NNS",4,1,1,17293961,2,1.26E+018,"testalpha"
,"presentincreased capacity of proliferation","VBN NN IN NN",4,1,1,17013515,2,2.35E+018,"testalpha"
,"propofol n o fentanyl","   NN",4,1,1,17236635,"pubmed1",3.87E+018,"testalpha"
,"methods male rattus norvegicus","NNS NN NN NN",4,1,1,17293964,2,2.73E+018,"testalpha"
,"glactosidase activity oftranscription fusions","NN NN NN NNS",4,1,1,16964327,"pubmed1",8.73E+018,"testalpha"
,"current system increasing numbers","JJ NN VBG NNS",4,1,1,16770858,"pubmed1",2.10E+018,"testalpha"
,"riskperception and high impulsivity","NN CC JJ NN",4,1,1,16426559,"pubmed1",2.43E+018,"testalpha"
,"institute of immunology zagreb","NN IN NN ",4,1,1,17010264,2,6.08E+018,"testalpha"
,"vital driving related information","JJ NN VBN NN",4,1,1,16427019,"pubmed1",3.37E+018,"testalpha"
,"hereditary syndromes ofgastrointestinal tumours","JJ NNS JJ NNS",4,1,1,17139893,2,8.57E+018,"testalpha"
,"penicillamine and nevirapine models","NN CC NN NNS",4,1,1,16594644,"pubmed1",7.51E+017,"testalpha"
,"analyzed data from patients","VBD NNS IN NNS",4,1,1,16696443,2,8.54E+018,"testalpha"
,"water content amino acid","NN JJ NNP NN",4,1,1,16701880,"pubmed1",3.30E+018,"testalpha"
,"overexpression of growth factors","NN IN NN NNS",4,1,1,16479030,2,3.21E+018,"testalpha"
,"lesions versus normal skin","NNS IN JJ NN",4,1,1,17034836,2,2.57E+018,"testalpha"
,"clinical condition of limb","JJ NN IN NN",4,1,1,16549898,2,7.72E+018,"testalpha"
,"hadneo adjuvant radio chemotherapy"," JJ NN NN",4,1,1,16612911,2,3.62E+018,"testalpha"
,"protein kinase c pkc","NN NN NN ",4,1,1,17016035,2,3.09E+018,"testalpha"
,"pyridine carboxylate hemihydrate c","NN NN NN NN",4,1,1,16456283,2,8.77E+018,"testalpha"
,"tissues during stress conditions","NNS IN NN NNS",4,1,1,16770441,"pubmed1",1.07E+018,"testalpha"
,"tandem trinucleotide repeats tssr","NN VB VBZ ",4,1,1,16733558,"pubmed1",7.73E+017,"testalpha"
,"features in various organs","NNS IN JJ NNS",4,1,1,16514846,2,3.88E+018,"testalpha"
,"considerable claims and predictions","JJ NNS CC NNS",4,1,1,16596744,"pubmed1",2.04E+018,"testalpha"
,"par weighting scores todetermine","NN NN NNS NN",4,1,1,17438832,2,1.63E+018,"testalpha"
,"autoimmune pancreatitis in ourhospital","NN NN IN NN",4,1,1,16333694,"pubmed1",3.45E+018,"testalpha"
,"leukocyte counts fibroblasts vessel","NNP NNS NNS NN",4,1,1,17293959,2,4.93E+018,"testalpha"
,"impair correct electrocardiogram analysis","VB VB NN NN",4,1,1,16365330,"pubmed1",6.52E+018,"testalpha"
,"fromanalysis of variance anova","NN IN NN NNP",4,1,1,17293963,2,9.11E+018,"testalpha"
,"policies for preplacement screening","NNS IN NN NN",4,1,1,16438093,"pubmed1",1.85E+018,"testalpha"
,"generation by inducing apoptosis","NN IN VBG NN",4,1,1,17016038,2,8.14E+018,"testalpha"
,"reproducible system of agrobacterium","JJ NN IN NN",4,1,1,16582986,"pubmed1",2.01E+018,"testalpha"
,"category of linear relationship","NN IN JJ NN",4,1,1,16505901,"pubmed1",8.14E+018,"testalpha"
,"reconstruction of thick sections","NN IN JJ NNS",4,1,1,16730369,2,1.36E+018,"testalpha"
,"discovery of new medicines","NN IN JJ NNS",4,1,1,16369099,2,4.73E+018,"testalpha"
,"ofexperimental inflammatory joint disease","NN JJ JJ NN",4,1,1,16399028,"pubmed1",6.09E+018,"testalpha"
,"lesions in immunosuppressed patients","NNS IN VBN NNS",4,1,1,16585985,2,7.09E+015,"testalpha"
,"administered topatients at risk","VBD NNS IN NN",4,1,1,16424647,2,1.20E+018,"testalpha"
,"female at weeks gestation","NN IN NNS NN",4,1,1,16916187,"pubmed1",4.59E+018,"testalpha"
,"hypercalcemiaon thyroid c cells"," NN NN NNS",4,1,1,16762403,2,4.43E+018,"testalpha"
,"toxic epidermal necrolysis stevens","JJ JJ NN NNS",4,1,1,16710577,2,6.50E+018,"testalpha"
,"apoptosis isa frequent event","NN  JJ NN",4,1,1,16569423,2,1.54E+018,"testalpha"
,"gammopathies in blood donors","NNS IN NN NNS",4,1,1,16956121,2,6.21E+017,"testalpha"
,"reviewing publication curriculum vitae","VBG NN NN ",4,1,1,16399035,"pubmed1",8.80E+018,"testalpha"
,"amino acid sequence identity","NNP NN NN NN",4,1,1,16511256,2,3.53E+018,"testalpha"
,"presence of lipid peroxidation","NN IN NN NN",4,1,1,17013507,2,4.07E+018,"testalpha"
,"onchemical analysis of prototypes","JJ NN IN NNS",4,1,1,16790262,2,3.67E+018,"testalpha"
,"subjects while anoxious stimulus","NNS IN JJ NN",4,1,1,17236636,"pubmed1",9.07E+018,"testalpha"
,"absolute reduction of vas","JJ NN IN ",4,1,1,16436793,"pubmed1",3.73E+018,"testalpha"
,"japanesecedar pollen patch test","NN NN NN NN",4,1,1,16648919,2,4.20E+018,"testalpha"
,"ointment and oral nifedipine","NN CC JJ NN",4,1,1,16612915,"pubmed1",4.87E+017,"testalpha"
,"fivesquatter settlements in karachi","NN NNS IN NNP",4,1,1,16412373,"pubmed1",7.27E+018,"testalpha"
,"odds ratio using yatescorrection","NNS NN VBG NN",4,1,1,16365333,"pubmed1",8.27E+018,"testalpha"
,"rapid progress and maturation","JJ NN CC NN",4,1,1,16369088,2,3.83E+018,"testalpha"
,"prevention of thequiescent g","NN IN NN ",4,1,1,16988902,"pubmed1",3.60E+018,"testalpha"
,"ofheart rate systolic blood","NN NN JJ NN",4,1,1,17067136,"pubmed1",4.00E+018,"testalpha"
,"dehydration of carbon dioxide","NN IN NN NN",4,1,1,16511248,2,6.34E+018,"testalpha"
,"group oxygen in nitrogen","NN NN IN NN",4,1,1,16451147,"pubmed1",4.21E+018,"testalpha"
,"contrary promote cell death","NN VB NN NN",4,1,1,16696437,2,3.48E+018,"testalpha"
,"intraperitoneal chemotherapy and systemicchemotherapy","NN NN CC NN",4,1,1,17139879,2,5.20E+018,"testalpha"
,"d mannosylgroups of mucosubstances"," NNS IN NNS",4,1,1,16996581,2,1.95E+018,"testalpha"
,"presentation and survey data","NN CC NN NNS",4,1,1,16365338,"pubmed1",3.55E+018,"testalpha"
,"marker indicating agood prognosis","NN VBG NN NN",4,1,1,16914901,2,8.73E+018,"testalpha"
,"self reported offending behaviours","NN VBD VBG NNS",4,1,1,16405859,"pubmed1",4.57E+018,"testalpha"
,"galactosidases from thermophilic organisms","NNS IN JJ NNS",4,1,1,16511274,2,3.91E+018,"testalpha"
,"human phosphate binding protein","JJ NN VBG NN",4,1,1,16511265,2,6.96E+018,"testalpha"
,"frenchhospitals in german hospitals","NNS IN NN NNS",4,1,1,16451154,"pubmed1",4.31E+018,"testalpha"
,"antibiotic regimens and timing","JJ NNS CC NN",4,1,1,16673611,2,1.15E+018,"testalpha"
,"region total motorvehicle casualty","NN JJ NN NN",4,1,1,16169506,"pubmed1",1.90E+018,"testalpha"
,"changes in surface structure","NNS IN NN NN",4,1,1,16584166,"pubmed1",6.60E+017,"testalpha"
,"administration and best brain","NN CC JJT NN",4,1,1,16584167,"pubmed1",1.24E+018,"testalpha"
,"time evolution of species","NN NN IN NN",4,1,1,17318329,"pubmed1",3.46E+017,"testalpha"
,"nausea vomiting arthralgias ormyalgias","NNP VBG NNP NNP",4,1,1,16696448,2,2.50E+018,"testalpha"
,"changes in cell viability","NNS IN NN NN",4,1,1,16696445,2,1.52E+018,"testalpha"
,"interpretations by pediatric eps","NNS IN JJ ",4,1,1,16436791,"pubmed1",3.94E+018,"testalpha"
,"variety oflow sequence identity","NN VB NN NN",4,1,1,16421452,2,5.78E+018,"testalpha"
,"impairment ofneonatal platelet function","NN NN NN NN",4,1,1,16549890,2,8.56E+018,"testalpha"
,"patients use ambulance care","NNS VB NN NN",4,1,1,16321535,"pubmed1",8.91E+018,"testalpha"
,"internal medicine resident program","JJ NN NN NN",4,1,1,16377826,"pubmed1",7.43E+018,"testalpha"
,"i ori with unit","  IN NN",4,1,1,16511274,2,3.70E+018,"testalpha"
,"ofrandomized controlled trials rcts","VBN VBN NNS ",4,1,1,16365332,"pubmed1",8.58E+018,"testalpha"
,"gibbs freeenergy deltago enthalpy","NNS NN NNP ",4,1,1,17019442,"pubmed1",1.19E+017,"testalpha"
,"plots and contour plots","NNS CC JJ NNS",4,1,1,16584161,"pubmed1",1.63E+018,"testalpha"
,"implications for heavy vehicle","NNS IN JJ NN",4,1,1,16221468,"pubmed1",3.76E+018,"testalpha"
,"tremor headache palpitation nervousness","NN NN NN NN",4,1,1,16479025,2,1.16E+018,"testalpha"
,"uterinesarcomas diagnostic procedures treatment","NNP JJ NNS NN",4,1,1,17338203,2,6.00E+018,"testalpha"
,"hour restrictions onmedical students","NN NNS JJ NNS",4,1,1,16377822,"pubmed1",7.13E+018,"testalpha"
,"importantdimensions of safety climate","NNS IN NN NN",4,1,1,16442068,"pubmed1",2.77E+018,"testalpha"
,"factors promoting neuronal death","NNS VBG JJ NN",4,1,1,17265697,2,4.47E+018,"testalpha"
,"significant morbidity and mortality","JJ NN CC NN",4,1,1,16436789,"pubmed1",7.68E+018,"testalpha"
,"complexes of ac thr","NNS IN  ",4,1,1,17117212,"pubmed1",1.23E+018,"testalpha"
,"nucleus ofthe trapezoid body","NN NNP VB NN",4,1,1,16949651,2,6.27E+018,"testalpha"
,"title compounds hexaaquacobalt ii","NN VBZ NN ",4,1,1,16397335,2,6.80E+017,"testalpha"
,"exposed skin of atopic","VBN NN IN NN",4,1,1,16603095,2,6.71E+018,"testalpha"
,"measured meanarterial pressure map","VBN JJ NN NN",4,1,1,17013507,2,2.82E+018,"testalpha"
,"cell viability activated caspase","NN NN VBN NN",4,1,1,16951739,"pubmed1",6.83E+018,"testalpha"
,"images with d anatomy","NNS IN  NN",4,1,1,16399038,"pubmed1",9.07E+018,"testalpha"
,"granulocyte colony stimulatingfactor therapy","NNP NN NN NN",4,1,1,17016039,2,8.97E+018,"testalpha"
,"gal and h oglc"," CC  ",4,1,1,16456293,2,8.81E+018,"testalpha"
,"wide range ofreported incidences","JJ NN VBN NNS",4,1,1,16451151,"pubmed1",5.74E+018,"testalpha"
,"theamount of remaining ice","NN IN VBG NN",4,1,1,17285746,"pubmed1",4.98E+018,"testalpha"
,"pattern of high grade","NN IN JJ NN",4,1,1,16612936,"pubmed1",2.08E+018,"testalpha"
,"cell detachment from substratum","NN NN IN NN",4,1,1,16956122,2,6.25E+018,"testalpha"
,"heart from biochemical damage","NN IN JJ NN",4,1,1,17338197,2,4.26E+018,"testalpha"
,"liverechogenicity grade moderate increase","NN NN JJ NN",4,1,1,16673610,2,5.60E+018,"testalpha"
,"rare complication of malignancy","JJ NN IN NN",4,1,1,16673614,2,1.67E+018,"testalpha"
,"medical center between march","JJ NN IN NN",4,1,1,16549889,2,2.57E+018,"testalpha"
,"conclusion peroral retinoic acidsupplement","NN JJ JJ NN",4,1,1,16612919,"pubmed1",2.18E+018,"testalpha"
,"standards for research records","NNS IN NN NNS",4,1,1,16377817,"pubmed1",4.12E+018,"testalpha"
,"patients had diabetes type","NNS VBD NN NN",4,1,1,16955188,2,1.98E+018,"testalpha"
,"increased immunoreactivities of enos","VBN NNS IN ",4,1,1,16762404,2,7.19E+018,"testalpha"
,"variable clinical cross reactivity","JJ JJ NN NN",4,1,1,16673562,2,4.02E+018,"testalpha"
,"oxygenation and ventilation parameters","NN CC NN NNS",4,1,1,16451149,"pubmed1",3.30E+018,"testalpha"
,"main etiology for mortality","JJS NN IN NN",4,1,1,16479030,2,6.40E+018,"testalpha"
,"pivotal role in spermatogenesis","JJ NN IN NN",4,1,1,16919708,2,7.93E+018,"testalpha"
,"mass naked bipolar nuclei","NN JJ JJ ",4,1,1,16514838,2,7.60E+018,"testalpha"
,"review case control study","NN NN NN NN",4,1,1,16417901,"pubmed1",2.17E+017,"testalpha"
,"bowel cm in length","NN  IN NN",4,1,1,16612930,"pubmed1",3.90E+018,"testalpha"
,"maturated autologous split thickness","VBN JJ NN NN",4,1,1,16999269,2,1.45E+017,"testalpha"
,"delays and neurobehavioral problems","NNS CC JJ NNS",4,1,1,16808045,"pubmed1",8.29E+018,"testalpha"
,"andthe occurrence of colloids","NNP NN IN NNS",4,1,1,16569423,2,2.01E+018,"testalpha"
,"therapy in particular stage","NN IN JJ NN",4,1,1,17311742,2,1.15E+018,"testalpha"
,"anypropofol related respiratory event"," VBN NN NN",4,1,1,16365337,"pubmed1",8.89E+018,"testalpha"
,"fatal crashes in relation","JJ NNS IN NN",4,1,1,16236235,"pubmed1",7.04E+018,"testalpha"
,"were monthly motor vehicle","VBD JJ NN NN",4,1,1,16169506,"pubmed1",2.19E+018,"testalpha"
,"women were subjected tothe","NNS VBD VBN NNP",4,1,1,17067140,"pubmed1",9.03E+018,"testalpha"
,"variables comprising bloodpressure body","NNS VBG NN NN",4,1,1,16479027,2,7.05E+018,"testalpha"
,"totalcolectomised fap and uc","VBN  CC ",4,1,1,17139887,2,5.97E+018,"testalpha"
,"follicles and reduced number","NNS CC VBN NN",4,1,1,17311739,2,4.55E+018,"testalpha"
,"performance during regular exercise","NN IN JJ NN",4,1,1,16918070,"pubmed1",2.86E+018,"testalpha"
,"daily living whounderwent non","JJ NN NN ",4,1,1,16451146,"pubmed1",2.71E+018,"testalpha"
,"apfel score iii ponv","NNP NN  ",4,1,1,17236637,"pubmed1",2.75E+018,"testalpha"
,"needs support from future","VBZ NN IN NN",4,1,1,16874421,2,7.41E+018,"testalpha"
,"penilemalignancy squamous cell carcinomas","NN JJ NN NNP",4,1,1,17311737,2,5.72E+018,"testalpha"
,"hydrogen bondingnetwork perdeuterated hca","NN NN VBN ",4,1,1,16511248,2,8.31E+017,"testalpha"
,"acetic acid ethanol solution","JJ NN NN NN",4,1,1,16996581,2,3.04E+018,"testalpha"
,"factor in cardiovascular diseases","NN IN JJ NNS",4,1,1,17265692,2,1.22E+018,"testalpha"
,"cells in tumor response","NNS IN NN NN",4,1,1,16951739,"pubmed1",9.20E+018,"testalpha"
,"human stromal cell precursors","JJ JJ NN NNS",4,1,1,17016038,2,6.63E+017,"testalpha"
,"gst family of genes"," NN IN NNS",4,1,1,17019444,"pubmed1",2.03E+018,"testalpha"
,"months median survival rate","NNS JJ NN NN",4,1,1,17139879,2,6.21E+018,"testalpha"
,"patients in clinical trials","NNS IN JJ NNS",4,1,1,16424660,2,7.13E+018,"testalpha"
,"mechanicalventilation vasopressors inotropes corticosteroids","NN NNS NNS NNS",4,1,1,16365336,"pubmed1",2.27E+017,"testalpha"
,"control group and group","NN NN CC NN",4,1,1,16612917,"pubmed1",1.05E+017,"testalpha"
,"factor receptor related gene","NN NN VBN ",4,1,1,16955181,2,8.29E+018,"testalpha"
,"antigens for immunotherapy purposes","NNS IN NN NNS",4,1,1,16404477,"pubmed1",8.43E+018,"testalpha"
,"mechanics and gas exchange","NNS CC NN NN",4,1,1,16451155,"pubmed1",2.42E+018,"testalpha"
,"states pharmacopeia usp type","NNS   NN",4,1,1,16584139,"pubmed1",2.32E+018,"testalpha"
,"conclusions by adding modalities","NNS IN VBG NNS",4,1,1,17139885,2,7.76E+018,"testalpha"
,"grafting cabg were randomizedto","VBG  VBD ",4,1,1,16451153,"pubmed1",7.75E+018,"testalpha"
,"cell carcinomas in patients","NN NNP IN NNS",4,1,1,16710578,2,6.91E+018,"testalpha"
,"method and characterized fordrug","NN CC VBN NN",4,1,1,16584167,"pubmed1",8.68E+018,"testalpha"
,"skeletal tb in children","NN  IN NNS",4,1,1,16612935,"pubmed1",3.40E+018,"testalpha"
,"behavior and cancer screening","NN CC NN NN",4,1,1,16596897,"pubmed1",2.71E+018,"testalpha"
,"considerable variability among individuals","JJ NN IN NNS",4,1,1,17067139,"pubmed1",6.41E+017,"testalpha"
,"rodent cach promoter regions","NN  NN NNS",4,1,1,16951743,"pubmed1",4.71E+018,"testalpha"
,"used thermal treatment sample","VBN JJ NN NN",4,1,1,17293968,2,3.44E+017,"testalpha"
,"monthly motor vehicle casualties","JJ NN NN NNS",4,1,1,16169506,"pubmed1",1.15E+018,"testalpha"
,"active role risk ratio","JJ NN NN NN",4,1,1,17106601,2,5.89E+018,"testalpha"
,"impeller clearance agitator type","NN NN NN NN",4,1,1,16594638,"pubmed1",6.44E+018,"testalpha"
,"enzyme shares amino acid"," NNS NNP NN",4,1,1,16511256,2,6.72E+018,"testalpha"
,"developed dyspnea and lacticacidosis","VBD NNP CC NN",4,1,1,16673614,2,2.31E+018,"testalpha"
,"clinical evaluation of patients","JJ NN IN NNS",4,1,1,17328144,2,5.65E+018,"testalpha"
,"group vreceived saline ml","NN VBN NN ",4,1,1,17067136,"pubmed1",4.62E+018,"testalpha"
,"monophospho n acetylneuraminic acid","  JJ NN",4,1,1,16511286,2,8.79E+018,"testalpha"
,"safety guaranteed ineuropean union","NN VBN JJ NN",4,1,1,16999268,2,8.60E+018,"testalpha"
,"peakbupivacaine concentration during hes","NN NN IN ",4,1,1,17067137,"pubmed1",9.61E+017,"testalpha"
,"apronounced g phase radiosensitivity","VBN  NN NN",4,1,1,16404475,"pubmed1",4.34E+018,"testalpha"
,"family of animal proteins","NN IN NN NNS",4,1,1,16511251,2,6.85E+018,"testalpha"
,"class of signalling molecules","NN IN VBG NNS",4,1,1,16369100,2,1.61E+018,"testalpha"
,"combinatorial syntactic b context","JJ JJ NN NN",4,1,1,17347785,"pubmed1",3.76E+018,"testalpha"
,"definition and biologic behavior","NN CC JJ NN",4,1,1,16603102,2,9.02E+018,"testalpha"
,"ofrespiratory infections in newborns","NN NNS IN NNS",4,1,1,17019441,"pubmed1",5.01E+018,"testalpha"
,"oral corticosteroids pulse intravenousmethylprednisolone","JJ NNS NN NN",4,1,1,16955189,2,7.52E+018,"testalpha"
,"day case surgery re","NN NN NN ",4,1,1,16451148,"pubmed1",2.65E+018,"testalpha"
,"i and cam ii"," CC  ",4,1,1,16949651,2,2.88E+018,"testalpha"
,"atf cre binding sites","  VBG NNS",4,1,1,16395528,"pubmed1",1.41E+018,"testalpha"
,"normal healthy volunteers werealso","JJ JJ NNS ",4,1,1,16523217,"pubmed1",5.45E+018,"testalpha"
,"occupational illnesses and injuries","JJ NNS CC NNS",4,1,1,16438093,"pubmed1",1.74E+018,"testalpha"
,"differential control ofthe expression","JJ NN NNP NN",4,1,1,16949651,2,1.17E+018,"testalpha"
,"activities and substrate dependentpolymorphism","NNS CC NN NN",4,1,1,17019438,"pubmed1",4.17E+018,"testalpha"
,"group tl vs mmol","NN   ",4,1,1,17338197,2,2.55E+018,"testalpha"
,"ischaemia reperfusion induced liver","NN NN VBN NN",4,1,1,16612918,"pubmed1",3.03E+018,"testalpha"
,"n received bilateralauricular acupressure"," VBD JJ NN",4,1,1,16365322,"pubmed1",6.75E+018,"testalpha"
,"therapy of lung cancer","NN IN NN NN",4,1,1,17117606,2,6.49E+016,"testalpha"
,"studies and molecular diagnostics","NNS CC JJ NNS",4,1,1,16929381,"pubmed1",7.86E+018,"testalpha"
,"modalities and represents thetreatment","NNS CC VBZ NN",4,1,1,16859612,2,2.62E+018,"testalpha"
,"thestability after orthodontic treatment","NN IN JJ NN",4,1,1,17438831,2,2.88E+018,"testalpha"
,"folliculitis decalvans folliculitis abscedens","NN NNS NN NNS",4,1,1,17311739,2,2.93E+018,"testalpha"
,"ml kg fresh frozenplasma","  JJ NNP",4,1,1,16451158,"pubmed1",7.39E+018,"testalpha"
,"expenditures in pharmaceutical research","NNS IN JJ NN",4,1,1,16596744,"pubmed1",2.13E+018,"testalpha"
,"term and preterm infants","NN CC JJ NNS",4,1,1,16549889,2,3.18E+018,"testalpha"
,"coli translocation and cytokines"," NN CC NNS",4,1,1,17293960,2,4.87E+017,"testalpha"
,"head and neck injuries","NN CC NN NNS",4,1,1,16436798,"pubmed1",4.79E+018,"testalpha"
,"properties ofthe composite skin","NNS NNP JJ NN",4,1,1,16999269,2,2.57E+018,"testalpha"
,"bipolar nuclei and cellballs","JJ  CC NNS",4,1,1,16514838,2,4.85E+017,"testalpha"
,"mdm bcl andother proteins","  JJ NNS",4,1,1,17117604,2,9.19E+018,"testalpha"
,"imagery of themedium conclusions","NN IN NN NNS",4,1,1,16474001,"pubmed1",5.24E+018,"testalpha"
,"manometricfeatures and good response","NNS CC JJ NN",4,1,1,17338194,2,6.79E+018,"testalpha"
,"involving sleds snow discs","VBG NNS NN NNS",4,1,1,16436798,"pubmed1",2.44E+018,"testalpha"
,"hepatic arterial phasegre images","JJ JJ  NNS",4,1,1,16317488,"pubmed1",7.42E+018,"testalpha"
,"theida bu mel schedule","NNP   NN",4,1,1,16424643,2,8.28E+018,"testalpha"
,"records of patients withcirrhosis","NNS IN NNS NN",4,1,1,16333710,"pubmed1",8.66E+018,"testalpha"
,"trend of thermal injuries","NN IN JJ NNS",4,1,1,16999265,2,7.92E+018,"testalpha"
,"large number of studies","JJ NN IN NNS",4,1,1,17117604,2,4.89E+018,"testalpha"
,"materials used inenhancing aesthetics","NNS VBD VBG NN",4,1,1,16696438,2,8.55E+018,"testalpha"
,"morbidity andmortality in pakistan","NN NN IN NNP",4,1,1,16412373,"pubmed1",6.20E+018,"testalpha"
,"ingroups and mg kg","NNS CC  ",4,1,1,16612917,"pubmed1",7.30E+018,"testalpha"
,"bleeding episodes beforestarting therapy","VBG NNS VBG NN",4,1,1,16424649,2,1.11E+018,"testalpha"
,"appropriate choice of therapy","JJ NN IN NN",4,1,1,17311742,2,1.29E+018,"testalpha"
,"expressing diversity forcontinuous variables","VBG NN JJ NNS",4,1,1,16988905,"pubmed1",6.58E+018,"testalpha"
,"seventhpostoperative day tensile strength","JJ NN IN NN",4,1,1,16612919,"pubmed1",2.87E+018,"testalpha"
,"healthcare providers doctors nurses","NN NNS NNS NNS",4,1,1,16710575,2,4.58E+018,"testalpha"
,"rule governed sign mediatedinteractions","NN VBN NN NNS",4,1,1,16988903,"pubmed1",2.18E+018,"testalpha"
,"cervix vagina and anus"," NNP CC ",4,1,1,17010274,2,4.41E+018,"testalpha"
,"assessthe frequency and spectrum","NNP NN CC NN",4,1,1,17106597,2,3.07E+018,"testalpha"
,"expression in previous studies","NN IN JJ NNS",4,1,1,16809885,2,2.25E+017,"testalpha"
,"beta l lactoside c","NN  VB NN",4,1,1,16456293,2,6.81E+018,"testalpha"
,"strongestpredictor of recurrent stroke","NN IN NN NN",4,1,1,16436789,"pubmed1",6.51E+018,"testalpha"
,"timp and significantnegative correlation"," CC JJ NN",4,1,1,16585983,2,1.92E+018,"testalpha"
,"apache iii scores presence","NNP  NNS NN",4,1,1,17117607,2,6.50E+018,"testalpha"
,"ch bridged peptide withl"," VBN VB ",4,1,1,16496038,"pubmed1",5.61E+018,"testalpha"
,"ccp scaling program scala"," VBG NN NNP",4,1,1,16369096,2,1.15E+018,"testalpha"
,"urethraand stress urinary incontinent","NN NN JJ NN",4,1,1,16962646,2,2.47E+018,"testalpha"
,"index pci and months","NN  CC NNS",4,1,1,17139879,2,5.59E+018,"testalpha"
,"cell line fertilized oocyte","NN NN VBN NNP",4,1,1,17265694,2,6.31E+018,"testalpha"
,"quality and tosuggest strategies","NN CC NN NNS",4,1,1,16369100,2,7.56E+018,"testalpha"
,"ras various transcription factors"," JJ NN NNS",4,1,1,17115080,"pubmed1",4.28E+018,"testalpha"
,"horikoshii ot ph kda","   ",4,1,1,16511260,2,1.74E+018,"testalpha"
,"strategies for awide variety","NNS IN VB NN",4,1,1,17068636,"pubmed1",3.90E+018,"testalpha"
,"induced diabetic liver injury","VBN JJ NN NN",4,1,1,16714049,2,6.46E+018,"testalpha"
,"roles in determining theconsequences","NNS IN VBG NNS",4,1,1,16594641,"pubmed1",1.94E+018,"testalpha"
,"illnesses involve respiratory failure","NNS VBP NN NN",4,1,1,16400088,"pubmed1",4.13E+018,"testalpha"
,"rat brain following iv","NN NN VBG ",4,1,1,16584167,"pubmed1",7.88E+018,"testalpha"
,"absorption i e iron","NN   NN",4,1,1,17119325,2,6.83E+018,"testalpha"
,"combined effects of obstruction","VBN NNS IN NN",4,1,1,16549898,2,2.90E+018,"testalpha"
,"patient with pulmonary tuberculosis","NN IN JJ NN",4,1,1,17370569,"pubmed1",3.03E+018,"testalpha"
,"thelowest odds of injury","NN NNS IN NN",4,1,1,16197912,"pubmed1",6.06E+018,"testalpha"
,"hepatitis groups health care","NN NNS NN NN",4,1,1,16696442,2,5.16E+018,"testalpha"
,"dermatitis and other skindiseases","NN CC JJ NNS",4,1,1,16874414,2,7.18E+018,"testalpha"
,"nonprofit foundation for profit","JJ NN IN NN",4,1,1,16365335,"pubmed1",6.49E+018,"testalpha"
,"phase contrast enhanced mdct","NN NN VBN ",4,1,1,16333701,"pubmed1",3.70E+018,"testalpha"
,"changes characteristic for apoptosis","NNS NN IN NN",4,1,1,16951739,"pubmed1",7.29E+018,"testalpha"
,"first indicators of thedevelopment","JJ NNS IN NN",4,1,1,16585990,2,4.82E+018,"testalpha"
,"toskin inflammation in atopic","NNP NN IN NN",4,1,1,16648910,2,6.53E+018,"testalpha"
,"smooth musclecells and fibrocytes","JJ NNS CC NNS",4,1,1,16962646,2,7.63E+018,"testalpha"
,"increase of liver echogenicity","NN IN NN NN",4,1,1,16673610,2,5.47E+018,"testalpha"
,"include activation of protein","VBP NN IN NN",4,1,1,16479030,2,6.59E+018,"testalpha"
,"years post treatment par","NNS NN NN NN",4,1,1,17438832,2,3.98E+018,"testalpha"
,"surface properties ofvarious cell","NN NNS JJ NN",4,1,1,16414103,2,6.38E+018,"testalpha"
,"systemic fulminant vasculitis inassociation","JJ JJ NN NN",4,1,1,16424662,2,7.27E+018,"testalpha"
,"wall and progressive occlusion","NN CC JJ NN",4,1,1,17007910,2,6.66E+018,"testalpha"
,"shoulder while others regard","NN IN NNS NN",4,1,1,16916183,"pubmed1",9.07E+018,"testalpha"
,"merit of linkingtp cytology","NN IN  NN",4,1,1,16514842,2,3.49E+018,"testalpha"
,"cl fractalkine cxcl ip"," NN  ",4,1,1,16594639,"pubmed1",6.15E+018,"testalpha"
,"atomic force microscope afm","JJ NN NN ",4,1,1,16411737,"pubmed1",1.43E+018,"testalpha"
,"motive dimensions in drivers","NN NNS IN NNS",4,1,1,16443186,"pubmed1",4.97E+018,"testalpha"
,"chemical and mid spectrum","NN CC JJ NN",4,1,1,16696436,2,4.78E+018,"testalpha"
,"database created using incident","NN VBN VBG NN",4,1,1,16426557,"pubmed1",4.99E+018,"testalpha"
,"repairvarious types of injuries","JJ NNS IN NNS",4,1,1,16714053,2,8.28E+018,"testalpha"
,"level epx leveland urine","NN  NN NN",4,1,1,16859611,2,4.62E+018,"testalpha"
,"review article examines issues","NN NN NNS NNS",4,1,1,16918067,"pubmed1",3.42E+018,"testalpha"
,"binding protein atf creb","VBG NN  ",4,1,1,16395528,"pubmed1",5.76E+018,"testalpha"
,"l'eclairage insideimage colour blocks","NN NN JJ NNS",4,1,1,16648914,2,2.50E+018,"testalpha"
,"eosinophilia and systemic symptoms","NNP CC JJ NNS",4,1,1,16710584,2,4.98E+018,"testalpha"
,"information flow from dna","NN NN IN ",4,1,1,16505901,"pubmed1",7.71E+018,"testalpha"
,"risk perception and impulsivity","NN NN CC NN",4,1,1,16426559,"pubmed1",4.86E+018,"testalpha"
,"method was used cases","NN VBD VBN NNS",4,1,1,16514836,2,8.11E+017,"testalpha"
,"demonstration of msu crystalson","NN IN  NN",4,1,1,16514850,2,1.80E+018,"testalpha"
,"liver metastases further gains","NN NNS JJ NNS",4,1,1,17139885,2,8.26E+018,"testalpha"
,"paper uses dutch travel","NN VBZ NN NN",4,1,1,16426560,"pubmed1",6.66E+018,"testalpha"
,"n o andc h","   ",4,1,1,16397334,2,1.66E+018,"testalpha"
,"safety of air travel","NN IN NN NN",4,1,1,16427020,"pubmed1",5.34E+018,"testalpha"
,"bovine pericardium and anticalcification","NN NN CC NN",4,1,1,16701880,"pubmed1",7.85E+017,"testalpha"
,"changes in local psoriasis","NNS IN JJ NN",4,1,1,16585986,2,6.14E+018,"testalpha"
,"degree of aggregation andbetter","NN IN NN NN",4,1,1,16511282,2,7.44E+018,"testalpha"
,"patients with fii fvii","NNS IN  ",4,1,1,16424651,2,2.88E+018,"testalpha"
,"factors of organic solvent","NNS IN JJ NN",4,1,1,16808045,"pubmed1",8.97E+018,"testalpha"
,"field microscopy of fna","NN  IN ",4,1,1,16514850,2,1.52E+018,"testalpha"
,"hours scholarly activity hours","NNS JJ NN NNS",4,1,1,16436795,"pubmed1",4.29E+018,"testalpha"
,"beta cell line min","NN NN NN ",4,1,1,16701853,"pubmed1",3.39E+018,"testalpha"
,"drug candidates during lead","NN NNS IN NN",4,1,1,16584115,"pubmed1",6.31E+018,"testalpha"
,"transformation plasmids were re","NN NNS VBD ",4,1,1,16582987,"pubmed1",3.64E+018,"testalpha"
,"cedar pollinosis and controlsubjects","NN NN CC NNS",4,1,1,16648919,2,5.28E+018,"testalpha"
,"culture with pcr andbiomerieux","NN IN  NNP",4,1,1,17019441,"pubmed1",6.75E+018,"testalpha"
,"nir carbocyanine dyes indocyanine"," NN  NN",4,1,1,16399028,"pubmed1",7.97E+018,"testalpha"
,"semi quantitative rt pcr"," JJ  ",4,1,1,16951744,"pubmed1",4.68E+018,"testalpha"
,"hypothalamic pituitary adrenal hpa","JJ NN NN ",4,1,1,16462408,"pubmed1",1.42E+018,"testalpha"
,"n with mild tomoderate"," IN JJ NN",4,1,1,16585986,2,2.57E+018,"testalpha"
,"min ischemia morphological examination"," NN JJ NN",4,1,1,17265693,2,6.13E+018,"testalpha"
,"month period ina contact","NN NN  NN",4,1,1,16710586,2,5.80E+018,"testalpha"
,"rs atcerrahpasa medical faculty","  JJ NN",4,1,1,16696444,2,6.79E+017,"testalpha"
,"pressure product between baselineand","NN NN IN NN",4,1,1,17067136,"pubmed1",6.98E+018,"testalpha"
,"reading without computer aid","NN IN NN NN",4,1,1,16399036,"pubmed1",1.59E+018,"testalpha"
,"period of steroid treatment","NN IN VB NN",4,1,1,16245020,"pubmed1",8.98E+018,"testalpha"
,"chain of amino acid","NN IN NNP NN",4,1,1,16770447,"pubmed1",2.32E+018,"testalpha"
,"toe amputation or oedema","NN NN CC NN",4,1,1,16955188,2,4.95E+018,"testalpha"
,"patients with psychiatric disorders","NNS IN JJ NNS",4,1,1,17139890,2,8.80E+018,"testalpha"
,"remarkable pasi score reduction","JJ  NN NN",4,1,1,16585984,2,3.92E+018,"testalpha"
,"fluoridated hydroxyapatite fha discs","VBN JJ  NNS",4,1,1,16701866,"pubmed1",4.07E+018,"testalpha"
,"months and cytotoxic chemotherapy","NNS CC JJ NN",4,1,1,16918065,"pubmed1",2.93E+018,"testalpha"
,"exact role of serum","JJ NN IN NN",4,1,1,17010262,2,3.59E+018,"testalpha"
,"coincident with improved mood","NN IN VBN NN",4,1,1,16377826,"pubmed1",6.15E+018,"testalpha"
,"varicelliform eruption or eczemaherpeticum","NN NN CC NN",4,1,1,17311741,2,8.35E+018,"testalpha"
,"assesstrends of motor vehicle","NNS IN NN NN",4,1,1,16169506,"pubmed1",5.45E+018,"testalpha"
,"morefavourable long term survival","JJ JJ NN NN",4,1,1,16451156,"pubmed1",3.19E+018,"testalpha"
,"bupivacaine during hes k","NN IN  ",4,1,1,17067137,"pubmed1",5.68E+018,"testalpha"
,"groups control sida sida","NNS NN  ",4,1,1,17013511,2,4.73E+018,"testalpha"
,"row computedtomography imaging defines","VB NN VBG NNS",4,1,1,16399039,"pubmed1",5.31E+018,"testalpha"
,"skin with previousallergic dermatitis","NN IN JJ NN",4,1,1,16585981,2,5.09E+017,"testalpha"
,"transfer of human pathogens","NN IN JJ NNS",4,1,1,16594642,"pubmed1",2.78E+018,"testalpha"
,"programs that offer ways","NNS IN NN NNS",4,1,1,16473998,"pubmed1",7.77E+018,"testalpha"
,"toxo allergic dermatitis andcollagenosis"," JJ NN NN",4,1,1,16603101,2,3.20E+017,"testalpha"
,"non standard methylated phenylalanine"," JJ VBN NN",4,1,1,16523218,"pubmed1",4.31E+018,"testalpha"
,"sialic acid on thyroid","JJ NN IN NN",4,1,1,16720036,2,1.80E+018,"testalpha"
,"procedure of t lymphocyte","NN IN  NNP",4,1,1,17016035,2,8.73E+018,"testalpha"
,"various temperatures using va","JJ NNS VBG ",4,1,1,17019442,"pubmed1",8.27E+018,"testalpha"
,"high discriminatory power specificity","JJ JJ NN NN",4,1,1,16365326,"pubmed1",8.25E+018,"testalpha"
,"hazards and subjective measures","NNS CC JJ NNS",4,1,1,16226211,"pubmed1",9.32E+017,"testalpha"
,"ofdevelopments in therapy strategies","NNS IN NN NNS",4,1,1,17117607,2,3.31E+018,"testalpha"
,"factor replacement in patients","NN NN IN NNS",4,1,1,16549892,2,4.80E+018,"testalpha"
,"band uvb photochemotherapy puva","NN  NN ",4,1,1,17311742,2,8.73E+018,"testalpha"
,"respiratorydisturbances biomerieux test pcr","NNS NNP NN ",4,1,1,17019441,"pubmed1",2.87E+018,"testalpha"
,"patients with t dm","NNS IN  ",4,1,1,16918068,"pubmed1",9.82E+017,"testalpha"
,"structure as search models","NN IN NN NNS",4,1,1,16511279,2,1.31E+018,"testalpha"
,"topical non steroid therapy","JJ  VB NN",4,1,1,17010269,2,2.26E+016,"testalpha"
,"andpolice coded severity scales","NN VBN NN NNS",4,1,1,16426556,"pubmed1",1.11E+018,"testalpha"
,"modification icd cm codes","NN   NNS",4,1,1,16365331,"pubmed1",3.30E+018,"testalpha"
,"abnormalities but withoutsignificant increases","NNS CC JJ NNS",4,1,1,16809886,2,4.32E+017,"testalpha"
,"costimulatory molecules and arepoor","NN NNS CC NN",4,1,1,16733557,"pubmed1",2.39E+018,"testalpha"
,"process that allows incidents","NN IN VBZ NNS",4,1,1,16321534,"pubmed1",7.82E+018,"testalpha"
,"problems includes early detection","NNS VBZ JJ NN",4,1,1,16859619,2,6.83E+018,"testalpha"
,"region of macroscopic tumor","NN IN NN NN",4,1,1,17117605,2,5.23E+018,"testalpha"
,"changes and special stains","NNS CC JJ NNS",4,1,1,16514844,2,1.28E+018,"testalpha"
,"differentiated dc or generationof","VBN  CC ",4,1,1,16404477,"pubmed1",4.87E+018,"testalpha"
,"tissue of adult balb","NN IN NN ",4,1,1,16950501,2,3.87E+018,"testalpha"
,"increased prevalence of atopic","VBN NN IN NN",4,1,1,16648916,2,3.42E+018,"testalpha"
,"world of grafting materials","NN IN VBG NNS",4,1,1,16956114,2,2.60E+018,"testalpha"
,"w cm and g","  CC ",4,1,1,17293959,2,1.56E+018,"testalpha"
,"agood quality of life","NN NN IN NN",4,1,1,17139900,2,7.10E+017,"testalpha"
,"amplified thetitanium surface area","VBN NN NN NN",4,1,1,17293968,2,6.25E+018,"testalpha"
,"pediatric eps with digital","JJ  IN NN",4,1,1,16436791,"pubmed1",1.40E+018,"testalpha"
,"trans epidermal water loss","NNS JJ NN NN",4,1,1,16874414,2,4.99E+018,"testalpha"
,"v o och polyanion","   NN",4,1,1,16456275,2,8.27E+018,"testalpha"
,"patients and local pain","NNS CC JJ NN",4,1,1,16722347,2,4.41E+018,"testalpha"
,"areaand severity index pasi","NN NN NN ",4,1,1,16585984,2,4.83E+018,"testalpha"
,"hawith lower molecular weight","NN JJR JJ NN",4,1,1,16733556,"pubmed1",1.00E+018,"testalpha"
,"thehistory mechanisms of action","NN NNS IN NN",4,1,1,16809883,2,5.42E+018,"testalpha"
,"police coded crash severity","NNS VBN NN NN",4,1,1,16426556,"pubmed1",6.33E+018,"testalpha"
,"fatigue was responsible foraround","NN VBD JJ NN",4,1,1,16423319,"pubmed1",5.39E+018,"testalpha"
,"arthritis and gastrointestinal disorderssuch","NN CC JJ NN",4,1,1,17318328,"pubmed1",1.34E+018,"testalpha"
,"carbohydrate drugs and diagnostictests","NN NNS CC NNS",4,1,1,16730370,2,3.02E+017,"testalpha"
,"revascularization within days results","NN IN NNS NNS",4,1,1,16365321,"pubmed1",7.28E+018,"testalpha"
,"showed mk immunoreactivity days","VBD  NN NNS",4,1,1,16965805,2,1.62E+018,"testalpha"
,"rapid progression of theskin","JJ NN IN NNP",4,1,1,16603099,2,4.75E+018,"testalpha"
,"monaco for oncogenichuman papillomavirus","NNP IN NN NN",4,1,1,16514835,2,4.84E+018,"testalpha"
,"urine although extensive organ","NN IN JJ NN",4,1,1,16714048,2,7.71E+018,"testalpha"
,"methods probabilistic data recordlinkage","NNS JJ NN NN",4,1,1,16043107,"pubmed1",8.11E+018,"testalpha"
,"atwo way forced choice"," NN VBD NN",4,1,1,17133956,2,2.34E+018,"testalpha"
,"cardinal sign and symptoms","JJ NN CC NNS",4,1,1,16479029,2,3.61E+018,"testalpha"
,"atcandidate sites for conservation","NN NNS IN NN",4,1,1,16988906,"pubmed1",8.75E+018,"testalpha"
,"higher proportion of voters","JJR NN IN NNS",4,1,1,16423318,"pubmed1",3.37E+018,"testalpha"
,"errors and interchange amino","NNS CC NN NNP",4,1,1,17294912,2,1.99E+018,"testalpha"
,"nasal cavities was performedwhereas","NN NNS VBD NNS",4,1,1,17370567,"pubmed1",8.43E+018,"testalpha"
,"breast skin heart colon","NN NN NN NN",4,1,1,16514845,2,6.28E+018,"testalpha"
,"health www cdc gov","NN   ",4,1,1,16438095,"pubmed1",6.14E+018,"testalpha"
,"results importantdevelopments in healthcare","NNS NNS IN NN",4,1,1,16473988,"pubmed1",1.17E+018,"testalpha"
,"tomographic magneticresonance imaging endoscopic","JJ NN VBG NN",4,1,1,16333694,"pubmed1",5.06E+018,"testalpha"
,"isolated bygel permeation chromatography","VBN NNP NN NN",4,1,1,16565748,"pubmed1",4.95E+017,"testalpha"
,"using transmission electron microscopy","VBG NN NN ",4,1,1,16253314,2,9.50E+015,"testalpha"
,"studies details of patients","NNS NNS IN NNS",4,1,1,16710586,2,8.19E+018,"testalpha"
,"degranulation of mast cells","NN IN  NNS",4,1,1,16585982,2,4.18E+018,"testalpha"
,"bonds involving thecarboxylate anions","NNS VBG NN NNS",4,1,1,16456289,2,3.84E+018,"testalpha"
,"oxime group in position","JJ NN IN NN",4,1,1,17438836,2,8.20E+018,"testalpha"
,"cb from endometrial samplings"," IN JJ NNS",4,1,1,16514842,2,4.59E+017,"testalpha"
,"c gal o gal","NN   ",4,1,1,16456293,2,8.07E+018,"testalpha"
,"quality for surgical practice","NN IN JJ NN",4,1,1,17139882,2,3.54E+018,"testalpha"
,"sucralfate gel and microwave","NN  CC NN",4,1,1,16584168,"pubmed1",5.41E+018,"testalpha"
,"types cl clp cp","NNS   ",4,1,1,17165598,2,7.07E+018,"testalpha"
,"cell current andcapacitance recording","NN JJ NN NN",4,1,1,16395521,"pubmed1",3.90E+018,"testalpha"
,"model for studying spontaneoushypercholesterolemia","NN IN VBG NN",4,1,1,17007910,2,7.20E+018,"testalpha"
,"collagen induced dense granule","NN VBN JJ NN",4,1,1,17068635,"pubmed1",4.75E+018,"testalpha"
,"safe long term treatment","JJ JJ NN NN",4,1,1,17010269,2,5.20E+018,"testalpha"
,"percentages of pre law","NNS IN  NN",4,1,1,16223468,"pubmed1",4.64E+018,"testalpha"
,"study included thyroid fnaspecimens","NN VBD NN NNS",4,1,1,16514836,2,6.85E+018,"testalpha"
,"sores with v y","NNS IN  ",4,1,1,17165597,2,5.77E+018,"testalpha"
,"positive days after appearance","JJ NNS IN NN",4,1,1,16955191,2,5.67E+018,"testalpha"
,"chromosome putative open readingframes","NN JJ JJ NNS",4,1,1,16964327,"pubmed1",7.62E+018,"testalpha"
,"delivery system for ecologicalpesticides","NN NN IN NNS",4,1,1,16584150,"pubmed1",2.57E+018,"testalpha"
,"confirmation of clinical suspicion","NN IN JJ NN",4,1,1,16256177,2,6.84E+018,"testalpha"
,"mbarand mbar of suction","NN  IN NN",4,1,1,16874414,2,7.18E+018,"testalpha"
,"junctions important forintercellular communication","NNS JJ JJ NN",4,1,1,17106596,2,6.56E+018,"testalpha"
,"illumination by non coherent","NN IN  NN",4,1,1,16585985,2,8.41E+018,"testalpha"
,"dislocation reduction cardioversion fracture","NN NN NN NN",4,1,1,16365337,"pubmed1",3.80E+018,"testalpha"
,"node and liver metastases"," CC NN NNS",4,1,1,16430945,2,7.84E+018,"testalpha"
,"mol and activationentropy deltas"," CC  NNS",4,1,1,17117212,"pubmed1",4.84E+018,"testalpha"
,"topic for further investigation","NN IN JJ NN",4,1,1,16997356,2,7.58E+018,"testalpha"
,"candidate agents for prevention","NN NNS IN NN",4,1,1,17128290,"pubmed1",7.21E+018,"testalpha"
,"demand for pain relief","NN IN NN NN",4,1,1,16955184,2,5.83E+018,"testalpha"
,"computer aided diagnosis cad","NN VBN NN ",4,1,1,16399036,"pubmed1",1.26E+018,"testalpha"
,"mortality associated withcritical illness","NN VBN JJ NN",4,1,1,16462409,"pubmed1",5.20E+018,"testalpha"
,"prevalence andcharacteristics of anemia","NN NNS IN NN",4,1,1,16673554,2,1.74E+018,"testalpha"
,"advanced driver assistance systems","VBN NN NN NNS",4,1,1,16406188,"pubmed1",8.13E+018,"testalpha"
,"type of ophthalmological complications","NN IN JJ NNS",4,1,1,17106598,2,1.62E+018,"testalpha"
,"c d cys phe","NN   ",4,1,1,16496038,"pubmed1",3.38E+018,"testalpha"
,"conformational properties of ac","JJ NNS IN ",4,1,1,16528414,"pubmed1",3.43E+018,"testalpha"
,"intravenous infusions of ibandronate","JJ NNS IN NN",4,1,1,17016034,2,8.63E+018,"testalpha"
,"reporting period ateach center","VBG NN NN NN",4,1,1,16365337,"pubmed1",2.16E+018,"testalpha"
,"heart lung and brain","NN NN CC NN",4,1,1,16762404,2,6.03E+018,"testalpha"
,"allpatients received oral chemotherapy","NNS VBD JJ NN",4,1,1,16914906,2,8.86E+018,"testalpha"
,"system foramyloid fibril formation","NN VB NNP NN",4,1,1,16511269,2,1.84E+016,"testalpha"
,"child with critical endocrine","NN IN JJ NN",4,1,1,16462411,"pubmed1",3.18E+018,"testalpha"
,"o patients in group"," NNS IN NN",4,1,1,16451147,"pubmed1",1.54E+018,"testalpha"
,"affect clinical symptoms therapeuticresults","VB JJ NNS NNS",4,1,1,16914904,2,5.37E+018,"testalpha"
,"eradication therapydecreased platelet activation","NN VBN NN NN",4,1,1,16809885,2,6.89E+018,"testalpha"
,"skills among turkish drivers","NNS IN JJ NNS",4,1,1,16443186,"pubmed1",4.48E+017,"testalpha"
,"elastic fibers and lamellae","JJ NNS CC NNS",4,1,1,16714053,2,2.13E+018,"testalpha"
,"new procedure percutaneous introduction","JJ NN JJ NN",4,1,1,16612909,2,3.75E+018,"testalpha"
,"surgery presence of ascites","NN NN IN NNS",4,1,1,17117604,2,7.87E+018,"testalpha"
,"severity of pruritus p","NN IN NN ",4,1,1,16585987,2,6.16E+018,"testalpha"
,"graph setdesignator is r","NN NN VBZ NN",4,1,1,16456283,2,7.03E+018,"testalpha"
,"centralized systems of review","VBN NNS IN NN",4,1,1,16770859,"pubmed1",6.49E+018,"testalpha"
,"segmentation in dynamic contrast","NN IN JJ NN",4,1,1,16399033,"pubmed1",1.12E+018,"testalpha"
,"cells in monolayer culturewas","NNS IN NN ",4,1,1,16701879,"pubmed1",7.84E+018,"testalpha"
,"matchingde identified ambulance records"," VBN NN NNS",4,1,1,16365326,"pubmed1",3.58E+018,"testalpha"
,"hsc required i deletion"," VBN  NN",4,1,1,16511258,2,8.51E+018,"testalpha"
,"area area telediastolic tdv","NN NN JJ ",4,1,1,16989140,2,2.61E+018,"testalpha"
,"pdt for actinic keratosis"," IN JJ NN",4,1,1,16955183,2,3.00E+018,"testalpha"
,"remaining ice using mtm","VBG NN VBG ",4,1,1,17285746,"pubmed1",9.18E+018,"testalpha"
,"number of diffraction images","NN IN NN NNS",4,1,1,16369100,2,6.24E+017,"testalpha"
,"ofwavelength nm in association","NN  IN NN",4,1,1,17293963,2,4.28E+018,"testalpha"
,"effective targetingfollowing intranasal administration","JJ VBG NN NN",4,1,1,16584167,"pubmed1",4.44E+018,"testalpha"
,"treatment incases of atopic","NN NNS IN NN",4,1,1,16603103,2,1.77E+018,"testalpha"
,"c h pi interactions","NN   NNS",4,1,1,16397328,2,7.41E+018,"testalpha"
,"endo t sugarpuckering n","  VBG ",4,1,1,16456292,2,8.51E+018,"testalpha"
,"containing ferroglycine sulfate conclusion","VBG NN NN NN",4,1,1,16809890,2,5.92E+018,"testalpha"
,"reducing theincidence of phlebitis","VBG NN IN NN",4,1,1,16584164,"pubmed1",6.75E+018,"testalpha"
,"result of c inhibitor","NN IN NN NN",4,1,1,16451161,"pubmed1",8.22E+018,"testalpha"
,"skin surveillancecultures detected biotypes","NN NNS VBD NNS",4,1,1,17311736,2,2.73E+018,"testalpha"
,"smallbowel ischemia reperfusion injury","NN NN NN NN",4,1,1,17293960,2,2.70E+018,"testalpha"
,"repeated doses microg kg","VBN NNS NNP ",4,1,1,16424649,2,4.69E+018,"testalpha"
,"pacs study period vs"," NN NN ",4,1,1,16436791,"pubmed1",8.30E+018,"testalpha"
,"communicationpatterns and interpersonal relationships","NNS CC JJ NNS",4,1,1,16596898,"pubmed1",5.98E+018,"testalpha"
,"dio responsibility scale diors"," NN NN NNS",4,1,1,16377812,"pubmed1",3.46E+018,"testalpha"
,"bothbasal and squamous cell","NN CC JJ NN",4,1,1,16603102,2,6.49E+018,"testalpha"
,"discusses body composition measurements","NNS NN NN NNS",4,1,1,16918067,"pubmed1",7.33E+018,"testalpha"
,"missing monographs updating monographs","VBG NNS VBG NNS",4,1,1,17285738,"pubmed1",1.06E+018,"testalpha"
,"fair and marginal gdl","NN CC JJ ",4,1,1,16171767,"pubmed1",5.14E+018,"testalpha"
,"b molecules on wehi","NN NNS IN ",4,1,1,17117211,"pubmed1",1.98E+018,"testalpha"
,"ofeight mitochondrial transcripts nd","NN JJ NNS ",4,1,1,16389406,"pubmed1",1.51E+017,"testalpha"
,"selectiveoxyfunctionalization of unactivated carbon","NN IN VBN NN",4,1,1,16411734,"pubmed1",8.13E+018,"testalpha"
,"phecg interpretation andadvance emergency"," NN NN NN",4,1,1,16365334,"pubmed1",1.23E+018,"testalpha"
,"dtp for mucoadhesive microemulsions"," IN JJ NNS",4,1,1,16584167,"pubmed1",5.66E+018,"testalpha"
,"dynamic force measurements ofthe","JJ NN NNS NNP",4,1,1,16410837,"pubmed1",6.34E+018,"testalpha"
,"free radicals derived fromartery","JJ NNS VBN NN",4,1,1,17106515,"pubmed1",1.68E+018,"testalpha"
,"pediatricians problems of diagnosis","NNS NNS IN NN",4,1,1,17139897,2,4.25E+018,"testalpha"
,"vulva penis and orophaynx"," NNP CC ",4,1,1,17010274,2,7.57E+018,"testalpha"
,"heads of elongated spermatids","NNS IN VBN NNS",4,1,1,16325891,2,6.08E+018,"testalpha"
,"growing season autumn fall","VBG NN NN NN",4,1,1,16733064,2,6.79E+018,"testalpha"
,"complexes in partial bladder","NNS IN JJ NN",4,1,1,16253314,2,1.38E+017,"testalpha"
,"patient with kid syndrome","NN IN NN NN",4,1,1,17106596,2,1.63E+018,"testalpha"
,"flow island sural flap","NN NN JJ ",4,1,1,16722345,2,4.66E+018,"testalpha"
,"ethenoadenine epsilona n ethenocytosine","NN NNP  NN",4,1,1,16582987,"pubmed1",6.90E+018,"testalpha"
,"acid ua levels andcreatine","NN  NNS NN",4,1,1,17338197,2,8.82E+018,"testalpha"
,"nature of airborne contactans","NN IN NNP NNS",4,1,1,17010263,2,1.33E+018,"testalpha"
,"atf creb in cells","  IN NNS",4,1,1,16395528,"pubmed1",4.27E+018,"testalpha"
,"preventive strategies including pharmacotherapy","JJ NNS VBG NN",4,1,1,16436789,"pubmed1",5.68E+018,"testalpha"
,"episodes per person years","NNS IN NN NNS",4,1,1,16412373,"pubmed1",5.94E+018,"testalpha"
,"t cell line dose"," NN NN NN",4,1,1,16770447,"pubmed1",8.33E+018,"testalpha"
,"safety and health www","NN CC NN ",4,1,1,16438095,"pubmed1",1.68E+018,"testalpha"
,"statistical treatment using analysis","JJ NN VBG NN",4,1,1,17293959,2,3.48E+018,"testalpha"
,"noveltherapeutic procedures against virus","JJ NNS IN NN",4,1,1,16395523,"pubmed1",1.02E+018,"testalpha"
,"disclosedhigher liver regeneration indices","JJ NN NN NNS",4,1,1,17013511,2,8.56E+017,"testalpha"
,"institute of medicine iom","NN IN NN ",4,1,1,16473996,"pubmed1",3.46E+018,"testalpha"
,"prevalence of diabetes mellitus","NN IN NN NN",4,1,1,16462410,"pubmed1",4.08E+018,"testalpha"
,"tool forfreeze drying process","NN NN VBG NN",4,1,1,17285744,"pubmed1",4.26E+018,"testalpha"
,"basis of knowndrosophila melanogaster","NN IN NNP NN",4,1,1,16770443,"pubmed1",6.71E+018,"testalpha"
,"positive correlations with waist","JJ NNS IN NN",4,1,1,16673610,2,2.75E+018,"testalpha"
,"confirmed onb cll cells","VBN   NNS",4,1,1,16424654,2,8.12E+018,"testalpha"
,"increasedplatelet cd p expression","NN   NN",4,1,1,16809885,2,6.70E+018,"testalpha"
,"r x exon nt","NN NN  ",4,1,1,16424658,2,9.14E+018,"testalpha"
,"adapting and adopting nationalguidelines","NN CC VBG NNS",4,1,1,16377816,"pubmed1",6.95E+018,"testalpha"
,"thyroid function patients methods","NN NN NNS NNS",4,1,1,16479025,2,7.96E+018,"testalpha"
,"cytotoxicity of chitosan edta","NN IN JJ ",4,1,1,17285741,"pubmed1",4.17E+018,"testalpha"
,"inos and endothelial nos"," CC JJ NNS",4,1,1,16566960,2,2.65E+018,"testalpha"
,"background levels of dna","NN NNS IN ",4,1,1,16582984,"pubmed1",8.13E+018,"testalpha"
,"patients with other anemias","NNS IN JJ NNP",4,1,1,17016037,2,1.65E+018,"testalpha"
,"medium with fetal bovine","NN IN JJ NN",4,1,1,16443258,2,1.81E+018,"testalpha"
,"medical problems smoking cocaine","JJ NNS NN NN",4,1,1,16436792,"pubmed1",4.07E+018,"testalpha"
,"azoxymethane happened inthe week","NN VBD NNP NN",4,1,1,17293962,2,2.22E+018,"testalpha"
,"kg increased liver regeneration"," VBN NN NN",4,1,1,17013510,2,3.95E+018,"testalpha"
,"widespread distribution of bse","JJ NN IN ",4,1,1,16770445,"pubmed1",6.46E+018,"testalpha"
,"buffer containing mm tris","NN VBG  ",4,1,1,16511255,2,7.76E+018,"testalpha"
,"pfkfb and pfkfb gene"," CC  ",4,1,1,17143338,"pubmed1",6.99E+018,"testalpha"
,"company level safety climate","NN NN NN NN",4,1,1,16430845,"pubmed1",5.40E+018,"testalpha"
,"flexural strength of glass","JJ NN IN NN",4,1,1,16701864,"pubmed1",6.83E+018,"testalpha"
,"manage ment and thesingularities","VB NN CC NNS",4,1,1,17067134,"pubmed1",1.24E+018,"testalpha"
,"n or histology n"," CC NN ",4,1,1,16333704,"pubmed1",1.67E+018,"testalpha"
,"virtual irb review system","JJ  NN NN",4,1,1,16770858,"pubmed1",6.54E+018,"testalpha"
,"oral hypoglycaemic agents liver","JJ JJ NNS NN",4,1,1,16673610,2,1.78E+018,"testalpha"
,"disease with skin fragility","NN IN NN NN",4,1,1,17106603,2,6.75E+018,"testalpha"
,"growth factor withneurotrophic activity","NN NN JJ NN",4,1,1,16965805,2,1.17E+018,"testalpha"
,"food and drug administration","NN CC NN NN",4,1,1,17010274,2,2.70E+018,"testalpha"
,"theimmunohistochemical localisation of caspase","JJ NN IN NN",4,1,1,17034836,2,3.67E+018,"testalpha"
,"contrast tosplit sample studies","NN NN NN NNS",4,1,1,16514841,2,8.07E+018,"testalpha"
,"surgical procedure tl vs","JJ NN  ",4,1,1,17338197,2,6.04E+018,"testalpha"
,"agonist induced platelet responses","NN VBN NN NNS",4,1,1,17068635,"pubmed1",5.20E+018,"testalpha"
,"positive history ofatopic dermatitis","JJ NN NN NN",4,1,1,16648913,2,8.27E+018,"testalpha"
,"data andapache iii scores","NNS NNP  NNS",4,1,1,17117607,2,2.55E+018,"testalpha"
,"national institute foroccupational safety","JJ NN JJ NN",4,1,1,16438095,"pubmed1",6.62E+018,"testalpha"
,"receive cream puva onone","VB NN  NN",4,1,1,16585984,2,2.89E+018,"testalpha"
,"imputability was assessed inthe","NN VBD VBN NNP",4,1,1,17106600,2,1.90E+018,"testalpha"
,"potentiometricand spectroscopic uv vis","NN NN  ",4,1,1,16496037,"pubmed1",3.52E+018,"testalpha"
,"significant increase in alcohol","JJ NN IN NN",4,1,1,16169506,"pubmed1",8.96E+018,"testalpha"
,"pasi score reduction nm"," NN NN ",4,1,1,16585984,2,4.14E+018,"testalpha"
,"pa necessitating anaccurate interpretation"," VBG NN NN",4,1,1,16514848,2,4.84E+018,"testalpha"
,"volume of distribution forescitalopram","NN IN NN NN",4,1,1,16584121,"pubmed1",3.88E+017,"testalpha"
,"calcium binding protein functions","NN VBG NN NNS",4,1,1,17046052,2,7.65E+018,"testalpha"
,"types of fora patients","NNS IN  NNS",4,1,1,16710575,2,8.66E+018,"testalpha"
,"diffractive optical element basedglossmeter","JJ JJ NN NN",4,1,1,16584166,"pubmed1",6.82E+018,"testalpha"
,"funded researchers inacademic positions","VBN NNS JJ NNS",4,1,1,16473996,"pubmed1",6.87E+018,"testalpha"
,"rats after pulmonary instillation","NNS IN JJ NN",4,1,1,17293964,2,6.72E+018,"testalpha"
,"activity and d dimer","NN CC  NN",4,1,1,16549898,2,1.57E+017,"testalpha"
,"nir fluorescence imaging basedon"," NN VBG NNP",4,1,1,16399028,"pubmed1",4.21E+017,"testalpha"
,"management of cerebral concussion","NN IN JJ NN",4,1,1,16436787,"pubmed1",2.74E+018,"testalpha"
,"carcinomas and facial skin","NNP CC JJ NN",4,1,1,17165596,2,6.83E+018,"testalpha"
,"study was designed toinvestigate","NN VBD VBN NN",4,1,1,16762404,2,4.35E+018,"testalpha"
,"prognosis in adult atopic","NN IN NN NN",4,1,1,16648916,2,8.12E+018,"testalpha"
,"oxidative phosphorylation and glycolysis","JJ NN CC NN",4,1,1,16951738,"pubmed1",8.26E+018,"testalpha"
,"more k linked ubiquitins","JJR  VBN NNS",4,1,1,16421449,2,7.46E+018,"testalpha"
,"regulations anumber of agencies","NNS NN IN NNS",4,1,1,16438095,"pubmed1",1.50E+018,"testalpha"
,"andintersection level crash models","NN NN NN NNS",4,1,1,16451795,"pubmed1",2.55E+018,"testalpha"
,"severe recurrence requiring furthertreatment","JJ NN VBG NN",4,1,1,16956118,2,6.82E+017,"testalpha"
,"increased endothelial cell turnover","JJ JJ NN NN",4,1,1,16722347,2,4.69E+018,"testalpha"
,"superficial basal cell carcinomas","JJ NN NN NNP",4,1,1,16955185,2,1.56E+018,"testalpha"
,"reached years ofclinical success","VBN NNS JJ NN",4,1,1,16613741,2,7.56E+018,"testalpha"
,"ischemicpreconditioning ipc on rat","VBG  IN NN",4,1,1,17013508,2,9.04E+018,"testalpha"
,"lung and pulmonary vasculature","NN CC JJ NN",4,1,1,16537087,2,8.80E+018,"testalpha"
,"immune function and angiogenesis","JJ NN CC NN",4,1,1,16369100,2,5.48E+018,"testalpha"
,"human beta globin hiv","JJ NN NNP ",4,1,1,16823609,"pubmed1",1.57E+018,"testalpha"
,"sialic acid bindinglectins tritrichomonas","JJ NN NNS NNP",4,1,1,16720036,2,3.66E+018,"testalpha"
,"allergen and elicitspecific ige","NN CC NNP ",4,1,1,16511273,2,8.83E+018,"testalpha"
,"conviction rates of people","NN NNS IN NNS",4,1,1,16423318,"pubmed1",6.17E+018,"testalpha"
,"kidney transplant recipients withhps","NN JJ NNS ",4,1,1,16914905,2,2.75E+018,"testalpha"
,"clinicallyrelevant pollen associated food","JJ NN VBN NN",4,1,1,16648913,2,7.49E+018,"testalpha"
,"fviiconstruct and vector control","NN CC NN NN",4,1,1,16914903,2,2.35E+018,"testalpha"
,"cases of hpv infection","NNS IN  NN",4,1,1,17139883,2,6.67E+018,"testalpha"
,"crash in western australia","NN IN JJ NNP",4,1,1,16221468,"pubmed1",7.64E+018,"testalpha"
,"long term hemoglobin neutrophil","JJ NN NNP ",4,1,1,17119322,2,6.00E+018,"testalpha"
,"level into human therapies","NN IN JJ NNS",4,1,1,17269167,2,6.57E+018,"testalpha"
,"mass and photo activatedresin","NN CC NN NNP",4,1,1,16701862,"pubmed1",5.15E+018,"testalpha"
,"mol and theresulting differences"," CC VBG NNS",4,1,1,16701853,"pubmed1",2.61E+016,"testalpha"
,"cessation of peptide administration","NN IN VB NN",4,1,1,17143339,"pubmed1",6.73E+018,"testalpha"
,"number of erector pilimuscles","NN IN NN NNS",4,1,1,17311739,2,2.77E+018,"testalpha"
,"hb at various temperaturesand"," IN JJ NN",4,1,1,17019442,"pubmed1",9.18E+018,"testalpha"
,"been mentored forthe position","VBN VBN NNP NN",4,1,1,16436795,"pubmed1",8.95E+018,"testalpha"
,"correct number of cells","VB NN IN NNS",4,1,1,16919708,2,4.47E+018,"testalpha"
,"triclinic system with thesymmetry","JJ NN IN NN",4,1,1,16434797,2,4.37E+018,"testalpha"
,"opens new possibilities inthe","VBZ JJ NNS NNP",4,1,1,16317492,"pubmed1",7.71E+017,"testalpha"
,"agents i e aspirin","NNS   NN",4,1,1,16549893,2,8.09E+018,"testalpha"
,"hanging drop vapor diffusion","VBG NN  NN",4,1,1,16511280,2,3.58E+018,"testalpha"
,"calculation of deltago deltaho","NN IN NNP NNP",4,1,1,17019442,"pubmed1",8.96E+018,"testalpha"
,"nail graftprevented alar collapse"," VBN  NN",4,1,1,17165594,2,9.23E+017,"testalpha"
,"patient developedsino pulmonary aspergillosis","NN NNP JJ NN",4,1,1,17370567,"pubmed1",5.68E+018,"testalpha"
,"hydroxybenzoyl coa thioesterase motifs","  NN ",4,1,1,16511283,2,6.33E+018,"testalpha"
,"detecting small bowel lesions","VBG JJ NN NNS",4,1,1,16447095,"pubmed1",6.87E+017,"testalpha"
,"vehicle crash hospitalization ratesand","NN NN NN NN",4,1,1,16139232,"pubmed1",2.89E+018,"testalpha"
,"method such asadjustment factor","NN JJ NN NN",4,1,1,16430844,"pubmed1",6.53E+018,"testalpha"
,"reported psychiatric morbidity contributes","VBD JJ NN NNS",4,1,1,16710573,2,6.99E+016,"testalpha"
,"thestretch er pelvis neck","NN  NNP NN",4,1,1,17067135,"pubmed1",2.89E+018,"testalpha"
,"peripubertal females in comparison","NN NNS IN NN",4,1,1,16714054,2,6.89E+017,"testalpha"
,"stem celltransplantations from hla","VB NNS IN ",4,1,1,16918066,"pubmed1",3.40E+017,"testalpha"
,"orlarge b cell lymphomas","JJ NN NN NNP",4,1,1,16612936,"pubmed1",1.61E+018,"testalpha"
,"distal sensory polyneuropathy dsp","NN NN JJ ",4,1,1,16462406,"pubmed1",3.66E+018,"testalpha"
,"treatment of anal cancerpatients","NN IN  NNS",4,1,1,17139883,2,7.64E+018,"testalpha"
,"intravenous catheter insertion sites","JJ NN NN NNS",4,1,1,17311736,2,1.57E+018,"testalpha"
,"dna lesions in e"," NNS IN ",4,1,1,16582987,"pubmed1",4.87E+018,"testalpha"
,"increased risk for hypoglycemia","VBN NN IN NN",4,1,1,17438837,2,7.13E+018,"testalpha"
,"range years mean age","NN NNS VBP NN",4,1,1,16333710,"pubmed1",7.90E+018,"testalpha"
,"ofpigment protein complexes photophosphorylation","NN NN NNS NN",4,1,1,17106510,"pubmed1",8.24E+017,"testalpha"
,"hstfr and murine stfr"," CC NN ",4,1,1,17119325,2,8.76E+018,"testalpha"
,"l range ic nmol"," NN JJ ",4,1,1,16594645,"pubmed1",4.79E+018,"testalpha"
,"resin variations in resin","NNP NNS IN NNP",4,1,1,16701862,"pubmed1",3.21E+018,"testalpha"
,"anomalous signals from theselenium","JJ NNS IN NN",4,1,1,16511280,2,5.45E+018,"testalpha"
,"linear chains of edge","JJ NNS IN NN",4,1,1,16456295,2,2.08E+018,"testalpha"
,"mays nadp metype panicum","  JJ NN",4,1,1,17106510,"pubmed1",2.38E+018,"testalpha"
,"were assessed pressure volume","VBD VBN NN NN",4,1,1,16451155,"pubmed1",4.54E+017,"testalpha"
,"study of p andp","NN IN  ",4,1,1,16733561,"pubmed1",1.34E+018,"testalpha"
,"tissue extensibility and loss","NN NN CC NN",4,1,1,16962646,2,4.12E+018,"testalpha"
,"ones or recombinant factor","NNS CC JJ NN",4,1,1,16914907,2,3.32E+018,"testalpha"
,"admissions in emergency rooms","NNS IN NN NNS",4,1,1,17013521,2,9.66E+017,"testalpha"
,"anddifferentiation of rat bone","NN IN NN NN",4,1,1,16443258,2,8.85E+017,"testalpha"
,"c degrees c alt","NN NNS NN ",4,1,1,16696441,2,8.47E+018,"testalpha"
,"feces diarrhea black feces","NNS NN JJ NNS",4,1,1,16424650,2,7.57E+018,"testalpha"
,"uses data on motor","VBZ NNS IN NN",4,1,1,16171767,"pubmed1",4.66E+018,"testalpha"
,"injury episodesper person years","NN NN NN NNS",4,1,1,16412373,"pubmed1",6.60E+018,"testalpha"
,"system of agrobacterium mediatedtransient","NN IN NN NN",4,1,1,16582986,"pubmed1",8.88E+018,"testalpha"
,"mental illness in mass","JJ NN IN NN",4,1,1,16474001,"pubmed1",7.51E+018,"testalpha"
,"drugs cladribine and fludarabine","NNS NN CC NN",4,1,1,16421443,2,1.58E+018,"testalpha"
,"demonstratethe importance of close","NNP NN IN NN",4,1,1,17106602,2,6.32E+018,"testalpha"
,"diseases nor ssri intake","NNS CC  NN",4,1,1,16549890,2,5.69E+017,"testalpha"
,"important factors for presence","JJ NNS IN NN",4,1,1,16955183,2,5.62E+018,"testalpha"
,"subconfluence in standard growth","NN IN JJ NN",4,1,1,16395527,"pubmed1",5.77E+018,"testalpha"
,"purified using affinity column","VBN VBG NN NN",4,1,1,16511286,2,3.28E+018,"testalpha"
,"daily living and abdominalsurgery","JJ NN CC NN",4,1,1,16451146,"pubmed1",4.83E+017,"testalpha"
,"min and infused ml"," CC VBN ",4,1,1,16762404,2,1.68E+018,"testalpha"
,"cell line ea hy","NN NN  ",4,1,1,16733560,"pubmed1",8.63E+018,"testalpha"
,"initial low dose phase","JJ JJ NN NN",4,1,1,17119327,2,1.59E+018,"testalpha"
,"arterial disease neuropathy toe","JJ NN JJ NN",4,1,1,16955188,2,4.63E+018,"testalpha"
,"startle responses showed non","VB NNS VBD ",4,1,1,17133954,2,1.38E+018,"testalpha"
,"soft tissue breast skin","JJ NN NN NN",4,1,1,16514845,2,2.42E+018,"testalpha"
,"gram positive soil bacterium"," JJ NN NN",4,1,1,16964327,"pubmed1",3.60E+018,"testalpha"
,"heart rate and electrocardiography","NN NN CC NN",4,1,1,16436797,"pubmed1",6.27E+018,"testalpha"
,"communicationpatterns of aa couples","NNS IN  NNS",4,1,1,16596898,"pubmed1",1.62E+018,"testalpha"
,"pulmonary clinic of cipto","JJ NN IN ",4,1,1,16479024,2,1.48E+018,"testalpha"
,"conclusions emergency medicine pds","NNS NN NN ",4,1,1,16436795,"pubmed1",4.15E+018,"testalpha"
,"lok of medical practice"," IN JJ NN",4,1,1,16673559,2,1.56E+018,"testalpha"
,"activated immune cell antigen","VBN JJ NN NN",4,1,1,16929383,"pubmed1",2.97E+018,"testalpha"
,"men rated theirroad traffic","NNS VBN NN NN",4,1,1,16112069,"pubmed1",3.40E+018,"testalpha"
,"programmed death ligand pd","VBN NN NN ",4,1,1,16530813,2,5.21E+018,"testalpha"
,"t n rectal tumor","  NN NN",4,1,1,17139887,2,3.57E+018,"testalpha"
,"gly on fvii function"," IN  NN",4,1,1,16914903,2,4.27E+018,"testalpha"
,"theprotonated pyrimidine n atom","VBN NN  NN",4,1,1,16456283,2,2.18E+018,"testalpha"
,"vector ofegfp positive cells","NN  JJ NNS",4,1,1,17160143,"pubmed1",2.05E+018,"testalpha"
,"platelet count at day","NN NN IN NN",4,1,1,16424648,2,2.20E+018,"testalpha"
,"hemangiomas after microbubble injection","NNP IN JJ NN",4,1,1,16333704,"pubmed1",4.22E+018,"testalpha"
,"control and arthritic animals","NN CC JJ NNS",4,1,1,16399028,"pubmed1",6.42E+018,"testalpha"
,"caesarean section and thestrategy","JJ NN CC NN",4,1,1,16916188,"pubmed1",5.09E+017,"testalpha"
,"factors c fos c","NNS NN  NN",4,1,1,17115080,"pubmed1",5.29E+018,"testalpha"
,"deceased donors for health","JJ NNS IN NN",4,1,1,16999268,2,5.43E+018,"testalpha"
,"fibrosis and morphologic conversion","NN CC JJ NN",4,1,1,17013515,2,2.59E+018,"testalpha"
,"groupwith apfel score iii","NN NNP NN ",4,1,1,17236637,"pubmed1",7.00E+015,"testalpha"
,"antidotes mainlyanticholinergics in combination","NNS NNS IN NN",4,1,1,16956120,2,2.13E+017,"testalpha"
,"variety of disease states","NN IN NN NNS",4,1,1,16770444,"pubmed1",3.50E+018,"testalpha"
,"fall in map activation","NN IN NN NN",4,1,1,17013507,2,7.62E+018,"testalpha"
,"occurringregulatory t cells cd","NN  NNS ",4,1,1,17016036,2,2.93E+018,"testalpha"
,"operative diagnosis of intestinalobstruction","JJ NN IN NN",4,1,1,16612930,"pubmed1",2.34E+018,"testalpha"
,"post operative pain treatment","NN JJ NN NN",4,1,1,16451145,"pubmed1",7.98E+018,"testalpha"
,"hyporesponsivenessfound in psoriatic skin","NN IN JJ NN",4,1,1,16874421,2,5.90E+018,"testalpha"
,"thefunction of pharmacopeial forum","NN IN JJ NN",4,1,1,17285738,"pubmed1",2.65E+018,"testalpha"
,"expression system takes advantage","NN NN VBZ NN",4,1,1,16733563,"pubmed1",5.87E+018,"testalpha"
,"findings and radiographic features","NNS CC JJ NNS",4,1,1,16673614,2,7.76E+018,"testalpha"
,"dna into e coli"," IN  ",4,1,1,16582987,"pubmed1",3.11E+018,"testalpha"
,"egfp asa reporter gene","  NN ",4,1,1,16404477,"pubmed1",7.96E+018,"testalpha"
,"groups presented similar pattern","NNS VBN JJ NN",4,1,1,17293957,2,6.59E+018,"testalpha"
,"inprovider hours of hours","NN NNS IN NNS",4,1,1,16365329,"pubmed1",7.71E+018,"testalpha"
,"inosiplex dosage was mg","JJ NN VBD ",4,1,1,16955187,2,6.50E+018,"testalpha"
,"morphology of thehippocampal neurons","NN IN JJ NNS",4,1,1,17133953,2,9.13E+018,"testalpha"
,"exploratory study of police","JJ NN IN NN",4,1,1,16221468,"pubmed1",4.87E+018,"testalpha"
,"early stages of lesionformation","JJ NNS IN NN",4,1,1,17007910,2,3.98E+018,"testalpha"
,"blistering disease awaitsfurther investigation","VBG NN JJ NN",4,1,1,16710577,2,3.61E+018,"testalpha"
,"operations requiring blood transfusions","NNS VBG NN NNS",4,1,1,16809890,2,4.59E+018,"testalpha"
,"glasgow coma score andto","NN  NN ",4,1,1,16491215,2,4.77E+018,"testalpha"
,"lymph nodes with pregranulomatoussinus","NN NNS IN NN",4,1,1,16256177,2,8.99E+018,"testalpha"
,"methyl and crystal violet"," CC NN NN",4,1,1,16542712,2,1.39E+018,"testalpha"
,"symmetry of thediffraction pattern","NN IN NN NN",4,1,1,16369096,2,3.70E+018,"testalpha"
,"biochemical models of ht","JJ NNS IN ",4,1,1,16594640,"pubmed1",7.67E+018,"testalpha"
,"pretreatment with salineor ami","NN IN  ",4,1,1,16594642,"pubmed1",3.10E+018,"testalpha"
,"cell based tissue engineering","NN VBN NN NN",4,1,1,16443258,2,7.30E+018,"testalpha"
,"detailedreview of individual articles","NN IN JJ NNS",4,1,1,16399035,"pubmed1",6.77E+018,"testalpha"
,"unactivated carbon hydrogen bonds","VBN NN NN NNS",4,1,1,16411734,"pubmed1",8.37E+018,"testalpha"
,"administration and safety training","NN CC NN NN",4,1,1,16442068,"pubmed1",1.35E+018,"testalpha"
,"ii bis hexafluorophosphate co","  NN ",4,1,1,16456276,2,2.46E+018,"testalpha"
,"old female from kenya","JJ NN IN ",4,1,1,16918063,"pubmed1",4.43E+018,"testalpha"
,"examination determination of serum","NN NN IN NN",4,1,1,16479028,2,7.10E+017,"testalpha"
,"trolox equivalent antioxidant capacity","NNP NN JJ NN",4,1,1,17293970,2,7.21E+017,"testalpha"
,"therapy and regenerative medicine","NN CC JJ NN",4,1,1,17160143,"pubmed1",6.76E+018,"testalpha"
,"title compound hydroxy diphenylethanone","NN NN NN NN",4,1,1,16397328,2,6.08E+018,"testalpha"
,"year and yearsurvival rates","NN CC NN NNS",4,1,1,17139879,2,7.93E+018,"testalpha"
,"adipo fascial peduncle post"," JJ NN NN",4,1,1,16722345,2,2.06E+018,"testalpha"
,"visualization or non visualizationof","NN CC  ",4,1,1,16673610,2,7.30E+018,"testalpha"
,"regulation of neurodegenerative processes","NN IN JJ NNS",4,1,1,17265696,2,5.05E+018,"testalpha"
,"theedp and edp hcg"," CC  ",4,1,1,16714054,2,9.20E+018,"testalpha"
,"key issues for future","JJ NNS IN NN",4,1,1,17285739,"pubmed1",3.15E+018,"testalpha"
,"reported collisioninvolvement among g","VBN NN IN ",4,1,1,16112070,"pubmed1",5.70E+018,"testalpha"
,"pathogenetic role of tt","JJ NN IN ",4,1,1,16696442,2,4.08E+018,"testalpha"
,"metipranolol n and levobunolol","  CC ",4,1,1,17106597,2,3.41E+018,"testalpha"
,"chi square and wilcoxontests"," NN CC NNS",4,1,1,17293971,2,7.46E+017,"testalpha"
,"number of fatal crashes","NN IN JJ NNS",4,1,1,16198299,"pubmed1",1.56E+018,"testalpha"
,"activity of therespiratory chain","NN IN NN NN",4,1,1,16951738,"pubmed1",1.01E+018,"testalpha"
,"risk for teratogenic outcome","NN IN JJ NN",4,1,1,16808045,"pubmed1",2.49E+018,"testalpha"
,"betweenhumanistic values and performance","JJ NNS CC NN",4,1,1,16377814,"pubmed1",8.78E+018,"testalpha"
,"derived neural progenitor fraction","VBN JJ NN NN",4,1,1,17265690,2,6.38E+018,"testalpha"
,"high risk for ponv","JJ NN IN ",4,1,1,17236637,"pubmed1",1.29E+018,"testalpha"
,"aptt and international normalization"," CC JJ NN",4,1,1,16451158,"pubmed1",3.54E+018,"testalpha"
,"k protein in ratmitochondria"," NN IN NNP",4,1,1,16496041,"pubmed1",1.85E+018,"testalpha"
,"vwf intron variable number"," NNP JJ NN",4,1,1,16424652,2,3.54E+018,"testalpha"
,"peg hydrogelplatform throughout weeks"," NN IN NNS",4,1,1,16701853,"pubmed1",6.10E+018,"testalpha"
,"ace inhibitor provoked angioedema","NN NN VBD NN",4,1,1,16451161,"pubmed1",8.08E+018,"testalpha"
,"anyisoform of human acylphosphatase","NN IN JJ NN",4,1,1,16511269,2,4.06E+018,"testalpha"
,"blunted increase in heart","VBN NN IN NN",4,1,1,16874421,2,3.33E+018,"testalpha"
,"progressive myocardial iron deposition","JJ JJ NN NN",4,1,1,16424659,2,3.59E+018,"testalpha"
,"system and skin surveillance","NN CC NN NN",4,1,1,17311736,2,4.49E+017,"testalpha"
,"b time and error","NN NN CC NN",4,1,1,16479025,2,1.61E+018,"testalpha"
,"more primitive progenitor cells","JJR JJ NN NNS",4,1,1,16696440,2,5.82E+018,"testalpha"
,"time of antibiotic administration","NN IN JJ NN",4,1,1,16365336,"pubmed1",4.29E+018,"testalpha"
,"endocrine cells and fs","NN NNS CC ",4,1,1,16569423,2,1.10E+018,"testalpha"
,"aromaticcompound degradation in bacteria","NN NN IN NNS",4,1,1,16511281,2,3.64E+018,"testalpha"
,"medicine andassumed teaching responsibilities","NN VBN VBG NNS",4,1,1,16377822,"pubmed1",8.93E+018,"testalpha"
,"acid sa inducible vch","NN  JJ ",4,1,1,16395526,"pubmed1",7.76E+018,"testalpha"
,"fourth postoperative day animals","JJ JJ NN NNS",4,1,1,16612916,"pubmed1",6.97E+018,"testalpha"
,"induced tumour necrosis factor","VBN JJ NN NN",4,1,1,16955181,2,4.73E+018,"testalpha"
,"significant difference in tmt","JJ NN IN ",4,1,1,16479025,2,3.11E+018,"testalpha"
,"develop strategies in identifyingpatients","VB NNS IN NNS",4,1,1,16424642,2,8.65E+018,"testalpha"
,"n diethylaminoethyl dextran ddexma","  NN ",4,1,1,16701854,"pubmed1",2.94E+018,"testalpha"
,"previouslydeveloped volume growing vg","VBD NN VBG ",4,1,1,16399033,"pubmed1",1.55E+018,"testalpha"
,"areas of high grade","NNS IN JJ NN",4,1,1,16514851,2,1.09E+018,"testalpha"
,"treatment options and stress","NN NNS CC NN",4,1,1,17370568,"pubmed1",4.35E+018,"testalpha"
,"ofthem psba psbb psbc","NNP   ",4,1,1,17106511,"pubmed1",9.34E+016,"testalpha"
,"frequent event in dermatomyositis","JJ NN IN NN",4,1,1,17106602,2,5.38E+018,"testalpha"
,"normalizes ph and optimizesproduction","VBZ  CC NN",4,1,1,17294912,2,8.49E+018,"testalpha"
,"andstearoyl arachidonoyl phosphatidylcholine chlorohydrins","  NN NNS",4,1,1,17128291,"pubmed1",1.23E+018,"testalpha"
,"active contrast medium extravasation","JJ NN NN NN",4,1,1,16317492,"pubmed1",5.30E+018,"testalpha"
,"complex ofac thr glu","JJ   ",4,1,1,17117212,"pubmed1",1.40E+018,"testalpha"
,"groups with study sessions","NNS IN NN NNS",4,1,1,16436796,"pubmed1",2.63E+018,"testalpha"
,"testing for detecting biopsy","NN IN VBG NN",4,1,1,16514835,2,5.49E+018,"testalpha"
,"blind clinicalstudies with comparisons","JJ NNS IN NNS",4,1,1,16451144,"pubmed1",5.38E+018,"testalpha"
,"particle size analysis zeta","NN NN NN ",4,1,1,17285747,"pubmed1",5.45E+018,"testalpha"
,"bse associated prp d"," VBN  ",4,1,1,16770445,"pubmed1",3.79E+018,"testalpha"
,"consistent changes in respiratory","JJ NNS IN NN",4,1,1,17133957,2,2.22E+018,"testalpha"
,"updatingmethods for temporal transfer","NNS IN JJ NN",4,1,1,16414003,"pubmed1",1.69E+018,"testalpha"
,"anatomy in endoscopic ultrasonography","NN IN NN NN",4,1,1,16399038,"pubmed1",1.16E+018,"testalpha"
,"i poly diaqua mu","  NNP ",4,1,1,16397335,2,6.47E+018,"testalpha"
,"fact that despitegreat advances","NN IN JJ NNS",4,1,1,16400088,"pubmed1",2.35E+017,"testalpha"
,"outcome of such studies","NN IN JJ NNS",4,1,1,17106599,2,6.10E+018,"testalpha"
,"electrophoretic light scattering andelectron","JJ NN VBG NNP",4,1,1,17285741,"pubmed1",6.72E+018,"testalpha"
,"full thickness or split","JJ NN CC NN",4,1,1,17165599,2,2.75E+018,"testalpha"
,"workpolicies post injury administration","NNS NN NN NN",4,1,1,16442068,"pubmed1",3.35E+018,"testalpha"
,"cap genes in ins","NN NNS IN ",4,1,1,16395520,"pubmed1",3.34E+018,"testalpha"
,"relief oftopical morphine gel","NN JJ NN ",4,1,1,16955184,2,2.82E+018,"testalpha"
,"cell and cell matrix","NN CC NN NNP",4,1,1,16713618,2,3.07E+018,"testalpha"
,"occurrence of anindolent mcl","NN IN NN ",4,1,1,16424661,2,4.42E+018,"testalpha"
,"local open field performance","JJ JJ NN NN",4,1,1,17133954,2,7.24E+018,"testalpha"
,"di mu thiosulfato tetrasodium","  NN NN",4,1,1,16397335,2,5.70E+018,"testalpha"
,"hours slept orfewer hours","NNS VBD NN NNS",4,1,1,16377826,"pubmed1",5.94E+018,"testalpha"
,"shock in hospital mortality","NN IN NN NN",4,1,1,16365336,"pubmed1",2.19E+018,"testalpha"
,"groups connecting h lysines","NNS VBG  NNS",4,1,1,17019436,"pubmed1",2.09E+018,"testalpha"
,"treatment among criticalcare patients","NN IN NN NNS",4,1,1,16462409,"pubmed1",1.89E+018,"testalpha"
,"control groups infuture research","NN NNS NN NN",4,1,1,16451151,"pubmed1",8.90E+018,"testalpha"
,"gerbils global forebrain ischemia","NNS JJ VB NN",4,1,1,17265693,2,4.09E+018,"testalpha"
,"themean serum ada activity","JJ NN  NN",4,1,1,16956117,2,2.17E+018,"testalpha"
,"controversial results concerning pon","JJ NNS IN ",4,1,1,17106515,"pubmed1",4.42E+018,"testalpha"
,"v pretreatment with magnesium"," NN IN NN",4,1,1,17067136,"pubmed1",7.05E+018,"testalpha"
,"importance of gamma probe","NN IN NN NN",4,1,1,16491216,2,1.05E+018,"testalpha"
,"model of abdominal sepsis","NN IN JJ NN",4,1,1,17293958,2,5.29E+018,"testalpha"
,"marked dose dependent hepatocyte","VBN NN JJ NNP",4,1,1,16696445,2,7.14E+018,"testalpha"
,"amarker of cell proliferation","NN IN NN NN",4,1,1,16514834,2,3.74E+018,"testalpha"
,"years group i years","NNS VBP  NNS",4,1,1,16809889,2,6.12E+017,"testalpha"
,"ourcohort by telephone calls","NN IN NN NNS",4,1,1,16696444,2,6.81E+018,"testalpha"
,"grade markedincrease of liver","NN NN IN NN",4,1,1,16673610,2,5.92E+018,"testalpha"
,"cells at different stages","NNS IN JJ NNS",4,1,1,16569423,2,8.13E+018,"testalpha"
,"n h o interaction","   NN",4,1,1,16456295,2,9.59E+017,"testalpha"
,"lesions in transplant recipients","NNS IN JJ NNS",4,1,1,16585985,2,6.50E+018,"testalpha"
,"use vs and cocaine","NN  CC NN",4,1,1,16436792,"pubmed1",3.42E+018,"testalpha"
,"implementation of resident work","NN IN NN NN",4,1,1,16377822,"pubmed1",3.30E+018,"testalpha"
,"conventional methods of ad","JJ NNS IN NN",4,1,1,17328144,2,4.65E+018,"testalpha"
,"good result in hips","NN NN IN ",4,1,1,17438833,2,7.59E+018,"testalpha"
,"search for preventive measures","NN IN JJ NNS",4,1,1,16613748,2,3.28E+018,"testalpha"
,"cross sectionalstudies of hospital","VB NNS IN NN",4,1,1,17106600,2,4.06E+018,"testalpha"
,"withthe b glucuronidase gus","NNP NN NN ",4,1,1,16395526,"pubmed1",7.83E+018,"testalpha"
,"diagnosis of inflammatory rheumaticdisease","NN IN JJ NN",4,1,1,16603101,2,5.36E+018,"testalpha"
,"beta globin hiv protease","NN NNP  NN",4,1,1,16823609,"pubmed1",5.51E+018,"testalpha"
,"items high perceived risk","NNS JJ VBN NN",4,1,1,16191426,"pubmed1",1.62E+018,"testalpha"
,"activities between mesophyll chloroplasts","NNS IN NN NNS",4,1,1,17106510,"pubmed1",9.08E+018,"testalpha"
,"ast altand gamma gt"," NN NN ",4,1,1,17013510,2,2.26E+018,"testalpha"
,"column chromatographic methods crystals","NN JJ NNS NNS",4,1,1,16511253,2,6.66E+018,"testalpha"
,"species from skin surveillance","NN IN NN NN",4,1,1,17311736,2,1.71E+018,"testalpha"
,"successful transit of contrast","JJ NN IN NN",4,1,1,16252139,"pubmed1",3.04E+018,"testalpha"
,"internal fixation in allpatients","JJ NN IN NNS",4,1,1,16613748,2,3.42E+018,"testalpha"
,"otherauthoritative standards and information","JJ NNS CC NN",4,1,1,17285738,"pubmed1",1.10E+018,"testalpha"
,"modafinil increased perceived alertness"," VBN VBN NN",4,1,1,16436796,"pubmed1",3.95E+018,"testalpha"
,"patients with typical symptoms","NNS IN JJ NNS",4,1,1,16916183,"pubmed1",3.53E+018,"testalpha"
,"cells growth hormone gh","NNS NN NN ",4,1,1,16564564,2,4.99E+017,"testalpha"
,"gloves and socks syndrome","NNS CC NNS NN",4,1,1,17010266,2,7.25E+018,"testalpha"
,"vincristine prednisolone or fludarabine","NN NN CC NN",4,1,1,16424646,2,6.23E+018,"testalpha"
,"positive cells isolated fromcord","JJ NNS VBN NN",4,1,1,17160143,"pubmed1",6.08E+018,"testalpha"
,"adult intensive care units","NN JJ NN NNS",4,1,1,16451154,"pubmed1",3.84E+018,"testalpha"
,"hourrestrictions had significant effects","NNS VBD JJ NNS",4,1,1,16377822,"pubmed1",1.43E+017,"testalpha"
,"iron absorption stfr levels","NN NN  NNS",4,1,1,17119325,2,5.01E+018,"testalpha"
,"factors of postoperative morbidityafter","NNS IN JJ NN",4,1,1,16989147,2,4.48E+018,"testalpha"
,"net increase in perfusion","JJ NN IN NN",4,1,1,17014894,2,5.52E+018,"testalpha"
,"foractivation of t cell","NN IN  NN",4,1,1,16511262,2,5.28E+018,"testalpha"
,"limb ischaemia for atherosclerosisconsequences","NN NN IN NNS",4,1,1,16612914,"pubmed1",6.04E+018,"testalpha"
,"andpancreatic cancer cell lines","JJ NN NN NNS",4,1,1,17143338,"pubmed1",2.56E+018,"testalpha"
,"relocation and metallic synthesis","NN CC JJ NN",4,1,1,17293966,2,7.50E+018,"testalpha"
,"recognition ofcomplications of liver","NN NNS IN NN",4,1,1,17013506,2,1.80E+018,"testalpha"
,"binding sites k i","VBG NNS  ",4,1,1,16594645,"pubmed1",6.52E+018,"testalpha"
,"identify sphincter defects anorectalabscesses","VB NN NNS NNS",4,1,1,17139898,2,6.81E+017,"testalpha"
,"amount of basicfibroblast growth","NN IN JJS NN",4,1,1,17106595,2,9.35E+017,"testalpha"
,"ornegative attitudes towards patients","JJ NNS IN NNS",4,1,1,16330213,"pubmed1",6.08E+018,"testalpha"
,"contrast agent focal liverlesions","NN NN JJ NNS",4,1,1,16333704,"pubmed1",6.40E+018,"testalpha"
,"pei plus radiofrequency ablation"," CC NN NN",4,1,1,16333710,"pubmed1",2.61E+018,"testalpha"
,"correspond tothe second calcium","VB NNP JJ NN",4,1,1,16511247,2,6.30E+018,"testalpha"
,"prediction of model parameters","NN IN NN NNS",4,1,1,17285748,"pubmed1",5.44E+018,"testalpha"
,"advantages pitfalls and economicalconsiderations","NNS NNS CC NNS",4,1,1,17236645,"pubmed1",9.11E+018,"testalpha"
,"cirrhotic patients with bleedingcomplications","JJ NNS IN NNS",4,1,1,16523217,"pubmed1",8.60E+018,"testalpha"
,"use of antiplatelet medications","NN IN NN NNS",4,1,1,16436789,"pubmed1",3.18E+016,"testalpha"
,"arterial cord blood haemoglobinand","JJ NN NN NN",4,1,1,16809888,2,4.24E+018,"testalpha"
,"patients without carvedilol pretreatment","NNS IN  NN",4,1,1,17338197,2,4.80E+018,"testalpha"
,"road markings andpavement resurfacings","NN NNS NN NNS",4,1,1,16236232,"pubmed1",6.28E+018,"testalpha"
,"complications of atopic dermatitis","NNS IN NN NN",4,1,1,17106598,2,5.20E+018,"testalpha"
,"mortality ratethan was euglycemia","NN NNP VBD NN",4,1,1,16436794,"pubmed1",6.20E+018,"testalpha"
,"homogeneous series for disease","JJ NN IN NN",4,1,1,17119322,2,1.78E+018,"testalpha"
,"tumors and liver metastases","NNS CC NN NNS",4,1,1,16430945,2,2.18E+018,"testalpha"
,"andpoly mu glycinato mu","NN  NN ",4,1,1,16397335,2,2.52E+018,"testalpha"
,"association between safety climate","NN IN NN NN",4,1,1,16430845,"pubmed1",8.56E+016,"testalpha"
,"poor activity with h","JJ NN IN ",4,1,1,16410836,"pubmed1",4.15E+018,"testalpha"
,"identified case reports case","VBN NN NNS NN",4,1,1,16365335,"pubmed1",7.33E+018,"testalpha"
,"orhands free mobile phone","NNS JJ JJ NN",4,1,1,16191426,"pubmed1",2.17E+017,"testalpha"
,"simple wayof analysing data","JJ  VBG NNS",4,1,1,16369098,2,6.90E+018,"testalpha"
,"thechain length dependence test","VB NN NN NN",4,1,1,16411735,"pubmed1",7.70E+018,"testalpha"
,"microspheres with amean diameter","NNS IN JJ NN",4,1,1,16594643,"pubmed1",8.70E+018,"testalpha"
,"solution containingscfa butyrate propionate","NN  NN NN",4,1,1,16491218,2,2.76E+018,"testalpha"
,"acute myeloid leukemia aml","JJ VB NN ",4,1,1,16914901,2,1.93E+018,"testalpha"
,"epithelialcells in chronic group","NNS IN JJ NN",4,1,1,16491217,2,1.19E+018,"testalpha"
,"free rna polymerase ii","JJ  NN ",4,1,1,16421445,2,5.61E+018,"testalpha"
,"life strategies and pre","NN NNS CC ",4,1,1,17347785,"pubmed1",5.02E+018,"testalpha"
,"hcg exerted opposite effects"," VBN JJ NNS",4,1,1,16714054,2,4.47E+018,"testalpha"
,"free mobile phone conversation","JJ JJ NN NN",4,1,1,16226211,"pubmed1",3.64E+018,"testalpha"
,"cys nh and h","  CC ",4,1,1,16496038,"pubmed1",3.84E+018,"testalpha"
,"intubating dose of rocuronium","VBG NN IN NN",4,1,1,16916186,"pubmed1",6.22E+018,"testalpha"
,"chest pain after emergency","NN NN IN NN",4,1,1,16436792,"pubmed1",5.77E+018,"testalpha"
,"school educated enlisted male","NN VBN VBD NN",4,1,1,16405857,"pubmed1",2.82E+018,"testalpha"
,"students with agraduated license","NNS IN VBN NN",4,1,1,16112070,"pubmed1",8.91E+018,"testalpha"
,"probability sample of u","NN NN IN ",4,1,1,16436798,"pubmed1",4.05E+018,"testalpha"
,"o gal h oglc","   ",4,1,1,16456293,2,1.59E+018,"testalpha"
,"artifact and minimizing itseffect","NN CC VBG NN",4,1,1,16399032,"pubmed1",2.69E+018,"testalpha"
,"using mtt test microscopic","VBG  NN NN",4,1,1,16951739,"pubmed1",8.26E+018,"testalpha"
,"detection of neurofilament protein","NN IN NN NN",4,1,1,16919707,2,5.41E+015,"testalpha"
,"work related data systems","NN VBN NNS NNS",4,1,1,16043107,"pubmed1",2.44E+018,"testalpha"
,"serum sil r levelwas","NN  NN ",4,1,1,16603096,2,6.35E+018,"testalpha"
,"component in clinical practice","NN IN JJ NN",4,1,1,16462410,"pubmed1",7.36E+017,"testalpha"
,"creation ofnovel zinc fingers","NN NN NN NNS",4,1,1,16411739,"pubmed1",1.88E+017,"testalpha"
,"surgical treatment of morbidobesity","JJ NN IN NN",4,1,1,17013519,2,4.56E+018,"testalpha"
,"swedish organ transplant cohort","JJ NN JJ NN",4,1,1,16710578,2,2.99E+018,"testalpha"
,"results questionnairerespondents and interviewees","NNS NNS CC NNS",4,1,1,16377820,"pubmed1",2.29E+018,"testalpha"
,"drains placement andpatients observation","NNS NN NNS NN",4,1,1,16956123,2,1.13E+018,"testalpha"
,"electronic error reporting system","JJ NN NN NN",4,1,1,16377828,"pubmed1",2.78E+018,"testalpha"
,"review of oursingle center","NN IN NN NN",4,1,1,16424648,2,4.72E+018,"testalpha"
,"adistinction between transgenic n","NN IN JJ ",4,1,1,16951742,"pubmed1",3.50E+018,"testalpha"
,"lower traces of paraphenylenediamine","JJR NNS IN NN",4,1,1,16700150,2,2.29E+018,"testalpha"
,"theadministration of volume expanders","NN IN NN NNS",4,1,1,16762404,2,6.97E+018,"testalpha"
,"goal in competitive sports","NN IN JJ NNS",4,1,1,16918070,"pubmed1",3.91E+018,"testalpha"
,"binding consensus sequences gdsgvgkt","VBG NN NNS ",4,1,1,16365637,"pubmed1",7.87E+017,"testalpha"
,"iii tetraphenylborate mniimniii c"," NN  NN",4,1,1,16456265,2,7.45E+018,"testalpha"
,"dpg and inositolhexakis phosphate"," CC NNP NN",4,1,1,17019442,"pubmed1",8.18E+017,"testalpha"
,"driving forces of evolutionarynovelty","VBG NNS IN NN",4,1,1,17347785,"pubmed1",6.05E+018,"testalpha"
,"tomography and granular hypointensity","NN CC JJ NN",4,1,1,16314989,"pubmed1",1.22E+018,"testalpha"
,"hmsh gene in patients","  IN NNS",4,1,1,17139886,2,1.59E+018,"testalpha"
,"amnion and chorioamnion grafts","NN CC NN NNS",4,1,1,16999268,2,7.29E+018,"testalpha"
,"asignificant increase of serum","JJ NN IN NN",4,1,1,16603096,2,1.26E+018,"testalpha"
,"immune defence and metastasis","JJ NN CC NN",4,1,1,16511286,2,8.01E+018,"testalpha"
,"ofintra abdominal infection management","JJ JJ NN NN",4,1,1,16612906,2,2.35E+018,"testalpha"
,"analysis using anova variance","NN VBG NNP NN",4,1,1,17293969,2,5.62E+018,"testalpha"
,"group e g folliculitis","NN   NN",4,1,1,17311739,2,7.70E+018,"testalpha"
,"grade and lymph node","NN CC NN ",4,1,1,17139886,2,4.86E+018,"testalpha"
,"term bone marrowculture medium","NN NN NN NN",4,1,1,17016038,2,6.69E+018,"testalpha"
,"risky behaviors infrequent seat","JJ NNS JJ NN",4,1,1,16426559,"pubmed1",5.40E+018,"testalpha"
,"n administration of ip"," NN IN ",4,1,1,17293962,2,2.32E+018,"testalpha"
,"dsh hadmore positive attitudes"," IN JJ NNS",4,1,1,16330213,"pubmed1",2.03E+018,"testalpha"
,"exclusion of cardiac air","NN IN JJ NN",4,1,1,16956123,2,1.60E+017,"testalpha"
,"tail prick blood sample","NN NNP NN NN",4,1,1,16951742,"pubmed1",1.96E+018,"testalpha"
,"list of such enzymes","NN IN JJ NNS",4,1,1,16410835,"pubmed1",3.69E+018,"testalpha"
,"endometrial samplings processed bythe","JJ NNS VBN NNP",4,1,1,16514842,2,6.14E+018,"testalpha"
,"therapy dbt training program","NN  NN NN",4,1,1,16473997,"pubmed1",4.46E+018,"testalpha"
,"tyr c d cys"," NN  ",4,1,1,16496038,"pubmed1",2.25E+018,"testalpha"
,"blood cpa tested platelet","NN  VBN NN",4,1,1,16549890,2,7.51E+018,"testalpha"
,"itp patients with h"," NNS IN ",4,1,1,16809885,2,5.07E+017,"testalpha"
,"x ray diffraction crystals","NN  NN NNS",4,1,1,16369101,2,6.42E+018,"testalpha"
,"pancreas are rare tumors","NNS VBP JJ NNS",4,1,1,16132429,"pubmed1",2.28E+018,"testalpha"
,"patients haveexperienced pain anxiety","NNS VBN NN NN",4,1,1,17236646,"pubmed1",7.73E+017,"testalpha"
,"reactions with thiazine dyes","NNS IN NN ",4,1,1,16542712,2,2.95E+018,"testalpha"
,"certain subsets of students","JJ NNS IN NNS",4,1,1,16473990,"pubmed1",3.87E+018,"testalpha"
,"histophysiological effects of resuscitation","JJ NNS IN NN",4,1,1,16762404,2,1.59E+018,"testalpha"
,"cd high t cells"," JJ  NNS",4,1,1,17016036,2,2.75E+018,"testalpha"
,"conclusion clinical characteristics course","NN JJ NNS NN",4,1,1,16696444,2,1.47E+017,"testalpha"
,"sepsis after surgery laparoscopic","NN IN NN NN",4,1,1,16914908,2,4.18E+018,"testalpha"
,"increasing patient age andspecific","VBG NN NN NNP",4,1,1,16365337,"pubmed1",6.43E+018,"testalpha"
,"perceived risk lowperceived prevalence","VBN NN VBN NN",4,1,1,16191426,"pubmed1",2.28E+018,"testalpha"
,"gene product ylr cp"," NN  ",4,1,1,17146497,"pubmed1",5.56E+018,"testalpha"
,"nucleus cytoplasm and mitochondria","NN NN CC NNP",4,1,1,16496041,"pubmed1",4.06E+018,"testalpha"
,"uvb enhanced migrationof melanocytes"," VBN  NNS",4,1,1,17106595,2,7.06E+018,"testalpha"
,"tumour sections from patientswith","JJ NNS IN NN",4,1,1,17139902,2,3.59E+018,"testalpha"
,"bridged peptide withl configuration","VBN VB  NN",4,1,1,16496038,"pubmed1",1.26E+018,"testalpha"
,"systematic reviews in emergency","JJ NNS IN NN",4,1,1,16365332,"pubmed1",5.67E+018,"testalpha"
,"structure intermolecularo h n","NN NNP  ",4,1,1,16456295,2,3.49E+018,"testalpha"
,"theautophosphorylation sites in l","NN NNS IN ",4,1,1,16404475,"pubmed1",6.36E+018,"testalpha"
,"cell cellinteractions or cell","NN NNS CC NN",4,1,1,16511286,2,7.28E+018,"testalpha"
,"alsoreduces cell cell adhesion","NNS NN NN NN",4,1,1,16564564,2,1.42E+018,"testalpha"
,"groupi metabotropic glutamate receptors"," NN NN NNS",4,1,1,17265692,2,4.81E+018,"testalpha"
,"nurse roles and responsibilities","NN NNS CC NNS",4,1,1,16438092,"pubmed1",7.97E+018,"testalpha"
,"mvc riskamong returning combat"," IN VBG NN",4,1,1,16405857,"pubmed1",5.36E+018,"testalpha"
,"stage of change model","NN IN NN NN",4,1,1,16365327,"pubmed1",9.22E+018,"testalpha"
,"patients with documentedcerebrovascular event","NNS IN JJ NN",4,1,1,16914907,2,1.52E+018,"testalpha"
,"case offemoropedal bypass graft","NN NN VB NN",4,1,1,16612921,"pubmed1",7.15E+018,"testalpha"
,"postoperative complications incertain cardiosurgery","JJ NNS VB NN",4,1,1,16722344,2,7.98E+018,"testalpha"
,"aminoglycosides including gentamicin gen","NNS VBG NNP ",4,1,1,16999986,2,8.62E+018,"testalpha"
,"requiredendotracheal intubation prolonged observation","NN NN VBN NN",4,1,1,16365337,"pubmed1",2.98E+018,"testalpha"
,"silica by directphysical adsorption","NNP IN JJ NN",4,1,1,16701857,"pubmed1",4.58E+018,"testalpha"
,"harmful cells tissue homeostasis","JJ NNS NN NN",4,1,1,16696437,2,1.35E+018,"testalpha"
,"study changes in barrier","NN NNS IN NN",4,1,1,16874414,2,8.81E+018,"testalpha"
,"human p gene exons","JJ   NNS",4,1,1,16582987,"pubmed1",6.13E+018,"testalpha"
,"significant reduction in number","JJ NN IN NN",4,1,1,16762403,2,1.40E+018,"testalpha"
,"knowledge long lasting hours","NN JJ VBG NNS",4,1,1,16916186,"pubmed1",8.59E+018,"testalpha"
,"stabilized hsa containingna octanoate","VBN  NNP NN",4,1,1,17285745,"pubmed1",8.11E+018,"testalpha"
,"ratio of subjective equality","NN IN JJ NN",4,1,1,17133956,2,7.44E+018,"testalpha"
,"collected bymeans of swabs","VBN NNS IN NNS",4,1,1,17293963,2,2.10E+018,"testalpha"
,"open andsequence randomized study","JJ NN VBN NN",4,1,1,16365330,"pubmed1",1.49E+018,"testalpha"
,"relationships among minority patients","NNS IN NN NNS",4,1,1,16596898,"pubmed1",6.11E+018,"testalpha"
,"proofof product microbiology check"," NN NN NN",4,1,1,16999268,2,8.25E+018,"testalpha"
,"word naming test totrigger","NN VBG NN NN",4,1,1,16874421,2,1.52E+018,"testalpha"
,"kg day for days"," NN IN NNS",4,1,1,17133953,2,2.02E+018,"testalpha"
,"perineum including rare primary","NN VBG JJ NN",4,1,1,16514847,2,4.99E+018,"testalpha"
,"regression is toour knowledge","NN VBZ JJ NN",4,1,1,16603102,2,9.31E+017,"testalpha"
,"leading tosynthesis of nd","VBG NN IN ",4,1,1,16389406,"pubmed1",4.43E+018,"testalpha"
,"general condition of thepatient","JJ NN IN NN",4,1,1,17117604,2,3.36E+017,"testalpha"
,"prp and cga protein"," CC  NN",4,1,1,16919707,2,7.31E+018,"testalpha"
,"l isoleucyl l serine","   NN",4,1,1,16397334,2,9.02E+018,"testalpha"
,"fatty liver toischemia reperfusion","JJ NN NN NN",4,1,1,17013514,2,5.33E+018,"testalpha"
,"ofculprit drugs in patients","NN NNS IN NNS",4,1,1,16710577,2,8.10E+018,"testalpha"
,"antioxidant properties paraoxonase pon","JJ NNS NN ",4,1,1,17106515,"pubmed1",7.42E+018,"testalpha"
,"factors affecting measured diffraction","NNS VBG VBN NN",4,1,1,16369096,2,2.14E+018,"testalpha"
,"toxicity overall survival os","NN JJ NN ",4,1,1,16424643,2,5.72E+018,"testalpha"
,"shortern alkyl chain lengths","JJ  NN NNS",4,1,1,16594645,"pubmed1",8.01E+018,"testalpha"
,"hpvclearance persistence after cone","NN NN IN NN",4,1,1,16514834,2,1.91E+017,"testalpha"
,"aids and cognitive function","NNS CC JJ NN",4,1,1,16613748,2,3.19E+018,"testalpha"
,"pain eructation pyrosis meteorism","NN NN NN NN",4,1,1,16424650,2,9.04E+018,"testalpha"
,"prodromal stages of cimf","JJ NNS IN ",4,1,1,16424657,2,7.89E+018,"testalpha"
,"direct measurement of arterialpressure","JJ NN IN NN",4,1,1,16762404,2,3.36E+018,"testalpha"
,"self injection ofmineral oil","NN NN JJ NN",4,1,1,17294911,2,1.22E+018,"testalpha"
,"diethylethane diamine dihydrate c","NN NN NN NN",4,1,1,16456284,2,1.40E+018,"testalpha"
,"clinical reports of ebv","JJ NNS IN ",4,1,1,16955191,2,6.42E+018,"testalpha"
,"cellballs were cytologic features","NNS VBD JJ NNS",4,1,1,16514838,2,6.82E+018,"testalpha"
,"induced acuterenal failure arf","VBN JJ NN ",4,1,1,16999986,2,4.79E+018,"testalpha"
,"barr virus ebv infection"," NN  NN",4,1,1,16955191,2,6.10E+018,"testalpha"
,"joules cm for seconds","NNS  IN NNS",4,1,1,17293969,2,4.90E+018,"testalpha"
,"cerebral venous thrombosis cvt","JJ JJ NN ",4,1,1,16549893,2,6.46E+018,"testalpha"
,"dye in phase i"," IN NN ",4,1,1,16951739,"pubmed1",1.02E+018,"testalpha"
,"new class of heme","JJ NN IN ",4,1,1,16411738,"pubmed1",7.52E+015,"testalpha"
,"sem scanning electron microscopy"," VBG NN ",4,1,1,17293968,2,1.79E+018,"testalpha"
,"escitalopram clearancethan is child","NN NNP VBZ NN",4,1,1,16584121,"pubmed1",6.48E+018,"testalpha"
,"active compensation for theknee","JJ NN IN NN",4,1,1,16919313,2,1.01E+017,"testalpha"
,"intensive care units icus","JJ NN NNS ",4,1,1,16451154,"pubmed1",1.52E+018,"testalpha"
,"assertion thatsensor based systems","NN NN VBN NNS",4,1,1,16129405,"pubmed1",8.58E+018,"testalpha"
,"receptors are described briefly","NNS VBP VBN NN",4,1,1,16594640,"pubmed1",4.41E+018,"testalpha"
,"perineal soft tissue sarcomas","NN JJ NN NNP",4,1,1,16514847,2,8.23E+018,"testalpha"
,"villus height wall width","NN NN NN NN",4,1,1,17293957,2,9.15E+018,"testalpha"
,"apoptosis signal transduction pathwayin","NN NN NN ",4,1,1,16330085,2,4.46E+017,"testalpha"
,"oilpolymer assisted cicatrisation process","NN VBN NN NN",4,1,1,17293971,2,2.81E+018,"testalpha"
,"days incubation of alanine","NNS NN IN NN",4,1,1,16696441,2,9.14E+018,"testalpha"
,"mechanisms of action pharmacology","NNS IN NN NN",4,1,1,16809883,2,3.69E+018,"testalpha"
,"slides using specific monoclonalantibodies","NNS VBG JJ NNS",4,1,1,16514836,2,1.77E+018,"testalpha"
,"sle factors other thaninflammation"," NNS JJ NN",4,1,1,16479028,2,3.29E+018,"testalpha"
,"mean values standard deviations","VB NNS JJ NNS",4,1,1,16399030,"pubmed1",7.00E+018,"testalpha"
,"title compound pt c","NN NN  NN",4,1,1,16397333,2,4.03E+018,"testalpha"
,"collected group of patients","VBN NN IN NNS",4,1,1,17438832,2,5.84E+016,"testalpha"
,"findings of gastric xanthomas","NNS IN JJ NNP",4,1,1,16514844,2,6.66E+018,"testalpha"
,"suggesting theirinsufficient tissue expression","VBG NN NN NN",4,1,1,16585983,2,2.82E+018,"testalpha"
,"pboo group without furthertreatment"," NN IN NN",4,1,1,16253314,2,1.58E+018,"testalpha"
,"patients or week vacop","NNS CC NN NNP",4,1,1,16424644,2,1.41E+018,"testalpha"
,"catalyzed nitration of tyrosine","VBN NN IN NN",4,1,1,16951741,"pubmed1",7.31E+018,"testalpha"
,"set of indices hkls","NN IN NNS ",4,1,1,16369093,2,6.47E+018,"testalpha"
,"areas for future emergency","NNS IN NN NN",4,1,1,16436787,"pubmed1",6.88E+018,"testalpha"
,"artemisiaarborescens l essential oil","NNS  JJ NN",4,1,1,16584150,"pubmed1",1.63E+018,"testalpha"
,"studies revealed atypicalmethylotrophic pathway","NNS VBD JJ NN",4,1,1,17019438,"pubmed1",9.85E+017,"testalpha"
,"level and gsh px","NN CC  ",4,1,1,17160142,"pubmed1",7.56E+018,"testalpha"
,"vascular resistance system index","JJ NN NN NN",4,1,1,16491220,2,3.49E+018,"testalpha"
,"ofstress fibers and relocation","NN NNS CC NN",4,1,1,17115079,"pubmed1",2.68E+018,"testalpha"
,"physicians were critical tothis","NNS VBD JJ NNP",4,1,1,16377827,"pubmed1",2.64E+018,"testalpha"
,"related injuries wri amongcavhs","VBN NNS  ",4,1,1,16438093,"pubmed1",1.43E+018,"testalpha"
,"based study examined motor","VBN NN VBD NN",4,1,1,16139232,"pubmed1",5.35E+018,"testalpha"
,"right pneumonectomy for lung","JJ NN IN NN",4,1,1,16617761,"pubmed1",7.64E+018,"testalpha"
,"weeks old g body","NNS JJ  NN",4,1,1,17133954,2,2.99E+018,"testalpha"
,"radar based proximity warning","NN VBD NN NN",4,1,1,16129405,"pubmed1",8.05E+018,"testalpha"
,"arm of chromosome mds","NN IN NN ",4,1,1,17016041,2,3.88E+018,"testalpha"
,"level of anxiety level","NN IN NN NN",4,1,1,16365322,"pubmed1",6.31E+018,"testalpha"
,"shows apronounced g phase","VBZ VBN  NN",4,1,1,16404475,"pubmed1",8.88E+015,"testalpha"
,"oncommunication with primary care","NN IN JJ NN",4,1,1,16596897,"pubmed1",1.89E+017,"testalpha"
,"dosage was mg kg","NN VBD  ",4,1,1,16955187,2,6.44E+018,"testalpha"
,"general population norms p","JJ NN NNS ",4,1,1,16377826,"pubmed1",1.45E+017,"testalpha"
,"alongstanding imbalance between energy","VBG NN IN NN",4,1,1,16479031,2,6.30E+018,"testalpha"
,"confirmed damage tohippocampal neurons","VBN NN JJ NNS",4,1,1,17133953,2,1.95E+018,"testalpha"
,"asbacterial type or plant","JJ NN CC NN",4,1,1,17143335,"pubmed1",4.19E+018,"testalpha"
,"mannosidase from thermotoga maritima","NN IN NNP NN",4,1,1,16511275,2,9.15E+018,"testalpha"
,"years confidence interval ci","NNS NN NN ",4,1,1,16436795,"pubmed1",7.85E+018,"testalpha"
,"years of age patients","NNS IN NN NNS",4,1,1,16613748,2,6.60E+018,"testalpha"
,"computer literacy for physicians","NN NN IN NNS",4,1,1,16473991,"pubmed1",4.13E+018,"testalpha"
,"sessions but worsened sleep","NNS CC VBN NN",4,1,1,16436796,"pubmed1",4.19E+018,"testalpha"
,"pro apoptotic bcl family","JJ JJ  NN",4,1,1,16424655,2,2.96E+018,"testalpha"
,"gene expression and chromatinorganization"," NN CC NN",4,1,1,16582985,"pubmed1",4.98E+018,"testalpha"
,"important role in sa","JJ NN IN ",4,1,1,16395526,"pubmed1",6.54E+018,"testalpha"
,"gal o glc c","   NN",4,1,1,16456293,2,4.32E+018,"testalpha"
,"intake and energy expenditure","NN CC NN NN",4,1,1,16479031,2,5.83E+018,"testalpha"
,"carcinogen n acetoxy acetylaminofluorene","NN  NN NN",4,1,1,17143337,"pubmed1",7.58E+018,"testalpha"
,"radiologic practice in conjunctionwith","JJ NN IN NN",4,1,1,16317488,"pubmed1",1.70E+017,"testalpha"
,"n and nephrocalcinosis n"," CC NN ",4,1,1,16956119,2,1.38E+018,"testalpha"
,"results within minutes patients","NNS IN NNS NNS",4,1,1,16916181,"pubmed1",8.26E+018,"testalpha"
,"phosphate dehydrogenase g pd","NN NN  ",4,1,1,17046053,2,8.68E+018,"testalpha"
,"extended stem loop structure","VBN VB NN NN",4,1,1,16770443,"pubmed1",2.37E+018,"testalpha"
,"changes in liver enzymes","NNS IN NN NNS",4,1,1,16673555,2,5.94E+018,"testalpha"
,"auc during hes k"," IN  ",4,1,1,17067137,"pubmed1",2.35E+018,"testalpha"
,"shortchain fatty acids scfa","VB JJ NNS ",4,1,1,17293957,2,2.20E+018,"testalpha"
,"inassociation with congenital adrenal","NN IN NN NN",4,1,1,16245020,"pubmed1",4.76E+018,"testalpha"
,"fa fixationgave poor results"," VB JJ NNS",4,1,1,16950501,2,4.34E+018,"testalpha"
,"leaf leaflet and trichomes"," NN CC NNS",4,1,1,17486414,"pubmed1",7.06E+018,"testalpha"
,"implantation but does changethe","NN CC VBZ NNP",4,1,1,16584758,2,1.22E+018,"testalpha"
,"gma and triethylene glycoldimethacrylate"," CC NN NN",4,1,1,16701856,"pubmed1",6.99E+018,"testalpha"
,"organizational factors and workers","JJ NNS CC NNS",4,1,1,16442068,"pubmed1",8.05E+018,"testalpha"
,"nutrient admixtures structured triglycerides","NN NNS VBN NNS",4,1,1,17285747,"pubmed1",2.72E+018,"testalpha"
,"rate and reduced oxygen","NN CC VBN NN",4,1,1,17068635,"pubmed1",8.41E+018,"testalpha"
,"peroxide nitrite orcytochrome c","VB JJ NN NN",4,1,1,16951741,"pubmed1",7.65E+018,"testalpha"
,"long period of time","JJ NN IN NN",4,1,1,16424651,2,8.15E+018,"testalpha"
,"view energy balance body","NN NN NN NN",4,1,1,16918067,"pubmed1",4.28E+018,"testalpha"
,"c terminal sh domain","NN NN  NN",4,1,1,16511262,2,7.41E+018,"testalpha"
,"dle lichen planus graft"," NNP NN NN",4,1,1,17311739,2,7.01E+018,"testalpha"
,"number offos immunoreactive nuclei","NN  JJ ",4,1,1,17007911,2,8.91E+017,"testalpha"
,"anemia and inflammatory anemia","NN CC JJ NN",4,1,1,16673554,2,3.26E+017,"testalpha"
,"results with total laparoscopic","NNS IN JJ NN",4,1,1,16612910,2,7.75E+018,"testalpha"
,"water control group n","NN NN NN ",4,1,1,17293970,2,2.21E+018,"testalpha"
,"comparing dmtreatment with placebo","VBG NN IN ",4,1,1,16451144,"pubmed1",8.59E+018,"testalpha"
,"education for medical students","NN IN JJ NNS",4,1,1,16377822,"pubmed1",3.15E+018,"testalpha"
,"prognosis in aml patients","NN IN  NNS",4,1,1,16914901,2,1.66E+018,"testalpha"
,"comprised patientswith chronic itp","VBN NN JJ ",4,1,1,16424649,2,8.30E+018,"testalpha"
,"used andother lipid parameters","VBN JJ NN NNS",4,1,1,17106515,"pubmed1",8.70E+018,"testalpha"
,"m with bm blasts"," IN  NNS",4,1,1,16914909,2,1.87E+018,"testalpha"
,"difficulties and treatment outcome","NNS CC NN NN",4,1,1,16424653,2,2.47E+018,"testalpha"
,"values given asmedian range","NNS VBN JJ NN",4,1,1,16451153,"pubmed1",1.78E+018,"testalpha"
,"transduction ofcd positive cells","NN  JJ NNS",4,1,1,17160143,"pubmed1",3.98E+018,"testalpha"
,"yields unsatisfactorylong term results","NNS IN NN NNS",4,1,1,16955185,2,2.45E+017,"testalpha"
,"response disturbing constituent ina","NN JJ NN ",4,1,1,16648911,2,9.03E+018,"testalpha"
,"multi step staining protocol"," NN VBG NN",4,1,1,16730369,2,5.79E+018,"testalpha"
,"ambisome ciprofloxacin and imipenem","NN NNP CC ",4,1,1,17370569,"pubmed1",6.58E+018,"testalpha"
,"induced insulinsecretion in rat","VBN NN IN NN",4,1,1,16395520,"pubmed1",2.15E+018,"testalpha"
,"presentation symptoms date ofdiagnosis","NN NNS NN NN",4,1,1,16696444,2,1.63E+018,"testalpha"
,"important cause of morbidity","JJ NN IN NN",4,1,1,16405857,"pubmed1",1.31E+018,"testalpha"
,"thehydrodynamic gene transfer technique","JJ  VB NN",4,1,1,17119325,2,4.28E+018,"testalpha"
,"bun levels morphological changes"," NNS JJ NNS",4,1,1,16999986,2,6.50E+018,"testalpha"
,"head injury used helmets","NN NN VBN NNS",4,1,1,16223468,"pubmed1",9.02E+018,"testalpha"
,"accompanied byerythema and pruritus","VBN NN CC NN",4,1,1,16696448,2,2.16E+018,"testalpha"
,"virus likesystems synthetic viruses","NN NNS JJ NNS",4,1,1,17285739,"pubmed1",1.03E+017,"testalpha"
,"size and size distribution","NN CC NN NN",4,1,1,16584167,"pubmed1",1.01E+018,"testalpha"
,"assessed inisolated platelet membrane","VBN VBN NN NN",4,1,1,16523217,"pubmed1",4.99E+018,"testalpha"
,"increasedroad mileage and road","NN NN CC NN",4,1,1,16451795,"pubmed1",1.61E+018,"testalpha"
,"cause of colonic symptoms","NN IN JJ NNS",4,1,1,16989154,2,6.15E+018,"testalpha"
,"atom and high coordination","NN CC JJ NN",4,1,1,16365636,"pubmed1",1.84E+017,"testalpha"
,"ct showed multiple liver"," VBD JJ NN",4,1,1,17119328,2,1.71E+018,"testalpha"
,"l transfected hek cellsunderwent"," VBN  NN",4,1,1,16951744,"pubmed1",6.00E+018,"testalpha"
,"canthoplastyas unique reconstructive tools"," JJ JJ NNS",4,1,1,17165595,2,1.41E+018,"testalpha"
,"lower inflection points uip","JJR NN NNS ",4,1,1,16451155,"pubmed1",4.28E+018,"testalpha"
,"corresponding figures in hai","JJ NNS IN ",4,1,1,16112069,"pubmed1",3.51E+018,"testalpha"
,"symptomatic oral lichen planus","JJ JJ NNP NN",4,1,1,16710580,2,9.65E+017,"testalpha"
,"histopathological liver damage scores","JJ NN NN NNS",4,1,1,16612918,"pubmed1",8.10E+018,"testalpha"
,"oil polymer indogs joints","NN NN NNS NNS",4,1,1,17293971,2,7.96E+018,"testalpha"
,"nucleotide binding oligomerization domain","VB VBG NN NN",4,1,1,16648910,2,2.62E+018,"testalpha"
,"hoarseness and diagnosis oflaryngeal","NN CC NN NN",4,1,1,16479029,2,2.38E+018,"testalpha"
,"andglutathione peroxidases gsh pxs","NN NNS  ",4,1,1,17160142,"pubmed1",8.18E+017,"testalpha"
,"based contrast agent injection","VBN NN NN NN",4,1,1,16333704,"pubmed1",7.26E+018,"testalpha"
,"bp bp and bp","  CC ",4,1,1,16951742,"pubmed1",3.24E+018,"testalpha"
,"cells with pminv egfp","NNS IN  ",4,1,1,17160143,"pubmed1",7.82E+018,"testalpha"
,"time course of thrombocytopenia","NN NN IN NNP",4,1,1,16594642,"pubmed1",4.49E+018,"testalpha"
,"membrane associated pigment protein","NN VBN NN NN",4,1,1,17106511,"pubmed1",5.07E+018,"testalpha"
,"included inthe differential diagnosis","VBN NNP JJ NN",4,1,1,16612930,"pubmed1",2.86E+018,"testalpha"
,"experienced more pain p","VBN JJR NN ",4,1,1,16955183,2,9.15E+018,"testalpha"
,"transfected hek cellsunderwent apoptosis","VBN  NN NN",4,1,1,16951744,"pubmed1",4.78E+018,"testalpha"
,"chemical and biochemical analysis","NN CC JJ NN",4,1,1,16764914,2,6.10E+017,"testalpha"
,"blistering disease with skin","VBG NN IN NN",4,1,1,17106603,2,1.44E+018,"testalpha"
,"standard yeast identification procedures","JJ NN NN NNS",4,1,1,17019438,"pubmed1",6.23E+018,"testalpha"
,"experiments using transient immunosuppressivetherapy","NNS VBG NN NN",4,1,1,16701881,"pubmed1",5.84E+018,"testalpha"
,"theinteraction of metabolic enzymes","NN IN JJ NNS",4,1,1,16410835,"pubmed1",4.58E+018,"testalpha"
,"yeast proteasomal subunit rpn","NN JJ JJ ",4,1,1,16421449,2,8.03E+018,"testalpha"
,"manner in ins cells","NN IN  NNS",4,1,1,16395520,"pubmed1",3.10E+018,"testalpha"
,"treatment period bothtest groups","NN NN NN NNS",4,1,1,16585984,2,6.89E+018,"testalpha"
,"treatment of intestinal failure","NN IN JJ NN",4,1,1,17013518,2,6.87E+018,"testalpha"
,"colleagues and supervisory physicians","NNS CC NN NNS",4,1,1,16377827,"pubmed1",6.10E+018,"testalpha"
,"dui intensivesupervision program disp"," NN NN ",4,1,1,16202465,"pubmed1",3.52E+018,"testalpha"
,"patients withdukes c colon","NNS VBZ NN NN",4,1,1,17139902,2,6.37E+018,"testalpha"
,"therelationships between placental size","NNS IN NN NN",4,1,1,16809888,2,6.29E+017,"testalpha"
,"p expression after eradication"," NN IN NN",4,1,1,16809885,2,4.37E+018,"testalpha"
,"prevention and control programs","NN CC NN NNS",4,1,1,16596897,"pubmed1",6.51E+018,"testalpha"
,"basal level of pfkfb","NN NN IN ",4,1,1,17143338,"pubmed1",2.59E+018,"testalpha"
,"article aimsto give synchrotron","NN NNP VB NNP",4,1,1,16369089,2,8.09E+018,"testalpha"
,"body mass index waist","NN NN NN NN",4,1,1,16479027,2,7.33E+018,"testalpha"
,"transplantation pbsct in adult","NN  IN NN",4,1,1,17119322,2,1.34E+018,"testalpha"
,"phase of sarcoidosis psh","NN IN NN ",4,1,1,16256177,2,5.06E+018,"testalpha"
,"bcr abl genevariants e","  NNS ",4,1,1,16914906,2,1.15E+018,"testalpha"
,"pu m pu r","   NN",4,1,1,17019439,"pubmed1",5.32E+018,"testalpha"
,"better characterized inthe skin","JJR VBN NNP NN",4,1,1,16874416,2,4.80E+018,"testalpha"
,"reduced length of stay","VBD NN IN NN",4,1,1,16377816,"pubmed1",5.57E+018,"testalpha"
,"complete inhibition of alt","JJ NN IN ",4,1,1,16696441,2,2.41E+018,"testalpha"
,"testes of adultwistar rats","NNS IN NN NNS",4,1,1,16325891,2,1.79E+017,"testalpha"
,"graduated licensing system gls","VBN VBG NN ",4,1,1,16112070,"pubmed1",8.61E+018,"testalpha"
,"reconstruct real world crashes","VB JJ NN NNS",4,1,1,16054101,"pubmed1",4.69E+018,"testalpha"
,"case management cm specialty","NN NN  NN",4,1,1,16438092,"pubmed1",8.37E+018,"testalpha"
,"dynamic morphology and cytoskeletal","JJ NN CC NN",4,1,1,16956122,2,6.25E+018,"testalpha"
,"clinical impressions throughout thecase","JJ NNS IN NN",4,1,1,16365338,"pubmed1",7.30E+018,"testalpha"
,"pds including national meetings"," VBG JJ NNS",4,1,1,16436795,"pubmed1",5.13E+018,"testalpha"
,"fever and new pulmonaryinfiltrates","NN CC JJ NNS",4,1,1,16918060,"pubmed1",6.79E+018,"testalpha"
,"regulation of c fos","NN IN NN ",4,1,1,17007911,2,4.16E+018,"testalpha"
,"amplicons with expected sizesof","NNS IN VBN ",4,1,1,16951742,"pubmed1",1.37E+018,"testalpha"
,"corresponding mixed valence diacetate","JJ VBN NN NN",4,1,1,16456265,2,4.45E+018,"testalpha"
,"p inhibitor mdm table"," NN  NN",4,1,1,17115080,"pubmed1",2.71E+017,"testalpha"
,"accidents permillion passenger trips","NNS NN NN NNS",4,1,1,16434013,"pubmed1",8.70E+018,"testalpha"
,"signaling mechanism for iron","VBG NN IN NN",4,1,1,17119325,2,6.84E+018,"testalpha"
,"injury circumstances in depth","NN NNS IN NN",4,1,1,16412373,"pubmed1",2.75E+018,"testalpha"
,"h mca thread occlusion","  NN NN",4,1,1,17265689,2,8.42E+018,"testalpha"
,"natural bone adouble diffusion","JJ NN JJ NN",4,1,1,16701861,"pubmed1",3.47E+018,"testalpha"
,"circulating ox ldl sandwich","VBG   NN",4,1,1,17106515,"pubmed1",2.68E+017,"testalpha"
,"grunwald giemsa stain immunocytochemistry","NNP  VB NN",4,1,1,16514836,2,3.75E+018,"testalpha"
,"imaging n or histology","VBG  CC NN",4,1,1,16333704,"pubmed1",1.10E+018,"testalpha"
,"thesimulated patient care sessions","VBN NN NN NNS",4,1,1,16436796,"pubmed1",3.53E+018,"testalpha"
,"con centration after induction","JJ NN IN NN",4,1,1,17067136,"pubmed1",5.06E+018,"testalpha"
,"usesthe notions of language","NNP NNS IN NN",4,1,1,16988903,"pubmed1",8.59E+018,"testalpha"
,"resistance rating in australia","NN NN IN NNP",4,1,1,16111641,"pubmed1",9.98E+017,"testalpha"
,"bridged manganesecomplex di mu","VBN JJ  ",4,1,1,16456265,2,6.51E+018,"testalpha"
,"inverse correlation with vegf","JJ NN IN ",4,1,1,16317488,"pubmed1",4.41E+018,"testalpha"
,"laser light ofwavelength nm","NN JJ NN ",4,1,1,17293963,2,1.34E+018,"testalpha"
,"therapeutic aspects of hepatitis","JJ NNS IN NN",4,1,1,17013506,2,5.03E+018,"testalpha"
,"polyclonal antibodies directedagainst sp","JJ NNS IN ",4,1,1,16256177,2,2.97E+018,"testalpha"
,"waves and produce images","NNS CC VB NNS",4,1,1,17139898,2,6.41E+018,"testalpha"
,"h and u nag"," CC  ",4,1,1,16956119,2,2.34E+018,"testalpha"
,"peripancreatic veins and d","JJ NNS CC ",4,1,1,16333694,"pubmed1",4.35E+018,"testalpha"
,"arrest rates and alcohol","NN NNS CC NN",4,1,1,16423318,"pubmed1",5.53E+018,"testalpha"
,"ns infusion ng ml"," NN  ",4,1,1,17067137,"pubmed1",7.17E+018,"testalpha"
,"immune response anastomotic resistance","JJ NN JJ NN",4,1,1,17293972,2,1.94E+017,"testalpha"
,"messenger ribonucleic acid mrna","NN JJ NN ",4,1,1,17285740,"pubmed1",3.51E+018,"testalpha"
,"c c inhibited efflux","NN NN VBN NN",4,1,1,16594645,"pubmed1",5.18E+018,"testalpha"
,"title dipeptides c h","NN NNS NN ",4,1,1,16397334,2,8.80E+018,"testalpha"
,"history of thromboembolism p","NN IN NN ",4,1,1,16696443,2,3.81E+018,"testalpha"
,"potential activity of mitochondrialdehydrogenases","NN NN IN NNS",4,1,1,16696445,2,2.30E+018,"testalpha"
,"increasedlife expectancy for patients","JJ NN IN NNS",4,1,1,16462405,"pubmed1",1.76E+018,"testalpha"
,"proteins in thedenatured state","NNS IN VBN NN",4,1,1,16365636,"pubmed1",7.78E+018,"testalpha"
,"andassumed teaching responsibilities pediatrics","VBN VBG NNS NNS",4,1,1,16377822,"pubmed1",2.40E+018,"testalpha"
,"glycogen stores up topre","NN NNS IN ",4,1,1,16921609,"pubmed1",5.74E+017,"testalpha"
,"mediators of ischemic injury","NNS IN JJ NN",4,1,1,17265689,2,8.63E+018,"testalpha"
,"overall process and identification","JJ NN CC NN",4,1,1,17063208,"pubmed1",2.34E+018,"testalpha"
,"acase study of selenium","NN NN IN NN",4,1,1,16369100,2,1.29E+018,"testalpha"
,"countingthe number of cells","NNP NN IN NNS",4,1,1,16730370,2,3.93E+018,"testalpha"
,"relate todisparity cultural competence","NN NN JJ NN",4,1,1,16473988,"pubmed1",8.15E+018,"testalpha"
,"surface area by method","NN NN IN NN",4,1,1,17293968,2,1.09E+018,"testalpha"
,"appendages of begoniaand 'water","NNS IN NN NN",4,1,1,17486414,"pubmed1",8.86E+018,"testalpha"
,"trial and error approach","NN CC NN NN",4,1,1,16918069,"pubmed1",3.99E+018,"testalpha"
,"results show significant differences","NNS VB JJ NNS",4,1,1,16451154,"pubmed1",5.40E+017,"testalpha"
,"motor vehicle accidents unemployment","NN NN NNS NN",4,1,1,17013520,2,1.32E+018,"testalpha"
,"bone destruction and resorption","NN NN CC NN",4,1,1,17016034,2,8.76E+018,"testalpha"
,"scale results in optimization","NN NNS IN NN",4,1,1,16701858,"pubmed1",1.98E+018,"testalpha"
,"affinity of sitesfor oxygen","NN IN JJ NN",4,1,1,17019442,"pubmed1",8.86E+018,"testalpha"
,"surgical resection using varioscope","JJ NN VBG NNP",4,1,1,16722347,2,3.51E+018,"testalpha"
,"minimize cognitive dissonance clinicians","VB JJ NN NNS",4,1,1,16365325,"pubmed1",6.40E+018,"testalpha"
,"computed tomography reversible ischemiccolitis","VBN NN JJ NN",4,1,1,16333702,"pubmed1",5.58E+018,"testalpha"
,"ala nhme n acetyl","   ",4,1,1,16528414,"pubmed1",7.97E+018,"testalpha"
,"use of biological agents","NN IN JJ NNS",4,1,1,16696436,2,4.34E+018,"testalpha"
,"animportant class of devices","JJ NN IN NNS",4,1,1,16701857,"pubmed1",3.47E+018,"testalpha"
,"conclusion nonviral transfectionof cord","NN JJ  NN",4,1,1,16404477,"pubmed1",7.18E+018,"testalpha"
,"transcriptional regulation of genes","JJ NN IN NNS",4,1,1,16770443,"pubmed1",2.92E+018,"testalpha"
,"model system foramyloid fibril","NN NN VB NNP",4,1,1,16511269,2,5.76E+018,"testalpha"
,"follicles by inducing fibroplasias","NNS IN VBG NNP",4,1,1,16983449,2,2.68E+018,"testalpha"
,"mvch gusconstruct with mutation"," NN IN NN",4,1,1,16395526,"pubmed1",7.84E+018,"testalpha"
,"experience that included cases","NN IN VBD NNS",4,1,1,17139883,2,8.02E+018,"testalpha"
,"peer breast health educators","NN NN NN NNS",4,1,1,16596901,"pubmed1",9.21E+018,"testalpha"
,"relative crash involvement risk","JJ NN NN NN",4,1,1,16054104,"pubmed1",3.12E+018,"testalpha"
,"consensus sequences gdsgvgkt wdtagq","NN NNS  ",4,1,1,16365637,"pubmed1",6.31E+018,"testalpha"
,"treatment of ethics training","NN IN NNS NN",4,1,1,16473995,"pubmed1",5.86E+018,"testalpha"
,"types of energy absorbingguardrail","NNS IN NN NN",4,1,1,16054101,"pubmed1",4.38E+018,"testalpha"
,"basic types isolated cleft","JJ NNS VBN NN",4,1,1,17165598,2,2.86E+018,"testalpha"
,"targeted group of congregants","VBN NN IN NNS",4,1,1,16596897,"pubmed1",1.42E+018,"testalpha"
,"methyl d aspartic acid","  JJ NN",4,1,1,17133957,2,4.02E+018,"testalpha"
,"sequence acdcrgdcfcggklaklakklaklak binds selectivelyto","NN NNP NNS ",4,1,1,17143339,"pubmed1",4.55E+018,"testalpha"
,"growth factor beta tgf","NN NN NN ",4,1,1,16762404,2,5.98E+018,"testalpha"
,"hand and low immunogenicity","NN CC JJ NN",4,1,1,17285739,"pubmed1",7.37E+018,"testalpha"
,"protein protein kinase c","NN NN NN NN",4,1,1,16424642,2,3.82E+018,"testalpha"
,"sign mediatedinteractions between organisms","NN NNS IN NNS",4,1,1,16988903,"pubmed1",6.55E+018,"testalpha"
,"susceptibilitytesting data in children","VBG NNS IN NNS",4,1,1,16365328,"pubmed1",2.78E+018,"testalpha"
,"tumor measuring x cm","NN VBG NN ",4,1,1,16603102,2,7.77E+018,"testalpha"
,"foracademic emergency medicine saem","JJ NN NN ",4,1,1,16365332,"pubmed1",8.91E+018,"testalpha"
,"network of hydrogen bonds","NN IN NN NNS",4,1,1,16434797,2,5.65E+018,"testalpha"
,"vapour diffusionmethod using ammonium","JJ NN VBG NN",4,1,1,16511268,2,1.47E+018,"testalpha"
,"hfe h d polymorphism","   NN",4,1,1,16424658,2,6.49E+018,"testalpha"
,"gastric cancer cell line","JJ NN NN NN",4,1,1,17143338,"pubmed1",3.70E+018,"testalpha"
,"ofthe analysis of case","NNP NN IN NN",4,1,1,16417901,"pubmed1",5.07E+018,"testalpha"
,"tssr from homosapiens hs"," IN NNS ",4,1,1,16733558,"pubmed1",8.12E+018,"testalpha"
,"biotinpair for loading rates","NN IN VBG NNS",4,1,1,16410837,"pubmed1",6.57E+018,"testalpha"
,"localization of acd hands","NN IN  NNS",4,1,1,17010264,2,2.09E+018,"testalpha"
,"full sequence acdcrgdcfcggklaklakklaklak binds","JJ NN NNP NNS",4,1,1,17143339,"pubmed1",4.99E+018,"testalpha"
,"thecase presentation and survey","NN NN CC NN",4,1,1,16365338,"pubmed1",1.74E+018,"testalpha"
,"peritoneum lymph nodes brain","NN NN NNS NN",4,1,1,17139900,2,1.34E+018,"testalpha"
,"poisson regression with death","NN NN IN NN",4,1,1,16426561,"pubmed1",9.08E+018,"testalpha"
,"objectives serial ct lung","NNS JJ  NN",4,1,1,16399029,"pubmed1",4.17E+018,"testalpha"
,"was administeredwith liposomal amphotericin","VBD NN JJ NNP",4,1,1,16918060,"pubmed1",3.78E+018,"testalpha"
,"complication of factor replacement","NN IN NN NN",4,1,1,16549892,2,1.38E+018,"testalpha"
,"pre treatment with capsaicin"," NN IN NNP",4,1,1,16955183,2,1.56E+018,"testalpha"
,"substance achieved abetter result","NN VBN NN NN",4,1,1,17293969,2,6.67E+018,"testalpha"
,"constants km and vmax","NNS  CC ",4,1,1,16929383,"pubmed1",3.22E+018,"testalpha"
,"tiva with mivacurium propofol"," IN NN ",4,1,1,17236637,"pubmed1",2.97E+018,"testalpha"
,"pfa on cryosections brain"," IN NNS NN",4,1,1,16950501,2,6.66E+018,"testalpha"
,"pain relief oftopical morphine","NN NN JJ NN",4,1,1,16955184,2,6.73E+018,"testalpha"
,"threebranches policy and standards","NNS NN CC NNS",4,1,1,16770860,"pubmed1",4.84E+018,"testalpha"
,"chemotherapeutic agent for leukemias","JJ NN IN NNP",4,1,1,16421443,2,8.47E+018,"testalpha"
,"pressure was mm hg","NN VBD  ",4,1,1,16491219,2,4.21E+018,"testalpha"
,"crohn'sdisease and previous radiation","NN CC JJ NN",4,1,1,17139891,2,5.92E+018,"testalpha"
,"arecent paper by c","NN NN IN NN",4,1,1,16988905,"pubmed1",3.85E+018,"testalpha"
,"ellman dualfrequency radiofrequency generator","NN NN NN NN",4,1,1,17139880,2,7.75E+018,"testalpha"
,"macaque mhc i mamu","JJ   ",4,1,1,16511250,2,8.65E+018,"testalpha"
,"new samples about month","JJ NNS IN NN",4,1,1,16809889,2,4.14E+018,"testalpha"
,"survival using univariate andmultivariate","NN VBG NN NN",4,1,1,16451146,"pubmed1",2.10E+018,"testalpha"
,"themixed valence mnii mniii","VBN NN  ",4,1,1,16456265,2,8.62E+018,"testalpha"
,"grade of cin p","NN IN  ",4,1,1,16514834,2,2.99E+018,"testalpha"
,"median width andtraffic volumes","JJ NN NNP NNS",4,1,1,16442487,"pubmed1",2.19E+018,"testalpha"
,"witheither single or multi","JJ NN CC ",4,1,1,16585988,2,5.35E+018,"testalpha"
,"p ns and infusion","  CC NN",4,1,1,17236635,"pubmed1",8.10E+018,"testalpha"
,"language and visual imagery","NN CC JJ NN",4,1,1,16474001,"pubmed1",2.06E+018,"testalpha"
,"process variables on coat","NN NNS IN NN",4,1,1,17285748,"pubmed1",7.40E+018,"testalpha"
,"determine pyruvate kinase activation","VB NN NN NN",4,1,1,17013507,2,2.79E+018,"testalpha"
,"bovine hsc required i","NN  VBN ",4,1,1,16511258,2,7.57E+018,"testalpha"
,"orthorhombic p space group","JJ  NN NN",4,1,1,16511254,2,1.97E+018,"testalpha"
,"hds and asct arm"," CC  NN",4,1,1,16424644,2,9.04E+018,"testalpha"
,"anion mediated lysine arginine","NN VBN NN NN",4,1,1,17019436,"pubmed1",4.13E+017,"testalpha"
,"used asthe exposure measure","VBN NNP NN NN",4,1,1,16426560,"pubmed1",1.80E+018,"testalpha"
,"lung tissues were observedunder","NN NNS VBD NN",4,1,1,16395522,"pubmed1",2.70E+018,"testalpha"
,"thiobarbituric acid reactive substancesin","JJ NN JJ NNP",4,1,1,16395529,"pubmed1",4.08E+018,"testalpha"
,"femoral troclea with theimplantation","JJ  IN NN",4,1,1,17293971,2,7.83E+017,"testalpha"
,"individualization of bypassing agent","NN IN VBG NN",4,1,1,16549892,2,5.31E+017,"testalpha"
,"greatlyimproved resolution over wax","VBN NN IN ",4,1,1,17007910,2,8.25E+018,"testalpha"
,"correlation with serum c","NN IN NN NN",4,1,1,16673610,2,3.96E+018,"testalpha"
,"place after habituation sessions","NN IN NN NNS",4,1,1,17133955,2,3.81E+018,"testalpha"
,"detection of cervical lesions","NN IN JJ NNS",4,1,1,16514841,2,9.53E+017,"testalpha"
,"treatment of thrombosis ininfancy","NN IN NN NN",4,1,1,16549901,2,1.14E+018,"testalpha"
,"high grade b cell","JJ NN NN NN",4,1,1,16612936,"pubmed1",5.37E+018,"testalpha"
,"additional culture negative samples","JJ NN JJ NNS",4,1,1,16710579,2,2.69E+018,"testalpha"
,"blood haemoglobinand haematocrit levels","NN NN NN NNS",4,1,1,16809888,2,1.45E+018,"testalpha"
,"subjects at h levocetirizine","NNS IN  NN",4,1,1,16874418,2,7.35E+018,"testalpha"
,"level and activities ofgsh","NN CC NNS ",4,1,1,16404476,"pubmed1",8.79E+018,"testalpha"
,"sccpatients and cin lesions","NNS CC  NNS",4,1,1,16514834,2,3.96E+018,"testalpha"
,"cells and candida infections","NNS CC NNP NNS",4,1,1,16514841,2,6.95E+018,"testalpha"
,"theexpressions of fas ligand","NNS IN  NN",4,1,1,17016035,2,7.98E+018,"testalpha"
,"data for shape analysis","NNS IN NN NN",4,1,1,16722348,2,1.79E+016,"testalpha"
,"digestions using hyaluronidase chondroitinase","NNS VBG NN NN",4,1,1,16764914,2,8.33E+018,"testalpha"
,"andhydrazine n atoms cis","NN  NNS ",4,1,1,16397330,2,1.38E+017,"testalpha"
,"polyclonal antisera morphometric differences","JJ NN JJ NNS",4,1,1,16714054,2,6.72E+018,"testalpha"
,"induction group vreceived saline","NN NN VBN NN",4,1,1,17067136,"pubmed1",2.34E+018,"testalpha"
,"young month old youngadult","JJ NN JJ NN",4,1,1,17046052,2,1.07E+018,"testalpha"
,"method for assessment triage","NN IN NN NN",4,1,1,16491215,2,4.05E+018,"testalpha"
,"terminal deoxynucleotidyltransferase mediated deoxyuridine","NN NN VBN NN",4,1,1,16395522,"pubmed1",8.13E+018,"testalpha"
,"profile burnout syndrome maslach","NN NN NN NN",4,1,1,16451152,"pubmed1",8.52E+017,"testalpha"
,"criteria asia pacific modification","NNS  NNP NN",4,1,1,16479027,2,7.06E+018,"testalpha"
,"bedone by careful examination","NN IN JJ NN",4,1,1,16956115,2,4.41E+018,"testalpha"
,"data onvas and oswestry","NNS NN CC NN",4,1,1,17688033,2,4.39E+018,"testalpha"
,"sleep quantities epworth sleepiness","NN NNS JJ NN",4,1,1,16377826,"pubmed1",6.99E+018,"testalpha"
,"bilateralauricular acupressure at sham","JJ NN IN ",4,1,1,16365322,"pubmed1",6.77E+018,"testalpha"
,"photoinitiatedpolymerization of dimethacrylated poly","NN IN VBN ",4,1,1,16701853,"pubmed1",4.14E+018,"testalpha"
,"gastric andpancreatic cancer cell","JJ JJ NN NN",4,1,1,17143338,"pubmed1",1.17E+017,"testalpha"
,"exchanges between dsba anddsbc","NNS IN  ",4,1,1,17019443,"pubmed1",2.82E+018,"testalpha"
,"recorded resting pressure cm","VBN VBG NN ",4,1,1,17139884,2,8.83E+018,"testalpha"
,"enabled wouldchange therapeutic discovery","VBD NN JJ NN",4,1,1,16596744,"pubmed1",2.38E+016,"testalpha"
,"st necrectomy and application"," NN CC NN",4,1,1,16999267,2,8.71E+017,"testalpha"
,"l phenol g l"," NN  ",4,1,1,17019438,"pubmed1",5.13E+018,"testalpha"
,"iron si levels iron","NN  NNS NN",4,1,1,16809890,2,8.52E+018,"testalpha"
,"diabetes dyslipidemia kidney heart","NN NN NN NN",4,1,1,16479031,2,7.04E+018,"testalpha"
,"average age of patients","NN NN IN NNS",4,1,1,17294910,2,7.62E+018,"testalpha"
,"differentials and leadership theory","NNS CC NN NN",4,1,1,16209925,"pubmed1",8.99E+018,"testalpha"
,"subsequent gel retardation assay","JJ  NN NN",4,1,1,17285741,"pubmed1",1.07E+018,"testalpha"
,"errors or misjudging situations","NNS CC VBG NNS",4,1,1,16423319,"pubmed1",5.57E+018,"testalpha"
,"single centerprospective study platelet","JJ JJ NN NN",4,1,1,16549890,2,5.95E+017,"testalpha"
,"acute coronary syndrome trials","JJ NN NN NNS",4,1,1,16365321,"pubmed1",6.32E+018,"testalpha"
,"semi rigid plaster castand"," JJ NN NN",4,1,1,16612914,"pubmed1",5.33E+018,"testalpha"
,"diagnosis of amyloidosis phantomamyloidosis","NN IN NN NN",4,1,1,16714051,2,5.45E+018,"testalpha"
,"molecular andmorphological changes characteristic","JJ JJ NNS NN",4,1,1,16951739,"pubmed1",4.32E+018,"testalpha"
,"vivo data onneurosteroid involvement"," NNS VB NN",4,1,1,17265696,2,5.92E+018,"testalpha"
,"cell production per crypt","NN NN IN NN",4,1,1,16491217,2,8.90E+018,"testalpha"
,"fibrillarcomponent of amyloid deposits","NN IN VB NNS",4,1,1,16764914,2,8.79E+018,"testalpha"
,"elevated level ofhpnpase protein","VBN NN NN NN",4,1,1,16505900,"pubmed1",8.24E+018,"testalpha"
,"following extensive total body","VBG JJ NN NN",4,1,1,17165599,2,4.96E+018,"testalpha"
,"protein c rhapc administration","NN NN  NN",4,1,1,16365336,"pubmed1",6.24E+018,"testalpha"
,"phenotypic screen or selection","NN NN CC NN",4,1,1,16369090,2,8.43E+018,"testalpha"
,"pedal bypasses for salvage","VB NNS IN NN",4,1,1,16612921,"pubmed1",5.53E+018,"testalpha"
,"changes in laboratory values","NNS IN NN NNS",4,1,1,16585986,2,2.18E+017,"testalpha"
,"response on re exposure","NN IN  NN",4,1,1,16585981,2,6.95E+017,"testalpha"
,"expression of tenascin tn","NN IN NNP ",4,1,1,16430945,2,3.09E+018,"testalpha"
,"number of apparentlyminor test","NN IN NN NN",4,1,1,17438830,2,5.46E+018,"testalpha"
,"hydrogen peroxide nitrite orcytochrome","NN VB JJ NN",4,1,1,16951741,"pubmed1",4.63E+017,"testalpha"
,"organelles of malassezia yeasts","NNS IN NNP NNS",4,1,1,16874415,2,4.53E+018,"testalpha"
,"locoregional lymph node metastasis","JJ NN  NN",4,1,1,16673556,2,1.08E+018,"testalpha"
,"larger outer activation barrier","JJR JJ NN NN",4,1,1,16410837,"pubmed1",1.11E+017,"testalpha"
,"form ofstrictures matted bowel","NN NNS VBN NN",4,1,1,16447095,"pubmed1",7.71E+018,"testalpha"
,"osteosclerotic stages of cimf","JJ NNS IN ",4,1,1,16424657,2,1.75E+018,"testalpha"
,"pollen associated food allergens","NN VBN NN NNS",4,1,1,16648913,2,9.10E+017,"testalpha"
,"cases with adequate material","NNS IN JJ NN",4,1,1,16514842,2,1.98E+018,"testalpha"
,"novel particulate carrier systemsuch","NN NN NN NN",4,1,1,17285742,"pubmed1",5.43E+018,"testalpha"
,"education status in thefield","NN NN IN NN",4,1,1,16999271,2,5.57E+018,"testalpha"
,"vct cpt dfr dbr","   ",4,1,1,16479025,2,1.73E+018,"testalpha"
,"ratio of helmet use","NN IN VB NN",4,1,1,16223468,"pubmed1",3.83E+018,"testalpha"
,"oxidation of hydrocarbons performedunder","NN IN NNS NN",4,1,1,16411734,"pubmed1",7.78E+018,"testalpha"
,"fair programs reduce night","JJ NNS VB NN",4,1,1,16171767,"pubmed1",9.12E+018,"testalpha"
,"jejunum and large intestine","NN CC JJ NN",4,1,1,16491217,2,9.12E+018,"testalpha"
,"urine mouse liver kidneyhomogenates","NN NN NN NNS",4,1,1,17285740,"pubmed1",4.34E+018,"testalpha"
,"tissue diseases including dermatomyositis","NN NNS IN NN",4,1,1,17106602,2,5.53E+018,"testalpha"
,"l were defined ashypoglycemia"," VBD VBN NN",4,1,1,17438837,2,1.99E+017,"testalpha"
,"management in emergency care","NN IN NN NN",4,1,1,16451149,"pubmed1",2.82E+017,"testalpha"
,"impact of resident work","NN IN NN NN",4,1,1,16377823,"pubmed1",1.51E+018,"testalpha"
,"derived cells including pgc","VBN NNS IN ",4,1,1,17265694,2,3.41E+018,"testalpha"
,"bundle sheathchloroplasts of c","NN NNS IN NN",4,1,1,17106510,"pubmed1",7.52E+018,"testalpha"
,"product identified human ctgf","NN VBD JJ ",4,1,1,16395527,"pubmed1",7.08E+018,"testalpha"
,"receive bispectal index bis","VB NN NN ",4,1,1,16451145,"pubmed1",2.09E+018,"testalpha"
,"opportunityto influence work pace"," NN NN NN",4,1,1,16451152,"pubmed1",2.82E+018,"testalpha"
,"orthopedic surgery banjica belgrade","JJ NN NNP NN",4,1,1,17688033,2,3.57E+018,"testalpha"
,"achieving publication insuch periodicals","VBG NN NN NNS",4,1,1,16399035,"pubmed1",8.26E+018,"testalpha"
,"blood loss was ml","NN NN VBD ",4,1,1,17013513,2,7.76E+018,"testalpha"
,"developed dermatitis onthe arms","VBD NN NNP NNS",4,1,1,16585981,2,8.97E+016,"testalpha"
,"range and thatr behaves","NN CC  NNS",4,1,1,17019437,"pubmed1",2.78E+017,"testalpha"
,"rates of idec idef","NNS IN  ",4,1,1,16809889,2,2.73E+018,"testalpha"
,"composition ofpigment protein complexes","NN NN NN NNS",4,1,1,17106510,"pubmed1",7.06E+018,"testalpha"
,"presence of zea m","NN IN  ",4,1,1,16963110,2,1.46E+018,"testalpha"
,"non human sign mediatedinteractions"," JJ NN NNS",4,1,1,16988903,"pubmed1",3.37E+018,"testalpha"
,"care physical therapy medication","NN JJ NN NN",4,1,1,17688033,2,5.20E+018,"testalpha"
,"strains agl and eha","NNS  CC ",4,1,1,16582986,"pubmed1",2.83E+018,"testalpha"
,"general clinical factor whichincreases","JJ JJ NN NNS",4,1,1,16989147,2,2.65E+018,"testalpha"
,"mhz radio wave energy"," NN NN NN",4,1,1,17139880,2,7.50E+018,"testalpha"
,"plasma concentrations of bothproteins","NNP NNS IN NNS",4,1,1,16585983,2,6.13E+018,"testalpha"
,"low treatment relatedcomplication rates","JJ NN NN NNS",4,1,1,17139900,2,6.17E+018,"testalpha"
,"motor block at incision","NN NN IN NN",4,1,1,16617756,"pubmed1",1.37E+018,"testalpha"
,"lymph nodes or distantmetastasis","NN NNS CC NN",4,1,1,17139888,2,2.73E+018,"testalpha"
,"subsequent loss of f","JJ NN IN NN",4,1,1,16956122,2,2.37E+018,"testalpha"
,"glycinato di mu thiosulfato","NN   NN",4,1,1,16397335,2,2.74E+018,"testalpha"
,"ormotion sickness in patients","NN NN IN NNS",4,1,1,17236637,"pubmed1",2.92E+018,"testalpha"
,"days after diagnosis severity","NNS IN NN NN",4,1,1,16451155,"pubmed1",2.35E+018,"testalpha"
,"properties inthe structure function","NNS NNP NN NN",4,1,1,16929383,"pubmed1",3.65E+018,"testalpha"
,"proliferate differentiate upregulate costimulatorymolecules","VBP NN NN NNS",4,1,1,16733557,"pubmed1",3.66E+018,"testalpha"
,"solid lipid nanoparticulate dispersion","JJ NN NN NN",4,1,1,17285742,"pubmed1",3.78E+018,"testalpha"
,"setting rs at cerrahpasa","VBG  IN ",4,1,1,16696444,2,8.53E+018,"testalpha"
,"bilateral cryptorchidism and aright","JJ NN CC NN",4,1,1,16612933,"pubmed1",3.79E+018,"testalpha"
,"outcome of ear acupuncture","NN IN NN NN",4,1,1,16955182,2,3.07E+018,"testalpha"
,"temporal fluorescence intensity course","JJ NN NN NN",4,1,1,16399028,"pubmed1",2.40E+018,"testalpha"
,"hospitalization disability and death","NN NN CC NN",4,1,1,16412373,"pubmed1",4.37E+018,"testalpha"
,"n and mg n"," CC  ",4,1,1,16424650,2,4.96E+017,"testalpha"
,"method ofchoice for exclusion","NN NN IN NN",4,1,1,16956123,2,4.63E+018,"testalpha"
,"group of examined patients","NN IN VBD NNS",4,1,1,16989147,2,5.16E+018,"testalpha"
,"responsive rna binding regulatoryelement","JJ  VBG NN",4,1,1,16410835,"pubmed1",7.83E+018,"testalpha"
,"level of gc attransitions","NN IN  NNS",4,1,1,16733554,"pubmed1",2.11E+018,"testalpha"
,"heme by mn iii"," IN  ",4,1,1,16421446,2,4.81E+018,"testalpha"
,"active disulfide cysteine residues","JJ VB NN NNS",4,1,1,16421453,2,3.77E+018,"testalpha"
,"ti disks after days"," NNS IN NNS",4,1,1,16701867,"pubmed1",1.93E+017,"testalpha"
,"limited understanding of radiation","JJ NN IN NN",4,1,1,16369092,2,4.13E+018,"testalpha"
,"release tablets of zidovudine","NN NNS IN NN",4,1,1,16584139,"pubmed1",5.96E+018,"testalpha"
,"approach for certain subsets","NN IN JJ NNS",4,1,1,16473990,"pubmed1",1.70E+017,"testalpha"
,"inverse sa responsive cis","JJ  JJ ",4,1,1,16395526,"pubmed1",3.45E+018,"testalpha"
,"arepoor antigen presenting cells","NN NN VBG NNS",4,1,1,16733557,"pubmed1",5.38E+018,"testalpha"
,"depletion during chemotherapy couldbe","NN IN NN ",4,1,1,16951739,"pubmed1",7.23E+018,"testalpha"
,"peripheral blood tlymphocyte proliferation","JJ NN NNP NN",4,1,1,17016035,2,4.76E+018,"testalpha"
,"n nonsmokers and nondrinkers"," NNS CC NNS",4,1,1,16956116,2,4.25E+018,"testalpha"
,"animportant co stimulatory molecule","JJ  JJ NN",4,1,1,16511253,2,5.67E+018,"testalpha"
,"identification ofindividual oxidized proteins","NN JJ VBN NNS",4,1,1,17063208,"pubmed1",6.08E+018,"testalpha"
,"node metastasis andsurvival time"," NN NN NN",4,1,1,16530813,2,4.48E+018,"testalpha"
,"vegf expression in hccs"," NN IN ",4,1,1,16317488,"pubmed1",9.66E+017,"testalpha"
,"solution provoked rolling movements","NN VBD VBG NNS",4,1,1,16447096,"pubmed1",3.01E+018,"testalpha"
,"impairment from theirsustained fracture","NN IN VBN NN",4,1,1,16613748,2,9.16E+018,"testalpha"
,"type ii cda ii","NN   ",4,1,1,17117609,2,9.18E+018,"testalpha"
,"reduced thetunel positive cardiomyocytes","VBN NN JJ NNS",4,1,1,16566960,2,3.76E+018,"testalpha"
,"target geneexpression in ins","NN NN IN ",4,1,1,16395520,"pubmed1",6.48E+018,"testalpha"
,"cause of acute diverticulitis","NN IN JJ NN",4,1,1,17338195,2,9.02E+018,"testalpha"
,"receptor tfr r x","NN  NN NN",4,1,1,16424658,2,1.32E+018,"testalpha"
,"rare event in childhood","JJ NN IN NN",4,1,1,16549901,2,7.02E+018,"testalpha"
,"differentiation potential mpcs canbecome","NN NN  NN",4,1,1,16696440,2,5.69E+018,"testalpha"
,"severe forms of psoriasis","JJ NNS IN NN",4,1,1,16585983,2,7.15E+018,"testalpha"
,"nausea vomiting bowel dysfunction","NNP VBG NN NN",4,1,1,16916180,"pubmed1",2.66E+018,"testalpha"
,"gsh px superoxide dismutase","  VB NN",4,1,1,16999986,2,3.01E+018,"testalpha"
,"cat activities and gsh","NN NNS CC ",4,1,1,16999986,2,6.87E+018,"testalpha"
,"square planar ni ii","NN NN  ",4,1,1,17117212,"pubmed1",1.78E+018,"testalpha"
,"fiber reinforced composites frc","NN VBD NNS ",4,1,1,16701856,"pubmed1",7.92E+018,"testalpha"
,"coagulate tissues radiofrequency rf","NN NNS NN ",4,1,1,17139880,2,1.18E+018,"testalpha"
,"preventtransport related spinal cord","NN VBN JJ NN",4,1,1,16111641,"pubmed1",7.94E+018,"testalpha"
,"mean values of neutrophils","JJ NNS IN NNS",4,1,1,16491220,2,6.59E+018,"testalpha"
,"serum iron si levels","NN NN  NNS",4,1,1,16809890,2,5.11E+018,"testalpha"
,"m slooffiae m restricta","   ",4,1,1,16874415,2,1.71E+018,"testalpha"
,"lower frequency of trinucleotidestandems","JJR NN IN NNS",4,1,1,16733558,"pubmed1",7.42E+018,"testalpha"
,"deltaala nhme and ac","NNP  CC ",4,1,1,16528414,"pubmed1",3.92E+018,"testalpha"
,"periodontium and surrounding tissues","NN CC VBG NNS",4,1,1,17049369,2,4.30E+018,"testalpha"
,"knee amputation according toghormley","NN NN IN NNP",4,1,1,16612914,"pubmed1",6.11E+018,"testalpha"
,"perfusedfor measurement of infarct","JJ NN IN NN",4,1,1,17265691,2,1.48E+018,"testalpha"
,"remaining lesions additional enhancementpatterns","VBG NNS JJ NNS",4,1,1,16333704,"pubmed1",5.39E+018,"testalpha"
,"old man and year","JJ NN CC NN",4,1,1,16514849,2,7.20E+018,"testalpha"
,"pathway of melanocyte migration","NN IN NNP NN",4,1,1,17106595,2,4.98E+018,"testalpha"
,"brieflybloodstained fta filter discs","VBN  NN NNS",4,1,1,16951742,"pubmed1",4.48E+018,"testalpha"
,"enlargement b multifocal narrowing","NN NN JJ NN",4,1,1,16333694,"pubmed1",4.53E+018,"testalpha"
,"withaa and healthy subjects"," CC JJ NNS",4,1,1,17010262,2,2.71E+018,"testalpha"
,"modifications onthe original assay","NNS NNP JJ NN",4,1,1,17293970,2,6.01E+016,"testalpha"
,"molecular weights m n","JJ VBZ  ",4,1,1,16701853,"pubmed1",4.54E+018,"testalpha"
,"presence of tacsimate hepes","NN IN NN NNS",4,1,1,16511256,2,1.52E+018,"testalpha"
,"g proteins on silicon"," NNS IN NN",4,1,1,16701857,"pubmed1",7.24E+017,"testalpha"
,"angle betweenthe major axes","NN NNP JJ NNS",4,1,1,16399030,"pubmed1",5.45E+018,"testalpha"
,"nhme and ac deltaala"," CC  NNP",4,1,1,16528414,"pubmed1",8.14E+018,"testalpha"
,"signal decrease forboth doses","NN VB JJ NNS",4,1,1,16399028,"pubmed1",1.15E+018,"testalpha"
,"series of consecutive lesions","NN IN JJ NNS",4,1,1,16333704,"pubmed1",3.95E+018,"testalpha"
,"characteristics of nonfatal sledding","NNS IN NN NN",4,1,1,16436798,"pubmed1",7.79E+018,"testalpha"
,"ankle or foot injuries","NN CC NN NNS",4,1,1,16436790,"pubmed1",8.63E+018,"testalpha"
,"carboxyl c o h"," NN  ",4,1,1,16456276,2,3.12E+016,"testalpha"
,"lamina propria in iri","NNP NNP IN ",4,1,1,16491218,2,5.67E+018,"testalpha"
,"fatalities fatalities of teendrivers","NNS NNS IN NNS",4,1,1,16171767,"pubmed1",6.64E+018,"testalpha"
,"possible role of ua","JJ NN IN ",4,1,1,17338197,2,9.00E+018,"testalpha"
,"curves for inexperienced personnel","NNS IN JJ NNS",4,1,1,16451149,"pubmed1",6.28E+018,"testalpha"
,"lajunen t summala h","NN  NNP ",4,1,1,16443186,"pubmed1",6.49E+018,"testalpha"
,"enzymatic functions and rna","JJ NNS CC ",4,1,1,16410835,"pubmed1",8.16E+017,"testalpha"
,"genes in ins cells","NNS IN  NNS",4,1,1,16395520,"pubmed1",7.54E+018,"testalpha"
,"vial heat transfer coefficients"," NN VB NNS",4,1,1,17285746,"pubmed1",6.03E+018,"testalpha"
,"hydration and skin irritation","NN CC NN NN",4,1,1,17285742,"pubmed1",8.04E+018,"testalpha"
,"cleft lip cl cleft","NN NN  NN",4,1,1,17165598,2,4.70E+018,"testalpha"
,"power differentials and leadership","NN NNS CC NN",4,1,1,16209925,"pubmed1",1.13E+018,"testalpha"
,"neutropenia incidence of infections","NNP NN IN NNS",4,1,1,16424643,2,7.37E+018,"testalpha"
,"concentration of micromol l","NN IN  ",4,1,1,16566960,2,4.76E+018,"testalpha"
,"hccs inverselyon opposed phase"," NNP VBN NN",4,1,1,16317488,"pubmed1",2.25E+018,"testalpha"
,"residues ser ser ser","NNS   ",4,1,1,16511282,2,7.38E+018,"testalpha"
,"thedevelopment of implant recipient","NN IN JJ NN",4,1,1,16696438,2,2.57E+018,"testalpha"
,"hour target co ordination","NN NN  NN",4,1,1,16377191,"pubmed1",5.35E+018,"testalpha"
,"patients inan increasing range","NNS  VBG NN",4,1,1,16462404,"pubmed1",8.36E+018,"testalpha"
,"significantnegative correlation with mmp","JJ NN IN ",4,1,1,16585983,2,6.08E+018,"testalpha"
,"rats wasused comprising groups","NNS VBN VBG NNS",4,1,1,17293967,2,4.94E+018,"testalpha"
,"triazole r against malassezia","JJ NN IN NNP",4,1,1,16874415,2,4.08E+018,"testalpha"
,"increase in distensibility p","NN IN NN ",4,1,1,16874414,2,7.34E+018,"testalpha"
,"total ige and coexistence","JJ  CC NN",4,1,1,16859611,2,4.37E+018,"testalpha"
,"meth inducedhyperthermia aberrant dopamine"," NN JJ NN",4,1,1,16808044,"pubmed1",1.18E+018,"testalpha"
,"patient multiple hyperechoic images","NN JJ JJ NNS",4,1,1,16447096,"pubmed1",2.27E+018,"testalpha"
,"association ofstevens johnson syndrome","NN NNS NN NN",4,1,1,16603101,2,8.72E+018,"testalpha"
,"secondaryinstability rate after non","NN NN IN ",4,1,1,16613748,2,1.32E+018,"testalpha"
,"sige toclinical relevant food"," JJ JJ NN",4,1,1,16673562,2,1.03E+018,"testalpha"
,"present study investigated effects","JJ NN VBD NNS",4,1,1,17265691,2,7.59E+018,"testalpha"
,"characterized aspartylglucosaminidases with alphabeta","VBN NNS IN NN",4,1,1,17143335,"pubmed1",1.48E+018,"testalpha"
,"life and survival rate","NN CC NN NN",4,1,1,16479034,2,3.31E+018,"testalpha"
,"topublication was months ci","NN VBD NNS ",4,1,1,16365332,"pubmed1",2.19E+018,"testalpha"
,"aspartic acid changeat amino","JJ NN JJ NNP",4,1,1,16585980,2,3.04E+018,"testalpha"
,"l immunolocalization and patient"," NN CC NN",4,1,1,16530813,2,3.05E+018,"testalpha"
,"information on alternativeantithrombotic use","NN IN JJ NN",4,1,1,16549902,2,1.37E+018,"testalpha"
,"doses forinvasive fungal infections","NNS JJ JJ NNS",4,1,1,17370566,"pubmed1",2.42E+018,"testalpha"
,"layer resistance ie mtm","NN NN  ",4,1,1,17285746,"pubmed1",7.31E+018,"testalpha"
,"hematologic biochemicaland immunologic studies","JJ NN JJ NNS",4,1,1,16603101,2,7.80E+018,"testalpha"
,"high percentage of cases","JJ NN IN NNS",4,1,1,16514841,2,4.18E+017,"testalpha"
,"ld dose of m"," NN IN ",4,1,1,16436788,"pubmed1",3.38E+017,"testalpha"
,"curriculum vitae and mayencourage","NN  CC NN",4,1,1,16399035,"pubmed1",1.31E+018,"testalpha"
,"factors for decreased survival","NNS IN VBD NN",4,1,1,16451146,"pubmed1",8.02E+018,"testalpha"
,"decreased levels of gitrl","VBD NNS IN ",4,1,1,16955181,2,7.69E+018,"testalpha"
,"dyes from secondary reagents"," IN JJ NNS",4,1,1,16730369,2,6.47E+018,"testalpha"
,"laser treatment by animal","NN NN IN NN",4,1,1,16648911,2,5.63E+018,"testalpha"
,"neurons platelets neutrophils mast","NNS NNS NNS ",4,1,1,16770441,"pubmed1",4.25E+017,"testalpha"
,"abetter result than laser","NN NN IN NN",4,1,1,17293969,2,8.70E+018,"testalpha"
,"transperitoneal left retrorenal accesswas","NN VBN JJ ",4,1,1,16612910,2,3.65E+017,"testalpha"
,"activity from human epidermis","NN IN JJ NN",4,1,1,16648912,2,1.83E+017,"testalpha"
,"highest number of patients","JJT NN IN NNS",4,1,1,16696444,2,2.42E+018,"testalpha"
,"diagnosis of ttp inthis","NN IN  NNP",4,1,1,16424653,2,4.71E+018,"testalpha"
,"case of fungal infection","NN IN JJ NN",4,1,1,16603097,2,3.94E+018,"testalpha"
,"cartilages forcorrection of pectum","NNS NN IN NN",4,1,1,16956118,2,5.89E+018,"testalpha"
,"obstetrics gynecology and surgery","NNS NN CC NN",4,1,1,16377822,"pubmed1",8.98E+018,"testalpha"
,"chronic postsurgical pain cpsp","JJ JJ NN ",4,1,1,17236639,"pubmed1",5.94E+018,"testalpha"
,"showedincreased calcium and ct","VBN NN CC ",4,1,1,16762403,2,5.00E+018,"testalpha"
,"prevalence of laryngeal tuberculosis","NN IN NN NN",4,1,1,16479029,2,8.86E+018,"testalpha"
,"selection and hole filling","NN CC NN NN",4,1,1,16399033,"pubmed1",3.83E+018,"testalpha"
,"rapid cell adhesion event","JJ NN NN NN",4,1,1,16511251,2,6.94E+018,"testalpha"
,"azoxymethane increase expression sod","NN NN NN ",4,1,1,17293962,2,9.78E+017,"testalpha"
,"attacks and complications ofdiverticulitis","NNS CC NNS NN",4,1,1,17338195,2,3.15E+018,"testalpha"
,"andlungs after prolonged hypercalcemia","NNS IN VBN NN",4,1,1,16762403,2,5.81E+018,"testalpha"
,"human tissues and cells","JJ NNS CC NNS",4,1,1,16999268,2,2.03E+018,"testalpha"
,"inhibitory effect of onoo","NN NN IN ",4,1,1,17068635,"pubmed1",2.07E+018,"testalpha"
,"purified cd cord blood","VBN  NN NN",4,1,1,16404477,"pubmed1",2.52E+018,"testalpha"
,"norway and morbidity data","NN CC NN NNS",4,1,1,16451156,"pubmed1",8.90E+018,"testalpha"
,"forneurosteroids e g transcription","NNS   NN",4,1,1,17265696,2,1.87E+018,"testalpha"
,"stability of thusprepared sbf","NN IN VBN ",4,1,1,16701876,"pubmed1",3.72E+018,"testalpha"
,"discharge times or mms","NN NNS CC ",4,1,1,16451145,"pubmed1",2.61E+018,"testalpha"
,"detachment from substratum cell","NN IN NN NN",4,1,1,16956122,2,1.99E+018,"testalpha"
,"risk ailt and sptcl","NN  CC ",4,1,1,16914902,2,3.71E+018,"testalpha"
,"major abdominal surgery data","JJ JJ NN NNS",4,1,1,17236639,"pubmed1",4.24E+018,"testalpha"
,"apotent p fak inhibitor","NN   NN",4,1,1,17106595,2,7.63E+018,"testalpha"
,"theme involving reactive species","NN VBG JJ NN",4,1,1,16808044,"pubmed1",1.51E+018,"testalpha"
,"vision received mg kgmethylprednisolone","NN VBD  NN",4,1,1,16955189,2,7.04E+018,"testalpha"
,"deviation ratio of hccs","NN NN IN ",4,1,1,16317488,"pubmed1",4.13E+018,"testalpha"
,"hdm patients grass pollen"," NNS NN NN",4,1,1,17328144,2,2.74E+018,"testalpha"
,"receiver operating characteristic roc","NN VBG NN ",4,1,1,16399036,"pubmed1",7.18E+017,"testalpha"
,"retinoid xreceptor rxr ligands","VB NN  NNS",4,1,1,16395520,"pubmed1",7.33E+018,"testalpha"
,"mixtures containing structured lipids","NNS VBG VBN NNS",4,1,1,17285747,"pubmed1",4.49E+018,"testalpha"
,"injury and brain injury","NN CC NN NN",4,1,1,16417901,"pubmed1",8.11E+018,"testalpha"
,"psbc psbd and psbs","  CC ",4,1,1,17106511,"pubmed1",1.50E+018,"testalpha"
,"sem in evaluating thecorrosion"," IN VBG NN",4,1,1,16701867,"pubmed1",4.29E+018,"testalpha"
,"ability for occupational health","NN IN JJ NN",4,1,1,16438092,"pubmed1",6.82E+018,"testalpha"
,"c h in i","NN  IN ",4,1,1,16456284,2,6.44E+017,"testalpha"
,"patents with mitral valve","NNS IN JJ NN",4,1,1,16989140,2,1.28E+018,"testalpha"
,"peg based encapsulation platform"," VBN NN NN",4,1,1,16701853,"pubmed1",9.79E+017,"testalpha"
,"alcohol related motor vehicle","NN VBN NN NN",4,1,1,16169506,"pubmed1",3.58E+018,"testalpha"
,"volemicreplacement until pam mmhg","NN IN  ",4,1,1,16491220,2,3.16E+018,"testalpha"
,"years underwent clinical assessment","NNS NN JJ NN",4,1,1,16809886,2,2.94E+018,"testalpha"
,"protein atf creb family","NN   NN",4,1,1,16395528,"pubmed1",3.67E+018,"testalpha"
,"normal keratinocyte cytoarchitectural differentiation","JJ NNP JJ NN",4,1,1,17311737,2,6.00E+018,"testalpha"
,"clinicalmorphological spectrum of patients","JJ NN IN NNS",4,1,1,16955192,2,4.24E+018,"testalpha"
,"evidence from animal models","NN IN NN NNS",4,1,1,17370566,"pubmed1",8.97E+018,"testalpha"
,"sbfwith different ionic contents","NN JJ JJ NNS",4,1,1,16701876,"pubmed1",2.46E+018,"testalpha"
,"variety of satured hydrocarbons","NN IN VBN NNS",4,1,1,16411734,"pubmed1",4.58E+018,"testalpha"
,"chondroitinase ac and b","NN  CC NN",4,1,1,16764914,2,4.89E+018,"testalpha"
,"c resp of hemodialysis","NN  IN NN",4,1,1,16696442,2,7.37E+018,"testalpha"
,"length cdna of humanp","NN  IN ",4,1,1,16582987,"pubmed1",3.25E+018,"testalpha"
,"pnh and parvovirus b"," CC NN NN",4,1,1,17119324,2,7.04E+018,"testalpha"
,"hydrogen bonds in n","NN NNS IN ",4,1,1,16456284,2,3.52E+018,"testalpha"
,"significant number of drivers","JJ NN IN NNS",4,1,1,16405858,"pubmed1",4.43E+018,"testalpha"
,"genes ppars upregulated boththe","NNS NNS VBN NNP",4,1,1,16395520,"pubmed1",3.61E+017,"testalpha"
,"surveys of driving behaviourand","NNS IN VBG NN",4,1,1,16112070,"pubmed1",3.79E+018,"testalpha"
,"volume and contact angles","NN CC NN NNS",4,1,1,16701858,"pubmed1",9.01E+018,"testalpha"
,"clinical use of dm","JJ NN IN ",4,1,1,16451144,"pubmed1",9.14E+018,"testalpha"
,"risk drivers and support","NN NNS CC NN",4,1,1,16236235,"pubmed1",1.89E+018,"testalpha"
,"peristalsis and extraintestinal complications","NN CC JJ NNS",4,1,1,16447095,"pubmed1",4.11E+017,"testalpha"
,"dsc and ltxrd studies"," CC  NNS",4,1,1,17285745,"pubmed1",2.52E+018,"testalpha"
,"maximum pain during treatment","JJ NN IN NN",4,1,1,16955183,2,8.84E+018,"testalpha"
,"c centred monoclinic space","NN VBN JJ NN",4,1,1,16511275,2,7.50E+018,"testalpha"
,"challenged traditional research record","VBN JJ NN NN",4,1,1,16377817,"pubmed1",6.62E+017,"testalpha"
,"lung cancer in patients","NN NN IN NNS",4,1,1,17117606,2,4.68E+018,"testalpha"
,"gradients effective valve area","NNS JJ NN NN",4,1,1,16989140,2,7.88E+018,"testalpha"
,"variety of clinical findings","NN IN JJ NNS",4,1,1,17338203,2,4.14E+018,"testalpha"
,"sustained release zidovudine tablets","VBN NN NN NNS",4,1,1,16584139,"pubmed1",5.56E+018,"testalpha"
,"inotropes corticosteroids and rhapc","NNS NNS CC ",4,1,1,16365336,"pubmed1",7.70E+018,"testalpha"
,"methods using theibd patients","NNS VBG  NNS",4,1,1,16673554,2,4.18E+018,"testalpha"
,"crystal synchrotron x ray","NN NNP NN ",4,1,1,16456276,2,5.84E+018,"testalpha"
,"blooded animals and humans","VBN NNS CC NNS",4,1,1,17019438,"pubmed1",1.61E+018,"testalpha"
,"age of onset method","NN IN VB NN",4,1,1,16696444,2,5.70E+018,"testalpha"
,"attend conferences and residentsfound","VB NNS CC NN",4,1,1,16377823,"pubmed1",4.58E+018,"testalpha"
,"withinthis rural tennessee community","NNP JJ NN NN",4,1,1,16596901,"pubmed1",4.72E+018,"testalpha"
,"low risk of metastasis","JJ NN IN NN",4,1,1,17139888,2,5.52E+018,"testalpha"
,"soluble tgf beta type","JJ  NN NN",4,1,1,16733563,"pubmed1",1.17E+018,"testalpha"
,"protein per vertebrate aryl","NN IN NN ",4,1,1,16411738,"pubmed1",4.98E+018,"testalpha"
,"performed volemicreplacement until pam","VBN NN IN ",4,1,1,16491220,2,8.42E+017,"testalpha"
,"years duration of thrombocytopenia","NNS NN IN NNP",4,1,1,16424649,2,8.73E+018,"testalpha"
,"uninjured skeletal muscle mkwas","JJ NN NN ",4,1,1,16965805,2,7.97E+018,"testalpha"
,"vessel neoformation fibrosisand collagen","NN NN NN NN",4,1,1,17293959,2,3.87E+018,"testalpha"
,"increase in gst activity","NN IN  NN",4,1,1,16404476,"pubmed1",2.45E+018,"testalpha"
,"detection of humanpapillomavirus hpv","NN IN NN ",4,1,1,17019439,"pubmed1",4.60E+017,"testalpha"
,"rhizotomy using image analysis","NN VBG NN NN",4,1,1,16414104,2,3.79E+018,"testalpha"
,"total ige between patients","JJ  IN NNS",4,1,1,17010262,2,8.53E+018,"testalpha"
,"management of colorectal cancer","NN IN NN NN",4,1,1,17139901,2,2.07E+018,"testalpha"
,"eosinophil cationic protein level"," JJ NN NN",4,1,1,16859611,2,8.26E+018,"testalpha"
,"fap and uc patients"," CC  NNS",4,1,1,17139887,2,7.50E+018,"testalpha"
,"forms of heart disease","NNS IN NN NN",4,1,1,17014894,2,1.28E+018,"testalpha"
,"nick end labeling assay"," NN VBG NN",4,1,1,16395522,"pubmed1",8.49E+018,"testalpha"
,"vehicles tominimize crash harm","NNS VB NN NN",4,1,1,16426556,"pubmed1",3.03E+018,"testalpha"
,"patients with actinic keratosesor","NNS IN JJ NN",4,1,1,16955184,2,7.47E+018,"testalpha"
,"mean area under curves","VB NN IN NNS",4,1,1,17067137,"pubmed1",1.50E+018,"testalpha"
,"amino o methyl beta","NNP   NN",4,1,1,16456292,2,1.68E+018,"testalpha"
,"forwardand backward repetition dfr","NN JJ NN ",4,1,1,16479025,2,6.34E+018,"testalpha"
,"period h vs p","NN   ",4,1,1,16451147,"pubmed1",4.41E+018,"testalpha"
,"dyefor sentinel node sn","JJ NN  ",4,1,1,16491216,2,6.15E+018,"testalpha"
,"respondents on several variables","NNS IN JJ NNS",4,1,1,16330213,"pubmed1",8.96E+018,"testalpha"
,"large number of diffraction","JJ NN IN NN",4,1,1,16369100,2,3.27E+018,"testalpha"
,"ser ser ser ser","   ",4,1,1,16511282,2,3.87E+018,"testalpha"
,"mouse leukemia l cells","NN NN  NNS",4,1,1,16505899,"pubmed1",7.76E+018,"testalpha"
,"demonstrated agood response pc","VBN NN NN ",4,1,1,16424649,2,3.85E+018,"testalpha"
,"means of meta analysis","NNS IN  NN",4,1,1,16427020,"pubmed1",7.28E+018,"testalpha"
,"diameter was seen fiber","NN VBD VBN NN",4,1,1,16701855,"pubmed1",5.44E+018,"testalpha"
,"quantity of leached residualmonomers","NN IN VBN NNS",4,1,1,16701856,"pubmed1",7.30E+018,"testalpha"
,"africanamericans if health education","NNS IN NN NN",4,1,1,16596897,"pubmed1",6.98E+018,"testalpha"
,"members of expert committees","NNS IN NN NNS",4,1,1,17285738,"pubmed1",1.73E+018,"testalpha"
,"using analysis of variance","VBG NN IN NN",4,1,1,17293959,2,7.54E+018,"testalpha"
,"american directors ofmedical student","JJ NNS JJ NN",4,1,1,16473991,"pubmed1",7.47E+018,"testalpha"
,"dna in cervical smears"," IN JJ NNS",4,1,1,17019439,"pubmed1",8.36E+018,"testalpha"
,"real significance incausing road","JJ NN VBG NN",4,1,1,16191426,"pubmed1",8.89E+017,"testalpha"
,"serialsagittal sections of teeth","NN NNS IN NNS",4,1,1,17049369,2,4.17E+018,"testalpha"
,"powerful predictor forcardiovascular morbidity","JJ NN JJ NN",4,1,1,16462412,"pubmed1",1.13E+018,"testalpha"
,"protein bmp in bone","NN  IN NN",4,1,1,17293969,2,4.10E+018,"testalpha"
,"generation glutathioneperoxidase gsh px","NN NN  ",4,1,1,16999986,2,6.88E+018,"testalpha"
,"short communication includes comments","JJ NN VBZ NNS",4,1,1,16988905,"pubmed1",5.60E+018,"testalpha"
,"included patients with adand","VBD NNS IN NN",4,1,1,17328144,2,3.49E+018,"testalpha"
,"care and secondary care","NN CC JJ NN",4,1,1,16514839,2,2.33E+018,"testalpha"
,"human cd positive cells","JJ  JJ NNS",4,1,1,17160143,"pubmed1",6.30E+018,"testalpha"
,"release profile and bioadhesivestrength","NN NN CC NN",4,1,1,16584161,"pubmed1",5.28E+018,"testalpha"
,"bioenergetic metabolismof hela cells","JJ   NNS",4,1,1,16951738,"pubmed1",7.01E+018,"testalpha"
,"heavy vehicle safety management","JJ NN NN NN",4,1,1,16221468,"pubmed1",6.34E+018,"testalpha"
,"tl vs u l","   ",4,1,1,17338197,2,6.56E+018,"testalpha"
,"persistent mullerian duct syndrome","JJ JJ  NN",4,1,1,16612933,"pubmed1",3.81E+018,"testalpha"
,"numerous small confluent petechiae","JJ JJ NN ",4,1,1,17010266,2,7.04E+018,"testalpha"
,"reactions at injection sites","NNS IN NN NNS",4,1,1,17106600,2,6.06E+018,"testalpha"
,"tolerance of fatty liver","NN IN JJ NN",4,1,1,17013514,2,1.30E+018,"testalpha"
,"limited number of reports","JJ NN IN NNS",4,1,1,16999269,2,8.53E+018,"testalpha"
,"study examined programmed death","NN VBD VBN NN",4,1,1,16530813,2,3.53E+018,"testalpha"
,"changes of day length","NNS IN NN NN",4,1,1,17133952,2,9.71E+016,"testalpha"
,"matched forcontrast flow transit","VBN JJS NN NN",4,1,1,16399037,"pubmed1",3.93E+018,"testalpha"
,"tool indiagnosing soft tissue","NN VBG JJ NN",4,1,1,16514847,2,1.25E+018,"testalpha"
,"appearances of bilateral giant","NNS IN JJ NN",4,1,1,16245020,"pubmed1",4.48E+018,"testalpha"
,"ascorbic acid and glutathioneon","JJ NN CC NN",4,1,1,16395529,"pubmed1",7.02E+018,"testalpha"
,"specific ige antibodies sige","JJ  NNS ",4,1,1,16673562,2,5.19E+018,"testalpha"
,"fvii or fx defects"," CC  NNS",4,1,1,16424651,2,8.29E+018,"testalpha"
,"resolution and heavy atoms","NN CC JJ NNS",4,1,1,16421448,2,2.51E+018,"testalpha"
,"surgery with cardiopulmonary bypass","NN IN JJ NN",4,1,1,16549902,2,1.30E+018,"testalpha"
,"reduce morbidity and mortality","VB NN CC NN",4,1,1,16462412,"pubmed1",1.74E+018,"testalpha"
,"o and lactic acid"," CC JJ NN",4,1,1,16701867,"pubmed1",5.38E+018,"testalpha"
,"physical and mental health","NN CC JJ NN",4,1,1,16377815,"pubmed1",3.07E+018,"testalpha"
,"assessment min after histamineapplication","NN  IN NN",4,1,1,16955182,2,6.73E+018,"testalpha"
,"pre transplant chemotherapy mobilization"," JJ NN NN",4,1,1,17119322,2,7.23E+018,"testalpha"
,"showingantitumour efficacy of electroporation","JJ NN IN NN",4,1,1,16388313,"pubmed1",1.60E+017,"testalpha"
,"manage thattension i e","VB NN  ",4,1,1,16377814,"pubmed1",3.49E+018,"testalpha"
,"requirement than affp infusion","NN IN  NN",4,1,1,16451158,"pubmed1",6.46E+018,"testalpha"
,"spoiled gradient recalled echo","VBN NN VBD ",4,1,1,16317488,"pubmed1",1.26E+018,"testalpha"
,"increasing thenumber of licenses","VBG NN IN NNS",4,1,1,16198299,"pubmed1",7.35E+018,"testalpha"
,"monomer release into water","NN NN IN NN",4,1,1,16701856,"pubmed1",6.26E+018,"testalpha"
,"role in sperm activation","NN IN JJ NN",4,1,1,17084885,2,6.68E+018,"testalpha"
,"andsurvival time of patients","NN NN IN NNS",4,1,1,16530813,2,2.36E+018,"testalpha"
,"ahigher alkaline phosphatase alp","JJ NN NN ",4,1,1,16701866,"pubmed1",9.20E+018,"testalpha"
,"rhbfgf on melanocyte migration"," IN NNP NN",4,1,1,17106595,2,4.10E+018,"testalpha"
,"distribution type causes severity","NN NN VBZ NN",4,1,1,16412373,"pubmed1",4.64E+018,"testalpha"
,"efficacy of cream puvatherapy","NN IN NN NN",4,1,1,16585984,2,4.56E+018,"testalpha"
,"types of orofacial clefts","NNS IN JJ NNS",4,1,1,17165598,2,6.05E+018,"testalpha"
,"using potentiometry electronic absorption","VBG NN JJ NN",4,1,1,17117212,"pubmed1",1.98E+018,"testalpha"
,"form of iv iron","NN IN  NN",4,1,1,16673554,2,3.99E+018,"testalpha"
,"t r q exon"," NN  ",4,1,1,16424658,2,7.21E+017,"testalpha"
,"questionnaire that usedvarious rating","NN IN JJ NN",4,1,1,16377825,"pubmed1",1.25E+018,"testalpha"
,"exponential phase of growth","JJ NN IN NN",4,1,1,16964327,"pubmed1",7.31E+017,"testalpha"
,"important hemostatic challenges forcongenital","JJ JJ NNS NN",4,1,1,16424651,2,5.69E+018,"testalpha"
,"tests dueto negligible changes","NNS  JJ NNS",4,1,1,16701876,"pubmed1",2.35E+018,"testalpha"
,"fc binds native tgf"," NNS JJ ",4,1,1,16733563,"pubmed1",3.39E+016,"testalpha"
,"patients with chest pain","NNS IN NN NN",4,1,1,16365321,"pubmed1",7.46E+018,"testalpha"
,"cap development calcification ofthe","NN NN NN NNP",4,1,1,17007910,2,3.82E+018,"testalpha"
,"adult testis on postoperation","NN NN IN NN",4,1,1,16395525,"pubmed1",4.74E+018,"testalpha"
,"control hearts apoptosis induction","NN NNS NN NN",4,1,1,16566960,2,7.42E+018,"testalpha"
,"correlate with current data","NN IN JJ NN",4,1,1,17338203,2,1.97E+017,"testalpha"
,"development of tumour vasculature","NN IN JJ NN",4,1,1,16388313,"pubmed1",5.82E+017,"testalpha"
,"injury scale ais score","NN NN  NN",4,1,1,16426556,"pubmed1",2.02E+018,"testalpha"
,"safety climates shared perceptionsof","NN NNS VBD ",4,1,1,16430845,"pubmed1",5.31E+018,"testalpha"
,"dysfunction urinary retention pruritus","NN JJ NN NN",4,1,1,16916180,"pubmed1",5.02E+018,"testalpha"
,"epigenetic dna modification rnatranscription","JJ  NN NN",4,1,1,16505901,"pubmed1",7.82E+018,"testalpha"
,"performed undercardiopulmonary bypass cpb","VBN JJ NN ",4,1,1,16451153,"pubmed1",8.00E+017,"testalpha"
,"cluster of uropathogenic strains","NN IN JJ NNS",4,1,1,16421447,2,3.60E+018,"testalpha"
,"diversity in moisturizer formulation","NN IN NNP NN",4,1,1,16859617,2,2.73E+018,"testalpha"
,"intensity hepatic arterial vascularity","NN JJ JJ NN",4,1,1,16317488,"pubmed1",8.84E+018,"testalpha"
,"recurrent severe life threatheningepisodes","NN JJ NN NNS",4,1,1,16673613,2,1.45E+018,"testalpha"
,"site tromphoblastictumor and mycosis","NN NN CC NN",4,1,1,16983449,2,8.65E+018,"testalpha"
,"following beta interferon treatment","VBG NN NNP NN",4,1,1,16505900,"pubmed1",4.25E+018,"testalpha"
,"sham group underwent laparotomy"," NN NN NN",4,1,1,17293970,2,3.72E+018,"testalpha"
,"crash car occupant structure","NN NN NN NN",4,1,1,16126153,"pubmed1",8.91E+018,"testalpha"
,"mpa years after surgery"," NNS IN NN",4,1,1,16999269,2,8.61E+018,"testalpha"
,"pain scores at rest","NN NNS IN NN",4,1,1,16451144,"pubmed1",4.36E+018,"testalpha"
,"uvb photochemotherapy puva baths"," NN  NNS",4,1,1,17311742,2,6.15E+018,"testalpha"
,"police and hospital records","NN CC NN NNS",4,1,1,16221468,"pubmed1",9.22E+018,"testalpha"
,"overall cost of thetreatment","JJ NN IN NN",4,1,1,16613748,2,8.89E+018,"testalpha"
,"spontaneous recoveryin sensorimotor function","JJ  NN NN",4,1,1,17265691,2,1.59E+018,"testalpha"
,"job and life satisfaction","NN CC NN NN",4,1,1,16377815,"pubmed1",1.25E+018,"testalpha"
,"myocardial infarction and patients","JJ NN CC NNS",4,1,1,16914907,2,7.50E+018,"testalpha"
,"research orhealth care application","NN NN NN NN",4,1,1,16479033,2,4.55E+018,"testalpha"
,"ethics organizations and b","NNS NNS CC NN",4,1,1,16770857,"pubmed1",1.14E+018,"testalpha"
,"hemisphere showshigher metabolic activation","NN JJ JJ NN",4,1,1,17133958,2,8.28E+018,"testalpha"
,"fluorescence in situ hybridization","NN IN  NN",4,1,1,16424657,2,9.12E+017,"testalpha"
,"ini r glucan rats"," NN JJ NNS",4,1,1,17293960,2,4.40E+018,"testalpha"
,"proliferation morphology and differentiation","NN NN CC NN",4,1,1,16701866,"pubmed1",3.08E+018,"testalpha"
,"history skin scratch test","NN NN NN NN",4,1,1,16648919,2,2.90E+018,"testalpha"
,"p analysisof variance panova","  NN NNP",4,1,1,17285748,"pubmed1",2.49E+017,"testalpha"
,"psii bind photosynthetic pigmentsin"," NN JJ NNP",4,1,1,17106511,"pubmed1",6.52E+018,"testalpha"
,"patients vs u l","NNS   ",4,1,1,17338197,2,9.01E+017,"testalpha"
,"need for ethics training","NN IN NNS NN",4,1,1,16473995,"pubmed1",2.78E+018,"testalpha"
,"human enzyme with glutathione","JJ  IN NN",4,1,1,16421451,2,6.28E+018,"testalpha"
,"sulfur clusters containing proteins","JJ NNS VBG NNS",4,1,1,17143336,"pubmed1",5.11E+018,"testalpha"
,"total cholesterol triglyceride ldl","JJ NN VB ",4,1,1,16479026,2,6.73E+018,"testalpha"
,"survival time was months","NN NN VBD NNS",4,1,1,17139879,2,2.71E+018,"testalpha"
,"dbr dfr vct cpt","   ",4,1,1,16479025,2,8.56E+017,"testalpha"
,"exclusioncriteria were iron therapy","NNP VBD NN NN",4,1,1,16809889,2,8.02E+018,"testalpha"
,"tenascin c tn c","NNP NN  NN",4,1,1,16414104,2,3.18E+018,"testalpha"
,"lower thanduring ns infusion","JJR VBG  NN",4,1,1,17067137,"pubmed1",1.21E+018,"testalpha"
,"term outcome of patients","NN NN IN NNS",4,1,1,16451156,"pubmed1",5.33E+017,"testalpha"
,"motorcycling activity via quasi","VBG NN IN ",4,1,1,16202466,"pubmed1",5.69E+018,"testalpha"
,"necessary educational componentsto train","JJ JJ NNP NN",4,1,1,16377823,"pubmed1",6.54E+018,"testalpha"
,"psoriasis patients regarding participation","NN NNS IN NN",4,1,1,17106601,2,9.39E+017,"testalpha"
,"l paracrine signaltransduction system"," NN NN NN",4,1,1,16919708,2,8.10E+017,"testalpha"
,"fas expression in pasmc"," NN IN ",4,1,1,16395522,"pubmed1",2.50E+017,"testalpha"
,"repair of tissue loss","NN IN NN NN",4,1,1,16722345,2,5.36E+018,"testalpha"
,"ii andpoly mu glycinato"," NN  NN",4,1,1,16397335,2,3.54E+018,"testalpha"
,"plasmidspact atf and patf","NN  CC ",4,1,1,16395528,"pubmed1",7.03E+018,"testalpha"
,"balance between various outcomes","NN IN JJ NNS",4,1,1,17068636,"pubmed1",1.79E+017,"testalpha"
,"forthe ac pc distance","NNP   NN",4,1,1,16399030,"pubmed1",7.83E+017,"testalpha"
,"well functioning doctor patient","NN VBG NN NN",4,1,1,16710573,2,2.43E+018,"testalpha"
,"sporadic colon cancer cells","JJ NN NN NNS",4,1,1,17139886,2,8.55E+018,"testalpha"
,"variety of biological samples","NN IN JJ NNS",4,1,1,17285740,"pubmed1",1.59E+018,"testalpha"
,"attitudes than non attendees","NNS IN  NNS",4,1,1,16330213,"pubmed1",6.93E+018,"testalpha"
,"designing vehicles tominimize crash","VBG NNS VB NN",4,1,1,16426556,"pubmed1",3.83E+018,"testalpha"
,"substratespecificity of pheb pheb","NN IN  ",4,1,1,16511281,2,5.44E+018,"testalpha"
,"positioning errors andnodule growth","VBG NNS NN NN",4,1,1,16399029,"pubmed1",3.26E+017,"testalpha"
,"e and murine monoclonalanti"," CC NN ",4,1,1,16594642,"pubmed1",3.20E+018,"testalpha"
,"g in animal models"," IN NN NNS",4,1,1,17133954,2,2.81E+018,"testalpha"
,"group and group andalso","NN CC NN ",4,1,1,16612917,"pubmed1",8.97E+018,"testalpha"
,"helping patients with latex","VBG NNS IN NNP",4,1,1,16916182,"pubmed1",4.75E+018,"testalpha"
,"ofannual county level crash","JJ NN NN NN",4,1,1,16451795,"pubmed1",1.27E+017,"testalpha"
,"workers resp of control","NNS  IN NN",4,1,1,16696442,2,8.69E+018,"testalpha"
,"hospital and yearmortality rates","NN CC NN NNS",4,1,1,16451156,"pubmed1",5.42E+018,"testalpha"
,"age gender race county","NN NN NN NN",4,1,1,16365326,"pubmed1",7.96E+018,"testalpha"
,"factors associatedwith endothelial dysfunction","NNS NN JJ NN",4,1,1,16479030,2,1.26E+018,"testalpha"
,"hour limitations on residents","NN NNS IN NNS",4,1,1,16377825,"pubmed1",5.60E+018,"testalpha"
,"controlled desflurane fentanyl n","VBN NN NN ",4,1,1,16451145,"pubmed1",3.37E+018,"testalpha"
,"b neuraminidase and chemical","NN NN CC NN",4,1,1,16764914,2,5.92E+018,"testalpha"
,"actual research record keepingpractices","JJ NN NN NNS",4,1,1,16377817,"pubmed1",7.22E+018,"testalpha"
,"regions supportsmarked cach induction","NNS VBD  NN",4,1,1,16951743,"pubmed1",4.68E+018,"testalpha"
,"themanagement of colorectal cancer","NN IN NN NN",4,1,1,16673565,2,1.09E+018,"testalpha"
,"findings of hyperdense images","NNS IN NN NNS",4,1,1,16447096,"pubmed1",3.58E+018,"testalpha"
,"impact on public health","NN IN JJ NN",4,1,1,17013520,2,1.27E+018,"testalpha"
,"comprising groups of animals","VBG NNS IN NNS",4,1,1,17293967,2,3.67E+018,"testalpha"
,"ige were measuredusing fluoroenzyme"," VBD VBG ",4,1,1,17010262,2,1.28E+018,"testalpha"
,"ito cells tofibrogenic form"," NNS JJ NN",4,1,1,16256175,2,1.20E+018,"testalpha"
,"increase of c fos","NN IN NN ",4,1,1,17007911,2,2.26E+017,"testalpha"
,"type duration or location","NN NN CC NN",4,1,1,16673554,2,1.06E+018,"testalpha"
,"bothtreatment and control arms","NN CC NN NNS",4,1,1,16436788,"pubmed1",4.52E+018,"testalpha"
,"components and cytochrome p","NNS CC NN ",4,1,1,16584121,"pubmed1",3.07E+018,"testalpha"
,"chronic itp at risk","JJ  IN NN",4,1,1,16424649,2,3.29E+018,"testalpha"
,"cartilage incision and resection","NN NN CC NN",4,1,1,16956118,2,8.59E+018,"testalpha"
,"personal medical history severity","JJ JJ NN NN",4,1,1,16956115,2,3.80E+018,"testalpha"
,"transduction pathway of melanocyte","NN NN IN NNP",4,1,1,17106595,2,6.66E+015,"testalpha"
,"application process and perceptions","NN NN CC NNS",4,1,1,16399040,"pubmed1",6.20E+018,"testalpha"
,"usingknown d melanogaster mirnas","VBN  NN NNP",4,1,1,16770443,"pubmed1",2.20E+018,"testalpha"
,"calibration factorsproduce better results","NN VB JJR NNS",4,1,1,16414003,"pubmed1",7.17E+018,"testalpha"
,"pudendal nerve terminal motor","NN NN NN NN",4,1,1,17139884,2,6.36E+018,"testalpha"
,"onvas and oswestry index","NN CC NN NN",4,1,1,17688033,2,7.92E+018,"testalpha"
,"substituent plays asignificant role","NN NNS JJ NN",4,1,1,16404478,"pubmed1",6.03E+018,"testalpha"
,"chrysosporium pannorum link hughes","NN NN NN NNS",4,1,1,16603097,2,6.40E+018,"testalpha"
,"enzymes ast altand gamma","NNS  NN NN",4,1,1,17013510,2,8.44E+018,"testalpha"
,"low temperature x ray","JJ NN NN ",4,1,1,17285745,"pubmed1",8.28E+018,"testalpha"
,"induced transient expiratory apnea","VBN NN NN NNP",4,1,1,17133957,2,7.47E+018,"testalpha"
,"andother rare uterine sarcomas","JJ JJ NN NNP",4,1,1,17338203,2,7.76E+018,"testalpha"
,"used rats wistar males","VBN NNS NN NNS",4,1,1,16491220,2,5.66E+017,"testalpha"
,"oxidized ldl ox ldl","VBN   ",4,1,1,17106515,"pubmed1",4.17E+018,"testalpha"
,"fixed volume of powder","VBN NN IN NN",4,1,1,17285749,"pubmed1",6.91E+018,"testalpha"
,"sleep deprivation subjective sleepiness","NN NN JJ NN",4,1,1,16377826,"pubmed1",7.42E+018,"testalpha"
,"grid into thefacial shape"," IN JJ NN",4,1,1,16722348,2,3.67E+018,"testalpha"
,"using retrospectivelyassigned icd codes","VBG VBN  NNS",4,1,1,16365331,"pubmed1",2.59E+018,"testalpha"
,"milled acp composites copolymers","VBN  NNS NNS",4,1,1,16701862,"pubmed1",2.61E+018,"testalpha"
,"allowinterchange between mapleson d","NN IN NN ",4,1,1,16451150,"pubmed1",8.72E+018,"testalpha"
,"cell therapy of demyelinatingdisorders","NN NN IN NNS",4,1,1,16956113,2,3.03E+018,"testalpha"
,"education committee reporting arrangements","NN NN NN NNS",4,1,1,16377812,"pubmed1",6.91E+018,"testalpha"
,"natural ligand fas l","JJ NN  ",4,1,1,16919708,2,2.20E+018,"testalpha"
,"patientwho underwent ear reconstruction"," NN NN NN",4,1,1,16722346,2,8.85E+018,"testalpha"
,"diamond tipped drill bit","NN VBD NN NN",4,1,1,17293969,2,1.54E+018,"testalpha"
,"problem in medical practice","NN IN JJ NN",4,1,1,17013514,2,5.44E+018,"testalpha"
,"eczema mean age years","NN VB NN NNS",4,1,1,16710574,2,8.63E+018,"testalpha"
,"nosignificant differences in pacu","JJ NNS IN ",4,1,1,16451145,"pubmed1",8.35E+018,"testalpha"
,"detailed dsc and ltxrd","VBN  CC ",4,1,1,17285745,"pubmed1",1.45E+018,"testalpha"
,"intrapulmonaryshunt and ventilation perfusion","NN CC NN NN",4,1,1,16451153,"pubmed1",3.11E+018,"testalpha"
,"beta d arabinofuranosyl h","NN   ",4,1,1,16421443,2,6.02E+018,"testalpha"
,"theamounts of bsa adsorption","NNS IN  NN",4,1,1,16701860,"pubmed1",4.21E+018,"testalpha"
,"apoor response cytotoxic drugs","NN NN JJ NNS",4,1,1,16424653,2,6.67E+018,"testalpha"
,"cover letter and self","VB NN CC NN",4,1,1,16377812,"pubmed1",1.06E+018,"testalpha"
,"neurovascular deficits limb deformities","JJ NNS NN NNS",4,1,1,16436790,"pubmed1",7.58E+018,"testalpha"
,"age marital status faculty","NN JJ NN NN",4,1,1,16377815,"pubmed1",3.59E+018,"testalpha"
,"regulation of several proteinsin","NN IN JJ NNP",4,1,1,17265689,2,4.71E+018,"testalpha"
,"non coding repetitive dna"," VBG JJ ",4,1,1,17347785,"pubmed1",2.25E+018,"testalpha"
,"nitric oxide synthase nos","JJ VB NN NNS",4,1,1,16566960,2,3.58E+018,"testalpha"
,"tissue nnos protein waspresent","NN  NN NN",4,1,1,16325891,2,8.18E+018,"testalpha"
,"gravida para caucasian female","NNP  JJ NN",4,1,1,16916187,"pubmed1",7.73E+017,"testalpha"
,"amodel of bovine islet","NN IN NN NN",4,1,1,16701881,"pubmed1",2.64E+017,"testalpha"
,"common evaluationgroups glem lok","JJ NNS  ",4,1,1,16673559,2,2.11E+018,"testalpha"
,"years cumulative survival rate","NNS JJ NN NN",4,1,1,17338203,2,7.45E+018,"testalpha"
,"gastriccancer cell lines mkn","NN NN NNS ",4,1,1,17143338,"pubmed1",2.06E+018,"testalpha"
,"withairborne allergens and irritants","NNP NNS CC NNS",4,1,1,17010263,2,2.36E+018,"testalpha"
,"order toexamine cross border","NN NN VB NN",4,1,1,16169506,"pubmed1",6.57E+018,"testalpha"
,"liver results in year","NN NNS IN NN",4,1,1,17139885,2,4.53E+018,"testalpha"
,"anal fistula anal polyps"," NN  ",4,1,1,17139880,2,3.92E+018,"testalpha"
,"brain neurons and glia","NN NNS CC ",4,1,1,16594639,"pubmed1",8.98E+018,"testalpha"
,"effect size of minutes","NN NN IN NNS",4,1,1,16436790,"pubmed1",2.14E+018,"testalpha"
,"sialicacids and glycosaminoglycans gags","NNS CC NNS ",4,1,1,16764914,2,6.21E+018,"testalpha"
,"fever malaise and weight","NN NN CC NN",4,1,1,16447096,"pubmed1",7.26E+017,"testalpha"
,"hiv and otherenveloped viruses"," CC VBD NNS",4,1,1,17128290,"pubmed1",4.80E+018,"testalpha"
,"motorcycle population like taiwan","NN NN IN NNP",4,1,1,16430844,"pubmed1",8.86E+017,"testalpha"
,"adjustment of staffing patterns","NN IN VBG NNS",4,1,1,16365329,"pubmed1",4.94E+018,"testalpha"
,"amb ambisome has nowbecome"," NN VBZ NN",4,1,1,17370566,"pubmed1",4.52E+017,"testalpha"
,"theconformational trajectory of saposin","JJ NN IN NNP",4,1,1,16511279,2,3.45E+018,"testalpha"
,"national laboratory advanced light","JJ NN VBD NN",4,1,1,16511256,2,8.13E+018,"testalpha"
,"dorsal side of rats","NN NN IN NNS",4,1,1,16574202,2,7.25E+018,"testalpha"
,"avoidance on criminal activity","NN IN JJ NN",4,1,1,16405859,"pubmed1",1.77E+018,"testalpha"
,"thpercentiles and bilateral infiltrates","NNS CC JJ NNS",4,1,1,16451155,"pubmed1",4.57E+018,"testalpha"
,"approach of ourproctologic patients","NN IN JJ NNS",4,1,1,16673559,2,7.22E+018,"testalpha"
,"morphology of dried sucralfate","NN IN VBN NN",4,1,1,16584168,"pubmed1",4.15E+017,"testalpha"
,"current postgraduate education status","JJ NN NN NN",4,1,1,16999271,2,7.12E+018,"testalpha"
,"resultof premature unilateral fusion"," JJ JJ NN",4,1,1,17438834,2,1.71E+018,"testalpha"
,"glu adopts twoalternate conformations"," VBZ NN NNS",4,1,1,16511247,2,4.44E+018,"testalpha"
,"health status poor ability","NN NN JJ NN",4,1,1,16236234,"pubmed1",8.33E+018,"testalpha"
,"tissue procedures and techniques","NN NNS CC NNS",4,1,1,16696438,2,8.46E+018,"testalpha"
,"surface coverage sc thepercentage","NN NN  NN",4,1,1,16549889,2,4.07E+018,"testalpha"
,"third part aconstitutive law","JJ NN JJ NN",4,1,1,16701859,"pubmed1",8.60E+018,"testalpha"
,"anal epithelium granulomas cases"," NN NNP NNS",4,1,1,17139883,2,4.26E+017,"testalpha"
,"variability in dio characteristics","NN IN  NNS",4,1,1,16377812,"pubmed1",8.94E+018,"testalpha"
,"response againstvirus specific antigens","NN NN JJ NNS",4,1,1,17010274,2,7.26E+018,"testalpha"
,"competitive exercise in youngsubjects","JJ NN IN NNS",4,1,1,16918070,"pubmed1",6.61E+018,"testalpha"
,"dehiscence and chylous drainage","NN CC JJ NN",4,1,1,16612923,"pubmed1",3.78E+018,"testalpha"
,"hospital records of infants","NN NNS IN NNS",4,1,1,17438837,2,6.06E+018,"testalpha"
,"todetect and quantify trisomy","NN CC VB NN",4,1,1,16424657,2,9.66E+017,"testalpha"
,"widelyrecommended road safety strategy","VBN NN NN NN",4,1,1,16198299,"pubmed1",5.41E+018,"testalpha"
,"secretion of antioxidant enzymes","NN IN JJ NNS",4,1,1,16410836,"pubmed1",3.25E+018,"testalpha"
,"incidence of opioid side","NN IN VB NN",4,1,1,16916180,"pubmed1",9.21E+018,"testalpha"
,"treatment centres in castilla","NN NNS IN NNP",4,1,1,16236233,"pubmed1",4.52E+017,"testalpha"
,"injury episodes per person","NN NNS IN NN",4,1,1,16412373,"pubmed1",2.91E+018,"testalpha"
,"initial clinicalevaluation and resuscitation","JJ NN CC NN",4,1,1,17067134,"pubmed1",2.52E+018,"testalpha"
,"gastrointestinal symptoms fatigue thrombocytopenia","JJ NNS NN NNP",4,1,1,17016040,2,8.39E+018,"testalpha"
,"thecombination of hdac inhibitors","NN IN  NNS",4,1,1,16424655,2,5.23E+018,"testalpha"
,"k channels katp channels"," NNS  NNS",4,1,1,16566960,2,6.78E+018,"testalpha"
,"pros gene on chromosome","NNS  IN NN",4,1,1,16673558,2,1.73E+018,"testalpha"
,"rb efflux ec nmol"," NN  ",4,1,1,16594645,"pubmed1",4.16E+018,"testalpha"
,"antigen pcna usingthe pc","NN  NNP ",4,1,1,17013511,2,5.19E+018,"testalpha"
,"education research orhealth care","NN NN NN NN",4,1,1,16479033,2,7.78E+016,"testalpha"
,"detect thedifferent gene expression","VB NN  NN",4,1,1,16951744,"pubmed1",6.20E+018,"testalpha"
,"showing stains byportal blood","VBG NNS NN NN",4,1,1,16317494,"pubmed1",5.98E+018,"testalpha"
,"data inclusive averageannual motor","NNS JJ JJ NN",4,1,1,16139232,"pubmed1",9.14E+018,"testalpha"
,"classical fibro osteosclerotic manifestations","JJ NNP JJ NNS",4,1,1,16424657,2,6.88E+018,"testalpha"
,"intravenous catheter and isolatesof","JJ NN CC ",4,1,1,17311736,2,8.79E+017,"testalpha"
,"rms error nodule growth"," NN NN NN",4,1,1,16399029,"pubmed1",2.28E+018,"testalpha"
,"concurrent chemotherapy e g","JJ NN  ",4,1,1,17117605,2,3.42E+018,"testalpha"
,"early engraftment thetotal number","JJ NN NN NN",4,1,1,17119322,2,6.82E+018,"testalpha"
,"limited knowledge of nf","JJ NN IN ",4,1,1,17068636,"pubmed1",1.95E+018,"testalpha"
,"theabsence of intramural ganglion","NN IN JJ NN",4,1,1,17139897,2,7.45E+018,"testalpha"
,"themaximum level of transient","JJ NN IN NN",4,1,1,16582986,"pubmed1",1.87E+018,"testalpha"
,"recentrandomized clinical trials rct","VBN JJ NNS ",4,1,1,17139892,2,6.37E+018,"testalpha"
,"first h aftersurgery post","JJ  NN NN",4,1,1,16451158,"pubmed1",6.32E+018,"testalpha"
,"conclusions stronger gdl programs","NNS JJR  NNS",4,1,1,16171767,"pubmed1",1.07E+018,"testalpha"
,"patients from group b","NNS IN NN NN",4,1,1,16989140,2,5.13E+018,"testalpha"
,"distributed monitors in europe","VBN NNS IN NNP",4,1,1,17236645,"pubmed1",8.30E+018,"testalpha"
,"levels at synapses function","NNS IN NNS NN",4,1,1,16496042,"pubmed1",4.45E+017,"testalpha"
,"millions ofpeople per year","NNS NNS IN NN",4,1,1,16511290,2,6.67E+018,"testalpha"
,"setting time h hardness","VBG NN  NN",4,1,1,16701865,"pubmed1",1.14E+018,"testalpha"
,"accidents was caused bypassengers","NNS VBD VBN NNS",4,1,1,16434013,"pubmed1",9.25E+017,"testalpha"
,"established system including evidence","VBN NN IN NN",4,1,1,16321534,"pubmed1",3.77E+018,"testalpha"
,"drunk driver binge drinking","JJ NN NN NN",4,1,1,16426559,"pubmed1",4.08E+018,"testalpha"
,"rings make dihedral angles","NNS VBP JJ NNS",4,1,1,16397328,2,2.61E+018,"testalpha"
,"alkb resultsin increased sensitivity"," NNP VBD NN",4,1,1,16733554,"pubmed1",9.65E+017,"testalpha"
,"inhibits agonist induced platelet","NNS NN VBN NN",4,1,1,17068635,"pubmed1",1.75E+018,"testalpha"
,"alkaliphilic nocardiopsis sp strain","JJ NN  NN",4,1,1,16511252,2,1.73E+017,"testalpha"
,"ambulance transport and care","NN NN CC NN",4,1,1,16321535,"pubmed1",7.88E+016,"testalpha"
,"groups of cuboidal tumor","NNS IN NN NN",4,1,1,16514846,2,7.69E+018,"testalpha"
,"airway bifurcations for comparisonwith","NN NNS IN NN",4,1,1,16399039,"pubmed1",4.07E+018,"testalpha"
,"levels of safety skills","NNS IN NN NNS",4,1,1,16443186,"pubmed1",6.78E+018,"testalpha"
,"exocytosis innormal bath solution","NN JJ NN NN",4,1,1,16395521,"pubmed1",8.44E+018,"testalpha"
,"virus hcv related cirrhosis","NN  VBN NN",4,1,1,17119328,2,7.45E+018,"testalpha"
,"adjustment for age gender","NN IN NN NN",4,1,1,16436794,"pubmed1",3.98E+018,"testalpha"
,"strength of glass fibres","NN IN NN NNS",4,1,1,16701864,"pubmed1",6.39E+018,"testalpha"
,"plausible explanations in terms","JJ NNS IN NNS",4,1,1,16496038,"pubmed1",2.26E+018,"testalpha"
,"main systematicreview and guidelines","JJS NN CC NNS",4,1,1,16918069,"pubmed1",7.14E+018,"testalpha"
,"injury of thethoracic duct","NN IN JJ ",4,1,1,16612923,"pubmed1",3.94E+018,"testalpha"
,"key enzyme of aromaticcompound","JJ  IN NN",4,1,1,16511281,2,9.77E+017,"testalpha"
,"acting elements andfour w","VBG NNS JJ ",4,1,1,16395526,"pubmed1",7.47E+018,"testalpha"
,"cell migration and cancer","NN NN CC NN",4,1,1,16713618,2,1.87E+018,"testalpha"
,"functional characterization of delta","JJ NN IN NN",4,1,1,17063209,"pubmed1",6.63E+018,"testalpha"
,"n male and female"," NN CC NN",4,1,1,16859613,2,1.45E+017,"testalpha"
,"report multidetector computedtomographic findings","NN NN JJ NNS",4,1,1,16132430,"pubmed1",4.02E+017,"testalpha"
,"standard seriesof contact allergens","JJ  NN NNS",4,1,1,17010264,2,6.07E+018,"testalpha"
,"y advancement fasciocutaneousdorsal thigh"," NN NN NN",4,1,1,17165597,2,5.52E+018,"testalpha"
,"ph values as afunction"," NNS IN NN",4,1,1,16701857,"pubmed1",5.97E+018,"testalpha"
,"cases requiring cardiopulmonary bypass","NNS VBG JJ NN",4,1,1,16549902,2,5.90E+018,"testalpha"
,"phase and opposed phase","NN CC VBN NN",4,1,1,16447077,"pubmed1",4.10E+018,"testalpha"
,"chimeric soluble tgf beta","JJ JJ  NN",4,1,1,16733563,"pubmed1",3.62E+018,"testalpha"
,"terms of clinical practice","NNS IN JJ NN",4,1,1,16617757,"pubmed1",8.03E+018,"testalpha"
,"treatment for scd patients","NN IN  NNS",4,1,1,16424656,2,9.20E+017,"testalpha"
,"variables of true matches","NNS IN JJ NNS",4,1,1,16365326,"pubmed1",6.87E+018,"testalpha"
,"acetate and lead citrate","NN CC VB NN",4,1,1,16574202,2,4.59E+017,"testalpha"
,"hiv vaccine strategies andtherapeutics"," NN NNS NNS",4,1,1,16511250,2,1.51E+018,"testalpha"
,"head computed tomography ct","NN VBN NN ",4,1,1,16436787,"pubmed1",1.27E+018,"testalpha"
,"reasons for such differences","NNS IN JJ NNS",4,1,1,16451154,"pubmed1",8.82E+018,"testalpha"
,"displayed normal diameters smallerthan","VBN JJ NNS NNP",4,1,1,16447095,"pubmed1",3.35E+018,"testalpha"
,"conducted october through october","VBN NN IN NN",4,1,1,16365333,"pubmed1",2.57E+017,"testalpha"
,"plasma anti xa levelsthan","NNP IN  NNP",4,1,1,16549902,2,7.76E+017,"testalpha"
,"dermatologists and occupational physicians","NNS CC JJ NNS",4,1,1,17010263,2,6.99E+018,"testalpha"
,"mental illness in film","JJ NN IN NN",4,1,1,16474001,"pubmed1",3.93E+018,"testalpha"
,"realization of allelic polymorphismof","NN IN JJ ",4,1,1,16733564,"pubmed1",4.18E+017,"testalpha"
,"regenerative capacity of hepatocyte","JJ NN IN NNP",4,1,1,17013517,2,3.10E+018,"testalpha"
,"er gene product ylr","  NN ",4,1,1,17146497,"pubmed1",8.35E+018,"testalpha"
,"use of dbt results","NN IN  NNS",4,1,1,16473997,"pubmed1",9.11E+018,"testalpha"
,"phosphoric acid c h","JJ NN NN ",4,1,1,16456284,2,8.54E+018,"testalpha"
,"genes in wild type","NNS IN JJ NN",4,1,1,17146497,"pubmed1",3.11E+018,"testalpha"
,"assessed arange of smoking","VBN NN IN NN",4,1,1,16365327,"pubmed1",1.76E+018,"testalpha"
,"selected ad patient cohort","VBN NN NN NN",4,1,1,16648913,2,2.19E+018,"testalpha"
,"suggest thatestradiol and hcg","VBP  CC ",4,1,1,16714054,2,8.13E+018,"testalpha"
,"endothelium ofhypoxia exposed rats","NN  VBN NNS",4,1,1,16537087,2,7.44E+018,"testalpha"
,"causes of chronic liver","NNS IN JJ NN",4,1,1,17013519,2,4.86E+018,"testalpha"
,"medicines for nonmedical purposes","NNS IN JJ NNS",4,1,1,16436793,"pubmed1",6.81E+018,"testalpha"
,"successful treatment of iron","JJ NN IN NN",4,1,1,17117609,2,7.21E+016,"testalpha"
,"mr imaging applies differentsequence"," VBG VBZ NN",4,1,1,16447077,"pubmed1",6.65E+018,"testalpha"
,"cell preparations withan emphasis","NN NNS NNP NN",4,1,1,16996581,2,6.42E+018,"testalpha"
,"smoking patients with beta","NN NNS IN NN",4,1,1,16809886,2,1.61E+018,"testalpha"
,"square rms error mm","NN  NN ",4,1,1,16399039,"pubmed1",5.33E+018,"testalpha"
,"control groupcomprised healthy males","NN VBN JJ NNS",4,1,1,16956116,2,2.17E+018,"testalpha"
,"theprevalence of cervical abnormalities","NN IN JJ NNS",4,1,1,16514839,2,6.86E+018,"testalpha"
,"admission and lowermortality rates","NN CC NN NNS",4,1,1,16462404,"pubmed1",9.14E+018,"testalpha"
,"used method for thedemonstration","VBN NN IN NN",4,1,1,16542712,2,2.58E+018,"testalpha"
,"symptoms date ofdiagnosis date","NNS NN NN NN",4,1,1,16696444,2,5.36E+018,"testalpha"
,"agonist for cannabinoid receptors","NN IN VB NNS",4,1,1,16808043,"pubmed1",2.48E+018,"testalpha"
,"cm in fivedifferent sites"," IN NN NNS",4,1,1,17013509,2,3.80E+018,"testalpha"
,"prevalence of atopic dermatitis","NN IN NN NN",4,1,1,16648916,2,2.88E+018,"testalpha"
,"comparison with control tissue","NN IN NN NN",4,1,1,16404476,"pubmed1",2.83E+018,"testalpha"
,"renal dysfunction with bortezomib","JJ NN IN ",4,1,1,17119326,2,6.87E+018,"testalpha"
,"liquefies sweat glands viacavitation","NNS NN NNS NN",4,1,1,16710583,2,8.97E+018,"testalpha"
,"officefor human research protections","JJ JJ NN NNS",4,1,1,16770858,"pubmed1",5.58E+018,"testalpha"
,"te fly ga minv"," VB  ",4,1,1,17160143,"pubmed1",8.78E+017,"testalpha"
,"pattern of theabove markers","NN IN VB NNS",4,1,1,16919707,2,4.35E+018,"testalpha"
,"hemisphere after h mca","NN IN  ",4,1,1,17265689,2,4.91E+018,"testalpha"
,"characterize propofol procedural sedation","VB  JJ NN",4,1,1,16365337,"pubmed1",7.09E+018,"testalpha"
,"support from future studies","NN IN NN NNS",4,1,1,16874421,2,6.32E+018,"testalpha"
,"mechanisms tomaintain immuno surveillance","NNS VB NNP NN",4,1,1,16648910,2,8.38E+018,"testalpha"
,"tissue bank of thefaculty","NN NN IN NN",4,1,1,16999268,2,3.17E+018,"testalpha"
,"different panoramas of sti","JJ NNS IN ",4,1,1,16874417,2,6.91E+018,"testalpha"
,"tissue banks took place","NN NNS VBD NN",4,1,1,16999268,2,6.54E+018,"testalpha"
,"severity scores thoracic injuries","NN NNS JJ NNS",4,1,1,16549896,2,4.56E+018,"testalpha"
,"various ano rectal pathologies","JJ  NN NNS",4,1,1,17139880,2,3.64E+018,"testalpha"
,"pathogenesis of atopic dermatitis","NN IN NN NN",4,1,1,16955181,2,8.87E+018,"testalpha"
,"published reports of techniques","VBN NNS IN NNS",4,1,1,16369091,2,7.05E+018,"testalpha"
,"head injuries in san","NN NNS IN ",4,1,1,16223468,"pubmed1",1.67E+018,"testalpha"
,"protein from rat tissue","NN IN NN NN",4,1,1,17143337,"pubmed1",6.26E+018,"testalpha"
,"making process and treatmentknowledge","VBG NN CC NN",4,1,1,17106601,2,5.37E+018,"testalpha"
,"airway management in emergency","NN NN IN NN",4,1,1,16451149,"pubmed1",5.61E+018,"testalpha"
,"thevicinity of railway tracks","NN IN NN NNS",4,1,1,17294910,2,2.85E+018,"testalpha"
,"consequent permanent dopaminergic deficits","NN JJ JJ NNS",4,1,1,16808044,"pubmed1",5.33E+018,"testalpha"
,"metastatic diseaseand locoregional lymph","JJ NN JJ NN",4,1,1,16673556,2,1.53E+018,"testalpha"
,"inos andincreased enos immunoreactivity"," VBN  NN",4,1,1,16566960,2,8.34E+018,"testalpha"
,"last few years meta","JJ JJ NNS ",4,1,1,16603103,2,5.40E+018,"testalpha"
,"urinarytract infections in children","NN NNS IN NNS",4,1,1,16365328,"pubmed1",8.79E+018,"testalpha"
,"capacity of proliferation mobility","NN IN NN NN",4,1,1,17013515,2,7.74E+018,"testalpha"
,"transvaginal endorectal and perineal","JJ NN CC NN",4,1,1,17139884,2,8.24E+018,"testalpha"
,"nmda receptors with ap"," NNS IN ",4,1,1,17133957,2,4.27E+018,"testalpha"
,"thenonquiescent cell duplication time","NN NN NN NN",4,1,1,16988902,"pubmed1",4.59E+017,"testalpha"
,"semistructured interviews of deans","VBN NNS IN NNS",4,1,1,16377814,"pubmed1",2.91E+018,"testalpha"
,"experiencesand rationales underlying items","NN NNS VBG NNS",4,1,1,16377820,"pubmed1",9.65E+017,"testalpha"
,"ratiois about running light","NNP IN VBG NN",4,1,1,16061188,"pubmed1",1.43E+018,"testalpha"
,"thehereditary nonpolyposis colorectal cancer","JJ NN NN NN",4,1,1,17139886,2,4.22E+018,"testalpha"
,"isobaric bupivacaine viaepidural catheter","JJ NN JJ NN",4,1,1,16916188,"pubmed1",5.18E+018,"testalpha"
,"thedevelopment of medical knowledge","NN IN JJ NN",4,1,1,16479033,2,5.02E+017,"testalpha"
,"histologic subtypes general symptoms","JJ NNS JJ NNS",4,1,1,16914904,2,7.78E+018,"testalpha"
,"discussion average age percentof","NN NN NN ",4,1,1,17338203,2,8.88E+018,"testalpha"
,"evoked rb efflux ec","VBD  NN ",4,1,1,16594645,"pubmed1",5.42E+018,"testalpha"
,"perceptions of fatalism influence","NNS IN NN NN",4,1,1,16596899,"pubmed1",1.66E+018,"testalpha"
,"number of necessary operations","NN IN JJ NNS",4,1,1,17165597,2,5.90E+017,"testalpha"
,"release mucoadhesivecompressed hydrophilic matrices","NN VBN JJ NNS",4,1,1,16584161,"pubmed1",3.55E+018,"testalpha"
,"regressions with fixed effects","NNS IN VBN NNS",4,1,1,16171767,"pubmed1",1.64E+018,"testalpha"
,"oriented clerkships obstetrics gynecology","VBN NNS NNS NN",4,1,1,16377822,"pubmed1",4.81E+018,"testalpha"
,"higheramount of serum ua","NN IN NN ",4,1,1,17338197,2,5.84E+017,"testalpha"
,"thehomeorhesis and tumor cell","NN CC NN NN",4,1,1,16988902,"pubmed1",5.05E+018,"testalpha"
,"loss of coagulation activity","NN IN NN NN",4,1,1,16914903,2,8.04E+018,"testalpha"
,"pharmacokinetic behavior of icg","JJ NN IN ",4,1,1,16399028,"pubmed1",8.14E+018,"testalpha"
,"transcripts originating fromsatellite i","NNS VBG JJ ",4,1,1,16496041,"pubmed1",6.00E+018,"testalpha"
,"perception of road accident","NN IN NN NN",4,1,1,16191426,"pubmed1",8.98E+018,"testalpha"
,"range of means minutes","NN IN NNS NNS",4,1,1,16365334,"pubmed1",1.50E+018,"testalpha"
,"efficiency of viral vectors","NN IN JJ NNS",4,1,1,17285739,"pubmed1",9.56E+017,"testalpha"
,"views on melanogenesis inpro","NNS IN NN ",4,1,1,16951740,"pubmed1",1.81E+018,"testalpha"
,"energy absorbingguardrail end terminals","NN NN NN NNS",4,1,1,16054101,"pubmed1",6.68E+018,"testalpha"
,"reactions across sectional study","NNS IN JJ NN",4,1,1,17106599,2,7.20E+018,"testalpha"
,"min while mug glycosylase"," IN  NN",4,1,1,16582987,"pubmed1",1.85E+018,"testalpha"
,"role of several sm","NN IN JJ ",4,1,1,16594640,"pubmed1",2.27E+018,"testalpha"
,"bisulfite toluidine blue abt","JJ NN JJ ",4,1,1,16714048,2,7.02E+018,"testalpha"
,"density course and visualization","NN NN CC NN",4,1,1,16399037,"pubmed1",5.72E+017,"testalpha"
,"pediatric body composition healthystatus","JJ NN NN NN",4,1,1,16918067,"pubmed1",4.80E+018,"testalpha"
,"human endometrium endometrial tissue","JJ NN JJ NN",4,1,1,16423381,2,2.08E+017,"testalpha"
,"cystine containing parent peptides","NN VBG NN NNS",4,1,1,16496038,"pubmed1",1.93E+018,"testalpha"
,"triiodothyronine and itsnuclear receptors","NN CC JJ NNS",4,1,1,17115080,"pubmed1",9.13E+018,"testalpha"
,"enzymes in helminths secretion","NNS IN NNS NN",4,1,1,16410836,"pubmed1",5.13E+018,"testalpha"
,"arterial phase mdct images","JJ NN  NNS",4,1,1,16333701,"pubmed1",8.33E+018,"testalpha"
,"d aspartic acid nmda"," JJ NN ",4,1,1,17133957,2,4.72E+018,"testalpha"
,"severe type vwd families","JJ NN  NNS",4,1,1,16424652,2,6.27E+018,"testalpha"
,"primocultures of rat hepatocytes","NNS IN NN NNS",4,1,1,16696445,2,5.38E+018,"testalpha"
,"enzymatic method while hdl","JJ NN IN ",4,1,1,16479026,2,8.91E+018,"testalpha"
,"differences in patient satisfaction","NNS IN NN NN",4,1,1,16436790,"pubmed1",3.72E+018,"testalpha"
,"connecting h lysines andarginines","VBG  NNS NNS",4,1,1,17019436,"pubmed1",7.36E+018,"testalpha"
,"solutions including explicit declaration","NNS VBG JJ NN",4,1,1,16399040,"pubmed1",2.33E+018,"testalpha"
,"conclusion cmlpatients in thailand","NN NNS IN NN",4,1,1,16914906,2,9.54E+017,"testalpha"
,"erythroblastoid cell lines kg","VB NN NNS ",4,1,1,17160143,"pubmed1",8.66E+018,"testalpha"
,"hypoglycaemic agents liver echogenicity","JJ NNS NN NN",4,1,1,16673610,2,5.60E+018,"testalpha"
,"hyperkeratosis and aggressive periodontitis","NN CC JJ NN",4,1,1,16585980,2,2.18E+018,"testalpha"
,"patients completed asecond pain","NNS VBN JJ NN",4,1,1,16436793,"pubmed1",4.67E+018,"testalpha"
,"ulcer appearing beforespecific ebv","NN VBG NNP ",4,1,1,16955191,2,3.18E+018,"testalpha"
,"great number of muscle","JJ NN IN NN",4,1,1,16893562,2,9.20E+018,"testalpha"
,"ast incubated ina medium"," VBN  NN",4,1,1,16696441,2,5.78E+018,"testalpha"
,"crash rates per kilometre","NN NNS IN NN",4,1,1,16426560,"pubmed1",9.33E+017,"testalpha"
,"stability concepts in ecology","NN NNS IN NN",4,1,1,16823610,"pubmed1",9.07E+018,"testalpha"
,"variable number of tandem","JJ NN IN NN",4,1,1,16733564,"pubmed1",8.44E+018,"testalpha"
,"future development of experimentaldesigns","NN NN IN NNS",4,1,1,17016038,2,3.65E+018,"testalpha"
,"specimens contained glass fibers","NNS VBD NN NNS",4,1,1,16701856,"pubmed1",5.39E+018,"testalpha"
,"staticinflation pressures from cm","NN NNS IN ",4,1,1,16399039,"pubmed1",3.38E+017,"testalpha"
,"title compound amino o","NN NN NNP ",4,1,1,16456292,2,4.58E+018,"testalpha"
,"trace elements copper zinc","VB NNS NN NN",4,1,1,17160142,"pubmed1",5.37E+018,"testalpha"
,"ventilation perfusion v q","NN NN  ",4,1,1,16451153,"pubmed1",4.20E+018,"testalpha"
,"numerous osteoclastlike multinucleated giant","JJ NN VBN NN",4,1,1,16514845,2,1.10E+018,"testalpha"
,"late endosomes and lysosomes","JJ NNS CC NNS",4,1,1,16365637,"pubmed1",8.97E+018,"testalpha"
,"hydrophobic interactions ofthe side","JJ NNS NNP NN",4,1,1,16365636,"pubmed1",1.96E+018,"testalpha"
,"sea urchin cell systems","NN IN NN NNS",4,1,1,16414103,2,1.11E+018,"testalpha"
,"fungal infections in children","JJ NNS IN NNS",4,1,1,16918061,"pubmed1",2.63E+018,"testalpha"
,"animal models of dhrs","NN NNS IN ",4,1,1,16594644,"pubmed1",2.59E+018,"testalpha"
,"knowledge of nf kappab","NN IN  ",4,1,1,17068636,"pubmed1",2.55E+018,"testalpha"
,"infection samples obtained monthafter","NN NNS VBN NN",4,1,1,16809889,2,5.57E+018,"testalpha"
,"immune escape oftumor cells","JJ VB NN NNS",4,1,1,17117211,"pubmed1",5.95E+018,"testalpha"
,"administrations of sme smme","NNS IN  ",4,1,1,16584167,"pubmed1",3.69E+017,"testalpha"
,"devices of biological origins","NNS IN JJ NNS",4,1,1,16999268,2,5.23E+018,"testalpha"
,"challenges forcongenital coagulation disorders","NNS NN NN NNS",4,1,1,16424651,2,4.73E+018,"testalpha"
,"management cm specialty examination","NN  NN NN",4,1,1,16438092,"pubmed1",3.91E+018,"testalpha"
,"cyclophosphamide tetrahydropyranyl adriamycin vincristine","VB NN NNP NN",4,1,1,17119328,2,3.33E+018,"testalpha"
,"inhibition of g pd","NN IN  ",4,1,1,17046053,2,5.65E+018,"testalpha"
,"cell migration proteases inflammation","NN NN NNS NN",4,1,1,16730054,2,8.63E+017,"testalpha"
,"containing scfa glutamine scfa","VBG  NN ",4,1,1,17293957,2,8.39E+018,"testalpha"
,"normal thyroid glands adenomas","JJ NN NNS NNP",4,1,1,16720036,2,4.69E+018,"testalpha"
,"homogenates of patientswho underwent","NNS IN  NN",4,1,1,16696441,2,4.68E+018,"testalpha"
,"taste andpotential side effects","NN JJ NN NNS",4,1,1,16252139,"pubmed1",4.17E+018,"testalpha"
,"acid desaturase named sk","NN NN VBN ",4,1,1,17063209,"pubmed1",9.11E+018,"testalpha"
,"case of amyloid disease","NN IN VB NN",4,1,1,16790262,2,9.16E+018,"testalpha"
,"acid isomerase from propionibacterium","NN NN IN NN",4,1,1,16511289,2,2.37E+018,"testalpha"
,"antigen presenting cells apcs","NN VBG NNS ",4,1,1,16733557,"pubmed1",1.92E+018,"testalpha"
,"retroviral vector pminv egfp","JJ NN  ",4,1,1,17160143,"pubmed1",2.95E+018,"testalpha"
,"routine culture on agar","JJ NN IN ",4,1,1,16710579,2,2.44E+018,"testalpha"
,"patients years of ageor","NNS NNS IN ",4,1,1,16436798,"pubmed1",2.17E+018,"testalpha"
,"double readings generated sensitivities","NN NNS VBN NNS",4,1,1,16399036,"pubmed1",1.34E+018,"testalpha"
,"nodular areas inthe right","JJ NNS NNP NN",4,1,1,16514851,2,7.50E+018,"testalpha"
,"vs control was p"," NN VBD ",4,1,1,17293963,2,7.43E+018,"testalpha"
,"invct and fine tremor"," CC JJ NN",4,1,1,16479025,2,6.36E+018,"testalpha"
,"seizure induced c fos","NN VBN NN ",4,1,1,17007911,2,2.45E+018,"testalpha"
,"level of therapeutic specificity","NN IN JJ NN",4,1,1,17285739,"pubmed1",1.17E+018,"testalpha"
,"intra patient randomized study","JJ NN VBN NN",4,1,1,16585985,2,8.36E+018,"testalpha"
,"bowel distention small bowel","NN NN JJ NN",4,1,1,16252139,"pubmed1",4.90E+018,"testalpha"
,"isolated cleft lip cl","VBN NN NN ",4,1,1,17165598,2,6.89E+018,"testalpha"
,"ions in human plasma"," IN JJ NNP",4,1,1,16511265,2,5.65E+018,"testalpha"
,"evokedneurotoxicity disturbances in methylation","NN NNS IN NN",4,1,1,17265692,2,2.36E+017,"testalpha"
,"biological sample and retainits","JJ NN CC NNS",4,1,1,16411737,"pubmed1",1.81E+017,"testalpha"
,"ottawa ankle rules oar","NNP NN NNS ",4,1,1,16436790,"pubmed1",8.80E+018,"testalpha"
,"involving brain tissue pathology","VBG NN NN NN",4,1,1,16436787,"pubmed1",1.26E+018,"testalpha"
,"cells priorto encapsulation min","NNS NNP NN ",4,1,1,16701853,"pubmed1",9.40E+017,"testalpha"
,"human epidermis and toinvestigate","JJ NN CC NN",4,1,1,16648912,2,5.47E+018,"testalpha"
,"attention under different task","NN IN JJ NN",4,1,1,16427019,"pubmed1",7.43E+018,"testalpha"
,"times betweencsav venom groups","NNS  NN NNS",4,1,1,16436788,"pubmed1",1.62E+018,"testalpha"
,"specific dermatological problemswith keratinization","JJ JJ NN NN",4,1,1,16574202,2,2.80E+018,"testalpha"
,"several human leukemia cells","JJ JJ NN NNS",4,1,1,16809887,2,8.05E+018,"testalpha"
,"azoxymethane aom group aom","NN  NN ",4,1,1,17293967,2,3.00E+018,"testalpha"
,"march convention available atwww","NN NN JJ ",4,1,1,17285738,"pubmed1",5.50E+018,"testalpha"
,"t cell subsetsinto allergen"," NN NNP NN",4,1,1,16603095,2,8.63E+017,"testalpha"
,"skin lesions in asubgroup","NN NNS IN NN",4,1,1,16648919,2,8.08E+017,"testalpha"
,"asignificant role in pah","JJ NN IN ",4,1,1,16404478,"pubmed1",2.81E+017,"testalpha"
,"driving force behind evolution","VBG NN IN NN",4,1,1,16988903,"pubmed1",1.63E+018,"testalpha"
,"disruption of nest building","NN IN NN NN",4,1,1,17265693,2,3.91E+018,"testalpha"
,"sensitivity of confidence interval","NN IN NN NN",4,1,1,16365333,"pubmed1",3.17E+018,"testalpha"
,"clearancethan is child pugh","NNP VBZ NN ",4,1,1,16584121,"pubmed1",4.00E+017,"testalpha"
,"hdac inhibitors and proteasome"," NNS CC NN",4,1,1,16424655,2,1.78E+018,"testalpha"
,"sample favoredwork hour restrictions","NN NN NN NNS",4,1,1,16377823,"pubmed1",4.77E+018,"testalpha"
,"fundamentals and new advances","NNS CC JJ NNS",4,1,1,16730054,2,8.09E+018,"testalpha"
,"rate in diabetic patients","NN IN JJ NNS",4,1,1,16989147,2,3.49E+018,"testalpha"
,"electroporation weattempted intramuscular transfer","NN VBN JJ NN",4,1,1,16388313,"pubmed1",3.61E+018,"testalpha"
,"following excision of basal","VBG NN IN NN",4,1,1,17165594,2,5.73E+018,"testalpha"
,"normal chest good results","JJ NN NN NNS",4,1,1,16956118,2,7.23E+018,"testalpha"
,"percent of tanzanian patients","NN IN JJ NNS",4,1,1,16874417,2,2.15E+018,"testalpha"
,"pure ad n male","JJ NN  NN",4,1,1,16859613,2,1.59E+018,"testalpha"
,"mechanisms of phenotypic realization","NNS IN NN NN",4,1,1,16733564,"pubmed1",5.35E+018,"testalpha"
,"nodes with pregranulomatoussinus histiocytosis","NNS IN NN NN",4,1,1,16256177,2,6.11E+018,"testalpha"
,"non productive painless cough"," JJ NN NN",4,1,1,16612936,"pubmed1",1.92E+018,"testalpha"
,"infusion of hes k","NN IN  ",4,1,1,17067137,"pubmed1",6.63E+018,"testalpha"
,"restriction fragment lengthpolymorphism analysis","NN NN NN NN",4,1,1,16733555,"pubmed1",6.21E+017,"testalpha"
,"cell tumor of bone","NN NN IN NN",4,1,1,16514850,2,6.94E+018,"testalpha"
,"skin grafts arealternative procedures","NN NNS JJ NNS",4,1,1,17165596,2,6.98E+018,"testalpha"
,"molecular models ofthe receptors","JJ NNS NNP NNS",4,1,1,16594640,"pubmed1",2.59E+018,"testalpha"
,"yjl c yjr c"," NN  NN",4,1,1,17146497,"pubmed1",7.26E+018,"testalpha"
,"ofmetalloproteinase timp in plasma","NN  IN NNP",4,1,1,16585983,2,2.58E+018,"testalpha"
,"intrachain interactions and thecontributions","VB NNS CC NNS",4,1,1,16411735,"pubmed1",2.02E+018,"testalpha"
,"secretion during exercise results","NN IN VB NNS",4,1,1,16921608,"pubmed1",2.97E+018,"testalpha"
,"erythrocyte sedimentation rateand c","NNP NN NN NN",4,1,1,16809889,2,8.38E+018,"testalpha"
,"patients achieved complete remissions","NNS VBN JJ NNS",4,1,1,16424645,2,4.32E+018,"testalpha"
,"assessment for mild tbiwhen","NN IN JJ NNP",4,1,1,16365331,"pubmed1",7.49E+018,"testalpha"
,"ad patients aged years","NN NNS VBN NNS",4,1,1,17328144,2,5.81E+018,"testalpha"
,"low molecular mass lysine","JJ JJ NN NN",4,1,1,16496039,"pubmed1",7.44E+018,"testalpha"
,"long lasting hours potentiationof","JJ VBG NNS ",4,1,1,16916186,"pubmed1",7.87E+018,"testalpha"
,"area severity index pasi","NN NN NN ",4,1,1,17311738,2,5.49E+018,"testalpha"
,"rhdv specific antibodies inrabbits"," JJ NNS NNS",4,1,1,16733562,"pubmed1",6.26E+018,"testalpha"
,"canprovide special interest doctors","VB JJ NN NNS",4,1,1,17139882,2,7.72E+018,"testalpha"
,"higher rates of hospital","JJR NNS IN NN",4,1,1,16462412,"pubmed1",8.06E+018,"testalpha"
,"missouri columbiaschool of medicine","NNP NN IN NN",4,1,1,16377828,"pubmed1",1.35E+018,"testalpha"
,"systemic expression inpsoriatic patients","JJ NN JJ NNS",4,1,1,16874421,2,7.91E+018,"testalpha"
,"selective liver ischemia andreperfusion","JJ NN NN NN",4,1,1,17013507,2,4.11E+018,"testalpha"
,"distilled water control group","VBN NN NN NN",4,1,1,17293970,2,8.68E+018,"testalpha"
,"carotid artery injection ofn"," NN NN ",4,1,1,17133957,2,6.81E+017,"testalpha"
,"reconstructed skin in burns","JJ NN IN NNS",4,1,1,16999269,2,3.90E+018,"testalpha"
,"planners designers and maintenance","NNS NNS CC NN",4,1,1,16054101,"pubmed1",5.38E+018,"testalpha"
,"cb associated protein cap"," VBN NN NN",4,1,1,16395520,"pubmed1",8.05E+018,"testalpha"
,"n and abnormal n"," CC JJ ",4,1,1,17019439,"pubmed1",8.95E+018,"testalpha"
,"caa with human p"," IN JJ ",4,1,1,16582987,"pubmed1",1.35E+018,"testalpha"
,"police under reporting problem","NN IN VBG NN",4,1,1,16430844,"pubmed1",3.67E+018,"testalpha"
,"hydrocortisoneand mg of dexchlorpheniramine","NN  IN NN",4,1,1,16451161,"pubmed1",2.66E+018,"testalpha"
,"death following cortical culture","NN VBG JJ NN",4,1,1,17265688,2,5.37E+018,"testalpha"
,"neutrophilicgroup e g folliculitis","NN   NN",4,1,1,17311739,2,5.78E+018,"testalpha"
,"committee rrc core competencies","NN  NN NNS",4,1,1,16473998,"pubmed1",5.94E+018,"testalpha"
,"weakpositivity for sialic acid","NN IN JJ NN",4,1,1,16720036,2,4.02E+018,"testalpha"
,"therapy oncology group toxicity","NN NN NN NN",4,1,1,17117605,2,6.37E+017,"testalpha"
,"sh domain ansh domain"," NN  NN",4,1,1,16511262,2,8.59E+018,"testalpha"
,"compensation data forthe period","NN NNS NNP NN",4,1,1,16043107,"pubmed1",8.41E+018,"testalpha"
,"sequestration between group pss","NN IN NN ",4,1,1,16491220,2,4.32E+018,"testalpha"
,"graduate medical education acgme","NN JJ NN ",4,1,1,16377812,"pubmed1",7.91E+017,"testalpha"
,"infrared ft ir raman","VBN   NN",4,1,1,16701876,"pubmed1",4.05E+018,"testalpha"
,"promote cell death majority","VB NN NN NN",4,1,1,16696437,2,8.54E+018,"testalpha"
,"shell of theterrestrial tortoise","NN IN JJ NN",4,1,1,16733064,2,1.91E+018,"testalpha"
,"bg or mg dl"," CC  ",4,1,1,16436794,"pubmed1",4.64E+018,"testalpha"
,"regression showed glycemic control","NN VBD JJ NN",4,1,1,16436794,"pubmed1",4.82E+018,"testalpha"
,"interval ci for patients","NN  IN NNS",4,1,1,16549894,2,3.06E+018,"testalpha"
,"structuredeterminations use synchrotron radiation","NNS VB NNP NN",4,1,1,16369089,2,3.40E+018,"testalpha"
,"changes in bax whichfacilitate","NNS IN  NN",4,1,1,16424655,2,6.80E+018,"testalpha"
,"identified fromgrapevine vitis amurensis","VBN NN NN NN",4,1,1,16395526,"pubmed1",2.57E+018,"testalpha"
,"year for empathic concern","NN IN JJ NN",4,1,1,16377826,"pubmed1",7.44E+018,"testalpha"
,"duringembryogenesis in various organs","NN IN JJ NNS",4,1,1,17265694,2,2.43E+017,"testalpha"
,"smme and sss werefound"," CC  NN",4,1,1,16584167,"pubmed1",9.03E+018,"testalpha"
,"screeningguidelines and breast cancer","NNS CC NN NN",4,1,1,16596895,"pubmed1",5.48E+018,"testalpha"
,"model proteins with mm","NN NNS IN ",4,1,1,16696441,2,9.35E+017,"testalpha"
,"fii fvii and fx","  CC ",4,1,1,16424651,2,7.85E+018,"testalpha"
,"reactive protein crp andhematocrit","JJ NN  NN",4,1,1,17119323,2,6.33E+018,"testalpha"
,"chaetopterus variopedatus spermh histone","NN NN  NN",4,1,1,17019436,"pubmed1",9.08E+018,"testalpha"
,"avariable distribution of pv","JJ NN IN ",4,1,1,17046052,2,2.07E+018,"testalpha"
,"improvedcognitive performance of emergency","JJ NN IN NN",4,1,1,16436796,"pubmed1",3.44E+018,"testalpha"
,"orthodontic treatment and stability","JJ NN CC NN",4,1,1,17438832,2,9.30E+015,"testalpha"
,"significant incidence in westernworld","JJ NN IN NN",4,1,1,16673565,2,4.97E+018,"testalpha"
,"visual analog scale vas","JJ NN NN ",4,1,1,16436793,"pubmed1",3.32E+018,"testalpha"
,"process of cell death","NN IN NN NN",4,1,1,16696437,2,4.33E+018,"testalpha"
,"coordination and reactivity pattern","NN CC NN NN",4,1,1,17117212,"pubmed1",5.07E+018,"testalpha"
,"drugs antibiotics diuretics retinoids","NNS NNS NNS NNS",4,1,1,17106603,2,3.60E+018,"testalpha"
,"h more brain areas"," JJR NN NNS",4,1,1,17133952,2,8.54E+018,"testalpha"
,"pancreatic duct peripancreatic vessels","JJ  JJ NNS",4,1,1,16333694,"pubmed1",8.88E+018,"testalpha"
,"summary of current postgraduate","NN IN JJ NN",4,1,1,16999271,2,7.05E+018,"testalpha"
,"published case control studies","VBN NN NN NNS",4,1,1,16417901,"pubmed1",3.48E+017,"testalpha"
,"mental healthcare increasing diversity","JJ NN VBG NN",4,1,1,16473988,"pubmed1",5.38E+018,"testalpha"
,"recognition of special situations","NN IN JJ NNS",4,1,1,16988904,"pubmed1",6.07E+018,"testalpha"
,"major histocompatibility complex mhc","JJ NN JJ ",4,1,1,16511266,2,8.42E+017,"testalpha"
,"receptor related protein lrp","NN VBN NN ",4,1,1,16965805,2,5.53E+018,"testalpha"
,"temperature low chamber pressure","NN JJ NN NN",4,1,1,17285744,"pubmed1",3.71E+018,"testalpha"
,"computed tomography and angiography","VBN NN CC NN",4,1,1,16612926,"pubmed1",5.19E+018,"testalpha"
,"reactions lacking alcohol oxidase","NNS VBG NN NN",4,1,1,17019438,"pubmed1",4.36E+016,"testalpha"
,"withhaematologic malignancies disseminated fusarium","JJ NNS VBN NN",4,1,1,16918066,"pubmed1",5.39E+018,"testalpha"
,"appropriate modifications of diet","JJ NNS IN NN",4,1,1,16921608,"pubmed1",4.90E+018,"testalpha"
,"matches andnonmatches confidence intervals","NNS NNS NN NNS",4,1,1,16365326,"pubmed1",5.41E+018,"testalpha"
,"nonacademic general surgery residency","JJ JJ NN NN",4,1,1,16377820,"pubmed1",1.68E+018,"testalpha"
,"woman with erythema gyratum","NN IN NN NN",4,1,1,16955192,2,7.44E+018,"testalpha"
,"levels andcreatine phosphokinase cpk","NNS NN NN ",4,1,1,17338197,2,4.65E+017,"testalpha"
,"postnatal maturation spontaneous exploration","NN NN JJ NN",4,1,1,16808045,"pubmed1",1.80E+018,"testalpha"
,"risk for road accidentinvolvement","NN IN NN NN",4,1,1,16443186,"pubmed1",7.94E+018,"testalpha"
,"proper analysisof periorbital anatomy","JJ  NN NN",4,1,1,17165595,2,7.63E+018,"testalpha"
,"existing evidence from animal","VBG NN IN NN",4,1,1,17370566,"pubmed1",6.44E+018,"testalpha"
,"genes or such phenomena","NNS CC JJ NNS",4,1,1,16505901,"pubmed1",6.21E+018,"testalpha"
,"mitochondrial katp channel blockers","JJ  NN NNS",4,1,1,16566960,2,7.89E+018,"testalpha"
,"concentration of mgi ml","NN IN  ",4,1,1,16399037,"pubmed1",8.89E+018,"testalpha"
,"asolvent based pan coating","NN VBN NN NN",4,1,1,17285748,"pubmed1",4.78E+017,"testalpha"
,"symptoms and associatedextrapulmonary manifestations","NNS CC JJ NNS",4,1,1,16696444,2,7.03E+018,"testalpha"
,"secondary outcomes were patientsatisfaction","JJ NNS VBD NN",4,1,1,16436790,"pubmed1",7.65E+018,"testalpha"
,"deposition inlymph node metastases","NN NN  NNS",4,1,1,16430945,2,5.44E+018,"testalpha"
,"unnecessary appendectomy of threepatients","JJ NN IN NNS",4,1,1,16612913,"pubmed1",8.57E+017,"testalpha"
,"abnormal blood lipid levels","JJ NN NN NNS",4,1,1,16462412,"pubmed1",3.88E+018,"testalpha"
,"assisted ventilation with bag","VBN NN IN NN",4,1,1,16365337,"pubmed1",8.22E+018,"testalpha"
,"rethrombosis or adverse events","NN CC JJ NNS",4,1,1,16549901,2,2.29E+018,"testalpha"
,"year old gravida para","NN JJ NNP ",4,1,1,16916187,"pubmed1",6.96E+018,"testalpha"
,"involve fibrous cap development","VBP JJ NN NN",4,1,1,17007910,2,8.90E+018,"testalpha"
,"heterogeneous hyperechogenicity on ultrasound","JJ NN IN NN",4,1,1,16314989,"pubmed1",1.53E+018,"testalpha"
,"sialyltransferase pm from pasteurella","NN  IN NNP",4,1,1,16511286,2,1.93E+018,"testalpha"
,"patients with unspecified ptcl","NNS IN JJ ",4,1,1,16914902,2,7.11E+018,"testalpha"
,"strand complementationmechanism of fiber","NN NN IN NN",4,1,1,16421447,2,6.11E+018,"testalpha"
,"age years completed thequestionnaires","NN NNS VBN NNS",4,1,1,16710574,2,4.91E+018,"testalpha"
,"virus infections inwestern countries","NN NNS JJ NNS",4,1,1,16511290,2,1.27E+018,"testalpha"
,"such forms of roadrage","JJ NNS IN NN",4,1,1,16434012,"pubmed1",1.99E+016,"testalpha"
,"extension of treated animals'lifespan","NN IN VBN NNP",4,1,1,16733559,"pubmed1",5.84E+018,"testalpha"
,"deduced pp fad protein","VBN  NN NN",4,1,1,17063209,"pubmed1",2.13E+018,"testalpha"
,"screening preventive measures training","NN JJ NNS NN",4,1,1,16438093,"pubmed1",1.14E+018,"testalpha"
,"high risk non hodgkinlymphomas","JJ NN  NNP",4,1,1,16424644,2,3.65E+018,"testalpha"
,"treatment of iron overload","NN IN NN NN",4,1,1,17117609,2,1.54E+018,"testalpha"
,"number of squamous cells","NN IN JJ NNS",4,1,1,16514841,2,5.90E+018,"testalpha"
,"d polylepsis venom injection"," NN NN NN",4,1,1,16436788,"pubmed1",8.93E+018,"testalpha"
,"network of departments ofdermatology","NN IN NNS NN",4,1,1,17106597,2,3.36E+018,"testalpha"
,"proliferation and renal effect","NN CC JJ NN",4,1,1,16479034,2,1.58E+018,"testalpha"
,"dose range from mg","NN NN IN ",4,1,1,16770447,"pubmed1",8.03E+018,"testalpha"
,"immunoreactivity in theconnective tissues","NN IN JJ NNS",4,1,1,17084885,2,7.09E+017,"testalpha"
,"people and other equipment","NNS CC JJ NN",4,1,1,16129405,"pubmed1",5.74E+018,"testalpha"
,"tert butyl oxidobenzyl n","   ",4,1,1,16456265,2,5.68E+018,"testalpha"
,"patients with small bowel","NNS IN JJ NN",4,1,1,16447095,"pubmed1",1.59E+018,"testalpha"
,"bile duct in patients","NN  IN NNS",4,1,1,16333694,"pubmed1",4.42E+018,"testalpha"
,"reducing edema normalizes ph","VBG NN VBZ ",4,1,1,17294912,2,1.96E+018,"testalpha"
,"levels ofmonitored nutritional parameters","NNS VBN JJ NNS",4,1,1,16999267,2,3.91E+018,"testalpha"
,"degree of spontaneous remyelination","NN IN JJ NN",4,1,1,16956113,2,2.94E+018,"testalpha"
,"lower deposition inlymph node","JJR NN NN ",4,1,1,16430945,2,4.55E+018,"testalpha"
,"azoxymethaneadministration aom n administration","NN   NN",4,1,1,17293962,2,4.59E+017,"testalpha"
,"neutropenia and mild thrombocytopenia","NNP CC JJ NNP",4,1,1,17119324,2,5.96E+018,"testalpha"
,"methylation processes and nmda","NN NNS CC ",4,1,1,17265692,2,9.02E+018,"testalpha"
,"earlier surveyof senior residents","JJR  JJ NNS",4,1,1,16399040,"pubmed1",2.78E+018,"testalpha"
,"h of atopy patch"," IN  NN",4,1,1,16648919,2,3.97E+018,"testalpha"
,"e g non steroidal","   NN",4,1,1,17106603,2,9.06E+018,"testalpha"
,"rats wistar males adult","NNS NN NNS NN",4,1,1,16491220,2,7.60E+018,"testalpha"
,"skin hydration studies inalbino","NN NN NNS NNP",4,1,1,17285742,"pubmed1",5.94E+018,"testalpha"
,"lucidum extract stimulated pi","NN VB VBN ",4,1,1,16964326,"pubmed1",2.30E+018,"testalpha"
,"changes and executive functioninpatients","NNS CC JJ NNS",4,1,1,16479025,2,6.22E+018,"testalpha"
,"potential biodistribution of sme","JJ NN IN ",4,1,1,16584167,"pubmed1",2.80E+018,"testalpha"
,"timeelectronic hand over form","JJ NN IN NN",4,1,1,16377191,"pubmed1",6.10E+018,"testalpha"
,"abscess incision and drainage","NN NN CC NN",4,1,1,16365337,"pubmed1",1.97E+018,"testalpha"
,"changed shape and distribution","VBN NN CC NN",4,1,1,17115079,"pubmed1",4.92E+018,"testalpha"
,"acid and sambucus nigra","NN CC NN NN",4,1,1,16720036,2,3.43E+018,"testalpha"
,"bowelsand need radical surgery","NN NN JJ NN",4,1,1,17139893,2,1.54E+018,"testalpha"
,"min of reperfusion i"," IN NN ",4,1,1,17293960,2,3.57E+018,"testalpha"
,"probiotics streptococcus thermophiluse lactobacillus","NNS NN IN NN",4,1,1,17293972,2,2.47E+018,"testalpha"
,"minimal forair dried microspheres","JJ NN VBD NNS",4,1,1,16594643,"pubmed1",8.57E+018,"testalpha"
,"prognosis of hemophagocytic syndrome","NN IN JJ NN",4,1,1,16914905,2,1.11E+018,"testalpha"
,"double blinded controlled experiments","NN VBN VBN NNS",4,1,1,17236636,"pubmed1",2.47E+018,"testalpha"
,"blot of cardiac protein","NN IN JJ NN",4,1,1,16365323,"pubmed1",7.75E+018,"testalpha"
,"mediatedinteractions i e communication","NNS   NN",4,1,1,16988903,"pubmed1",2.44E+018,"testalpha"
,"crashes among unbelted drivers","NNS IN VBN NNS",4,1,1,16236235,"pubmed1",4.73E+018,"testalpha"
,"andpolyadenylated human mitochondrial mrnas","VBN NN JJ NNP",4,1,1,16389406,"pubmed1",5.89E+018,"testalpha"
,"regeneration after partial hepatectomy","NN IN JJ NN",4,1,1,17013511,2,7.12E+018,"testalpha"
,"express transfected plasmid constructs","NN VBN JJ NNS",4,1,1,17119325,2,6.13E+017,"testalpha"
,"upper extremity digital arteries","JJ NN NN NNS",4,1,1,16696443,2,6.87E+018,"testalpha"
,"primary antibodyagainst collagen i","NN IN NN ",4,1,1,16574202,2,3.04E+018,"testalpha"
,"b patients demonstrated agood","NN NNS VBN NN",4,1,1,16424649,2,8.84E+018,"testalpha"
,"differences betweencaregivers and patients","NNS NNS CC NNS",4,1,1,16321533,"pubmed1",4.15E+018,"testalpha"
,"seconds after injection p","NNS IN NN ",4,1,1,16399037,"pubmed1",3.33E+018,"testalpha"
,"cd cd cd hla","   ",4,1,1,16733557,"pubmed1",3.87E+018,"testalpha"
,"plasma urine mouse liver","NNP NN NN NN",4,1,1,17285740,"pubmed1",1.00E+017,"testalpha"
,"class i mhc i","NN   ",4,1,1,16511250,2,2.71E+018,"testalpha"
,"children attribute meaning todepictions","NNS VBP NN NNS",4,1,1,16474001,"pubmed1",3.91E+018,"testalpha"
,"induced hypersensitivity reactions dhrs","VBN NN NNS ",4,1,1,16594644,"pubmed1",1.81E+018,"testalpha"
,"nonalcoholic fatty liver disease","JJ JJ NN NN",4,1,1,17013519,2,4.12E+018,"testalpha"
,"eosin h e masson","NNP   NN",4,1,1,16574202,2,7.01E+018,"testalpha"
,"system of atf activity","NN IN  NN",4,1,1,16395528,"pubmed1",1.47E+018,"testalpha"
,"role of satellite irna","NN IN NN ",4,1,1,16496041,"pubmed1",3.76E+018,"testalpha"
,"different osteoblastic cell activities","JJ JJ NN NNS",4,1,1,16701866,"pubmed1",4.49E+017,"testalpha"
,"grb like adaptor protein"," IN NN NN",4,1,1,16511262,2,5.33E+018,"testalpha"
,"days after thecaesarean section","NNS IN JJ NN",4,1,1,17067140,"pubmed1",6.68E+017,"testalpha"
,"solution containing polyethylene glycol","NN VBG NN NN",4,1,1,16447095,"pubmed1",5.50E+018,"testalpha"
,"deals with von willebrand","NNS IN  NN",4,1,1,16424651,2,9.11E+017,"testalpha"
,"week vacop b arm","NN NNP NN NN",4,1,1,16424644,2,1.86E+018,"testalpha"
,"b chronic lymphocytic leukemia","NN JJ JJ NN",4,1,1,16424654,2,1.97E+018,"testalpha"
,"efficientoxyfunctionalizations with high selectivity","NNS IN JJ NN",4,1,1,16411734,"pubmed1",5.78E+017,"testalpha"
,"data concerning patientswith congenital","NNS IN NN NN",4,1,1,16424651,2,8.57E+018,"testalpha"
,"assessment of pulmonary enhancement","NN IN JJ NN",4,1,1,16399029,"pubmed1",7.19E+018,"testalpha"
,"mortality rate unadjustedlogistic regression","NN NN JJ NN",4,1,1,16436794,"pubmed1",3.40E+018,"testalpha"
,"mmol l vs mg","   ",4,1,1,17438837,2,8.78E+018,"testalpha"
,"guinea pigileum and mouse","NNP NN CC NN",4,1,1,16496038,"pubmed1",8.28E+018,"testalpha"
,"fused hbt hydroxybenzoyl coa","VBN   ",4,1,1,16511283,2,6.88E+017,"testalpha"
,"length n using rho","NN  VBG ",4,1,1,16733558,"pubmed1",4.64E+018,"testalpha"
,"version of green fluorescent","NN IN JJ NN",4,1,1,16404477,"pubmed1",1.07E+018,"testalpha"
,"boysand girls mean age","NN NNS VBP NN",4,1,1,17106598,2,3.24E+017,"testalpha"
,"lacking lineage specific markers","VBG NN JJ NNS",4,1,1,16404477,"pubmed1",3.11E+018,"testalpha"
,"scientists in implementing thesemodels","NNS IN VBG NNS",4,1,1,16584115,"pubmed1",2.48E+018,"testalpha"
,"ef fractional shortening fs"," JJ VBG ",4,1,1,16989140,2,5.51E+018,"testalpha"
,"pudendal latency left branch","NN NN VBN NN",4,1,1,17139884,2,8.70E+018,"testalpha"
,"quiescentand proliferating human cd","NN VBG JJ ",4,1,1,16951739,"pubmed1",3.93E+018,"testalpha"
,"o multidetector row computedtomography"," NN VB NN",4,1,1,16399039,"pubmed1",2.27E+017,"testalpha"
,"drivers in different age","NNS IN JJ NN",4,1,1,16226211,"pubmed1",4.62E+018,"testalpha"
,"efforts in basic research","NNS IN JJ NN",4,1,1,16648910,2,1.18E+017,"testalpha"
,"ischemia induces enhanced locomotoractivity","NN NNS VBN NN",4,1,1,17265693,2,5.56E+018,"testalpha"
,"aspergillosis caused byaspergillus flavus","NN VBN NN ",4,1,1,17370567,"pubmed1",6.64E+018,"testalpha"
,"anacid caco molar ratio","NN  JJ NN",4,1,1,16594643,"pubmed1",9.75E+017,"testalpha"
,"cervical abnormalities and makerecommendations","JJ NNS CC NNS",4,1,1,16514839,2,6.57E+018,"testalpha"
,"tissue breast skin heart","NN NN NN NN",4,1,1,16514845,2,4.84E+018,"testalpha"
,"giant ulcero vegetative tumor","NN NNP JJ NN",4,1,1,16603102,2,5.09E+018,"testalpha"
,"history severity of malocclusionand","NN NN IN NN",4,1,1,16956115,2,1.36E+018,"testalpha"
,"rr using linear regression"," VBG JJ NN",4,1,1,16399035,"pubmed1",4.79E+018,"testalpha"
,"loss or nail plate","NN CC  NN",4,1,1,17165594,2,4.24E+018,"testalpha"
,"resolution with arefined rcryst","NN IN VBN NN",4,1,1,16511271,2,4.95E+018,"testalpha"
,"antiemetic efficacy of supplementaloxygen","JJ NN IN NN",4,1,1,16451147,"pubmed1",4.87E+018,"testalpha"
,"time todecannulation was days","NN NN VBD NNS",4,1,1,16451156,"pubmed1",5.91E+017,"testalpha"
,"fine tremor headache palpitation","JJ NN NN NN",4,1,1,16479025,2,4.30E+017,"testalpha"
,"phosphatidylcholine and stearoyl arachidonoylphosphatidylcholine","NN CC  NN",4,1,1,17128291,"pubmed1",1.55E+018,"testalpha"
,"visual analog scales vas","JJ NN NNS ",4,1,1,17688033,2,7.59E+018,"testalpha"
,"overall properties and problems","JJ NNS CC NNS",4,1,1,16594638,"pubmed1",7.69E+018,"testalpha"
,"csf administration in ku"," NN IN ",4,1,1,16809884,2,3.17E+018,"testalpha"
,"related health improvement methods","VBN NN NN NNS",4,1,1,16365327,"pubmed1",1.43E+018,"testalpha"
,"thisvaries by patient demographics","NNS IN NN NNS",4,1,1,16436792,"pubmed1",3.70E+018,"testalpha"
,"ischemic animals showed arestoration","JJ NNS VBD NN",4,1,1,17438835,2,2.84E+017,"testalpha"
,"forpatients with fatty liver","NNS IN JJ NN",4,1,1,16673555,2,8.32E+018,"testalpha"
,"ofdexamethasone suppression test acth","NN NN NN ",4,1,1,16603099,2,4.43E+018,"testalpha"
,"rat hearts identical pvimmunoreactivity","NN NNS JJ NN",4,1,1,17046052,2,6.40E+017,"testalpha"
,"cd on b cll"," IN NN ",4,1,1,16424654,2,8.63E+018,"testalpha"
,"kidneyhomogenates and human liver","NNS CC JJ NN",4,1,1,17285740,"pubmed1",2.62E+017,"testalpha"
,"match processbetween fellowship directors","NN IN NN NNS",4,1,1,16399040,"pubmed1",2.62E+018,"testalpha"
,"maximum release of fitc","JJ NN IN ",4,1,1,16701879,"pubmed1",3.03E+018,"testalpha"
,"p in stage iii"," IN NN ",4,1,1,17139895,2,2.69E+018,"testalpha"
,"loss of somethylakoid polypeptides","NN IN VB NNS",4,1,1,17106510,"pubmed1",5.12E+018,"testalpha"
,"underwent allogeneic stem celltransplantation","NN JJ VB NN",4,1,1,16914906,2,2.51E+018,"testalpha"
,"was added skin lesions","VBD VBN NN NNS",4,1,1,16955192,2,2.11E+018,"testalpha"
,"deltago deltaho and deltaso","NNP NNP CC ",4,1,1,17019442,"pubmed1",5.25E+018,"testalpha"
,"elements in imprint smears","NNS IN NN NNS",4,1,1,16514849,2,5.21E+018,"testalpha"
,"signaling protein protein kinase","VBG NN NN NN",4,1,1,16424642,2,8.66E+018,"testalpha"
,"comparative analysis oftssr sequence","JJ NN  NN",4,1,1,16733558,"pubmed1",4.20E+018,"testalpha"
,"regulation of gene expression","NN IN  NN",4,1,1,16505901,"pubmed1",3.66E+018,"testalpha"
,"year pgy residents p","NN  NNS ",4,1,1,16377825,"pubmed1",3.88E+018,"testalpha"
,"scoring system showed cases","VBG NN VBD NNS",4,1,1,16648915,2,4.32E+018,"testalpha"
,"model inidentifying provider staffing","NN VBG NN NN",4,1,1,16365329,"pubmed1",1.86E+018,"testalpha"
,"h after reaching conversion"," IN VBG NN",4,1,1,16970980,2,6.69E+018,"testalpha"
,"emergency department ed physician","NN NN VBD NN",4,1,1,16436789,"pubmed1",8.94E+018,"testalpha"
,"relative changes in genetranscription","JJ NNS IN NN",4,1,1,16733561,"pubmed1",3.49E+018,"testalpha"
,"structure in theeukaryotic cell","NN IN JJ NN",4,1,1,16410835,"pubmed1",3.62E+018,"testalpha"
,"binding data for oxygenation","VBG NNS IN NN",4,1,1,17019442,"pubmed1",7.26E+018,"testalpha"
,"evaluation of colour symmetry","NN IN JJ NN",4,1,1,16648914,2,6.25E+018,"testalpha"
,"was studied byzeta potential","VBD VBN NN NN",4,1,1,16584150,"pubmed1",7.09E+018,"testalpha"
,"employee health charts andcomputer","NN NN NNS NN",4,1,1,16438093,"pubmed1",4.02E+018,"testalpha"
,"indicators constitute comparable collectives","NNS VB JJ NNS",4,1,1,16988904,"pubmed1",2.53E+018,"testalpha"
,"plate let analyzer cpa","NN VBD NNP ",4,1,1,16549889,2,5.70E+018,"testalpha"
,"predetermined dose of joules","VBN NN IN NNS",4,1,1,17293969,2,1.10E+018,"testalpha"
,"drosophilasingle minded protein sim","NN VBN NN ",4,1,1,16411738,"pubmed1",2.84E+018,"testalpha"
,"range nature and urgency","NN NN CC NN",4,1,1,16321534,"pubmed1",7.74E+016,"testalpha"
,"city regions of windsor","NN NNS IN NN",4,1,1,16169506,"pubmed1",7.27E+018,"testalpha"
,"passenger trips through taipei","NN NNS IN NNP",4,1,1,16434013,"pubmed1",2.06E+018,"testalpha"
,"acetyl coa hydrolase cach","  NN ",4,1,1,16951743,"pubmed1",7.45E+018,"testalpha"
,"possibility of rat thymidylatesynthase","NN IN NN NN",4,1,1,16505899,"pubmed1",3.42E+018,"testalpha"
,"were victims of road","VBD NNS IN NN",4,1,1,16956123,2,1.40E+018,"testalpha"
,"phorbolmyristate acetate and h","NN NN CC ",4,1,1,17016035,2,5.72E+018,"testalpha"
,"model of residency research","NN IN NN NN",4,1,1,16473996,"pubmed1",6.75E+018,"testalpha"
,"incidence of ocular involvement","NN IN JJ NN",4,1,1,17106598,2,7.60E+018,"testalpha"
,"arterial phasegre images equilibrium","JJ  NNS NN",4,1,1,16317488,"pubmed1",8.48E+018,"testalpha"
,"theproportion of low frequencies","NN IN JJ NNS",4,1,1,17133954,2,4.49E+018,"testalpha"
,"fever of unknown origin","NN IN JJ NN",4,1,1,16918063,"pubmed1",6.93E+018,"testalpha"
,"function had significant difference","NN VBD JJ NN",4,1,1,16479025,2,6.90E+017,"testalpha"
,"gef dh ph tandem","   NN",4,1,1,17019437,"pubmed1",2.09E+018,"testalpha"
,"n and segmental enteritis"," CC NN NN",4,1,1,16447095,"pubmed1",5.02E+018,"testalpha"
,"aspects of driving performance","NNS IN VBG NN",4,1,1,16226211,"pubmed1",9.21E+018,"testalpha"
,"does notaffect that reaction","VBZ NN IN NN",4,1,1,17133955,2,3.70E+018,"testalpha"
,"measures arthritis disease activity","NNS NN NN NN",4,1,1,17311738,2,6.22E+018,"testalpha"
,"fusion protein was constructedand","NN NN VBD NN",4,1,1,17117211,"pubmed1",7.97E+018,"testalpha"
,"accident and personal characteristics","NN CC JJ NNS",4,1,1,16434013,"pubmed1",2.08E+018,"testalpha"
,"bottleneck for high throughput","NN IN JJ NN",4,1,1,16421450,2,8.71E+018,"testalpha"
,"subcortical white matter ofthe","JJ JJ NN NNP",4,1,1,16399034,"pubmed1",6.95E+018,"testalpha"
,"urolithiasis n and nephrocalcinosis","NN  CC NN",4,1,1,16956119,2,3.95E+018,"testalpha"
,"interpretation andadvance emergency department","NN NN NN NN",4,1,1,16365334,"pubmed1",2.92E+017,"testalpha"
,"serum than inthe control","NN IN NNP NN",4,1,1,16764913,2,4.82E+017,"testalpha"
,"largest bilateral adrenal myelolipomas","JJT JJ NN NNP",4,1,1,16245020,"pubmed1",1.57E+017,"testalpha"
,"tumor type and cases","NN NN CC NNS",4,1,1,16899283,2,7.15E+018,"testalpha"
,"radiology gastrointestinal endoscopy correlation","NN JJ  NN",4,1,1,16399038,"pubmed1",8.94E+018,"testalpha"
,"increased production of ige","VBN NN IN ",4,1,1,16603096,2,3.29E+016,"testalpha"
,"growth of neural nerve","NN IN JJ NN",4,1,1,17010267,2,1.74E+018,"testalpha"
,"patients with hps male","NNS IN  NN",4,1,1,16914905,2,6.07E+018,"testalpha"
,"headache palpitation nervousness forgetfulness","NN NN NN NN",4,1,1,16479025,2,5.53E+018,"testalpha"
,"enzyme in trna biogenesis"," IN  NN",4,1,1,16648912,2,1.21E+018,"testalpha"
,"processesincluding cytokinasis vesicle trafficking","VBG NN NN NN",4,1,1,16511282,2,3.93E+017,"testalpha"
,"atopic dermatitis face involvement","NN NN NN NN",4,1,1,17106598,2,6.59E+018,"testalpha"
,"quantify theinfluence of deployment","VB NN IN NN",4,1,1,16405857,"pubmed1",7.16E+017,"testalpha"
,"results in year survival","NNS IN NN NN",4,1,1,17139885,2,5.24E+017,"testalpha"
,"basic hypotheses of dhrs","JJ NNS IN ",4,1,1,16594644,"pubmed1",6.72E+018,"testalpha"
,"includemeans percentages and t","NNS NNS CC ",4,1,1,16377820,"pubmed1",6.85E+018,"testalpha"
,"effects on sinusoidal microcirculation","NNS IN NN NN",4,1,1,17013514,2,7.79E+017,"testalpha"
,"using ahigh resolution lattice","VBG VB NN NN",4,1,1,16365636,"pubmed1",8.77E+018,"testalpha"
,"ordering clinical pathway intervention","VBG JJ NN NN",4,1,1,16436790,"pubmed1",3.69E+018,"testalpha"
,"treatment affected stromal regulation","NN VBN JJ NN",4,1,1,17016038,2,8.94E+018,"testalpha"
,"ribeirao preto facultyof medicine","   NN",4,1,1,17013504,2,3.79E+018,"testalpha"
,"pathohistology conclusion adequate diagnosis","NN NN JJ NN",4,1,1,17338203,2,4.20E+018,"testalpha"
,"large number of patients","JJ NN IN NNS",4,1,1,16400088,"pubmed1",3.37E+018,"testalpha"
,"synthesis and processing ofdioxygen","NN CC NN NN",4,1,1,17143336,"pubmed1",2.20E+018,"testalpha"
,"cells allows rapid mass","NNS VBZ JJ NN",4,1,1,16414103,2,5.96E+017,"testalpha"
,"years with patients theauthors","NNS IN NNS NNS",4,1,1,16722344,2,3.43E+018,"testalpha"
,"inducing substance achieved abetter","VBG NN VBN NN",4,1,1,17293969,2,7.79E+018,"testalpha"
,"local reactions at injection","JJ NNS IN NN",4,1,1,17106600,2,7.84E+018,"testalpha"
,"theimprovement of psoriatic arthritis","NN IN JJ NN",4,1,1,17311738,2,8.16E+018,"testalpha"
,"longitudinal study of pulmonaryfunction","JJ NN IN NN",4,1,1,16809886,2,6.50E+018,"testalpha"
,"nadh ubiquinone oxidoreductase succinate"," NN NN NN",4,1,1,17068635,"pubmed1",2.78E+018,"testalpha"
,"ofneutrophils sequestration in interstitium","NNS NN IN NN",4,1,1,16491220,2,6.06E+018,"testalpha"
,"having anextracellular sema domain","VBG JJ  NN",4,1,1,16369100,2,2.60E+018,"testalpha"
,"dose of mg kg","NN IN  ",4,1,1,16424649,2,2.33E+018,"testalpha"
,"proposal for such reform","NN IN JJ NN",4,1,1,16770860,"pubmed1",3.92E+018,"testalpha"
,"woman underwent tracheal resection","NN NN NN NN",4,1,1,16612923,"pubmed1",2.15E+017,"testalpha"
,"serum or blood samples","NN CC NN NNS",4,1,1,16714050,2,2.83E+017,"testalpha"
,"current views on melanogenesis","JJ NNS IN NN",4,1,1,16951740,"pubmed1",9.21E+018,"testalpha"
,"miscellaneous findings included case","JJ NNS VBD NN",4,1,1,16514841,2,7.20E+018,"testalpha"
,"originating fromsatellite i dna","VBG JJ  ",4,1,1,16496041,"pubmed1",6.35E+018,"testalpha"
,"drug and infliximab allowingbetter","NN CC  NN",4,1,1,16673554,2,5.79E+017,"testalpha"
,"cement system and theeffect","NN NN CC NN",4,1,1,16701863,"pubmed1",3.00E+018,"testalpha"
,"new council of experts","JJ NN IN NNS",4,1,1,17285738,"pubmed1",4.80E+018,"testalpha"
,"authors verified external anal","NNS VBN JJ ",4,1,1,17139884,2,3.01E+018,"testalpha"
,"subsequent liposomal amphotericinb therapy","JJ JJ  NN",4,1,1,16918062,"pubmed1",1.57E+018,"testalpha"
,"interpretation of positive reactions","NN IN JJ NNS",4,1,1,16874422,2,5.89E+017,"testalpha"
,"pcr technique andthe protein"," NN NNP NN",4,1,1,16511262,2,4.10E+018,"testalpha"
,"b binding protein c","NN VBG NN NN",4,1,1,16964325,"pubmed1",4.32E+018,"testalpha"
,"forcardiovascular morbidity and mortality","JJ NN CC NN",4,1,1,16462412,"pubmed1",9.20E+018,"testalpha"
,"be reduced ifcenterline rumble","VB VBN NN NN",4,1,1,16423319,"pubmed1",5.18E+018,"testalpha"
,"evoked strong calcium signal","VBD JJ NN NN",4,1,1,17115079,"pubmed1",1.16E+018,"testalpha"
,"large numbers of incidents","JJ NNS IN NNS",4,1,1,16321534,"pubmed1",4.70E+018,"testalpha"
,"bi directionalinduction in decision"," NN IN NN",4,1,1,16426557,"pubmed1",8.57E+017,"testalpha"
,"resin andutilizing milled acp","NNP VBG VBN ",4,1,1,16701862,"pubmed1",4.12E+017,"testalpha"
,"normal forthe ac pc","JJ NNP  ",4,1,1,16399030,"pubmed1",6.23E+018,"testalpha"
,"intake whichindicates cross sensitivity","NN NNS VBP NN",4,1,1,16710584,2,1.41E+018,"testalpha"
,"possibility of ifs cb","NN IN  ",4,1,1,16514842,2,7.43E+016,"testalpha"
,"tissue shows bettermechanical properties","NN NNS JJ NNS",4,1,1,16701880,"pubmed1",1.65E+018,"testalpha"
,"impact of non recurringcongestion","NN IN  NN",4,1,1,16426557,"pubmed1",6.04E+018,"testalpha"
,"patients requiring majoramputations patients","NNS VBG NNS NNS",4,1,1,16612914,"pubmed1",1.73E+018,"testalpha"
,"ramppresence and median barrier","NN CC JJ NN",4,1,1,16442487,"pubmed1",8.80E+018,"testalpha"
,"differences between bupivacaineand ropivacaine","NNS IN NN NN",4,1,1,16617757,"pubmed1",2.83E+018,"testalpha"
,"aright irreducible inguinal hernia","NN JJ JJ NNP",4,1,1,16612933,"pubmed1",7.80E+018,"testalpha"
,"hourrequirements without compromising patient","NNS IN VBG NN",4,1,1,16377824,"pubmed1",2.97E+018,"testalpha"
,"mivacurium propofol and remifentanil","NN  CC ",4,1,1,17236637,"pubmed1",5.96E+018,"testalpha"
,"effect of formulation parameters","NN IN NN NNS",4,1,1,17285750,"pubmed1",4.85E+018,"testalpha"
,"anon selected ad patient"," VBN NN NN",4,1,1,16648913,2,4.36E+017,"testalpha"
,"increased iron absorption i","JJ NN NN ",4,1,1,17119325,2,6.68E+018,"testalpha"
,"cytological evaluation revealed casesof","JJ NN VBD ",4,1,1,17139883,2,3.11E+018,"testalpha"
,"confirmed vlp or vls","VBN  CC ",4,1,1,16955190,2,5.05E+018,"testalpha"
,"longinterstimulus interval ax trials","NN NN NN NNS",4,1,1,16436796,"pubmed1",3.11E+018,"testalpha"
,"d of hypoxia fas"," IN  ",4,1,1,16395522,"pubmed1",4.84E+018,"testalpha"
,"severe problem in china","JJ NN IN NN",4,1,1,16061188,"pubmed1",6.25E+018,"testalpha"
,"safety climate i e","NN NN  ",4,1,1,16442068,"pubmed1",4.65E+018,"testalpha"
,"episode of hemorrhagic shock","NN IN JJ NN",4,1,1,16365323,"pubmed1",2.56E+018,"testalpha"
,"physicianevaluation for twisting ankle","NN IN VBG NN",4,1,1,16436790,"pubmed1",9.05E+017,"testalpha"
,"inflammatorymediators attracting inflammatory cells","NNS VBG JJ NNS",4,1,1,16983449,2,7.81E+018,"testalpha"
,"overall theheterozygosity rate i","JJ NN NN ",4,1,1,16424652,2,4.53E+018,"testalpha"
,"atwo compartment open model"," NN JJ NN",4,1,1,17067137,"pubmed1",1.70E+018,"testalpha"
,"agood response pc k","NN NN  ",4,1,1,16424649,2,8.11E+018,"testalpha"
,"treatment of primary b","NN IN JJ NN",4,1,1,17143339,"pubmed1",5.47E+018,"testalpha"
,"delta fatty aciddesaturase gene","NN JJ NN ",4,1,1,17063209,"pubmed1",1.99E+018,"testalpha"
,"inhibited scaffold degradation ina","VBN JJ NN ",4,1,1,16701855,"pubmed1",7.46E+018,"testalpha"
,"re offense for dispparticipants"," NN IN NNS",4,1,1,16202465,"pubmed1",4.81E+017,"testalpha"
,"positive correlation with serum","JJ NN IN NN",4,1,1,16673610,2,9.05E+018,"testalpha"
,"dependent gsh peroxidase gsh","JJ  NN ",4,1,1,16404476,"pubmed1",6.52E+018,"testalpha"
,"revealed anovel catalytic mechanism","VBD NN JJ NN",4,1,1,16421444,2,1.04E+018,"testalpha"
,"increased work and stress","VBN NN CC NN",4,1,1,16377820,"pubmed1",8.06E+018,"testalpha"
,"response inflammation proliferation apoptosis","NN NN NN NN",4,1,1,17068636,"pubmed1",8.87E+018,"testalpha"
,"safety profile of therapy","VB NN IN NN",4,1,1,17133953,2,2.27E+018,"testalpha"
,"induced changes in renaltissue","VBN NNS IN NN",4,1,1,16999986,2,4.64E+018,"testalpha"
,"cases with overlapping features","NNS IN VBG NNS",4,1,1,17311737,2,8.25E+018,"testalpha"
,"exon of hmsh gene"," IN  ",4,1,1,17139886,2,6.59E+018,"testalpha"
,"institutional review board approval","JJ NN NN NN",4,1,1,16377815,"pubmed1",4.13E+018,"testalpha"
,"sh domain ofgads gads"," NN NNS ",4,1,1,16511262,2,6.50E+018,"testalpha"
,"ofcox inhibitors following pboo"," NNS VBG ",4,1,1,16253314,2,1.94E+018,"testalpha"
,"experience personality and skill","NN NN CC NN",4,1,1,16443186,"pubmed1",3.28E+018,"testalpha"
,"dose sequential chemotherapy hds","NN JJ NN ",4,1,1,16424644,2,2.15E+018,"testalpha"
,"cd cells in tumor"," NNS IN NN",4,1,1,16951739,"pubmed1",2.12E+018,"testalpha"
,"adversebiobehavioral outcomes following abuse","JJ NNS VBG NN",4,1,1,16808045,"pubmed1",3.82E+018,"testalpha"
,"paramecium by pcr amplification","NN IN  NN",4,1,1,16365637,"pubmed1",1.85E+018,"testalpha"
,"relevant cardiovascularand respiratory events","JJ NN NN NNS",4,1,1,16365337,"pubmed1",4.79E+017,"testalpha"
,"band of dermal sclerosis","NN IN JJ NN",4,1,1,17311737,2,5.08E+018,"testalpha"
,"period of assisted ventilation","NN IN VBN NN",4,1,1,16365337,"pubmed1",8.87E+018,"testalpha"
,"ii extradiol cleaving catecholicdioxygenases","  VBG NNS",4,1,1,16511281,2,6.73E+018,"testalpha"
,"rats underwent laparotomy toperform","NNS NN NN NN",4,1,1,17293970,2,6.33E+018,"testalpha"
,"incidence of lane departures","NN IN NN NNS",4,1,1,16423319,"pubmed1",5.61E+017,"testalpha"
,"genes in several cancer","NNS IN JJ NN",4,1,1,17143338,"pubmed1",2.38E+018,"testalpha"
,"cases with paraphenylenediamine poisoning","NNS IN NN NN",4,1,1,16700150,2,5.25E+018,"testalpha"
,"inthe aetiology of acne","NNP NN IN ",4,1,1,16874416,2,4.72E+018,"testalpha"
,"complication after restorative rectal","NN IN JJ NN",4,1,1,17139896,2,6.17E+018,"testalpha"
,"curves at coronary ebt","NNS IN JJ ",4,1,1,16399037,"pubmed1",6.38E+017,"testalpha"
,"patients undergoing gynaecologicallaparoscopic day","NNS VBG NN NN",4,1,1,16451148,"pubmed1",5.05E+018,"testalpha"
,"costimulatorymolecules and increase antigen","NNS CC VB NN",4,1,1,16733557,"pubmed1",6.47E+018,"testalpha"
,"oral manifestations of systemicdiseases","JJ NNS IN NNS",4,1,1,17010270,2,3.46E+017,"testalpha"
,"clinical improvement low riskof","JJ NN JJ ",4,1,1,16859612,2,3.74E+018,"testalpha"
,"spirituality onhealth risk behavior","NN NN NN NN",4,1,1,16596897,"pubmed1",1.03E+018,"testalpha"
,"education program directors acknowledgeits","NN NN NNS NNS",4,1,1,16473995,"pubmed1",9.07E+018,"testalpha"
,"vivo in untreated acne"," IN JJ ",4,1,1,16874416,2,8.92E+018,"testalpha"
,"indication in high riskpatients","NN IN JJ NNS",4,1,1,17013518,2,8.48E+018,"testalpha"
,"cs endometrial stromal sarcomas"," JJ JJ NNP",4,1,1,17338203,2,7.09E+017,"testalpha"
,"desflurane or sevoflurane orpropofol","NN CC NN ",4,1,1,16916184,"pubmed1",8.25E+018,"testalpha"
,"ofso called antioxidant enzymes"," VBN JJ NNS",4,1,1,17063208,"pubmed1",6.64E+018,"testalpha"
,"maintenance of regularphysical activity","NN IN JJ NN",4,1,1,16921608,"pubmed1",8.88E+018,"testalpha"
,"risk for ponv pain","NN IN  NN",4,1,1,16451147,"pubmed1",1.91E+018,"testalpha"
,"immunohistochemical determination oflymph node","JJ NN NN ",4,1,1,16256177,2,6.38E+018,"testalpha"
,"region with moderate intensities","NN IN JJ NNS",4,1,1,16949651,2,5.39E+018,"testalpha"
,"resorbable polycaprolactone surface coating","JJ NN NN NN",4,1,1,16701863,"pubmed1",8.11E+018,"testalpha"
,"amideand non resorbable bis","NN  JJ ",4,1,1,16701856,"pubmed1",4.90E+017,"testalpha"
,"ak adenosine amp pcp"," NN  ",4,1,1,16421444,2,1.03E+018,"testalpha"
,"had drug induced thrombocytopenia","VBN NN VBN NNP",4,1,1,16809885,2,7.77E+018,"testalpha"
,"extract stimulated pi kinase","VB VBN  NN",4,1,1,16964326,"pubmed1",1.43E+018,"testalpha"
,"significant alteration in cell","JJ NN IN NN",4,1,1,16491217,2,5.40E+018,"testalpha"
,"associated withdecreased survival rates","VBN VBN NN NNS",4,1,1,16451146,"pubmed1",2.10E+018,"testalpha"
,"lymph node or distantmetastases","NN  CC NNS",4,1,1,16603102,2,9.30E+017,"testalpha"
,"report questionnaires from crash","NN NNS IN NN",4,1,1,16054104,"pubmed1",3.71E+018,"testalpha"
,"analysis insolution d dmso","NN NN  ",4,1,1,16496039,"pubmed1",4.83E+018,"testalpha"
,"age was year range","NN VBD NN NN",4,1,1,17139879,2,7.23E+018,"testalpha"
,"stated thatthey had atopic","VBD NNP VBD NN",4,1,1,16648913,2,3.75E+018,"testalpha"
,"magnify temperature heterogeneity mtm","VB NN NN ",4,1,1,17285744,"pubmed1",8.70E+018,"testalpha"
,"alt and ast activities"," CC  NNS",4,1,1,16696441,2,5.68E+018,"testalpha"
,"expression throughcomputer assisted image","NN NN VBN NN",4,1,1,17293967,2,2.42E+018,"testalpha"
,"sulfonate ans and dansyl","NN  CC ",4,1,1,16714053,2,3.64E+018,"testalpha"
,"initial setting time h","JJ VBG NN ",4,1,1,16701865,"pubmed1",8.64E+018,"testalpha"
,"non ssri exposedfull term","  NN NN",4,1,1,16549890,2,4.38E+018,"testalpha"
,"industrial production of proteins","JJ NN IN NNS",4,1,1,16582986,"pubmed1",1.91E+018,"testalpha"
,"released injune next year","VBN NN JJ NN",4,1,1,17010274,2,7.15E+018,"testalpha"
,"dexamethasone provided significantsymptomatic protection","NN VBD JJ NN",4,1,1,17007911,2,6.77E+018,"testalpha"
,"toxic reactivespecies and consequent","JJ NNS CC NN",4,1,1,16808044,"pubmed1",2.41E+018,"testalpha"
,"model for themixed valence","NN IN VBN NN",4,1,1,16456265,2,8.75E+018,"testalpha"
,"disparities in mental healthcare","NNS IN JJ NN",4,1,1,16473988,"pubmed1",3.71E+018,"testalpha"
,"hypoxia induced lung damage"," VBN NN NN",4,1,1,16537087,2,7.00E+018,"testalpha"
,"volume growing vg method","NN VBG  NN",4,1,1,16399033,"pubmed1",3.35E+018,"testalpha"
,"peptides by re engineering","NNS IN  NN",4,1,1,16411739,"pubmed1",3.12E+016,"testalpha"
,"examine select risk factors","VB JJ NN NNS",4,1,1,16438093,"pubmed1",2.84E+018,"testalpha"
,"fall of arterialblood pressure","NN IN NN NN",4,1,1,16612920,"pubmed1",8.44E+018,"testalpha"
,"ameliorate immunoprotection of alginatemicrocapsules","NN NN IN NNS",4,1,1,16701881,"pubmed1",1.61E+018,"testalpha"
,"brain injury among bicyclistswho","NN NN IN ",4,1,1,16417901,"pubmed1",2.99E+018,"testalpha"
,"human factors in consumer","JJ NNS IN NN",4,1,1,16434013,"pubmed1",4.53E+018,"testalpha"
,"number of antiviral lectins","NN IN JJ NNS",4,1,1,17128290,"pubmed1",4.19E+018,"testalpha"
,"microscopy stromal collagen fibers"," JJ NN NNS",4,1,1,16899283,2,3.20E+017,"testalpha"
,"calcification in asubcutaneous rat","NN IN JJ NN",4,1,1,16701880,"pubmed1",3.53E+018,"testalpha"
,"ear acupuncture by objective","NN NN IN NN",4,1,1,16955182,2,1.48E+018,"testalpha"
,"respiratory mechanics and gas","NN NNS CC NN",4,1,1,16451155,"pubmed1",7.58E+018,"testalpha"
,"ofcomplications of liver disease","NNS IN NN NN",4,1,1,17013506,2,6.81E+018,"testalpha"
,"progression free survival pfs","NN JJ NN ",4,1,1,16424643,2,9.12E+018,"testalpha"
,"authors encourage physicians healthcare","NNS VB NNS NN",4,1,1,16365322,"pubmed1",7.10E+017,"testalpha"
,"leiden mutation inone case","JJ NN NN NN",4,1,1,16696443,2,6.06E+018,"testalpha"
,"preventing new skin lesions","VBG JJ NN NNS",4,1,1,16585985,2,1.84E+018,"testalpha"
,"diseases presented withhigher mean","NNS VBN JJ NN",4,1,1,16859611,2,3.29E+018,"testalpha"
,"using affinity and ion","VBG NN CC ",4,1,1,16511253,2,3.95E+017,"testalpha"
,"levels in u cells","NNS IN  NNS",4,1,1,17128291,"pubmed1",8.24E+018,"testalpha"
,"immunoproliferative small intestinaldisease n","JJ JJ NN ",4,1,1,16447095,"pubmed1",6.04E+018,"testalpha"
,"certain environmental carcinogens e","JJ JJ NNS ",4,1,1,16582987,"pubmed1",8.54E+018,"testalpha"
,"ligand on t cells","NN IN  NNS",4,1,1,17016035,2,5.99E+016,"testalpha"
,"value and negative predictivevalue","NN CC NN NN",4,1,1,16514835,2,8.89E+018,"testalpha"
,"antibiotics fluid resuscitation mechanicalventilation","NNS NN NN NN",4,1,1,16365336,"pubmed1",8.06E+018,"testalpha"
,"postoperative analgesiaafter caesarean delivery","JJ NN JJ NN",4,1,1,16617755,"pubmed1",3.28E+018,"testalpha"
,"biaxialflexure strength bfs degree","NN NN  NN",4,1,1,16701862,"pubmed1",7.08E+018,"testalpha"
,"homogenous good agreement betweenmtm","JJ JJ NN ",4,1,1,17285744,"pubmed1",6.51E+018,"testalpha"
,"mean size ofinserted valve","JJ NN VBN NN",4,1,1,16989140,2,5.83E+017,"testalpha"
,"dose of joules cm","NN IN NNS ",4,1,1,17293969,2,7.03E+018,"testalpha"
,"surgical treatment of basal","JJ NN IN NN",4,1,1,17165596,2,8.22E+018,"testalpha"
,"held mobile phone use","VBN JJ NN NN",4,1,1,16157285,"pubmed1",5.69E+018,"testalpha"
,"c overexpression of growth","NN NN IN NN",4,1,1,16479030,2,2.09E+018,"testalpha"
,"database and make recommendations","NN CC VB NNS",4,1,1,16321534,"pubmed1",4.30E+018,"testalpha"
,"volume densities in tsh","NN NNS IN ",4,1,1,16714054,2,1.22E+018,"testalpha"
,"mediated lysine arginine interactions","VBN NN NN NNS",4,1,1,17019436,"pubmed1",2.99E+017,"testalpha"
,"haemoglobin and haematocrit levels","NNP CC NN NNS",4,1,1,16809888,2,7.24E+018,"testalpha"
,"poverty level higher percentage","NN NN JJR NN",4,1,1,16451795,"pubmed1",1.39E+018,"testalpha"
,"use of restraint systems","NN IN NN NNS",4,1,1,16426561,"pubmed1",4.86E+018,"testalpha"
,"condition for product reimbursement","NN IN NN NN",4,1,1,16999268,2,3.13E+018,"testalpha"
,"constipation but takes underconsideration","NN CC VBZ NN",4,1,1,17139889,2,2.69E+017,"testalpha"
,"c n c c","NN  NN NN",4,1,1,16456282,2,3.38E+018,"testalpha"
,"i and ii cd"," CC  ",4,1,1,16733557,"pubmed1",4.89E+018,"testalpha"
,"ability to attract attention","NN IN VB NN",4,1,1,16427019,"pubmed1",4.08E+018,"testalpha"
,"number of case reportsare","NN IN NN NN",4,1,1,16983449,2,8.83E+018,"testalpha"
,"total leukocytes and neutrophilscounts","JJ NNS CC NNS",4,1,1,17293958,2,2.20E+018,"testalpha"
,"use and costs oficus","NN CC NNS NN",4,1,1,16451154,"pubmed1",2.94E+018,"testalpha"
,"cells infused correlated withthe","NNS VBN VBN NNP",4,1,1,17119322,2,7.66E+018,"testalpha"
,"patients with early disease","NNS IN JJ NN",4,1,1,17117604,2,3.79E+018,"testalpha"
,"deposition of durapatite roughness","NN IN JJ NN",4,1,1,17293968,2,2.17E+018,"testalpha"
,"forthe treatment of hemangiomas","NNP NN IN NNP",4,1,1,16722347,2,2.66E+017,"testalpha"
,"foreign body giant cells","JJ NN NN NNS",4,1,1,16514850,2,8.47E+017,"testalpha"
,"changes inobserved seat belt","NNS VBN NN NN",4,1,1,16236235,"pubmed1",5.54E+017,"testalpha"
,"institute for occupational safety","NN IN JJ NN",4,1,1,16129405,"pubmed1",1.20E+017,"testalpha"
,"way of identifyingapoptotic cells","NN IN JJ NNS",4,1,1,16395525,"pubmed1",3.10E+018,"testalpha"
,"transoid conformation with respect","VB NN IN NN",4,1,1,16456295,2,8.20E+018,"testalpha"
,"frequency ofmonoclonal gammopathies occurrence","NN JJ NNS NN",4,1,1,16956121,2,8.46E+018,"testalpha"
,"structural integrity but influences","JJ NN CC NNS",4,1,1,16733556,"pubmed1",5.04E+018,"testalpha"
,"account for fewer admission","NN IN JJR NN",4,1,1,16462404,"pubmed1",8.13E+018,"testalpha"
,"waist circumference triglycerides whr","NN NN NNS ",4,1,1,16673610,2,2.04E+018,"testalpha"
,"earlyclinical experience l amb","JJ NN  ",4,1,1,17370566,"pubmed1",7.99E+018,"testalpha"
,"thepresence of polymerase inhibitors","NN IN NN NNS",4,1,1,17019440,"pubmed1",6.05E+017,"testalpha"
,"positive cells with pminv","JJ NNS IN ",4,1,1,17160143,"pubmed1",8.05E+018,"testalpha"
,"reinforcementwith oral iron therapy","NN JJ NN NN",4,1,1,16809890,2,1.20E+018,"testalpha"
,"therapy withlow dose cytosine","NN VB NN NN",4,1,1,16914909,2,7.45E+018,"testalpha"
,"suggestmanagement by applying dressings","NN IN VBG NNS",4,1,1,16696446,2,7.08E+017,"testalpha"
,"was months in patients","VBD NNS IN NNS",4,1,1,17139879,2,8.68E+018,"testalpha"
,"rate ratios for risk","NN NNS IN NN",4,1,1,16236234,"pubmed1",2.64E+018,"testalpha"
,"thermal injuries in slovakiasince","JJ NNS IN NN",4,1,1,16999265,2,7.77E+018,"testalpha"
,"pulmonary embolism thrombosis recurrence","JJ NN NN NN",4,1,1,16549899,2,7.53E+017,"testalpha"
,"rearrangementof coding dna sequences"," VBG  NNS",4,1,1,16505901,"pubmed1",4.62E+018,"testalpha"
,"wasexamined taking bovine serum","VBN VBG NN NN",4,1,1,16701860,"pubmed1",6.74E+018,"testalpha"
,"study demonstrates deranged circulation","NN VBZ VBN NN",4,1,1,16451157,"pubmed1",2.38E+018,"testalpha"
,"date of birth desflurane","NN IN NN NN",4,1,1,16451145,"pubmed1",3.30E+018,"testalpha"
,"targeted health education outreach","VBN NN NN NN",4,1,1,16596897,"pubmed1",4.56E+018,"testalpha"
,"manipulations of road width","NNS IN NN NN",4,1,1,16426558,"pubmed1",2.60E+018,"testalpha"
,"cases of hashimoto thyroiditis","NNS IN NNP NN",4,1,1,16514836,2,6.57E+017,"testalpha"
,"laparatomies and terminal ileumexteriorization","NNS CC NN NN",4,1,1,16612919,"pubmed1",5.28E+018,"testalpha"
,"new possibilities inthe assessment","JJ NNS NNP NN",4,1,1,16317492,"pubmed1",7.08E+018,"testalpha"
,"ofgenital vulval lichen planus","NN NN NNP NN",4,1,1,16955190,2,2.77E+018,"testalpha"
,"means of linear o","NNS IN JJ ",4,1,1,16397328,2,6.33E+018,"testalpha"
,"serumconcentration of total ige","NN IN JJ ",4,1,1,16859611,2,7.80E+017,"testalpha"
,"patient experienced grade toxicity","JJ VBN NN NN",4,1,1,17117605,2,3.35E+018,"testalpha"
,"lower lectinbinding ligand levels","JJR VBG NN NNS",4,1,1,16414103,2,6.98E+017,"testalpha"
,"antibodies inrabbits and guinea","NNS NNS CC NNP",4,1,1,16733562,"pubmed1",4.63E+018,"testalpha"
,"strategy was used toadminister","NN VBD VBN NN",4,1,1,16377812,"pubmed1",2.59E+018,"testalpha"
,"work of surgical faculty","NN IN JJ NN",4,1,1,16377820,"pubmed1",3.64E+018,"testalpha"
,"chronic ulcers donor site","JJ NNS NN NN",4,1,1,17010268,2,4.88E+018,"testalpha"
,"status of muscle fibers","NN IN NN NNS",4,1,1,16893562,2,1.90E+018,"testalpha"
,"negative rate cytomorphologic features","JJ NN JJ NNS",4,1,1,16514836,2,4.98E+018,"testalpha"
,"infused correlated withthe neutrophil","VBN VBN NNP ",4,1,1,17119322,2,3.46E+018,"testalpha"
,"capillaries veinsand or lymphatics","NNS NN CC NNS",4,1,1,16722347,2,2.75E+018,"testalpha"
,"cecum with varying involvement","NN IN VBG NN",4,1,1,16333702,"pubmed1",2.79E+018,"testalpha"
,"distention small bowel wall","NN JJ NN NN",4,1,1,16252139,"pubmed1",4.43E+018,"testalpha"
,"hours areallocation of providers","NNS NN IN NNS",4,1,1,16365329,"pubmed1",3.00E+018,"testalpha"
,"sme smme and sss","  CC ",4,1,1,16584167,"pubmed1",7.53E+018,"testalpha"
,"intravascular time density curves","JJ NN NN NNS",4,1,1,16399037,"pubmed1",4.21E+018,"testalpha"
,"common sexuallytransmitted infection sti","JJ VBN NN ",4,1,1,17010274,2,3.56E+018,"testalpha"
,"developed recurrentbortezomib induced rhabdomyolysis","VBD  VBN NN",4,1,1,17016040,2,9.08E+018,"testalpha"
,"u nag cr activity","   NN",4,1,1,16956119,2,5.51E+018,"testalpha"
,"known risk factors present","VBN NN NNS NN",4,1,1,17338203,2,8.74E+018,"testalpha"
,"groups of small tointermediate","NNS IN JJ NN",4,1,1,16514851,2,5.24E+018,"testalpha"
,"urine andileal conduit urine","NN NN NN NN",4,1,1,16514843,2,6.11E+018,"testalpha"
,"treat osmidrosis withfew complications","VB NN  NNS",4,1,1,16710583,2,5.64E+018,"testalpha"
,"study design as part","NN NN IN NN",4,1,1,16514834,2,2.30E+018,"testalpha"
,"determined viaenzyme linked immunosorbent","VBN  VBN NN",4,1,1,16594642,"pubmed1",6.25E+018,"testalpha"
,"chain triglycerides as lipidcomponents","NN NNS IN NNS",4,1,1,17285747,"pubmed1",2.95E+018,"testalpha"
,"crash from thepolice report","NN IN NN NN",4,1,1,16221468,"pubmed1",7.24E+018,"testalpha"
,"sialic acid moiety fromcytidine","JJ NN NN NN",4,1,1,16511286,2,2.40E+018,"testalpha"
,"spatial correlation in crash","JJ NN IN NN",4,1,1,16451795,"pubmed1",1.66E+018,"testalpha"
,"impact on research misconductinquiries","NN IN NN NNS",4,1,1,16377817,"pubmed1",7.02E+018,"testalpha"
,"healedand maturated autologous split","NN VBN JJ NN",4,1,1,16999269,2,8.92E+018,"testalpha"
,"bead assay similar results"," NN JJ NNS",4,1,1,16414103,2,6.43E+018,"testalpha"
,"uk transport research laboratory"," NN NN NN",4,1,1,16430844,"pubmed1",2.40E+018,"testalpha"
,"cross border safety impact","NN NN NN NN",4,1,1,16169506,"pubmed1",3.67E+018,"testalpha"
,"glutamine on theserum trolox","NN IN NN NNP",4,1,1,17293970,2,9.76E+017,"testalpha"
,"americans withinthe faith community","NNS NNP NN NN",4,1,1,16596897,"pubmed1",3.66E+018,"testalpha"
,"assessed using anindirect immunoperoxidase","VBN VBG NN NN",4,1,1,16443258,2,3.70E+018,"testalpha"
,"positron emission tomography pet","NNP NN NN NN",4,1,1,16333707,"pubmed1",1.03E+018,"testalpha"
,"hpa axis and stimulates","  CC NNS",4,1,1,16462408,"pubmed1",5.30E+018,"testalpha"
,"lactide b poly ethylene","VB NN  NN",4,1,1,16701879,"pubmed1",2.95E+018,"testalpha"
,"ultrasound anddetermined pudendal nerve","NN VBN NN NN",4,1,1,17139884,2,9.09E+018,"testalpha"
,"sedation experiencefor ed psa","NN JJ VBD ",4,1,1,16365337,"pubmed1",5.27E+018,"testalpha"
,"map alanine aminotransferase alt","NN NN NN ",4,1,1,17013507,2,4.43E+018,"testalpha"
,"ina medium containing d"," NN VBG ",4,1,1,16696441,2,9.12E+018,"testalpha"
,"children without urolithiasis nephrocalcinosis","NNS IN NN NN",4,1,1,16956119,2,2.05E+018,"testalpha"
,"weighting of characters contradictions","NN IN NNS NNS",4,1,1,17486414,"pubmed1",2.18E+018,"testalpha"
,"pep ck type plants","  NN NNS",4,1,1,17106510,"pubmed1",7.74E+018,"testalpha"
,"findings of signet ring","NNS IN NN NN",4,1,1,16514844,2,7.42E+018,"testalpha"
,"prompt initiation ofappropriate therapy","VB NN NN NN",4,1,1,17106602,2,7.45E+018,"testalpha"
,"crystals of oxyhba c","NNS IN  NN",4,1,1,16511276,2,6.78E+018,"testalpha"
,"degrees c with co","NNS NN IN ",4,1,1,17160143,"pubmed1",2.69E+018,"testalpha"
,"several cancer cell lines","JJ NN NN NNS",4,1,1,17143338,"pubmed1",3.93E+018,"testalpha"
,"sectional survey of patients","JJ NN IN NNS",4,1,1,16514839,2,3.05E+018,"testalpha"
,"weights m n g","VBZ   ",4,1,1,16701853,"pubmed1",4.25E+018,"testalpha"
,"mean area of nuclei","JJ NN IN ",4,1,1,16730053,2,7.64E+018,"testalpha"
,"fallopian tubesand left testicle","JJ NN VBN NN",4,1,1,16612933,"pubmed1",5.38E+018,"testalpha"
,"twomain classifications vascular tumors","VB NNS JJ NNS",4,1,1,16722347,2,8.86E+018,"testalpha"
,"were pneumothorax in patients","VBD  IN NNS",4,1,1,16956118,2,3.80E+018,"testalpha"
,"homologyof paramecium rab isoforms"," NN  NNS",4,1,1,16365637,"pubmed1",3.35E+018,"testalpha"
,"inaddition uniaxial mechanical testing","NN JJ JJ NN",4,1,1,16701855,"pubmed1",3.19E+018,"testalpha"
,"bite lesions by p","VB NNS IN ",4,1,1,16874418,2,2.72E+018,"testalpha"
,"examinationplus naked eye tme","NN JJ NN ",4,1,1,17139882,2,3.92E+018,"testalpha"
,"ability of direct methods","NN IN JJ NNS",4,1,1,16421448,2,5.14E+018,"testalpha"
,"useda sage based assay","NNP  VBN NN",4,1,1,16496041,"pubmed1",7.51E+017,"testalpha"
,"subsequent severe ischemia reperfusion","JJ JJ NN NN",4,1,1,17438835,2,8.38E+018,"testalpha"
,"g csf on proliferation","  IN NN",4,1,1,16809884,2,2.55E+018,"testalpha"
,"related traffic crashes involvingdrivers","VBN NN NNS NNS",4,1,1,16043107,"pubmed1",5.83E+018,"testalpha"
,"drug release in vitropenetration","NN NN IN NN",4,1,1,17285742,"pubmed1",4.60E+018,"testalpha"
,"enthalpy deltaho and entropy"," NNP CC ",4,1,1,17019442,"pubmed1",3.22E+018,"testalpha"
,"examine relationships between perceptions","VB NNS IN NNS",4,1,1,16596899,"pubmed1",5.01E+018,"testalpha"
,"kpa mmhg median th","  JJ ",4,1,1,16451155,"pubmed1",6.90E+018,"testalpha"
,"asdiagnostic peritoneal lavage ultrasound","JJ NN NN NN",4,1,1,17013521,2,1.93E+018,"testalpha"
,"th century czech republic"," NN NN NN",4,1,1,17438834,2,3.30E+018,"testalpha"
,"carrying capacity or haemoglobin","VBG NN CC NNP",4,1,1,16809888,2,3.46E+018,"testalpha"
,"low rate of cardivascularand","JJ NN IN NN",4,1,1,16696439,2,9.03E+018,"testalpha"
,"u nag in children","  IN NNS",4,1,1,16956119,2,7.69E+018,"testalpha"
,"methodology developed inthis research","NN VBD NNP NN",4,1,1,16442487,"pubmed1",4.02E+018,"testalpha"
,"term icer inducible camp","NN  JJ NN",4,1,1,17265688,2,8.23E+018,"testalpha"
,"mediator of pi kinase","NN IN  NN",4,1,1,16964326,"pubmed1",7.87E+018,"testalpha"
,"sequencesof adarb and trpm","  CC ",4,1,1,16733555,"pubmed1",5.06E+018,"testalpha"
,"overall survival os rate","JJ NN  NN",4,1,1,16914906,2,7.67E+017,"testalpha"
,"physiological mechanism of homeostasis","JJ NN IN NN",4,1,1,17034836,2,7.58E+018,"testalpha"
,"andpercutaneous transhepatic liver biopsy","JJ JJ NN NN",4,1,1,16447097,"pubmed1",2.63E+018,"testalpha"
,"majority of dna lesions","NN IN  NNS",4,1,1,16582987,"pubmed1",8.55E+017,"testalpha"
,"morphologicalfeatures in dying cells","NNS IN VBG NNS",4,1,1,16956122,2,9.60E+017,"testalpha"
,"anorectal angle is degrees","NN NN VBZ NNS",4,1,1,17139884,2,3.59E+018,"testalpha"
,"measurement of serum aminotransferases","NN IN NN NNS",4,1,1,17013508,2,6.31E+018,"testalpha"
,"false positive shock advice","JJ JJ NN NN",4,1,1,16365330,"pubmed1",2.77E+018,"testalpha"
,"scores at rest time","NNS IN NN NN",4,1,1,16451144,"pubmed1",2.80E+017,"testalpha"
,"postulated forundulator data collection","VBN NN NNS NN",4,1,1,16369095,2,8.96E+017,"testalpha"
,"thinprep and conventional smears"," CC JJ NNS",4,1,1,16514841,2,7.64E+018,"testalpha"
,"different glyco proteinic allergens","JJ  JJ NNS",4,1,1,16673562,2,5.87E+018,"testalpha"
,"attitudes than younger andless","NNS IN JJR NN",4,1,1,16330213,"pubmed1",5.77E+018,"testalpha"
,"preparation before hcii technique","NN IN  NN",4,1,1,16514835,2,3.23E+018,"testalpha"
,"psoriasis patients compared withcontrols","NN NNS VBN NNS",4,1,1,16874421,2,3.33E+018,"testalpha"
,"percutaneous ethanol injection pei","JJ NN NN ",4,1,1,16333710,"pubmed1",8.04E+018,"testalpha"
,"couldinhibit tobacco mosaic virus","NN NN JJ NN",4,1,1,16395523,"pubmed1",2.13E+018,"testalpha"
,"cannabinoids and interact withneurotransmitter","NNS CC NN NN",4,1,1,16594639,"pubmed1",9.88E+017,"testalpha"
,"including elevations in factor","VBG NNS IN NN",4,1,1,16549898,2,6.38E+018,"testalpha"
,"cause of young peo","NN IN JJ ",4,1,1,17067135,"pubmed1",9.15E+018,"testalpha"
,"bath puva cream puva","NN  NN ",4,1,1,16585984,2,5.18E+018,"testalpha"
,"rates in san diego","NNS IN  NNP",4,1,1,16223468,"pubmed1",4.67E+018,"testalpha"
,"andregional research ethics boards","JJ NN NNS NNS",4,1,1,16770860,"pubmed1",3.15E+018,"testalpha"
,"therapy with high dose","NN IN JJ NN",4,1,1,16809891,2,3.39E+018,"testalpha"
,"solubleb igg fusion protein","  NN NN",4,1,1,17117211,"pubmed1",8.48E+018,"testalpha"
,"systemic hypothermia and normothermia","JJ NN CC NN",4,1,1,16451153,"pubmed1",8.73E+018,"testalpha"
,"hardness values using liquids","NN NNS VBG NNS",4,1,1,16701865,"pubmed1",6.10E+017,"testalpha"
,"driverattitudes and safe driver","NNS CC JJ NN",4,1,1,16061188,"pubmed1",9.09E+018,"testalpha"
,"acute care and community","JJ NN CC NN",4,1,1,16596895,"pubmed1",7.18E+018,"testalpha"
,"gene expression inthe animal"," NN NNP NN",4,1,1,16505901,"pubmed1",5.49E+018,"testalpha"
,"clp salinegroup rats n"," NN NNS ",4,1,1,17293958,2,7.07E+018,"testalpha"
,"withseveral satellite smaller ulcerations","JJ NN JJR NNS",4,1,1,16603099,2,6.95E+018,"testalpha"
,"incapacitationthan classical warfare agents","NNP JJ NN NNS",4,1,1,16696436,2,6.47E+018,"testalpha"
,"ray sources formacromolecular crystallography"," NNS JJ NN",4,1,1,16369095,2,7.88E+018,"testalpha"
,"clinical data in humans","JJ NN IN NNS",4,1,1,17265697,2,4.44E+018,"testalpha"
,"small proportion of presentations","JJ NN IN NNS",4,1,1,16673560,2,8.45E+018,"testalpha"
,"myelofibrosis cimf by fluorescence","NN  IN NN",4,1,1,16424657,2,3.05E+018,"testalpha"
,"stimulation ofy pretreated cells","NN  VBN NNS",4,1,1,17115079,"pubmed1",6.03E+018,"testalpha"
,"eye tme quality assessment","NN  NN NN",4,1,1,17139882,2,5.06E+018,"testalpha"
,"squamousintraepithelial lesion squamous cell","JJ NN JJ NN",4,1,1,16514840,2,3.40E+018,"testalpha"
,"morphologic changes of lung","JJ NNS IN NN",4,1,1,16395522,"pubmed1",5.65E+018,"testalpha"
,"endoscopic distal duodenal biopsies","NN NN JJ NNS",4,1,1,16673560,2,8.06E+018,"testalpha"
,"publication ofrandomized controlled trials","NN VBN VBN NNS",4,1,1,16365332,"pubmed1",9.73E+017,"testalpha"
,"highpercentage of serious crashes","NN IN JJ NNS",4,1,1,16423319,"pubmed1",2.16E+018,"testalpha"
,"photochemical center of psii","JJ NN IN ",4,1,1,17106511,"pubmed1",1.84E+018,"testalpha"
,"findings of cell changes","NNS IN NN NNS",4,1,1,17119329,2,3.97E+018,"testalpha"
,"side of rats n","NN IN NNS ",4,1,1,16574202,2,4.65E+018,"testalpha"
,"spermatids and elongating spermatids","NNS CC VBG NNS",4,1,1,16395525,"pubmed1",3.48E+018,"testalpha"
,"cells per high powermicroscopic","NNS IN JJ NN",4,1,1,16514841,2,1.36E+018,"testalpha"
,"activity suppress t cellapoptosis","NN VB  NN",4,1,1,17016035,2,5.11E+018,"testalpha"
,"support from crash data","NN IN NN NNS",4,1,1,16426560,"pubmed1",8.60E+018,"testalpha"
,"investigated suppression of murine","VBD NN IN NN",4,1,1,16733559,"pubmed1",2.23E+018,"testalpha"
,"localization of zea m","NN IN  ",4,1,1,16963110,2,6.22E+016,"testalpha"
,"cyclophosphamide doxorubicin vincristine prednisolone","VB NNP NN NN",4,1,1,16424646,2,2.93E+018,"testalpha"
,"principal sensory trigeminal nucleus","JJS NN JJ NN",4,1,1,16949651,2,1.42E+018,"testalpha"
,"pregnancy outcomes developmental delays","NN NNS NN NNS",4,1,1,16808045,"pubmed1",2.09E+018,"testalpha"
,"group of leiomyosarcomas lms","NN IN NNP ",4,1,1,17338203,2,1.58E+018,"testalpha"
,"method evaluations of fourclerkships","NN NNS IN NNS",4,1,1,16377822,"pubmed1",5.59E+018,"testalpha"
,"beta d ribofuranosyl h","NN   ",4,1,1,16456292,2,8.10E+018,"testalpha"
,"primary colorectal and gastrictumors","NN NN CC NNS",4,1,1,16430945,2,4.84E+018,"testalpha"
,"sensitive technique was foundto","JJ NN VBD ",4,1,1,17019439,"pubmed1",4.64E+017,"testalpha"
,"h pyrazolo d pyrimidinemonohydrate"," NNP  NN",4,1,1,16456292,2,6.55E+018,"testalpha"
,"rates conclusion clinical characteristics","NNS NN JJ NNS",4,1,1,16696444,2,7.42E+017,"testalpha"
,"ray images with d"," NNS IN ",4,1,1,16399038,"pubmed1",6.17E+018,"testalpha"
,"prevented byselective cox inhibitor","VBD JJ  NN",4,1,1,16253314,2,9.21E+018,"testalpha"
,"safetyclimate on injury rates","NN IN NN NNS",4,1,1,16430845,"pubmed1",3.90E+018,"testalpha"
,"tube modified billbao dotter","NN VBN  NN",4,1,1,16447095,"pubmed1",8.88E+018,"testalpha"
,"mmp and tissue inhibitor"," CC NN NN",4,1,1,16585983,2,8.39E+018,"testalpha"
,"industrial environment with examples","JJ NN IN NNS",4,1,1,16369099,2,4.94E+016,"testalpha"
,"precursors theyeast tim p","NNS JJS  ",4,1,1,16511294,2,7.04E+018,"testalpha"
,"postoperative use of opioides","JJ NN IN NNS",4,1,1,17236637,"pubmed1",6.98E+018,"testalpha"
,"coordination bymain chain carbonyl","NN VB NN NN",4,1,1,17143335,"pubmed1",1.45E+018,"testalpha"
,"responsiveness of pfkfb andpfkfb","NN IN  ",4,1,1,17143338,"pubmed1",6.02E+018,"testalpha"
,"national industry specific injury","JJ NN JJ NN",4,1,1,16430845,"pubmed1",2.32E+018,"testalpha"
,"pertinence of such procedure","NN IN JJ NN",4,1,1,17067135,"pubmed1",8.01E+018,"testalpha"
,"electrondensity of zonula adherens","NN IN NN NNS",4,1,1,16253314,2,2.14E+018,"testalpha"
,"gas transfer study carbon","NN VB NN NN",4,1,1,16809886,2,4.81E+018,"testalpha"
,"methanol g l phenol","NN   NN",4,1,1,17019438,"pubmed1",3.70E+017,"testalpha"
,"causes thesepersistent dopaminergic deficits","NNS NN JJ NNS",4,1,1,16808044,"pubmed1",5.11E+018,"testalpha"
,"symptoms of frozen shoulder","NNS IN VBN NN",4,1,1,16916183,"pubmed1",6.62E+018,"testalpha"
,"non hydrolysable atp analog"," JJ  NN",4,1,1,16421444,2,4.36E+018,"testalpha"
,"allelic ylr c disruptionof","JJ  NN ",4,1,1,17146497,"pubmed1",1.79E+018,"testalpha"
,"several dried sucralfate gels","JJ VBD NN ",4,1,1,16584168,"pubmed1",6.40E+018,"testalpha"
,"gel and sucralfate nongel"," CC NN NNP",4,1,1,16584168,"pubmed1",6.44E+018,"testalpha"
,"movement experiment and imagination","NN NN CC NN",4,1,1,17133951,2,7.78E+018,"testalpha"
,"reconstruction after cancer excision","NN IN NN NN",4,1,1,16722346,2,2.02E+018,"testalpha"
,"caspase immunolabelled perivascular cell","NN VBN JJ NN",4,1,1,17034836,2,8.15E+017,"testalpha"
,"filled microbubble contrast agent","VBN JJ NN NN",4,1,1,16333704,"pubmed1",3.89E+018,"testalpha"
,"option for screening patients","NN IN NN NNS",4,1,1,16317492,"pubmed1",8.80E+018,"testalpha"
,"compared toadjacent normal tissues","VBN NN JJ NNS",4,1,1,16404476,"pubmed1",2.68E+017,"testalpha"
,"decreasesthe length of stay","NNP NN IN NN",4,1,1,16436790,"pubmed1",4.85E+018,"testalpha"
,"treatment regimens at week","NN NNS IN NN",4,1,1,16585987,2,1.73E+018,"testalpha"
,"pbs using thetapping mode"," VBG VBG NN",4,1,1,16701857,"pubmed1",1.07E+018,"testalpha"
,"tools and newantifungal treatments","NNS CC JJ NNS",4,1,1,16918059,"pubmed1",5.01E+018,"testalpha"
,"effects of theseoxidation products","NNS IN NN NNS",4,1,1,17128291,"pubmed1",8.77E+017,"testalpha"
,"acutehomocysteine induced neuronal damage","NN VBN JJ NN",4,1,1,17265692,2,3.28E+018,"testalpha"
,"mds combined orsequential immunomodulatory"," VBN JJ NN",4,1,1,17016041,2,4.91E+018,"testalpha"
,"treated withintensity modulated radiotherapy","VBN NN VBN NN",4,1,1,17117605,2,7.77E+018,"testalpha"
,"ofvegf expression in hcc"," NN IN ",4,1,1,16317488,"pubmed1",2.13E+018,"testalpha"
,"phosphorylated focal adhesion kinase","VBN JJ NN NN",4,1,1,17106595,2,3.14E+018,"testalpha"
,"reperfusion i r injury","NN  NN NN",4,1,1,17013514,2,4.39E+017,"testalpha"
,"enantiomorphic compounds c h","JJ VBZ NN ",4,1,1,16456281,2,2.19E+018,"testalpha"
,"complete dephosphorylation of adenine","JJ NN IN NN",4,1,1,16770441,"pubmed1",8.61E+018,"testalpha"
,"number of regulated proteins","NN IN VBN NNS",4,1,1,17265689,2,6.18E+017,"testalpha"
,"h n o andc","   ",4,1,1,16397334,2,6.03E+018,"testalpha"
,"intrahepatic portal venous branches","JJ NN JJ NNS",4,1,1,16447097,"pubmed1",4.28E+018,"testalpha"
,"tml and recorded pathologicvalues"," CC VBN NNS",4,1,1,17139884,2,5.35E+018,"testalpha"
,"molecular mass around kda","JJ NN IN ",4,1,1,16733562,"pubmed1",2.36E+018,"testalpha"
,"aminocarbonyl phenolate c h","NN NN NN ",4,1,1,16456282,2,4.72E+018,"testalpha"
,"ccaat boxes thetypical criteria"," NNS JJ NNS",4,1,1,16951743,"pubmed1",7.22E+018,"testalpha"
,"n normal animals treatedwith"," JJ NNS NN",4,1,1,17293959,2,7.43E+018,"testalpha"
,"standards guidelines and policies","NNS NNS CC NNS",4,1,1,16438093,"pubmed1",7.56E+018,"testalpha"
,"poor outcome among patientsdependent","JJ NN IN NN",4,1,1,16451146,"pubmed1",4.94E+018,"testalpha"
,"younger andless experienced nurses","JJR NN VBD NNS",4,1,1,16330213,"pubmed1",8.68E+018,"testalpha"
,"deficiencies of fii fvii","NNS IN  ",4,1,1,16424651,2,7.34E+018,"testalpha"
,"major viral life strategies","JJ JJ NN NNS",4,1,1,17347785,"pubmed1",1.88E+018,"testalpha"
,"aftercorrection of dietary inbalances","NN IN JJ NNS",4,1,1,16956119,2,3.49E+018,"testalpha"
,"iii slippedcapital femoral epiphysis"," NN JJ NN",4,1,1,16696447,2,4.63E+018,"testalpha"
,"patients demonstrated agood response","NNS VBN NN NN",4,1,1,16424649,2,1.95E+018,"testalpha"
,"occurrence of amyloid tumors","NN IN VB NNS",4,1,1,16714048,2,5.66E+018,"testalpha"
,"polymers and mild conditions","NNS CC JJ NNS",4,1,1,16594643,"pubmed1",8.38E+018,"testalpha"
,"mesophyll and bundle sheathchloroplasts","NN CC NN NNS",4,1,1,17106510,"pubmed1",6.62E+018,"testalpha"
,"low cost diagnostic method","JJ NN NN NN",4,1,1,17139883,2,9.09E+018,"testalpha"
,"patients with completecytoreduction cc","NNS IN NN ",4,1,1,17139879,2,9.21E+018,"testalpha"
,"organs e g bone","NNS   NN",4,1,1,16696440,2,3.61E+018,"testalpha"
,"ice using mtm data","NN VBG  NNS",4,1,1,17285746,"pubmed1",3.53E+018,"testalpha"
,"leukemia aml subtype m","NN  JJ ",4,1,1,16914909,2,1.52E+018,"testalpha"
,"completed visual analog scales","VBN JJ NN NNS",4,1,1,16436796,"pubmed1",3.59E+018,"testalpha"
,"epsilona n ethenocytosine epsilonc","NNP  NN ",4,1,1,16582987,"pubmed1",5.47E+018,"testalpha"
,"cultured mousespermatogonia gc cells","VBN NNP  NNS",4,1,1,16395525,"pubmed1",5.62E+018,"testalpha"
,"oro genital contact p"," NN NN ",4,1,1,16648915,2,5.76E+018,"testalpha"
,"expandingthe indications for resection","NNP NNS IN NN",4,1,1,17139901,2,7.37E+018,"testalpha"
,"germ cells during spermatogenesis","NN NNS IN NN",4,1,1,16330085,2,7.67E+018,"testalpha"
,"advanced life support units","VBN NN NN NNS",4,1,1,16491215,2,8.05E+018,"testalpha"
,"set of experiments puva","NN IN NNS ",4,1,1,17016038,2,5.38E+018,"testalpha"
,"evidence for non pathogenicity","NN IN  NN",4,1,1,16603097,2,3.83E+018,"testalpha"
,"andischemia reperfusion i r","NN NN  NN",4,1,1,16764913,2,2.77E+018,"testalpha"
,"x ray computed tomography","NN  VBN NN",4,1,1,16809891,2,8.56E+018,"testalpha"
,"almostall patients with cvt","JJ NNS IN ",4,1,1,16549893,2,1.99E+016,"testalpha"
,"andduring standard acne regimens","VBG JJ  NNS",4,1,1,16874416,2,6.10E+018,"testalpha"
,"major bcr abl genevariants","JJ   NNS",4,1,1,16914906,2,1.70E+017,"testalpha"
,"pcr thatof ppargamma mrna","  NN ",4,1,1,16809887,2,4.52E+018,"testalpha"
,"trainer breast health education","NN NN NN NN",4,1,1,16596901,"pubmed1",8.47E+018,"testalpha"
,"elevations in factor viii","NNS IN NN ",4,1,1,16549898,2,7.57E+018,"testalpha"
,"ii inter residue hydrogen"," NN NN NN",4,1,1,16456293,2,5.34E+018,"testalpha"
,"comparisons between mean ofneutrophils","NNS IN VB NNS",4,1,1,16491220,2,4.53E+018,"testalpha"
,"time staff and wri","NN NN CC ",4,1,1,16438093,"pubmed1",6.95E+018,"testalpha"
,"picture ofsarcoidosis and non","NN NN CC ",4,1,1,16256177,2,2.79E+018,"testalpha"
,"use of skin prick","NN IN NN NNP",4,1,1,16859613,2,5.50E+018,"testalpha"
,"level by latex agglutinationtest","NN IN NNP NN",4,1,1,16479028,2,3.91E+018,"testalpha"
,"forearms hands and fingers","NNS NNS CC NNS",4,1,1,16603097,2,3.36E+018,"testalpha"
,"pneumopericardium following blunt chest","NN VBG JJ NN",4,1,1,16956123,2,5.92E+018,"testalpha"
,"events resolved withsupportive interventions","NNS VBN JJ NNS",4,1,1,16365337,"pubmed1",5.54E+018,"testalpha"
,"frequencies of gastrointestinal symptoms","NNS IN JJ NNS",4,1,1,16424650,2,8.25E+018,"testalpha"
,"e and e oncoproteines"," CC  NNS",4,1,1,17010274,2,1.00E+018,"testalpha"
,"fcm clustering based method"," VBG VBN NN",4,1,1,16399033,"pubmed1",8.11E+018,"testalpha"
,"healthcare settings but theirtolerance","NN NNS CC NN",4,1,1,16648917,2,1.06E+018,"testalpha"
,"kh domains frompyrococcus horikoshii"," NNS NN ",4,1,1,16511260,2,5.24E+018,"testalpha"
,"reconstructive surgery in hips","JJ NN IN ",4,1,1,17438833,2,9.75E+017,"testalpha"
,"approaches for quantitative determination","NNS IN JJ NN",4,1,1,17007910,2,2.50E+018,"testalpha"
,"ischemia induced cardiac dysfunction","NN VBN JJ NN",4,1,1,16566960,2,1.41E+018,"testalpha"
,"z mays and p","  CC ",4,1,1,17106510,"pubmed1",5.78E+018,"testalpha"
,"mi waspresent in cases"," NN IN NNS",4,1,1,16914907,2,5.66E+018,"testalpha"
,"seizure induced fos protein","NN VBN  NN",4,1,1,17007911,2,5.80E+018,"testalpha"
,"oil g l methanol","NN   NN",4,1,1,17019438,"pubmed1",8.89E+018,"testalpha"
,"patients with mild forms","NNS IN JJ NNS",4,1,1,16585983,2,1.88E+017,"testalpha"
,"small amount of zea","JJ NN IN ",4,1,1,16963110,2,1.91E+018,"testalpha"
,"weeks of gestation results","NNS IN NN NNS",4,1,1,16424650,2,1.68E+018,"testalpha"
,"methyl and carbonyl substituents"," CC NN NNS",4,1,1,16404478,"pubmed1",6.64E+018,"testalpha"
,"parameters of lipid profile","NNS IN NN NN",4,1,1,17106515,"pubmed1",1.28E+018,"testalpha"
,"tgfbeta activation with tsp","NN NN IN ",4,1,1,16733556,"pubmed1",2.20E+018,"testalpha"
,"andinteraction of potential comorbidities","NN IN JJ NNS",4,1,1,16462404,"pubmed1",7.79E+017,"testalpha"
,"amount of glycated proteins","NN IN VBN NNS",4,1,1,16696441,2,7.34E+017,"testalpha"
,"experiences for young physicians","NNS IN JJ NNS",4,1,1,16377827,"pubmed1",1.64E+018,"testalpha"
,"rat model oral administration","NN NN JJ NN",4,1,1,16612917,"pubmed1",1.87E+018,"testalpha"
,"dex or other gcs"," CC JJ ",4,1,1,17133953,2,5.17E+018,"testalpha"
,"conducted aretrospective case file","VBN JJ NN NN",4,1,1,16112068,"pubmed1",1.44E+017,"testalpha"
,"structure determination ofbiological macromolecules","NN NN JJ NNS",4,1,1,16369089,2,1.71E+018,"testalpha"
,"pancreas without von recklinghausen","NNS IN  NNP",4,1,1,16132429,"pubmed1",8.18E+018,"testalpha"
,"gynaecologicallaparoscopic day case surgery","NN NN NN NN",4,1,1,16451148,"pubmed1",4.93E+018,"testalpha"
,"matched case control setting","VBN NN NN NN",4,1,1,16549894,2,2.68E+018,"testalpha"
,"levels of total ige","NNS IN JJ ",4,1,1,17010262,2,7.83E+018,"testalpha"
,"passengers present and fatalities","NNS NN CC NNS",4,1,1,16171767,"pubmed1",3.63E+018,"testalpha"
,"head and neck region","NN CC NN NN",4,1,1,17117605,2,9.32E+016,"testalpha"
,"thyroiditis follicular neoplasms hurthle","NN JJ NNS ",4,1,1,16514836,2,3.03E+018,"testalpha"
,"dimensional structure of smua","JJ NN IN ",4,1,1,16511267,2,3.48E+018,"testalpha"
,"determined using radioactivity count","VBN VBG NN NN",4,1,1,17293960,2,7.04E+018,"testalpha"
,"diverticulum with special reference","NN IN JJ NN",4,1,1,16252140,"pubmed1",3.14E+018,"testalpha"
,"k cell lines g"," NN NNS ",4,1,1,16809884,2,3.42E+018,"testalpha"
,"committee with supporting staff","NN IN VBG NN",4,1,1,16770860,"pubmed1",8.45E+018,"testalpha"
,"age groups and differentenvironmental","NN NNS CC NN",4,1,1,16226211,"pubmed1",6.11E+017,"testalpha"
,"educational activities morning report","JJ NNS NN NN",4,1,1,16377825,"pubmed1",9.12E+017,"testalpha"
,"residues vlsat dktnv laawg","NNS   ",4,1,1,16770447,"pubmed1",6.30E+018,"testalpha"
,"risk hpv hr hpv","NN   ",4,1,1,16514834,2,2.59E+018,"testalpha"
,"control as applied inthe","NN IN VBN NNP",4,1,1,16999268,2,8.14E+018,"testalpha"
,"therapy culture ofpleural fluid","NN NN JJ NN",4,1,1,17370569,"pubmed1",7.76E+017,"testalpha"
,"patientsatisfaction compliance and health","NN NN CC NN",4,1,1,17106601,2,7.78E+018,"testalpha"
,"ina variety of non"," NN IN ",4,1,1,16511249,2,5.58E+018,"testalpha"
,"virus positivity in nodularsclerosis","NN NN IN NN",4,1,1,16914904,2,7.39E+018,"testalpha"
,"specificity positive predictive value","NN JJ JJ NN",4,1,1,16514835,2,3.27E+018,"testalpha"
,"signaling system adenosine mediates","VBG NN NN NNS",4,1,1,16770441,"pubmed1",8.02E+018,"testalpha"
,"crashes median barrier selection","NNS JJ NN NN",4,1,1,16442487,"pubmed1",2.74E+018,"testalpha"
,"suspected small bowel disorder","VBN JJ NN NN",4,1,1,16447095,"pubmed1",5.03E+018,"testalpha"
,"ad with respiratory symptoms","NN IN NN NNS",4,1,1,16859613,2,6.56E+018,"testalpha"
,"region mutations in hamp","NN NNS IN ",4,1,1,16424658,2,1.86E+018,"testalpha"
,"diet and stroke education","NN CC NN NN",4,1,1,16436789,"pubmed1",5.27E+018,"testalpha"
,"block underlying genetic lesions","NN VBG JJ NNS",4,1,1,16914901,2,5.12E+018,"testalpha"
,"exact value of ibandronate","JJ NN IN NN",4,1,1,17016034,2,3.87E+017,"testalpha"
,"macaque mhc imolecule mamu","JJ  NN ",4,1,1,16511250,2,2.40E+018,"testalpha"
,"analgesics andantihyperalgesic drugs contributes","NNS NN NNS NNS",4,1,1,17236639,"pubmed1",7.34E+018,"testalpha"
,"enzymatic reactivity toward gti","JJ NN IN ",4,1,1,17285740,"pubmed1",3.99E+018,"testalpha"
,"dependent manner in ins","JJ NN IN ",4,1,1,16395520,"pubmed1",3.32E+018,"testalpha"
,"inflammatory disease involving activation","JJ NN VBG NN",4,1,1,17128291,"pubmed1",4.46E+018,"testalpha"
,"dose dependent significant decrease","NN JJ JJ NN",4,1,1,17007911,2,8.35E+018,"testalpha"
,"picture of lactic acidosis","NN IN JJ NN",4,1,1,16673614,2,4.02E+018,"testalpha"
,"variations in resin composition","NNS IN NNP NN",4,1,1,16701862,"pubmed1",4.82E+018,"testalpha"
,"relation between alcohol dependence","NN IN NN NN",4,1,1,16236233,"pubmed1",9.20E+018,"testalpha"
,"convenientreporter system of atf","NN NN IN ",4,1,1,16395528,"pubmed1",2.79E+018,"testalpha"
,"maximum squeeze pressure cm","JJ NN NN ",4,1,1,17139884,2,3.79E+018,"testalpha"
,"capture assay and pcr","VB NN CC ",4,1,1,17019439,"pubmed1",2.62E+018,"testalpha"
,"found todeplete atp levels","VBN JJ  NNS",4,1,1,17128291,"pubmed1",5.14E+018,"testalpha"
,"males transport related injury","NNS NN VBN NN",4,1,1,16111641,"pubmed1",5.19E+018,"testalpha"
,"patients with spinal cord","NNS IN JJ NN",4,1,1,16916187,"pubmed1",2.54E+018,"testalpha"
,"activity of serum adenosine","NN IN NN NN",4,1,1,16956117,2,1.41E+018,"testalpha"
,"education of medical students","NN IN JJ NNS",4,1,1,16473990,"pubmed1",9.01E+018,"testalpha"
,"false negative code assignments","JJ JJ NN NNS",4,1,1,16365331,"pubmed1",2.52E+018,"testalpha"
,"water at degrees c","NN IN NNS NN",4,1,1,17236636,"pubmed1",4.47E+018,"testalpha"
,"offingers hand or forearm","NNS NN CC NN",4,1,1,16451159,"pubmed1",5.28E+018,"testalpha"
,"spirituality on thehealth risk","NN IN NN NN",4,1,1,16596897,"pubmed1",2.79E+018,"testalpha"
,"idec idef and ida","  CC ",4,1,1,16809889,2,3.89E+018,"testalpha"
,"u kg body weight","  NN NN",4,1,1,17119327,2,1.71E+018,"testalpha"
,"low number of protein","JJ NN IN NN",4,1,1,16410835,"pubmed1",1.31E+018,"testalpha"
,"factor whichincreases postoperative morbidity","NN NNS JJ NN",4,1,1,16989147,2,8.52E+018,"testalpha"
,"mg kg day prednisolone","  NN NN",4,1,1,16955189,2,3.13E+018,"testalpha"
,"bis phenyl glycidyl dimethacrylate"," NN  NN",4,1,1,16701856,"pubmed1",3.71E+018,"testalpha"
,"pf c h o"," NN  ",4,1,1,16397333,2,1.77E+018,"testalpha"
,"human thyroid epithelial cells","JJ NN JJ NNS",4,1,1,17046053,2,1.04E+018,"testalpha"
,"gsh content serum creatinine"," JJ NN NN",4,1,1,16999986,2,1.59E+017,"testalpha"
,"neurosciences for medical students","NNS IN JJ NNS",4,1,1,16473989,"pubmed1",4.08E+018,"testalpha"
,"following week betamethasone cream","VBG NN NN NN",4,1,1,16696448,2,6.28E+018,"testalpha"
,"highfidelity with relevant laboratory","NN IN JJ NN",4,1,1,16365338,"pubmed1",8.24E+018,"testalpha"
,"cream and calcipotriol groups","NN CC  NNS",4,1,1,16585986,2,1.42E+018,"testalpha"
,"corresponded toelevated hnrnp k","VBN VBN  ",4,1,1,16496041,"pubmed1",6.11E+018,"testalpha"
,"educationalsatisfaction after duty hours","NN IN NN NNS",4,1,1,16377825,"pubmed1",7.14E+018,"testalpha"
,"time of mf diagnosis","NN IN  NN",4,1,1,16859615,2,2.89E+018,"testalpha"
,"method ofcontrolling skin inflammation","NN VBG NN NN",4,1,1,17328144,2,9.21E+018,"testalpha"
,"primary esophageal motility disorders","JJ NN NN NNS",4,1,1,17338194,2,4.34E+018,"testalpha"
,"mean values of agnor","JJ NNS IN NN",4,1,1,17293964,2,4.97E+018,"testalpha"
,"diagnosis of parotid tumors","NN IN  NNS",4,1,1,16514845,2,2.47E+018,"testalpha"
,"ofthe pineal gland pinealectomy","NNP NN NN NN",4,1,1,16491217,2,5.88E+018,"testalpha"
,"healthy full term neonates","JJ JJ NN NNS",4,1,1,16549890,2,5.76E+018,"testalpha"
,"hypoxia responsiveness of pfkfb"," NN IN ",4,1,1,17143338,"pubmed1",7.70E+018,"testalpha"
,"nucleotide exchange and gtphydrolysis","VB NN CC NN",4,1,1,17019437,"pubmed1",6.11E+018,"testalpha"
,"costeffectiveness and adequate predictability","NN CC JJ NN",4,1,1,16584115,"pubmed1",1.81E+018,"testalpha"
,"methyl aminolevulinate photodynamic therapymay"," NN JJ NN",4,1,1,16585985,2,3.72E+018,"testalpha"
,"evaluation of small bowel","NN IN JJ NN",4,1,1,16447095,"pubmed1",1.75E+018,"testalpha"
,"health and reducing workproductivity","NN CC VBG NN",4,1,1,16859619,2,6.38E+016,"testalpha"
,"n n and mg","  CC ",4,1,1,16424650,2,8.40E+018,"testalpha"
,"traditional resident education tenets","JJ NN NN NNS",4,1,1,16377824,"pubmed1",2.62E+018,"testalpha"
,"stimulation with microg ml","NN IN NNP ",4,1,1,16710577,2,7.53E+018,"testalpha"
,"induced accumulation ofexcitatory amino","VBN NN NN NNP",4,1,1,17133953,2,3.49E+018,"testalpha"
,"solution has imaging characteristics","NN VBZ VBG NNS",4,1,1,16252139,"pubmed1",2.93E+018,"testalpha"
,"themany possibilities of contact","NN NNS IN NN",4,1,1,16916182,"pubmed1",3.25E+018,"testalpha"
,"cells indicatingprimary lens fiber","NNS JJ NN NN",4,1,1,16325892,2,8.50E+017,"testalpha"
,"portion of human igg","NN IN JJ ",4,1,1,16733563,"pubmed1",4.58E+018,"testalpha"
,"andinterpreting such time series","VBG JJ NN NN",4,1,1,17318329,"pubmed1",4.69E+017,"testalpha"
,"vs and cocaine use"," CC NN NN",4,1,1,16436792,"pubmed1",5.99E+018,"testalpha"
,"therapeutic options for childhood","JJ NNS IN NN",4,1,1,17311742,2,1.55E+018,"testalpha"
,"economic deregulation on transport","JJ NN IN NN",4,1,1,16427020,"pubmed1",1.35E+018,"testalpha"
,"high thermostability above k","JJ NN IN ",4,1,1,16511287,2,2.42E+018,"testalpha"
,"decrease in blood perfusion","NN IN NN NN",4,1,1,17438835,2,4.30E+018,"testalpha"
,"entire process of protein","JJ NN IN NN",4,1,1,16421450,2,3.85E+018,"testalpha"
,"scars skin contractures dermatosclerosis","NNS NN NNS NN",4,1,1,17293973,2,1.10E+018,"testalpha"
,"localization of potential ion","NN IN JJ ",4,1,1,16770442,"pubmed1",5.63E+018,"testalpha"
,"median barrier crash frequency","JJ NN NN NN",4,1,1,16442487,"pubmed1",8.22E+018,"testalpha"
,"identifypublishing trends by em","VBG NNS IN ",4,1,1,16365335,"pubmed1",2.03E+018,"testalpha"
,"tertiary care medical centers","JJ NN JJ NNS",4,1,1,16514840,2,9.64E+017,"testalpha"
,"grade squamous intraepithelial lesion","NN JJ JJ NN",4,1,1,16514841,2,5.24E+018,"testalpha"
,"arterial phase gre images","JJ NN  NNS",4,1,1,16317488,"pubmed1",8.38E+018,"testalpha"
,"exercise and physicalactivity weight","NN CC NN NN",4,1,1,16596897,"pubmed1",1.87E+018,"testalpha"
,"risk management committee meetings","NN NN NN NNS",4,1,1,16321534,"pubmed1",9.98E+016,"testalpha"
,"approach toachieving sustained expression","NN VBG VBN NN",4,1,1,17119325,2,7.15E+017,"testalpha"
,"countingthe number of fatalities","NNP NN IN NNS",4,1,1,16430844,"pubmed1",2.69E+017,"testalpha"
,"low number of cd","JJ NN IN ",4,1,1,17119322,2,2.09E+018,"testalpha"
,"acid and glutathioneon hemolysis","NN CC NN NN",4,1,1,16395529,"pubmed1",7.23E+017,"testalpha"
,"normal adult skeletal muscle","JJ NN NN NN",4,1,1,16965805,2,1.25E+018,"testalpha"
,"positive cases of amyloidosis","JJ NNS IN NN",4,1,1,16714051,2,6.90E+018,"testalpha"
,"globulins and iga length","NNS CC  NN",4,1,1,17293972,2,1.58E+018,"testalpha"
,"blood vessels and nerves","NN NNS CC NNS",4,1,1,16710583,2,3.58E+018,"testalpha"
,"posterior inferior mi waspresent","JJ JJ  NN",4,1,1,16914907,2,3.67E+018,"testalpha"
,"mellitus and rheumatoid arthritis","NN CC VB NN",4,1,1,16710576,2,3.95E+018,"testalpha"
,"blueprint and verifiedoccupational health","NN CC JJ NN",4,1,1,16438092,"pubmed1",1.89E+018,"testalpha"
,"practices of african americancongregants","NNS IN JJ NNS",4,1,1,16596897,"pubmed1",2.41E+018,"testalpha"
,"duty hour requirements patient","NN NN NNS NN",4,1,1,16377824,"pubmed1",1.93E+018,"testalpha"
,"enrolled including children withacute","VBD VBG NNS NN",4,1,1,16424647,2,6.56E+018,"testalpha"
,"therapeutic approach for kidney","JJ NN IN NN",4,1,1,16914905,2,2.44E+018,"testalpha"
,"bad regions e g","JJ NNS  ",4,1,1,16369096,2,6.71E+018,"testalpha"
,"criteria included severe illness","NNS VBD JJ NN",4,1,1,16365327,"pubmed1",7.56E+018,"testalpha"
,"dependentactivation of tgfbeta axis","NN IN NN ",4,1,1,16733556,"pubmed1",7.42E+018,"testalpha"
,"andproposals for preventive measures","NNS IN JJ NNS",4,1,1,16999265,2,5.20E+018,"testalpha"
,"patients relapsed needingnew pulses","NNS VBN VB NNS",4,1,1,16955189,2,9.06E+018,"testalpha"
,"dose rate effect relates","NN NN NN NNS",4,1,1,16421442,2,1.36E+018,"testalpha"
,"buffer ledto higher encapsulation","NN  JJR NN",4,1,1,16594643,"pubmed1",5.43E+018,"testalpha"
,"prognostic factor affecting outcome","JJ NN VBG NN",4,1,1,16424645,2,5.78E+018,"testalpha"
,"autogenous graft in surgicalcorrection","JJ NN IN NN",4,1,1,17293971,2,5.60E+017,"testalpha"
,"fas l in bullspermatozoa","  IN ",4,1,1,16919708,2,2.64E+018,"testalpha"
,"exchange protocol and crystallizationconditions","NN NN CC NNS",4,1,1,16511265,2,1.52E+018,"testalpha"
,"b neuron specific enolase","NN NNP JJ NN",4,1,1,16919707,2,6.97E+018,"testalpha"
,"frequency of positive test","NN IN JJ NN",4,1,1,17106597,2,7.52E+018,"testalpha"
,"review focuses onvarious aspects","NN VBZ JJ NNS",4,1,1,16808046,"pubmed1",8.03E+018,"testalpha"
,"methacrylatedn n diethylaminoethyl dextran","   NN",4,1,1,16701854,"pubmed1",4.12E+018,"testalpha"
,"hours and phone use","NNS CC NN NN",4,1,1,16157285,"pubmed1",8.20E+018,"testalpha"
,"spectroscopic uv vis cd","NN   ",4,1,1,16496037,"pubmed1",3.26E+018,"testalpha"
,"hydroxy diphenylethanone ethylthiosemicarbazone c","NN NN NN NN",4,1,1,16397328,2,7.09E+018,"testalpha"
,"clear cut acute effects","JJ NN JJ NNS",4,1,1,17133954,2,4.54E+018,"testalpha"
,"diminishes synthesis of rna","VBZ NN IN ",4,1,1,16696445,2,3.07E+018,"testalpha"
,"phenolate c h n","NN NN  ",4,1,1,16456282,2,4.83E+018,"testalpha"
,"inmale sprague dawley rats","NN NN NNP NNS",4,1,1,16762404,2,3.81E+018,"testalpha"
,"health problems and co","NN NNS CC ",4,1,1,16808045,"pubmed1",1.99E+018,"testalpha"
,"expression sod while inositolhexaphosphate","NN  IN NN",4,1,1,17293962,2,8.51E+018,"testalpha"
,"formulations are suitable carriers","NNS VBP JJ NNS",4,1,1,16584150,"pubmed1",1.74E+018,"testalpha"
,"theconcentrations of serum tsa","NNS IN NN ",4,1,1,16956116,2,5.47E+018,"testalpha"
,"year and year survival","NN CC NN NN",4,1,1,17139879,2,5.98E+018,"testalpha"
,"patients and timely detectionand","NNS CC JJ NN",4,1,1,16612921,"pubmed1",2.72E+018,"testalpha"
,"vials with low resistance","NNS IN JJ NN",4,1,1,17285744,"pubmed1",2.23E+018,"testalpha"
,"dextran ddexma and ddexma","NN  CC ",4,1,1,16701854,"pubmed1",5.58E+018,"testalpha"
,"inh beta betaa andbetab"," NN  ",4,1,1,16423381,2,5.05E+018,"testalpha"
,"repair mmr system guards","NN  NN NNS",4,1,1,17139886,2,3.16E+018,"testalpha"
,"paramedical students insertedthe ilma","JJ NNS NNP ",4,1,1,16451149,"pubmed1",1.00E+018,"testalpha"
,"charnley low frictional torque","NNP JJ JJ NN",4,1,1,16613741,2,4.06E+018,"testalpha"
,"identification of specific cell","NN IN JJ NN",4,1,1,16730369,2,3.76E+018,"testalpha"
,"hyperplastic nodules showing stains","JJ NNS VBG NNS",4,1,1,16317494,"pubmed1",1.61E+018,"testalpha"
,"disorders characterizedby abnormal proliferation","NNS JJ JJ NN",4,1,1,16914901,2,4.40E+018,"testalpha"
,"cell tumor andhemophagocytic syndrome","NN NN JJ NN",4,1,1,16809892,2,5.63E+018,"testalpha"
,"high risk hpv hr","JJ NN  ",4,1,1,16514834,2,9.16E+018,"testalpha"
,"thishucb derived neural progenitor"," VBN JJ NN",4,1,1,17265690,2,6.88E+018,"testalpha"
,"nails from healthy controls","NNS IN JJ NNS",4,1,1,16710579,2,4.31E+018,"testalpha"
,"content vs than bovine","JJ  IN NN",4,1,1,16701880,"pubmed1",4.56E+018,"testalpha"
,"complications andto identify risk","NNS  VB NN",4,1,1,17106598,2,6.68E+018,"testalpha"
,"fitz hugh curtis syndrome","  NN NN",4,1,1,16132430,"pubmed1",4.45E+018,"testalpha"
,"directors acknowledgeits critical importance","NNS NNS JJ NN",4,1,1,16473995,"pubmed1",8.69E+017,"testalpha"
,"nuclei per section area"," IN NN NN",4,1,1,17007911,2,7.65E+018,"testalpha"
,"number of molecular replacement","NN IN JJ NN",4,1,1,16421452,2,2.25E+018,"testalpha"
,"potential problems and solutions","NN NNS CC NNS",4,1,1,16436795,"pubmed1",8.40E+017,"testalpha"
,"anastomosis with pph gun","NN IN  NN",4,1,1,17139887,2,3.94E+018,"testalpha"
,"major causes of mortality","JJ NNS IN NN",4,1,1,17236644,"pubmed1",5.04E+018,"testalpha"
,"visualization and colonic transit","NN CC JJ NN",4,1,1,16252139,"pubmed1",8.82E+015,"testalpha"
,"hinders therapeutic approaches inmany","VBZ JJ NNS NN",4,1,1,17068636,"pubmed1",4.75E+018,"testalpha"
,"h n pf c","   NN",4,1,1,16397333,2,7.90E+018,"testalpha"
,"results of hip arthroplasties","NNS IN NN NNS",4,1,1,16613748,2,3.15E+018,"testalpha"
,"pyruvate kinase pk activation","NN NN  NN",4,1,1,17013507,2,3.02E+018,"testalpha"
,"computers and applying computer","NNS CC VBG NN",4,1,1,16473991,"pubmed1",4.11E+018,"testalpha"
,"range of pathological conditions","NN IN JJ NNS",4,1,1,17265697,2,6.16E+018,"testalpha"
,"right colonsamples and quantitation","JJ NNS CC NN",4,1,1,17293967,2,2.57E+018,"testalpha"
,"venom csav n najavenom","NN   NN",4,1,1,16436788,"pubmed1",8.07E+018,"testalpha"
,"toallergy clinics or departments","NN NNS CC NNS",4,1,1,17106600,2,7.72E+018,"testalpha"
,"levels in platelet membrane","NNS IN NN NN",4,1,1,16523217,"pubmed1",2.18E+018,"testalpha"
,"colour components cie l","JJ NNS  ",4,1,1,16648914,2,7.36E+018,"testalpha"
,"knowledge erythema gyratum repens","NN NN NN NNS",4,1,1,16955192,2,9.15E+018,"testalpha"
,"cases of genital ulcers","NNS IN NN NNS",4,1,1,16955191,2,3.57E+018,"testalpha"
,"human research protections ohrp","JJ NN NNS ",4,1,1,16770858,"pubmed1",7.70E+018,"testalpha"
,"cefdinir provides good coverage","NN VBZ JJ NN",4,1,1,16365328,"pubmed1",2.45E+018,"testalpha"
,"support and breast cancer","NN CC NN NN",4,1,1,16596901,"pubmed1",2.57E+018,"testalpha"
,"positive diagnosis of amyloidosis","JJ NN IN NN",4,1,1,16714051,2,2.76E+018,"testalpha"
,"iii scores and serum"," NNS CC NN",4,1,1,17117607,2,6.30E+018,"testalpha"
,"nucleic acids into target","JJ NNS IN NN",4,1,1,17285739,"pubmed1",5.19E+018,"testalpha"
,"multiple organfailure with rhabdomyolysis","JJ NN IN NN",4,1,1,16451160,"pubmed1",1.47E+018,"testalpha"
,"recognized apoptosis signal transduction","VBN NN NN NN",4,1,1,16330085,2,3.07E+018,"testalpha"
,"cell saver and ml","NN NN CC ",4,1,1,17013513,2,5.81E+018,"testalpha"
,"improve interprofessionalcollaboration in dermatology","VB NN IN NN",4,1,1,16710575,2,5.98E+018,"testalpha"
,"higherconcentration at micromol l","NN IN  ",4,1,1,16566960,2,4.73E+018,"testalpha"
,"main form of haemoglobin","JJS NN IN NNP",4,1,1,16511276,2,7.12E+017,"testalpha"
,"system adenosine mediates neurotransmission","NN NN NNS NN",4,1,1,16770441,"pubmed1",5.15E+018,"testalpha"
,"opioid remifentanil during apropofol","VB  IN ",4,1,1,16451148,"pubmed1",3.86E+018,"testalpha"
,"objective healthstatus before operations","NN NN IN NNS",4,1,1,17338197,2,8.97E+017,"testalpha"
,"release pharmacokinetic profile ofzidovudine","NN JJ NN NN",4,1,1,16584139,"pubmed1",8.92E+018,"testalpha"
,"different task conditions participants","JJ NN NNS NNS",4,1,1,16427019,"pubmed1",8.94E+018,"testalpha"
,"colonyforming units g cfu","VBG NNS  ",4,1,1,17293960,2,8.77E+018,"testalpha"
,"addition of ifs cb","NN IN  ",4,1,1,16514842,2,4.17E+018,"testalpha"
,"major radiologicalsigns were appendiceal","JJ NNS VBD NN",4,1,1,16612913,"pubmed1",6.41E+018,"testalpha"
,"test for real worldconditions","NN IN JJ NNS",4,1,1,16054101,"pubmed1",2.69E+017,"testalpha"
,"eructation pyrosis meteorism borborygmi","NN NN NN ",4,1,1,16424650,2,3.16E+018,"testalpha"
,"residual shunt after transcatheter","JJ NN IN NN",4,1,1,16612922,"pubmed1",7.97E+018,"testalpha"
,"liver ischemia for minutes","NN NN IN NNS",4,1,1,17013508,2,5.26E+018,"testalpha"
,"cellactivation and killing activity","NN CC VBG NN",4,1,1,17117211,"pubmed1",7.23E+018,"testalpha"
,"populations of healthy individuals","NNS IN JJ NNS",4,1,1,16929381,"pubmed1",2.38E+018,"testalpha"
,"risk behavior and cancer","NN NN CC NN",4,1,1,16596897,"pubmed1",1.97E+018,"testalpha"
,"nmda receptor antagonist dextromethorphan"," NN NN NNP",4,1,1,16451144,"pubmed1",7.54E+018,"testalpha"
,"information network of departments","NN NN IN NNS",4,1,1,17106597,2,4.11E+018,"testalpha"
,"enhance t lymphocyte activity","VB  NNP NN",4,1,1,17016035,2,6.10E+018,"testalpha"
,"student education by apa","NN NN IN ",4,1,1,16473991,"pubmed1",8.80E+018,"testalpha"
,"option for testing platelet","NN IN NN NN",4,1,1,16549889,2,1.74E+018,"testalpha"
,"patientswith major beta thalassemia","NN NN NN NN",4,1,1,16809886,2,3.18E+018,"testalpha"
,"left vetricular lv performance","VBN JJ  NN",4,1,1,16989140,2,1.95E+018,"testalpha"
,"journals over thesame period","NNS IN VBD NN",4,1,1,16365335,"pubmed1",1.00E+018,"testalpha"
,"toelevated hnrnp k protein","VBN   NN",4,1,1,16496041,"pubmed1",5.59E+018,"testalpha"
,"allocate scarce health careresources","VB JJ NN NNS",4,1,1,16400088,"pubmed1",6.15E+018,"testalpha"
,"igd b cell receptor"," NN NN NN",4,1,1,16964325,"pubmed1",1.43E+018,"testalpha"
,"university of michiganmedical school","NN IN JJ NN",4,1,1,16377822,"pubmed1",3.78E+017,"testalpha"
,"membrane salivary glands pharynx","NN JJ NNS ",4,1,1,17117605,2,5.74E+018,"testalpha"
,"discussion of theliaison committee","NN IN NN NN",4,1,1,16473988,"pubmed1",9.13E+018,"testalpha"
,"nse immunoreactive nerve fibres"," JJ NN NNS",4,1,1,16919707,2,2.22E+018,"testalpha"
,"amp activated protein kinase"," VBN NN NN",4,1,1,16964326,"pubmed1",8.20E+018,"testalpha"
,"provideeducation support and breast","NN NN CC NN",4,1,1,16596901,"pubmed1",3.45E+018,"testalpha"
,"mucosal weight cryptdepth villus","NN NN NN NN",4,1,1,17293957,2,6.73E+018,"testalpha"
,"theories of deterministic chaos","NNS IN JJ NN",4,1,1,16505901,"pubmed1",6.56E+018,"testalpha"
,"freeze drying was conductedunder","NN VBG VBD NN",4,1,1,17285744,"pubmed1",7.71E+018,"testalpha"
,"abl gene variant groups","  NN NNS",4,1,1,16914906,2,6.37E+018,"testalpha"
,"value of thymidylate synthase","NN IN NN NN",4,1,1,17139902,2,3.45E+018,"testalpha"
,"atp analog amp pcp"," NN  ",4,1,1,16421444,2,3.52E+017,"testalpha"
,"laboratory x ray source","NN NN  NN",4,1,1,16511283,2,7.47E+018,"testalpha"
,"mortality after acute stroke","NN IN JJ NN",4,1,1,16436794,"pubmed1",5.95E+018,"testalpha"
,"diphenyl hydantoin calcium sulfate","NN VB NN NN",4,1,1,17285749,"pubmed1",5.03E+017,"testalpha"
,"apoptosis regulatorygene since c","NN NN IN NN",4,1,1,16809887,2,7.85E+018,"testalpha"
,"using response surface methodology","VBG NN NN NN",4,1,1,16584161,"pubmed1",9.08E+018,"testalpha"
,"cases of uterine sarcomas","NNS IN NN NNP",4,1,1,17338203,2,7.33E+018,"testalpha"
,"uva light in thepresence"," NN IN NN",4,1,1,17016038,2,2.97E+017,"testalpha"
,"netherlands with ppsb sd","NNS IN  ",4,1,1,16916181,"pubmed1",2.25E+018,"testalpha"
,"pediatric emergency physicians eps","JJ NN NNS ",4,1,1,16436791,"pubmed1",2.17E+018,"testalpha"
,"additional patients withfvii deficiency","JJ NNS  NN",4,1,1,16424651,2,8.37E+018,"testalpha"
,"mu thiosulfato dipotassium i"," NN NN ",4,1,1,16397335,2,9.11E+018,"testalpha"
,"cc and cc scores"," CC  NNS",4,1,1,17139879,2,3.42E+018,"testalpha"
,"crypts in right colon","NNS IN JJ NN",4,1,1,17293962,2,1.01E+018,"testalpha"
,"nh hexapeptide representing residues"," VB VBG NNS",4,1,1,17117212,"pubmed1",2.55E+018,"testalpha"
,"crystallization and preliminary x","NN CC JJ NN",4,1,1,16511269,2,6.82E+018,"testalpha"
,"main reason for medicalexamination","JJS NN IN NN",4,1,1,17338203,2,2.52E+017,"testalpha"
,"markers vwf and vwf","NNS  CC ",4,1,1,16424652,2,6.10E+018,"testalpha"
,"t lymphocyte proliferation andapoptosis"," NNP NN NN",4,1,1,17016035,2,1.98E+018,"testalpha"
,"minutes of stabilization blood","NNS IN NN NN",4,1,1,16365323,"pubmed1",2.62E+017,"testalpha"
,"antimicrobial therapy further influences","JJ NN JJ NNS",4,1,1,16612906,2,8.47E+018,"testalpha"
,"methods of teachingand training","NNS IN NN NN",4,1,1,16999271,2,1.14E+018,"testalpha"
,"vectors towardartificial synthetic viruses","NNS JJ JJ NNS",4,1,1,17285739,"pubmed1",3.77E+018,"testalpha"
,"equipment indications and localization","NN NNS CC NN",4,1,1,17139898,2,6.24E+018,"testalpha"
,"l carvedilol pretreated patients","  VBN NNS",4,1,1,17338197,2,6.68E+018,"testalpha"
,"trabecular formation in theanimals","JJ NN IN NNS",4,1,1,17293965,2,4.00E+018,"testalpha"
,"cellular proliferation but alsoreduces","JJ NN CC NNS",4,1,1,16564564,2,4.91E+018,"testalpha"
,"membrane ras various transcription","NN  JJ NN",4,1,1,17115080,"pubmed1",4.36E+018,"testalpha"
,"designated institutional official dio","VBN JJ NN ",4,1,1,16377812,"pubmed1",8.15E+018,"testalpha"
,"ofm estimates of displacement"," NNS IN NN",4,1,1,16399029,"pubmed1",7.59E+018,"testalpha"
,"residency research training elements","NN NN NN NNS",4,1,1,16473996,"pubmed1",6.26E+018,"testalpha"
,"urinary excretion ratio ofs","JJ NN NN ",4,1,1,16584121,"pubmed1",1.81E+018,"testalpha"
,"erythrocyte hb and meanerythrocyte","NNP  CC NNP",4,1,1,16809890,2,8.40E+018,"testalpha"
,"describe non human sign","VB  JJ NN",4,1,1,16988903,"pubmed1",2.86E+018,"testalpha"
,"different authors year survival","JJ NNS NN NN",4,1,1,17139900,2,7.23E+018,"testalpha"
,"modern application ofoptical techniques","JJ NN JJ NNS",4,1,1,17013504,2,7.01E+018,"testalpha"
,"thinprep pap smear slide","  JJ NN",4,1,1,16514841,2,6.74E+018,"testalpha"
,"patient with metastatic mm","NN IN JJ ",4,1,1,16859616,2,1.25E+018,"testalpha"
,"recurrent severe bleeding episodes","NN JJ VBG NNS",4,1,1,16424649,2,6.62E+018,"testalpha"
,"hs before clp clp"," IN  ",4,1,1,17293958,2,6.11E+017,"testalpha"
,"patients and soft sternum","NNS CC JJ NN",4,1,1,16956118,2,5.65E+018,"testalpha"
,"skills and attitudes questionnaire","NNS CC NNS NN",4,1,1,16377828,"pubmed1",1.78E+018,"testalpha"
,"patients different therapeutic modalities","NNS JJ JJ NNS",4,1,1,16859612,2,6.91E+017,"testalpha"
,"urinary retention pruritus sedation","JJ NN NN NN",4,1,1,16916180,"pubmed1",2.50E+018,"testalpha"
,"acid diglucamide monosodium salt","NN VB NN NN",4,1,1,16399028,"pubmed1",1.15E+016,"testalpha"
,"case showed fiveplexiform neurofibromas","NN VBD NN NNP",4,1,1,17010267,2,6.14E+017,"testalpha"
,"anon apoptotic defensive role"," JJ JJ NN",4,1,1,16919708,2,6.57E+018,"testalpha"
,"multiple logistic regression techniques","JJ JJ NN NNS",4,1,1,16405858,"pubmed1",4.74E+018,"testalpha"
,"flow rate and volume","NN NN CC NN",4,1,1,16491219,2,4.65E+018,"testalpha"
,"dg autoradiography in rats"," NN IN NNS",4,1,1,17133958,2,4.30E+018,"testalpha"
,"corticosteroids pulse intravenousmethylprednisolone decreases","NNS NN NN NNS",4,1,1,16955189,2,5.00E+018,"testalpha"
,"published research on depictionsof","VBN NN IN ",4,1,1,16474001,"pubmed1",8.17E+018,"testalpha"
,"recovery of cognitive function","NN IN JJ NN",4,1,1,16451145,"pubmed1",6.43E+018,"testalpha"
,"pulmonary embolism femoral vein","JJ NN JJ NN",4,1,1,16696443,2,8.75E+018,"testalpha"
,"solution for electron microscopy","NN IN NN ",4,1,1,16574202,2,3.02E+018,"testalpha"
,"quantities of organized bundles","NNS IN VBN NNS",4,1,1,16574202,2,4.61E+018,"testalpha"
,"stem cell pbsc transplantation","VB NN  NN",4,1,1,17119322,2,5.26E+018,"testalpha"
,"faculty support and developmentprograms","NN NN CC NNS",4,1,1,16377815,"pubmed1",2.16E+018,"testalpha"
,"i k c h","  NN ",4,1,1,16397335,2,7.78E+018,"testalpha"
,"wide variety of dna","JJ NN IN ",4,1,1,16411739,"pubmed1",5.34E+018,"testalpha"
,"option in patients withacute","NN IN NNS NN",4,1,1,16333701,"pubmed1",4.20E+018,"testalpha"
,"level of thyroid function","NN IN NN NN",4,1,1,16479025,2,2.48E+018,"testalpha"
,"dyserythropoietic anemia type ii","JJ NN NN ",4,1,1,17117609,2,1.04E+018,"testalpha"
,"heterogeneities of hccs onimages","NNS IN  NNS",4,1,1,16317488,"pubmed1",7.41E+018,"testalpha"
,"openfield and startle behavior","NN CC VB NN",4,1,1,17133954,2,2.19E+018,"testalpha"
,"converting enzyme ace inhibitors","VBG  NN NNS",4,1,1,16451161,"pubmed1",2.52E+018,"testalpha"
,"preservation efficiency ofacetone ac","NN NN NN ",4,1,1,16950501,2,8.04E+018,"testalpha"
,"inducing fibroplasias via inflammatorymediators","VBG NNP IN NNS",4,1,1,16983449,2,4.87E+018,"testalpha"
,"activity and oxygen consumption","NN CC NN NN",4,1,1,17068635,"pubmed1",3.49E+018,"testalpha"
,"case by case evaluation","NN IN NN NN",4,1,1,16673611,2,3.28E+018,"testalpha"
,"thecourse of amyloid fibril","NN IN VB NNP",4,1,1,16714052,2,6.97E+018,"testalpha"
,"higher roc curve p","JJR  NN ",4,1,1,16399036,"pubmed1",7.45E+017,"testalpha"
,"protein kinase c overexpression","NN NN NN NN",4,1,1,16479030,2,3.24E+017,"testalpha"
,"place since student faculty","NN IN NN NN",4,1,1,16473991,"pubmed1",8.79E+018,"testalpha"
,"mandated bythe residency review","VBN NNP NN NN",4,1,1,16473998,"pubmed1",9.19E+018,"testalpha"
,"d glucan treated animals"," JJ VBN NNS",4,1,1,16612917,"pubmed1",2.18E+018,"testalpha"
,"gsh px sod cat","   NN",4,1,1,16999986,2,5.84E+018,"testalpha"
,"thatnatural genome editing competences","JJ NN NN NNS",4,1,1,17347785,"pubmed1",4.38E+018,"testalpha"
,"picolinate anion via o","NN NN IN ",4,1,1,16456283,2,7.41E+018,"testalpha"
,"co l lactide b","  VB NN",4,1,1,16701879,"pubmed1",6.47E+018,"testalpha"
,"completeness of data sources","NN IN NNS NNS",4,1,1,16221468,"pubmed1",3.11E+018,"testalpha"
,"distinct scutes and hinge","JJ NNS CC NN",4,1,1,16733064,2,8.95E+017,"testalpha"
,"raising concerns in regard","VBG NNS IN NN",4,1,1,16612929,"pubmed1",8.41E+018,"testalpha"
,"whereasmicromanagement and difficult people","NN CC JJ NNS",4,1,1,16377814,"pubmed1",4.72E+018,"testalpha"
,"medicine em program directors","NN  NN NNS",4,1,1,16436795,"pubmed1",4.95E+018,"testalpha"
,"vessels and right hemi","NNS CC JJ ",4,1,1,16673610,2,8.09E+018,"testalpha"
,"setting reaction without affectingstrength","NN NN IN NN",4,1,1,16701865,"pubmed1",7.16E+018,"testalpha"
,"cells by stimulationwith gm","NNS IN NN ",4,1,1,16404477,"pubmed1",2.23E+018,"testalpha"
,"established prothrombotic risk factors","VBN JJ NN NNS",4,1,1,16549894,2,3.45E+018,"testalpha"
,"identifythe high risk areas","NNP JJ NN NNS",4,1,1,16321534,"pubmed1",4.40E+018,"testalpha"
,"current system of oversight","JJ NN IN NN",4,1,1,16770860,"pubmed1",3.77E+018,"testalpha"
,"conditions yielded yellow hexagonalcrystals","NNS VBD JJ NNS",4,1,1,16511277,2,2.02E+018,"testalpha"
,"findings for injury prevention","NNS IN NN NN",4,1,1,16436798,"pubmed1",6.82E+016,"testalpha"
,"performance test cpt vigilance","NN NN  NN",4,1,1,16479025,2,7.04E+018,"testalpha"
,"age dependent th percentiles","NN JJ  NNS",4,1,1,16549894,2,7.41E+017,"testalpha"
,"clinical applications for pet","JJ NNS IN NN",4,1,1,16333707,"pubmed1",3.14E+018,"testalpha"
,"dimethylarsenate dma v andexhibits","NN   NNS",4,1,1,17019444,"pubmed1",2.49E+018,"testalpha"
,"lucida lamina densa border","NNP NNP NNP NN",4,1,1,16955192,2,4.51E+018,"testalpha"
,"purified nqrf fad domain","VBN  NN NN",4,1,1,16511277,2,6.08E+018,"testalpha"
,"life threatheningepisodes of haematemesis","NN NNS IN NN",4,1,1,16673613,2,2.43E+018,"testalpha"
,"crystal structure as search","NN NN IN NN",4,1,1,16511279,2,3.67E+018,"testalpha"
,"characteristics course and prognosis","NNS NN CC NN",4,1,1,16696444,2,9.03E+018,"testalpha"
,"diabetes dyslipidemia and hypertension","NN NN CC NN",4,1,1,17013519,2,4.31E+018,"testalpha"
,"uptake pathway about fold","NN NN IN NN",4,1,1,16964326,"pubmed1",8.47E+018,"testalpha"
,"causes ofhypoalbuminemia in patients","NNS NN IN NNS",4,1,1,17117607,2,6.75E+017,"testalpha"
,"gastric brushing cytology findings","JJ NN NN NNS",4,1,1,16514844,2,1.03E+018,"testalpha"
,"key concepts prototypical technology","JJ NNS JJ NN",4,1,1,16473991,"pubmed1",3.97E+018,"testalpha"
,"graft along experimental periodand","NN IN JJ NN",4,1,1,17293971,2,2.43E+018,"testalpha"
,"colony stimulating factors g","NN JJ NNS ",4,1,1,16424645,2,6.01E+018,"testalpha"
,"differentdosages on rat skin","NNS IN NN NN",4,1,1,16574202,2,5.54E+018,"testalpha"
,"increasing range of care","VBG NN IN NN",4,1,1,16462404,"pubmed1",8.14E+018,"testalpha"
,"inthe protection of proteins","NNP NN IN NNS",4,1,1,17063208,"pubmed1",3.34E+018,"testalpha"
,"candidates formolecular targeted therapy","NNS JJ VBN NN",4,1,1,16424655,2,6.13E+018,"testalpha"
,"publication of strauss andkligman","NN IN VB NN",4,1,1,16603103,2,6.26E+018,"testalpha"
,"charged groups connecting h","VBN NNS VBG ",4,1,1,17019436,"pubmed1",2.12E+018,"testalpha"
,"studies and neuronal cell","NNS CC JJ NN",4,1,1,17265697,2,4.53E+018,"testalpha"
,"cells cytokines and growth","NNS NNS CC NN",4,1,1,17013516,2,3.64E+018,"testalpha"
,"experimental interventionthan were abstracts","JJ NNP VBD NNS",4,1,1,16365332,"pubmed1",3.01E+016,"testalpha"
,"endoneurial extracellular matrix ecm","JJ JJ NNP ",4,1,1,16414104,2,6.17E+018,"testalpha"
,"aviation or road transport","NN CC NN NN",4,1,1,16427020,"pubmed1",8.95E+018,"testalpha"
,"sarckatp channel blocker hmr"," NN NN ",4,1,1,16566960,2,1.55E+018,"testalpha"
,"adverse impacts onacademic faculty","JJ NNS JJ NN",4,1,1,16377815,"pubmed1",4.95E+018,"testalpha"
,"oral tyrosine kinase inhibitors","JJ NN NN NNS",4,1,1,16914906,2,6.52E+018,"testalpha"
,"expression of t cell","NN IN  NN",4,1,1,16424654,2,6.25E+018,"testalpha"
,"survey that collected self","NN IN VBN NN",4,1,1,16112069,"pubmed1",1.70E+018,"testalpha"
,"subclinical disease and gy","JJ NN CC ",4,1,1,17117605,2,3.97E+018,"testalpha"
,"colonization and healthy controls","NN CC JJ NNS",4,1,1,16603098,2,5.37E+018,"testalpha"
,"neoplasms hurthle cell tumors","NNS  NN NNS",4,1,1,16514836,2,1.56E+018,"testalpha"
,"severe dysphagiaand aspiration pneumonia","JJ NN NN NNP",4,1,1,16673615,2,5.63E+018,"testalpha"
,"scale randomized clinical trial","NN VBN JJ NN",4,1,1,16424656,2,8.62E+018,"testalpha"
,"block in various painfulsituations","NN IN JJ NNS",4,1,1,16916183,"pubmed1",6.53E+018,"testalpha"
,"arginine methyl ester l","NN  NN ",4,1,1,16764913,2,3.87E+017,"testalpha"
,"values but correlated negativelywith","NNS CC VBN NN",4,1,1,16377814,"pubmed1",2.69E+018,"testalpha"
,"use of specific kinase","NN IN JJ NN",4,1,1,16956122,2,7.73E+018,"testalpha"
,"be weighed againstthe necessity","VB VBD NNP NN",4,1,1,16999266,2,4.40E+018,"testalpha"
,"increased resources and support","VBN NNS CC NN",4,1,1,16436795,"pubmed1",6.13E+018,"testalpha"
,"sheathchloroplasts of c plants","NNS IN NN NNS",4,1,1,17106510,"pubmed1",3.52E+018,"testalpha"
,"andpostoperative limitations of activity","JJ NNS IN NN",4,1,1,16612909,2,1.57E+018,"testalpha"
,"review committee rrc core","NN NN  NN",4,1,1,16473998,"pubmed1",2.01E+018,"testalpha"
,"cell turnover vascular malformations","NN NN JJ NNS",4,1,1,16722347,2,5.85E+018,"testalpha"
,"higher water content vs","JJR NN JJ ",4,1,1,16701880,"pubmed1",5.02E+018,"testalpha"
,"cases of tuberculosis n","NNS IN NN ",4,1,1,16447095,"pubmed1",1.40E+017,"testalpha"
,"injury in humans afterconcussion","NN IN NNS NN",4,1,1,16436787,"pubmed1",8.12E+018,"testalpha"
,"anterior resection with tmeare","JJ NN IN NN",4,1,1,17139896,2,7.23E+018,"testalpha"
,"decreased cr and bun","VBD  CC ",4,1,1,16999986,2,8.83E+018,"testalpha"
,"controls for motorcycling activity","NNS IN VBG NN",4,1,1,16202466,"pubmed1",5.67E+018,"testalpha"
,"death in certain regions","NN IN JJ NNS",4,1,1,17013520,2,6.90E+018,"testalpha"
,"cell and tissue studies","NN CC NN NNS",4,1,1,16730369,2,6.09E+018,"testalpha"
,"serum for lipid profile","NN IN NN NN",4,1,1,16479026,2,2.66E+018,"testalpha"
,"surface structure changesof sodium","NN NN  NN",4,1,1,16584166,"pubmed1",3.08E+016,"testalpha"
,"ac and posterior commissures"," CC JJ NNS",4,1,1,16399030,"pubmed1",1.11E+018,"testalpha"
,"form closed shell structure","VB VBN NN NN",4,1,1,16701854,"pubmed1",4.46E+018,"testalpha"
,"propionibacterium acnes pai catalyzesthe","NN NNS  NNP",4,1,1,16511289,2,5.67E+018,"testalpha"
,"cross sectional study withconvenience","NN JJ NN NN",4,1,1,16436792,"pubmed1",5.86E+018,"testalpha"
,"therestrictions on patient care","NNS IN NN NN",4,1,1,16377823,"pubmed1",8.90E+018,"testalpha"
,"significance of serum ada","NN IN NN ",4,1,1,16956117,2,7.84E+018,"testalpha"
,"squeeze pressure cm h","NN NN  ",4,1,1,17139884,2,6.35E+018,"testalpha"
,"vas for perceived exaggeration"," IN VBN NN",4,1,1,16436793,"pubmed1",7.56E+018,"testalpha"
,"residues usingcomputer graphics software","NNS NN NNS NN",4,1,1,16421450,2,3.26E+018,"testalpha"
,"nic affords n n","JJ NNS  ",4,1,1,16594645,"pubmed1",6.56E+018,"testalpha"
,"dnmt b nbs rad"," NN  ",4,1,1,16914901,2,4.54E+018,"testalpha"
,"patients with positive spt","NNS IN JJ ",4,1,1,16859611,2,4.49E+018,"testalpha"
,"electrostatic charge control capabilities","JJ NN NN NNS",4,1,1,17285749,"pubmed1",2.57E+018,"testalpha"
,"congenital naevi in children","NN  IN NNS",4,1,1,16710582,2,3.38E+018,"testalpha"
,"homosapiens hs mus musculus","NNS   NN",4,1,1,16733558,"pubmed1",5.26E+018,"testalpha"
,"dismutase sod with use","NN  IN NN",4,1,1,17293962,2,3.05E+018,"testalpha"
,"cases necessitating effectiveantithrombotic treatment","NNS VBG JJ NN",4,1,1,16549901,2,4.17E+018,"testalpha"
,"transfusion requirement than affp","NN NN IN ",4,1,1,16451158,"pubmed1",2.85E+018,"testalpha"
,"bibliographies and grant agency","NNS CC NN NN",4,1,1,16365334,"pubmed1",4.89E+017,"testalpha"
,"protein sequences of rab","NN NNS IN ",4,1,1,16365637,"pubmed1",4.83E+018,"testalpha"
,"intensive care unit byintensivists","JJ NN NN NNS",4,1,1,16365336,"pubmed1",7.74E+018,"testalpha"
,"spontaneous hematomas and rupture","JJ NNP CC NN",4,1,1,16317492,"pubmed1",8.42E+018,"testalpha"
,"ipc and ipc group"," CC  NN",4,1,1,17013508,2,4.79E+018,"testalpha"
,"rna from dna chains"," IN  NNS",4,1,1,17294912,2,2.89E+018,"testalpha"
,"issue of platelet function","NN IN NN NN",4,1,1,16549889,2,4.47E+018,"testalpha"
,"sme sumatriptan succinatemicroemulsions ssme"," NNP NNS ",4,1,1,16584167,"pubmed1",7.27E+018,"testalpha"
,"thin platesplines tps method","JJ NNS  NN",4,1,1,16722348,2,6.00E+018,"testalpha"
,"rareclones with improved protein","NNS IN VBN NN",4,1,1,16369090,2,2.83E+018,"testalpha"
,"mglul or mglu receptor"," CC  NN",4,1,1,17265692,2,3.37E+018,"testalpha"
,"thickness skin grafts conclusion","NN NN NNS NN",4,1,1,17165596,2,4.20E+018,"testalpha"
,"risks in complex cases","NNS IN JJ NNS",4,1,1,16612926,"pubmed1",3.22E+017,"testalpha"
,"simian immunodeficiency virus siv","JJ NN NN ",4,1,1,16511250,2,7.20E+018,"testalpha"
,"dorsal and ventral roots","NN CC JJ NNS",4,1,1,16414104,2,8.42E+018,"testalpha"
,"occupational healthnurse specialist cohn","JJ NN NN ",4,1,1,16438092,"pubmed1",2.89E+018,"testalpha"
,"dispersion showed mean particle","NN VBD VB NN",4,1,1,17285742,"pubmed1",4.76E+018,"testalpha"
,"injections of desferrioxamine mg","NNS IN NN ",4,1,1,16612918,"pubmed1",2.36E+018,"testalpha"
,"fine processing on p","JJ NN IN ",4,1,1,16399031,"pubmed1",5.73E+018,"testalpha"
,"mean arterial blood pressure","VB JJ NN NN",4,1,1,16365323,"pubmed1",8.22E+017,"testalpha"
,"theteratogenic effects of abuse","JJ NNS IN NN",4,1,1,16808045,"pubmed1",8.78E+018,"testalpha"
,"factors enhancers and silencers","NNS NNS CC NNS",4,1,1,16505901,"pubmed1",1.55E+018,"testalpha"
,"driving using moderated regressionanalyses","NN VBG VBN NNS",4,1,1,16443186,"pubmed1",2.49E+018,"testalpha"
,"complement and extracellular matrix","NN CC JJ NNP",4,1,1,16964325,"pubmed1",5.57E+018,"testalpha"
,"significant gastrointestinal side effects","JJ JJ NN NNS",4,1,1,16424650,2,8.36E+018,"testalpha"
,"diameter of artemisiaarborescens l","NN IN NNS ",4,1,1,16584150,"pubmed1",1.39E+018,"testalpha"
,"nowadaysin cases of nonunions","NNP NNS IN NNS",4,1,1,16613748,2,1.98E+018,"testalpha"
,"vte were identified usingmultivariate"," VBD VBN NN",4,1,1,16549896,2,4.02E+018,"testalpha"
,"severe illness cognitive insufficiency","JJ NN JJ NN",4,1,1,16365327,"pubmed1",3.30E+018,"testalpha"
,"inidentifying provider staffing patterns","VBG NN NN NNS",4,1,1,16365329,"pubmed1",3.20E+018,"testalpha"
,"acid side chains tyr","NN NN NNS ",4,1,1,16511248,2,1.68E+018,"testalpha"
,"eradicated inca free bath","VBN  JJ NN",4,1,1,16395521,"pubmed1",7.39E+018,"testalpha"
,"weeks and group b","NNS CC NN NN",4,1,1,16424649,2,8.68E+018,"testalpha"
,"antibioticsand conventional amphotericin b","NN JJ NNP NN",4,1,1,16918064,"pubmed1",8.78E+017,"testalpha"
,"proliferation and apoptosis initp","NN CC NN ",4,1,1,17016035,2,5.43E+018,"testalpha"
,"service education on dsh","NN NN IN ",4,1,1,16330213,"pubmed1",7.98E+018,"testalpha"
,"considerable burden on society","JJ NN IN NN",4,1,1,17013520,2,2.21E+018,"testalpha"
,"naevi and atypical naevi"," CC JJ ",4,1,1,16648914,2,7.16E+018,"testalpha"
,"presence ofthe auditory radiations","NN NNP NN NNS",4,1,1,16399034,"pubmed1",6.63E+018,"testalpha"
,"necrolysis and stevens johnson","NN CC NNS NN",4,1,1,16710577,2,8.57E+018,"testalpha"
,"galactosidases agaa agab andagaa","NNS   ",4,1,1,16511274,2,3.15E+018,"testalpha"
,"effect ofdizocilpine maleate mk","NN NN NN ",4,1,1,17133953,2,2.33E+018,"testalpha"
,"hypogonadism and congestiveheart failure","NN CC NN NN",4,1,1,16424663,2,6.56E+018,"testalpha"
,"whr and liver echogenicity"," CC NN NN",4,1,1,16673610,2,4.87E+018,"testalpha"
,"hospital stay was days","NN NN VBD NNS",4,1,1,16956118,2,7.94E+018,"testalpha"
,"common congenital heart defect","JJ NN NN NN",4,1,1,16612922,"pubmed1",8.76E+018,"testalpha"
,"size and changes proportion","NN CC NNS NN",4,1,1,16918067,"pubmed1",6.90E+018,"testalpha"
,"extracellular saccharase from culture","JJ NN IN NN",4,1,1,16970980,2,8.81E+018,"testalpha"
,"considering villous architecture inflammationand","VBG JJ NN NN",4,1,1,16673563,2,2.41E+018,"testalpha"
,"pdna chitosan edta particles"," JJ  NNS",4,1,1,17285741,"pubmed1",4.60E+018,"testalpha"
,"sequences during somatic recombination","NNS IN JJ NN",4,1,1,16505901,"pubmed1",5.92E+018,"testalpha"
,"mouse leukemia cell line","NN NN NN NN",4,1,1,17117211,"pubmed1",3.31E+018,"testalpha"
,"congenital dyserythropoietic anemia type","NN JJ NN NN",4,1,1,17117609,2,3.06E+018,"testalpha"
,"vas pain scores p"," NN NNS ",4,1,1,16436793,"pubmed1",3.51E+018,"testalpha"
,"mammography and cytologic features","NN CC JJ NNS",4,1,1,16514838,2,2.16E+018,"testalpha"
,"result of hivdisease hiv","NN IN NN ",4,1,1,16462405,"pubmed1",7.71E+018,"testalpha"
,"mg kg and cause","  CC NN",4,1,1,17013510,2,7.81E+018,"testalpha"
,"i with pbs washing"," IN  NN",4,1,1,16514835,2,8.74E+018,"testalpha"
,"encephalopathy infection in smallruminants","JJ NN IN NNS",4,1,1,16770445,"pubmed1",5.13E+018,"testalpha"
,"survivalrates of stratified risk","NNS IN VBN NN",4,1,1,16451146,"pubmed1",5.37E+018,"testalpha"
,"license and court systemsare","NN CC NN NN",4,1,1,16112068,"pubmed1",1.43E+017,"testalpha"
,"data and ignore nonconfirmatory","NNS CC VB NN",4,1,1,16365325,"pubmed1",1.61E+018,"testalpha"
,"name of acolour space","NN IN JJ NN",4,1,1,16648914,2,3.64E+018,"testalpha"
,"show thatthe antioxidant system","VBP NNP JJ NN",4,1,1,16404476,"pubmed1",2.38E+016,"testalpha"
,"microg kg day ip","NNP  NN ",4,1,1,16714049,2,1.51E+018,"testalpha"
,"patientswith psoriasis and eczema","NN NN CC NN",4,1,1,16710574,2,8.13E+018,"testalpha"
,"cl hco mmol l","   ",4,1,1,16701876,"pubmed1",5.09E+017,"testalpha"
,"biologic behavior of mtc","JJ NN IN ",4,1,1,16603102,2,6.74E+018,"testalpha"
,"interfacial polymerization of methacrylatedn","JJ NN IN ",4,1,1,16701854,"pubmed1",1.44E+018,"testalpha"
,"using quantitative pcr qpcr","VBG JJ  ",4,1,1,16914901,2,1.88E+018,"testalpha"
,"gal o gal c","   NN",4,1,1,16456293,2,3.12E+018,"testalpha"
,"bipolar nuclei and cell","JJ  CC NN",4,1,1,16514838,2,6.08E+018,"testalpha"
,"diminished destruction of erythrocytes","VBN NN IN NNS",4,1,1,17117609,2,6.28E+018,"testalpha"
,"affectthermoregulation water and energy","NN NN CC NN",4,1,1,17133952,2,8.50E+018,"testalpha"
,"health evaluation apache ii","NN NN NNP ",4,1,1,16365336,"pubmed1",7.56E+018,"testalpha"
,"addition post operative transfusion","NN NN JJ NN",4,1,1,16451158,"pubmed1",2.83E+018,"testalpha"
,"casualties in windsor ontario","NNS IN NN NNP",4,1,1,16169506,"pubmed1",1.39E+018,"testalpha"
,"cd cells in transient"," NNS IN NN",4,1,1,17265691,2,6.69E+018,"testalpha"
,"largest series from asingle","JJT NN IN NN",4,1,1,16424653,2,2.33E+018,"testalpha"
,"murine beta cell line","NN NN NN NN",4,1,1,16701853,"pubmed1",5.18E+018,"testalpha"
,"automated external defibrillators aeds","VBN JJ NNS ",4,1,1,16365330,"pubmed1",1.66E+018,"testalpha"
,"adenosine and gamma phosphate","NN CC NN NN",4,1,1,16421444,2,4.02E+018,"testalpha"
,"ng ml and ts","  CC ",4,1,1,16809889,2,8.81E+018,"testalpha"
,"regionsof mutation hot spots"," NN JJ NNS",4,1,1,16582987,"pubmed1",7.14E+017,"testalpha"
,"ligand than thenormal control","NN IN JJ NN",4,1,1,16710577,2,5.44E+018,"testalpha"
,"freeenergy deltago enthalpy deltaho","NN NNP  NNP",4,1,1,17019442,"pubmed1",5.66E+018,"testalpha"
,"hypothesis that classical morphology","NN IN JJ NN",4,1,1,17486414,"pubmed1",5.75E+018,"testalpha"
,"time of rhapc administration","NN IN  NN",4,1,1,16365336,"pubmed1",2.59E+018,"testalpha"
,"assessed thesensitivity and specificity","VBN NN CC NN",4,1,1,16451151,"pubmed1",3.25E+018,"testalpha"
,"long term bone marrowculture","JJ NN NN NN",4,1,1,17016038,2,3.97E+018,"testalpha"
,"unilateral fusion of neurocranim","JJ NN IN ",4,1,1,17438834,2,8.44E+018,"testalpha"
,"thoracic injuries spinal injuries","JJ NNS JJ NNS",4,1,1,16549896,2,3.06E+018,"testalpha"
,"pahs fluorescence andinner filter"," NN NN NN",4,1,1,16404478,"pubmed1",8.19E+018,"testalpha"
,"biasor time lag bias","NN NN VB NN",4,1,1,16365332,"pubmed1",7.71E+018,"testalpha"
,"outcome variables were serum","NN NNS VBD NN",4,1,1,17293972,2,5.32E+018,"testalpha"
,"values associated torisk measures","NNS VBN JJ NNS",4,1,1,16126153,"pubmed1",1.50E+018,"testalpha"
,"pressure sores with v","NN NNS IN ",4,1,1,17165597,2,6.00E+018,"testalpha"
,"towardimproved water maze performance","VBN NN NN NN",4,1,1,17265691,2,6.57E+018,"testalpha"
,"more adults with atopic","JJR NNS IN NN",4,1,1,16648916,2,3.50E+018,"testalpha"
,"questionnaire skin prick tests","NN NN NNP NNS",4,1,1,16648913,2,6.98E+018,"testalpha"
,"gma tegdma resin system"," NN NNP NN",4,1,1,16701856,"pubmed1",8.22E+018,"testalpha"
,"continuous performance task f","JJ NN NN NN",4,1,1,16436796,"pubmed1",7.70E+018,"testalpha"
,"possible torecommend dose regimens","JJ NN NN NNS",4,1,1,16451144,"pubmed1",6.08E+018,"testalpha"
,"whole cell current andcapacitance","JJ NN JJ NN",4,1,1,16395521,"pubmed1",2.31E+016,"testalpha"
,"aaaf and other derivatives"," CC JJ NNS",4,1,1,17143337,"pubmed1",1.46E+018,"testalpha"
,"interpretation by thepediatric ep","NN IN JJ ",4,1,1,16436791,"pubmed1",4.25E+018,"testalpha"
,"fields of materials science","NNS IN NNS NN",4,1,1,16701861,"pubmed1",6.18E+018,"testalpha"
,"complexity of work p","NN IN NN ",4,1,1,16451152,"pubmed1",4.45E+018,"testalpha"
,"seconds for fine processing","NNS IN JJ NN",4,1,1,16399031,"pubmed1",6.72E+018,"testalpha"
,"negative binomial regression models","JJ JJ NN NNS",4,1,1,16442487,"pubmed1",9.01E+018,"testalpha"
,"clinical examination and laboratory","JJ NN CC NN",4,1,1,16673615,2,6.95E+018,"testalpha"
,"o h c pyridine","  NN NN",4,1,1,16456276,2,4.39E+018,"testalpha"
,"includes gastrointestinal symptoms fatigue","VBZ JJ NNS NN",4,1,1,17016040,2,8.98E+018,"testalpha"
,"presence of consanguine marriages","NN IN NN NNS",4,1,1,16710576,2,4.74E+018,"testalpha"
,"squeezepressure cm h o","NN   ",4,1,1,17139884,2,2.72E+018,"testalpha"
,"administration of ml kg","NN IN  ",4,1,1,16451158,"pubmed1",5.01E+018,"testalpha"
,"balloon dilation of native","NN NN IN NN",4,1,1,16612929,"pubmed1",2.26E+018,"testalpha"
,"designations by theinsurance institute","NNS IN NN NN",4,1,1,16171767,"pubmed1",5.95E+018,"testalpha"
,"decrease in tablet surface","NN IN NN NN",4,1,1,16584166,"pubmed1",2.97E+018,"testalpha"
,"degeneration and free body","NN CC JJ NN",4,1,1,17293966,2,8.85E+018,"testalpha"
,"biotoxins are botulinumtoxin tetanus","NNS VBP  NN",4,1,1,16696436,2,3.45E+018,"testalpha"
,"slides while nuclear detail","NNS IN JJ NN",4,1,1,16514836,2,7.25E+018,"testalpha"
,"ii years group iii"," NNS VBP ",4,1,1,16809889,2,2.42E+018,"testalpha"
,"key problem in thetreatment","JJ NN IN NN",4,1,1,16999270,2,7.88E+018,"testalpha"
,"studies on duration reproduction","NNS IN NN NN",4,1,1,17133956,2,3.11E+018,"testalpha"
,"range years and ad","NN NNS CC NN",4,1,1,16859613,2,6.96E+018,"testalpha"
,"cleft types cl clp","NN NNS  ",4,1,1,17165598,2,1.11E+018,"testalpha"
,"tissue loss throughthe use","NN NN NNP NN",4,1,1,16722345,2,6.65E+017,"testalpha"
,"veterans healthcare system cavhs","NNS NN NN ",4,1,1,16438093,"pubmed1",8.48E+018,"testalpha"
,"variations in mobile phone","NNS IN JJ NN",4,1,1,16157285,"pubmed1",2.29E+018,"testalpha"
,"known d melanogaster mirnas","VBN  NN NNP",4,1,1,16770443,"pubmed1",1.28E+018,"testalpha"
,"raman andx ray analyses","NN   NNS",4,1,1,16701876,"pubmed1",2.06E+018,"testalpha"
,"systemfor retroviral vector transduction","JJ JJ NN NN",4,1,1,17160143,"pubmed1",8.32E+018,"testalpha"
,"was slightlybetter in e","VBD NN IN ",4,1,1,16914906,2,4.33E+018,"testalpha"
,"screen system seroa monaco","NN NN  NNP",4,1,1,16514835,2,3.73E+017,"testalpha"
,"ruby laser in children"," NN IN NNS",4,1,1,16710582,2,6.63E+018,"testalpha"
,"nugc gastric cancer cell"," JJ NN NN",4,1,1,17143338,"pubmed1",4.53E+018,"testalpha"
,"anterior division of theright","JJ NN IN NN",4,1,1,16612928,"pubmed1",2.57E+018,"testalpha"
,"significance level of p","NN NN IN ",4,1,1,17293963,2,8.91E+017,"testalpha"
,"drugs for paintreatment treatment","NNS IN NN NN",4,1,1,16916184,"pubmed1",1.48E+018,"testalpha"
,"withtype diabetes t dm","JJ NN  ",4,1,1,16918068,"pubmed1",1.32E+018,"testalpha"
,"level activities of selenium","NN NNS IN NN",4,1,1,16404476,"pubmed1",5.44E+018,"testalpha"
,"vascularity andheterogeneity of hccs","NN NN IN ",4,1,1,16317488,"pubmed1",7.11E+018,"testalpha"
,"age sex tumor location","NN NN NN NN",4,1,1,16530813,2,3.23E+018,"testalpha"
,"ly r cell line"," NN NN NN",4,1,1,16404475,"pubmed1",6.28E+018,"testalpha"
,"background although supplemental oxygen","NN IN JJ NN",4,1,1,16451147,"pubmed1",6.48E+018,"testalpha"
,"ofcollagen and other components","NN CC JJ NNS",4,1,1,17013515,2,6.88E+018,"testalpha"
,"revealed atypicalmethylotrophic pathway reactions","VBD JJ NN NNS",4,1,1,17019438,"pubmed1",9.95E+017,"testalpha"
,"combined triple injection isfaster","VBN NN NN NN",4,1,1,16451159,"pubmed1",8.88E+018,"testalpha"
,"cedar pollinosis without eruption","NN NN IN NN",4,1,1,16648919,2,3.72E+018,"testalpha"
,"sustained expression of stfr","VBN NN IN ",4,1,1,17119325,2,6.58E+018,"testalpha"
,"patients with obstructed defecation","NNS IN VBN NN",4,1,1,17139889,2,7.21E+018,"testalpha"
,"ebv associated genital ulcers"," VBN NN NNS",4,1,1,16955191,2,1.59E+018,"testalpha"
,"ld l d h","   ",4,1,1,17133952,2,2.59E+017,"testalpha"
,"factors in consumer product","NNS IN NN NN",4,1,1,16434013,"pubmed1",1.61E+018,"testalpha"
,"sm in molecular models"," IN JJ NNS",4,1,1,16594640,"pubmed1",7.41E+018,"testalpha"
,"laws and regulations anumber","NNS CC NNS NN",4,1,1,16438095,"pubmed1",3.42E+017,"testalpha"
,"differences between bupivacaine andropivacaine","NNS IN NN NN",4,1,1,16617757,"pubmed1",7.57E+018,"testalpha"
,"legislation serious head injury","NN JJ NN NN",4,1,1,16223468,"pubmed1",1.34E+018,"testalpha"
,"layer resistances obtained bymtm","NN NNS VBN ",4,1,1,17285744,"pubmed1",3.53E+018,"testalpha"
,"fulfils except acidosis thecriteria","NNS VB NN NNP",4,1,1,16451160,"pubmed1",6.15E+018,"testalpha"
,"measurement of skin mechanics","NN IN NN NNS",4,1,1,16874414,2,1.21E+018,"testalpha"
,"x ray powder diffraction","NN  NN NN",4,1,1,17285745,"pubmed1",8.38E+017,"testalpha"
,"modified erlanger atopy score","VBN NN  NN",4,1,1,16648917,2,4.71E+018,"testalpha"
,"important public health consequences","JJ JJ NN NNS",4,1,1,17013520,2,1.18E+018,"testalpha"
,"state free radical concentration","NN JJ JJ NN",4,1,1,16421442,2,5.91E+018,"testalpha"
,"mrna in isolated platelets"," IN VBN NNS",4,1,1,16733564,"pubmed1",5.83E+018,"testalpha"
,"vegf ind values ofhccs","  NNS ",4,1,1,16317488,"pubmed1",2.83E+018,"testalpha"
,"araft of public health","NN IN JJ NN",4,1,1,16111641,"pubmed1",6.99E+018,"testalpha"
,"patient satisfaction ratings p","NN NN NNS ",4,1,1,16436790,"pubmed1",2.38E+018,"testalpha"
,"mpa and theflexural modulus"," CC JJ NN",4,1,1,16701864,"pubmed1",3.68E+018,"testalpha"
,"motif for protein dimerization","NN IN NN NN",4,1,1,16325892,2,5.23E+018,"testalpha"
,"minutes afterthe preconditioning procedure","NNS NNP VBG NN",4,1,1,17013508,2,1.01E+018,"testalpha"
,"operative abdominopelvic irradiation andanastomoses","JJ JJ NN NNS",4,1,1,16612919,"pubmed1",7.44E+018,"testalpha"
,"sme ssme sumatriptan solution","  NNP NN",4,1,1,16584167,"pubmed1",3.04E+017,"testalpha"
,"coded crash severity groupings","VBN NN NN NNS",4,1,1,16426556,"pubmed1",7.04E+018,"testalpha"
,"inreconstructing full thickness ala","VBG JJ NN ",4,1,1,17165594,2,6.20E+018,"testalpha"
,"regular source of health","JJ NN IN NN",4,1,1,16365327,"pubmed1",4.95E+018,"testalpha"
,"likely influences injury occurrence","JJ NNS NN NN",4,1,1,16442068,"pubmed1",3.97E+018,"testalpha"
,"cat activities glutathione gsh","NN NNS NN ",4,1,1,16999986,2,1.20E+018,"testalpha"
,"nic evoked rb effluxas","JJ VBD  NNP",4,1,1,16594645,"pubmed1",5.82E+018,"testalpha"
,"days after appearance ofthe","NNS IN NN NNP",4,1,1,16955191,2,2.68E+018,"testalpha"
,"sample preparation before hcii","NN NN IN ",4,1,1,16514835,2,8.24E+018,"testalpha"
,"was year range years","VBD NN NN NNS",4,1,1,17139879,2,4.08E+018,"testalpha"
,"i years group ii"," NNS VBP ",4,1,1,16809889,2,5.24E+018,"testalpha"
,"discussion resolution of issues","NN NN IN NNS",4,1,1,16321534,"pubmed1",3.96E+018,"testalpha"
,"allocation in western australia","NN IN JJ NNP",4,1,1,16221468,"pubmed1",4.63E+018,"testalpha"
,"circulating igg anti basement","VBG  IN NN",4,1,1,16955192,2,8.64E+018,"testalpha"
,"dimethacrylated poly ethylene glycol","VBN  NN NN",4,1,1,16701853,"pubmed1",3.95E+018,"testalpha"
,"liver toischemia reperfusion insult","NN NN NN NN",4,1,1,17013514,2,3.07E+018,"testalpha"
,"drying was conductedunder conditions","VBG VBD NN NNS",4,1,1,17285744,"pubmed1",4.79E+018,"testalpha"
,"crystal structure intermolecularo h","NN NN NNP ",4,1,1,16456295,2,6.27E+018,"testalpha"
,"determine whetherintravascular time density","VB JJ NN NN",4,1,1,16399037,"pubmed1",8.75E+018,"testalpha"
,"thosepatients with nste chest","NNS IN  NN",4,1,1,16365321,"pubmed1",3.27E+018,"testalpha"
,"transient reversible ischemic colitis","NN JJ JJ NN",4,1,1,16333702,"pubmed1",8.83E+018,"testalpha"
,"protein surfaces near tothe","NN NNS IN NNP",4,1,1,16421453,2,5.57E+018,"testalpha"
,"model for end liver","NN IN NN NN",4,1,1,17013512,2,9.93E+017,"testalpha"
,"septic shock further studies","JJ NN JJ NNS",4,1,1,16365336,"pubmed1",2.34E+018,"testalpha"
,"infection stimulated host phagocytes","NN VBN NN NNS",4,1,1,16410836,"pubmed1",4.95E+018,"testalpha"
,"invasive splenorenal shunt operation","JJ JJ NN NN",4,1,1,16673613,2,1.51E+018,"testalpha"
,"differences in pregnancy outcome","NNS IN NN NN",4,1,1,16603098,2,3.26E+017,"testalpha"
,"temporalgyrus stg using diffusion","NN  VBG NN",4,1,1,16399034,"pubmed1",5.34E+018,"testalpha"
,"relationship between agnor expression","NN IN NN NN",4,1,1,17293964,2,5.49E+018,"testalpha"
,"molecules containing full length","NNS VBG JJ NN",4,1,1,16389406,"pubmed1",3.94E+017,"testalpha"
,"stages region of interest","NNS NN IN NN",4,1,1,16399033,"pubmed1",2.56E+018,"testalpha"
,"dicarboxylic acid diglucamide monosodium","JJ NN VB NN",4,1,1,16399028,"pubmed1",1.35E+018,"testalpha"
,"light and electron microscopy","NN CC NN ",4,1,1,16574202,2,4.62E+018,"testalpha"
,"patients with mutations g","NNS IN NNS ",4,1,1,16585980,2,1.56E+017,"testalpha"
,"aselective sarckatp channel blocker","JJ  NN NN",4,1,1,16566960,2,8.91E+018,"testalpha"
,"changes in road safety","NNS IN NN NN",4,1,1,16427020,"pubmed1",6.29E+018,"testalpha"
,"injected thecerebrospinal fluid csf","VBD JJ NN ",4,1,1,16916188,"pubmed1",7.73E+018,"testalpha"
,"wall thickness luminal narrowing","NN NN JJ NN",4,1,1,16447095,"pubmed1",8.30E+018,"testalpha"
,"compensation for theknee instability","NN IN NN NN",4,1,1,16919313,2,9.78E+017,"testalpha"
,"inositolhexaphosphate ip and azoxymethane","NN  CC NN",4,1,1,17293967,2,1.21E+018,"testalpha"
,"food allergy in infants","NN NN IN NNS",4,1,1,17438830,2,3.27E+018,"testalpha"
,"o glc c glc","  NN ",4,1,1,16456293,2,2.38E+018,"testalpha"
,"cd hla class i","  NN ",4,1,1,16733557,"pubmed1",4.17E+018,"testalpha"
,"coronary artery bypass graft","NN NN VB NN",4,1,1,16451151,"pubmed1",2.37E+018,"testalpha"
,"lesion membershipmap connected component","NN  VBN NN",4,1,1,16399033,"pubmed1",6.56E+017,"testalpha"
,"pertaining broumov ossuary th","VBG  JJ ",4,1,1,17438834,2,1.78E+018,"testalpha"
,"protection at mg kg","NN IN  ",4,1,1,17013510,2,8.06E+018,"testalpha"
,"year end sleep quantities","NN NN NN NNS",4,1,1,16377826,"pubmed1",6.09E+018,"testalpha"
,"productivity and safety appropriatelyto","NN CC NN ",4,1,1,16434013,"pubmed1",4.17E+018,"testalpha"
,"principles expression and practice","NNS NN CC NN",4,1,1,16596897,"pubmed1",4.35E+018,"testalpha"
,"tasks degraded overalldriving performance","NNS VBN VBG NN",4,1,1,16226211,"pubmed1",9.11E+018,"testalpha"
,"betterdefinition of ecp mechanisms","NN IN  NNS",4,1,1,17016038,2,4.70E+018,"testalpha"
,"transport deregulation ontransport safety","NN NN NN NN",4,1,1,16427020,"pubmed1",4.30E+018,"testalpha"
,"symptoms but canalso cause","NNS CC  NN",4,1,1,16511290,2,7.27E+017,"testalpha"
,"role of soluble fas","NN IN JJ ",4,1,1,16710577,2,7.63E+018,"testalpha"
,"various organs e g","JJ NNS  ",4,1,1,16696440,2,3.03E+018,"testalpha"
,"methods computed tomographic magneticresonance","NNS VBN JJ NN",4,1,1,16333694,"pubmed1",2.80E+018,"testalpha"
,"n x including doctors"," NN IN NNS",4,1,1,16710575,2,5.76E+018,"testalpha"
,"related tovarious diseases e","VBN JJ NNS ",4,1,1,16956116,2,7.35E+016,"testalpha"
,"growth and extended survival","NN CC VBN NN",4,1,1,16388313,"pubmed1",3.13E+018,"testalpha"
,"linking agents triacryloyl hexahydro","VBG NNS  ",4,1,1,16565748,"pubmed1",9.43E+017,"testalpha"
,"charge measurements were reproduciblewith","NN NNS VBD NN",4,1,1,17285749,"pubmed1",6.05E+017,"testalpha"
,"jejunum or distal duodenum","NN CC NN NN",4,1,1,16673563,2,2.63E+018,"testalpha"
,"effect of retinoic acid","NN IN JJ NN",4,1,1,16612919,"pubmed1",6.67E+018,"testalpha"
,"inadequate treatment of ethics","JJ NN IN NNS",4,1,1,16473995,"pubmed1",6.22E+018,"testalpha"
,"andlocalized forms of psoriasis","VBN NNS IN NN",4,1,1,17010269,2,5.52E+018,"testalpha"
,"random mer disulfide bridge","JJ  VB NN",4,1,1,17019437,"pubmed1",7.08E+018,"testalpha"
,"effects of traffic safety","NNS IN NN NN",4,1,1,16406188,"pubmed1",1.27E+018,"testalpha"
,"sme and intranasal administrations"," CC NN NNS",4,1,1,16584167,"pubmed1",3.60E+018,"testalpha"
,"subcapsular cataract and retinaldetachment","JJ NN CC NN",4,1,1,17106598,2,1.46E+018,"testalpha"
,"side and nm uvb","NN CC  ",4,1,1,16585984,2,5.61E+018,"testalpha"
,"modality of iron overload","NN IN NN NN",4,1,1,17117609,2,7.41E+018,"testalpha"
,"structuralcharacteristics are acquired pfs","NNS VBP VBD ",4,1,1,16714052,2,4.15E+018,"testalpha"
,"control group simulated operation","NN NN VBN NN",4,1,1,17013508,2,8.63E+017,"testalpha"
,"biogenic amines and hormonalpeptides","JJ NNS CC NNS",4,1,1,16997356,2,7.58E+018,"testalpha"
,"investigation for possible drugallergy","NN IN JJ NN",4,1,1,17106599,2,7.60E+018,"testalpha"
,"expressed specificallyin vascular tissue","VBN  JJ NN",4,1,1,16395526,"pubmed1",7.14E+018,"testalpha"
,"rare form of male","JJ NN IN NN",4,1,1,16612933,"pubmed1",3.64E+018,"testalpha"
,"orofacial cleft types cl","JJ NN NNS ",4,1,1,17165598,2,6.23E+018,"testalpha"
,"palliative surgery transient pain","JJ NN NN NN",4,1,1,17438833,2,6.94E+018,"testalpha"
,"component of dried sucralfate","NN IN VBN NN",4,1,1,16584168,"pubmed1",1.94E+018,"testalpha"
,"values ofr r parameters","NNS  NN NNS",4,1,1,16999269,2,3.89E+018,"testalpha"
,"frequency of coeliac diseaseanti","NN IN JJ ",4,1,1,16874419,2,4.48E+018,"testalpha"
,"patients t vs mmol","NNS   ",4,1,1,17338197,2,3.83E+017,"testalpha"
,"total cholesterol ldl cholesterol","NN NN  NN",4,1,1,16479026,2,2.29E+018,"testalpha"
,"transition of pc membranes","NN IN  NNS",4,1,1,16964324,"pubmed1",2.19E+018,"testalpha"
,"common etiology of nasal","JJ NN IN NN",4,1,1,17165594,2,1.12E+018,"testalpha"
,"sa cis acting element","  VBG NN",4,1,1,16395526,"pubmed1",2.56E+018,"testalpha"
,"operation in cirrhotic rats","NN IN JJ NNS",4,1,1,17013508,2,4.22E+018,"testalpha"
,"dependent enzymes in liver","JJ NNS IN NN",4,1,1,16404476,"pubmed1",9.19E+018,"testalpha"
,"undetermined significance sil ratio","JJ NN  NN",4,1,1,16514839,2,7.88E+018,"testalpha"
,"anilino naphthalene sulfonate ans","NNP NN NN ",4,1,1,16714053,2,4.74E+018,"testalpha"
,"symptoms of laryngeal tuberculosis","NNS IN NN NN",4,1,1,16479029,2,3.30E+018,"testalpha"
,"samples using external standardisation","NNS VBG JJ NN",4,1,1,16700150,2,7.32E+018,"testalpha"
,"pain control in allpatients","NN NN IN NNS",4,1,1,16722347,2,2.76E+018,"testalpha"
,"lowerlimbs impeding perpetual mechanisms","NNS VBG JJ NNS",4,1,1,17293973,2,2.61E+018,"testalpha"
,"ordering ankle or foot","VBG NN CC NN",4,1,1,16436790,"pubmed1",1.42E+018,"testalpha"
,"crystals at different dose","NNS IN JJ NN",4,1,1,16421442,2,8.64E+018,"testalpha"
,"gastrointestinal leiomyomas and completeendoscopic","JJ NNP CC NN",4,1,1,16989154,2,8.99E+018,"testalpha"
,"resting pressure cm h","VBG NN  ",4,1,1,17139884,2,8.37E+018,"testalpha"
,"labeled dna in mcf","VBD  IN ",4,1,1,16701879,"pubmed1",1.04E+018,"testalpha"
,"discs with various fluoride","NNS IN JJ NN",4,1,1,16701866,"pubmed1",7.20E+018,"testalpha"
,"phenyl glycidyl dimethacrylate i","NN  NN ",4,1,1,16701856,"pubmed1",8.00E+018,"testalpha"
,"experience with early goal","NN IN JJ NN",4,1,1,16365336,"pubmed1",4.98E+018,"testalpha"
,"model of intraperitoneal n","NN IN NN ",4,1,1,16436788,"pubmed1",2.91E+018,"testalpha"
,"therapeutic agent in b","JJ NN IN NN",4,1,1,16809887,2,6.80E+018,"testalpha"
,"floor muscleswith surrounding tissues","NN NN VBG NNS",4,1,1,17139898,2,6.64E+017,"testalpha"
,"incompleteevacuation and digital support","NN CC NN NN",4,1,1,17139884,2,2.20E+018,"testalpha"
,"rapid extraction freegenotyping method","JJ NN VBG NN",4,1,1,16951742,"pubmed1",3.49E+018,"testalpha"
,"alltypes of genetic repair","NNS IN JJ NN",4,1,1,17347785,"pubmed1",8.29E+018,"testalpha"
,"l gal for d","  IN ",4,1,1,16456293,2,2.75E+018,"testalpha"
,"nerve terminal motor latency","NN NN NN NN",4,1,1,17139884,2,8.92E+018,"testalpha"
,"interact via pi pi","NN IN  ",4,1,1,16456285,2,2.22E+018,"testalpha"
,"theif in primary tumors"," IN JJ NNS",4,1,1,16430945,2,3.22E+018,"testalpha"
,"integral membrane protein cora","JJ NN NN ",4,1,1,16511288,2,3.26E+017,"testalpha"
,"ischemia for minutes afterthe","NN IN NNS NNP",4,1,1,17013508,2,5.37E+018,"testalpha"
,"single multi colour image","JJ  JJ NN",4,1,1,16730369,2,1.42E+018,"testalpha"
,"standardizedstressful procedure mental arithmetic","JJ NN JJ NN",4,1,1,16874421,2,5.82E+018,"testalpha"
,"crash records and workers","NN NNS CC NNS",4,1,1,16043107,"pubmed1",2.31E+018,"testalpha"
,"advances in optical techniques","NNS IN JJ NNS",4,1,1,17013504,2,3.22E+018,"testalpha"
,"total laparoscopic aorticaneurysm repair","JJ NN  NN",4,1,1,16612910,2,1.17E+018,"testalpha"
,"convincing pesticides including chlorphenol","JJ NNS VBG NN",4,1,1,17016033,2,7.77E+018,"testalpha"
,"older group of patients","JJR NN IN NNS",4,1,1,16613748,2,2.76E+018,"testalpha"
,"platelet counts after months","NN NNS IN NNS",4,1,1,16809885,2,8.53E+018,"testalpha"
,"regulator of theclassical pathway","NN IN JJ NN",4,1,1,16964325,"pubmed1",6.50E+018,"testalpha"
,"vascular supply with blood","JJ NN IN NN",4,1,1,17294912,2,5.88E+018,"testalpha"
,"intestinal elongation measurements wereto","JJ NN NNS ",4,1,1,16612919,"pubmed1",3.01E+018,"testalpha"
,"marker of proximal tubulardamage","NN IN JJ NN",4,1,1,16956119,2,2.00E+018,"testalpha"
,"typical occupational exposure onfetal","JJ JJ NN NN",4,1,1,16808045,"pubmed1",4.18E+018,"testalpha"
,"halothane anesthetized adult male","NN VBN NN NN",4,1,1,17265691,2,3.12E+018,"testalpha"
,"adequate predictability of absorption","JJ NN IN NN",4,1,1,16584115,"pubmed1",3.30E+017,"testalpha"
,"band ultraviolet b uvb","NN NN NN ",4,1,1,17106595,2,4.79E+018,"testalpha"
,"state specific intrachain interactions","NN JJ VB NNS",4,1,1,16411735,"pubmed1",4.81E+018,"testalpha"
,"catheter group in patients","NN NN IN NNS",4,1,1,16451159,"pubmed1",3.73E+018,"testalpha"
,"cognitive control andworking memory","JJ NN VBG NN",4,1,1,16436796,"pubmed1",8.62E+017,"testalpha"
,"stating name and date","VBG NN CC NN",4,1,1,16451145,"pubmed1",2.47E+018,"testalpha"
,"polymerase fingerprint analysis dpfa","NN NN NN ",4,1,1,16582987,"pubmed1",4.28E+018,"testalpha"
,"chains tyr asn asn","NNS   ",4,1,1,16511248,2,6.01E+018,"testalpha"
,"time directed transfer function","NN VBN VB NN",4,1,1,17133951,2,3.74E+018,"testalpha"
,"affected byadjacent negative tests","VBN NN JJ NNS",4,1,1,16874422,2,4.22E+018,"testalpha"
,"ill children with attention","JJ NNS IN NN",4,1,1,16462411,"pubmed1",8.38E+017,"testalpha"
,"epithelial cells viaadhesive fimbriae","JJ NNS JJ ",4,1,1,16511280,2,1.18E+018,"testalpha"
,"requiring cardiopulmonary bypass surgery","VBG JJ NN NN",4,1,1,16549902,2,6.13E+018,"testalpha"
,"carries atrp cys gly","VBZ   ",4,1,1,16421453,2,6.25E+018,"testalpha"
,"additionalpatients with prothrombin deficiency","NNS IN NNP NN",4,1,1,16424651,2,5.25E+018,"testalpha"
,"c mutations in subjects","NN NNS IN NNS",4,1,1,16585980,2,3.49E+018,"testalpha"
,"p h quinoneoxidoreductase nqo","  NN ",4,1,1,16929382,"pubmed1",6.27E+018,"testalpha"
,"methods sixtyadults wistar rats","NNS NNS NN NNS",4,1,1,17293972,2,2.16E+018,"testalpha"
,"introducing research training inpsychiatry","VBG NN NN NN",4,1,1,16473989,"pubmed1",6.82E+018,"testalpha"
,"elevated liver function tests","VBN NN NN NNS",4,1,1,16673555,2,1.97E+018,"testalpha"
,"increased support and resources","VBN NN CC NNS",4,1,1,16436795,"pubmed1",7.41E+018,"testalpha"
,"underestimate parameters and confidence","VB NNS CC NN",4,1,1,16126153,"pubmed1",7.36E+018,"testalpha"
,"apcs by cd lactivation"," IN  NN",4,1,1,16733557,"pubmed1",2.79E+018,"testalpha"
,"structure of human saposin","NN IN JJ NNP",4,1,1,16511279,2,7.91E+018,"testalpha"
,"ige between patients withaa"," IN NNS ",4,1,1,17010262,2,2.41E+018,"testalpha"
,"identity models utilizing proteases","NN NNS VBG NNS",4,1,1,16421452,2,7.78E+018,"testalpha"
,"overall day fatality trend","JJ NN NN NN",4,1,1,16430844,"pubmed1",7.22E+018,"testalpha"
,"phosphatidylcholine stearoyl linoleoyl phosphatidylcholine","NN   NN",4,1,1,17128291,"pubmed1",5.72E+018,"testalpha"
,"probabilistic linkage for matchingde","JJ NN IN ",4,1,1,16365326,"pubmed1",3.13E+018,"testalpha"
,"changes in rapid sequence","NNS IN JJ NN",4,1,1,17067136,"pubmed1",5.25E+018,"testalpha"
,"allotransplants xenotransplants and amnion","NNS NNS CC NN",4,1,1,16999270,2,4.70E+018,"testalpha"
,"cirrhotic rats with ischemia","JJ NNS IN NN",4,1,1,17013508,2,5.44E+018,"testalpha"
,"administrationof ip aom n","   ",4,1,1,17293962,2,4.49E+018,"testalpha"
,"skeletal muscle cells protein","NN NN NNS NN",4,1,1,16964326,"pubmed1",5.46E+018,"testalpha"
,"certain non natural dsba","JJ  JJ ",4,1,1,17019443,"pubmed1",2.79E+018,"testalpha"
,"major pathologies including developmental","JJ NNS VBG NN",4,1,1,16582985,"pubmed1",3.88E+018,"testalpha"
,"late phases of ards","JJ NNS IN ",4,1,1,16451155,"pubmed1",6.08E+018,"testalpha"
,"hematopoiesis after granulocyte colony","NN IN NNP NN",4,1,1,17016039,2,7.60E+018,"testalpha"
,"lens cells indicatingprimary lens","NN NNS JJ NN",4,1,1,16325892,2,3.35E+018,"testalpha"
,"structures of algal lectins","NNS IN JJ NNS",4,1,1,17128290,"pubmed1",2.48E+018,"testalpha"
,"thepatients undergoing radiofrequency catheter","NNS VBG NN NN",4,1,1,16696443,2,2.84E+018,"testalpha"
,"females years of age","NNS NNS IN NN",4,1,1,17010274,2,5.12E+018,"testalpha"
,"ala and j cm"," CC  ",4,1,1,16955185,2,7.44E+018,"testalpha"
,"expression of pp fad","NN IN  NN",4,1,1,17063209,"pubmed1",6.03E+018,"testalpha"
,"australian spinalcord injury register","JJ NN NN NN",4,1,1,16111641,"pubmed1",4.45E+018,"testalpha"
,"definitive diagnosis of uterine","JJ NN IN NN",4,1,1,17338203,2,4.46E+018,"testalpha"
,"iron sulfur cluster proteins","NN JJ NN NNS",4,1,1,17143336,"pubmed1",7.48E+018,"testalpha"
,"human cach cdna encodes","JJ   NNS",4,1,1,16951743,"pubmed1",7.27E+018,"testalpha"
,"worm chaetopterus variopedatus spermh"," NN NN ",4,1,1,17019436,"pubmed1",6.38E+018,"testalpha"
,"correlation in crash data","NN IN NN NNS",4,1,1,16451795,"pubmed1",8.56E+018,"testalpha"
,"patients without superior vena","NNS IN JJ ",4,1,1,16617761,"pubmed1",1.51E+018,"testalpha"
,"l at aplastic crises"," IN JJ NNS",4,1,1,17119324,2,6.98E+018,"testalpha"
,"space groupc with unit","NN  IN NN",4,1,1,16511271,2,2.63E+018,"testalpha"
,"nucleotide free rab gtpase","VB JJ  NN",4,1,1,16511278,2,5.08E+018,"testalpha"
,"relationship between driving hours","NN IN VBG NNS",4,1,1,16157285,"pubmed1",7.67E+017,"testalpha"
,"detect bad regions e","VB JJ NNS ",4,1,1,16369096,2,4.48E+018,"testalpha"
,"nadp metype panicum miliaceum"," JJ NN NN",4,1,1,17106510,"pubmed1",4.49E+018,"testalpha"
,"months of treated areas","NNS IN VBN NNS",4,1,1,16585985,2,2.97E+018,"testalpha"
,"massive mucus and contrast","JJ NN CC NN",4,1,1,16245013,"pubmed1",3.67E+018,"testalpha"
,"related toxicity overall survival","VBN NN JJ NN",4,1,1,16424643,2,8.62E+018,"testalpha"
,"meteorism borborygmi colicpain flatulence","NN  VB NN",4,1,1,16424650,2,1.81E+018,"testalpha"
,"canbecome more attractive source","NN JJR JJ NN",4,1,1,16696440,2,5.75E+018,"testalpha"
,"naked nuclei and scatteredcells","JJ  CC NNS",4,1,1,16514847,2,2.59E+018,"testalpha"
,"current strategies and controversies","JJ NNS CC NNS",4,1,1,17139901,2,1.70E+018,"testalpha"
,"part in theregenerative process","NN IN JJ NN",4,1,1,17013517,2,2.77E+018,"testalpha"
,"units blsu and alsu","NNS  CC ",4,1,1,16491215,2,6.12E+018,"testalpha"
,"increased prevalence ofthyroidopathies diabetes","VBN NN NNS NN",4,1,1,16710576,2,8.82E+018,"testalpha"
,"incident and discussion resolution","NN CC NN NN",4,1,1,16321534,"pubmed1",6.69E+018,"testalpha"
,"energy production and utilization","NN NN CC NN",4,1,1,16462411,"pubmed1",4.19E+018,"testalpha"
,"similar pattern in weight","JJ NN IN NN",4,1,1,17293957,2,3.80E+018,"testalpha"
,"squamous cells endocervical component","JJ NNS JJ NN",4,1,1,16514841,2,8.28E+018,"testalpha"
,"risk non hodgkinlymphomas nhl","NN  NNP ",4,1,1,16424644,2,8.45E+017,"testalpha"
,"viral hepatitis via depletion","JJ NN IN NN",4,1,1,16696445,2,9.45E+017,"testalpha"
,"hpnpase mrna level results","NN  NN NNS",4,1,1,16505900,"pubmed1",4.45E+018,"testalpha"
,"pdzrhogef and iii gtp"," CC  ",4,1,1,17019437,"pubmed1",4.33E+018,"testalpha"
,"group c andgroup v","NN NN NN ",4,1,1,17067136,"pubmed1",5.27E+018,"testalpha"
,"contrast enhanced computed tomography","NN VBN VBN NN",4,1,1,16333704,"pubmed1",3.05E+018,"testalpha"
,"plasmid dna within min","JJ  IN ",4,1,1,16582987,"pubmed1",9.09E+018,"testalpha"
,"clearance and body weight","NN CC NN NN",4,1,1,16584121,"pubmed1",5.30E+018,"testalpha"
,"various fields of materials","JJ NNS IN NNS",4,1,1,16701861,"pubmed1",2.47E+018,"testalpha"
,"comprising bloodpressure body mass","VBG NN NN NN",4,1,1,16479027,2,3.80E+018,"testalpha"
,"curricular goals methods andassessments","JJ NNS NNS NNS",4,1,1,16473990,"pubmed1",5.99E+018,"testalpha"
,"d cys phe d","   ",4,1,1,16496038,"pubmed1",7.75E+018,"testalpha"
,"presence of ischemia reperfusion","NN IN NN NN",4,1,1,16491218,2,6.98E+018,"testalpha"
,"negative crp patients showeddyslipidaemia","JJ  NNS NN",4,1,1,16479028,2,3.34E+018,"testalpha"
,"properties towardstransfected cortical neurons","NNS VBN JJ NNS",4,1,1,17265688,2,6.06E+018,"testalpha"
,"reading sensitivity and specificity","NN NN CC NN",4,1,1,16399036,"pubmed1",8.80E+018,"testalpha"
,"cancer cells by cell","NN NNS IN NN",4,1,1,16511286,2,2.98E+018,"testalpha"
,"resuscitation with different plasmasubstitutes","NN IN JJ NNS",4,1,1,16762404,2,5.68E+018,"testalpha"
,"px activity in ckd"," NN IN ",4,1,1,17160142,"pubmed1",3.10E+018,"testalpha"
,"liquid crystals ii derivatizedcalixarenes","JJ NNS  NNS",4,1,1,16411740,"pubmed1",6.35E+017,"testalpha"
,"operating characteristic roc curves","VBG NN  NNS",4,1,1,16399036,"pubmed1",6.35E+018,"testalpha"
,"min celiac artery occlusion"," JJ NN NN",4,1,1,17438835,2,4.63E+018,"testalpha"
,"trial of consecutive adultpatients","NN IN JJ NNS",4,1,1,16436790,"pubmed1",2.20E+018,"testalpha"
,"small bowel wall visualization","JJ NN NN NN",4,1,1,16252139,"pubmed1",6.45E+018,"testalpha"
,"controversies in thesurgical management","NNS IN JJ NN",4,1,1,17139901,2,4.45E+018,"testalpha"
,"integrated boost sib imrt","VBN NN  ",4,1,1,17117605,2,7.44E+017,"testalpha"
,"wouldchange therapeutic discovery development","NN JJ NN NN",4,1,1,16596744,"pubmed1",6.54E+018,"testalpha"
,"craniotomy and tumor resection","NN CC NN NN",4,1,1,16514849,2,2.61E+018,"testalpha"
,"atf cre binding elementinto","  VBG NNP",4,1,1,16395528,"pubmed1",2.58E+018,"testalpha"
,"major beta thalassemia males","NN NN NN NNS",4,1,1,16809886,2,5.75E+018,"testalpha"
,"teaching of family skillsinto","NN IN NN NNP",4,1,1,16473998,"pubmed1",7.83E+018,"testalpha"
,"demonstrated theassociation between life","VBN NN IN NN",4,1,1,16918068,"pubmed1",6.50E+018,"testalpha"
,"extra carbohydrate supply andrebound","JJ NN NN NN",4,1,1,16921609,"pubmed1",7.01E+018,"testalpha"
,"measures training and education","NNS NN CC NN",4,1,1,16438093,"pubmed1",1.14E+018,"testalpha"
,"induced dense granule secretion","VBN JJ NN NN",4,1,1,17068635,"pubmed1",1.27E+018,"testalpha"
,"forcorrection of pectum excavatum","NN IN NN NN",4,1,1,16956118,2,6.68E+018,"testalpha"
,"particle onan energy landscape","NN  NN NN",4,1,1,16823610,"pubmed1",3.53E+018,"testalpha"
,"prothrombin complex factor deficiencies","NNP JJ NN NNS",4,1,1,16424651,2,6.51E+018,"testalpha"
,"laboratory advanced light source","NN VBD NN NN",4,1,1,16511256,2,2.31E+018,"testalpha"
,"prognostic ability of response","JJ NN IN NN",4,1,1,16584161,"pubmed1",8.08E+017,"testalpha"
,"problems and solutions salary","NNS CC NNS NN",4,1,1,16436795,"pubmed1",9.06E+018,"testalpha"
,"fibers thenumber and area","NNS NN CC NN",4,1,1,16730053,2,4.11E+018,"testalpha"
,"effect of nitropropionic acid","NN IN JJ NN",4,1,1,17133954,2,4.49E+018,"testalpha"
,"discovery development and delivery","NN NN CC NN",4,1,1,16596744,"pubmed1",9.07E+018,"testalpha"
,"wide range of cells","JJ NN IN NNS",4,1,1,16713618,2,8.46E+018,"testalpha"
,"arylesterase paraoxonaseactivities of pon","NN NNS IN ",4,1,1,17106515,"pubmed1",3.37E+018,"testalpha"
,"cancer screeningguidelines and breast","NN NNS CC NN",4,1,1,16596895,"pubmed1",4.57E+018,"testalpha"
,"diagnosis of atypical glandularcells","NN IN JJ NNS",4,1,1,16514840,2,7.60E+018,"testalpha"
,"tissue hemodynamics after fluid","NN NNS IN NN",4,1,1,16762404,2,5.33E+018,"testalpha"
,"absolute contraindication for surgery","JJ NN IN NN",4,1,1,17139900,2,1.54E+018,"testalpha"
,"hpv testingfor detecting cin"," JJ VBG ",4,1,1,16514835,2,4.91E+018,"testalpha"
,"were patients aged years","VBD NNS VBN NNS",4,1,1,16451146,"pubmed1",3.12E+018,"testalpha"
,"di mu acetato mu","  NN ",4,1,1,16456265,2,8.27E+018,"testalpha"
,"investigated variables comprising bloodpressure","VBD NNS VBG NN",4,1,1,16479027,2,7.51E+018,"testalpha"
,"physician dependent risk factors","NN JJ NN NNS",4,1,1,16436793,"pubmed1",9.04E+018,"testalpha"
,"non resorbable bis gma"," JJ  ",4,1,1,16701856,"pubmed1",7.74E+018,"testalpha"
,"excretion ratio ofs r","NN NN  NN",4,1,1,16584121,"pubmed1",7.24E+017,"testalpha"
,"mm visual analog scale"," JJ NN NN",4,1,1,16436793,"pubmed1",3.59E+018,"testalpha"
,"putative mechanisms of homocysteine","JJ NNS IN NN",4,1,1,17265692,2,7.04E+018,"testalpha"
,"lobulated mass with air","VBN NN IN NN",4,1,1,16612936,"pubmed1",5.09E+018,"testalpha"
,"cell membrane protein dipeptidyl","NN NN NN ",4,1,1,16929383,"pubmed1",6.19E+018,"testalpha"
,"multiple logistic regression model","JJ JJ NN NN",4,1,1,16648915,2,2.63E+018,"testalpha"
,"requirements and recovery profiles","NNS CC NN NNS",4,1,1,17236635,"pubmed1",9.99E+017,"testalpha"
,"fas l paracrine signaltransduction","  NN NN",4,1,1,16919708,2,5.77E+018,"testalpha"
,"methyl beta d ribofuranosyl"," NN  ",4,1,1,16456292,2,1.43E+018,"testalpha"
,"followed treatment for year","VBD NN IN NN",4,1,1,16236233,"pubmed1",6.21E+018,"testalpha"
,"use in females years","NN IN NNS NNS",4,1,1,17010274,2,1.75E+018,"testalpha"
,"results obtainedby various authors","NNS JJ JJ NNS",4,1,1,16603103,2,8.06E+018,"testalpha"
,"entering clinical psychiatry neuroscienceresearch","VBG JJ NN NN",4,1,1,16473990,"pubmed1",8.67E+018,"testalpha"
,"percentage of long term","NN IN JJ NN",4,1,1,16733557,"pubmed1",2.73E+018,"testalpha"
,"cell attachment and migration","NN NN CC NN",4,1,1,16701861,"pubmed1",2.58E+018,"testalpha"
,"involvement infemales with olp","NN NNS IN ",4,1,1,16955190,2,6.32E+018,"testalpha"
,"provide answers tospecific questions","VB NNS NNP NNS",4,1,1,16369099,2,4.80E+018,"testalpha"
,"early recognition and treatment","JJ NN CC NN",4,1,1,16462412,"pubmed1",6.44E+018,"testalpha"
,"shares amino acid sequence","NNS NNP NN NN",4,1,1,16511256,2,7.42E+018,"testalpha"
,"marketed tablet zidovir cipla","VBN NN  ",4,1,1,16584139,"pubmed1",7.34E+018,"testalpha"
,"cases including carrying luggage","NNS IN VBG NN",4,1,1,16434013,"pubmed1",5.29E+018,"testalpha"
,"thrombosis recurrence and post","NN NN CC NN",4,1,1,16549899,2,2.23E+018,"testalpha"
,"included thoracicinjuries odds ratio","VBD NNS NNS NN",4,1,1,16549896,2,5.43E+018,"testalpha"
,"fas fas l paracrine","   NN",4,1,1,16919708,2,3.36E+018,"testalpha"
,"presence of bone atrophy","NN IN NN NN",4,1,1,16613748,2,5.10E+018,"testalpha"
,"cancer willresult in death","NN NN IN NN",4,1,1,16596899,"pubmed1",6.14E+017,"testalpha"
,"case ofthe ipc group","NN NNP  NN",4,1,1,17013508,2,7.88E+018,"testalpha"
,"ts and serum iron"," CC NN NN",4,1,1,16809889,2,7.32E+018,"testalpha"
,"impact andrear end collisions","NN JJ NN NNS",4,1,1,16197912,"pubmed1",9.00E+018,"testalpha"
,"lymphocyte proliferation and apoptosis","NNP NN CC NN",4,1,1,17016035,2,7.38E+018,"testalpha"
,"mini mental status mmst"," JJ NN ",4,1,1,16451145,"pubmed1",5.16E+018,"testalpha"
,"assesment forlaryngeal surgical therapy","NN NN JJ NN",4,1,1,16989147,2,4.54E+017,"testalpha"
,"ultrasound examination revealed urolithiasis","NN NN VBD NN",4,1,1,16956119,2,8.14E+018,"testalpha"
,"detected criticalstenoses at months","VBD NNS IN NNS",4,1,1,16612921,"pubmed1",7.85E+018,"testalpha"
,"bea paracrine signaling system"," NN VBG NN",4,1,1,16330085,2,7.66E+018,"testalpha"
,"minimum inhibitory concentration sub","JJ NN NN NN",4,1,1,17106514,"pubmed1",8.45E+018,"testalpha"
,"steel beam longitudinal barriers","NN NN JJ NNS",4,1,1,16054101,"pubmed1",8.74E+018,"testalpha"
,"proliferation and affect status","NN CC VB NN",4,1,1,17265694,2,7.62E+018,"testalpha"
,"causes severity and circumstances","VBZ NN CC NNS",4,1,1,16412373,"pubmed1",5.45E+018,"testalpha"
,"population of stem cells","NN IN VB NNS",4,1,1,17265694,2,9.18E+018,"testalpha"
,"cross linking agents triacryloyl","VB VBG NNS ",4,1,1,16565748,"pubmed1",3.56E+018,"testalpha"
,"unit costs of crashes","NN NNS IN NNS",4,1,1,16426556,"pubmed1",7.10E+018,"testalpha"
,"rates of hospital acquiredinfections","NNS IN NN NNS",4,1,1,16462412,"pubmed1",1.82E+018,"testalpha"
,"p fak and melanocyte","  CC NNP",4,1,1,17106595,2,1.97E+018,"testalpha"
,"simplex virus type hsv","JJ NN NN ",4,1,1,16648915,2,1.05E+018,"testalpha"
,"time of recovery return","NN IN NN NN",4,1,1,16451145,"pubmed1",6.29E+018,"testalpha"
,"failure hepaticfailure ionic disorder","NN NN JJ NN",4,1,1,16916186,"pubmed1",2.58E+018,"testalpha"
,"fatal crashes in maine","JJ NNS IN NN",4,1,1,16423319,"pubmed1",4.65E+018,"testalpha"
,"eradication therapydecreased cd p","NN VBN  ",4,1,1,16809885,2,3.67E+018,"testalpha"
,"therapy in ameliorating toxicity","NN IN VBG NN",4,1,1,16436797,"pubmed1",5.25E+017,"testalpha"
,"levels of dna damage","NNS IN  NN",4,1,1,16582984,"pubmed1",1.89E+018,"testalpha"
,"artificial membrane permeability assay","JJ NN NN NN",4,1,1,16584115,"pubmed1",8.24E+018,"testalpha"
,"cells expressing fas l","NNS VBG  ",4,1,1,16330085,2,3.53E+018,"testalpha"
,"r xy r xy","NN  NN ",4,1,1,16914909,2,2.76E+018,"testalpha"
,"u l but lowerincrease","  CC NN",4,1,1,17338197,2,4.04E+018,"testalpha"
,"tumor of theparotid gland","NN IN  NN",4,1,1,16514845,2,4.51E+018,"testalpha"
,"many different aggregated conformations","NN JJ VBN NNS",4,1,1,16714052,2,3.92E+016,"testalpha"
,"fad from saccharomyces kluyveri","NN IN NNS NN",4,1,1,17063209,"pubmed1",1.22E+018,"testalpha"
,"acid on thyroid gland","NN IN NN NN",4,1,1,16720036,2,6.40E+017,"testalpha"
,"institutions while providingunprecedented expert","NNS IN VBN NN",4,1,1,16770858,"pubmed1",2.55E+018,"testalpha"
,"dokuz eylul university hospital","  NN NN",4,1,1,17139879,2,4.76E+018,"testalpha"
,"eg poor predictabilityfor transporter"," JJ JJ NN",4,1,1,16584115,"pubmed1",5.47E+017,"testalpha"
,"c and increased theresponse","NN CC VBD NN",4,1,1,16395521,"pubmed1",3.84E+017,"testalpha"
,"transplantation after high dose","NN IN JJ NN",4,1,1,16809891,2,4.63E+018,"testalpha"
,"small consideringthe total cost","JJ NNP NN NN",4,1,1,16916184,"pubmed1",7.43E+018,"testalpha"
,"showedsome improvement after l","NN NN IN ",4,1,1,16424656,2,6.41E+018,"testalpha"
,"form for economic analysis","NN IN JJ NN",4,1,1,16426556,"pubmed1",3.95E+018,"testalpha"
,"known schlogl physical theory","VBN  JJ NN",4,1,1,16988902,"pubmed1",6.27E+018,"testalpha"
,"suppression of murine b","NN IN NN NN",4,1,1,16733559,"pubmed1",8.42E+018,"testalpha"
,"length ofstay or h","NN NN CC ",4,1,1,16549896,2,8.78E+018,"testalpha"
,"cox proportional hazards model"," JJ NNS NN",4,1,1,16202465,"pubmed1",5.89E+018,"testalpha"
,"type ofvasculitis in patients","NN NN IN NNS",4,1,1,16603099,2,7.78E+017,"testalpha"
,"glandularcells favor endometrial origin","NNS VB JJ NN",4,1,1,16514840,2,7.11E+018,"testalpha"
,"component after whichthe individual","NN IN NNP NN",4,1,1,17438831,2,1.10E+018,"testalpha"
,"oversight of clinical research","NN IN JJ NN",4,1,1,16770857,"pubmed1",2.81E+018,"testalpha"
,"high expression of cell","JJ NN IN NN",4,1,1,16951744,"pubmed1",6.73E+018,"testalpha"
,"profile for fatal mvc","NN IN JJ ",4,1,1,16405857,"pubmed1",3.71E+018,"testalpha"
,"reminderpostcard and replacement survey","NN CC NN NN",4,1,1,16377812,"pubmed1",6.12E+018,"testalpha"
,"discovery of specific genotypes","NN IN JJ NNS",4,1,1,16549895,2,5.43E+018,"testalpha"
,"oxidesynthase nos inhibitor n","NN NNS NN ",4,1,1,16764913,2,6.09E+018,"testalpha"
,"peptide gly gly leu","VB   ",4,1,1,16496040,"pubmed1",6.95E+018,"testalpha"
,"patterns of urinary pathogens","NNS IN JJ NNS",4,1,1,16365328,"pubmed1",1.34E+018,"testalpha"
,"sectioned pairs of vessels","VBN NNS IN NNS",4,1,1,16828846,2,3.75E+018,"testalpha"
,"h o on morphology","  IN NN",4,1,1,17046053,2,5.33E+018,"testalpha"
,"sc incombination with gm"," NN IN ",4,1,1,16914909,2,2.35E+018,"testalpha"
,"caseascertainment using international classification","NN VBG JJ NN",4,1,1,16365331,"pubmed1",5.70E+018,"testalpha"
,"methods with shorter learning","NNS IN JJR NN",4,1,1,16451149,"pubmed1",2.95E+017,"testalpha"
,"activity against themalassezia yeasts","NN IN NNP NNS",4,1,1,16874415,2,4.06E+018,"testalpha"
,"combination with selective cox","NN IN JJ ",4,1,1,16253314,2,6.37E+018,"testalpha"
,"validatedscales measuring depression anxiety","NNS VBG NN NN",4,1,1,16377815,"pubmed1",5.60E+018,"testalpha"
,"management in atopic dermatitis","NN IN NN NN",4,1,1,16648910,2,3.41E+018,"testalpha"
,"provides evidence that pfkfb","VBZ NN IN ",4,1,1,17143338,"pubmed1",7.76E+018,"testalpha"
,"retrospective assessment ofcontrast enhancement","JJ NN JJS NN",4,1,1,16333704,"pubmed1",5.47E+018,"testalpha"
,"practice guidelines for dsh","NN NNS IN ",4,1,1,16330213,"pubmed1",2.58E+018,"testalpha"
,"prostheses medicaments and bullousdiseases","NNS NNS CC NNS",4,1,1,17010270,2,1.68E+018,"testalpha"
,"stability againstcoagulation during storage","NN NN IN NN",4,1,1,16701854,"pubmed1",8.02E+018,"testalpha"
,"expression of heatshock proteins","NN IN NN NNS",4,1,1,16365323,"pubmed1",2.17E+018,"testalpha"
,"ns and infusion requirements"," CC NN NNS",4,1,1,17236635,"pubmed1",1.17E+018,"testalpha"
,"polyps sinuses and anal"," NNS CC ",4,1,1,17139880,2,6.56E+018,"testalpha"
,"use of poly hydroxyproline","NN IN  NN",4,1,1,16701856,"pubmed1",5.63E+018,"testalpha"
,"characteristics of self referrals","NNS IN NN NNS",4,1,1,16321533,"pubmed1",6.91E+018,"testalpha"
,"modulus of elasticity reinforcement","NN IN NN NN",4,1,1,16701863,"pubmed1",5.71E+018,"testalpha"
,"points of thebinding curve","NNS IN VBG NN",4,1,1,17019442,"pubmed1",8.87E+018,"testalpha"
,"qualitative analysisof carbohydrate components","JJ  NN NNS",4,1,1,16542712,2,7.96E+018,"testalpha"
,"patients and high consumption","NNS CC JJ NN",4,1,1,16710581,2,7.33E+018,"testalpha"
,"incidence and relative numbers","NN CC JJ NNS",4,1,1,17165598,2,7.00E+018,"testalpha"
,"number of venous segments","NN IN JJ NNS",4,1,1,16549898,2,2.20E+018,"testalpha"
,"identification of cellular mechanisms","NN IN JJ NNS",4,1,1,16809883,2,5.24E+017,"testalpha"
,"triage nurses before physicianevaluation","NN NNS IN NN",4,1,1,16436790,"pubmed1",2.54E+018,"testalpha"
,"tools and epigenetic treatment","NNS CC JJ NN",4,1,1,16582985,"pubmed1",5.66E+018,"testalpha"
,"mortalityand length of survival","NN NN IN NN",4,1,1,16596895,"pubmed1",5.26E+018,"testalpha"
,"options are available forthe","NNS VBP JJ NNP",4,1,1,16722347,2,2.83E+018,"testalpha"
,"performance of various instruments","NN IN JJ NNS",4,1,1,16369089,2,3.54E+018,"testalpha"
,"pulmonaryfunction in asymptomatic non","NN IN JJ ",4,1,1,16809886,2,2.34E+017,"testalpha"
,"preventable causes of cirrhosis","JJ NNS IN NN",4,1,1,17013520,2,5.71E+018,"testalpha"
,"inflammatory bowel disease ibd","JJ NN NN ",4,1,1,16673554,2,3.74E+017,"testalpha"
,"end of theobservation period","NN IN NN NN",4,1,1,16613748,2,8.47E+018,"testalpha"
,"deregulation of rail transport","NN IN NN NN",4,1,1,16427020,"pubmed1",1.14E+018,"testalpha"
,"date oftransplantation and death","NN NN CC NN",4,1,1,16710578,2,5.24E+018,"testalpha"
,"hormone tsh producing cells","NN  VBG NNS",4,1,1,16714054,2,2.12E+018,"testalpha"
,"sungorus wasstudied using immunohistochemistry","NN VBN VBG NN",4,1,1,17133952,2,5.24E+018,"testalpha"
,"minimal level of safety","JJ NN IN NN",4,1,1,16999268,2,5.13E+018,"testalpha"
,"taipei metro rapid transit","NNP NN JJ NN",4,1,1,16434013,"pubmed1",6.39E+018,"testalpha"
,"headlights and turn signals","NNS CC VB NNS",4,1,1,16061188,"pubmed1",1.14E+018,"testalpha"
,"resistance and mechanical properties","NN CC JJ NNS",4,1,1,16701867,"pubmed1",5.38E+018,"testalpha"
,"expression of peripheral nachrs","NN IN JJ NNP",4,1,1,16594641,"pubmed1",1.39E+018,"testalpha"
,"requires consultants with specialinterest","VBZ NNS IN NN",4,1,1,17139882,2,1.81E+017,"testalpha"
,"andthe soft shelled turtle","NNP JJ VBN NN",4,1,1,16733064,2,2.14E+018,"testalpha"
,"verysimilar regarding gender age","JJ VBG NN NN",4,1,1,17139896,2,8.13E+018,"testalpha"
,"values h after surgery","NNS  IN NN",4,1,1,16451153,"pubmed1",5.78E+018,"testalpha"
,"particular stage of thedisease","JJ NN IN NN",4,1,1,17311742,2,7.80E+018,"testalpha"
,"nutritional deficiencies dental prostheses","JJ NNS JJ NNS",4,1,1,17010270,2,5.16E+018,"testalpha"
,"control group had antibodies","NN NN VBD NNS",4,1,1,16874419,2,7.55E+018,"testalpha"
,"analysis of case control","NN IN NN NN",4,1,1,16417901,"pubmed1",4.72E+018,"testalpha"
,"trials as potential drugs","NNS IN JJ NNS",4,1,1,17128290,"pubmed1",5.35E+018,"testalpha"
,"induced variations in hn","VBN NNS IN ",4,1,1,16770442,"pubmed1",6.66E+018,"testalpha"
,"strain with high translation","NN IN JJ NN",4,1,1,17106514,"pubmed1",1.43E+018,"testalpha"
,"minutes in thecontrol group","NNS IN NN NN",4,1,1,16436788,"pubmed1",3.13E+018,"testalpha"
,"consequences of physical activity","NNS IN JJ NN",4,1,1,16921608,"pubmed1",8.47E+018,"testalpha"
,"intensity course for icg","NN NN IN ",4,1,1,16399028,"pubmed1",4.77E+018,"testalpha"
,"dextran macrodex or d","NN NN CC ",4,1,1,16762404,2,6.64E+018,"testalpha"
,"characteristic of hl andindependent","NN IN  NN",4,1,1,17016036,2,8.56E+018,"testalpha"
,"mouse liver and kidneyhomogenates","NN NN CC NNS",4,1,1,17285740,"pubmed1",7.94E+018,"testalpha"
,"pose diagnostic and treatment","NN NN CC NN",4,1,1,16462411,"pubmed1",7.27E+018,"testalpha"
,"serine and l methionyl","NN CC  NN",4,1,1,16397334,2,2.81E+018,"testalpha"
,"kappab nf kappab transcription","   NN",4,1,1,17068636,"pubmed1",1.36E+018,"testalpha"
,"numerous types of energy","JJ NNS IN NN",4,1,1,16054101,"pubmed1",8.51E+018,"testalpha"
,"predictive value and negative","JJ NN CC NN",4,1,1,16514835,2,6.02E+018,"testalpha"
,"mk non competitive nmda","  JJ ",4,1,1,17133953,2,2.31E+017,"testalpha"
,"importance of close monitoring","NN IN NN NN",4,1,1,17106602,2,1.43E+018,"testalpha"
,"cultural competence and diversity","JJ NN CC NN",4,1,1,16473988,"pubmed1",5.09E+018,"testalpha"
,"polygonal cells with round","JJ NNS IN NN",4,1,1,16514851,2,1.44E+018,"testalpha"
,"fora near future crash"," IN JJ NN",4,1,1,16405858,"pubmed1",4.07E+017,"testalpha"
,"malignant treatment with lasers","JJ NN IN NNS",4,1,1,16710582,2,7.32E+016,"testalpha"
,"bias and gray literature","NN CC JJ NN",4,1,1,16365332,"pubmed1",2.15E+018,"testalpha"
,"years but traditional healers","NNS CC JJ NNS",4,1,1,16412373,"pubmed1",8.50E+018,"testalpha"
,"activity and good stability","NN CC JJ NN",4,1,1,16970980,2,1.71E+018,"testalpha"
,"aggressive treatment of anemia","JJ NN IN NN",4,1,1,16673554,2,3.30E+018,"testalpha"
,"error reporting and disclosureexperiences","NN NN CC NNS",4,1,1,16377828,"pubmed1",1.32E+017,"testalpha"
,"skills and enhanced physicianaccountability","NNS CC VBN NN",4,1,1,16377816,"pubmed1",5.36E+018,"testalpha"
,"yellow hexagonalcrystals with dimensions","JJ NNS IN NNS",4,1,1,16511277,2,5.13E+018,"testalpha"
,"results pretreatment with u","NNS NN IN ",4,1,1,16365323,"pubmed1",6.43E+018,"testalpha"
,"patients byfocused unenhanced sct","NNS VBN VBN ",4,1,1,16612913,"pubmed1",3.27E+018,"testalpha"
,"complex process using electronicdevices","JJ NN VBG NNS",4,1,1,17139898,2,2.22E+018,"testalpha"
,"support for thisprescribing practice","NN IN VBG NN",4,1,1,16365328,"pubmed1",3.61E+018,"testalpha"
,"cost of hospital stay","NN IN NN NN",4,1,1,16916184,"pubmed1",5.27E+018,"testalpha"
,"papillary clusters small papillae","JJ NNS JJ NNS",4,1,1,16514838,2,1.62E+018,"testalpha"
,"pluripotent stem cells psc","NN VB NNS ",4,1,1,17265694,2,8.81E+017,"testalpha"
,"bp were fused withthe"," VBD VBN NNP",4,1,1,16395526,"pubmed1",6.88E+018,"testalpha"
,"o co c h","  NN ",4,1,1,16397335,2,1.86E+018,"testalpha"
,"tothe messenger ribonucleic acid","NNP NN JJ NN",4,1,1,17285740,"pubmed1",3.67E+018,"testalpha"
,"suppressor genes yjl c","NN NNS  NN",4,1,1,17146497,"pubmed1",3.63E+018,"testalpha"
,"groups and differentenvironmental complexities","NNS CC NN NNS",4,1,1,16226211,"pubmed1",9.13E+018,"testalpha"
,"terms of cost effectiveness","NNS IN NN NN",4,1,1,16916184,"pubmed1",1.17E+018,"testalpha"
,"maximal anal resting pressure","JJ  VBG NN",4,1,1,16612915,"pubmed1",9.18E+018,"testalpha"
,"epidermis of psoriaticskin lesions","NN IN NNP NNS",4,1,1,17034836,2,7.85E+017,"testalpha"
,"platelet cd p expression","NN   NN",4,1,1,16809885,2,2.58E+018,"testalpha"
,"dismutase and catalase inthe","NN CC NN NNP",4,1,1,17063208,"pubmed1",2.08E+018,"testalpha"
,"capsules possess good stability","NNS VB JJ NN",4,1,1,16701854,"pubmed1",2.21E+018,"testalpha"
,"inhibits cellgrowth via induction","NNS NN IN NN",4,1,1,16809887,2,7.43E+018,"testalpha"
,"mobilization chemotherapy conditioning regimen","NN NN VBG NN",4,1,1,17119322,2,1.88E+018,"testalpha"
,"rheumatoid arthritis in families","VB NN IN NNS",4,1,1,16710576,2,4.16E+018,"testalpha"
,"wall ureter and kidney","NN NN CC NN",4,1,1,17139900,2,7.65E+018,"testalpha"
,"yjl cp and yjr","  CC ",4,1,1,17146497,"pubmed1",1.88E+018,"testalpha"
,"inflammation atherosclerosis transplant rejection","NN NN JJ NN",4,1,1,16770444,"pubmed1",5.30E+018,"testalpha"
,"sp and cd antibodies"," CC  NNS",4,1,1,16256177,2,6.73E+018,"testalpha"
,"acute myocardial infarction mi","JJ JJ NN ",4,1,1,16365321,"pubmed1",5.81E+018,"testalpha"
,"driver assistance systems adas","NN NN NNS ",4,1,1,16406188,"pubmed1",6.97E+018,"testalpha"
,"lymphocyte infusion and donor","NNP NN CC NN",4,1,1,16914909,2,2.34E+018,"testalpha"
,"reactive sinushistiocytosis in lymph","JJ NN IN NN",4,1,1,16256177,2,5.18E+017,"testalpha"
,"model drury c g","NN NNP NN ",4,1,1,16434013,"pubmed1",9.22E+018,"testalpha"
,"puberty carthesian x y","NN JJ NN ",4,1,1,16722348,2,4.06E+017,"testalpha"
,"gypsies gg and children","NNS  CC NNS",4,1,1,17165598,2,3.10E+017,"testalpha"
,"developed lethal cytomegalovirus pneumonitis","VBD JJ NN NN",4,1,1,16918065,"pubmed1",8.52E+018,"testalpha"
,"data about epidermal trna","NNS IN JJ ",4,1,1,16648912,2,4.43E+018,"testalpha"
,"crystal structures of hca","NN NNS IN ",4,1,1,16511248,2,6.31E+018,"testalpha"
,"holistic approach greek olos","JJ NN JJ ",4,1,1,17139889,2,6.73E+018,"testalpha"
,"psoriasis area severity index","NN NN NN NN",4,1,1,17311738,2,8.90E+018,"testalpha"
,"locus volume and boundary","NN NN CC NN",4,1,1,16988902,"pubmed1",1.53E+018,"testalpha"
,"activity in cirrhotic tissue","NN IN JJ NN",4,1,1,16404476,"pubmed1",8.59E+018,"testalpha"
,"thenumbers of leucocytes neutrophils","NNS IN NNS NNS",4,1,1,17293961,2,2.73E+017,"testalpha"
,"body surface area burns","NN NN NN NNS",4,1,1,17165599,2,1.31E+018,"testalpha"
,"serum level of ifn","NN NN IN ",4,1,1,16603096,2,1.71E+018,"testalpha"
,"mds with deletion ofthe"," IN NN NNP",4,1,1,17016041,2,2.05E+018,"testalpha"
,"bfs of unmilled acp"," IN VBN ",4,1,1,16701862,"pubmed1",5.42E+018,"testalpha"
,"function of thyroid hormones","NN IN NN NNS",4,1,1,17115080,"pubmed1",6.64E+018,"testalpha"
,"cavities was performedwhereas surgery","NNS VBD NNS NN",4,1,1,17370567,"pubmed1",8.14E+018,"testalpha"
,"using appropriateflow marker microdialysis","VBG VB NN NN",4,1,1,17438835,2,1.08E+018,"testalpha"
,"factors of thromboembolism results","NNS IN NN NNS",4,1,1,16696443,2,8.45E+018,"testalpha"
,"mechanism maintainingthe correct number","NN NNP VB NN",4,1,1,16919708,2,2.20E+018,"testalpha"
,"incidence trends and nature","NN NNS CC NN",4,1,1,16162331,"pubmed1",4.76E+018,"testalpha"
,"obvious correlation in lung","JJ NN IN NN",4,1,1,16762403,2,2.22E+018,"testalpha"
,"modified billbao dotter tube","VBN  NN NN",4,1,1,16447095,"pubmed1",1.83E+018,"testalpha"
,"dsba anddsbc or dsbd","  CC ",4,1,1,17019443,"pubmed1",8.11E+018,"testalpha"
,"major secretory protein component","JJ NN NN NN",4,1,1,16511271,2,2.17E+018,"testalpha"
,"metro rapid transit mrt","NN JJ NN ",4,1,1,16434013,"pubmed1",2.01E+018,"testalpha"
,"clinical hours scholarly activity","JJ NNS JJ NN",4,1,1,16436795,"pubmed1",5.05E+018,"testalpha"
,"technique in developing countries","NN IN VBG NNS",4,1,1,16424652,2,7.39E+018,"testalpha"
,"patients with intestinal failure","NNS IN JJ NN",4,1,1,17013518,2,4.95E+018,"testalpha"
,"orchidopexy and hernia repair"," CC NNP NN",4,1,1,16612933,"pubmed1",5.04E+018,"testalpha"
,"product reimbursement by insurance","NN NN IN NN",4,1,1,16999268,2,2.33E+018,"testalpha"
,"pdt or surgical tracheostomy"," CC JJ NN",4,1,1,16451156,"pubmed1",4.66E+018,"testalpha"
,"based systems for proximity","VBN NNS IN NN",4,1,1,16129405,"pubmed1",7.48E+018,"testalpha"
,"windsor region total motorvehicle","NN NN JJ NN",4,1,1,16169506,"pubmed1",4.28E+018,"testalpha"
,"patientssigns of anastomotic leakage","NNS IN JJ NN",4,1,1,16612911,2,4.86E+018,"testalpha"
,"quantitation of tgf beta","NN IN  NN",4,1,1,17293967,2,4.21E+018,"testalpha"
,"safety in modern healthcare","NN IN JJ NN",4,1,1,16321534,"pubmed1",5.75E+018,"testalpha"
,"chronic idiopathic thrombocytopenicpurpura itp","JJ JJ NNP ",4,1,1,16809885,2,8.72E+018,"testalpha"
,"e g transcription factors","  NN NNS",4,1,1,17265696,2,1.68E+018,"testalpha"
,"future development of macromolecularcrystallography","NN NN IN NN",4,1,1,16369088,2,2.43E+017,"testalpha"
,"consequencesduring regional coronary occlusion","VBG JJ NN NN",4,1,1,16451157,"pubmed1",7.88E+018,"testalpha"
,"treatment of complex anorectal","NN IN JJ NN",4,1,1,17139877,2,7.33E+018,"testalpha"
,"combinations between different modalities","NNS IN JJ NNS",4,1,1,17486414,"pubmed1",7.04E+018,"testalpha"
,"drug induced blistering disease","NN VBN VBG NN",4,1,1,16710577,2,2.60E+018,"testalpha"
,"mean globule size nm","VB NN NN ",4,1,1,16584167,"pubmed1",6.83E+018,"testalpha"
,"morphology and cytoskeletal changes","NN CC NN NNS",4,1,1,16956122,2,8.70E+018,"testalpha"
,"dl or required transfusion"," CC VBN NN",4,1,1,16424649,2,4.31E+018,"testalpha"
,"long term complete remission","JJ NN JJ NN",4,1,1,16955185,2,1.15E+018,"testalpha"
,"form of caenorhabditis elegansunc","NN IN NN ",4,1,1,16496042,"pubmed1",3.00E+018,"testalpha"
,"visualize changes between studies","VB NNS IN NNS",4,1,1,16399029,"pubmed1",6.08E+018,"testalpha"
,"uric acid ua levels","JJ NN  NNS",4,1,1,17338197,2,2.65E+018,"testalpha"
,"pi kinase and ampk"," NN CC ",4,1,1,16964326,"pubmed1",1.29E+018,"testalpha"
,"use existingevidence from literature","VB NN IN NN",4,1,1,16918069,"pubmed1",6.55E+018,"testalpha"
,"regression analysis consideringage inflammation","NN NN NN NN",4,1,1,17119323,2,7.75E+018,"testalpha"
,"requirecomplex experimentation or prediction","JJ NN CC NN",4,1,1,17285748,"pubmed1",6.99E+017,"testalpha"
,"lv performance in patients"," NN IN NNS",4,1,1,16989140,2,7.29E+018,"testalpha"
,"crash frequency on pennsylvania","NN NN IN NNP",4,1,1,16442487,"pubmed1",7.84E+017,"testalpha"
,"estimating equation models gee","VBG NN NNS ",4,1,1,16126153,"pubmed1",5.67E+018,"testalpha"
,"study patients withatopic dermatitis","NN NNS NN NN",4,1,1,16603096,2,6.36E+018,"testalpha"
,"tobacco root treated withsa","NN NN VBN ",4,1,1,16395526,"pubmed1",3.03E+017,"testalpha"
,"pelvis liver and lung","NNP NN CC NN",4,1,1,17139900,2,3.12E+018,"testalpha"
,"sv ejection fraction ef"," NN NN ",4,1,1,16989140,2,4.85E+018,"testalpha"
,"patients and control subjects","NNS CC NN NNS",4,1,1,16479026,2,9.10E+018,"testalpha"
,"expressions of food allergy","NNS IN NN NN",4,1,1,16673561,2,6.96E+018,"testalpha"
,"hexafluorophosphate co c h","NN  NN ",4,1,1,16456276,2,3.78E+018,"testalpha"
,"low grade squamous intraepitheliallesion","JJ NN JJ NN",4,1,1,16514835,2,8.15E+018,"testalpha"
,"follow ups was yearsafter","VB NNS VBD NN",4,1,1,17438833,2,8.41E+018,"testalpha"
,"bis sulfate co h"," NN  ",4,1,1,16397335,2,7.32E+018,"testalpha"
,"interventions and hasserious implications","NNS CC JJ NNS",4,1,1,16426558,"pubmed1",7.61E+018,"testalpha"
,"adults are blepharitis keratoconjunctivitis","NNS VBP NN NN",4,1,1,17106598,2,8.68E+018,"testalpha"
,"times by phone conference","NNS IN NN NN",4,1,1,16473991,"pubmed1",8.09E+018,"testalpha"
,"dimer clotocclusiveness clot persistence","NN NN NN NN",4,1,1,16549898,2,2.80E+018,"testalpha"
,"misinterpretation by researchers offindings","NN IN NNS NNS",4,1,1,16122689,"pubmed1",6.62E+018,"testalpha"
,"cells withthe highest response","NNS NNP JJS NN",4,1,1,17143338,"pubmed1",7.10E+017,"testalpha"
,"causes hepatitis virus band","NNS NN NN NN",4,1,1,17013520,2,3.18E+017,"testalpha"
,"patients with urolithiasis nephrocalcinosis","NNS IN NN NN",4,1,1,16956119,2,8.34E+018,"testalpha"
,"fiberscopy revealed glassy edemaof"," VBD JJ ",4,1,1,16451161,"pubmed1",8.48E+018,"testalpha"
,"crash data for pennsylvania","NN NNS IN NNP",4,1,1,16451795,"pubmed1",3.07E+018,"testalpha"
,"perturbations inhibited dna synthesis","NNS VBN  NN",4,1,1,16582987,"pubmed1",7.84E+018,"testalpha"
,"developed apractical reporter vector","VBN JJ NN NN",4,1,1,16395528,"pubmed1",5.67E+018,"testalpha"
,"spatial descriptors or indices","JJ NNS CC NNS",4,1,1,16823608,"pubmed1",7.40E+018,"testalpha"
,"peroral retinoic acidsupplement administration","JJ JJ NN NN",4,1,1,16612919,"pubmed1",7.85E+018,"testalpha"
,"deployment and inpatient diagnosis","NN CC NN NN",4,1,1,16405857,"pubmed1",1.83E+017,"testalpha"
,"larger dose than bupivacaine","JJR NN IN NN",4,1,1,16617756,"pubmed1",4.21E+018,"testalpha"
,"c terminal beta strands","NN NN NN NNS",4,1,1,16421447,2,2.64E+018,"testalpha"
,"cellular senescence and growth","JJ NN CC NN",4,1,1,16505900,"pubmed1",8.39E+018,"testalpha"
,"ethylene glycol ppdo plla","NN NN  ",4,1,1,16701879,"pubmed1",2.75E+018,"testalpha"
,"presence of higher plasminogenconcentration","NN IN JJR NN",4,1,1,16549888,2,5.23E+018,"testalpha"
,"acid tartaric acid water","NN JJ NN NN",4,1,1,16701865,"pubmed1",4.76E+018,"testalpha"
,"medical students in psychiatry","JJ NNS IN NN",4,1,1,16473990,"pubmed1",6.71E+018,"testalpha"
,"burn intensivecare unit icu","NN NN NN ",4,1,1,17294910,2,6.59E+018,"testalpha"
,"dimer in space groupc","NN IN NN ",4,1,1,16511271,2,1.10E+018,"testalpha"
,"replacement in patients withoutinhibitors","NN IN NNS NNS",4,1,1,16549892,2,7.22E+018,"testalpha"
,"successrate of beta tricalciumphosphate","NN IN NN NN",4,1,1,16956114,2,1.57E+018,"testalpha"
,"ents with malignant colonobstruction"," IN JJ NN",4,1,1,17139878,2,3.36E+018,"testalpha"
,"activity spontaneous locomotor activity","NN JJ NN NN",4,1,1,17133954,2,7.71E+017,"testalpha"
,"aspirates of follicular lesions","NNS IN JJ NNS",4,1,1,16514837,2,9.65E+017,"testalpha"
,"indicators of radiation damage","NNS IN NN NN",4,1,1,16421442,2,1.45E+018,"testalpha"
,"morphologic findings therapy stratification","JJ NNS NN NN",4,1,1,16333707,"pubmed1",5.46E+018,"testalpha"
,"free survival in arms","JJ NN IN NNS",4,1,1,16424644,2,5.62E+018,"testalpha"
,"ppd and probe group"," CC NN NN",4,1,1,16491216,2,5.03E+018,"testalpha"
,"thepercentage of total area","NN IN JJ NN",4,1,1,16549889,2,1.15E+018,"testalpha"
,"different types of shell","JJ NNS IN NN",4,1,1,16733064,2,5.66E+018,"testalpha"
,"chronic dermatologicaldiseases n x","JJ NNS  NN",4,1,1,16710575,2,2.04E+018,"testalpha"
,"high levels of depression","JJ NNS IN NN",4,1,1,16377815,"pubmed1",8.36E+018,"testalpha"
,"morphologic study of utilization","JJ NN IN NN",4,1,1,17293971,2,7.16E+018,"testalpha"
,"assigned topre established organ","VBN  VBN NN",4,1,1,17486414,"pubmed1",3.51E+017,"testalpha"
,"inrabbits and guinea pigs","NNS CC NNP NNS",4,1,1,16733562,"pubmed1",2.09E+018,"testalpha"
,"adverse events including hypoglycemicand","JJ NNS VBG NN",4,1,1,16918068,"pubmed1",4.02E+018,"testalpha"
,"protective effect of ag","JJ NN IN ",4,1,1,16999986,2,1.60E+018,"testalpha"
,"cardioversion fracture reduction abscess","NN NN NN NN",4,1,1,16365337,"pubmed1",2.82E+018,"testalpha"
,"salicylic acid sodium carbonate","JJ NN NN NN",4,1,1,17285749,"pubmed1",8.33E+018,"testalpha"
,"alleles vntr and vntr","NNS  CC ",4,1,1,16424652,2,4.40E+018,"testalpha"
,"atrophicus necrobiosis lipoidica sarcoidosis","NN NN NNP NN",4,1,1,17311739,2,7.41E+018,"testalpha"
,"queries describingphysician patient interactions","NNS JJ NN NNS",4,1,1,16436793,"pubmed1",2.28E+018,"testalpha"
,"mechanism of genetic information","NN IN JJ NN",4,1,1,16505901,"pubmed1",6.57E+018,"testalpha"
,"ctl responses inmacaque monkeys"," NNS JJ NNS",4,1,1,16511250,2,5.76E+018,"testalpha"
,"hydrolysis of carboxylphosphate bonds","NN IN NN NNS",4,1,1,16511269,2,2.31E+018,"testalpha"
,"domains and tothe yeast","NNS CC NNP NN",4,1,1,16421449,2,4.62E+018,"testalpha"
,"ankle andfoot limitation determinates","NN JJ NN NNS",4,1,1,17293973,2,3.73E+018,"testalpha"
,"f tularensis histidine acidphosphatase","NN NN NN NN",4,1,1,16511256,2,8.31E+018,"testalpha"
,"concentration and gsh pxactivity","NN CC  NN",4,1,1,17160142,"pubmed1",2.42E+018,"testalpha"
,"properties of undulator sources","NNS IN NN NNS",4,1,1,16369095,2,4.10E+018,"testalpha"
,"emulsion with dissolved i","NN IN VBN ",4,1,1,17117608,2,1.30E+018,"testalpha"
,"convention available atwww usp","NN JJ  ",4,1,1,17285738,"pubmed1",4.79E+018,"testalpha"
,"publications andpatient support group","NNS NN NN NN",4,1,1,17106594,2,5.66E+018,"testalpha"
,"inefficiency of ac fixation","NN IN  NN",4,1,1,16950501,2,2.48E+018,"testalpha"
,"addition of computedtomography ct","NN IN NN ",4,1,1,16333707,"pubmed1",1.69E+018,"testalpha"
,"enabling detection ofthe y","VBG NN NNP ",4,1,1,16929381,"pubmed1",6.04E+018,"testalpha"
,"inwistar rats by occlusion","NN NNS IN NN",4,1,1,17013508,2,1.61E+018,"testalpha"
,"standing history of cutaneouslesions","VBG NN IN NNS",4,1,1,16874423,2,8.04E+018,"testalpha"
,"n magneticresonance imaging n"," NN VBG ",4,1,1,16333704,"pubmed1",6.94E+017,"testalpha"
,"metaphases beside bm cells","NNS IN  NNS",4,1,1,16914909,2,2.24E+018,"testalpha"
,"conjunction with substance abusedisorders","NN IN NN NNS",4,1,1,16426559,"pubmed1",1.13E+018,"testalpha"
,"determination and managerial mandates","NN CC JJ NNS",4,1,1,16988904,"pubmed1",4.08E+018,"testalpha"
,"coverage against common pathogens","NN IN JJ NNS",4,1,1,16365328,"pubmed1",2.32E+018,"testalpha"
,"component clinical orct evidence","NN JJ  NN",4,1,1,17139900,2,3.51E+018,"testalpha"
,"differentiated tumours and clark","VBN NNS CC NN",4,1,1,16710578,2,6.06E+018,"testalpha"
,"epidermal differentiation and proliferation","JJ NN CC NN",4,1,1,16648912,2,5.12E+018,"testalpha"
,"high total cholesterol ldl","JJ NN NN ",4,1,1,16479026,2,1.87E+018,"testalpha"
,"antigen i cfa i","NN   ",4,1,1,16511280,2,7.68E+018,"testalpha"
,"absolute avoidance of contact","JJ NN IN NN",4,1,1,16916182,"pubmed1",6.84E+018,"testalpha"
,"equilibrium phase gre images","NN NN  NNS",4,1,1,16317488,"pubmed1",3.67E+018,"testalpha"
,"gender concomitanthypertension and diabetes","NN NN CC NN",4,1,1,16436794,"pubmed1",1.52E+017,"testalpha"
,"susceptibility locus withinchromosomal region","NN NN JJ NN",4,1,1,16733555,"pubmed1",8.07E+018,"testalpha"
,"vagotomy followed bypharmacological blockade","NN VBD JJ NN",4,1,1,17133957,2,3.91E+017,"testalpha"
,"effect of electrical ear","NN IN JJ NN",4,1,1,16955182,2,3.32E+018,"testalpha"
,"redirecting patients included system","VBG NNS VBD NN",4,1,1,16365324,"pubmed1",7.30E+017,"testalpha"
,"safety belts running lights","NN VBZ VBG NNS",4,1,1,16061188,"pubmed1",1.44E+017,"testalpha"
,"selective use ofcox inhibitors","JJ NN  NNS",4,1,1,16253314,2,8.15E+017,"testalpha"
,"control and experimental rats","NN CC JJ NNS",4,1,1,16762403,2,4.41E+018,"testalpha"
,"physiological basis ofeach index","JJ NN NN NN",4,1,1,17236645,"pubmed1",4.96E+018,"testalpha"
,"checklist of common physical","NN IN JJ NN",4,1,1,16377815,"pubmed1",2.38E+018,"testalpha"
,"hema mep molar ratio","  JJ NN",4,1,1,16701862,"pubmed1",5.38E+018,"testalpha"
,"imbalance between energy intake","NN IN NN NN",4,1,1,16479031,2,4.26E+018,"testalpha"
,"albino wistar rats rattus","NNP NN NNS NN",4,1,1,17293969,2,7.37E+018,"testalpha"
,"possibility ofusing soluble fas","NN VBG JJ ",4,1,1,16710577,2,7.07E+018,"testalpha"
,"strength and controlled release","NN CC VBN NN",4,1,1,16584161,"pubmed1",2.11E+018,"testalpha"
,"relative number of clp","JJ NN IN ",4,1,1,17165598,2,5.14E+018,"testalpha"
,"months in micromepoxy resin","NNS IN NN NNP",4,1,1,17007910,2,4.49E+018,"testalpha"
,"suprarenal gland removal significantimprovement","JJ NN NN NN",4,1,1,16603099,2,7.91E+018,"testalpha"
,"treatment par weighting scores","NN NN NN NNS",4,1,1,17438832,2,1.53E+018,"testalpha"
,"problems and co drug","NNS CC  NN",4,1,1,16808045,"pubmed1",4.06E+018,"testalpha"
,"function of compression force","NN IN NN NN",4,1,1,16584166,"pubmed1",1.61E+018,"testalpha"
,"cellsand smooth muscle cells","NN JJ NN NNS",4,1,1,16770441,"pubmed1",6.11E+018,"testalpha"
,"measures of mortalityand length","NNS IN NN NN",4,1,1,16596895,"pubmed1",7.49E+018,"testalpha"
,"protein in boar testis","NN IN  NN",4,1,1,17084885,2,1.58E+018,"testalpha"
,"hca vi from saliva","  IN ",4,1,1,16511271,2,8.73E+018,"testalpha"
,"regulatorygene since c myc","NN IN NN ",4,1,1,16809887,2,8.45E+018,"testalpha"
,"clinical diagnoses in case","JJ NNS IN NN",4,1,1,16514850,2,1.26E+018,"testalpha"
,"training and sustain performance","NN CC VB NN",4,1,1,16918070,"pubmed1",5.71E+018,"testalpha"
,"post operative blood loss","NN JJ NN NN",4,1,1,16451158,"pubmed1",6.30E+018,"testalpha"
,"time contrast specific systems","NN NN JJ NNS",4,1,1,16317492,"pubmed1",2.77E+018,"testalpha"
,"soluble fas ligand secretionby","JJ  NN ",4,1,1,16710577,2,1.16E+018,"testalpha"
,"enzyme immunoassay in patients"," NN IN NNS",4,1,1,16585983,2,6.03E+017,"testalpha"
,"val phe lys thr","   ",4,1,1,16496040,"pubmed1",9.12E+018,"testalpha"
,"side manner for weeks","NN NN IN NNS",4,1,1,16585987,2,7.95E+018,"testalpha"
,"lymphnodes and liver metastases","NNS CC NN NNS",4,1,1,17139879,2,1.24E+018,"testalpha"
,"was seen fiber diameters","VBD VBN NN NNS",4,1,1,16701855,"pubmed1",4.50E+018,"testalpha"
,"polystyrene surface coated plates","NN NN VBN NNS",4,1,1,16549889,2,2.89E+018,"testalpha"
,"neurotransmission conduction secretion vasodilation","NN NN NN NN",4,1,1,16770441,"pubmed1",2.26E+018,"testalpha"
,"processes and nmda receptor","NNS CC  NN",4,1,1,17265692,2,8.97E+018,"testalpha"
,"t polymorphism in exon"," NN IN ",4,1,1,16733564,"pubmed1",2.88E+018,"testalpha"
,"byinverted filter sedimentation ifs","VBN NN NN ",4,1,1,16514842,2,1.00E+018,"testalpha"
,"dipeptidyl peptidase iv dppiv"," NN  ",4,1,1,16929383,"pubmed1",7.42E+018,"testalpha"
,"derived natural genome editing","VBN JJ NN NN",4,1,1,17347785,"pubmed1",5.55E+018,"testalpha"
,"induced dhrs inlarge breed","VBN  JJ NN",4,1,1,16594644,"pubmed1",5.02E+018,"testalpha"
,"sinushistiocytosis in lymph nodes","NN IN NN NNS",4,1,1,16256177,2,6.56E+018,"testalpha"
,"conclusion hps pathogenesis inkidney","NN  NN NN",4,1,1,16914905,2,2.72E+018,"testalpha"
,"skullcollection from pertaining broumov","NN IN VBG ",4,1,1,17438834,2,3.57E+018,"testalpha"
,"atomic structures of proteins","JJ NNS IN NNS",4,1,1,16369101,2,7.61E+018,"testalpha"
,"cholesterol triglyceride ldl cholesterol","NN VB  NN",4,1,1,16479026,2,1.31E+018,"testalpha"
,"primary salivary gland neoplasm","NN JJ NN NN",4,1,1,16514848,2,6.41E+018,"testalpha"
,"important strengths and weaknessesof","JJ NNS CC ",4,1,1,16474001,"pubmed1",1.32E+018,"testalpha"
,"titles report titles timespent","NNS VBP NNS NN",4,1,1,16377812,"pubmed1",7.10E+018,"testalpha"
,"acetate or pure saline","NN CC JJ NN",4,1,1,16491218,2,3.84E+018,"testalpha"
,"ointment with triamcinoloneacetonide ointment","NN IN VB NN",4,1,1,16710580,2,6.44E+016,"testalpha"
,"affinity and oligomeric form","NN CC JJ NN",4,1,1,17143335,"pubmed1",2.50E+018,"testalpha"
,"appearance on baseline ultrasound","NN IN NN NN",4,1,1,16333704,"pubmed1",9.05E+018,"testalpha"
,"donorligand n n bis","NN   ",4,1,1,16456265,2,9.10E+018,"testalpha"
,"assay and thetotal number","NN CC NN NN",4,1,1,16582984,"pubmed1",2.78E+018,"testalpha"
,"morphinegel or placebo gel","NNP CC  ",4,1,1,16955184,2,4.83E+018,"testalpha"
,"years pre and years","NNS  CC NNS",4,1,1,16169506,"pubmed1",2.06E+017,"testalpha"
,"education outreach and programming","NN NN CC NN",4,1,1,16596897,"pubmed1",8.41E+018,"testalpha"
,"e colisepsis and flare"," NN CC NN",4,1,1,16603100,2,2.15E+017,"testalpha"
,"macrophages and fibroblast population","NNS CC JJS NN",4,1,1,16612917,"pubmed1",8.06E+016,"testalpha"
,"antigens on b cell","NNS IN NN NN",4,1,1,16424654,2,9.20E+018,"testalpha"
,"substitution of mn iii","NN IN  ",4,1,1,16421446,2,4.22E+017,"testalpha"
,"specificity of sige tests","NN IN  NNS",4,1,1,16673562,2,3.01E+018,"testalpha"
,"chromatic excimer light clearedpalmoplantar","JJ NN JJ NN",4,1,1,16585984,2,5.79E+018,"testalpha"
,"cell blocks byinverted filter","NN NNS VBN NN",4,1,1,16514842,2,2.68E+018,"testalpha"
,"atypical appearance on baseline","JJ NN IN NN",4,1,1,16333704,"pubmed1",3.38E+018,"testalpha"
,"skin hydration and skin","NN NN CC NN",4,1,1,17285742,"pubmed1",5.51E+018,"testalpha"
,"withhearing loss and keratitis","VBG NN CC NN",4,1,1,17106596,2,5.52E+017,"testalpha"
,"linoleoyl phosphatidylcholine and stearoyl"," NN CC ",4,1,1,17128291,"pubmed1",2.59E+018,"testalpha"
,"used toassess sensorimotor function","VBN NN NN NN",4,1,1,17265691,2,8.95E+018,"testalpha"
,"project nearedcompletion considerable claims","NN NN JJ NNS",4,1,1,16596744,"pubmed1",7.41E+018,"testalpha"
,"data confirm thegrowing importance","NNS VBP VBG NN",4,1,1,16648915,2,1.12E+018,"testalpha"
,"lanes were used toestimate","NNS VBD VBN NN",4,1,1,16442487,"pubmed1",1.23E+018,"testalpha"
,"pavementmarkings and pavement resurfacings","NNS CC NN NNS",4,1,1,16236232,"pubmed1",5.93E+018,"testalpha"
,"age gender disease type","NN NN NN NN",4,1,1,16673554,2,5.50E+018,"testalpha"
,"pancreatic cancer cell line","JJ NN NN NN",4,1,1,17143338,"pubmed1",9.07E+018,"testalpha"
,"key response disturbing constituent","JJS NN JJ NN",4,1,1,16648911,2,4.22E+018,"testalpha"
,"m in licensed establishments"," IN VBN NNS",4,1,1,16169506,"pubmed1",2.44E+018,"testalpha"
,"status and healthy status","NN CC JJ NN",4,1,1,16918067,"pubmed1",7.67E+018,"testalpha"
,"hyperosmolar hyperglycemic statesin patients","JJ JJ NNP NNS",4,1,1,16462410,"pubmed1",1.24E+018,"testalpha"
,"tool for risk stratification","NN IN NN NN",4,1,1,16365321,"pubmed1",4.58E+018,"testalpha"
,"stress and free oxygen","NN CC JJ NN",4,1,1,16673555,2,2.59E+018,"testalpha"
,"composition bold blood oxygenationlevel","NN JJ NN NN",4,1,1,16447077,"pubmed1",5.35E+018,"testalpha"
,"tomoderate occupational solvent exposure","NN JJ NN NN",4,1,1,16808045,"pubmed1",7.58E+018,"testalpha"
,"pain syndromeand warranting evaluation","NN NN VBG NN",4,1,1,16365321,"pubmed1",3.61E+018,"testalpha"
,"climate measures and theirinteraction","NN NNS CC NN",4,1,1,16202466,"pubmed1",6.85E+017,"testalpha"
,"abdominal pain and intermittentnausea","JJ NN CC NNP",4,1,1,16612930,"pubmed1",6.34E+018,"testalpha"
,"neuronal cell culture experiments","JJ NN NN NNS",4,1,1,17265697,2,7.29E+018,"testalpha"
,"control diet and nutrition","NN NN CC NN",4,1,1,16596897,"pubmed1",1.26E+018,"testalpha"
,"pancytopenia with high fever","NNP IN JJ NN",4,1,1,16809892,2,4.79E+017,"testalpha"
,"m for years pre"," IN NNS ",4,1,1,16169506,"pubmed1",5.89E+018,"testalpha"
,"additive character of topo","JJ NN IN ",4,1,1,16714051,2,7.55E+018,"testalpha"
,"slight increase of liverechogenicity","JJ NN IN NN",4,1,1,16673610,2,5.09E+018,"testalpha"
,"subsetsinto allergen exposed skin","NNP NN VBN NN",4,1,1,16603095,2,6.69E+018,"testalpha"
,"releasematrix tablets of zidovudine","NNP NNS IN NN",4,1,1,16584139,"pubmed1",2.73E+018,"testalpha"
,"il beta il il"," NN  ",4,1,1,17293960,2,8.36E+018,"testalpha"
,"publication on patch testing","NN IN NN NN",4,1,1,17438830,2,1.13E+018,"testalpha"
,"participation in treatment decisions","NN IN NN NNS",4,1,1,17106601,2,4.76E+018,"testalpha"
,"nerves lymphatics or veins","NNS NNS CC NNS",4,1,1,17139900,2,4.98E+018,"testalpha"
,"temperature phase theunit cell","NN NN JJ NN",4,1,1,16434797,2,8.03E+018,"testalpha"
,"basal conditions resected gut","NN NNS VBN NN",4,1,1,17293957,2,3.48E+018,"testalpha"
,"andcomputer and manual databases","NN CC JJ NNS",4,1,1,16438093,"pubmed1",6.32E+018,"testalpha"
,"saccharomyces cerevisiae excreting protonsin","NNS  VBG NNP",4,1,1,17146497,"pubmed1",7.69E+018,"testalpha"
,"igamma and iigamma isoforms","NN CC NN NNS",4,1,1,17265688,2,7.31E+018,"testalpha"
,"teenage motor vehicle fatalities","JJ NN NN NNS",4,1,1,16171767,"pubmed1",7.07E+018,"testalpha"
,"surface contributes tohigher average","NN NNS JJ NN",4,1,1,16584166,"pubmed1",1.46E+018,"testalpha"
,"lower thanthe actual values","JJR NNP JJ NNS",4,1,1,17285744,"pubmed1",2.27E+018,"testalpha"
,"costs of patientsreceiving chemotherapy","NNS IN VBG NN",4,1,1,16424646,2,6.38E+018,"testalpha"
,"pathologies namelyhemorrhoids anal fistula","NNS NNS  NN",4,1,1,17139880,2,6.71E+018,"testalpha"
,"dyslipidaemia in sle factors","NN IN  NNS",4,1,1,16479028,2,6.12E+018,"testalpha"
,"uba domains and tothe"," NNS CC NNP",4,1,1,16421449,2,5.75E+017,"testalpha"
,"lm showed nomicrocirculation modification"," VBD NN NN",4,1,1,17438835,2,2.81E+018,"testalpha"
,"patients years of age","NNS NNS IN NN",4,1,1,16436798,"pubmed1",8.63E+017,"testalpha"
,"comparison of survival times","NN IN NN NNS",4,1,1,16436788,"pubmed1",3.31E+018,"testalpha"
,"hypertrophic scars and tissue","JJ NNS CC NN",4,1,1,17165599,2,3.03E+018,"testalpha"
,"replacement with posterior leaflet","NN IN JJ NN",4,1,1,16989140,2,5.49E+018,"testalpha"
,"council for graduate medicaleducation","NN IN NN NN",4,1,1,16377825,"pubmed1",4.24E+018,"testalpha"
,"factors is supposed toelevate","NNS VBZ VBN NN",4,1,1,17236637,"pubmed1",4.39E+018,"testalpha"
,"chains via hydrogen bonds","NNS IN NN NNS",4,1,1,16456294,2,7.44E+018,"testalpha"
,"compound n hydroxybenzamido ethylammonioethyl","NN   ",4,1,1,16456282,2,2.94E+018,"testalpha"
,"long term survival rate","JJ NN NN NN",4,1,1,16314992,"pubmed1",1.85E+018,"testalpha"
,"cultures min and hafter","NNS  CC NN",4,1,1,16582987,"pubmed1",1.45E+018,"testalpha"
,"nodules showing stains byportal","NNS VBG NNS NN",4,1,1,16317494,"pubmed1",8.92E+018,"testalpha"
,"expression of adhesion molecules","NN IN NN NNS",4,1,1,16603095,2,7.95E+018,"testalpha"
,"time and mean pulse","NN CC VB NN",4,1,1,16399037,"pubmed1",8.73E+018,"testalpha"
,"following growingseason spring summer","VBG NN NN NN",4,1,1,16733064,2,6.44E+018,"testalpha"
,"patient developed severe sepsis","NN VBD JJ NN",4,1,1,16914908,2,1.06E+018,"testalpha"
,"preexisting pa necessitating anaccurate","VBG  VBG NN",4,1,1,16514848,2,2.93E+018,"testalpha"
,"natural log of population","JJ NN IN NN",4,1,1,16111641,"pubmed1",2.04E+018,"testalpha"
,"courses for maximum release","NNS IN JJ NN",4,1,1,16701879,"pubmed1",5.67E+018,"testalpha"
,"conservation of momentum andconservation","NN IN NN NN",4,1,1,16054101,"pubmed1",7.97E+018,"testalpha"
,"inthe pacu and recovery","NNP  CC NN",4,1,1,16451145,"pubmed1",4.99E+018,"testalpha"
,"percutaneous dilatation tracheostomy pdt","JJ NN NN ",4,1,1,16451156,"pubmed1",3.46E+018,"testalpha"
,"ml with magnesium mg"," IN NN ",4,1,1,17067136,"pubmed1",4.45E+018,"testalpha"
,"potentiometry electronic absorption spectroscopy","NN JJ NN ",4,1,1,17117212,"pubmed1",2.30E+018,"testalpha"
,"pdt of superficial basal"," IN JJ NN",4,1,1,16955185,2,6.35E+018,"testalpha"
,"appearance with bilateral cryptorchidism","NN IN JJ NN",4,1,1,16612933,"pubmed1",9.02E+018,"testalpha"
,"evidence of explicit memory","NN IN JJ NN",4,1,1,17236636,"pubmed1",1.78E+018,"testalpha"
,"andlaser diffraction analysis ld","NN NN NN ",4,1,1,16584150,"pubmed1",8.54E+018,"testalpha"
,"iumpyridine carboxylate c h","NN NN NN ",4,1,1,16456283,2,2.95E+018,"testalpha"
,"body weight b i","NN NN NN ",4,1,1,16549901,2,7.40E+018,"testalpha"
,"thanpatients with cc score","NNS IN  NN",4,1,1,17139879,2,4.17E+018,"testalpha"
,"abt reaction sialic acid"," NN JJ NN",4,1,1,16714048,2,5.42E+018,"testalpha"
,"cys gly on fvii","  IN ",4,1,1,16914903,2,2.74E+017,"testalpha"
,"healthcare providers and emergency","NN NNS CC NN",4,1,1,16365322,"pubmed1",7.95E+018,"testalpha"
,"h o detoxifying enzymes","  VBG NNS",4,1,1,16410836,"pubmed1",6.95E+018,"testalpha"
,"symptoms of heart failure","NNS IN NN NN",4,1,1,16914907,2,2.97E+018,"testalpha"
,"research athand ensure consistency","NN NN VB NN",4,1,1,16770858,"pubmed1",5.06E+018,"testalpha"
,"drosophila period clock protein","NNP NN NN NN",4,1,1,16411738,"pubmed1",3.03E+018,"testalpha"
,"membrane protein dipeptidyl peptidase","NN NN  NN",4,1,1,16929383,"pubmed1",6.71E+018,"testalpha"
,"range mmhg in group","NN  IN NN",4,1,1,16612916,"pubmed1",8.90E+018,"testalpha"
,"lactoside c h o","VB NN  ",4,1,1,16456293,2,3.28E+018,"testalpha"
,"carrier matrix for nanoparticulategene","NN NNP IN NN",4,1,1,17285741,"pubmed1",8.69E+018,"testalpha"
,"combinedwith lowered speed limits","NN VBD NN NNS",4,1,1,16423319,"pubmed1",8.53E+018,"testalpha"
,"dynamic contact withstainless steel","JJ NN NN NN",4,1,1,17285749,"pubmed1",3.00E+018,"testalpha"
,"cell carcinomas cloacogenic carcinomas","NN NNP JJ NNP",4,1,1,17139883,2,1.86E+018,"testalpha"
,"thetotal number of chromosome","NN NN IN NN",4,1,1,16582984,"pubmed1",2.12E+018,"testalpha"
,"enhance cd t cell","VB   NN",4,1,1,16511253,2,4.74E+018,"testalpha"
,"accuracy of diagnostic interpretation","NN IN JJ NN",4,1,1,16436791,"pubmed1",1.26E+018,"testalpha"
,"decreases fos immunoreactivity probablyby","NNS  NN ",4,1,1,17007911,2,2.86E+018,"testalpha"
,"stimulated c peptide gcp","VBN NN VB ",4,1,1,16673610,2,7.88E+018,"testalpha"
,"experimental model ofischemia reperfusion","JJ NN NN NN",4,1,1,17293970,2,6.44E+017,"testalpha"
,"hyperthermophilic repressor shows uniquedna","JJ NN VBZ ",4,1,1,16511254,2,8.90E+018,"testalpha"
,"inthe chain of treatment","NNP NN IN NN",4,1,1,16710575,2,8.95E+018,"testalpha"
,"o by anorectal manometry"," IN NN NN",4,1,1,17139884,2,1.93E+018,"testalpha"
,"oriented tissuesparing surgery facilitates","VBN VBG NN NNS",4,1,1,17139901,2,3.69E+018,"testalpha"
,"r against malassezia yeasts","NN IN NNP NNS",4,1,1,16874415,2,7.69E+018,"testalpha"
,"reaction with masson trichrome","NN IN NN NN",4,1,1,16514844,2,4.55E+018,"testalpha"
,"mop and uva light"," CC  NN",4,1,1,17016038,2,5.34E+018,"testalpha"
,"abnormalities related tolower si","NNS VBN NN ",4,1,1,16809889,2,6.11E+017,"testalpha"
,"freeze drying process design","NN VBG NN NN",4,1,1,17285746,"pubmed1",6.70E+018,"testalpha"
,"comparable collectives whereasdifferent domains","JJ NNS NN NNS",4,1,1,16988904,"pubmed1",6.68E+018,"testalpha"
,"implications of thecurrent rrc","NNS IN NN ",4,1,1,16473998,"pubmed1",7.55E+018,"testalpha"
,"injury risk of differentmodels","NN NN IN NNS",4,1,1,16111641,"pubmed1",1.84E+018,"testalpha"
,"revealed thatrecombinant stbetarii fc","VBD JJ  ",4,1,1,16733563,"pubmed1",5.58E+018,"testalpha"
,"n terminal sh domain"," NN  NN",4,1,1,16511262,2,8.82E+018,"testalpha"
,"form of hcmv infection","NN IN  NN",4,1,1,17019440,"pubmed1",9.09E+018,"testalpha"
,"same diagnosis and therapy","JJ NN CC NN",4,1,1,16722348,2,3.78E+018,"testalpha"
,"acids and sulfated gags","NNS CC VBN ",4,1,1,16714048,2,5.19E+018,"testalpha"
,"prevalence of high scores","NN IN JJ NNS",4,1,1,16377826,"pubmed1",5.85E+018,"testalpha"
,"activity and platelet count","NN CC NN NN",4,1,1,17016035,2,1.55E+018,"testalpha"
,"other areas ofmolecular biology","JJ NNS JJ NN",4,1,1,16596744,"pubmed1",3.69E+018,"testalpha"
,"diagnosis and week p","NN CC NN ",4,1,1,16809890,2,2.59E+018,"testalpha"
,"g n control group","  NN NN",4,1,1,17293959,2,3.93E+018,"testalpha"
,"hpv after treatment ofcin"," IN NN NNP",4,1,1,16514834,2,5.23E+018,"testalpha"
,"continuouslyevery minute for min","NN NN IN ",4,1,1,16451159,"pubmed1",6.80E+018,"testalpha"
,"autologousperipheral blood stem cell","JJ NN VB NN",4,1,1,17119322,2,8.12E+017,"testalpha"
,"thecontrol of gene expression","NN IN  NN",4,1,1,17143336,"pubmed1",8.50E+018,"testalpha"
,"weighted gre images t","JJ  NNS ",4,1,1,16317488,"pubmed1",3.80E+018,"testalpha"
,"gene with least variability"," IN JJS NN",4,1,1,16733561,"pubmed1",2.95E+016,"testalpha"
,"occurrence of cellular fusion","NN IN JJ NN",4,1,1,17013517,2,2.14E+018,"testalpha"
,"acids and premature termination","NNS CC JJ NN",4,1,1,16424663,2,7.15E+018,"testalpha"
,"filter basedpcr using transgene","NN  VBG NN",4,1,1,16951742,"pubmed1",5.02E+018,"testalpha"
,"condensed phase environments isdifficult","VBN NN NNS NN",4,1,1,16411736,"pubmed1",1.97E+018,"testalpha"
,"recognizedphagocytosis of viral particles","NN IN JJ NNS",4,1,1,17019440,"pubmed1",8.00E+018,"testalpha"
,"humans with threebranches policy","NNS IN NNS NN",4,1,1,16770860,"pubmed1",6.10E+018,"testalpha"
,"swedish cohort appears tobe","JJ NN VBZ ",4,1,1,16710578,2,6.95E+017,"testalpha"
,"safety requirements for areas","NN NNS IN NNS",4,1,1,16365330,"pubmed1",5.55E+018,"testalpha"
,"v o ch o","   ",4,1,1,16456275,2,8.61E+018,"testalpha"
,"inpreparation for neutron diffraction","NN IN NN NN",4,1,1,16511248,2,2.44E+018,"testalpha"
,"backward repetition dfr dbr","JJ NN  ",4,1,1,16479025,2,4.00E+017,"testalpha"
,"kind of light source","NN IN NN NN",4,1,1,16585984,2,2.68E+018,"testalpha"
,"turtle chrysemys picta andthe","NN   NNP",4,1,1,16733064,2,3.19E+018,"testalpha"
,"egfp retroviral vector ofegfp"," JJ NN ",4,1,1,17160143,"pubmed1",6.96E+018,"testalpha"
,"barriers high carrier rates","NNS JJ NN NNS",4,1,1,16710581,2,7.97E+018,"testalpha"
,"average increase inprovider hours","NN NN NN NNS",4,1,1,16365329,"pubmed1",1.84E+018,"testalpha"
,"experimental approach thechain length","JJ NN VB NN",4,1,1,16411735,"pubmed1",5.31E+018,"testalpha"
,"minor major injury episodes","JJ JJ NN NNS",4,1,1,16412373,"pubmed1",8.36E+018,"testalpha"
,"frompyrococcus horikoshii ot ph","NN   ",4,1,1,16511260,2,1.85E+018,"testalpha"
,"othersignificant predictors of collisions","JJ NNS IN NNS",4,1,1,16112070,"pubmed1",1.48E+018,"testalpha"
,"stand point of view","VB NN IN NN",4,1,1,16956115,2,1.99E+018,"testalpha"
,"complete diffraction data sets","JJ NN NNS NNS",4,1,1,16511259,2,3.36E+018,"testalpha"
,"genital ulcers in femalesare","NN NNS IN NN",4,1,1,16955191,2,3.34E+018,"testalpha"
,"included conclusions probabilistic linkage","VBD NNS JJ NN",4,1,1,16365326,"pubmed1",5.66E+018,"testalpha"
,"allocation of donor livers","NN IN NN NNS",4,1,1,17013505,2,8.96E+018,"testalpha"
,"catalase cat activities glutathione","NN NN NNS NN",4,1,1,16999986,2,5.97E+018,"testalpha"
,"improve insight in themechanisms","VB NN IN NNS",4,1,1,16406188,"pubmed1",8.92E+018,"testalpha"
,"accompanying c myc abnormality","VBG NN  NN",4,1,1,16809887,2,8.01E+018,"testalpha"
,"old have higher risk","JJ NN JJR NN",4,1,1,16197912,"pubmed1",2.71E+018,"testalpha"
,"course and proper management","NN CC JJ NN",4,1,1,17294911,2,8.32E+018,"testalpha"
,"embryos whilst cord blood","  NN NN",4,1,1,17269167,2,3.71E+018,"testalpha"
,"iii form of ovine"," NN IN NN",4,1,1,16421446,2,7.65E+018,"testalpha"
,"contrast enhanced mr images","NN VBN  NNS",4,1,1,16399033,"pubmed1",8.13E+018,"testalpha"
,"ndni possesses high affinity"," VBZ JJ NN",4,1,1,16594645,"pubmed1",1.79E+017,"testalpha"
,"plasmafactor viii coagulant activity","NN  JJ NN",4,1,1,16673613,2,1.80E+018,"testalpha"
,"be indispensable inexperimental cell","VB JJ NN NN",4,1,1,16730369,2,1.29E+018,"testalpha"
,"theconsequences of nicotine use","NNS IN NN NN",4,1,1,16594641,"pubmed1",3.62E+018,"testalpha"
,"injury in rats wistar","NN IN NNS NN",4,1,1,16714049,2,6.74E+018,"testalpha"
,"human t cell leukemia","JJ  NN NN",4,1,1,16421452,2,1.54E+018,"testalpha"
,"t or t n"," CC  ",4,1,1,17139887,2,4.44E+018,"testalpha"
,"phosphate buffered saline pbs","NN VBN NN ",4,1,1,16701857,"pubmed1",8.11E+018,"testalpha"
,"curve of calculated fluorescence","NN IN VBN NN",4,1,1,16404478,"pubmed1",7.25E+018,"testalpha"
,"theaetiopathogenesis of skin depigmentation","NN IN NN NN",4,1,1,16710576,2,2.15E+018,"testalpha"
,"fracture reduction abscess incision","NN NN NN NN",4,1,1,16365337,"pubmed1",5.36E+018,"testalpha"
,"scores and mean percent","NNS CC VB NN",4,1,1,17067136,"pubmed1",1.70E+018,"testalpha"
,"foreducators regarding medical education","NNS IN JJ NN",4,1,1,16473991,"pubmed1",3.42E+018,"testalpha"
,"membrane thickness presented results","NN NN VBD NNS",4,1,1,16964324,"pubmed1",1.48E+018,"testalpha"
,"inflammatory cells including eosinophils","JJ NNS VBG NNS",4,1,1,16859611,2,1.55E+018,"testalpha"
,"clinical presentation and symptoms","JJ NN CC NNS",4,1,1,16696444,2,3.99E+018,"testalpha"
,"surrounding structures including morphologicalvariability","VBG NNS IN NN",4,1,1,16399031,"pubmed1",6.04E+018,"testalpha"
,"were atopic modified erlanger","VBD NN VBN NN",4,1,1,16648917,2,8.94E+018,"testalpha"
,"collection of contrast material","NN IN NN NN",4,1,1,16333701,"pubmed1",2.39E+018,"testalpha"
,"ventilation distribution and changes","NN NN CC NNS",4,1,1,16399039,"pubmed1",2.69E+018,"testalpha"
,"cells and isolated cell","NNS CC VBN NN",4,1,1,16733563,"pubmed1",7.78E+018,"testalpha"
,"blockage of tgfbeta action","NN IN NN NN",4,1,1,16733556,"pubmed1",5.52E+018,"testalpha"
,"h h more brain","  JJR NN",4,1,1,17133952,2,6.88E+018,"testalpha"
,"etiology resp of acutehepatitis","NN  IN NN",4,1,1,16696442,2,7.07E+018,"testalpha"
,"g lucidum extractmay stimulate"," NN NN NN",4,1,1,16964326,"pubmed1",2.81E+018,"testalpha"
,"indications contraindications andadverse effects","NNS NNS NN NNS",4,1,1,17236644,"pubmed1",5.84E+018,"testalpha"
,"counter ions and solvent","VB  CC NN",4,1,1,16397333,2,3.58E+018,"testalpha"
,"variables on coat weight","NNS IN NN NN",4,1,1,17285748,"pubmed1",6.89E+018,"testalpha"
,"was induced inwistar rats","VBD VBN NN NNS",4,1,1,17013508,2,2.43E+018,"testalpha"
,"transmembrane receptor protein fas","NN NN NN ",4,1,1,16330085,2,8.32E+018,"testalpha"
,"domains frompyrococcus horikoshii ot","NNS NN  ",4,1,1,16511260,2,4.74E+018,"testalpha"
,"composition measurements underlying principles","NN NNS VBG NNS",4,1,1,16918067,"pubmed1",5.40E+018,"testalpha"
,"ultrastructural examination of rat","JJ NN IN NN",4,1,1,16574202,2,8.56E+018,"testalpha"
,"correlation between pd l","NN IN  ",4,1,1,16530813,2,1.08E+017,"testalpha"
,"adhesion migration and apoptosis","NN NN CC NN",4,1,1,16430945,2,7.27E+018,"testalpha"
,"perceived risk for traffic","VBN NN IN NN",4,1,1,16112069,"pubmed1",5.41E+018,"testalpha"
,"coli and purified withoutmembrane"," CC VBN NN",4,1,1,16511288,2,9.58E+017,"testalpha"
,"curettage of treatment areas","NN IN NN NNS",4,1,1,16955184,2,1.95E+018,"testalpha"
,"types of airborne allergy","NNS IN NNP NN",4,1,1,17328144,2,7.93E+018,"testalpha"
,"performed dynamic force measurements","VBN JJ NN NNS",4,1,1,16410837,"pubmed1",8.01E+018,"testalpha"
,"monoclonal gammopathies in blood","JJ NNS IN NN",4,1,1,16956121,2,3.90E+018,"testalpha"
,"preparing pre metastatic niches","VBG  JJ NNS",4,1,1,16730054,2,6.28E+018,"testalpha"
,"ofurinary n acetyl beta","JJ   NN",4,1,1,16956119,2,6.17E+018,"testalpha"
,"number of published case","NN IN VBN NN",4,1,1,16417901,"pubmed1",4.85E+018,"testalpha"
,"topsoriasis area and severity","NN NN CC NN",4,1,1,16585983,2,7.38E+018,"testalpha"
,"murine model of intraperitoneal","NN NN IN NN",4,1,1,16436788,"pubmed1",4.20E+018,"testalpha"
,"reduce emergencydepartment ed overcrowding","VB NN VBD NN",4,1,1,16365324,"pubmed1",8.99E+017,"testalpha"
,"q switched ruby laser"," VBD  NN",4,1,1,16859612,2,6.22E+017,"testalpha"
,"cyclicmonophosphate camp phosphodiesterase activity","NN NN NN NN",4,1,1,16411738,"pubmed1",4.00E+018,"testalpha"
,"surgical controls mean age","JJ NNS VBP NN",4,1,1,16451151,"pubmed1",3.87E+018,"testalpha"
,"event based injury rate","NN VBN NN NN",4,1,1,16236234,"pubmed1",2.39E+018,"testalpha"
,"dimensional polymeric chains ofmolecules","JJ JJ NNS NNS",4,1,1,16397330,2,6.23E+018,"testalpha"
,"typicalimmediate type allergens aeroallergens","NN NN NNS NNS",4,1,1,17438830,2,7.99E+018,"testalpha"
,"cys gly pro cys","  JJ ",4,1,1,16421453,2,8.63E+018,"testalpha"
,"stablepatient with blunt injury","NN IN JJ NN",4,1,1,17013521,2,1.68E+018,"testalpha"
,"therapy in patients whoseblood","NN IN NNS NN",4,1,1,16809890,2,5.81E+018,"testalpha"
,"initial phase x u","JJ NN NN ",4,1,1,17119327,2,1.67E+018,"testalpha"
,"reaction scheme is extrapolatedto","NN NN VBZ ",4,1,1,16770446,"pubmed1",2.79E+017,"testalpha"
,"end of h ischemia","NN IN  NN",4,1,1,17265689,2,6.30E+018,"testalpha"
,"samples were collected bymeans","NNS VBD VBN NNS",4,1,1,17293963,2,6.41E+018,"testalpha"
,"strength and intestinal elongation","NN CC JJ NN",4,1,1,16612919,"pubmed1",3.64E+018,"testalpha"
,"afterapplying solutions containing aha","VBG NNS VBG ",4,1,1,16574202,2,4.36E+018,"testalpha"
,"binding protein in boar","VBG NN IN ",4,1,1,17084885,2,6.10E+018,"testalpha"
,"levels was detected p","NNS VBD VBD ",4,1,1,16673555,2,3.22E+018,"testalpha"
,"neuron specific enolase nse","NNP JJ NN ",4,1,1,16919707,2,3.02E+018,"testalpha"
,"antagonists mk memantine oramantadine","NNS  NN NN",4,1,1,17265692,2,8.11E+018,"testalpha"
,"kidney disease ckd patients","NN NN  NNS",4,1,1,17160142,"pubmed1",8.13E+018,"testalpha"
,"several causes ofroad accidents","JJ NNS NN NNS",4,1,1,16191426,"pubmed1",1.50E+018,"testalpha"
,"impact of driver education","NN IN NN NN",4,1,1,16112070,"pubmed1",6.25E+018,"testalpha"
,"liver echogenicity with impairedvisualization","NN NN IN NN",4,1,1,16673610,2,3.53E+018,"testalpha"
,"todepictions of mental illness","NNS IN JJ NN",4,1,1,16474001,"pubmed1",2.38E+018,"testalpha"
,"revealed aspects of bothbasal","VBD NNS IN NN",4,1,1,16603102,2,7.12E+018,"testalpha"
,"microemulsions sme sumatriptan succinatemicroemulsions","NNS  NNP NNS",4,1,1,16584167,"pubmed1",4.53E+018,"testalpha"
,"contraindications for surgery timing","NNS IN NN NN",4,1,1,17139901,2,8.89E+018,"testalpha"
,"long n alkyl chain","JJ   NN",4,1,1,16594645,"pubmed1",5.82E+018,"testalpha"
,"patients with associated problems","NNS IN VBN NNS",4,1,1,17139890,2,5.76E+018,"testalpha"
,"therapeutic option in cases","JJ NN IN NNS",4,1,1,17013515,2,6.62E+017,"testalpha"
,"low grade b cell","JJ NN NN NN",4,1,1,16612936,"pubmed1",7.72E+018,"testalpha"
,"tendon sheath giant cell","NNP NN NN NN",4,1,1,16514850,2,7.03E+018,"testalpha"
,"sc disease scd children"," NN  NNS",4,1,1,16424656,2,3.68E+018,"testalpha"
,"introduction of new products","NN IN JJ NNS",4,1,1,17285738,"pubmed1",7.81E+018,"testalpha"
,"n celiac disease n"," JJ NN ",4,1,1,16447095,"pubmed1",3.83E+018,"testalpha"
,"new evidence suggests thatcomponents","JJ NN VBZ NNS",4,1,1,16648910,2,9.20E+017,"testalpha"
,"platform withpancreatic beta cells","NN JJ NN NNS",4,1,1,16701853,"pubmed1",2.98E+017,"testalpha"
,"parameters and confidence intervals","NNS CC NN NNS",4,1,1,16126153,"pubmed1",4.86E+018,"testalpha"
,"images hepatic arterial phasegre","NNS JJ JJ ",4,1,1,16317488,"pubmed1",5.30E+018,"testalpha"
,"emergency medicine em program","NN NN  NN",4,1,1,16436795,"pubmed1",6.34E+018,"testalpha"
,"mutations withbipolar affective disorder","NNS JJ JJ NN",4,1,1,16733555,"pubmed1",7.44E+018,"testalpha"
,"potent drug i e","JJ NN  ",4,1,1,16823607,"pubmed1",4.13E+018,"testalpha"
,"residents minor major injury","NNS JJ JJ NN",4,1,1,16412373,"pubmed1",7.33E+018,"testalpha"
,"non acupuncture assessment weeks"," NN NN NNS",4,1,1,16955182,2,4.42E+018,"testalpha"
,"persons cases and others","NNS NNS CC NNS",4,1,1,16434013,"pubmed1",6.76E+018,"testalpha"
,"c fos in aminopyridine","NN  IN NN",4,1,1,17007911,2,2.25E+018,"testalpha"
,"heart surgery in order","NN NN IN NN",4,1,1,17338197,2,6.95E+018,"testalpha"
,"need forcommunication with patients","NN NN IN NNS",4,1,1,16377190,"pubmed1",7.85E+018,"testalpha"
,"water n fiber solution","NN  NN NN",4,1,1,16252139,"pubmed1",6.20E+018,"testalpha"
,"reductase formatedehydrogenase and unspecific","NN NN CC NNP",4,1,1,17019438,"pubmed1",7.69E+018,"testalpha"
,"health care professionals effort","NN NN NNS NN",4,1,1,16918071,"pubmed1",5.28E+018,"testalpha"
,"virus showstypical calicivirus morphology","NN JJ NN NN",4,1,1,16733562,"pubmed1",7.82E+018,"testalpha"
,"inthe right parotid area","NNP NN  NN",4,1,1,16514851,2,8.34E+018,"testalpha"
,"forthe construction of bioprostheses","NNP NN IN NNS",4,1,1,16714053,2,6.19E+018,"testalpha"
,"sensitivity andspecificity of pcr","NN NN IN ",4,1,1,17019441,"pubmed1",1.96E+018,"testalpha"
,"n and levobunolol n"," CC  ",4,1,1,17106597,2,9.21E+018,"testalpha"
,"use of ancillary techniques","NN IN JJ NNS",4,1,1,16514836,2,4.24E+018,"testalpha"
,"stability of total nutrient","NN IN JJ NN",4,1,1,17285747,"pubmed1",2.35E+018,"testalpha"
,"information about selected photochemicalproperties","NN IN VBN NNS",4,1,1,17106510,"pubmed1",2.55E+018,"testalpha"
,"asymmetric unit and diffract","JJ NN CC NN",4,1,1,16511289,2,1.30E+018,"testalpha"
,"were measuredusing fluoroenzyme immunoassay","VBD VBG  NN",4,1,1,17010262,2,5.36E+018,"testalpha"
,"areas races and individuals","NNS NNS CC NNS",4,1,1,16696444,2,5.55E+017,"testalpha"
,"thrombotic complications after rfa","JJ NNS IN ",4,1,1,16696443,2,7.91E+018,"testalpha"
,"surface molecules without therequirement","NN NNS IN NN",4,1,1,16414103,2,2.97E+018,"testalpha"
,"polyethylene glycol peg n","NN NN  ",4,1,1,16252139,"pubmed1",1.04E+018,"testalpha"
,"sperm population expresses fas","JJ NN VBZ ",4,1,1,16919708,2,3.86E+018,"testalpha"
,"receptor antagonists mk memantine","NN NNS  NN",4,1,1,17265692,2,9.01E+018,"testalpha"
,"derivedcd cells on sensorimotor"," NNS IN NN",4,1,1,17265691,2,4.10E+018,"testalpha"
,"specificdifferences between ethnic groups","NNS IN JJ NNS",4,1,1,17165598,2,4.32E+018,"testalpha"
,"mutations in hamp fpn","NNS IN  ",4,1,1,16424658,2,2.21E+017,"testalpha"
,"treatment support in clinicalpractice","NN NN IN NN",4,1,1,16710575,2,5.34E+018,"testalpha"
,"low grade lymphomas respiratory","JJ NN NNP NN",4,1,1,16612936,"pubmed1",1.45E+018,"testalpha"
,"injuries suggesting high energy","NNS VBG JJ NN",4,1,1,16491215,2,6.55E+018,"testalpha"
,"make way for increasedvolume","VB NN IN NN",4,1,1,16377816,"pubmed1",6.14E+018,"testalpha"
,"andpathological characteristics of uterine","JJ NNS IN NN",4,1,1,17338203,2,3.37E+017,"testalpha"
,"hasa variable low basal"," JJ JJ NN",4,1,1,17143338,"pubmed1",6.62E+017,"testalpha"
,"publication status and time","NN NN CC NN",4,1,1,16365332,"pubmed1",4.61E+018,"testalpha"
,"indication of elevatedcrash rates","NN IN NN NNS",4,1,1,16426560,"pubmed1",3.81E+017,"testalpha"
,"ventral roots and dorsal","JJ NNS CC NN",4,1,1,16414104,2,6.38E+018,"testalpha"
,"conclusion thin layer cytology","NN JJ NN NN",4,1,1,16514836,2,8.68E+018,"testalpha"
,"dosesof glucocorticosteroids and antibiotics"," NNS CC NNS",4,1,1,16603100,2,6.79E+018,"testalpha"
,"inbrazil as malva branca","NNP IN  NNP",4,1,1,17013511,2,6.16E+018,"testalpha"
,"cd ratio moderate increase"," NN JJ NN",4,1,1,16256177,2,9.11E+018,"testalpha"
,"ora related crystal structure"," VBN NN NN",4,1,1,16511279,2,8.12E+018,"testalpha"
,"first time within month","JJ NN IN NN",4,1,1,16809889,2,4.25E+018,"testalpha"
,"cytochrome p c cyp","NN  NN ",4,1,1,16584121,"pubmed1",2.87E+018,"testalpha"
,"forcontrast flow transit time","JJS NN NN NN",4,1,1,16399037,"pubmed1",3.60E+018,"testalpha"
,"kg for consecutive days"," IN JJ NNS",4,1,1,16424649,2,4.63E+018,"testalpha"
,"tegdma residual monomer release","NN JJ NN NN",4,1,1,16701856,"pubmed1",2.14E+018,"testalpha"
,"disease neuropathy toe amputation","NN JJ NN NN",4,1,1,16955188,2,4.14E+018,"testalpha"
,"search model amino acid","NN NN NNP NN",4,1,1,16511256,2,2.46E+018,"testalpha"
,"children with central venousthrombosis","NNS IN JJ NN",4,1,1,16549897,2,6.53E+018,"testalpha"
,"liver imprintsand chicken blood","NN NN NN NN",4,1,1,16996581,2,4.79E+018,"testalpha"
,"providing graduate medicaleducation gme","VBG NN NN ",4,1,1,16377812,"pubmed1",6.74E+018,"testalpha"
,"using cleardefinitions for classifications","VBG NNS IN NNS",4,1,1,16321534,"pubmed1",6.55E+018,"testalpha"
,"o contacts stabilizethe crystal"," NNS NNP NN",4,1,1,16456296,2,3.88E+018,"testalpha"
,"investigatethe activity of atf","NNP NN IN ",4,1,1,16395528,"pubmed1",1.47E+018,"testalpha"
,"ldl cholesterol in patients"," NN IN NNS",4,1,1,16479028,2,6.31E+018,"testalpha"
,"erythronate phosphate dehydrogenase catalyses","NN NN NN NNS",4,1,1,16511285,2,3.62E+018,"testalpha"
,"control among african americans","NN IN JJ NNS",4,1,1,16596897,"pubmed1",5.61E+018,"testalpha"
,"platelet counts in patients","NN NNS IN NNS",4,1,1,16809885,2,1.16E+018,"testalpha"
,"use on multiple organs","NN IN JJ NNS",4,1,1,16594641,"pubmed1",2.57E+018,"testalpha"
,"rates of nadh oxidation","NNS IN  NN",4,1,1,16511277,2,2.16E+018,"testalpha"
,"percutaneous ablation therapy pat","JJ NN NN ",4,1,1,16333710,"pubmed1",7.79E+018,"testalpha"
,"monitoring and adverse event","NN CC JJ NN",4,1,1,16770858,"pubmed1",5.51E+018,"testalpha"
,"prostaglandins and otherbioactive substances","NNS CC JJ NNS",4,1,1,17013515,2,1.98E+018,"testalpha"
,"patients and high ldl","NNS CC JJ ",4,1,1,16479028,2,7.41E+018,"testalpha"
,"circumstances in depth interviews","NNS IN NN NNS",4,1,1,16412373,"pubmed1",7.35E+018,"testalpha"
,"hepatitis of unknown etiology","NN IN JJ NN",4,1,1,16696442,2,7.17E+018,"testalpha"
,"proliferation of myeloid precursors","NN IN VB NNS",4,1,1,16914901,2,6.63E+018,"testalpha"
,"hypoxic regulation of pfkfb","JJ NN IN ",4,1,1,17143338,"pubmed1",8.29E+018,"testalpha"
,"neutropenicpatients with advanced stage","NNS IN VBN NN",4,1,1,16809884,2,3.88E+018,"testalpha"
,"own beta blocker topicalmedications","JJ NN NN NNS",4,1,1,17106597,2,3.45E+018,"testalpha"
,"withmutations in connexin proteins","NNS IN  NNS",4,1,1,17106596,2,7.31E+018,"testalpha"
,"directed destination control program","VBN NN NN NN",4,1,1,16365324,"pubmed1",1.56E+018,"testalpha"
,"evacuation with self digital","NN IN NN NN",4,1,1,17139884,2,4.44E+018,"testalpha"
,"prevalence of bacterial vaginosis","NN IN JJ NN",4,1,1,16603098,2,8.00E+017,"testalpha"
,"agents liver echogenicity shows","NNS NN NN NNS",4,1,1,16673610,2,1.88E+017,"testalpha"
,"encapsulation platform withpancreatic beta","NN NN JJ NN",4,1,1,16701853,"pubmed1",6.82E+018,"testalpha"
,"vehicles with uslicence plates","NNS IN NN NNS",4,1,1,16169506,"pubmed1",4.09E+018,"testalpha"
,"age group isthe group","NN NN NNP NN",4,1,1,16696444,2,2.44E+018,"testalpha"
,"year patient andgraft survival","NN NN NN NN",4,1,1,17013505,2,3.82E+018,"testalpha"
,"benign endometrium endometrial polyp","JJ NN JJ ",4,1,1,16514840,2,5.65E+018,"testalpha"
,"byselective cox inhibitor treatment","JJ  NN NN",4,1,1,16253314,2,1.88E+018,"testalpha"
,"submucosal and myenteric plexuses","NN CC JJ NNS",4,1,1,17139897,2,2.90E+018,"testalpha"
,"dimensional clustersof intestinal columnar","JJ  JJ NN",4,1,1,16514843,2,3.07E+018,"testalpha"
,"complement by binding c","NN IN NN NN",4,1,1,16964325,"pubmed1",4.34E+018,"testalpha"
,"chromatography mass spectrometry lc","NN NN NN ",4,1,1,17285740,"pubmed1",2.12E+018,"testalpha"
,"r effects on sinusoidal","NN NNS IN NN",4,1,1,17013514,2,7.97E+018,"testalpha"
,"clinic women man age","NN NNS NN NN",4,1,1,16710586,2,2.40E+018,"testalpha"
,"recovery of coronary flow","NN IN NN NN",4,1,1,16566960,2,5.27E+018,"testalpha"
,"bioterroristagent illnesses involve respiratory","NN NNS VBP NN",4,1,1,16400088,"pubmed1",9.09E+018,"testalpha"
,"study carbon monoxide diffusion","NN NN VB NN",4,1,1,16809886,2,2.01E+018,"testalpha"
,"mild tbi icd codes","JJ   NNS",4,1,1,16365331,"pubmed1",3.19E+018,"testalpha"
,"relationships between sleep deprivation","NNS IN NN NN",4,1,1,16377826,"pubmed1",6.10E+017,"testalpha"
,"postmenopausal womenwith known risk","NN NN VBN NN",4,1,1,17338203,2,4.08E+018,"testalpha"
,"result ofdexamethasone suppression test","NN NN NN NN",4,1,1,16603099,2,6.71E+018,"testalpha"
,"found inthe flash cells","VBN NNP NN NNS",4,1,1,16824585,2,1.35E+018,"testalpha"
,"prognosis accompanying c myc","NN VBG NN ",4,1,1,16809887,2,6.94E+018,"testalpha"
,"chemotherapies for germ cell","NNS IN NN NN",4,1,1,16809892,2,1.36E+018,"testalpha"
,"crp level by latex"," NN IN NNP",4,1,1,16479028,2,2.80E+018,"testalpha"
,"contents of usp nf","NNS IN  ",4,1,1,17285738,"pubmed1",8.28E+018,"testalpha"
,"objectives activity of serum","NNS NN IN NN",4,1,1,16956117,2,9.17E+018,"testalpha"
,"poor prognosis subset ofpatients","JJ NN VB NNS",4,1,1,17119326,2,1.51E+018,"testalpha"
,"cytologic smears containedcellular zones","JJ NNS JJ NNS",4,1,1,16514849,2,3.35E+018,"testalpha"
,"supports thehypothesis that aa","NNS NN IN ",4,1,1,17010262,2,8.03E+018,"testalpha"
,"therapy stratification and monitoring","NN NN CC NN",4,1,1,16333707,"pubmed1",6.84E+018,"testalpha"
,"trends in breast cancer","NNS IN NN NN",4,1,1,16596895,"pubmed1",5.24E+018,"testalpha"
,"cationic lipid mediated uptake","JJ NN VBN NN",4,1,1,16701879,"pubmed1",8.70E+018,"testalpha"
,"inhibitors and p inhibitor","NNS CC  NN",4,1,1,17115080,"pubmed1",2.24E+018,"testalpha"
,"effect of physiological age","NN IN JJ NN",4,1,1,16549888,2,6.99E+018,"testalpha"
,"general surgery residency programs","JJ NN NN NNS",4,1,1,16377820,"pubmed1",8.77E+017,"testalpha"
,"effect of l arginine","NN IN  NN",4,1,1,16395522,"pubmed1",1.87E+018,"testalpha"
,"males females mean age","NNS NNS VBP NN",4,1,1,16236233,"pubmed1",7.95E+018,"testalpha"
,"acute phase proteins apps","JJ NN NNS ",4,1,1,16714050,2,7.64E+018,"testalpha"
,"patient care and safety","NN NN CC NN",4,1,1,16462412,"pubmed1",6.08E+018,"testalpha"
,"rapid reversal of anticoagulation","JJ NN IN NN",4,1,1,16916181,"pubmed1",4.29E+018,"testalpha"
,"sida groups disclosedhigher liver"," NNS JJ NN",4,1,1,17013511,2,3.18E+017,"testalpha"
,"complexes withother transcription factors","NNS JJ NN NNS",4,1,1,17115080,"pubmed1",7.87E+018,"testalpha"
,"products containing timolol n","NNS VBG  ",4,1,1,17106597,2,5.35E+018,"testalpha"
,"cells indicating reduced proliferation","NNS VBG VBN NN",4,1,1,16874412,2,4.92E+018,"testalpha"
,"option for fit patients","NN IN VB NNS",4,1,1,16613748,2,3.78E+018,"testalpha"
,"acupressurepoints for hip pain","NNS IN NN NN",4,1,1,16365322,"pubmed1",4.93E+018,"testalpha"
,"assessment score in patients","NN NN IN NNS",4,1,1,17236637,"pubmed1",6.56E+018,"testalpha"
,"substrate of dck thandeoxycytidine","NN IN  NN",4,1,1,16421443,2,8.01E+018,"testalpha"
,"rules oar before physician","NNS  IN NN",4,1,1,16436790,"pubmed1",1.46E+018,"testalpha"
,"starting place since student","VBG NN IN NN",4,1,1,16473991,"pubmed1",8.16E+018,"testalpha"
,"sa inducible vch promoter"," JJ  NN",4,1,1,16395526,"pubmed1",8.43E+018,"testalpha"
,"flexural strength and modulus","JJ NN CC NN",4,1,1,16701863,"pubmed1",3.34E+018,"testalpha"
,"number of different authors","NN IN JJ NNS",4,1,1,17139900,2,2.85E+018,"testalpha"
,"rapid clot resolution elevation","JJ NN NN NN",4,1,1,16549898,2,8.99E+018,"testalpha"
,"enzyme amino acid sequence"," NNP NN NN",4,1,1,16505899,"pubmed1",4.03E+018,"testalpha"
,"open label clinical trial","JJ NN JJ NN",4,1,1,16424647,2,2.99E+018,"testalpha"
,"temperature x ray powder","NN NN  NN",4,1,1,17285745,"pubmed1",9.21E+018,"testalpha"
,"sequence in proximity ofthe","NN IN NN NNP",4,1,1,16964327,"pubmed1",8.33E+018,"testalpha"
,"long periods of neutropenia","JJ NNS IN NNP",4,1,1,17370567,"pubmed1",7.71E+018,"testalpha"
,"using light and electron","VBG NN CC NN",4,1,1,16574202,2,2.53E+018,"testalpha"
,"licensed establishments in ontario","VBN NNS IN NNP",4,1,1,16169506,"pubmed1",7.58E+018,"testalpha"
,"initial stroke or tia","JJ NN CC ",4,1,1,16436789,"pubmed1",1.86E+018,"testalpha"
,"thylakoid membrane associated pigment","VB NN VBN NN",4,1,1,17106511,"pubmed1",7.79E+018,"testalpha"
,"interference rnai silences gene","NN  NNS ",4,1,1,16395523,"pubmed1",2.14E+017,"testalpha"
,"medical education lcme standards","JJ NN  NNS",4,1,1,16473988,"pubmed1",7.80E+018,"testalpha"
,"industrial hygienists www acgih","JJ NNS  ",4,1,1,16438095,"pubmed1",4.56E+018,"testalpha"
,"articleswith funded public foundation","NN VBN JJ NN",4,1,1,16365335,"pubmed1",4.13E+017,"testalpha"
,"morphometrical features of musclespindles","JJ NNS IN NNS",4,1,1,16730053,2,2.96E+018,"testalpha"
,"optimize drug release profile","VB NN NN NN",4,1,1,16584161,"pubmed1",8.02E+018,"testalpha"
,"weeks treatment with gtnand","NNS NN IN NN",4,1,1,16612915,"pubmed1",3.14E+017,"testalpha"
,"thickness presence of ulceration","NN NN IN NN",4,1,1,16585990,2,3.73E+018,"testalpha"
,"luc bearing activatingtranscription factor"," NN NN NN",4,1,1,16395528,"pubmed1",4.51E+018,"testalpha"
,"epsilonc and n ethenoguanine"," CC  NN",4,1,1,16582987,"pubmed1",5.04E+018,"testalpha"
,"comparison ofconsecutive serial sections","NN JJ JJ NNS",4,1,1,16542712,2,4.64E+017,"testalpha"
,"g d and r","  CC NN",4,1,1,16585980,2,3.31E+018,"testalpha"
,"bovine spongiform encephalopathy infection","NN NN JJ NN",4,1,1,16770445,"pubmed1",5.56E+017,"testalpha"
,"exhibited non fickian drug","VBN  JJ NN",4,1,1,16584161,"pubmed1",1.98E+018,"testalpha"
,"combinations of common variables","NNS IN JJ NNS",4,1,1,16365326,"pubmed1",1.39E+018,"testalpha"
,"beam on reminiscent liver","NN IN JJ NN",4,1,1,17013509,2,2.48E+018,"testalpha"
,"sufficient gains for shareholders","JJ NNS IN NNS",4,1,1,16596744,"pubmed1",4.00E+018,"testalpha"
,"patients with acute abdomen","NNS IN JJ NN",4,1,1,16612930,"pubmed1",4.95E+018,"testalpha"
,"intraluminal injection of glutamine","JJ NN IN NN",4,1,1,17293970,2,7.14E+018,"testalpha"
,"cause of intestinal obstruction","NN IN JJ NN",4,1,1,16612930,"pubmed1",2.54E+017,"testalpha"
,"metabolic syndrome component beinghypertension","JJ NN NN NN",4,1,1,16479027,2,2.24E+018,"testalpha"
,"cells expression of pfkfb","NNS NN IN ",4,1,1,17143338,"pubmed1",1.63E+018,"testalpha"
,"indiagnosing soft tissue lessions","VBG JJ NN NNS",4,1,1,16514847,2,1.04E+017,"testalpha"
,"children with congenital naevi","NNS IN NN ",4,1,1,16710582,2,5.67E+018,"testalpha"
,"main pancreaticduct c narrowing","JJS NN NN NN",4,1,1,16333694,"pubmed1",6.79E+018,"testalpha"
,"loss postoperative complications reoperations","NN JJ NNS NNS",4,1,1,17139896,2,1.38E+018,"testalpha"
,"endocrine pathophysiology keen history","NN NN JJ NN",4,1,1,16462411,"pubmed1",4.31E+018,"testalpha"
,"children neededhigher daily doses","NNS JJ JJ NNS",4,1,1,16549902,2,8.21E+018,"testalpha"
,"c activates glucocerebrosidase andbeta","NN NNS NN NN",4,1,1,16511279,2,5.22E+018,"testalpha"
,"aml patients afterautologous pbsct"," NNS JJ ",4,1,1,17119322,2,6.29E+018,"testalpha"
,"oar before physician evaluation"," IN NN NN",4,1,1,16436790,"pubmed1",8.61E+018,"testalpha"
,"g resection and retreat"," NN CC NN",4,1,1,17293966,2,3.35E+018,"testalpha"
,"sham or naive animals"," CC JJ NNS",4,1,1,17265693,2,7.28E+018,"testalpha"
,"clustersof intestinal columnar cells"," JJ NN NNS",4,1,1,16514843,2,5.19E+018,"testalpha"
,"relative number of cp","JJ NN IN ",4,1,1,17165598,2,2.13E+018,"testalpha"
,"age dependent percentiles p","NN JJ NNS ",4,1,1,16549894,2,2.78E+018,"testalpha"
,"images active gi bleedingis","NNS JJ  ",4,1,1,16333701,"pubmed1",1.14E+018,"testalpha"
,"asthe agricultural health study","NNP JJ NN NN",4,1,1,17016033,2,2.72E+017,"testalpha"
,"analysis of numerous analytes","NN IN JJ NNS",4,1,1,16714050,2,5.66E+018,"testalpha"
,"predictive link between subject","JJ NN IN NN",4,1,1,16399039,"pubmed1",2.88E+017,"testalpha"
,"direct drugacquisition and post","JJ NN CC NN",4,1,1,16451145,"pubmed1",8.27E+018,"testalpha"
,"local psoriasis severity index","JJ NN NN NN",4,1,1,16585986,2,2.71E+017,"testalpha"
,"absence of intrahepatic portal","NN IN JJ NN",4,1,1,16447097,"pubmed1",3.85E+018,"testalpha"
,"linear fashion controlledby genes","JJ NN JJ NNS",4,1,1,16505901,"pubmed1",6.71E+018,"testalpha"
,"lower reactivity of heart","JJR NN IN NN",4,1,1,16874421,2,5.71E+017,"testalpha"
,"puncture clp in rats","NN  IN NNS",4,1,1,17293958,2,2.57E+017,"testalpha"
,"nodal non hodgkinlymphomas nhl","NN  NNP ",4,1,1,16612936,"pubmed1",6.41E+018,"testalpha"
,"tothe consensual qualitative research","NNP JJ JJ NN",4,1,1,16710575,2,1.27E+018,"testalpha"
,"laryngeal surgery comparing patients","NN NN VBG NNS",4,1,1,16989147,2,6.40E+018,"testalpha"
,"risk factorshemodialysis and transfusion","NN NN CC NN",4,1,1,16696442,2,8.07E+018,"testalpha"
,"rare chromosomal abnormality oftrisomy","JJ JJ NN NN",4,1,1,16809892,2,4.41E+018,"testalpha"
,"compression of thetransposed flap","NN IN VBN ",4,1,1,16722345,2,7.15E+018,"testalpha"
,"kinetic study of p","JJ NN IN ",4,1,1,16733561,"pubmed1",8.66E+018,"testalpha"
,"resolution forthe apo form","NN NNP  NN",4,1,1,16511293,2,9.95E+016,"testalpha"
,"analsquamous intraepithelial lesions asil","JJ JJ NNS ",4,1,1,17139883,2,9.24E+017,"testalpha"
,"such asischemia or anoxia","JJ NN CC ",4,1,1,16770441,"pubmed1",6.86E+018,"testalpha"
,"marker of ischemic metabolism","NN IN JJ NN",4,1,1,16451157,"pubmed1",7.04E+018,"testalpha"
,"incubated overnight degrees c","VBN JJ NNS NN",4,1,1,17049369,2,8.49E+018,"testalpha"
,"object selection and hole","NN NN CC NN",4,1,1,16399033,"pubmed1",1.52E+018,"testalpha"
,"papillary carcinomas whereasmoderate positivity","JJ NNP NN NN",4,1,1,16720036,2,3.59E+018,"testalpha"
,"iron si concentration idef","NN  NN ",4,1,1,16809889,2,8.79E+018,"testalpha"
,"iron absorption i e","NN NN  ",4,1,1,17119325,2,3.22E+018,"testalpha"
,"fatal disabling injury crashes","JJ VBG NN NNS",4,1,1,16426556,"pubmed1",1.23E+017,"testalpha"
,"c degrees c degrees","NN NNS NN NNS",4,1,1,16696441,2,3.58E+018,"testalpha"
,"immunodeficiency virus hiv infection","NN NN  NN",4,1,1,16462404,"pubmed1",2.84E+018,"testalpha"
,"factor kappab nf kappab","NN   ",4,1,1,17068636,"pubmed1",9.12E+018,"testalpha"
,"incidence ofspecific cleft types","NN NNP NN NNS",4,1,1,17165598,2,8.17E+018,"testalpha"
,"undergoing gynaecologicallaparoscopic day case","VBG NN NN NN",4,1,1,16451148,"pubmed1",3.33E+017,"testalpha"
,"remission using flow cytometry","NN VBG NN NN",4,1,1,17016036,2,7.43E+018,"testalpha"
,"prevailing state of safety","VBG NN IN NN",4,1,1,16442068,"pubmed1",3.31E+018,"testalpha"
,"applicability performance anddiagnostic yield","NN NN JJ NN",4,1,1,16447095,"pubmed1",7.97E+018,"testalpha"
,"zidovir cipla ltd mumbai","   ",4,1,1,16584139,"pubmed1",6.20E+018,"testalpha"
,"patients at high risk","NNS IN JJ NN",4,1,1,16673611,2,1.67E+018,"testalpha"
,"mutation in alkb resultsin","NN IN  NNP",4,1,1,16733554,"pubmed1",1.18E+018,"testalpha"
,"fixation produced less reliableresults","NN VBD JJR NNS",4,1,1,16701855,"pubmed1",8.97E+018,"testalpha"
,"c ora related crystal","NN  VBN NN",4,1,1,16511279,2,3.37E+018,"testalpha"
,"group iv receivedintramuscular injections","NN  JJ NNS",4,1,1,16612918,"pubmed1",1.33E+018,"testalpha"
,"emergency medical services staff","NN JJ NNS NN",4,1,1,16365330,"pubmed1",7.87E+018,"testalpha"
,"being used forano rectal","VBG VBN NN NN",4,1,1,17139880,2,4.14E+018,"testalpha"
,"macrophages and bacteria canalso","NNS CC NNS ",4,1,1,16701867,"pubmed1",4.42E+018,"testalpha"
,"block were tested continuouslyevery","NN VBD VBN NN",4,1,1,16451159,"pubmed1",7.05E+018,"testalpha"
,"femoral neck nowadaysin cases","JJ NN NNP NNS",4,1,1,16613748,2,3.90E+017,"testalpha"
,"hospital discharge register study","NN NN NN NN",4,1,1,16162331,"pubmed1",1.02E+018,"testalpha"
,"phenoxyacetic acid herbicides organochlorines","JJ NN NNS NNS",4,1,1,17016033,2,6.54E+018,"testalpha"
,"ultrasound examinations of patients","NN NNS IN NNS",4,1,1,16333710,"pubmed1",3.46E+018,"testalpha"
,"lifestylefactors and unknown etiologies","NNS CC JJ NNS",4,1,1,16462405,"pubmed1",1.51E+018,"testalpha"
,"new patterns of illness","JJ NNS IN NN",4,1,1,16462404,"pubmed1",5.13E+018,"testalpha"
,"retinoids and local immunomodulators","NNS CC JJ NNS",4,1,1,17311742,2,7.45E+018,"testalpha"
,"study examined motor vehicle","NN VBD NN NN",4,1,1,16139232,"pubmed1",1.93E+018,"testalpha"
,"behavior of osteoblastic cells","NN IN JJ NNS",4,1,1,16701866,"pubmed1",1.37E+017,"testalpha"
,"thresholding region growing d","VBG NN VBG ",4,1,1,16399031,"pubmed1",8.24E+018,"testalpha"
,"d configuration in position"," NN IN NN",4,1,1,16496038,"pubmed1",3.37E+017,"testalpha"
,"deregulation of road transport","NN IN NN NN",4,1,1,16427020,"pubmed1",3.07E+018,"testalpha"
,"capture andpu m pu","VB   ",4,1,1,17019439,"pubmed1",8.40E+018,"testalpha"
,"g dl e globulins","   NNS",4,1,1,17293972,2,4.10E+018,"testalpha"
,"barriers protect errant vehicles","NNS VB JJ NNS",4,1,1,16054101,"pubmed1",2.39E+018,"testalpha"
,"factor viii or ix","NN  CC ",4,1,1,16549891,2,1.15E+018,"testalpha"
,"black feces and use","JJ NNS CC NN",4,1,1,16424650,2,1.40E+018,"testalpha"
,"ledto higher encapsulation efficiency"," JJR NN NN",4,1,1,16594643,"pubmed1",5.02E+018,"testalpha"
,"clinical stages histologic subtypes","JJ NNS JJ NNS",4,1,1,16914904,2,6.00E+018,"testalpha"
,"tools in food allergy","NNS IN NN NN",4,1,1,16673561,2,1.78E+018,"testalpha"
,"shunt and v qmismatch","NN CC  NN",4,1,1,16451153,"pubmed1",4.11E+017,"testalpha"
,"groupings within selected crash","NNS IN VBN NN",4,1,1,16426556,"pubmed1",9.08E+018,"testalpha"
,"increased resistance tosaline injection","VBN NN NN NN",4,1,1,16491219,2,3.06E+018,"testalpha"
,"levels of depressive symptoms","NNS IN JJ NNS",4,1,1,16377815,"pubmed1",6.54E+018,"testalpha"
,"end liver disease value","NN NN NN NN",4,1,1,17013512,2,4.74E+018,"testalpha"
,"task analysis in anesthetists","NN NN IN NNS",4,1,1,16451152,"pubmed1",2.87E+018,"testalpha"
,"confounding factors low riskperception","VBG NNS JJ NN",4,1,1,16426559,"pubmed1",2.30E+018,"testalpha"
,"work pace and participation","NN NN CC NN",4,1,1,16451152,"pubmed1",1.40E+018,"testalpha"
,"case control study design","NN NN NN NN",4,1,1,16417901,"pubmed1",5.58E+018,"testalpha"
,"understanding of radiation damage","NN IN NN NN",4,1,1,16369092,2,4.31E+018,"testalpha"
,"theresulting differences in hydrogel","VBG NNS IN NNP",4,1,1,16701853,"pubmed1",5.36E+018,"testalpha"
,"position for alonger period","NN IN NN NN",4,1,1,16436795,"pubmed1",1.32E+018,"testalpha"
,"crashes were non intersection","NNS VBD  NN",4,1,1,16426556,"pubmed1",8.89E+018,"testalpha"
,"resp of control group"," IN NN NN",4,1,1,16696442,2,5.76E+018,"testalpha"
,"decrease in opioid consumption","NN IN VB NN",4,1,1,16451144,"pubmed1",8.47E+018,"testalpha"
,"serine residues ser ser","NN NNS  ",4,1,1,16511282,2,7.75E+018,"testalpha"
,"ward team call system","NN NN NN NN",4,1,1,16377824,"pubmed1",7.15E+018,"testalpha"
,"cortex in thecontralateral hemisphere","NNP IN JJ NN",4,1,1,17133958,2,6.57E+018,"testalpha"
,"certain risk factors predisposechildren","JJ NN NNS NNS",4,1,1,16549898,2,4.15E+018,"testalpha"
,"certified occupational healthnurse specialist","VBN JJ NN NN",4,1,1,16438092,"pubmed1",8.40E+017,"testalpha"
,"accepted therapy for palmoplantarpsoriasis","VBN NN IN NN",4,1,1,16585984,2,9.19E+018,"testalpha"
,"compressive strength of aglass","JJ NN IN NN",4,1,1,16701865,"pubmed1",1.94E+018,"testalpha"
,"ligation and puncture clp","NN CC NN ",4,1,1,17293958,2,9.67E+017,"testalpha"
,"academic medical school faculty","JJ JJ NN NN",4,1,1,16377815,"pubmed1",5.31E+018,"testalpha"
,"central tumor free portion","JJ NN JJ NN",4,1,1,16603102,2,3.78E+018,"testalpha"
,"gas exchange and hemodynamics","NN NN CC NNS",4,1,1,16451155,"pubmed1",2.57E+018,"testalpha"
,"was applied hand immersion","VBD VBN NN NN",4,1,1,17236636,"pubmed1",5.95E+018,"testalpha"
,"dilution technique minimalinhibitory concentrations","NN NN NN NNS",4,1,1,16874415,2,1.26E+018,"testalpha"
,"n n diethyl n","   ",4,1,1,16456284,2,7.54E+018,"testalpha"
,"alignment of biological information","NN IN JJ NN",4,1,1,16596744,"pubmed1",6.70E+017,"testalpha"
,"g n normal animals","  JJ NNS",4,1,1,17293959,2,4.65E+017,"testalpha"
,"patch of hair loss","NN IN NN NN",4,1,1,17010262,2,2.01E+018,"testalpha"
,"negative impact on performance","JJ NN IN NN",4,1,1,16226211,"pubmed1",4.68E+018,"testalpha"
,"duration of follow ups","NN IN VB NNS",4,1,1,17438833,2,6.56E+018,"testalpha"
,"primary superficial basal cell","JJ JJ NN NN",4,1,1,16955185,2,4.67E+018,"testalpha"
,"perceptions of breast cancer","NNS IN NN NN",4,1,1,16596898,"pubmed1",3.67E+018,"testalpha"
,"allow conservative management exceptions","VBP JJ NN NNS",4,1,1,17013521,2,7.64E+018,"testalpha"
,"ofusing soluble fas ligand","VBG JJ  NN",4,1,1,16710577,2,6.49E+018,"testalpha"
,"specificity for catechol derivatives","NN IN NN NNS",4,1,1,16511281,2,8.08E+018,"testalpha"
,"zn containing hydroxyapatite znhap"," VBG JJ NN",4,1,1,16701860,"pubmed1",4.01E+018,"testalpha"
,"computedtomography measures of ventilation","NN NNS IN NN",4,1,1,16399039,"pubmed1",6.70E+018,"testalpha"
,"rearrangement and subsequent loss","NN CC JJ NN",4,1,1,16956122,2,3.40E+018,"testalpha"
,"allosteric regulation of somemembrane","JJ NN IN NN",4,1,1,17265696,2,7.94E+018,"testalpha"
,"studies after steroid therapy","NNS IN VB NN",4,1,1,16333694,"pubmed1",8.94E+018,"testalpha"
,"synchrotron radiation for data","NNP NN IN NNS",4,1,1,16369089,2,4.39E+018,"testalpha"
,"study incidence distribution type","VB NN NN NN",4,1,1,16412373,"pubmed1",5.60E+017,"testalpha"
,"medium containing azide bloodagar","NN VBG VB NN",4,1,1,17293963,2,7.87E+018,"testalpha"
,"short term toxicity test","JJ NN NN NN",4,1,1,16696445,2,2.69E+018,"testalpha"
,"high risk groups score","JJ NN NNS NN",4,1,1,16914906,2,3.55E+017,"testalpha"
,"lack of expectedstatistical associations","NN IN JJ NNS",4,1,1,16874417,2,6.39E+018,"testalpha"
,"small bowel resection wistar","JJ NN NN NN",4,1,1,17293957,2,2.83E+018,"testalpha"
,"second year medical students","JJ NN JJ NNS",4,1,1,16377828,"pubmed1",6.64E+018,"testalpha"
,"severity of fungal infections","NN IN JJ NNS",4,1,1,16918061,"pubmed1",5.18E+018,"testalpha"
,"requirements forimmunotherapy in cancer","NNS NN IN NN",4,1,1,16404477,"pubmed1",1.65E+018,"testalpha"
,"receptor antagonist dextromethorphan dm","NN NN NNP ",4,1,1,16451144,"pubmed1",2.80E+017,"testalpha"
,"cs point group symmetry"," NN NN NN",4,1,1,16456289,2,4.95E+017,"testalpha"
,"new emerging threat agents","JJ VBG NN NNS",4,1,1,16696436,2,8.14E+018,"testalpha"
,"hela and nih t"," CC  ",4,1,1,16395528,"pubmed1",3.05E+018,"testalpha"
,"computerized assessment of likelihood","JJ NN IN NN",4,1,1,16399033,"pubmed1",8.06E+018,"testalpha"
,"tlymphocytes from itp children","NNS IN  NNS",4,1,1,17016035,2,5.87E+018,"testalpha"
,"mrna degradation in asequence"," NN IN NN",4,1,1,16395523,"pubmed1",7.95E+018,"testalpha"
,"inperipheral blood t lymphocytes","JJ NN  NNS",4,1,1,17016035,2,1.13E+018,"testalpha"
,"quantity of residual monomers","NN IN JJ NNS",4,1,1,16701856,"pubmed1",4.46E+017,"testalpha"
,"nucleation of hydroxyapatite crystals","NN IN JJ NNS",4,1,1,16701861,"pubmed1",7.10E+018,"testalpha"
,"paroxysmal nocturnal hemoglobinuria pnh","JJ JJ NNP ",4,1,1,17119324,2,4.57E+017,"testalpha"
,"high perceived prevalence items","JJ VBN NN NNS",4,1,1,16191426,"pubmed1",2.78E+018,"testalpha"
,"treatment of such diseases","NN IN JJ NNS",4,1,1,16511265,2,7.72E+018,"testalpha"
,"mms and elevated level"," CC VBN NN",4,1,1,16733554,"pubmed1",8.82E+018,"testalpha"
,"cumulative percentage of drug","JJ NN IN NN",4,1,1,17285748,"pubmed1",5.20E+018,"testalpha"
,"presence of inh betaa","NN IN  ",4,1,1,16423381,2,2.47E+018,"testalpha"
,"technologies or diverse study","NNS CC JJ NN",4,1,1,16770858,"pubmed1",4.95E+018,"testalpha"
,"triple layer apaap protocol","NN NN  NN",4,1,1,16256177,2,5.56E+018,"testalpha"
,"months and platelet count","NNS CC NN NN",4,1,1,16424649,2,1.86E+018,"testalpha"
,"hospital and participated inin","NN CC VBD ",4,1,1,16377827,"pubmed1",8.40E+018,"testalpha"
,"cluster ofdna dependent protein","NN  JJ NN",4,1,1,16404475,"pubmed1",9.10E+018,"testalpha"
,"faculty institution and societal","NN NN CC NN",4,1,1,16473991,"pubmed1",8.56E+018,"testalpha"
,"observed inspecimens from beta","VBN NNS IN NN",4,1,1,16612917,"pubmed1",6.50E+016,"testalpha"
,"tissuesparing surgery facilitates reresection","VBG NN NNS NN",4,1,1,17139901,2,6.78E+017,"testalpha"
,"abnormal asymmetrical head shape","JJ JJ NN NN",4,1,1,17438834,2,7.04E+018,"testalpha"
,"rats were perfusedfor measurement","NNS VBD JJ NN",4,1,1,17265691,2,5.00E+018,"testalpha"
,"summary estimate of effect","NN NN IN NN",4,1,1,16427020,"pubmed1",1.54E+018,"testalpha"
,"cause of severe sepsis","NN IN JJ NN",4,1,1,16612906,2,5.46E+018,"testalpha"
,"colocalisation of inhibin betab","NN IN NNP ",4,1,1,16423381,2,3.95E+018,"testalpha"
,"hetero dimerization of ppargamma","NNP NN IN NN",4,1,1,16395520,"pubmed1",5.68E+018,"testalpha"
,"experience with lateral canthoplasties","NN IN JJ NNS",4,1,1,17165595,2,5.86E+018,"testalpha"
,"shortening fs and segmental","VBG  CC NN",4,1,1,16989140,2,1.83E+018,"testalpha"
,"differences in pacu discharge","NNS IN  NN",4,1,1,16451145,"pubmed1",8.85E+018,"testalpha"
,"legislation increased helmet use","NN VBN VB NN",4,1,1,16223468,"pubmed1",6.40E+018,"testalpha"
,"urease antigen ureb f","NN NN  NN",4,1,1,16496040,"pubmed1",6.41E+018,"testalpha"
,"technique hcii digene gaithersburg","NN  NN NNP",4,1,1,16514835,2,5.00E+018,"testalpha"
,"domain of colicin d","NN IN NNP ",4,1,1,16511255,2,6.56E+018,"testalpha"
,"correctionof saphenous vein reflux"," JJ NN NN",4,1,1,16612909,2,7.91E+018,"testalpha"
,"blood pressure afterhemorrhagic shock","NN NN JJ NN",4,1,1,16365323,"pubmed1",9.40E+016,"testalpha"
,"solution group lrs lactatedringer","NN NN  NN",4,1,1,16491220,2,1.64E+018,"testalpha"
,"biologic subgroups in aml","JJ NNS IN ",4,1,1,16914901,2,5.87E+018,"testalpha"
,"remyelination from endogenoussources precursor","NN IN NNS NN",4,1,1,16956113,2,4.22E+018,"testalpha"
,"time course of impairment","NN NN IN NN",4,1,1,16451155,"pubmed1",8.55E+018,"testalpha"
,"recombinant vibrio salmonicida catalase","JJ NNP NNP NN",4,1,1,16511268,2,2.71E+018,"testalpha"
,"inhibit cucumber mosaic virus","VB NN JJ NN",4,1,1,16395523,"pubmed1",8.31E+017,"testalpha"
,"science medicine and technology","NN NN CC NN",4,1,1,16596899,"pubmed1",3.86E+018,"testalpha"
,"equations for largedeformation mechanics","NNS IN NN NNS",4,1,1,16399039,"pubmed1",3.60E+018,"testalpha"
,"size was found toaffect","NN VBD VBN NN",4,1,1,17285748,"pubmed1",7.18E+018,"testalpha"
,"heart beta adrenergic receptors","NN NN JJ NNS",4,1,1,16874421,2,4.90E+018,"testalpha"
,"belong tothe orthorhombic space","VB NNP JJ NN",4,1,1,16511285,2,9.10E+018,"testalpha"
,"sss and marketed product"," CC VBN NN",4,1,1,16584167,"pubmed1",2.21E+018,"testalpha"
,"produced higher day fatalities","VBN JJR NN NNS",4,1,1,16430844,"pubmed1",2.92E+018,"testalpha"
,"confirm theexistence of carbohydrate","VB NN IN NN",4,1,1,16714048,2,6.57E+018,"testalpha"
,"problems smoking cocaine use","NNS NN NN NN",4,1,1,16436792,"pubmed1",8.12E+018,"testalpha"
,"leucine zipper domain structure","NN NN NN NN",4,1,1,16325892,2,5.29E+018,"testalpha"
,"endocrinology department withvarious thyroid","NN NN JJ NN",4,1,1,16514836,2,5.27E+018,"testalpha"
,"dpfa and identified sites"," CC VBN NNS",4,1,1,16582987,"pubmed1",7.90E+017,"testalpha"
,"anastomotic resistance and colonicmucosal","JJ NN CC NN",4,1,1,17293972,2,1.74E+018,"testalpha"
,"rate of dried gelpowders","NN IN VBN NNS",4,1,1,16584168,"pubmed1",6.51E+018,"testalpha"
,"gal c glc c"," NN  NN",4,1,1,16456293,2,3.87E+018,"testalpha"
,"assessment visualization of coronary","NN NN IN NN",4,1,1,16399037,"pubmed1",3.20E+018,"testalpha"
,"workers and controls p","NNS CC NNS ",4,1,1,16696442,2,8.76E+018,"testalpha"
,"years apache ii score","NNS NNP  NN",4,1,1,16365336,"pubmed1",2.14E+018,"testalpha"
,"study is immunohistochemical determination","NN VBZ JJ NN",4,1,1,16256177,2,8.09E+018,"testalpha"
,"review of scientific publications","NN IN JJ NNS",4,1,1,17013516,2,8.96E+018,"testalpha"
,"n o donorligand n","  NN ",4,1,1,16456265,2,1.48E+018,"testalpha"
,"verified external anal sphincters","VBN JJ  NNS",4,1,1,17139884,2,2.22E+018,"testalpha"
,"target for new treatmentpossibilities","NN IN JJ NNS",4,1,1,16770444,"pubmed1",4.22E+017,"testalpha"
,"antiplatelet medications anticoagulants andantihypertensives","NN NNS NNS NNS",4,1,1,16436789,"pubmed1",4.43E+018,"testalpha"
,"count showed notable differences","NN VBD JJ NNS",4,1,1,16696442,2,7.44E+018,"testalpha"
,"methodology with meanpercentage error","NN IN NN NN",4,1,1,16584161,"pubmed1",8.33E+018,"testalpha"
,"material from ulcerated positions","NN IN VBN NNS",4,1,1,17139883,2,3.39E+018,"testalpha"
,"glut and cap genes"," CC NN NNS",4,1,1,16395520,"pubmed1",2.64E+018,"testalpha"
,"similar cumulative drug release","JJ JJ NN NN",4,1,1,17285748,"pubmed1",3.54E+018,"testalpha"
,"lipid peroxidation cascade werefound","NN NN NN NN",4,1,1,16764913,2,2.86E+018,"testalpha"
,"odontoblasts periodontal ligament fibroblasts","NNS NN NN NNS",4,1,1,17049369,2,6.15E+018,"testalpha"
,"cultural differences different panoramas","JJ NNS JJ NNS",4,1,1,16874417,2,2.66E+018,"testalpha"
,"containing nod proteins andtoll","VBG NN NNS NN",4,1,1,16648910,2,3.50E+018,"testalpha"
,"threemain causes of death","VB NNS IN NN",4,1,1,17013520,2,4.04E+018,"testalpha"
,"generation of disulfide bonds","NN IN VB NNS",4,1,1,17019443,"pubmed1",1.67E+018,"testalpha"
,"vasculitides with elevated ancatitres","NNS IN VBN NNS",4,1,1,16648918,2,1.44E+018,"testalpha"
,"world crashes highway planners","NN NNS NN NNS",4,1,1,16054101,"pubmed1",1.69E+018,"testalpha"
,"treatment withchop cyclophosphamide doxorubicin","NN NN VB NNP",4,1,1,16424646,2,3.29E+018,"testalpha"
,"competences of viral agents","NNS IN JJ NNS",4,1,1,17347785,"pubmed1",5.80E+018,"testalpha"
,"biological agents as weapons","JJ NNS IN NNS",4,1,1,16696436,2,7.79E+017,"testalpha"
,"ofcellular divisions of yeast","JJ NNS IN NN",4,1,1,17106513,"pubmed1",4.85E+018,"testalpha"
,"role of surgical auditor","NN IN JJ NN",4,1,1,17139882,2,6.55E+018,"testalpha"
,"medicine annals of emergency","NN NNS IN NN",4,1,1,16365335,"pubmed1",2.05E+018,"testalpha"
,"difference between cd immunolocalisation","NN IN  NN",4,1,1,16713618,2,2.37E+018,"testalpha"
,"few years meta analysis","JJ NNS  NN",4,1,1,16603103,2,5.30E+018,"testalpha"
,"utilization of radiation damageare","NN IN NN NN",4,1,1,16369098,2,6.81E+018,"testalpha"
,"standard tube thoracostomy insertion","JJ NN NN NN",4,1,1,16365333,"pubmed1",3.99E+016,"testalpha"
,"medical services ems employ","JJ NNS  NN",4,1,1,16365334,"pubmed1",5.15E+017,"testalpha"
,"smears revealed numerous osteoclastlike","NNS VBD JJ NN",4,1,1,16514845,2,1.41E+018,"testalpha"
,"evaluationand comparison of cie","NN NN IN ",4,1,1,16648914,2,2.85E+018,"testalpha"
,"apcs for t cell"," IN  NN",4,1,1,16733557,"pubmed1",2.45E+018,"testalpha"
,"chronic end stage liver","JJ NN NN NN",4,1,1,17013505,2,3.86E+018,"testalpha"
,"nd co co atp","   ",4,1,1,16389406,"pubmed1",6.82E+017,"testalpha"
,"polarizing microscopy stromal collagen","VBG  JJ NN",4,1,1,16899283,2,2.08E+018,"testalpha"
,"urea nitrogen bun levels"," NN  NNS",4,1,1,16999986,2,4.38E+018,"testalpha"
,"decreased activity of therespiratory","VBD NN IN NN",4,1,1,16951738,"pubmed1",1.86E+018,"testalpha"
,"classes ofmacromolecules including proteins","NNS NNS IN NNS",4,1,1,17160142,"pubmed1",7.21E+017,"testalpha"
,"activity inperipheral blood t","NN JJ NN ",4,1,1,17016035,2,4.51E+018,"testalpha"
,"skin from aha treatedgroups","NN IN  NNS",4,1,1,16574202,2,3.79E+018,"testalpha"
,"endometrial origin agc em","JJ NN  ",4,1,1,16514840,2,2.88E+018,"testalpha"
,"operated controls by immunohistochemistry","VBD NNS IN NN",4,1,1,16325891,2,7.25E+018,"testalpha"
,"internalfixation and prosthetic replacement","NN CC JJ NN",4,1,1,16613748,2,6.47E+018,"testalpha"
,"grass pollen and grass","NN NN CC NN",4,1,1,17328144,2,5.04E+018,"testalpha"
,"group increasesthe binding affinity","NN NNP VBG NN",4,1,1,16404478,"pubmed1",7.02E+018,"testalpha"
,"variety of staff members","NN IN NN NNS",4,1,1,16377191,"pubmed1",3.82E+018,"testalpha"
,"progressive increase inthe cell","JJ NN NNP NN",4,1,1,17106513,"pubmed1",7.18E+018,"testalpha"
,"requiring expertise in ethics","VBG NN IN NNS",4,1,1,16770858,"pubmed1",8.33E+018,"testalpha"
,"node reactive sinushistiocytosis rsh"," JJ NN ",4,1,1,16256177,2,2.93E+018,"testalpha"
,"tissucol duo baxter ag","NN  NN ",4,1,1,16696446,2,4.80E+018,"testalpha"
,"classical medicines gene therapy","JJ NNS  NN",4,1,1,17285739,"pubmed1",2.88E+018,"testalpha"
,"lactic acidosis mild orno","JJ NN JJ ",4,1,1,16673614,2,6.09E+018,"testalpha"
,"tointermediate sized polygonal cells","NN VBN JJ NNS",4,1,1,16514851,2,7.91E+018,"testalpha"
,"n di tert butyl","   ",4,1,1,16456265,2,5.75E+018,"testalpha"
,"full thickness skin grafts","JJ NN NN NNS",4,1,1,17165596,2,6.98E+018,"testalpha"
,"loss and keratitis ichthyosis","NN CC NN NN",4,1,1,17106596,2,1.73E+018,"testalpha"
,"mkn and nugc cancer"," CC  NN",4,1,1,17143338,"pubmed1",3.91E+018,"testalpha"
,"methodfor estimating fractal d","JJ VBG NN ",4,1,1,16823606,"pubmed1",4.47E+017,"testalpha"
,"nt antiviral treatment inplants"," JJ NN NNS",4,1,1,16395523,"pubmed1",8.05E+017,"testalpha"
,"subse quent tracheal intubation"," NN NN NN",4,1,1,17067136,"pubmed1",7.84E+018,"testalpha"
,"maternal diseases nor ssri","JJ NNS CC ",4,1,1,16549890,2,6.21E+018,"testalpha"
,"needle aspiration fna smears","NN NN  NNS",4,1,1,16514850,2,5.74E+018,"testalpha"
,"inthe last months p","NNP JJ NNS ",4,1,1,16648915,2,7.64E+018,"testalpha"
,"inh betaa and betab","  CC ",4,1,1,16423381,2,7.66E+018,"testalpha"
,"develop cardioprotection against peri","VB NN IN ",4,1,1,16451157,"pubmed1",8.68E+016,"testalpha"
,"activity of severe psoriasis","NN IN JJ NN",4,1,1,16956117,2,9.83E+017,"testalpha"
,"pressure map alanine aminotransferase","NN NN NN NN",4,1,1,17013507,2,9.15E+018,"testalpha"
,"trend towardimproved water maze","NN VBN NN NN",4,1,1,17265691,2,2.41E+018,"testalpha"
,"specific assessments andtreatments patient","JJ NNS NNS NN",4,1,1,16462405,"pubmed1",8.60E+018,"testalpha"
,"basis of antibioticsusceptibility breakpoints","NN IN NN NNS",4,1,1,16365328,"pubmed1",1.91E+018,"testalpha"
,"wide variability in dio","JJ NN IN ",4,1,1,16377812,"pubmed1",2.39E+018,"testalpha"
,"derived cells transcription factor","VBN NNS NN NN",4,1,1,17265694,2,3.30E+018,"testalpha"
,"chosen incubationtemperature degrees c","VBN NN NNS NN",4,1,1,16696441,2,2.50E+017,"testalpha"
,"identified bypcr using primers","VBN  VBG NNS",4,1,1,16696442,2,5.10E+018,"testalpha"
,"ligand fl togenerate dc","NN  NN ",4,1,1,16404477,"pubmed1",5.70E+018,"testalpha"
,"ecp mechanisms of action"," NNS IN NN",4,1,1,17016038,2,2.05E+018,"testalpha"
,"caseating granulomas in biopsy","VBG NNP IN NN",4,1,1,16256177,2,3.78E+018,"testalpha"
,"drivingskills and low ratings","NNS CC JJ NNS",4,1,1,16443186,"pubmed1",1.82E+018,"testalpha"
,"hospital with high voltage","NN IN JJ NN",4,1,1,17294910,2,4.42E+018,"testalpha"
,"development of early iron","NN IN JJ NN",4,1,1,16424659,2,4.93E+018,"testalpha"
,"woman with severe dysphagiaand","NN IN JJ NN",4,1,1,16673615,2,2.09E+018,"testalpha"
,"ofequivocal morphologic findings therapy","JJ JJ NNS NN",4,1,1,16333707,"pubmed1",8.55E+018,"testalpha"
,"control tissue besides itslevel","NN NN IN NN",4,1,1,16404476,"pubmed1",6.31E+018,"testalpha"
,"antioxidant agent onhypobaric hypoxia","JJ NN JJ ",4,1,1,16537087,2,4.52E+018,"testalpha"
,"organizational effectiveness and systems","JJ NN CC NNS",4,1,1,16377814,"pubmed1",6.00E+018,"testalpha"
,"option thatprovides optimal results","NN NNS JJ NNS",4,1,1,17139901,2,5.05E+018,"testalpha"
,"disease control and prevention","NN NN CC NN",4,1,1,16511256,2,3.61E+018,"testalpha"
,"investigated glutathione level activities","VBD NN NN NNS",4,1,1,16404476,"pubmed1",8.80E+018,"testalpha"
,"differentiation ofequivocal morphologic findings","NN JJ JJ NNS",4,1,1,16333707,"pubmed1",1.73E+018,"testalpha"
,"cd intracellular il t"," JJ  ",4,1,1,17016036,2,3.96E+018,"testalpha"
,"link safety climate i","NN NN NN ",4,1,1,16442068,"pubmed1",5.56E+018,"testalpha"
,"incorporation of h glucosamine","NN IN  NN",4,1,1,16733556,"pubmed1",4.35E+018,"testalpha"
,"large number of nf","JJ NN IN ",4,1,1,17068636,"pubmed1",9.08E+018,"testalpha"
,"trainees and patient care","NNS CC NN NN",4,1,1,16377815,"pubmed1",6.09E+018,"testalpha"
,"flow cytometry healthy patients","NN NN JJ NNS",4,1,1,17016036,2,3.51E+018,"testalpha"
,"more patients in bupivacaine","JJR NNS IN NN",4,1,1,16617756,"pubmed1",5.59E+018,"testalpha"
,"prognostic value of thymidylate","JJ NN IN NN",4,1,1,17139902,2,5.02E+018,"testalpha"
,"drivers of heavy vehicles","NNS IN JJ NNS",4,1,1,16157285,"pubmed1",2.17E+018,"testalpha"
,"using b f murine","VBG NN NN NN",4,1,1,16388313,"pubmed1",6.62E+017,"testalpha"
,"asoutcome data for shape","NN NNS IN NN",4,1,1,16722348,2,4.11E+018,"testalpha"
,"water and sodium dodecylsulphate","NN CC NN NN",4,1,1,16648917,2,5.01E+018,"testalpha"
,"invasion but contribute toskin","NN CC VB NNP",4,1,1,16648910,2,7.14E+018,"testalpha"
,"grade or large b","NN CC JJ NN",4,1,1,16612936,"pubmed1",7.98E+018,"testalpha"
,"acute coronary syndrome patients","JJ NN NN NNS",4,1,1,16377816,"pubmed1",2.33E+017,"testalpha"
,"cell death upon treatment","NN NN IN NN",4,1,1,16951739,"pubmed1",4.10E+017,"testalpha"
,"diagnostic accuracy of tp","JJ NN IN ",4,1,1,16514842,2,8.63E+018,"testalpha"
,"lag sipp queueing analysis","VB  VBG NN",4,1,1,16365329,"pubmed1",1.39E+018,"testalpha"
,"thedownregulation of c myc","NN IN NN ",4,1,1,16809887,2,7.19E+018,"testalpha"
,"dependent influence on mucoadhesion","JJ NN IN NN",4,1,1,17285750,"pubmed1",2.33E+018,"testalpha"
,"volume stroke volume sv","NN NN NN ",4,1,1,16989140,2,8.53E+018,"testalpha"
,"sod promoted bythe administration"," VBN NNP NN",4,1,1,17293962,2,1.34E+018,"testalpha"
,"enos inos and tgf","  CC ",4,1,1,16762404,2,7.03E+018,"testalpha"
,"mixed group e g","VBN NN  ",4,1,1,17311739,2,5.91E+018,"testalpha"
,"significant changes in road","JJ NNS IN NN",4,1,1,16427020,"pubmed1",7.64E+018,"testalpha"
,"driver licensesuspensions and traffic","NN NNS CC NN",4,1,1,16405858,"pubmed1",1.61E+016,"testalpha"
,"malformations are congenital abnormalities","NNS VBP NN NNS",4,1,1,16722347,2,7.05E+018,"testalpha"
,"knowledge includingvariability in algorithm","NN NN IN NN",4,1,1,16399031,"pubmed1",3.12E+018,"testalpha"
,"decrease in tgf beta","NN IN  NN",4,1,1,17293967,2,8.84E+018,"testalpha"
,"blood oxygenationlevel dependent sequences","NN NN JJ NNS",4,1,1,16447077,"pubmed1",4.28E+017,"testalpha"
,"research training in psychiatry","NN NN IN NN",4,1,1,16473989,"pubmed1",7.68E+018,"testalpha"
,"bipolar hemiarthroplastyby evaluating patients","JJ  VBG NNS",4,1,1,16613748,2,8.42E+018,"testalpha"
,"more dsk uba molecules","JJR   NNS",4,1,1,16421449,2,1.31E+018,"testalpha"
,"ac and b neuraminidase"," CC NN NN",4,1,1,16764914,2,3.70E+018,"testalpha"
,"sonoenteroclysis displayed normal diameters","NN VBN JJ NNS",4,1,1,16447095,"pubmed1",2.62E+018,"testalpha"
,"includingvariability in algorithm formulation","NN IN NN NN",4,1,1,16399031,"pubmed1",1.89E+018,"testalpha"
,"changes in hep cells","NNS IN  NNS",4,1,1,16956122,2,3.29E+018,"testalpha"
,"transportation infrastructure and amount","NN NN CC NN",4,1,1,16451795,"pubmed1",7.68E+018,"testalpha"
,"olanzapine mg multiple mm","NN  JJ ",4,1,1,16696448,2,4.42E+018,"testalpha"
,"diverse processesincluding cytokinasis vesicle","JJ VBG NN NN",4,1,1,16511282,2,4.77E+018,"testalpha"
,"foroccupational safety and health","JJ NN CC NN",4,1,1,16438095,"pubmed1",6.86E+018,"testalpha"
,"range months clinical presentations","VBP NNS JJ NNS",4,1,1,16914906,2,6.05E+018,"testalpha"
,"anastomosis and group iii","NN CC NN ",4,1,1,16612919,"pubmed1",3.66E+018,"testalpha"
,"i e management commitment","  NN NN",4,1,1,16442068,"pubmed1",2.19E+018,"testalpha"
,"safety belt use ratiois","NN NN NN NNP",4,1,1,16061188,"pubmed1",5.50E+018,"testalpha"
,"was obtained t rubrum","VBD VBN  NN",4,1,1,16710579,2,8.93E+018,"testalpha"
,"transfection of human cord","NN IN JJ NN",4,1,1,16404477,"pubmed1",4.14E+018,"testalpha"
,"significant role in thewarburg","JJ NN IN NNP",4,1,1,17143338,"pubmed1",7.88E+018,"testalpha"
,"manner with ic values","NN IN JJ NNS",4,1,1,17019444,"pubmed1",7.49E+018,"testalpha"
,"sod and catalase cat"," CC NN NN",4,1,1,16999986,2,8.54E+017,"testalpha"
,"cases were validated mvcdeaths","NNS VBD VBD NNS",4,1,1,16405857,"pubmed1",8.62E+018,"testalpha"
,"included dislocation reduction cardioversion","VBD NN NN NN",4,1,1,16365337,"pubmed1",2.40E+018,"testalpha"
,"liquid volume and contact","JJ NN CC NN",4,1,1,16701858,"pubmed1",5.28E+018,"testalpha"
,"surface of follicular cells","NN IN JJ NNS",4,1,1,16720036,2,8.42E+017,"testalpha"
,"management of solar lentigines","NN IN JJ NNS",4,1,1,16859612,2,7.28E+018,"testalpha"
,"harmful effects of lipidchlorohydrins","JJ NNS IN NNS",4,1,1,17128291,"pubmed1",5.16E+018,"testalpha"
,"loweredfaculty expectations and standards","NN NNS CC NNS",4,1,1,16377820,"pubmed1",6.43E+018,"testalpha"
,"ileal conduit specimens shows","NN NN NNS NNS",4,1,1,16514843,2,2.28E+018,"testalpha"
,"instabilities and mental retardation","NNS CC JJ NN",4,1,1,16582985,"pubmed1",5.73E+018,"testalpha"
,"cellular mechanisms thatconfer drug","JJ NNS VB NN",4,1,1,16809883,2,8.27E+018,"testalpha"
,"beta glactosidase activity oftranscription","NN NN NN NN",4,1,1,16964327,"pubmed1",7.46E+018,"testalpha"
,"ct concentrations in rat"," NNS IN NN",4,1,1,16762403,2,3.34E+017,"testalpha"
,"requirements and maintained quality","NNS CC VBN NN",4,1,1,16377824,"pubmed1",2.41E+018,"testalpha"
,"used toestimate median barrier","VBN NN JJ NN",4,1,1,16442487,"pubmed1",2.54E+018,"testalpha"
,"help patients avoid strokerecurrence","VB NNS VB NN",4,1,1,16436789,"pubmed1",4.56E+018,"testalpha"
,"receiving propofol for psa","VBG  IN ",4,1,1,16365337,"pubmed1",4.96E+018,"testalpha"
,"success of insertion oxygenation","NN IN NN NN",4,1,1,16451149,"pubmed1",8.31E+018,"testalpha"
,"crystal structures of itsheme","NN NNS IN NN",4,1,1,16411738,"pubmed1",5.95E+016,"testalpha"
,"venous catheter tunnel infection","JJ NN NN NN",4,1,1,16918062,"pubmed1",7.62E+017,"testalpha"
,"bile duct carcinoid tumours","NN  VB NNS",4,1,1,16612931,"pubmed1",1.75E+018,"testalpha"
,"functions and rna metabolism","NNS CC  NN",4,1,1,16410835,"pubmed1",7.93E+018,"testalpha"
,"due tomisregistration between image","JJ NN IN NN",4,1,1,16399029,"pubmed1",3.32E+018,"testalpha"
,"measures for early recognition","NNS IN JJ NN",4,1,1,17013506,2,6.75E+018,"testalpha"
,"hb hct erythrocyte countsand","  NNP NN",4,1,1,17117609,2,2.62E+018,"testalpha"
,"month old adult rats","NN JJ NN NNS",4,1,1,17046052,2,4.85E+018,"testalpha"
,"level numerous endocrine cells","NN JJ NN NNS",4,1,1,16569423,2,8.40E+018,"testalpha"
,"sinuses and anal papillae","NNS CC  NNS",4,1,1,17139880,2,1.07E+018,"testalpha"
,"showedstacks of msu crystals","NNS IN  NNS",4,1,1,16514850,2,1.46E+018,"testalpha"
,"decreased inos andincreased enos","VBD  VBN ",4,1,1,16566960,2,3.63E+018,"testalpha"
,"moderate increase of liver","JJ NN IN NN",4,1,1,16673610,2,1.36E+018,"testalpha"
,"injuries involving sleds snow","NNS VBG NNS NN",4,1,1,16436798,"pubmed1",5.07E+018,"testalpha"
,"clinicalassessment of mild tbi","NN IN JJ ",4,1,1,16365331,"pubmed1",3.93E+018,"testalpha"
,"leukemia with high grade","NN IN JJ NN",4,1,1,16424647,2,1.25E+018,"testalpha"
,"iron overload and inflammation","NN NN CC NN",4,1,1,17119323,2,9.03E+018,"testalpha"
,"hashimoto thyroiditis follicular neoplasms","NNP NN JJ NNS",4,1,1,16514836,2,8.96E+018,"testalpha"
,"performed restriction fragment lengthpolymorphism","VBN NN NN NN",4,1,1,16733555,"pubmed1",8.44E+018,"testalpha"
,"time of writingthis manuscript","NN IN NNP NN",4,1,1,17269167,2,6.43E+018,"testalpha"
,"median crashes median barrier","JJ NNS JJ NN",4,1,1,16442487,"pubmed1",8.86E+018,"testalpha"
,"distention small bowel distention","NN JJ NN NN",4,1,1,16252139,"pubmed1",1.06E+018,"testalpha"
,"large proportions of psoriasis","JJ NNS IN NN",4,1,1,17106601,2,3.25E+018,"testalpha"
,"pharmacology of theavailable agents","NN IN JJ NNS",4,1,1,17236644,"pubmed1",3.22E+018,"testalpha"
,"carcinogens and toxic agents","NNS CC JJ NNS",4,1,1,16594641,"pubmed1",2.48E+018,"testalpha"
,"ellerby andcoworkers full sequence","JJ NNS JJ NN",4,1,1,17143339,"pubmed1",1.28E+018,"testalpha"
,"cells in psoriatic lesions","NNS IN JJ NNS",4,1,1,17034836,2,5.97E+018,"testalpha"
,"ada binding cell membrane"," VBG NN NN",4,1,1,16929383,"pubmed1",8.92E+018,"testalpha"
,"hydrolysis of dihydrouraciland dihydrothymine","NN IN NN NN",4,1,1,16511257,2,2.87E+018,"testalpha"
,"studies of protein dynamics","NNS IN NN NNS",4,1,1,16365636,"pubmed1",5.95E+017,"testalpha"
,"literature regardingdifferent treatment regimens","NN NN NN NNS",4,1,1,16549891,2,3.66E+018,"testalpha"
,"depictions of mental illness","NNS IN JJ NN",4,1,1,16474001,"pubmed1",3.31E+018,"testalpha"
,"emergency department ed notification","NN NN VBD NN",4,1,1,16365334,"pubmed1",7.05E+018,"testalpha"
,"vivo skin hydration studies"," NN NN NNS",4,1,1,17285742,"pubmed1",6.18E+018,"testalpha"
,"article reviews recent publications","NN NNS JJ NNS",4,1,1,16710573,2,6.77E+018,"testalpha"
,"york and included auniversity"," CC VBD NN",4,1,1,16365324,"pubmed1",2.13E+018,"testalpha"
,"influences of liquid volume","NNS IN JJ NN",4,1,1,16701858,"pubmed1",4.89E+018,"testalpha"
,"ethenocytosine epsilonc and n","NN  CC ",4,1,1,16582987,"pubmed1",4.95E+018,"testalpha"
,"impact of extended drinkinghours","NN IN VBN NNS",4,1,1,16169506,"pubmed1",3.03E+018,"testalpha"
,"cdc adult immunization schedule"," NN NN NN",4,1,1,16438095,"pubmed1",2.29E+018,"testalpha"
,"group ofrecidivist drink drivers","NN NN NN NNS",4,1,1,16405859,"pubmed1",7.58E+018,"testalpha"
,"cardiological point of view","JJ NN IN NN",4,1,1,16914907,2,9.65E+017,"testalpha"
,"log of population treatedas","NN IN NN NNP",4,1,1,16111641,"pubmed1",7.87E+018,"testalpha"
,"resistance of cp ti","NN IN  ",4,1,1,16701867,"pubmed1",3.42E+018,"testalpha"
,"andccpp pe treated animals","  VBN NNS",4,1,1,16584758,2,5.24E+018,"testalpha"
,"weather conditions transportation infrastructure","NN NNS NN NN",4,1,1,16451795,"pubmed1",5.24E+018,"testalpha"
,"inflammation embryogenesis immune defence","NN NN JJ NN",4,1,1,16511286,2,1.27E+018,"testalpha"
,"cartilage tendon and myocardium","NN NNP CC NN",4,1,1,16696440,2,1.40E+018,"testalpha"
,"patients with inhibitors clearlyindicates","NNS IN NNS NNS",4,1,1,16914907,2,7.73E+018,"testalpha"
,"purpose comparative morphologic study","NN JJ JJ NN",4,1,1,17293971,2,5.72E+017,"testalpha"
,"isolated fromc bl mice","VBN   ",4,1,1,17128291,"pubmed1",4.51E+018,"testalpha"
,"protein in preformed polymerase","NN IN VBN NN",4,1,1,16421445,2,4.29E+018,"testalpha"
,"isolationand purification from homogenates","NN NN IN NNS",4,1,1,16648912,2,1.00E+018,"testalpha"
,"negativeprognostic factors causing progression","JJ NNS VBG NN",4,1,1,16673555,2,2.31E+018,"testalpha"
,"patients with hematologic malignancies","NNS IN JJ NNS",4,1,1,16424647,2,5.20E+018,"testalpha"
,"eachcondition with crash culpability","NN IN NN NN",4,1,1,16054104,"pubmed1",1.13E+018,"testalpha"
,"histochemical indicators ofdifferentiated function","JJ NNS VBN NN",4,1,1,17046053,2,6.22E+018,"testalpha"
,"importantclinical problem in children","JJ NN IN NNS",4,1,1,16549900,2,4.31E+018,"testalpha"
,"dna synthesis on undamagedtemplate"," NN IN NN",4,1,1,16582987,"pubmed1",6.43E+018,"testalpha"
,"cancers andcorresponding nonmalignant tissue","NNS VBG JJ NN",4,1,1,17143338,"pubmed1",1.26E+018,"testalpha"
,"ischemic stroke at dr","JJ NN IN ",4,1,1,16479026,2,8.53E+018,"testalpha"
,"fludarabine topatients with indolent","NN NNS IN NN",4,1,1,16424646,2,1.74E+018,"testalpha"
,"gdsgvgkt wdtagq nkld sak","   ",4,1,1,16365637,"pubmed1",3.20E+018,"testalpha"
,"functional group in anthracene","JJ NN IN NN",4,1,1,16404478,"pubmed1",8.91E+018,"testalpha"
,"translocating nadh quinone oxidoreductase","VBG  NN NN",4,1,1,16511277,2,3.93E+018,"testalpha"
,"strand conformation polymorphism andsequence","NN NN NN NN",4,1,1,16733555,"pubmed1",8.95E+018,"testalpha"
,"b c and d","NN NN CC ",4,1,1,16511279,2,1.25E+018,"testalpha"
,"platelet aggregation anddense granule","NN NN NN NN",4,1,1,17068635,"pubmed1",5.59E+018,"testalpha"
,"d isomer specific hydroxyacid"," NN JJ NN",4,1,1,16511285,2,5.33E+018,"testalpha"
,"treatment but obtained pain","NN CC VBN NN",4,1,1,16916183,"pubmed1",3.42E+018,"testalpha"
,"patients receivingresections of basal","NNS NNS IN NN",4,1,1,17165596,2,2.35E+018,"testalpha"
,"need for further surgery","NN IN JJ NN",4,1,1,16612914,"pubmed1",3.72E+017,"testalpha"
,"bilirubin and normal values","NNP CC JJ NNS",4,1,1,17117609,2,6.60E+018,"testalpha"
,"oxide dependent vasodilatory response","VB JJ NN NN",4,1,1,16479030,2,7.84E+018,"testalpha"
,"neutralization rateand buffering capacity","NN NN VBG NN",4,1,1,16584168,"pubmed1",8.46E+018,"testalpha"
,"toleratedvalproate but developed dress","NN CC VBN NN",4,1,1,16710584,2,7.67E+018,"testalpha"
,"satellite irna in mitochondria","NN  IN NNP",4,1,1,16496041,"pubmed1",2.11E+018,"testalpha"
,"ad patients as markers","NN NNS IN NNS",4,1,1,16859611,2,4.63E+018,"testalpha"
,"enhancement and functional changes","NN CC JJ NNS",4,1,1,16399029,"pubmed1",6.58E+018,"testalpha"
,"x kg for min","NN  IN ",4,1,1,17067136,"pubmed1",8.71E+018,"testalpha"
,"relationship between amyloid fibrils","NN IN VB NNS",4,1,1,16542712,2,7.92E+018,"testalpha"
,"united states pharmacopeia usp","VBN NNS  ",4,1,1,16584139,"pubmed1",2.55E+018,"testalpha"
,"decade amphotericin b deoxycholate","NN NNP NN NN",4,1,1,17370566,"pubmed1",5.45E+018,"testalpha"
,"lossof time for research"," NN IN NN",4,1,1,16377820,"pubmed1",6.73E+018,"testalpha"
,"functional improvement in patients","JJ NN IN NNS",4,1,1,16722347,2,5.49E+018,"testalpha"
,"initio by direct methods","NN IN JJ NNS",4,1,1,16421448,2,4.23E+018,"testalpha"
,"alcoholism and related problems","NN CC VBN NNS",4,1,1,16859619,2,7.97E+018,"testalpha"
,"beta cells lbetat cells","NN NNS NN NNS",4,1,1,16395521,"pubmed1",3.18E+018,"testalpha"
,"induced cardiac dysfunction e","VBN JJ NN ",4,1,1,16566960,2,6.47E+018,"testalpha"
,"presents magnetic resonance images","VBZ JJ NN NNS",4,1,1,16177871,"pubmed1",4.67E+018,"testalpha"
,"glycoproteins and adenosine triphosphatases","NNS CC NN NNS",4,1,1,16523217,"pubmed1",5.05E+018,"testalpha"
,"eukaryote paramecium by pcr","VBD NN IN ",4,1,1,16365637,"pubmed1",2.12E+017,"testalpha"
,"detectionof individual ecm molecules"," JJ  NNS",4,1,1,16414104,2,2.70E+018,"testalpha"
,"chronic kidney disease ckd","JJ NN NN ",4,1,1,17160142,"pubmed1",5.76E+018,"testalpha"
,"pre and postoperative period"," CC JJ NN",4,1,1,17293972,2,3.77E+018,"testalpha"
,"cytotoxic t lymphocyte ctl","JJ  NNP ",4,1,1,16511250,2,2.85E+018,"testalpha"
,"enhancing quality of life","VBG NN IN NN",4,1,1,16918068,"pubmed1",2.02E+018,"testalpha"
,"facilitation of sustained attention","NN IN VBN NN",4,1,1,16436796,"pubmed1",4.81E+018,"testalpha"
,"single chain of amino","JJ NN IN NNP",4,1,1,16770447,"pubmed1",4.82E+018,"testalpha"
,"internal time representation lossrate","JJ NN NN NN",4,1,1,17133956,2,5.04E+018,"testalpha"
,"clone of plasma cells","NN IN NNP NNS",4,1,1,16714048,2,2.33E+018,"testalpha"
,"leukemia l cells tsr","NN  NNS ",4,1,1,16505899,"pubmed1",9.55E+017,"testalpha"
,"emergency department ed sites","NN NN VBD NNS",4,1,1,16365337,"pubmed1",3.35E+018,"testalpha"
,"n pyridylamino aminomethyl methylphenol"," NNP  NN",4,1,1,16456265,2,1.75E+018,"testalpha"
,"had primary irritation index","VBD JJ NN NN",4,1,1,17285742,"pubmed1",3.04E+018,"testalpha"
,"target lesion between baseline","NN NN IN NN",4,1,1,16585986,2,6.20E+018,"testalpha"
,"type of cell death","NN IN NN NN",4,1,1,16956122,2,7.36E+018,"testalpha"
,"murine model statistical analysis","NN NN JJ NN",4,1,1,16436788,"pubmed1",3.81E+018,"testalpha"
,"poisoned ratsregardless of type","VBN NN IN NN",4,1,1,16956120,2,3.37E+018,"testalpha"
,"ed visits in andto","VBD NNS IN ",4,1,1,16436798,"pubmed1",3.78E+018,"testalpha"
,"ofthe composite skin graft","NNP JJ NN NN",4,1,1,16999269,2,2.45E+018,"testalpha"
,"ct or mr images"," CC  NNS",4,1,1,16317488,"pubmed1",5.83E+018,"testalpha"
,"post pacs study period","NN  NN NN",4,1,1,16436791,"pubmed1",7.17E+018,"testalpha"
,"bronchoalveolarlavage fluid corrected l","NN NN VBN ",4,1,1,16918060,"pubmed1",2.38E+018,"testalpha"
,"interest in contrast agents","NN IN NN NNS",4,1,1,16411740,"pubmed1",4.43E+018,"testalpha"
,"adjunctive therapy for patients","JJ NN IN NNS",4,1,1,16859617,2,4.25E+018,"testalpha"
,"purpura itp in children","NNP  IN NNS",4,1,1,16424648,2,4.71E+018,"testalpha"
,"drying process analytical technology","VBG NN JJ NN",4,1,1,17285744,"pubmed1",2.29E+018,"testalpha"
,"advancing stem cell medicine","VBG VB NN NN",4,1,1,17269167,2,9.17E+018,"testalpha"
,"containing allylglycine residues inplace","VBG NN NNS NN",4,1,1,16496038,"pubmed1",1.12E+018,"testalpha"
,"chroniccholecystitis and multiple gallstones","NN CC JJ NNS",4,1,1,16132429,"pubmed1",8.31E+018,"testalpha"
,"cells cd cd cd","NNS   ",4,1,1,17119322,2,2.50E+018,"testalpha"
,"effects and high patient","NNS CC JJ NN",4,1,1,16859612,2,8.08E+018,"testalpha"
,"resected patients with rectal","VBN NNS IN NN",4,1,1,17139895,2,2.84E+018,"testalpha"
,"divisions andyeast cell volume","NNS JJS NN NN",4,1,1,17106513,"pubmed1",9.10E+018,"testalpha"
,"invivo post transplantation properties"," NN NN NNS",4,1,1,17265690,2,6.18E+018,"testalpha"
,"children and adolescents withmoderate","NNS CC NNS NN",4,1,1,16585987,2,3.74E+018,"testalpha"
,"fos expression andintracellular fos"," NN JJ ",4,1,1,17007911,2,1.32E+018,"testalpha"
,"acute respiratory distress syndrome","JJ NN NN NN",4,1,1,16451155,"pubmed1",2.14E+018,"testalpha"
,"life span of thepheromone","NN NN IN NN",4,1,1,17106513,"pubmed1",3.86E+017,"testalpha"
,"allpatients underwent abdominal ultrasound","NNS NN JJ NN",4,1,1,16447095,"pubmed1",5.00E+018,"testalpha"
,"selected photochemicalproperties of mesophyll","VBN NNS IN NN",4,1,1,17106510,"pubmed1",1.50E+018,"testalpha"
,"conditions resected gut specimen","NNS VBN NN NN",4,1,1,17293957,2,9.57E+017,"testalpha"
,"secreting amurine monoclonal antiplatelet","VBG NN JJ NN",4,1,1,16594642,"pubmed1",4.23E+018,"testalpha"
,"studies while retrospective cohorts","NNS IN JJ NNS",4,1,1,17016033,2,4.43E+016,"testalpha"
,"areas of histamine inducedalloknesis","NNS IN NN NN",4,1,1,16955182,2,1.81E+018,"testalpha"
,"stimulated exocytosis innormal bath","VBN NN JJ NN",4,1,1,16395521,"pubmed1",6.03E+018,"testalpha"
,"lowermortality rates new patterns","NN NNS JJ NNS",4,1,1,16462404,"pubmed1",8.23E+018,"testalpha"
,"roots of transgenic tobaccos","NNS IN JJ NNP",4,1,1,16395526,"pubmed1",4.20E+018,"testalpha"
,"neurological tests and laboratory","JJ NNS CC NN",4,1,1,17688033,2,3.13E+018,"testalpha"
,"umbilical cords and adults","JJ NNS CC NNS",4,1,1,16549888,2,2.52E+017,"testalpha"
,"formation of thosecollateral circulations","NN IN JJ NNS",4,1,1,17014894,2,4.89E+018,"testalpha"
,"n or abrupt n"," CC JJ ",4,1,1,16333694,"pubmed1",5.75E+018,"testalpha"
,"spinalmuscular atrophy type i","JJ NN NN ",4,1,1,16730053,2,1.25E+018,"testalpha"
,"resorcina adhesive ormetallic synthesis","NNP JJ JJ NN",4,1,1,17293966,2,6.33E+018,"testalpha"
,"ma inthe nonpregnant group"," NNP JJ NN",4,1,1,17067140,"pubmed1",5.33E+018,"testalpha"
,"electron paramagnetic resonance epr","NN JJ NN ",4,1,1,16964324,"pubmed1",6.90E+017,"testalpha"
,"ourresults suggest possible role","NNS VBP JJ NN",4,1,1,17338197,2,8.90E+018,"testalpha"
,"tumour necrosis factor tnf","JJ NN NN ",4,1,1,16511253,2,4.46E+018,"testalpha"
,"andattitudes toward medical informatics","NNS IN JJ NNS",4,1,1,16473991,"pubmed1",5.27E+018,"testalpha"
,"polypeptides of amino acids","NNS IN NNP NNS",4,1,1,16365637,"pubmed1",7.92E+018,"testalpha"
,"emergency department ed patients","NN NN VBD NNS",4,1,1,16365327,"pubmed1",7.25E+018,"testalpha"
,"describe correctlythe complex relationships","VB NNP JJ NNS",4,1,1,16505901,"pubmed1",6.32E+018,"testalpha"
,"phenylalanine residues of threeoxytocin","NN NNS IN NNP",4,1,1,16523218,"pubmed1",8.59E+018,"testalpha"
,"blood counts blood chemistry","NN NNS NN NN",4,1,1,16479024,2,4.31E+018,"testalpha"
,"teen driverfatalities day time"," NNS NN NN",4,1,1,16171767,"pubmed1",6.59E+018,"testalpha"
,"light source molecular replacement","NN NN JJ NN",4,1,1,16511256,2,7.21E+018,"testalpha"
,"asp val gln phe","   ",4,1,1,16496040,"pubmed1",1.53E+018,"testalpha"
,"reduced number of erector","VBN NN IN NN",4,1,1,17311739,2,8.71E+018,"testalpha"
,"nature of hospitalisation forinjuries","NN IN NN NNS",4,1,1,16162331,"pubmed1",3.72E+018,"testalpha"
,"effect of new accreditation","NN IN JJ NN",4,1,1,16377812,"pubmed1",6.65E+018,"testalpha"
,"analyze areas of knowledge","VB NNS IN NN",4,1,1,16438092,"pubmed1",6.76E+018,"testalpha"
,"preventable excessive alcohol consumption","JJ JJ NN NN",4,1,1,17013520,2,9.09E+018,"testalpha"
,"loss of conformational freedom","NN IN JJ NN",4,1,1,16369101,2,6.18E+018,"testalpha"
,"process in underlying components","NN IN VBG NNS",4,1,1,16406188,"pubmed1",1.50E+018,"testalpha"
,"reach significance after correction","VB NN IN NN",4,1,1,16054104,"pubmed1",6.00E+018,"testalpha"
,"scheduled fora total colectomy","VBN  NN NN",4,1,1,16603100,2,4.92E+017,"testalpha"
,"proteinasedigestion i with pbs","NN  IN ",4,1,1,16514835,2,5.54E+018,"testalpha"
,"term neutrophil and platelet","VBP  CC NN",4,1,1,17119322,2,5.62E+018,"testalpha"
,"syntheticppargamma ligand inhibited cell","NN NN VBN NN",4,1,1,16809887,2,8.79E+018,"testalpha"
,"mutational specificity of alkb","JJ NN IN ",4,1,1,16733554,"pubmed1",9.13E+017,"testalpha"
,"children and normal mode","NNS CC JJ NN",4,1,1,16710582,2,1.50E+018,"testalpha"
,"levels of triglyceride p","NNS IN VB ",4,1,1,16673555,2,7.85E+018,"testalpha"
,"sa responsive cis actingelements"," JJ  NNS",4,1,1,16395526,"pubmed1",6.45E+018,"testalpha"
,"determine metabolic syndrome results","VB JJ NN NNS",4,1,1,16479027,2,6.28E+017,"testalpha"
,"proportion of affected children","NN IN VBN NNS",4,1,1,16549898,2,7.98E+018,"testalpha"
,"female passengers aged years","NN NNS VBN NNS",4,1,1,16434013,"pubmed1",2.97E+017,"testalpha"
,"sleep disturbance fine tremor","NN NN JJ NN",4,1,1,16479025,2,2.00E+018,"testalpha"
,"afterautologous peripheral blood transplantation","JJ JJ NN NN",4,1,1,16918064,"pubmed1",6.43E+018,"testalpha"
,"genetic expression level cells","JJ NN NN NNS",4,1,1,17294912,2,4.12E+018,"testalpha"
,"atopic dermatitis in adults","NN NN IN NNS",4,1,1,17106598,2,7.51E+018,"testalpha"
,"px activity and creatininelevel"," NN CC NN",4,1,1,17160142,"pubmed1",7.97E+018,"testalpha"
,"biphosphonates and hip protectors","NNS CC NN NNS",4,1,1,16613748,2,8.37E+018,"testalpha"
,"body function and body","NN NN CC NN",4,1,1,16918067,"pubmed1",8.75E+018,"testalpha"
,"times for stating name","NNS IN VBG NN",4,1,1,16451145,"pubmed1",2.15E+018,"testalpha"
,"theb lyp g method","   NN",4,1,1,16528413,"pubmed1",2.27E+018,"testalpha"
,"firmness in defective feedback","NN IN JJ NN",4,1,1,17294912,2,9.04E+017,"testalpha"
,"united states pharmacopeia apparatus","VBN NNS  NN",4,1,1,16594638,"pubmed1",1.43E+018,"testalpha"
,"minv egfp packaging cell","  NN NN",4,1,1,17160143,"pubmed1",7.54E+018,"testalpha"
,"drugs forprevention of transmission","NNS NN IN NN",4,1,1,17128290,"pubmed1",5.61E+018,"testalpha"
,"adsorption property with regard","NN NN IN NN",4,1,1,16701860,"pubmed1",6.74E+017,"testalpha"
,"rats by l name","NNS IN  NN",4,1,1,16764913,2,8.61E+018,"testalpha"
,"arborescens l essential oil","NNS  JJ NN",4,1,1,16584150,"pubmed1",3.51E+018,"testalpha"
,"extracted premolars from children","VBN NNS IN NNS",4,1,1,17049369,2,5.48E+018,"testalpha"
,"bynorthern blot and rt","JJ NN CC ",4,1,1,16365637,"pubmed1",8.80E+018,"testalpha"
,"nugc and panc cancers"," CC  NNS",4,1,1,17143338,"pubmed1",9.08E+018,"testalpha"
,"year year and yearsurvival","NN NN CC NN",4,1,1,17139879,2,7.94E+018,"testalpha"
,"oxidizing conditions e g","VBG NNS  ",4,1,1,16411734,"pubmed1",2.10E+018,"testalpha"
,"inthe treatment of itp","NNP NN IN ",4,1,1,16594642,"pubmed1",6.87E+018,"testalpha"
,"needs patient needs physicianaffiliation","VBZ NN VBZ NN",4,1,1,16365324,"pubmed1",4.07E+018,"testalpha"
,"seen inthe tumor cells","VBN NNP NN NNS",4,1,1,16430945,2,1.33E+018,"testalpha"
,"magneticresonance imaging endoscopic retrograde","NN VBG NN NN",4,1,1,16333694,"pubmed1",4.81E+018,"testalpha"
,"difference between re andse","NN IN  ",4,1,1,16451148,"pubmed1",8.19E+018,"testalpha"
,"paper and practical hints","NN CC JJ NNS",4,1,1,16921609,"pubmed1",3.99E+018,"testalpha"
,"carvedilol pretreatment mean age"," NN VB NN",4,1,1,17338197,2,6.96E+018,"testalpha"
,"mm and rattus norvegicus"," CC NN NN",4,1,1,16733558,"pubmed1",9.16E+018,"testalpha"
,"surgical resection of metastases","JJ NN IN NNS",4,1,1,17139885,2,6.23E+018,"testalpha"
,"twocases of postparotidectomy fistulae","NNS IN NN NNS",4,1,1,16696446,2,6.50E+018,"testalpha"
,"weights ofmonomer and dimer","VBZ NN CC NN",4,1,1,16505899,"pubmed1",2.23E+018,"testalpha"
,"d pteronyssinus in patients"," NN IN NNS",4,1,1,16859613,2,7.92E+018,"testalpha"
,"stability and qualitative aspects","NN CC JJ NNS",4,1,1,16988902,"pubmed1",2.58E+018,"testalpha"
,"cad reading improvesdiagnostic performance"," NN JJ NN",4,1,1,16399036,"pubmed1",3.64E+018,"testalpha"
,"factor beta tgf beta","NN NN  NN",4,1,1,16762404,2,7.39E+018,"testalpha"
,"vulval lichen planus vlp","NN NNP NN ",4,1,1,16955190,2,9.68E+017,"testalpha"
,"lack of short term","NN IN JJ NN",4,1,1,16585987,2,3.86E+018,"testalpha"
,"d andlow dose ivig"," VB NN ",4,1,1,16424649,2,2.94E+018,"testalpha"
,"karyotypes xy r p","NNS  NN ",4,1,1,16914909,2,1.95E+018,"testalpha"
,"patients were allergic tothiuram","NNS VBD JJ NN",4,1,1,16710586,2,6.09E+018,"testalpha"
,"coupled radio frequency system","VBN NN NN NN",4,1,1,16701874,"pubmed1",4.32E+018,"testalpha"
,"licensed active car drivers","VBN JJ NN NNS",4,1,1,16191426,"pubmed1",7.55E+018,"testalpha"
,"mass lesions in ourdatabase","NN NNS IN NN",4,1,1,16399033,"pubmed1",2.95E+018,"testalpha"
,"increments in inflation pressure","NNS IN NN NN",4,1,1,16399039,"pubmed1",4.68E+018,"testalpha"
,"cholesterol and high total","NN CC JJ NN",4,1,1,16479026,2,5.94E+018,"testalpha"
,"possible drug induced exanthema","JJ NN VBN NN",4,1,1,17106599,2,8.85E+018,"testalpha"
,"type and vehicle type","NN CC NN NN",4,1,1,16221468,"pubmed1",8.65E+016,"testalpha"
,"years at different institutions","NNS IN JJ NNS",4,1,1,16333710,"pubmed1",3.18E+018,"testalpha"
,"additional numerical aberrations inaddition","JJ JJ NNS NN",4,1,1,16914909,2,1.10E+018,"testalpha"
,"appeared h after transformationof","VBD  IN ",4,1,1,16582987,"pubmed1",3.95E+018,"testalpha"
,"influx andcellular signal transduction","NN JJ NN NN",4,1,1,16395521,"pubmed1",4.50E+018,"testalpha"
,"sirasapproach and electron density","NN CC NN NN",4,1,1,16511280,2,8.92E+017,"testalpha"
,"compound di mu acetato","NN   NN",4,1,1,16456276,2,8.23E+018,"testalpha"
,"thecentral c c single","JJ NN NN NN",4,1,1,16456295,2,1.16E+018,"testalpha"
,"dermatitis show active eczema","NN NN JJ NN",4,1,1,16648913,2,6.30E+018,"testalpha"
,"barrel cortex significant increases","NN NNP JJ NNS",4,1,1,17133958,2,5.06E+018,"testalpha"
,"parenchyma and pulmonary endothelium"," CC JJ NN",4,1,1,16537087,2,4.57E+018,"testalpha"
,"vacuolization in epidermal keratinocytes","NN IN JJ NNS",4,1,1,16574202,2,4.91E+018,"testalpha"
,"mrna in cultured mousespermatogonia"," IN VBN NNP",4,1,1,16395525,"pubmed1",2.46E+018,"testalpha"
,"alcohol related motor vehiclecasualties","NN VBN NN NNS",4,1,1,16169506,"pubmed1",7.89E+018,"testalpha"
,"protein dipeptidyl peptidase iv","NN  NN ",4,1,1,16929383,"pubmed1",2.75E+018,"testalpha"
,"venereal disease research laboratory","NN NN NN NN",4,1,1,16874420,2,5.84E+018,"testalpha"
,"closure under stress e","NN IN NN ",4,1,1,16962646,2,6.38E+018,"testalpha"
,"request and supplemental analgesic","NN CC JJ NN",4,1,1,16451144,"pubmed1",5.57E+018,"testalpha"
,"using primers from n","VBG NNS IN ",4,1,1,16696442,2,5.12E+018,"testalpha"
,"trips through taipei metro","NNS IN NNP NN",4,1,1,16434013,"pubmed1",6.39E+018,"testalpha"
,"patients f m withsymptoms","NNS NN  NNS",4,1,1,16479025,2,7.39E+018,"testalpha"
,"determination of extracellular enzyme","NN IN JJ ",4,1,1,16970980,2,3.54E+018,"testalpha"
,"times or mms scores","NNS CC  NNS",4,1,1,16451145,"pubmed1",5.84E+018,"testalpha"
,"folliculitis decalvans dissecting cellulitis","NN NNS VBG NN",4,1,1,17311739,2,7.34E+018,"testalpha"
,"fn patient foreach time"," NN NN NN",4,1,1,16436791,"pubmed1",1.46E+018,"testalpha"
,"stain conclusion gastric brushing","VB NN JJ NN",4,1,1,16514844,2,6.41E+018,"testalpha"
,"small airway growth media","JJ NN NN NNS",4,1,1,16395527,"pubmed1",4.97E+018,"testalpha"
,"oral administration of beta","JJ NN IN NN",4,1,1,16612917,"pubmed1",3.06E+018,"testalpha"
,"executive functioninpatients with hyperthyroidism","JJ NNS IN NN",4,1,1,16479025,2,7.99E+018,"testalpha"
,"determination of lesion size","NN IN NN NN",4,1,1,17007910,2,5.09E+018,"testalpha"
,"factors va and viiia","NNS  CC ",4,1,1,16549894,2,4.03E+018,"testalpha"
,"phenomenon of behavioural adaptation","NN IN JJ NN",4,1,1,16426558,"pubmed1",1.20E+018,"testalpha"
,"long time drawn interest","JJ NN VBN NN",4,1,1,16673565,2,4.97E+018,"testalpha"
,"withdukes c colon cancer","VBZ NN NN NN",4,1,1,17139902,2,5.97E+018,"testalpha"
,"progression pulmonary embolism thrombosis","NN JJ NN NN",4,1,1,16549899,2,1.21E+018,"testalpha"
,"cpa tested platelet function"," VBN NN NN",4,1,1,16549890,2,1.75E+018,"testalpha"
,"vs min ng ml","   ",4,1,1,17067137,"pubmed1",1.81E+018,"testalpha"
,"antiperoxidase immunohistochemicalprocedure for binding","NN NN IN NN",4,1,1,16714054,2,9.45E+017,"testalpha"
,"mg kg per day","  IN NN",4,1,1,16612918,"pubmed1",7.54E+018,"testalpha"
,"types of shell growth","NNS IN NN NN",4,1,1,16733064,2,5.44E+018,"testalpha"
,"images ofrectal and anal","NNS NN CC ",4,1,1,17139898,2,4.83E+018,"testalpha"
,"morbidity mortality andresource use","NN NN NN NN",4,1,1,16612906,2,6.45E+018,"testalpha"
,"promising source of neuralprogenitors","JJ NN IN NNS",4,1,1,17265690,2,3.93E+018,"testalpha"
,"ofnanoparticles with high relaxivity","NNS IN JJ NN",4,1,1,16411740,"pubmed1",8.71E+018,"testalpha"
,"myocardial iron deposition andthe","JJ NN NN NNP",4,1,1,16424659,2,6.39E+017,"testalpha"
,"affinity and ion exchange","NN CC  NN",4,1,1,16511253,2,4.44E+018,"testalpha"
,"materials and methods computationaltechniques","NNS CC NNS NNS",4,1,1,16399039,"pubmed1",7.58E+018,"testalpha"
,"transarterial injection pluscatheter method","JJ NN NN NN",4,1,1,16451159,"pubmed1",6.87E+018,"testalpha"
,"cell attachment proliferation morphology","NN NN NN NN",4,1,1,16701866,"pubmed1",6.99E+018,"testalpha"
,"process of protein structuralrefinement","NN IN NN NN",4,1,1,16421450,2,1.97E+017,"testalpha"
,"rates male sex dependency","NNS NN NN NN",4,1,1,16451146,"pubmed1",7.09E+018,"testalpha"
,"samples shows rugous roughness","NNS NNS JJ NN",4,1,1,17293968,2,2.90E+018,"testalpha"
,"wide range of clinicalpresentations","JJ NN IN NNS",4,1,1,17010262,2,5.47E+018,"testalpha"
,"seated passengers of cars","VBN NNS IN NNS",4,1,1,16426561,"pubmed1",9.07E+018,"testalpha"
,"patient care and resident","NN NN CC NN",4,1,1,16377824,"pubmed1",3.72E+018,"testalpha"
,"killed respiratory rate heart","VBN NN NN NN",4,1,1,16436797,"pubmed1",8.63E+018,"testalpha"
,"uterine sarcomas diagnostic procedures","NN NNP JJ NNS",4,1,1,17338203,2,8.77E+018,"testalpha"
,"volume of emergency care","NN IN NN NN",4,1,1,16365325,"pubmed1",3.29E+018,"testalpha"
,"resection for rectal cancer","NN IN NN NN",4,1,1,17139900,2,1.80E+018,"testalpha"
,"survival despite conventional therapy","NN IN JJ NN",4,1,1,16424661,2,2.73E+018,"testalpha"
,"severeards patients pao fio","NNS NNS  ",4,1,1,16451155,"pubmed1",8.98E+018,"testalpha"
,"necrosis factor tnf family","NN NN  NN",4,1,1,16511253,2,9.96E+017,"testalpha"
,"bm examination and therapy"," NN CC NN",4,1,1,16914909,2,2.04E+018,"testalpha"
,"frequent problem waspositive breath","JJ NN JJ NN",4,1,1,16236233,"pubmed1",4.94E+018,"testalpha"
,"activated protein c rhapc","VBN NN NN ",4,1,1,16365336,"pubmed1",2.23E+018,"testalpha"
,"double mutant k m","JJ JJ  ",4,1,1,16511247,2,2.87E+017,"testalpha"
,"differences inthe relative orientations","NNS NNP JJ NNS",4,1,1,16456276,2,3.93E+018,"testalpha"
,"hnrnp k protein levels","  NN NNS",4,1,1,16496041,"pubmed1",2.52E+018,"testalpha"
,"obtained results of u","VBN NNS IN ",4,1,1,16956119,2,3.53E+018,"testalpha"
,"relationship between diversityand classification","NN IN NN NN",4,1,1,16988905,"pubmed1",1.27E+018,"testalpha"
,"cohesive groups of cuboidal","JJ NNS IN NN",4,1,1,16514846,2,9.09E+018,"testalpha"
,"patients was similar being","NNS VBD JJ NN",4,1,1,16914906,2,5.54E+018,"testalpha"
,"interpersonal relationships and communicationpatterns","JJ NNS CC NNS",4,1,1,16596898,"pubmed1",2.08E+018,"testalpha"
,"narrowing of peripancreatic veins","NN IN JJ NNS",4,1,1,16333694,"pubmed1",3.09E+018,"testalpha"
,"principles of quality control","NNS IN NN NN",4,1,1,16999268,2,4.27E+018,"testalpha"
,"sport utilityvehicles and vans","NN NNS CC NNS",4,1,1,16197912,"pubmed1",4.89E+018,"testalpha"
,"complex regulation of theglyoxylate","JJ NN IN NN",4,1,1,17146497,"pubmed1",1.59E+018,"testalpha"
,"fragments identified twomulticopy suppressor","NNS VBN  NN",4,1,1,17146497,"pubmed1",1.66E+018,"testalpha"
,"imaging characteristics of multiplesolutions","VBG NNS IN NNS",4,1,1,16252139,"pubmed1",7.29E+018,"testalpha"
,"consequences because ofits involvement","NNS IN NNS NN",4,1,1,17013520,2,2.71E+018,"testalpha"
,"agents recombinant factor viia","NNS JJ NN ",4,1,1,16549892,2,8.57E+018,"testalpha"
,"rootstumps weeks after injury","NNS NNS IN NN",4,1,1,16414104,2,5.40E+018,"testalpha"
,"risk of head injury","NN IN NN NN",4,1,1,16417901,"pubmed1",6.09E+018,"testalpha"
,"shows asignificant positive correlation","NNS JJ JJ NN",4,1,1,16673610,2,8.99E+018,"testalpha"
,"total cholesterol hdl p","NN NN  ",4,1,1,17106515,"pubmed1",6.55E+018,"testalpha"
,"forty mice with lyme","NN  IN ",4,1,1,16399028,"pubmed1",1.57E+018,"testalpha"
,"maximum squeezepressure cm h","JJ NN  ",4,1,1,17139884,2,8.33E+018,"testalpha"
,"block of nociceptive inputs","NN IN JJ NNS",4,1,1,17236639,"pubmed1",6.47E+018,"testalpha"
,"role in cell adhesion","NN IN NN NN",4,1,1,16713618,2,4.86E+018,"testalpha"
,"bacteria in infected skin","NNS IN VBN NN",4,1,1,17293963,2,2.89E+018,"testalpha"
,"ofthermal injuries in slovakia","JJ NNS IN NNP",4,1,1,16999265,2,6.22E+018,"testalpha"
,"types of skin substitutes","NNS IN NN NNS",4,1,1,16999270,2,6.68E+018,"testalpha"
,"cells and fs cells","NNS CC  NNS",4,1,1,16569423,2,2.90E+018,"testalpha"
,"cre luc bearing activatingtranscription","  NN NN",4,1,1,16395528,"pubmed1",2.27E+018,"testalpha"
,"rate of cardivascularand cancer","NN IN NN NN",4,1,1,16696439,2,4.55E+018,"testalpha"
,"non significant p value"," JJ  NN",4,1,1,16479028,2,5.09E+018,"testalpha"
,"disorders altered regulation ofnf","NNS VBN NN ",4,1,1,17068636,"pubmed1",8.17E+017,"testalpha"
,"respiratory tracts of newborns","NN NNS IN NNS",4,1,1,17019441,"pubmed1",7.36E+018,"testalpha"
,"interleukin and haem oxygenase","NNP CC  NN",4,1,1,16770444,"pubmed1",8.63E+018,"testalpha"
,"pepsinogen activation into pepsin","NN NN IN NNP",4,1,1,16770446,"pubmed1",5.52E+018,"testalpha"
,"inquiry concerninghaemorrhoids anal fissure","NN NNS  NN",4,1,1,16673559,2,3.89E+018,"testalpha"
,"wall using anilino naphthalene","NN VBG NNP NN",4,1,1,16714053,2,6.58E+018,"testalpha"
,"establishes natural defence mechanisms","VBZ JJ NN NNS",4,1,1,16648910,2,5.87E+018,"testalpha"
,"cetirizine mg p o","NN   ",4,1,1,16696448,2,7.09E+018,"testalpha"
,"cord blood derivedcd cells","NN NN  NNS",4,1,1,17265691,2,5.22E+018,"testalpha"
,"parameters of surfacecoverage sc","NNS IN NN ",4,1,1,16549890,2,3.09E+018,"testalpha"
,"electrocardiogram phecg interpretation andadvance","NN  NN NN",4,1,1,16365334,"pubmed1",5.32E+017,"testalpha"
,"atime period of months","JJ NN IN NNS",4,1,1,16603096,2,6.39E+018,"testalpha"
,"blood stem cells pb","NN VB NNS ",4,1,1,16914909,2,2.54E+018,"testalpha"
,"chemical cross linking agents","NN VB VBG NNS",4,1,1,16565748,"pubmed1",9.14E+018,"testalpha"
,"increase hospital functional capacity","NN NN JJ NN",4,1,1,16377816,"pubmed1",6.73E+018,"testalpha"
,"morphological features of pituitary","JJ NNS IN NN",4,1,1,16714054,2,5.92E+018,"testalpha"
,"acid desaturase in p","NN NN IN ",4,1,1,17063209,"pubmed1",7.24E+018,"testalpha"
,"tomography guide fine needleaspiration","NN NN JJ NN",4,1,1,16514848,2,6.28E+018,"testalpha"
,"similar unit cell parameters","JJ NN NN NNS",4,1,1,16511254,2,5.48E+018,"testalpha"
,"bypass graft cabg patients","VB NN  NNS",4,1,1,16451151,"pubmed1",8.66E+018,"testalpha"
,"weeks and x iu","NNS CC NN ",4,1,1,16256175,2,4.29E+018,"testalpha"
,"day fatality adjustment factors","NN NN NN NNS",4,1,1,16430844,"pubmed1",3.56E+018,"testalpha"
,"assembly in organic matrices","NN IN JJ NNS",4,1,1,16701861,"pubmed1",1.16E+018,"testalpha"
,"salineor ami g kg","   ",4,1,1,16594642,"pubmed1",6.63E+018,"testalpha"
,"cells with large numbers","NNS IN JJ NNS",4,1,1,16414103,2,4.26E+018,"testalpha"
,"l methionyl l serine"," NN  NN",4,1,1,16397334,2,4.93E+018,"testalpha"
,"oligomeric alphabeta alphabeta interface","JJ NN NN NN",4,1,1,17143335,"pubmed1",9.12E+018,"testalpha"
,"decrease for total motorvehicle","NN IN JJ NN",4,1,1,16169506,"pubmed1",8.43E+018,"testalpha"
,"mkn nugc and panc","  CC ",4,1,1,17143338,"pubmed1",2.75E+018,"testalpha"
,"proliferation anddifferentiation of rat","NN NN IN NN",4,1,1,16443258,2,6.97E+017,"testalpha"
,"saline solution group hss","NN NN NN ",4,1,1,16491220,2,4.04E+018,"testalpha"
,"relationship between pd l","NN IN  ",4,1,1,16530813,2,6.19E+018,"testalpha"
,"sustained release pharmacokinetic profile","VBN NN JJ NN",4,1,1,16584139,"pubmed1",2.89E+018,"testalpha"
,"degrees x ray diffraction","NNS NN  NN",4,1,1,16511275,2,8.77E+018,"testalpha"
,"diameters of type i","NNS IN NN ",4,1,1,16919313,2,7.38E+018,"testalpha"
,"predictors of response tosplenectomy","NNS IN NN NN",4,1,1,16424648,2,1.60E+017,"testalpha"
,"presence of food sige","NN IN NN ",4,1,1,16673562,2,3.89E+018,"testalpha"
,"growth factors citocins prostaglandins","NN NNS NNS NNS",4,1,1,17013515,2,7.62E+018,"testalpha"
,"cytoplasmic ratios andpleomorphic nuclei","JJ NNS JJ ",4,1,1,16514847,2,1.96E+018,"testalpha"
,"mild tbiwhen accurate case","JJ NNP JJ NN",4,1,1,16365331,"pubmed1",8.09E+018,"testalpha"
,"example sulfonamide induced dhrs","NN VB VBN ",4,1,1,16594644,"pubmed1",6.54E+018,"testalpha"
,"malignancies or gastrointestinal tract","NNS CC JJ NN",4,1,1,17010267,2,3.17E+018,"testalpha"
,"mean duration of treatment","JJ NN IN NN",4,1,1,16549901,2,1.01E+017,"testalpha"
,"completion of bupivacaine infusion","NN IN NN NN",4,1,1,17067137,"pubmed1",8.13E+018,"testalpha"
,"syndrome and congenital adrenal","NN CC NN NN",4,1,1,16245020,"pubmed1",8.57E+017,"testalpha"
,"outcome in mcao rats","NN IN  NNS",4,1,1,17265691,2,4.28E+018,"testalpha"
,"delayed bythe sodic diclofenac","VBN NNP JJ NN",4,1,1,17293965,2,7.66E+018,"testalpha"
,"radiologic findings of autoimmune","JJ NNS IN NN",4,1,1,16333694,"pubmed1",1.37E+018,"testalpha"
,"nest building after test","NN NN IN NN",4,1,1,17265693,2,2.22E+018,"testalpha"
,"d glucosaminidase u nag"," NN  ",4,1,1,16956119,2,5.56E+018,"testalpha"
,"rna mrna directs thecreation","  VBZ NN",4,1,1,17294912,2,6.68E+018,"testalpha"
,"tablet zidovir cipla ltd","NN   ",4,1,1,16584139,"pubmed1",2.81E+018,"testalpha"
,"cost of providing treatment","NN IN VBG NN",4,1,1,16424646,2,5.81E+018,"testalpha"
,"underwent laparotomy without artery","NN NN IN NN",4,1,1,17293970,2,8.86E+018,"testalpha"
,"r ly r cell","NN  NN NN",4,1,1,16404475,"pubmed1",3.02E+018,"testalpha"
,"carotid sinus nerves csns"," NN NNS ",4,1,1,17133957,2,4.34E+018,"testalpha"
,"cord blood haemoglobinand haematocrit","NN NN NN NN",4,1,1,16809888,2,3.97E+018,"testalpha"
,"product accident investigation hum","NN NN NN NN",4,1,1,16434013,"pubmed1",4.29E+017,"testalpha"
,"true differences indissolution rates","JJ NNS NN NNS",4,1,1,16594638,"pubmed1",8.65E+018,"testalpha"
,"toeducation and clinical care","NN CC JJ NN",4,1,1,16473991,"pubmed1",5.14E+018,"testalpha"
,"recent years considerable attention","JJ NNS JJ NN",4,1,1,16411737,"pubmed1",7.10E+018,"testalpha"
,"bondingnetwork perdeuterated hca ii","NN VBN  ",4,1,1,16511248,2,5.88E+018,"testalpha"
,"nature alsomakes mechanistic studies","NN VBZ JJ NNS",4,1,1,16594644,"pubmed1",3.40E+018,"testalpha"
,"risk intermediate high hi","NN JJ JJ ",4,1,1,16424644,2,8.14E+018,"testalpha"
,"mdct images active gi"," NNS JJ ",4,1,1,16333701,"pubmed1",6.57E+018,"testalpha"
,"postal questionnaire skin prick","JJ NN NN NNP",4,1,1,16648913,2,3.36E+018,"testalpha"
,"antiviral treatment in plants","JJ NN IN NNS",4,1,1,16395523,"pubmed1",1.20E+018,"testalpha"
,"situations illegal unsafe speed","NNS JJ NN NN",4,1,1,16423319,"pubmed1",1.36E+018,"testalpha"
,"prospective multicenter randomized trial","JJ NN VBN NN",4,1,1,16424644,2,2.98E+018,"testalpha"
,"esi liquid chromatography mass"," JJ NN NN",4,1,1,17285740,"pubmed1",5.10E+018,"testalpha"
,"results fromanalysis of variance","NNS NN IN NN",4,1,1,17293963,2,5.58E+018,"testalpha"
,"part aconstitutive law representative","NN JJ NN NN",4,1,1,16701859,"pubmed1",5.12E+018,"testalpha"
,"treatedusing donor lymphocyte infusion","VBG NN NNP NN",4,1,1,16914909,2,6.62E+018,"testalpha"
,"likelihoodgeneralized linear regression analyses","VBN JJ NN NNS",4,1,1,16202466,"pubmed1",3.79E+018,"testalpha"
,"time trend and space","NN NN CC NN",4,1,1,16451795,"pubmed1",2.72E+018,"testalpha"
,"renal vessels for min","JJ NNS IN ",4,1,1,16764913,2,1.76E+018,"testalpha"
,"infection management and impact","NN NN CC NN",4,1,1,16612906,2,1.16E+016,"testalpha"
,"preventing catheter related thrombosis","VBG NN VBN NN",4,1,1,16549897,2,5.33E+018,"testalpha"
,"helping trainees developmoral agency","VBG NNS JJ NN",4,1,1,16473995,"pubmed1",6.48E+018,"testalpha"
,"basic properties of undulator","JJ NNS IN NN",4,1,1,16369095,2,2.24E+018,"testalpha"
,"dcl provided clearer fluorescent"," VBN JJR NN",4,1,1,16714053,2,6.23E+018,"testalpha"
,"high injury severity scores","JJ NN NN NNS",4,1,1,16549896,2,3.77E+018,"testalpha"
,"insufficiency and acute distress","NN CC JJ NN",4,1,1,16365327,"pubmed1",2.49E+018,"testalpha"
,"sheath giant cell tumor","NN NN NN NN",4,1,1,16514850,2,2.25E+018,"testalpha"
,"n and untranslated region"," CC VBN NN",4,1,1,16696442,2,5.21E+017,"testalpha"
,"patient with acute leukaemia","NN IN JJ NN",4,1,1,16918059,"pubmed1",6.42E+018,"testalpha"
,"evaluation apache iii scores","NN NNP  NNS",4,1,1,17117607,2,2.18E+018,"testalpha"
,"ultrasound in check upexamination","NN IN NN NN",4,1,1,17438838,2,8.46E+018,"testalpha"
,"lesions yielded purulent material","NNS VBD NN NN",4,1,1,16447096,"pubmed1",2.20E+018,"testalpha"
,"typical bond lengthsand angles","JJ NN NN NNS",4,1,1,16456289,2,3.98E+018,"testalpha"
,"questionnaire probed faculty work","NN VBD NN NN",4,1,1,16377820,"pubmed1",7.48E+018,"testalpha"
,"co atp and cyt","  CC ",4,1,1,16389406,"pubmed1",4.58E+018,"testalpha"
,"non gypsy andone parent"," NN NN NN",4,1,1,17165598,2,6.33E+018,"testalpha"
,"skin lesions of ad","NN NNS IN NN",4,1,1,16603095,2,6.32E+018,"testalpha"
,"ofdiverticulitis require surgical procedure","NN VB JJ NN",4,1,1,17338195,2,6.59E+018,"testalpha"
,"end terminals are devices","NN NNS VBP NNS",4,1,1,16054101,"pubmed1",4.13E+018,"testalpha"
,"changes in thesite site","NNS IN JJ NN",4,1,1,17019442,"pubmed1",9.22E+017,"testalpha"
,"degree of renal dysfunction","NN IN JJ NN",4,1,1,17016034,2,9.21E+018,"testalpha"
,"nasal speech and aspiration","NN NN CC NN",4,1,1,16673615,2,4.19E+017,"testalpha"
,"composition healthystatus and energy","NN NN CC NN",4,1,1,16918067,"pubmed1",5.89E+018,"testalpha"
,"fibroblasts vessel neoformation fibrosisand","NNS NN NN NN",4,1,1,17293959,2,5.58E+018,"testalpha"
,"review research on depictions","VB NN IN NNS",4,1,1,16474001,"pubmed1",4.01E+018,"testalpha"
,"cr and bun levels"," CC  NNS",4,1,1,16999986,2,9.19E+018,"testalpha"
,"induced e coli cells","VBN   NNS",4,1,1,16582987,"pubmed1",7.75E+018,"testalpha"
,"twofold rotation axis bridgesthe","JJ NN  NNP",4,1,1,16456283,2,5.35E+018,"testalpha"
,"enzyme in adenosine metabolism"," IN NN NN",4,1,1,16421444,2,2.95E+018,"testalpha"
,"angina myocardialinfarction and heart","NN NN CC NN",4,1,1,17014894,2,4.36E+018,"testalpha"
,"receiving small bowel resection","VBG JJ NN NN",4,1,1,17293957,2,4.84E+018,"testalpha"
,"relative risk for drivers","JJ NN IN NNS",4,1,1,16054104,"pubmed1",9.08E+018,"testalpha"
,"ige than control subjects"," IN NN NNS",4,1,1,16859613,2,4.14E+018,"testalpha"
,"artery bypass graft cabg","NN VB NN ",4,1,1,16451151,"pubmed1",3.41E+018,"testalpha"
,"hour requirements patient care","NN NNS NN NN",4,1,1,16377824,"pubmed1",9.09E+018,"testalpha"
,"dosage ofperoral glucocorticosteroid sulfasalazine","NN JJ VB NN",4,1,1,16603100,2,1.46E+018,"testalpha"
,"root mean square rms","NN VB NN ",4,1,1,16399039,"pubmed1",8.69E+018,"testalpha"
,"crashes while driverinattention distraction","NNS IN NN NN",4,1,1,16423319,"pubmed1",7.95E+016,"testalpha"
,"breast cancer clinical practice","NN NN JJ NN",4,1,1,16596895,"pubmed1",7.82E+018,"testalpha"
,"risk of ocular complications","NN IN JJ NNS",4,1,1,16955189,2,1.66E+017,"testalpha"
,"light and electron microscopic","NN CC NN NN",4,1,1,16714049,2,1.85E+018,"testalpha"
,"cirrhosis and thepreventive strategies","NN CC JJ NNS",4,1,1,17013520,2,7.09E+018,"testalpha"
,"falls n and burns","VBZ  CC NNS",4,1,1,16412373,"pubmed1",7.18E+017,"testalpha"
,"correlations with waist circumference","NNS IN NN NN",4,1,1,16673610,2,2.81E+018,"testalpha"
,"iii score and presence"," NN CC NN",4,1,1,17117607,2,8.92E+018,"testalpha"
,"thepancreatic cancer cell line","JJ NN NN NN",4,1,1,17143338,"pubmed1",5.35E+017,"testalpha"
,"chronic dermatologicaldiseases on quality","JJ NNS IN NN",4,1,1,16710574,2,3.40E+018,"testalpha"
,"significant difference for p","JJ NN IN ",4,1,1,17013507,2,4.65E+018,"testalpha"
,"morphology and patient skin","NN CC NN NN",4,1,1,16722347,2,3.91E+018,"testalpha"
,"systems adas related measures","NNS  VBN NNS",4,1,1,16406188,"pubmed1",3.33E+018,"testalpha"
,"colon cancer ht cells","NN NN  NNS",4,1,1,16733561,"pubmed1",1.47E+018,"testalpha"
,"followed bya consequent formation","VBD  NN NN",4,1,1,16696441,2,9.04E+018,"testalpha"
,"capsule like rim enhancement","NN IN NN NN",4,1,1,16333694,"pubmed1",5.42E+018,"testalpha"
,"relationship between breslow thicknessand","NN IN VB NN",4,1,1,16585990,2,2.11E+018,"testalpha"
,"lyme arthritis and controls"," NN CC NNS",4,1,1,16399028,"pubmed1",4.47E+018,"testalpha"
,"bupivacaine or clonidine microg","NN CC NN NNP",4,1,1,17236639,"pubmed1",1.59E+018,"testalpha"
,"control of bleeding splenectomy","NN IN VBG NN",4,1,1,16424649,2,8.65E+015,"testalpha"
,"transformation and give rise","NN CC VB NN",4,1,1,17265694,2,8.12E+018,"testalpha"
,"hen egg white lysozyme","NN NN JJ ",4,1,1,16770442,"pubmed1",7.83E+018,"testalpha"
,"arange of ph values","NN IN  NNS",4,1,1,16996581,2,4.58E+018,"testalpha"
,"developing ina parallel fashion","VBG  JJ NN",4,1,1,16369088,2,2.19E+018,"testalpha"
,"increased use of betablockers","VBN NN IN NNS",4,1,1,16377816,"pubmed1",6.17E+018,"testalpha"
,"media inhibited scaffold degradation","NNS VBN JJ NN",4,1,1,16701855,"pubmed1",8.21E+018,"testalpha"
,"showeda high physical stability","NNP JJ JJ NN",4,1,1,16584150,"pubmed1",7.25E+018,"testalpha"
,"closing time and ontario","VBG NN CC NNP",4,1,1,16169506,"pubmed1",3.95E+018,"testalpha"
,"thesurgical management of colorectal","JJ NN IN NN",4,1,1,17139901,2,9.18E+018,"testalpha"
,"circular contralateral areas cm","JJ JJ NNS ",4,1,1,16585985,2,6.91E+018,"testalpha"
,"ser ile lys glu","   ",4,1,1,16496040,"pubmed1",2.07E+018,"testalpha"
,"using interactive color intensity","VBG JJ NN NN",4,1,1,16399038,"pubmed1",5.00E+018,"testalpha"
,"type diabetes dyslipidemia kidney","NN NN NN NN",4,1,1,16479031,2,1.21E+017,"testalpha"
,"availability and accessibilityof breast","NN CC  NN",4,1,1,16596895,"pubmed1",5.85E+016,"testalpha"
,"elapid envenomations naja naja","JJ NNS  ",4,1,1,16436788,"pubmed1",1.96E+018,"testalpha"
,"pennsylvania school of medicine","NNP NN IN NN",4,1,1,16377826,"pubmed1",4.34E+018,"testalpha"
,"role further improve dio","NN JJ VB ",4,1,1,16377812,"pubmed1",2.58E+018,"testalpha"
,"acupressure at sham points","NN IN  NNS",4,1,1,16365322,"pubmed1",5.38E+018,"testalpha"
,"deformation of thelung tissue","NN IN JJ NN",4,1,1,16399039,"pubmed1",2.38E+018,"testalpha"
,"transdifferentiation of fibroblasts intomyofibroblasts","NN IN NNS NNS",4,1,1,16395524,"pubmed1",2.36E+018,"testalpha"
,"anal resting pressure marp"," VBG NN ",4,1,1,16612915,"pubmed1",8.55E+018,"testalpha"
,"theprevalence of traffic problems","NN IN NN NNS",4,1,1,16236233,"pubmed1",9.00E+018,"testalpha"
,"enzymatic properties endogenous tsp","JJ NNS JJ ",4,1,1,16505899,"pubmed1",9.69E+017,"testalpha"
,"afunction of storage time","NN IN NN NN",4,1,1,17285747,"pubmed1",3.00E+018,"testalpha"
,"seen onthe initial examinations","VBN NNP JJ NNS",4,1,1,16333694,"pubmed1",6.94E+018,"testalpha"
,"world of dermatology publications","NN IN NN NNS",4,1,1,17106594,2,5.56E+018,"testalpha"
,"examination and thorax radiography","NN CC  NN",4,1,1,16696444,2,7.67E+018,"testalpha"
,"dipotassium i k c","NN   NN",4,1,1,16397335,2,3.67E+018,"testalpha"
,"burnoutinventory and working conditions","NN CC VBG NNS",4,1,1,16451152,"pubmed1",3.61E+016,"testalpha"
,"ofdna dependent protein kinase"," JJ NN NN",4,1,1,16404475,"pubmed1",8.75E+018,"testalpha"
,"n acetyltryptophanate and nacl"," NN CC ",4,1,1,17285745,"pubmed1",8.28E+018,"testalpha"
,"g r exon nt"," NN  ",4,1,1,16424658,2,6.97E+017,"testalpha"
,"h o by anorectal","  IN NN",4,1,1,17139884,2,1.53E+018,"testalpha"
,"self efficacy odds ratio","NN NN NNS NN",4,1,1,16365327,"pubmed1",9.22E+018,"testalpha"
,"decrease and treatment withhcg","NN CC NN ",4,1,1,16714054,2,8.45E+018,"testalpha"
,"simulate patient positioning errors","NN NN VBG NNS",4,1,1,16399029,"pubmed1",4.56E+016,"testalpha"
,"inelastic response of bone","JJ NN IN NN",4,1,1,16701859,"pubmed1",3.17E+018,"testalpha"
,"high grade squamousintraepithelial lesion","JJ NN JJ NN",4,1,1,16514840,2,3.27E+018,"testalpha"
,"light trucks sport utilityvehicles","NN NNS NN NNS",4,1,1,16197912,"pubmed1",5.95E+018,"testalpha"
,"genital ulcer appearing beforespecific","NN NN VBG NNP",4,1,1,16955191,2,1.30E+017,"testalpha"
,"protein kinase c ormicrotubule","NN NN NN NN",4,1,1,17265696,2,7.91E+018,"testalpha"
,"role fordifferentiation during skeletal","NN NN IN NN",4,1,1,16965805,2,5.83E+018,"testalpha"
,"n acetyl beta d","  NN ",4,1,1,16956119,2,5.26E+018,"testalpha"
,"myc e f cyclins","  NN NNS",4,1,1,17115080,"pubmed1",5.77E+018,"testalpha"
,"group i and ii","NN  CC ",4,1,1,17293966,2,7.76E+018,"testalpha"
,"screening inafrican american population","NN JJ JJ NN",4,1,1,16596899,"pubmed1",2.38E+018,"testalpha"
,"changes in lung function","NNS IN NN NN",4,1,1,16809886,2,1.68E+018,"testalpha"
,"acupuncture by objective measures","NN IN NN NNS",4,1,1,16955182,2,1.13E+018,"testalpha"
,"therapy with inosiplex isoprinosine","NN IN JJ NN",4,1,1,16955187,2,9.15E+018,"testalpha"
,"effective alternative tounfractioned heparins","JJ NN VBN NNS",4,1,1,16549901,2,3.47E+018,"testalpha"
,"enzyme activity intracellular activity"," NN JJ NN",4,1,1,16970980,2,7.30E+018,"testalpha"
,"proposed scale up rules","VBN NN IN NNS",4,1,1,17285748,"pubmed1",2.13E+018,"testalpha"
,"time standards for countingthe","NN NNS IN NNP",4,1,1,16430844,"pubmed1",4.46E+018,"testalpha"
,"invasion lymph node metastasis","NN NN  NN",4,1,1,16530813,2,9.03E+018,"testalpha"
,"function in psoriatic patients","NN IN JJ NNS",4,1,1,16874421,2,6.41E+018,"testalpha"
,"source of free iron","NN IN JJ NN",4,1,1,17143336,"pubmed1",1.74E+018,"testalpha"
,"better substrate of dck","JJR NN IN ",4,1,1,16421443,2,4.95E+018,"testalpha"
,"bonds and adjacent chains","NNS CC JJ NNS",4,1,1,16456294,2,3.10E+018,"testalpha"
,"family despite extensive investigation","NN IN JJ NN",4,1,1,16673558,2,6.14E+018,"testalpha"
,"medications total parenteral nutrition","NNS JJ JJ NN",4,1,1,16549897,2,7.17E+018,"testalpha"
,"issues driving pharmaceutical productivity","NNS VBG JJ NN",4,1,1,16596744,"pubmed1",2.62E+018,"testalpha"
,"color doppler ultrasound findings","NN NN NN NNS",4,1,1,16333710,"pubmed1",8.16E+017,"testalpha"
,"forsplit thickness skin grafts","NN NN NN NNS",4,1,1,17165596,2,3.66E+018,"testalpha"
,"unc levels at synapses"," NNS IN NNS",4,1,1,16496042,"pubmed1",3.92E+018,"testalpha"
,"distinct change in theirappearances","JJ NN IN NNS",4,1,1,16245020,"pubmed1",1.11E+018,"testalpha"
,"data from visualanalog scales","NN IN NN NNS",4,1,1,16436796,"pubmed1",3.95E+018,"testalpha"
,"radiation inducedwound healing inhibition","NN NN VBG NN",4,1,1,16612919,"pubmed1",7.20E+018,"testalpha"
,"assessment ofcontrast enhancement patterns","NN JJS NN NNS",4,1,1,16333704,"pubmed1",5.45E+018,"testalpha"
,"type of tracheostomy pdt","NN IN NN ",4,1,1,16451156,"pubmed1",5.60E+018,"testalpha"
,"ions and solvent molecules"," CC NN NNS",4,1,1,16397333,2,6.76E+018,"testalpha"
,"patient characteristics underlying diagnosis","NN NNS VBG NN",4,1,1,16549897,2,5.92E+018,"testalpha"
,"general patients with gid","JJ NNS IN ",4,1,1,17139890,2,4.09E+018,"testalpha"
,"thepresumed stevens johnson syndrome","VBN NNS NN NN",4,1,1,16603101,2,4.84E+018,"testalpha"
,"ventilation with bag valve","NN IN NN NN",4,1,1,16365337,"pubmed1",2.82E+018,"testalpha"
,"support units alsu doctor","NN NNS  NN",4,1,1,16491215,2,6.60E+018,"testalpha"
,"manometric temperature measurement mtm","JJ NN NN ",4,1,1,17285744,"pubmed1",8.74E+018,"testalpha"
,"clinical recovery direct drugacquisition","JJ NN JJ NN",4,1,1,16451145,"pubmed1",1.12E+018,"testalpha"
,"c c n c","NN NN  NN",4,1,1,16456282,2,1.62E+017,"testalpha"
,"diagnosticinterpretation of mammographic calcifications","NN IN JJ NNS",4,1,1,16399036,"pubmed1",7.14E+018,"testalpha"
,"uncommon association in terms","JJ NN IN NNS",4,1,1,16424653,2,2.56E+018,"testalpha"
,"full time academic physicians","JJ NN JJ NNS",4,1,1,16377815,"pubmed1",5.85E+018,"testalpha"
,"prick test spt results","NNP NN  NNS",4,1,1,16859611,2,5.87E+018,"testalpha"
,"conclusion intravenous iron therapy","NN JJ NN NN",4,1,1,16809890,2,4.05E+018,"testalpha"
,"c ormicrotubule associated proteins","NN NN VBN NNS",4,1,1,17265696,2,9.22E+018,"testalpha"
,"d analogs retinoids tars"," NNS NNS ",4,1,1,17010269,2,6.22E+018,"testalpha"
,"drug induced hypersensitivity reactions","NN VBN NN NNS",4,1,1,16594644,"pubmed1",2.58E+018,"testalpha"
,"form virus like particles","VB NN IN NNS",4,1,1,16733562,"pubmed1",3.94E+018,"testalpha"
,"regional myocardialischemia and reperfusion","JJ NN CC NN",4,1,1,16451157,"pubmed1",1.24E+018,"testalpha"
,"low attenuation oral contrast","JJ NN JJ NN",4,1,1,16252139,"pubmed1",1.52E+018,"testalpha"
,"dose dependent inhibitory effect","NN JJ NN NN",4,1,1,16648912,2,6.54E+018,"testalpha"
,"lipid levels characterize metabolicsyndrome","NN NNS VB NN",4,1,1,16462412,"pubmed1",5.37E+018,"testalpha"
,"i r induced damage"," NN VBN NN",4,1,1,16764913,2,8.20E+018,"testalpha"
,"comparisonwith predicted internal displacements","NN VBD JJ NNS",4,1,1,16399039,"pubmed1",5.51E+018,"testalpha"
,"serial pcr for hpvclearance","JJ  IN NN",4,1,1,16514834,2,1.58E+018,"testalpha"
,"impact on patients outcome","NN IN NNS NN",4,1,1,16612906,2,4.09E+018,"testalpha"
,"square and multivariate analysis","NN CC NN NN",4,1,1,16479026,2,3.11E+018,"testalpha"
,"tumor types and controls","NN NNS CC NNS",4,1,1,16899283,2,8.09E+018,"testalpha"
,"leukemia cells recent studies","NN NNS JJ NNS",4,1,1,16809887,2,7.83E+018,"testalpha"
,"prednisolone thp cop incombination","NN  NN NN",4,1,1,17119328,2,3.46E+018,"testalpha"
,"concentrations of matrix metalloproteinase","NNS IN NNP NN",4,1,1,16585983,2,4.92E+018,"testalpha"
,"presence of severe liver","NN IN JJ NN",4,1,1,16424659,2,6.06E+018,"testalpha"
,"state of manganese catalase","NN IN NN NN",4,1,1,16456265,2,5.99E+018,"testalpha"
,"encourage physicians healthcare providers","VB NNS NN NNS",4,1,1,16365322,"pubmed1",7.42E+018,"testalpha"
,"n with azoxymethaneadministration aom"," IN NN ",4,1,1,17293962,2,3.05E+018,"testalpha"
,"blocks byinverted filter sedimentation","NNS VBN NN NN",4,1,1,16514842,2,9.99E+017,"testalpha"
,"was months and platelet","VBD NNS CC NN",4,1,1,16424649,2,8.66E+018,"testalpha"
,"adulttissues by other investigators","NNS IN JJ NNS",4,1,1,17265694,2,2.17E+018,"testalpha"
,"mothers withpregnancy induced hypertension","NNS NN VBN NN",4,1,1,16549889,2,2.84E+018,"testalpha"
,"treating patients withimatinib mesylate","VBG NNS  NN",4,1,1,16809884,2,3.31E+018,"testalpha"
,"modern data processing program","JJ NN NN NN",4,1,1,16369093,2,8.80E+016,"testalpha"
,"years mean age years","NNS VBP NN NNS",4,1,1,16333710,"pubmed1",9.41E+017,"testalpha"
,"detailed temperature and ph","VBN NN CC ",4,1,1,17117212,"pubmed1",8.73E+018,"testalpha"
,"fromcardiovascular system samples blood","JJ NN NNS NN",4,1,1,17311736,2,5.56E+018,"testalpha"
,"full understanding of variouscharacteristics","JJ NN IN NNS",4,1,1,16426557,"pubmed1",5.68E+018,"testalpha"
,"nutrition exercise and physicalactivity","NN NN CC NN",4,1,1,16596897,"pubmed1",3.09E+018,"testalpha"
,"morphological distance between plant","JJ NN IN NN",4,1,1,17486414,"pubmed1",4.88E+018,"testalpha"
,"defined pathology characteristic manometricfeatures","VBN NN NN NNS",4,1,1,17338194,2,5.85E+017,"testalpha"
,"sugars and different phconditions","NNS CC JJ NNS",4,1,1,16730370,2,7.91E+018,"testalpha"
,"testis until postoperation day","NN IN NN NN",4,1,1,16395525,"pubmed1",7.29E+018,"testalpha"
,"pulmonarymucormycosis and liposomal amphotericin","NN CC JJ NNP",4,1,1,16918065,"pubmed1",8.98E+018,"testalpha"
,"work strain and job","NN NN CC NN",4,1,1,16377815,"pubmed1",4.19E+018,"testalpha"
,"expressed vp gene inthe","VBN   NNP",4,1,1,16733562,"pubmed1",1.18E+018,"testalpha"
,"themechanisms of cytotoxic effects","NNS IN JJ NNS",4,1,1,16424655,2,8.14E+018,"testalpha"
,"conclusion patent blue dye","NN NN JJ ",4,1,1,16491216,2,3.20E+018,"testalpha"
,"intermediate beta thalassemia males","JJ NN NN NNS",4,1,1,16809886,2,4.19E+018,"testalpha"
,"engineering replication transcription translation","NN NN NN NN",4,1,1,17347785,"pubmed1",3.77E+018,"testalpha"
,"mm and renal failure"," CC JJ NN",4,1,1,17119326,2,4.43E+018,"testalpha"
,"pyridylamino aminomethyl methylphenol h","NNP  NN ",4,1,1,16456265,2,9.84E+017,"testalpha"
,"practical hints are providedto","JJ NNS VBP ",4,1,1,16921609,"pubmed1",7.43E+018,"testalpha"
,"cereals grains and legumes","NNS NNS CC NNS",4,1,1,16673562,2,6.87E+018,"testalpha"
,"statistical analysis results ioversol","JJ NN NNS NNP",4,1,1,16399037,"pubmed1",6.09E+017,"testalpha"
,"regulation of pfkfb andpfkfb","NN IN  ",4,1,1,17143338,"pubmed1",1.31E+018,"testalpha"
,"rejection in different animal","NN IN JJ NN",4,1,1,16701881,"pubmed1",3.08E+018,"testalpha"
,"week themedian percentage changes","NN JJ NN NNS",4,1,1,16585986,2,5.72E+018,"testalpha"
,"human thyroid gland specimens","JJ NN NN NNS",4,1,1,16720036,2,5.79E+018,"testalpha"
,"withgranulocyte colony stimulating factor","NNP NN JJ NN",4,1,1,17119324,2,4.81E+018,"testalpha"
,"pattern in weight evolution","NN IN NN NN",4,1,1,17293957,2,5.74E+018,"testalpha"
,"donor strand complemented variant","NN NN VBN NN",4,1,1,16511280,2,7.23E+018,"testalpha"
,"pair substitutions and cc","NN NNS CC ",4,1,1,16733554,"pubmed1",4.15E+018,"testalpha"
,"aneurysmal disease aortic sarcomas","JJ NN JJ NNP",4,1,1,16314988,"pubmed1",2.12E+018,"testalpha"
,"oral chemotherapy and underwent","JJ NN CC NN",4,1,1,16914906,2,5.44E+018,"testalpha"
,"vaccine for hepatitis virusc","NN IN NN ",4,1,1,17013520,2,4.85E+018,"testalpha"
,"clinical response of patients","JJ NN IN NNS",4,1,1,16549892,2,3.48E+018,"testalpha"
,"thegrowing season new corneocytes","VBG NN JJ NNS",4,1,1,16733064,2,3.88E+017,"testalpha"
,"development of novel cancer","NN IN NN NN",4,1,1,16388313,"pubmed1",4.55E+018,"testalpha"
,"cancer pathology breast cancer","NN NN NN NN",4,1,1,16596895,"pubmed1",7.15E+018,"testalpha"
,"coding sequence of adarb","VBG NN IN ",4,1,1,16733555,"pubmed1",3.48E+018,"testalpha"
,"theinternal review and staff","JJ NN CC NN",4,1,1,16321534,"pubmed1",9.06E+018,"testalpha"
,"perfusion pressure management brain","NN NN NN NN",4,1,1,17067134,"pubmed1",1.14E+018,"testalpha"
,"patients with cardiac complications","NNS IN JJ NNS",4,1,1,16424656,2,7.29E+018,"testalpha"
,"value of educational activities","NN IN JJ NNS",4,1,1,16377825,"pubmed1",5.47E+017,"testalpha"
,"uterus werelocalised using tunel","NN VBN VBG NN",4,1,1,16584758,2,1.99E+018,"testalpha"
,"event in re pigmentation","NN IN  NN",4,1,1,17106595,2,1.08E+016,"testalpha"
,"somecases appearance of membrane","NNS NN IN NN",4,1,1,16956122,2,1.69E+018,"testalpha"
,"cin or worsewas specificity"," CC  NN",4,1,1,16514835,2,7.12E+017,"testalpha"
,"annual rate of change","JJ NN IN NN",4,1,1,16111641,"pubmed1",6.63E+018,"testalpha"
,"ilma laryngeal tube lt"," NN NN ",4,1,1,16451149,"pubmed1",8.63E+017,"testalpha"
,"drug development andtherapeutic decision","NN NN JJ NN",4,1,1,16596744,"pubmed1",6.34E+018,"testalpha"
,"group m received saline","NN  VBD NN",4,1,1,17067136,"pubmed1",7.88E+018,"testalpha"
,"self reported behavior questions","NN VBN NN NNS",4,1,1,16377828,"pubmed1",8.41E+018,"testalpha"
,"climate measures asstatistical controls","NN NNS JJ NNS",4,1,1,16202466,"pubmed1",7.54E+018,"testalpha"
,"alow prevalence of alcohol"," NN IN NN",4,1,1,16423318,"pubmed1",5.21E+018,"testalpha"
,"andsemet substituted afcora crystals","VB VBN NNP NNS",4,1,1,16511288,2,7.63E+018,"testalpha"
,"regarding grade iv mucositis","VBG NN  NN",4,1,1,16424643,2,8.82E+018,"testalpha"
,"curative resection for rectal","JJ NN IN NN",4,1,1,17139900,2,3.57E+018,"testalpha"
,"attractive framework todesign novel","JJ NN JJ NN",4,1,1,16411739,"pubmed1",5.36E+018,"testalpha"
,"eczematous changes and infiltrationof","JJ NNS CC ",4,1,1,16648919,2,4.93E+018,"testalpha"
,"drivers resist successful rehabilitation","NNS VB JJ NN",4,1,1,16202465,"pubmed1",1.08E+018,"testalpha"
,"colon or small intestine","NN CC JJ NN",4,1,1,16132430,"pubmed1",5.49E+018,"testalpha"
,"thatbeta adrenergic receptor hyporesponsiveness","NN JJ NN NN",4,1,1,16874421,2,8.60E+018,"testalpha"
,"procedures for critical indications","NNS IN JJ NNS",4,1,1,17165596,2,2.36E+018,"testalpha"
,"local coronary artery flow","JJ NN NN NN",4,1,1,16451157,"pubmed1",1.72E+018,"testalpha"
,"lymphoblastic leukemia developed fever","JJ NN VBD NN",4,1,1,16918065,"pubmed1",5.05E+017,"testalpha"
,"novel dna binding peptides","NN  VBG NNS",4,1,1,16411739,"pubmed1",1.76E+018,"testalpha"
,"intracranialpressure and cerebral perfusion","NN CC JJ NN",4,1,1,17067134,"pubmed1",1.66E+018,"testalpha"
,"minutes for patch placement","NNS IN NN NN",4,1,1,16617761,"pubmed1",4.09E+017,"testalpha"
,"tlymphocyte proliferation and apoptosis","NNP NN CC NN",4,1,1,17016035,2,1.22E+018,"testalpha"
,"different possible enhancement patterns","JJ JJ NN NNS",4,1,1,16333704,"pubmed1",4.24E+018,"testalpha"
,"certain percentage of allcases","JJ NN IN NNS",4,1,1,17139894,2,6.40E+018,"testalpha"
,"photochemical characteristics of mesophyll","JJ NNS IN NN",4,1,1,17106510,"pubmed1",8.62E+018,"testalpha"
,"depletion of uridine nucleotides","NN IN NN NNS",4,1,1,16696445,2,4.83E+018,"testalpha"
,"important public health goal","JJ JJ NN NN",4,1,1,16696436,2,3.72E+018,"testalpha"
,"physiologic saline solution group","JJ NN NN NN",4,1,1,16491220,2,5.94E+018,"testalpha"
,"laboratory data andapache iii","NN NNS NNP ",4,1,1,17117607,2,3.62E+018,"testalpha"
,"genes yjl c yjr","NNS  NN ",4,1,1,17146497,"pubmed1",4.07E+018,"testalpha"
,"dotter tube and images","NN NN CC NNS",4,1,1,16447095,"pubmed1",4.62E+018,"testalpha"
,"thymidylate synthase ts epidermalgrowth","NN NN  NN",4,1,1,17139902,2,7.48E+018,"testalpha"
,"ad rs n male","NN   NN",4,1,1,16859613,2,2.48E+018,"testalpha"
,"produce luminescent liquid crystals","VB NN JJ NNS",4,1,1,16411740,"pubmed1",8.48E+018,"testalpha"
,"allows cleardistinction between crystals","VBZ NN IN NNS",4,1,1,16421445,2,1.05E+018,"testalpha"
,"formation of thiobarbituric acid","NN IN JJ NN",4,1,1,16395529,"pubmed1",4.79E+018,"testalpha"
,"au mg protein p","  NN ",4,1,1,16696441,2,7.79E+018,"testalpha"
,"sequence locatedat identical positions","NN NNP JJ NNS",4,1,1,16365637,"pubmed1",5.36E+018,"testalpha"
,"bound delta and delta","VBN NN CC NN",4,1,1,17063209,"pubmed1",7.97E+018,"testalpha"
,"dma v andexhibits thioltransferase","  NNS NN",4,1,1,17019444,"pubmed1",6.74E+018,"testalpha"
,"thickness or split thickness","NN CC NN NN",4,1,1,17165599,2,4.33E+018,"testalpha"
,"dna modification rnatranscription mrna"," NN NN ",4,1,1,16505901,"pubmed1",2.95E+017,"testalpha"
,"representing residues ofhuman histone","VBG NNS NN NN",4,1,1,17117212,"pubmed1",7.99E+018,"testalpha"
,"formation in sodiumchloride particles","NN IN VB NNS",4,1,1,16584166,"pubmed1",7.55E+018,"testalpha"
,"outcomes after facial skin","NNS IN JJ NN",4,1,1,17165596,2,8.83E+018,"testalpha"
,"iii and group iv"," CC NN ",4,1,1,16612918,"pubmed1",2.93E+018,"testalpha"
,"arthritis symptoms as improvement","NN NNS IN NN",4,1,1,17311738,2,3.13E+018,"testalpha"
,"deposition in hypertrophic scars","NN IN JJ NNS",4,1,1,16874413,2,3.18E+018,"testalpha"
,"flow marker lithiummicrodialysis lm","NN NN NN ",4,1,1,17438835,2,8.19E+018,"testalpha"
,"terms of clinical improvement","NNS IN JJ NN",4,1,1,16479024,2,8.22E+018,"testalpha"
,"conclusions duty hour restrictions","NNS NN NN NNS",4,1,1,16377820,"pubmed1",6.90E+018,"testalpha"
,"properties than calf tissue","NNS IN NN NN",4,1,1,16701880,"pubmed1",4.78E+016,"testalpha"
,"action for future development","NN IN NN NN",4,1,1,17016038,2,4.60E+018,"testalpha"
,"cells of theseminiferous tubules","NNS IN JJ NNS",4,1,1,17084885,2,2.33E+018,"testalpha"
,"call system metacgme requirements","NN NN  NNS",4,1,1,16377824,"pubmed1",4.06E+018,"testalpha"
,"addition eradication therapydecreased cd","NN NN VBN ",4,1,1,16809885,2,6.66E+018,"testalpha"
,"microg l and microg","NNP  CC NNP",4,1,1,17117609,2,6.76E+018,"testalpha"
,"directive ec from march","NN  IN NN",4,1,1,16999268,2,1.62E+018,"testalpha"
,"mg kg confidence interval","  NN NN",4,1,1,16436797,"pubmed1",4.73E+018,"testalpha"
,"significant decrease of serum","JJ NN IN NN",4,1,1,16603096,2,1.33E+018,"testalpha"
,"seeds in pf formation","NNS IN  NN",4,1,1,16714052,2,6.10E+018,"testalpha"
,"folddecrease in mortality risk","NN IN NN NN",4,1,1,16436794,"pubmed1",1.71E+018,"testalpha"
,"mediates neurotransmission conduction secretion","NNS NN NN NN",4,1,1,16770441,"pubmed1",2.66E+018,"testalpha"
,"side impact andrear end","NN NN JJ NN",4,1,1,16197912,"pubmed1",3.77E+018,"testalpha"
,"high level of thyroid","JJ NN IN NN",4,1,1,16479025,2,6.76E+018,"testalpha"
,"coli lacz mutants cc","  NNS ",4,1,1,16733554,"pubmed1",6.54E+018,"testalpha"
,"indicate thattopical methyl aminolevulinate","VB JJ  NN",4,1,1,16585985,2,1.14E+018,"testalpha"
,"ischemia exacerbates brain injury","NN NNS NN NN",4,1,1,16436794,"pubmed1",4.28E+017,"testalpha"
,"theirtolerance among atopic subjects","NN IN NN NNS",4,1,1,16648917,2,5.98E+018,"testalpha"
,"markedincrease of liver echogenicity","NN IN NN NN",4,1,1,16673610,2,1.35E+018,"testalpha"
,"previous achievementsfor appointments promotions","JJ JJ NNS NNS",4,1,1,16399035,"pubmed1",5.77E+017,"testalpha"
,"adult volunteers with dt","NN NNS IN ",4,1,1,16399034,"pubmed1",2.69E+018,"testalpha"
,"adjacent bone producing skeletaldestruction","JJ NN VBG NN",4,1,1,16714048,2,3.09E+018,"testalpha"
,"nasi defects lining deficiencies"," NNS VBG NNS",4,1,1,17165594,2,8.32E+017,"testalpha"
,"reportsare of uncertain importance","NN IN JJ NN",4,1,1,16983449,2,1.74E+018,"testalpha"
,"midbrain brain stem region","VB NN VB NN",4,1,1,16949651,2,2.37E+018,"testalpha"
,"workplace injury rates butthey","NN NN NNS NNP",4,1,1,16430845,"pubmed1",1.34E+018,"testalpha"
,"samplings processed bythe thinprep","NNS VBN NNP ",4,1,1,16514842,2,4.31E+018,"testalpha"
,"immune reaction for fn","JJ NN IN ",4,1,1,16430945,2,4.94E+018,"testalpha"
,"short outburst of gamma","JJ NN IN NN",4,1,1,17133951,2,9.07E+018,"testalpha"
,"histopathological analysis of livertissues","JJ NN IN NNS",4,1,1,16612918,"pubmed1",7.15E+018,"testalpha"
,"analysis of different types","NN IN JJ NNS",4,1,1,16406188,"pubmed1",7.63E+018,"testalpha"
,"content serum creatinine cr","JJ NN NN ",4,1,1,16999986,2,6.53E+018,"testalpha"
,"map d transport system","NN  NN NN",4,1,1,16451150,"pubmed1",5.25E+018,"testalpha"
,"fatalities among year olddrivers","NNS IN NN NNS",4,1,1,16171767,"pubmed1",7.84E+018,"testalpha"
,"inspection of university policies","NN IN NN NNS",4,1,1,16377817,"pubmed1",3.90E+018,"testalpha"
,"role of food allergy","NN IN NN NN",4,1,1,16648913,2,3.05E+018,"testalpha"
,"excitotoxic action of glutamate","JJ NN IN NN",4,1,1,17265697,2,3.72E+018,"testalpha"
,"times higher drug concentration","NNS JJR NN NN",4,1,1,17285742,"pubmed1",2.76E+018,"testalpha"
,"apparent benefit in os","JJ NN IN ",4,1,1,16424643,2,2.22E+018,"testalpha"
,"presence of massive mucus","NN IN JJ NN",4,1,1,16245013,"pubmed1",1.34E+018,"testalpha"
,"patients were monitoredfor psa","NNS VBD JJ ",4,1,1,16365337,"pubmed1",3.42E+018,"testalpha"
,"blot and rt pcr","NN CC  ",4,1,1,16365637,"pubmed1",3.03E+017,"testalpha"
,"cd cord blood cells"," NN NN NNS",4,1,1,16404477,"pubmed1",7.46E+018,"testalpha"
,"assessed theresponse of platelet","VBN NN IN NN",4,1,1,16809885,2,4.74E+018,"testalpha"
,"hemostatic challenges forcongenital coagulation","JJ NNS NN NN",4,1,1,16424651,2,5.75E+018,"testalpha"
,"influence thevalues of dna","NN NNS IN ",4,1,1,16582984,"pubmed1",4.51E+018,"testalpha"
,"fewtopics for future research","NNS IN NN NN",4,1,1,16988902,"pubmed1",6.57E+018,"testalpha"
,"o h o n","   ",4,1,1,16397335,2,1.51E+018,"testalpha"
,"hydrogen peroxide h o","NN VB  ",4,1,1,17046053,2,3.73E+018,"testalpha"
,"cd cd hla class","   NN",4,1,1,16733557,"pubmed1",1.36E+017,"testalpha"
,"peripheral blood mononuclear cells","JJ NN JJ NNS",4,1,1,16710577,2,3.44E+018,"testalpha"
,"signs of pulmonarytumour embolism","NNS IN JJ NN",4,1,1,16673614,2,5.15E+018,"testalpha"
,"pg and mean mg"," CC VB ",4,1,1,16989140,2,2.40E+018,"testalpha"
,"ph than chitosancontrol particles"," IN NN NNS",4,1,1,17285741,"pubmed1",8.28E+018,"testalpha"
,"p andp waf mrna","   ",4,1,1,16733561,"pubmed1",7.87E+018,"testalpha"
,"flowingstream of isotonic sorensen","NN IN JJ NNP",4,1,1,16584164,"pubmed1",2.46E+016,"testalpha"
,"timolol n metipranolol n","   ",4,1,1,17106597,2,7.34E+018,"testalpha"
,"ofthe y c mutation","NNP  NN NN",4,1,1,16929381,"pubmed1",6.74E+018,"testalpha"
,"incases of atopic dermatitis","NNS IN NN NN",4,1,1,16603103,2,2.49E+018,"testalpha"
,"typology or dynamic morphology","NN CC JJ NN",4,1,1,17486414,"pubmed1",8.78E+018,"testalpha"
,"short therapy with rituximab","JJ NN IN ",4,1,1,16424661,2,2.64E+018,"testalpha"
,"formation of stem loopstructure","NN IN VB NN",4,1,1,16770443,"pubmed1",3.37E+018,"testalpha"
,"blood pressure and heart","NN NN CC NN",4,1,1,16365322,"pubmed1",6.49E+018,"testalpha"
,"tests and laboratory analyses","NNS CC NN NNS",4,1,1,17688033,2,4.32E+018,"testalpha"
,"purpose although bowel preparation","NN IN NN NN",4,1,1,16612916,"pubmed1",2.71E+018,"testalpha"
,"motor vehicle crashes mvcs","NN NN NNS ",4,1,1,16405857,"pubmed1",3.26E+018,"testalpha"
,"activity of theconsidered peptides","NN IN VBN NNS",4,1,1,16523218,"pubmed1",8.98E+018,"testalpha"
,"growth and sexual maturation","NN CC JJ NN",4,1,1,16462411,"pubmed1",7.58E+018,"testalpha"
,"asymmetry in dermoscopic images","NN IN NN NNS",4,1,1,16648914,2,2.29E+017,"testalpha"
,"priorto encapsulation min beta","NNP NN  NN",4,1,1,16701853,"pubmed1",5.60E+018,"testalpha"
,"victim by abbreviated injury","NN IN VBN NN",4,1,1,16426556,"pubmed1",1.10E+018,"testalpha"
,"abbreviated injury scale ais","VBN NN NN ",4,1,1,16426556,"pubmed1",8.35E+018,"testalpha"
,"unsectioned cell preparations withan","VBN NN NNS NNP",4,1,1,16996581,2,5.41E+018,"testalpha"
,"regulates appetite and adiposity","NNS NN CC NN",4,1,1,16479031,2,9.15E+017,"testalpha"
,"thecurrent rrc core competency","NN  NN NN",4,1,1,16473998,"pubmed1",8.44E+018,"testalpha"
,"treatment and clinical outcome","NN CC JJ NN",4,1,1,16696447,2,5.81E+018,"testalpha"
,"bp andischemia reperfusion i"," NN NN ",4,1,1,16764913,2,4.51E+018,"testalpha"
,"anesthetized adult male wistar","VBN NN NN NN",4,1,1,17265691,2,9.01E+018,"testalpha"
,"enzymatic digestions using hyaluronidase","JJ NNS VBG NN",4,1,1,16764914,2,4.58E+018,"testalpha"
,"additional enhancementpatterns diffuse contrast","JJ NNS IN NN",4,1,1,16333704,"pubmed1",3.00E+017,"testalpha"
,"lack of monoclonal immunoglobulins","NN IN JJ NNS",4,1,1,16714048,2,5.47E+018,"testalpha"
,"notimpair whole blood cpa","NN JJ NN ",4,1,1,16549890,2,6.98E+018,"testalpha"
,"stimulated theproliferation of blast","VBN NN IN NN",4,1,1,16809884,2,4.39E+018,"testalpha"
,"clinical study radiographic macroscopic","JJ NN JJ NN",4,1,1,17293966,2,1.12E+018,"testalpha"
,"practical point of view","JJ NN IN NN",4,1,1,17063208,"pubmed1",8.88E+018,"testalpha"
,"prepared using titration method","VBN VBG NN NN",4,1,1,16584167,"pubmed1",5.18E+018,"testalpha"
,"cells in rat thyroid","NNS IN NN NN",4,1,1,16762403,2,4.92E+018,"testalpha"
,"months of therapy feia","NNS IN NN ",4,1,1,16603096,2,4.79E+018,"testalpha"
,"dicumarol quinone binding site","NN NN VBG NN",4,1,1,16929382,"pubmed1",8.75E+018,"testalpha"
,"case of purple urine","NN IN JJ NN",4,1,1,16673616,2,1.91E+018,"testalpha"
,"heme redox dependentstructural changes"," JJ JJ NNS",4,1,1,16411738,"pubmed1",6.63E+018,"testalpha"
,"cipla ltd mumbai india","   NNP",4,1,1,16584139,"pubmed1",1.55E+016,"testalpha"
,"theclear separation between organs","JJ NN IN NNS",4,1,1,17486414,"pubmed1",3.20E+018,"testalpha"
,"activity of p mapk","NN IN  ",4,1,1,16964326,"pubmed1",3.04E+018,"testalpha"
,"signals for muscle cell","NNS IN NN NN",4,1,1,16410836,"pubmed1",2.54E+018,"testalpha"
,"suitable substrate for cell","JJ NN IN NN",4,1,1,16701861,"pubmed1",4.24E+016,"testalpha"
,"nt long noncoding rnas"," JJ VBG ",4,1,1,16770443,"pubmed1",4.21E+018,"testalpha"
,"enos mrna and activity","  CC NN",4,1,1,16733564,"pubmed1",5.66E+018,"testalpha"
,"detected ngf in nuclei","VBD  IN ",4,1,1,16325891,2,4.97E+018,"testalpha"
,"multidisciplinary approach regarding diagnosis","JJ NN VBG NN",4,1,1,16722347,2,7.30E+018,"testalpha"
,"vntr analysis revealed thepresence"," NN VBD NN",4,1,1,16424652,2,2.10E+018,"testalpha"
,"patients with atopic disorders","NNS IN NN NNS",4,1,1,16603096,2,7.64E+018,"testalpha"
,"bone adouble diffusion technique","NN JJ NN NN",4,1,1,16701861,"pubmed1",6.12E+018,"testalpha"
,"earlier explanations ofthis phenomenon","JJR NNS NNP NN",4,1,1,16421451,2,2.05E+018,"testalpha"
,"other ethnic groups p","JJ JJ NNS ",4,1,1,16436793,"pubmed1",8.39E+018,"testalpha"
,"opioidconsumption or patient satisfaction","NN CC NN NN",4,1,1,16451147,"pubmed1",6.26E+018,"testalpha"
,"nhme n acetyl n","   ",4,1,1,16528414,"pubmed1",2.65E+017,"testalpha"
,"gender anatomicsite histogenetic type","NN JJ JJ NN",4,1,1,16585990,2,6.69E+018,"testalpha"
,"regionalization ofsperm membrane antigens","NN JJ NN NNS",4,1,1,16330085,2,2.45E+018,"testalpha"
,"frequentextrapulmonary site of involvement","JJ NN IN NN",4,1,1,16696444,2,2.84E+018,"testalpha"
,"important thandifferences between institutions","JJ NNS IN NNS",4,1,1,16617757,"pubmed1",2.47E+018,"testalpha"
,"ch ch bridged peptides","  VBN NNS",4,1,1,16496038,"pubmed1",5.75E+018,"testalpha"
,"vapour diffusion methodand peg","JJ NN NN ",4,1,1,16511276,2,1.17E+018,"testalpha"
,"reviews surveys of university","NNS NNS IN NN",4,1,1,16377817,"pubmed1",2.14E+018,"testalpha"
,"parenchyma main pancreatic duct"," JJ JJ ",4,1,1,16333694,"pubmed1",1.56E+018,"testalpha"
,"records within theacademic research","NNS IN JJ NN",4,1,1,16377817,"pubmed1",3.68E+018,"testalpha"
,"acetyl beta d glucosaminidase"," NN  NN",4,1,1,16956119,2,3.64E+018,"testalpha"
,"anddiagnostic yield of sonoenteroclysis","JJ NN IN NN",4,1,1,16447095,"pubmed1",3.12E+018,"testalpha"
,"water and energy balance","NN CC NN NN",4,1,1,17133952,2,7.41E+018,"testalpha"
,"r and l y","NN CC  ",4,1,1,16404475,"pubmed1",8.54E+018,"testalpha"
,"involving vehicles with ontario","VBG NNS IN NNP",4,1,1,16169506,"pubmed1",2.05E+018,"testalpha"
,"effect model i e","NN NN  ",4,1,1,16126153,"pubmed1",1.48E+018,"testalpha"
,"acute respiratory syndrome sars","JJ NN NN ",4,1,1,17128290,"pubmed1",2.83E+018,"testalpha"
,"b colour components cie","NN JJ NNS ",4,1,1,16648914,2,2.77E+018,"testalpha"
,"radiation for data collection","NN IN NNS NN",4,1,1,16369089,2,5.38E+018,"testalpha"
,"influences patientsmorbidity and mortality","NNS NN CC NN",4,1,1,16612906,2,1.91E+018,"testalpha"
,"large sizedpseudo aneurysm lack","JJ JJ  NN",4,1,1,16612927,"pubmed1",3.71E+018,"testalpha"
,"mapleson d system design","NN  NN NN",4,1,1,16451150,"pubmed1",5.30E+018,"testalpha"
,"atwww usp org aboutusp","   ",4,1,1,17285738,"pubmed1",5.30E+018,"testalpha"
,"welldifferentiated squamous cell carcinomas","VBN JJ NN NNP",4,1,1,17139883,2,4.01E+018,"testalpha"
,"using fluorescence spectroscopy chemicaldenaturation","VBG NN  NN",4,1,1,17019437,"pubmed1",8.64E+018,"testalpha"
,"upper respiratory tract infection","JJ NN NN NN",4,1,1,16603101,2,7.28E+018,"testalpha"
,"undergoing radiofrequency catheter ablation","VBG NN NN NN",4,1,1,16696443,2,4.45E+017,"testalpha"
,"manunderwent routine abdominal ultrasound","NN JJ JJ NN",4,1,1,16132429,"pubmed1",2.00E+018,"testalpha"
,"study of rct abstracts","NN IN  NNS",4,1,1,16365332,"pubmed1",7.63E+018,"testalpha"
,"member of thenuclear receptor","NN IN JJ NN",4,1,1,16809887,2,3.92E+018,"testalpha"
,"ourmeasures of international icu","NNS IN JJ ",4,1,1,16451154,"pubmed1",2.55E+018,"testalpha"
,"diseases evolves around melanocytes","NNS NNS IN NNS",4,1,1,16859616,2,5.23E+018,"testalpha"
,"description of incident clearance","NN IN NN NN",4,1,1,16426557,"pubmed1",2.81E+018,"testalpha"
,"kinetics of nucleotide exchange","NNS IN VB NN",4,1,1,17019437,"pubmed1",2.34E+018,"testalpha"
,"effect of onoo onplatelet","NN IN  NN",4,1,1,17068635,"pubmed1",7.05E+018,"testalpha"
,"systems biomems and bioimplants","NNS NNS CC NNS",4,1,1,16701857,"pubmed1",1.17E+018,"testalpha"
,"inhibited migration and proliferation","VBN NN CC NN",4,1,1,16733560,"pubmed1",2.14E+017,"testalpha"
,"copolymerpoly p dioxanone co","NN  NN ",4,1,1,16701879,"pubmed1",5.92E+018,"testalpha"
,"score and serum level","NN CC NN NN",4,1,1,16603096,2,8.72E+018,"testalpha"
,"mediatedtransient gene expression assay","NN  NN NN",4,1,1,16582986,"pubmed1",2.22E+018,"testalpha"
,"crystals of free rna","NNS IN JJ ",4,1,1,16421445,2,1.98E+018,"testalpha"
,"bivalentsquare planar platinum ii","NN NN NN ",4,1,1,16397333,2,7.90E+018,"testalpha"
,"non natural dsba substrates"," JJ  NNS",4,1,1,17019443,"pubmed1",1.46E+018,"testalpha"
,"age asa score habitat","NN  NN NN",4,1,1,16613748,2,5.59E+018,"testalpha"
,"c b binding protein","NN NN VBG NN",4,1,1,16964325,"pubmed1",1.92E+018,"testalpha"
,"program radiology fellowship match","NN NN NN NN",4,1,1,16399040,"pubmed1",5.68E+018,"testalpha"
,"level ofexpression and hypoxia","NN NN CC ",4,1,1,17143338,"pubmed1",1.53E+016,"testalpha"
,"divided doses for weeks","VBN NNS IN NNS",4,1,1,16955187,2,8.00E+018,"testalpha"
,"hour restrictions with loweredfaculty","NN NNS IN NN",4,1,1,16377820,"pubmed1",5.24E+018,"testalpha"
,"cell growth insufficient atp","NN NN JJ ",4,1,1,16951738,"pubmed1",3.39E+018,"testalpha"
,"h pi benzene interactions","  NN NNS",4,1,1,16397328,2,5.00E+018,"testalpha"
,"paraphenylenediamine in post mortem","NN IN NN NN",4,1,1,16700150,2,6.16E+018,"testalpha"
,"b continuous performance test","NN JJ NN NN",4,1,1,16479025,2,2.22E+018,"testalpha"
,"fluoride containing fha discsthan","NN VBG  NNP",4,1,1,16701866,"pubmed1",5.98E+018,"testalpha"
,"pre hospital pediatric traumaclassification"," NN JJ NN",4,1,1,16491215,2,4.73E+018,"testalpha"
,"group received inositolhexaphosphate ip","NN VBD NN ",4,1,1,17293967,2,6.59E+018,"testalpha"
,"perception impulsivity substance abuse","NN NN NN NN",4,1,1,16426559,"pubmed1",7.95E+018,"testalpha"
,"current concepts and availabletreatments","JJ NNS CC NNS",4,1,1,17013518,2,8.31E+018,"testalpha"
,"l selectins in theepidermis"," NNS IN NN",4,1,1,16603095,2,1.61E+018,"testalpha"
,"ace inhibitor induced angioedema","NN NN VBN NN",4,1,1,16451161,"pubmed1",5.90E+018,"testalpha"
,"visual impact within days","JJ NN IN NNS",4,1,1,16955189,2,5.22E+018,"testalpha"
,"were observedunder optical microscope","VBD NN JJ NN",4,1,1,16395522,"pubmed1",1.66E+018,"testalpha"
,"anda necrotic haemorrhagic base"," JJ JJ NN",4,1,1,16603100,2,7.33E+018,"testalpha"
,"specific rates by age","JJ NNS IN NN",4,1,1,16111641,"pubmed1",4.90E+018,"testalpha"
,"maine department of transportationand","NN NN IN NN",4,1,1,16423319,"pubmed1",6.54E+018,"testalpha"
,"damagedafferent and motor nerve","NN CC NN NN",4,1,1,16414104,2,8.06E+018,"testalpha"
,"h pi ring interaction","  NN NN",4,1,1,16397330,2,6.48E+018,"testalpha"
,"retroauricular areas and forehead","JJ NNS CC NN",4,1,1,16603100,2,8.68E+018,"testalpha"
,"were recorded pulse methylprednisolone","VBD VBN NN NN",4,1,1,16955189,2,1.11E+018,"testalpha"
,"resection with tmeare methods","NN IN NN NNS",4,1,1,17139896,2,4.55E+018,"testalpha"
,"cell division differentiation growth","NN NN NN NN",4,1,1,16569423,2,8.78E+018,"testalpha"
,"statistical significance of association","JJ NN IN NN",4,1,1,16479028,2,3.19E+018,"testalpha"
,"ink after nd yag","NN IN  ",4,1,1,16648911,2,6.39E+018,"testalpha"
,"chronic sleep deprivation depression","JJ NN NN NN",4,1,1,16377826,"pubmed1",8.03E+018,"testalpha"
,"side effects byretinoic acid","NN NNS JJ NN",4,1,1,16612919,"pubmed1",1.56E+018,"testalpha"
,"conformations of globular proteins","NNS IN JJ NNS",4,1,1,16365636,"pubmed1",2.56E+018,"testalpha"
,"combination with hydrophobic ethyl","NN IN JJ ",4,1,1,16584139,"pubmed1",7.49E+018,"testalpha"
,"properties ofbiomolecules e g","NNS NNS  ",4,1,1,16701857,"pubmed1",6.67E+018,"testalpha"
,"cell proliferation andinduce apoptosis","NN NN VB NN",4,1,1,16809887,2,3.87E+018,"testalpha"
,"choice for modern macromolecularcrystallography","NN IN JJ NN",4,1,1,16369095,2,5.91E+018,"testalpha"
,"contact withstainless steel surfaces","NN NN NN NNS",4,1,1,17285749,"pubmed1",2.06E+018,"testalpha"
,"pelger huet in kidney","NN  IN NN",4,1,1,17119329,2,5.64E+018,"testalpha"
,"dna pkautophosphorylation sites abcde"," NN NNS ",4,1,1,16404475,"pubmed1",3.47E+018,"testalpha"
,"common carotid artery injection","JJ  NN NN",4,1,1,17133957,2,6.58E+018,"testalpha"
,"function in endometrial pathogenesis","NN IN JJ NN",4,1,1,16423381,2,5.71E+018,"testalpha"
,"ofbupicavaine sufentanil and clonidine","NN  CC NN",4,1,1,17236639,"pubmed1",3.40E+018,"testalpha"
,"lines under hypoxic conditions","NNS IN JJ NNS",4,1,1,17143338,"pubmed1",1.55E+018,"testalpha"
,"n v o ch","   ",4,1,1,16456275,2,6.18E+018,"testalpha"
,"total root mean square","JJ NN VB NN",4,1,1,16399039,"pubmed1",6.55E+018,"testalpha"
,"lipoxygenase cox cyclooxygenase inhibitors","NN  NN NNS",4,1,1,16456296,2,6.00E+018,"testalpha"
,"tumour necrosis factor receptor","JJ NN NN NN",4,1,1,16955181,2,7.05E+018,"testalpha"
,"c and d act","NN CC  NN",4,1,1,16511279,2,7.33E+018,"testalpha"
,"sulfate conclusion intravenous iron","NN NN JJ NN",4,1,1,16809890,2,1.39E+018,"testalpha"
,"influence of cyp c","NN IN  NN",4,1,1,16584121,"pubmed1",5.96E+018,"testalpha"
,"ph profile ofadenosine deamination"," NN NN NN",4,1,1,16929383,"pubmed1",9.21E+018,"testalpha"
,"important role inendometrial carcinogenesis","JJ NN JJ NN",4,1,1,16423381,2,3.27E+018,"testalpha"
,"containing aha week n","VBG  NN ",4,1,1,16574202,2,6.99E+018,"testalpha"
,"spectrum of biological behavior","NN IN JJ NN",4,1,1,16899283,2,7.21E+018,"testalpha"
,"fromthe cardiovascular system samples","NNP JJ NN NNS",4,1,1,17311736,2,8.92E+018,"testalpha"
,"asymptomatic patients withbeta thalassemia","JJ NNS NN NN",4,1,1,16809886,2,8.11E+018,"testalpha"
,"dose phase and thesubsequent","NN NN CC NN",4,1,1,17119327,2,2.73E+018,"testalpha"
,"goals adaptation of specializedcurricula","NNS NN IN NN",4,1,1,16999271,2,1.69E+018,"testalpha"
,"mammalian long chain acyl","JJ JJ NN ",4,1,1,16511283,2,5.13E+018,"testalpha"
,"protective effects of erdosteine","JJ NNS IN NN",4,1,1,16537087,2,8.53E+018,"testalpha"
,"species in thephysiological ph","NN IN JJ ",4,1,1,16496037,"pubmed1",8.43E+018,"testalpha"
,"theends of longitudinal barriers","NNS IN JJ NNS",4,1,1,16054101,"pubmed1",3.38E+018,"testalpha"
,"willebrand factor vwf intron","NN NN  NNP",4,1,1,16424652,2,8.49E+018,"testalpha"
,"serum enzymes ast altand","NN NNS  NN",4,1,1,17013510,2,1.31E+017,"testalpha"
,"structure analysis from dataacquisition","NN NN IN NN",4,1,1,16369097,2,4.97E+018,"testalpha"
,"hdl andldl cholesterol p","  NN ",4,1,1,16479028,2,5.19E+018,"testalpha"
,"diglucamide monosodium salt sidag","VB NN NN ",4,1,1,16399028,"pubmed1",2.49E+018,"testalpha"
,"individual time control p","JJ NN NN ",4,1,1,16451152,"pubmed1",9.03E+018,"testalpha"
,"togetherwith daily wound care","NN JJ VBD NN",4,1,1,16603100,2,5.30E+016,"testalpha"
,"ilma in anaesthetized patients"," IN VBN NNS",4,1,1,16451149,"pubmed1",7.91E+018,"testalpha"
,"lspatterns were identified pattern","NNS VBD VBN NN",4,1,1,17311737,2,5.49E+018,"testalpha"
,"effects were recorded pulse","NNS VBD VBN NN",4,1,1,16955189,2,7.30E+018,"testalpha"
,"range of care settings","NN IN NN NNS",4,1,1,16462404,"pubmed1",2.68E+018,"testalpha"
,"images standard deviation ratio","NNS JJ NN NN",4,1,1,16317488,"pubmed1",2.70E+018,"testalpha"
,"ahigh resolution lattice model","VB NN NN NN",4,1,1,16365636,"pubmed1",2.23E+018,"testalpha"
,"paper examines alternative updatingmethods","NN NNS NN NNS",4,1,1,16414003,"pubmed1",5.49E+018,"testalpha"
,"modifications regarding equipment indications","NNS IN NN NNS",4,1,1,17139898,2,8.06E+018,"testalpha"
,"hct erythrocyte countsand mcv"," NNP NN ",4,1,1,17117609,2,8.93E+018,"testalpha"
,"pd activity and vitality"," NN CC NN",4,1,1,17046053,2,6.17E+018,"testalpha"
,"aminolevulinate cream mg g","NN NN  ",4,1,1,16585985,2,4.88E+018,"testalpha"
,"signed rank test andspearman","VBD NN NN NN",4,1,1,16874414,2,7.77E+018,"testalpha"
,"cardiac specific assessments andtreatments","JJ JJ NNS NNS",4,1,1,16462405,"pubmed1",2.09E+018,"testalpha"
,"essential part of thetreatment","JJ NN IN NN",4,1,1,16436789,"pubmed1",6.80E+018,"testalpha"
,"week of tb treatment","NN IN  NN",4,1,1,16479024,2,1.33E+018,"testalpha"
,"pair of n h","NN IN  ",4,1,1,16456283,2,5.40E+018,"testalpha"
,"neurons showed robust changes","NNS VBD JJ NNS",4,1,1,17133953,2,1.75E+018,"testalpha"
,"hyperglycemia perhyp during hours","NN  IN NNS",4,1,1,16436794,"pubmed1",6.70E+018,"testalpha"
,"bleeding changes in size","VBG NNS IN NN",4,1,1,16585990,2,1.29E+018,"testalpha"
,"identified anf box protein","VBN  NN NN",4,1,1,16496042,"pubmed1",2.57E+017,"testalpha"
,"tars and dithranol local"," CC NN NN",4,1,1,17311742,2,5.15E+016,"testalpha"
,"level of transient gfp","NN IN NN ",4,1,1,16582986,"pubmed1",2.01E+018,"testalpha"
,"administrative hours and teaching","JJ NNS CC NN",4,1,1,16436795,"pubmed1",3.47E+018,"testalpha"
,"randomized trial comprised patientswith","VBN NN VBN NN",4,1,1,16424649,2,4.60E+018,"testalpha"
,"improvement after l carnitine","NN IN  NN",4,1,1,16424656,2,9.14E+018,"testalpha"
,"concerninghaemorrhoids anal fissure abscess","NNS  NN NN",4,1,1,16673559,2,4.45E+017,"testalpha"
,"were calculated fromthe mtm","VBD VBN NNP ",4,1,1,17285746,"pubmed1",9.63E+017,"testalpha"
,"hiv or hpv viruses"," CC  NNS",4,1,1,17139883,2,7.12E+018,"testalpha"
,"improvedgelation and rheological properties","NN CC JJ NNS",4,1,1,17285743,"pubmed1",5.47E+018,"testalpha"
,"demyelination in white matter","NN IN JJ NN",4,1,1,16956113,2,5.33E+018,"testalpha"
,"cryptdepth villus height wall","NN NN NN NN",4,1,1,17293957,2,6.44E+018,"testalpha"
,"friction and wear mechanisms","NN CC VB NNS",4,1,1,16701857,"pubmed1",7.99E+018,"testalpha"
,"c nmr analysis insolution","NN  NN NN",4,1,1,16496039,"pubmed1",8.44E+018,"testalpha"
,"provided alternativediagnoses in patients","VBN NNS IN NNS",4,1,1,16612913,"pubmed1",2.34E+018,"testalpha"
,"form of thylakoid membrane","NN IN VB NN",4,1,1,17106511,"pubmed1",1.73E+018,"testalpha"
,"applied min before illumination","VBN  IN NN",4,1,1,16955184,2,9.30E+016,"testalpha"
,"withthe host cellular signals","NNP NN JJ NNS",4,1,1,16410836,"pubmed1",6.86E+018,"testalpha"
,"cd and cd t"," CC  ",4,1,1,17016035,2,4.90E+018,"testalpha"
,"wide range of adaptivefunctions","JJ NN IN NNS",4,1,1,17265695,2,2.89E+018,"testalpha"
,"values were derived post","NNS VBD VBN NN",4,1,1,16399036,"pubmed1",6.71E+018,"testalpha"
,"symptoms ad rs n","NNS NN  ",4,1,1,16859613,2,9.20E+018,"testalpha"
,"reliablemolecular marker of blood","JJ NN IN NN",4,1,1,16828846,2,7.19E+018,"testalpha"
,"e ige between patients","  IN NNS",4,1,1,17010262,2,7.86E+018,"testalpha"
,"suchni ii dependent hydrolysis","  JJ NN",4,1,1,17117212,"pubmed1",7.22E+018,"testalpha"
,"fly ga minv egfp","VB   ",4,1,1,17160143,"pubmed1",6.28E+018,"testalpha"
,"encounter hiv infected patients","NN  VBN NNS",4,1,1,16462404,"pubmed1",6.38E+018,"testalpha"
,"value of record linkagetechniques","NN IN NN NNS",4,1,1,16043107,"pubmed1",7.63E+018,"testalpha"
,"ni ii dependent cleavage","  JJ NN",4,1,1,17117212,"pubmed1",8.50E+018,"testalpha"
,"jefferson medicalcollege clinical efficiency","NN NN JJ NN",4,1,1,16377816,"pubmed1",7.08E+018,"testalpha"
,"risk perception impulsivity substance","NN NN NN NN",4,1,1,16426559,"pubmed1",7.00E+018,"testalpha"
,"hips andosseous palliative surgery"," JJ JJ NN",4,1,1,17438833,2,6.52E+018,"testalpha"
,"complexes by x ray","NNS IN NN ",4,1,1,16369101,2,3.05E+018,"testalpha"
,"sarcoidosis vary indifferent studies","NN VBP JJ NNS",4,1,1,16696444,2,1.73E+018,"testalpha"
,"current state of knowledge","JJ NN IN NN",4,1,1,17106511,"pubmed1",2.01E+018,"testalpha"
,"patient knowledge and doctor","NN NN CC NN",4,1,1,17106601,2,8.78E+018,"testalpha"
,"standard emscare controlled trials","JJ NN VBN NNS",4,1,1,16365334,"pubmed1",1.91E+018,"testalpha"
,"bowel resection wistar rats","NN NN NN NNS",4,1,1,17293957,2,8.98E+018,"testalpha"
,"importance in parastomal hernia","NN IN JJ NNP",4,1,1,17139894,2,4.20E+018,"testalpha"
,"number of ct positivecells","NN IN  NNS",4,1,1,16762403,2,7.53E+018,"testalpha"
,"measurements ofthe adhesive forces","NNS NNP JJ NNS",4,1,1,16410837,"pubmed1",2.56E+017,"testalpha"
,"low interactions of cd","JJ NNS IN ",4,1,1,16713618,2,6.87E+018,"testalpha"
,"seroa monaco for oncogenichuman"," NNP IN NN",4,1,1,16514835,2,1.80E+018,"testalpha"
,"results low hdl cholesterol","NNS JJ  NN",4,1,1,16479026,2,5.79E+018,"testalpha"
,"plasmid constructs of humanstfr","JJ NNS IN ",4,1,1,17119325,2,6.80E+018,"testalpha"
,"patients with inferior extremity","NNS IN JJ NN",4,1,1,16491216,2,3.82E+018,"testalpha"
,"ori with unit cell"," IN NN NN",4,1,1,16511274,2,6.07E+018,"testalpha"
,"severe liver iron overload","JJ NN NN NN",4,1,1,16424659,2,1.40E+017,"testalpha"
,"engaging format for theresident","JJ NN IN NN",4,1,1,16365338,"pubmed1",2.73E+018,"testalpha"
,"apoptosis in itp children","NN IN  NNS",4,1,1,17016035,2,4.93E+018,"testalpha"
,"oligonucleosomal dna degradation whichis","JJ  NN NNP",4,1,1,16951739,"pubmed1",2.94E+018,"testalpha"
,"abeta blocking agent esmolol","NN VBG NN ",4,1,1,16451148,"pubmed1",3.08E+018,"testalpha"
,"slight non significant increase","JJ  JJ NN",4,1,1,17106597,2,1.96E+018,"testalpha"
,"forimmunotherapy in cancer patients","NN IN NN NNS",4,1,1,16404477,"pubmed1",4.00E+018,"testalpha"
,"diverse system of hydrogen","JJ NN IN NN",4,1,1,16397344,2,7.98E+018,"testalpha"
,"diagnostic option in patients","JJ NN IN NNS",4,1,1,16333701,"pubmed1",1.77E+018,"testalpha"
,"rats i r group","NNS  NN NN",4,1,1,17013508,2,8.21E+018,"testalpha"
,"majority of patients witha","NN IN NNS NN",4,1,1,16696443,2,1.60E+018,"testalpha"
,"efflux ec nmol l","NN   ",4,1,1,16594645,"pubmed1",8.26E+018,"testalpha"
,"ns and csav ns"," CC  ",4,1,1,16436788,"pubmed1",5.56E+018,"testalpha"
,"sites k i nmol","NNS   ",4,1,1,16594645,"pubmed1",7.80E+016,"testalpha"
,"tert butyl methyl h","   ",4,1,1,16456281,2,5.35E+017,"testalpha"
,"critical thatresident training programs","JJ NN NN NNS",4,1,1,16377827,"pubmed1",1.36E+018,"testalpha"
,"stump healing wasvery good","NNP VBG NN NN",4,1,1,16612914,"pubmed1",4.23E+018,"testalpha"
,"estimates ofannual county level","NNS JJ NN NN",4,1,1,16451795,"pubmed1",9.01E+018,"testalpha"
,"level of dna pk","NN IN  ",4,1,1,16404475,"pubmed1",2.25E+018,"testalpha"
,"glycemic control on mortality","JJ NN IN NN",4,1,1,16436794,"pubmed1",3.42E+018,"testalpha"
,"significant morbidity mortality andresource","JJ NN NN NN",4,1,1,16612906,2,1.90E+018,"testalpha"
,"aroentgenogram ordering clinical pathway","NN VBG JJ NN",4,1,1,16436790,"pubmed1",8.53E+018,"testalpha"
,"t cell activation inpsoriasis"," NN NN NN",4,1,1,16956117,2,9.19E+018,"testalpha"
,"greater increase in intravasculardensity","JJR NN IN NN",4,1,1,16399037,"pubmed1",3.65E+018,"testalpha"
,"road segment andintersection level","NN NN NN NN",4,1,1,16451795,"pubmed1",5.13E+018,"testalpha"
,"was inserted followingre identification","VBD VBN  NN",4,1,1,16916188,"pubmed1",6.15E+018,"testalpha"
,"weeklynarrowband uvb and combination","NN  CC NN",4,1,1,16585987,2,5.28E+018,"testalpha"
,"membrane proteins thatcan bind","NN NNS JJ NN",4,1,1,16964325,"pubmed1",6.69E+018,"testalpha"
,"vehicle and minimize theprobability","NN CC VB NN",4,1,1,16054101,"pubmed1",7.89E+017,"testalpha"
,"role of theskin barrier","NN IN NNP NN",4,1,1,16874414,2,6.47E+018,"testalpha"
,"treatments on maximal anal","NNS IN JJ ",4,1,1,16612915,"pubmed1",1.60E+018,"testalpha"
,"acidosis thecriteria of propofol","NN NNP IN ",4,1,1,16451160,"pubmed1",6.42E+018,"testalpha"
,"therapy and oral erythromycin","NN CC JJ NNP",4,1,1,17311740,2,3.06E+018,"testalpha"
,"selected fromthe general population","VBN NNP JJ NN",4,1,1,16582984,"pubmed1",6.25E+018,"testalpha"
,"genetic text but aprecise","JJ NN CC NN",4,1,1,17347785,"pubmed1",6.43E+018,"testalpha"
,"follows self efficacy odds","VBZ NN NN NNS",4,1,1,16365327,"pubmed1",8.45E+018,"testalpha"
,"crucial element of psoriasisaggravation","JJ NN IN NN",4,1,1,16585983,2,4.42E+018,"testalpha"
,"phasegre images equilibrium phase"," NNS NN NN",4,1,1,16317488,"pubmed1",1.65E+018,"testalpha"
,"bioresorbable poly hydroxyproline amideand","JJ  NN NN",4,1,1,16701856,"pubmed1",4.18E+018,"testalpha"
,"test sites were patch","NN NNS VBD NN",4,1,1,16585981,2,7.41E+018,"testalpha"
,"mmse trail making test"," NN VBG NN",4,1,1,16479025,2,2.08E+018,"testalpha"
,"thicknesses of several tens","NNS IN JJ NNS",4,1,1,16701854,"pubmed1",9.80E+017,"testalpha"
,"chemistry on solid support","NN IN JJ NN",4,1,1,16496039,"pubmed1",8.31E+018,"testalpha"
,"belts running lights headlights","VBZ VBG NNS NNS",4,1,1,16061188,"pubmed1",5.64E+018,"testalpha"
,"arbitrary choice in terms","JJ NN IN NNS",4,1,1,17486414,"pubmed1",4.31E+018,"testalpha"
,"anatural course of regression","JJ NN IN NN",4,1,1,16859618,2,5.46E+018,"testalpha"
,"steroid steroid beta d","VB VB NN ",4,1,1,16612917,"pubmed1",6.20E+018,"testalpha"
,"injury administration and safety","NN NN CC NN",4,1,1,16442068,"pubmed1",7.91E+018,"testalpha"
,"rate based injurymeasures claims","NN VBN NNS NNS",4,1,1,16430845,"pubmed1",4.42E+018,"testalpha"
,"review of employee health","NN IN NN NN",4,1,1,16438093,"pubmed1",5.35E+018,"testalpha"
,"infarct in transgenic mice","NN IN JJ ",4,1,1,17014894,2,5.30E+017,"testalpha"
,"evaluation between patientsand nurses","NN IN NN NNS",4,1,1,16321533,"pubmed1",4.11E+018,"testalpha"
,"water and mg kg","NN CC  ",4,1,1,17013511,2,7.98E+018,"testalpha"
,"diagnostic implication in carcinomatousdifferentiation","JJ NN IN NN",4,1,1,16673564,2,5.69E+018,"testalpha"
,"males fall related injury","NNS VB VBN NN",4,1,1,16111641,"pubmed1",1.03E+017,"testalpha"
,"acontrol group of subjects","NN NN IN NNS",4,1,1,16733555,"pubmed1",2.06E+018,"testalpha"
,"l skeletal muscle cells"," NN NN NNS",4,1,1,16964326,"pubmed1",1.71E+018,"testalpha"
,"acpcomposites milled acp composites","NNS VBN  NNS",4,1,1,16701862,"pubmed1",2.38E+017,"testalpha"
,"growth factor receptor inhibitor","NN NN NN NN",4,1,1,16874412,2,3.52E+018,"testalpha"
,"nitrogen and saline ml","NN CC NN ",4,1,1,16451147,"pubmed1",2.24E+018,"testalpha"
,"n and utr primers"," CC  NNS",4,1,1,16696442,2,3.04E+018,"testalpha"
,"em program directors pds"," NN NNS ",4,1,1,16436795,"pubmed1",5.75E+018,"testalpha"
,"correlation with vct cpt","NN IN  ",4,1,1,16479025,2,1.95E+018,"testalpha"
,"primary pulmonary lymphomas ppl","JJ JJ NNP ",4,1,1,16612936,"pubmed1",6.81E+018,"testalpha"
,"definition of different prognosticfactors","NN IN JJ NNS",4,1,1,17117607,2,1.47E+018,"testalpha"
,"groups named g n","NNS VBN  ",4,1,1,17293959,2,3.67E+017,"testalpha"
,"eti inemergency airway management"," NN NN NN",4,1,1,16451149,"pubmed1",7.09E+018,"testalpha"
,"neoplastic tumors contains element","JJ NNS VBZ NN",4,1,1,16733559,"pubmed1",6.02E+018,"testalpha"
,"significant decreases in capacitance","JJ NNS IN NN",4,1,1,16874414,2,7.11E+018,"testalpha"
,"nicotine dependence self efficacy","NN NN NN NN",4,1,1,16365327,"pubmed1",6.44E+018,"testalpha"
,"rate of bacterial vaginosis","NN IN JJ NN",4,1,1,16603098,2,6.29E+018,"testalpha"
,"insertion andoxygenation and ventilation","NN NN CC NN",4,1,1,16451149,"pubmed1",2.89E+018,"testalpha"
,"form containing ferroglycine sulfate","NN VBG NN NN",4,1,1,16809890,2,1.17E+018,"testalpha"
,"monoxide diffusion capacity dl","VB NN NN ",4,1,1,16809886,2,4.30E+017,"testalpha"
,"influence breast cancer screening","NN NN NN NN",4,1,1,16596899,"pubmed1",2.66E+018,"testalpha"
,"protein with coiled coil","NN IN VBN NN",4,1,1,16496042,"pubmed1",7.90E+018,"testalpha"
,"mild traumatic brain injury","JJ JJ NN NN",4,1,1,16365331,"pubmed1",3.43E+017,"testalpha"
,"decreasing lean body mass","VBG VB NN NN",4,1,1,16921608,"pubmed1",7.56E+018,"testalpha"
,"education times and costs","NN NNS CC NNS",4,1,1,16399038,"pubmed1",7.48E+018,"testalpha"
,"sufentanil and clonidine microg"," CC NN NNP",4,1,1,17236639,"pubmed1",5.83E+018,"testalpha"
,"mummifying effect of azoles","VBG NN IN NNS",4,1,1,16874415,2,1.86E+018,"testalpha"
,"crashes than belted drivers","NNS IN VBD NNS",4,1,1,16236235,"pubmed1",2.63E+017,"testalpha"
,"be peritoneum lymph nodes","VB NN NN NNS",4,1,1,17139900,2,4.90E+018,"testalpha"
,"potential usefulness of thisapproach","JJ NN IN NN",4,1,1,16899283,2,5.41E+018,"testalpha"
,"water lossand skin capacitance","NN NN NN NN",4,1,1,16874414,2,7.72E+018,"testalpha"
,"time calcium level lymphocyte","NN NN NN NNP",4,1,1,16479024,2,1.38E+018,"testalpha"
,"life support recom mendations","NN NN NNP NNS",4,1,1,17067135,"pubmed1",4.04E+018,"testalpha"
,"further molecular pcr productanalyses","JJ JJ  NNS",4,1,1,17019438,"pubmed1",3.00E+017,"testalpha"
,"methylprednisolone mg i v","NN   ",4,1,1,16696448,2,3.42E+018,"testalpha"
,"pathological processes of werdnig","JJ NNS IN ",4,1,1,16730053,2,7.85E+018,"testalpha"
,"adequate cardiovascular fitness andpractise","JJ JJ NN NN",4,1,1,16918068,"pubmed1",1.90E+018,"testalpha"
,"accumulation of cells withlangerhans","NN IN NNS NNS",4,1,1,16585988,2,3.28E+018,"testalpha"
,"hcii technique after directtreatment"," NN IN NN",4,1,1,16514835,2,5.18E+018,"testalpha"
,"comparing pre and post","VBG  CC NN",4,1,1,16223468,"pubmed1",7.03E+018,"testalpha"
,"ambulance diversion hours methods","NN NN NNS NNS",4,1,1,16365324,"pubmed1",7.86E+018,"testalpha"
,"effects of therapeutic ultrasound","NNS IN JJ NN",4,1,1,17293959,2,6.38E+018,"testalpha"
,"small vehicles berms people","JJ NNS NNS NNS",4,1,1,16129405,"pubmed1",3.97E+018,"testalpha"
,"nervousness forgetfulness and diarrhea","NN NN CC NN",4,1,1,16479025,2,3.78E+018,"testalpha"
,"leveland urine epx level","NN NN  NN",4,1,1,16859611,2,4.92E+018,"testalpha"
,"red blood cell salvage","JJ NN NN NN",4,1,1,17013513,2,2.34E+018,"testalpha"
,"approach canreveal specific modes","NN NN JJ NNS",4,1,1,16594640,"pubmed1",8.75E+018,"testalpha"
,"training in education program","NN IN NN NN",4,1,1,16473995,"pubmed1",7.16E+018,"testalpha"
,"months of lumbar puncture","NNS IN NNP NN",4,1,1,16874420,2,5.49E+017,"testalpha"
,"availability of high resolution","NN IN JJ NN",4,1,1,16511248,2,2.90E+018,"testalpha"
,"pinealectomy ofnew born rats","NN VB VBN NNS",4,1,1,16491217,2,1.62E+018,"testalpha"
,"nonalcoholicfatty liver disease nafld","JJ NN NN ",4,1,1,16673555,2,4.45E+018,"testalpha"
,"served duringtimes of ground","VBN NNS IN NN",4,1,1,16405857,"pubmed1",2.19E+018,"testalpha"
,"problems and poor morale","NNS CC JJ NN",4,1,1,16377814,"pubmed1",6.24E+018,"testalpha"
,"charmm and cedar potentialenergy"," CC NN NN",4,1,1,16388314,"pubmed1",5.52E+018,"testalpha"
,"status poor ability toconcentrate","NN JJ NN NN",4,1,1,16236234,"pubmed1",8.19E+018,"testalpha"
,"ray datacollection and processing"," NN CC NN",4,1,1,16369099,2,6.81E+018,"testalpha"
,"scattered intestinal mucosal cells","VBN JJ NN NNS",4,1,1,16514843,2,8.55E+017,"testalpha"
,"possible drugallergy including blood","JJ NN IN NN",4,1,1,17106599,2,8.45E+018,"testalpha"
,"coverage ofthe false aneurysm","NN NNP JJ ",4,1,1,16612926,"pubmed1",3.16E+018,"testalpha"
,"theeffect of mechanical compaction","NN IN JJ NN",4,1,1,16701863,"pubmed1",7.30E+018,"testalpha"
,"central sensitization and hencereduces","JJ NN CC NNS",4,1,1,17236639,"pubmed1",5.21E+017,"testalpha"
,"roche diagnostics upon admission","NNP NNS IN NN",4,1,1,16916181,"pubmed1",2.18E+018,"testalpha"
,"quality crystals of rv","NN NNS IN ",4,1,1,16511284,2,6.65E+018,"testalpha"
,"received thesolvent of dexamethasone","VBD NN IN NN",4,1,1,17007911,2,7.97E+018,"testalpha"
,"national andregional research ethics","JJ JJ NN NNS",4,1,1,16770860,"pubmed1",2.88E+018,"testalpha"
,"embolism femoral vein muralthrombus","NN JJ NN NNP",4,1,1,16696443,2,8.79E+018,"testalpha"
,"imprintsand chicken blood smears","NN NN NN NNS",4,1,1,16996581,2,7.91E+018,"testalpha"
,"eg episodic binge exposures"," JJ NN NNS",4,1,1,16808045,"pubmed1",1.15E+017,"testalpha"
,"patients seen ina contact","NNS VBN  NN",4,1,1,16710586,2,4.05E+018,"testalpha"
,"constructs of humanstfr hstfr","NNS IN  ",4,1,1,17119325,2,1.65E+018,"testalpha"
,"background was diagnosed withhemochromatosis","NN VBD VBN NN",4,1,1,16424663,2,6.91E+018,"testalpha"
,"patient was onambisome treatment","NN VBD NN NN",4,1,1,17370567,"pubmed1",6.38E+018,"testalpha"
,"theproliferating cell nuclear antigen","VBG NN JJ NN",4,1,1,17013509,2,8.41E+018,"testalpha"
,"verifiedoccupational health nurse roles","JJ NN NN NNS",4,1,1,16438092,"pubmed1",1.84E+018,"testalpha"
,"sulphate and fragrance mix","NN CC NN NN",4,1,1,16874422,2,2.72E+017,"testalpha"
,"fixed temperature difference deltat","VBN NN NN NN",4,1,1,17285744,"pubmed1",6.53E+018,"testalpha"
,"skin resembling atopic dermatitis","NN VBG NN NN",4,1,1,16955181,2,4.05E+018,"testalpha"
,"standard therapy for patients","JJ NN IN NNS",4,1,1,16424660,2,4.62E+018,"testalpha"
,"certain properties including sensitivity","JJ NNS VBG NN",4,1,1,16505899,"pubmed1",2.59E+018,"testalpha"
,"mean intrinsic gibbs freeenergy","VB NN NNS NN",4,1,1,17019442,"pubmed1",2.11E+018,"testalpha"
,"total sialic acid tsa","JJ JJ NN ",4,1,1,16956116,2,5.92E+018,"testalpha"
,"effect of ascorbic acid","NN IN JJ NN",4,1,1,16395529,"pubmed1",8.55E+018,"testalpha"
,"burn and reconstructive surgerydepartment","NN CC JJ NN",4,1,1,16999270,2,1.89E+018,"testalpha"
,"anautocrine fashion with lrp","NN NN IN ",4,1,1,16965805,2,1.07E+018,"testalpha"
,"measures of predictive performance","NNS IN JJ NN",4,1,1,16414003,"pubmed1",1.39E+018,"testalpha"
,"inprevalence of specific reactions","NN IN JJ NNS",4,1,1,17106600,2,6.80E+018,"testalpha"
,"clinical features with hereditaryangioedema","JJ NNS IN NN",4,1,1,16451161,"pubmed1",2.64E+018,"testalpha"
,"response but asignificant correlation","NN CC JJ NN",4,1,1,16955185,2,6.11E+018,"testalpha"
,"lean body mass ameliorates","VB NN NN NNS",4,1,1,16921608,"pubmed1",5.96E+017,"testalpha"
,"months low molecular weight","NNS JJ JJ NN",4,1,1,16549900,2,2.41E+018,"testalpha"
,"included ina prospective study","VBN  JJ NN",4,1,1,16451159,"pubmed1",1.29E+018,"testalpha"
,"vessels in brain heart","NNS IN NN NN",4,1,1,16762404,2,6.06E+018,"testalpha"
,"population expresses fas l","NN VBZ  ",4,1,1,16919708,2,8.63E+018,"testalpha"
,"ofhigh risk subclinical disease","VB NN JJ NN",4,1,1,17117605,2,3.68E+018,"testalpha"
,"slides and cell blocks","NNS CC NN NNS",4,1,1,16514837,2,4.91E+018,"testalpha"
,"types of immunoregulatory tcells","NNS IN NN NNS",4,1,1,17016036,2,3.49E+018,"testalpha"
,"hypogonadotrophic hypogonadism and congestiveheart","JJ NN CC NN",4,1,1,16424663,2,8.06E+018,"testalpha"
,"enrollment of cml patients","NN IN  NNS",4,1,1,16424660,2,3.83E+018,"testalpha"
,"recessive disorder characterized bypalmoplantar","JJ NN VBN NN",4,1,1,16585980,2,5.72E+018,"testalpha"
,"asecond set of experiments","JJ NN IN NNS",4,1,1,17016038,2,4.55E+018,"testalpha"
,"size invasion lymph node","NN NN NN ",4,1,1,16530813,2,8.30E+018,"testalpha"
,"potassium calcium and phosphorus","NN NN CC NN",4,1,1,16424647,2,6.95E+017,"testalpha"
,"om produced negligible levels"," VBN JJ NNS",4,1,1,16443258,2,7.96E+018,"testalpha"
,"adiscrete point in time","JJ NN IN NN",4,1,1,16442068,"pubmed1",3.55E+018,"testalpha"
,"g and g p"," CC  ",4,1,1,17293969,2,8.92E+018,"testalpha"
,"ratethan was euglycemia odds","NNP VBD NN NNS",4,1,1,16436794,"pubmed1",7.66E+017,"testalpha"
,"distinct class of agonists","JJ NN IN NNS",4,1,1,16808043,"pubmed1",1.17E+018,"testalpha"
,"culture system facilitated differentiation","NN NN VBN NN",4,1,1,16443258,2,4.62E+018,"testalpha"
,"oflow power laser application","VB NN NN NN",4,1,1,17293969,2,1.53E+018,"testalpha"
,"marked inability of theparticipants","VBN NN IN NNS",4,1,1,16426558,"pubmed1",9.01E+017,"testalpha"
,"c or normothermic degrees","NN CC JJ NNS",4,1,1,16451153,"pubmed1",5.54E+018,"testalpha"
,"leaving theempty standard defect","VBG JJ NN NN",4,1,1,17293966,2,5.89E+018,"testalpha"
,"pre and years post"," CC NNS NN",4,1,1,16169506,"pubmed1",1.14E+018,"testalpha"
,"using colloids and crystalloids","VBG NNS CC NNS",4,1,1,16762404,2,4.59E+018,"testalpha"
,"drivers with high exposure","NNS IN JJ NN",4,1,1,16157285,"pubmed1",1.34E+018,"testalpha"
,"factors ii vii ix","NNS   ",4,1,1,16916181,"pubmed1",6.21E+018,"testalpha"
,"cytokines during bowelischemia reperfusion","NNS IN NN NN",4,1,1,17293960,2,8.54E+018,"testalpha"
,"n without conceivable cross"," IN JJ NN",4,1,1,17106597,2,2.88E+018,"testalpha"
,"theuk national health service"," JJ NN NN",4,1,1,16424646,2,4.00E+018,"testalpha"
,"differences in survival curves","NNS IN NN NNS",4,1,1,17139895,2,2.75E+018,"testalpha"
,"interactions and patient ethnicity","NNS CC NN NN",4,1,1,16436793,"pubmed1",3.89E+018,"testalpha"
,"processcreates uneven human subjects","NNS JJ JJ NNS",4,1,1,16770858,"pubmed1",1.43E+018,"testalpha"
,"choice for uncomplicatedsymptomatic gallstones","NN IN JJ NNS",4,1,1,16447096,"pubmed1",2.36E+018,"testalpha"
,"patients resp of healthcare","NNS  IN NN",4,1,1,16696442,2,9.14E+018,"testalpha"
,"utilization fluidand electrolyte balance","NN NN NNP NN",4,1,1,16462411,"pubmed1",2.03E+018,"testalpha"
,"cd on b cells"," IN NN NNS",4,1,1,16424654,2,3.56E+018,"testalpha"
,"gee andlm underestimate parameters","  VB NNS",4,1,1,16126153,"pubmed1",2.42E+017,"testalpha"
,"following order unmilled acpcomposites","VBG NN VBN NNS",4,1,1,16701862,"pubmed1",2.65E+018,"testalpha"
,"biomarkers formal cognitive andbalance","NNS JJ JJ NN",4,1,1,16436787,"pubmed1",5.49E+018,"testalpha"
,"complications location and size","NNS NN CC NN",4,1,1,16612925,"pubmed1",8.88E+018,"testalpha"
,"drad possessing anadditional c"," VBG JJ NN",4,1,1,16421447,2,2.46E+018,"testalpha"
,"terminus by constitutive transportelement","NN IN JJ NN",4,1,1,16733560,"pubmed1",5.61E+018,"testalpha"
,"tunica media tgf beta","NNP NNS  NN",4,1,1,16395524,"pubmed1",9.06E+018,"testalpha"
,"criteria in threealcoholic treatment","NNS IN JJ NN",4,1,1,16236233,"pubmed1",7.32E+018,"testalpha"
,"anhydrase ii hca ii","NN   ",4,1,1,16511248,2,5.98E+018,"testalpha"
,"earlyintensification with high dose","NN IN JJ NN",4,1,1,16424644,2,5.02E+018,"testalpha"
,"kg of body weight"," IN NN NN",4,1,1,17293967,2,3.02E+018,"testalpha"
,"disease blood test results","NN NN NN NNS",4,1,1,16673554,2,7.21E+018,"testalpha"
,"t test with post"," NN IN NN",4,1,1,17293963,2,2.14E+018,"testalpha"
,"embase current contents dissertation","NN JJ NNS NN",4,1,1,16365334,"pubmed1",3.15E+018,"testalpha"
,"statistics and mortality data","NNS CC NN NNS",4,1,1,16236235,"pubmed1",6.23E+018,"testalpha"
,"compressive therapy and surgeries","JJ NN CC NNS",4,1,1,17293973,2,2.57E+018,"testalpha"
,"histology because early metastases","NN IN JJ NNS",4,1,1,17338203,2,6.86E+018,"testalpha"
,"using combination of eudragits","VBG NN IN NNS",4,1,1,16584139,"pubmed1",7.33E+017,"testalpha"
,"cancer tissue in comparison","NN NN IN NN",4,1,1,16404476,"pubmed1",7.24E+018,"testalpha"
,"persistent post occupational dermatitis","JJ NN JJ NN",4,1,1,16710586,2,9.11E+018,"testalpha"
,"severe systemic side effects","JJ JJ NN NNS",4,1,1,16956117,2,7.50E+018,"testalpha"
,"prick tests for allergens","NNP NNS IN NNS",4,1,1,16648913,2,5.06E+018,"testalpha"
,"thegeneration of knockout mouse","NN IN NN NN",4,1,1,16808046,"pubmed1",3.16E+018,"testalpha"
,"rat skin from aha","NN NN IN ",4,1,1,16574202,2,8.61E+018,"testalpha"
,"induction and subsequentlyadministered vecuronium","NN CC VBN NN",4,1,1,17067136,"pubmed1",6.76E+017,"testalpha"
,"cd intracellular il tr"," JJ  ",4,1,1,17016036,2,6.80E+018,"testalpha"
,"hydrophilic matrices of atenolol","JJ NNS IN ",4,1,1,16584161,"pubmed1",4.96E+018,"testalpha"
,"survey of patients andphysicians","NN IN NNS NNS",4,1,1,16514839,2,1.47E+018,"testalpha"
,"patients with acute hip","NNS IN JJ NN",4,1,1,16365322,"pubmed1",8.23E+018,"testalpha"
,"n x and healthcare"," NN CC NN",4,1,1,16710575,2,4.48E+018,"testalpha"
,"saline ml with magnesium","NN  IN NN",4,1,1,17067136,"pubmed1",2.65E+018,"testalpha"
,"cm h o conclusions","   NNS",4,1,1,16399039,"pubmed1",7.17E+018,"testalpha"
,"body increases in size","NN NNS IN NN",4,1,1,16918067,"pubmed1",4.27E+018,"testalpha"
,"nb estimates ofannual county"," NNS JJ NN",4,1,1,16451795,"pubmed1",8.47E+018,"testalpha"
,"available emergencyhealth care resources","JJ NN NN NNS",4,1,1,16365324,"pubmed1",2.89E+018,"testalpha"
,"controlledhemorrhagic shock with use","JJ NN IN NN",4,1,1,16491220,2,5.50E+018,"testalpha"
,"proliferation andmigration of neo","NN NN IN ",4,1,1,16874412,2,5.40E+018,"testalpha"
,"mu acetato mu n"," NN  ",4,1,1,16456265,2,8.53E+018,"testalpha"
,"formation of age products","NN IN NN NNS",4,1,1,16696441,2,2.72E+018,"testalpha"
,"adopting nationalguidelines for patients","VBG NNS IN NNS",4,1,1,16377816,"pubmed1",5.78E+018,"testalpha"
,"chemotherapy in hi hr","NN IN  ",4,1,1,16424644,2,6.98E+018,"testalpha"
,"nuts among mammalian foods"," IN JJ NNS",4,1,1,16673562,2,6.12E+018,"testalpha"
,"possible etiology in patients","JJ NN IN NNS",4,1,1,16424662,2,4.10E+018,"testalpha"
,"retrospective cross sectional multicentrestudy","JJ NN JJ NN",4,1,1,16451154,"pubmed1",3.11E+018,"testalpha"
,"rgd c gg d"," NN  ",4,1,1,17143339,"pubmed1",6.21E+018,"testalpha"
,"mechanics over time ventilatory","NNS IN NN NN",4,1,1,16451155,"pubmed1",6.20E+018,"testalpha"
,"bp and sequence locatedat"," CC NN NNP",4,1,1,16365637,"pubmed1",5.97E+018,"testalpha"
,"rat andnevirapine induced skin","NN NN VBN NN",4,1,1,16594644,"pubmed1",4.24E+018,"testalpha"
,"thecardiovascular system and skin","JJ NN CC NN",4,1,1,17311736,2,3.66E+018,"testalpha"
,"thecontributions of end groups","NNS IN NN NNS",4,1,1,16411735,"pubmed1",2.25E+018,"testalpha"
,"approaches for advanced disease","NNS IN VBN NN",4,1,1,16612931,"pubmed1",1.86E+018,"testalpha"
,"thioltransferase and dehydroascorbate reductase","NN CC NN NN",4,1,1,17019444,"pubmed1",2.45E+017,"testalpha"
,"blood cells from controlpopulation","NN NNS IN NN",4,1,1,16582984,"pubmed1",7.31E+018,"testalpha"
,"religion spirituality andcancer control","NN NN NN NN",4,1,1,16596897,"pubmed1",2.82E+018,"testalpha"
,"complex formof cuh l","NN   ",4,1,1,16496037,"pubmed1",8.08E+017,"testalpha"
,"diagnostic method for patients","JJ NN IN NNS",4,1,1,16333701,"pubmed1",8.67E+018,"testalpha"
,"date ofbirth gender date","NN JJ NN NN",4,1,1,16221468,"pubmed1",1.18E+018,"testalpha"
,"contact dermatitis research group","NN NN NN NN",4,1,1,17010264,2,7.18E+018,"testalpha"
,"transform infrared ft ir","NN VBN  ",4,1,1,16701876,"pubmed1",8.72E+017,"testalpha"
,"comparison of cie l","NN IN  ",4,1,1,16648914,2,5.69E+018,"testalpha"
,"feedback tostaff and evolution","NN NN CC NN",4,1,1,16321534,"pubmed1",4.40E+018,"testalpha"
,"glutathione and ascorbic acid","NN CC JJ NN",4,1,1,16395529,"pubmed1",3.53E+018,"testalpha"
,"clinical presentation diagnosis prognosis","JJ NN NN NN",4,1,1,16918066,"pubmed1",5.75E+018,"testalpha"
,"weak c h pi","JJ NN  ",4,1,1,16397330,2,3.19E+018,"testalpha"
,"continuity of patient care","NN IN NN NN",4,1,1,16377823,"pubmed1",4.12E+018,"testalpha"
,"ium pyridine carboxylate hemihydrate"," NN NN NN",4,1,1,16456283,2,1.37E+018,"testalpha"
,"use of allogenic blood","NN IN JJ NN",4,1,1,16451158,"pubmed1",8.44E+018,"testalpha"
,"peritoneal reflection of rectum","NN NN IN NN",4,1,1,16612917,"pubmed1",6.75E+018,"testalpha"
,"ligand inhibited cell growth","NN VBN NN NN",4,1,1,16809887,2,7.77E+018,"testalpha"
,"tetrapeptide analogues h tyr","VB NNS  ",4,1,1,16496038,"pubmed1",4.82E+018,"testalpha"
,"ofthe ex vivo transduction","NNP   NN",4,1,1,17160143,"pubmed1",1.19E+018,"testalpha"
,"keyparameters pan load pan","NNS NN NN NN",4,1,1,17285748,"pubmed1",6.16E+018,"testalpha"
,"talking respondents perceived driver","VBG NNS VBN NN",4,1,1,16112069,"pubmed1",8.23E+018,"testalpha"
,"seen ina contact dermatitis","VBN  NN NN",4,1,1,16710586,2,4.48E+018,"testalpha"
,"presence of ocular complications","NN IN JJ NNS",4,1,1,17106598,2,5.83E+018,"testalpha"
,"completed asecond pain vas","VBN JJ NN ",4,1,1,16436793,"pubmed1",1.22E+018,"testalpha"
,"was identified case reports","VBD VBN NN NNS",4,1,1,16365335,"pubmed1",3.58E+018,"testalpha"
,"based medicine and treatments","VBN NN CC NNS",4,1,1,17318328,"pubmed1",8.61E+018,"testalpha"
,"physical stability of types","JJ NN IN NNS",4,1,1,17285747,"pubmed1",7.41E+018,"testalpha"
,"vomiting ponv inthe desflurane","VBG  NNP NN",4,1,1,16451145,"pubmed1",1.75E+018,"testalpha"
,"angiographicand computed tomographic ct","NN VBN JJ ",4,1,1,16317492,"pubmed1",7.18E+018,"testalpha"
,"compared withhumid sucralfate gel","VBN JJ NN ",4,1,1,16584168,"pubmed1",7.25E+018,"testalpha"
,"stimulating effect on secretion","JJ NN IN NN",4,1,1,16395521,"pubmed1",4.10E+017,"testalpha"
,"torepair cytotoxic dna lesions","NN JJ  NNS",4,1,1,16733554,"pubmed1",6.91E+018,"testalpha"
,"drop vapour diffusion methodand","NN JJ NN NN",4,1,1,16511276,2,7.78E+018,"testalpha"
,"collected self report data","VBN NN NN NNS",4,1,1,16112069,"pubmed1",5.72E+018,"testalpha"
,"remissions in acute lymphoblasticleukemia","NNS IN JJ NN",4,1,1,16733557,"pubmed1",6.64E+018,"testalpha"
,"meat derived fatty acid","NN VBN JJ NN",4,1,1,16511289,2,7.76E+018,"testalpha"
,"experience withindications and use","NN NNS CC NN",4,1,1,16999270,2,7.94E+018,"testalpha"
,"develop predictivecrash frequency tools","VB NN NN NNS",4,1,1,16442487,"pubmed1",4.47E+018,"testalpha"
,"plantsand various other species","NN JJ JJ NN",4,1,1,16511272,2,4.76E+018,"testalpha"
,"infection areindependent risk factors","NN NN NN NNS",4,1,1,16673613,2,4.29E+018,"testalpha"
,"recursive pcr technique andthe","JJ  NN NNP",4,1,1,16511262,2,7.74E+017,"testalpha"
,"follicular cells and presence","JJ NNS CC NN",4,1,1,16514837,2,8.17E+018,"testalpha"
,"alveolar process shows retrusion","JJ NN VBZ NN",4,1,1,16722348,2,8.32E+018,"testalpha"
,"associated withelevated serum tsa","VBN VBN NN ",4,1,1,16956116,2,4.34E+018,"testalpha"
,"enhancement or inhibition ofnf","NN CC NN ",4,1,1,17068636,"pubmed1",4.54E+018,"testalpha"
,"expression in right colonwith","NN IN NN NN",4,1,1,17293967,2,1.03E+018,"testalpha"
,"stroke patients and control","NN NNS CC NN",4,1,1,16479026,2,8.14E+018,"testalpha"
,"ml h kg vs","   ",4,1,1,16594642,"pubmed1",2.24E+018,"testalpha"
,"majority ofthe orthodontic patients","NN NNP JJ NNS",4,1,1,17438832,2,5.81E+017,"testalpha"
,"activities of succinate dehydrogenase","NNS IN NN NN",4,1,1,16919313,2,6.83E+018,"testalpha"
,"hpv using polymerase chain"," VBG NN NN",4,1,1,16514834,2,7.58E+018,"testalpha"
,"interferon wasdiscontinued ms treatment","NNP VBN  NN",4,1,1,17016041,2,6.76E+018,"testalpha"
,"median bursting pressure values","JJ VBG NN NNS",4,1,1,16612916,"pubmed1",3.78E+018,"testalpha"
,"epidermotropism presence of mucin","NN NN IN NNP",4,1,1,16859615,2,5.28E+018,"testalpha"
,"reduction in mean marp","NN IN VB ",4,1,1,16612915,"pubmed1",8.53E+018,"testalpha"
,"ahypoxia l arg group","   NN",4,1,1,16395522,"pubmed1",2.94E+018,"testalpha"
,"greater work stress relatedto","JJR NN NN ",4,1,1,16438094,"pubmed1",8.77E+017,"testalpha"
,"area of intrafusal fibers","NN IN NN NNS",4,1,1,16730053,2,4.92E+018,"testalpha"
,"work context in thevicinity","VB NN IN NN",4,1,1,17294910,2,4.48E+018,"testalpha"
,"glycolitic pathway and presence","JJ NN CC NN",4,1,1,17013507,2,1.96E+018,"testalpha"
,"aftermicrobubble based contrast agent","JJ VBN NN NN",4,1,1,16333704,"pubmed1",1.96E+017,"testalpha"
,"screening of monoclonal gammopathies","NN IN JJ NNS",4,1,1,16956121,2,2.76E+018,"testalpha"
,"heterogeneityin stage of change"," NN IN NN",4,1,1,16365327,"pubmed1",6.16E+018,"testalpha"
,"nocardiopsis sp strain f","NN  NN NN",4,1,1,16511252,2,8.19E+018,"testalpha"
,"nasi defects following excision"," NNS VBG NN",4,1,1,17165594,2,3.86E+018,"testalpha"
,"hs mus musculus mm","  NN ",4,1,1,16733558,"pubmed1",3.84E+018,"testalpha"
,"detectable specific ige inserum","JJ JJ  NN",4,1,1,16859611,2,8.11E+018,"testalpha"
,"ability toconcentrate bad risk","NN NN JJ NN",4,1,1,16236234,"pubmed1",6.03E+018,"testalpha"
,"information isi listed radiology","NN  VBN NN",4,1,1,16399035,"pubmed1",4.17E+018,"testalpha"
,"nucleusaccumbens limbic system hippocampus","NNS JJ NN NN",4,1,1,16594639,"pubmed1",6.06E+018,"testalpha"
,"high signal in elisa","JJ NN IN ",4,1,1,17019437,"pubmed1",1.53E+018,"testalpha"
,"protein g affinity chromatography","NN  NN NN",4,1,1,17117211,"pubmed1",6.69E+018,"testalpha"
,"mg kg ast level","   NN",4,1,1,17013510,2,3.29E+018,"testalpha"
,"csav and d polylepsis"," CC  NN",4,1,1,16436788,"pubmed1",5.88E+018,"testalpha"
,"pollen wall and goldparticles","NN NN CC NNS",4,1,1,16963110,2,6.72E+017,"testalpha"
,"blocks bywater soluble exohydrolases","NNS NN JJ NNS",4,1,1,16511279,2,6.73E+018,"testalpha"
,"regulatory effect oniron absorption","JJ NN NNP NN",4,1,1,17119325,2,4.91E+018,"testalpha"
,"birefringence of msu crystals","NN IN  NNS",4,1,1,16514850,2,5.89E+018,"testalpha"
,"effects on patientsatisfaction compliance","NNS IN NN NN",4,1,1,17106601,2,3.12E+018,"testalpha"
,"higher uptake of stinto","JJR NN IN NNP",4,1,1,16584167,"pubmed1",2.88E+018,"testalpha"
,"scottish descent with hemochromatosis","JJ NN IN NN",4,1,1,16424658,2,4.01E+018,"testalpha"
,"i r than ini"," NN IN ",4,1,1,17293960,2,6.59E+018,"testalpha"
,"values or double baseline","NNS CC JJ NN",4,1,1,16424649,2,5.64E+018,"testalpha"
,"psychiatry residency review committee","NN NN NN NN",4,1,1,16473996,"pubmed1",3.01E+018,"testalpha"
,"toe nailonychomycosis positive culture","NN NN JJ NN",4,1,1,16955188,2,3.32E+018,"testalpha"
,"ofgrowth at degrees c","NN IN NNS NN",4,1,1,17019438,"pubmed1",1.55E+018,"testalpha"
,"combination of size distribution","NN IN NN NN",4,1,1,17285747,"pubmed1",1.05E+018,"testalpha"
,"unit or length ofstay","NN CC NN NN",4,1,1,16549896,2,8.95E+018,"testalpha"
,"arthritis disease activity improvement","NN NN NN NN",4,1,1,17311738,2,5.39E+018,"testalpha"
,"nucleotide metabolizing enzymes andcholinesterase","VB VBG NNS NN",4,1,1,16410836,"pubmed1",6.25E+018,"testalpha"
,"consensus peroxisome proliferatorresponsive element","NN NN JJ NN",4,1,1,16951743,"pubmed1",3.09E+018,"testalpha"
,"ona multivariate autoregressive model"," NN JJ NN",4,1,1,17133951,2,6.02E+018,"testalpha"
,"augmented quicktime vr apple","VBD JJ  NNS",4,1,1,16399038,"pubmed1",1.69E+018,"testalpha"
,"satisfaction ratings p value","NN NNS  NN",4,1,1,16436790,"pubmed1",5.42E+018,"testalpha"
,"cases with advanced stage","NNS IN VBN NN",4,1,1,16809884,2,5.17E+018,"testalpha"
,"modalities of sample preparation","NNS IN NN NN",4,1,1,16514835,2,6.30E+018,"testalpha"
,"cytokine release inhibitory drugs","NN NN NN NNS",4,1,1,17019444,"pubmed1",9.18E+018,"testalpha"
,"latex agglutinationtest and lipid","NNP NN CC NN",4,1,1,16479028,2,4.87E+018,"testalpha"
,"input was received fromthe","NN VBD VBN NNP",4,1,1,16473991,"pubmed1",7.85E+018,"testalpha"
,"cellular therapies in neurologicaldisorders","JJ NNS IN NNS",4,1,1,17265690,2,6.58E+018,"testalpha"
,"administration of ip n","NN IN  ",4,1,1,17293962,2,7.89E+018,"testalpha"
,"classification offemoral neck fractures","NN JJ NN NNS",4,1,1,16613748,2,4.58E+018,"testalpha"
,"infection epilepsy cerebral degeneration","NN NN JJ NN",4,1,1,16479025,2,6.68E+018,"testalpha"
,"sensitivity of sige tests","NN IN  NNS",4,1,1,16673562,2,2.82E+018,"testalpha"
,"histological examination of sn","JJ NN IN ",4,1,1,16491216,2,8.51E+017,"testalpha"
,"kip family ofcdk inhibitors"," NN  NNS",4,1,1,17115080,"pubmed1",6.18E+018,"testalpha"
,"vehicle person or change","NN NN CC NN",4,1,1,16129405,"pubmed1",2.51E+018,"testalpha"
,"reported inassociation with congenital","VBD NN IN NN",4,1,1,16245020,"pubmed1",5.35E+018,"testalpha"
,"high turnover of patients","JJ NN IN NNS",4,1,1,16321534,"pubmed1",8.59E+018,"testalpha"
,"sensitivity and specificity values","NN CC NN NNS",4,1,1,16399036,"pubmed1",4.60E+018,"testalpha"
,"further drink driving behaviours","JJ NN NN NNS",4,1,1,16405859,"pubmed1",5.95E+018,"testalpha"
,"thecondition that prompted admission","NN IN VBD NN",4,1,1,16462412,"pubmed1",2.25E+018,"testalpha"
,"carotenoid membrane interaction effects","VB NN NN NNS",4,1,1,16964324,"pubmed1",3.69E+018,"testalpha"
,"collection of eating habits","NN IN VBG NNS",4,1,1,16696439,2,1.13E+018,"testalpha"
,"sigma theta and zeta","NN NN CC ",4,1,1,17019444,"pubmed1",4.93E+017,"testalpha"
,"double blind sham control","JJ JJ  NN",4,1,1,16365322,"pubmed1",3.07E+018,"testalpha"
,"depression anxiety work strain","NN NN NN NN",4,1,1,16377815,"pubmed1",7.25E+018,"testalpha"
,"hemolytic anemia and birthdefects","JJ NN CC NNS",4,1,1,17010266,2,4.30E+018,"testalpha"
,"genome of f tularensis","NN IN NN NN",4,1,1,16511256,2,6.62E+018,"testalpha"
,"first unload reload tests","JJ VB NN NNS",4,1,1,16701859,"pubmed1",8.52E+018,"testalpha"
,"naja venom csav n"," NN  ",4,1,1,16436788,"pubmed1",3.75E+018,"testalpha"
,"immunolocalization and patient age","NN CC NN NN",4,1,1,16530813,2,4.55E+018,"testalpha"
,"o gal c gal","  NN ",4,1,1,16456293,2,4.32E+018,"testalpha"
,"changes in driver mortality","NNS IN NN NN",4,1,1,16236235,"pubmed1",2.80E+018,"testalpha"
,"year of case ascertainment","NN IN NN NN",4,1,1,16405857,"pubmed1",4.75E+017,"testalpha"
,"results oralpretreatment during days","NNS NN IN NNS",4,1,1,17013510,2,7.98E+018,"testalpha"
,"background aggressive non hodgkin","NN JJ  NNP",4,1,1,16424645,2,5.12E+018,"testalpha"
,"lower meanchannel fluorescence values","JJR NN NN NNS",4,1,1,17016037,2,8.49E+018,"testalpha"
,"pcr npcr viral dna","  JJ ",4,1,1,17019440,"pubmed1",1.87E+018,"testalpha"
,"effects of median barrierinstallation","NNS IN JJ NN",4,1,1,16442487,"pubmed1",3.49E+018,"testalpha"
,"subjective data from visualanalog","JJ NN IN NN",4,1,1,16436796,"pubmed1",3.05E+018,"testalpha"
,"venom csav increased survival","NN  VBN NN",4,1,1,16436788,"pubmed1",1.40E+017,"testalpha"
,"regimen followedby high dose","NN JJ JJ NN",4,1,1,16914902,2,5.02E+018,"testalpha"
,"mental status mmst test","JJ NN  NN",4,1,1,16451145,"pubmed1",2.67E+017,"testalpha"
,"departement years old women","NN NNS JJ NNS",4,1,1,17139884,2,4.99E+017,"testalpha"
,"dehydrogenase g pd activity","NN   NN",4,1,1,17046053,2,2.02E+018,"testalpha"
,"exons using dna polymerase","NNS VBG  NN",4,1,1,16582987,"pubmed1",2.10E+018,"testalpha"
,"high number of crystal","JJ NN IN NN",4,1,1,16369099,2,5.63E+016,"testalpha"
,"health education and outreach","NN NN CC NN",4,1,1,16596897,"pubmed1",1.30E+018,"testalpha"
,"joint health outcomes barriers","JJ NN NNS NNS",4,1,1,16549891,2,1.53E+018,"testalpha"
,"vibrio salmonicida catalase vsc","NNP NNP NN ",4,1,1,16511268,2,7.15E+017,"testalpha"
,"ondriving skills and capabilities","VBG NNS CC NNS",4,1,1,16061188,"pubmed1",1.90E+018,"testalpha"
,"effects on pituitary tsh","NNS IN NN ",4,1,1,16714054,2,2.82E+018,"testalpha"
,"enzyme solutions plasma urine"," NNS NNP NN",4,1,1,17285740,"pubmed1",2.39E+018,"testalpha"
,"injuries for heavy vehicle","NNS IN JJ NN",4,1,1,16221468,"pubmed1",4.52E+018,"testalpha"
,"recom mendations including advances","NNP NNS IN NNS",4,1,1,17067135,"pubmed1",6.62E+018,"testalpha"
,"carboxylate hemihydrate c h","NN NN NN ",4,1,1,16456283,2,5.82E+018,"testalpha"
,"ofsurgical therapy of lung","JJ NN IN NN",4,1,1,17117606,2,6.59E+018,"testalpha"
,"cytomorphologic features in intraoperativeimprint","JJ NNS IN NN",4,1,1,16514849,2,1.18E+018,"testalpha"
,"health agencies and relief","NN NNS CC NN",4,1,1,16400088,"pubmed1",6.65E+016,"testalpha"
,"case reports case series","NN NNS NN NN",4,1,1,16365335,"pubmed1",7.21E+018,"testalpha"
,"identification of ac andpc","NN IN  ",4,1,1,16399031,"pubmed1",1.14E+017,"testalpha"
,"t and ct cell"," CC  NN",4,1,1,16701879,"pubmed1",4.89E+018,"testalpha"
,"compound amino o methyl","NN NNP  ",4,1,1,16456292,2,7.56E+018,"testalpha"
,"hydrogen sulfurand nitrogen metabolism","NN NN NN NN",4,1,1,17143336,"pubmed1",2.38E+018,"testalpha"
,"media tgf beta protein","NNS  NN NN",4,1,1,16395524,"pubmed1",7.62E+017,"testalpha"
,"corticosteroid preparations calcipotriol tars","VB NNS  ",4,1,1,17311742,2,8.99E+017,"testalpha"
,"e g folliculitis decalvans","  NN NNS",4,1,1,17311739,2,7.16E+018,"testalpha"
,"program directors pds andcompare","NN NNS  NN",4,1,1,16436795,"pubmed1",5.91E+018,"testalpha"
,"tiger and antelope hair","NN CC NNP NN",4,1,1,16603097,2,4.66E+018,"testalpha"
,"methods thehazard of re","NNS NN IN ",4,1,1,16202465,"pubmed1",6.28E+018,"testalpha"
,"anopheles gambiae usingknown d","NNS  VBN ",4,1,1,16770443,"pubmed1",1.86E+018,"testalpha"
,"intermolecular interaction o h","JJ NN  ",4,1,1,16397328,2,8.80E+018,"testalpha"
,"tregsand skin homing t","NN NN VBG ",4,1,1,16955181,2,5.85E+018,"testalpha"
,"stem cell line hucb","VB NN NN ",4,1,1,17265690,2,4.35E+018,"testalpha"
,"concentration during hes k","NN IN  ",4,1,1,17067137,"pubmed1",8.86E+018,"testalpha"
,"early recovery after desflurane","JJ NN IN NN",4,1,1,16451145,"pubmed1",4.33E+018,"testalpha"
,"lectures advice from others","NNS NN IN NNS",4,1,1,16436795,"pubmed1",6.49E+018,"testalpha"
,"inos and tgf beta"," CC  NN",4,1,1,16762404,2,3.53E+018,"testalpha"
,"determine prothromboticstates in patients","VB NNS IN NNS",4,1,1,16696443,2,7.37E+018,"testalpha"
,"catalases andglutathione peroxidases gsh","NNS NN NNS ",4,1,1,17160142,"pubmed1",1.79E+018,"testalpha"
,"serious head injury ratesare","JJ NN NN NN",4,1,1,16223468,"pubmed1",6.07E+018,"testalpha"
,"mesophyll chloroplasts of c","NN NNS IN NN",4,1,1,17106510,"pubmed1",7.42E+018,"testalpha"
,"bisulfite toluidine pbt method","JJ NN  NN",4,1,1,16714053,2,3.39E+018,"testalpha"
,"genomic creativity enzymatic inventions","JJ NN JJ NNS",4,1,1,17347785,"pubmed1",7.59E+018,"testalpha"
,"glycolytic activity and oxygen","JJ NN CC NN",4,1,1,17068635,"pubmed1",4.83E+018,"testalpha"
,"model protein hemoglobin hb","NN NN NNP ",4,1,1,16594643,"pubmed1",4.94E+018,"testalpha"
,"addition of special ingredients","NN IN JJ NNS",4,1,1,16859617,2,2.98E+018,"testalpha"
,"cd cells at r"," NNS IN NN",4,1,1,17119322,2,6.35E+018,"testalpha"
,"authors year survival rate","NNS NN NN NN",4,1,1,17139900,2,5.37E+018,"testalpha"
,"certain aspects of cognitivefunction","JJ NNS IN NN",4,1,1,16436796,"pubmed1",4.43E+018,"testalpha"
,"total laryngectomy in patients","JJ NN IN NNS",4,1,1,16989147,2,5.45E+018,"testalpha"
,"norvegicus albinus wistar lineage","NN NN NN NN",4,1,1,17293964,2,5.79E+017,"testalpha"
,"disease or chronic liver","NN CC JJ NN",4,1,1,16479027,2,4.25E+018,"testalpha"
,"metabolism after regional myocardialischemia","NN IN JJ NN",4,1,1,16451157,"pubmed1",2.11E+018,"testalpha"
,"measurement methods of teachingand","NN NNS IN NN",4,1,1,16999271,2,3.12E+018,"testalpha"
,"elicitspecific ige and t","NNP  CC ",4,1,1,16511273,2,2.62E+018,"testalpha"
,"efficiency ofdck for clofarabine","NN  IN NN",4,1,1,16421443,2,2.30E+018,"testalpha"
,"i e iron deficiency","  NN NN",4,1,1,17119325,2,3.56E+018,"testalpha"
,"genome editing by omnipresent","NN NN IN NN",4,1,1,17347785,"pubmed1",7.78E+018,"testalpha"
,"children with high injury","NNS IN JJ NN",4,1,1,16549896,2,1.56E+018,"testalpha"
,"effectsof x ray damage"," NN  NN",4,1,1,16369092,2,8.07E+018,"testalpha"
,"heterogeneous group of disorders","JJ NN IN NNS",4,1,1,16914901,2,4.09E+018,"testalpha"
,"variables were ph bicarbonate","NNS VBD  NN",4,1,1,16491220,2,2.74E+018,"testalpha"
,"sign of active compensation","NN IN JJ NN",4,1,1,16919313,2,1.96E+018,"testalpha"
,"arare event but transposition","NN NN CC NN",4,1,1,17106514,"pubmed1",8.54E+018,"testalpha"
,"lcs but clinical sequelae"," CC JJ NNS",4,1,1,16447096,"pubmed1",9.08E+017,"testalpha"
,"united states pharmacopeial convention","VBN NNS JJ NN",4,1,1,17285738,"pubmed1",8.76E+018,"testalpha"
,"teaching and residency conferences","NN CC NN NNS",4,1,1,16436795,"pubmed1",1.14E+018,"testalpha"
,"elucidation of mechanisms anddevelopment","NN IN NNS NN",4,1,1,17265690,2,2.19E+018,"testalpha"
,"prednisolone or fludarabine topatients","NN CC NN NNS",4,1,1,16424646,2,2.78E+016,"testalpha"
,"months after adrenalectomy thepatient","NNS IN NN NN",4,1,1,16177871,"pubmed1",2.93E+018,"testalpha"
,"sphincter function after month","NN NN IN NN",4,1,1,17139887,2,9.01E+018,"testalpha"
,"substitute for endotracheal intubation","NN IN NN NN",4,1,1,16451149,"pubmed1",5.39E+018,"testalpha"
,"coarselygranular salt and pepper","JJ NN CC NN",4,1,1,16514846,2,1.80E+018,"testalpha"
,"constitutional functions of protein","JJ NNS IN NN",4,1,1,17347785,"pubmed1",3.11E+018,"testalpha"
,"analgesic efficacy of dm","NN NN IN ",4,1,1,16451144,"pubmed1",1.16E+018,"testalpha"
,"gestational age lga infants","JJ NN  NNS",4,1,1,17438837,2,9.18E+018,"testalpha"
,"pattern of eeg activity","NN IN  NN",4,1,1,17133951,2,5.49E+018,"testalpha"
,"upperand lower inflection points","NN JJR NN NNS",4,1,1,16451155,"pubmed1",1.73E+018,"testalpha"
,"plasmid dna by cells","JJ  IN NNS",4,1,1,16701879,"pubmed1",8.93E+018,"testalpha"
,"excluding repeated estimates andpatients","VBG VBN NNS NNS",4,1,1,16874420,2,3.58E+018,"testalpha"
,"lr with high risk"," IN JJ NN",4,1,1,16514834,2,5.92E+018,"testalpha"
,"groups basedon definitive diagnosis","NNS NNP JJ NN",4,1,1,17338203,2,5.33E+018,"testalpha"
,"gastrointestinal sideeffects of iron","JJ NNS IN NN",4,1,1,16424650,2,2.63E+018,"testalpha"
,"patients with microscopic polyangiitis","NNS IN NN NN",4,1,1,16648918,2,5.74E+018,"testalpha"
,"domain containing nod proteins","NN VBG NN NNS",4,1,1,16648910,2,6.06E+017,"testalpha"
,"catheter was inserted followingre","NN VBD VBN ",4,1,1,16916188,"pubmed1",1.39E+018,"testalpha"
,"condensation activation of caspase","NN NN IN NN",4,1,1,16951739,"pubmed1",7.39E+018,"testalpha"
,"minute ischemia without ipc","NN NN IN ",4,1,1,17013508,2,3.66E+018,"testalpha"
,"patients and prompt initiation","NNS CC VB NN",4,1,1,17106602,2,8.53E+018,"testalpha"
,"promutagenic exocyclic adductsinto dna","JJ JJ NNP ",4,1,1,16582987,"pubmed1",8.24E+018,"testalpha"
,"apertures oscillation width resolution","NNS NN NN NN",4,1,1,16369094,2,3.21E+018,"testalpha"
,"pyrimidinemonohydrate c h n","NN NN  ",4,1,1,16456292,2,8.44E+018,"testalpha"
,"failure and acute coronary","NN CC JJ NN",4,1,1,16377816,"pubmed1",8.74E+017,"testalpha"
,"cytokines and moleculescontaining phosphorylcholine","NNS CC VBG NN",4,1,1,16410836,"pubmed1",3.46E+018,"testalpha"
,"b cell acutelymphoblastic leukaemia","NN NN JJ NN",4,1,1,17370567,"pubmed1",8.69E+018,"testalpha"
,"aminotransferase alt glycemia gly","NN  NN ",4,1,1,17013507,2,8.59E+018,"testalpha"
,"temporal characteristics obtained fromexperiment","JJ NNS VBN NN",4,1,1,16594640,"pubmed1",6.78E+018,"testalpha"
,"tetraaquadiglycinatocobalt ii bis sulfate","NN   NN",4,1,1,16397335,2,3.78E+018,"testalpha"
,"mu thiosulfato tetrasodium i"," NN NN ",4,1,1,16397335,2,3.58E+018,"testalpha"
,"education of primary care","NN IN JJ NN",4,1,1,16696436,2,2.66E+017,"testalpha"
,"damage on eventual data","NN IN JJ NN",4,1,1,16369100,2,5.62E+018,"testalpha"
,"ofinjuries among hospital employees","NNS IN NN NNS",4,1,1,16438093,"pubmed1",7.92E+018,"testalpha"
,"received rhapc in addition","VBD  IN NN",4,1,1,16365336,"pubmed1",2.27E+018,"testalpha"
,"analyticalformulation of eclipsing ranges","NN IN VBG NNS",4,1,1,17318329,"pubmed1",5.42E+018,"testalpha"
,"ige mediated airborne allergy"," VBN NNP NN",4,1,1,17328144,2,2.05E+017,"testalpha"
,"age body mass index","NN NN NN NN",4,1,1,16479027,2,4.87E+018,"testalpha"
,"composite particles showed improvedgelation","JJ NNS VBD NN",4,1,1,17285743,"pubmed1",3.09E+018,"testalpha"
,"thepreferred fluid for resuscitation","VBN NN IN NN",4,1,1,16762404,2,9.01E+018,"testalpha"
,"assessed change over time","VBN NN IN NN",4,1,1,16377828,"pubmed1",4.76E+018,"testalpha"
,"platelets and platelet aggregation","NNS CC NN NN",4,1,1,16549889,2,4.65E+018,"testalpha"
,"qualitative morphological analyse trough","JJ JJ  NN",4,1,1,17293968,2,7.90E+018,"testalpha"
,"role in cellular response","NN IN JJ NN",4,1,1,17143336,"pubmed1",3.13E+017,"testalpha"
,"transfected purified cd cord","VBN VBN  NN",4,1,1,16404477,"pubmed1",2.77E+018,"testalpha"
,"laden macrophages myoepithelial cells","JJ NNS JJ NNS",4,1,1,16514838,2,6.05E+018,"testalpha"
,"laparotomy without artery occlusion","NN IN NN NN",4,1,1,17293970,2,7.85E+018,"testalpha"
,"acids interactionenergies in proteins","NNS NNS IN NNS",4,1,1,16823609,"pubmed1",5.20E+016,"testalpha"
,"conducive toformation of crystal","JJ NN IN NN",4,1,1,16369101,2,3.26E+018,"testalpha"
,"create value for patients","VB NN IN NNS",4,1,1,16596744,"pubmed1",2.65E+018,"testalpha"
,"po h po iii","   ",4,1,1,16456284,2,1.76E+018,"testalpha"
,"n and chronic group"," CC JJ NN",4,1,1,16491217,2,3.53E+018,"testalpha"
,"total of follicular lesions","NN IN JJ NNS",4,1,1,16514837,2,6.70E+018,"testalpha"
,"peer reviewed literature address","NN VBD NN NN",4,1,1,16596897,"pubmed1",1.39E+018,"testalpha"
,"dimerization ofhuman growth hormone","NN NN NN NN",4,1,1,16565748,"pubmed1",2.38E+018,"testalpha"
,"ac z deltaabu nme","   ",4,1,1,16528413,"pubmed1",6.28E+018,"testalpha"
,"diffusion weighted imaging sequences","NN JJ VBG NNS",4,1,1,16447077,"pubmed1",8.89E+018,"testalpha"
,"showed improvement in platelet","VBD NN IN NN",4,1,1,16809885,2,5.18E+018,"testalpha"
,"o and cmh o"," CC  ",4,1,1,16451155,"pubmed1",5.43E+018,"testalpha"
,"control in diabetic patients","NN IN JJ NNS",4,1,1,16479030,2,3.25E+018,"testalpha"
,"injurymeasures claims per employees","NNS NNS IN NNS",4,1,1,16430845,"pubmed1",3.98E+018,"testalpha"
,"models various radiological endoscopic","NNS JJ JJ NN",4,1,1,16399038,"pubmed1",4.42E+018,"testalpha"
,"medication or corset treatment","NN CC VB NN",4,1,1,17688033,2,2.00E+017,"testalpha"
,"capacity or haemoglobin haematocrit","NN CC NNP NN",4,1,1,16809888,2,2.25E+018,"testalpha"
,"nt c t r"," NN  NN",4,1,1,16424658,2,3.87E+017,"testalpha"
,"group in surgical procedures","NN IN JJ NNS",4,1,1,16451145,"pubmed1",7.58E+017,"testalpha"
,"inducedhyperthermia aberrant dopamine da","NN JJ NN ",4,1,1,16808044,"pubmed1",6.25E+018,"testalpha"
,"percentage of rai improvement","NN IN  NN",4,1,1,17311738,2,2.47E+018,"testalpha"
,"enrolled males mean age","VBD NNS VBP NN",4,1,1,16955188,2,7.62E+018,"testalpha"
,"includeshundreds of transcription factors","NNS IN NN NNS",4,1,1,16505901,"pubmed1",6.85E+018,"testalpha"
,"were included intothe study","VBD VBN NNP NN",4,1,1,17139899,2,2.17E+018,"testalpha"
,"system reliablydetected small vehicles","NN VBN JJ NNS",4,1,1,16129405,"pubmed1",6.67E+018,"testalpha"
,"describesoutcomes of several cancer","NNS IN JJ NN",4,1,1,16596897,"pubmed1",2.66E+018,"testalpha"
,"keratoconus uveitis subcapsular cataract","NN NN JJ NN",4,1,1,17106598,2,7.53E+018,"testalpha"
,"poly ethylene glycol ppdo"," NN NN ",4,1,1,16701879,"pubmed1",2.46E+017,"testalpha"
,"designers andtesters of roadside","NNS NNS IN NN",4,1,1,16054101,"pubmed1",6.73E+018,"testalpha"
,"sledding related injuriesin u","NN VBN NNP ",4,1,1,16436798,"pubmed1",2.27E+018,"testalpha"
,"ndst hdac atrx fos","   ",4,1,1,16914901,2,7.34E+018,"testalpha"
,"effects of perioperative administration","NNS IN JJ NN",4,1,1,17293972,2,1.52E+017,"testalpha"
,"safety climate likely influences","NN NN JJ NNS",4,1,1,16442068,"pubmed1",2.47E+018,"testalpha"
,"inflection points uip lip","NN NNS  NN",4,1,1,16451155,"pubmed1",5.58E+018,"testalpha"
,"atf creb family oftranscription","  NN NN",4,1,1,16395528,"pubmed1",3.01E+018,"testalpha"
,"morning report andteaching others","NN NN VBG NNS",4,1,1,16377825,"pubmed1",5.58E+018,"testalpha"
,"results shunt and v","NNS NN CC ",4,1,1,16451153,"pubmed1",7.38E+018,"testalpha"
,"using appropriate evaluation measures","VBG JJ NN NNS",4,1,1,16414003,"pubmed1",2.20E+018,"testalpha"
,"ablationwith pulsed laser energy","NN VBN NN NN",4,1,1,16612909,2,7.06E+018,"testalpha"
,"drivers used mobile phones","NNS VBN JJ NNS",4,1,1,16157285,"pubmed1",4.59E+016,"testalpha"
,"areas inthe right parotid","NNS NNP NN ",4,1,1,16514851,2,6.07E+018,"testalpha"
,"healthy males n nonsmokers","JJ NNS  NNS",4,1,1,16956116,2,2.68E+018,"testalpha"
,"inhibition of myosin ii","NN IN NNP ",4,1,1,17115079,"pubmed1",7.25E+018,"testalpha"
,"manner for evaluating thestability","NN IN VBG NN",4,1,1,17438831,2,2.07E+018,"testalpha"
,"open fractures ornonisolated ankle","JJ NNS VBN NN",4,1,1,16436790,"pubmed1",5.79E+018,"testalpha"
,"rats hadperoral retinoic acid","NNS JJ JJ NN",4,1,1,16612919,"pubmed1",8.67E+018,"testalpha"
,"inhibitor of i gdp","NN IN  ",4,1,1,17019437,"pubmed1",2.61E+018,"testalpha"
,"luminescent liquid crystals ii","NN JJ NNS ",4,1,1,16411740,"pubmed1",6.36E+018,"testalpha"
,"fungus for human beings","NN IN JJ NNS",4,1,1,16603097,2,8.50E+018,"testalpha"
,"old man withprevious obliteration","JJ NN JJ NN",4,1,1,16612926,"pubmed1",5.67E+017,"testalpha"
,"msec right branch msec"," NN NN ",4,1,1,17139884,2,6.53E+018,"testalpha"
,"aresult of work hour","NN IN NN NN",4,1,1,16377823,"pubmed1",3.38E+018,"testalpha"
,"lung and brain tissues","NN CC NN NNS",4,1,1,16762404,2,4.81E+017,"testalpha"
,"significant increase in tgf","JJ NN IN ",4,1,1,17293967,2,7.80E+017,"testalpha"
,"airway flow and pressure","NN NN CC NN",4,1,1,16399039,"pubmed1",5.92E+017,"testalpha"
,"novel area of investigation","JJ NN IN NN",4,1,1,16253314,2,2.69E+018,"testalpha"
,"sources and identifying biases","NNS CC VBG NNS",4,1,1,16221468,"pubmed1",4.15E+018,"testalpha"
,"photochemical activities between mesophyll","JJ NNS IN NN",4,1,1,17106510,"pubmed1",6.43E+018,"testalpha"
,"development agenda shouldinclude assessment","NN NN VB NN",4,1,1,16412373,"pubmed1",4.92E+018,"testalpha"
,"subsetsof cd cells cd","  NNS ",4,1,1,17119322,2,8.82E+018,"testalpha"
,"erythroidine ic nmol l","NN JJ  ",4,1,1,16594645,"pubmed1",5.55E+018,"testalpha"
,"distinctivecytology in intraoperative smears","NN IN JJ NNS",4,1,1,16514849,2,3.71E+018,"testalpha"
,"structure of ii inter","NN IN  NN",4,1,1,16456293,2,5.96E+017,"testalpha"
,"keratitis ichthyosis deafness kid","NN NN NN NN",4,1,1,17106596,2,2.97E+018,"testalpha"
,"being injured bya bicycle","VBG VBN  NN",4,1,1,16112069,"pubmed1",8.39E+018,"testalpha"
,"b cell non hodgkin","NN NN  NNP",4,1,1,16424654,2,2.05E+018,"testalpha"
,"respiratory rate heart rate","NN NN NN NN",4,1,1,16436797,"pubmed1",7.19E+018,"testalpha"
,"data of clinical applications","NNS IN JJ NNS",4,1,1,16333707,"pubmed1",6.60E+018,"testalpha"
,"early identification avoidedincisional biopsy","JJ NN JJ NN",4,1,1,16514847,2,2.50E+018,"testalpha"
,"neurosyphilistested venereal disease research","VBN NN NN NN",4,1,1,16874420,2,3.81E+018,"testalpha"
,"pregnant women with heterozygoushemoglobinopathies","JJ NNS IN NNS",4,1,1,17119327,2,3.46E+018,"testalpha"
,"activation of peripheral nmda","NN IN JJ ",4,1,1,17133957,2,6.35E+017,"testalpha"
,"twosuppressor gene products yjl","NN  NNS ",4,1,1,17146497,"pubmed1",5.93E+018,"testalpha"
,"glue tissucol duo baxter","NN NN  NN",4,1,1,16696446,2,1.61E+018,"testalpha"
,"singleintrapulmonary instillation of b","JJ NN IN NN",4,1,1,17293964,2,2.69E+018,"testalpha"
,"c fos c myc","NN  NN ",4,1,1,17115080,"pubmed1",3.17E+018,"testalpha"
,"mainpancreatic duct peripancreatic vessels","JJ  JJ NNS",4,1,1,16333694,"pubmed1",3.90E+017,"testalpha"
,"promoter regions supportsmarked cach","NN NNS VBD ",4,1,1,16951743,"pubmed1",4.33E+017,"testalpha"
,"inca free bath solution"," JJ NN NN",4,1,1,16395521,"pubmed1",3.14E+018,"testalpha"
,"pronounced hirsutism and skin","VBN NN CC NN",4,1,1,16603099,2,1.01E+018,"testalpha"
,"atherogenic index ai total","JJ NN  NN",4,1,1,17106515,"pubmed1",3.37E+018,"testalpha"
,"significant effect in cord","JJ NN IN NN",4,1,1,16549888,2,2.14E+018,"testalpha"
,"m c warr m"," NN  ",4,1,1,16405859,"pubmed1",7.02E+018,"testalpha"
,"practice by using evidence","NN IN VBG NN",4,1,1,16377816,"pubmed1",4.62E+018,"testalpha"
,"affect clinical duration orrecovery","VB JJ NN NN",4,1,1,17236635,"pubmed1",7.50E+018,"testalpha"
,"bronchialepithelial cell derived ctgf","JJ NN VBN ",4,1,1,16395527,"pubmed1",6.87E+018,"testalpha"
,"l name i r"," NN  NN",4,1,1,16764913,2,7.65E+018,"testalpha"
,"studies exploringbeta adrenergic function","NNS NN JJ NN",4,1,1,16874421,2,4.02E+018,"testalpha"
,"controls neither maternal diseases","NNS CC JJ NNS",4,1,1,16549890,2,6.94E+018,"testalpha"
,"symbolic description of theanatomy","JJ NN IN NN",4,1,1,16399038,"pubmed1",8.83E+017,"testalpha"
,"dimensions background leadership challenges","NNS NN NN NNS",4,1,1,16377814,"pubmed1",3.87E+018,"testalpha"
,"life threateningacute clinical situation","NN NN JJ NN",4,1,1,16612920,"pubmed1",2.14E+017,"testalpha"
,"modification of myosin ii","NN IN NNP ",4,1,1,17115079,"pubmed1",1.18E+018,"testalpha"
,"hydroxylase human beta globin","NN JJ NN NNP",4,1,1,16823609,"pubmed1",9.19E+018,"testalpha"
,"influence of oxalic acid","NN IN JJ NN",4,1,1,16701865,"pubmed1",4.79E+017,"testalpha"
,"cn ala thr towardscopper","   NN",4,1,1,16496037,"pubmed1",6.57E+018,"testalpha"
,"cfu g and radioactivity","  CC NN",4,1,1,17293960,2,3.25E+018,"testalpha"
,"patients with differentbcr abl","NNS IN  ",4,1,1,16914906,2,3.38E+018,"testalpha"
,"spine and upper extremity","NN CC JJ NN",4,1,1,16438094,"pubmed1",1.29E+018,"testalpha"
,"higher levels ofdna damage","JJR NNS  NN",4,1,1,16582984,"pubmed1",6.58E+018,"testalpha"
,"patients postoperative mortality rate","NNS JJ NN NN",4,1,1,17139895,2,6.57E+018,"testalpha"
,"level bloodclotting time calcium","NN VBG NN NN",4,1,1,16479024,2,9.09E+018,"testalpha"
,"high impulsivity in conjunction","JJ NN IN NN",4,1,1,16426559,"pubmed1",4.32E+018,"testalpha"
,"targeted high crash segments","VBN JJ NN NNS",4,1,1,16423319,"pubmed1",1.51E+018,"testalpha"
,"real world crashes highway","JJ NN NNS NN",4,1,1,16054101,"pubmed1",1.71E+018,"testalpha"
,"powerful stimulant of abuse","JJ NN IN NN",4,1,1,16808044,"pubmed1",7.59E+018,"testalpha"
,"andmultivariate analysis with cox","NN NN IN ",4,1,1,16451146,"pubmed1",8.45E+018,"testalpha"
,"improve outcomes for patients","VB NNS IN NNS",4,1,1,16365336,"pubmed1",8.77E+018,"testalpha"
,"seated passengers in vehicles","VBN NNS IN NNS",4,1,1,16426561,"pubmed1",8.78E+018,"testalpha"
,"level of rna metabolism","NN IN  NN",4,1,1,16951738,"pubmed1",9.08E+018,"testalpha"
,"city hospital in australia","NN NN IN NNP",4,1,1,16330213,"pubmed1",3.14E+018,"testalpha"
,"rate limiting step inactivation","NN VBG NN NN",4,1,1,16421443,2,6.18E+018,"testalpha"
,"results ts egfrand vegf","NNS  NN ",4,1,1,17139902,2,3.11E+018,"testalpha"
,"eliminating pathogenic e coli","VBG JJ  ",4,1,1,17293961,2,6.14E+018,"testalpha"
,"major injury episodes hospitalizations","JJ NN NNS NNS",4,1,1,16412373,"pubmed1",6.38E+018,"testalpha"
,"ethical principles and pitfalls","JJ NNS CC NNS",4,1,1,16400088,"pubmed1",6.50E+018,"testalpha"
,"motor vehicle injury collisions","NN NN NN NNS",4,1,1,16169506,"pubmed1",3.99E+018,"testalpha"
,"cm light dose yields"," NN NN NNS",4,1,1,16955185,2,7.36E+018,"testalpha"
,"uvb irradiationstimulated cultured keratinocytes"," VBN VBN NNS",4,1,1,17106595,2,4.29E+018,"testalpha"
,"n pyridylamino aminomethyl methylphenolato"," NNP  NN",4,1,1,16456265,2,5.72E+018,"testalpha"
,"interface is able todiscriminate","NN VBZ JJ NN",4,1,1,17143335,"pubmed1",6.05E+018,"testalpha"
,"autologous split thickness skin","JJ NN NN NN",4,1,1,16999269,2,7.16E+018,"testalpha"
,"hemoglobin level bloodclotting time","NNP NN VBG NN",4,1,1,16479024,2,4.28E+018,"testalpha"
,"cancer andits molecular links","NN NNS JJ NNS",4,1,1,16514834,2,8.06E+018,"testalpha"
,"andselected antibiotics in children","VBN NNS IN NNS",4,1,1,16365328,"pubmed1",4.77E+018,"testalpha"
,"flt lg ndst hdac","   ",4,1,1,16914901,2,8.47E+018,"testalpha"
,"activity with h o","NN IN  ",4,1,1,16410836,"pubmed1",8.83E+018,"testalpha"
,"common toother ntn hydrolases","JJ JJ  NNS",4,1,1,17143335,"pubmed1",6.35E+018,"testalpha"
,"min injection rate acetate"," NN NN NN",4,1,1,16584164,"pubmed1",6.75E+018,"testalpha"
,"positive tanzanian sti patients","JJ JJ  NNS",4,1,1,16874417,2,3.85E+018,"testalpha"
,"ability of re tobe","NN IN  ",4,1,1,16451148,"pubmed1",1.10E+018,"testalpha"
,"st of june st"," IN  ",4,1,1,17139899,2,8.56E+018,"testalpha"
,"advancement fasciocutaneousdorsal thigh flap","NN NN NN ",4,1,1,17165597,2,4.81E+018,"testalpha"
,"retrospective study included patients","JJ NN VBD NNS",4,1,1,16914904,2,1.75E+018,"testalpha"
,"groups of free living","NNS IN JJ NN",4,1,1,16951740,"pubmed1",7.77E+018,"testalpha"
,"m n g mol","   ",4,1,1,16701853,"pubmed1",5.05E+018,"testalpha"
,"vital registration data inorder","JJ NN NNS NN",4,1,1,16430844,"pubmed1",6.15E+018,"testalpha"
,"crash hospitalization and death","NN NN CC NN",4,1,1,16139232,"pubmed1",2.52E+018,"testalpha"
,"molecules on wehi cells","NNS IN  NNS",4,1,1,17117211,"pubmed1",4.24E+018,"testalpha"
,"organochlorines and organophosphate insecticides","NNS CC NN NNS",4,1,1,17016033,2,8.78E+018,"testalpha"
,"carbon oxygen hydrogen sulfurand","NN NN NN NN",4,1,1,17143336,"pubmed1",3.74E+018,"testalpha"
,"collagen fibers smooth musclecells","NN NNS JJ NNS",4,1,1,16962646,2,4.20E+018,"testalpha"
,"todui crime from arrest"," NN IN NN",4,1,1,16112068,"pubmed1",8.24E+018,"testalpha"
,"nag cr and u","  CC ",4,1,1,16956119,2,2.12E+017,"testalpha"
,"deformedileocecal junction mass lesions","JJ NN NN NNS",4,1,1,16447095,"pubmed1",8.74E+018,"testalpha"
,"glandular cells of undeterminedsignificance","JJ NNS IN NN",4,1,1,16514841,2,7.10E+018,"testalpha"
,"unwanted effects while maintainingor","JJ NNS IN NN",4,1,1,16916180,"pubmed1",9.18E+017,"testalpha"
,"initial cytologicaldiagnosis in cases","JJ NN IN NNS",4,1,1,17139883,2,8.49E+018,"testalpha"
,"findings and histopathological evidence","NNS CC JJ NN",4,1,1,16999986,2,3.11E+018,"testalpha"
,"changes indefined muscle fibres","NNS VBN NN NNS",4,1,1,16919313,2,3.83E+018,"testalpha"
,"children with mild atopicdermatitis","NNS IN JJ NN",4,1,1,17106598,2,4.76E+018,"testalpha"
,"muscle cells protein kinase","NN NNS NN NN",4,1,1,16964326,"pubmed1",4.67E+018,"testalpha"
,"growth insufficient atp production","NN JJ  NN",4,1,1,16951738,"pubmed1",2.72E+018,"testalpha"
,"immune response in cancerpatients","JJ NN IN NNS",4,1,1,16404477,"pubmed1",8.26E+018,"testalpha"
,"vapour diffusion using peg","JJ NN VBG ",4,1,1,16511283,2,3.00E+018,"testalpha"
,"efficiency oftransduction of cd","NN NN IN ",4,1,1,17160143,"pubmed1",4.77E+018,"testalpha"
,"thetime dependent tumor locus","JJ JJ NN NN",4,1,1,16988902,"pubmed1",4.18E+018,"testalpha"
,"hadsignificant decrease on attention","JJ NN IN NN",4,1,1,16479025,2,2.50E+018,"testalpha"
,"ccl mcp cxcl sdf","   ",4,1,1,16594639,"pubmed1",9.90E+017,"testalpha"
,"von willebrand factor vwf"," NN NN ",4,1,1,16424652,2,4.23E+017,"testalpha"
,"endoscopic or haptic manifestations","NN CC JJ NNS",4,1,1,16399038,"pubmed1",1.91E+018,"testalpha"
,"chow control group n","NN NN NN ",4,1,1,17293957,2,7.02E+018,"testalpha"
,"building after test ischemia","NN IN NN NN",4,1,1,17265693,2,4.91E+018,"testalpha"
,"configuration inposition was fold","NN NN VBD NN",4,1,1,16496038,"pubmed1",6.84E+017,"testalpha"
,"itspotential benefits as treatment","JJ NNS IN NN",4,1,1,16424656,2,2.78E+018,"testalpha"
,"pi ring interaction binds"," NN NN NNS",4,1,1,16397330,2,4.15E+018,"testalpha"
,"proteins andtoll like receptors","NNS NN IN NNS",4,1,1,16648910,2,1.85E+018,"testalpha"
,"accuracy of endometrial cytology","NN IN JJ NN",4,1,1,16514842,2,8.52E+018,"testalpha"
,"intensified double chop regimen","VBN JJ  NN",4,1,1,16914902,2,2.71E+018,"testalpha"
,"drug release improved skin","NN NN VBN NN",4,1,1,17285742,"pubmed1",8.73E+018,"testalpha"
,"total parenteral nutrition tpn","NN JJ NN ",4,1,1,17013518,2,5.10E+018,"testalpha"
,"analysis of cytosolic class","NN IN JJ NN",4,1,1,16511275,2,2.96E+018,"testalpha"
,"freshwater turtle chrysemys picta","NN NN  ",4,1,1,16733064,2,8.94E+018,"testalpha"
,"progression of theskin lesion","NN IN NNP NN",4,1,1,16603099,2,2.76E+018,"testalpha"
,"extramedullary hematopoiesis after granulocyte","JJ NN IN NNP",4,1,1,17016039,2,1.78E+018,"testalpha"
,"ofthe left femoral troclea","NNP VBD JJ ",4,1,1,17293971,2,4.45E+018,"testalpha"
,"nic evoked rb efflux","JJ VBD  NN",4,1,1,16594645,"pubmed1",7.50E+018,"testalpha"
,"treatment for saving cognitivefunctions","NN IN VBG NNS",4,1,1,16956120,2,5.41E+018,"testalpha"
,"immunoreactivities of enos inos","NNS IN  ",4,1,1,16762404,2,3.95E+018,"testalpha"
,"intermediate levels of flt","JJ NNS IN ",4,1,1,16914901,2,3.05E+017,"testalpha"
,"activity improvement by percent","NN NN IN NN",4,1,1,17311738,2,4.96E+018,"testalpha"
,"skeletal muscle and brain","NN NN CC NN",4,1,1,16770441,"pubmed1",6.97E+017,"testalpha"
,"persons against tumor development","NNS IN NN NN",4,1,1,17010274,2,8.13E+018,"testalpha"
,"rabbit hemorrhagic disease virus","NN JJ NN NN",4,1,1,16733562,"pubmed1",7.09E+018,"testalpha"
,"relative measures of transferability","JJ NNS IN NN",4,1,1,16414003,"pubmed1",7.31E+018,"testalpha"
,"reasonable level of precision","JJ NN IN NN",4,1,1,17285749,"pubmed1",2.04E+018,"testalpha"
,"peptide containing allylglycine residues","VB VBG NN NNS",4,1,1,16496038,"pubmed1",1.60E+018,"testalpha"
,"cd c cd cd"," NN  ",4,1,1,16733557,"pubmed1",6.92E+018,"testalpha"
,"diverse group of pigments","JJ NN IN NNS",4,1,1,16951740,"pubmed1",1.67E+018,"testalpha"
,"optical element basedglossmeter dog","JJ NN NN NN",4,1,1,16584166,"pubmed1",7.62E+018,"testalpha"
,"skinchanges and bone deformities","NNS CC NN NNS",4,1,1,17010267,2,6.19E+018,"testalpha"
,"gastresophageal refluxand anxiety states","NN NN NN NNS",4,1,1,17338194,2,9.00E+018,"testalpha"
,"types mscs and mpcs","NNS  CC ",4,1,1,16696440,2,6.77E+018,"testalpha"
,"thousands of proven carcinogens","NNS IN VBN NNS",4,1,1,16594641,"pubmed1",7.89E+018,"testalpha"
,"transplantation was cirrhosis cases","NN VBD NN NNS",4,1,1,17013513,2,3.22E+018,"testalpha"
,"results total antioxidant capacity","NNS JJ JJ NN",4,1,1,17293970,2,5.17E+017,"testalpha"
,"illness and anticipated cessation","NN CC VBN NN",4,1,1,16365327,"pubmed1",3.07E+018,"testalpha"
,"interval betweenthe spinal injection","NN NNP JJ NN",4,1,1,16617756,"pubmed1",8.19E+017,"testalpha"
,"pollen and grass andmugwort","NN CC NN NN",4,1,1,17328144,2,5.76E+018,"testalpha"
,"cholesterol or arylesterase paraoxonaseactivities","NN CC NN NNS",4,1,1,17106515,"pubmed1",5.72E+018,"testalpha"
,"number diameter and area","NN NN CC NN",4,1,1,16730053,2,5.72E+018,"testalpha"
,"major conformations of glu","JJ NNS IN ",4,1,1,16511247,2,4.84E+018,"testalpha"
,"purpose repeat impaired drivers","NN VB VBN NNS",4,1,1,16202465,"pubmed1",2.30E+018,"testalpha"
,"human papillomavirus hpv infection","JJ NN  NN",4,1,1,17010274,2,8.85E+018,"testalpha"
,"post treatment par weighting","NN NN NN NN",4,1,1,17438832,2,8.31E+018,"testalpha"
,"sternotomy and endovascular coverage","NN CC JJ NN",4,1,1,16612926,"pubmed1",3.72E+018,"testalpha"
,"processed bythe thinprep tp","VBN NNP  ",4,1,1,16514842,2,1.24E+018,"testalpha"
,"nn gypsy children bothparents"," NN NNS NNS",4,1,1,17165598,2,4.70E+018,"testalpha"
,"carbon monoxide diffusion capacity","NN VB NN NN",4,1,1,16809886,2,1.73E+018,"testalpha"
,"pph gun johnson andjohnson"," NN NN NN",4,1,1,17139887,2,4.56E+018,"testalpha"
,"protein corresponded toelevated hnrnp","NN VBN VBN ",4,1,1,16496041,"pubmed1",1.64E+018,"testalpha"
,"theireffects on membrane properties","NNS IN NN NNS",4,1,1,16964324,"pubmed1",4.65E+018,"testalpha"
,"distancesof cm and cm","  CC ",4,1,1,16874422,2,4.99E+018,"testalpha"
,"medical conditions subjective symptoms","JJ NNS JJ NNS",4,1,1,16054104,"pubmed1",8.70E+018,"testalpha"
,"individual indications contraindications andadverse","JJ NNS NNS NN",4,1,1,17236644,"pubmed1",9.19E+018,"testalpha"
,"university hospitaldepartment of dermatology","NN NN IN NN",4,1,1,17106600,2,3.36E+018,"testalpha"
,"recognition and treatment ofhyperglycemia","NN CC NN NN",4,1,1,16462412,"pubmed1",2.95E+018,"testalpha"
,"advances in cryocrystallographic techniques","NNS IN JJ NNS",4,1,1,16369092,2,6.80E+018,"testalpha"
,"raise hemoglobin hb concentrations","VB NNP  NNS",4,1,1,16809890,2,1.40E+018,"testalpha"
,"specifichaemoglobin scavenger receptor hbsr","NNP NN NN ",4,1,1,16770444,"pubmed1",6.83E+018,"testalpha"
,"wereaustralian triage scale category","JJ NN NN NN",4,1,1,16377190,"pubmed1",8.04E+018,"testalpha"
,"ada activity in psoriasis"," NN IN NN",4,1,1,16956117,2,5.06E+018,"testalpha"
,"lesions involve fibrous cap","NNS VBP JJ NN",4,1,1,17007910,2,7.65E+018,"testalpha"
,"hes k and hes","  CC ",4,1,1,17067137,"pubmed1",7.26E+018,"testalpha"
,"complexwith nucleotide free rab","NN VB JJ ",4,1,1,16511278,2,5.07E+018,"testalpha"
,"release fromair dried microspheres","NN NN VBD NNS",4,1,1,16594643,"pubmed1",7.96E+018,"testalpha"
,"pro cys motif residues","JJ  NN NNS",4,1,1,16421453,2,6.91E+018,"testalpha"
,"serum levels of ige","NN NNS IN ",4,1,1,17010262,2,9.00E+018,"testalpha"
,"promoter fragments with mutation","NN NNS IN NN",4,1,1,16395526,"pubmed1",8.33E+018,"testalpha"
,"oligoadenylated mitochondrial transcriptsare precursors","VBN JJ NN NNS",4,1,1,16389406,"pubmed1",2.55E+017,"testalpha"
,"hips after soft tissue"," IN JJ NN",4,1,1,17438833,2,1.53E+018,"testalpha"
,"discrimination function indicates time","NN NN VBZ NN",4,1,1,17133956,2,8.34E+018,"testalpha"
,"acc coexisting withdedifferentiated ones"," VBG VBN NNS",4,1,1,16514851,2,1.65E+018,"testalpha"
,"cytosolic acetyl coa hydrolase","JJ   NN",4,1,1,16951743,"pubmed1",2.77E+018,"testalpha"
,"fas expression by smoothmuscle"," NN IN NN",4,1,1,16395522,"pubmed1",8.08E+018,"testalpha"
,"targeted therapy for leukemia","VBN NN IN NN",4,1,1,16424655,2,2.81E+018,"testalpha"
,"car occupant structure multilevel","NN NN NN NN",4,1,1,16126153,"pubmed1",6.97E+018,"testalpha"
,"n acetoxy acetylaminofluorene aaaf"," NN NN ",4,1,1,17143337,"pubmed1",7.95E+017,"testalpha"
,"inch and inch vector","NN CC NN NN",4,1,1,17285748,"pubmed1",8.60E+018,"testalpha"
,"implications for road safety","NNS IN NN NN",4,1,1,16426558,"pubmed1",5.25E+018,"testalpha"
,"extension of amino acids","NN IN NNP NNS",4,1,1,16421447,2,5.47E+018,"testalpha"
,"aneurysmformation after balloon dilation","NN IN NN NN",4,1,1,16612929,"pubmed1",5.05E+017,"testalpha"
,"ct scanning magnetic resonance"," VBG JJ NN",4,1,1,16436787,"pubmed1",7.38E+018,"testalpha"
,"annexin v following days","  VBG NNS",4,1,1,17016038,2,1.09E+018,"testalpha"
,"plant type l asparaginases","NN NN  NNS",4,1,1,17143335,"pubmed1",4.87E+018,"testalpha"
,"protein and real time","NN CC JJ NN",4,1,1,16809887,2,4.10E+018,"testalpha"
,"information on saccharide inhibitionand","NN IN VB NN",4,1,1,16730370,2,3.36E+018,"testalpha"
,"factor camp responsive element","NN NN JJ NN",4,1,1,16395528,"pubmed1",8.95E+018,"testalpha"
,"partial biodegradation of methanol","JJ NN IN NN",4,1,1,17019438,"pubmed1",3.37E+018,"testalpha"
,"renal cortex were group","JJ NNP VBD NN",4,1,1,16491220,2,9.13E+018,"testalpha"
,"progression ttp andoverall survival","NN  JJ NN",4,1,1,17139902,2,6.83E+018,"testalpha"
,"thesitting drop vapor diffusion","VBG NN  NN",4,1,1,16511259,2,6.76E+018,"testalpha"
,"germ cell population throughone","NN NN NN NN",4,1,1,16919708,2,4.68E+018,"testalpha"
,"threeoxytocin analogs phe o","NNP NNS  ",4,1,1,16523218,"pubmed1",5.92E+018,"testalpha"
,"years low molecular weight","NNS JJ JJ NN",4,1,1,16549901,2,7.98E+018,"testalpha"
,"serum levels of cr","NN NNS IN ",4,1,1,16999986,2,5.71E+018,"testalpha"
,"immunohistochemistry and western blot","NN CC JJ NN",4,1,1,16325891,2,6.44E+018,"testalpha"
,"inflammatory hostresponse with elimination","JJ NN IN NN",4,1,1,16603102,2,5.38E+018,"testalpha"
,"crystallization mechanism and resultantpolymorphism","NN NN CC NN",4,1,1,16456276,2,7.16E+018,"testalpha"
,"subjects with metabolic syndrome","NNS IN JJ NN",4,1,1,16479027,2,4.33E+018,"testalpha"
,"sandwich elisa method r","NN  NN NN",4,1,1,16603096,2,6.00E+018,"testalpha"
,"patient foreach time period","NN NN NN NN",4,1,1,16436791,"pubmed1",5.99E+018,"testalpha"
,"women age range years","NNS VBP NN NNS",4,1,1,16333710,"pubmed1",2.75E+018,"testalpha"
,"endoanal ultrasound anddetermined pudendal","JJ NN VBN NN",4,1,1,17139884,2,8.81E+018,"testalpha"
,"functional outcome in mcao","JJ NN IN ",4,1,1,17265691,2,8.60E+018,"testalpha"
,"age andspecific clinical procedure","NN NNP JJ NN",4,1,1,16365337,"pubmed1",3.21E+018,"testalpha"
,"replication associated kda protein","NN VBN  NN",4,1,1,16395523,"pubmed1",2.16E+018,"testalpha"
,"aminomethyl methylphenol h ldtb"," NN  ",4,1,1,16456265,2,5.78E+018,"testalpha"
,"n ii andpoly mu","  NN ",4,1,1,16397335,2,8.38E+018,"testalpha"
,"host disease andseveral autoimmune","NN NN JJ NN",4,1,1,17016038,2,4.11E+018,"testalpha"
,"nic evoked dopamine release","JJ VBD NN NN",4,1,1,16594645,"pubmed1",3.66E+017,"testalpha"
,"spectrum of several threat","NN IN JJ NN",4,1,1,16696436,2,1.13E+017,"testalpha"
,"was mm hg conclusions","VBD   NNS",4,1,1,16491219,2,6.47E+017,"testalpha"
,"emergency department ed patient","NN NN VBD NN",4,1,1,16365329,"pubmed1",7.45E+018,"testalpha"
,"prolonged disease free survival","VBN NN JJ NN",4,1,1,16612931,"pubmed1",3.31E+018,"testalpha"
,"pennsylvania for full bayes","NNP IN JJ NNS",4,1,1,16451795,"pubmed1",3.79E+018,"testalpha"
,"organ and choroid plexus","NN CC VB NN",4,1,1,17133952,2,1.33E+017,"testalpha"
,"intent of thecommon rule","NN IN JJ NN",4,1,1,16770858,"pubmed1",9.19E+018,"testalpha"
,"function sdtf based ona","NN  VBN ",4,1,1,17133951,2,7.16E+018,"testalpha"
,"capture assay with pcrs","VB NN IN ",4,1,1,17019439,"pubmed1",7.67E+018,"testalpha"
,"metastasis or survival time","NN CC NN NN",4,1,1,16530813,2,1.94E+018,"testalpha"
,"random effect model i","JJ NN NN ",4,1,1,16126153,"pubmed1",8.04E+018,"testalpha"
,"ponv inthe desflurane vs"," NNP NN ",4,1,1,16451145,"pubmed1",9.09E+018,"testalpha"
,"malignant clone in hematologicalneoplasias","JJ NN IN NNP",4,1,1,16914909,2,7.92E+018,"testalpha"
,"cam mrnas in thenuclei"," NNP IN ",4,1,1,16949651,2,8.61E+018,"testalpha"
,"results from patients patients","NNS IN NNS NNS",4,1,1,17338203,2,7.28E+017,"testalpha"
,"type protect organs fromischemia","NN VB NNS NN",4,1,1,16365323,"pubmed1",1.59E+018,"testalpha"
,"diphosphoglycerate dpg and inositolhexakis","NN  CC NNP",4,1,1,17019442,"pubmed1",4.57E+018,"testalpha"
,"initialsetting time h hardness","VBG NN  NN",4,1,1,16701865,"pubmed1",7.74E+018,"testalpha"
,"hemihydrate c h n","NN NN  ",4,1,1,16456283,2,4.65E+017,"testalpha"
,"withchronic idiopathic myelofibrosis cimf","JJ JJ NN ",4,1,1,16424657,2,5.52E+018,"testalpha"
,"stem cell factor scf","VB NN NN ",4,1,1,16404477,"pubmed1",9.12E+018,"testalpha"
,"rapid method for screening","JJ NN IN NN",4,1,1,16584164,"pubmed1",7.16E+018,"testalpha"
,"apoptotic smooth muscle cells","JJ JJ NN NNS",4,1,1,16395522,"pubmed1",3.31E+018,"testalpha"
,"reactive oxygen and ornitrogen","JJ NN CC NN",4,1,1,16808044,"pubmed1",8.42E+018,"testalpha"
,"directors and senior residents","NNS CC JJ NNS",4,1,1,16399040,"pubmed1",6.74E+018,"testalpha"
,"decomposition of reactive oxygen","NN IN JJ NN",4,1,1,17063208,"pubmed1",5.68E+018,"testalpha"
,"toxicity scale for skin","NN NN IN NN",4,1,1,17117605,2,8.92E+018,"testalpha"
,"percentage ofnormal ejaculated spermatozoa","NN JJ VBN ",4,1,1,16330085,2,6.88E+018,"testalpha"
,"correlations with iron metabolism","NNS IN NN NN",4,1,1,17119323,2,7.60E+018,"testalpha"
,"equipment and high clientload","NN CC JJ NN",4,1,1,16438094,"pubmed1",3.62E+018,"testalpha"
,"annual event based injury","JJ NN VBN NN",4,1,1,16236234,"pubmed1",7.77E+018,"testalpha"
,"prolonged observation or admission","VBN NN CC NN",4,1,1,16365337,"pubmed1",5.30E+018,"testalpha"
,"plasminogen activator inhibitor type","NN NN NN NN",4,1,1,16549888,2,1.65E+018,"testalpha"
,"structure of f tularensis","NN IN NN NN",4,1,1,16511256,2,7.33E+017,"testalpha"
,"visual analogue scale vas","JJ NN NN ",4,1,1,17067140,"pubmed1",3.48E+018,"testalpha"
,"were controls shampinealectomy c","VBD NNS NN NN",4,1,1,16491217,2,7.82E+018,"testalpha"
,"treatment and years aftertreatment","NN CC NNS NN",4,1,1,17438831,2,3.15E+018,"testalpha"
,"ofthe patients required dialysis","NNP NNS VBN NN",4,1,1,16424647,2,3.14E+018,"testalpha"
,"postsurgical pain cpsp development","JJ NN  NN",4,1,1,17236639,"pubmed1",5.70E+018,"testalpha"
,"compare time of recovery","VB NN IN NN",4,1,1,16451145,"pubmed1",4.78E+018,"testalpha"
,"anthracenecarboxylic acid dihydroxyanthraquinone dihydroxyanthraquinone","JJ NN NN NN",4,1,1,16404478,"pubmed1",4.30E+018,"testalpha"
,"cells from normal subjects","NNS IN JJ NNS",4,1,1,17016037,2,3.48E+018,"testalpha"
,"hospitalization time in laryngeal","NN NN IN NN",4,1,1,16989147,2,4.09E+018,"testalpha"
,"mhc i molecules remains","  NNS NNS",4,1,1,16511250,2,1.36E+018,"testalpha"
,"mode of binding ofcarbohydrates","NN IN NN NNS",4,1,1,17128290,"pubmed1",1.05E+018,"testalpha"
,"emergency physicians obtained thehistory","NN NNS VBN NN",4,1,1,16436792,"pubmed1",4.07E+018,"testalpha"
,"oscillation width resolution limit","NN NN NN NN",4,1,1,16369094,2,2.20E+018,"testalpha"
,"large intestine cryptepithelial cells","JJ NN JJ NNS",4,1,1,16491217,2,7.06E+018,"testalpha"
,"identified expression of ppargamma","VBD NN IN NN",4,1,1,16809887,2,4.40E+018,"testalpha"
,"associates fta filter paper","NNS  NN NN",4,1,1,16951742,"pubmed1",9.27E+017,"testalpha"
,"maintained ed sepsis registry","VBN VBD NN NN",4,1,1,16365336,"pubmed1",1.48E+018,"testalpha"
,"cases of end stage","NNS IN NN NN",4,1,1,17013520,2,3.26E+018,"testalpha"
,"induce expression of heatshock","VB NN IN NN",4,1,1,16365323,"pubmed1",3.43E+017,"testalpha"
,"dorsal and ventral rootstumps","NN CC JJ NNS",4,1,1,16414104,2,5.49E+017,"testalpha"
,"necessary corrections regarding pahs","JJ NNS IN ",4,1,1,16404478,"pubmed1",1.77E+018,"testalpha"
,"pixel rms error nodule","NNP  NN NN",4,1,1,16399029,"pubmed1",3.93E+018,"testalpha"
,"molecular diagnostics of polg","JJ NNS IN ",4,1,1,16929381,"pubmed1",6.12E+018,"testalpha"
,"use l and l","VB  CC ",4,1,1,17010274,2,4.77E+017,"testalpha"
,"platelet function under flow","NN NN IN NN",4,1,1,16549889,2,8.74E+017,"testalpha"
,"fatalities and serious injuries","NNS CC JJ NNS",4,1,1,16221468,"pubmed1",5.38E+017,"testalpha"
,"mucous membrane salivary glands","JJ NN JJ NNS",4,1,1,17117605,2,2.16E+018,"testalpha"
,"path characteristicused is tortuousity","NN VBN VBZ NN",4,1,1,16823606,"pubmed1",1.96E+018,"testalpha"
,"nonenzymatic glycation followed bya","JJ NN VBD ",4,1,1,16696441,2,4.86E+018,"testalpha"
,"using hyaluronidase chondroitinase ac","VBG NN NN ",4,1,1,16764914,2,3.00E+018,"testalpha"
,"cell pbsc transplantation pbsct","NN  NN ",4,1,1,17119322,2,3.79E+018,"testalpha"
,"base balance improved base","NN NN VBN NN",4,1,1,16365323,"pubmed1",8.44E+018,"testalpha"
,"mass index developing standards","NN NN VBG NNS",4,1,1,16438093,"pubmed1",2.45E+018,"testalpha"
,"fluidity order and polarity","NN NN CC NN",4,1,1,16964324,"pubmed1",6.02E+018,"testalpha"
,"speeding citations and drivers","VBG NNS CC NNS",4,1,1,16405858,"pubmed1",1.11E+017,"testalpha"
,"flow global hemodynamicsand registration","NN JJ NN NN",4,1,1,16451157,"pubmed1",2.44E+018,"testalpha"
,"fertilized oocyte and precursors","VBN NNP CC NNS",4,1,1,17265694,2,1.11E+015,"testalpha"
,"measures of driving performance","NNS IN VBG NN",4,1,1,16226211,"pubmed1",3.65E+018,"testalpha"
,"decreases insupplemental opioid consumption","NNS NN VB NN",4,1,1,16451144,"pubmed1",9.13E+018,"testalpha"
,"surgical pathology ingeneral sct","JJ NN JJ ",4,1,1,16612913,"pubmed1",8.05E+018,"testalpha"
,"endosomes and lysosomes phagosome","NNS CC NNS NN",4,1,1,16365637,"pubmed1",1.80E+018,"testalpha"
,"friction and wear properties","NN CC VB NNS",4,1,1,16701857,"pubmed1",6.45E+018,"testalpha"
,"activation of response entropy","NN IN NN ",4,1,1,16451148,"pubmed1",2.65E+018,"testalpha"
,"carephysicians on cervical cytology","NNS IN JJ NN",4,1,1,16514839,2,3.20E+018,"testalpha"
,"equivalent classes ofquotient spaces","JJ NNS NN NNS",4,1,1,16823609,"pubmed1",5.57E+018,"testalpha"
,"cells on theta slides","NNS IN NN NNS",4,1,1,16514841,2,9.23E+017,"testalpha"
,"case reports demonstratethe importance","NN NNS NNP NN",4,1,1,17106602,2,5.61E+017,"testalpha"
,"molecules that inhibit thesignals","NNS IN VB NNS",4,1,1,16330085,2,7.53E+017,"testalpha"
,"activationentropy deltas j mol"," NNS  ",4,1,1,17117212,"pubmed1",5.40E+018,"testalpha"
,"prevalence ofthyroidopathies diabetes mellitus","NN NNS NN NN",4,1,1,16710576,2,8.11E+018,"testalpha"
,"gouty tophi giant cell","NN  NN NN",4,1,1,16514850,2,3.64E+017,"testalpha"
,"changing dynamics in ct","VBG NNS IN ",4,1,1,16762403,2,1.65E+018,"testalpha"
,"various typesof inflammatory cells","JJ  JJ NNS",4,1,1,16859611,2,6.85E+018,"testalpha"
,"isomer specific hydroxyacid dehydrogenase","NN JJ NN NN",4,1,1,16511285,2,3.07E+018,"testalpha"
,"system is feasible inthe","NN VBZ JJ NNP",4,1,1,16514835,2,8.99E+018,"testalpha"
,"lateral films of patients","JJ NNS IN NNS",4,1,1,16722348,2,8.41E+018,"testalpha"
,"asil post radiation injuri"," NN NN NNP",4,1,1,17139883,2,9.16E+018,"testalpha"
,"chronic lymphocytic leukemia b","JJ JJ NN NN",4,1,1,16424654,2,1.76E+018,"testalpha"
,"toestimate median barrier crash","NN JJ NN NN",4,1,1,16442487,"pubmed1",1.50E+018,"testalpha"
,"open clinical trial patients","JJ JJ NN NNS",4,1,1,17311738,2,9.15E+018,"testalpha"
,"multifarious nature of biodiversity","JJ NN IN NN",4,1,1,16988904,"pubmed1",8.31E+018,"testalpha"
,"alcohol drugs and medicines","NN NNS CC NNS",4,1,1,16191426,"pubmed1",4.13E+018,"testalpha"
,"fluorescence microscope after incubation","NN NN IN NN",4,1,1,16421445,2,6.05E+018,"testalpha"
,"frequency of administrative tasks","NN IN JJ NNS",4,1,1,16377825,"pubmed1",5.45E+018,"testalpha"
,"attention for unclear symptomsand","NN IN JJ NN",4,1,1,17338203,2,5.52E+018,"testalpha"
,"necrosis ofthe cytoplasmic organelles","NN NNP JJ NNS",4,1,1,16874415,2,8.94E+018,"testalpha"
,"predicted effect site concentrations","VBD NN NN NNS",4,1,1,17067138,"pubmed1",4.02E+018,"testalpha"
,"conclusion different contrast enhancementpatterns","NN JJ NN NNS",4,1,1,16333704,"pubmed1",6.94E+018,"testalpha"
,"disorder characterized bypalmoplantar hyperkeratosis","NN VBN NN NN",4,1,1,16585980,2,8.05E+018,"testalpha"
,"repeats tssr from homosapiens","VBZ  IN NNS",4,1,1,16733558,"pubmed1",3.39E+017,"testalpha"
,"dose chemotherapy in april","NN NN IN NNP",4,1,1,16809891,2,6.21E+017,"testalpha"
,"structural differences between puva","JJ NNS IN ",4,1,1,17016038,2,5.62E+018,"testalpha"
,"thoracic drains placement andpatients","JJ NNS NN NNS",4,1,1,16956123,2,7.62E+018,"testalpha"
,"forming proteins named septins","VBG NNS VBN NNS",4,1,1,16511282,2,4.09E+018,"testalpha"
,"b immunoglobuling fusion protein","NN VBG NN NN",4,1,1,17117211,"pubmed1",2.64E+018,"testalpha"
,"space group i ori","NN NN  ",4,1,1,16511274,2,5.16E+018,"testalpha"
,"subsets of cd cells","NNS IN  NNS",4,1,1,17119322,2,8.26E+018,"testalpha"
,"pain wasassessed pre illumination","NN VBN  NN",4,1,1,16955184,2,5.80E+018,"testalpha"
,"reduced risk of head","VBN NN IN NN",4,1,1,16417901,"pubmed1",9.00E+018,"testalpha"
,"time and night time","NN CC NN NN",4,1,1,16171767,"pubmed1",6.05E+018,"testalpha"
,"virus in liver injury","NN IN NN NN",4,1,1,16696442,2,5.60E+018,"testalpha"
,"rabbits showed sustained release","NNS VBD VBN NN",4,1,1,16584139,"pubmed1",5.95E+018,"testalpha"
,"man with hepatitis c","NN IN NN NN",4,1,1,17119328,2,4.58E+018,"testalpha"
,"prevention www cdc gov","NN   ",4,1,1,16438095,"pubmed1",9.09E+018,"testalpha"
,"cell divisions replicative life","NN NNS JJ NN",4,1,1,17106513,"pubmed1",5.48E+018,"testalpha"
,"chlorphenol and phenoxyacetic acid","NN CC JJ NN",4,1,1,17016033,2,3.38E+018,"testalpha"
,"oxide synthase nos activity","VB NN NNS NN",4,1,1,16566960,2,5.91E+018,"testalpha"
,"ivig treatment of childhood"," NN IN NN",4,1,1,16424649,2,5.34E+018,"testalpha"
,"accumulation ofexcitatory amino acids","NN NN NNP NNS",4,1,1,17133953,2,9.64E+017,"testalpha"
,"protein immunoreactivity in theneocortex","NN NN IN NNP",4,1,1,17007911,2,5.70E+018,"testalpha"
,"negative correlation with vct","JJ NN IN ",4,1,1,16479025,2,7.46E+018,"testalpha"
,"distilled water and mg","VBN NN CC ",4,1,1,17013511,2,8.91E+018,"testalpha"
,"variety ofbiological events e","NN JJ NNS ",4,1,1,16696437,2,9.84E+017,"testalpha"
,"body compositionand energy expenditure","NN NN NN NN",4,1,1,16918067,"pubmed1",6.83E+018,"testalpha"
,"females age range years","NNS VBP NN NNS",4,1,1,16809886,2,4.21E+018,"testalpha"
,"differentiate into specialized tissues","NN IN VBN NNS",4,1,1,16696440,2,5.17E+018,"testalpha"
,"diabetes require adequate amounts","NN VB JJ NNS",4,1,1,16918070,"pubmed1",3.27E+018,"testalpha"
,"protein was tested forbioactivity","NN VBD VBN NN",4,1,1,17117211,"pubmed1",8.94E+018,"testalpha"
,"hospitaland report recent changes","NN NN JJ NNS",4,1,1,16321534,"pubmed1",3.01E+018,"testalpha"
,"x and healthcare providers","NN CC NN NNS",4,1,1,16710575,2,4.84E+018,"testalpha"
,"full activity after month","JJ NN IN NN",4,1,1,16956118,2,7.47E+018,"testalpha"
,"patients without extrathoracic involvement","NNS IN JJ NN",4,1,1,16696444,2,2.15E+018,"testalpha"
,"proteins yield x ray","NNS NN NN ",4,1,1,16369101,2,7.75E+018,"testalpha"
,"introduction of olanzapine mg","NN IN NN ",4,1,1,16696448,2,1.02E+018,"testalpha"
,"induce less motor block","VB JJR NN NN",4,1,1,16617756,"pubmed1",3.98E+017,"testalpha"
,"reporting process new initiatives","VBG NN JJ NNS",4,1,1,16321534,"pubmed1",9.01E+018,"testalpha"
,"sige tests with foods"," NNS IN NNS",4,1,1,16673562,2,2.90E+018,"testalpha"
,"photodynamic therapyafter superficial curettage","JJ NN JJ NN",4,1,1,16955184,2,1.04E+018,"testalpha"
,"administration is useless andcompliance","NN VBZ JJ NN",4,1,1,16809890,2,8.33E+018,"testalpha"
,"opportunities for learning interactions","NNS IN VBG NNS",4,1,1,16377827,"pubmed1",3.43E+018,"testalpha"
,"coefficient error is largelya","NN NN VBZ ",4,1,1,17285746,"pubmed1",7.40E+018,"testalpha"
,"multisessionconventional percutaneous ethanol injection","JJ JJ NN NN",4,1,1,16333710,"pubmed1",1.54E+018,"testalpha"
,"use of oral contraceptives","NN IN JJ NNS",4,1,1,16696443,2,6.05E+018,"testalpha"
,"changes of glutathione level","NNS IN NN NN",4,1,1,16404476,"pubmed1",7.90E+018,"testalpha"
,"dependent fashion by use","JJ NN IN NN",4,1,1,17285739,"pubmed1",2.16E+018,"testalpha"
,"keratosesor basal cell carcinomas","NN NN NN NNP",4,1,1,16955184,2,9.06E+018,"testalpha"
,"inducible antagonists of creb","JJ NNS IN ",4,1,1,17265688,2,1.57E+018,"testalpha"
,"time tmt b time","NN  NN NN",4,1,1,16479025,2,3.17E+018,"testalpha"
,"natural substrate htra protease","JJ NN  NN",4,1,1,17019443,"pubmed1",4.21E+018,"testalpha"
,"developmentof ad into respiratory"," NN IN NN",4,1,1,17328144,2,3.36E+018,"testalpha"
,"demographics work hours support","NNS VBP NNS NN",4,1,1,16436795,"pubmed1",6.85E+018,"testalpha"
,"fak and melanocyte migration"," CC NNP NN",4,1,1,17106595,2,2.63E+017,"testalpha"
,"light nm light dose","NN  NN NN",4,1,1,16585985,2,5.35E+018,"testalpha"
,"studies with larger case","NNS IN JJR NN",4,1,1,16956117,2,5.97E+018,"testalpha"
,"bothmodel and x ray","NN CC NN ",4,1,1,16369097,2,9.21E+018,"testalpha"
,"lesion morphology and patient","NN NN CC NN",4,1,1,16722347,2,7.70E+018,"testalpha"
,"ml group and oxygen"," NN CC NN",4,1,1,16451147,"pubmed1",4.71E+018,"testalpha"
,"use in critical care","NN IN JJ NN",4,1,1,16451154,"pubmed1",5.99E+018,"testalpha"
,"thickness skin graftsand skin","NN NN NN NN",4,1,1,17165596,2,5.33E+018,"testalpha"
,"oriented clerkships internal medicine","VBN NNS JJ NN",4,1,1,16377822,"pubmed1",3.95E+018,"testalpha"
,"bioremediation and wastewater decontamination","NN CC NN NN",4,1,1,17019438,"pubmed1",9.95E+016,"testalpha"
,"p methods male rattus"," NNS NN NN",4,1,1,17293964,2,1.72E+018,"testalpha"
,"myosin ii system andcalcium","NNP  NN NN",4,1,1,17115079,"pubmed1",3.21E+018,"testalpha"
,"start of infusion animals","NN IN NN NNS",4,1,1,16436797,"pubmed1",1.97E+018,"testalpha"
,"develop complications requiring surgery","VB NNS VBG NN",4,1,1,17338195,2,3.90E+018,"testalpha"
,"indices mean erythrocyte volume","NNS VBP NNP NN",4,1,1,16809890,2,8.60E+018,"testalpha"
,"term control of disease","VBP NN IN NN",4,1,1,16424648,2,5.55E+018,"testalpha"
,"collagen fibers inthe dermis","NN NNS NNP NN",4,1,1,16574202,2,6.76E+018,"testalpha"
,"localanesthetics in equipotent doses","NNS IN NN NNS",4,1,1,16617756,"pubmed1",3.07E+017,"testalpha"
,"was p with unit","VBD  IN NN",4,1,1,16511281,2,3.14E+018,"testalpha"
,"titles timespent accomplishing responsibilities","NNS NN VBG NNS",4,1,1,16377812,"pubmed1",9.11E+018,"testalpha"
,"agar forgram negative bacteria"," NN JJ NNS",4,1,1,17293963,2,3.38E+018,"testalpha"
,"stable plant or animal","JJ NN CC NN",4,1,1,16673562,2,7.36E+018,"testalpha"
,"combination ofthe rnai technique","NN NNP  NN",4,1,1,16395523,"pubmed1",5.34E+018,"testalpha"
,"andc h n o","   ",4,1,1,16397334,2,4.93E+018,"testalpha"
,"glass fiber reinforced composites","NN NN VBD NNS",4,1,1,16701856,"pubmed1",3.03E+018,"testalpha"
,"examination revealed eczematous changes","NN VBD JJ NNS",4,1,1,16648919,2,5.45E+018,"testalpha"
,"pressure and rate pressure","NN CC NN NN",4,1,1,17067136,"pubmed1",4.96E+018,"testalpha"
,"inflammatory effects in abdominalsepsis","JJ NNS IN NN",4,1,1,17293958,2,9.02E+017,"testalpha"
,"mm hg in thepreperitoneal","  IN NN",4,1,1,16491219,2,2.22E+018,"testalpha"
,"collisioninvolvement among g license","NN IN  NN",4,1,1,16112070,"pubmed1",2.74E+018,"testalpha"
,"scfa glutamine scfa group"," NN  NN",4,1,1,17293957,2,8.46E+018,"testalpha"
,"interactions with medical colleagues","NNS IN JJ NNS",4,1,1,16377827,"pubmed1",3.25E+018,"testalpha"
,"condition of thepatient tumor","NN IN NN NN",4,1,1,17117604,2,5.92E+018,"testalpha"
,"galactosidase assay and spectrofluorometry","NN NN CC NN",4,1,1,16701879,"pubmed1",4.88E+017,"testalpha"
,"was measured withthe warren","VBD VBN NNP NNS",4,1,1,16956116,2,2.40E+018,"testalpha"
,"group pss physiologic saline","NN  JJ NN",4,1,1,16491220,2,5.86E+018,"testalpha"
,"excretion ofurinary n acetyl","NN JJ  ",4,1,1,16956119,2,7.51E+018,"testalpha"
,"utility of human cord","NN IN JJ NN",4,1,1,17269167,2,2.65E+018,"testalpha"
,"incertified occupational health nurse","VBN JJ NN NN",4,1,1,16438092,"pubmed1",7.24E+018,"testalpha"
,"group of theobtained crystal","NN IN VBN NN",4,1,1,16511281,2,1.71E+018,"testalpha"
,"study ofeight mitochondrial transcripts","NN NN JJ NNS",4,1,1,16389406,"pubmed1",3.62E+018,"testalpha"
,"tissue and soft tissue","NN CC JJ NN",4,1,1,16696438,2,8.96E+018,"testalpha"
,"q exon nt g","   ",4,1,1,16424658,2,1.62E+018,"testalpha"
,"andlater regrowth of sensory","NN NN IN NN",4,1,1,16414104,2,1.86E+018,"testalpha"
,"fas ligand on cd"," NN IN ",4,1,1,17016035,2,3.06E+018,"testalpha"
,"found toincrease caspase activity","VBN NN NN NN",4,1,1,17128291,"pubmed1",9.02E+018,"testalpha"
,"systems and inlymphoid organs","NNS CC VB NNS",4,1,1,16770445,"pubmed1",7.98E+018,"testalpha"
,"ofthe biological available tests","NNP JJ JJ NNS",4,1,1,16673561,2,3.35E+017,"testalpha"
,"variety of cellular processes","NN IN JJ NNS",4,1,1,16511258,2,3.51E+018,"testalpha"
,"production in hela cells","NN IN  NNS",4,1,1,16951738,"pubmed1",2.59E+018,"testalpha"
,"total protein content vs","NN NN JJ ",4,1,1,16701880,"pubmed1",3.88E+018,"testalpha"
,"patientswho underwent organ transplantation"," NN NN NN",4,1,1,16710578,2,4.14E+018,"testalpha"
,"acutephysiology and chronic health","NN CC JJ NN",4,1,1,16365336,"pubmed1",7.35E+018,"testalpha"
,"reduced mu and delta","VBN  CC NN",4,1,1,16496038,"pubmed1",1.98E+018,"testalpha"
,"consistency in human subjects","NN IN JJ NNS",4,1,1,16770858,"pubmed1",7.97E+017,"testalpha"
,"influences shorterfive year survival","NNS JJ NN NN",4,1,1,17139902,2,5.92E+018,"testalpha"
,"faculty in limited studies","NN IN VBN NNS",4,1,1,16377815,"pubmed1",3.66E+018,"testalpha"
,"triglycerides whr and liver","NNS  CC NN",4,1,1,16673610,2,8.87E+018,"testalpha"
,"urethral closure under stress","JJ NN IN NN",4,1,1,16962646,2,8.61E+018,"testalpha"
,"oral lichen planus olp","JJ NNP NN ",4,1,1,16955190,2,2.55E+018,"testalpha"
,"real time pcr thatof","JJ NN  ",4,1,1,16809887,2,1.23E+018,"testalpha"
,"positive cells thedetailed optimization","JJ NNS VBN NN",4,1,1,17160143,"pubmed1",2.22E+018,"testalpha"
,"extent of ischemicbrain damage","NN IN VB NN",4,1,1,17265693,2,5.03E+017,"testalpha"
,"calcium sulfate dihydrate cimetidine","NN NN NN NN",4,1,1,17285749,"pubmed1",2.59E+018,"testalpha"
,"h type zinc finger"," NN NN NN",4,1,1,16411739,"pubmed1",2.59E+018,"testalpha"
,"high study related stress","JJ NN VBN NN",4,1,1,16236234,"pubmed1",1.33E+018,"testalpha"
,"effect of laser beam","NN IN NN NN",4,1,1,17013509,2,5.98E+018,"testalpha"
,"digital support during defecation","NN NN IN NN",4,1,1,17139884,2,6.14E+018,"testalpha"
,"dismutase sod and catalase","NN  CC NN",4,1,1,16999986,2,7.14E+018,"testalpha"
,"number of insertion attempts","NN IN NN NNS",4,1,1,16451149,"pubmed1",7.51E+018,"testalpha"
,"fractures with asteep fracture","NNS IN JJ NN",4,1,1,16613748,2,2.87E+018,"testalpha"
,"june st of december","  IN NN",4,1,1,17139899,2,1.89E+018,"testalpha"
,"based radiology subspecialty fellowshipprograms","VBN NN NN NNS",4,1,1,16399040,"pubmed1",1.77E+018,"testalpha"
,"derivatizedcalixarenes for f f","NNS IN NN NN",4,1,1,16411740,"pubmed1",9.16E+018,"testalpha"
,"variables representing risky driving","NNS VBG JJ NN",4,1,1,16443186,"pubmed1",3.11E+018,"testalpha"
,"anxiety level of pain","NN NN IN NN",4,1,1,16365322,"pubmed1",1.45E+018,"testalpha"
,"radiographs andrepair of root","NNS NN IN NN",4,1,1,16956115,2,3.17E+018,"testalpha"
,"rates by age sex","NNS IN NN NN",4,1,1,16111641,"pubmed1",9.69E+017,"testalpha"
,"results of hpv testing","NNS IN  NN",4,1,1,16514835,2,5.08E+018,"testalpha"
,"results carvedilol pretreated patients","NNS  VBN NNS",4,1,1,17338197,2,5.48E+018,"testalpha"
,"asample concept of operations","NNS NN IN NNS",4,1,1,16400088,"pubmed1",8.93E+018,"testalpha"
,"stearoyl oleoyl phosphatidylcholine stearoyl","  NN ",4,1,1,17128291,"pubmed1",7.10E+018,"testalpha"
,"malignancies disseminated fusarium infection","NNS VBN NN NN",4,1,1,16918066,"pubmed1",2.00E+018,"testalpha"
,"emphasis on shoot leaf","NN IN VB ",4,1,1,17486414,"pubmed1",2.37E+018,"testalpha"
,"anterior resection with primaryanastomosis","JJ NN IN NN",4,1,1,17139896,2,7.00E+018,"testalpha"
,"stasis capillary stasis changes","NN JJ NN NNS",4,1,1,17294912,2,2.16E+018,"testalpha"
,"conflicting reports on theirfrequencies","VBG NNS IN NNS",4,1,1,16929381,"pubmed1",1.48E+018,"testalpha"
,"inthe cytoplasm of round","NNP NN IN NN",4,1,1,16395525,"pubmed1",3.77E+018,"testalpha"
,"large set of data","JJ NN IN NNS",4,1,1,17106597,2,5.08E+018,"testalpha"
,"patients withrheumatic mitral stenosis","NNS JJ JJ NN",4,1,1,16989140,2,5.57E+018,"testalpha"
,"process affecting gene expression","NN VBG  NN",4,1,1,16582985,"pubmed1",4.65E+018,"testalpha"
,"possessing wild type enzyme","VBG JJ NN ",4,1,1,16404475,"pubmed1",6.09E+018,"testalpha"
,"c albicans fromcardiovascular system","NN NNS JJ NN",4,1,1,17311736,2,8.02E+018,"testalpha"
,"appropriate wavelength and pulse","JJ NN CC NN",4,1,1,16722347,2,8.07E+018,"testalpha"
,"airborne allergy hdm grass","NNP NN  NN",4,1,1,17328144,2,3.57E+018,"testalpha"
,"dependent half scan shadingartifact","JJ NN VB NN",4,1,1,16399032,"pubmed1",8.39E+018,"testalpha"
,"treated patients vs u","VBN NNS  ",4,1,1,17338197,2,8.02E+018,"testalpha"
,"extradiol cleaving catecholic dioxygenase"," VBG JJ NN",4,1,1,16511281,2,5.72E+017,"testalpha"
,"hypercalcemia and renal failure","NN CC JJ NN",4,1,1,16714048,2,1.93E+018,"testalpha"
,"bfgf rhbfgf on melanocyte","  IN NNP",4,1,1,17106595,2,5.73E+017,"testalpha"
,"crystalline phase upon hydration","JJ NN IN NN",4,1,1,17285743,"pubmed1",1.89E+018,"testalpha"
,"artery injection ofn methyl","NN NN  ",4,1,1,17133957,2,3.90E+018,"testalpha"
,"influence of alcohol increases","NN IN NN NNS",4,1,1,16236233,"pubmed1",4.80E+018,"testalpha"
,"lung tissues increased immunoreactivities","NN NNS VBN NNS",4,1,1,16762404,2,1.89E+018,"testalpha"
,"independent doublereadings by radiologists","JJ NNS IN NNS",4,1,1,16399036,"pubmed1",1.71E+018,"testalpha"
,"use of safer form","NN IN JJR NN",4,1,1,16673554,2,8.21E+018,"testalpha"
,"white patients smoking vs","JJ NNS NN ",4,1,1,16436792,"pubmed1",9.53E+017,"testalpha"
,"cirrhosis was induced inwistar","NN VBD VBN NN",4,1,1,17013508,2,2.25E+018,"testalpha"
,"competences integratethe whole toolbox","NNS NNP JJ NN",4,1,1,17347785,"pubmed1",6.69E+018,"testalpha"
,"adherent cells in culture","NN NNS IN NN",4,1,1,16443258,2,7.40E+018,"testalpha"
,"malaise and weight loss","NN CC NN NN",4,1,1,16447096,"pubmed1",6.29E+018,"testalpha"
,"long period further studies","JJ NN JJ NNS",4,1,1,16956117,2,4.10E+018,"testalpha"
,"levels in nonalcoholicfatty liver","NNS IN JJ NN",4,1,1,16673555,2,7.79E+018,"testalpha"
,"vntr in thevwf marker"," IN  NN",4,1,1,16424652,2,8.04E+018,"testalpha"
,"g site in avery"," NN IN NN",4,1,1,16421451,2,5.71E+017,"testalpha"
,"case by peripheral routes","NN IN JJ NNS",4,1,1,16770445,"pubmed1",5.67E+018,"testalpha"
,"ofdrivers use turn signals","NNS VB VB NNS",4,1,1,16061188,"pubmed1",3.81E+017,"testalpha"
,"inhomogeneous enhancement and peripheralenhancement","JJ NN CC NN",4,1,1,16132429,"pubmed1",3.01E+018,"testalpha"
,"oncoagulation experience with hes","NN NN IN ",4,1,1,16451158,"pubmed1",8.73E+018,"testalpha"
,"formation of new blood","NN IN JJ NN",4,1,1,16388313,"pubmed1",1.79E+018,"testalpha"
,"thebio availability of cytokines"," NN IN NNS",4,1,1,17013516,2,2.47E+018,"testalpha"
,"constants ofreactions involving quantum","NNS NNS VBG NN",4,1,1,16411736,"pubmed1",2.30E+018,"testalpha"
,"long day ld l","JJ NN  ",4,1,1,17133952,2,2.38E+018,"testalpha"
,"insulins elicited more reactions","NNS VBN JJR NNS",4,1,1,17106600,2,1.88E+018,"testalpha"
,"oversight ofresearch involving humans","NN NN VBG NNS",4,1,1,16770860,"pubmed1",5.22E+018,"testalpha"
,"ami pretreatment nadir platelet"," NN NN NN",4,1,1,16594642,"pubmed1",2.37E+018,"testalpha"
,"dose of cd cells","NN IN  NNS",4,1,1,17119322,2,7.13E+018,"testalpha"
,"inafrican american population groups","JJ JJ NN NNS",4,1,1,16596899,"pubmed1",4.52E+018,"testalpha"
,"min and hafter transformation"," CC NN NN",4,1,1,16582987,"pubmed1",4.60E+018,"testalpha"
,"disorders and extracolonic causes","NNS CC JJ NNS",4,1,1,17139890,2,9.13E+018,"testalpha"
,"anadditional c terminal extension","JJ NN NN NN",4,1,1,16421447,2,9.09E+018,"testalpha"
,"percentage of expression throughcomputer","NN IN NN NN",4,1,1,17293967,2,2.82E+018,"testalpha"
,"perceptions of employees safety","NNS IN NNS NN",4,1,1,16442068,"pubmed1",2.65E+018,"testalpha"
,"apparent effect on histology","JJ NN IN NN",4,1,1,16874412,2,3.88E+018,"testalpha"
,"differentmedia water acetone phosphate","NNP NN NN NN",4,1,1,16701874,"pubmed1",1.88E+018,"testalpha"
,"continuous performance test cpt","JJ NN NN ",4,1,1,16479025,2,2.24E+018,"testalpha"
,"sharper increase indiastolic blood","JJR NN JJ NN",4,1,1,16874421,2,7.62E+018,"testalpha"
,"changing morbidity and mortality","VBG NN CC NN",4,1,1,16859618,2,1.13E+017,"testalpha"
,"significant association of lr","JJ NN IN ",4,1,1,16514834,2,9.10E+018,"testalpha"
,"years survival for r","NNS NN IN NN",4,1,1,17139895,2,3.46E+018,"testalpha"
,"mcao rats after systemicadministration"," NNS IN NN",4,1,1,17265691,2,8.52E+018,"testalpha"
,"large diffraction quality crystals","JJ NN NN NNS",4,1,1,16511256,2,2.92E+018,"testalpha"
,"deals with i r","NNS IN  NN",4,1,1,17013514,2,3.86E+018,"testalpha"
,"andintracellular fos protein localization","JJ  NN NN",4,1,1,17007911,2,5.03E+018,"testalpha"
,"relevant ige binding sites","JJ  VBG NNS",4,1,1,16673562,2,1.82E+018,"testalpha"
,"emergency care alternative methods","NN NN NN NNS",4,1,1,16451149,"pubmed1",2.50E+018,"testalpha"
,"switch uponadenosine binding sequesters","NN NN VBG NNS",4,1,1,16421444,2,8.68E+018,"testalpha"
,"error andenhancing patient safety","NN VBG NN NN",4,1,1,16321534,"pubmed1",3.26E+018,"testalpha"
,"tumor in specific quantities","NN IN JJ NNS",4,1,1,16988902,"pubmed1",8.11E+018,"testalpha"
,"cancer diagnosis and theirphysicians","NN NN CC NNS",4,1,1,16596898,"pubmed1",9.08E+018,"testalpha"
,"constituent ina blue tattoo","NN  JJ ",4,1,1,16648911,2,2.81E+017,"testalpha"
,"specific therapy or transfusions","JJ NN CC NNS",4,1,1,16673557,2,1.77E+016,"testalpha"
,"rats weighing g n","NNS VBG  ",4,1,1,16762404,2,6.26E+018,"testalpha"
,"accordance withprevious results meis","NN JJ NNS ",4,1,1,16914901,2,8.27E+017,"testalpha"
,"particle size of nm","NN NN IN ",4,1,1,17285742,"pubmed1",8.18E+018,"testalpha"
,"profile ofadenosine deamination reaction","NN NN NN NN",4,1,1,16929383,"pubmed1",6.06E+018,"testalpha"
,"cd cd and sp","  CC ",4,1,1,16256177,2,8.65E+018,"testalpha"
,"risky behaviors risk perception","JJ NNS NN NN",4,1,1,16426559,"pubmed1",5.47E+018,"testalpha"
,"hyperthyroid patients rr vct","VB NNS  ",4,1,1,16479025,2,4.89E+018,"testalpha"
,"floor surgeon general surgeon","NN NN JJ NN",4,1,1,17139877,2,5.99E+018,"testalpha"
,"blue tattoo inkcontaining titanium","JJ  VBG NN",4,1,1,16648911,2,7.11E+018,"testalpha"
,"other groups conclusion laser","JJ NNS NN NN",4,1,1,17013509,2,2.79E+018,"testalpha"
,"nephrocalcinosis impairment of kidneyfunction","NN NN IN NN",4,1,1,17016034,2,7.58E+018,"testalpha"
,"controlled anisotropicopen pore architecture","VBN VB  NN",4,1,1,16701861,"pubmed1",3.29E+017,"testalpha"
,"ofthis expensive treatment regimen","NNP JJ NN NN",4,1,1,16549891,2,2.18E+018,"testalpha"
,"cerebral ischemia exacerbates brain","JJ NN NNS NN",4,1,1,16436794,"pubmed1",4.92E+018,"testalpha"
,"electronic injury surveillance system","JJ NN NN NN",4,1,1,16436798,"pubmed1",3.12E+018,"testalpha"
,"electrolyte solution containing polyethylene","NNP NN VBG NN",4,1,1,16447095,"pubmed1",2.81E+018,"testalpha"
,"total ige and antigen","NN  CC NN",4,1,1,16603096,2,3.60E+018,"testalpha"
,"high dose sequential chemotherapy","JJ NN JJ NN",4,1,1,16424644,2,3.06E+018,"testalpha"
,"study subjects for feedback","NN NNS IN NN",4,1,1,16252139,"pubmed1",6.41E+018,"testalpha"
,"muralthrombus and upper extremity","NNP CC JJ NN",4,1,1,16696443,2,5.40E+018,"testalpha"
,"given ip in drinkingwater","VBN  IN NN",4,1,1,17293967,2,5.42E+018,"testalpha"
,"correction ability transfer trna","NN NN VB ",4,1,1,17294912,2,4.98E+018,"testalpha"
,"time consuming cell culture","NN VBG NN NN",4,1,1,16414103,2,1.41E+018,"testalpha"
,"system ofregional ethics organizations","NN JJ NNS NNS",4,1,1,16770857,"pubmed1",6.67E+018,"testalpha"
,"protein carries atrp cys","NN VBZ  ",4,1,1,16421453,2,8.81E+018,"testalpha"
,"membrane building blocks bywater","NN NN NNS NN",4,1,1,16511279,2,1.50E+018,"testalpha"
,"radicals derived fromartery wall","NNS VBN NN NN",4,1,1,17106515,"pubmed1",6.11E+018,"testalpha"
,"name mgkg for days","NN  IN NNS",4,1,1,16764913,2,2.51E+018,"testalpha"
,"extension was traced byfluorescence","NN VBD VBN NN",4,1,1,16874412,2,4.09E+017,"testalpha"
,"dependent tumor locus volume","JJ NN NN NN",4,1,1,16988902,"pubmed1",4.80E+018,"testalpha"
,"rotation axis bridgesthe carboxylate","NN  NNP NN",4,1,1,16456283,2,9.05E+018,"testalpha"
,"reaction showedcorrelative staining patterns","NN JJ VBG NNS",4,1,1,16542712,2,7.74E+018,"testalpha"
,"noevidence of previous research","NN IN JJ NN",4,1,1,16399035,"pubmed1",2.77E+018,"testalpha"
,"difference in year patient","NN IN NN NN",4,1,1,17013505,2,2.82E+018,"testalpha"
,"inthe majority of cases","NNP NN IN NNS",4,1,1,16612920,"pubmed1",2.55E+018,"testalpha"
,"caa induced dna damage"," VBN  NN",4,1,1,16582987,"pubmed1",1.40E+018,"testalpha"
,"series of significant problems","NN IN JJ NNS",4,1,1,16770860,"pubmed1",6.54E+018,"testalpha"
,"sorption ws of composites","NN  IN NNS",4,1,1,16701862,"pubmed1",5.15E+018,"testalpha"
,"industry specific injury rates","NN JJ NN NNS",4,1,1,16430845,"pubmed1",2.47E+018,"testalpha"
,"ts egfr and vegfcarries","  CC NNS",4,1,1,17139902,2,3.47E+018,"testalpha"
,"reduce fresh gas flow","VB JJ NN NN",4,1,1,16451150,"pubmed1",9.19E+018,"testalpha"
,"suspicion of internal iliacartery","NN IN JJ NN",4,1,1,16612928,"pubmed1",5.30E+018,"testalpha"
,"indications for intestine transplantation","NNS IN NN NN",4,1,1,17013518,2,5.29E+018,"testalpha"
,"transcriptsare precursors of molecules","NN NNS IN NNS",4,1,1,16389406,"pubmed1",3.06E+018,"testalpha"
,"fiber diameter and pore","NN NN CC ",4,1,1,16701855,"pubmed1",2.39E+018,"testalpha"
,"behavior of m phenyleneethynylene","NN IN  NN",4,1,1,16411735,"pubmed1",2.07E+018,"testalpha"
,"exonuclease apredicted splicing factor","NN VBN VBG NN",4,1,1,16496042,"pubmed1",5.16E+018,"testalpha"
,"new advances in cancermetastasis","JJ NNS IN NN",4,1,1,16730054,2,4.58E+017,"testalpha"
,"fluidity of platelet membrane","NN IN NN NN",4,1,1,16523217,"pubmed1",3.02E+018,"testalpha"
,"c and c analogs","NN CC NN NNS",4,1,1,16594645,"pubmed1",2.02E+018,"testalpha"
,"years meta analysis technology","NNS  NN NN",4,1,1,16603103,2,8.38E+017,"testalpha"
,"end of surgery group","NN IN NN NN",4,1,1,16451147,"pubmed1",5.06E+018,"testalpha"
,"cumulative drug release profiles","JJ NN NN NNS",4,1,1,17285748,"pubmed1",1.16E+018,"testalpha"
,"adsorption of essential proteins","NN IN JJ NNS",4,1,1,16701860,"pubmed1",1.25E+018,"testalpha"
,"amyloid tumors in nsmm","VB NNS IN ",4,1,1,16714048,2,1.79E+018,"testalpha"
,"purple urine bag syndrome","JJ NN NN NN",4,1,1,16673616,2,8.14E+018,"testalpha"
,"use of endovascular techniques","NN IN JJ NNS",4,1,1,16314990,"pubmed1",3.87E+016,"testalpha"
,"theoretical morphospace and therelationship","JJ NN CC NN",4,1,1,17486414,"pubmed1",6.37E+018,"testalpha"
,"issues for future developments","NNS IN NN NNS",4,1,1,17285739,"pubmed1",4.28E+018,"testalpha"
,"ofnovel structures of drug","NN NNS IN NN",4,1,1,16369099,2,4.18E+018,"testalpha"
,"oxidobenzyl n pyridylamino aminomethyl","  NNP ",4,1,1,16456265,2,1.38E+018,"testalpha"
,"reverse transcription pcr rt","VB NN  ",4,1,1,17019440,"pubmed1",5.43E+018,"testalpha"
,"scores opioidconsumption or patient","NNS NN CC NN",4,1,1,16451147,"pubmed1",5.12E+018,"testalpha"
,"anhydrase vi hca vi","NN   ",4,1,1,16511271,2,5.00E+018,"testalpha"
,"mobility contractility and synthesis","NN NN CC NN",4,1,1,17013515,2,6.30E+018,"testalpha"
,"level of seat belt","NN IN NN NN",4,1,1,16236235,"pubmed1",7.47E+017,"testalpha"
,"growth media proliferating cells","NN NNS VBG NNS",4,1,1,16395527,"pubmed1",3.07E+018,"testalpha"
,"agrobacterium mediated transient expression","NN VBN NN NN",4,1,1,16395523,"pubmed1",1.92E+018,"testalpha"
,"densities in tsh cells","NNS IN  NNS",4,1,1,16714054,2,9.03E+018,"testalpha"
,"investigate risk perception impulsivity","VB NN NN NN",4,1,1,16426559,"pubmed1",5.47E+018,"testalpha"
,"automatic identification of ac","JJ NN IN ",4,1,1,16399031,"pubmed1",7.82E+018,"testalpha"
,"fitness andpractise regular exercise","NN NN JJ NN",4,1,1,16918068,"pubmed1",7.88E+018,"testalpha"
,"cell and cell substrate","NN CC NN NN",4,1,1,17049369,2,6.46E+018,"testalpha"
,"years post policy change","NNS NN NN NN",4,1,1,16169506,"pubmed1",5.11E+018,"testalpha"
,"measurements of local coronary","NNS IN JJ NN",4,1,1,16451157,"pubmed1",7.36E+018,"testalpha"
,"e and l selectins"," CC  NNS",4,1,1,16603095,2,5.83E+018,"testalpha"
,"pain patients with respect","NN NNS IN NN",4,1,1,16365321,"pubmed1",5.51E+018,"testalpha"
,"anticoagulation within minutes ofadministration","NN IN NNS NN",4,1,1,16916181,"pubmed1",4.93E+018,"testalpha"
,"other parametersthe major axis","JJ NNP JJ ",4,1,1,16399030,"pubmed1",4.39E+018,"testalpha"
,"expansion and protect activatedcd","NN CC VB ",4,1,1,16511253,2,3.08E+018,"testalpha"
,"mast cells and lymphocytes"," NNS CC NNS",4,1,1,16713618,2,5.60E+018,"testalpha"
,"althougha higher total protein"," JJR NN NN",4,1,1,16594643,"pubmed1",4.49E+018,"testalpha"
,"azs indexafter and months"," NN CC NNS",4,1,1,17328144,2,3.12E+018,"testalpha"
,"time calculation of theamount","NN NN IN NN",4,1,1,17285746,"pubmed1",1.20E+017,"testalpha"
,"care unit or length","NN NN CC NN",4,1,1,16549896,2,2.24E+018,"testalpha"
,"islet transplantation in rats","NN NN IN NNS",4,1,1,16701881,"pubmed1",6.42E+018,"testalpha"
,"satellite i rna levels","NN   NNS",4,1,1,16496041,"pubmed1",1.05E+018,"testalpha"
,"graft or abifurcated graft","NN CC VBN NN",4,1,1,16612910,2,8.44E+018,"testalpha"
,"clp and isolated cleft"," CC VBN NN",4,1,1,17165598,2,6.93E+018,"testalpha"
,"anesthetic variables fgf v","JJ NNS  ",4,1,1,16451150,"pubmed1",7.70E+018,"testalpha"
,"manifestations of cardiovascular abnormalities","NNS IN JJ NNS",4,1,1,16424656,2,7.55E+018,"testalpha"
,"clusters small papillae cell","NNS JJ NNS NN",4,1,1,16514838,2,6.44E+018,"testalpha"
,"chlamydia prevalence and kap","NNP NN CC ",4,1,1,16514839,2,7.43E+018,"testalpha"
,"rat thyroid glands andlungs","NN NN NNS NNS",4,1,1,16762403,2,1.32E+017,"testalpha"
,"penetrating injury vitalsigns intubation","JJ NN NNS NN",4,1,1,16365326,"pubmed1",8.89E+018,"testalpha"
,"vs mmol l t","   ",4,1,1,17338197,2,3.50E+018,"testalpha"
,"resident work hour restrictions","NN NN NN NNS",4,1,1,16377822,"pubmed1",8.42E+018,"testalpha"
,"lasertreatment with ruby laser","NN IN  NN",4,1,1,16710582,2,2.48E+018,"testalpha"
,"latehyper isoechoic appearance n","NN JJ NN ",4,1,1,16333704,"pubmed1",7.14E+018,"testalpha"
,"min ofbowel ischemia min"," NN NN ",4,1,1,17293960,2,1.55E+018,"testalpha"
,"mg mg in group","  IN NN",4,1,1,16612916,"pubmed1",4.74E+018,"testalpha"
,"data system with surname","NNS NN IN NN",4,1,1,16221468,"pubmed1",7.47E+018,"testalpha"
,"education and technology methods","NN CC NN NNS",4,1,1,16473991,"pubmed1",7.43E+018,"testalpha"
,"use of immunosuppressive drug","NN IN JJ NN",4,1,1,16673554,2,1.09E+018,"testalpha"
,"selection and lead optimizationprocesses","NN CC VB NNS",4,1,1,16584115,"pubmed1",2.04E+017,"testalpha"
,"higher levels of eosinophil","JJR NNS IN ",4,1,1,16859611,2,8.56E+018,"testalpha"
,"important issues regarding ageingdrivers","JJ NNS IN NNS",4,1,1,16198299,"pubmed1",2.98E+018,"testalpha"
,"tgf beta induced collagen"," NN VBN NN",4,1,1,16874413,2,8.06E+018,"testalpha"
,"species ros and rns","NN  CC ",4,1,1,16808044,"pubmed1",3.98E+018,"testalpha"
,"white matter ofthe hg","JJ NN NNP ",4,1,1,16399034,"pubmed1",6.68E+018,"testalpha"
,"lack of adequate faculty","NN IN JJ NN",4,1,1,16436795,"pubmed1",6.76E+018,"testalpha"
,"using diffusion tensor dt","VBG NN NN ",4,1,1,16399034,"pubmed1",6.44E+018,"testalpha"
,"serum and urine levels","NN CC NN NNS",4,1,1,16859611,2,5.87E+018,"testalpha"
,"healed withinmonths without complications","VBD NNS IN NNS",4,1,1,16696446,2,8.03E+018,"testalpha"
,"role of low hdl","NN IN JJ ",4,1,1,16479026,2,2.12E+017,"testalpha"
,"ratios for risk factors","NNS IN NN NNS",4,1,1,16236234,"pubmed1",4.15E+018,"testalpha"
,"ami g kg iv","   ",4,1,1,16594642,"pubmed1",7.18E+018,"testalpha"
,"integrity officials focus groups","NN NNS VBP NNS",4,1,1,16377817,"pubmed1",4.67E+017,"testalpha"
,"co morbidity secondary instability"," NN JJ NN",4,1,1,16613748,2,5.37E+018,"testalpha"
,"surface laser irradiationshows roughness","NN NN VBZ NN",4,1,1,17293968,2,5.91E+018,"testalpha"
,"vaccines novo helisen depot","NNS  NNP NN",4,1,1,16603096,2,8.10E+018,"testalpha"
,"tests functional mri positron","NNS JJ  NNP",4,1,1,16436787,"pubmed1",4.01E+018,"testalpha"
,"ability of response surface","NN IN NN NN",4,1,1,16584161,"pubmed1",5.94E+018,"testalpha"
,"vehicles with ontario licence","NNS IN NNP NN",4,1,1,16169506,"pubmed1",1.62E+017,"testalpha"
,"light on stromal precursors","NN IN JJ NNS",4,1,1,17016038,2,3.31E+018,"testalpha"
,"genomic regulation of c","JJ NN IN NN",4,1,1,17007911,2,8.49E+018,"testalpha"
,"treatmentof t gondii infections","   NNS",4,1,1,16421444,2,1.37E+018,"testalpha"
,"cohort of gulf war","NN IN NN NN",4,1,1,16405857,"pubmed1",3.89E+018,"testalpha"
,"isolation ofrnase p activity","NN NN  NN",4,1,1,16648912,2,1.37E+018,"testalpha"
,"crash road user type","NN NN NN NN",4,1,1,16221468,"pubmed1",2.22E+018,"testalpha"
,"embedded brain using gold","VBN NN VBG NN",4,1,1,16828846,2,8.38E+017,"testalpha"
,"fungus present inorganic residues","NN JJ JJ NNS",4,1,1,16603097,2,8.06E+018,"testalpha"
,"difference in crash counts","NN IN NN NNS",4,1,1,16122689,"pubmed1",8.85E+018,"testalpha"
,"combination of literature reviews","NN IN NN NNS",4,1,1,16377817,"pubmed1",2.68E+018,"testalpha"
,"significant increase of c","JJ NN IN NN",4,1,1,17007911,2,4.82E+018,"testalpha"
,"enzymatic activities and substrate","JJ NNS CC NN",4,1,1,17019438,"pubmed1",8.95E+018,"testalpha"
,"differentiation during theperiimplantation embryo","NN IN NN ",4,1,1,16808046,"pubmed1",2.55E+018,"testalpha"
,"recognition of target molecules","NN IN NN NNS",4,1,1,16411737,"pubmed1",6.90E+018,"testalpha"
,"atpulmonary function tests pfts","JJ NN NNS ",4,1,1,16809886,2,6.28E+018,"testalpha"
,"presence of establishedprothrombotic risk","NN IN JJ NN",4,1,1,16549894,2,5.72E+018,"testalpha"
,"activatory molecules i e","NN NNS  ",4,1,1,16733557,"pubmed1",9.14E+018,"testalpha"
,"microemulsion of ss smp","NN IN  ",4,1,1,16584167,"pubmed1",7.60E+017,"testalpha"
,"achievement of optimal body","NN IN JJ NN",4,1,1,16549898,2,2.28E+018,"testalpha"
,"postulatedto regulate neuronal function"," VB JJ NN",4,1,1,17265696,2,8.93E+018,"testalpha"
,"transfection of differentiated dc","NN IN VBN ",4,1,1,16404477,"pubmed1",8.28E+018,"testalpha"
,"use of high concentrations","NN IN JJ NNS",4,1,1,16511258,2,1.71E+017,"testalpha"
,"applied beta blockercontaining eye","VBN NN VBG NN",4,1,1,17106597,2,7.38E+018,"testalpha"
,"variability in dissolution measurements","NN IN NN NNS",4,1,1,16594638,"pubmed1",5.89E+018,"testalpha"
,"grades poor health status","NNS JJ NN NN",4,1,1,16236234,"pubmed1",1.34E+018,"testalpha"
,"diacetate bridged manganesecomplex di","NN VBN JJ ",4,1,1,16456265,2,4.97E+018,"testalpha"
,"strength of aglass ionomer","NN IN NN NN",4,1,1,16701865,"pubmed1",1.82E+018,"testalpha"
,"alt glycemia gly hepaticglycogen"," NN  NN",4,1,1,17013507,2,5.52E+017,"testalpha"
,"i bifurcated hydrogen bonds"," VBN NN NNS",4,1,1,16456283,2,3.80E+018,"testalpha"
,"lower workplace injury rates","JJR NN NN NNS",4,1,1,16430845,"pubmed1",3.28E+018,"testalpha"
,"study supplemental oxygen administration","NN JJ NN NN",4,1,1,16451147,"pubmed1",1.48E+018,"testalpha"
,"member amassin from thesea","NN NNP IN NNP",4,1,1,16511251,2,1.74E+018,"testalpha"
,"f f element separation","NN NN NN NN",4,1,1,16411740,"pubmed1",5.07E+018,"testalpha"
,"c h pi ring","NN   NN",4,1,1,16397330,2,4.76E+018,"testalpha"
,"electrophoresis on polyacrylamide gel","NN IN VB ",4,1,1,16424652,2,7.50E+018,"testalpha"
,"transport of arachidonoylglycerol ag","NN IN NN ",4,1,1,16808043,"pubmed1",7.91E+018,"testalpha"
,"therelevant advantages and disadvantages","JJ NNS CC NNS",4,1,1,16722344,2,6.96E+018,"testalpha"
,"hexamers at higher proteinconcentrations","NNS IN JJR NNS",4,1,1,16511254,2,6.36E+018,"testalpha"
,"pressures from cm h","NNS IN  ",4,1,1,16399039,"pubmed1",3.73E+018,"testalpha"
,"unaffected hs family members","JJ  NN NNS",4,1,1,17016037,2,8.13E+017,"testalpha"
,"control group included patients","NN NN VBD NNS",4,1,1,17328144,2,2.55E+018,"testalpha"
,"greater variability in dissolution","JJR NN IN NN",4,1,1,16594638,"pubmed1",2.96E+018,"testalpha"
,"b patients complete remission","NN NNS JJ NN",4,1,1,16424644,2,2.29E+018,"testalpha"
,"oddsand abbott biotyping method","NN NNP VBG NN",4,1,1,17311736,2,2.39E+018,"testalpha"
,"feasibility of preparing cell","NN IN VBG NN",4,1,1,16514842,2,6.92E+018,"testalpha"
,"ii dependent hydrolysis reactions"," JJ NN NNS",4,1,1,17117212,"pubmed1",1.40E+018,"testalpha"
,"microspheres althougha higher total","NNS  JJR NN",4,1,1,16594643,"pubmed1",2.01E+018,"testalpha"
,"value of spiral computerizedtomography","NN IN NN NN",4,1,1,16612913,"pubmed1",7.04E+018,"testalpha"
,"ofhydrolysis yielded activation energy","NN VBD NN NN",4,1,1,17117212,"pubmed1",7.55E+018,"testalpha"
,"decrease morbidity and mortality","VB NN CC NN",4,1,1,16462409,"pubmed1",5.18E+018,"testalpha"
,"took place in rochester","VBD NN IN NN",4,1,1,16365324,"pubmed1",9.65E+017,"testalpha"
,"resulting full thickness defect","VBG JJ NN NN",4,1,1,16722343,2,6.96E+018,"testalpha"
,"patients pneumonia in patients","NNS NNP IN NNS",4,1,1,16956118,2,8.52E+017,"testalpha"
,"d post treatment pt"," NN NN ",4,1,1,17014894,2,4.16E+018,"testalpha"
,"terminus by trna val","NN IN  ",4,1,1,16733560,"pubmed1",4.45E+017,"testalpha"
,"hps in kidney transplantrecipients"," IN NN NNS",4,1,1,16914905,2,8.08E+018,"testalpha"
,"total parenteral nutrition admixtures","JJ JJ NN NNS",4,1,1,17285747,"pubmed1",4.70E+017,"testalpha"
,"hb increase g dl"," NN  ",4,1,1,17119327,2,9.07E+018,"testalpha"
,"hsil or low grade"," CC JJ NN",4,1,1,16514835,2,9.09E+018,"testalpha"
,"type of blastic crisis","NN IN JJ NN",4,1,1,16914906,2,4.14E+018,"testalpha"
,"patients grass pollen allergens","NNS NN NN NNS",4,1,1,17328144,2,8.26E+018,"testalpha"
,"question of weighting ofcriteria","NN IN NN NNP",4,1,1,17486414,"pubmed1",3.66E+018,"testalpha"
,"kb were identified byhybridization"," VBD VBN NN",4,1,1,16365637,"pubmed1",4.45E+018,"testalpha"
,"warm edge vialsor vials","JJ NN NN NNS",4,1,1,17285744,"pubmed1",4.30E+018,"testalpha"
,"cd dr and cd","  CC ",4,1,1,17119322,2,2.09E+018,"testalpha"
,"remice at different events","NN IN JJ NNS",4,1,1,17067138,"pubmed1",6.83E+018,"testalpha"
,"recorded pathologicvalues of n","VBN NNS IN ",4,1,1,17139884,2,5.77E+018,"testalpha"
,"were allergic tothiuram mix","VBD JJ NN NN",4,1,1,16710586,2,3.89E+018,"testalpha"
,"associated withlower motorcyclist fatality","VBN NN NN NN",4,1,1,16202466,"pubmed1",8.50E+018,"testalpha"
,"stress and less satisfaction","NN CC JJR NN",4,1,1,16377820,"pubmed1",8.61E+018,"testalpha"
,"objectives to characterize emergency","NNS IN VB NN",4,1,1,16436795,"pubmed1",9.01E+018,"testalpha"
,"design urinespecimens from cases","NN NNS IN NNS",4,1,1,16514843,2,4.62E+018,"testalpha"
,"lesions allow conservative management","NNS VBP JJ NN",4,1,1,17013521,2,5.93E+017,"testalpha"
,"hepatic stellate cells hsc","JJ NN NNS ",4,1,1,17013515,2,1.93E+018,"testalpha"
,"synthase ts epidermalgrowth factor","NN  NN NN",4,1,1,17139902,2,9.44E+017,"testalpha"
,"dynamic morphology theclear separation","JJ NN JJ NN",4,1,1,17486414,"pubmed1",5.12E+018,"testalpha"
,"relapses before clinical findings","NNS IN JJ NNS",4,1,1,16956117,2,5.46E+018,"testalpha"
,"strictenforcement of match rules","NN IN VB NNS",4,1,1,16399040,"pubmed1",5.64E+018,"testalpha"
,"disturbances in methylation processes","NNS IN NN NNS",4,1,1,17265692,2,4.13E+018,"testalpha"
,"normal karyotypes xy r","JJ NNS  NN",4,1,1,16914909,2,4.68E+018,"testalpha"
,"factor scf and flt","NN  CC ",4,1,1,16404477,"pubmed1",7.19E+018,"testalpha"
,"author reported extramural fundingrates","NN VBD JJ NNS",4,1,1,16365335,"pubmed1",4.84E+018,"testalpha"
,"contacts stabilizethe crystal structure","NNS NNP NN NN",4,1,1,16456296,2,1.70E+018,"testalpha"
,"sma and desminimmunopositive ito"," CC JJ ",4,1,1,16256175,2,4.19E+018,"testalpha"
,"mis were anterolateral cases"," VBD JJ NNS",4,1,1,16914907,2,7.91E+018,"testalpha"
,"male albino wistar rats","NN NNP NN NNS",4,1,1,17293969,2,3.07E+018,"testalpha"
,"literature for afm studies","NN IN  NNS",4,1,1,16410837,"pubmed1",1.55E+018,"testalpha"
,"markers of dental innervation","NNS IN JJ NN",4,1,1,16919707,2,2.94E+018,"testalpha"
,"determination of serum crp","NN IN NN ",4,1,1,16479028,2,7.94E+018,"testalpha"
,"cell line hucb nsc","NN NN  ",4,1,1,17265690,2,1.21E+018,"testalpha"
,"plasma gsh px activity","NNP   NN",4,1,1,17160142,"pubmed1",4.59E+018,"testalpha"
,"tests on mean differences","NNS IN VB NNS",4,1,1,16377820,"pubmed1",6.98E+018,"testalpha"
,"patients showing good control","NNS VBG JJ NN",4,1,1,16424649,2,4.51E+018,"testalpha"
,"hypoxia induced pulmonary hypertension"," VBN JJ NN",4,1,1,16537087,2,7.42E+018,"testalpha"
,"nosignificant age difference p","JJ NN NN ",4,1,1,16221468,"pubmed1",1.33E+018,"testalpha"
,"patientsthan in controls p","NNP IN NNS ",4,1,1,16730053,2,8.89E+018,"testalpha"
,"survival benefit in patients","NN NN IN NNS",4,1,1,16436794,"pubmed1",8.76E+018,"testalpha"
,"raretypes of skin reactions","NNS IN NN NNS",4,1,1,17106599,2,1.07E+018,"testalpha"
,"eczemaherpeticum of herpetic lesions","NN IN JJ NNS",4,1,1,17311741,2,2.35E+018,"testalpha"
,"granted registration number mtb","VBN NN NN ",4,1,1,16999268,2,8.70E+018,"testalpha"
,"healthcare providers n x","NN NNS  NN",4,1,1,16710575,2,7.64E+018,"testalpha"
,"arsenate monomethylarsenate mma v","NN NN  ",4,1,1,17019444,"pubmed1",7.93E+018,"testalpha"
,"employing nm uvb radiation","VBG   NN",4,1,1,16585984,2,6.85E+018,"testalpha"
,"therapeutic implications forthe development","JJ NNS NNP NN",4,1,1,16388313,"pubmed1",7.61E+018,"testalpha"
,"holarctica live vaccine strain","NNP VB NN NN",4,1,1,16511256,2,7.76E+018,"testalpha"
,"initial values within hourafter","JJ NNS IN NN",4,1,1,16594642,"pubmed1",8.19E+018,"testalpha"
,"using anumeric rating scale","VBG JJ NN NN",4,1,1,16955184,2,7.12E+017,"testalpha"
,"majority of hypoglycaemia episodes","NN IN NN NNS",4,1,1,16918071,"pubmed1",6.67E+017,"testalpha"
,"fibrosis and portal hypertension","NN CC NN NN",4,1,1,17013515,2,1.40E+018,"testalpha"
,"cardiac biomarker at admission","JJ NN IN NN",4,1,1,16365321,"pubmed1",5.90E+018,"testalpha"
,"days and nosignificant changes","NNS CC JJ NNS",4,1,1,16424649,2,6.59E+016,"testalpha"
,"attention during post treatment","NN IN NN NN",4,1,1,16333710,"pubmed1",2.95E+017,"testalpha"
,"long chain acyl coa","JJ NN  ",4,1,1,16511283,2,5.60E+018,"testalpha"
,"exogenous induction of remyelination","JJ NN IN NN",4,1,1,16956113,2,5.42E+018,"testalpha"
,"disease since recurrent aphthousstomatitis","NN IN NN NN",4,1,1,16874419,2,6.15E+017,"testalpha"
,"regulator of apoptosis andproliferation","NN IN NN NN",4,1,1,17115080,"pubmed1",6.30E+018,"testalpha"
,"chain conformations of amino","NN NNS IN NNP",4,1,1,16523218,"pubmed1",7.98E+018,"testalpha"
,"type fviiconstruct and vector","NN NN CC NN",4,1,1,16914903,2,8.99E+018,"testalpha"
,"important role inthe progression","JJ NN NNP NN",4,1,1,16673555,2,4.50E+018,"testalpha"
,"o gal with h","  IN ",4,1,1,16456293,2,9.13E+018,"testalpha"
,"lead electrocardiogram phecg interpretation","NN NN  NN",4,1,1,16365334,"pubmed1",8.80E+018,"testalpha"
,"male predominance inboth databases","NN NN JJ NNS",4,1,1,16491215,2,4.32E+018,"testalpha"
,"transient ischemic attack tia","NN JJ NN ",4,1,1,16436789,"pubmed1",2.95E+017,"testalpha"
,"abl expressing leukaemic cells"," VBG JJ NNS",4,1,1,16809884,2,3.66E+018,"testalpha"
,"daysafter elective caesarean section","NN JJ JJ NN",4,1,1,17067140,"pubmed1",1.10E+018,"testalpha"
,"kg bodyweight b i"," NN NN ",4,1,1,16549901,2,3.96E+018,"testalpha"
,"bonds and c h","NNS CC NN ",4,1,1,16397328,2,1.50E+018,"testalpha"
,"infection analsquamous intraepithelial lesions","NN JJ JJ NNS",4,1,1,17139883,2,1.26E+018,"testalpha"
,"change after duty hourrestrictions","NN IN NN NNS",4,1,1,16377825,"pubmed1",2.59E+018,"testalpha"
,"mechanisticbiology in such terms","NN IN JJ NNS",4,1,1,16988903,"pubmed1",4.49E+018,"testalpha"
,"altered regulation ofnf kappab","VBN NN  ",4,1,1,17068636,"pubmed1",3.50E+018,"testalpha"
,"uncommon primary salivary gland","JJ NN JJ NN",4,1,1,16514848,2,7.00E+018,"testalpha"
,"reduction by nad p","NN IN  ",4,1,1,16929382,"pubmed1",6.72E+018,"testalpha"
,"modified reliable change index","VBN JJ NN NN",4,1,1,16451151,"pubmed1",2.82E+018,"testalpha"
,"dna synthesis and processing"," NN CC NN",4,1,1,17143336,"pubmed1",4.05E+018,"testalpha"
,"forabdominal pelvic ct examination","JJ JJ  NN",4,1,1,16252139,"pubmed1",7.02E+018,"testalpha"
,"donator site less time","NN NN JJR NN",4,1,1,16722345,2,3.51E+018,"testalpha"
,"fb models reveal theexistence"," NNS VB NN",4,1,1,16451795,"pubmed1",2.76E+018,"testalpha"
,"groupr unit cell parameters"," NN NN NNS",4,1,1,16511283,2,6.11E+017,"testalpha"
,"patients had extrathoracic involvement","NNS VBD JJ NN",4,1,1,16696444,2,4.90E+018,"testalpha"
,"increase in right ventricle","NN IN NN NN",4,1,1,16537087,2,4.15E+017,"testalpha"
,"investigate changes indefined muscle","VB NNS VBN NN",4,1,1,16919313,2,8.50E+018,"testalpha"
,"releasing neuronal growth factors","VBG JJ NN NNS",4,1,1,17265695,2,6.53E+018,"testalpha"
,"cell saver system haemonetics","NN NN NN NNS",4,1,1,17013513,2,7.35E+018,"testalpha"
,"ondansetron mg group o","NNP  NN ",4,1,1,16451147,"pubmed1",5.23E+018,"testalpha"
,"following ivadministration of sme","VBG NN IN ",4,1,1,16584167,"pubmed1",2.32E+018,"testalpha"
,"fundingrates for original research","NNS IN JJ NN",4,1,1,16365335,"pubmed1",3.83E+018,"testalpha"
,"reporter gene chitosan edta","NN  JJ ",4,1,1,17285741,"pubmed1",1.95E+018,"testalpha"
,"regulation ofadherent hematopoietic cell","NN NN JJ NN",4,1,1,17016038,2,4.57E+018,"testalpha"
,"used forstabilizing hsa nacl","VBN VBG  ",4,1,1,17285745,"pubmed1",3.60E+018,"testalpha"
,"prehospital care in sao","NN NN IN ",4,1,1,16491215,2,3.72E+018,"testalpha"
,"arterialblood pressure inducing ischaemia","NN NN VBG NN",4,1,1,16612920,"pubmed1",8.88E+018,"testalpha"
,"increasing theexpressions of fas","VBG NNS IN ",4,1,1,17016035,2,4.15E+017,"testalpha"
,"patients hadneo adjuvant radio","NNS  JJ NN",4,1,1,16612911,2,8.16E+018,"testalpha"
,"product converted oleic acid","NN VBN JJ NN",4,1,1,17063209,"pubmed1",6.99E+018,"testalpha"
,"administration of intravenous therapy","NN IN JJ NN",4,1,1,16549897,2,7.39E+018,"testalpha"
,"effective tool allowing directenhancement","JJ NN VBG NN",4,1,1,16369101,2,1.26E+018,"testalpha"
,"study of inorganic crystal","NN IN JJ NN",4,1,1,16701861,"pubmed1",6.36E+018,"testalpha"
,"material and methods ppsb","NN CC NNS ",4,1,1,16916181,"pubmed1",2.36E+018,"testalpha"
,"mop inhibits stromal layer"," NNS JJ NN",4,1,1,17016038,2,2.53E+018,"testalpha"
,"complete release until hours","JJ NN IN NNS",4,1,1,16584161,"pubmed1",8.94E+016,"testalpha"
,"proliferator activated receptor gamma","NN VBN NN NN",4,1,1,16809887,2,6.03E+018,"testalpha"
,"patients withperitoneal cancer index","NNS NN NN NN",4,1,1,17139879,2,6.38E+018,"testalpha"
,"case of apoor response","NN IN NN NN",4,1,1,16424653,2,5.72E+018,"testalpha"
,"late stages of ards","JJ NNS IN ",4,1,1,16451155,"pubmed1",3.75E+018,"testalpha"
,"groups between control group","NNS IN NN NN",4,1,1,16612917,"pubmed1",3.44E+018,"testalpha"
,"conventional chemotherapy in hi","JJ NN IN ",4,1,1,16424644,2,8.30E+018,"testalpha"
,"females and fourmales underwent","NNS CC NNS NN",4,1,1,17139891,2,5.68E+018,"testalpha"
,"men years of age","NNS NNS IN NN",4,1,1,16914907,2,9.00E+018,"testalpha"
,"antigen ureb f ser","NN  NN ",4,1,1,16496040,"pubmed1",7.11E+018,"testalpha"
,"hospital and antifungal treatment","NN CC JJ NN",4,1,1,17370567,"pubmed1",4.52E+018,"testalpha"
,"o methyl beta d","  NN ",4,1,1,16456292,2,3.62E+018,"testalpha"
,"evaluate associations between neoplasticchanges","VB NNS IN NNS",4,1,1,16720036,2,1.27E+018,"testalpha"
,"knowledge and doctor patient","NN CC NN NN",4,1,1,17106601,2,5.92E+018,"testalpha"
,"molecular understanding ofhematologic malignancies","JJ NN JJ NNS",4,1,1,16424642,2,5.27E+018,"testalpha"
,"equal amounts of ringeracetate","JJ NNS IN NN",4,1,1,16365323,"pubmed1",1.02E+018,"testalpha"
,"year os and pfs","NN  CC ",4,1,1,16424643,2,5.33E+018,"testalpha"
,"affected stromal regulation ofadherent","VBN JJ NN NN",4,1,1,17016038,2,1.93E+018,"testalpha"
,"frequency ofgenital vulval lichen","NN NN NN NNP",4,1,1,16955190,2,8.04E+017,"testalpha"
,"pdt induced pain p"," VBN NN ",4,1,1,16955183,2,6.67E+018,"testalpha"
,"availablestructures of legume lectins","NNS IN NN NNS",4,1,1,16511291,2,2.43E+018,"testalpha"
,"increase in e clearance","NN IN  NN",4,1,1,16594642,"pubmed1",8.52E+018,"testalpha"
,"article quality circumventing detailedreview","NN NN VBG NN",4,1,1,16399035,"pubmed1",6.66E+018,"testalpha"
,"such asthe agricultural health","JJ NNP JJ NN",4,1,1,17016033,2,3.80E+018,"testalpha"
,"cell attracting chemokine ccl","NN VBG NN ",4,1,1,16955181,2,7.13E+018,"testalpha"
,"compliance and age atdiscontinuation","NN CC NN NN",4,1,1,16549891,2,5.34E+018,"testalpha"
,"amount of zea m","NN IN  ",4,1,1,16963110,2,2.73E+018,"testalpha"
,"coeliac disease since recurrent","JJ NN IN NN",4,1,1,16874419,2,7.30E+018,"testalpha"
,"commemoratethe importance of histomorphometry","NNP NN IN NN",4,1,1,16956114,2,9.10E+018,"testalpha"
,"criteria for nf diagnosis","NNS IN  NN",4,1,1,17010267,2,7.50E+018,"testalpha"
,"b hemodynamic data pg","NN JJ NN ",4,1,1,16989140,2,4.99E+018,"testalpha"
,"rat chow control group","NN NN NN NN",4,1,1,17293957,2,6.37E+018,"testalpha"
,"rates of hypoferritinemia idec","NNS IN NN ",4,1,1,16809889,2,3.33E+017,"testalpha"
,"advances in analytical technologies","NNS IN JJ NNS",4,1,1,17285738,"pubmed1",5.12E+018,"testalpha"
,"choice in terms ofcharacter","NN IN NNS NN",4,1,1,17486414,"pubmed1",1.20E+018,"testalpha"
,"conformational stiffness hydrophobic interactions","JJ NN JJ NNS",4,1,1,16365636,"pubmed1",8.94E+018,"testalpha"
,"boostedc fos mrna expression","   NN",4,1,1,17007911,2,7.99E+018,"testalpha"
,"stages of lesionformation lipid","NNS IN NN NN",4,1,1,17007910,2,2.35E+018,"testalpha"
,"high levels of safety","JJ NNS IN NN",4,1,1,16443186,"pubmed1",1.08E+018,"testalpha"
,"program local correlation coefficient","NN NN NN NN",4,1,1,16421450,2,2.10E+018,"testalpha"
,"multiple rounds of refinement","JJ NNS IN NN",4,1,1,16421450,2,4.89E+017,"testalpha"
,"intensity based segmentation ray","NN VBN NN ",4,1,1,16399038,"pubmed1",4.67E+018,"testalpha"
,"ch and ch ch"," CC  ",4,1,1,16496038,"pubmed1",6.92E+018,"testalpha"
,"essential chaperones with roles","JJ NNS IN NNS",4,1,1,16511258,2,6.90E+018,"testalpha"
,"c h n hydrogen","NN   NN",4,1,1,16456284,2,3.45E+017,"testalpha"
,"depot for atime period","NN IN JJ NN",4,1,1,16603096,2,2.94E+018,"testalpha"
,"growthhormone and human interferon","NN CC JJ NNP",4,1,1,16565748,"pubmed1",3.73E+018,"testalpha"
,"unilateral cryptorchidism model ofthe","JJ NN NN NNP",4,1,1,16395525,"pubmed1",4.72E+017,"testalpha"
,"models yield useful information","NNS NN JJ NN",4,1,1,16414003,"pubmed1",3.91E+018,"testalpha"
,"previous ponv ormotion sickness","JJ  NN NN",4,1,1,17236637,"pubmed1",5.33E+018,"testalpha"
,"group of hereditary syndromes","NN IN JJ NNS",4,1,1,17139893,2,7.48E+018,"testalpha"
,"lone l and l","JJ  CC ",4,1,1,17010274,2,1.86E+018,"testalpha"
,"laser application and gen","NN NN CC ",4,1,1,17293969,2,8.63E+018,"testalpha"
,"use of mobile phones","NN IN JJ NNS",4,1,1,16157285,"pubmed1",5.25E+018,"testalpha"
,"d pyrimidinemonohydrate c h"," NN NN ",4,1,1,16456292,2,6.40E+018,"testalpha"
,"role and expression levels","NN CC NN NNS",4,1,1,16424642,2,1.49E+018,"testalpha"
,"pressure cm h o","NN   ",4,1,1,17139884,2,7.59E+018,"testalpha"
,"tocollect thinprep cytyc corp","NN   ",4,1,1,16514841,2,8.82E+018,"testalpha"
,"show typical bond lengthsand","VBP JJ NN NN",4,1,1,16456289,2,3.96E+018,"testalpha"
,"problem of alcoholismat workplace","NN IN NN NN",4,1,1,16859619,2,4.18E+018,"testalpha"
,"study of adults withatopic","NN IN NNS NN",4,1,1,16648916,2,7.27E+018,"testalpha"
,"dose at months r","NN IN NNS NN",4,1,1,17119322,2,3.74E+018,"testalpha"
,"regular exercise and duringcompetitions","JJ NN CC NNS",4,1,1,16918070,"pubmed1",6.40E+018,"testalpha"
,"arecalled mid spectrum agents","VBN JJ NN NNS",4,1,1,16696436,2,7.63E+018,"testalpha"
,"type and demographic factors","NN CC JJ NNS",4,1,1,16405858,"pubmed1",1.57E+017,"testalpha"
,"level of dff icad","NN IN  ",4,1,1,16951739,"pubmed1",9.07E+017,"testalpha"
,"consecutive patients and visitors","JJ NNS CC NNS",4,1,1,16365327,"pubmed1",9.33E+017,"testalpha"
,"great deal of expertise","JJ NN IN NN",4,1,1,16421450,2,1.92E+018,"testalpha"
,"normal liver texture grade","JJ NN NN NN",4,1,1,16673610,2,1.30E+018,"testalpha"
,"sonography of leg veins","NN IN NN NNS",4,1,1,16603099,2,6.14E+018,"testalpha"
,"monochromatic excimer light therapy","JJ NN JJ NN",4,1,1,16585984,2,5.84E+017,"testalpha"
,"summit on medical student","NN IN JJ NN",4,1,1,16473991,"pubmed1",3.65E+017,"testalpha"
,"average fall in plasma","JJ NN IN NNP",4,1,1,16918071,"pubmed1",7.41E+018,"testalpha"
,"bis pyridylmethyl aminomethyl n","   ",4,1,1,16456265,2,7.18E+018,"testalpha"
,"theimmunity pathogenesis of itp","NN NN IN ",4,1,1,17016035,2,5.96E+018,"testalpha"
,"acute renalfunction and calcium","JJ NN CC NN",4,1,1,17016034,2,7.19E+018,"testalpha"
,"ponv requires accurate riskstratification"," VBZ JJ NN",4,1,1,17236637,"pubmed1",1.55E+018,"testalpha"
,"fnawhen atypical cytomorphologic characteristics","NNP JJ JJ NNS",4,1,1,16514848,2,8.20E+018,"testalpha"
,"findings of autoimmune pancreatitis","NNS IN NN NN",4,1,1,16333694,"pubmed1",8.31E+018,"testalpha"
,"apo form of rhoa"," NN IN ",4,1,1,17019437,"pubmed1",7.12E+018,"testalpha"
,"blood of swiss albino","NN IN JJ NNP",4,1,1,16584167,"pubmed1",6.16E+017,"testalpha"
,"clear majority of head","JJ NN IN NN",4,1,1,16423319,"pubmed1",1.16E+018,"testalpha"
,"time and tmt b","NN CC  NN",4,1,1,16479025,2,4.23E+018,"testalpha"
,"permeability assay and caco","NN NN CC ",4,1,1,16584115,"pubmed1",3.25E+018,"testalpha"
,"colonic symptoms in clinicalpractice","JJ NNS IN NN",4,1,1,16989154,2,1.82E+018,"testalpha"
,"pituitary adrenal hpa axis","NN NN  ",4,1,1,16462408,"pubmed1",3.12E+017,"testalpha"
,"diagnosis of ulcerative colitis","NN IN JJ NN",4,1,1,16603100,2,3.12E+018,"testalpha"
,"deep vein thrombosis dvt","JJ NN NN ",4,1,1,16549898,2,7.23E+018,"testalpha"
,"intron variable number oftandem","NNP JJ NN NNP",4,1,1,16424652,2,9.01E+018,"testalpha"
,"kinetic stability of theemulsions","JJ NN IN NNS",4,1,1,17285747,"pubmed1",1.79E+018,"testalpha"
,"elongating spermatids within seminiferoustubules","VBG NNS IN NNS",4,1,1,16395525,"pubmed1",4.61E+018,"testalpha"
,"aromaticpi pi stacking interactions","  VBG NNS",4,1,1,16456284,2,7.28E+016,"testalpha"
,"respiratory symptoms ad rs","NN NNS NN ",4,1,1,16859613,2,2.24E+018,"testalpha"
,"prevention potential of thistreatment","NN NN IN NN",4,1,1,16585985,2,1.71E+018,"testalpha"
,"novo helisen depot allergyvaccines"," NNP NN NNS",4,1,1,17328144,2,2.37E+018,"testalpha"
,"disease mannanoligosacharides g animal","NN NNS  NN",4,1,1,17293961,2,7.29E+017,"testalpha"
,"permeability and transport characteristicsof","NN CC NN ",4,1,1,16584115,"pubmed1",6.76E+018,"testalpha"
,"bowelischemia min of reperfusion","NN  IN NN",4,1,1,17293960,2,6.45E+018,"testalpha"
,"showeda similar thin fiber","NNP JJ JJ NN",4,1,1,16899283,2,6.32E+018,"testalpha"
,"results bipolar affective disordermay","NNS JJ JJ NN",4,1,1,16733555,"pubmed1",2.11E+018,"testalpha"
,"recorded pulse methylprednisolone therapy","VBN NN NN NN",4,1,1,16955189,2,7.43E+018,"testalpha"
,"twoinverse sa responsive elements","NN  JJ NNS",4,1,1,16395526,"pubmed1",6.56E+018,"testalpha"
,"use of specific transcription","NN IN JJ NN",4,1,1,17285739,"pubmed1",2.55E+018,"testalpha"
,"homozygous cys gly mutation","JJ   NN",4,1,1,16914903,2,1.22E+018,"testalpha"
,"ofdissolution medium on matrix","NN NN IN NNP",4,1,1,16584139,"pubmed1",6.87E+018,"testalpha"
,"cytokinasis vesicle trafficking apoptosis","NN NN NN NN",4,1,1,16511282,2,4.30E+018,"testalpha"
,"metastatic tumorwith multicentric involvement","JJ NN JJ NN",4,1,1,16514850,2,3.67E+018,"testalpha"
,"hospital stay early surgery","NN NN JJ NN",4,1,1,16613748,2,1.18E+018,"testalpha"
,"sme and ssme weretransparent"," CC  NN",4,1,1,16584167,"pubmed1",7.07E+018,"testalpha"
,"perceptions ofthe national resident","NNS NNP JJ NN",4,1,1,16399040,"pubmed1",4.16E+018,"testalpha"
,"differentiation grade of primarytumors","NN NN IN NNS",4,1,1,16430945,2,4.79E+018,"testalpha"
,"foster research training inpsychiatry","VB NN NN NN",4,1,1,16473989,"pubmed1",4.18E+018,"testalpha"
,"applying computer technology toeducation","VBG NN NN NN",4,1,1,16473991,"pubmed1",3.81E+018,"testalpha"
,"number of cd cells","NN IN  NNS",4,1,1,17119322,2,4.61E+018,"testalpha"
,"heterozygous deficiencies of fii","JJ NNS IN ",4,1,1,16424651,2,3.35E+018,"testalpha"
,"wild type andmutant codons","JJ NN JJ NNS",4,1,1,16823609,"pubmed1",1.50E+018,"testalpha"
,"care and resident education","NN CC NN NN",4,1,1,16377824,"pubmed1",4.22E+018,"testalpha"
,"duration of profound neutropenia","NN IN JJ NNP",4,1,1,16424643,2,8.35E+018,"testalpha"
,"artery smooth muscle cells","NN JJ NN NNS",4,1,1,16395522,"pubmed1",3.27E+017,"testalpha"
,"labeled red blood cells","VBD JJ NN NNS",4,1,1,17016037,2,7.59E+018,"testalpha"
,"interventional therapies in themanagement","JJ NNS IN NN",4,1,1,16673565,2,4.26E+018,"testalpha"
,"strong connections amongalgebraic relationships","JJ NNS JJ NNS",4,1,1,16823609,"pubmed1",6.32E+018,"testalpha"
,"following significant risk factors","VBG JJ NN NNS",4,1,1,16054104,"pubmed1",5.01E+018,"testalpha"
,"cases of skeletal tb","NNS IN NN ",4,1,1,16612935,"pubmed1",8.46E+018,"testalpha"
,"stress conditions such asischemia","NN NNS JJ NN",4,1,1,16770441,"pubmed1",9.21E+018,"testalpha"
,"age presence ofbleeding location","NN NN VBG NN",4,1,1,16585990,2,5.30E+017,"testalpha"
,"range ic micromol l","NN JJ  ",4,1,1,16594645,"pubmed1",8.52E+018,"testalpha"
,"tothe spastic hip subluxation","NNP JJ NN NN",4,1,1,17438833,2,8.68E+018,"testalpha"
,"increased lifespan hiv patients","VBN NNP  NNS",4,1,1,16462405,"pubmed1",8.56E+018,"testalpha"
,"prediction of injury severity","NN IN NN NN",4,1,1,16197912,"pubmed1",8.37E+018,"testalpha"
,"age drivers travelling morekilometres","NN NNS VBG NNS",4,1,1,16426560,"pubmed1",2.68E+018,"testalpha"
,"titres of mpo anca","NNS IN  ",4,1,1,16648918,2,2.78E+018,"testalpha"
,"volunteers with dt images","NNS IN  NNS",4,1,1,16399034,"pubmed1",1.78E+018,"testalpha"
,"mutationmethods screens and selections","NNS NNS CC NNS",4,1,1,16369090,2,7.86E+016,"testalpha"
,"correct picture of eeg","JJ NN IN ",4,1,1,17133951,2,5.11E+018,"testalpha"
,"situations because ofothers road","NNS IN NNS NN",4,1,1,16157285,"pubmed1",5.32E+018,"testalpha"
,"months after starting therapy","NNS IN VBG NN",4,1,1,16874416,2,4.06E+018,"testalpha"
,"therapy egdt corticosteroid administration","NN  VB NN",4,1,1,16365336,"pubmed1",9.12E+018,"testalpha"
,"problem ofinjuries among hospital","NN NNS IN NN",4,1,1,16438093,"pubmed1",7.64E+018,"testalpha"
,"useful research training models","JJ NN NN NNS",4,1,1,16473989,"pubmed1",2.63E+018,"testalpha"
,"lmwh in pediatric patients"," IN JJ NNS",4,1,1,16549901,2,3.39E+018,"testalpha"
,"wellto long term treatment"," JJ NN NN",4,1,1,17106596,2,6.08E+018,"testalpha"
,"thesite site interaction extent","JJ NN NN NN",4,1,1,17019442,"pubmed1",7.31E+018,"testalpha"
,"real need foreffective medicines","JJ NN JJ NNS",4,1,1,16511290,2,7.12E+018,"testalpha"
,"patient cohort was dividedinto","NN NN VBD NNP",4,1,1,16424649,2,7.53E+018,"testalpha"
,"lhcb lhcb lhcb lhcb","   ",4,1,1,17106511,"pubmed1",8.39E+018,"testalpha"
,"cm and progressive pain"," CC JJ NN",4,1,1,16612927,"pubmed1",2.59E+018,"testalpha"
,"equations for large deformation","NNS IN JJ NN",4,1,1,16399039,"pubmed1",5.08E+018,"testalpha"
,"ofbone morphogenetic protein bmp","NN JJ NN ",4,1,1,17293969,2,4.11E+018,"testalpha"
,"using acounterbalanced study design","VBG VBN NN NN",4,1,1,16399036,"pubmed1",3.26E+018,"testalpha"
,"normal c inhibitor values","JJ NN NN NNS",4,1,1,16451161,"pubmed1",2.97E+018,"testalpha"
,"mn iii for fe","  IN ",4,1,1,16421446,2,3.09E+018,"testalpha"
,"induced fos protein immunoreactivity","VBN  NN NN",4,1,1,17007911,2,6.24E+018,"testalpha"
,"p from human epidermis"," IN JJ NN",4,1,1,16648912,2,6.24E+018,"testalpha"
,"pcs andlaser diffraction analysis"," NN NN NN",4,1,1,16584150,"pubmed1",8.37E+018,"testalpha"
,"control tissue nnos protein","NN NN  NN",4,1,1,16325891,2,2.89E+017,"testalpha"
,"isomerization of linoleic acid","NN IN JJ NN",4,1,1,16511289,2,3.75E+018,"testalpha"
,"vital dyefor sentinel node","JJ JJ NN ",4,1,1,16491216,2,4.84E+018,"testalpha"
,"pitfall in emergency care","NN IN NN NN",4,1,1,16365325,"pubmed1",5.94E+018,"testalpha"
,"ct hepatic arteriography n"," JJ NN ",4,1,1,16317488,"pubmed1",2.41E+018,"testalpha"
,"site inthe active center","NN NNP JJ NN",4,1,1,16929382,"pubmed1",8.58E+016,"testalpha"
,"yag nm laser treatment","  NN NN",4,1,1,16648911,2,6.51E+018,"testalpha"
,"mu glycinato di mu"," NN  ",4,1,1,16397335,2,7.89E+018,"testalpha"
,"l y r ly","  NN ",4,1,1,16404475,"pubmed1",1.44E+018,"testalpha"
,"patient interactions and patient","NN NNS CC NN",4,1,1,16436793,"pubmed1",3.24E+018,"testalpha"
,"disorderssuch as cushing syndrome","NN IN VBG NN",4,1,1,16245020,"pubmed1",4.71E+018,"testalpha"
,"title compound n hydroxybenzamido","NN NN  ",4,1,1,16456282,2,8.18E+018,"testalpha"
,"manganese ion with respect","NN  IN NN",4,1,1,16421446,2,5.45E+018,"testalpha"
,"validated self administered questionnaire","VBD NN VBD NN",4,1,1,16710574,2,3.53E+018,"testalpha"
,"l and mg x"," CC  NN",4,1,1,16770447,"pubmed1",3.80E+018,"testalpha"
,"vomiting ponv in onestudy","VBG  IN NN",4,1,1,16451147,"pubmed1",5.02E+018,"testalpha"
,"butyl methyl tolylsulfonyl oxazolidine","  NN NN",4,1,1,16456281,2,7.98E+018,"testalpha"
,"patientwith factor vii fvii","NN NN  ",4,1,1,16914903,2,3.25E+018,"testalpha"
,"ile lys glu asp","   ",4,1,1,16496040,"pubmed1",5.24E+018,"testalpha"
,"asymmetry in melanocytic lesions","NN IN JJ NNS",4,1,1,16648914,2,6.45E+018,"testalpha"
,"platelet function of neonates","NN NN IN NNS",4,1,1,16549890,2,8.60E+018,"testalpha"
,"estimate adherence reduced adherence","NN NN VBD NN",4,1,1,16710573,2,5.39E+018,"testalpha"
,"azithromycinfor upper respiratory tract","JJ JJ NN NN",4,1,1,16603101,2,5.86E+018,"testalpha"
,"basal level of expression","NN NN IN NN",4,1,1,17143338,"pubmed1",1.81E+018,"testalpha"
,"crystals belonged tospace group","NNS VBD NN NN",4,1,1,16511252,2,9.47E+017,"testalpha"
,"dynamic therapy of acne","JJ NN IN ",4,1,1,16874416,2,3.50E+018,"testalpha"
,"efficacy of drugs orfoodstuffs","NN IN NNS NNS",4,1,1,17007910,2,3.21E+018,"testalpha"
,"calcitonina and sodic diclofenac","NNP CC JJ NN",4,1,1,17293965,2,1.99E+018,"testalpha"
,"st and sumatriptan succinate"," CC NNP NN",4,1,1,16584167,"pubmed1",1.02E+017,"testalpha"
,"translocator arnt and drosophilasingle","NN  CC NN",4,1,1,16411738,"pubmed1",4.28E+018,"testalpha"
,"transcripts nd nd nd","NNS   ",4,1,1,16389406,"pubmed1",5.55E+018,"testalpha"
,"revision clinical modification icd","NN JJ NN ",4,1,1,16365331,"pubmed1",5.44E+018,"testalpha"
,"hbsr andsoluble cd hbsr"," JJ  ",4,1,1,16770444,"pubmed1",6.76E+018,"testalpha"
,"ischemia without st segment","NN IN  NN",4,1,1,16365321,"pubmed1",6.82E+018,"testalpha"
,"duringcritical illness prolonged activation","JJ NN VBN NN",4,1,1,16462408,"pubmed1",4.17E+018,"testalpha"
,"examines theimportance of research","NNS NN IN NN",4,1,1,16209925,"pubmed1",8.24E+017,"testalpha"
,"type of injury risk","NN IN NN NN",4,1,1,16430845,"pubmed1",1.95E+018,"testalpha"
,"bearing full length cdna","NN JJ NN ",4,1,1,16582987,"pubmed1",3.62E+017,"testalpha"
,"estimation method such asadjustment","NN NN JJ NN",4,1,1,16430844,"pubmed1",6.44E+017,"testalpha"
,"b progesterone receptors protein","NN NN NNS NN",4,1,1,17265696,2,7.76E+018,"testalpha"
,"data for radiation damage","NNS IN NN NN",4,1,1,16369098,2,4.96E+018,"testalpha"
,"superoxide dismutase and catalase","VB NN CC NN",4,1,1,17063208,"pubmed1",8.94E+018,"testalpha"
,"cd immunolocalisation and hyaluronate"," NN CC NN",4,1,1,16713618,2,4.77E+018,"testalpha"
,"analysis of variance anova","NN IN NN NNP",4,1,1,17293959,2,7.81E+018,"testalpha"
,"proliferation and apoptosis ofbcr","NN CC NN ",4,1,1,16809884,2,8.75E+018,"testalpha"
,"i e communication processes","  NN NNS",4,1,1,16988903,"pubmed1",5.12E+018,"testalpha"
,"vehicle safety management andresource","NN NN NN NN",4,1,1,16221468,"pubmed1",4.02E+018,"testalpha"
,"design of dual lox","NN IN JJ ",4,1,1,16456296,2,4.80E+018,"testalpha"
,"carbohydrategroup of various glycoproteins","NN IN JJ NNS",4,1,1,16511286,2,8.05E+018,"testalpha"
,"randomized study included women","VBN NN VBD NNS",4,1,1,16603098,2,2.50E+018,"testalpha"
,"showed prolonged drug release","VBD VBN NN NN",4,1,1,17285742,"pubmed1",5.47E+018,"testalpha"
,"sonologists performed retrospective assessment","NNS VBN JJ NN",4,1,1,16333704,"pubmed1",1.40E+018,"testalpha"
,"tochanges in second year","NNS IN JJ NN",4,1,1,16377828,"pubmed1",7.83E+018,"testalpha"
,"providing circumferential margin examinationplus","VBG JJ NN NN",4,1,1,17139882,2,4.05E+017,"testalpha"
,"metastases in lymphatic nodes","NNS IN JJ NNS",4,1,1,16859616,2,4.41E+017,"testalpha"
,"production and utilization fluidand","NN CC NN NN",4,1,1,16462411,"pubmed1",2.96E+018,"testalpha"
,"acid alginate up lvg","NN NN IN ",4,1,1,16701881,"pubmed1",5.38E+017,"testalpha"
,"diagnosed sonography of leg","VBN NN IN NN",4,1,1,16603099,2,3.72E+018,"testalpha"
,"enablers of systemic leadership","NNS IN JJ NN",4,1,1,16377814,"pubmed1",4.28E+018,"testalpha"
,"infusionof factor viii concentrates"," NN  NNS",4,1,1,16914907,2,2.55E+018,"testalpha"
,"large variations in product","JJ NNS IN NN",4,1,1,17285744,"pubmed1",4.31E+018,"testalpha"
,"determining theconsequences of nicotine","VBG NNS IN NN",4,1,1,16594641,"pubmed1",1.66E+018,"testalpha"
,"ddexma plamcopolymers and plam"," NNS CC ",4,1,1,16701854,"pubmed1",5.57E+018,"testalpha"
,"cc indicating frameshift mutations"," VBG NN NNS",4,1,1,16733554,"pubmed1",7.12E+018,"testalpha"
,"ed patient arrivalrates necessitates","VBD NN NNS NNS",4,1,1,16365329,"pubmed1",3.50E+018,"testalpha"
,"gender age tumor level","NN NN NN NN",4,1,1,17139896,2,2.58E+018,"testalpha"
,"optimal reversal of anticoagulation","JJ NN IN NN",4,1,1,16916181,"pubmed1",5.43E+017,"testalpha"
,"infusion and ml min","NN CC  ",4,1,1,17067137,"pubmed1",5.87E+018,"testalpha"
,"taken fromthe cardiovascular system","VBN NNP JJ NN",4,1,1,17311736,2,2.91E+016,"testalpha"
,"opioids and other classes","NNS CC JJ NNS",4,1,1,16594639,"pubmed1",4.31E+018,"testalpha"
,"hours of expectant management","NNS IN JJ NN",4,1,1,16612913,"pubmed1",3.35E+018,"testalpha"
,"correlation of ultrasound images","NN IN NN NNS",4,1,1,16399038,"pubmed1",5.43E+017,"testalpha"
,"essential oil loaded sln","JJ NN VBN ",4,1,1,16584150,"pubmed1",2.32E+018,"testalpha"
,"bundles of collagen fibers","NNS IN NN NNS",4,1,1,16574202,2,3.62E+018,"testalpha"
,"pooland dna damage recognition","NN  NN NN",4,1,1,17143336,"pubmed1",5.30E+017,"testalpha"
,"site for future care","NN IN NN NN",4,1,1,16436790,"pubmed1",6.81E+018,"testalpha"
,"glycated proteins andadvanced glycation","VBN NNS VBN NN",4,1,1,16696441,2,5.45E+018,"testalpha"
,"flux tohigh flux membrane","NN VB NN NN",4,1,1,17106603,2,7.73E+016,"testalpha"
,"morphological relationships andstructural variability","JJ NNS JJ NN",4,1,1,16399030,"pubmed1",7.90E+018,"testalpha"
,"atp sensitive k channels"," JJ  NNS",4,1,1,16566960,2,1.60E+018,"testalpha"
,"university hospital in order","NN NN IN NN",4,1,1,17106599,2,4.97E+017,"testalpha"
,"effect on plasma gsh","NN IN NNP ",4,1,1,17160142,"pubmed1",6.88E+018,"testalpha"
,"t maintenance infusion requirements"," NN NN NNS",4,1,1,17236635,"pubmed1",6.13E+018,"testalpha"
,"tube turningit clockwise degrees","NN JJ NN NNS",4,1,1,16365333,"pubmed1",8.48E+018,"testalpha"
,"ldl and hdl cholesterol"," CC  NN",4,1,1,17106515,"pubmed1",3.05E+018,"testalpha"
,"partial bladder outlet obstruction","JJ NN NN NN",4,1,1,16253314,2,6.26E+018,"testalpha"
,"recovery following autologousperipheral blood","NN VBG JJ NN",4,1,1,17119322,2,6.23E+018,"testalpha"
,"thyroid disorders over years","NN NNS IN NNS",4,1,1,16514836,2,7.76E+018,"testalpha"
,"cells and lung endocrine","NNS CC NN NN",4,1,1,16762403,2,2.54E+018,"testalpha"
,"iodine anions andsamarium cations","NN NNS NN NNS",4,1,1,16421448,2,8.27E+018,"testalpha"
,"immunofluorescence and immunoblotting examinations","NN CC VBG NNS",4,1,1,16874424,2,2.63E+018,"testalpha"
,"tothe hypoxia mimic dimethyloxalylglycine","NNP  JJ NN",4,1,1,17143338,"pubmed1",5.14E+018,"testalpha"
,"catheter sensory block level","NN NN NN NN",4,1,1,16916188,"pubmed1",6.00E+018,"testalpha"
,"uvb and combination therapy"," CC NN NN",4,1,1,16585987,2,1.12E+018,"testalpha"
,"allergyvaccines of appropriate composition","NNS IN JJ NN",4,1,1,17328144,2,6.52E+018,"testalpha"
,"developed acomputerized lesion segmentation","VBN VBN NN NN",4,1,1,16399033,"pubmed1",8.25E+018,"testalpha"
,"opioids are excellent painkillers","NNS VBP JJ NNS",4,1,1,16916180,"pubmed1",7.99E+018,"testalpha"
,"administration of dietcontaining probiotics","NN IN VBG NNS",4,1,1,17293972,2,4.77E+018,"testalpha"
,"intestinaldisease n and segmental","NN  CC NN",4,1,1,16447095,"pubmed1",5.03E+018,"testalpha"
,"isto avoid wasting time"," VB VBG NN",4,1,1,17067135,"pubmed1",4.14E+017,"testalpha"
,"severity index pasi score","NN NN  NN",4,1,1,16585984,2,8.73E+018,"testalpha"
,"toanalyse and describe patients"," CC VB NNS",4,1,1,16321535,"pubmed1",2.39E+018,"testalpha"
,"meis and meis expression"," CC  NN",4,1,1,16914901,2,3.23E+018,"testalpha"
,"involvement in fatal crashes","NN IN JJ NNS",4,1,1,16236235,"pubmed1",3.70E+018,"testalpha"
,"vitropenetration in vivo skin","NN IN  NN",4,1,1,17285742,"pubmed1",2.39E+017,"testalpha"
,"way forced choice task","NN VBD NN NN",4,1,1,17133956,2,3.94E+018,"testalpha"
,"spectrum threat agents theeffects","NN NN NNS NNS",4,1,1,16696436,2,3.80E+018,"testalpha"
,"containing full length poly","VBG JJ NN ",4,1,1,16389406,"pubmed1",4.70E+018,"testalpha"
,"endothelium of blood vessels","NN IN NN NNS",4,1,1,17143339,"pubmed1",5.12E+018,"testalpha"
,"atopic modified erlanger atopy","NN VBN NN ",4,1,1,16648917,2,8.30E+018,"testalpha"
,"binds via cell surface","NNS IN NN NN",4,1,1,16730370,2,5.71E+018,"testalpha"
,"apo form crystal structure"," NN NN NN",4,1,1,16511293,2,1.45E+017,"testalpha"
,"yearsof age closed reduction"," NN VBD NN",4,1,1,16613748,2,2.74E+018,"testalpha"
,"patients formutations in trpm","NNS NNS IN ",4,1,1,16733555,"pubmed1",3.67E+018,"testalpha"
,"theboard of certified safety","NN IN VBN NN",4,1,1,16438092,"pubmed1",7.44E+018,"testalpha"
,"apparent diffusion coefficient adc","JJ NN NN ",4,1,1,16399034,"pubmed1",3.43E+018,"testalpha"
,"means of reducing recidivism","NNS IN VBG NN",4,1,1,16202465,"pubmed1",8.16E+018,"testalpha"
,"patients and methods forty","NNS CC NNS NN",4,1,1,17119323,2,8.39E+018,"testalpha"
,"buffered saline pbs solution","VBN NN  NN",4,1,1,16701857,"pubmed1",6.45E+017,"testalpha"
,"increased risk of overdistension","VBN NN IN NN",4,1,1,16451155,"pubmed1",3.48E+018,"testalpha"
,"dipeptides c h n","NNS NN  ",4,1,1,16397334,2,6.44E+018,"testalpha"
,"n or focal n"," CC JJ ",4,1,1,16333694,"pubmed1",4.91E+018,"testalpha"
,"sequence of sgm vp","NN IN  ",4,1,1,16733562,"pubmed1",5.44E+018,"testalpha"
,"heavy vehicles in denmark","JJ NNS IN NN",4,1,1,16157285,"pubmed1",6.02E+018,"testalpha"
,"term toxicity test exposure","NN NN NN NN",4,1,1,16696445,2,5.62E+018,"testalpha"
,"theassociation between life style","NN IN NN NN",4,1,1,16918068,"pubmed1",9.21E+018,"testalpha"
,"neutrophil count and r"," NN CC NN",4,1,1,17119322,2,5.40E+018,"testalpha"
,"assessment of patients objective","NN IN NNS NN",4,1,1,17338197,2,8.98E+018,"testalpha"
,"substantial body of research","JJ NN IN NN",4,1,1,16157285,"pubmed1",7.76E+018,"testalpha"
,"equal weighting of characters","JJ NN IN NNS",4,1,1,17486414,"pubmed1",8.31E+018,"testalpha"
,"late ards cmh o","JJ   ",4,1,1,16451155,"pubmed1",3.27E+018,"testalpha"
,"theta and zeta members","NN CC  NNS",4,1,1,17019444,"pubmed1",5.39E+018,"testalpha"
,"parenchyma against i r"," IN  NN",4,1,1,17013514,2,4.80E+018,"testalpha"
,"present case control study","JJ NN NN NN",4,1,1,16549894,2,1.96E+018,"testalpha"
,"positive patients were rast","JJ NNS VBD ",4,1,1,16859613,2,6.08E+018,"testalpha"
,"treatment for liver diseases","NN IN NN NNS",4,1,1,17013516,2,2.64E+018,"testalpha"
,"epiphyllous appendages of begoniaand","JJ NNS IN NN",4,1,1,17486414,"pubmed1",5.86E+018,"testalpha"
,"dermis thinautologous epidermal graft","NN JJ JJ NN",4,1,1,16999269,2,9.22E+018,"testalpha"
,"hundredfiftyseven patients with rectal","VBN NNS IN NN",4,1,1,17139896,2,4.08E+018,"testalpha"
,"medicalschools following institutional review","NNS VBG JJ NN",4,1,1,16377815,"pubmed1",8.22E+018,"testalpha"
,"grapes hops rice honey","NNS  NN NN",4,1,1,16859619,2,3.05E+018,"testalpha"
,"library from thermal environment","NN IN JJ NN",4,1,1,16511287,2,3.92E+018,"testalpha"
,"existence of nonapoptotic celldeath","NN IN JJ NN",4,1,1,16956122,2,4.22E+018,"testalpha"
,"medium on matrix tablet","NN IN NNP NN",4,1,1,16584139,"pubmed1",3.22E+018,"testalpha"
,"varioustemperatures and ph values","NNS CC  NNS",4,1,1,17117212,"pubmed1",6.88E+018,"testalpha"
,"required administration ofrecombinant factor","VBN NN JJ NN",4,1,1,16914908,2,2.28E+018,"testalpha"
,"acetone phosphate buffered saline","NN NN VBN NN",4,1,1,16701874,"pubmed1",5.25E+018,"testalpha"
,"glu asp val gln","   ",4,1,1,16496040,"pubmed1",4.22E+018,"testalpha"
,"test and specific ige","NN CC JJ ",4,1,1,16648919,2,4.83E+018,"testalpha"
,"aggression in theemergency field","NN IN NN NN",4,1,1,16209925,"pubmed1",4.84E+017,"testalpha"
,"showedimprovements in iron deficiency","NNS IN NN NN",4,1,1,16809890,2,7.58E+018,"testalpha"
,"cobra and dendroaspis polylepsis","NNP CC  NN",4,1,1,16436788,"pubmed1",5.89E+018,"testalpha"
,"frozen pelvis aneuploid tumors","VBN NNP VB NNS",4,1,1,17139900,2,1.12E+018,"testalpha"
,"treatment of acute attacks","NN IN JJ NNS",4,1,1,16584167,"pubmed1",8.07E+018,"testalpha"
,"factors at levels eachwas","NNS IN NNS ",4,1,1,16584161,"pubmed1",8.26E+017,"testalpha"
,"sustained attention cognitive control","VBN NN JJ NN",4,1,1,16436796,"pubmed1",4.56E+018,"testalpha"
,"red stainingand polarizing microscopy","JJ NN VBG ",4,1,1,16899283,2,5.22E+018,"testalpha"
,"atoms withsufficient scattering power","NNS NN VBG NN",4,1,1,16421448,2,1.68E+018,"testalpha"
,"adsorption on znhap particles","NN IN NN NNS",4,1,1,16701860,"pubmed1",5.73E+018,"testalpha"
,"specific properties inthe structure","JJ NNS NNP NN",4,1,1,16929383,"pubmed1",5.68E+018,"testalpha"
,"yeast inmany commercial systems","NN NN JJ NNS",4,1,1,17063208,"pubmed1",5.54E+018,"testalpha"
,"unmilled acpcomposites milled acp","VBN NNS VBN ",4,1,1,16701862,"pubmed1",4.58E+018,"testalpha"
,"uva light puva treatment"," NN  NN",4,1,1,17016038,2,3.76E+018,"testalpha"
,"cream puva monochromatic excimer","NN  JJ NN",4,1,1,16585984,2,8.02E+018,"testalpha"
,"usingimmunofluorescence microscopy and spectrofluorimetry","NN  CC NN",4,1,1,16956122,2,8.95E+018,"testalpha"
,"uses data onthe review","VBZ NNS NNP NN",4,1,1,16770859,"pubmed1",6.25E+018,"testalpha"
,"limbs with pulmonary embolism","NNS IN JJ NN",4,1,1,16673558,2,8.64E+018,"testalpha"
,"beta cells priorto encapsulation","NN NNS NNP NN",4,1,1,16701853,"pubmed1",2.77E+018,"testalpha"
,"receiving csav and d","VBG  CC ",4,1,1,16436788,"pubmed1",7.30E+018,"testalpha"
,"arterialembolotherapy with acrylic glue","NN IN JJ NN",4,1,1,16612928,"pubmed1",6.19E+018,"testalpha"
,"treatments were performed atintervals","NNS VBD VBN NNS",4,1,1,16710582,2,7.92E+018,"testalpha"
,"increased pc in children","VBD  IN NNS",4,1,1,16424649,2,1.95E+018,"testalpha"
,"gme practice and outcomes"," NN CC NNS",4,1,1,16377812,"pubmed1",4.59E+018,"testalpha"
,"score w azs total","NN   NN",4,1,1,16603096,2,8.41E+018,"testalpha"
,"ischemia induced accumulation ofexcitatory","NN VBN NN NN",4,1,1,17133953,2,8.20E+018,"testalpha"
,"thegrowing importance of hsv","VBG NN IN ",4,1,1,16648915,2,6.97E+018,"testalpha"
,"studies available dm hasthe","NNS JJ  NNP",4,1,1,16451144,"pubmed1",7.83E+018,"testalpha"
,"deviations and coefficients ofvariation","NNS CC NNS NN",4,1,1,16399030,"pubmed1",6.55E+018,"testalpha"
,"observed contrast enhancement pattern","VBN NN NN NN",4,1,1,16333704,"pubmed1",6.09E+018,"testalpha"
,"ribbons by n h","NNS IN  ",4,1,1,16456284,2,7.75E+018,"testalpha"
,"use of viable xenograftsit","NN IN JJ NN",4,1,1,16999268,2,2.50E+018,"testalpha"
,"inducedalloknesis in healthy volunteers","NN IN JJ NNS",4,1,1,16955182,2,7.57E+018,"testalpha"
,"ems diversion decreased hours"," NN VBD NNS",4,1,1,16365324,"pubmed1",6.15E+018,"testalpha"
,"imagingappearance of lower extremity","NN IN JJR NN",4,1,1,16612924,"pubmed1",4.48E+018,"testalpha"
,"erroneous punctures and insufflations","JJ NNS CC NNS",4,1,1,16491219,2,2.53E+018,"testalpha"
,"advances in science medicine","NNS IN NN NN",4,1,1,16596899,"pubmed1",2.69E+018,"testalpha"
,"safer form of iv","JJR NN IN ",4,1,1,16673554,2,1.85E+018,"testalpha"
,"radiological stage signs symptoms","JJ NN NNS NNS",4,1,1,16696444,2,2.71E+018,"testalpha"
,"light and transmission electron","NN CC NN NN",4,1,1,16828846,2,3.48E+018,"testalpha"
,"zea m beta expansin","  NN NNP",4,1,1,16963110,2,8.28E+018,"testalpha"
,"consumption but have noeffect","NN CC VBP NN",4,1,1,16916180,"pubmed1",2.85E+018,"testalpha"
,"blind sham control study","JJ  NN NN",4,1,1,16365322,"pubmed1",1.93E+018,"testalpha"
,"perform aortic aneurysm repair","VB JJ  NN",4,1,1,16612910,2,7.37E+018,"testalpha"
,"utr primers according topatients"," NNS IN NNS",4,1,1,16696442,2,6.33E+018,"testalpha"
,"betweenvariables in contingency tables","NNS IN NN NNS",4,1,1,16733558,"pubmed1",5.93E+018,"testalpha"
,"age range years underwent","VBP NN NNS NN",4,1,1,16809886,2,3.49E+018,"testalpha"
,"need of more complexresearch","NN IN JJR NN",4,1,1,17311739,2,5.41E+018,"testalpha"
,"plasmid transfected ins cells","JJ VBN  NNS",4,1,1,16395521,"pubmed1",7.37E+018,"testalpha"
,"number of chromosome aberrations","NN IN NN NNS",4,1,1,16582984,"pubmed1",1.98E+018,"testalpha"
,"alginate and short term","NN CC JJ NN",4,1,1,16701881,"pubmed1",5.55E+018,"testalpha"
,"il were measured byelisa"," VBD VBN ",4,1,1,17293960,2,5.11E+018,"testalpha"
,"topre established organ categories"," VBN NN NNS",4,1,1,17486414,"pubmed1",4.43E+018,"testalpha"
,"health services in tanzania","NN NNS IN NNP",4,1,1,16874417,2,1.50E+018,"testalpha"
,"activity in l skeletal","NN IN  NN",4,1,1,16964326,"pubmed1",5.43E+018,"testalpha"
,"skills buffer thenegative effect","NNS NN JJ NN",4,1,1,16443186,"pubmed1",7.02E+017,"testalpha"
,"methods usingcurrent educational principles","NNS NN JJ NNS",4,1,1,16473990,"pubmed1",4.75E+018,"testalpha"
,"factor renal failure hepaticfailure","NN JJ NN NN",4,1,1,16916186,"pubmed1",9.01E+018,"testalpha"
,"c myc e f","NN   NN",4,1,1,17115080,"pubmed1",1.79E+018,"testalpha"
,"pre pacs study period","  NN NN",4,1,1,16436791,"pubmed1",6.89E+018,"testalpha"
,"cultivations of chrysosporium pannorum","NNS IN NN NN",4,1,1,16603097,2,7.82E+018,"testalpha"
,"values were shared amongdeans","NNS VBD VBN NNS",4,1,1,16377814,"pubmed1",6.02E+018,"testalpha"
,"dermatitis patients presenting airborne","NN NNS VBG NNP",4,1,1,16603103,2,2.83E+018,"testalpha"
,"prospects of lymph node","NNS IN NN ",4,1,1,16603102,2,7.03E+018,"testalpha"
,"underwentsurgery with clinical improvement","NN IN JJ NN",4,1,1,16549900,2,4.14E+018,"testalpha"
,"vincristine and prednisolone thp","NN CC NN ",4,1,1,17119328,2,1.36E+018,"testalpha"
,"rasburicase was administered topatients","NN VBD VBD NNS",4,1,1,16424647,2,7.99E+018,"testalpha"
,"organism in blood samples","NN IN NN NNS",4,1,1,16730370,2,6.34E+018,"testalpha"
,"scrapie like clinical symptoms"," IN JJ NNS",4,1,1,16770445,"pubmed1",5.68E+018,"testalpha"
,"media by supplementing themedia","NNS IN VBG NNP",4,1,1,16701855,"pubmed1",8.58E+018,"testalpha"
,"surgery in dokuz eylul","NN IN  ",4,1,1,17139879,2,6.73E+018,"testalpha"
,"time initialsetting time h","NN VBG NN ",4,1,1,16701865,"pubmed1",2.86E+018,"testalpha"
,"legume lectins as search","NN NNS IN NN",4,1,1,16511291,2,1.08E+017,"testalpha"
,"trail making test tmt","NN VBG NN ",4,1,1,16479025,2,4.52E+018,"testalpha"
,"critical tothis coping process","JJ NNP VBG NN",4,1,1,16377827,"pubmed1",2.08E+018,"testalpha"
,"k independent plant type"," JJ NN NN",4,1,1,17143335,"pubmed1",5.30E+018,"testalpha"
,"skin and hypertrophic scartissue","NN CC JJ NN",4,1,1,16874413,2,3.38E+018,"testalpha"
,"investigators in otherbiomedical areas","NNS IN JJ NNS",4,1,1,16365332,"pubmed1",6.53E+018,"testalpha"
,"medical problem and challenge","JJ NN CC NN",4,1,1,16613748,2,6.49E+018,"testalpha"
,"soluble form andincreased levels","JJ NN VBN NNS",4,1,1,16955181,2,8.32E+018,"testalpha"
,"immunohistochemical detectionof individual ecm","JJ  JJ ",4,1,1,16414104,2,6.46E+018,"testalpha"
,"artery segments isolated fromc","NN NNS VBN ",4,1,1,17128291,"pubmed1",7.93E+018,"testalpha"
,"takeadvantage of marginal specimens","NN IN JJ NNS",4,1,1,17013514,2,7.01E+018,"testalpha"
,"overalldriving performance degraded responses","VBG NN VBN NNS",4,1,1,16226211,"pubmed1",3.89E+018,"testalpha"
,"presence of granulocyte monocyte","NN IN NNP NNP",4,1,1,16404477,"pubmed1",6.93E+018,"testalpha"
,"clinical records andimaging studies","JJ NNS VBG NNS",4,1,1,16696447,2,3.25E+018,"testalpha"
,"patients were referred forevaluation","NNS VBD VBD NN",4,1,1,17106599,2,8.18E+018,"testalpha"
,"severity of lung injury","NN IN NN NN",4,1,1,16451155,"pubmed1",2.72E+018,"testalpha"
,"person based school injury","NN VBN NN NN",4,1,1,16236234,"pubmed1",4.90E+018,"testalpha"
,"liver parenchyma against i","NN  IN ",4,1,1,17013514,2,3.57E+018,"testalpha"
,"cell ballsand large sheets","NN NN JJ NNS",4,1,1,16514838,2,8.59E+018,"testalpha"
,"n peripheral nodular enhancement"," JJ JJ NN",4,1,1,16333704,"pubmed1",7.06E+018,"testalpha"
,"assisted liverresection for colorectal","VBN NN IN NN",4,1,1,17139901,2,6.90E+018,"testalpha"
,"orientations and repeated times","NNS CC VBN NNS",4,1,1,16399034,"pubmed1",4.85E+018,"testalpha"
,"transforming growth factorbeta tgf","VBG NN NN ",4,1,1,17293967,2,8.97E+018,"testalpha"
,"residual monomer bis phenyl","JJ NN  NN",4,1,1,16701856,"pubmed1",8.18E+018,"testalpha"
,"dependent change ofinternal representations","JJ NN JJ NNS",4,1,1,17133956,2,8.30E+017,"testalpha"
,"autoradiography in rats days","NN IN NNS NNS",4,1,1,17133958,2,7.99E+018,"testalpha"
,"patients with retained stonesafter","NNS IN VBN NN",4,1,1,16447096,"pubmed1",8.05E+018,"testalpha"
,"compare thelevel of expression","VB NN IN NN",4,1,1,16430945,2,3.20E+018,"testalpha"
,"inpatients during ambulance transport","NNS IN NN NN",4,1,1,16365322,"pubmed1",2.07E+018,"testalpha"
,"ap treatment while pretreatment"," NN IN NN",4,1,1,17007911,2,1.53E+018,"testalpha"
,"p p mdm bcl","   ",4,1,1,17117604,2,3.64E+018,"testalpha"
,"predictor of escitalopram clearancethan","NN IN NN NNP",4,1,1,16584121,"pubmed1",3.10E+018,"testalpha"
,"fos c myc e"," NN  ",4,1,1,17115080,"pubmed1",9.37E+016,"testalpha"
,"space dependent cellular fluid","NN JJ JJ NN",4,1,1,16988902,"pubmed1",3.87E+018,"testalpha"
,"reduction in platelet activationwas","NN IN NN ",4,1,1,16809885,2,3.75E+018,"testalpha"
,"stimulation prevented implicit memory","NN VBD JJ NN",4,1,1,17236636,"pubmed1",6.01E+018,"testalpha"
,"membrane generating signaling events","NN VBG VBG NNS",4,1,1,17013516,2,5.15E+018,"testalpha"
,"degrees c degrees c","NNS NN NNS NN",4,1,1,16696441,2,3.33E+018,"testalpha"
,"death inalcoholics are diseases","NN NNS VBP NNS",4,1,1,16859619,2,7.96E+018,"testalpha"
,"effect on day time","NN IN NN NN",4,1,1,16171767,"pubmed1",1.94E+018,"testalpha"
,"psoriasis areaand severity index","NN NN NN NN",4,1,1,16585984,2,4.75E+018,"testalpha"
,"motor vehicle crash fatality","NN NN NN NN",4,1,1,16139232,"pubmed1",2.32E+018,"testalpha"
,"high risk aggressive nhl","JJ NN JJ ",4,1,1,16424645,2,1.68E+018,"testalpha"
,"cellulitis and mixed group","NN CC VBN NN",4,1,1,17311739,2,2.77E+018,"testalpha"
,"shifts and torecord symptoms","NNS CC NN NNS",4,1,1,16436796,"pubmed1",8.53E+018,"testalpha"
,"data quality and tosuggest","NN NN CC NN",4,1,1,16369100,2,6.03E+018,"testalpha"
,"postdocs or full time"," CC JJ NN",4,1,1,16473996,"pubmed1",6.14E+018,"testalpha"
,"mismatch repair mmr system","NN NN  NN",4,1,1,17139886,2,7.85E+018,"testalpha"
,"liposomal amphotericin b therapy","JJ NNP NN NN",4,1,1,16918065,"pubmed1",1.05E+018,"testalpha"
,"term additive therapeutic efficacy","NN JJ JJ NN",4,1,1,16585987,2,3.20E+018,"testalpha"
,"iron deposition andthe development","NN NN NNP NN",4,1,1,16424659,2,5.60E+018,"testalpha"
,"non significant pre post"," JJ  NN",4,1,1,16169506,"pubmed1",4.31E+018,"testalpha"
,"programsreduced teen passenger fatalities","VBN  NN NNS",4,1,1,16171767,"pubmed1",6.29E+018,"testalpha"
,"contact clinic women man","NN NN NNS NN",4,1,1,16710586,2,8.13E+018,"testalpha"
,"paper uses data onthe","NN VBZ NNS NNP",4,1,1,16770859,"pubmed1",5.76E+018,"testalpha"
,"death rates among children","NN NNS IN NNS",4,1,1,16139232,"pubmed1",8.88E+018,"testalpha"
,"cellshad high saccharase activity"," JJ NN NN",4,1,1,16970980,2,7.12E+018,"testalpha"
,"oligomerization domain containing nod","NN NN VBG NN",4,1,1,16648910,2,6.03E+018,"testalpha"
,"vs ml min kg","   ",4,1,1,17067137,"pubmed1",6.13E+018,"testalpha"
,"requirements and blood loss","NNS CC NN NN",4,1,1,16451158,"pubmed1",7.78E+018,"testalpha"
,"novo adult aml patients"," NN  NNS",4,1,1,16914901,2,5.15E+018,"testalpha"
,"properties including sensitivity tothe","NNS VBG NN NNP",4,1,1,16505899,"pubmed1",4.07E+018,"testalpha"
,"onpractical safe driving guidelines","JJ JJ NN NNS",4,1,1,16061188,"pubmed1",2.37E+018,"testalpha"
,"hemoglobin neutrophil and platelet","NNP  CC NN",4,1,1,17119322,2,7.60E+017,"testalpha"
,"episodes of mildgastrointestinal symptoms","NNS IN JJ NNS",4,1,1,16874419,2,3.40E+018,"testalpha"
,"andatypical hyperplastic tissue p","JJ JJ NN ",4,1,1,16423381,2,5.94E+018,"testalpha"
,"past years of rtresidents","JJ NNS IN NNS",4,1,1,16473996,"pubmed1",4.57E+018,"testalpha"
,"defensive role against injuries","JJ NN IN NNS",4,1,1,16919708,2,6.56E+018,"testalpha"
,"patients smoking vs alcohol","NNS NN  NN",4,1,1,16436792,"pubmed1",4.41E+018,"testalpha"
,"patients with latex allergy","NNS IN NNP NN",4,1,1,16916182,"pubmed1",8.90E+018,"testalpha"
,"bonds bind neighbouring chains","NNS NN VBG NNS",4,1,1,16456289,2,2.47E+018,"testalpha"
,"mediatethe highest possible level","NNP JJS JJ NN",4,1,1,17285739,"pubmed1",9.05E+018,"testalpha"
,"r injury in nos","NN NN IN NNS",4,1,1,16764913,2,4.59E+017,"testalpha"
,"trends in spinal cord","NNS IN JJ NN",4,1,1,16111641,"pubmed1",1.19E+018,"testalpha"
,"pleomorphic cellswith irregular nuclei","JJ NN JJ ",4,1,1,16514851,2,4.87E+018,"testalpha"
,"propofol infusion syndrome pris"," NN NN ",4,1,1,16451160,"pubmed1",2.34E+018,"testalpha"
,"applications of breast magneticresonance","NNS IN NN NN",4,1,1,16399033,"pubmed1",8.65E+018,"testalpha"
,"cause of lower git","NN IN JJR ",4,1,1,16612928,"pubmed1",4.81E+018,"testalpha"
,"bursting pressure and tissue","VBG NN CC NN",4,1,1,16612916,"pubmed1",2.21E+018,"testalpha"
,"requirementand postoperative pain relief","NN JJ NN NN",4,1,1,16916188,"pubmed1",4.25E+018,"testalpha"
,"hormonal receptors for tumor","JJ NNS IN NN",4,1,1,17117604,2,9.14E+018,"testalpha"
,"coloanal anastomosis with pph","JJ NN IN ",4,1,1,17139887,2,4.23E+018,"testalpha"
,"sevenpatients underwent surgical resection","NNS NN JJ NN",4,1,1,16722347,2,3.11E+018,"testalpha"
,"sc and average size"," CC JJ NN",4,1,1,16549890,2,1.34E+018,"testalpha"
,"patient participation in treatment","NN NN IN NN",4,1,1,17106601,2,4.53E+017,"testalpha"
,"replacement therapy forhemophilia patients","NN NN NNP NNS",4,1,1,16549892,2,6.34E+018,"testalpha"
,"bone abdominal wall ureter","NN JJ NN NN",4,1,1,17139900,2,4.73E+018,"testalpha"
,"efficacy of using colloids","NN IN VBG NNS",4,1,1,16762404,2,7.16E+018,"testalpha"
,"portion of substrate analogues","NN IN NN NNS",4,1,1,16421451,2,4.59E+018,"testalpha"
,"underlying diagnosis and treatment","VBG NN CC NN",4,1,1,16549897,2,5.87E+018,"testalpha"
,"breast cancer pathology breast","NN NN NN NN",4,1,1,16596895,"pubmed1",4.38E+018,"testalpha"
,"tml isnormaly left branch"," NNP VBD NN",4,1,1,17139884,2,3.46E+016,"testalpha"
,"disseminated fusarium solani infection","VBN NN NNP NN",4,1,1,16918066,"pubmed1",7.18E+018,"testalpha"
,"oligomerization ii point mutations","NN  NN NNS",4,1,1,16511258,2,5.53E+015,"testalpha"
,"optimal results for patients","JJ NNS IN NNS",4,1,1,17139901,2,3.93E+018,"testalpha"
,"curves ofunaided independent double","NNS VBN JJ NN",4,1,1,16399036,"pubmed1",5.26E+018,"testalpha"
,"brief high concentration binge","JJ JJ NN NN",4,1,1,16808045,"pubmed1",5.88E+018,"testalpha"
,"group or placebo group","NN CC  NN",4,1,1,16955187,2,2.03E+018,"testalpha"
,"diagnostic and therapeutic measures","NN CC JJ NNS",4,1,1,16612920,"pubmed1",5.78E+018,"testalpha"
,"ng ml vs ng","   ",4,1,1,17067137,"pubmed1",8.86E+018,"testalpha"
,"specificity of varioustopooptical reactions","NN IN JJ NNS",4,1,1,16764914,2,5.33E+018,"testalpha"
,"nitric oxidesynthase nos inhibitor","JJ NN NNS NN",4,1,1,16764913,2,1.63E+018,"testalpha"
,"induction group creceived saline","NN NN VBN NN",4,1,1,17067136,"pubmed1",5.24E+017,"testalpha"
,"plasmase level and gsh","NN NN CC ",4,1,1,17160142,"pubmed1",2.65E+018,"testalpha"
,"special stains helped differentiate","JJ NNS VBD NN",4,1,1,16514844,2,4.36E+018,"testalpha"
,"acid upon theworking time","NN IN VBG NN",4,1,1,16701865,"pubmed1",6.96E+018,"testalpha"
,"angiogenesis at d post","NN IN  NN",4,1,1,17014894,2,5.05E+018,"testalpha"
,"gulf war era veterans","NN NN NN NNS",4,1,1,16405857,"pubmed1",1.04E+018,"testalpha"
,"beta adrenergic receptor hyporesponsivenessfound","NN JJ NN NN",4,1,1,16874421,2,4.28E+018,"testalpha"
,"msu crystalson polarizing microscopy"," NN VBG ",4,1,1,16514850,2,5.86E+018,"testalpha"
,"nanoparticulate dispersion and itsgel","NN NN CC NNP",4,1,1,17285742,"pubmed1",6.24E+018,"testalpha"
,"possibilities andlimitations of contrast","NNS NNS IN NN",4,1,1,16317492,"pubmed1",6.66E+017,"testalpha"
,"remotemicrocirculation within studied organs","NN IN VBN NNS",4,1,1,17438835,2,4.08E+018,"testalpha"
,"effect of intra operativeradiotherapy","NN IN JJ NN",4,1,1,16612919,"pubmed1",9.07E+018,"testalpha"
,"antagonist on neurotoxic effect","NN IN JJ NN",4,1,1,17133953,2,3.82E+018,"testalpha"
,"topicalsteroid therapy topical non","VB NN JJ ",4,1,1,17010269,2,4.73E+018,"testalpha"
,"pkc activity and platelet"," NN CC NN",4,1,1,17016035,2,6.83E+018,"testalpha"
,"clear preference in technique","JJ NN IN NN",4,1,1,16617755,"pubmed1",2.41E+018,"testalpha"
,"complete blood counts blood","JJ NN NNS NN",4,1,1,16479024,2,4.74E+018,"testalpha"
,"ofrisk perception and impulsivity","JJ NN CC NN",4,1,1,16426559,"pubmed1",8.26E+018,"testalpha"
,"hemoglobinuria pnh and parvovirus","NNP  CC NN",4,1,1,17119324,2,5.64E+018,"testalpha"
,"degradation controls unc levels","NN NNS  NNS",4,1,1,16496042,"pubmed1",4.67E+018,"testalpha"
,"binding cell membrane protein","VBG NN NN NN",4,1,1,16929383,"pubmed1",7.71E+018,"testalpha"
,"rate was local recurrency","NN VBD JJ NN",4,1,1,17139899,2,5.00E+018,"testalpha"
,"septicemia hyperglycemia venous thrombosis","NN NN JJ NN",4,1,1,17013518,2,7.77E+018,"testalpha"
,"cone and plateletanalyzer cpa","NN CC NNP ",4,1,1,16549890,2,5.84E+018,"testalpha"
,"symptoms and subjective evaluations","NNS CC JJ NNS",4,1,1,16436796,"pubmed1",7.46E+018,"testalpha"
,"phosphates by n h","NNS IN  ",4,1,1,16456284,2,5.76E+018,"testalpha"
,"pre and post legislation"," CC NN NN",4,1,1,16223468,"pubmed1",1.16E+018,"testalpha"
,"group and point group","NN CC NN NN",4,1,1,16369096,2,2.71E+018,"testalpha"
,"healthy volunteers thehd patients","JJ NNS  NNS",4,1,1,17119323,2,8.77E+018,"testalpha"
,"stranded dna ssdna immunohistochemistry","VBN   NN",4,1,1,16569423,2,4.01E+018,"testalpha"
,"deprivation subjective sleepiness burnout","NN JJ NN NN",4,1,1,16377826,"pubmed1",8.85E+018,"testalpha"
,"correlation in lung neuroendocrine","NN IN NN NN",4,1,1,16762403,2,4.48E+018,"testalpha"
,"positive soil bacterium bacillus","JJ NN NN NN",4,1,1,16964327,"pubmed1",3.24E+018,"testalpha"
,"sedation included dislocation reduction","NN VBD NN NN",4,1,1,16365337,"pubmed1",1.40E+017,"testalpha"
,"victims ofwork related crashes","NNS NN VBN NNS",4,1,1,16043107,"pubmed1",1.58E+017,"testalpha"
,"substrates of eukaryotic origin","NNS IN JJ NN",4,1,1,17019443,"pubmed1",8.91E+018,"testalpha"
,"specimens as fatty livers","NNS IN JJ NNS",4,1,1,17013514,2,7.08E+018,"testalpha"
,"phe d cys nh","   ",4,1,1,16496038,"pubmed1",8.16E+018,"testalpha"
,"exacerbates brain injury andworsens","NNS NN NN NNS",4,1,1,16436794,"pubmed1",5.08E+018,"testalpha"
,"release in gastric fluid","NN IN JJ NN",4,1,1,16594643,"pubmed1",6.10E+018,"testalpha"
,"forming calcium phosphate cement","VBG NN NN NN",4,1,1,16701863,"pubmed1",3.23E+018,"testalpha"
,"change at amino acid","NN IN NNP NN",4,1,1,16585980,2,9.19E+018,"testalpha"
,"difference deltat degrees c","NN NN NNS NN",4,1,1,17285744,"pubmed1",8.41E+018,"testalpha"
,"poorerprognosis than classic mf","NN IN JJ ",4,1,1,16859615,2,3.39E+018,"testalpha"
,"old man complained ofheadache","JJ NN VBD NNP",4,1,1,16612920,"pubmed1",6.01E+018,"testalpha"
,"areas of disease reactivation","NNS IN NN NN",4,1,1,17311737,2,8.64E+018,"testalpha"
,"brain injury tbi caseascertainment","NN NN  NN",4,1,1,16365331,"pubmed1",8.07E+018,"testalpha"
,"ratings of safety skills","NNS IN NN NNS",4,1,1,16443186,"pubmed1",4.95E+018,"testalpha"
,"excellent alternative for patients","JJ NN IN NNS",4,1,1,16613748,2,2.74E+018,"testalpha"
,"children had severe underlyingproblems","NNS VBD JJ NNS",4,1,1,16549902,2,6.63E+018,"testalpha"
,"surface of cement grafts","NN IN NN NNS",4,1,1,16701863,"pubmed1",9.12E+018,"testalpha"
,"common hfe h d","JJ   ",4,1,1,16424658,2,2.99E+018,"testalpha"
,"major problem in patients","JJ NN IN NNS",4,1,1,17139900,2,8.25E+018,"testalpha"
,"activating transcription factor atf","VBG NN NN ",4,1,1,16395528,"pubmed1",7.00E+018,"testalpha"
,"unusual involvement of extramedullaryhematopoiesis","JJ NN IN NN",4,1,1,17016039,2,5.43E+018,"testalpha"
,"leadership challenges organizational effectiveness","NN NNS JJ NN",4,1,1,16377814,"pubmed1",2.04E+018,"testalpha"
,"abuse patterns of use","NN NNS IN NN",4,1,1,16808045,"pubmed1",5.95E+018,"testalpha"
,"diagnosticaccuracy of thyroid fna","NN IN NN ",4,1,1,16514836,2,6.00E+017,"testalpha"
,"sepsis using cecal ligation","NN VBG JJ NN",4,1,1,17293958,2,4.99E+018,"testalpha"
,"finding opens new possibilities","NN VBZ JJ NNS",4,1,1,16317492,"pubmed1",3.36E+018,"testalpha"
,"were tested continuouslyevery minute","VBD VBN NN NN",4,1,1,16451159,"pubmed1",3.73E+018,"testalpha"
,"phi o gal c","   NN",4,1,1,16456293,2,6.92E+018,"testalpha"
,"difference in serum levels","NN IN NN NNS",4,1,1,17010262,2,5.75E+018,"testalpha"
,"maintained quality patient care","VBN NN NN NN",4,1,1,16377824,"pubmed1",7.93E+018,"testalpha"
,"septic shock and anapache","JJ NN CC NNP",4,1,1,16365336,"pubmed1",6.40E+018,"testalpha"
,"h nic binding sites"," JJ VBG NNS",4,1,1,16594645,"pubmed1",7.47E+018,"testalpha"
,"patients with mild andmoderate","NNS IN JJ NN",4,1,1,16584121,"pubmed1",4.69E+018,"testalpha"
,"criteria for severe sepsis","NNS IN JJ NN",4,1,1,16365336,"pubmed1",2.96E+018,"testalpha"
,"standardisedrate of spinal cord","NN IN JJ NN",4,1,1,16111641,"pubmed1",2.01E+018,"testalpha"
,"settings ie long term","NNS  JJ NN",4,1,1,16808045,"pubmed1",6.28E+018,"testalpha"
,"cream puva onone side","NN  NN NN",4,1,1,16585984,2,8.41E+018,"testalpha"
,"clinic of cipto mangunkusumo","NN IN  ",4,1,1,16479024,2,5.79E+018,"testalpha"
,"high dose of dex","JJ NN IN ",4,1,1,17133953,2,2.25E+018,"testalpha"
,"tohigh flux membrane haemodialysis","VB NN NN NN",4,1,1,17106603,2,1.22E+018,"testalpha"
,"hepatic arterial phase gre","JJ JJ NN ",4,1,1,16317488,"pubmed1",4.79E+018,"testalpha"
,"discrete time branching process","JJ NN VBG NN",4,1,1,16823607,"pubmed1",3.96E+018,"testalpha"
,"parenteral nutrition and blood","JJ NN CC NN",4,1,1,16549897,2,5.45E+017,"testalpha"
,"stromal sarcomas ess adenosarcomas","JJ NNP  NNP",4,1,1,17338203,2,3.65E+018,"testalpha"
,"complicated ethicalissues and science","VBN NNS CC NN",4,1,1,16770858,"pubmed1",3.23E+018,"testalpha"
,"chances of impacted fractures","NNS IN VBN NNS",4,1,1,16613748,2,8.99E+018,"testalpha"
,"narrow band ultraviolet b","JJ NN NN NN",4,1,1,17106595,2,7.99E+018,"testalpha"
,"pressure central venous oxygen","NN JJ JJ NN",4,1,1,16365336,"pubmed1",6.07E+018,"testalpha"
,"inappropriate use of ambulance","JJ NN IN NN",4,1,1,16321535,"pubmed1",6.00E+018,"testalpha"
,"fragmentation or point mutation","NN CC NN NN",4,1,1,16369090,2,4.34E+017,"testalpha"
,"administration ofrecombinant factor viia","NN JJ NN ",4,1,1,16914908,2,2.57E+018,"testalpha"
,"bound ligands organic phosphates","VBN NNS JJ NNS",4,1,1,17019442,"pubmed1",2.00E+018,"testalpha"
,"diuretics retinoids intense uv","NNS NNS JJ ",4,1,1,17106603,2,1.02E+017,"testalpha"
,"transgenic tobaccos with thevch","JJ NNP IN ",4,1,1,16395526,"pubmed1",5.59E+018,"testalpha"
,"propofoltarget controlled infusion tci","NN VBN NN ",4,1,1,17236636,"pubmed1",4.43E+018,"testalpha"
,"bis gma and triethylene","  CC NN",4,1,1,16701856,"pubmed1",8.82E+018,"testalpha"
,"histidine acid phosphatase family","NN NN NN NN",4,1,1,16511256,2,4.91E+016,"testalpha"
,"complications incertain cardiosurgery patients","NNS VB NN NNS",4,1,1,16722344,2,8.23E+018,"testalpha"
,"levels of cholesterol phospholipids","NNS IN NN NNS",4,1,1,16523217,"pubmed1",2.72E+018,"testalpha"
,"thirtyeight percent of patients","NN NN IN NNS",4,1,1,16696444,2,3.20E+018,"testalpha"
,"covalent attachment of edta","NN NN IN ",4,1,1,17285741,"pubmed1",3.27E+018,"testalpha"
,"risk for adverse events","NN IN JJ NNS",4,1,1,16365321,"pubmed1",2.32E+018,"testalpha"
,"biodegradation of methanol g","NN IN NN ",4,1,1,17019438,"pubmed1",3.96E+017,"testalpha"
,"survival for r resectedpatients","NN IN NN NNS",4,1,1,17139895,2,7.20E+018,"testalpha"
,"large b cell lymphomas","JJ NN NN NNP",4,1,1,16612936,"pubmed1",6.21E+018,"testalpha"
,"aminotransferases alt and ast","NNS  CC ",4,1,1,17013508,2,6.71E+018,"testalpha"
,"phase transition of pc","NN NN IN ",4,1,1,16964324,"pubmed1",8.17E+018,"testalpha"
,"c albicans taken fromthe","NN NNS VBN NNP",4,1,1,17311736,2,3.19E+018,"testalpha"
,"treatments for liver metastases","NNS IN NN NNS",4,1,1,17139885,2,7.85E+018,"testalpha"
,"sensitive k channels katp","JJ  NNS ",4,1,1,16566960,2,2.61E+018,"testalpha"
,"acid changeat amino acid","NN JJ NNP NN",4,1,1,16585980,2,7.38E+017,"testalpha"
,"b and nseand lack","NN CC NN NN",4,1,1,16919707,2,8.13E+018,"testalpha"
,"intrathecal use duringcesarean section","JJ NN JJ NN",4,1,1,16617756,"pubmed1",7.40E+018,"testalpha"
,"urinelevel of eosinophil protein","NN IN  NN",4,1,1,16859611,2,7.06E+018,"testalpha"
,"indicating positivecorrelations between pkc","VBG NNS IN ",4,1,1,17016035,2,4.17E+017,"testalpha"
,"interest in various fields","NN IN JJ NNS",4,1,1,16701861,"pubmed1",2.44E+018,"testalpha"
,"non treated patients t"," VBN NNS ",4,1,1,17338197,2,2.27E+018,"testalpha"
,"reaction pcr in samples","NN  IN NNS",4,1,1,17007911,2,6.31E+018,"testalpha"
,"treatment of diabetes mellitus","NN IN NN NN",4,1,1,16918071,"pubmed1",4.56E+018,"testalpha"
,"prothrombin complex concentrates neitherof","NNP JJ NNS ",4,1,1,16549892,2,2.50E+018,"testalpha"
,"p fak on melanocytes","  IN NNS",4,1,1,17106595,2,1.22E+018,"testalpha"
,"survival os and progression","NN  CC NN",4,1,1,16424643,2,4.54E+018,"testalpha"
,"crystalstructures of human saposin","NNS IN JJ NNP",4,1,1,16511279,2,3.84E+018,"testalpha"
,"perioperative haemorrhage required administration","JJ NN VBN NN",4,1,1,16914908,2,1.83E+018,"testalpha"
,"effect of steroids antihistamines","NN IN NNS NNS",4,1,1,16451161,"pubmed1",1.21E+018,"testalpha"
,"assessmentof depression by means"," NN IN NNS",4,1,1,17013512,2,6.60E+018,"testalpha"
,"costimulatory adhesion and activatory","NN NN CC NN",4,1,1,16733557,"pubmed1",7.32E+018,"testalpha"
,"link between apoptosis andthe","NN IN NN NNP",4,1,1,16569423,2,2.49E+018,"testalpha"
,"acid moiety fromcytidine monophospho","NN NN NN ",4,1,1,16511286,2,2.61E+018,"testalpha"
,"belonged tospace group p","VBD NN NN ",4,1,1,16511252,2,5.13E+017,"testalpha"
,"hospital salatamedical school university","NN JJ NN NN",4,1,1,16918061,"pubmed1",8.28E+018,"testalpha"
,"various types of skin","JJ NNS IN NN",4,1,1,16999270,2,2.12E+018,"testalpha"
,"cells and has beenfound","NNS CC VBZ NN",4,1,1,17128291,"pubmed1",6.27E+018,"testalpha"
,"risk for developing type","NN IN VBG NN",4,1,1,16479030,2,2.75E+018,"testalpha"
,"remove redundant cells atthe","VB JJ NNS NNP",4,1,1,16919708,2,8.62E+018,"testalpha"
,"care in academic medicalcenters","NN IN JJ NNS",4,1,1,16377816,"pubmed1",3.29E+018,"testalpha"
,"multipleassociated injuries and pneumopericardium","VBN NNS CC NN",4,1,1,16956123,2,3.60E+018,"testalpha"
,"immunohistochemical detection of neurofilament","JJ NN IN NN",4,1,1,16919707,2,2.32E+017,"testalpha"
,"properties andspontaneous differentiation potential","NNS JJ NN NN",4,1,1,16696440,2,1.62E+018,"testalpha"
,"beta galactosidase reporter gene","NN NN NN ",4,1,1,17285741,"pubmed1",2.03E+018,"testalpha"
,"wild type mice lens","JJ NN  NN",4,1,1,16325892,2,8.00E+018,"testalpha"
,"cancer prevention and control","NN NN CC NN",4,1,1,16596897,"pubmed1",4.21E+018,"testalpha"
,"increase in injury prevention","NN IN NN NN",4,1,1,16436798,"pubmed1",7.64E+018,"testalpha"
,"transfectionof cord blood dc"," NN NN ",4,1,1,16404477,"pubmed1",1.39E+018,"testalpha"
,"motor blockade analgesic outcome","NN NN NN NN",4,1,1,16617757,"pubmed1",4.00E+018,"testalpha"
,"saline ml for min","NN  IN ",4,1,1,17067136,"pubmed1",7.84E+018,"testalpha"
,"th revision clinical modification"," NN JJ NN",4,1,1,16365331,"pubmed1",3.43E+018,"testalpha"
,"conclusions in patients years","NNS IN NNS NNS",4,1,1,16451146,"pubmed1",6.50E+018,"testalpha"
,"c h o ii","NN   ",4,1,1,16456293,2,1.36E+018,"testalpha"
,"improved insulinsensitivity decreased weight","VBN NN VBD NN",4,1,1,16918068,"pubmed1",5.69E+018,"testalpha"
,"itsgel showed prolonged drug","NNP VBD VBN NN",4,1,1,17285742,"pubmed1",4.40E+018,"testalpha"
,"number of veno occlusivecrises","NN IN  NNS",4,1,1,16424656,2,3.66E+018,"testalpha"
,"anocclusive hypodense filling defect","JJ NN NN NN",4,1,1,16399029,"pubmed1",1.27E+018,"testalpha"
,"icer igamma and iigamma"," NN CC NN",4,1,1,17265688,2,5.34E+018,"testalpha"
,"study reports on trends","NN NNS IN NNS",4,1,1,16111641,"pubmed1",5.00E+017,"testalpha"
,"medical education committee reporting","JJ NN NN NN",4,1,1,16377812,"pubmed1",1.64E+018,"testalpha"
,"proteins andadvanced glycation end","NNS VBN NN NN",4,1,1,16696441,2,1.68E+018,"testalpha"
,"incombination with gm csf","NN IN  ",4,1,1,16914909,2,2.09E+018,"testalpha"
,"pharmacology of synthetic hormone","NN IN JJ NN",4,1,1,16462411,"pubmed1",8.52E+018,"testalpha"
,"herbicides organochlorines and organophosphate","NNS NNS CC NN",4,1,1,17016033,2,2.70E+018,"testalpha"
,"d in developing lenscells"," IN VBG NNS",4,1,1,16325892,2,1.40E+018,"testalpha"
,"reduction in waiting list","NN IN VBG NN",4,1,1,17013505,2,5.13E+018,"testalpha"
,"showed early stagesof inflammation","VBD JJ  NN",4,1,1,16399028,"pubmed1",4.05E+018,"testalpha"
,"clinical score and serum","JJ NN CC NN",4,1,1,16603096,2,3.43E+018,"testalpha"
,"oleoyl phosphatidylcholine stearoyl linoleoyl"," NN  ",4,1,1,17128291,"pubmed1",7.54E+018,"testalpha"
,"blockade analgesic outcome mode","NN NN NN NN",4,1,1,16617757,"pubmed1",5.88E+017,"testalpha"
,"report hla g kda","NN   ",4,1,1,16511266,2,3.36E+018,"testalpha"
,"diversity of probable functions","NN IN JJ NNS",4,1,1,16964327,"pubmed1",1.10E+018,"testalpha"
,"pulsed pigment specific lasers","VBN NN JJ NNS",4,1,1,16859612,2,3.51E+018,"testalpha"
,"male wistar rats weeks","NN NN NNS NNS",4,1,1,17133954,2,6.87E+018,"testalpha"
,"glc and psi c"," CC  NN",4,1,1,16456293,2,2.17E+018,"testalpha"
,"fna showedstacks of msu"," NNS IN ",4,1,1,16514850,2,3.73E+018,"testalpha"
,"systematic quality measurement methods","JJ NN NN NNS",4,1,1,16999271,2,1.33E+018,"testalpha"
,"securing theepidural catheter patients","VBG JJ NN NNS",4,1,1,16617756,"pubmed1",6.31E+018,"testalpha"
,"terms of structural motifs","NNS IN JJ ",4,1,1,16594640,"pubmed1",3.09E+018,"testalpha"
,"light and polarizationmicroscopic level","NN CC NN NN",4,1,1,16542712,2,9.36E+017,"testalpha"
,"partial hematologicalremission cytogenetic assessment","JJ NN JJ NN",4,1,1,16914909,2,7.37E+018,"testalpha"
,"ethnic groups african americanwomen","JJ NNS JJ NNS",4,1,1,16596895,"pubmed1",7.46E+018,"testalpha"
,"study provided useful baselineinformation","NN VBD JJ NN",4,1,1,16236234,"pubmed1",7.78E+018,"testalpha"
,"benign tumors of childhood","JJ NNS IN NN",4,1,1,16859618,2,2.41E+018,"testalpha"
,"tumor size invasion lymph","NN NN NN NN",4,1,1,16530813,2,2.23E+018,"testalpha"
,"reactivity of heart beta","NN IN NN NN",4,1,1,16874421,2,7.66E+018,"testalpha"
,"method and synchrotron data","NN CC NNP NNS",4,1,1,16511274,2,7.19E+018,"testalpha"
,"first h of immersion","JJ  IN NN",4,1,1,16701856,"pubmed1",6.26E+018,"testalpha"
,"block copolymerpoly p dioxanone","NN NN  NN",4,1,1,16701879,"pubmed1",1.93E+018,"testalpha"
,"relapsed patient with mm","VBN NN IN ",4,1,1,17119326,2,1.46E+018,"testalpha"
,"research was identified case","NN VBD VBN NN",4,1,1,16365335,"pubmed1",6.06E+018,"testalpha"
,"cases within normal limits","NNS IN JJ NNS",4,1,1,16514850,2,7.44E+018,"testalpha"
,"corium and hypodermis act","NN CC NN NN",4,1,1,17294912,2,5.37E+018,"testalpha"
,"hepatic arterial blood flow","JJ JJ NN NN",4,1,1,16317494,"pubmed1",1.15E+018,"testalpha"
,"anterior cruciate ligament rupture","JJ NN NN NN",4,1,1,16919313,2,4.03E+017,"testalpha"
,"fold increase inflexural strength","NN NN JJ NN",4,1,1,16701863,"pubmed1",1.17E+018,"testalpha"
,"amputation for critical limb","NN IN JJ NN",4,1,1,16612914,"pubmed1",1.32E+018,"testalpha"
,"model lungsurface during inflation","JJ NN IN NN",4,1,1,16399039,"pubmed1",6.56E+016,"testalpha"
,"old women with incompleteevacuation","JJ NNS IN NN",4,1,1,17139884,2,5.37E+018,"testalpha"
,"using twoconformation dependent antibodies","VBG NN JJ NNS",4,1,1,16511266,2,5.80E+018,"testalpha"
,"liposomal ampotericin b l","JJ NNP NN ",4,1,1,17370566,"pubmed1",3.38E+018,"testalpha"
,"h n o resides","   NNS",4,1,1,16456295,2,7.55E+018,"testalpha"
,"cases low grade lg","NNS JJ NN ",4,1,1,17338203,2,5.84E+018,"testalpha"
,"acutemyeloid leukemia and adults","VB NN CC NNS",4,1,1,16424647,2,1.88E+018,"testalpha"
,"mechanical index real time","JJ NN JJ NN",4,1,1,16317492,"pubmed1",4.03E+018,"testalpha"
,"indicatingprimary lens fiber cells","JJ NN NN NNS",4,1,1,16325892,2,1.84E+018,"testalpha"
,"transient activation of caspase","NN NN IN NN",4,1,1,16956122,2,4.88E+018,"testalpha"
,"decline of ctgf transcripts","NN IN  NNS",4,1,1,16395527,"pubmed1",4.68E+018,"testalpha"
,"plasma polymerization using diethylene","NNP NN VBG NN",4,1,1,16701874,"pubmed1",6.24E+018,"testalpha"
,"overall adult and child","JJ NN CC NN",4,1,1,16223468,"pubmed1",8.50E+018,"testalpha"
,"function aselectron transfer groups","NN NNP VB NNS",4,1,1,17143336,"pubmed1",4.74E+017,"testalpha"
,"ac l abu nme","   ",4,1,1,16528413,"pubmed1",7.17E+016,"testalpha"
,"specific symptoms such asarthralgias","JJ NNS JJ NNP",4,1,1,16648918,2,3.23E+018,"testalpha"
,"pollen associated food allergy","NN VBN NN NN",4,1,1,16648913,2,5.85E+018,"testalpha"
,"screening for surface molecules","NN IN NN NNS",4,1,1,16414103,2,3.58E+018,"testalpha"
,"reticulocyte index and rdw","NNP NN CC ",4,1,1,17117609,2,2.10E+016,"testalpha"
,"ofbiomolecules e g proteins","NNS   NNS",4,1,1,16701857,"pubmed1",2.69E+018,"testalpha"
,"non ssri exposed neonates","  VBN NNS",4,1,1,16549890,2,5.58E+018,"testalpha"
,"studythe effects of carotenoids","NNP NNS IN NNS",4,1,1,16964324,"pubmed1",6.77E+018,"testalpha"
,"occurred toa higher degree","VBD  JJR NN",4,1,1,16528413,"pubmed1",2.44E+018,"testalpha"
,"results good programs reducetotal","NNS JJ NNS NN",4,1,1,16171767,"pubmed1",2.03E+018,"testalpha"
,"providers and emergency rescuers","NNS CC NN NNS",4,1,1,16365322,"pubmed1",5.69E+018,"testalpha"
,"recombinant human bfgf rhbfgf","JJ JJ  ",4,1,1,17106595,2,9.03E+018,"testalpha"
,"flinders technology associates fta","NNS NN NNS ",4,1,1,16951742,"pubmed1",7.74E+018,"testalpha"
,"advances in molecular biologyand","NNS IN JJ NN",4,1,1,16505901,"pubmed1",2.76E+018,"testalpha"
,"shorterlength of hospital stay","NN IN NN NN",4,1,1,16613748,2,8.14E+018,"testalpha"
,"severityand concentrations of matrix","NN NNS IN NNP",4,1,1,16585983,2,5.54E+018,"testalpha"
,"bacterial type l asparaginases","JJ NN  NNS",4,1,1,17143335,"pubmed1",1.23E+018,"testalpha"
,"survival encapsulated min beta","NN VBN  NN",4,1,1,16701853,"pubmed1",5.00E+018,"testalpha"
,"revisions of deterrence theory","NNS IN NN NN",4,1,1,16405859,"pubmed1",3.94E+018,"testalpha"
,"larger incidence of impairment","JJR NN IN NN",4,1,1,16451151,"pubmed1",7.31E+018,"testalpha"
,"skinsurfaces from age onwards","NNS IN NN NNS",4,1,1,16859612,2,5.92E+018,"testalpha"
,"immune thrombocytopenic purpura itp","JJ JJ NNP ",4,1,1,16424649,2,6.76E+017,"testalpha"
,"cells apcs for t","NNS  IN ",4,1,1,16733557,"pubmed1",3.15E+018,"testalpha"
,"ni ii complexes ofac","  NNS ",4,1,1,17117212,"pubmed1",3.88E+018,"testalpha"
,"dose of dbt training","NN IN  NN",4,1,1,16473997,"pubmed1",5.39E+018,"testalpha"
,"analyticaltool for modelling crash","NN IN VBG NN",4,1,1,16126153,"pubmed1",2.28E+018,"testalpha"
,"cytometry healthy patients n","NN JJ NNS ",4,1,1,17016036,2,4.41E+018,"testalpha"
,"inthis group of patients","NNP NN IN NNS",4,1,1,17338203,2,7.06E+018,"testalpha"
,"kneeafter anterior cruciate ligament","NN JJ NN NN",4,1,1,16919313,2,1.47E+018,"testalpha"
,"symptoms and questions aboutthe","NNS CC NNS NNP",4,1,1,16377815,"pubmed1",6.68E+018,"testalpha"
,"significant difference inneutrophils sequestration","JJ NN NNS NN",4,1,1,16491220,2,4.63E+018,"testalpha"
,"advancement of psychiatry gap","NN IN NN NN",4,1,1,16473998,"pubmed1",4.39E+018,"testalpha"
,"changes initiate intramolecular signal","NNS VBP JJ NN",4,1,1,16411738,"pubmed1",2.51E+017,"testalpha"
,"topical gels enriched withsln","JJ  VBN ",4,1,1,17285742,"pubmed1",4.08E+018,"testalpha"
,"devices used tocollect thinprep","NNS VBN NN ",4,1,1,16514841,2,4.65E+018,"testalpha"
,"evoked bystimulation of vibrissae","VBD NN IN ",4,1,1,17133958,2,2.54E+018,"testalpha"
,"hiv seropositive female patient"," JJ NN NN",4,1,1,16673613,2,1.09E+018,"testalpha"
,"gt after partial hepatectomy"," IN JJ NN",4,1,1,17013510,2,5.57E+018,"testalpha"
,"biologistsanalyse characteristics of animal"," NNS IN NN",4,1,1,16823606,"pubmed1",4.14E+018,"testalpha"
,"overall survival progression freesurvival","JJ NN NN NN",4,1,1,16424644,2,3.99E+018,"testalpha"
,"stated restingpressure cm h","VBD NN  ",4,1,1,17139884,2,3.26E+018,"testalpha"
,"significant differences between respondents","JJ NNS IN NNS",4,1,1,16330213,"pubmed1",8.14E+018,"testalpha"
,"detailedcharacterization of disulfide exchange","NN IN VB NN",4,1,1,17019443,"pubmed1",8.81E+018,"testalpha"
,"environment compared withyounger drivers","NN VBN NN NNS",4,1,1,16226211,"pubmed1",3.85E+018,"testalpha"
,"university of missouri columbiaschool","NN IN NNP NN",4,1,1,16377828,"pubmed1",3.99E+018,"testalpha"
,"therapydecreased cd p expression","VBN   NN",4,1,1,16809885,2,5.36E+017,"testalpha"
,"versatile application ingenetic engineering","JJ NN JJ NN",4,1,1,16951740,"pubmed1",8.10E+018,"testalpha"
,"history of individual patients","NN IN JJ NNS",4,1,1,16710575,2,6.52E+018,"testalpha"
,"cup shaped structures onthe","NN VBN NNS NNP",4,1,1,16733562,"pubmed1",1.52E+018,"testalpha"
,"chemo viruses and synthesis"," NNS CC NN",4,1,1,17285739,"pubmed1",1.93E+018,"testalpha"
,"pressure volume pv curves","NN NN  NNS",4,1,1,16451155,"pubmed1",3.24E+018,"testalpha"
,"diet plan or dietprogram","NN NN CC NN",4,1,1,16696439,2,6.97E+018,"testalpha"
,"theheterozygosity rate i e","NN NN  ",4,1,1,16424652,2,2.83E+018,"testalpha"
,"interactions and c h","NNS CC NN ",4,1,1,16456296,2,6.61E+018,"testalpha"
,"coefficient vm and solvent","NN  CC NN",4,1,1,16511252,2,5.64E+018,"testalpha"
,"immune cell antigen cd","JJ NN NN ",4,1,1,16929383,"pubmed1",4.36E+018,"testalpha"
,"effective medical protection andtreatment","JJ JJ NN NN",4,1,1,16696436,2,2.82E+018,"testalpha"
,"concentration and measuredfiber diameter","NN CC NN NN",4,1,1,16701855,"pubmed1",4.31E+018,"testalpha"
,"binding inhibition by fdump","VBG NN IN NNP",4,1,1,16505899,"pubmed1",1.49E+018,"testalpha"
,"burns chronic ulcers donor","NNS JJ NNS NN",4,1,1,17010268,2,3.37E+018,"testalpha"
,"bp and rab b"," CC  NN",4,1,1,16365637,"pubmed1",2.69E+018,"testalpha"
,"cells possessing wild type","NNS VBG JJ NN",4,1,1,16404475,"pubmed1",8.17E+018,"testalpha"
,"formetastases neo adjuvant therapy","NNS  JJ NN",4,1,1,17139882,2,6.38E+018,"testalpha"
,"transfect immortalized humanendothelial cell","NN VBN JJ NN",4,1,1,16733560,"pubmed1",7.44E+018,"testalpha"
,"graftsand skin extension closures","NN NN NN NNS",4,1,1,17165596,2,9.22E+018,"testalpha"
,"values of hillequation parameters","NNS IN NN NNS",4,1,1,17019442,"pubmed1",8.04E+018,"testalpha"
,"treatment of theemergent episode","NN IN NN NN",4,1,1,16462410,"pubmed1",3.16E+018,"testalpha"
,"lower incidence of severehypotension","JJR NN IN NN",4,1,1,16617756,"pubmed1",9.13E+017,"testalpha"
,"meld model for end"," NN IN NN",4,1,1,17013512,2,3.88E+017,"testalpha"
,"surgical care physical therapy","JJ NN JJ NN",4,1,1,17688033,2,1.18E+018,"testalpha"
,"capture ii technique hcii","VB  NN ",4,1,1,16514835,2,3.93E+018,"testalpha"
,"amounts of macronutrients tosupport","NNS IN NNS NN",4,1,1,16918070,"pubmed1",5.75E+018,"testalpha"
,"cd l interactionstimulates b","  NNS NN",4,1,1,16733557,"pubmed1",8.09E+018,"testalpha"
,"thickness luminal narrowing intestinaldilatation","NN JJ NN NN",4,1,1,16447095,"pubmed1",6.37E+018,"testalpha"
,"achievement of complete remission","NN IN JJ NN",4,1,1,16424645,2,1.14E+018,"testalpha"
,"identification of cells changes","NN IN NNS NNS",4,1,1,17293964,2,5.64E+018,"testalpha"
,"values of agnor dots","NNS IN NN NNS",4,1,1,17293964,2,6.80E+018,"testalpha"
,"investigated using fluorescence spectroscopy","VBD VBG NN ",4,1,1,17019437,"pubmed1",3.23E+018,"testalpha"
,"risk of severe injuriesto","NN IN JJ NNP",4,1,1,16197912,"pubmed1",1.51E+018,"testalpha"
,"studied withcolloidal silicon dioxide","VBN NN NN NN",4,1,1,17285749,"pubmed1",6.69E+018,"testalpha"
,"kg h for h","  IN ",4,1,1,16451160,"pubmed1",4.16E+018,"testalpha"
,"c mutation in exon","NN NN IN ",4,1,1,16585980,2,5.67E+018,"testalpha"
,"roles of different healthcare","NNS IN JJ NN",4,1,1,16710575,2,3.65E+018,"testalpha"
,"viability albuminproduction mitochondrial membrane","NN NN JJ NN",4,1,1,16696445,2,8.73E+017,"testalpha"
,"current complication of factor","JJ NN IN NN",4,1,1,16549892,2,4.82E+018,"testalpha"
,"context of defining biodiversity","NN IN VBG NN",4,1,1,16988906,"pubmed1",7.38E+018,"testalpha"
,"mode of delivery andneonatal","NN IN NN NN",4,1,1,16617757,"pubmed1",5.91E+018,"testalpha"
,"major role in cell","JJ NN IN NN",4,1,1,16713618,2,9.08E+018,"testalpha"
,"characteristics of possible tandem","NNS IN JJ NN",4,1,1,16733558,"pubmed1",1.63E+018,"testalpha"
,"selenium independent gshperoxidase selenium","NN JJ NN NN",4,1,1,16404476,"pubmed1",4.19E+018,"testalpha"
,"results results of chlamydia","NNS NNS IN NNP",4,1,1,16514839,2,1.35E+018,"testalpha"
,"knee of rabbits afterthe","NN IN NNS NNP",4,1,1,17293966,2,4.54E+018,"testalpha"
,"aspartate nmda receptor antagonist","NN  NN NN",4,1,1,16451144,"pubmed1",5.33E+018,"testalpha"
,"blood stem celltransplantation pbsct","NN VB NN ",4,1,1,16914902,2,3.59E+018,"testalpha"
,"patients with pci p","NNS IN  ",4,1,1,17139879,2,3.41E+018,"testalpha"
,"nmol mg protein p","  NN ",4,1,1,16696441,2,1.27E+018,"testalpha"
,"metabolic syndrome improved insulinsensitivity","JJ NN VBN NN",4,1,1,16918068,"pubmed1",6.33E+018,"testalpha"
,"second order apparent rate","JJ NN JJ NN",4,1,1,17019443,"pubmed1",3.99E+018,"testalpha"
,"cortex and anterior vibrissae","NNP CC JJ ",4,1,1,17133958,2,1.30E+017,"testalpha"
,"vestibular glands isa topic","JJ NNS  NN",4,1,1,16997356,2,4.98E+018,"testalpha"
,"withperitoneal cancer index pci","NN NN NN ",4,1,1,17139879,2,6.81E+018,"testalpha"
,"orderregulatory and constitutional functions","NN CC JJ NNS",4,1,1,17347785,"pubmed1",1.46E+018,"testalpha"
,"contribute toan increased rate","VB  VBN NN",4,1,1,16603098,2,9.62E+017,"testalpha"
,"errant vehicles from roadside","JJ NNS IN NN",4,1,1,16054101,"pubmed1",3.04E+018,"testalpha"
,"severe haemorrhage and cardio","JJ NN CC NN",4,1,1,16916181,"pubmed1",5.49E+018,"testalpha"
,"known hif dependent genes","VBN  JJ NNS",4,1,1,17143338,"pubmed1",2.89E+018,"testalpha"
,"low riskof adverse effects","JJ  JJ NNS",4,1,1,16859612,2,7.17E+018,"testalpha"
,"acute hepatitis groups health","JJ NN NNS NN",4,1,1,16696442,2,8.17E+018,"testalpha"
,"health care increased attention","NN NN VBN NN",4,1,1,16365327,"pubmed1",8.88E+018,"testalpha"
,"organized bundles of collagen","VBN NNS IN NN",4,1,1,16574202,2,7.29E+018,"testalpha"
,"independent sample t test","JJ NN  NN",4,1,1,16436790,"pubmed1",4.52E+017,"testalpha"
,"group after coloanal anastomosis","NN IN JJ NN",4,1,1,17139896,2,8.09E+018,"testalpha"
,"high identity with delta","JJ NN IN NN",4,1,1,17063209,"pubmed1",6.33E+018,"testalpha"
,"beneficial effects inthe treatment","JJ NNS NNP NN",4,1,1,16594642,"pubmed1",3.85E+018,"testalpha"
,"significant increase inpositive patch","JJ NN JJ NN",4,1,1,17106597,2,6.09E+018,"testalpha"
,"inclusion incertified occupational health","NN VBN JJ NN",4,1,1,16438092,"pubmed1",2.32E+018,"testalpha"
,"pressure values were range","NN NNS VBD NN",4,1,1,16612916,"pubmed1",7.10E+018,"testalpha"
,"expression of p fak","NN IN  ",4,1,1,17106595,2,2.42E+018,"testalpha"
,"driving safety and theirunsafe","VBG NN CC NN",4,1,1,16061188,"pubmed1",5.36E+018,"testalpha"
,"food andwaterborne diarrheal disease","NN NNP NN NN",4,1,1,16511280,2,8.14E+018,"testalpha"
,"interaction extent of cooperativity","NN NN IN NN",4,1,1,17019442,"pubmed1",7.47E+018,"testalpha"
,"range ic nmol l","NN JJ  ",4,1,1,16594645,"pubmed1",2.05E+017,"testalpha"
,"thromboembolism vte deepvenous thrombosis","NN  JJ NN",4,1,1,16549896,2,3.82E+018,"testalpha"
,"ph values byenzymatic degradation"," NNS JJ NN",4,1,1,17285741,"pubmed1",5.43E+018,"testalpha"
,"od external anal sphincters"," JJ  NNS",4,1,1,17139884,2,4.58E+018,"testalpha"
,"high prevalence of pft","JJ NN IN ",4,1,1,16809886,2,6.60E+018,"testalpha"
,"skin in full thicknessburns","NN IN JJ NNS",4,1,1,16999269,2,1.97E+018,"testalpha"
,"uterine differentiation during theperiimplantation","NN NN IN NN",4,1,1,16808046,"pubmed1",3.40E+018,"testalpha"
,"patients with beta thalassemia","NNS IN NN NN",4,1,1,16809886,2,2.86E+018,"testalpha"
,"extensive work up provedto","JJ NN IN ",4,1,1,16673557,2,1.16E+018,"testalpha"
,"thepreventable cases of end","JJ NNS IN NN",4,1,1,17013520,2,5.85E+018,"testalpha"
,"rattus norvegicus albinus wistar","NN NN NN NN",4,1,1,17293964,2,5.84E+018,"testalpha"
,"terminal steroidogenic acuteregulatory protein","NN JJ NN NN",4,1,1,16951743,"pubmed1",4.89E+018,"testalpha"
,"procedure tl vs u","NN   ",4,1,1,17338197,2,4.92E+017,"testalpha"
,"mild andmoderate hepatic impairment","JJ NN JJ NN",4,1,1,16584121,"pubmed1",4.24E+018,"testalpha"
,"work heterologous expressionand purification","NN JJ NN NN",4,1,1,16511251,2,1.53E+018,"testalpha"
,"serum levels ofalanine aminotransferase","NN NNS NN NN",4,1,1,17013509,2,2.52E+018,"testalpha"
,"method bayesian reasoning metacognition","NN JJ NN NN",4,1,1,16365325,"pubmed1",4.07E+018,"testalpha"
,"specific t cell activation","JJ  NN NN",4,1,1,16956117,2,8.81E+018,"testalpha"
,"order of alkyl chains","NN IN  NNS",4,1,1,16964324,"pubmed1",5.95E+018,"testalpha"
,"beta makes thecorresponding turn","NN VBZ VBG NN",4,1,1,16421453,2,5.07E+018,"testalpha"
,"existence of homologousfood allergens","NN IN NN NNS",4,1,1,16673562,2,5.71E+018,"testalpha"
,"risk low perceivedprevalence items","NN JJ NN NNS",4,1,1,16191426,"pubmed1",5.26E+018,"testalpha"
,"component cholesterol triglyceride hdl","NN NN VB ",4,1,1,16479028,2,9.14E+018,"testalpha"
,"humanpleural fluid and bovine","JJ NN CC NN",4,1,1,16929383,"pubmed1",4.31E+018,"testalpha"
,"mental health andjob satisfaction","JJ NN  NN",4,1,1,16377815,"pubmed1",3.53E+018,"testalpha"
,"tumor specific immune response","NN JJ JJ NN",4,1,1,16404477,"pubmed1",6.44E+018,"testalpha"
,"nqr from pathogenic andmarine"," IN JJ NN",4,1,1,16511277,2,7.71E+018,"testalpha"
,"drugs betamethasone calcipotriol dithranol","NNS NN  NN",4,1,1,16874412,2,5.50E+018,"testalpha"
,"thenegative effect of overconfidence","JJ NN IN NN",4,1,1,16443186,"pubmed1",5.18E+018,"testalpha"
,"gypsy and non gypsypopulations","NN CC  NNS",4,1,1,17165598,2,8.53E+018,"testalpha"
,"organization at adiscrete point","NN IN JJ NN",4,1,1,16442068,"pubmed1",8.82E+018,"testalpha"
,"shields accurate kv values","VBZ JJ  NNS",4,1,1,17285746,"pubmed1",1.06E+018,"testalpha"
,"receptor related gene gitr","NN VBN  ",4,1,1,16955181,2,5.18E+018,"testalpha"
,"n c h n"," NN  ",4,1,1,16397333,2,8.11E+018,"testalpha"
,"cytomorphology of bladder urine","NN IN NN NN",4,1,1,16514843,2,3.06E+018,"testalpha"
,"structure changesof sodium chloride","NN  NN NN",4,1,1,16584166,"pubmed1",9.20E+018,"testalpha"
,"hbt hydroxybenzoyl coa thioesterase","   NN",4,1,1,16511283,2,2.04E+018,"testalpha"
,"following days of culture","VBG NNS IN NN",4,1,1,17016038,2,5.84E+018,"testalpha"
,"activated receptor ppar isoforms","VBN NN  NNS",4,1,1,16395520,"pubmed1",5.78E+018,"testalpha"
,"branca on liver regeneration","NNP IN NN NN",4,1,1,17013511,2,3.49E+018,"testalpha"
,"px superoxide dismutase sod"," VB NN ",4,1,1,16999986,2,3.00E+018,"testalpha"
,"therelationships between measures variables","NNS IN NNS NNS",4,1,1,16406188,"pubmed1",7.02E+018,"testalpha"
,"need of training physician","NN IN VBG NN",4,1,1,16473996,"pubmed1",2.44E+018,"testalpha"
,"ordination of resources increasedcommunication","NN IN NNS NN",4,1,1,16377191,"pubmed1",3.77E+018,"testalpha"
,"cytochrome c catalyzed nitration","NN NN VBN NN",4,1,1,16951741,"pubmed1",1.21E+018,"testalpha"
,"n control group g"," NN NN ",4,1,1,17293959,2,7.98E+017,"testalpha"
,"spectrum of cytochrome c","NN IN NN NN",4,1,1,16951741,"pubmed1",6.22E+018,"testalpha"
,"coronary artery disease cad","NN NN NN ",4,1,1,17014894,2,4.04E+018,"testalpha"
,"r tert butyl methyl","NN   ",4,1,1,16456281,2,4.23E+017,"testalpha"
,"hdl cholesterol or arylesterase"," NN CC NN",4,1,1,17106515,"pubmed1",2.12E+018,"testalpha"
,"lv volume stroke volume"," NN NN NN",4,1,1,16989140,2,6.02E+016,"testalpha"
,"used forano rectal surgeries","VBN NN NN NNS",4,1,1,17139880,2,1.14E+018,"testalpha"
,"proliferation but alsoreduces cell","NN CC NNS NN",4,1,1,16564564,2,4.29E+018,"testalpha"
,"andto identify risk factors"," VB NN NNS",4,1,1,17106598,2,2.83E+018,"testalpha"
,"efficiency and bed availability","NN CC NN NN",4,1,1,16377816,"pubmed1",1.56E+018,"testalpha"
,"prothrombotic state at presentation","JJ NN IN NN",4,1,1,16549900,2,2.08E+018,"testalpha"
,"quality beam apertures oscillation","NN NN NNS NN",4,1,1,16369094,2,7.79E+017,"testalpha"
,"deep epidermal cell layers","JJ JJ NN NNS",4,1,1,16824585,2,8.82E+017,"testalpha"
,"basement membrane zone auto","NN NN NN NN",4,1,1,16955192,2,5.13E+018,"testalpha"
,"paresis and periodic paralysis","NN CC JJ NN",4,1,1,16479025,2,2.12E+018,"testalpha"
,"artery flow global hemodynamicsand","NN NN JJ NN",4,1,1,16451157,"pubmed1",6.35E+018,"testalpha"
,"poly ethylene glycol pegdm"," NN NN ",4,1,1,16701853,"pubmed1",9.07E+018,"testalpha"
,"applications for pet ct","NNS IN NN ",4,1,1,16333707,"pubmed1",1.17E+018,"testalpha"
,"acute phase proteinsin serum","JJ NN NNP NN",4,1,1,16714050,2,6.64E+018,"testalpha"
,"kv were calculated fromthe"," VBD VBN NNP",4,1,1,17285746,"pubmed1",8.66E+016,"testalpha"
,"herpes simplex virus type","NNS JJ NN NN",4,1,1,16648915,2,4.24E+017,"testalpha"
,"years or older whounderwent","NNS CC JJR NN",4,1,1,16451146,"pubmed1",7.67E+018,"testalpha"
,"chain fatty acids scfa","NN JJ NNS ",4,1,1,16491218,2,6.17E+018,"testalpha"
,"service forclinicians and pathologists","NN NNS CC NNS",4,1,1,16790262,2,3.34E+018,"testalpha"
,"fasciculation and subse quent","NN CC  NN",4,1,1,17067136,"pubmed1",5.49E+018,"testalpha"
,"fusion of neurocranim sutures","NN IN  NNS",4,1,1,17438834,2,6.79E+018,"testalpha"
,"initial treatment while patient","JJ NN IN NN",4,1,1,16424653,2,6.44E+018,"testalpha"
,"pharmaceutical research and developmentare","JJ NN CC NN",4,1,1,16596744,"pubmed1",1.03E+018,"testalpha"
,"cell nucleus and bind","NN NN CC NN",4,1,1,16996581,2,4.36E+018,"testalpha"
,"activation cascade during apoptosis","NN NN IN NN",4,1,1,17034836,2,2.11E+018,"testalpha"
,"o and maximum squeeze"," CC JJ NN",4,1,1,17139884,2,8.69E+018,"testalpha"
,"type of substituent plays","NN IN NN NNS",4,1,1,16404478,"pubmed1",2.04E+018,"testalpha"
,"demographicinformation and pain treatments","NN CC NN NNS",4,1,1,16436793,"pubmed1",7.37E+018,"testalpha"
,"nos inhibitor n omega","NNS NN  NNP",4,1,1,16764913,2,3.50E+018,"testalpha"
,"beta in short term","NN IN JJ NN",4,1,1,17293967,2,1.03E+018,"testalpha"
,"granulocytecolony stimulating factor g","NN JJ NN ",4,1,1,16809884,2,9.65E+017,"testalpha"
,"pricktests with fresh foods","NNS IN JJ NNS",4,1,1,16673562,2,6.36E+018,"testalpha"
,"liver echogenicity and serumc","NN NN CC ",4,1,1,16673610,2,5.92E+018,"testalpha"
,"diagnostic criteria for nf","JJ NNS IN ",4,1,1,17010267,2,8.39E+018,"testalpha"
,"allergy vaccines novo helisen","NN NNS  NNP",4,1,1,16603096,2,5.36E+018,"testalpha"
,"allogeneic mixed lymphocyte tumor","JJ VBN NNP NN",4,1,1,17117211,"pubmed1",3.63E+018,"testalpha"
,"beta galactoside binding protein","NN VB VBG NN",4,1,1,17084885,2,2.40E+018,"testalpha"
,"intranasal administrations of sme","NN NNS IN ",4,1,1,16584167,"pubmed1",8.56E+018,"testalpha"
,"cycle and usp staff","NN CC  NN",4,1,1,17285738,"pubmed1",8.05E+018,"testalpha"
,"intervention group had triagenurses","NN NN VBD NNS",4,1,1,16436790,"pubmed1",3.12E+018,"testalpha"
,"total number of patients","JJ NN IN NNS",4,1,1,17294910,2,2.58E+018,"testalpha"
,"bymain chain carbonyl groups","VB NN NN NNS",4,1,1,17143335,"pubmed1",4.12E+017,"testalpha"
,"results methods of assessment","NNS NNS IN NN",4,1,1,16473998,"pubmed1",4.09E+018,"testalpha"
,"clerkships as restricted work","NNS IN VBN NN",4,1,1,16377822,"pubmed1",3.25E+018,"testalpha"
,"assess attitudes towards patients","VB NNS IN NNS",4,1,1,16330213,"pubmed1",7.59E+018,"testalpha"
,"questionnaire study of adults","NN NN IN NNS",4,1,1,16648916,2,1.03E+018,"testalpha"
,"yl ethane diamine c"," NN NN NN",4,1,1,16456284,2,8.01E+018,"testalpha"
,"compared tothe other institution","VBN NNP JJ NN",4,1,1,16617757,"pubmed1",7.05E+018,"testalpha"
,"blood and intravenous catheter","NN CC JJ NN",4,1,1,17311736,2,7.22E+017,"testalpha"
,"hazard of re offense","NN IN  NN",4,1,1,16202465,"pubmed1",6.09E+018,"testalpha"
,"pyrimidine nucleosides and adp","NN NNS CC ",4,1,1,16421443,2,8.04E+018,"testalpha"
,"get liver and muscle","VB NN CC NN",4,1,1,16921609,"pubmed1",7.54E+018,"testalpha"
,"assayed specimens lacking pp","VBN NNS VBG ",4,1,1,17019440,"pubmed1",2.82E+018,"testalpha"
,"examples of such biotoxins","NNS IN JJ NNS",4,1,1,16696436,2,2.22E+018,"testalpha"
,"operative treatmentof minor liver","JJ  JJ NN",4,1,1,17013521,2,8.05E+018,"testalpha"
,"ed length of stay","VBD NN IN NN",4,1,1,16365336,"pubmed1",6.33E+018,"testalpha"
,"pharmacopeia usp type i","  NN ",4,1,1,16584139,"pubmed1",8.04E+018,"testalpha"
,"employment in liver transplantation","NN IN NN NN",4,1,1,17013514,2,3.96E+018,"testalpha"
,"patients with autoimmune pancreatitis","NNS IN NN NN",4,1,1,16333694,"pubmed1",3.53E+018,"testalpha"
,"pharmacokinetic parameters drug targetingefficiency","JJ NNS NN NN",4,1,1,16584167,"pubmed1",3.12E+018,"testalpha"
,"containedsurepath preservative fluid tripath","NN JJ NN NN",4,1,1,16514841,2,3.23E+018,"testalpha"
,"modalities asdiagnostic peritoneal lavage","NNS JJ NN NN",4,1,1,17013521,2,7.48E+018,"testalpha"
,"recovery after desflurane fentanyl","NN IN NN NN",4,1,1,16451145,"pubmed1",4.32E+018,"testalpha"
,"specific dff cad endonuclease","JJ   NN",4,1,1,16951739,"pubmed1",7.60E+018,"testalpha"
,"types isolated cleft lip","NNS VBN NN NN",4,1,1,17165598,2,1.49E+018,"testalpha"
,"silicon dioxide magnesium stearate","NN NN NN NN",4,1,1,17285749,"pubmed1",6.05E+018,"testalpha"
,"results of chlamydia prevalence","NNS IN NNP NN",4,1,1,16514839,2,1.77E+018,"testalpha"
,"relative numbersof specific types","JJ  JJ NNS",4,1,1,17165598,2,2.74E+018,"testalpha"
,"triethylene glycoldimethacrylate i e","NN NN  ",4,1,1,16701856,"pubmed1",4.31E+018,"testalpha"
,"case reports of children","NN NNS IN NNS",4,1,1,16549902,2,4.35E+017,"testalpha"
,"transporter glut and cb","NN  CC ",4,1,1,16395520,"pubmed1",9.46E+017,"testalpha"
,"allogenic blood blood products","JJ NN NN NNS",4,1,1,16451158,"pubmed1",3.16E+018,"testalpha"
,"related thrombosis in children","VBN NN IN NNS",4,1,1,16549897,2,5.36E+018,"testalpha"
,"important role in tissue","JJ NN IN NN",4,1,1,17265694,2,9.16E+018,"testalpha"
,"problem affecting millions ofpeople","NN VBG NNS NNS",4,1,1,16479031,2,7.56E+018,"testalpha"
,"pelvis neck and chest","NNP NN CC NN",4,1,1,17067135,"pubmed1",7.46E+018,"testalpha"
,"proximity ofthe transcription start","NN NNP NN NN",4,1,1,16964327,"pubmed1",3.48E+018,"testalpha"
,"thegroups after successful insertion","NNS IN JJ NN",4,1,1,16451149,"pubmed1",3.62E+018,"testalpha"
,"prophylaxis screening and treatment"," NN CC NN",4,1,1,16549896,2,4.34E+018,"testalpha"
,"high catalytic efficiency ofdck","JJ JJ NN ",4,1,1,16421443,2,5.61E+018,"testalpha"
,"bone repair in treatedanimals","NN NN IN NNS",4,1,1,17293965,2,6.35E+018,"testalpha"
,"mrna in endocrine cells"," IN NN NNS",4,1,1,16569423,2,2.42E+018,"testalpha"
,"liver hemangiomas on contrast","NN NNP IN NN",4,1,1,16333704,"pubmed1",1.31E+018,"testalpha"
,"infarctswith angiogenesis at d","NN NN IN ",4,1,1,17014894,2,7.65E+018,"testalpha"
,"westernblot analysis identified expression","NN NN VBD NN",4,1,1,16809887,2,8.86E+018,"testalpha"
,"results of photodynamic therapy","NNS IN JJ NN",4,1,1,16955186,2,2.25E+018,"testalpha"
,"increased serum iron levels","VBD NN NN NNS",4,1,1,17119325,2,7.29E+018,"testalpha"
,"local ph and others","JJ  CC NNS",4,1,1,17294912,2,1.65E+018,"testalpha"
,"gitrl in plasma fromatopic"," IN NNP NN",4,1,1,16955181,2,4.42E+018,"testalpha"
,"support during defecation giant","NN IN NN NN",4,1,1,17139884,2,5.23E+018,"testalpha"
,"cells with rock inhibitor","NNS IN NN NN",4,1,1,17115079,"pubmed1",9.06E+018,"testalpha"
,"atopic dermatitis and persons","NN NN CC NNS",4,1,1,16648913,2,2.70E+018,"testalpha"
,"ng dl and grade","  CC NN",4,1,1,16673610,2,5.14E+018,"testalpha"
,"stay or pelvic sepsis","NN CC JJ NN",4,1,1,17139896,2,5.82E+018,"testalpha"
,"residues including sialic acids","NNS IN JJ NNS",4,1,1,16714048,2,4.21E+018,"testalpha"
,"evaluate cord bloodneonatal platelet","VB NN NN NN",4,1,1,16549889,2,6.91E+018,"testalpha"
,"patients with various dermatologicdisorders","NNS IN JJ NNS",4,1,1,16859617,2,8.30E+018,"testalpha"
,"selenium dependent gsh peroxidase","NN JJ  NN",4,1,1,16404476,"pubmed1",6.33E+018,"testalpha"
,"achievedcomplete response cr patient","JJ NN  NN",4,1,1,16914902,2,4.06E+018,"testalpha"
,"hydrophilic mounting medium gum","JJ VBG NN NN",4,1,1,16714051,2,3.83E+018,"testalpha"
,"extensive haemorrhage or necrosis","JJ NN CC NN",4,1,1,16612920,"pubmed1",4.98E+018,"testalpha"
,"pathogenic factor inthe aetiology","JJ NN NNP NN",4,1,1,16874416,2,4.02E+018,"testalpha"
,"free amplitude voltages fluorescence","JJ VB NNS NN",4,1,1,16701857,"pubmed1",3.22E+018,"testalpha"
,"band ultraviolet uv b","NN NN  NN",4,1,1,16710585,2,7.09E+018,"testalpha"
,"blood cells by stimulationwith","NN NNS IN NN",4,1,1,16404477,"pubmed1",1.89E+018,"testalpha"
,"assessment by human observers","NN IN JJ NNS",4,1,1,16648914,2,5.55E+018,"testalpha"
,"normal renal function tests","JJ JJ NN NNS",4,1,1,16956119,2,1.78E+016,"testalpha"
,"retrospective determination ofculprit drugs","JJ NN NN NNS",4,1,1,16710577,2,8.73E+018,"testalpha"
,"concentration ofthe chemical messengers","NN NNP NN NNS",4,1,1,16479030,2,7.74E+018,"testalpha"
,"dc of glass fiber"," IN NN NN",4,1,1,16701856,"pubmed1",4.09E+018,"testalpha"
,"conventional glass ionomer liquids","JJ NN NN NNS",4,1,1,16701865,"pubmed1",3.59E+018,"testalpha"
,"haveappropriate strategy or measure","NN NN CC NN",4,1,1,16479033,2,7.28E+018,"testalpha"
,"protein moiety of ldl","NN NN IN ",4,1,1,17128291,"pubmed1",4.34E+018,"testalpha"
,"progression of fatty liver","NN IN JJ NN",4,1,1,16673555,2,5.83E+017,"testalpha"
,"variety oflimitations for analysis","NN NNS IN NN",4,1,1,16112068,"pubmed1",8.32E+018,"testalpha"
,"inguinal lymphatic basins sn","JJ JJ NNS ",4,1,1,16491216,2,3.63E+018,"testalpha"
,"visualization of coronary arteries","NN IN NN NNS",4,1,1,16399037,"pubmed1",8.45E+018,"testalpha"
,"experienced more application site","VBN JJR NN NN",4,1,1,16585986,2,4.36E+018,"testalpha"
,"osteoclastlike multinucleated giant cellsand","NN VBN NN NN",4,1,1,16514845,2,4.43E+018,"testalpha"
,"rate for statistical analysis","NN IN JJ NN",4,1,1,16399037,"pubmed1",2.54E+018,"testalpha"
,"case specific incidentmanagement strategies","NN JJ NN NNS",4,1,1,16426557,"pubmed1",6.24E+018,"testalpha"
,"several reports published inthe","JJ NNS VBD NNP",4,1,1,16596897,"pubmed1",1.53E+018,"testalpha"
,"dopamine da or glutamate","NN  CC NN",4,1,1,16808044,"pubmed1",5.48E+017,"testalpha"
,"index and themaslach burnout","NN CC NN NN",4,1,1,16377826,"pubmed1",9.16E+018,"testalpha"
,"inducedapoptosis and mitochondrial translocation","NN CC JJ NN",4,1,1,16424655,2,9.95E+017,"testalpha"
,"histological grade and lymph","JJ NN CC NN",4,1,1,17139886,2,1.29E+017,"testalpha"
,"results smaller trabecular formation","NNS JJR JJ NN",4,1,1,17293965,2,1.39E+017,"testalpha"
,"effect on driver fatalities","NN IN NN NNS",4,1,1,16171767,"pubmed1",4.76E+018,"testalpha"
,"minority patients and theirphysicians","NN NNS CC NNS",4,1,1,16596898,"pubmed1",4.46E+018,"testalpha"
,"induced hela and jurkat","VBN  CC ",4,1,1,16505900,"pubmed1",7.69E+017,"testalpha"
,"adolescents and young adults","NNS CC JJ NNS",4,1,1,16918068,"pubmed1",6.29E+018,"testalpha"
,"further divisions andyeast cell","JJ NNS JJS NN",4,1,1,17106513,"pubmed1",8.21E+018,"testalpha"
,"double readings of mammographiccalcifications","NN NNS IN NNS",4,1,1,16399036,"pubmed1",7.35E+018,"testalpha"
,"epidermal water lossand skin","JJ NN NN NN",4,1,1,16874414,2,1.55E+018,"testalpha"
,"delayed consequences of dna","VBN NNS IN ",4,1,1,16582987,"pubmed1",3.60E+018,"testalpha"
,"ratio for limited resources","NN IN VBN NNS",4,1,1,16054101,"pubmed1",5.23E+018,"testalpha"
,"protein expressed onactivated antigen","NN VBD VBN NN",4,1,1,16511253,2,6.47E+017,"testalpha"
,"monomers by high performance","NNS IN JJ NN",4,1,1,16701856,"pubmed1",8.84E+018,"testalpha"
,"kg fresh frozenplasma ffp"," JJ NNP ",4,1,1,16451158,"pubmed1",2.27E+018,"testalpha"
,"otheranimals sham group underwent","NNS  NN NN",4,1,1,17293970,2,6.62E+018,"testalpha"
,"electronmicroscopy observation and x"," NN CC NN",4,1,1,16701860,"pubmed1",7.33E+017,"testalpha"
,"goldparticles immunolabelling zea m","NNS VBG  ",4,1,1,16963110,2,6.43E+018,"testalpha"
,"patient age sex tumor","NN NN NN NN",4,1,1,16530813,2,3.49E+018,"testalpha"
,"randomised trialbupivacaine and ropivacaine","VBN NN CC NN",4,1,1,16617757,"pubmed1",5.38E+018,"testalpha"
,"allergy hdm grass pollen","NN  NN NN",4,1,1,17328144,2,1.82E+018,"testalpha"
,"absence of inflammatory cells","NN IN JJ NNS",4,1,1,17293971,2,4.81E+018,"testalpha"
,"genital human papillomavirus hpv","NN JJ NN ",4,1,1,17010274,2,2.98E+017,"testalpha"
,"methodology male sprague dawley","NN NN NN NNP",4,1,1,16612917,"pubmed1",6.70E+018,"testalpha"
,"process of liver diseases","NN IN NN NNS",4,1,1,16404476,"pubmed1",4.11E+018,"testalpha"
,"positive persons against tumor","JJ NNS IN NN",4,1,1,17010274,2,2.01E+018,"testalpha"
,"substitution of l gal","NN IN  ",4,1,1,16456293,2,7.43E+018,"testalpha"
,"abdominal ultrasound before cholecystectomy","JJ NN IN NN",4,1,1,16132429,"pubmed1",2.16E+018,"testalpha"
,"similar thin fiber distribution","JJ JJ NN NN",4,1,1,16899283,2,7.21E+018,"testalpha"
,"functionalparameters on imaged function","NNS IN VBN NN",4,1,1,16399039,"pubmed1",6.86E+018,"testalpha"
,"afest from archaeoglobus fulgidus","NN IN NNP NN",4,1,1,16511287,2,4.84E+018,"testalpha"
,"orthorhombic space group i","JJ NN NN ",4,1,1,16511292,2,5.48E+018,"testalpha"
,"incidences of false positiveclassifications","NNS IN JJ NNS",4,1,1,16451151,"pubmed1",1.45E+018,"testalpha"
,"hydrolysable atp analog amp","JJ  NN ",4,1,1,16421444,2,1.54E+017,"testalpha"
,"patients tend todevelop th","NNS VBP VB ",4,1,1,16648910,2,8.63E+018,"testalpha"
,"institution providing graduate medicaleducation","NN VBG NN NN",4,1,1,16377812,"pubmed1",1.72E+018,"testalpha"
,"promote workplace health forsonographers","VB NN NN NNS",4,1,1,16438094,"pubmed1",2.01E+017,"testalpha"
,"short term preoperative radiotherapy","NN NN JJ NN",4,1,1,17139896,2,8.16E+018,"testalpha"
,"weight uniformity andmembrane characteristics","NN NN NN NNS",4,1,1,17285748,"pubmed1",8.13E+018,"testalpha"
,"c cd cd cd","NN   ",4,1,1,16733557,"pubmed1",5.30E+018,"testalpha"
,"ray because thefractured leg"," IN VBN NN",4,1,1,16613748,2,5.91E+018,"testalpha"
,"ondepictions of mental illness","NNS IN JJ NN",4,1,1,16474001,"pubmed1",1.45E+018,"testalpha"
,"studies on amyloid deposits","NNS IN VB NNS",4,1,1,16542712,2,5.33E+018,"testalpha"
,"patients and increased satisfaction","NNS CC VBN NN",4,1,1,16377816,"pubmed1",4.26E+017,"testalpha"
,"ear acupuncture on areas","NN NN IN NNS",4,1,1,16955182,2,1.55E+018,"testalpha"
,"space for radiobiological enhancement","NN IN JJ NN",4,1,1,17117605,2,8.68E+018,"testalpha"
,"sialic acids and methods","JJ NNS CC NNS",4,1,1,16542712,2,4.14E+018,"testalpha"
,"ring system is planar","NN NN VBZ NN",4,1,1,16456285,2,7.86E+018,"testalpha"
,"th th century czech","  NN NN",4,1,1,17438834,2,6.47E+018,"testalpha"
,"anticoagulanteffect by inactivating factors","NN IN VBG NNS",4,1,1,16549894,2,5.13E+018,"testalpha"
,"conclusion neo adjuvant radio","NN  JJ NN",4,1,1,16612911,2,7.34E+018,"testalpha"
,"pretreatment nadir platelet count","NN NN NN NN",4,1,1,16594642,"pubmed1",8.12E+018,"testalpha"
,"toxic effects but alsoto","JJ NNS CC NNP",4,1,1,16956120,2,2.44E+018,"testalpha"
,"severe acute respiratory syndrome","JJ JJ NN NN",4,1,1,16400088,"pubmed1",8.91E+018,"testalpha"
,"biological effects of theseoxidation","JJ NNS IN NN",4,1,1,17128291,"pubmed1",2.35E+018,"testalpha"
,"degree of resulting damage","NN IN VBG NN",4,1,1,17294912,2,4.57E+017,"testalpha"
,"developed web based program","VBD  VBN NN",4,1,1,16770857,"pubmed1",8.02E+018,"testalpha"
,"gradient recalled echo gre","NN VBD  ",4,1,1,16317488,"pubmed1",2.86E+018,"testalpha"
,"reperfusion and attenuated translocation","NN CC VBN NN",4,1,1,17293960,2,1.71E+018,"testalpha"
,"improved soluble protein expression","VBN JJ NN NN",4,1,1,16369090,2,4.14E+018,"testalpha"
,"mitochondrial peripheral membrane protein","JJ JJ NN NN",4,1,1,16511294,2,6.46E+018,"testalpha"
,"characterize extended releasematrix tablets","VB VBN NNP NNS",4,1,1,16584139,"pubmed1",5.86E+018,"testalpha"
,"patients with self harm","NNS IN NN NN",4,1,1,16330213,"pubmed1",5.23E+018,"testalpha"
,"pain but alearning curve","NN CC VBG NN",4,1,1,16612912,"pubmed1",8.64E+018,"testalpha"
,"training by helping trainees","NN IN VBG NNS",4,1,1,16473995,"pubmed1",5.79E+018,"testalpha"
,"medial condylus and relocation","JJ NN CC NN",4,1,1,17293966,2,9.21E+017,"testalpha"
,"decrease on attention concentration","NN IN NN NN",4,1,1,16479025,2,5.71E+018,"testalpha"
,"various detectorand crystal parameters","JJ NN NN NNS",4,1,1,16369093,2,3.00E+018,"testalpha"
,"ofthe nucleus and cytoplasm","NNP NN CC NN",4,1,1,17133953,2,1.57E+016,"testalpha"
,"common genital involvement infemales","JJ NN NN NNS",4,1,1,16955190,2,2.64E+018,"testalpha"
,"activities of nadh ubiquinone","NNS IN  NN",4,1,1,17068635,"pubmed1",2.97E+018,"testalpha"
,"history of myocardial infarction","NN IN JJ NN",4,1,1,16054104,"pubmed1",7.36E+018,"testalpha"
,"disparities in breast cancer","NNS IN NN NN",4,1,1,16596900,"pubmed1",8.71E+018,"testalpha"
,"hemodynamics after fluid resuscitation","NNS IN NN NN",4,1,1,16762404,2,5.97E+017,"testalpha"
,"mice andthis stimulated neovascularization"," NNP VBN NN",4,1,1,17014894,2,5.22E+018,"testalpha"
,"t vs mmol l","   ",4,1,1,17338197,2,5.22E+018,"testalpha"
,"recorded events and thecategory","VBN NNS CC NN",4,1,1,16321534,"pubmed1",3.13E+018,"testalpha"
,"increased membrane sialic acid","VBD NN JJ NN",4,1,1,16720036,2,7.09E+018,"testalpha"
,"naja venomsurvived mean sd"," VBN VB ",4,1,1,16436788,"pubmed1",7.18E+018,"testalpha"
,"linkage preference maackia amurensis","NN NN NNP NN",4,1,1,16720036,2,9.02E+018,"testalpha"
,"replacement ofcysteine by glycine","NN NN IN NN",4,1,1,16914903,2,1.11E+018,"testalpha"
,"nascentelements of amyloid structure","NNS IN VB NN",4,1,1,16714052,2,3.72E+018,"testalpha"
,"morbidity and hospitalization time","NN CC NN NN",4,1,1,16989147,2,5.11E+018,"testalpha"
,"hematology unit ain shams","NN NN  NNS",4,1,1,16424649,2,5.18E+018,"testalpha"
,"positive acute phase proteins","JJ JJ NN NNS",4,1,1,16714050,2,5.17E+018,"testalpha"
,"tsp dependentactivation of tgfbeta"," NN IN NN",4,1,1,16733556,"pubmed1",9.22E+018,"testalpha"
,"developing countries like taiwan","VBG NNS IN NNP",4,1,1,16430844,"pubmed1",1.46E+018,"testalpha"
,"perception and high impulsivity","NN CC JJ NN",4,1,1,16426559,"pubmed1",3.53E+018,"testalpha"
,"c mycexpression by tgz","NN NN IN ",4,1,1,16809887,2,4.98E+018,"testalpha"
,"end stage renal failure","NN NN JJ NN",4,1,1,17119326,2,1.36E+018,"testalpha"
,"dhrs inlarge breed dogs"," JJ NN NNS",4,1,1,16594644,"pubmed1",7.02E+018,"testalpha"
,"sites of hospitalized patients","NNS IN VBN NNS",4,1,1,17311736,2,4.64E+018,"testalpha"
,"treatment modalities e g","NN NNS  ",4,1,1,16733557,"pubmed1",2.01E+018,"testalpha"
,"wide spectrum of use","JJ NN IN NN",4,1,1,16574202,2,4.39E+018,"testalpha"
,"pyridoxine erythronate phosphate dehydrogenase","NN NN NN NN",4,1,1,16511285,2,6.85E+018,"testalpha"
,"induced damage todopaminergic neurons","VBN NN JJ NNS",4,1,1,16808044,"pubmed1",4.89E+018,"testalpha"
,"withprevious results meis downregulation","JJ NNS  NN",4,1,1,16914901,2,3.77E+017,"testalpha"
,"gene named atp c"," VBN  NN",4,1,1,17311740,2,7.48E+018,"testalpha"
,"laawg kvggn apafg aeale","   NN",4,1,1,16770447,"pubmed1",2.42E+018,"testalpha"
,"combination of sensitivity andspecificity","NN IN NN NN",4,1,1,16451151,"pubmed1",2.36E+018,"testalpha"
,"role in tissue organ","NN IN NN NN",4,1,1,17265694,2,6.81E+018,"testalpha"
,"neurological signs and symptoms","JJ NNS CC NNS",4,1,1,17370568,"pubmed1",2.61E+018,"testalpha"
,"fatality trend within days","NN NN IN NNS",4,1,1,16430844,"pubmed1",2.84E+018,"testalpha"
,"context of traffic injury","NN IN NN NN",4,1,1,16112069,"pubmed1",5.79E+018,"testalpha"
,"influence of hypercalcemiaon thyroid","NN IN  NN",4,1,1,16762403,2,1.78E+017,"testalpha"
,"blockade of nmda receptors","NN IN  NNS",4,1,1,17133957,2,3.36E+018,"testalpha"
,"standard deviations and coefficients","JJ NNS CC NNS",4,1,1,16399030,"pubmed1",1.35E+017,"testalpha"
,"parallax control allowunlimited freedom","VB NN VBN NN",4,1,1,16722347,2,9.10E+018,"testalpha"
,"cementum of cellular type","NN IN JJ NN",4,1,1,16956115,2,5.62E+018,"testalpha"
,"humourallectins nucleotide binding oligomerization","NNS VB VBG NN",4,1,1,16648910,2,4.20E+018,"testalpha"
,"brain areas express dyn","NN NNS VB ",4,1,1,17133952,2,7.49E+018,"testalpha"
,"technique findings possibilities andlimitations","NN NNS NNS NNS",4,1,1,16317492,"pubmed1",5.07E+018,"testalpha"
,"edema ofhands and feet","NN NNS CC NNS",4,1,1,17010266,2,1.67E+018,"testalpha"
,"f gene from patients","NN  IN NNS",4,1,1,16914903,2,8.83E+018,"testalpha"
,"routine indication for laser","NN NN IN NN",4,1,1,16585989,2,3.56E+018,"testalpha"
,"threesignificant amino acid differences","JJ NNP NN NNS",4,1,1,16421453,2,4.26E+018,"testalpha"
,"platelets by reversetranscription pcr","NNS IN NN ",4,1,1,16733564,"pubmed1",3.58E+018,"testalpha"
,"psii core complex whilethe"," NN JJ NNP",4,1,1,17106511,"pubmed1",4.02E+018,"testalpha"
,"rear seatedpassengers for accidents","JJ NNS IN NNS",4,1,1,16426561,"pubmed1",2.93E+018,"testalpha"
,"respiratory mechanics over time","NN NNS IN NN",4,1,1,16451155,"pubmed1",1.99E+016,"testalpha"
,"useful toprotect against ischaemia","JJ NN IN NN",4,1,1,16612918,"pubmed1",7.27E+018,"testalpha"
,"attractive source of adult","JJ NN IN NN",4,1,1,16696440,2,3.55E+018,"testalpha"
,"optimistic indication of range","JJ NN IN NN",4,1,1,17318329,"pubmed1",3.91E+018,"testalpha"
,"superior vena cava svc","JJ   ",4,1,1,16617761,"pubmed1",8.40E+018,"testalpha"
,"surgical tracheostomy and time","JJ NN CC NN",4,1,1,16451156,"pubmed1",9.10E+018,"testalpha"
,"surepath prepstainslide processor tripath","NN VB NN NN",4,1,1,16514841,2,6.84E+018,"testalpha"
,"theeffect of antifungal treatment","NN IN JJ NN",4,1,1,16603098,2,9.16E+018,"testalpha"
,"myelodysplastic syndrome mds fab","JJ NN  ",4,1,1,16914909,2,4.26E+018,"testalpha"
,"apoptotic bcl family proteins","JJ  NN NNS",4,1,1,16424655,2,2.23E+018,"testalpha"
,"treated toregulate scaffold degradation","VBN NN JJ NN",4,1,1,16701855,"pubmed1",8.48E+018,"testalpha"
,"distribution during hes infusion","NN IN  NN",4,1,1,17067137,"pubmed1",6.38E+017,"testalpha"
,"analysed byscanning electron microscopy","VBN VBG NN ",4,1,1,16701861,"pubmed1",1.89E+018,"testalpha"
,"inhibitors and proteasome inhibitors","NNS CC NN NNS",4,1,1,16424655,2,6.53E+018,"testalpha"
,"practical standards as regards","JJ NNS IN NNS",4,1,1,17265690,2,4.08E+018,"testalpha"
,"n ethenoadenine epsilona n"," NN NNP ",4,1,1,16582987,"pubmed1",7.30E+018,"testalpha"
,"afterconcussion with particular emphasis","NN IN JJ NN",4,1,1,16436787,"pubmed1",4.76E+018,"testalpha"
,"score months in patients","NN NNS IN NNS",4,1,1,17139879,2,8.57E+018,"testalpha"
,"high risk preoperative score","JJ NN JJ NN",4,1,1,17236637,"pubmed1",7.04E+018,"testalpha"
,"results knowledge of skills","NNS NN IN NNS",4,1,1,16473991,"pubmed1",8.19E+018,"testalpha"
,"disease pre transplant chemotherapy","NN  JJ NN",4,1,1,17119322,2,4.16E+017,"testalpha"
,"mm mgcl at ph","  IN ",4,1,1,16648912,2,6.48E+018,"testalpha"
,"andtesters of roadside safety","NNS IN NN NN",4,1,1,16054101,"pubmed1",8.80E+018,"testalpha"
,"used tocollect thinprep cytyc","VBN NN  ",4,1,1,16514841,2,1.82E+018,"testalpha"
,"blood tests and skin","NN NNS CC NN",4,1,1,17106599,2,6.60E+018,"testalpha"
,"greaterlevels of work strain","NNS IN NN NN",4,1,1,16377815,"pubmed1",4.04E+018,"testalpha"
,"transcription of genes withoutany","NN IN NNS NN",4,1,1,16582985,"pubmed1",2.98E+018,"testalpha"
,"v staining following days"," VBG VBG NNS",4,1,1,17016038,2,7.08E+018,"testalpha"
,"vessel geometry peak vessel","NN NN NN NN",4,1,1,16594638,"pubmed1",3.07E+018,"testalpha"
,"theoretical treatiseand practical process","JJ NN JJ NN",4,1,1,16988904,"pubmed1",4.25E+015,"testalpha"
,"heart and cerebrovascular disease","NN CC JJ NN",4,1,1,16479031,2,6.10E+018,"testalpha"
,"spf primer set andhome"," NN VBN NN",4,1,1,17019439,"pubmed1",2.95E+018,"testalpha"
,"h c pyridine interaction"," NN NN NN",4,1,1,16456276,2,4.17E+018,"testalpha"
,"usp type i dissolutionapparatus"," NN  NN",4,1,1,16584139,"pubmed1",4.87E+018,"testalpha"
,"cell dose at months","NN NN IN NNS",4,1,1,17119322,2,3.74E+018,"testalpha"
,"immunization and thefoot swelling","NN CC JJ NN",4,1,1,16585982,2,5.42E+018,"testalpha"
,"lesions group i n","NNS VBP  ",4,1,1,16956117,2,9.97E+016,"testalpha"
,"stimulationwith gm csf scf","NN   ",4,1,1,16404477,"pubmed1",2.10E+018,"testalpha"
,"phospholipids stearoyl oleoyl phosphatidylcholine","NNS   NN",4,1,1,17128291,"pubmed1",5.72E+018,"testalpha"
,"major allergen from m","JJ NN IN ",4,1,1,16511273,2,4.99E+018,"testalpha"
,"marked decrease inheart rate","VBN VB NN NN",4,1,1,16436797,"pubmed1",6.91E+018,"testalpha"
,"amb used athigher doses"," VBN JJ NNS",4,1,1,17370566,"pubmed1",2.26E+018,"testalpha"
,"mobilization treatment ofall patients","NN NN JJ NNS",4,1,1,16613748,2,7.39E+018,"testalpha"
,"pathogenesis of atherosclerotic lesions","NN IN JJ NNS",4,1,1,17007910,2,2.13E+016,"testalpha"
,"mechanisms including bone destruction","NNS VBG NN NN",4,1,1,17016034,2,1.74E+018,"testalpha"
,"practice guidelines mentoring nurses","NN NNS VBG NNS",4,1,1,16330213,"pubmed1",3.43E+018,"testalpha"
,"cancer cell line panc","NN NN NN ",4,1,1,17143338,"pubmed1",9.22E+018,"testalpha"
,"beta and des arg","NN CC NNP ",4,1,1,16395527,"pubmed1",5.60E+018,"testalpha"
,"gene in methylotrophic yeast"," IN JJ NN",4,1,1,17063209,"pubmed1",5.80E+017,"testalpha"
,"amongthe major health problems","NNP JJ NN NNS",4,1,1,16479029,2,4.02E+018,"testalpha"
,"molecular weight heparins lmwh","JJ NN NNS ",4,1,1,16549901,2,5.79E+018,"testalpha"
,"disease infantile spinalmuscular atrophy","NN JJ JJ NN",4,1,1,16730053,2,8.61E+018,"testalpha"
,"brain and peripheral nervoussystem","NN CC JJ NN",4,1,1,16594641,"pubmed1",1.03E+018,"testalpha"
,"proliferator activated receptor ppar","NN VBN NN ",4,1,1,16395520,"pubmed1",8.59E+017,"testalpha"
,"diffusion using peg mmeas","NN VBG  NNS",4,1,1,16511283,2,8.89E+018,"testalpha"
,"methods male patients carvedilol","NNS NN NNS ",4,1,1,17338197,2,8.77E+018,"testalpha"
,"surgeries with increasing frequency","NNS IN VBG NN",4,1,1,17139880,2,3.00E+018,"testalpha"
,"mesenteric lymph nodes liver","JJ NN NNS NN",4,1,1,17293960,2,8.84E+018,"testalpha"
,"mortalityrates following extensive total","NNS VBG JJ NN",4,1,1,17165599,2,5.37E+018,"testalpha"
,"remarkable increase after days","JJ NN IN NNS",4,1,1,17285747,"pubmed1",9.17E+016,"testalpha"
,"abundant class of nt","JJ NN IN ",4,1,1,16770443,"pubmed1",8.88E+018,"testalpha"
,"right thigh and abdomen","JJ NN CC NN",4,1,1,16603100,2,6.62E+017,"testalpha"
,"analogues h tyr c","NNS   NN",4,1,1,16496038,"pubmed1",8.77E+018,"testalpha"
,"wrong care and act","JJ NN CC NN",4,1,1,16473995,"pubmed1",3.98E+018,"testalpha"
,"acth dependent cushing syndrome"," JJ VBG NN",4,1,1,16603099,2,1.55E+018,"testalpha"
,"cop incombination with rituximab","NN NN IN ",4,1,1,17119328,2,3.20E+018,"testalpha"
,"were ph bicarbonate base","VBD  NN NN",4,1,1,16491220,2,1.04E+018,"testalpha"
,"chloroform droplets or plam","NN NNS CC ",4,1,1,16701854,"pubmed1",7.73E+018,"testalpha"
,"ligand secretionby peripheral blood","NN  JJ NN",4,1,1,16710577,2,7.08E+018,"testalpha"
,"impact of human serum","NN IN JJ NN",4,1,1,17285745,"pubmed1",2.15E+018,"testalpha"
,"device closure of asd","NN NN IN ",4,1,1,16612922,"pubmed1",8.94E+018,"testalpha"
,"work policies post injury","VB NNS NN NN",4,1,1,16442068,"pubmed1",3.42E+017,"testalpha"
,"agents for magnetic resonance","NNS IN JJ NN",4,1,1,16411740,"pubmed1",1.29E+018,"testalpha"
,"epithelial component in similarproportions","JJ NN IN NNS",4,1,1,16514851,2,7.57E+018,"testalpha"
,"x after h recovery","NN IN  NN",4,1,1,17265691,2,2.57E+018,"testalpha"
,"glycosylation of cell structures","NN IN NN NNS",4,1,1,16720036,2,3.71E+018,"testalpha"
,"fb injury crash models"," NN NN NNS",4,1,1,16451795,"pubmed1",1.26E+018,"testalpha"
,"band uvb enhanced migrationof","NN  VBN ",4,1,1,17106595,2,6.29E+018,"testalpha"
,"atypicalcells cellularity nuclear atypia","NNS NN JJ NNP",4,1,1,16514838,2,5.79E+018,"testalpha"
,"test for paired samples","NN IN VBN NNS",4,1,1,17293969,2,8.67E+018,"testalpha"
,"part of conducting researchand","NN IN VBG NN",4,1,1,16770859,"pubmed1",3.81E+018,"testalpha"
,"manual intervention free refinement","JJ NN JJ NN",4,1,1,16421450,2,5.97E+018,"testalpha"
,"cell of hematopoetic origin","NN IN JJ NN",4,1,1,17013517,2,8.71E+018,"testalpha"
,"adult in patientswith psoriasis","NN IN NN NN",4,1,1,16710574,2,8.79E+017,"testalpha"
,"brain biopsy had identicalmorphology","NN NN VBD NN",4,1,1,16918065,"pubmed1",1.82E+018,"testalpha"
,"translocations across mitochondrial membranes","NNS IN JJ NNS",4,1,1,16511294,2,5.87E+018,"testalpha"
,"surgeons use full thickness","NNS VB JJ NN",4,1,1,17165599,2,1.37E+018,"testalpha"
,"mg kg induced transient","  VBN NN",4,1,1,17133957,2,3.00E+018,"testalpha"
,"rules are postulated forundulator","NNS VBP VBN NN",4,1,1,16369095,2,9.19E+018,"testalpha"
,"neutrophil and platelet engraftment"," CC NN NN",4,1,1,17119322,2,7.20E+018,"testalpha"
,"vector with ltr retroviralpromoter","NN IN  NN",4,1,1,17160143,"pubmed1",4.92E+018,"testalpha"
,"system with surname initials","NN IN NN NNS",4,1,1,16221468,"pubmed1",3.88E+018,"testalpha"
,"conditioning group regarding grade","VBG NN VBG NN",4,1,1,16424643,2,6.76E+018,"testalpha"
,"retrograde cholangiopancreatographic andultrasonographic findings","NN JJ JJ NNS",4,1,1,16333694,"pubmed1",1.98E+017,"testalpha"
,"antagonists ly and mpep","NNS  CC ",4,1,1,17265692,2,2.59E+016,"testalpha"
,"rp esi liquid chromatography","  JJ NN",4,1,1,17285740,"pubmed1",7.41E+018,"testalpha"
,"latency left branch msec","NN VBN NN ",4,1,1,17139884,2,5.15E+018,"testalpha"
,"values of pn tml","NNS IN  ",4,1,1,17139884,2,6.51E+018,"testalpha"
,"inregular breast cancer screening","JJ NN NN NN",4,1,1,16596899,"pubmed1",4.91E+018,"testalpha"
,"observational study was tomeasure","JJ NN VBD NN",4,1,1,17067139,"pubmed1",3.82E+018,"testalpha"
,"inthe head and body","NNP NN CC NN",4,1,1,17084885,2,6.27E+018,"testalpha"
,"molecules in atopic dermatitis","NNS IN NN NN",4,1,1,16603095,2,2.73E+017,"testalpha"
,"associated duty hour restrictions","VBN NN NN NNS",4,1,1,16377820,"pubmed1",8.50E+018,"testalpha"
,"ventral roots and weeks","JJ NNS CC NNS",4,1,1,16414104,2,1.49E+017,"testalpha"
,"factor replacement therapy forhemophilia","NN NN NN NNP",4,1,1,16549892,2,1.47E+018,"testalpha"
,"shared perceptions of employees","VBD NNS IN NNS",4,1,1,16442068,"pubmed1",7.89E+018,"testalpha"
,"metabolic enzyme rna interactions","JJ   NNS",4,1,1,16410835,"pubmed1",1.66E+018,"testalpha"
,"forthe ddexma plam capsules","NNP   NNS",4,1,1,16701854,"pubmed1",2.70E+018,"testalpha"
,"human body for restoration","JJ NN IN NN",4,1,1,17294911,2,4.27E+018,"testalpha"
,"injection and late phase","NN CC JJ NN",4,1,1,16333704,"pubmed1",3.69E+018,"testalpha"
,"surgical procedures showed afaster","JJ NNS VBD NN",4,1,1,16451145,"pubmed1",1.39E+018,"testalpha"
,"control of inflammatory processes","NN IN JJ NNS",4,1,1,16770444,"pubmed1",1.85E+018,"testalpha"
,"astandardized data collection sheet","VBN NNS NN NN",4,1,1,16365337,"pubmed1",8.02E+018,"testalpha"
,"variation in emergency department","NN IN NN NN",4,1,1,16365329,"pubmed1",1.00E+018,"testalpha"
,"small intestine epithelial cells","JJ NN JJ NNS",4,1,1,16511280,2,8.36E+018,"testalpha"
,"sustained physical activity muscles","VBN JJ NN NNS",4,1,1,16921609,"pubmed1",4.16E+018,"testalpha"
,"diversified t wand spgr","JJ   ",4,1,1,16399031,"pubmed1",4.34E+018,"testalpha"
,"total cd cell dose","JJ  NN NN",4,1,1,17119322,2,3.69E+018,"testalpha"
,"absent radii andthrombocytopenia tar","JJ  NNP ",4,1,1,16874423,2,9.15E+018,"testalpha"
,"low anterior resection syndrome","JJ JJ NN NN",4,1,1,17139896,2,9.13E+018,"testalpha"
,"importance of thisantioxidative system","NN IN JJ NN",4,1,1,17046053,2,8.19E+018,"testalpha"
,"studies involving brain tissue","NNS VBG NN NN",4,1,1,16436787,"pubmed1",6.89E+018,"testalpha"
,"competitive nmda glutamate receptor","JJ  NN NN",4,1,1,17133953,2,1.13E+018,"testalpha"
,"regulation of theglyoxylate cycle","NN IN NN NN",4,1,1,17146497,"pubmed1",7.17E+018,"testalpha"
,"agar dilution technique minimalinhibitory"," NN NN NN",4,1,1,16874415,2,3.15E+017,"testalpha"
,"day in uk hospitals","NN IN  NNS",4,1,1,16451154,"pubmed1",4.93E+018,"testalpha"
,"stroke at dr ciptomangunkusumo","NN IN  ",4,1,1,16479026,2,5.59E+017,"testalpha"
,"byappearance of multiple foci","NN IN JJ ",4,1,1,16956113,2,4.36E+018,"testalpha"
,"vasculardiseases in trained subjects","NNS IN VBN NNS",4,1,1,16918068,"pubmed1",6.89E+018,"testalpha"
,"leupsi cn ala thr","NNP   ",4,1,1,16496037,"pubmed1",1.34E+018,"testalpha"
,"weigh polyethylene cup bothcomponents","VB NN NN NNS",4,1,1,16613741,2,1.52E+018,"testalpha"
,"groups with acinic morphology","NNS IN JJ NN",4,1,1,16514851,2,3.28E+018,"testalpha"
,"pai catalyzesthe double bond"," NNP JJ NN",4,1,1,16511289,2,2.15E+018,"testalpha"
,"stay for heart failure","NN IN NN NN",4,1,1,16377816,"pubmed1",8.69E+018,"testalpha"
,"post operative lung function","NN JJ NN NN",4,1,1,16451153,"pubmed1",8.87E+018,"testalpha"
,"epidermal necrolysis and stevens","JJ NN CC NNS",4,1,1,16710577,2,3.15E+018,"testalpha"
,"length of contactand increase","NN IN NN NN",4,1,1,17010265,2,6.11E+018,"testalpha"
,"mechanism of urethral closure","NN IN JJ NN",4,1,1,16962646,2,6.34E+018,"testalpha"
,"series abstracts and meta","NN NNS CC ",4,1,1,16365335,"pubmed1",1.65E+018,"testalpha"
,"hours conclusions duty hour","NNS NNS NN NN",4,1,1,16377820,"pubmed1",2.34E+018,"testalpha"
,"ninety age and gender","NN NN CC NN",4,1,1,16451151,"pubmed1",2.42E+018,"testalpha"
,"absence of urothelial cells","NN IN JJ NNS",4,1,1,16514843,2,8.42E+018,"testalpha"
,"differential diagnosis with mtc","JJ NN IN ",4,1,1,16514846,2,5.72E+018,"testalpha"
,"asymptomatic thrombotic complications contributedto","JJ JJ NNS ",4,1,1,16696443,2,6.78E+017,"testalpha"
,"nonfatal sledding related injuriesin","NN NN VBN NNP",4,1,1,16436798,"pubmed1",8.99E+018,"testalpha"
,"stage coated wet microspheres","NN VBN JJ NNS",4,1,1,16594643,"pubmed1",6.14E+018,"testalpha"
,"recent developments in healthcare","JJ NNS IN NN",4,1,1,16473988,"pubmed1",2.97E+018,"testalpha"
,"o and n h"," CC  ",4,1,1,16397328,2,7.62E+018,"testalpha"
,"patients with actinic keratoses","NNS IN JJ NNS",4,1,1,16585985,2,1.51E+018,"testalpha"
,"hemi diaphragm grade markedincrease","  NN NN",4,1,1,16673610,2,1.95E+018,"testalpha"
,"complement fluid phase regulator","NN NN NN NN",4,1,1,16964325,"pubmed1",5.66E+017,"testalpha"
,"sonoenteroclysis showed thickened bowel","NN VBD VBN NN",4,1,1,16447095,"pubmed1",8.90E+017,"testalpha"
,"possible anca associated vasculitides","JJ  VBN NNS",4,1,1,16648918,2,7.16E+018,"testalpha"
,"dktnv laawg kvggn apafg","   ",4,1,1,16770447,"pubmed1",5.51E+017,"testalpha"
,"droplets or plam containingchloroform","NNS CC  NN",4,1,1,16701854,"pubmed1",6.42E+018,"testalpha"
,"betweenfindings on magnetic resonance","NNS IN JJ NN",4,1,1,16317488,"pubmed1",8.79E+018,"testalpha"
,"thatprecursor cells take part","NN NNS VB NN",4,1,1,17013517,2,1.59E+018,"testalpha"
,"treatments and care plans","NNS CC NN NNS",4,1,1,16365325,"pubmed1",1.70E+018,"testalpha"
,"maximize resourceutilization increase hospital","VB NN NN NN",4,1,1,16377816,"pubmed1",8.88E+017,"testalpha"
,"reports published inthe peer","NNS VBD NNP NN",4,1,1,16596897,"pubmed1",8.92E+018,"testalpha"
,"pityriasis versicolor and seborrhoeicdermatitis","NN NN CC NN",4,1,1,16874415,2,8.38E+018,"testalpha"
,"cd fmc and cd","  CC ",4,1,1,16424654,2,1.63E+018,"testalpha"
,"enzyme part and plays"," NN CC NNS",4,1,1,17294912,2,6.19E+018,"testalpha"
,"african american faith community","JJ JJ NN NN",4,1,1,16596897,"pubmed1",8.29E+015,"testalpha"
,"several breaches ininfection control","JJ NNS NN NN",4,1,1,16710581,2,6.66E+018,"testalpha"
,"solution n polyethylene glycol","NN  NN NN",4,1,1,16252139,"pubmed1",6.64E+018,"testalpha"
,"experiment in dose mg","NN IN NN ",4,1,1,17293962,2,7.16E+018,"testalpha"
,"examination of healthy skin","NN IN JJ NN",4,1,1,16999269,2,2.87E+017,"testalpha"
,"ofbiological events e g","JJ NNS  ",4,1,1,16696437,2,8.53E+018,"testalpha"
,"summary of datahighlighting trends","NN IN VBG NNS",4,1,1,16596900,"pubmed1",4.69E+018,"testalpha"
,"bothproteins in psoriatic patients","NNS IN JJ NNS",4,1,1,16585983,2,5.68E+018,"testalpha"
,"vte included thoracicinjuries odds"," VBD NNS NNS",4,1,1,16549896,2,2.42E+018,"testalpha"
,"liverresection for colorectal cancer","NN IN NN NN",4,1,1,17139901,2,8.00E+018,"testalpha"
,"essential oil intosolid lipid","JJ NN JJ NN",4,1,1,16584150,"pubmed1",2.23E+018,"testalpha"
,"extirpative surgery and reconstructionconsiderations","JJ NN CC NNS",4,1,1,16514847,2,3.80E+018,"testalpha"
,"i ii and iii","  CC ",4,1,1,16456284,2,2.47E+018,"testalpha"
,"efficacy ofpatent blue dye","NN NN JJ ",4,1,1,16491216,2,7.02E+018,"testalpha"
,"event reporting available online","NN NN JJ NN",4,1,1,16770858,"pubmed1",4.55E+018,"testalpha"
,"significant lesion including endometrialadenocarcinomas","JJ NN IN NNP",4,1,1,16514840,2,1.87E+018,"testalpha"
,"index real time contrast","NN JJ NN NN",4,1,1,16317492,"pubmed1",4.76E+017,"testalpha"
,"reasons for redirecting patients","NNS IN VBG NNS",4,1,1,16365324,"pubmed1",4.05E+018,"testalpha"
,"gamma phosphate of atp","NN NN IN ",4,1,1,16421444,2,1.94E+018,"testalpha"
,"high affinity for h","JJ NN IN ",4,1,1,16594645,"pubmed1",8.82E+017,"testalpha"
,"indicating reduced proliferation andmigration","VBG VBN NN NN",4,1,1,16874412,2,6.63E+018,"testalpha"
,"optimized technetium labeled m","VBN NN VBD ",4,1,1,16584167,"pubmed1",3.45E+018,"testalpha"
,"results of different research","NNS IN JJ NN",4,1,1,16603103,2,4.90E+018,"testalpha"
,"analysis of deltago values","NN IN NNP NNS",4,1,1,17019442,"pubmed1",1.54E+018,"testalpha"
,"induce cross reactive ige","VB NN JJ ",4,1,1,16673562,2,5.16E+018,"testalpha"
,"cases virtual body models","NNS JJ NN NNS",4,1,1,16399038,"pubmed1",1.68E+018,"testalpha"
,"positive cultivations of chrysosporium","JJ NNS IN NN",4,1,1,16603097,2,8.10E+018,"testalpha"
,"water memory testing hours","NN NN NN NNS",4,1,1,17236636,"pubmed1",6.53E+018,"testalpha"
,"injuries or venous catheters","NNS CC JJ NNS",4,1,1,16549896,2,5.05E+018,"testalpha"
,"kinase activity in l","NN NN IN ",4,1,1,16964326,"pubmed1",2.69E+018,"testalpha"
,"driving hours and phone","VBG NNS CC NN",4,1,1,16157285,"pubmed1",1.74E+018,"testalpha"
,"transformedhuman immunodeficiency virus hiv","NN NN NN ",4,1,1,16462404,"pubmed1",7.13E+018,"testalpha"
,"b resp of chronichepatitis","NN  IN NN",4,1,1,16696442,2,2.06E+018,"testalpha"
,"select internal candidates outsidethe","VB JJ NNS NNP",4,1,1,16399040,"pubmed1",4.57E+018,"testalpha"
,"groupcomprised healthy males n","VBN JJ NNS ",4,1,1,16956116,2,2.46E+018,"testalpha"
,"nuclear localization of glycoproteins","JJ NN IN NNS",4,1,1,16996581,2,5.93E+018,"testalpha"
,"mg kg bodyweight b","  NN NN",4,1,1,16549901,2,8.02E+017,"testalpha"
,"palliation of symptoms agood","NN IN NNS NN",4,1,1,17139900,2,7.98E+018,"testalpha"
,"case with low symmetry","NN IN JJ NN",4,1,1,16369100,2,7.12E+018,"testalpha"
,"greater risk for head","JJR NN IN NN",4,1,1,16197912,"pubmed1",6.18E+018,"testalpha"
,"thecrystal unit cell parameters","NN NN NN NNS",4,1,1,16369093,2,3.19E+018,"testalpha"
,"cad reading yielded sensitivity"," NN VBD NN",4,1,1,16399036,"pubmed1",3.80E+018,"testalpha"
,"consensual qualitative research approach","JJ JJ NN NN",4,1,1,16710575,2,9.78E+017,"testalpha"
,"andsimulation of surgical procedures","NN IN JJ NNS",4,1,1,16399038,"pubmed1",4.73E+018,"testalpha"
,"rat pancreatic beta cells","NN JJ NN NNS",4,1,1,16395521,"pubmed1",5.04E+018,"testalpha"
,"cells x or x","NNS NN CC NN",4,1,1,17265691,2,6.83E+018,"testalpha"
,"lymphocyte activity suppress t","NNP NN VB ",4,1,1,17016035,2,5.20E+018,"testalpha"
,"population under poverty level","NN IN NN NN",4,1,1,16451795,"pubmed1",1.42E+017,"testalpha"
,"sialic acids and glycosaminoglycans","JJ NNS CC NNS",4,1,1,16542712,2,7.44E+018,"testalpha"
,"patients andnurses for ponv","NNS NNS IN ",4,1,1,17236637,"pubmed1",4.04E+018,"testalpha"
,"primitive orthorhombicp with unit","JJ  IN NN",4,1,1,16511260,2,5.35E+018,"testalpha"
,"rate frequency of brdu","NN NN IN ",4,1,1,16874412,2,9.14E+018,"testalpha"
,"therapy mg kg day","NN   NN",4,1,1,16955189,2,2.58E+018,"testalpha"
,"persistentchange of tunnel arrangement","NN IN NN NN",4,1,1,17133955,2,3.71E+018,"testalpha"
,"rate and oxygen consumption","NN CC NN NN",4,1,1,17068635,"pubmed1",3.91E+017,"testalpha"
,"recognition or binding properties","NN CC VBG NNS",4,1,1,16701857,"pubmed1",6.75E+018,"testalpha"
,"beta beta subunits betaa","NN NN NNS ",4,1,1,16423381,2,3.55E+018,"testalpha"
,"expression by guiding mrna","NN IN VBG ",4,1,1,16395523,"pubmed1",8.24E+018,"testalpha"
,"format for theresident learner","NN IN NN NN",4,1,1,16365338,"pubmed1",9.22E+018,"testalpha"
,"adenosine metabolism in t","NN NN IN ",4,1,1,16421444,2,7.33E+018,"testalpha"
,"kg body weight treatment"," NN NN NN",4,1,1,17119327,2,1.20E+018,"testalpha"
,"police reported crash data","NN VBD NN NNS",4,1,1,16430844,"pubmed1",1.50E+018,"testalpha"
,"race county hospital date","NN NN NN NN",4,1,1,16365326,"pubmed1",2.48E+018,"testalpha"
,"results suggest thatrecidivist drink","NNS VBP NN NN",4,1,1,16405859,"pubmed1",2.06E+018,"testalpha"
,"inconclusion use of poly","NN NN IN ",4,1,1,16701856,"pubmed1",7.10E+018,"testalpha"
,"reduction of actinic area","NN IN JJ NN",4,1,1,16955183,2,6.42E+018,"testalpha"
,"promise of genomic medicine","NN IN JJ NN",4,1,1,16596744,"pubmed1",7.17E+018,"testalpha"
,"used forsystematic conservation planning","VBN JJ NN NN",4,1,1,16988906,"pubmed1",2.28E+018,"testalpha"
,"oil intosolid lipid nanoparticles","NN JJ NN NNS",4,1,1,16584150,"pubmed1",7.16E+017,"testalpha"
,"chi square and multivariate"," NN CC NN",4,1,1,16479026,2,2.95E+018,"testalpha"
,"beta thyrotropic polyclonal antisera","NN NN JJ NN",4,1,1,16714054,2,2.89E+018,"testalpha"
,"available positions and strictenforcement","JJ NNS CC NN",4,1,1,16399040,"pubmed1",6.81E+018,"testalpha"
,"time young driver fatalities","NN JJ NN NNS",4,1,1,16171767,"pubmed1",3.19E+018,"testalpha"
,"hpo and cl hco"," CC  ",4,1,1,16701876,"pubmed1",8.45E+018,"testalpha"
,"periodontal ligament fibroblasts cementocytes","NN NN NNS NNS",4,1,1,17049369,2,5.54E+018,"testalpha"
,"ask questions of patients","VB NNS IN NNS",4,1,1,16436792,"pubmed1",4.04E+018,"testalpha"
,"correlation of x ray","NN IN NN ",4,1,1,16399038,"pubmed1",1.04E+018,"testalpha"
,"antisecretory effects of onoo","NN NNS IN ",4,1,1,17068635,"pubmed1",7.31E+018,"testalpha"
,"andexhibits thioltransferase and dehydroascorbate","NNS NN CC NN",4,1,1,17019444,"pubmed1",5.90E+018,"testalpha"
,"proliferating endothelial tumor cells","VBG JJ NN NNS",4,1,1,16859618,2,3.30E+017,"testalpha"
,"support and clinical supervision","NN CC JJ NN",4,1,1,16377191,"pubmed1",8.36E+018,"testalpha"
,"plateletfunction and lower sc","NN CC JJR ",4,1,1,16549890,2,7.33E+018,"testalpha"
,"influence of radiation damage","NN IN NN NN",4,1,1,16369094,2,3.64E+018,"testalpha"
,"degradation pathway and catalyses","NN NN CC NNS",4,1,1,16511257,2,1.66E+018,"testalpha"
,"infection of traumatized skin","NN IN VBN NN",4,1,1,16859614,2,5.36E+018,"testalpha"
,"regulation ofdsk adaptor function","NN  NN NN",4,1,1,16421449,2,1.11E+018,"testalpha"
,"column are connected toeach","NN VBP VBN NN",4,1,1,16397328,2,2.54E+018,"testalpha"
,"specific forms of heart","JJ NNS IN NN",4,1,1,17014894,2,8.65E+018,"testalpha"
,"initial setting times decreasedwith","JJ VBG NNS NN",4,1,1,16701865,"pubmed1",4.32E+018,"testalpha"
,"using colour addition theory","VBG JJ NN NN",4,1,1,16730369,2,6.18E+018,"testalpha"
,"csf stem cell factor"," VB NN NN",4,1,1,16404477,"pubmed1",4.67E+018,"testalpha"
,"results pancreatic parenchymal enlargement","NNS JJ JJ NN",4,1,1,16333694,"pubmed1",2.05E+018,"testalpha"
,"processes inprinciple causing species","NNS NNS VBG NN",4,1,1,17318329,"pubmed1",4.16E+018,"testalpha"
,"cytochrome c and hydrogen","NN NN CC NN",4,1,1,16951741,"pubmed1",8.48E+018,"testalpha"
,"coatings in differentmedia water","NNS IN NNP NN",4,1,1,16701874,"pubmed1",8.91E+018,"testalpha"
,"rates offalse positive classification","NNS JJ JJ NN",4,1,1,16451151,"pubmed1",1.44E+018,"testalpha"
,"millionus dollars per crash","NN NNS IN NN",4,1,1,16426556,"pubmed1",3.25E+018,"testalpha"
,"carbonic anhydrase ii hca","JJ NN  ",4,1,1,16511248,2,7.88E+016,"testalpha"
,"employees claims per h","NNS NNS IN ",4,1,1,16430845,"pubmed1",7.80E+018,"testalpha"
,"stress profile burnout syndrome","NN NN NN NN",4,1,1,16451152,"pubmed1",8.87E+018,"testalpha"
,"excretion of indoxyl sulphate","NN IN  NN",4,1,1,16673616,2,4.48E+018,"testalpha"
,"phosphate buffer at rates","NN NN IN NNS",4,1,1,16584164,"pubmed1",3.07E+018,"testalpha"
,"relatedto pdt induced pain","  VBN NN",4,1,1,16955183,2,2.68E+018,"testalpha"
,"artery circulation being unableto","NN NN VBG ",4,1,1,16479030,2,6.31E+017,"testalpha"
,"tests after structural disorders","NNS IN JJ NNS",4,1,1,17139890,2,3.69E+018,"testalpha"
,"innitrogen and ondansetron mg","NN CC NNP ",4,1,1,16451147,"pubmed1",5.49E+018,"testalpha"
,"tophi giant cell tumor"," NN NN NN",4,1,1,16514850,2,6.28E+018,"testalpha"
,"vs p in stage","  IN NN",4,1,1,17139895,2,8.34E+018,"testalpha"
,"conclusion ngf and nnos","NN  CC ",4,1,1,16325891,2,8.39E+018,"testalpha"
,"inappropriate treatments and care","JJ NNS CC NN",4,1,1,16365325,"pubmed1",6.52E+018,"testalpha"
,"third ventricles interhemispheric fissure","JJ NNS JJ NN",4,1,1,16399031,"pubmed1",4.31E+018,"testalpha"
,"total hip replacement surgery","JJ NN NN NN",4,1,1,16916184,"pubmed1",8.97E+018,"testalpha"
,"serum c peptide levels","NN NN VB NNS",4,1,1,16673610,2,5.36E+017,"testalpha"
,"calcium phosphate acp composites","NN NN  NNS",4,1,1,16701862,"pubmed1",8.14E+018,"testalpha"
,"degrees left lateral tilt","NNS VBN JJ NN",4,1,1,16617756,"pubmed1",8.88E+018,"testalpha"
,"radiation butselenomethionine substituted crystals","NN NN VBN NNS",4,1,1,16511288,2,2.55E+018,"testalpha"
,"contrast intravenouslidocaine and corticosteroids","NN NN CC NNS",4,1,1,16916180,"pubmed1",2.12E+018,"testalpha"
,"abuse eg episodic binge","NN  JJ NN",4,1,1,16808045,"pubmed1",5.46E+018,"testalpha"
,"treated patients t vs","VBN NNS  ",4,1,1,17338197,2,8.43E+018,"testalpha"
,"investigate details on structuralparameters","VB NNS IN NNS",4,1,1,16411737,"pubmed1",6.21E+018,"testalpha"
,"meat or other animal","NN CC JJ NN",4,1,1,16859614,2,3.42E+018,"testalpha"
,"use of immunosuppressive treatment","NN IN JJ NN",4,1,1,16673554,2,6.01E+018,"testalpha"
,"gelofusine c dextran macrodex","NN NN NN NN",4,1,1,16762404,2,3.03E+018,"testalpha"
,"th dominated immune responses"," VBN JJ NNS",4,1,1,16648910,2,1.98E+017,"testalpha"
,"n acetylneuraminic acid cmp"," JJ NN ",4,1,1,16511286,2,1.15E+018,"testalpha"
,"liver ischemia and minutes","NN NN CC NNS",4,1,1,17013507,2,3.53E+018,"testalpha"
,"granulocyte monocyte colonystimulating factor","NNP NNP VBG NN",4,1,1,16404477,"pubmed1",5.48E+018,"testalpha"
,"single stranded rna virus","NN VBN  NN",4,1,1,16733562,"pubmed1",1.71E+018,"testalpha"
,"examined patients hadconcurrent diabetes","VBD NNS NN NN",4,1,1,16989147,2,1.92E+018,"testalpha"
,"hemodynamicsand registration of arrhythmias","NN NN IN NNP",4,1,1,16451157,"pubmed1",4.98E+018,"testalpha"
,"rat liver by peroxisome","NN NN IN NN",4,1,1,16951743,"pubmed1",3.36E+018,"testalpha"
,"supranodosal vagotomy midcervical vagotomy","NN NN JJ NN",4,1,1,17133957,2,4.55E+018,"testalpha"
,"series of squamous cell","NN IN JJ NN",4,1,1,16514834,2,1.76E+018,"testalpha"
,"results during theintervention month","NNS IN NN NN",4,1,1,16365324,"pubmed1",5.05E+018,"testalpha"
,"arginine repressor of thermotoga","NN NN IN NNP",4,1,1,16511254,2,5.65E+018,"testalpha"
,"media with different counterions","NNS IN JJ NNS",4,1,1,17285750,"pubmed1",5.91E+018,"testalpha"
,"hexagonal space group p","JJ NN NN ",4,1,1,16511288,2,2.66E+018,"testalpha"
,"direction and stacked pi","NN CC VBN ",4,1,1,16456296,2,4.90E+018,"testalpha"
,"myeloid leukemic celllines hl","VB JJ NNS ",4,1,1,16424655,2,6.64E+018,"testalpha"
,"terms of victim task","NNS IN NN NN",4,1,1,16434013,"pubmed1",2.08E+018,"testalpha"
,"development of faculty leadership","NN IN NN NN",4,1,1,16377816,"pubmed1",6.90E+018,"testalpha"
,"ofcdk inhibitors and p"," NNS CC ",4,1,1,17115080,"pubmed1",1.99E+018,"testalpha"
,"andgraduate medical education committee","NN JJ NN NN",4,1,1,16377812,"pubmed1",6.11E+018,"testalpha"
,"patients with unexplained hypoxemia","NNS IN VBN NN",4,1,1,16673614,2,5.08E+018,"testalpha"
,"postdural puncture headache pdph","JJ NN NN ",4,1,1,16916188,"pubmed1",2.91E+018,"testalpha"
,"conclusion radiofrequency proctological proceduresare","NN NN JJ NN",4,1,1,17139880,2,2.19E+018,"testalpha"
,"surgeons and other physicians","NNS CC JJ NNS",4,1,1,16999271,2,5.66E+018,"testalpha"
,"pt c h n"," NN  ",4,1,1,16397333,2,3.44E+018,"testalpha"
,"designing various drug deliverysystems","VBG JJ NN NNS",4,1,1,17285743,"pubmed1",2.95E+017,"testalpha"
,"depictions evoked sympathy others","NNS VBD NN NNS",4,1,1,16474001,"pubmed1",8.10E+018,"testalpha"
,"methods of assessment challenges","NNS IN NN NNS",4,1,1,16473998,"pubmed1",7.61E+018,"testalpha"
,"heart during body growth","NN IN NN NN",4,1,1,17046052,2,7.95E+017,"testalpha"
,"medications e g non","NNS   ",4,1,1,17106603,2,2.78E+018,"testalpha"
,"quinone binding site inthe","NN VBG NN NNP",4,1,1,16929382,"pubmed1",7.36E+018,"testalpha"
,"tothe introduction of novel","NNP NN IN NN",4,1,1,17016040,2,5.10E+018,"testalpha"
,"fs and segmental lv"," CC NN ",4,1,1,16989140,2,3.54E+018,"testalpha"
,"doctors nurses and pharmacists","NNS NNS CC NNS",4,1,1,16710575,2,4.48E+018,"testalpha"
,"upregulation of allassessed costimulatory","NN IN VBN NN",4,1,1,16733557,"pubmed1",5.92E+018,"testalpha"
,"analysis of cataractous lenses","NN IN JJ NNS",4,1,1,16696441,2,4.53E+018,"testalpha"
,"coexpressionof cd or cd","  CC ",4,1,1,16424654,2,4.60E+018,"testalpha"
,"role of wnt beta","NN IN  NN",4,1,1,16874413,2,6.04E+018,"testalpha"
,"vas and theoswestry index"," CC NN NN",4,1,1,17688033,2,2.08E+018,"testalpha"
,"superior vena cava syndrome","JJ   NN",4,1,1,16617761,"pubmed1",7.95E+018,"testalpha"
,"treatment by animal experiments","NN IN NN NNS",4,1,1,16648911,2,8.08E+018,"testalpha"
,"injury increase of ua","NN NN IN ",4,1,1,17338197,2,2.51E+018,"testalpha"
,"carbonic anhydrase vi hca","JJ NN  ",4,1,1,16511271,2,3.91E+018,"testalpha"
,"endoscopic snareelectrocauterisation without complications","NN NN IN NNS",4,1,1,16989154,2,1.49E+018,"testalpha"
,"incomparisons between g g","NNS IN  ",4,1,1,17293969,2,3.81E+018,"testalpha"
,"cord bloodneonatal platelet function","NN NN NN NN",4,1,1,16549889,2,5.68E+018,"testalpha"
,"reductionof arsenate monomethylarsenate mma"," NN NN ",4,1,1,17019444,"pubmed1",5.04E+018,"testalpha"
,"cytoplasmic calcium binding protein","JJ NN VBG NN",4,1,1,17046052,2,4.00E+018,"testalpha"
,"supplementary marker forcytologic diagnosis","JJ NN JJ NN",4,1,1,16514837,2,7.62E+018,"testalpha"
,"activated receptor gamma ppargamma","VBN NN NN NN",4,1,1,16809887,2,3.66E+018,"testalpha"
,"comparing durations of pairs","VBG NNS IN NNS",4,1,1,17133956,2,7.68E+018,"testalpha"
,"anincidental parotid parapharyngeal mass","NN  NN NN",4,1,1,16514848,2,1.94E+018,"testalpha"
,"normothermic degrees c cpb","JJ NNS NN ",4,1,1,16451153,"pubmed1",3.74E+018,"testalpha"
,"identified sites of thehighest","VBN NNS IN NN",4,1,1,16582987,"pubmed1",5.59E+018,"testalpha"
,"allergy inchildren and adults","NN NNS CC NNS",4,1,1,16673561,2,3.39E+018,"testalpha"
,"fickian drug release kinetics","JJ NN NN NNS",4,1,1,16584161,"pubmed1",9.21E+018,"testalpha"
,"association with functional adrenal","NN IN JJ NN",4,1,1,16245020,"pubmed1",6.16E+018,"testalpha"
,"detection of nucleic acids","NN IN JJ NNS",4,1,1,16421445,2,3.40E+018,"testalpha"
,"numerous skin lesions thepatient","JJ NN NNS NN",4,1,1,16603099,2,5.08E+018,"testalpha"
,"zonula adherens and zonula","NN NNS CC NN",4,1,1,16253314,2,8.36E+018,"testalpha"
,"bayes fb hierarchical models","NNS  JJ NNS",4,1,1,16451795,"pubmed1",9.10E+018,"testalpha"
,"european countries france uk","JJ NNS NN ",4,1,1,16451154,"pubmed1",8.25E+018,"testalpha"
,"new zealand white rabbits","JJ NN JJ NNS",4,1,1,16395525,"pubmed1",5.99E+018,"testalpha"
,"hypertrophic scars and keloids","JJ NNS CC NNS",4,1,1,16874413,2,4.53E+018,"testalpha"
,"kinase protein kinase c","NN NN NN NN",4,1,1,17265696,2,3.38E+018,"testalpha"
,"reported ofthe successful use","VBN NNP JJ NN",4,1,1,16859612,2,3.15E+017,"testalpha"
,"ox ldl and hdl","  CC ",4,1,1,17106515,"pubmed1",3.22E+018,"testalpha"
,"preoperative diagnosis of uterine","JJ NN IN NN",4,1,1,17338203,2,9.19E+018,"testalpha"
,"line derived cells transcription","NN VBN NNS NN",4,1,1,17265694,2,1.46E+018,"testalpha"
,"factors for ophthalmological complications","NNS IN JJ NNS",4,1,1,17106598,2,8.98E+018,"testalpha"
,"epigenetic process affecting gene","JJ NN VBG ",4,1,1,16582985,"pubmed1",9.12E+018,"testalpha"
,"engineering studies in order","NN NNS IN NN",4,1,1,16511267,2,2.46E+018,"testalpha"
,"proportion of unsatisfactory smears","NN IN JJ NNS",4,1,1,16514839,2,6.32E+018,"testalpha"
,"methyl aminolevulinate cream mg"," NN NN ",4,1,1,16585985,2,6.79E+017,"testalpha"
,"paper describes theoretical simulations","NN VBZ JJ NNS",4,1,1,16523218,"pubmed1",4.36E+018,"testalpha"
,"mediate numerous matrix disorders","NN JJ NNP NNS",4,1,1,16733556,"pubmed1",6.19E+017,"testalpha"
,"stage ofchange including nicotine","NN NN IN NN",4,1,1,16365327,"pubmed1",6.01E+018,"testalpha"
,"follicular mucinosis perifolliculitis capitisabscedens","JJ NN NN NNS",4,1,1,17311739,2,2.33E+018,"testalpha"
,"forces undernear physiological conditions","NNS JJ JJ NNS",4,1,1,16411737,"pubmed1",1.24E+018,"testalpha"
,"main class of neuroglia","JJS NN IN NNP",4,1,1,17265695,2,3.46E+018,"testalpha"
,"marker of blood brain","NN IN NN NN",4,1,1,16828846,2,2.78E+018,"testalpha"
,"number ofco morbid conditions","NN  VB NNS",4,1,1,17117607,2,9.02E+018,"testalpha"
,"putative ribosomal rna processing","JJ JJ  NN",4,1,1,16511260,2,1.61E+018,"testalpha"
,"landscape ecology spatial descriptors","NN NN JJ NNS",4,1,1,16823608,"pubmed1",4.64E+018,"testalpha"
,"examined ox ldl level","VBD   NN",4,1,1,17106515,"pubmed1",2.70E+018,"testalpha"
,"examined programmed death ligand","VBD VBN NN NN",4,1,1,16530813,2,3.98E+018,"testalpha"
,"humanstfr hstfr and murine","  CC NN",4,1,1,17119325,2,7.82E+018,"testalpha"
,"hdac inhibitors against leukemia"," NNS IN NN",4,1,1,16424655,2,8.81E+018,"testalpha"
,"cells with normal karyotypes","NNS IN JJ NNS",4,1,1,16914909,2,1.94E+018,"testalpha"
,"thetotal number of cd","NN NN IN ",4,1,1,17119322,2,1.16E+018,"testalpha"
,"response morbidity mortality predictors","NN NN NN NNS",4,1,1,16424648,2,7.54E+018,"testalpha"
,"scanning calorimetry dsc cryomicroscopy","VBG NN  ",4,1,1,17285745,"pubmed1",3.76E+018,"testalpha"
,"clinical benefit and economicalconsiderations","JJ NN CC NNS",4,1,1,17236645,"pubmed1",2.44E+018,"testalpha"
,"hormones and growth factors","NNS CC NN NNS",4,1,1,16714054,2,8.40E+018,"testalpha"
,"intermediate aggregates encompass nascentelements","JJ NNS NN NNS",4,1,1,16714052,2,6.94E+018,"testalpha"
,"anaesthetic care unit pacu","JJ NN NN ",4,1,1,16451145,"pubmed1",3.94E+018,"testalpha"
,"saccharase from culture medium","NN IN NN NN",4,1,1,16970980,2,7.38E+018,"testalpha"
,"mutation of hmsh gene","NN IN  ",4,1,1,17139886,2,6.09E+018,"testalpha"
,"msec and right branch"," CC JJ NN",4,1,1,17139884,2,3.52E+018,"testalpha"
,"load dcwith protein antigens","NN NN NN NNS",4,1,1,16404477,"pubmed1",4.14E+018,"testalpha"
,"mutations of hmsh gene","NNS IN  ",4,1,1,17139886,2,4.48E+018,"testalpha"
,"datix database of allincidents"," NN IN NNS",4,1,1,16321534,"pubmed1",6.90E+018,"testalpha"
,"periplasmic domain of cora","JJ NN IN ",4,1,1,16511288,2,7.28E+018,"testalpha"
,"thick sections frommouse ileum","JJ NNS IN NN",4,1,1,16730369,2,4.00E+018,"testalpha"
,"intraepithelial lesions asil post","JJ NNS  NN",4,1,1,17139883,2,7.70E+018,"testalpha"
,"onlyincreased apache iii score","VBN NNP  NN",4,1,1,17117607,2,4.75E+018,"testalpha"
,"amongafrican american women breast","JJ JJ NNS NN",4,1,1,16596895,"pubmed1",1.30E+018,"testalpha"
,"human cord blood dc","JJ NN NN ",4,1,1,16404477,"pubmed1",7.77E+018,"testalpha"
,"cells with scant cytoplasm","NNS IN JJ NN",4,1,1,16514847,2,4.24E+018,"testalpha"
,"neuroradiology functionalneurosurgery human brain","NN NN JJ NN",4,1,1,16399031,"pubmed1",6.62E+018,"testalpha"
,"therectus muscle of abdomen","NN NN IN NN",4,1,1,17139894,2,8.20E+018,"testalpha"
,"thegroup with paliative operations","NN IN JJ NNS",4,1,1,17139895,2,1.52E+018,"testalpha"
,"limiting factor for thesescans","VBG NN IN NNS",4,1,1,16399032,"pubmed1",4.89E+018,"testalpha"
,"enlargement and inflammatory changes","NN CC JJ NNS",4,1,1,16612913,"pubmed1",1.23E+018,"testalpha"
,"elisa and total leukocytes"," CC JJ NNS",4,1,1,17293958,2,5.17E+018,"testalpha"
,"indian cobra and dendroaspis","JJ NNP CC ",4,1,1,16436788,"pubmed1",9.65E+017,"testalpha"
,"theperitoneal cavity initial pressure","NN NN JJ NN",4,1,1,16491219,2,8.93E+018,"testalpha"
,"incidence of ponv corresponds","NN IN  NNS",4,1,1,17236637,"pubmed1",9.16E+018,"testalpha"
,"gene inthe baculovirus system"," NNP NN NN",4,1,1,16733562,"pubmed1",5.13E+018,"testalpha"
,"endocrine cells fs cells","NN NNS  NNS",4,1,1,16569423,2,8.35E+018,"testalpha"
,"mouse liver imprintsand chicken","NN NN NN NN",4,1,1,16996581,2,9.22E+018,"testalpha"
,"content amino acid composition","JJ NNP NN NN",4,1,1,16701880,"pubmed1",1.54E+018,"testalpha"
,"ofinvolvement in fatal crashes","NN IN JJ NNS",4,1,1,16236235,"pubmed1",7.66E+018,"testalpha"
,"followinginjection of tritiated histidine","NN IN VBN NN",4,1,1,16733064,2,4.95E+018,"testalpha"
,"compute rate constants ofreactions","VB NN NNS NNS",4,1,1,16411736,"pubmed1",4.81E+018,"testalpha"
,"poly hydroxyproline amideand non"," NN NN ",4,1,1,16701856,"pubmed1",6.92E+018,"testalpha"
,"ex vivo transduction system","  NN NN",4,1,1,17160143,"pubmed1",5.88E+018,"testalpha"
,"hepatic hilo for minutes","JJ  IN NNS",4,1,1,17293970,2,1.88E+018,"testalpha"
,"iron metabolism markers c","NN NN NNS NN",4,1,1,17119323,2,4.55E+018,"testalpha"
,"areas were challenged withmdbgn","NNS VBD VBN ",4,1,1,16585981,2,2.20E+018,"testalpha"
,"pressure sores represent recurrent","NN NNS VBP NN",4,1,1,17165597,2,6.44E+018,"testalpha"
,"patients with advanced disease","NNS IN VBN NN",4,1,1,17139901,2,1.30E+018,"testalpha"
,"microscopy and autoradiography followinginjection"," CC NN NN",4,1,1,16733064,2,9.91E+016,"testalpha"
,"comparison with ac deltaala","NN IN  NNP",4,1,1,16528414,"pubmed1",8.71E+017,"testalpha"
,"receptors and nucleoside transporters","NNS CC VB NNS",4,1,1,16770441,"pubmed1",5.55E+018,"testalpha"
,"presented ascumbersome expensive time","VBN NN JJ NN",4,1,1,16770859,"pubmed1",1.86E+018,"testalpha"
,"tssr with higher frequency"," IN JJR NN",4,1,1,16733558,"pubmed1",4.21E+017,"testalpha"
,"thepresent study immunoblot analysis","NN NN NN NN",4,1,1,16963110,2,4.29E+017,"testalpha"
,"particles vlps of hpv","NNS  IN ",4,1,1,17010274,2,7.56E+018,"testalpha"
,"variability in baseline damage","NN IN NN NN",4,1,1,16582984,"pubmed1",1.40E+018,"testalpha"
,"t cell associated antigens"," NN VBN NNS",4,1,1,16424654,2,2.37E+018,"testalpha"
,"enzymes superoxide dismutases catalases","NNS VB NNS NNS",4,1,1,17160142,"pubmed1",6.98E+018,"testalpha"
,"tissue composition bold blood","NN NN JJ NN",4,1,1,16447077,"pubmed1",5.65E+018,"testalpha"
,"cancer and differential diagnosis","NN CC JJ NN",4,1,1,16514846,2,8.08E+018,"testalpha"
,"greater immunoreactivity of inos","JJR NN IN ",4,1,1,16566960,2,7.75E+018,"testalpha"
,"seconds until reaching mm","NNS IN VBG ",4,1,1,16491219,2,1.40E+017,"testalpha"
,"right hemi diaphragm grade","JJ   NN",4,1,1,16673610,2,6.01E+018,"testalpha"
,"charge was studied byzeta","NN VBD VBN NN",4,1,1,16584150,"pubmed1",6.01E+018,"testalpha"
,"statusof several mutations remains"," JJ NNS NNS",4,1,1,16929381,"pubmed1",3.76E+018,"testalpha"
,"development of antidotes mainlyanticholinergics","NN IN NNS NNS",4,1,1,16956120,2,9.09E+018,"testalpha"
,"showed gitr and gitrl","VBD  CC ",4,1,1,16955181,2,2.76E+018,"testalpha"
,"spinal cord injury risk","JJ NN NN NN",4,1,1,16111641,"pubmed1",7.57E+018,"testalpha"
,"incubation with afluorescent dye","NN IN NN ",4,1,1,16421445,2,3.51E+018,"testalpha"
,"surgical procedure in order","JJ NN IN NN",4,1,1,17293973,2,6.19E+018,"testalpha"
,"lowered levels of porphyrins","VBD NNS IN NNS",4,1,1,16874416,2,4.43E+018,"testalpha"
,"geneexpression and enos activity","NN CC  NN",4,1,1,16733564,"pubmed1",7.44E+018,"testalpha"
,"expression of c myc","NN IN NN ",4,1,1,16809887,2,3.93E+018,"testalpha"
,"measurements lipidprofile fasting blood","NNS IN VBG NN",4,1,1,16479027,2,8.74E+018,"testalpha"
,"formidable food andwaterborne diarrheal","JJ NN NNP NN",4,1,1,16511280,2,6.92E+018,"testalpha"
,"survival of cd t","NN IN  ",4,1,1,16511253,2,6.97E+018,"testalpha"
,"diastolic function and pulmonaryhypertension","JJ NN CC NN",4,1,1,16424656,2,8.56E+018,"testalpha"
,"biopsies of healthy skin","NNS IN JJ NN",4,1,1,17034836,2,4.22E+018,"testalpha"
,"ige mediated food allergy"," VBN NN NN",4,1,1,16673561,2,5.38E+018,"testalpha"
,"proliferation apoptosis and calcium","NN NN CC NN",4,1,1,17068636,"pubmed1",5.95E+018,"testalpha"
,"asthe value of release","NNP NN IN NN",4,1,1,16584161,"pubmed1",3.00E+018,"testalpha"
,"antibiotics and parenteral nutrition","NNS CC JJ NN",4,1,1,16612911,2,7.43E+018,"testalpha"
,"july recombinant urate oxidase"," JJ NN NN",4,1,1,16424647,2,3.09E+018,"testalpha"
,"directs thecreation of proteins","VBZ NN IN NNS",4,1,1,17294912,2,8.17E+018,"testalpha"
,"fibrinolytic system during childhood","JJ NN IN NN",4,1,1,16549888,2,6.04E+018,"testalpha"
,"patients hada positive history","NNS  JJ NN",4,1,1,16696443,2,6.89E+018,"testalpha"
,"ina contact dermatitis clinic"," NN NN NN",4,1,1,16710586,2,1.07E+017,"testalpha"
,"ng dl liver echogenicity","  NN NN",4,1,1,16673610,2,5.91E+018,"testalpha"
,"outtransient transfections of baby","NN NNS IN NN",4,1,1,16914903,2,3.01E+018,"testalpha"
,"restraint systems and seat","NN NNS CC NN",4,1,1,16426561,"pubmed1",5.00E+018,"testalpha"
,"patients at amean time","NNS IN JJ NN",4,1,1,16451159,"pubmed1",6.24E+017,"testalpha"
,"performed formal dbtsince graduation","VBN JJ NN NN",4,1,1,16473997,"pubmed1",4.19E+018,"testalpha"
,"glycerophosphate and ascorbic acid","NN CC JJ NN",4,1,1,16443258,2,8.33E+017,"testalpha"
,"low stress conditions rats","JJ NN NNS NNS",4,1,1,17133955,2,1.94E+018,"testalpha"
,"evaluated using transmission electron","VBN VBG NN NN",4,1,1,16253314,2,4.48E+018,"testalpha"
,"abnormal liver function tests","JJ NN NN NNS",4,1,1,16424663,2,2.07E+017,"testalpha"
,"problem in realizingthe concept","NN IN NNP NN",4,1,1,17285739,"pubmed1",8.46E+018,"testalpha"
,"voluntary physician directed destination","JJ NN VBN NN",4,1,1,16365324,"pubmed1",2.98E+018,"testalpha"
,"sugarpuckering n type sugar","VBG  NN NN",4,1,1,16456292,2,1.17E+018,"testalpha"
,"wear betweenpatients under years","VB NNS IN NNS",4,1,1,16613748,2,7.57E+018,"testalpha"
,"good programs reducetotal fatalities","JJ NNS NN NNS",4,1,1,16171767,"pubmed1",8.86E+018,"testalpha"
,"o fentanyl or propofol"," NN CC ",4,1,1,17236635,"pubmed1",6.23E+018,"testalpha"
,"degrees c cpb oxygenation","NNS NN  NN",4,1,1,16451153,"pubmed1",3.23E+018,"testalpha"
,"achieved sufficient reactivation potency","VBN JJ NN NN",4,1,1,17438836,2,4.40E+017,"testalpha"
,"augmented inhibition of tumor","VBD NN IN NN",4,1,1,16733559,"pubmed1",2.04E+018,"testalpha"
,"sleep deprivation depression burnout","NN NN NN NN",4,1,1,16377826,"pubmed1",1.24E+018,"testalpha"
,"radii andthrombocytopenia tar syndrome"," NNP  NN",4,1,1,16874423,2,4.66E+018,"testalpha"
,"thepersonal hygiene and possibilities","JJ NN CC NNS",4,1,1,17438833,2,5.23E+017,"testalpha"
,"ldl high density lipoproteins"," JJ NN NNS",4,1,1,17106515,"pubmed1",8.05E+018,"testalpha"
,"inosiplex group or placebo","JJ NN CC ",4,1,1,16955187,2,1.30E+018,"testalpha"
,"conditions participants were split","NNS NNS VBD NN",4,1,1,16427019,"pubmed1",5.48E+018,"testalpha"
,"inhibition ofgrowth at degrees","NN NN IN NNS",4,1,1,17019438,"pubmed1",3.30E+018,"testalpha"
,"response of psoriatic skin","NN IN JJ NN",4,1,1,16874421,2,7.88E+017,"testalpha"
,"expression index vegf ind","NN NN  ",4,1,1,16317488,"pubmed1",5.04E+018,"testalpha"
,"acetato mu n n","NN   ",4,1,1,16456265,2,2.42E+018,"testalpha"
,"serines and metal proteins","NNS CC NN NNS",4,1,1,17013516,2,5.95E+018,"testalpha"
,"injured rat muscle regeneration","VBN NN NN NN",4,1,1,16965805,2,7.77E+018,"testalpha"
,"tension free vaginal tape","NN JJ JJ NN",4,1,1,16962646,2,7.80E+018,"testalpha"
,"safety management andresource allocation","NN NN NN NN",4,1,1,16221468,"pubmed1",8.24E+018,"testalpha"
,"mononuclear cells from bone","JJ NNS IN NN",4,1,1,16733557,"pubmed1",7.29E+018,"testalpha"
,"ligament fibroblasts and cementoblasts","NN NNS CC NNS",4,1,1,17049369,2,8.55E+018,"testalpha"
,"cancer and withrectal cancer","NN CC NN NN",4,1,1,17139895,2,6.80E+018,"testalpha"
,"cys phe cys nh","   ",4,1,1,16496038,"pubmed1",1.55E+018,"testalpha"
,"purified hydrocarbon from petroleum","VBN NN IN NN",4,1,1,17294911,2,7.66E+018,"testalpha"
,"tromphoblastictumor and mycosis fungoides","NN CC NN NNS",4,1,1,16983449,2,3.93E+018,"testalpha"
,"assay with pcrs usingdifferent","NN IN  NN",4,1,1,17019439,"pubmed1",2.10E+018,"testalpha"
,"foods themeasurement of food","NNS NN IN NN",4,1,1,16673562,2,2.24E+018,"testalpha"
,"bioinformatical study further revealsa","JJ NN JJ NNP",4,1,1,16951743,"pubmed1",6.40E+018,"testalpha"
,"routine work from residents","JJ NN IN NNS",4,1,1,16377820,"pubmed1",7.21E+018,"testalpha"
,"buffer species than phosphate","NN NN IN NN",4,1,1,16584164,"pubmed1",5.91E+018,"testalpha"
,"substantial difference in methodology","JJ NN IN NN",4,1,1,16451144,"pubmed1",7.31E+018,"testalpha"
,"dose than bupivacaine orlevobupivacaine","NN IN NN NN",4,1,1,16617756,"pubmed1",3.49E+018,"testalpha"
,"frequency inpatients and controls","NN NNS CC NNS",4,1,1,16733555,"pubmed1",3.40E+018,"testalpha"
,"wayto perform aortic aneurysm"," VB JJ ",4,1,1,16612910,2,4.47E+018,"testalpha"
,"andultrasonographic findings of patients","JJ NNS IN NNS",4,1,1,16333694,"pubmed1",8.99E+018,"testalpha"
,"hospitalization and death rates","NN CC NN NNS",4,1,1,16139232,"pubmed1",8.39E+018,"testalpha"
,"safety climate and injury","NN NN CC NN",4,1,1,16430845,"pubmed1",8.04E+018,"testalpha"
,"larger number of shortenmers","JJR NN IN NNS",4,1,1,17285740,"pubmed1",8.40E+018,"testalpha"
,"cells in small cell","NNS IN JJ NN",4,1,1,16997356,2,7.76E+018,"testalpha"
,"building test and measurement","NN NN CC NN",4,1,1,17265693,2,1.91E+018,"testalpha"
,"pathogenesis of cardiovasculardisease cvd","NN IN NN ",4,1,1,16479030,2,1.25E+018,"testalpha"
,"treatment or t depletion","NN CC  NN",4,1,1,17115080,"pubmed1",5.46E+018,"testalpha"
,"species individual time series","NN JJ NN NN",4,1,1,17318329,"pubmed1",3.62E+018,"testalpha"
,"increasing body mass index","VBG NN NN NN",4,1,1,16438093,"pubmed1",3.68E+018,"testalpha"
,"persistence after cone treatment","NN IN NN NN",4,1,1,16514834,2,7.52E+018,"testalpha"
,"alcohol impaireddrivers in utah","NN NNS IN ",4,1,1,16112068,"pubmed1",6.08E+018,"testalpha"
,"explaining theprinciples of radiofrequency","VBG NNS IN NN",4,1,1,17139880,2,2.85E+018,"testalpha"
,"gaschromatography iontrap mass spectrometry","NN NN NN NN",4,1,1,16700150,2,5.96E+018,"testalpha"
,"theslides incubated overnight degrees","NNS VBN JJ NNS",4,1,1,17049369,2,3.45E+018,"testalpha"
,"ptclu achievedcomplete response cr"," JJ NN ",4,1,1,16914902,2,3.42E+017,"testalpha"
,"ebv by latent membrane"," IN JJ NN",4,1,1,16914904,2,3.54E+018,"testalpha"
,"oxygen consumption ofresting platelets","NN NN VBG NNS",4,1,1,17068635,"pubmed1",8.54E+018,"testalpha"
,"ironabsorption serum iron levels","NN NN NN NNS",4,1,1,17119325,2,2.25E+018,"testalpha"
,"k using polyethylene glycol"," VBG NN NN",4,1,1,16511269,2,2.31E+018,"testalpha"
,"subcutaneous administration of azoxymethane","JJ NN IN NN",4,1,1,17293962,2,5.29E+018,"testalpha"
,"thegeneral infection control measures","JJ NN NN NNS",4,1,1,16710581,2,2.34E+017,"testalpha"
,"regenerative hepatocellular alterations thatbecome","JJ JJ NNS NN",4,1,1,17013515,2,7.66E+018,"testalpha"
,"cells pb sc incombination","NNS   NN",4,1,1,16914909,2,7.14E+018,"testalpha"
,"gender type of diabetes","NN NN IN NN",4,1,1,16955188,2,4.68E+018,"testalpha"
,"quantitativedevelopment of antiproliferative drugs","NN IN JJ NNS",4,1,1,16988902,"pubmed1",2.76E+018,"testalpha"
,"measures from absolute effects","NNS IN JJ NNS",4,1,1,16406188,"pubmed1",7.60E+018,"testalpha"
,"drugs influencing neuromuscular function","NNS VBG JJ NN",4,1,1,16916186,"pubmed1",6.10E+018,"testalpha"
,"following institutional review board","VBG JJ NN NN",4,1,1,16377815,"pubmed1",9.17E+016,"testalpha"
,"using anindirect immunoperoxidase technique","VBG NN NN NN",4,1,1,16443258,2,8.44E+018,"testalpha"
,"institute for highway safety","NN IN NN NN",4,1,1,16171767,"pubmed1",6.82E+018,"testalpha"
,"san francisco aftersystem changes"," NNP NN NNS",4,1,1,16377825,"pubmed1",7.25E+018,"testalpha"
,"activate transcription of genes","NN NN IN NNS",4,1,1,16582985,"pubmed1",2.52E+018,"testalpha"
,"terms of presenting features","NNS IN VBG NNS",4,1,1,16424653,2,8.89E+018,"testalpha"
,"caa induced dna lesions"," VBN  NNS",4,1,1,16582987,"pubmed1",1.51E+018,"testalpha"
,"hepatic resections sepsis liver","JJ NNS NN NN",4,1,1,17013514,2,5.65E+016,"testalpha"
,"pregranulomatous phase of sarcoidosis","JJ NN IN NN",4,1,1,16256177,2,2.27E+018,"testalpha"
,"cases and reveals amyloidosis","NNS CC VBZ NN",4,1,1,16714051,2,3.53E+018,"testalpha"
,"creams ointments and solutions","NNS NNS CC NNS",4,1,1,16710573,2,3.17E+018,"testalpha"
,"occupants of light trucks","NNS IN NN NNS",4,1,1,16197912,"pubmed1",4.74E+018,"testalpha"
,"hazard of dui re","NN IN  ",4,1,1,16202465,"pubmed1",7.35E+018,"testalpha"
,"was injected glutamine glutamine","VBD VBD NN NN",4,1,1,17293970,2,7.29E+018,"testalpha"
,"azoles against malassezia spp","NNS IN NNP ",4,1,1,16874415,2,8.53E+018,"testalpha"
,"expression and hypoxic regulation","NN CC JJ NN",4,1,1,17143338,"pubmed1",8.32E+018,"testalpha"
,"epidural puncture in children","JJ NN IN NNS",4,1,1,17067139,"pubmed1",9.15E+018,"testalpha"
,"list of treatment modalities","NN IN NN NNS",4,1,1,16955186,2,8.44E+018,"testalpha"
,"rab genes in theparamecium"," NNS IN NN",4,1,1,16365637,"pubmed1",4.46E+018,"testalpha"
,"hiv infected patients inan"," VBN NNS ",4,1,1,16462404,"pubmed1",3.46E+018,"testalpha"
,"center experience in china","NN NN IN NN",4,1,1,16424648,2,7.74E+018,"testalpha"
,"non coherent red light"," NN JJ NN",4,1,1,16585985,2,4.53E+018,"testalpha"
,"non existing side effects"," VBG NN NNS",4,1,1,16424650,2,4.94E+018,"testalpha"
,"post ischemic stroke patients","NN JJ NN NNS",4,1,1,16479026,2,4.22E+018,"testalpha"
,"cardiovasculardisease cvd in diabetes","NN  IN NN",4,1,1,16479030,2,3.30E+018,"testalpha"
,"myocardialinfarction and heart failure","NN CC NN NN",4,1,1,17014894,2,7.90E+018,"testalpha"
,"ethnic background and religion","JJ NN CC NN",4,1,1,16696439,2,5.53E+018,"testalpha"
,"triage nurses ordering ankle","NN NNS VBG NN",4,1,1,16436790,"pubmed1",5.05E+018,"testalpha"
,"cd cd high t","  JJ ",4,1,1,17016036,2,5.31E+017,"testalpha"
,"existing phosphate buffer specieswas","VBG NN NN ",4,1,1,16584164,"pubmed1",7.54E+018,"testalpha"
,"tissueregeneration after partial hepatectomy","NN IN JJ NN",4,1,1,17013504,2,3.60E+017,"testalpha"
,"primary colon cancer cc","JJ NN NN ",4,1,1,17139902,2,3.93E+018,"testalpha"
,"tricalciumphosphate and deproteinized bovine","NN CC VBN NN",4,1,1,16956114,2,1.30E+016,"testalpha"
,"ear and leftear acupuncture","NN CC JJ NN",4,1,1,16955182,2,7.81E+018,"testalpha"
,"preoperative score for ponv","JJ NN IN ",4,1,1,17236637,"pubmed1",5.83E+018,"testalpha"
,"ofaccreditation of institutional rebs","NN IN JJ ",4,1,1,16770860,"pubmed1",4.33E+018,"testalpha"
,"use of artificial skin","NN IN JJ NN",4,1,1,16999266,2,4.13E+017,"testalpha"
,"activity beneficial inthe treatment","NN JJ NNP NN",4,1,1,16918071,"pubmed1",4.84E+018,"testalpha"
,"antigen ki and topoisomerase","NN  CC NN",4,1,1,17117604,2,5.66E+018,"testalpha"
,"microspheres while other formulations","NNS IN JJ NNS",4,1,1,16594643,"pubmed1",8.96E+018,"testalpha"
,"significant differences in resource","JJ NNS IN NN",4,1,1,16451154,"pubmed1",6.91E+018,"testalpha"
,"level of enos mrna","NN IN  ",4,1,1,16733564,"pubmed1",6.24E+018,"testalpha"
,"castingvisualization with subvoxel resolution","NN IN NNP NN",4,1,1,16399038,"pubmed1",2.74E+018,"testalpha"
,"interactions form anr ring","NNS NN  NN",4,1,1,16456295,2,8.47E+017,"testalpha"
,"mmhg median th thpercentiles"," JJ  NNS",4,1,1,16451155,"pubmed1",7.77E+018,"testalpha"
,"procedures multisessionconventional percutaneous ethanol","NNS JJ JJ NN",4,1,1,16333710,"pubmed1",1.42E+018,"testalpha"
,"isolated nbds and sbds","VBN  CC ",4,1,1,16511258,2,4.69E+018,"testalpha"
,"analogs with long n","NNS IN JJ ",4,1,1,16594645,"pubmed1",7.19E+017,"testalpha"
,"apoptosis of endothelial cells","NN IN JJ NNS",4,1,1,17143339,"pubmed1",7.53E+018,"testalpha"
,"member states within years","NN NNS IN NNS",4,1,1,16999268,2,5.95E+018,"testalpha"
,"multi detectorcomputed tomogra phy"," VBN NN ",4,1,1,17067135,"pubmed1",5.48E+018,"testalpha"
,"pcr and enos enzyme"," CC  ",4,1,1,16733564,"pubmed1",6.61E+018,"testalpha"
,"mss protein in complexwith"," NN IN NN",4,1,1,16511278,2,6.01E+018,"testalpha"
,"technetium labeled m tc","NN VBD  ",4,1,1,16584167,"pubmed1",6.31E+018,"testalpha"
,"disorders of energy production","NNS IN NN NN",4,1,1,16462411,"pubmed1",6.26E+018,"testalpha"
,"prevention of recurrent events","NN IN NN NNS",4,1,1,16436789,"pubmed1",2.01E+018,"testalpha"
,"parliament and council directive","NN CC NN NN",4,1,1,16999268,2,8.05E+018,"testalpha"
,"amyloid fibrils contain sialicacids","VB NNS VB NNS",4,1,1,16764914,2,7.51E+018,"testalpha"
,"diagnosis of substance abuse","NN IN NN NN",4,1,1,16405857,"pubmed1",3.85E+018,"testalpha"
,"was demonstrated thatserum tnf","VBD VBN NN ",4,1,1,17293958,2,6.85E+018,"testalpha"
,"days of cell culture","NNS IN NN NN",4,1,1,16701867,"pubmed1",7.92E+018,"testalpha"
,"lymphocytic leukemia b cll","JJ NN NN ",4,1,1,16424654,2,7.75E+018,"testalpha"
,"count and cd p","NN CC  ",4,1,1,16809885,2,4.03E+018,"testalpha"
,"simplestmodel of n methyl","NN IN  ",4,1,1,16528414,"pubmed1",8.67E+018,"testalpha"
,"durations of presented time","NNS IN VBN NN",4,1,1,17133956,2,6.07E+018,"testalpha"
,"cell tumor mixed type","NN NN VBN NN",4,1,1,16809892,2,6.27E+018,"testalpha"
,"theexperiment at mg kg","NN IN  ",4,1,1,17293967,2,4.47E+018,"testalpha"
,"iron pooland dna damage","NN NN  NN",4,1,1,17143336,"pubmed1",5.87E+018,"testalpha"
,"model amino acid sequence","NN NNP NN NN",4,1,1,16511256,2,1.59E+018,"testalpha"
,"atopic dermatitis and specificimmunotherapy","NN NN CC NN",4,1,1,16603103,2,1.26E+017,"testalpha"
,"weight and lactic acidconcentration","NN CC JJ NN",4,1,1,17285750,"pubmed1",4.78E+018,"testalpha"
,"polymerization using diethylene glycoldimethyl","NN VBG NN ",4,1,1,16701874,"pubmed1",9.60E+017,"testalpha"
,"carbohydrate drugsand diagnostic tests","NN NN NN NNS",4,1,1,16730370,2,2.21E+018,"testalpha"
,"dc or generationof dc"," CC  ",4,1,1,16404477,"pubmed1",7.45E+016,"testalpha"
,"camp responsive element atf","NN JJ NN ",4,1,1,16395528,"pubmed1",5.78E+018,"testalpha"
,"theregulation of cell metabolism","NN IN NN NN",4,1,1,16410835,"pubmed1",2.75E+018,"testalpha"
,"ind values of hccs"," NNS IN ",4,1,1,16317488,"pubmed1",1.11E+018,"testalpha"
,"immortalized humanendothelial cell line","VBN JJ NN NN",4,1,1,16733560,"pubmed1",3.77E+018,"testalpha"
,"thrombocytopenia ie following ami","NNP  VBG ",4,1,1,16594642,"pubmed1",3.63E+018,"testalpha"
,"arranged elongated lens cells","VBN VBN NN NNS",4,1,1,16325892,2,8.40E+018,"testalpha"
,"sulfate dihydrate cimetidine grades","NN NN NN NNS",4,1,1,17285749,"pubmed1",9.03E+018,"testalpha"
,"agents mimic natural ingredients","NNS JJ JJ NNS",4,1,1,16859617,2,3.78E+018,"testalpha"
,"improvement in platelet counts","NN IN NN NNS",4,1,1,16809885,2,2.18E+017,"testalpha"
,"disease andseveral autoimmune diseases","NN JJ NN NNS",4,1,1,17016038,2,3.72E+018,"testalpha"
,"assay and platelet count","NN CC NN NN",4,1,1,16594642,"pubmed1",7.26E+018,"testalpha"
,"thehysteresis and provide insight","NN CC VB NN",4,1,1,16701859,"pubmed1",8.74E+018,"testalpha"
,"effect of hepatic impairment","NN IN JJ NN",4,1,1,16584121,"pubmed1",3.40E+018,"testalpha"
,"proteins wasexamined taking bovine","NNS VBN VBG NN",4,1,1,16701860,"pubmed1",1.83E+016,"testalpha"
,"simple andcomplex road environments","JJ JJ NN NNS",4,1,1,16226211,"pubmed1",1.18E+018,"testalpha"
,"techniques for total hip","NNS IN JJ NN",4,1,1,16916184,"pubmed1",8.51E+018,"testalpha"
,"perceived exaggeration of symptoms","VBN NN IN NNS",4,1,1,16436793,"pubmed1",2.64E+018,"testalpha"
,"low micromol l range","JJ   NN",4,1,1,16594645,"pubmed1",4.56E+018,"testalpha"
,"major reason for hospitalizations","JJ NN IN NNS",4,1,1,16412373,"pubmed1",2.21E+018,"testalpha"
,"gm csf scf fl","   ",4,1,1,16404477,"pubmed1",5.08E+018,"testalpha"
,"da or glutamate transmission"," CC NN NN",4,1,1,16808044,"pubmed1",3.18E+018,"testalpha"
,"nonlinear reaction diffusionequation rde","JJ NN NN ",4,1,1,16988902,"pubmed1",3.87E+018,"testalpha"
,"blood and feces collection","NN CC NNS NN",4,1,1,17293961,2,6.22E+018,"testalpha"
,"functions ft and tshs","NNS  CC ",4,1,1,16479025,2,2.00E+018,"testalpha"
,"population in age groups","NN IN NN NNS",4,1,1,16451795,"pubmed1",5.20E+018,"testalpha"
,"hyperbaric bupivacaine and fentanyl","JJ NN CC NN",4,1,1,16916188,"pubmed1",8.92E+018,"testalpha"
,"anintraperitoneal injection of iu","NN NN IN ",4,1,1,16762403,2,8.24E+018,"testalpha"
,"life support units alsu","NN NN NNS ",4,1,1,16491215,2,3.12E+018,"testalpha"
,"selective cox inhibitor treatment","JJ  NN NN",4,1,1,16253314,2,3.83E+017,"testalpha"
,"day with good control","NN IN JJ NN",4,1,1,16424649,2,8.91E+018,"testalpha"
,"threaten vital life processes","VB JJ NN NNS",4,1,1,16859618,2,6.48E+018,"testalpha"
,"hexapeptide representing residues ofhuman","VB VBG NNS NN",4,1,1,17117212,"pubmed1",7.83E+017,"testalpha"
,"themechanisms between traffic safety","NNS IN NN NN",4,1,1,16406188,"pubmed1",3.02E+018,"testalpha"
,"blue methyl and crystal","JJ  CC NN",4,1,1,16542712,2,8.99E+018,"testalpha"
,"compositeparticles using different concentrations","NNS VBG JJ NNS",4,1,1,17285743,"pubmed1",6.68E+018,"testalpha"
,"portosystemic venous shunt sipsvs","JJ JJ NN ",4,1,1,17438838,2,2.01E+018,"testalpha"
,"therapy in diabetic patients","NN IN JJ NNS",4,1,1,16989147,2,1.93E+018,"testalpha"
,"concentrations used forstabilizing hsa","NNS VBN VBG ",4,1,1,17285745,"pubmed1",8.65E+018,"testalpha"
,"stromal layers human bone","JJ NNS JJ NN",4,1,1,17016038,2,8.30E+018,"testalpha"
,"haemoglobin scavengerreceptor cd hbsr","NNP NN  ",4,1,1,16770444,"pubmed1",5.44E+018,"testalpha"
,"contacted n person years","VBN  NN NNS",4,1,1,16412373,"pubmed1",3.13E+018,"testalpha"
,"structured framework for contributoryfactors","VBN NN IN NNS",4,1,1,16321534,"pubmed1",6.28E+018,"testalpha"
,"treats protein crystallography asa","VBZ NN NN ",4,1,1,16369088,2,1.39E+018,"testalpha"
,"mg kg i p","   ",4,1,1,17133954,2,1.65E+018,"testalpha"
,"adjustment of hazard risk","NN IN NN NN",4,1,1,16430845,"pubmed1",3.89E+018,"testalpha"
,"organs systems and diseases","NNS NNS CC NNS",4,1,1,16594641,"pubmed1",1.15E+018,"testalpha"
,"increased ratings of risk","JJ NNS IN NN",4,1,1,16426558,"pubmed1",5.47E+018,"testalpha"
,"importance of airway management","NN IN NN NN",4,1,1,16451149,"pubmed1",6.63E+018,"testalpha"
,"tt virus in liver"," NN IN NN",4,1,1,16696442,2,8.61E+018,"testalpha"
,"healthy skin from age","JJ NN IN NN",4,1,1,17034836,2,2.35E+018,"testalpha"
,"aspiration of saline solution","NN IN NN NN",4,1,1,16447096,"pubmed1",7.70E+018,"testalpha"
,"tmt b time dbr"," NN NN ",4,1,1,16479025,2,4.00E+018,"testalpha"
,"pattern of unintentional school","NN IN JJ NN",4,1,1,16236234,"pubmed1",7.55E+018,"testalpha"
,"ofunaided independent double readings","VBN JJ NN NNS",4,1,1,16399036,"pubmed1",2.07E+018,"testalpha"
,"peptide called r cwsfpgyac","VB VBN NN ",4,1,1,17019437,"pubmed1",4.04E+018,"testalpha"
,"reduce oligomerization ii point","VB NN  NN",4,1,1,16511258,2,6.14E+018,"testalpha"
,"children withpre exercise plasma","NNS  VB NNP",4,1,1,16918071,"pubmed1",1.25E+018,"testalpha"
,"therapeutic aspects ofhepatitis c","JJ NNS NN NN",4,1,1,17013506,2,6.37E+018,"testalpha"
,"severeatopic dermatitis in children","NN NN IN NNS",4,1,1,16585987,2,5.34E+018,"testalpha"
,"overnight shifts and torecord","JJ NNS CC NN",4,1,1,16436796,"pubmed1",8.96E+018,"testalpha"
,"method r and d","NN NN CC ",4,1,1,16603096,2,6.13E+018,"testalpha"
,"use of pedicle muscle","NN IN NN NN",4,1,1,16722344,2,6.05E+018,"testalpha"
,"containing mm tris hcl","VBG   ",4,1,1,16511255,2,6.58E+018,"testalpha"
,"sport utility vehicles pose","NN NN NNS NN",4,1,1,16111641,"pubmed1",4.01E+018,"testalpha"
,"components of extracellular matrix","NNS IN JJ NNP",4,1,1,17013515,2,7.39E+018,"testalpha"
,"findings indicate thattopical methyl","NNS VB JJ ",4,1,1,16585985,2,2.78E+018,"testalpha"
,"way anova and covariance","NN NNP CC NN",4,1,1,16491220,2,3.11E+018,"testalpha"
,"total of main chain","NN IN JJ NN",4,1,1,16511247,2,8.79E+018,"testalpha"
,"levels without anemia idec","NNS IN NN ",4,1,1,16809889,2,6.35E+018,"testalpha"
,"nir emission and iv"," NN CC ",4,1,1,16411740,"pubmed1",6.05E+018,"testalpha"
,"expression in primary colon","NN IN JJ NN",4,1,1,17139902,2,9.02E+018,"testalpha"
,"ill matched residues usingcomputer","JJ VBN NNS NN",4,1,1,16421450,2,6.54E+017,"testalpha"
,"compliance and health outcomes","NN CC NN NNS",4,1,1,17106601,2,1.14E+018,"testalpha"
,"prevalence items lowperceived risk","NN NNS VBN NN",4,1,1,16191426,"pubmed1",5.86E+018,"testalpha"
,"fatalities among teen passengers","NNS IN  NNS",4,1,1,16171767,"pubmed1",8.16E+018,"testalpha"
,"cd hyaluronatesynthase and hyaluronate"," NN CC NN",4,1,1,16713618,2,6.68E+018,"testalpha"
,"black widow spider induces","JJ NN NN NNS",4,1,1,16395521,"pubmed1",8.59E+018,"testalpha"
,"themean age of sample","JJ NN IN NN",4,1,1,16479025,2,1.20E+018,"testalpha"
,"healthcare policy includingeliminating disparities","NN NN VBG NNS",4,1,1,16473988,"pubmed1",1.47E+018,"testalpha"
,"combined prevalence for lsil","VBN NN IN ",4,1,1,16514839,2,2.09E+018,"testalpha"
,"thoracostomy tube turningit clockwise","NN NN JJ NN",4,1,1,16365333,"pubmed1",4.95E+018,"testalpha"
,"years among kidneytransplant recipients","NNS IN JJ NNS",4,1,1,16914905,2,4.42E+018,"testalpha"
,"associated protein cap genes","VBN NN NN NNS",4,1,1,16395520,"pubmed1",8.06E+018,"testalpha"
,"number of crystal structures","NN IN NN NNS",4,1,1,16369099,2,2.14E+018,"testalpha"
,"result for tbo vs","NN IN  ",4,1,1,17293963,2,8.76E+018,"testalpha"
,"production and utilization fluid","NN CC NN NN",4,1,1,16462411,"pubmed1",7.62E+018,"testalpha"
,"movement on cold water","NN IN JJ NN",4,1,1,17236636,"pubmed1",8.89E+018,"testalpha"
,"cognitive impairment in albinowistar","JJ NN IN NN",4,1,1,16956120,2,5.10E+018,"testalpha"
,"prognostic factor incervical cancer","JJ NN JJ NN",4,1,1,16514834,2,5.70E+018,"testalpha"
,"molecules and arepoor antigen","NNS CC NN NN",4,1,1,16733557,"pubmed1",8.85E+018,"testalpha"
,"increased levels of ua","VBN NNS IN ",4,1,1,17338197,2,5.74E+018,"testalpha"
,"andnonmatches confidence intervals ci","NNS NN NNS ",4,1,1,16365326,"pubmed1",6.42E+018,"testalpha"
,"beneficial factor during cabg","JJ NN IN ",4,1,1,17338197,2,3.19E+018,"testalpha"
,"fistula and faecal incontinence","NN CC JJ NN",4,1,1,16673559,2,1.86E+018,"testalpha"
,"hyperreactivity on re exposure","NN IN  NN",4,1,1,16585981,2,5.43E+018,"testalpha"
,"surepath tripath imaging inc","NN NN VBG ",4,1,1,16514840,2,5.80E+018,"testalpha"
,"migration and cancer metastasis","NN CC NN NN",4,1,1,16713618,2,7.09E+016,"testalpha"
,"proteins with mm d","NNS IN  ",4,1,1,16696441,2,6.75E+018,"testalpha"
,"nicotinic acetylcholine receptors nachr","JJ NN NNS ",4,1,1,16594641,"pubmed1",1.85E+018,"testalpha"
,"mlm generalized estimating equation"," VBN VBG NN",4,1,1,16126153,"pubmed1",3.15E+018,"testalpha"
,"interference observed is sequence","NN VBN VBZ NN",4,1,1,16395523,"pubmed1",7.54E+018,"testalpha"
,"trnase domain of colicin","NN NN IN NNP",4,1,1,16511255,2,3.38E+018,"testalpha"
,"n polyethylene glycol peg"," NN NN ",4,1,1,16252139,"pubmed1",8.44E+018,"testalpha"
,"crystal diffracts x rays","NN NNS NN NNS",4,1,1,16511250,2,5.45E+018,"testalpha"
,"reactions of ratsto changes","NNS IN NNP NNS",4,1,1,17133955,2,1.62E+018,"testalpha"
,"high insensitive nd yag","JJ JJ  ",4,1,1,17293968,2,1.98E+018,"testalpha"
,"acute renal failure arf","JJ JJ NN ",4,1,1,17117607,2,3.50E+017,"testalpha"
,"aminobenzoic acid paba molecule","JJ NN  NN",4,1,1,16397344,2,8.10E+018,"testalpha"
,"adhesion between epiploic appendixes","NN IN JJ NNS",4,1,1,16612930,"pubmed1",4.70E+018,"testalpha"
,"significant decrease of seizure","JJ NN IN NN",4,1,1,17007911,2,8.29E+018,"testalpha"
,"unadjustedmodel company level safety","NN NN NN NN",4,1,1,16430845,"pubmed1",6.01E+018,"testalpha"
,"full thickness skin graftsand","JJ NN NN NN",4,1,1,17165596,2,7.30E+018,"testalpha"
,"tfr r x exon"," NN NN ",4,1,1,16424658,2,7.52E+018,"testalpha"
,"road safety strategy relates","NN NN NN NNS",4,1,1,16198299,"pubmed1",8.01E+018,"testalpha"
,"aresolution using room temperature","NN VBG NN NN",4,1,1,16511247,2,8.78E+018,"testalpha"
,"professionalism andoffering didactic instruction","NN VBG JJ NN",4,1,1,16473995,"pubmed1",9.80E+017,"testalpha"
,"tothe non retinoic acid","NNP  JJ NN",4,1,1,16612919,"pubmed1",1.19E+018,"testalpha"
,"ulcerated center showed sclerotictissue","VBN NN VBD NN",4,1,1,16603102,2,3.10E+017,"testalpha"
,"liver metastases from patients","NN NNS IN NNS",4,1,1,16430945,2,7.40E+018,"testalpha"
,"improvementsin acid base balance","NNP NN NN NN",4,1,1,16365323,"pubmed1",5.81E+018,"testalpha"
,"cucumber mosaic virus cmv","NN JJ NN ",4,1,1,16395523,"pubmed1",3.53E+018,"testalpha"
,"benefit oflipid emulsion therapy","NN JJ NN NN",4,1,1,16436797,"pubmed1",3.89E+017,"testalpha"
,"extended survival oftreated mice","VBN NN VBN ",4,1,1,16388313,"pubmed1",3.59E+018,"testalpha"
,"distention and colonic transit","NN CC JJ NN",4,1,1,16252139,"pubmed1",9.19E+018,"testalpha"
,"ahistory of t sci","NN IN  ",4,1,1,16916187,"pubmed1",2.85E+018,"testalpha"
,"approach of brain injury","NN IN NN NN",4,1,1,17265689,2,8.27E+018,"testalpha"
,"autoimmune diseases with efficacy","NN NNS IN NN",4,1,1,17016038,2,8.07E+018,"testalpha"
,"inhibitsthe signaling protein protein","NNP VBG NN NN",4,1,1,16424642,2,2.39E+018,"testalpha"
,"male patients mean age","NN NNS VBP NN",4,1,1,17010267,2,8.09E+018,"testalpha"
,"cd and cd cd"," CC  ",4,1,1,17119322,2,1.84E+017,"testalpha"
,"sonoenteroclysis and barium enteroclysis","NN CC NN NN",4,1,1,16447095,"pubmed1",4.81E+018,"testalpha"
,"outer membrane receptor hasr","JJ NN NN ",4,1,1,16511263,2,1.78E+018,"testalpha"
,"vs alcohol use vs"," NN NN ",4,1,1,16436792,"pubmed1",7.02E+018,"testalpha"
,"histology or outgrowth parameters","NN CC NN NNS",4,1,1,16874412,2,5.15E+018,"testalpha"
,"selected patients with ad","VBN NNS IN NN",4,1,1,17328144,2,4.07E+018,"testalpha"
,"flt expression intermediate levels"," NN JJ NNS",4,1,1,16914901,2,7.30E+018,"testalpha"
,"detection of intermolecular forces","NN IN JJ NNS",4,1,1,16411737,"pubmed1",7.01E+018,"testalpha"
,"information anxietylevel pain level","NN NN NN NN",4,1,1,16365322,"pubmed1",3.34E+018,"testalpha"
,"traumatic brain injury tbi","JJ NN NN ",4,1,1,16365331,"pubmed1",6.68E+018,"testalpha"
,"representations of past durations","NNS IN JJ NNS",4,1,1,17133956,2,5.41E+018,"testalpha"
,"brain adarb and trpm","NN  CC ",4,1,1,16733555,"pubmed1",4.98E+018,"testalpha"
,"revealed thepresence of vntr","VBD NN IN ",4,1,1,16424652,2,4.61E+018,"testalpha"
,"pap smears and chlamydia"," NNS CC NNP",4,1,1,16514839,2,2.52E+018,"testalpha"
,"finger motif of transcription","NN NN IN NN",4,1,1,16411739,"pubmed1",5.47E+018,"testalpha"
,"infantile spinalmuscular atrophy type","JJ JJ NN NN",4,1,1,16730053,2,2.43E+018,"testalpha"
,"using primocultures of rat","VBG NNS IN NN",4,1,1,16696445,2,2.71E+017,"testalpha"
,"viscosity guluronic acid alginate","NN JJ NN NN",4,1,1,16701881,"pubmed1",2.75E+017,"testalpha"
,"drug release for hours","NN NN IN NNS",4,1,1,16584139,"pubmed1",5.18E+018,"testalpha"
,"residues between strands beta","NNS IN NNS NN",4,1,1,16421453,2,1.60E+018,"testalpha"
,"vitrooxidation of certain non","NN IN JJ ",4,1,1,17019443,"pubmed1",5.26E+018,"testalpha"
,"v q mismatch pre","  NN ",4,1,1,16451153,"pubmed1",2.83E+018,"testalpha"
,"levels ofnuclear encoded rnas","NNS JJ VBN ",4,1,1,16496041,"pubmed1",5.17E+018,"testalpha"
,"diesel oil g l","NN NN  ",4,1,1,17019438,"pubmed1",2.32E+018,"testalpha"
,"department ed patient arrivalrates","NN VBD NN NNS",4,1,1,16365329,"pubmed1",5.73E+018,"testalpha"
,"grass and mugwort pollenallergens","NN CC NN NNS",4,1,1,17328144,2,9.03E+018,"testalpha"
,"receptor protein fas triggers","NN NN  NNS",4,1,1,16330085,2,7.82E+016,"testalpha"
,"combined pet and ctoffers","VBN NN CC NNS",4,1,1,16333707,"pubmed1",4.77E+018,"testalpha"
,"humanendothelial cell line ea","JJ NN NN ",4,1,1,16733560,"pubmed1",6.62E+018,"testalpha"
,"regulated tomaintain blood pressure","VBN VB NN NN",4,1,1,16365323,"pubmed1",7.71E+018,"testalpha"
,"greater job dissatisfaction p","JJR NN NN ",4,1,1,16451152,"pubmed1",9.21E+017,"testalpha"
,"patients with diabetes mellitus","NNS IN NN NN",4,1,1,16989147,2,2.66E+018,"testalpha"
,"degrees molecules form chains","NNS NNS NN NNS",4,1,1,16456294,2,1.23E+018,"testalpha"
,"tgf beta and tgf"," NN CC ",4,1,1,16733563,"pubmed1",5.05E+018,"testalpha"
,"high ratings of drivingskills","JJ NNS IN NNS",4,1,1,16443186,"pubmed1",1.07E+018,"testalpha"
,"tool for structure determination","NN IN NN NN",4,1,1,16369089,2,6.10E+017,"testalpha"
,"level of epigenetic dna","NN IN JJ ",4,1,1,16505901,"pubmed1",5.48E+018,"testalpha"
,"patient developedprogressive invasive infection","NN JJ JJ NN",4,1,1,16918060,"pubmed1",1.05E+017,"testalpha"
,"neonatal hypoglycemia inlga infants","JJ NN  NNS",4,1,1,17438837,2,6.97E+018,"testalpha"
,"strain depression and anxiety","NN NN CC NN",4,1,1,16377815,"pubmed1",2.10E+018,"testalpha"
,"acute cutaneous drug reactions","JJ JJ NN NNS",4,1,1,17106599,2,5.70E+018,"testalpha"
,"patients with previous drug","NNS IN JJ NN",4,1,1,16710577,2,3.26E+018,"testalpha"
,"dna mismatch repair mmr"," NN NN ",4,1,1,17139886,2,4.82E+018,"testalpha"
,"translocation and cytokines secretion","NN CC NNS NN",4,1,1,17293960,2,6.15E+018,"testalpha"
,"feature of diabetic complications","NN IN JJ NNS",4,1,1,16733556,"pubmed1",8.90E+018,"testalpha"
,"smoking vs alcohol use","NN  NN NN",4,1,1,16436792,"pubmed1",4.04E+018,"testalpha"
,"apoptosisassay in human thyroid","NN IN JJ NN",4,1,1,17046053,2,3.99E+018,"testalpha"
,"received atotal of treatment","VBD NN IN NN",4,1,1,16424646,2,5.94E+018,"testalpha"
,"intracellular calcium excessive release","JJ NN JJ NN",4,1,1,17265697,2,6.07E+018,"testalpha"
,"glycol through anasojejunal tube","NN IN JJ NN",4,1,1,16447095,"pubmed1",2.47E+018,"testalpha"
,"months of therapy p","NNS IN NN ",4,1,1,16603096,2,2.70E+018,"testalpha"
,"surface of recovered capsules","NN IN VBD NNS",4,1,1,16701881,"pubmed1",6.73E+018,"testalpha"
,"utilization of castor oil","NN IN NN NN",4,1,1,17293971,2,4.49E+018,"testalpha"
,"gly gly leu val","   ",4,1,1,16496040,"pubmed1",4.66E+018,"testalpha"
,"preliminary modelpredicts airway displacements","JJ NNS NN NNS",4,1,1,16399039,"pubmed1",4.70E+018,"testalpha"
,"injected microg kg day","VBD NNP  NN",4,1,1,16714049,2,7.04E+018,"testalpha"
,"pi interactions and c"," NNS CC NN",4,1,1,16456296,2,3.56E+018,"testalpha"
,"sections on postoperative day","NNS IN JJ NN",4,1,1,17265691,2,8.72E+018,"testalpha"
,"ns infusion and min"," NN CC ",4,1,1,17067137,"pubmed1",3.11E+018,"testalpha"
,"various aspects of crystallography","JJ NNS IN NN",4,1,1,16369088,2,6.48E+017,"testalpha"
,"terminal motor latency pn","NN NN NN ",4,1,1,17139884,2,4.16E+017,"testalpha"
,"inter residue hydrogen bonds","NN NN NN NNS",4,1,1,16456293,2,5.47E+018,"testalpha"
,"cross over study withlevocetirizine","NN IN NN NN",4,1,1,16874418,2,9.07E+018,"testalpha"
,"positive attitudes than non","JJ NNS IN ",4,1,1,16330213,"pubmed1",1.75E+018,"testalpha"
,"effects of ppargamma ligands","NNS IN NN NNS",4,1,1,16809887,2,1.26E+018,"testalpha"
,"forearm in healthy volunteers","NN IN JJ NNS",4,1,1,16874414,2,5.53E+018,"testalpha"
,"insoil bioremediation and wastewater","NN NN CC NN",4,1,1,17019438,"pubmed1",7.19E+018,"testalpha"
,"nme and ac l"," CC  ",4,1,1,16528413,"pubmed1",3.24E+018,"testalpha"
,"clinical manifestations and prognosis","JJ NNS CC NN",4,1,1,16696444,2,4.14E+017,"testalpha"
,"concerns has been theinstitutionalization","NNS VBZ VBN NN",4,1,1,16770859,"pubmed1",6.64E+018,"testalpha"
,"properties of grafted skin","NNS IN VBN NN",4,1,1,16999269,2,7.93E+018,"testalpha"
,"investigated lung nodule assessment","VBD NN NN NN",4,1,1,16399029,"pubmed1",6.97E+018,"testalpha"
,"depigmentation ofskin and hair","NN NNP CC NN",4,1,1,17106595,2,5.78E+018,"testalpha"
,"drop vapourdiffusion at k","NN NN IN ",4,1,1,16511292,2,7.29E+018,"testalpha"
,"index waist circumference laboratory","NN NN NN NN",4,1,1,16479027,2,5.89E+018,"testalpha"
,"hippocampal neurons developing days","JJ NNS VBG NNS",4,1,1,17265693,2,7.03E+018,"testalpha"
,"pluronic colloidal silicondioxide dispersion","JJ NN VB NN",4,1,1,17285743,"pubmed1",4.42E+018,"testalpha"
,"lesions in e coli","NNS IN  ",4,1,1,16582987,"pubmed1",1.38E+018,"testalpha"
,"computer aid yielded sensitivity","NN NN VBD NN",4,1,1,16399036,"pubmed1",1.85E+018,"testalpha"
,"sets of e coli","NNS IN  ",4,1,1,16733554,"pubmed1",4.29E+017,"testalpha"
,"spontaneous clearance ofhpv infection","JJ NN  NN",4,1,1,17010274,2,6.76E+017,"testalpha"
,"constipation thin feces diarrhea","NN JJ NNS NN",4,1,1,16424650,2,2.93E+018,"testalpha"
,"enablers restrainers for leadership","NNS NNS IN NN",4,1,1,16377814,"pubmed1",8.67E+018,"testalpha"
,"systemic vasculitis in association","JJ NN IN NN",4,1,1,16424662,2,3.93E+018,"testalpha"
,"terms as merging fusion","NNS IN VBG NN",4,1,1,16988903,"pubmed1",8.68E+018,"testalpha"
,"time of supervened p","NN IN VBN ",4,1,1,16491220,2,6.72E+018,"testalpha"
,"materials and methods forty","NNS CC NNS NN",4,1,1,16399028,"pubmed1",1.73E+018,"testalpha"
,"ofpurinergic signaling system adenosine","JJ VBG NN NN",4,1,1,16770441,"pubmed1",6.23E+017,"testalpha"
,"further improve dio performance","JJ VB  NN",4,1,1,16377812,"pubmed1",9.18E+018,"testalpha"
,"drug release profiles f","NN NN NNS NN",4,1,1,17285748,"pubmed1",5.25E+018,"testalpha"
,"role of beta d","NN IN NN ",4,1,1,17293960,2,3.51E+018,"testalpha"
,"concentration binge prenataltoluene exposure","NN NN NN NN",4,1,1,16808045,"pubmed1",5.64E+018,"testalpha"
,"vitrousing simulated body fluid","VBG VBN NN NN",4,1,1,16701876,"pubmed1",6.71E+018,"testalpha"
,"exotic elapid envenomations naja","JJ JJ NNS ",4,1,1,16436788,"pubmed1",3.03E+018,"testalpha"
,"intravenous liposomal amphotericin b","JJ JJ NNP NN",4,1,1,17370565,"pubmed1",8.36E+018,"testalpha"
,"n immunoproliferative small intestinaldisease"," JJ JJ NN",4,1,1,16447095,"pubmed1",1.35E+018,"testalpha"
,"goal directed therapy egdt","NN VBN NN ",4,1,1,16365336,"pubmed1",8.74E+018,"testalpha"
,"nm light dose j"," NN NN ",4,1,1,16585985,2,5.94E+018,"testalpha"
,"days and theanathomic peaces","NNS CC JJ NNS",4,1,1,17293971,2,2.15E+018,"testalpha"
,"type or plant type","NN CC NN NN",4,1,1,17143335,"pubmed1",1.02E+018,"testalpha"
,"prevalence of chronic sleep","NN IN JJ NN",4,1,1,16377826,"pubmed1",8.99E+018,"testalpha"
,"increase inpositive patch reactions","NN JJ NN NNS",4,1,1,17106597,2,4.16E+018,"testalpha"
,"driving behaviourand related factors","VBG NN VBN NNS",4,1,1,16112070,"pubmed1",3.49E+018,"testalpha"
,"subjects n unaffected hs","NNS  JJ ",4,1,1,17016037,2,1.49E+018,"testalpha"
,"quality of life qol","NN IN NN ",4,1,1,16710574,2,3.43E+018,"testalpha"
,"durapatite amplified thetitanium surface","JJ VBN NN NN",4,1,1,17293968,2,4.56E+018,"testalpha"
,"apurine nucleoside analog clofarabine","NN VB NN NN",4,1,1,16421443,2,4.42E+018,"testalpha"
,"coagucheck pro roche diagnostics","NN JJ NNP NNS",4,1,1,16916181,"pubmed1",7.44E+018,"testalpha"
,"byblocking rho associated kinase","VBG  VBN NN",4,1,1,17115079,"pubmed1",2.55E+017,"testalpha"
,"methods used rats wistar","NNS VBN NNS NN",4,1,1,16491220,2,4.71E+018,"testalpha"
,"hd patients andits correlations"," NNS NNS NNS",4,1,1,17119323,2,3.67E+018,"testalpha"
,"prevalent condition successful treatment","JJ NN JJ NN",4,1,1,16612909,2,2.21E+018,"testalpha"
,"solutions plasma urine mouse","NNS NNP NN NN",4,1,1,17285740,"pubmed1",2.31E+018,"testalpha"
,"markers c reactive protein","NNS NN JJ NN",4,1,1,17119323,2,6.30E+018,"testalpha"
,"ampotericin b l amb","NNP NN  ",4,1,1,17370566,"pubmed1",6.70E+018,"testalpha"
,"growth factor beta tgfbeta","NN NN NN NN",4,1,1,16733556,"pubmed1",1.01E+018,"testalpha"
,"be treated withgranulocyte colony","VB VBN NNP NN",4,1,1,17119324,2,8.86E+018,"testalpha"
,"c terminal functional domain","NN NN JJ NN",4,1,1,16411738,"pubmed1",3.75E+018,"testalpha"
,"survival times betweencsav venom","NN NNS  NN",4,1,1,16436788,"pubmed1",2.11E+018,"testalpha"
,"assessment of specific rates","NN IN JJ NNS",4,1,1,16111641,"pubmed1",6.26E+018,"testalpha"
,"activity hours administrative hours","NN NNS JJ NNS",4,1,1,16436795,"pubmed1",5.90E+018,"testalpha"
,"matched residues usingcomputer graphics","VBN NNS NN NNS",4,1,1,16421450,2,1.04E+018,"testalpha"
,"apoptosis including oligonucleosomaldna fragmentation","NN IN  NN",4,1,1,16951739,"pubmed1",8.50E+018,"testalpha"
,"lack of brain injury","NN IN NN NN",4,1,1,16436787,"pubmed1",6.98E+018,"testalpha"
,"ofdizocilpine maleate mk non","NN NN  ",4,1,1,17133953,2,6.00E+018,"testalpha"
,"platelet function in infants","NN NN IN NNS",4,1,1,16549889,2,3.90E+018,"testalpha"
,"anddetermined pudendal nerve terminal","VBN NN NN NN",4,1,1,17139884,2,7.61E+018,"testalpha"
,"enablingnumerical assessment of asymmetry","JJ NN IN NN",4,1,1,16648914,2,2.27E+018,"testalpha"
,"theauthors describe technical aspects","NNS VBP JJ NNS",4,1,1,16722344,2,2.48E+018,"testalpha"
,"dimeric units per virion","JJ NNS IN NN",4,1,1,16733562,"pubmed1",5.95E+018,"testalpha"
,"tremor in hyperthyroid patients","NN IN VB NNS",4,1,1,16479025,2,8.82E+018,"testalpha"
,"epidermal necrolysis stevens johnson","JJ NN NNS NN",4,1,1,16710577,2,5.84E+018,"testalpha"
,"need for epidural supplementation","NN IN JJ NN",4,1,1,16617756,"pubmed1",9.08E+018,"testalpha"
,"coordinator and stated thatthey","NN CC VBD NNP",4,1,1,16436795,"pubmed1",1.91E+018,"testalpha"
,"reversetranscription pcr and enos","NN  CC ",4,1,1,16733564,"pubmed1",8.24E+017,"testalpha"
,"gamma probe detection gpd","NN NN NN ",4,1,1,16491216,2,1.40E+018,"testalpha"
,"special true test strips","JJ JJ NN NNS",4,1,1,16874422,2,8.64E+018,"testalpha"
,"difference in surgical outcome","NN IN JJ NN",4,1,1,17139896,2,5.03E+018,"testalpha"
,"independent predictors of mortality","JJ NNS IN NN",4,1,1,17117607,2,1.31E+018,"testalpha"
,"control t maintenance infusion","NN  NN NN",4,1,1,17236635,"pubmed1",1.17E+018,"testalpha"
,"alterations in hepatic microcirculation","NNS IN JJ NN",4,1,1,17013514,2,3.90E+018,"testalpha"
,"medical services ems providers","JJ NNS  NNS",4,1,1,16365324,"pubmed1",6.16E+017,"testalpha"
,"andp waf mrna increase","   NN",4,1,1,16733561,"pubmed1",5.70E+018,"testalpha"
,"g l within h","  IN ",4,1,1,17019438,"pubmed1",3.13E+018,"testalpha"
,"months in patients withperitoneal","NNS IN NNS NN",4,1,1,17139879,2,8.47E+018,"testalpha"
,"monoclonal mouse anti cd","JJ NN IN ",4,1,1,17049369,2,8.58E+018,"testalpha"
,"axisof cc and eccentricities","  CC NNS",4,1,1,16399030,"pubmed1",2.85E+018,"testalpha"
,"increasing diversity in thehealthcare","VBG NN IN NN",4,1,1,16473988,"pubmed1",3.63E+018,"testalpha"
,"andpu m pu r","   NN",4,1,1,17019439,"pubmed1",7.91E+018,"testalpha"
,"central nervous system involvement","JJ JJ NN NN",4,1,1,16918060,"pubmed1",4.83E+018,"testalpha"
,"manifestations with neurological signs","NNS IN JJ NNS",4,1,1,17370568,"pubmed1",4.41E+018,"testalpha"
,"development of diagnostic tests","NN IN JJ NNS",4,1,1,16730370,2,2.94E+018,"testalpha"
,"care education and job","NN NN CC NN",4,1,1,16377823,"pubmed1",7.52E+018,"testalpha"
,"cobrapla cob in anaesthetizedpatients","  IN NNS",4,1,1,16451149,"pubmed1",1.32E+018,"testalpha"
,"incidence of total response","NN IN JJ NN",4,1,1,16451147,"pubmed1",5.18E+018,"testalpha"
,"hetolerated treatment with ambisome","VBN NN IN NN",4,1,1,17370567,"pubmed1",3.90E+018,"testalpha"
,"baby hamster kidney cells","NN NN NN NNS",4,1,1,16914903,2,8.25E+018,"testalpha"
,"year old woman underwent","NN JJ NN NN",4,1,1,16612923,"pubmed1",5.15E+018,"testalpha"
,"was confirmed onb cll","VBD VBN  ",4,1,1,16424654,2,8.08E+018,"testalpha"
,"globin hiv protease andhiv","NNP  NN ",4,1,1,16823609,"pubmed1",4.10E+018,"testalpha"
,"implantation of acovered stent","NN IN VBN NN",4,1,1,16314990,"pubmed1",6.48E+018,"testalpha"
,"sex and nutritional status","NN CC JJ NN",4,1,1,16479024,2,4.53E+018,"testalpha"
,"cross border drinking consequences","VB NN NN NNS",4,1,1,16169506,"pubmed1",5.88E+018,"testalpha"
,"primarycultures of cerebellar granule","NNS IN JJ NN",4,1,1,17265692,2,2.14E+018,"testalpha"
,"ofpatent blue dye pbd","NN JJ  ",4,1,1,16491216,2,5.10E+017,"testalpha"
,"following pretreatment with salineor","VBG NN IN ",4,1,1,16594642,"pubmed1",2.60E+018,"testalpha"
,"agent in electron beam","NN IN NN NN",4,1,1,16399037,"pubmed1",5.35E+018,"testalpha"
,"compound hydroxy diphenylethanone ethylthiosemicarbazone","NN NN NN NN",4,1,1,16397328,2,7.10E+018,"testalpha"
,"innumbers of active fibroblasts","NNS IN JJ NNS",4,1,1,16574202,2,4.63E+018,"testalpha"
,"need forheterologous blood transfusion","NN JJ NN NN",4,1,1,17013513,2,5.68E+018,"testalpha"
,"reperfusion injury iri methods","NN NN  NNS",4,1,1,16491218,2,9.03E+018,"testalpha"
,"stress wereimportant risk factors","NN JJ NN NNS",4,1,1,16236234,"pubmed1",3.83E+018,"testalpha"
,"speed limit of miles","NN NN IN NNS",4,1,1,16426556,"pubmed1",6.61E+018,"testalpha"
,"metalloproteinase mmp and tissue","NN  CC NN",4,1,1,16585983,2,8.76E+017,"testalpha"
,"onestudy in abdominal surgery","NN IN JJ NN",4,1,1,16451147,"pubmed1",5.40E+018,"testalpha"
,"therapeutic difference between patients","JJ NN IN NNS",4,1,1,16955187,2,2.26E+018,"testalpha"
,"x ray films ofpatients","NN  NNS NNS",4,1,1,16722348,2,4.10E+018,"testalpha"
,"pituitary tsh immunoreactive cells","NN  JJ NNS",4,1,1,16714054,2,8.31E+018,"testalpha"
,"accurate estimate of thecrystal","JJ NN IN NN",4,1,1,16369093,2,7.98E+018,"testalpha"
,"intracellular parasite toxoplasma gondii","JJ JJ NNP ",4,1,1,16421444,2,2.03E+018,"testalpha"
,"pollen coat and wall","NN NN CC NN",4,1,1,16963110,2,1.18E+018,"testalpha"
,"anorectal angle was degrees","NN NN VBD NNS",4,1,1,17139884,2,8.98E+017,"testalpha"
,"glycation followed bya consequent","NN VBD  NN",4,1,1,16696441,2,5.89E+018,"testalpha"
,"membranes play critical roles","NNS VB JJ NNS",4,1,1,16511294,2,6.09E+018,"testalpha"
,"improvedpostoperative pain control mortality","JJ NN NN NN",4,1,1,17236639,"pubmed1",8.33E+018,"testalpha"
,"group b in patients","NN NN IN NNS",4,1,1,16989140,2,2.19E+018,"testalpha"
,"characteristic of large scale","NN IN JJ NN",4,1,1,16411734,"pubmed1",6.86E+016,"testalpha"
,"fatalities in reported crashes","NNS IN VBN NNS",4,1,1,16430844,"pubmed1",5.73E+017,"testalpha"
,"aml patients after autologouspbsct"," NNS IN ",4,1,1,17119322,2,5.64E+018,"testalpha"
,"apple computer inc cupertino","NNS NN  NNP",4,1,1,16399038,"pubmed1",2.94E+018,"testalpha"
,"used forthe rapid reversal","VBN NNP JJ NN",4,1,1,16916181,"pubmed1",6.64E+018,"testalpha"
,"international normalization ratio inr","JJ NN NN ",4,1,1,16451158,"pubmed1",8.72E+018,"testalpha"
,"pathogenesis of bovine spongiform","NN IN NN NN",4,1,1,16770445,"pubmed1",3.92E+018,"testalpha"
,"adenosine mediates neurotransmission conduction","NN NNS NN NN",4,1,1,16770441,"pubmed1",5.99E+018,"testalpha"
,"combination of edp hcg","NN IN  ",4,1,1,16714054,2,6.57E+018,"testalpha"
,"altered sensations andprevious traumas","VBN NNS JJ NNP",4,1,1,16585990,2,7.92E+018,"testalpha"
,"greatest risk of vte","JJT NN IN ",4,1,1,16549896,2,8.36E+018,"testalpha"
,"physician scientists in psychiatry","NN NNS IN NN",4,1,1,16473996,"pubmed1",4.93E+018,"testalpha"
,"observations provide further evidence","NNS VB JJ NN",4,1,1,16330085,2,6.62E+017,"testalpha"
,"occupant structure multilevel models","NN NN NN NNS",4,1,1,16126153,"pubmed1",8.45E+018,"testalpha"
,"bowel dysfunction urinary retention","NN NN JJ NN",4,1,1,16916180,"pubmed1",2.12E+018,"testalpha"
,"nodules cases of hashimoto","NNS NNS IN NNP",4,1,1,16514836,2,6.22E+018,"testalpha"
,"site severity of injury","NN NN IN NN",4,1,1,16223468,"pubmed1",4.95E+018,"testalpha"
,"ais score into u"," NN IN ",4,1,1,16426556,"pubmed1",2.67E+018,"testalpha"
,"increase in platelet counts","NN IN NN NNS",4,1,1,16809885,2,8.75E+018,"testalpha"
,"induced aggregation of hen","VBN NN IN NN",4,1,1,16770442,"pubmed1",1.28E+018,"testalpha"
,"types of total nutrient","NNS IN JJ NN",4,1,1,17285747,"pubmed1",7.11E+018,"testalpha"
,"low ratings of safety","JJ NNS IN NN",4,1,1,16443186,"pubmed1",5.42E+018,"testalpha"
,"research ethics boards i","NN NNS NNS ",4,1,1,16770860,"pubmed1",1.05E+017,"testalpha"
,"major cause of morbidity","JJ NN IN NN",4,1,1,16412373,"pubmed1",2.67E+018,"testalpha"
,"systematicreview and guidelines database","NN CC NNS NN",4,1,1,16918069,"pubmed1",8.59E+018,"testalpha"
,"infusion ng ml vs","NN   ",4,1,1,17067137,"pubmed1",4.47E+018,"testalpha"
,"injury hospitalization and fatality","NN NN CC NN",4,1,1,16139232,"pubmed1",1.90E+018,"testalpha"
,"such good x ray","JJ JJ NN ",4,1,1,16369095,2,5.23E+018,"testalpha"
,"resolve nanometer sized details","VB NN VBN NNS",4,1,1,16411737,"pubmed1",3.67E+018,"testalpha"
,"underthe influence of alcohol","NNP NN IN NN",4,1,1,16423318,"pubmed1",1.41E+018,"testalpha"
,"thesize distribution and encapsulation","VB NN CC NN",4,1,1,16594643,"pubmed1",4.71E+017,"testalpha"
,"l range ic micromol"," NN JJ ",4,1,1,16594645,"pubmed1",4.99E+018,"testalpha"
,"group of icu patients","NN IN  NNS",4,1,1,16451156,"pubmed1",7.00E+018,"testalpha"
,"scale oxidation of hydrocarbons","NN NN IN NNS",4,1,1,16411734,"pubmed1",1.46E+018,"testalpha"
,"analytical methodology developed inthis","JJ NN VBD NNP",4,1,1,16442487,"pubmed1",7.73E+017,"testalpha"
,"effects of advanced driver","NNS IN VBN NN",4,1,1,16406188,"pubmed1",9.20E+018,"testalpha"
,"corticosteroid therapy with methylprednisolone","VB NN IN NN",4,1,1,16603101,2,3.84E+018,"testalpha"
,"values of hb hct","NNS IN  ",4,1,1,17117609,2,5.38E+018,"testalpha"
,"positivity for sialic acid","NN IN JJ NN",4,1,1,16720036,2,6.00E+018,"testalpha"
,"male gamete atvarious stages","NN JJ JJ NNS",4,1,1,16330085,2,6.82E+018,"testalpha"
,"deltaho and entropy deltaso","NNP CC  ",4,1,1,17019442,"pubmed1",2.23E+018,"testalpha"
,"wide excision with cm","JJ NN IN ",4,1,1,16612932,"pubmed1",4.06E+018,"testalpha"
,"histological features of olp","JJ NNS IN ",4,1,1,16955190,2,8.40E+018,"testalpha"
,"school grades poor health","NN NNS JJ NN",4,1,1,16236234,"pubmed1",8.14E+018,"testalpha"
,"fluorescence andinner filter effect","NN NN NN NN",4,1,1,16404478,"pubmed1",7.30E+018,"testalpha"
,"growing field of mr","VBG NN IN ",4,1,1,16447077,"pubmed1",5.32E+018,"testalpha"
,"human homologue althoughthe insertion","JJ NN NNP NN",4,1,1,16421453,2,4.19E+018,"testalpha"
,"given rise toincreasing interest","VBN NN VBG NN",4,1,1,16701861,"pubmed1",1.06E+018,"testalpha"
,"lung kidney ovary andbladder","NN NN JJ NN",4,1,1,16514845,2,7.12E+017,"testalpha"
,"panicum maximum pep ck","NN JJ  ",4,1,1,17106510,"pubmed1",7.74E+018,"testalpha"
,"rated theirroad traffic vulnerability","VBN NN NN NN",4,1,1,16112069,"pubmed1",5.39E+018,"testalpha"
,"research ethics review process","NN NNS NN NN",4,1,1,16770859,"pubmed1",3.50E+018,"testalpha"
,"cases withdiaphragmatic hydatid disease","NNS JJ  NN",4,1,1,16612925,"pubmed1",5.30E+018,"testalpha"
,"different geographical processes inprinciple","JJ JJ NNS NNS",4,1,1,17318329,"pubmed1",8.63E+018,"testalpha"
,"xy r p q"," NN  ",4,1,1,16914909,2,3.24E+018,"testalpha"
,"endothelial cells of vessels","JJ NNS IN NNS",4,1,1,16762404,2,3.02E+018,"testalpha"
,"bp and i r"," CC  NN",4,1,1,16764913,2,1.91E+017,"testalpha"
,"volumes in tsh cells","NNS IN  NNS",4,1,1,16714054,2,4.77E+018,"testalpha"
,"predict accidents in eachtraffic","VB NNS IN NNP",4,1,1,16414003,"pubmed1",3.11E+018,"testalpha"
,"extensive involvement group ii","JJ NN NN ",4,1,1,16956117,2,2.94E+018,"testalpha"
,"andsafe method of treatment","NN NN IN NN",4,1,1,17328144,2,4.89E+018,"testalpha"
,"indirect result of hivdisease","JJ NN IN NN",4,1,1,16462405,"pubmed1",4.92E+017,"testalpha"
,"pulse therapy mg kg","NN NN  ",4,1,1,16955189,2,2.99E+018,"testalpha"
,"toluene in occupational settings","NN IN JJ NNS",4,1,1,16808045,"pubmed1",8.18E+018,"testalpha"
,"receiving abeta blocking agent","VBG NN VBG NN",4,1,1,16451148,"pubmed1",1.74E+017,"testalpha"
,"induction and subsequent induction","NN CC JJ NN",4,1,1,16770444,"pubmed1",2.51E+018,"testalpha"
,"relief during photodynamic therapy","NN IN JJ NN",4,1,1,16955184,2,7.14E+018,"testalpha"
,"righthg and stg p"," CC  ",4,1,1,16399034,"pubmed1",2.85E+018,"testalpha"
,"puvatherapy with monochromatic excimer","NN IN JJ NN",4,1,1,16585984,2,5.05E+018,"testalpha"
,"uv vis cd epr","   ",4,1,1,16496037,"pubmed1",1.35E+018,"testalpha"
,"iron prophylaxis in pregnancy","NN  IN NN",4,1,1,16424650,2,3.75E+018,"testalpha"
,"theshortage of assistance impact","NN IN NN NN",4,1,1,16612907,2,2.40E+018,"testalpha"
,"survival in selected patients","NN IN VBN NNS",4,1,1,17139879,2,2.94E+018,"testalpha"
,"dna dependent protein kinase"," JJ NN NN",4,1,1,16404475,"pubmed1",9.25E+017,"testalpha"
,"product temperature anddry layer","NN NN JJ NN",4,1,1,17285744,"pubmed1",1.97E+018,"testalpha"
,"regarding diagnosis and treatmentof","VBG NN CC ",4,1,1,16722347,2,3.57E+017,"testalpha"
,"analysis and representation ofstability","NN CC NN NN",4,1,1,16823610,"pubmed1",6.16E+018,"testalpha"
,"ischemia min of reperfusion","NN  IN NN",4,1,1,17293960,2,8.31E+017,"testalpha"
,"immunolocalization andclinical pathological features","NN JJ JJ NNS",4,1,1,16530813,2,1.54E+018,"testalpha"
,"methyl aminolevulinate photodynamic therapy"," NN JJ NN",4,1,1,16585985,2,4.50E+018,"testalpha"
,"motif of transcription factor","NN IN NN NN",4,1,1,16411739,"pubmed1",4.96E+018,"testalpha"
,"polymerization of methacrylatedn n","NN IN  ",4,1,1,16701854,"pubmed1",8.08E+018,"testalpha"
,"i r and group"," NN CC NN",4,1,1,17293960,2,7.34E+018,"testalpha"
,"fundamental mechanisms of anorectal","JJ NNS IN NN",4,1,1,17139877,2,4.82E+018,"testalpha"
,"scales vas and theoswestry","NNS  CC NN",4,1,1,17688033,2,8.20E+018,"testalpha"
,"perceptions of arrest certainty","NNS IN NN NN",4,1,1,16405859,"pubmed1",9.09E+018,"testalpha"
,"variety of dosing regimens","NN IN VBG NNS",4,1,1,16451144,"pubmed1",6.47E+018,"testalpha"
,"n acetyl n methyl","   ",4,1,1,16528414,"pubmed1",9.05E+018,"testalpha"
,"molecules forman r hydrogen","NNS NN NN NN",4,1,1,16456284,2,7.82E+018,"testalpha"
,"aneurysm by stent graft"," IN NN NN",4,1,1,16612926,"pubmed1",1.46E+018,"testalpha"
,"was traced byfluorescence microscopy","VBD VBN NN ",4,1,1,16874412,2,4.91E+018,"testalpha"
,"ina blue tattoo ink"," JJ  NN",4,1,1,16648911,2,5.51E+018,"testalpha"
,"high throughput structure analysis","JJ NN NN NN",4,1,1,16421450,2,3.73E+018,"testalpha"
,"gender race county hospital","NN NN NN NN",4,1,1,16365326,"pubmed1",7.23E+018,"testalpha"
,"prognosis for high grade","NN IN JJ NN",4,1,1,16612936,"pubmed1",9.53E+017,"testalpha"
,"case of fungal sinusitis","NN IN JJ NN",4,1,1,16918064,"pubmed1",8.16E+018,"testalpha"
,"paper by c ricotta","NN IN NN NNP",4,1,1,16988905,"pubmed1",6.81E+018,"testalpha"
,"f and p analysisof","NN CC  ",4,1,1,17285748,"pubmed1",2.54E+018,"testalpha"
,"indicatorsof survivability and resource"," NN CC NN",4,1,1,16400088,"pubmed1",9.11E+018,"testalpha"
,"imaging records of patients","VBG NNS IN NNS",4,1,1,16333710,"pubmed1",6.86E+018,"testalpha"
,"study on banked tissue","NN IN VBD NN",4,1,1,16564564,2,2.22E+018,"testalpha"
,"zone and decreased time","NN CC VBD NN",4,1,1,17133955,2,6.44E+018,"testalpha"
,"cell cycle related molecules","NN NN VBN NNS",4,1,1,16325892,2,8.72E+018,"testalpha"
,"metabolism of myocardial muscle","NN IN JJ NN",4,1,1,16479030,2,5.16E+018,"testalpha"
,"b poly ethylene glycol","NN  NN NN",4,1,1,16701879,"pubmed1",7.74E+018,"testalpha"
,"e induced thrombocytopenia ie"," VBN NNP ",4,1,1,16594642,"pubmed1",4.42E+018,"testalpha"
,"majority of available studies","NN IN JJ NNS",4,1,1,17236646,"pubmed1",8.78E+018,"testalpha"
,"age of onset years","NN IN VB NNS",4,1,1,16710586,2,6.36E+018,"testalpha"
,"skin grafts conclusion local","NN NNS NN NN",4,1,1,17165596,2,7.84E+018,"testalpha"
,"quinoneoxidoreductase nqo dt diaphorase","NN   NN",4,1,1,16929382,"pubmed1",2.95E+018,"testalpha"
,"characteristics of uterine sarcomas","NNS IN NN NNP",4,1,1,17338203,2,3.42E+018,"testalpha"
,"r than ini r","NN IN  NN",4,1,1,17293960,2,5.09E+018,"testalpha"
,"tissuerelease procedures in hips","NN NNS IN ",4,1,1,17438833,2,8.88E+018,"testalpha"
,"fiber solution and di","NN NN CC ",4,1,1,16252139,"pubmed1",2.47E+018,"testalpha"
,"pulmonary instillation of benzo","JJ NN IN NNP",4,1,1,17293964,2,6.92E+018,"testalpha"
,"skin surface by patients","NN NN IN NNS",4,1,1,16710573,2,3.19E+017,"testalpha"
,"common transport breathing apparatus","JJ NN VBG NN",4,1,1,16451150,"pubmed1",2.46E+018,"testalpha"
,"hyperglycemia after cerebral ischemia","NN IN JJ NN",4,1,1,16436794,"pubmed1",2.30E+018,"testalpha"
,"correction of pectus excavatum","NN IN NN NN",4,1,1,16956118,2,5.31E+018,"testalpha"
,"variety of affected molecularmechanisms","NN IN VBN NNS",4,1,1,16549895,2,1.18E+018,"testalpha"
,"expression inthe animal organism","NN NNP NN NN",4,1,1,16505901,"pubmed1",7.47E+018,"testalpha"
,"classification of diseases th","NN IN NNS ",4,1,1,16365331,"pubmed1",4.50E+018,"testalpha"
,"lg ndst hdac atrx","   ",4,1,1,16914901,2,7.79E+018,"testalpha"
,"greb and gfh crystals"," CC  NNS",4,1,1,16511259,2,6.12E+017,"testalpha"
,"nd nd and cyt","  CC ",4,1,1,16389406,"pubmed1",7.33E+018,"testalpha"
,"exposurevalues tlvs and beis","NNS  CC ",4,1,1,16438095,"pubmed1",4.89E+018,"testalpha"
,"uses ofefficient light sources","VBZ NN JJ NNS",4,1,1,17013504,2,4.68E+018,"testalpha"
,"gs ns expression system","  NN NN",4,1,1,16733563,"pubmed1",7.95E+017,"testalpha"
,"concepts for expandingthe indications","NNS IN NNP NNS",4,1,1,17139901,2,6.73E+018,"testalpha"
,"usual oral corticosteroids pulse","JJ JJ NNS NN",4,1,1,16955189,2,8.01E+018,"testalpha"
,"release rate exponent n","NN NN NN ",4,1,1,16584161,"pubmed1",5.42E+018,"testalpha"
,"complications in children withatopic","NNS IN NNS NN",4,1,1,17106598,2,2.16E+018,"testalpha"
,"multifunctional bacterial arginine repressors","JJ JJ NN NNS",4,1,1,16511254,2,4.69E+017,"testalpha"
,"spider induces and augmentsneurotransmitter","NN NNS CC NN",4,1,1,16395521,"pubmed1",1.17E+018,"testalpha"
,"map d and mapleson","NN  CC NN",4,1,1,16451150,"pubmed1",6.59E+018,"testalpha"
,"anterior part of hischest","JJ NN IN NN",4,1,1,16612932,"pubmed1",5.88E+018,"testalpha"
,"n pseudopelade brocq n"," NN  ",4,1,1,17311739,2,4.07E+018,"testalpha"
,"nag creatinine ratio u"," NN NN ",4,1,1,16956119,2,2.48E+018,"testalpha"
,"survival rate after reresection","NN NN IN NN",4,1,1,17139900,2,2.21E+018,"testalpha"
,"veterinary control of breed","JJ NN IN NN",4,1,1,16999268,2,1.77E+018,"testalpha"
,"vs instage i p"," NN  ",4,1,1,17139895,2,4.17E+018,"testalpha"
,"prolonged treatment withhigh doses","VBN NN VB NNS",4,1,1,17133953,2,4.30E+018,"testalpha"
,"associatedorgan dysfunctions and complications","VBD NNS CC NNS",4,1,1,17067134,"pubmed1",8.01E+018,"testalpha"
,"form lower trianglesimilarity matrices","VB JJR NN NNS",4,1,1,16191426,"pubmed1",2.60E+017,"testalpha"
,"individual timi risk indicator","JJ  NN NN",4,1,1,16365321,"pubmed1",1.66E+017,"testalpha"
,"decreasing anxiety and pain","VBG NN CC NN",4,1,1,16365322,"pubmed1",5.54E+018,"testalpha"
,"activityin generalized linear regression"," VBN JJ NN",4,1,1,16202466,"pubmed1",6.35E+018,"testalpha"
,"keratodermia mutilans withhearing loss","NN NNS VBG NN",4,1,1,17106596,2,3.52E+018,"testalpha"
,"primary tumors and liver","JJ NNS CC NN",4,1,1,16430945,2,1.26E+018,"testalpha"
,"molecular mass lysine dendrimers","JJ NN NN NNS",4,1,1,16496039,"pubmed1",8.87E+018,"testalpha"
,"treatment for selected patients","NN IN VBN NNS",4,1,1,17328144,2,1.77E+018,"testalpha"
,"apoptosis and calcium homeostasis","NN CC NN NN",4,1,1,17068636,"pubmed1",4.99E+018,"testalpha"
,"skin inflammation in ad","NN NN IN NN",4,1,1,17328144,2,5.31E+018,"testalpha"
,"vehicle crash injury hospitalization","NN NN NN NN",4,1,1,16139232,"pubmed1",2.78E+016,"testalpha"
,"ofthe multiple cam mrna","NNP JJ  ",4,1,1,16949651,2,2.26E+017,"testalpha"
,"radicals and apoptotic events","NNS CC JJ NNS",4,1,1,17265697,2,4.97E+018,"testalpha"
,"synergistic action of fk","JJ NN IN ",4,1,1,16424655,2,2.26E+018,"testalpha"
,"tumor neovasculature and afterinternalization","NN NN CC NN",4,1,1,17143339,"pubmed1",5.64E+018,"testalpha"
,"relapse of non hodgkin","NN IN  NNP",4,1,1,17119328,2,6.49E+018,"testalpha"
,"temperature heterogeneity mtm resistance","NN NN  NN",4,1,1,17285744,"pubmed1",6.50E+018,"testalpha"
,"current use of dbt","JJ NN IN ",4,1,1,16473997,"pubmed1",5.93E+018,"testalpha"
,"dio and program director"," CC NN NN",4,1,1,16377812,"pubmed1",2.81E+018,"testalpha"
,"materials and methods tenradiologists","NNS CC NNS NNS",4,1,1,16399036,"pubmed1",6.52E+018,"testalpha"
,"presence of altered sensations","NN IN VBN NNS",4,1,1,16585990,2,3.63E+017,"testalpha"
,"global forebrain ischemia induces","JJ VB NN NNS",4,1,1,17265693,2,5.37E+018,"testalpha"
,"theternary complex ak adenosine","JJ JJ  NN",4,1,1,16421444,2,7.04E+018,"testalpha"
,"coherent red light nm","NN JJ NN ",4,1,1,16585985,2,7.65E+018,"testalpha"
,"thisreview highlights current evidence","NN NNS JJ NN",4,1,1,16594641,"pubmed1",6.31E+018,"testalpha"
,"respiratory and photosynthetic electron","NN CC JJ NN",4,1,1,17143336,"pubmed1",4.53E+018,"testalpha"
,"role patients with microscopic","NN NNS IN NN",4,1,1,16648918,2,5.32E+018,"testalpha"
,"self addressed stamped return","NN VBN VBN NN",4,1,1,16377812,"pubmed1",5.56E+018,"testalpha"
,"physicians and basicscience faculty","NNS CC NN NN",4,1,1,16377815,"pubmed1",8.09E+018,"testalpha"
,"ultrasound aftermicrobubble based contrast","NN JJ VBN NN",4,1,1,16333704,"pubmed1",5.88E+018,"testalpha"
,"differences between bursting pressure","NNS IN VBG NN",4,1,1,16612916,"pubmed1",8.27E+018,"testalpha"
,"personal characteristics of thepassengers","JJ NNS IN NNS",4,1,1,16434013,"pubmed1",5.88E+018,"testalpha"
,"population at multiple emergency","NN IN JJ NN",4,1,1,16365337,"pubmed1",7.63E+018,"testalpha"
,"diseases until february whenultrasonography","NNS IN JJ NN",4,1,1,17119328,2,4.31E+018,"testalpha"
,"assay and caco cells","NN CC  NNS",4,1,1,16584115,"pubmed1",8.09E+018,"testalpha"
,"ward call system metacgme","NN NN NN ",4,1,1,16377824,"pubmed1",5.20E+018,"testalpha"
,"fewer admission and lowermortality","JJR NN CC NN",4,1,1,16462404,"pubmed1",4.76E+018,"testalpha"
,"sites in l y","NNS IN  ",4,1,1,16404475,"pubmed1",1.68E+018,"testalpha"
,"steps in computer literacy","NNS IN NN NN",4,1,1,16473991,"pubmed1",5.98E+018,"testalpha"
,"prevent postdural puncture headache","VB JJ NN NN",4,1,1,16916188,"pubmed1",5.94E+018,"testalpha"
,"mostly large bowelsand need","JJ JJ NN NN",4,1,1,17139893,2,3.60E+018,"testalpha"
,"oral nifedipine retard patients","JJ NN NN NNS",4,1,1,16612915,"pubmed1",7.29E+018,"testalpha"
,"base deficit and lactato","NN NN CC NN",4,1,1,16491220,2,6.40E+018,"testalpha"
,"surface of collagen fibers","NN IN NN NNS",4,1,1,16714051,2,3.86E+018,"testalpha"
,"showed thatadministration of ag","VBD NN IN ",4,1,1,16999986,2,8.24E+018,"testalpha"
,"surrogate marker indicating agood","NN NN VBG NN",4,1,1,16914901,2,2.68E+018,"testalpha"
,"studies of duty hourrestrictions","NNS IN NN NNS",4,1,1,16377820,"pubmed1",7.10E+017,"testalpha"
,"patient developed septic shock","NN VBD JJ NN",4,1,1,16914908,2,5.06E+018,"testalpha"
,"historic data about thecomposer","JJ NN IN NN",4,1,1,17294913,2,4.29E+018,"testalpha"
,"volume via epidural needle","NN IN JJ NN",4,1,1,16916188,"pubmed1",3.98E+018,"testalpha"
,"desaturase named sk fad","NN VBN  NN",4,1,1,17063209,"pubmed1",7.76E+018,"testalpha"
,"first reports showingantitumour efficacy","JJ NNS JJ NN",4,1,1,16388313,"pubmed1",5.50E+018,"testalpha"
,"unpublished studies inclusion criteria","JJ NNS NN NNS",4,1,1,16365334,"pubmed1",5.04E+018,"testalpha"
,"cells pasmc in rats","NNS  IN NNS",4,1,1,16395522,"pubmed1",5.83E+018,"testalpha"
,"presented recurrences after treatment","VBN NNS IN NN",4,1,1,16955186,2,5.92E+018,"testalpha"
,"subjects female and male","NNS NN CC NN",4,1,1,17010264,2,2.05E+018,"testalpha"
,"subjects were current smokers","NNS VBD JJ NNS",4,1,1,16365327,"pubmed1",6.06E+018,"testalpha"
,"laryngeal tuberculosis in order","NN NN IN NN",4,1,1,16479029,2,1.02E+018,"testalpha"
,"selected sc disease scd","VBN  NN ",4,1,1,16424656,2,8.69E+018,"testalpha"
,"i r glucan rats"," NN JJ NNS",4,1,1,17293960,2,7.39E+018,"testalpha"
,"qmismatch deltapo increased post","NN  VBN NN",4,1,1,16451153,"pubmed1",9.05E+017,"testalpha"
,"dna polymerase fingerprint analysis"," NN NN NN",4,1,1,16582987,"pubmed1",4.80E+018,"testalpha"
,"drop vapor diffusion method","NN  NN NN",4,1,1,16511280,2,4.20E+018,"testalpha"
,"group regarding grade iv","NN VBG NN ",4,1,1,16424643,2,5.23E+018,"testalpha"
,"inexperimental cell and tissue","NN NN CC NN",4,1,1,16730369,2,2.65E+018,"testalpha"
,"receptors andarteriolar walls beta","NNS JJ NNS NN",4,1,1,16874421,2,8.38E+018,"testalpha"
,"ox ldl sandwich elisa","  NN ",4,1,1,17106515,"pubmed1",6.61E+018,"testalpha"
,"blood loss inmale sprague","NN NN NN NN",4,1,1,16762404,2,5.05E+017,"testalpha"
,"male sprague dawley rats","NN NN NNP NNS",4,1,1,16612917,"pubmed1",6.00E+018,"testalpha"
,"patients with fulminant systemicvasculitis","NNS IN JJ NN",4,1,1,16424662,2,9.12E+018,"testalpha"
,"morbid conditions and serum","VB NNS CC NN",4,1,1,17117607,2,5.36E+018,"testalpha"
,"notification versus standard emscare","NN IN JJ NN",4,1,1,16365334,"pubmed1",5.67E+018,"testalpha"
,"accuracy and improve patient","NN CC VB NN",4,1,1,16365325,"pubmed1",9.17E+018,"testalpha"
,"eukaryotic microorganisms in terms","JJ NNS IN NNS",4,1,1,16951740,"pubmed1",3.76E+018,"testalpha"
,"reduced toxicity of genevectors","VBN NN IN NNS",4,1,1,17285739,"pubmed1",7.71E+018,"testalpha"
,"cytokines levels and leukocyte","NNS NNS CC NNP",4,1,1,17293958,2,1.94E+017,"testalpha"
,"surface during sexual reproduction","NN IN JJ NN",4,1,1,16963110,2,7.79E+018,"testalpha"
,"knowledge skills and attitudes","NN NNS CC NNS",4,1,1,16377828,"pubmed1",6.20E+018,"testalpha"
,"granulomas in biopsy material","NNP IN NN NN",4,1,1,16256177,2,3.65E+018,"testalpha"
,"rat muscle regeneration process","NN NN NN NN",4,1,1,16965805,2,9.85E+017,"testalpha"
,"high density lipoproteins hdls","JJ NN NNS ",4,1,1,17106515,"pubmed1",6.39E+018,"testalpha"
,"progressive pain gavethe impression","JJ NN NNP NN",4,1,1,16612927,"pubmed1",8.83E+018,"testalpha"
,"pathogens community acquired vs","NNS NN VBD ",4,1,1,16365328,"pubmed1",8.56E+018,"testalpha"
,"transit mrt heavy capacitystations","NN  JJ NNS",4,1,1,16434013,"pubmed1",4.31E+018,"testalpha"
,"high grade orlarge b","JJ NN JJ NN",4,1,1,16612936,"pubmed1",4.35E+018,"testalpha"
,"ofmacromolecules including proteins lipids","NNS IN NNS NNS",4,1,1,17160142,"pubmed1",8.30E+018,"testalpha"
,"care and medical education","NN CC JJ NN",4,1,1,16377823,"pubmed1",8.84E+018,"testalpha"
,"syndrome mds with deletion","NN  IN NN",4,1,1,17016041,2,6.35E+018,"testalpha"
,"yield oftransgene expressing dc","NN NN VBG ",4,1,1,16404477,"pubmed1",7.39E+018,"testalpha"
,"min ischemia affects disturbances"," NN VBZ NNS",4,1,1,17265693,2,8.70E+018,"testalpha"
,"exercise diet and stroke","NN NN CC NN",4,1,1,16436789,"pubmed1",4.23E+018,"testalpha"
,"apparent rate constant kapp","JJ NN JJ ",4,1,1,17019443,"pubmed1",7.66E+018,"testalpha"
,"use of patient identifiers","NN IN NN NNS",4,1,1,16365326,"pubmed1",8.96E+018,"testalpha"
,"layers are more rigidthan","NNS VBP JJR NNP",4,1,1,16410837,"pubmed1",2.87E+018,"testalpha"
,"utilization of cervical specimens","NN IN JJ NNS",4,1,1,16514835,2,7.68E+018,"testalpha"
,"sports or physical activities","NNS CC JJ NNS",4,1,1,16918069,"pubmed1",6.04E+018,"testalpha"
,"elements shoots leaves trichomes","NNS NNS VBZ NNS",4,1,1,17486414,"pubmed1",7.00E+018,"testalpha"
,"foundation for profit industry","NN IN NN NN",4,1,1,16365335,"pubmed1",4.58E+018,"testalpha"
,"key stages of decision","JJ NNS IN NN",4,1,1,17139882,2,9.13E+018,"testalpha"
,"c c produced inhibition","NN NN VBD NN",4,1,1,16594645,"pubmed1",9.19E+018,"testalpha"
,"rectal pathologies namelyhemorrhoids anal","NN NNS NNS ",4,1,1,17139880,2,8.04E+018,"testalpha"
,"livers of c bl","NNS IN NN ",4,1,1,17119325,2,7.50E+018,"testalpha"
,"catalytic airoxidation of cycloalkanes","JJ NN IN NNS",4,1,1,16411734,"pubmed1",3.27E+017,"testalpha"
,"control group g n","NN NN  ",4,1,1,17293959,2,4.93E+018,"testalpha"
,"nomicrocirculation modification in colon","NN NN IN NN",4,1,1,17438835,2,6.30E+018,"testalpha"
,"doses of n n","NNS IN  ",4,1,1,16424650,2,3.57E+018,"testalpha"
,"degradation in bacteria cleaves","NN IN NNS NNS",4,1,1,16511281,2,5.81E+018,"testalpha"
,"mediated lipid peroxidation cascade","VBN NN NN NN",4,1,1,16764913,2,7.18E+018,"testalpha"
,"effects of osteogenic medium","NNS IN JJ NN",4,1,1,16443258,2,2.00E+017,"testalpha"
,"cc cc indicating frameshift","  VBG NN",4,1,1,16733554,"pubmed1",6.49E+017,"testalpha"
,"co ordinated treatment support"," VBN NN NN",4,1,1,16710575,2,9.82E+017,"testalpha"
,"frequency of catheter thrombosis","NN IN NN NN",4,1,1,16549897,2,7.71E+018,"testalpha"
,"typology and dynamic morphology","NN CC JJ NN",4,1,1,17486414,"pubmed1",7.88E+017,"testalpha"
,"ix and x ppsb"," CC NN ",4,1,1,16916181,"pubmed1",8.28E+018,"testalpha"
,"stress urinary incontinence sui","NN JJ NN ",4,1,1,16962646,2,4.68E+018,"testalpha"
,"probable mirnas have similarity","JJ NNP VBP NN",4,1,1,16770443,"pubmed1",2.54E+017,"testalpha"
,"combine occlusives and humectants","VB NNS CC NNS",4,1,1,16859617,2,4.77E+018,"testalpha"
,"number of sub clusters","NN IN NN NNS",4,1,1,16126153,"pubmed1",3.61E+018,"testalpha"
,"camel tiger and antelope","NN NN CC NNP",4,1,1,16603097,2,6.51E+018,"testalpha"
,"um onsuccinylcholine induced fasciculation"," NN VBN NN",4,1,1,17067136,"pubmed1",5.48E+018,"testalpha"
,"helminths and glutathioneperoxidase selenium","NNS CC NN NN",4,1,1,16410836,"pubmed1",7.51E+018,"testalpha"
,"terminal sh domain ofgads","NN  NN NNS",4,1,1,16511262,2,1.26E+018,"testalpha"
,"least month of therapy","JJS NN IN NN",4,1,1,16809890,2,1.03E+018,"testalpha"
,"diagnosis of possible anca","NN IN JJ ",4,1,1,16648918,2,5.93E+018,"testalpha"
,"small bowel or pancreas","JJ NN CC NNS",4,1,1,16673560,2,6.47E+018,"testalpha"
,"side effect inboth groups","NN NN JJ NNS",4,1,1,16710580,2,2.32E+018,"testalpha"
,"time in laryngeal surgery","NN IN NN NN",4,1,1,16989147,2,7.91E+018,"testalpha"
,"potentiate stress or ischemia","NN NN CC NN",4,1,1,17133953,2,5.89E+018,"testalpha"
,"hypothesized model on risk","VBN NN IN NN",4,1,1,16191426,"pubmed1",4.86E+018,"testalpha"
,"induced exocytosis by way","VBN NN IN NN",4,1,1,16395521,"pubmed1",8.42E+018,"testalpha"
,"progesterone receptors protein inases","NN NNS NN NNS",4,1,1,17265696,2,3.38E+018,"testalpha"
,"antigen in ejaculated spermatozoa","NN IN VBN ",4,1,1,16330085,2,9.21E+018,"testalpha"
,"frames rv and rv","NNS  CC ",4,1,1,16511284,2,4.21E+018,"testalpha"
,"inhousehold interviews in dar","JJ NNS IN ",4,1,1,16112069,"pubmed1",2.91E+018,"testalpha"
,"environment under lowstress conditions","NN IN NN NNS",4,1,1,17133955,2,3.36E+018,"testalpha"
,"conjugated linoleic acid whichis","VBN JJ NN NNP",4,1,1,16511289,2,5.67E+018,"testalpha"
,"methyl d aspartate nmda","  NN ",4,1,1,16451144,"pubmed1",7.09E+018,"testalpha"
,"todevelopment of colorectal cancer","NN IN NN NN",4,1,1,17139886,2,6.23E+018,"testalpha"
,"theantiaggregatory and antisecretory effects","NN CC NN NNS",4,1,1,17068635,"pubmed1",5.72E+017,"testalpha"
,"oxidation of low density","NN IN JJ NN",4,1,1,17128291,"pubmed1",2.88E+018,"testalpha"
,"tests for proceeding tothe","NNS IN VBG NNP",4,1,1,16673561,2,5.99E+018,"testalpha"
,"groups bacteria and radioactivity","NNS NNS CC NN",4,1,1,17293960,2,4.87E+018,"testalpha"
,"vivo fluorescence imaging ofexperimental"," NN VBG NN",4,1,1,16399028,"pubmed1",7.07E+018,"testalpha"
,"diagnoses ofatypical squamous cells","NNS JJ JJ NNS",4,1,1,16514835,2,7.81E+018,"testalpha"
,"l e e regions","   NNS",4,1,1,17019439,"pubmed1",5.49E+018,"testalpha"
,"study explores morphological relationships","NN NNS JJ NNS",4,1,1,16399030,"pubmed1",2.86E+018,"testalpha"
,"est pc encoded carboxylesterase","JJ  VBN NN",4,1,1,16511287,2,4.75E+018,"testalpha"
,"tl vs mmol l","   ",4,1,1,17338197,2,3.95E+018,"testalpha"
,"variables were serum proteins","NNS VBD NN NNS",4,1,1,17293972,2,5.62E+018,"testalpha"
,"map mmhg for minutes","NN  IN NNS",4,1,1,16491220,2,5.03E+017,"testalpha"
,"macroglia like cell phenotypes","NNP IN NN NNS",4,1,1,17265690,2,5.33E+018,"testalpha"
,"progression freesurvival and disease","NN NN CC NN",4,1,1,16424644,2,4.79E+018,"testalpha"
,"survival of hl patients","NN IN  NNS",4,1,1,16914904,2,1.94E+018,"testalpha"
,"apoptosis in b f","NN IN NN NN",4,1,1,17143339,"pubmed1",6.88E+018,"testalpha"
,"inpro and eukaryotic microorganisms"," CC JJ NNS",4,1,1,16951740,"pubmed1",4.61E+018,"testalpha"
,"theseanticipated changes informs constituents","VBN NNS NNS NNS",4,1,1,17285738,"pubmed1",5.25E+018,"testalpha"
,"patients divided byrisk factors","NNS VBN JJ NNS",4,1,1,16451146,"pubmed1",3.79E+018,"testalpha"
,"diagnosis of venous thromboembolism","NN IN JJ NN",4,1,1,16549896,2,4.65E+018,"testalpha"
,"tech bone inducing substance"," NN VBG NN",4,1,1,17293969,2,7.98E+018,"testalpha"
,"howhigh dose meth administration","VB NN  NN",4,1,1,16808044,"pubmed1",5.15E+018,"testalpha"
,"n primers ttv infection"," NNS  NN",4,1,1,16696442,2,5.46E+018,"testalpha"
,"use in quantitativetemporal studies","NN IN JJ NNS",4,1,1,16399032,"pubmed1",8.53E+018,"testalpha"
,"satisfaction ratingsdifferences between groups","NN NNS IN NNS",4,1,1,16436790,"pubmed1",8.31E+018,"testalpha"
,"cells cd intracellular il","NNS  JJ ",4,1,1,17016036,2,7.69E+018,"testalpha"
,"femoral vein and artery","JJ NN CC NN",4,1,1,16762404,2,8.23E+018,"testalpha"
,"infections present on bothpreparations","NNS NN IN NNS",4,1,1,16514841,2,8.13E+018,"testalpha"
,"tomisregistration between image sets","NN IN NN NNS",4,1,1,16399029,"pubmed1",9.15E+018,"testalpha"
,"part of diagnostic approach","NN IN JJ NN",4,1,1,16859611,2,2.58E+018,"testalpha"
,"solution and physiological saline","NN CC JJ NN",4,1,1,16762404,2,5.37E+018,"testalpha"
,"purchasing based onsafety considerations","VBG VBN NN NNS",4,1,1,16111641,"pubmed1",1.40E+018,"testalpha"
,"marked difference between cd","VBN NN IN ",4,1,1,16713618,2,2.49E+018,"testalpha"
,"results of ruby laser","NNS IN  NN",4,1,1,16710582,2,8.46E+018,"testalpha"
,"presence of bilateral phocomelia","NN IN JJ NNP",4,1,1,16874423,2,4.61E+017,"testalpha"
,"observed effects on thyrotrope","VBN NNS IN NNP",4,1,1,16714054,2,2.11E+018,"testalpha"
,"nuclei and cell balls"," CC NN NNS",4,1,1,16514838,2,3.66E+018,"testalpha"
,"microbial management in atopic","JJ NN IN NN",4,1,1,16648910,2,4.28E+018,"testalpha"
,"survey of arizona motorists","NN IN NNP NNS",4,1,1,16434012,"pubmed1",2.75E+018,"testalpha"
,"cd cd cd dr","   ",4,1,1,17119322,2,2.22E+018,"testalpha"
,"higher level of ua","JJR NN IN ",4,1,1,17338197,2,4.96E+018,"testalpha"
,"phosphorylatedby adenosine kinase ak","JJ NN NN ",4,1,1,16421444,2,9.50E+017,"testalpha"
,"development of vacuolization surface","NN IN NN NN",4,1,1,16956122,2,6.62E+018,"testalpha"
,"extent of pulpal inflammation","NN IN JJ NN",4,1,1,16919707,2,5.42E+018,"testalpha"
,"years standard deviation sd","NNS JJ NN ",4,1,1,16451151,"pubmed1",3.97E+018,"testalpha"
,"elected members of expert","VBN NNS IN NN",4,1,1,17285738,"pubmed1",4.62E+018,"testalpha"
,"aa and healthy subjects"," CC JJ NNS",4,1,1,17010262,2,1.34E+018,"testalpha"
,"hg in thepreperitoneal space"," IN NN NN",4,1,1,16491219,2,7.53E+018,"testalpha"
,"expansion of malignanthematopoietic progenitors","NN IN JJ NNS",4,1,1,17016041,2,3.50E+018,"testalpha"
,"mitochondrial membrane potential mmp","JJ NN NN ",4,1,1,17013508,2,8.50E+018,"testalpha"
,"bb ligand and bb"," NN CC ",4,1,1,16511253,2,2.28E+018,"testalpha"
,"prevalence ofanemia among ibd","NN NN IN ",4,1,1,16673554,2,8.43E+018,"testalpha"
,"kg induced transient expiratory"," VBN NN NN",4,1,1,17133957,2,7.76E+018,"testalpha"
,"impairment child pugh classification","NN NN  NN",4,1,1,16584121,"pubmed1",8.92E+018,"testalpha"
,"echo images standard deviation"," NNS JJ NN",4,1,1,16317488,"pubmed1",6.87E+018,"testalpha"
,"samples were assayed byenzyme","NNS VBD VBN ",4,1,1,16549888,2,1.36E+017,"testalpha"
,"fromgroups hp and laser","NNS  CC NN",4,1,1,17013509,2,4.75E+018,"testalpha"
,"toluidine blue azure ii","NN JJ JJ ",4,1,1,16574202,2,5.86E+018,"testalpha"
,"wear properties ofbiomolecules e","VB NNS NNS ",4,1,1,16701857,"pubmed1",6.49E+018,"testalpha"
,"protein shows high identity","NN NNS JJ NN",4,1,1,17063209,"pubmed1",1.75E+018,"testalpha"
,"urticaria and healthy individuals","NNP CC JJ NNS",4,1,1,16859611,2,4.33E+018,"testalpha"
,"cd p expression p","  NN ",4,1,1,16809885,2,4.63E+018,"testalpha"
,"nausea vomiting epigastric pain","NNP VBG JJ NN",4,1,1,16424650,2,7.04E+018,"testalpha"
,"cm and g n"," CC  ",4,1,1,17293959,2,3.38E+018,"testalpha"
,"mechanism penetrating injury vitalsigns","NN JJ NN NNS",4,1,1,16365326,"pubmed1",2.31E+018,"testalpha"
,"hypointensity ont weighted image","NN  JJ NN",4,1,1,16314989,"pubmed1",6.97E+018,"testalpha"
,"kidney transplant patients characterizedas","NN JJ NNS NNP",4,1,1,17119329,2,2.39E+018,"testalpha"
,"drain intothe inferior vena","VB NNP JJ ",4,1,1,16447097,"pubmed1",8.04E+018,"testalpha"
,"andpatient support group activities","NN NN NN NNS",4,1,1,17106594,2,5.82E+018,"testalpha"
,"pathway reactions lacking alcohol","NN NNS VBG NN",4,1,1,17019438,"pubmed1",4.84E+018,"testalpha"
,"cytokines and oxidative stress","NNS CC JJ NN",4,1,1,16479030,2,7.09E+017,"testalpha"
,"accreditation council on graduate","NN NN IN NN",4,1,1,16377824,"pubmed1",3.96E+017,"testalpha"
,"beta betaa andbetab subunits","NN   NNS",4,1,1,16423381,2,3.78E+017,"testalpha"
,"quantities epworth sleepiness scale","NNS JJ NN NN",4,1,1,16377826,"pubmed1",8.29E+018,"testalpha"
,"ofmolecular causes of reperfusion","JJ NNS IN NN",4,1,1,17338197,2,3.12E+018,"testalpha"
,"persons inthe control group","NNS NNP NN NN",4,1,1,16874419,2,1.33E+018,"testalpha"
,"peduncle post operative precautions","NN NN JJ NNS",4,1,1,16722345,2,8.56E+018,"testalpha"
,"pathophysiology behind stress inducedhyperglycemia","NN IN NN NN",4,1,1,16462409,"pubmed1",3.52E+018,"testalpha"
,"fentanyl n or propofol","NN  CC ",4,1,1,16451145,"pubmed1",5.61E+018,"testalpha"
,"toclinical relevant food allergens","JJ JJ NN NNS",4,1,1,16673562,2,6.31E+017,"testalpha"
,"length of stay tlos","NN IN NN ",4,1,1,16436790,"pubmed1",2.28E+018,"testalpha"
,"autochthonous microflora of soil","JJ NNP IN NN",4,1,1,17019438,"pubmed1",4.07E+017,"testalpha"
,"intrinsic gibbs freeenergy deltago","NN NNS NN NNP",4,1,1,17019442,"pubmed1",4.46E+018,"testalpha"
,"undergo surgery and decisions","VB NN CC NNS",4,1,1,17236644,"pubmed1",2.92E+018,"testalpha"
,"specific anatomy and function","JJ NN CC NN",4,1,1,16399039,"pubmed1",3.93E+018,"testalpha"
,"features and responded wellto","NNS CC VBD ",4,1,1,17106596,2,1.83E+018,"testalpha"
,"action ofbone morphogenetic protein","NN NN JJ NN",4,1,1,17293969,2,4.45E+018,"testalpha"
,"considerable suppression of tumorgrowth","JJ NN IN NN",4,1,1,16733559,"pubmed1",1.23E+018,"testalpha"
,"respondents perceived driver recklessness","NNS VBN NN NN",4,1,1,16112069,"pubmed1",8.62E+018,"testalpha"
,"ofcolloidal silicon dioxide magnesium","NN NN NN NN",4,1,1,17285749,"pubmed1",4.39E+018,"testalpha"
,"usefulness ofselected eosinophil proteins","NN VBN  NNS",4,1,1,16859611,2,5.44E+017,"testalpha"
,"pollen germination on thestigma","NN NN IN NN",4,1,1,16963110,2,4.29E+018,"testalpha"
,"fluid corrected l amb","NN VBN  ",4,1,1,16918060,"pubmed1",7.58E+018,"testalpha"
,"group nonehad full remission","NN  JJ NN",4,1,1,16955187,2,8.84E+015,"testalpha"
,"cpk levels but thiseffect"," NNS CC NN",4,1,1,17338197,2,4.02E+018,"testalpha"
,"median barrier offset distance","JJ NN VB NN",4,1,1,16442487,"pubmed1",4.72E+018,"testalpha"
,"disease is characterized byappearance","NN VBZ VBN NN",4,1,1,16956113,2,6.75E+018,"testalpha"
,"appearing beforespecific ebv serology","VBG NNP  NN",4,1,1,16955191,2,5.84E+018,"testalpha"
,"liver injury in stz","NN NN IN ",4,1,1,16714049,2,5.63E+018,"testalpha"
,"ii complexes of ac"," NNS IN ",4,1,1,17117212,"pubmed1",2.07E+018,"testalpha"
,"patients with severe sepsis","NNS IN JJ NN",4,1,1,16365336,"pubmed1",2.40E+018,"testalpha"
,"remaining patients showed abnormalities","VBG NNS VBD NNS",4,1,1,16447095,"pubmed1",7.70E+018,"testalpha"
,"group combination ofbupicavaine sufentanil","NN NN NN ",4,1,1,17236639,"pubmed1",1.55E+018,"testalpha"
,"day in wild type","NN IN JJ NN",4,1,1,16325892,2,5.02E+018,"testalpha"
,"t animals with gastroenteritis"," NNS IN NN",4,1,1,17293961,2,7.19E+018,"testalpha"
,"enzyme levels in platelet"," NNS IN NN",4,1,1,16523217,"pubmed1",3.13E+017,"testalpha"
,"diagnostic and treatment dilemmas","NN CC NN NNS",4,1,1,16462411,"pubmed1",1.72E+018,"testalpha"
,"local treatments for liver","JJ NNS IN NN",4,1,1,17139885,2,1.39E+018,"testalpha"
,"low density lipoproteins ldls","JJ NN NNS ",4,1,1,17106515,"pubmed1",4.85E+017,"testalpha"
,"international classification of diseases","JJ NN IN NNS",4,1,1,16365331,"pubmed1",6.20E+018,"testalpha"
,"tosynthesis of nd mrnas","NN IN  NNP",4,1,1,16389406,"pubmed1",7.37E+018,"testalpha"
,"free radical scavenger effects","JJ JJ NN NNS",4,1,1,16999986,2,4.17E+018,"testalpha"
,"heart of wistar rats","NN IN NN NNS",4,1,1,17046052,2,2.64E+018,"testalpha"
,"study including consecutivepregnant women","NN IN JJ NNS",4,1,1,17119327,2,4.07E+018,"testalpha"
,"foradverse pregnancy outcomes developmental","NN NN NNS NN",4,1,1,16808045,"pubmed1",5.46E+018,"testalpha"
,"fca of colon rats"," IN NN NNS",4,1,1,17293962,2,7.77E+018,"testalpha"
,"relationship between nutritional status","NN IN JJ NN",4,1,1,16918067,"pubmed1",7.60E+018,"testalpha"
,"different classes of proteins","JJ NNS IN NNS",4,1,1,16764914,2,8.10E+018,"testalpha"
,"excimer light clearedpalmoplantar psoriasis","NN JJ NN NN",4,1,1,16585984,2,2.79E+018,"testalpha"
,"augmented response on areas","VBD NN IN NNS",4,1,1,16585981,2,5.32E+018,"testalpha"
,"calls or home visits","NNS CC NN NNS",4,1,1,16696444,2,7.91E+018,"testalpha"
,"leukemia virus protease htlv","NN NN NN ",4,1,1,16421452,2,4.76E+018,"testalpha"
,"associatedwith mediastinal germ cell","NN JJ NN NN",4,1,1,16809892,2,3.21E+018,"testalpha"
,"cryptepithelial cells in rats","JJ NNS IN NNS",4,1,1,16491217,2,1.38E+018,"testalpha"
,"work hours support staff","VBP NNS NN NN",4,1,1,16436795,"pubmed1",1.71E+018,"testalpha"
,"trend and space time","NN CC NN NN",4,1,1,16451795,"pubmed1",4.26E+018,"testalpha"
,"records was undertaken toestimate","NNS VBD VBN NN",4,1,1,16221468,"pubmed1",2.54E+018,"testalpha"
,"streptococcus thermophiluse lactobacillus helveticus","NN IN NN NN",4,1,1,17293972,2,3.72E+018,"testalpha"
,"year recallfor hospitalization disability","NN JJ NN NN",4,1,1,16412373,"pubmed1",9.76E+017,"testalpha"
,"h i e followingthe","   NNP",4,1,1,16733561,"pubmed1",7.88E+018,"testalpha"
,"review and staff feedback","NN CC NN NN",4,1,1,16321534,"pubmed1",7.64E+018,"testalpha"
,"reported funding of reports","VBN NN IN NNS",4,1,1,16365335,"pubmed1",5.42E+018,"testalpha"
,"inthe peer reviewed literature","NNP NN VBD NN",4,1,1,16596897,"pubmed1",5.55E+018,"testalpha"
,"exonuclease enzyme solutions plasma","NN  NNS NNP",4,1,1,17285740,"pubmed1",2.79E+018,"testalpha"
,"ige and t cell"," CC  NN",4,1,1,16511273,2,6.18E+018,"testalpha"
,"response in granulomatous sarcoidosis","NN IN JJ NN",4,1,1,16256177,2,7.73E+018,"testalpha"
,"national virtual irb review","JJ JJ  NN",4,1,1,16770858,"pubmed1",4.80E+018,"testalpha"
,"andbalance tests functional mri","NN NNS JJ ",4,1,1,16436787,"pubmed1",6.16E+018,"testalpha"
,"artificial salivacontaining f h","JJ VBG NN ",4,1,1,16701867,"pubmed1",5.80E+018,"testalpha"
,"mean totalclearance of bupivacaine","VB NN IN NN",4,1,1,17067137,"pubmed1",7.49E+018,"testalpha"
,"development of alyophilization cycle","NN IN NN NN",4,1,1,17285745,"pubmed1",1.39E+018,"testalpha"
,"retrospectiveanalysis of patient records","NN IN NN NNS",4,1,1,16424646,2,4.83E+017,"testalpha"
,"micro andglutamine scfa p","NNP NN  ",4,1,1,17293957,2,5.37E+018,"testalpha"
,"theestablishment of threshold values","NN IN NN NNS",4,1,1,16424657,2,5.12E+018,"testalpha"
,"pi interactions in addition"," NNS IN NN",4,1,1,16397328,2,4.25E+018,"testalpha"
,"residues of threeoxytocin analogs","NNS IN NNP NNS",4,1,1,16523218,"pubmed1",7.73E+018,"testalpha"
,"department ofdermatology aarhus university","NN NN  NN",4,1,1,16710581,2,7.09E+018,"testalpha"
,"stronger inhibiting activitytowards lada","JJR VBG NNS ",4,1,1,16929383,"pubmed1",5.89E+017,"testalpha"
,"layers are thin forl","NNS VBP JJ ",4,1,1,16397334,2,6.12E+018,"testalpha"
,"addition threesignificant amino acid","NN JJ NNP NN",4,1,1,16421453,2,8.10E+018,"testalpha"
,"ofdrivers of different ages","NNS IN JJ NNS",4,1,1,16426560,"pubmed1",8.76E+018,"testalpha"
,"complications oftumor lysis syndrome","NNS NN NN NN",4,1,1,16424647,2,3.40E+018,"testalpha"
,"soft sternum in patients","JJ NN IN NNS",4,1,1,16956118,2,7.70E+018,"testalpha"
,"inthis study enzymatic digestions","NNP NN JJ NNS",4,1,1,16764914,2,4.56E+017,"testalpha"
,"sodium coordination bymain chain","NN NN VB NN",4,1,1,17143335,"pubmed1",8.30E+018,"testalpha"
,"moderate dose of hes","JJ NN IN ",4,1,1,16451158,"pubmed1",5.42E+018,"testalpha"
,"male patients than females","JJ NNS IN NNS",4,1,1,16479024,2,3.25E+018,"testalpha"
,"severity ofnail changes p","NN NN NNS ",4,1,1,16955188,2,2.14E+018,"testalpha"
,"workforce and cultural competence","NN CC JJ NN",4,1,1,16473988,"pubmed1",2.66E+018,"testalpha"
,"responded wellto long term","VBD  JJ NN",4,1,1,17106596,2,7.85E+018,"testalpha"
,"following cortical culture transfection","VBG JJ NN NN",4,1,1,17265688,2,5.70E+018,"testalpha"
,"manner nic evoked rb","NN JJ VBD ",4,1,1,16594645,"pubmed1",2.85E+018,"testalpha"
,"facial shape experienced bypatients","JJ NN VBD NNS",4,1,1,16722348,2,5.08E+018,"testalpha"
,"median period of years","JJ NN IN NNS",4,1,1,16914906,2,6.52E+018,"testalpha"
,"enos induciblenitric oxide synthase"," JJ VB NN",4,1,1,16762404,2,4.61E+018,"testalpha"
,"w azs total ige","  NN ",4,1,1,16603096,2,4.95E+018,"testalpha"
,"lethal cytomegalovirus pneumonitis whichwas","JJ NN NN ",4,1,1,16918065,"pubmed1",1.21E+018,"testalpha"
,"beta thalassemia major andintermedia","NN NN NN NNP",4,1,1,16809886,2,3.33E+018,"testalpha"
,"itp children phorbolmyristate acetate"," NNS NN NN",4,1,1,17016035,2,6.53E+018,"testalpha"
,"procedures against virus diseases","NNS IN NN NNS",4,1,1,16395523,"pubmed1",2.98E+018,"testalpha"
,"method while hdl cholesterol","NN IN  NN",4,1,1,16479026,2,2.55E+018,"testalpha"
,"nf kappab responsive genes","  JJ NNS",4,1,1,17068636,"pubmed1",1.42E+018,"testalpha"
,"color intensity based segmentation","NN NN VBN NN",4,1,1,16399038,"pubmed1",8.12E+018,"testalpha"
,"consensus guidelines recommending thisintervention","NN NNS VBG NN",4,1,1,16365334,"pubmed1",8.97E+018,"testalpha"
,"multifocal cases of skeletal","JJ NNS IN NN",4,1,1,16612935,"pubmed1",8.13E+018,"testalpha"
,"working time initialsetting time","VBG NN VBG NN",4,1,1,16701865,"pubmed1",2.17E+018,"testalpha"
,"injury collisions involving vehicles","NN NNS VBG NNS",4,1,1,16169506,"pubmed1",1.44E+017,"testalpha"
,"contrast enhancementindex of hccs","NN NN IN ",4,1,1,16317488,"pubmed1",4.38E+018,"testalpha"
,"corneum withimproved skin hydration","NN VBN NN NN",4,1,1,17285742,"pubmed1",9.16E+018,"testalpha"
,"school injuries in china","NN NNS IN NN",4,1,1,16236234,"pubmed1",5.77E+018,"testalpha"
,"adults mean age years","NNS VBP NN NNS",4,1,1,16648916,2,6.25E+016,"testalpha"
,"title compound di mu","NN NN  ",4,1,1,16456276,2,8.75E+018,"testalpha"
,"yielded activation energy e","VBD NN NN ",4,1,1,17117212,"pubmed1",8.92E+018,"testalpha"
,"use of impaired forelimb","NN IN VBN NN",4,1,1,17265691,2,2.48E+018,"testalpha"
,"quantum classical dynamical methods","NN JJ JJ NNS",4,1,1,16411736,"pubmed1",5.08E+018,"testalpha"
,"vehicles from roadside hazards","NNS IN NN NNS",4,1,1,16054101,"pubmed1",4.87E+018,"testalpha"
,"provides excellent images ofrectal","VBZ JJ NNS NN",4,1,1,17139898,2,7.97E+018,"testalpha"
,"activities ofgsh dependent enzymes","NNS  JJ NNS",4,1,1,16404476,"pubmed1",5.43E+018,"testalpha"
,"low ph buffer crystals","JJ  NN NNS",4,1,1,16511255,2,4.24E+018,"testalpha"
,"oxy derivatives anthraquinone anthracenemethanol"," NNS NN NN",4,1,1,16404478,"pubmed1",8.74E+018,"testalpha"
,"low symmetry moderate diffraction","JJ NN JJ NN",4,1,1,16369100,2,1.44E+018,"testalpha"
,"perfusion v q mismatch","NN   NN",4,1,1,16451153,"pubmed1",8.67E+018,"testalpha"
,"lesions and healthycontrol skin","NNS CC NN NN",4,1,1,17034836,2,4.33E+018,"testalpha"
,"lymph node and intestine","NN  CC NN",4,1,1,16730369,2,4.11E+017,"testalpha"
,"groups glutamine micro andglutamine","NNS NN NNP NN",4,1,1,17293957,2,2.08E+018,"testalpha"
,"ldland parameters of lipid","NN NNS IN NN",4,1,1,17106515,"pubmed1",5.42E+018,"testalpha"
,"cold water at degrees","JJ NN IN NNS",4,1,1,17236636,"pubmed1",5.60E+018,"testalpha"
,"accreditation requirements on gme","NN NNS IN ",4,1,1,16377812,"pubmed1",6.72E+018,"testalpha"
,"sulfasalazine and systemic antibiotics","NN CC JJ NNS",4,1,1,16603100,2,4.86E+018,"testalpha"
,"border drinking consequences data","NN NN NNS NNS",4,1,1,16169506,"pubmed1",5.97E+018,"testalpha"
,"inflammation and protected lung","NN CC VBN NN",4,1,1,16537087,2,2.34E+018,"testalpha"
,"bridge constrained peptide library","NN VBN VB NN",4,1,1,17019437,"pubmed1",7.01E+018,"testalpha"
,"incidence and prevalence estimates","NN CC NN NNS",4,1,1,16365331,"pubmed1",5.03E+018,"testalpha"
,"assumption special true test","NN JJ JJ NN",4,1,1,16874422,2,3.65E+018,"testalpha"
,"concentration of propofol propce","NN IN  ",4,1,1,17067138,"pubmed1",3.06E+018,"testalpha"
,"survival rate in conjunction","NN NN IN NN",4,1,1,16479034,2,5.27E+018,"testalpha"
,"normal saline ns d","JJ NN  ",4,1,1,16436788,"pubmed1",1.09E+018,"testalpha"
,"patientswith serious head injury","NN JJ NN NN",4,1,1,16223468,"pubmed1",4.50E+017,"testalpha"
,"meningitis and discuss treatment","NN CC VB NN",4,1,1,17370568,"pubmed1",1.95E+018,"testalpha"
,"self reported high ratings","NN VBN JJ NNS",4,1,1,16443186,"pubmed1",3.31E+017,"testalpha"
,"size of fluorescence areas","NN IN NN NNS",4,1,1,16955184,2,3.26E+018,"testalpha"
,"address anatomic andfunctional requirements","NN JJ JJ NNS",4,1,1,17165595,2,8.62E+018,"testalpha"
,"results of year experience","NNS IN NN NN",4,1,1,16956118,2,2.06E+018,"testalpha"
,"non cross reactive foodallergens"," NN JJ NNS",4,1,1,16673562,2,7.38E+017,"testalpha"
,"considering nsaids and antacids","VBG NNS CC NNS",4,1,1,17318328,"pubmed1",3.62E+018,"testalpha"
,"neo adjuvant radio chemotherapy"," JJ NN NN",4,1,1,16612911,2,7.30E+017,"testalpha"
,"agood prognosis in aml","NN NN IN ",4,1,1,16914901,2,6.91E+018,"testalpha"
,"vaccine for clinical use","NN IN JJ NN",4,1,1,17010274,2,1.02E+018,"testalpha"
,"approach tothe spastic hip","NN NNP JJ NN",4,1,1,17438833,2,2.66E+018,"testalpha"
,"actuarial overall survival progression","JJ JJ NN NN",4,1,1,16424644,2,1.40E+018,"testalpha"
,"immediate oral allergy syndromes","JJ JJ NN NNS",4,1,1,16673562,2,3.72E+018,"testalpha"
,"beneoplastic infectious bone pathologies","JJ JJ NN NNS",4,1,1,17010270,2,7.54E+018,"testalpha"
,"time profile of bupivacaine","NN NN IN NN",4,1,1,17067137,"pubmed1",6.98E+018,"testalpha"
,"experienced skin graft loss","VBN NN NN NN",4,1,1,17165594,2,6.84E+018,"testalpha"
,"pap smears from women"," NNS IN NNS",4,1,1,16514841,2,1.35E+018,"testalpha"
,"claims per employees claims","NNS IN NNS NNS",4,1,1,16430845,"pubmed1",7.43E+018,"testalpha"
,"hips osseous reconstructive surgery"," JJ JJ NN",4,1,1,17438833,2,3.61E+018,"testalpha"
,"range years and patients","NN NNS CC NNS",4,1,1,16809886,2,2.22E+018,"testalpha"
,"arginine groups of h","NN NNS IN ",4,1,1,17019436,"pubmed1",4.39E+018,"testalpha"
,"c reactive protein crp","NN JJ NN ",4,1,1,17119323,2,1.51E+018,"testalpha"
,"shock and anapache ii","NN CC NNP ",4,1,1,16365336,"pubmed1",4.19E+018,"testalpha"
,"transcatheter occlusion appears tobe","NN NN VBZ ",4,1,1,16612922,"pubmed1",2.40E+018,"testalpha"
,"active center of nqo","JJ NN IN ",4,1,1,16929382,"pubmed1",8.74E+018,"testalpha"
,"foraaaf induced lesions tfam"," VBN NNS ",4,1,1,17143337,"pubmed1",4.61E+018,"testalpha"
,"cascade during apoptosis apoptosis","NN IN NN NN",4,1,1,17034836,2,4.72E+018,"testalpha"
,"direct contact with meat","JJ NN IN NN",4,1,1,16859614,2,1.95E+017,"testalpha"
,"presenting features diagnostic difficulties","VBG NNS JJ NNS",4,1,1,16424653,2,8.52E+018,"testalpha"
,"level of pfkfb proteinexpression","NN IN  NN",4,1,1,17143338,"pubmed1",5.25E+018,"testalpha"
,"theregulation of epidermal differentiation","NN IN JJ NN",4,1,1,16648912,2,7.35E+018,"testalpha"
,"ultrastructural morphometry and immunohistochemistry","JJ NN CC NN",4,1,1,16253314,2,1.89E+018,"testalpha"
,"l serine and l"," NN CC ",4,1,1,16397334,2,5.97E+018,"testalpha"
,"muscular calf pump withdeterioration","JJ NN NN NN",4,1,1,17293973,2,1.02E+018,"testalpha"
,"years old theoldest years","NNS JJ NN NNS",4,1,1,17294910,2,6.23E+018,"testalpha"
,"decreasedwith increasing oxalic acid","NN VBG JJ NN",4,1,1,16701865,"pubmed1",2.44E+018,"testalpha"
,"work related traffic crash","NN VBN NN NN",4,1,1,16043107,"pubmed1",7.11E+018,"testalpha"
,"support of granulocyte colony","NN IN NNP NN",4,1,1,16424645,2,4.95E+018,"testalpha"
,"basic understanding of nf","JJ NN IN ",4,1,1,17068636,"pubmed1",8.81E+018,"testalpha"
,"risk of sensitization increases","NN IN NN NNS",4,1,1,17010265,2,3.93E+018,"testalpha"
,"ga minv egfp packaging","   NN",4,1,1,17160143,"pubmed1",2.62E+018,"testalpha"
,"etiology evidence based treatment","NN NN VBN NN",4,1,1,16462410,"pubmed1",9.22E+018,"testalpha"
,"restore normal blood pressure","VB JJ NN NN",4,1,1,16365323,"pubmed1",4.03E+018,"testalpha"
,"effect of resorbable polycaprolactone","NN IN JJ NN",4,1,1,16701863,"pubmed1",7.98E+018,"testalpha"
,"elderly peoplewith multiple co","JJ NN JJ ",4,1,1,16613748,2,2.29E+017,"testalpha"
,"impulsivity with risky behaviors","NN IN JJ NNS",4,1,1,16426559,"pubmed1",8.38E+018,"testalpha"
,"cell tumor of tendon","NN NN IN NNP",4,1,1,16514850,2,5.05E+018,"testalpha"
,"discussions about centralized review","NNS IN VBN NN",4,1,1,16770859,"pubmed1",7.52E+018,"testalpha"
,"coronarysyndrome and myocardial infarction","NN CC JJ NN",4,1,1,16436792,"pubmed1",3.87E+018,"testalpha"
,"reports previous sexual contact","NNS JJ JJ NN",4,1,1,16955191,2,5.20E+017,"testalpha"
,"metabolism throughthe glycolitic pathway","NN NNP JJ NN",4,1,1,17013507,2,4.84E+018,"testalpha"
,"maternal factors placental function","JJ NNS NN NN",4,1,1,16809888,2,2.07E+018,"testalpha"
,"improvement in patients withpsoriasis","NN IN NNS NN",4,1,1,17311738,2,7.91E+018,"testalpha"
,"lip cl cleft lip","NN  NN NN",4,1,1,17165598,2,5.60E+018,"testalpha"
,"pretreated patients and non","VBN NNS CC ",4,1,1,17338197,2,8.50E+018,"testalpha"
,"infusions joint health outcomes","NNS JJ NN NNS",4,1,1,16549891,2,6.41E+018,"testalpha"
,"changes in medical care","NNS IN JJ NN",4,1,1,16999271,2,6.20E+018,"testalpha"
,"electron beam tomography ebt","NN NN NN ",4,1,1,16399037,"pubmed1",2.95E+018,"testalpha"
,"cases and others loss","NNS CC NNS NN",4,1,1,16434013,"pubmed1",1.76E+018,"testalpha"
,"sarcomas diagnostic procedures andtreatment","NNP JJ NNS NN",4,1,1,17338203,2,4.29E+018,"testalpha"
,"lymphoblastic leukemia withhigh grade","JJ NN VB NN",4,1,1,16424647,2,7.70E+018,"testalpha"
,"calcium phosphate cement system","NN NN NN NN",4,1,1,16701863,"pubmed1",5.35E+018,"testalpha"
,"effect of local reorganization","NN IN JJ NN",4,1,1,16770442,"pubmed1",2.45E+018,"testalpha"
,"comet assay and thetotal","VB NN CC NN",4,1,1,16582984,"pubmed1",3.16E+018,"testalpha"
,"t cells from death"," NNS IN NN",4,1,1,16511253,2,2.28E+018,"testalpha"
,"lawrence berkeley national laboratory","NN NNP JJ NN",4,1,1,16511256,2,7.35E+018,"testalpha"
,"neoplastic tissue and consequent","JJ NN CC NN",4,1,1,16603102,2,5.88E+018,"testalpha"
,"reports blsu alsu pre","NNS   ",4,1,1,16491215,2,2.14E+018,"testalpha"
,"hela hep cell line","  NN NN",4,1,1,17117608,2,8.55E+018,"testalpha"
,"genes in theparamecium genome","NNS IN NN NN",4,1,1,16365637,"pubmed1",6.85E+017,"testalpha"
,"experience withpulse intravenous methylprednisolone","NN JJ JJ NN",4,1,1,16955189,2,3.44E+018,"testalpha"
,"level forthe nullity hypothesis","NN NNP NN NN",4,1,1,17293969,2,4.51E+018,"testalpha"
,"reported frequency of catheter","VBN NN IN NN",4,1,1,16549897,2,4.82E+018,"testalpha"
,"determining dry layer resistance","VBG JJ NN NN",4,1,1,17285744,"pubmed1",4.52E+018,"testalpha"
,"hypotension and neonatal outcome","NN CC JJ NN",4,1,1,16617756,"pubmed1",3.06E+017,"testalpha"
,"position crash type andenvironmental","NN NN NN NN",4,1,1,16197912,"pubmed1",7.38E+018,"testalpha"
,"magnesium mg x kg","NN  NN ",4,1,1,17067136,"pubmed1",3.33E+018,"testalpha"
,"thyroid glands adenomas andgoiters","NN NNS NNP NNS",4,1,1,16720036,2,5.67E+018,"testalpha"
,"costs ofa tiva regimen","NNS   NN",4,1,1,16451145,"pubmed1",1.28E+018,"testalpha"
,"short term colon carcinogenesis","JJ NN NN NN",4,1,1,17293967,2,9.15E+018,"testalpha"
,"oralazathioprine aza for years","NN  IN NNS",4,1,1,17016041,2,6.37E+018,"testalpha"
,"images of anatomic structures","NNS IN JJ NNS",4,1,1,17139898,2,6.51E+018,"testalpha"
,"perhyp during hours ofhospitalization"," IN NNS NN",4,1,1,16436794,"pubmed1",5.89E+018,"testalpha"
,"endogenous inhibitor of angiogenesis","JJ NN IN NN",4,1,1,16388313,"pubmed1",7.82E+018,"testalpha"
,"lymph node and liver","NN  CC NN",4,1,1,16430945,2,7.68E+018,"testalpha"
,"beta d glucan causes","NN  JJ NNS",4,1,1,16612917,"pubmed1",6.14E+018,"testalpha"
,"fasciculation and subsequent tracheal","NN CC JJ NN",4,1,1,17067136,"pubmed1",1.12E+018,"testalpha"
,"gradual decrease in plasma","JJ NN IN NNP",4,1,1,17160142,"pubmed1",7.61E+018,"testalpha"
,"generalized estimating equation models","VBN VBG NN NNS",4,1,1,16126153,"pubmed1",7.66E+018,"testalpha"
,"recurrence rate in patients","NN NN IN NNS",4,1,1,17139900,2,3.41E+018,"testalpha"
,"symptoms suggestive ofmyocardial ischemia","NNS JJ JJ NN",4,1,1,16365321,"pubmed1",2.85E+017,"testalpha"
,"fromangiotensin converting enzyme ace","NNP VBG  NN",4,1,1,16451161,"pubmed1",5.54E+018,"testalpha"
,"twononspecific nir carbocyanine dyes","NNP  NN ",4,1,1,16399028,"pubmed1",5.35E+018,"testalpha"
,"effects in decreasing anxiety","NNS IN VBG NN",4,1,1,16365322,"pubmed1",8.92E+018,"testalpha"
,"aphysician directed ambulance destination","JJ VBN NN NN",4,1,1,16365324,"pubmed1",4.86E+018,"testalpha"
,"chapter chromatography into smallerchapters","NN NN IN NNS",4,1,1,17285738,"pubmed1",4.39E+018,"testalpha"
,"using rho coefficient method","VBG  NN NN",4,1,1,16733558,"pubmed1",6.11E+018,"testalpha"
,"test ischemia in comparison","NN NN IN NN",4,1,1,17265693,2,1.42E+018,"testalpha"
,"secondary phase of management","JJ NN IN NN",4,1,1,17067134,"pubmed1",8.22E+018,"testalpha"
,"platelets in livercirrhotic patients","NNS IN JJ NNS",4,1,1,16523217,"pubmed1",4.90E+018,"testalpha"
,"short fragments of protein","JJ NNS IN NN",4,1,1,16365636,"pubmed1",1.25E+018,"testalpha"
,"definition of new dimensionlessparameters","NN IN JJ NNS",4,1,1,16770446,"pubmed1",6.96E+018,"testalpha"
,"dle n pseudopelade brocq","  NN ",4,1,1,17311739,2,5.88E+018,"testalpha"
,"mg and matched placebo"," CC VBN ",4,1,1,16874418,2,3.88E+018,"testalpha"
,"matrix for nanoparticulategene delivery","NNP IN NN NN",4,1,1,17285741,"pubmed1",3.26E+018,"testalpha"
,"colon cancer cell line","NN NN NN NN",4,1,1,16414103,2,6.61E+018,"testalpha"
,"c gal o glc","NN   ",4,1,1,16456293,2,8.07E+018,"testalpha"
,"use against serious headinjuries","NN IN JJ NNS",4,1,1,16223468,"pubmed1",7.44E+018,"testalpha"
,"aids and illegal substances","NNS CC JJ NNS",4,1,1,16918070,"pubmed1",8.08E+017,"testalpha"
,"dengue andwest nile viruses","NN NN  NNS",4,1,1,16511290,2,3.40E+018,"testalpha"
,"using flinders technology associates","VBG NNS NN NNS",4,1,1,16951742,"pubmed1",9.64E+017,"testalpha"
,"general symptoms are usuallypresent","JJ NNS VBP NN",4,1,1,16612936,"pubmed1",4.37E+018,"testalpha"
,"hpl hpl and hpl","  CC ",4,1,1,17013509,2,6.81E+018,"testalpha"
,"opioid related side effects","VB VBN NN NNS",4,1,1,16451144,"pubmed1",6.26E+018,"testalpha"
,"consisted ofresults from september","VBD NNS IN NN",4,1,1,16436791,"pubmed1",8.16E+018,"testalpha"
,"mm without renal failure"," IN JJ NN",4,1,1,17119326,2,4.24E+018,"testalpha"
,"ncbi protein database access"," NN NN NN",4,1,1,16505899,"pubmed1",7.27E+018,"testalpha"
,"h oglc and o","  CC ",4,1,1,16456293,2,6.96E+018,"testalpha"
,"gc at transitions andgc"," IN NNS ",4,1,1,16733554,"pubmed1",2.30E+018,"testalpha"
,"novel extracellular protein proteininteractions","NN JJ NN NNS",4,1,1,16511251,2,4.79E+018,"testalpha"
,"thepediatric hematology unit ain","JJ NN NN ",4,1,1,16424649,2,2.09E+018,"testalpha"
,"ofexpression and hypoxia responsiveness","NN CC  NN",4,1,1,17143338,"pubmed1",4.60E+018,"testalpha"
,"ofdiagnosis date and age","NN NN CC NN",4,1,1,16696444,2,2.30E+018,"testalpha"
,"changes during rapid sequence","NNS IN JJ NN",4,1,1,17067136,"pubmed1",4.04E+018,"testalpha"
,"dependent manner withsignificant effects","JJ NN JJ NNS",4,1,1,17128291,"pubmed1",1.05E+018,"testalpha"
,"reduction and internal fixation","NN CC JJ NN",4,1,1,16613748,2,3.40E+018,"testalpha"
,"induce apoptosis in b","VB NN IN NN",4,1,1,17143339,"pubmed1",8.79E+018,"testalpha"
,"self administered anonymous questionnaire","NN VBD JJ NN",4,1,1,16377815,"pubmed1",1.44E+018,"testalpha"
,"elevated blood calcium levels","VBN NN NN NNS",4,1,1,17016034,2,4.08E+018,"testalpha"
,"sleds snow discs snow","NNS NN NNS NN",4,1,1,16436798,"pubmed1",1.96E+018,"testalpha"
,"ofintermediate beta thalassemia patients","NN NN NN NNS",4,1,1,16809886,2,3.62E+018,"testalpha"
,"results of plasma polymerization","NNS IN NNP NN",4,1,1,16701874,"pubmed1",5.53E+018,"testalpha"
,"samples obtained monthafter treatment","NNS VBN NN NN",4,1,1,16809889,2,5.64E+018,"testalpha"
,"multiple gallstones and ultrasound","JJ NNS CC NN",4,1,1,16132429,"pubmed1",5.24E+018,"testalpha"
,"goal of mitigating roadside","NN IN VBG NN",4,1,1,16054101,"pubmed1",3.75E+018,"testalpha"
,"leftwith grotesque facial disfigurement","NN JJ JJ NN",4,1,1,17165599,2,7.37E+017,"testalpha"
,"highways including separate models","NNS VBG JJ NNS",4,1,1,16442487,"pubmed1",2.40E+018,"testalpha"
,"systems for proximity warning","NNS IN NN NN",4,1,1,16129405,"pubmed1",2.04E+018,"testalpha"
,"gender use of restraint","NN NN IN NN",4,1,1,16426561,"pubmed1",3.58E+018,"testalpha"
,"intra common carotid arteryinjection","JJ JJ  NN",4,1,1,17133957,2,8.25E+018,"testalpha"
,"involving vehicles with ontariolicence","VBG NNS IN NN",4,1,1,16169506,"pubmed1",1.74E+018,"testalpha"
,"assistance impact on quality","NN NN IN NN",4,1,1,16612907,2,2.76E+018,"testalpha"
,"hb concentration serum iron"," NN NN NN",4,1,1,16809890,2,7.33E+018,"testalpha"
,"reddish tender patch onthe","JJ NN NN NNP",4,1,1,16859614,2,3.59E+018,"testalpha"
,"adherens and occludens junctions","NNS CC NNS NNS",4,1,1,16253314,2,4.44E+018,"testalpha"
,"glycidyl dimethacrylate i e"," NN  ",4,1,1,16701856,"pubmed1",7.23E+018,"testalpha"
,"integrity but influences cell","NN CC NNS NN",4,1,1,16733556,"pubmed1",4.04E+018,"testalpha"
,"identified femalesand older occupants","VBD NN JJR NNS",4,1,1,16197912,"pubmed1",5.01E+017,"testalpha"
,"vertebrate aryl hydrocarbon receptor","NN  NN NN",4,1,1,16411738,"pubmed1",1.96E+018,"testalpha"
,"ofl asparaginases and highlights"," NNS CC NNS",4,1,1,17143335,"pubmed1",3.64E+018,"testalpha"
,"componentsof extracellular matrix ecm"," JJ NNP ",4,1,1,16733556,"pubmed1",8.32E+018,"testalpha"
,"developmental status of muscle","NN NN IN NN",4,1,1,16893562,2,3.50E+018,"testalpha"
,"scar and keloid tissues"," CC VB NNS",4,1,1,16874413,2,2.84E+018,"testalpha"
,"ntn hydrolases similar tothe"," NNS JJ NNP",4,1,1,17143335,"pubmed1",6.06E+017,"testalpha"
,"institute of sao carlos","NN IN  NNP",4,1,1,17013504,2,4.71E+018,"testalpha"
,"hydrolysis of membrane building","NN IN NN NN",4,1,1,16511279,2,7.87E+018,"testalpha"
,"months thedisease free survival","NNS NN JJ NN",4,1,1,16424645,2,6.16E+017,"testalpha"
,"fractions with atotal dose","NNS IN NN NN",4,1,1,17117605,2,6.14E+018,"testalpha"
,"age years recruited years","NN NNS VBN NNS",4,1,1,16648916,2,4.89E+018,"testalpha"
,"circles for assessing article","NNS IN VBG NN",4,1,1,16399035,"pubmed1",5.28E+018,"testalpha"
,"ultraviolet uv b prednisolone","NN  NN NN",4,1,1,16710585,2,5.87E+018,"testalpha"
,"conclusion independent double readings","NN JJ NN NNS",4,1,1,16399036,"pubmed1",7.50E+018,"testalpha"
,"mg of hydrocortisoneand mg"," IN NN ",4,1,1,16451161,"pubmed1",5.28E+018,"testalpha"
,"iron therapy for anyreason","NN NN IN NN",4,1,1,16809890,2,3.26E+018,"testalpha"
,"faceinvolvement external ocular signs","NN JJ JJ NNS",4,1,1,17106598,2,2.54E+018,"testalpha"
,"environmental carcinogens e g","JJ NNS  ",4,1,1,16582987,"pubmed1",4.39E+018,"testalpha"
,"high concentration binge prenataltoluene","JJ NN NN NN",4,1,1,16808045,"pubmed1",3.39E+018,"testalpha"
,"appointment diagnosis andtreatment decisions","NN NN NN NNS",4,1,1,16710575,2,5.49E+018,"testalpha"
,"probiotics enhanced theimmune response","NNS VBN NN NN",4,1,1,17293972,2,6.39E+018,"testalpha"
,"walls beta adrenergic receptors","NNS NN JJ NNS",4,1,1,16874421,2,2.61E+018,"testalpha"
,"interactions ofthe side chains","NNS NNP NN NNS",4,1,1,16365636,"pubmed1",2.06E+018,"testalpha"
,"cessation related health improvement","NN VBN NN NN",4,1,1,16365327,"pubmed1",3.62E+018,"testalpha"
,"clinical signs of vlp","JJ NNS IN ",4,1,1,16955190,2,6.19E+018,"testalpha"
,"ofanastomotic leakage or failure","JJ NN CC NN",4,1,1,16612911,2,1.07E+017,"testalpha"
,"required immediate tube thoracostomy","VBD JJ NN NN",4,1,1,16365333,"pubmed1",3.62E+018,"testalpha"
,"groups and normal saline","NNS CC JJ NN",4,1,1,16436788,"pubmed1",5.89E+018,"testalpha"
,"mutation of factor v","NN IN NN ",4,1,1,16710585,2,7.73E+017,"testalpha"
,"therapy further influences patientsmorbidity","NN JJ NNS NN",4,1,1,16612906,2,2.64E+018,"testalpha"
,"space group with unit","NN NN IN NN",4,1,1,16511254,2,1.27E+018,"testalpha"
,"enzymes assessed disclosedno difference","NNS VBN  NN",4,1,1,17013510,2,3.98E+018,"testalpha"
,"heart and lung tissues","NN CC NN NNS",4,1,1,16762404,2,3.50E+018,"testalpha"
,"germ line derived cells","NN NN VBN NNS",4,1,1,17265694,2,1.50E+018,"testalpha"
,"effects of abuse patterns","NNS IN NN NNS",4,1,1,16808045,"pubmed1",6.34E+018,"testalpha"
,"annals of emergency medicine","NNS IN NN NN",4,1,1,16365335,"pubmed1",1.27E+018,"testalpha"
,"planus vlp and vulval","NN  CC NN",4,1,1,16955190,2,4.77E+018,"testalpha"
,"mean satisfaction with theposition","NN NN IN NN",4,1,1,16436795,"pubmed1",5.87E+018,"testalpha"
,"high risk of ptclu","JJ NN IN ",4,1,1,16914902,2,2.02E+018,"testalpha"
,"part of larger syndromes","NN IN JJR NNS",4,1,1,16859618,2,3.64E+018,"testalpha"
,"locus withinchromosomal region q","NN JJ NN ",4,1,1,16733555,"pubmed1",1.77E+018,"testalpha"
,"characteristics of heavy vehicledrivers","NNS IN JJ NNS",4,1,1,16221468,"pubmed1",8.50E+018,"testalpha"
,"reported injury through employees","VBD NN IN NNS",4,1,1,16442068,"pubmed1",4.80E+018,"testalpha"
,"fna ofthyroid gland lesions"," VB NN NNS",4,1,1,16514836,2,8.49E+018,"testalpha"
,"effects at higher concentrations","NNS IN JJR NNS",4,1,1,17046053,2,6.80E+018,"testalpha"
,"possible base substitutions thepresence","JJ NN NNS NN",4,1,1,16733554,"pubmed1",3.87E+018,"testalpha"
,"significant difference in hyperkeratosis","JJ NN IN NN",4,1,1,16585980,2,6.59E+018,"testalpha"
,"hypointense rim on t","NN NN IN ",4,1,1,16252140,"pubmed1",6.33E+018,"testalpha"
,"adult balb c mice","NN  NN ",4,1,1,16950501,2,8.59E+018,"testalpha"
,"evidence thatnatural genome editing","NN JJ NN NN",4,1,1,17347785,"pubmed1",3.58E+018,"testalpha"
,"subtypes i and ii","NNS  CC ",4,1,1,17143335,"pubmed1",2.17E+018,"testalpha"
,"blood stem cell transplantation","NN VB NN NN",4,1,1,16809891,2,1.93E+018,"testalpha"
,"aggressive t cell non","JJ  NN ",4,1,1,16809891,2,5.27E+018,"testalpha"
,"inhibitor of activated proteinc","NN IN VBN ",4,1,1,16549894,2,3.02E+017,"testalpha"
,"important role incardiovascular diseases","JJ NN JJ NNS",4,1,1,16479034,2,2.07E+017,"testalpha"
,"polarized light andfluorescence microscopy","VBN NN NN ",4,1,1,16714053,2,8.95E+018,"testalpha"
,"dm inpost operative patients"," NN JJ NNS",4,1,1,16451144,"pubmed1",3.44E+018,"testalpha"
,"ion binding site residue"," VBG NN NN",4,1,1,16511247,2,3.12E+018,"testalpha"
,"methods self reporting questionnaires","NNS NN NN NNS",4,1,1,16451152,"pubmed1",1.06E+018,"testalpha"
,"local metabolism andblood flow","JJ NN NN NN",4,1,1,16451157,"pubmed1",4.90E+018,"testalpha"
,"fl and tumor necrosis"," CC NN NN",4,1,1,16404477,"pubmed1",8.41E+017,"testalpha"
,"undergo atp dependent autophosphorylation","VB  JJ NN",4,1,1,16404475,"pubmed1",3.91E+018,"testalpha"
,"bis hexafluorophosphate co c"," NN  NN",4,1,1,16456276,2,7.16E+018,"testalpha"
,"y r and l"," NN CC ",4,1,1,16404475,"pubmed1",3.09E+018,"testalpha"
,"b nbs rad mre","NN   ",4,1,1,16914901,2,4.91E+018,"testalpha"
,"protein kinase in ly","NN NN IN ",4,1,1,16404475,"pubmed1",2.18E+018,"testalpha"
,"positive effects on patientsatisfaction","JJ NNS IN NN",4,1,1,17106601,2,4.96E+018,"testalpha"
,"lesser extent on aggregation","JJR NN IN NN",4,1,1,17068635,"pubmed1",1.85E+018,"testalpha"
,"thiscarbohydrate containing hydrophilic medium","NN VBG JJ NN",4,1,1,16714051,2,6.60E+018,"testalpha"
,"measurement of molecular forces","NN IN JJ NNS",4,1,1,16411737,"pubmed1",8.71E+018,"testalpha"
,"college of rheumatology criteria","NN IN NN NNS",4,1,1,16479028,2,3.89E+018,"testalpha"
,"light microscopy revealed immunopositivity","NN  VBD NN",4,1,1,16828846,2,2.47E+018,"testalpha"
,"minutes confidence interval ci","NNS NN NN ",4,1,1,16365334,"pubmed1",4.02E+018,"testalpha"
,"class of heme enzymes","NN IN  NNS",4,1,1,16411738,"pubmed1",2.47E+018,"testalpha"
,"ventricularperformance during long term","NN IN JJ NN",4,1,1,16989140,2,4.39E+018,"testalpha"
,"emergency medicine rct abstracts","NN NN  NNS",4,1,1,16365332,"pubmed1",8.75E+018,"testalpha"
,"group e g dle","NN   ",4,1,1,17311739,2,5.58E+018,"testalpha"
,"centralvenous oxygen saturation monitoring","JJ NN NN NN",4,1,1,16365336,"pubmed1",1.19E+018,"testalpha"
,"conclusions thevariability in questions","NNS NN IN NNS",4,1,1,16436792,"pubmed1",6.61E+018,"testalpha"
,"pm from pasteurella multocida"," IN NNP NNP",4,1,1,16511286,2,7.46E+018,"testalpha"
,"rollovers and object impacts","NNS CC NN NNS",4,1,1,16426556,"pubmed1",8.92E+018,"testalpha"
,"culture on agar detection","NN IN  NN",4,1,1,16710579,2,5.32E+018,"testalpha"
,"week open clinical trial","NN JJ JJ NN",4,1,1,17311738,2,1.26E+018,"testalpha"
,"malabsorption despite negative celiacserology","NN IN JJ NN",4,1,1,16673560,2,5.93E+018,"testalpha"
,"extended drinking hours amendment","VBN NN NNS NN",4,1,1,16169506,"pubmed1",6.74E+018,"testalpha"
,"term survival among patients","NN NN IN NNS",4,1,1,16451146,"pubmed1",3.29E+015,"testalpha"
,"migration proteases inflammation coagulation","NN NNS NN NN",4,1,1,16730054,2,4.50E+017,"testalpha"
,"chain acyl coa thioesterase","NN   NN",4,1,1,16511283,2,3.05E+018,"testalpha"
,"reporting available online inreal","NN JJ NN NN",4,1,1,16770858,"pubmed1",5.35E+016,"testalpha"
,"injection of cyanine dyes","NN IN NN ",4,1,1,16399028,"pubmed1",2.12E+018,"testalpha"
,"beta lactamantibiotics and chemotherapeutics","NN NNS CC NNS",4,1,1,17106599,2,6.97E+018,"testalpha"
,"followedby high dose chemotherapy","JJ JJ NN NN",4,1,1,16914902,2,8.80E+018,"testalpha"
,"aesthetic outcomes after reconstructionsof","JJ NNS IN ",4,1,1,17165596,2,6.84E+018,"testalpha"
,"vwf intron vntr markers"," NNP  NNS",4,1,1,16424652,2,3.56E+018,"testalpha"
,"tube lt and cobrapla","NN  CC ",4,1,1,16451149,"pubmed1",3.91E+018,"testalpha"
,"regulatorynetworks major viral life","NNS JJ JJ NN",4,1,1,17347785,"pubmed1",5.46E+018,"testalpha"
,"results and pitfallsof erus","NNS CC  ",4,1,1,17139898,2,4.47E+018,"testalpha"
,"chain of treatment support","NN IN NN NN",4,1,1,16710575,2,2.83E+018,"testalpha"
,"x raydiffraction data analysis","NN NN NNS NN",4,1,1,16511269,2,2.01E+018,"testalpha"
,"lazaroidu e mg kg","   ",4,1,1,16365323,"pubmed1",2.05E+018,"testalpha"
,"side of salt split","NN IN NN NN",4,1,1,16955192,2,8.19E+018,"testalpha"
,"discussion aceinhibitor provoked angioedema","NN NN VBD NN",4,1,1,16451161,"pubmed1",7.64E+018,"testalpha"
,"purifyhuman carbonic anhydrase vi","NN JJ NN ",4,1,1,16511271,2,5.78E+018,"testalpha"
,"age atdiscontinuation of prophylaxis","NN NN IN ",4,1,1,16549891,2,8.59E+017,"testalpha"
,"tr and cd il"," CC  ",4,1,1,17016036,2,2.15E+018,"testalpha"
,"possibilities for environmental biotechnology","NNS IN JJ NN",4,1,1,17019438,"pubmed1",6.74E+018,"testalpha"
,"immobilized cells of protaminobacter","VBN NNS IN NN",4,1,1,16511267,2,5.35E+018,"testalpha"
,"photosystem ii psii bind","NN   NN",4,1,1,17106511,"pubmed1",6.59E+018,"testalpha"
,"pan load pan speed","NN NN NN NN",4,1,1,17285748,"pubmed1",2.88E+018,"testalpha"
,"identify underlying cathepsin c","VB VBG NNP NN",4,1,1,16585980,2,5.40E+018,"testalpha"
,"gold impregnation but adecrease","NN NN CC NN",4,1,1,16256175,2,6.71E+018,"testalpha"
,"protein crystallization and expression","NN NN CC NN",4,1,1,16369090,2,6.67E+018,"testalpha"
,"tidal volume or pressure","JJ NN CC NN",4,1,1,16451155,"pubmed1",4.74E+018,"testalpha"
,"end of procedure t","NN IN NN ",4,1,1,17338197,2,8.40E+017,"testalpha"
,"risk of symptomatic anastomoticleakage","NN IN JJ NN",4,1,1,16612911,2,5.87E+018,"testalpha"
,"ml culprit drug p"," NN NN ",4,1,1,16710577,2,8.00E+018,"testalpha"
,"silicondioxide dispersion in isopropyl","VB NN IN ",4,1,1,17285743,"pubmed1",7.96E+018,"testalpha"
,"bycrystallization and x ray","NN CC NN ",4,1,1,16511265,2,5.76E+018,"testalpha"
,"c italy from perimenopausal","NN NNP IN NN",4,1,1,16514842,2,4.03E+017,"testalpha"
,"various cytotoxic t lymphocyte","JJ JJ  NNP",4,1,1,16511250,2,1.89E+018,"testalpha"
,"pure ad group spt","JJ NN NN ",4,1,1,16859613,2,7.84E+018,"testalpha"
,"modulation ofthe input plasma","NN NNP NN NNP",4,1,1,16701874,"pubmed1",1.83E+018,"testalpha"
,"takingcorticosteroids beta blockers thiazides","NNS NN NNS NNS",4,1,1,16479027,2,5.26E+018,"testalpha"
,"age and weight shows","NN CC NN NNS",4,1,1,17067139,"pubmed1",3.10E+018,"testalpha"
,"pain along withphysical findings","NN IN JJ NNS",4,1,1,16549898,2,9.01E+018,"testalpha"
,"new educational goals adaptation","JJ JJ NNS NN",4,1,1,16999271,2,7.95E+018,"testalpha"
,"glutamate transmission or mitochondrialdisruption","NN NN CC NN",4,1,1,16808044,"pubmed1",7.43E+018,"testalpha"
,"history of alcohol abuse","NN IN NN NN",4,1,1,17013512,2,1.57E+018,"testalpha"
,"butyl oxidobenzyl n pyridylamino","   NNP",4,1,1,16456265,2,7.34E+018,"testalpha"
,"skeletal muscle and survivingmuscle","NN NN CC NN",4,1,1,16965805,2,5.30E+018,"testalpha"
,"pressure and heart rate","NN CC NN NN",4,1,1,16365322,"pubmed1",2.41E+018,"testalpha"
,"mortality predictors of response","NN NNS IN NN",4,1,1,16424648,2,5.09E+018,"testalpha"
,"px activity in cancer"," NN IN NN",4,1,1,16404476,"pubmed1",7.64E+018,"testalpha"
,"plasmid bearing full length","JJ NN JJ NN",4,1,1,16582987,"pubmed1",5.28E+018,"testalpha"
,"potentials andknowledge based protein","NNS NN VBN NN",4,1,1,16365636,"pubmed1",3.29E+018,"testalpha"
,"hemorrhagic disease virus rhdv","JJ NN NN ",4,1,1,16733562,"pubmed1",9.20E+015,"testalpha"
,"influx andaccelerated vesicle fusion","NN VBN NN NN",4,1,1,16395521,"pubmed1",3.56E+018,"testalpha"
,"university of cincinnatimedical center","NN IN JJ NN",4,1,1,16377824,"pubmed1",3.59E+018,"testalpha"
,"influence of ischemicpreconditioning ipc","NN IN VBG ",4,1,1,17013508,2,2.58E+018,"testalpha"
,"fish fruits and vegetable","NN NNS CC NN",4,1,1,16696439,2,3.75E+018,"testalpha"
,"min compared toplastic min"," VBN JJ ",4,1,1,16549888,2,9.82E+017,"testalpha"
,"effectson neuronal nicotinic acetylcholine","NN JJ JJ NN",4,1,1,16594641,"pubmed1",8.77E+018,"testalpha"
,"based school injury rate","VBN NN NN NN",4,1,1,16236234,"pubmed1",2.98E+018,"testalpha"
,"characterized fordrug content globule","VBN NN JJ NN",4,1,1,16584167,"pubmed1",2.87E+018,"testalpha"
,"malignant tissues compared toadjacent","JJ NNS VBN NN",4,1,1,16404476,"pubmed1",4.99E+018,"testalpha"
,"elderly and underserved women","NN CC VBN NNS",4,1,1,16596901,"pubmed1",3.96E+018,"testalpha"
,"affecting measured diffraction intensities","VBG VBN NN NNS",4,1,1,16369096,2,4.09E+018,"testalpha"
,"rat model of itp","NN NN IN ",4,1,1,16594642,"pubmed1",4.73E+018,"testalpha"
,"therepair of ionising radiation","NN IN VBG NN",4,1,1,16404475,"pubmed1",1.09E+017,"testalpha"
,"patients at years intervaland","NNS IN NNS NN",4,1,1,16673554,2,2.05E+018,"testalpha"
,"noticed following pulse therapy","VBD VBG NN NN",4,1,1,16955189,2,7.96E+018,"testalpha"
,"parameters on encapsulated islets","NNS IN VBN NNS",4,1,1,16701853,"pubmed1",6.07E+018,"testalpha"
,"report provides asample concept","NN VBZ NNS NN",4,1,1,16400088,"pubmed1",2.93E+018,"testalpha"
,"slovakia using twopcr methods","NNP VBG  NNS",4,1,1,16696442,2,2.56E+018,"testalpha"
,"type of skin reactions","NN IN NN NNS",4,1,1,17106599,2,6.75E+018,"testalpha"
,"ih urinary calcium excretion"," JJ NN NN",4,1,1,16956119,2,5.67E+018,"testalpha"
,"more cellattachment and proliferation","JJR NN CC NN",4,1,1,16701866,"pubmed1",2.46E+018,"testalpha"
,"withhigh doses of dexamethasone","VB NNS IN NN",4,1,1,17133953,2,2.45E+018,"testalpha"
,"mm tris hcl ph","   ",4,1,1,16511255,2,3.47E+018,"testalpha"
,"segment andintersection level crash","NN NN NN NN",4,1,1,16451795,"pubmed1",2.39E+018,"testalpha"
,"ontransport safety of deregulation","NN NN IN NN",4,1,1,16427020,"pubmed1",8.37E+018,"testalpha"
,"inducedupon pro apoptotic treatment","NN JJ JJ NN",4,1,1,17265688,2,4.91E+018,"testalpha"
,"treatment for days groups","NN IN NNS NNS",4,1,1,16612918,"pubmed1",4.44E+018,"testalpha"
,"use of yeast inmany","NN IN NN NN",4,1,1,17063208,"pubmed1",2.62E+018,"testalpha"
,"safety of g csf","NN IN  ",4,1,1,16809884,2,4.01E+018,"testalpha"
,"glycoconjugates in human thyroid","NNS IN JJ NN",4,1,1,16720036,2,7.59E+018,"testalpha"
,"brain in physiological conditions","NN IN JJ NNS",4,1,1,17265695,2,2.14E+018,"testalpha"
,"potentiatesrocuronium during maintenance infusion","NN IN NN NN",4,1,1,17236635,"pubmed1",4.36E+018,"testalpha"
,"number of surviving nerveagent","NN IN VBG NN",4,1,1,16956120,2,5.52E+018,"testalpha"
,"evident role in theirreactivity","JJ NN IN NN",4,1,1,16929382,"pubmed1",7.22E+018,"testalpha"
,"hela and jurkat cells"," CC  NNS",4,1,1,16505900,"pubmed1",8.81E+017,"testalpha"
,"test and use test","NN CC NN NN",4,1,1,16585981,2,4.13E+018,"testalpha"
,"process issuesregarding psychiatric care","NN VBG JJ NN",4,1,1,16473995,"pubmed1",9.08E+018,"testalpha"
,"white blood cell counts","JJ NN NN NNS",4,1,1,16914906,2,4.17E+018,"testalpha"
,"nerve agents andmustard agents","NN NNS NN NNS",4,1,1,16696436,2,7.06E+017,"testalpha"
,"characteristics ofmicrowave dried sucralfate","NNS VB VBD NN",4,1,1,16584168,"pubmed1",8.63E+018,"testalpha"
,"were identified usingmultivariate analysis","VBD VBN NN NN",4,1,1,16549896,2,2.54E+018,"testalpha"
,"induced hemolysis or inhibition","VBN NN CC NN",4,1,1,16395529,"pubmed1",8.27E+017,"testalpha"
,"ada activity of psoriatics"," NN IN NNS",4,1,1,16956117,2,3.45E+018,"testalpha"
,"augmented response on re","VBD NN IN ",4,1,1,16585981,2,5.62E+018,"testalpha"
,"expression of cell adhesion","NN IN NN NN",4,1,1,16951744,"pubmed1",5.02E+018,"testalpha"
,"number of previous crashes","NN IN JJ NNS",4,1,1,16405858,"pubmed1",4.54E+018,"testalpha"
,"cognitive performance in tabun","JJ NN IN NNP",4,1,1,16956120,2,8.78E+018,"testalpha"
,"human immunodeficiency virus hiv","JJ NN NN ",4,1,1,17128290,"pubmed1",3.24E+018,"testalpha"
,"encapsulation matrix affords control","NN NNP NNS NN",4,1,1,16701853,"pubmed1",4.48E+018,"testalpha"
,"syndrome hps in kidney","NN  IN NN",4,1,1,16914905,2,6.15E+018,"testalpha"
,"mitochondrial polynucleotide phosphorylase hpnpase","JJ VB NN NN",4,1,1,16505900,"pubmed1",6.33E+018,"testalpha"
,"ox ldl high density","  JJ NN",4,1,1,17106515,"pubmed1",9.02E+018,"testalpha"
,"l lactide b poly"," VB NN ",4,1,1,16701879,"pubmed1",5.43E+018,"testalpha"
,"aimsto give synchrotron users","NNP VB NNP NNS",4,1,1,16369089,2,3.39E+018,"testalpha"
,"levels and abnormal blood","NNS CC JJ NN",4,1,1,16462412,"pubmed1",9.01E+018,"testalpha"
,"estimates and estimate processes","NNS CC NN NNS",4,1,1,16126153,"pubmed1",7.34E+017,"testalpha"
,"collection about impaired drivers","NN IN VBN NNS",4,1,1,16112068,"pubmed1",2.93E+018,"testalpha"
,"ethnic groups and races","JJ NNS CC NNS",4,1,1,17165598,2,6.10E+018,"testalpha"
,"increase in helmet use","NN IN VB NN",4,1,1,16223468,"pubmed1",8.18E+018,"testalpha"
,"k protein represented transcripts"," NN VBD NNS",4,1,1,16496041,"pubmed1",6.87E+018,"testalpha"
,"presence of epidermal growth","NN IN JJ NN",4,1,1,16874412,2,1.38E+018,"testalpha"
,"gynaecological neoplasms and theirclassification","JJ NNS CC NN",4,1,1,17338203,2,5.74E+018,"testalpha"
,"precipitating factor renal failure","VBG NN JJ NN",4,1,1,16916186,"pubmed1",3.13E+018,"testalpha"
,"persistence of hr hpv","NN IN  ",4,1,1,16514834,2,8.88E+018,"testalpha"
,"revealed secondary structure perturbations","VBD JJ NN NNS",4,1,1,16582987,"pubmed1",8.69E+018,"testalpha"
,"glycemia gly hepaticglycogen gh","NN  NN ",4,1,1,17013507,2,4.19E+018,"testalpha"
,"distinctclinical forms of amyloidosis","JJ NNS IN NN",4,1,1,16764914,2,4.50E+018,"testalpha"
,"induces activation of beta","NNS NN IN NN",4,1,1,16874413,2,1.28E+018,"testalpha"
,"hypertension type diabetes dyslipidemia","NN NN NN NN",4,1,1,16479031,2,1.43E+017,"testalpha"
,"thepyrimidine nucleoside bound complexes","NN VB VBN NNS",4,1,1,16421443,2,7.09E+018,"testalpha"
,"serological testing forceliac disease","JJ NN JJ NN",4,1,1,16673560,2,1.37E+018,"testalpha"
,"support p and p","NN  CC ",4,1,1,16496039,"pubmed1",9.11E+018,"testalpha"
,"c cell morphology andcalcium","NN NN NN NN",4,1,1,17115079,"pubmed1",2.34E+018,"testalpha"
,"thrombolysisin myocardial infarction timi","NNP JJ NN ",4,1,1,16365321,"pubmed1",5.57E+018,"testalpha"
,"tothe orthorhombic space group","NNP JJ NN NN",4,1,1,16511285,2,2.26E+018,"testalpha"
,"acid composition and collagenand","NN NN CC NN",4,1,1,16701880,"pubmed1",8.00E+018,"testalpha"
,"valuable alternative diagnostic tool","JJ NN NN NN",4,1,1,16447097,"pubmed1",5.73E+018,"testalpha"
,"lesion location lesion morphology","NN NN NN NN",4,1,1,16722347,2,3.56E+018,"testalpha"
,"iga length and weight"," NN CC NN",4,1,1,17293972,2,9.94E+017,"testalpha"
,"parvovirus b infection ranges","NN NN NN NNS",4,1,1,17010266,2,7.94E+018,"testalpha"
,"numerous matrix disorders indiabetes","JJ NNP NNS NNS",4,1,1,16733556,"pubmed1",8.35E+018,"testalpha"
,"therapy feia cap system","NN  NN NN",4,1,1,16603096,2,8.58E+018,"testalpha"
,"shoulders give higher crash","NNS VB JJR NN",4,1,1,16423319,"pubmed1",6.36E+018,"testalpha"
,"patients in group ii","NNS IN NN ",4,1,1,16710580,2,7.66E+018,"testalpha"
,"greater potential foradverse pregnancy","JJR JJ NN NN",4,1,1,16808045,"pubmed1",5.18E+017,"testalpha"
,"diagnostic tools in food","JJ NNS IN NN",4,1,1,16673561,2,1.03E+018,"testalpha"
,"lanecollector or arterial roads","NN CC JJ NNS",4,1,1,16423319,"pubmed1",8.47E+018,"testalpha"
,"multifunctional outer membrane proteins","JJ JJ NN NNS",4,1,1,16964325,"pubmed1",8.31E+018,"testalpha"
,"physiology and chronic health","NN CC JJ NN",4,1,1,17117607,2,7.38E+018,"testalpha"
,"inpreparation for allogeneic bone","NN IN JJ NN",4,1,1,16914909,2,2.34E+018,"testalpha"
,"enhancing theireffects on membrane","VBG NNS IN NN",4,1,1,16964324,"pubmed1",7.30E+018,"testalpha"
,"gshperoxidase selenium dependent gsh","NN NN JJ ",4,1,1,16404476,"pubmed1",7.38E+018,"testalpha"
,"orbit sinuses and nasal","NN NNS CC NN",4,1,1,17370565,"pubmed1",3.55E+018,"testalpha"
,"number of hip fractures","NN IN NN NNS",4,1,1,16613748,2,4.29E+018,"testalpha"
,"participants n and acomparison","NNS  CC NN",4,1,1,16202465,"pubmed1",4.41E+018,"testalpha"
,"rise data more accurateresults","NN NNS JJR NNS",4,1,1,17285744,"pubmed1",4.50E+017,"testalpha"
,"short chain acyl derivatives","JJ NN  NNS",4,1,1,16511287,2,4.49E+018,"testalpha"
,"induced activation of counterregulatoryhormones","VBN NN IN NNS",4,1,1,16921608,"pubmed1",9.11E+017,"testalpha"
,"flexibility of nonviral vectors","NN IN JJ NNS",4,1,1,17285739,"pubmed1",7.03E+018,"testalpha"
,"consecutive anion cation pairs","JJ NN NN NNS",4,1,1,16456289,2,6.25E+018,"testalpha"
,"nonviral transfectionof cord blood","JJ  NN NN",4,1,1,16404477,"pubmed1",5.92E+018,"testalpha"
,"anions show typical bond","NNS VBP JJ NN",4,1,1,16456289,2,5.46E+017,"testalpha"
,"month old young month","NN JJ JJ NN",4,1,1,17046052,2,4.51E+018,"testalpha"
,"virus protease htlv pr","NN NN  ",4,1,1,16421452,2,2.76E+017,"testalpha"
,"hepatitis virus band c","NN NN NN NN",4,1,1,17013520,2,3.68E+018,"testalpha"
,"electron microscopy and autoradiography","NN  CC NN",4,1,1,16733064,2,2.97E+018,"testalpha"
,"ethics training as part","NNS NN IN NN",4,1,1,16473995,"pubmed1",3.16E+018,"testalpha"
,"cycles of bortezomib dexamethasone","NNS IN  NN",4,1,1,17119326,2,2.96E+018,"testalpha"
,"saposin c activates glucocerebrosidase","NNP NN NNS NN",4,1,1,16511279,2,8.87E+018,"testalpha"
,"adoption of practice guidelines","NN IN NN NNS",4,1,1,16330213,"pubmed1",7.45E+018,"testalpha"
,"patients with hiv infection","NNS IN  NN",4,1,1,16462405,"pubmed1",1.80E+018,"testalpha"
,"hours support staff potential","NNS NN NN NN",4,1,1,16436795,"pubmed1",8.97E+017,"testalpha"
,"phosphatases endonucleases and dna","NNS NNS CC ",4,1,1,16410836,"pubmed1",4.88E+018,"testalpha"
,"protein componentsof extracellular matrix","NN  JJ NNP",4,1,1,16733556,"pubmed1",4.73E+018,"testalpha"
,"reducing efficacy of capsaicin","VBG NN IN NNP",4,1,1,16955183,2,7.18E+018,"testalpha"
,"events during neurosurgical procedures","NNS IN JJ NNS",4,1,1,17067138,"pubmed1",5.11E+018,"testalpha"
,"thromboses are major causes","NNS VBP JJ NNS",4,1,1,17236644,"pubmed1",3.95E+018,"testalpha"
,"ht receptors targeted byhallucinogens"," NNS VBN NNS",4,1,1,16594640,"pubmed1",1.79E+018,"testalpha"
,"suffered post operative nausea","VBD NN JJ NNP",4,1,1,16451145,"pubmed1",7.19E+018,"testalpha"
,"mammalian foods and amongseafood","JJ NNS CC NN",4,1,1,16673562,2,7.38E+018,"testalpha"
,"left ventricle plusseptum weight","VBN NN NN NN",4,1,1,16537087,2,8.93E+018,"testalpha"
,"anemia among inflammatory bowel","NN IN JJ NN",4,1,1,16673554,2,5.81E+018,"testalpha"
,"liver tissue of adult","NN NN IN NN",4,1,1,16950501,2,9.02E+018,"testalpha"
,"pharmacopeia national formulary usp"," JJ JJ ",4,1,1,17285738,"pubmed1",3.74E+018,"testalpha"
,"picolinate o atoms bridges","NN  NNS NNS",4,1,1,16456283,2,9.01E+018,"testalpha"
,"accompanying pruritus by p","VBG NN IN ",4,1,1,16874418,2,1.55E+018,"testalpha"
,"evidence of positive outcome","NN IN JJ NN",4,1,1,16365332,"pubmed1",2.04E+018,"testalpha"
,"capsaicin cream forpain relief","NNP NN VB NN",4,1,1,16955183,2,2.65E+018,"testalpha"
,"occupied iodine anions andsamarium","VBN NN NNS NN",4,1,1,16421448,2,1.26E+018,"testalpha"
,"conclusions egdt corticosteroid administration","NNS  VB NN",4,1,1,16365336,"pubmed1",5.89E+018,"testalpha"
,"subjects with t dm","NNS IN  ",4,1,1,16918069,"pubmed1",8.50E+018,"testalpha"
,"prophylactic vaccines use l","JJ NNS VB ",4,1,1,17010274,2,7.09E+017,"testalpha"
,"valuable health care resources","JJ NN NN NNS",4,1,1,16321535,"pubmed1",8.80E+018,"testalpha"
,"levels of depression anxiety","NNS IN NN NN",4,1,1,16377815,"pubmed1",1.82E+017,"testalpha"
,"v y advancement fasciocutaneousdorsal","  NN NN",4,1,1,17165597,2,2.20E+018,"testalpha"
,"highway environments andfor drivers","NN NNS JJ NNS",4,1,1,16226211,"pubmed1",1.87E+018,"testalpha"
,"residual monomer and degree","JJ NN CC NN",4,1,1,16701856,"pubmed1",2.34E+017,"testalpha"
,"imaging applies differentsequence types","VBG VBZ NN NNS",4,1,1,16447077,"pubmed1",4.20E+017,"testalpha"
,"ards and dead space"," CC JJ NN",4,1,1,16451155,"pubmed1",8.51E+018,"testalpha"
,"peroperative mortality in patients","JJ NN IN NNS",4,1,1,17139879,2,8.21E+018,"testalpha"
,"blood blood products andaptt","NN NN NNS ",4,1,1,16451158,"pubmed1",7.20E+018,"testalpha"
,"follicular alterations in patients","JJ NNS IN NNS",4,1,1,16859615,2,3.63E+018,"testalpha"
,"temporal syndrome or temporalepilepsy","JJ NN CC NN",4,1,1,17294913,2,1.04E+018,"testalpha"
,"ofthe strong human cytomegalovirus","NNP JJ JJ NN",4,1,1,16733563,"pubmed1",8.24E+018,"testalpha"
,"potential applications insoil bioremediation","JJ NNS NN NN",4,1,1,17019438,"pubmed1",2.45E+018,"testalpha"
,"inother photosynthesis related processes","JJ NN VBN NNS",4,1,1,17106511,"pubmed1",4.36E+018,"testalpha"
,"well known herbal medicine","NN VBN JJ NN",4,1,1,17265697,2,4.95E+018,"testalpha"
,"showed afaster early recovery","VBD NN JJ NN",4,1,1,16451145,"pubmed1",7.36E+018,"testalpha"
,"hepatic impairment child pugh","JJ NN NN ",4,1,1,16584121,"pubmed1",6.96E+018,"testalpha"
,"superficial curettage of treatment","JJ NN IN NN",4,1,1,16955184,2,3.59E+018,"testalpha"
,"prothrombotic risk factors months","JJ NN NNS NNS",4,1,1,16549894,2,1.52E+018,"testalpha"
,"commercial glass ionomer powder","JJ NN NN NN",4,1,1,16701865,"pubmed1",3.06E+018,"testalpha"
,"role risk ratio rr","NN NN NN ",4,1,1,17106601,2,4.50E+018,"testalpha"
,"regression sensitivity and specificity","NN NN CC NN",4,1,1,17016037,2,3.71E+017,"testalpha"
,"wall and pelvic floor","NN CC JJ NN",4,1,1,17139898,2,4.45E+018,"testalpha"
,"less complications and shorterlength","JJR NNS CC NN",4,1,1,16613748,2,5.64E+018,"testalpha"
,"arteries using themonomeric ioversol","NNS VBG JJ NNP",4,1,1,16399037,"pubmed1",2.35E+018,"testalpha"
,"beta nicotinic receptors nachrs","NN JJ NNS NNP",4,1,1,16594645,"pubmed1",6.96E+018,"testalpha"
,"marp pain scores blood"," NN NNS NN",4,1,1,16612915,"pubmed1",5.09E+018,"testalpha"
,"cd cd dr andcd","   ",4,1,1,17119322,2,3.83E+018,"testalpha"
,"groups untreated control uc","NNS JJ NN ",4,1,1,16714049,2,5.14E+017,"testalpha"
,"distribution and location ofcarbohydrate","NN CC NN NN",4,1,1,16542712,2,4.22E+017,"testalpha"
,"chronic lymphocytic leukaemia developedzygomycosis","JJ JJ NN NN",4,1,1,17370565,"pubmed1",3.26E+018,"testalpha"
,"dcl showed elastic fibers"," VBD JJ NNS",4,1,1,16714053,2,6.82E+018,"testalpha"
,"biology todefine efficient protein","NN NN JJ NN",4,1,1,16369090,2,2.59E+018,"testalpha"
,"clofarabine andadp bound dck","NN  VBN ",4,1,1,16421443,2,6.46E+018,"testalpha"
,"medicinal chemistry projects crystal","JJ NN NNS NN",4,1,1,16369099,2,1.53E+018,"testalpha"
,"evaluation of newer techniques","NN IN JJR NNS",4,1,1,17165595,2,8.11E+018,"testalpha"
,"rat heart and increasedwith","NN NN CC NN",4,1,1,17046052,2,8.20E+018,"testalpha"
,"histone deacetylase hdac inhibitors","NN NN  NNS",4,1,1,16424655,2,4.84E+018,"testalpha"
,"ofantagonists of group metabotropic","NNS IN NN NN",4,1,1,17265692,2,7.40E+018,"testalpha"
,"related stress wereimportant risk","VBN NN JJ NN",4,1,1,16236234,"pubmed1",7.46E+018,"testalpha"
,"complementationmechanism of fiber formation","NN IN NN NN",4,1,1,16421447,2,4.01E+018,"testalpha"
,"role of ne cells","NN IN  NNS",4,1,1,16997356,2,8.10E+018,"testalpha"
,"technique for postoperative analgesiaafter","NN IN JJ NN",4,1,1,16617755,"pubmed1",3.10E+018,"testalpha"
,"discs demonstrated ahigher alkaline","NNS VBN JJ NN",4,1,1,16701866,"pubmed1",4.75E+017,"testalpha"
,"total dose of cd","JJ NN IN ",4,1,1,17119322,2,1.02E+018,"testalpha"
,"hyperplastic tumorstate and back","JJ NN CC NN",4,1,1,16988902,"pubmed1",7.66E+018,"testalpha"
,"specific salaries credentials andgraduate","JJ NNS NNS NN",4,1,1,16377812,"pubmed1",6.58E+018,"testalpha"
,"safetyclimate and occupational injury","NN CC JJ NN",4,1,1,16442068,"pubmed1",8.54E+018,"testalpha"
,"aminolaevulinic acidpdt in patients","JJ  IN NNS",4,1,1,16955183,2,8.22E+018,"testalpha"
,"such biotoxins are botulinumtoxin","JJ NNS VBP ",4,1,1,16696436,2,8.52E+018,"testalpha"
,"betweensed cm and age","VBN  CC NN",4,1,1,17067139,"pubmed1",5.59E+017,"testalpha"
,"related tolower si concentrations","VBN NN  NNS",4,1,1,16809889,2,4.94E+018,"testalpha"
,"linear hydrogen bonded chains","JJ NN VBN NNS",4,1,1,16456296,2,3.95E+018,"testalpha"
,"practices of african americans","NNS IN JJ NNS",4,1,1,16596897,"pubmed1",8.61E+018,"testalpha"
,"increasing grade of cin","VBG NN IN ",4,1,1,16514834,2,3.17E+018,"testalpha"
,"immunolocalisation and hyaluronate deposition","NN CC NN NN",4,1,1,16713618,2,7.86E+018,"testalpha"
,"dependency in daily living","NN IN JJ NN",4,1,1,16451146,"pubmed1",2.38E+016,"testalpha"
,"elimination of neoplastic tissue","NN IN JJ NN",4,1,1,16603102,2,4.63E+018,"testalpha"
,"tsa in pesticide exposure"," IN VB NN",4,1,1,16956116,2,8.72E+018,"testalpha"
,"st segment elevation nste"," NN NN ",4,1,1,16365321,"pubmed1",8.19E+018,"testalpha"
,"pbd and intra operativegpd"," CC JJ ",4,1,1,16491216,2,5.24E+017,"testalpha"
,"emergency care emergency physicians","NN NN NN NNS",4,1,1,16365325,"pubmed1",1.93E+018,"testalpha"
,"galactokinase from pyrococcus horikoshii","NN IN NN ",4,1,1,16511293,2,1.21E+018,"testalpha"
,"reducedmean neo epidermal thickness","JJ  JJ NN",4,1,1,16874412,2,1.86E+018,"testalpha"
,"changes gastresophageal refluxand anxiety","NNS NN NN NN",4,1,1,17338194,2,2.49E+018,"testalpha"
,"shock exposure of gut","NN NN IN NN",4,1,1,17438835,2,5.84E+017,"testalpha"
,"cerebro vascular disease brain","NNP JJ NN NN",4,1,1,16479025,2,8.70E+018,"testalpha"
,"th and th digital"," CC  NN",4,1,1,16612927,"pubmed1",4.72E+018,"testalpha"
,"living organisms in thecourse","VBG NNS IN NN",4,1,1,16951740,"pubmed1",6.26E+018,"testalpha"
,"areas of knowledge skill","NNS IN NN NN",4,1,1,16438092,"pubmed1",4.15E+018,"testalpha"
,"exactdetermination of amyloid type","NN IN VB NN",4,1,1,16714055,2,5.59E+018,"testalpha"
,"ir raman andx ray"," NN  ",4,1,1,16701876,"pubmed1",2.73E+018,"testalpha"
,"mechanisms of homocysteine evokedneurotoxicity","NNS IN NN NN",4,1,1,17265692,2,3.08E+018,"testalpha"
,"bim l transfected hek","  VBN ",4,1,1,16951744,"pubmed1",9.02E+018,"testalpha"
,"resectedpatients with colon cancer","NNS IN NN NN",4,1,1,17139895,2,6.98E+016,"testalpha"
,"further revealsa high degree","JJ NNP JJ NN",4,1,1,16951743,"pubmed1",1.73E+018,"testalpha"
,"ofdermatology aarhus university hospital","NN  NN NN",4,1,1,16710581,2,8.74E+018,"testalpha"
,"procedures and morphometric analyseson","NNS CC JJ NN",4,1,1,17293969,2,6.24E+018,"testalpha"
,"helminth homologues of cytokines","NN NNS IN NNS",4,1,1,16410836,"pubmed1",7.58E+018,"testalpha"
,"considered clinical history skintests","VBN JJ NN NNS",4,1,1,16673561,2,5.53E+018,"testalpha"
,"blood samples from patients","NN NNS IN NNS",4,1,1,16874419,2,2.91E+017,"testalpha"
,"crystals of theselenomethionine proteins","NNS IN NN NNS",4,1,1,16511259,2,6.32E+018,"testalpha"
,"protect organs fromischemia reperfusion","VB NNS NN NN",4,1,1,16365323,"pubmed1",1.63E+018,"testalpha"
,"diagnosis severity of lung","NN NN IN NN",4,1,1,16451155,"pubmed1",2.02E+018,"testalpha"
,"study period consisted ofresults","NN NN VBD NNS",4,1,1,16436791,"pubmed1",3.63E+018,"testalpha"
,"t lymphocyte ctl responses"," NNP  NNS",4,1,1,16511250,2,5.56E+017,"testalpha"
,"acomputerized lesion segmentation method","VBN NN NN NN",4,1,1,16399033,"pubmed1",8.52E+018,"testalpha"
,"end stage liver diseases","NN NN NN NNS",4,1,1,17013520,2,6.15E+018,"testalpha"
,"mu pi sigma theta","  NN NN",4,1,1,17019444,"pubmed1",1.81E+018,"testalpha"
,"typical morphological elements shoots","JJ JJ NNS NNS",4,1,1,17486414,"pubmed1",4.70E+018,"testalpha"
,"identification of mild tbi","NN IN JJ ",4,1,1,16365331,"pubmed1",6.02E+018,"testalpha"
,"anxiety inpatients during ambulance","NN NNS IN NN",4,1,1,16365322,"pubmed1",7.14E+018,"testalpha"
,"mm hg conclusions aspiration","  NNS NN",4,1,1,16491219,2,8.50E+018,"testalpha"
,"tricobalt ii bis hexafluorophosphate","NN   NN",4,1,1,16456276,2,5.22E+018,"testalpha"
,"mature uninjured skeletal muscle","JJ JJ NN NN",4,1,1,16965805,2,7.25E+018,"testalpha"
,"improved survival in addition","VBN NN IN NN",4,1,1,16451156,"pubmed1",8.33E+018,"testalpha"
,"shock and fluid resuscitation","NN CC NN NN",4,1,1,16365323,"pubmed1",5.89E+018,"testalpha"
,"sign ofdisseminated intravascular coagulation","NN VBN JJ NN",4,1,1,16916181,"pubmed1",4.11E+018,"testalpha"
,"mild immunoreactivity of enos","JJ NN IN ",4,1,1,16762404,2,5.97E+018,"testalpha"
,"stz induced diabetic liver"," VBN JJ NN",4,1,1,16714049,2,3.54E+018,"testalpha"
,"oxygenation of human hemoglobin","NN IN JJ NNP",4,1,1,17019442,"pubmed1",1.17E+018,"testalpha"
,"acid groups of mep","NN NNS IN ",4,1,1,16701862,"pubmed1",2.18E+018,"testalpha"
,"square error between thehalf","NN NN IN NN",4,1,1,16399032,"pubmed1",3.73E+018,"testalpha"
,"fxi deficiency and carriers"," NN CC NNS",4,1,1,16424651,2,5.51E+018,"testalpha"
,"acontinuous infusion of ringer","JJ NN IN NN",4,1,1,16365323,"pubmed1",7.79E+018,"testalpha"
,"replace eti inemergency airway","VB  NN NN",4,1,1,16451149,"pubmed1",1.76E+018,"testalpha"
,"include unsafe dietary patterns","VB NN JJ NNS",4,1,1,16918070,"pubmed1",4.65E+018,"testalpha"
,"localized formand extensive forms","JJ NN JJ NNS",4,1,1,17010262,2,3.35E+018,"testalpha"
,"c alt and ast","NN  CC ",4,1,1,16696441,2,3.09E+018,"testalpha"
,"overview of relevant mutationmethods","NN IN JJ NNS",4,1,1,16369090,2,4.11E+018,"testalpha"
,"retrospective review of oursingle","JJ NN IN NN",4,1,1,16424648,2,2.64E+018,"testalpha"
,"showed sclerotictissue without tumor","VBD NN IN NN",4,1,1,16603102,2,1.99E+018,"testalpha"
,"asct arm b patients"," NN NN NNS",4,1,1,16424644,2,8.47E+018,"testalpha"
,"cases indicative ofinfectious diseases","NNS JJ JJ NNS",4,1,1,16809889,2,8.93E+018,"testalpha"
,"em using cytohistologic correlation"," VBG JJ NN",4,1,1,16514840,2,4.69E+018,"testalpha"
,"nanometer sized details togetherwith","NN VBN NNS NN",4,1,1,16411737,"pubmed1",7.21E+018,"testalpha"
,"startle behavior of rats","VB NN IN NNS",4,1,1,17133954,2,1.48E+018,"testalpha"
,"wax embedded sectionsof thyroid"," VBN  NN",4,1,1,16762403,2,7.02E+018,"testalpha"
,"optimal prevention and treatment","JJ NN CC NN",4,1,1,16549898,2,6.09E+018,"testalpha"
,"nmr analysis insolution d"," NN NN ",4,1,1,16496039,"pubmed1",2.82E+018,"testalpha"
,"level of pfkfb protein","NN IN  NN",4,1,1,17143338,"pubmed1",7.04E+018,"testalpha"
,"n n bis pyridylmethyl","   ",4,1,1,16456265,2,6.67E+018,"testalpha"
,"function post anaesthetic care","NN NN JJ NN",4,1,1,16451145,"pubmed1",4.78E+018,"testalpha"
,"occupational health nurse cohn","JJ NN NN ",4,1,1,16438092,"pubmed1",3.30E+018,"testalpha"
,"period of expectant management","NN IN JJ NN",4,1,1,16612913,"pubmed1",8.99E+018,"testalpha"
,"review of therapeutic options","NN IN JJ NNS",4,1,1,17311742,2,9.00E+018,"testalpha"
,"d computer based models"," NN VBN NNS",4,1,1,16399038,"pubmed1",7.68E+018,"testalpha"
,"insertion oxygenation and ventilation","NN NN CC NN",4,1,1,16451149,"pubmed1",5.58E+018,"testalpha"
,"patientdestination by using patient","NN IN VBG NN",4,1,1,16365324,"pubmed1",8.81E+018,"testalpha"
,"erythropoiesis in hd patients","NN IN  NNS",4,1,1,17119323,2,5.92E+018,"testalpha"
,"c h o hydrogen","NN   NN",4,1,1,16397330,2,6.29E+018,"testalpha"
,"consequent formation of age","NN NN IN NN",4,1,1,16696441,2,1.43E+018,"testalpha"
,"record linkage identified drivers","NN NN VBD NNS",4,1,1,16043107,"pubmed1",1.81E+018,"testalpha"
,"orientation of substituted pyridines","NN IN VBN NNS",4,1,1,16397333,2,8.42E+018,"testalpha"
,"hand exercise induced activation","NN NN VBN NN",4,1,1,16921608,"pubmed1",5.22E+018,"testalpha"
,"heart colon lung kidney","NN NN NN NN",4,1,1,16514845,2,5.30E+018,"testalpha"
,"duration by p ns","NN IN  ",4,1,1,17236635,"pubmed1",7.07E+018,"testalpha"
,"analysis of tssr frequency","NN IN  NN",4,1,1,16733558,"pubmed1",8.91E+017,"testalpha"
,"socialsettings at conversational distances","NNS IN JJ NNS",4,1,1,17165599,2,4.51E+017,"testalpha"
,"group in anthracene molecule","NN IN NN NN",4,1,1,16404478,"pubmed1",5.12E+018,"testalpha"
,"counties are described conviction","NNS VBP VBN NN",4,1,1,16423318,"pubmed1",6.74E+018,"testalpha"
,"signs of anastomotic leakage","NNS IN JJ NN",4,1,1,16612911,2,8.29E+018,"testalpha"
,"drugs orfoodstuffs in retardation","NNS NNS IN NN",4,1,1,17007910,2,8.49E+018,"testalpha"
,"csav d polylepsisvenom ns","  NN ",4,1,1,16436788,"pubmed1",5.75E+018,"testalpha"
,"upper extremities arterial blood","JJ NNS JJ NN",4,1,1,16617761,"pubmed1",4.84E+018,"testalpha"
,"analysis of gus activity","NN IN  NN",4,1,1,16395526,"pubmed1",6.67E+018,"testalpha"
,"methods forty fiveconsecutive patients","NNS NN JJ NNS",4,1,1,16447095,"pubmed1",5.70E+018,"testalpha"
,"scanning magnetic resonance image","VBG JJ NN NN",4,1,1,16436787,"pubmed1",7.16E+018,"testalpha"
,"ethane diamine c h","NN NN NN ",4,1,1,16456284,2,7.76E+018,"testalpha"
,"tgf beta induces activation"," NN NNS NN",4,1,1,16874413,2,6.33E+018,"testalpha"
,"frequency of atopic dermatitis","NN IN NN NN",4,1,1,16648913,2,7.51E+018,"testalpha"
,"multidetector row computed tomography","NN VB VBN NN",4,1,1,16333701,"pubmed1",5.20E+018,"testalpha"
,"california san francisco aftersystem","NNP  NNP NN",4,1,1,16377825,"pubmed1",2.59E+018,"testalpha"
,"previousdrug induced blistering diseases","NN VBN VBG NNS",4,1,1,16710577,2,4.18E+018,"testalpha"
,"thefaculty hospital in hradec","NN NN IN ",4,1,1,16999268,2,6.54E+018,"testalpha"
,"case fulfils except acidosis","NN NNS VB NN",4,1,1,16451160,"pubmed1",1.26E+018,"testalpha"
,"none in negative control","NN IN JJ NN",4,1,1,16395527,"pubmed1",6.90E+018,"testalpha"
,"tentimes as much volume","NNS IN NN NN",4,1,1,16491219,2,6.68E+018,"testalpha"
,"plasma from umbilical cords","NNP IN JJ NNS",4,1,1,16549888,2,3.40E+018,"testalpha"
,"mutation p gly ser","NN   ",4,1,1,17106596,2,1.43E+018,"testalpha"
,"similar coordination and reactivity","JJ NN CC NN",4,1,1,17117212,"pubmed1",5.82E+018,"testalpha"
,"time topublication was months","NN NN VBD NNS",4,1,1,16365332,"pubmed1",2.59E+018,"testalpha"
,"thrombotic event myocardial infarctionsand","JJ NN JJ NN",4,1,1,16914907,2,8.71E+018,"testalpha"
,"molecular basis for fvii","JJ NN IN ",4,1,1,16914903,2,3.44E+018,"testalpha"
,"titanium surface area samples","NN NN NN NNS",4,1,1,17293968,2,4.89E+018,"testalpha"
,"hemoglobin hb owing tonontoxicity","NNP  VBG NN",4,1,1,16594643,"pubmed1",4.44E+018,"testalpha"
,"dte and direct drug"," CC JJ NN",4,1,1,16584167,"pubmed1",6.36E+018,"testalpha"
,"founder mated withwild type","NN VBN VB NN",4,1,1,16951742,"pubmed1",5.22E+017,"testalpha"
,"number of inflammatory cells","NN IN JJ NNS",4,1,1,16514850,2,4.78E+018,"testalpha"
,"fistula anal polyps sinuses","NN   NNS",4,1,1,17139880,2,5.32E+018,"testalpha"
,"complete resolution of thethrombus","JJ NN IN NNP",4,1,1,16549900,2,3.62E+018,"testalpha"
,"risk factors of thromboembolism","NN NNS IN NN",4,1,1,16696443,2,5.72E+018,"testalpha"
,"comparisons of hepatic injury","NNS IN JJ NN",4,1,1,17013521,2,6.72E+018,"testalpha"
,"multivariable models postgraduate year","JJ NNS NN NN",4,1,1,16377825,"pubmed1",7.23E+018,"testalpha"
,"source molecular replacement trials","NN JJ NN NNS",4,1,1,16511256,2,8.67E+018,"testalpha"
,"contralateral areas cm diameter","JJ NNS  NN",4,1,1,16585985,2,7.94E+017,"testalpha"
,"eosinophil proteins than ad"," NNS IN NN",4,1,1,16859611,2,8.10E+018,"testalpha"
,"minimal years education background","JJ NNS NN NN",4,1,1,16479025,2,6.83E+018,"testalpha"
,"others and self study","NNS CC NN NN",4,1,1,16436795,"pubmed1",4.09E+018,"testalpha"
,"sodium carbonate sodium salicylate","NN NN NN NN",4,1,1,17285749,"pubmed1",9.95E+017,"testalpha"
,"inhibitors are promising candidates","NNS VBP JJ NNS",4,1,1,16424655,2,6.34E+018,"testalpha"
,"children specific adaptation phenomena","NNS JJ NN NNS",4,1,1,16921609,"pubmed1",8.97E+018,"testalpha"
,"inspecimens from beta d","NNS IN NN ",4,1,1,16612917,"pubmed1",3.22E+018,"testalpha"
,"function as tested bycpa","NN IN VBN ",4,1,1,16549890,2,8.64E+017,"testalpha"
,"csns and midcervical vagotomy"," CC JJ NN",4,1,1,17133957,2,7.14E+018,"testalpha"
,"various acute phase proteinsin","JJ JJ NN NNP",4,1,1,16714050,2,3.48E+018,"testalpha"
,"altered expression program transcriptosome","VBN NN NN NN",4,1,1,16914901,2,4.19E+018,"testalpha"
,"reactivecarbohydrates including sialic acids","NNS IN JJ NNS",4,1,1,16542712,2,5.50E+018,"testalpha"
,"d anatomy in endoscopic"," NN IN NN",4,1,1,16399038,"pubmed1",1.09E+018,"testalpha"
,"model was usedto model","NN VBD  NN",4,1,1,16202465,"pubmed1",8.31E+018,"testalpha"
,"types of regulatory t","NNS IN JJ ",4,1,1,17016036,2,2.82E+018,"testalpha"
,"theadministration of ppsb sd","NN IN  ",4,1,1,16916181,"pubmed1",2.37E+018,"testalpha"
,"prognosis workup and treatment","NN NN CC NN",4,1,1,16514846,2,1.07E+018,"testalpha"
,"summary estimates of effect","NN NNS IN NN",4,1,1,16427020,"pubmed1",6.41E+018,"testalpha"
,"results lasertreatment with ruby","NNS NN IN ",4,1,1,16710582,2,4.79E+017,"testalpha"
,"level of anxiety inpatients","NN IN NN NNS",4,1,1,16365322,"pubmed1",1.64E+018,"testalpha"
,"irradiation and noanastomosis group","NN CC NN NN",4,1,1,16612919,"pubmed1",1.63E+017,"testalpha"
,"age and phone use","NN CC NN NN",4,1,1,16157285,"pubmed1",8.31E+018,"testalpha"
,"nodes and liver metastaseswas","NNS CC NN ",4,1,1,17139879,2,7.32E+018,"testalpha"
,"ir raman and x"," NN CC NN",4,1,1,16701876,"pubmed1",2.60E+018,"testalpha"
,"whenultrasonography and computed tomography","NN CC VBN NN",4,1,1,17119328,2,9.10E+018,"testalpha"
,"involvement group ii n","NN NN  ",4,1,1,16956117,2,7.25E+018,"testalpha"
,"b cell lymphomas isworse","NN NN NNP NN",4,1,1,16612936,"pubmed1",7.88E+017,"testalpha"
,"children boys and girls","NNS NNS CC NNS",4,1,1,16956119,2,9.10E+018,"testalpha"
,"differentiation of sinus histiocytosis","NN IN NN NN",4,1,1,16256177,2,8.55E+018,"testalpha"
,"surgery and re implantation","NN CC  NN",4,1,1,16451159,"pubmed1",3.64E+017,"testalpha"
,"methyl ester l name"," NN  NN",4,1,1,16764913,2,3.10E+018,"testalpha"
,"higher concentration of hmr","JJR NN IN ",4,1,1,16566960,2,8.30E+018,"testalpha"
,"governed sign mediatedinteractions i","VBN NN NNS ",4,1,1,16988903,"pubmed1",7.86E+017,"testalpha"
,"composition of common sbf","NN IN JJ ",4,1,1,16701876,"pubmed1",2.28E+018,"testalpha"
,"reminiscent liver after partialhepatectomy","JJ NN IN NN",4,1,1,17013509,2,3.56E+018,"testalpha"
,"receive week vacop b","VB NN NNP NN",4,1,1,16424644,2,2.30E+018,"testalpha"
,"enzyme inhibitors for heart"," NNS IN NN",4,1,1,16377816,"pubmed1",7.74E+018,"testalpha"
,"single patch of hair","JJ NN IN NN",4,1,1,17010262,2,1.13E+018,"testalpha"
,"splanchnic sympathetic outflow t","JJ JJ NN ",4,1,1,16916187,"pubmed1",5.59E+018,"testalpha"
,"produce growth factors citocins","VB NN NNS NNS",4,1,1,17013515,2,2.09E+018,"testalpha"
,"provides anoverview for nurse","VBZ NN IN NN",4,1,1,16596895,"pubmed1",6.71E+018,"testalpha"
,"human cytosolic acetyl coa","JJ JJ  ",4,1,1,16951743,"pubmed1",1.92E+018,"testalpha"
,"skin reconstructions were includedand","NN NNS VBD NN",4,1,1,17165596,2,6.35E+018,"testalpha"
,"normal limits in cases","JJ NNS IN NNS",4,1,1,16514850,2,8.46E+018,"testalpha"
,"production of transforming growth","NN IN VBG NN",4,1,1,16733556,"pubmed1",5.28E+018,"testalpha"
,"increased expression of hsp","VBN NN IN ",4,1,1,16365323,"pubmed1",4.78E+018,"testalpha"
,"essential oil if comparedwith","JJ NN IN NN",4,1,1,16584150,"pubmed1",6.13E+018,"testalpha"
,"educated enlisted male personnel","VBN VBD NN NNS",4,1,1,16405857,"pubmed1",8.67E+018,"testalpha"
,"crystallization and preliminaryx ray","NN CC  ",4,1,1,16511275,2,6.07E+018,"testalpha"
,"connective tissue properties mayaffect","JJ NN NNS NN",4,1,1,16962646,2,7.09E+017,"testalpha"
,"sign mediatedinteractions i e","NN NNS  ",4,1,1,16988903,"pubmed1",3.28E+018,"testalpha"
,"focusgroups of internal medicine","NNS IN JJ NN",4,1,1,16377823,"pubmed1",1.54E+018,"testalpha"
,"clearance persistence of hr","NN NN IN ",4,1,1,16514834,2,5.36E+018,"testalpha"
,"catheter is functioning treatment","NN VBZ VBG NN",4,1,1,16549897,2,6.19E+018,"testalpha"
,"choice ofthe ex vivo","NN NNP  ",4,1,1,17160143,"pubmed1",7.47E+018,"testalpha"
,"melanocytes via increased expression","NNS IN VBN NN",4,1,1,17106595,2,4.75E+017,"testalpha"
,"measuresinclude helmet use compliance","VB VB NN NN",4,1,1,16223468,"pubmed1",5.77E+018,"testalpha"
,"type zinc finger motif","NN NN NN NN",4,1,1,16411739,"pubmed1",8.24E+018,"testalpha"
,"university policies onresearch record","NN NNS NN NN",4,1,1,16377817,"pubmed1",5.22E+015,"testalpha"
,"cardiac dysfunction e g","JJ NN  ",4,1,1,16566960,2,8.62E+018,"testalpha"
,"injury and incomplete tetraplegiaand","NN CC JJ NN",4,1,1,16111641,"pubmed1",5.87E+018,"testalpha"
,"various types of immunoregulatory","JJ NNS IN NN",4,1,1,17016036,2,6.38E+018,"testalpha"
,"clinical examination of adults","JJ NN IN NNS",4,1,1,16648916,2,6.77E+018,"testalpha"
,"types of organisms producesubstances","NNS IN NNS NNS",4,1,1,16696436,2,6.41E+018,"testalpha"
,"bias time lag bias","NN NN VB NN",4,1,1,16365332,"pubmed1",3.35E+018,"testalpha"
,"ip and azoxymethane aom"," CC NN ",4,1,1,17293967,2,7.93E+018,"testalpha"
,"fast vapor pressure rise","JJ  NN NN",4,1,1,17285744,"pubmed1",9.51E+017,"testalpha"
,"systemic small vessel vasculitis","JJ JJ NN NN",4,1,1,16648918,2,6.07E+018,"testalpha"
,"was fitted toexperimental data","VBD VBN NN NNS",4,1,1,16404478,"pubmed1",4.96E+018,"testalpha"
,"mrna turnover in cells"," NN IN NNS",4,1,1,16389406,"pubmed1",7.30E+018,"testalpha"
,"hs family members n"," NN NNS ",4,1,1,17016037,2,8.39E+018,"testalpha"
,"t sugarpuckering n type"," VBG  NN",4,1,1,16456292,2,6.62E+018,"testalpha"
,"pigileum and mouse vas","NN CC NN ",4,1,1,16496038,"pubmed1",8.90E+018,"testalpha"
,"intraoperative red blood cell","JJ JJ NN NN",4,1,1,17013513,2,2.20E+018,"testalpha"
,"safety criteria associatedwith screening","NN NNS NN NN",4,1,1,16999268,2,4.78E+018,"testalpha"
,"cytoplasm and eccentric nuclei","NN CC JJ ",4,1,1,16514847,2,4.37E+018,"testalpha"
,"allergens hdm patients grass","NNS  NNS NN",4,1,1,17328144,2,2.69E+018,"testalpha"
,"important roles inembryonic development","JJ NNS JJ NN",4,1,1,16325892,2,3.36E+018,"testalpha"
,"oxidoreductase succinate dehydrogenaseand cytochrome","NN NN NN NN",4,1,1,17068635,"pubmed1",4.91E+018,"testalpha"
,"potential foradverse pregnancy outcomes","JJ NN NN NNS",4,1,1,16808045,"pubmed1",3.44E+018,"testalpha"
,"determining ankle and foot","VBG NN CC NN",4,1,1,17293973,2,2.78E+018,"testalpha"
,"significantlyattenuated bp in nos","VBN  IN NNS",4,1,1,16764913,2,8.41E+018,"testalpha"
,"significant consequences for patientcare","JJ NNS IN NN",4,1,1,16377823,"pubmed1",7.32E+017,"testalpha"
,"children with acute itp","NNS IN JJ ",4,1,1,16424649,2,5.05E+018,"testalpha"
,"bleeding contrast enhanced mdct","VBG NN VBN ",4,1,1,16333701,"pubmed1",3.89E+017,"testalpha"
,"extracts from rodent liver","NNS IN NN NN",4,1,1,17143337,"pubmed1",8.96E+018,"testalpha"
,"group lm showed nomicrocirculation","NN  VBD NN",4,1,1,17438835,2,2.93E+018,"testalpha"
,"climate i e management","NN   NN",4,1,1,16442068,"pubmed1",5.28E+018,"testalpha"
,"residencyresearch training for careers","NN NN IN NNS",4,1,1,16473996,"pubmed1",9.15E+018,"testalpha"
,"cells of pluripotent characteristics","NNS IN NN NNS",4,1,1,17265690,2,7.18E+018,"testalpha"
,"theproteomic approach of brain","JJ NN IN NN",4,1,1,17265689,2,1.82E+018,"testalpha"
,"type as matching fields","NN IN VBG NNS",4,1,1,16221468,"pubmed1",6.98E+018,"testalpha"
,"ssme sumatriptan solution sss"," NNP NN ",4,1,1,16584167,"pubmed1",1.27E+018,"testalpha"
,"epidermis ofthe limbs tail","NN NNP NNS NN",4,1,1,16733064,2,5.67E+018,"testalpha"
,"oxidative metabolism and glycerol","JJ NN CC NN",4,1,1,16919313,2,2.80E+018,"testalpha"
,"ccl cells boundspecific lectins"," NNS NNP NNS",4,1,1,16414103,2,3.48E+018,"testalpha"
,"receptors of vestibular nociceptor","NNS IN JJ NN",4,1,1,16997356,2,7.12E+018,"testalpha"
,"transfection of bim l","NN IN  ",4,1,1,16951744,"pubmed1",8.42E+018,"testalpha"
,"thestructure and fragmentation mode","NN CC NN NN",4,1,1,16496039,"pubmed1",5.43E+018,"testalpha"
,"leukemia cml patients diagnosedand","NN  NNS NN",4,1,1,16914906,2,3.59E+018,"testalpha"
,"monitoring of such patients","NN IN JJ NNS",4,1,1,17106602,2,8.41E+018,"testalpha"
,"complex ak adenosine amp","JJ  NN ",4,1,1,16421444,2,4.93E+018,"testalpha"
,"effects of h o","NNS IN  ",4,1,1,17046053,2,8.75E+018,"testalpha"
,"evaluation of metastatic diseaseand","NN IN JJ NN",4,1,1,16673556,2,2.88E+018,"testalpha"
,"clinical duration by p","JJ NN IN ",4,1,1,17236635,"pubmed1",2.87E+018,"testalpha"
,"effect of age gender","NN IN NN NN",4,1,1,16426561,"pubmed1",1.20E+018,"testalpha"
,"carvedilol pretreated group tl"," VBN NN ",4,1,1,17338197,2,6.45E+018,"testalpha"
,"unstabilized hsa detailed dsc","VBN  VBN ",4,1,1,17285745,"pubmed1",5.65E+018,"testalpha"
,"calcium ion binding site","NN  VBG NN",4,1,1,16511247,2,8.70E+018,"testalpha"
,"sheep with thearq arq","NN IN  ",4,1,1,16770445,"pubmed1",4.97E+018,"testalpha"
,"head on side impact","NN IN NN NN",4,1,1,16197912,"pubmed1",2.92E+018,"testalpha"
,"witha thromboembolic complication occurrence","NN JJ NN NN",4,1,1,16696443,2,7.10E+018,"testalpha"
,"precursors ofprimordial germ cells","NNS JJ NN NNS",4,1,1,17265694,2,4.64E+018,"testalpha"
,"theactivating routes in pepsinogen","VBG NNS IN NN",4,1,1,16770446,"pubmed1",6.15E+017,"testalpha"
,"statistical analysis using anova","JJ NN VBG NNP",4,1,1,17293969,2,4.22E+018,"testalpha"
,"centerprospective study platelet function","JJ NN NN NN",4,1,1,16549890,2,1.45E+018,"testalpha"
,"durd resistant mouse leukemia"," JJ NN NN",4,1,1,16505899,"pubmed1",6.40E+018,"testalpha"
,"age and annual driving","NN CC JJ NN",4,1,1,16054104,"pubmed1",2.92E+018,"testalpha"
,"calcium level lymphocyte count","NN NN NNP NN",4,1,1,16479024,2,7.48E+018,"testalpha"
,"respiratory mechanics and gasexchange","NN NNS CC NN",4,1,1,16451155,"pubmed1",6.56E+018,"testalpha"
,"weight and visceral fat","NN CC JJ NN",4,1,1,16918068,"pubmed1",7.67E+017,"testalpha"
,"care for several days","NN IN JJ NNS",4,1,1,16612911,2,4.06E+018,"testalpha"
,"prenotice letter surveywith self","NN NN NN NN",4,1,1,16377812,"pubmed1",1.56E+018,"testalpha"
,"dose reduction and therapyattenuation","NN NN CC NN",4,1,1,16424645,2,4.08E+018,"testalpha"
,"using patient and system","VBG NN CC NN",4,1,1,16365324,"pubmed1",6.71E+018,"testalpha"
,"nf kappab transcription factors","  NN NNS",4,1,1,17068636,"pubmed1",7.68E+018,"testalpha"
,"ionising radiation induced dsb","VBG NN VBN ",4,1,1,16404475,"pubmed1",5.39E+018,"testalpha"
,"breast lung and rib","NN NN CC ",4,1,1,16714048,2,8.63E+018,"testalpha"
,"weight cryptdepth villus height","NN NN NN NN",4,1,1,17293957,2,6.56E+017,"testalpha"
,"breach avoidance facilitator baf","NN NN NN ",4,1,1,16377191,"pubmed1",3.22E+018,"testalpha"
,"ibd patients at years"," NNS IN NNS",4,1,1,16673554,2,1.98E+018,"testalpha"
,"following iv and intranasal","VBG  CC NN",4,1,1,16584167,"pubmed1",4.46E+017,"testalpha"
,"direct contact survey approach","JJ NN NN NN",4,1,1,16399035,"pubmed1",1.44E+018,"testalpha"
,"catalytic subunit dna pkcs","JJ JJ  ",4,1,1,16404475,"pubmed1",8.31E+018,"testalpha"
,"major antigen of rhdv","JJ NN IN ",4,1,1,16733562,"pubmed1",9.08E+018,"testalpha"
,"other forloading rates pn","NN VBG NNS ",4,1,1,16410837,"pubmed1",7.09E+018,"testalpha"
,"death ligand pd l","NN NN  ",4,1,1,16530813,2,5.50E+018,"testalpha"
,"nonpolyposis colorectal cancer hnpcc","NN NN NN ",4,1,1,17139886,2,3.91E+018,"testalpha"
,"receptor nuclear translocator arnt","NN JJ NN ",4,1,1,16411738,"pubmed1",1.40E+018,"testalpha"
,"characteristics clinical presentation symptoms","NNS JJ NN NNS",4,1,1,16696444,2,1.78E+017,"testalpha"
,"function tests ultrasound examination","NN NNS NN NN",4,1,1,16956119,2,1.67E+018,"testalpha"
,"thec h type zinc","  NN NN",4,1,1,16411739,"pubmed1",4.01E+018,"testalpha"
,"deletions and g insertion","NNS CC  NN",4,1,1,16733554,"pubmed1",1.46E+015,"testalpha"
,"patient with relapsed mm","NN IN VBN ",4,1,1,17016040,2,3.84E+018,"testalpha"
,"torsion angles phi psi","NN NNS  ",4,1,1,16528414,"pubmed1",3.58E+018,"testalpha"
,"intubation incision and extubation","NN NN CC NN",4,1,1,17067138,"pubmed1",3.11E+018,"testalpha"
,"cancer clinical practice recommendations","NN JJ NN NNS",4,1,1,16596895,"pubmed1",5.36E+018,"testalpha"
,"dawley rats weighing g","NNP NNS VBG ",4,1,1,16762404,2,5.74E+017,"testalpha"
,"co atoms in i"," NNS IN ",4,1,1,16397335,2,3.05E+018,"testalpha"
,"n week n week"," NN  NN",4,1,1,16574202,2,7.02E+018,"testalpha"
,"deaths per person years","NNS IN NN NNS",4,1,1,16412373,"pubmed1",6.90E+018,"testalpha"
,"eosinophil proteins than patients"," NNS IN NNS",4,1,1,16859611,2,2.62E+018,"testalpha"
,"cocaine use and alcohol","NN NN CC NN",4,1,1,16436792,"pubmed1",5.14E+018,"testalpha"
,"extrinsic conditions stimulatingthe regrowth","NN NNS NNP NN",4,1,1,16414104,2,1.37E+018,"testalpha"
,"conformational transitions in peptides","JJ NNS IN NNS",4,1,1,16388314,"pubmed1",5.45E+018,"testalpha"
,"class i and ii","NN  CC ",4,1,1,16733557,"pubmed1",7.82E+018,"testalpha"
,"group showed significantsoluble fas","NN VBD JJ ",4,1,1,16710577,2,1.22E+018,"testalpha"
,"regarding pediatric body composition","VBG JJ NN NN",4,1,1,16918067,"pubmed1",6.14E+018,"testalpha"
,"c c space group","NN NN NN NN",4,1,1,16456295,2,4.08E+018,"testalpha"
,"given unchanged mortality rates","VBN JJ NN NNS",4,1,1,16436788,"pubmed1",4.61E+018,"testalpha"
,"hydrogen bonds involving thecarboxylate","NN NNS VBG NN",4,1,1,16456289,2,5.14E+018,"testalpha"
,"night time teen driver","NN NN  NN",4,1,1,16171767,"pubmed1",9.14E+017,"testalpha"
,"pharmacology and clinical trials","NN CC JJ NNS",4,1,1,16809883,2,7.46E+018,"testalpha"
,"substitutions thepresence of alkb","NNS NN IN ",4,1,1,16733554,"pubmed1",3.47E+018,"testalpha"
,"reorganization of protein backboneupon","NN IN NN NN",4,1,1,16770442,"pubmed1",8.78E+018,"testalpha"
,"restrictive pattern atpulmonary function","JJ NN JJ NN",4,1,1,16809886,2,1.81E+017,"testalpha"
,"cream comparedwith calcipotriol ointment","NN NN  NN",4,1,1,16585986,2,6.53E+018,"testalpha"
,"stages of graduated license","NNS IN VBN NN",4,1,1,16112070,"pubmed1",7.09E+018,"testalpha"
,"true syringomas ornormal findings","JJ NNP JJ NNS",4,1,1,16983449,2,7.55E+018,"testalpha"
,"term results of hip","NN NNS IN NN",4,1,1,16613748,2,8.81E+018,"testalpha"
,"cerebral perfusion pressure management","JJ NN NN NN",4,1,1,17067134,"pubmed1",5.60E+018,"testalpha"
,"dimer and tetramer forms","NN CC NN NNS",4,1,1,17019442,"pubmed1",7.37E+017,"testalpha"
,"input plasma power controls","NN NNP NN NNS",4,1,1,16701874,"pubmed1",6.25E+018,"testalpha"
,"detoxifying enzymes in helminths","VBG NNS IN NNS",4,1,1,16410836,"pubmed1",3.65E+018,"testalpha"
,"rates in elderly males","NNS IN JJ NNS",4,1,1,16111641,"pubmed1",9.16E+018,"testalpha"
,"erythro hydroxy nonyl adenine"," NN NN NN",4,1,1,16929383,"pubmed1",7.39E+018,"testalpha"
,"interviewees associated duty hour","NNS VBN NN NN",4,1,1,16377820,"pubmed1",8.90E+018,"testalpha"
,"sprains strains or fractures","NNS NNS CC NNS",4,1,1,16162331,"pubmed1",3.22E+018,"testalpha"
,"cohort study of rct","NN NN IN ",4,1,1,16365332,"pubmed1",4.79E+018,"testalpha"
,"feasibility and grid searches","NN CC  NNS",4,1,1,16584161,"pubmed1",7.45E+018,"testalpha"
,"reversal of renal dysfunction","NN IN JJ NN",4,1,1,17119326,2,1.34E+018,"testalpha"
,"chronic sleepdeprivation and mood","JJ NN CC NN",4,1,1,16377826,"pubmed1",2.56E+018,"testalpha"
,"deficiency and increased erythropoiesis","NN CC VBD NN",4,1,1,17119325,2,7.41E+018,"testalpha"
,"use among general drivers","NN IN JJ NNS",4,1,1,16236235,"pubmed1",7.00E+018,"testalpha"
,"effect of spontaneous precipitation","NN IN JJ NN",4,1,1,16701876,"pubmed1",2.15E+018,"testalpha"
,"driver mortality and changes","NN NN CC NNS",4,1,1,16236235,"pubmed1",1.90E+017,"testalpha"
,"lens homogenates of patientswho","NN NNS IN ",4,1,1,16696441,2,8.31E+018,"testalpha"
,"n using rho coefficient"," VBG  NN",4,1,1,16733558,"pubmed1",2.17E+018,"testalpha"
,"electron microscopy combined withmorphometry","NN  VBN NN",4,1,1,16253314,2,8.87E+017,"testalpha"
,"functional dna binding proteins","JJ  VBG NNS",4,1,1,16411739,"pubmed1",4.12E+018,"testalpha"
,"using room temperature data","VBG NN NN NNS",4,1,1,16511247,2,4.35E+018,"testalpha"
,"possible beta beta subunits","JJ NN NN NNS",4,1,1,16423381,2,1.13E+018,"testalpha"
,"therapy inpatients with itp","NN NNS IN ",4,1,1,16809885,2,3.67E+017,"testalpha"
,"l arginine l arg"," NN  ",4,1,1,16395522,"pubmed1",2.31E+018,"testalpha"
,"cortisol from theadrenal cortex","NNP IN JJ NNP",4,1,1,16462408,"pubmed1",7.02E+018,"testalpha"
,"cement has reached years","NN VBZ VBN NNS",4,1,1,16613741,2,3.08E+018,"testalpha"
,"biodiversity in onefull formulation","NN IN NN NN",4,1,1,16988904,"pubmed1",3.80E+018,"testalpha"
,"report year old female","NN NN JJ NN",4,1,1,17438838,2,6.23E+018,"testalpha"
,"morbidity in patientswith diabetes","NN IN NN NN",4,1,1,16479030,2,8.07E+018,"testalpha"
,"results complete surgical resection","NNS JJ JJ NN",4,1,1,17139885,2,1.20E+018,"testalpha"
,"pain relief after acombination","NN NN IN NN",4,1,1,16916183,"pubmed1",7.27E+018,"testalpha"
,"regression analysis and parameter","NN NN CC NN",4,1,1,16399030,"pubmed1",5.80E+018,"testalpha"
,"induce plateletactivation cd p","VB NN  ",4,1,1,16809885,2,7.70E+018,"testalpha"
,"implications for theincident reporting","NNS IN NN NN",4,1,1,16321534,"pubmed1",8.18E+018,"testalpha"
,"thanduring ns infusion ng","VBG  NN ",4,1,1,17067137,"pubmed1",8.57E+017,"testalpha"
,"g g and g","  CC ",4,1,1,17293969,2,5.74E+018,"testalpha"
,"burnout syndrome maslach burnoutinventory","NN NN NN NN",4,1,1,16451152,"pubmed1",3.88E+018,"testalpha"
,"born neonates with respiratorydisturbances","VBN NNS IN NNS",4,1,1,17019441,"pubmed1",8.92E+018,"testalpha"
,"neural nerve cell tissues","JJ NN NN NNS",4,1,1,17010267,2,4.42E+018,"testalpha"
,"active sitearchitecture and solvent","JJ NN CC NN",4,1,1,16511248,2,3.16E+017,"testalpha"
,"embedded centre of inversion","VBN NN IN NN",4,1,1,16456275,2,2.96E+018,"testalpha"
,"umbilical cord blood hucb","JJ NN NN ",4,1,1,17265690,2,5.45E+018,"testalpha"
,"unrecognized adrenocorticotropic hormone acth","JJ NN NN ",4,1,1,16603099,2,4.74E+018,"testalpha"
,"nuclear volume densities inthyrotropes","JJ NN NNS NNS",4,1,1,16714054,2,8.23E+018,"testalpha"
,"leaves trichomes andatypical structures","VBZ NNS JJ NNS",4,1,1,17486414,"pubmed1",6.35E+018,"testalpha"
,"cause encephalitis and fatalities","NN NN CC NNS",4,1,1,16511290,2,1.97E+017,"testalpha"
,"transformation of ito cells","NN IN  NNS",4,1,1,16256175,2,1.81E+018,"testalpha"
,"tissues results with cell","NNS NNS IN NN",4,1,1,17139880,2,9.98E+017,"testalpha"
,"sd l d h","   ",4,1,1,17133952,2,1.06E+016,"testalpha"
,"colorectal cancer liver metastases","NN NN NN NNS",4,1,1,17139901,2,5.80E+018,"testalpha"
,"iii trial of abivalent"," NN IN NN",4,1,1,17010274,2,6.17E+018,"testalpha"
,"bone pathologies oral manifestations","NN NNS JJ NNS",4,1,1,17010270,2,3.38E+018,"testalpha"
,"nmda receptor antagonists mk"," NN NNS ",4,1,1,17265692,2,8.23E+018,"testalpha"
,"hps male female age"," NN NN NN",4,1,1,16914905,2,4.60E+018,"testalpha"
,"inthe gene named atp","NNP  VBN ",4,1,1,17311740,2,6.37E+018,"testalpha"
,"n alkyl chain lengths","  NN NNS",4,1,1,16594645,"pubmed1",9.00E+018,"testalpha"
,"temperatures of supernatant harvesting","NNS IN JJ NN",4,1,1,17160143,"pubmed1",8.39E+018,"testalpha"
,"biological dressings offer promise","JJ NNS VBP NN",4,1,1,17010268,2,2.35E+018,"testalpha"
,"increase in heart rate","NN IN NN NN",4,1,1,16874421,2,7.69E+018,"testalpha"
,"supported work hour limitations","VBD NN NN NNS",4,1,1,16377823,"pubmed1",6.55E+018,"testalpha"
,"presence of fas antigen","NN IN  NN",4,1,1,16919708,2,3.47E+018,"testalpha"
,"blood flow dominant types","NN NN JJ NNS",4,1,1,16317494,"pubmed1",4.57E+017,"testalpha"
,"post operative pain score","NN JJ NN NN",4,1,1,16451144,"pubmed1",5.40E+018,"testalpha"
,"intrusion and other movements","NN CC JJ NNS",4,1,1,16956115,2,2.54E+018,"testalpha"
,"waist circumference laboratory measurements","NN NN NN NNS",4,1,1,16479027,2,2.58E+018,"testalpha"
,"apoptosis induced bylipoperoxidative damage","NN VBN JJ NN",4,1,1,16330085,2,5.81E+018,"testalpha"
,"pain patients were askedto","NN NNS VBD ",4,1,1,16436793,"pubmed1",7.16E+018,"testalpha"
,"kg for thepresumed stevens"," IN VBN NNS",4,1,1,16603101,2,6.39E+018,"testalpha"
,"health status of africanamericans","NN NN IN NNS",4,1,1,16596897,"pubmed1",8.30E+018,"testalpha"
,"colonic resection and anastomosis","JJ NN CC NN",4,1,1,16612916,"pubmed1",1.56E+017,"testalpha"
,"donors for health suitability","NNS IN NN NN",4,1,1,16999268,2,5.79E+018,"testalpha"
,"tuberculosis in order tomake","NN IN NN NN",4,1,1,16479029,2,1.88E+018,"testalpha"
,"consumer product accident investigation","NN NN NN NN",4,1,1,16434013,"pubmed1",8.13E+017,"testalpha"
,"metype panicum miliaceum nad","JJ NN NN ",4,1,1,17106510,"pubmed1",2.92E+018,"testalpha"
,"liquid based monolayers surepath","JJ VBN NNS NN",4,1,1,16514840,2,7.48E+018,"testalpha"
,"showed influence of ua","VBD NN IN ",4,1,1,17338197,2,4.34E+018,"testalpha"
,"improve performance and athletes","VB NN CC NNS",4,1,1,16918070,"pubmed1",7.56E+018,"testalpha"
,"psa related hypotensive events"," VBN JJ NNS",4,1,1,16365337,"pubmed1",5.05E+017,"testalpha"
,"thereversible hydration and dehydration","JJ NN CC NN",4,1,1,16511248,2,4.06E+017,"testalpha"
,"pyridylmethyl aminomethyl n di","   ",4,1,1,16456265,2,3.48E+018,"testalpha"
,"divisions replicative life span","NNS JJ NN NN",4,1,1,17106513,"pubmed1",2.41E+018,"testalpha"
,"tests showed anunderlying graves","NNS VBD VBG NNS",4,1,1,16673615,2,2.55E+018,"testalpha"
,"survival thanpatients with cc","NN NNS IN ",4,1,1,17139879,2,1.86E+018,"testalpha"
,"urgency evaluation between patientsand","NN NN IN NN",4,1,1,16321533,"pubmed1",3.06E+018,"testalpha"
,"use oforal contraceptives p","NN JJ NNS ",4,1,1,16696443,2,1.48E+018,"testalpha"
,"damage in cryocooledcrystals investigations","NN IN NNS NNS",4,1,1,16369092,2,3.39E+017,"testalpha"
,"mean level of eosinophilproteins","JJ NN IN NNS",4,1,1,16859611,2,5.15E+018,"testalpha"
,"fromthe normal hepatic architecture","NNP JJ JJ NN",4,1,1,17013515,2,4.08E+017,"testalpha"
,"smalland median pulmonary arteries","NN JJ JJ NNS",4,1,1,16395522,"pubmed1",1.52E+018,"testalpha"
,"lens cells of c","NN NNS IN NN",4,1,1,16325892,2,6.67E+018,"testalpha"
,"portography n and ct","NN  CC ",4,1,1,16317488,"pubmed1",5.65E+018,"testalpha"
,"followingboth univariate and multivariate","JJ NN CC NN",4,1,1,16955190,2,2.67E+017,"testalpha"
,"cr were expressed asz"," VBD VBN ",4,1,1,16956119,2,6.31E+018,"testalpha"
,"set ofall living patients","NN JJ NN NNS",4,1,1,17165598,2,8.41E+018,"testalpha"
,"ad rs group spt","NN  NN ",4,1,1,16859613,2,7.53E+018,"testalpha"
,"prevented implicit memory processing","VBD JJ NN NN",4,1,1,17236636,"pubmed1",4.44E+018,"testalpha"
,"conclusion considering increased prevalence","NN VBG VBN NN",4,1,1,16648916,2,5.71E+018,"testalpha"
,"extraction of mean intrinsic","NN IN VB NN",4,1,1,17019442,"pubmed1",4.30E+018,"testalpha"
,"rate in resected patients","NN IN VBN NNS",4,1,1,17139895,2,1.33E+018,"testalpha"
,"atp production by antimycin"," NN IN NNP",4,1,1,17068635,"pubmed1",7.41E+018,"testalpha"
,"small tissue fragmentsand material","JJ NN NN NN",4,1,1,16514842,2,4.40E+018,"testalpha"
,"heart rate f p","NN NN NN ",4,1,1,16365322,"pubmed1",2.91E+018,"testalpha"
,"changes and infiltrationof lymphocytes","NNS CC  NNS",4,1,1,16648919,2,6.29E+018,"testalpha"
,"carcinomas and anaplastic carcinomas","NNP CC JJ NNP",4,1,1,16514836,2,8.02E+018,"testalpha"
,"carbohydrate supply andrebound hyperglycaemia","NN NN NN NN",4,1,1,16921609,"pubmed1",6.87E+018,"testalpha"
,"group iii and years","VBP  CC NNS",4,1,1,16809889,2,4.69E+018,"testalpha"
,"characteristic birefringence of msu","NN NN IN ",4,1,1,16514850,2,8.87E+016,"testalpha"
,"inhibitory effect on rnase","NN NN IN NN",4,1,1,16648912,2,8.23E+018,"testalpha"
,"rapid pain relief andmobilization","JJ NN NN NN",4,1,1,16613748,2,1.29E+018,"testalpha"
,"inmicromolar concentrations for days","JJ NNS IN NNS",4,1,1,17265692,2,4.42E+017,"testalpha"
,"acid c h cln","NN NN  ",4,1,1,16456284,2,6.48E+018,"testalpha"
,"involving humans with threebranches","VBG NNS IN NNS",4,1,1,16770860,"pubmed1",9.71E+017,"testalpha"
,"pathophysiology of breast cancer","NN IN NN NN",4,1,1,16596895,"pubmed1",4.82E+018,"testalpha"
,"formulated sustained release zidovudine","VBD VBN NN NN",4,1,1,16584139,"pubmed1",3.38E+018,"testalpha"
,"wistar rats underwent laparotomy","NN NNS NN NN",4,1,1,17293970,2,5.10E+018,"testalpha"
,"affords n n alkylnicotiniumanalogs","NNS   NNS",4,1,1,16594645,"pubmed1",7.33E+017,"testalpha"
,"groups n naja venom","NNS   NN",4,1,1,16436788,"pubmed1",8.98E+018,"testalpha"
,"case of parallel infections","NN IN JJ NNS",4,1,1,17019441,"pubmed1",3.16E+018,"testalpha"
,"contents dissertation abstracts cochrane","NNS NN NNS NN",4,1,1,16365334,"pubmed1",7.49E+018,"testalpha"
,"hb and meanerythrocyte hb"," CC NNP ",4,1,1,16809890,2,9.73E+017,"testalpha"
,"recognition of adrenal dysfunction","NN IN NN NN",4,1,1,16462408,"pubmed1",8.81E+018,"testalpha"
,"axis ofcc and distance","  CC NN",4,1,1,16399030,"pubmed1",3.09E+018,"testalpha"
,"local recurrency and survival","JJ NN CC NN",4,1,1,17139899,2,3.57E+018,"testalpha"
,"smallmeasurable dose rate effect","JJ NN NN NN",4,1,1,16421442,2,7.60E+018,"testalpha"
,"anastomosis in theascending aorta","NN IN VBG NNP",4,1,1,16612926,"pubmed1",7.54E+018,"testalpha"
,"significant risk factors non","JJ NN NNS ",4,1,1,16054104,"pubmed1",9.20E+018,"testalpha"
,"teendrivers with passengers present","NNS IN NNS NN",4,1,1,16171767,"pubmed1",1.70E+018,"testalpha"
,"conserved functional microdomains fm","VBN JJ NNS ",4,1,1,16594640,"pubmed1",5.37E+018,"testalpha"
,"ofenteropathogenic bacteria in feces","JJ NNS IN NNS",4,1,1,17293961,2,3.83E+018,"testalpha"
,"serum levels of acth","NN NNS IN ",4,1,1,16603099,2,8.08E+018,"testalpha"
,"crystal quality beam apertures","NN NN NN NNS",4,1,1,16369094,2,3.19E+018,"testalpha"
,"use of radiography ct","NN IN NN ",4,1,1,17688033,2,8.93E+018,"testalpha"
,"authors l t g","NNS   ",4,1,1,16333710,"pubmed1",5.24E+018,"testalpha"
,"n c c backbone"," NN NN NN",4,1,1,16456282,2,2.44E+018,"testalpha"
,"department investigations reveal signs","NN NNS VB NNS",4,1,1,16377192,"pubmed1",3.81E+017,"testalpha"
,"degeneration and taking neurolepticsor","NN CC VBG NN",4,1,1,16479025,2,2.19E+018,"testalpha"
,"structural changes in themyocytes","JJ NNS IN NNS",4,1,1,17007910,2,8.02E+018,"testalpha"
,"e g in animal","  IN NN",4,1,1,17133954,2,2.13E+018,"testalpha"
,"systemic acute phase reaction","JJ JJ NN NN",4,1,1,16714050,2,6.32E+018,"testalpha"
,"traffic violation and motorists","NN NN CC NNS",4,1,1,16434012,"pubmed1",2.25E+018,"testalpha"
,"hepatic ischaemia reperfusion injury","JJ NN NN NN",4,1,1,16612918,"pubmed1",6.31E+017,"testalpha"
,"g mutation of hmsh"," NN IN ",4,1,1,17139886,2,2.72E+018,"testalpha"
,"d dimer clotocclusiveness clot"," NN NN NN",4,1,1,16549898,2,1.80E+018,"testalpha"
,"results compared tothe non","NNS VBN NNP ",4,1,1,16612919,"pubmed1",4.91E+018,"testalpha"
,"healthystatus and energy balance","NN CC NN NN",4,1,1,16918067,"pubmed1",1.74E+018,"testalpha"
,"mc untreated diabetic ud"," JJ JJ ",4,1,1,16714049,2,7.63E+018,"testalpha"
,"relationship betweeninduction of hpnpase","NN NN IN NN",4,1,1,16505900,"pubmed1",8.45E+017,"testalpha"
,"methods offormulating independent double","NNS VBG JJ NN",4,1,1,16399036,"pubmed1",3.09E+018,"testalpha"
,"itp boys and girls"," NNS CC NNS",4,1,1,16424649,2,4.59E+018,"testalpha"
,"doses of dexamethasone dex","NNS IN NN ",4,1,1,17133953,2,7.10E+018,"testalpha"
,"glycosidic torsionangles phi o","JJ NNS  ",4,1,1,16456293,2,5.02E+018,"testalpha"
,"insufficient amount of research","JJ NN IN NN",4,1,1,16474001,"pubmed1",3.68E+018,"testalpha"
,"cda patientswith mild anemia"," NN JJ NN",4,1,1,17117609,2,6.97E+018,"testalpha"
,"mildtbi incidence and prevalence"," NN CC NN",4,1,1,16365331,"pubmed1",2.87E+018,"testalpha"
,"full length recombinant vp","JJ NN JJ ",4,1,1,16733562,"pubmed1",8.61E+018,"testalpha"
,"havehigher rejection rates rrs","JJ NN NNS ",4,1,1,16399035,"pubmed1",8.79E+018,"testalpha"
,"motor vehicle crash injury","NN NN NN NN",4,1,1,16139232,"pubmed1",4.74E+018,"testalpha"
,"betweenbax and bax adaptor"," CC  NN",4,1,1,16424655,2,8.20E+018,"testalpha"
,"non pathogenicity of chrysosporium"," NN IN NN",4,1,1,16603097,2,7.76E+018,"testalpha"
,"naked eye tme quality","JJ NN  NN",4,1,1,17139882,2,5.38E+018,"testalpha"
,"cases of colorectal cancer","NNS IN NN NN",4,1,1,17139892,2,3.46E+018,"testalpha"
,"interaction between pineal gland","NN IN NN NN",4,1,1,16491217,2,2.56E+018,"testalpha"
,"parvovirus b pvb infection","NN NN  NN",4,1,1,17119324,2,7.67E+018,"testalpha"
,"evaporation of essential oil","NN IN JJ NN",4,1,1,16584150,"pubmed1",7.67E+018,"testalpha"
,"control in thousands ofreplicate","NN IN NNS NN",4,1,1,16730370,2,1.74E+018,"testalpha"
,"encoded carboxylesterase frompyrobaculum calidifontis","VBN NN NN NN",4,1,1,16511287,2,3.64E+018,"testalpha"
,"force on atopic dermatitis","NN IN NN NN",4,1,1,17438830,2,2.97E+018,"testalpha"
,"obstructive disease and diabetes","JJ NN CC NN",4,1,1,16594641,"pubmed1",4.47E+018,"testalpha"
,"measurement of infarct volumes","NN IN NN NNS",4,1,1,17265691,2,5.70E+018,"testalpha"
,"measurements underlying principles advantages","NNS VBG NNS NNS",4,1,1,16918067,"pubmed1",6.16E+018,"testalpha"
,"trend towards higher speed","NN IN JJR NN",4,1,1,16423319,"pubmed1",6.91E+018,"testalpha"
,"platelet count showed negativecorrelations","NN NN VBD NNS",4,1,1,17016035,2,6.76E+018,"testalpha"
,"discs were irradiated withlaser","NNS VBD VBN NN",4,1,1,17293968,2,4.38E+018,"testalpha"
,"clp clp salinegroup rats","  NN NNS",4,1,1,17293958,2,2.82E+018,"testalpha"
,"aminomethyl n di tert","   ",4,1,1,16456265,2,7.82E+018,"testalpha"
,"cell manipulations is theaim","NN NNS VBZ NN",4,1,1,16956113,2,3.30E+018,"testalpha"
,"showed multiple liver tumors","VBD JJ NN NNS",4,1,1,17119328,2,8.77E+018,"testalpha"
,"occupant seat position crash","NN NN NN NN",4,1,1,16197912,"pubmed1",7.38E+018,"testalpha"
,"scf and flt ligand"," CC  NN",4,1,1,16404477,"pubmed1",8.28E+018,"testalpha"
,"asymptomatic non smoking patients","JJ  NN NNS",4,1,1,16809886,2,6.36E+018,"testalpha"
,"thyroid pancreas soft tissue","NN NNS JJ NN",4,1,1,16514845,2,6.66E+018,"testalpha"
,"moreepisodes of deep vein","NNS IN JJ NN",4,1,1,16549898,2,9.56E+017,"testalpha"
,"pressure and tissue hydroxyproline","NN CC NN NN",4,1,1,16612916,"pubmed1",5.31E+018,"testalpha"
,"misjudging situations illegal unsafe","VBG NNS JJ NN",4,1,1,16423319,"pubmed1",3.84E+018,"testalpha"
,"dr and cd cd"," CC  ",4,1,1,17119322,2,2.76E+018,"testalpha"
,"c terminal steroidogenic acuteregulatory","NN NN JJ NN",4,1,1,16951743,"pubmed1",6.79E+018,"testalpha"
,"oxygen nitrogen sensing control","NN NN VBG NN",4,1,1,17143336,"pubmed1",3.85E+018,"testalpha"
,"infiltrationof lymphocytes and eosinophils"," NNS CC NNS",4,1,1,16648919,2,5.00E+018,"testalpha"
,"cytokines secretion in rats","NNS NN IN NNS",4,1,1,17293960,2,6.51E+018,"testalpha"
,"allow thecollection of diffraction","VB NN IN NN",4,1,1,16369089,2,3.78E+018,"testalpha"
,"acute reversal of anticoagulation","JJ NN IN NN",4,1,1,16916181,"pubmed1",1.25E+018,"testalpha"
,"stimulation of ht receptors","NN IN  NNS",4,1,1,16997356,2,1.87E+018,"testalpha"
,"anxiety and pain duringemergency","NN CC NN NN",4,1,1,16365322,"pubmed1",8.80E+018,"testalpha"
,"compound pt c h","NN  NN ",4,1,1,16397333,2,7.37E+018,"testalpha"
,"plan and clinical assesment","NN CC JJ NN",4,1,1,16989147,2,1.90E+018,"testalpha"
,"intensethird generation synchrotron source","JJ NN NNP NN",4,1,1,16421453,2,7.56E+018,"testalpha"
,"functioning treatment with anticoagulation","VBG NN IN NN",4,1,1,16549897,2,7.51E+018,"testalpha"
,"using immunohistochemistry electron microscopy","VBG NN NN ",4,1,1,16733064,2,6.19E+018,"testalpha"
,"introduction of systematic quality","NN IN JJ NN",4,1,1,16999271,2,7.53E+018,"testalpha"
,"sod while inositolhexaphosphate decreases"," IN NN NNS",4,1,1,17293962,2,3.87E+018,"testalpha"
,"ptcl ptclu achievedcomplete response","  JJ NN",4,1,1,16914902,2,6.37E+018,"testalpha"
,"work involve adult patients","NN VB NN NNS",4,1,1,17236639,"pubmed1",3.13E+017,"testalpha"
,"reagent in immunological tests","NN IN JJ NNS",4,1,1,16733562,"pubmed1",8.82E+018,"testalpha"
,"hepatic ischaemia for minutes","JJ NN IN NNS",4,1,1,16612918,"pubmed1",8.35E+017,"testalpha"
,"assuming fixed temperature difference","VBG VBN NN NN",4,1,1,17285744,"pubmed1",2.93E+018,"testalpha"
,"series from asingle centre","NN IN NN NN",4,1,1,16424653,2,2.31E+018,"testalpha"
,"theresponse of platelet count","NN IN NN NN",4,1,1,16809885,2,6.85E+018,"testalpha"
,"nodules were evaluatedusing papanicolaou","NNS VBD VBG ",4,1,1,16514837,2,4.96E+018,"testalpha"
,"effects on glycolysis rate","NNS IN NN NN",4,1,1,17068635,"pubmed1",5.66E+018,"testalpha"
,"comparison with conventional agents","NN IN JJ NNS",4,1,1,17236644,"pubmed1",6.56E+018,"testalpha"
,"task vct digit forwardand","NN  JJ NN",4,1,1,16479025,2,6.87E+018,"testalpha"
,"primer set andhome pcr","NN VBN NN ",4,1,1,17019439,"pubmed1",4.66E+018,"testalpha"
,"sac of small bowel"," IN JJ NN",4,1,1,17293970,2,5.61E+018,"testalpha"
,"slopes were used forcalculation","NNS VBD VBN NN",4,1,1,17067137,"pubmed1",5.14E+017,"testalpha"
,"migration of tregsand skin","NN IN NN NN",4,1,1,16955181,2,8.51E+018,"testalpha"
,"skin and mucous membranes","NN CC JJ NNS",4,1,1,16603101,2,8.84E+018,"testalpha"
,"ofthe cases experienced skin","NNP NNS VBN NN",4,1,1,17165594,2,5.44E+018,"testalpha"
,"rtresidents have become research","NNS VBP VBN NN",4,1,1,16473996,"pubmed1",1.13E+018,"testalpha"
,"issue in general pediatrics","NN IN JJ NNS",4,1,1,16462411,"pubmed1",1.10E+018,"testalpha"
,"inchildren undergoing cardiac surgery","NNS VBG JJ NN",4,1,1,16451158,"pubmed1",1.08E+018,"testalpha"
,"flap from theaffected auricle"," IN VBN NN",4,1,1,16722346,2,4.37E+018,"testalpha"
,"trophism in rats underwent","NN IN NNS NN",4,1,1,17293972,2,5.49E+018,"testalpha"
,"computed tomography n magneticresonance","VBN NN  NN",4,1,1,16333704,"pubmed1",1.25E+018,"testalpha"
,"models of invasive fungalinfections","NNS IN JJ NNS",4,1,1,17370566,"pubmed1",7.06E+018,"testalpha"
,"students insertedthe ilma lt","NNS NNP  ",4,1,1,16451149,"pubmed1",3.25E+016,"testalpha"
,"aetiology of acne lesions","NN IN  NNS",4,1,1,16874416,2,1.45E+018,"testalpha"
,"modeled usingbest fit ellipses","VBN NN VB NNS",4,1,1,16399030,"pubmed1",4.91E+018,"testalpha"
,"hand in cold water","NN IN JJ NN",4,1,1,17236636,"pubmed1",6.63E+018,"testalpha"
,"reimbursement by insurance companies","NN IN NN NNS",4,1,1,16999268,2,6.03E+018,"testalpha"
,"residues and side chains","NNS CC NN NNS",4,1,1,16511247,2,8.05E+018,"testalpha"
,"ofaccidents tickets overtaking tendencies","NNS NNS VBG NNS",4,1,1,16443186,"pubmed1",6.06E+017,"testalpha"
,"protect cells and tissues","VB NNS CC NNS",4,1,1,16770441,"pubmed1",7.36E+018,"testalpha"
,"dermatitis while positive malassezia","NN IN JJ NNP",4,1,1,16648916,2,2.66E+018,"testalpha"
,"groups ii iii iv","NNS   ",4,1,1,16612918,"pubmed1",3.71E+018,"testalpha"
,"assembly and mediates bacterialattachment","NN CC NNS NN",4,1,1,16511280,2,6.09E+018,"testalpha"
,"agent forabdominal pelvic ct","NN JJ JJ ",4,1,1,16252139,"pubmed1",8.54E+017,"testalpha"
,"document relevant toallogeneic transplants","NN JJ JJ NNS",4,1,1,16999268,2,1.60E+018,"testalpha"
,"treatment on facial congenital","NN IN JJ NN",4,1,1,16710582,2,5.63E+018,"testalpha"
,"skin symptoms of airbornedermatosis","NN NNS IN NN",4,1,1,17010263,2,8.03E+018,"testalpha"
,"mass index waist circumference","NN NN NN NN",4,1,1,16479027,2,8.12E+017,"testalpha"
,"factors for ischemic stroke","NNS IN JJ NN",4,1,1,16479026,2,1.66E+018,"testalpha"
,"department dle n pseudopelade","NN   NN",4,1,1,17311739,2,7.20E+018,"testalpha"
,"suggest thatrecidivist drink drivers","VBP NN NN NNS",4,1,1,16405859,"pubmed1",1.45E+018,"testalpha"
,"bound form of ada","VBN NN IN ",4,1,1,16929383,"pubmed1",2.38E+018,"testalpha"
,"reactivity pattern inni ii","NN NN  ",4,1,1,17117212,"pubmed1",8.97E+018,"testalpha"
,"gene inisolated human platelets"," VBN NN NNS",4,1,1,16733564,"pubmed1",1.79E+018,"testalpha"
,"fasting state fasting c","VBG NN VBG NN",4,1,1,16673610,2,3.76E+018,"testalpha"
,"possessing anadditional c terminal","VBG JJ NN NN",4,1,1,16421447,2,2.73E+018,"testalpha"
,"results sida and sida","NNS  CC ",4,1,1,17013511,2,1.38E+018,"testalpha"
,"carotid arteryinjection of nmda"," NN IN ",4,1,1,17133957,2,2.10E+018,"testalpha"
,"cancer cell line andcrl","NN NN NN ",4,1,1,16414103,2,5.24E+018,"testalpha"
,"digestive expressions of food","JJ NNS IN NN",4,1,1,16673561,2,4.72E+017,"testalpha"
,"blinded randomization group m","VBN NN NN ",4,1,1,17067136,"pubmed1",6.47E+018,"testalpha"
,"ability tointeract with rna","NN NN IN ",4,1,1,16410835,"pubmed1",7.62E+018,"testalpha"
,"increasethe density of b","NNP NN IN NN",4,1,1,17117211,"pubmed1",7.09E+018,"testalpha"
,"gly pro cys motif"," JJ  NN",4,1,1,16421453,2,8.10E+018,"testalpha"
,"standards for countingthe number","NNS IN NNP NN",4,1,1,16430844,"pubmed1",4.46E+018,"testalpha"
,"brain in acute attacks","NN IN JJ NNS",4,1,1,16584167,"pubmed1",6.63E+018,"testalpha"
,"topic of much discussion","NN IN NN NN",4,1,1,16770859,"pubmed1",5.79E+018,"testalpha"
,"single dose mg kg","JJ NN  ",4,1,1,16714049,2,6.43E+018,"testalpha"
,"explicit memory inany subject","JJ NN NN NN",4,1,1,17236636,"pubmed1",3.10E+017,"testalpha"
,"patients with deliberate self","NNS IN JJ NN",4,1,1,16330213,"pubmed1",3.19E+018,"testalpha"
,"results on radiologic practice","NNS IN JJ NN",4,1,1,16317488,"pubmed1",1.78E+018,"testalpha"
,"simulated body fluid sbf","VBN NN NN ",4,1,1,16701876,"pubmed1",4.44E+018,"testalpha"
,"abnormal cells on theta","JJ NNS IN NN",4,1,1,16514841,2,5.53E+018,"testalpha"
,"h n v o","   ",4,1,1,16456275,2,8.68E+017,"testalpha"
,"elderly population in order","NN NN IN NN",4,1,1,17010270,2,7.29E+018,"testalpha"
,"reduction of vas pain","NN IN  NN",4,1,1,16436793,"pubmed1",5.23E+018,"testalpha"
,"involves considerable radiation exposure","VBZ JJ NN NN",4,1,1,16447095,"pubmed1",2.77E+018,"testalpha"
,"helmet use among children","VB NN IN NNS",4,1,1,16223468,"pubmed1",5.37E+018,"testalpha"
,"synthase is found inthe","NN VBZ VBN NNP",4,1,1,16824585,2,9.19E+018,"testalpha"
,"significance included averagebowel diameter","NN VBD NN NN",4,1,1,16252139,"pubmed1",6.31E+018,"testalpha"
,"emergencysurgery and high asa","NN CC JJ ",4,1,1,16451146,"pubmed1",4.21E+018,"testalpha"
,"post operative activity level","NN JJ NN NN",4,1,1,16613741,2,2.78E+018,"testalpha"
,"year oldwoman with hiv","NN NN IN ",4,1,1,16673614,2,3.96E+018,"testalpha"
,"collagen in excessive amounts","NN IN JJ NNS",4,1,1,17294912,2,6.81E+018,"testalpha"
,"history ofatopic dermatitis show","NN NN NN NN",4,1,1,16648913,2,6.93E+018,"testalpha"
,"viral suppressors of rna","JJ NNS IN ",4,1,1,16582986,"pubmed1",1.83E+018,"testalpha"
,"gun crews or seamanshipoccupations","NN NNS CC NNS",4,1,1,16405857,"pubmed1",5.07E+018,"testalpha"
,"health symptoms and questions","NN NNS CC NNS",4,1,1,16377815,"pubmed1",7.08E+018,"testalpha"
,"comparesurvival rates and times","NN NNS CC NNS",4,1,1,16436788,"pubmed1",1.20E+018,"testalpha"
,"control group asignificant increase","NN NN JJ NN",4,1,1,16603096,2,5.80E+018,"testalpha"
,"arrival mg of hydrocortisoneand","NN  IN NN",4,1,1,16451161,"pubmed1",5.83E+018,"testalpha"
,"rat model ofmyocardial ischemia","NN NN JJ NN",4,1,1,16566960,2,6.34E+018,"testalpha"
,"condition of limb pain","NN IN NN NN",4,1,1,16549898,2,2.29E+018,"testalpha"
,"existing chemistry of alkanes","VBG NN IN NNS",4,1,1,16411734,"pubmed1",3.89E+018,"testalpha"
,"america and parts ofeurope","NNP CC NNS NNP",4,1,1,16511290,2,6.96E+018,"testalpha"
,"accidents unemployment domestic violence","NNS NN JJ NN",4,1,1,17013520,2,5.20E+018,"testalpha"
,"eosinophils in atopy patch","NNS IN  NN",4,1,1,16648919,2,6.68E+018,"testalpha"
,"slight modifications regarding equipment","JJ NNS IN NN",4,1,1,17139898,2,2.99E+018,"testalpha"
,"theapplication of mechanical stress","NN IN JJ NN",4,1,1,16874414,2,5.39E+018,"testalpha"
,"preserveproteins from specific cell","NNS IN JJ NN",4,1,1,16950501,2,2.39E+018,"testalpha"
,"lesions asil post radiation","NNS  NN NN",4,1,1,17139883,2,1.57E+017,"testalpha"
,"plasmiddna bearing interleukin gene"," NN NNP ",4,1,1,16733559,"pubmed1",7.07E+018,"testalpha"
,"legionella pneumophilamajor acid phosphatase","NNP JJ NN NN",4,1,1,16511256,2,7.40E+017,"testalpha"
,"spatial correlation time trend","JJ NN NN NN",4,1,1,16451795,"pubmed1",3.58E+018,"testalpha"
,"injury and fatal crash","NN CC JJ NN",4,1,1,16451795,"pubmed1",1.96E+018,"testalpha"
,"celldivisions accomplished replicative age","NNS VBN JJ NN",4,1,1,17106513,"pubmed1",8.55E+018,"testalpha"
,"classical degrees of freedom","JJ NNS IN NN",4,1,1,16411736,"pubmed1",8.47E+018,"testalpha"
,"complications anaesthetic manage ment","NNS JJ VB NN",4,1,1,17067134,"pubmed1",4.74E+018,"testalpha"
,"nolevels but decreased gsh","NNS CC VBD ",4,1,1,16999986,2,5.85E+018,"testalpha"
,"ards cmh o cmh","   ",4,1,1,16451155,"pubmed1",1.83E+018,"testalpha"
,"damaged dna into e","VBN  IN ",4,1,1,16582987,"pubmed1",4.10E+018,"testalpha"
,"using transgene specific primers","VBG NN JJ NNS",4,1,1,16951742,"pubmed1",8.54E+017,"testalpha"
,"pneumonectomy for lung cancerand","NN IN NN NN",4,1,1,16617761,"pubmed1",4.19E+017,"testalpha"
,"piercing n falls n","VBG  VBZ ",4,1,1,16412373,"pubmed1",2.04E+018,"testalpha"
,"injuries including aortic wall","NNS VBG JJ NN",4,1,1,16714053,2,3.92E+018,"testalpha"
,"groinsand intravenous catheter insertion","NN JJ NN NN",4,1,1,17311736,2,7.56E+018,"testalpha"
,"andutilizing milled acp filler","VBG VBN  NN",4,1,1,16701862,"pubmed1",7.28E+018,"testalpha"
,"anxietylevel pain level blood","NN NN NN NN",4,1,1,16365322,"pubmed1",4.62E+018,"testalpha"
,"k k or k","  CC ",4,1,1,17067137,"pubmed1",1.10E+017,"testalpha"
,"puncture in anaesthetized children","NN IN VBN NNS",4,1,1,17067139,"pubmed1",4.74E+018,"testalpha"
,"resistant mouse leukemia l","JJ NN NN ",4,1,1,16505899,"pubmed1",1.95E+018,"testalpha"
,"known lipid lowering effects","VBN NN VBG NNS",4,1,1,17293958,2,4.97E+018,"testalpha"
,"cutaneous squamous cell carcinomas","JJ JJ NN NNP",4,1,1,16710578,2,6.04E+018,"testalpha"
,"extremities arterial blood pressure","NNS JJ NN NN",4,1,1,16617761,"pubmed1",4.07E+018,"testalpha"
,"impact of chronic dermatologicaldiseases","NN IN JJ NNS",4,1,1,16710574,2,8.20E+018,"testalpha"
,"medicine residents at barnes","NN NNS IN NNS",4,1,1,16377823,"pubmed1",6.59E+018,"testalpha"
,"scales from psoriatic lesions","NNS IN JJ NNS",4,1,1,16585983,2,6.49E+018,"testalpha"
,"ct mri emng standardbattery","   NN",4,1,1,17688033,2,3.18E+018,"testalpha"
,"proteins dsk and rad","NNS  CC ",4,1,1,16421449,2,1.27E+018,"testalpha"
,"effects ofindustry specific hazards","NNS NN JJ NNS",4,1,1,16430845,"pubmed1",1.98E+018,"testalpha"
,"index vegf ind values","NN   NNS",4,1,1,16317488,"pubmed1",8.95E+018,"testalpha"
,"g cell cycle arrest"," NN NN NN",4,1,1,16809887,2,1.07E+018,"testalpha"
,"areas containing astroglial andoligodendrogliallike","NNS VBG JJ NN",4,1,1,16514849,2,8.47E+018,"testalpha"
,"health problem affecting millions","NN NN VBG NNS",4,1,1,16479031,2,2.25E+018,"testalpha"
,"analyze sensitivity and specificity","VB NN CC NN",4,1,1,17016037,2,1.02E+018,"testalpha"
,"scientific method bayesian reasoning","JJ NN JJ NN",4,1,1,16365325,"pubmed1",6.34E+018,"testalpha"
,"history of thromboembolic events","NN IN JJ NNS",4,1,1,16696443,2,3.50E+018,"testalpha"
,"fluid tripath imaging inc","NN NN VBG ",4,1,1,16514841,2,3.29E+018,"testalpha"
,"alternative mechanisms of actionand","NN NNS IN NN",4,1,1,16918062,"pubmed1",5.83E+018,"testalpha"
,"part of multi organ","NN IN  NN",4,1,1,16585988,2,1.67E+018,"testalpha"
,"perineal or trans anal","NN CC NNS ",4,1,1,17139891,2,1.09E+018,"testalpha"
,"intracellular targets forneurosteroids e","JJ NNS NNS ",4,1,1,17265696,2,9.38E+017,"testalpha"
,"endoscopic ultrasonography and simulation","NN NN CC NN",4,1,1,16399038,"pubmed1",1.40E+018,"testalpha"
,"basicfibroblast growth factor bfgf","JJS NN NN ",4,1,1,17106595,2,8.69E+018,"testalpha"
,"air filled microbubble contrast","NN VBN JJ NN",4,1,1,16333704,"pubmed1",3.62E+018,"testalpha"
,"high dose of prednisone","JJ NN IN NN",4,1,1,16955192,2,6.14E+018,"testalpha"
,"lattice model of proteins","NN NN IN NNS",4,1,1,16365636,"pubmed1",4.00E+018,"testalpha"
,"radical excision and reconstruction","JJ NN CC NN",4,1,1,16603102,2,6.20E+018,"testalpha"
,"analysis program enablingnumerical assessment","NN NN JJ NN",4,1,1,16648914,2,8.99E+018,"testalpha"
,"sera of adult persons"," IN NN NNS",4,1,1,16696442,2,4.57E+018,"testalpha"
,"acyl coa thioesterase acot","  NN ",4,1,1,16511283,2,8.47E+018,"testalpha"
,"photophosphorylation efficiency and fluorescenceemission","NN NN CC NN",4,1,1,17106510,"pubmed1",3.83E+018,"testalpha"
,"management and cancer screening","NN CC NN NN",4,1,1,16596897,"pubmed1",4.47E+018,"testalpha"
,"profile of therapy withgcs","NN IN NN ",4,1,1,17133953,2,5.26E+018,"testalpha"
,"significant increase in alt","JJ NN IN ",4,1,1,17013508,2,7.80E+017,"testalpha"
,"antibiotic prophylaxis before ercp","JJ  IN ",4,1,1,16673611,2,1.02E+018,"testalpha"
,"using synchrotron radiation butselenomethionine","VBG NNP NN NN",4,1,1,16511288,2,5.05E+018,"testalpha"
,"change in pesticide usage","NN IN VB NN",4,1,1,17016033,2,4.50E+018,"testalpha"
,"theimplementation of iron prophylaxis","NN IN NN ",4,1,1,16424650,2,3.53E+018,"testalpha"
,"previousallergic dermatitis from mdbgn","JJ NN IN ",4,1,1,16585981,2,5.73E+018,"testalpha"
,"hallmark of apoptotic cell","NN IN JJ NN",4,1,1,16951739,"pubmed1",6.67E+018,"testalpha"
,"properties ofamorphous calcium phosphate","NNS JJ NN NN",4,1,1,16701862,"pubmed1",5.97E+017,"testalpha"
,"iso osmolar dimericcontrast agent"," JJ JJS NN",4,1,1,16399037,"pubmed1",2.49E+018,"testalpha"
,"andcompliance with long term","NN IN JJ NN",4,1,1,16809890,2,2.92E+018,"testalpha"
,"todifferent kinds of stresses","NN NNS IN NNS",4,1,1,17063208,"pubmed1",6.10E+018,"testalpha"
,"physiological age dependent factors","JJ NN JJ NNS",4,1,1,16549888,2,4.47E+018,"testalpha"
,"patients with atopic eczema","NNS IN NN NN",4,1,1,16511273,2,3.51E+018,"testalpha"
,"serum and cerebrospinal fluid","NN CC JJ NN",4,1,1,16874420,2,1.23E+018,"testalpha"
,"texture grade slight increase","NN NN JJ NN",4,1,1,16673610,2,1.18E+018,"testalpha"
,"e extensive alopecic foci"," JJ JJ ",4,1,1,16603097,2,8.27E+018,"testalpha"
,"epidural distance correlated significantlywith","JJ NN VBN NN",4,1,1,17067139,"pubmed1",4.09E+018,"testalpha"
,"thyroid gland and changes","NN NN CC NNS",4,1,1,16720036,2,1.95E+018,"testalpha"
,"creation of anational level","NN IN JJ NN",4,1,1,16770860,"pubmed1",2.99E+018,"testalpha"
,"pon and circulating ox"," CC VBG ",4,1,1,17106515,"pubmed1",2.89E+018,"testalpha"
,"targets forneurosteroids e g","NNS NNS  ",4,1,1,17265696,2,4.58E+018,"testalpha"
,"space groupr unit cell","NN  NN NN",4,1,1,16511283,2,7.37E+018,"testalpha"
,"studies on red cellgsh","NNS IN JJ ",4,1,1,17160142,"pubmed1",5.31E+017,"testalpha"
,"children withacute lymphoblastic leukemia","NNS NN JJ NN",4,1,1,16424647,2,7.77E+018,"testalpha"
,"patientsdependent in daily living","NN IN JJ NN",4,1,1,16451146,"pubmed1",7.44E+016,"testalpha"
,"belted drivers suggesting selectiverecruitment","VBD NNS VBG NN",4,1,1,16236235,"pubmed1",2.40E+018,"testalpha"
,"c thehydrolysis of substrate","NN NN IN NN",4,1,1,16970980,2,7.08E+018,"testalpha"
,"chromosomal deletion and mds","JJ NN CC ",4,1,1,17016041,2,8.17E+018,"testalpha"
,"inclusion criteria included phecg","NN NNS VBD ",4,1,1,16365334,"pubmed1",5.26E+017,"testalpha"
,"present twocases of postparotidectomy","JJ NNS IN NN",4,1,1,16696446,2,3.81E+018,"testalpha"
,"differences in risk identification","NNS IN NN NN",4,1,1,16436792,"pubmed1",7.10E+018,"testalpha"
,"diagnosis of vonwillebrand disease","NN IN NN NN",4,1,1,16424652,2,5.04E+018,"testalpha"
,"expressions of fas ligand","NNS IN  NN",4,1,1,17016035,2,4.66E+018,"testalpha"
,"purified andrnase treated mitochondria","VBN NN VBN NNP",4,1,1,16496041,"pubmed1",3.61E+018,"testalpha"
,"natureand quality of work","NN NN IN NN",4,1,1,17438831,2,5.98E+018,"testalpha"
,"education and outreach efforts","NN CC NN NNS",4,1,1,16596897,"pubmed1",2.69E+018,"testalpha"
,"heavy vaginal yeast colonization","JJ JJ NN NN",4,1,1,16603098,2,6.84E+018,"testalpha"
,"temporal changes in lung","JJ NNS IN NN",4,1,1,16809886,2,1.06E+018,"testalpha"
,"regulatory role of dyn","JJ NN IN ",4,1,1,17133952,2,4.56E+018,"testalpha"
,"policies post injury administration","NNS NN NN NN",4,1,1,16442068,"pubmed1",5.06E+018,"testalpha"
,"lymph node reactive sinushistiocytosis","NN  JJ NN",4,1,1,16256177,2,4.17E+018,"testalpha"
,"stress relatedto waiting lists","NN  VBG NNS",4,1,1,16438094,"pubmed1",4.61E+018,"testalpha"
,"possibilitiesfor diagnosis and therapeutics","JJ NN CC NNS",4,1,1,17013504,2,6.81E+018,"testalpha"
,"hydroxyethylmethacrylate hema and methacryloxyethyl","NN  CC ",4,1,1,16701862,"pubmed1",8.35E+017,"testalpha"
,"complex interaction ofthe genome","JJ NN NNP NN",4,1,1,16505901,"pubmed1",9.13E+018,"testalpha"
,"nature and incidence ofinfections","NN CC NN NNS",4,1,1,16585986,2,8.08E+017,"testalpha"
,"intosolid lipid nanoparticles sln","JJ NN NNS ",4,1,1,16584150,"pubmed1",3.94E+018,"testalpha"
,"disturbance fine tremor headache","NN JJ NN NN",4,1,1,16479025,2,8.45E+017,"testalpha"
,"angles betweenthe mean planes","NNS NNP VB NNS",4,1,1,16456294,2,1.55E+018,"testalpha"
,"ureb f ser ile"," NN  ",4,1,1,16496040,"pubmed1",2.77E+018,"testalpha"
,"intopolymeric gels of carbopol","JJ  IN ",4,1,1,17285742,"pubmed1",4.21E+018,"testalpha"
,"h o n ii","   ",4,1,1,16397335,2,8.55E+018,"testalpha"
,"association betweenvariables in contingency","NN NNS IN NN",4,1,1,16733558,"pubmed1",3.91E+018,"testalpha"
,"binding at variouspartial oxygen","NN IN JJ NN",4,1,1,17019442,"pubmed1",4.84E+018,"testalpha"
,"underwent min celiac artery","NN  JJ NN",4,1,1,17438835,2,1.62E+018,"testalpha"
,"pattern of n chain","NN IN  NN",4,1,1,17285740,"pubmed1",6.13E+018,"testalpha"
,"invasive tension free repair","JJ NN JJ NN",4,1,1,16612912,"pubmed1",4.78E+018,"testalpha"
,"crystallization and expression conditions","NN CC NN NNS",4,1,1,16369090,2,5.68E+018,"testalpha"
,"mated withwild type mice","VBN VB NN ",4,1,1,16951742,"pubmed1",8.37E+018,"testalpha"
,"renal injury in diabetes","JJ NN IN NN",4,1,1,16733556,"pubmed1",4.91E+018,"testalpha"
,"native proteincrystals and diffract","JJ NNS CC NN",4,1,1,16511259,2,8.58E+018,"testalpha"
,"fna demonstration of msu"," NN IN ",4,1,1,16514850,2,1.17E+018,"testalpha"
,"nuclear antigen pcna usingthe","JJ NN  NNP",4,1,1,17013511,2,2.81E+018,"testalpha"
,"necrotic processes and apoptosis","JJ NNS CC NN",4,1,1,16566960,2,7.96E+018,"testalpha"
,"inflammationand specific diagnostic elements","NN JJ JJ NNS",4,1,1,16673563,2,3.78E+017,"testalpha"
,"therapy for immune thrombocytopenia","NN IN JJ NNP",4,1,1,16594642,"pubmed1",5.32E+018,"testalpha"
,"data collection and entry","NNS NN CC NN",4,1,1,16112068,"pubmed1",9.03E+018,"testalpha"
,"scale category or male","NN NN CC NN",4,1,1,16377190,"pubmed1",4.52E+018,"testalpha"
,"gun johnson andjohnson usa","NN NN NN ",4,1,1,17139887,2,5.44E+018,"testalpha"
,"theprevention of vascular complications","NN IN JJ NNS",4,1,1,16918068,"pubmed1",2.94E+017,"testalpha"
,"inthe assessment and management","NNP NN CC NN",4,1,1,16317492,"pubmed1",7.57E+018,"testalpha"
,"significantsoluble fas ligand secretion","JJ  NN NN",4,1,1,16710577,2,7.01E+017,"testalpha"
,"cpk activity in carvedilol"," NN IN ",4,1,1,17338197,2,2.83E+018,"testalpha"
,"echinocandins in pediatric patients","NNS IN JJ NNS",4,1,1,16918062,"pubmed1",2.29E+018,"testalpha"
,"suggests thatbeta adrenergic receptor","VBZ NN JJ NN",4,1,1,16874421,2,2.22E+018,"testalpha"
,"blind placebo controlled study","JJ  VBN NN",4,1,1,16955184,2,7.55E+018,"testalpha"
,"increased number of patients","VBN NN IN NNS",4,1,1,17013505,2,3.85E+018,"testalpha"
,"aftersurgery post operative blood","NN NN JJ NN",4,1,1,16451158,"pubmed1",1.49E+018,"testalpha"
,"m ammonium dihydrogen phosphate"," NN NN NN",4,1,1,16511285,2,5.48E+018,"testalpha"
,"life support units blsu","NN NN NNS ",4,1,1,16491215,2,1.17E+017,"testalpha"
,"av y advancement flap","  NN ",4,1,1,16722343,2,7.93E+018,"testalpha"
,"using life table analysis","VBG NN NN NN",4,1,1,16451146,"pubmed1",5.26E+018,"testalpha"
,"system development and regeneration","NN NN CC NN",4,1,1,16414104,2,4.99E+018,"testalpha"
,"adjustment for confounding factors","NN IN VBG NNS",4,1,1,16426559,"pubmed1",3.35E+018,"testalpha"
,"bortezomib velcade withpromising activity"," NN VBG NN",4,1,1,16809883,2,6.12E+018,"testalpha"
,"useful tool for evaluation","JJ NN IN NN",4,1,1,16673556,2,8.38E+018,"testalpha"
,"theinsurance institute for highway","NN NN IN NN",4,1,1,16171767,"pubmed1",1.12E+018,"testalpha"
,"long term hematopoietic recovery","JJ NN JJ NN",4,1,1,17119322,2,5.62E+018,"testalpha"
,"levels of selectedeosinophil proteins","NNS IN  NNS",4,1,1,16859611,2,4.89E+018,"testalpha"
,"higher survival rates conclusion","JJR NN NNS NN",4,1,1,16696444,2,1.78E+018,"testalpha"
,"possible need for patient","JJ NN IN NN",4,1,1,16365330,"pubmed1",3.47E+017,"testalpha"
,"current study assessed thesensitivity","JJ NN VBN NN",4,1,1,16451151,"pubmed1",2.57E+018,"testalpha"
,"risk lowperceived prevalence items","NN VBN NN NNS",4,1,1,16191426,"pubmed1",5.59E+018,"testalpha"
,"incidence of colorectal cancer","NN IN NN NN",4,1,1,17139895,2,9.12E+018,"testalpha"
,"polylepsis venom csav d","NN NN  ",4,1,1,16436788,"pubmed1",1.59E+018,"testalpha"
,"solution used toreanimation group","NN VBN NN NN",4,1,1,16491220,2,5.37E+018,"testalpha"
,"acute pulmonary embolism pe","JJ JJ NN ",4,1,1,16399029,"pubmed1",2.73E+018,"testalpha"
,"other cells expressing molecules","JJ NNS VBG NNS",4,1,1,16330085,2,4.18E+017,"testalpha"
,"physics institute of sao","NN NN IN ",4,1,1,17013504,2,2.72E+018,"testalpha"
,"inflammatory drugs antibiotics diuretics","JJ NNS NNS NNS",4,1,1,17106603,2,8.45E+018,"testalpha"
,"focus of aberrant crypts","NN IN JJ NNS",4,1,1,17293962,2,1.39E+018,"testalpha"
,"b with animals eachto","NN IN NNS ",4,1,1,17293972,2,3.44E+018,"testalpha"
,"ofmolecular biology and medicine","JJ NN CC NN",4,1,1,16596744,"pubmed1",6.24E+018,"testalpha"
,"support staff potential problems","NN NN NN NNS",4,1,1,16436795,"pubmed1",7.40E+018,"testalpha"
,"c terminus indispensablefor rab","NN NN JJ ",4,1,1,16365637,"pubmed1",5.06E+018,"testalpha"
,"viia and activated prothrombin"," CC VBN NNP",4,1,1,16549892,2,2.58E+018,"testalpha"
,"increase of liverechogenicity grade","NN IN NN NN",4,1,1,16673610,2,7.49E+018,"testalpha"
,"ponv in breast surgery"," IN NN NN",4,1,1,16451147,"pubmed1",5.14E+018,"testalpha"
,"increase of intestinal crypts","NN IN JJ NNS",4,1,1,16491217,2,9.11E+018,"testalpha"
,"non muscular pulmonary arterioles"," JJ JJ NNS",4,1,1,16395524,"pubmed1",5.17E+018,"testalpha"
,"genital herpes oro genital","NN NNS  NN",4,1,1,16648915,2,2.18E+018,"testalpha"
,"using mild acid hydrolysis","VBG JJ NN NN",4,1,1,16764914,2,1.45E+018,"testalpha"
,"performed atintervals of months","VBN NNS IN NNS",4,1,1,16710582,2,7.29E+018,"testalpha"
,"carriers in severe type","NNS IN JJ NN",4,1,1,16424652,2,2.96E+018,"testalpha"
,"shock model with hemorrhage","NN NN IN NN",4,1,1,16365323,"pubmed1",6.88E+018,"testalpha"
,"review board irb review","NN NN  NN",4,1,1,16770858,"pubmed1",6.53E+018,"testalpha"
,"weight b i d","NN NN  ",4,1,1,16549901,2,4.14E+018,"testalpha"
,"collection of diffraction data","NN IN NN NNS",4,1,1,16369092,2,7.78E+018,"testalpha"
,"real significance of road","JJ NN IN NN",4,1,1,16191426,"pubmed1",3.98E+018,"testalpha"
,"tobaccos with thevch gus","NNP IN  ",4,1,1,16395526,"pubmed1",3.91E+018,"testalpha"
,"disordered active site whichgets","VBN JJ NN NNS",4,1,1,17143335,"pubmed1",5.93E+018,"testalpha"
,"receivingresections of basal cell","NNS IN NN NN",4,1,1,17165596,2,1.38E+018,"testalpha"
,"model for enhancing residencyresearch","NN IN VBG NN",4,1,1,16473996,"pubmed1",7.80E+018,"testalpha"
,"chromosome xy r xy","NN  NN ",4,1,1,16914909,2,4.70E+018,"testalpha"
,"take appropriate countermeasuresto change","VB JJ NNP NN",4,1,1,16061188,"pubmed1",3.09E+018,"testalpha"
,"temperature of degrees c","NN IN NNS NN",4,1,1,16970980,2,1.94E+018,"testalpha"
,"mg kg increased liver","  VBN NN",4,1,1,17013510,2,4.73E+017,"testalpha"
,"failure as specific forms","NN IN JJ NNS",4,1,1,17014894,2,2.82E+018,"testalpha"
,"residue isa conformational flexibilizer","NN  JJ NNP",4,1,1,16528414,"pubmed1",3.52E+017,"testalpha"
,"immersion in cold water","NN IN JJ NN",4,1,1,17236636,"pubmed1",8.42E+018,"testalpha"
,"betweenmtm and vial method"," CC  NN",4,1,1,17285744,"pubmed1",3.87E+018,"testalpha"
,"accumulation of cholesterol deposits","NN IN NN NNS",4,1,1,17007910,2,1.11E+017,"testalpha"
,"use afteracute blood loss","NN NN NN NN",4,1,1,16762404,2,5.35E+015,"testalpha"
,"medical faculty of theuniversity","JJ NN IN NN",4,1,1,16696444,2,8.02E+018,"testalpha"
,"pointmutations in interdomain interfaces","NNS IN VB NNS",4,1,1,16511258,2,5.87E+017,"testalpha"
,"damage recognition and repair","NN NN CC NN",4,1,1,17143336,"pubmed1",8.11E+018,"testalpha"
,"chronic anal fissure caf","JJ  NN ",4,1,1,16612915,"pubmed1",7.91E+018,"testalpha"
,"saccharide inhibitionand ph effects","VB NN  NNS",4,1,1,16730370,2,2.90E+017,"testalpha"
,"ofmucous extravasation phenomenon control","JJ NN NN NN",4,1,1,16899283,2,4.35E+018,"testalpha"
,"treatment of haemodialysis associatedpseudoporphyria","NN IN NN NNP",4,1,1,17106603,2,4.04E+018,"testalpha"
,"chronic ulcers with non","JJ NNS IN ",4,1,1,17293973,2,3.64E+018,"testalpha"
,"regulators of membrane vesicle","NNS IN NN NN",4,1,1,16511278,2,8.37E+018,"testalpha"
,"current issues in rectal","JJ NNS IN NN",4,1,1,17139882,2,4.26E+018,"testalpha"
,"motor vehicle casualties majorinjuries","NN NN NNS NNS",4,1,1,16169506,"pubmed1",2.74E+016,"testalpha"
,"neurodegenerative disorders and delay","JJ NNS CC NN",4,1,1,17265697,2,6.32E+018,"testalpha"
,"thalassemia males and females","NN NNS CC NNS",4,1,1,16809886,2,6.29E+018,"testalpha"
,"tumorunderwent craniotomy and tumor","NN NN CC NN",4,1,1,16514849,2,7.50E+018,"testalpha"
,"patency rates and safety","NN NNS CC NN",4,1,1,16549901,2,5.34E+018,"testalpha"
,"behavior and high study","NN CC JJ NN",4,1,1,16236234,"pubmed1",6.26E+018,"testalpha"
,"failure ofthe molecular replacement","NN NNP JJ NN",4,1,1,16511279,2,8.95E+018,"testalpha"
,"make errors and interchange","VB NNS CC NN",4,1,1,17294912,2,8.43E+018,"testalpha"
,"higher age male sex","JJR NN NN NN",4,1,1,16451146,"pubmed1",8.21E+018,"testalpha"
,"anucleotide binding domain nbd","VB VBG NN ",4,1,1,16511258,2,8.43E+018,"testalpha"
,"mechanisms thatconfer drug resistance","NNS VB NN NN",4,1,1,16809883,2,3.96E+018,"testalpha"
,"april by histological bone","NNP IN JJ NN",4,1,1,16914909,2,3.55E+018,"testalpha"
,"plasma concentration time profile","NNP NN NN NN",4,1,1,17067137,"pubmed1",1.93E+018,"testalpha"
,"hospitalization ratesand death rates","NN NN NN NNS",4,1,1,16139232,"pubmed1",6.90E+017,"testalpha"
,"diaqua mu glycinato di","NNP  NN ",4,1,1,16397335,2,8.19E+018,"testalpha"
,"variables with tumour thickness","NNS IN JJ NN",4,1,1,16585990,2,1.89E+018,"testalpha"
,"enhancement patterns by consensus","NN NNS IN NN",4,1,1,16333704,"pubmed1",4.09E+018,"testalpha"
,"platelets neutrophils mast cellsand","NNS NNS  NN",4,1,1,16770441,"pubmed1",9.08E+018,"testalpha"
,"screening of ametagenomic dna","NN IN JJ ",4,1,1,16511287,2,8.74E+017,"testalpha"
,"had cc and scores","VBD  CC NNS",4,1,1,17139879,2,8.65E+018,"testalpha"
,"right or wrong care","NN CC JJ NN",4,1,1,16473995,"pubmed1",3.38E+018,"testalpha"
,"oral administration and afterabsorption","JJ NN CC NN",4,1,1,17013511,2,2.77E+017,"testalpha"
,"corrosion resistance of cp","NN NN IN ",4,1,1,16701867,"pubmed1",8.74E+017,"testalpha"
,"ph dependence of suchni"," NN IN ",4,1,1,17117212,"pubmed1",5.00E+018,"testalpha"
,"infarction timi risk score","NN  NN NN",4,1,1,16365321,"pubmed1",2.40E+018,"testalpha"
,"aman of scottish descent"," IN JJ NN",4,1,1,16424658,2,5.03E+018,"testalpha"
,"chains in alternate conformations","NNS IN JJ NNS",4,1,1,16421453,2,3.75E+018,"testalpha"
,"hemorrhagic shock and fluid","JJ NN CC NN",4,1,1,16365323,"pubmed1",6.40E+018,"testalpha"
,"anindolent mcl by years","NN  IN NNS",4,1,1,16424661,2,6.10E+018,"testalpha"
,"vaccine efficacy in women","NN NN IN NNS",4,1,1,17010274,2,4.59E+018,"testalpha"
,"lamina lucida lamina densa","NNP NNP NNP NNP",4,1,1,16955192,2,6.54E+018,"testalpha"
,"droplets drug loaded capsules","NNS NN VBN NNS",4,1,1,16701854,"pubmed1",3.55E+018,"testalpha"
,"neutral regarding patient care","JJ VBG NN NN",4,1,1,16377824,"pubmed1",8.31E+018,"testalpha"
,"genetic diagnosis of vonwillebrand","JJ NN IN NN",4,1,1,16424652,2,6.68E+018,"testalpha"
,"activity and vitality apoptosisassay","NN CC NN NN",4,1,1,17046053,2,4.11E+018,"testalpha"
,"thermostability above k este","NN IN  ",4,1,1,16511287,2,2.12E+018,"testalpha"
,"estimated intercepts and slopes","VBN NNS CC NNS",4,1,1,17067137,"pubmed1",7.64E+018,"testalpha"
,"tickets overtaking tendencies speed","NNS VBG NNS NN",4,1,1,16443186,"pubmed1",3.20E+018,"testalpha"
,"countries bordering themediterranean sea","NNS VBG JJ NN",4,1,1,16696439,2,3.19E+018,"testalpha"
,"carbopol p and sodium","  CC NN",4,1,1,16584161,"pubmed1",2.35E+018,"testalpha"
,"glycolysis rate and oxygen","NN NN CC NN",4,1,1,17068635,"pubmed1",5.39E+018,"testalpha"
,"prevalence rates of hypoferritinemia","NN NNS IN NN",4,1,1,16809889,2,7.29E+018,"testalpha"
,"group and oxygen innitrogen","NN CC NN NN",4,1,1,16451147,"pubmed1",5.98E+018,"testalpha"
,"following acute blood loss","VBG JJ NN NN",4,1,1,16762404,2,2.97E+018,"testalpha"
,"surgery oriented clerkships obstetrics","NN VBN NNS NNS",4,1,1,16377822,"pubmed1",6.47E+018,"testalpha"
,"viii activity and d"," NN CC ",4,1,1,16549898,2,1.70E+016,"testalpha"
,"advances in critical care","NNS IN JJ NN",4,1,1,16400088,"pubmed1",6.93E+018,"testalpha"
,"predictability of absorption potential","NN IN NN NN",4,1,1,16584115,"pubmed1",1.31E+018,"testalpha"
,"conformation generates chiral objects","NN VBZ JJ NNS",4,1,1,16397333,2,2.48E+018,"testalpha"
,"fraction with constant total","NN IN JJ NN",4,1,1,16955185,2,7.07E+018,"testalpha"
,"technology for distributing information","NN IN VBG NN",4,1,1,16479033,2,3.26E+017,"testalpha"
,"pet ct ingastrointestinal tumors","NN  JJ NNS",4,1,1,16333707,"pubmed1",9.07E+018,"testalpha"
,"ii complexes ofac thr"," NNS  ",4,1,1,17117212,"pubmed1",4.66E+018,"testalpha"
,"vectors onthe other hand","NNS NNP JJ NN",4,1,1,17285739,"pubmed1",6.69E+018,"testalpha"
,"knowndrosophila melanogaster pre mirnas","NNP NN  NNP",4,1,1,16770443,"pubmed1",5.05E+017,"testalpha"
,"origin hsc takes part","NN  VBZ NN",4,1,1,17013517,2,7.70E+018,"testalpha"
,"r p q xy","NN   ",4,1,1,16914909,2,1.27E+017,"testalpha"
,"bound acetate carboxyl group","VBN NN  NN",4,1,1,16456276,2,5.86E+018,"testalpha"
,"reaction pcr with primersets","NN  IN NNS",4,1,1,16514834,2,1.70E+018,"testalpha"
,"tothe site for future","NNP NN IN NN",4,1,1,16436790,"pubmed1",6.87E+017,"testalpha"
,"andoxygenation and ventilation parameters","NN CC NN NNS",4,1,1,16451149,"pubmed1",1.15E+018,"testalpha"
,"impressions throughout thecase presentation","NNS IN NN NN",4,1,1,16365338,"pubmed1",4.20E+018,"testalpha"
,"sex primary school grades","NN JJ NN NNS",4,1,1,16236234,"pubmed1",2.72E+016,"testalpha"
,"groups health care workers","NNS NN NN NNS",4,1,1,16696442,2,1.36E+018,"testalpha"
,"specificity foraaaf induced lesions","NN  VBN NNS",4,1,1,17143337,"pubmed1",3.88E+018,"testalpha"
,"wall with lossof stratification","NN IN  NN",4,1,1,16447095,"pubmed1",2.23E+018,"testalpha"
,"results of thisstudy show","NNS IN NN NN",4,1,1,16762404,2,8.90E+018,"testalpha"
,"psoriasis and healthy volunteers","NN CC JJ NNS",4,1,1,16956117,2,8.02E+018,"testalpha"
,"nd nd nd co","   ",4,1,1,16389406,"pubmed1",2.02E+018,"testalpha"
,"means minutes vs minutes","NNS NNS  NNS",4,1,1,16365334,"pubmed1",4.60E+018,"testalpha"
,"normal individuals and vwd","JJ NNS CC ",4,1,1,16424652,2,1.79E+018,"testalpha"
,"amarker of oxidative metabolism","NN IN JJ NN",4,1,1,16919313,2,8.96E+018,"testalpha"
,"min after acupuncture alloknesis"," IN NN NN",4,1,1,16955182,2,1.49E+018,"testalpha"
,"data collection and guidelines","NNS NN CC NNS",4,1,1,16369095,2,5.17E+018,"testalpha"
,"co h o co","   ",4,1,1,16397335,2,3.04E+018,"testalpha"
,"ss smp and sssinto","  CC NNP",4,1,1,16584167,"pubmed1",9.29E+017,"testalpha"
,"proportionof emergency medicine rct"," NN NN ",4,1,1,16365332,"pubmed1",2.59E+018,"testalpha"
,"frequency in human mrna","NN IN JJ ",4,1,1,16733558,"pubmed1",5.77E+018,"testalpha"
,"treatment of coral snakeenvenomations","NN IN JJ NNS",4,1,1,16436788,"pubmed1",6.65E+018,"testalpha"
,"patients but elevated liver","NNS CC VBN NN",4,1,1,16914905,2,6.07E+018,"testalpha"
,"growth arrest and apoptosis","NN NN CC NN",4,1,1,16569423,2,2.13E+018,"testalpha"
,"rrc core competency requirements"," NN NN NNS",4,1,1,16473998,"pubmed1",5.79E+018,"testalpha"
,"thepreperitoneal space initial pressure","NN NN JJ NN",4,1,1,16491219,2,3.90E+018,"testalpha"
,"clear features of ttp","JJ NNS IN ",4,1,1,16424653,2,1.39E+018,"testalpha"
,"diagnosis of systemic amyloidosis","NN IN JJ NN",4,1,1,16714055,2,8.10E+018,"testalpha"
,"activity of cytochrome c","NN IN NN NN",4,1,1,16951741,"pubmed1",3.39E+018,"testalpha"
,"histopathological evidence showed thatadministration","JJ NN VBD NN",4,1,1,16999986,2,5.00E+018,"testalpha"
,"women breast cancer pathology","NNS NN NN NN",4,1,1,16596895,"pubmed1",3.45E+018,"testalpha"
,"socks syndrome erythema infectiosum","NNS NN NN NN",4,1,1,17010266,2,7.67E+018,"testalpha"
,"present study determined theability","JJ NN VBN NN",4,1,1,16594645,"pubmed1",6.13E+018,"testalpha"
,"infants and childrenwith atopic","NNS CC NN NN",4,1,1,17438830,2,6.37E+018,"testalpha"
,"adequate amounts of macronutrients","JJ NNS IN NNS",4,1,1,16918070,"pubmed1",1.75E+018,"testalpha"
,"potential vaccine against rhdvand","JJ NN IN NN",4,1,1,16733562,"pubmed1",4.98E+018,"testalpha"
,"based segmentation ray castingvisualization","VBN NN  NN",4,1,1,16399038,"pubmed1",5.29E+018,"testalpha"
,"directives of theeuropean union","NNS IN JJ NN",4,1,1,16999268,2,2.93E+017,"testalpha"
,"nsmm and amyloid tumors"," CC VB NNS",4,1,1,16714048,2,8.29E+018,"testalpha"
,"mtm procedure used todetermine"," NN VBN NN",4,1,1,17285744,"pubmed1",1.77E+018,"testalpha"
,"m received saline ml"," VBD NN ",4,1,1,17067136,"pubmed1",4.49E+018,"testalpha"
,"nerve fibres and bundles","NN NNS CC NNS",4,1,1,16919707,2,1.74E+018,"testalpha"
,"use vs in multivariate","NN  IN NN",4,1,1,16436792,"pubmed1",1.16E+018,"testalpha"
,"pre and post surgery"," CC NN NN",4,1,1,17293973,2,7.00E+018,"testalpha"
,"values in mutational variants","NNS IN JJ NNS",4,1,1,16823609,"pubmed1",9.21E+018,"testalpha"
,"lackof evidence based guidelines"," NN VBN NNS",4,1,1,16549899,2,2.40E+018,"testalpha"
,"t cells indicating positivecorrelations"," NNS VBG NNS",4,1,1,17016035,2,2.79E+018,"testalpha"
,"left branch of n","VBD NN IN ",4,1,1,17139884,2,2.94E+018,"testalpha"
,"findapplication in gene therapy","NN IN  NN",4,1,1,16701879,"pubmed1",5.14E+018,"testalpha"
,"presentdefect od external anal","NN  JJ ",4,1,1,17139884,2,7.44E+018,"testalpha"
,"occupational exposure onfetal development","JJ NN NN NN",4,1,1,16808045,"pubmed1",8.68E+018,"testalpha"
,"were fused withthe b","VBD VBN NNP NN",4,1,1,16395526,"pubmed1",5.61E+018,"testalpha"
,"ion pair reversed phase"," NN VBD NN",4,1,1,17285740,"pubmed1",5.18E+018,"testalpha"
,"andblood pressure control lipid","NN NN NN NN",4,1,1,16921608,"pubmed1",7.22E+018,"testalpha"
,"overall rate ofcervical screening","JJ NN JJ NN",4,1,1,16514839,2,6.62E+018,"testalpha"
,"muscle cells in bronchi","NN NNS IN NNP",4,1,1,16770441,"pubmed1",4.33E+018,"testalpha"
,"thrombotic thrombocytopenic purpura ttp","JJ JJ NNP ",4,1,1,16424653,2,6.39E+018,"testalpha"
,"models conclusion specific recommendations","NNS NN JJ NNS",4,1,1,16473989,"pubmed1",3.51E+018,"testalpha"
,"method in different skinpathologies","NN IN JJ NNS",4,1,1,16999269,2,4.91E+017,"testalpha"
,"laws are associated withlower","NNS VBP VBN NN",4,1,1,16202466,"pubmed1",4.03E+018,"testalpha"
,"magnetic resonance imaging mri","JJ NN VBG ",4,1,1,16612920,"pubmed1",2.95E+018,"testalpha"
,"referto aviation or road","NNP NN CC NN",4,1,1,16427020,"pubmed1",8.53E+018,"testalpha"
,"characteristics of animal movement","NNS IN NN NN",4,1,1,16823606,"pubmed1",8.35E+018,"testalpha"
,"work hourrestrictions on patient","NN NNS IN NN",4,1,1,16377823,"pubmed1",4.85E+018,"testalpha"
,"ormicrotubule associated proteins i","NN VBN NNS ",4,1,1,17265696,2,6.37E+018,"testalpha"
,"data collected fromthe community","NNS VBN NNP NN",4,1,1,16596901,"pubmed1",4.63E+018,"testalpha"
,"e f cyclins cip"," NN NNS ",4,1,1,17115080,"pubmed1",5.56E+018,"testalpha"
,"nosignificant changes in pcs","JJ NNS IN ",4,1,1,16424649,2,1.27E+018,"testalpha"
,"recent revisions of deterrence","JJ NNS IN NN",4,1,1,16405859,"pubmed1",7.98E+018,"testalpha"
,"blood dc withplasmid dna","NN  JJ ",4,1,1,16404477,"pubmed1",1.52E+018,"testalpha"
,"structural procedural andperformance assessment","JJ JJ NN NN",4,1,1,16770857,"pubmed1",2.88E+018,"testalpha"
,"clinical modification icd cm","JJ NN  ",4,1,1,16365331,"pubmed1",8.97E+018,"testalpha"
,"wear mechanism of thebiomolecules","VB NN IN NNS",4,1,1,16701857,"pubmed1",7.50E+017,"testalpha"
,"ofac thr glu ser","   ",4,1,1,17117212,"pubmed1",7.95E+018,"testalpha"
,"aspirin low molecular weight","NN JJ JJ NN",4,1,1,16549893,2,8.56E+018,"testalpha"
,"athletes with type diabetes","NNS IN NN NN",4,1,1,16918070,"pubmed1",2.19E+018,"testalpha"
,"nongel powder in terms","NNP NN IN NNS",4,1,1,16584168,"pubmed1",2.36E+018,"testalpha"
,"pretreated group tl vs","VBN NN  ",4,1,1,17338197,2,6.53E+018,"testalpha"
,"mini review article examines"," NN NN NNS",4,1,1,16918067,"pubmed1",1.54E+017,"testalpha"
,"pre and posttreatment pain"," CC NN NN",4,1,1,16436793,"pubmed1",1.31E+018,"testalpha"
,"certain regions of africa","JJ NNS IN NNP",4,1,1,17013520,2,5.25E+018,"testalpha"
,"legal directives regulating theacquirement","JJ NNS VBG NN",4,1,1,16999271,2,1.89E+018,"testalpha"
,"lysosomalbiogenesis in mammalian cells","NN IN JJ NNS",4,1,1,16365637,"pubmed1",8.53E+018,"testalpha"
,"pcr for hpvclearance persistence"," IN NN NN",4,1,1,16514834,2,5.01E+018,"testalpha"
,"disorder of plasma cells","NN IN NNP NNS",4,1,1,16809883,2,3.86E+018,"testalpha"
,"aplacebo group in terms"," NN IN NNS",4,1,1,16479024,2,6.23E+018,"testalpha"
,"close monitoring and treatment","VB NN CC NN",4,1,1,16809889,2,7.66E+018,"testalpha"
,"thecriteria of propofol infusion","NNP IN  NN",4,1,1,16451160,"pubmed1",4.09E+018,"testalpha"
,"g tissue after days"," NN IN NNS",4,1,1,16701880,"pubmed1",6.77E+017,"testalpha"
,"substrate for cell attachment","NN IN NN NN",4,1,1,16701861,"pubmed1",6.21E+018,"testalpha"
,"detection using radiographs andrepair","NN VBG NNS NN",4,1,1,16956115,2,4.77E+017,"testalpha"
,"neonates with respiratorydisturbances biomerieux","NNS IN NNS NNP",4,1,1,17019441,"pubmed1",8.93E+018,"testalpha"
,"betweenthe patients with mutations","NNP NNS IN NNS",4,1,1,16585980,2,7.37E+018,"testalpha"
,"treatment for pain patients","NN IN NN NNS",4,1,1,16436793,"pubmed1",8.72E+018,"testalpha"
,"substance abuse thefinal model","NN NN JJ NN",4,1,1,16405857,"pubmed1",4.52E+018,"testalpha"
,"day time and night","NN NN CC NN",4,1,1,16171767,"pubmed1",7.66E+018,"testalpha"
,"thepermeability and transporter models","NN CC NN NNS",4,1,1,16584115,"pubmed1",6.62E+018,"testalpha"
,"increased recognition in children","VBN NN IN NNS",4,1,1,16549898,2,7.60E+018,"testalpha"
,"erythrocyte volume mean erythrocyte","NNP NN VB NNP",4,1,1,16809890,2,8.81E+018,"testalpha"
,"postoperative morbidity andpostoperative limitations","JJ NN JJ NNS",4,1,1,16612909,2,3.76E+018,"testalpha"
,"fiber solution n polyethylene","NN NN  NN",4,1,1,16252139,"pubmed1",3.20E+018,"testalpha"
,"lung tissueschanges of wistar","NN NNS IN NN",4,1,1,17293964,2,8.25E+018,"testalpha"
,"appropriatelyto prevent organizational accidents"," VB JJ NNS",4,1,1,16434013,"pubmed1",1.35E+018,"testalpha"
,"reduction of mitochondrial energy","NN IN JJ NN",4,1,1,17068635,"pubmed1",5.81E+018,"testalpha"
,"serum adenosine deaminase ada","NN NN NN ",4,1,1,16956117,2,7.63E+018,"testalpha"
,"possibilities oflow mechanical index","NNS VB JJ NN",4,1,1,16317492,"pubmed1",8.57E+017,"testalpha"
,"vmax km in lada","  IN ",4,1,1,16929383,"pubmed1",4.55E+018,"testalpha"
,"facts in mind mirsearch","NNS IN NN NN",4,1,1,16770443,"pubmed1",1.12E+018,"testalpha"
,"amount of nitrotyrosine formedwas","NN IN NN ",4,1,1,16951741,"pubmed1",4.48E+018,"testalpha"
,"immunohistochemistry for monitoring liver","NN IN VBG NN",4,1,1,16256175,2,5.44E+018,"testalpha"
,"levels iron binding capacity","NNS NN VBG NN",4,1,1,16809890,2,1.28E+018,"testalpha"
,"additional month after bone","JJ NN IN NN",4,1,1,16918065,"pubmed1",6.75E+018,"testalpha"
,"effectof recombinant human bfgf"," JJ JJ ",4,1,1,17106595,2,8.07E+018,"testalpha"
,"common metabolic syndrome component","JJ JJ NN NN",4,1,1,16479027,2,3.47E+018,"testalpha"
,"researchproject on research ethics","NN IN NN NNS",4,1,1,16377817,"pubmed1",7.77E+018,"testalpha"
,"june and june patients"," CC  NNS",4,1,1,16424645,2,1.89E+018,"testalpha"
,"tobacco mosaic virus tmv","NN JJ NN ",4,1,1,16395523,"pubmed1",9.88E+017,"testalpha"
,"women with ahypotonic urethra","NNS IN JJ ",4,1,1,16962646,2,6.72E+018,"testalpha"
,"lysis syndrome in patients","NN NN IN NNS",4,1,1,16424647,2,6.53E+018,"testalpha"
,"substituted pyridines anti conformation","VBN NNS IN NN",4,1,1,16397333,2,3.08E+018,"testalpha"
,"intensification with hds asctdoes","NN IN  NNS",4,1,1,16424644,2,5.45E+018,"testalpha"
,"sequelae of limb thrombi","NNS IN NN ",4,1,1,16549898,2,5.71E+018,"testalpha"
,"pain vas before discharge","NN  IN NN",4,1,1,16436793,"pubmed1",8.63E+018,"testalpha"
,"cervical mass screening program","JJ NN NN NN",4,1,1,16514839,2,7.81E+017,"testalpha"
,"formulation aids in localization","NN NNS IN NN",4,1,1,16399031,"pubmed1",8.32E+018,"testalpha"
,"ser ser and ser","  CC ",4,1,1,16511282,2,4.58E+018,"testalpha"
,"cancer cells and cell","NN NNS CC NN",4,1,1,16733561,"pubmed1",4.68E+018,"testalpha"
,"group sham saline n","NN  NN ",4,1,1,17293958,2,5.75E+017,"testalpha"
,"regarding gender age tumor","VBG NN NN NN",4,1,1,17139896,2,4.27E+018,"testalpha"
,"dio specific salaries credentials"," JJ NNS NNS",4,1,1,16377812,"pubmed1",5.69E+018,"testalpha"
,"changes changes in cell","NNS NNS IN NN",4,1,1,16696445,2,6.99E+018,"testalpha"
,"plasmiduptake studies with dna","NN NNS IN ",4,1,1,16701879,"pubmed1",2.58E+018,"testalpha"
,"unique finding in mtc","JJ NN IN ",4,1,1,16603102,2,4.43E+018,"testalpha"
,"peer reviewed radiology journals","VB VBN NN NNS",4,1,1,16399035,"pubmed1",5.45E+018,"testalpha"
,"characterization of crystal contents","NN IN NN NNS",4,1,1,16421445,2,4.67E+018,"testalpha"
,"infrequent seat belt use","JJ NN NN NN",4,1,1,16426559,"pubmed1",3.34E+017,"testalpha"
,"adenine nucleotides whichtakes place","NN NNS VBZ NN",4,1,1,16770441,"pubmed1",3.62E+017,"testalpha"
,"nerve growth factor ngf","NN NN NN ",4,1,1,16325891,2,6.92E+018,"testalpha"
,"patient and system variables","NN CC NN NNS",4,1,1,16365324,"pubmed1",5.28E+018,"testalpha"
,"graft loss or nail","NN NN CC ",4,1,1,17165594,2,4.72E+018,"testalpha"
,"cam i and cam","  CC ",4,1,1,16949651,2,3.36E+018,"testalpha"
,"mouse enzyme amino acid","NN  NNP NN",4,1,1,16505899,"pubmed1",7.87E+018,"testalpha"
,"proliferating human cd cells","VBG JJ  NNS",4,1,1,16951739,"pubmed1",6.85E+018,"testalpha"
,"therapy with methylprednisolone mg","NN IN NN ",4,1,1,16603101,2,2.17E+018,"testalpha"
,"mesenchymal stem cells mscs","JJ VB NNS ",4,1,1,16696440,2,7.00E+018,"testalpha"
,"dispase separated human epidermis","NN VBN NN NN",4,1,1,16648912,2,4.20E+018,"testalpha"
,"lower odds of self","JJR NNS IN NN",4,1,1,16112070,"pubmed1",8.81E+018,"testalpha"
,"iron therapy on bloodparameters","NN NN IN NNS",4,1,1,16809890,2,5.51E+018,"testalpha"
,"inthe literature for decades","NNP NN IN NNS",4,1,1,16730370,2,4.81E+018,"testalpha"
,"subjective outcomes and symptoms","JJ NNS CC NNS",4,1,1,16436796,"pubmed1",2.38E+018,"testalpha"
,"castor oil polymer indogs","NN NN NN NNS",4,1,1,17293971,2,1.53E+018,"testalpha"
,"time dbr dfr vct","NN   ",4,1,1,16479025,2,4.03E+018,"testalpha"
,"cohort comprised patientswho underwent","NN VBN  NN",4,1,1,16710578,2,1.69E+018,"testalpha"
,"oxide groups inthe coatings","VB NNS NNP NNS",4,1,1,16701874,"pubmed1",6.65E+018,"testalpha"
,"ttp andoverall survival os"," JJ NN ",4,1,1,17139902,2,6.10E+018,"testalpha"
,"disease with predominant involvement","NN IN JJ NN",4,1,1,16874424,2,7.11E+018,"testalpha"
,"horizontal alignment interchange ramppresence","NN NN NN NN",4,1,1,16442487,"pubmed1",1.59E+018,"testalpha"
,"interval ax trials f","NN NN NNS NN",4,1,1,16436796,"pubmed1",6.78E+017,"testalpha"
,"radial outgrowth rate frequency","JJ NN NN NN",4,1,1,16874412,2,6.89E+018,"testalpha"
,"diabetic patients with laryngectomyprocedures","JJ NNS IN NNS",4,1,1,16989147,2,3.99E+018,"testalpha"
,"assignment and physicochemical properties","NN CC JJ NNS",4,1,1,16823609,"pubmed1",2.98E+018,"testalpha"
,"determined hs after clp","VBN  IN ",4,1,1,17293958,2,4.40E+018,"testalpha"
,"electronic record datix database","JJ NN  NN",4,1,1,16321534,"pubmed1",1.89E+018,"testalpha"
,"bypharmacological blockade of nmda","JJ NN IN ",4,1,1,17133957,2,4.76E+018,"testalpha"
,"emergency medicine saem meetings","NN NN  NNS",4,1,1,16365332,"pubmed1",3.32E+018,"testalpha"
,"rt during psychiatry residency"," IN NN NN",4,1,1,16473996,"pubmed1",2.06E+018,"testalpha"
,"rapid tumorgrowth and death","JJ NN CC NN",4,1,1,17143339,"pubmed1",8.77E+018,"testalpha"
,"mechanism of drug release","NN IN NN NN",4,1,1,16584139,"pubmed1",3.44E+018,"testalpha"
,"certain fibrotic lung diseases","JJ JJ NN NNS",4,1,1,16395527,"pubmed1",5.81E+017,"testalpha"
,"physical activity measurement techniques","JJ NN NN NNS",4,1,1,16918067,"pubmed1",3.75E+017,"testalpha"
,"dynamic contrast enhanced mri","JJ NN VBN ",4,1,1,16399033,"pubmed1",7.45E+018,"testalpha"
,"familiarized environment under lowstress","VBN NN IN NN",4,1,1,17133955,2,8.27E+018,"testalpha"
,"stearoyl oleoyl phosphatidylcholine andstearoyl","  NN ",4,1,1,17128291,"pubmed1",3.28E+018,"testalpha"
,"better thanconventional dosage forms","JJR JJ NN NNS",4,1,1,16584139,"pubmed1",2.76E+018,"testalpha"
,"morphology and histochemical indicators","NN CC JJ NNS",4,1,1,17046053,2,2.81E+018,"testalpha"
,"region growing d projections","NN VBG  NNS",4,1,1,16399031,"pubmed1",2.66E+018,"testalpha"
,"correct perfectlyand in fact","VB NN IN NN",4,1,1,17294912,2,8.20E+018,"testalpha"
,"old woman underwent tracheal","JJ NN NN NN",4,1,1,16612923,"pubmed1",1.81E+018,"testalpha"
,"driving performance for drivers","VBG NN IN NNS",4,1,1,16226211,"pubmed1",3.16E+018,"testalpha"
,"work wehave analyzed transcription","NN VB VBD NN",4,1,1,16964327,"pubmed1",7.56E+018,"testalpha"
,"intraoperativeimprint smears from cases","NN NNS IN NNS",4,1,1,16514849,2,1.97E+018,"testalpha"
,"residual tumorfollowing surgery presence","JJ VBG NN NN",4,1,1,17117604,2,7.73E+018,"testalpha"
,"severity of atopic dermatitis","NN IN NN NN",4,1,1,17106598,2,7.74E+018,"testalpha"
,"di tert butyl oxidobenzyl","   ",4,1,1,16456265,2,9.36E+016,"testalpha"
,"binding domain sbd structures","VBG NN  NNS",4,1,1,16511258,2,5.94E+018,"testalpha"
,"women of reproductive age","NNS IN JJ NN",4,1,1,16808045,"pubmed1",8.52E+017,"testalpha"
,"behavioral correlates ofperceived vulnerability","JJ NNS VBN NN",4,1,1,16112069,"pubmed1",4.81E+018,"testalpha"
,"liver injury in rats","NN NN IN NNS",4,1,1,16714049,2,5.71E+018,"testalpha"
,"standard rat chow control","JJ NN NN NN",4,1,1,17293957,2,7.20E+017,"testalpha"
,"variable low basal level","JJ JJ NN NN",4,1,1,17143338,"pubmed1",8.61E+018,"testalpha"
,"growth of metastatic cancer","NN IN JJ NN",4,1,1,16730054,2,2.87E+018,"testalpha"
,"aspfkfb and pfkfb mrna"," CC  ",4,1,1,17143338,"pubmed1",3.21E+018,"testalpha"
,"stroke ais and children","NN  CC NNS",4,1,1,16549893,2,1.74E+018,"testalpha"
,"threat agents are biotoxins","NN NNS VBP NNS",4,1,1,16696436,2,3.75E+018,"testalpha"
,"cell line dose range","NN NN NN NN",4,1,1,16770447,"pubmed1",3.52E+017,"testalpha"
,"initial low rhepo dose","JJ JJ  NN",4,1,1,17119327,2,2.05E+018,"testalpha"
,"ec from march st"," IN NN ",4,1,1,16999268,2,8.26E+018,"testalpha"
,"differences were detected inany","NNS VBD VBD NN",4,1,1,16451148,"pubmed1",1.57E+018,"testalpha"
,"effect of intralipid treatment","NN IN JJ NN",4,1,1,16436797,"pubmed1",5.34E+018,"testalpha"
,"subtype m with bm","JJ  IN ",4,1,1,16914909,2,4.46E+018,"testalpha"
,"chloride in fragrance mix","NN IN NN NN",4,1,1,17010264,2,8.94E+018,"testalpha"
,"enzyme erythronate phosphate dehydrogenase"," NN NN NN",4,1,1,16511285,2,4.82E+018,"testalpha"
,"sea and food habits","NN CC NN NNS",4,1,1,16696439,2,3.31E+018,"testalpha"
,"showedactivity towards short chain","NN IN JJ NN",4,1,1,16511287,2,2.08E+018,"testalpha"
,"groups of h histone","NNS IN  NN",4,1,1,17019436,"pubmed1",6.58E+018,"testalpha"
,"p expression by flowcytometry"," NN IN NN",4,1,1,16809885,2,3.68E+018,"testalpha"
,"optimization ofthis expensive treatment","NN NNP JJ NN",4,1,1,16549891,2,1.54E+018,"testalpha"
,"condition improved inseveral days","NN VBN JJ NNS",4,1,1,16603101,2,3.13E+017,"testalpha"
,"using milled vs unmilledacp","VBG VBN  ",4,1,1,16701862,"pubmed1",8.61E+018,"testalpha"
,"r q exon nt","NN   ",4,1,1,16424658,2,7.12E+018,"testalpha"
,"amino acid residues vlsat","NNP NN NNS ",4,1,1,16770447,"pubmed1",8.96E+018,"testalpha"
,"analogue with d configuration","NN IN  NN",4,1,1,16496038,"pubmed1",5.67E+018,"testalpha"
,"action of predisposing agents","NN IN VBG NNS",4,1,1,17010270,2,2.41E+018,"testalpha"
,"pacs studyperiod included results"," NN VBD NNS",4,1,1,16436791,"pubmed1",6.83E+018,"testalpha"
,"reducing teenage motor vehicle","VBG JJ NN NN",4,1,1,16171767,"pubmed1",2.77E+018,"testalpha"
,"artery for several liver","NN IN JJ NN",4,1,1,16673565,2,3.31E+018,"testalpha"
,"monocyte colonystimulating factor gm","NNP VBG NN ",4,1,1,16404477,"pubmed1",1.09E+018,"testalpha"
,"x ray crystal structures","NN  NN NNS",4,1,1,16511248,2,2.16E+018,"testalpha"
,"ethylammonioethyl aminocarbonyl phenolate c"," NN NN NN",4,1,1,16456282,2,2.09E+018,"testalpha"
,"l and microg l"," CC NNP ",4,1,1,17117609,2,7.28E+018,"testalpha"
,"margin examinationplus naked eye","NN NN JJ NN",4,1,1,17139882,2,5.39E+018,"testalpha"
,"microscopy and transmission electron"," CC NN NN",4,1,1,16701854,"pubmed1",3.70E+017,"testalpha"
,"uterine epithelial cells growth","NN JJ NNS NN",4,1,1,16564564,2,3.65E+018,"testalpha"
,"reagent quantities and time","NN NNS CC NN",4,1,1,17293970,2,4.87E+018,"testalpha"
,"platelet count and cd","NN NN CC ",4,1,1,16809885,2,7.30E+018,"testalpha"
,"co c h o"," NN  ",4,1,1,16456276,2,6.15E+018,"testalpha"
,"reperfusion induced liver damage","NN VBN NN NN",4,1,1,16612918,"pubmed1",3.28E+018,"testalpha"
,"thecrystal structure of ii","NN NN IN ",4,1,1,16456293,2,5.48E+018,"testalpha"
,"recovery with acetate buffer","NN IN NN NN",4,1,1,16594643,"pubmed1",2.89E+018,"testalpha"
,"included system needs patient","VBD NN VBZ NN",4,1,1,16365324,"pubmed1",4.62E+018,"testalpha"
,"ultrasound examination asfollows grade","NN NN VBZ NN",4,1,1,16673610,2,8.16E+017,"testalpha"
,"mental illness in children","JJ NN IN NNS",4,1,1,16474001,"pubmed1",8.74E+018,"testalpha"
,"functional mri positron emission","JJ  NNP NN",4,1,1,16436787,"pubmed1",8.88E+017,"testalpha"
,"hardness and compressive strength","NN CC JJ NN",4,1,1,16701865,"pubmed1",4.46E+018,"testalpha"
,"free vaginal tape implantation","JJ JJ NN NN",4,1,1,16962646,2,1.24E+017,"testalpha"
,"ocular complications of atopic","JJ NNS IN NN",4,1,1,17106598,2,2.84E+017,"testalpha"
,"castor oilpolymer assisted cicatrisation","NN NN VBN NN",4,1,1,17293971,2,1.50E+018,"testalpha"
,"effect of intrinsic entropy","NN IN NN ",4,1,1,17019442,"pubmed1",7.73E+018,"testalpha"
,"life and physical fitness","NN CC JJ NN",4,1,1,16918068,"pubmed1",2.68E+018,"testalpha"
,"avoid collapse and instabilities","VB NN CC NNS",4,1,1,17285745,"pubmed1",1.95E+018,"testalpha"
,"thrombosed ulnar artery aneurysm","VBN NN NN ",4,1,1,16612927,"pubmed1",3.33E+018,"testalpha"
,"intestinal tract git haemorrhage","JJ NN  NN",4,1,1,16612928,"pubmed1",7.68E+018,"testalpha"
,"layers of bowel wall","NNS IN NN NN",4,1,1,16447095,"pubmed1",7.38E+018,"testalpha"
,"patient teaching and collaboration","NN NN CC NN",4,1,1,16462405,"pubmed1",4.07E+018,"testalpha"
,"inmedicine with fresh inputs","NN IN JJ NNS",4,1,1,17318328,"pubmed1",1.33E+018,"testalpha"
,"amino acids and places","NNP NNS CC NNS",4,1,1,17294912,2,2.97E+018,"testalpha"
,"eosinophils were determined hs","NNS VBD VBN ",4,1,1,17293958,2,6.48E+018,"testalpha"
,"procured aftergynecologic pap smears","VBN JJ  NNS",4,1,1,16514841,2,6.24E+018,"testalpha"
,"adaptive response induced e","JJ NN VBN ",4,1,1,16582987,"pubmed1",5.84E+018,"testalpha"
,"mapleson d map d","NN  NN ",4,1,1,16451150,"pubmed1",5.80E+018,"testalpha"
,"physiological effect of physicalexercise","JJ NN IN NN",4,1,1,16918068,"pubmed1",7.59E+018,"testalpha"
,"notreveal obvious surface differences","NN JJ NN NNS",4,1,1,16874415,2,2.02E+018,"testalpha"
,"effects of intraluminal injection","NNS IN JJ NN",4,1,1,17293970,2,6.38E+018,"testalpha"
,"teen driver fatalities fatalities"," NN NNS NNS",4,1,1,16171767,"pubmed1",6.25E+018,"testalpha"
,"pp pe andccpp pe","   ",4,1,1,16584758,2,8.98E+018,"testalpha"
,"mass spectrometry lc ms","NN NN  ",4,1,1,17285740,"pubmed1",2.35E+018,"testalpha"
,"flatulence constipation thin feces","NN NN JJ NNS",4,1,1,16424650,2,8.52E+018,"testalpha"
,"programmed cell death apoptosis","VBN NN NN NN",4,1,1,16696437,2,5.37E+018,"testalpha"
,"apparent gap inthe chain","JJ NN NNP NN",4,1,1,16710575,2,3.07E+018,"testalpha"
,"local departmentalclinical risk management","JJ JJ NN NN",4,1,1,16321534,"pubmed1",4.77E+018,"testalpha"
,"highest plasma mmp concentration","JJT NNP  NN",4,1,1,16585983,2,2.58E+018,"testalpha"
,"tgf beta type iireceptor"," NN NN NN",4,1,1,16733563,"pubmed1",5.10E+018,"testalpha"
,"withsymptoms of sweating sleep","NNS IN VBG NN",4,1,1,16479025,2,4.26E+018,"testalpha"
,"molecules into tetrameric units","NNS IN JJ NNS",4,1,1,16456285,2,1.25E+017,"testalpha"
,"colo anal anastomosis n","  NN ",4,1,1,17139896,2,6.90E+018,"testalpha"
,"efficient review process simplifies","JJ NN NN NNS",4,1,1,16438095,"pubmed1",6.35E+018,"testalpha"
,"anuprising crypt cell production","VBG NN NN NN",4,1,1,16491217,2,2.85E+018,"testalpha"
,"toexamine cross border drinking","NN VB NN NN",4,1,1,16169506,"pubmed1",3.91E+018,"testalpha"
,"encapsulation of pancreatic islets","NN IN JJ NNS",4,1,1,16701881,"pubmed1",3.47E+018,"testalpha"
,"keratolytics and topical immunomodulators","NNS CC JJ NNS",4,1,1,17010269,2,5.55E+018,"testalpha"
,"influence of impeller clearance","NN IN NN NN",4,1,1,16594638,"pubmed1",6.62E+018,"testalpha"
,"c h pi benzene","NN   NN",4,1,1,16397328,2,3.32E+018,"testalpha"
,"ofcervical screening among women","JJ NN IN NNS",4,1,1,16514839,2,5.60E+018,"testalpha"
,"sedation and respiratory depression","NN CC NN NN",4,1,1,16916180,"pubmed1",4.29E+018,"testalpha"
,"ph tandem from pdzrhogef"," NN IN ",4,1,1,17019437,"pubmed1",8.74E+018,"testalpha"
,"encapsulation min beta cells","NN  NN NNS",4,1,1,16701853,"pubmed1",2.08E+018,"testalpha"
,"decrease of ngfat weeks","NN IN NNP NNS",4,1,1,16325891,2,4.60E+018,"testalpha"
,"lesions of ad patients","NNS IN NN NNS",4,1,1,16603095,2,4.77E+018,"testalpha"
,"newborns with birth weight","NNS IN NN NN",4,1,1,17438837,2,3.44E+018,"testalpha"
,"years of age calendar","NNS IN NN NN",4,1,1,16613748,2,2.94E+018,"testalpha"
,"common belief among women","JJ NN IN NNS",4,1,1,16424650,2,7.00E+018,"testalpha"
,"metabolic events in order","JJ NNS IN NN",4,1,1,16918068,"pubmed1",8.25E+018,"testalpha"
,"changes in thepancreatic parenchyma","NNS IN JJ ",4,1,1,16333694,"pubmed1",6.34E+017,"testalpha"
,"adjusted hazard of dui","VBN NN IN ",4,1,1,16202465,"pubmed1",5.56E+018,"testalpha"
,"scoring systems and concepts","VBG NNS CC NNS",4,1,1,17139901,2,8.79E+018,"testalpha"
,"abuse and possible confounders","NN CC JJ NNS",4,1,1,16426559,"pubmed1",3.39E+018,"testalpha"
,"role of tt virus","NN IN  NN",4,1,1,16696442,2,1.36E+018,"testalpha"
,"dio titles report titles"," NNS VBP NNS",4,1,1,16377812,"pubmed1",6.07E+018,"testalpha"
,"dihydrodipicolinate synthase and reportedmethyltransferase","NN NN CC NN",4,1,1,16511261,2,8.03E+018,"testalpha"
,"summary of thegrowth factors","NN IN NN NNS",4,1,1,16956113,2,2.56E+018,"testalpha"
,"abuse patterns oftoluene exposure","NN NNS NN NN",4,1,1,16808045,"pubmed1",3.58E+017,"testalpha"
,"detoxification enzymes against epoxides","NN NNS IN NNS",4,1,1,16511284,2,7.18E+018,"testalpha"
,"versions of centralized review","NNS IN VBN NN",4,1,1,16770859,"pubmed1",1.87E+018,"testalpha"
,"physician evaluation decreasesthe length","NN NN NNP NN",4,1,1,16436790,"pubmed1",1.23E+018,"testalpha"
,"previous screenings ofgene expression","JJ NNS NN NN",4,1,1,17265689,2,6.55E+018,"testalpha"
,"model on risk andprevalence","NN IN NN NN",4,1,1,16191426,"pubmed1",8.43E+018,"testalpha"
,"disulfide exchange between dsba","VB NN IN ",4,1,1,17019443,"pubmed1",9.37E+017,"testalpha"
,"conflicts ofinterest in dermatology","NNS NN IN NN",4,1,1,17106594,2,8.25E+018,"testalpha"
,"cases with visceral metastasis","NNS IN JJ NN",4,1,1,17338205,2,3.67E+018,"testalpha"
,"play critical roles inmitochondrion","VB JJ NNS NN",4,1,1,16511294,2,1.25E+018,"testalpha"
,"defence mechanisms tomaintain immuno","NN NNS VB NNP",4,1,1,16648910,2,2.48E+018,"testalpha"
,"lipiodol emulsion and non"," NN CC ",4,1,1,17117608,2,4.93E+018,"testalpha"
,"oxygen in aerobic organisms","NN IN JJ NNS",4,1,1,17160142,"pubmed1",4.31E+018,"testalpha"
,"urinary tractinfections in children","JJ NNS IN NNS",4,1,1,16365328,"pubmed1",4.33E+017,"testalpha"
,"mean length of stay","VB NN IN NN",4,1,1,16436790,"pubmed1",6.03E+018,"testalpha"
,"vectors on theone hand","NNS IN NN NN",4,1,1,17285739,"pubmed1",5.79E+018,"testalpha"
,"patients with type diabetes","NNS IN NN NN",4,1,1,16918070,"pubmed1",5.75E+017,"testalpha"
,"research in thisimportant field","NN IN JJ NN",4,1,1,16474001,"pubmed1",3.13E+018,"testalpha"
,"amblyopia severity of atopic","NNP NN IN NN",4,1,1,17106598,2,5.07E+018,"testalpha"
,"different driver age groups","JJ NN NN NNS",4,1,1,16226211,"pubmed1",6.13E+018,"testalpha"
,"virus like particles vlps","NN IN NNS ",4,1,1,16733562,"pubmed1",3.71E+017,"testalpha"
,"required level of activation","VBN NN IN NN",4,1,1,17068636,"pubmed1",4.28E+018,"testalpha"
,"electrical activity spontaneous locomotor","JJ NN JJ NN",4,1,1,17133954,2,1.39E+018,"testalpha"
,"reaction scheme for zymogenactivation","NN NN IN NN",4,1,1,16770446,"pubmed1",4.03E+018,"testalpha"
,"images of small adrenal","NNS IN JJ NN",4,1,1,16177871,"pubmed1",8.75E+017,"testalpha"
,"conversion dc and water","NN  CC NN",4,1,1,16701862,"pubmed1",7.67E+018,"testalpha"
,"surviving nerveagent intoxicated individuals","VBG NN JJ NNS",4,1,1,16956120,2,3.55E+018,"testalpha"
,"inflammation precedes clinical diverticulitis","NN VBZ JJ NN",4,1,1,17338195,2,2.25E+018,"testalpha"
,"course of specific immunotherapy","NN IN JJ NN",4,1,1,16603096,2,8.19E+018,"testalpha"
,"throughput but less predictiveand","NN CC JJR NN",4,1,1,16584115,"pubmed1",2.57E+017,"testalpha"
,"selectedpatients curative surgical treatment","NNS JJ JJ NN",4,1,1,17139879,2,6.66E+018,"testalpha"
,"betweenthe sbd and nbd","NNP  CC ",4,1,1,16511258,2,3.57E+018,"testalpha"
,"months with atopic dermatitis","NNS IN NN NN",4,1,1,17106598,2,7.18E+018,"testalpha"
,"associated use of calcitonina","VBN NN IN NNP",4,1,1,17293965,2,6.13E+018,"testalpha"
,"affect encapsulated beta cell","VB VBN NN NN",4,1,1,16701853,"pubmed1",2.40E+018,"testalpha"
,"scars and tissue defects","NNS CC NN NNS",4,1,1,17165599,2,5.37E+018,"testalpha"
,"disease cancer immune deficiency","NN NN JJ NN",4,1,1,17265697,2,3.15E+018,"testalpha"
,"included women in earlypregnancy","VBD NNS IN NN",4,1,1,16603098,2,3.23E+018,"testalpha"
,"mistaken injections of gas","VBN NNS IN NN",4,1,1,16491219,2,2.04E+018,"testalpha"
,"study changes in skin","NN NNS IN NN",4,1,1,16874414,2,1.89E+018,"testalpha"
,"atp analog revealed anovel"," NN VBD NN",4,1,1,16421444,2,8.10E+018,"testalpha"
,"hi and high risk"," CC JJ NN",4,1,1,16424644,2,5.99E+018,"testalpha"
,"outcome measures pain scores","NN NNS NN NNS",4,1,1,16451144,"pubmed1",5.27E+018,"testalpha"
,"histocompatibility complex class i","NN JJ NN ",4,1,1,16511250,2,3.92E+016,"testalpha"
,"nature in termsof protection","NN IN  NN",4,1,1,16603103,2,7.05E+018,"testalpha"
,"significant pre post increase","JJ  NN NN",4,1,1,16169506,"pubmed1",9.16E+018,"testalpha"
,"vlp and vulval lichen"," CC NN NNP",4,1,1,16955190,2,2.14E+018,"testalpha"
,"n h vibration region","  NN NN",4,1,1,16528413,"pubmed1",5.28E+018,"testalpha"
,"ethics training in education","NNS NN IN NN",4,1,1,16473995,"pubmed1",9.76E+016,"testalpha"
,"enzyme of aromaticcompound degradation"," IN NN NN",4,1,1,16511281,2,6.77E+018,"testalpha"
,"regeneration requiremultiple systematic actions","NN NNS JJ NNS",4,1,1,17013516,2,5.34E+018,"testalpha"
,"patch test and use","NN NN CC NN",4,1,1,16585981,2,3.34E+018,"testalpha"
,"differenttemperature conditions reagent quantities","NN NNS NN NNS",4,1,1,17293970,2,6.11E+018,"testalpha"
,"authors analyse advantages pitfalls","NNS  NNS NNS",4,1,1,17236645,"pubmed1",3.23E+018,"testalpha"
,"memory testing hours post","NN NN NNS NN",4,1,1,17236636,"pubmed1",9.00E+018,"testalpha"
,"budding yeast saccharomyces cerevisiae","VBG NN NNS ",4,1,1,17063208,"pubmed1",4.09E+017,"testalpha"
,"endogenous tsp and tsr","JJ  CC ",4,1,1,16505899,"pubmed1",4.85E+018,"testalpha"
,"density of b molecules","NN IN NN NNS",4,1,1,17117211,"pubmed1",7.06E+018,"testalpha"
,"long arm of chromosome","JJ NN IN NN",4,1,1,17016041,2,7.30E+017,"testalpha"
,"specific kinase and caspaseinhibitors","JJ NN CC NNS",4,1,1,16956122,2,3.89E+018,"testalpha"
,"aggregated theestimates into costs","VBN NNS IN NNS",4,1,1,16426556,"pubmed1",4.18E+018,"testalpha"
,"enjoyable forall children adolescents","JJ JJ NNS NNS",4,1,1,16918068,"pubmed1",1.18E+018,"testalpha"
,"t cell attracting chemokine"," NN VBG NN",4,1,1,16955181,2,1.09E+018,"testalpha"
,"ichthyosis deafness kid syndrome","NN NN NN NN",4,1,1,17106596,2,4.91E+018,"testalpha"
,"best practices for research","JJT NNS IN NN",4,1,1,16377817,"pubmed1",8.85E+018,"testalpha"
,"generalized linear regression studies","VBN JJ NN NNS",4,1,1,16202466,"pubmed1",5.94E+018,"testalpha"
,"d h h conditions","   NNS",4,1,1,17133952,2,6.75E+017,"testalpha"
,"l homocysteine inmicromolar concentrations"," NN JJ NNS",4,1,1,17265692,2,3.84E+018,"testalpha"
,"nd nd nd nd","   ",4,1,1,16389406,"pubmed1",2.02E+018,"testalpha"
,"reproduciblewith relative standard deviations","NN JJ NN NNS",4,1,1,17285749,"pubmed1",1.02E+018,"testalpha"
,"beta glycosyl linkagesof beta","NN   NN",4,1,1,16511252,2,6.91E+018,"testalpha"
,"acute stroke or tiaencounter","JJ NN CC NN",4,1,1,16436789,"pubmed1",4.79E+018,"testalpha"
,"major source of morbidity","JJ NN IN NN",4,1,1,17014894,2,6.49E+018,"testalpha"
,"institute conducted aretrospective case","NN VBN JJ NN",4,1,1,16112068,"pubmed1",3.14E+018,"testalpha"
,"cancer ht cells aftertreatment","NN  NNS NN",4,1,1,16733561,"pubmed1",5.58E+017,"testalpha"
,"brain tissue pathology ct","NN NN NN ",4,1,1,16436787,"pubmed1",2.73E+018,"testalpha"
,"surgery banjica belgrade serbia","NN NNP NN NNP",4,1,1,17688033,2,6.48E+018,"testalpha"
,"specimens lacking pp antigen","NNS VBG  NN",4,1,1,17019440,"pubmed1",7.69E+018,"testalpha"
,"examined proteins and parameters","VBD NNS CC NNS",4,1,1,16859611,2,8.09E+017,"testalpha"
,"duringthe following week betamethasone","NNP VBG NN NN",4,1,1,16696448,2,4.59E+017,"testalpha"
,"analogue studied using potentiometry","NN VBN VBG NN",4,1,1,17117212,"pubmed1",1.57E+018,"testalpha"
,"o donorligand n n"," NN  ",4,1,1,16456265,2,7.69E+018,"testalpha"
,"electronmicroscopy and transmission electron"," CC NN NN",4,1,1,16874415,2,1.90E+018,"testalpha"
,"domain exhibited high rates","NN VBN JJ NNS",4,1,1,16511277,2,5.74E+016,"testalpha"
,"organic phosphates and oxygen","JJ NNS CC NN",4,1,1,17019442,"pubmed1",1.80E+018,"testalpha"
,"vermifuge vitamins and sorotheraphy","NNP NNS CC NN",4,1,1,17293961,2,1.17E+018,"testalpha"
,"text but aprecise genome","NN CC NN NN",4,1,1,17347785,"pubmed1",7.06E+018,"testalpha"
,"endogenousactivity of ppar isoforms","NN IN  NNS",4,1,1,16395520,"pubmed1",5.95E+018,"testalpha"
,"roadway conditions or b","NN NNS CC NN",4,1,1,16423319,"pubmed1",5.18E+018,"testalpha"
,"protein and cellrepellent properties","NN CC NN NNS",4,1,1,16701874,"pubmed1",2.59E+018,"testalpha"
,"filter sedimentation ifs cb","NN NN  ",4,1,1,16514842,2,4.96E+018,"testalpha"
,"title enantiomorphic compounds c","NN JJ VBZ NN",4,1,1,16456281,2,1.71E+018,"testalpha"
,"lack of participation possibilities","NN IN NN NNS",4,1,1,16451152,"pubmed1",7.71E+018,"testalpha"
,"femoral artery in apatient","JJ NN IN NN",4,1,1,17165597,2,4.32E+018,"testalpha"
,"incidence of pseudo pelger","NN IN JJ NN",4,1,1,17119329,2,1.99E+018,"testalpha"
,"leu val phe lys","   ",4,1,1,16496040,"pubmed1",2.22E+018,"testalpha"
,"current occupational healthnurse practice","JJ JJ NN NN",4,1,1,16438092,"pubmed1",3.76E+018,"testalpha"
,"effects on job satisfaction","NNS IN NN NN",4,1,1,16377823,"pubmed1",1.86E+018,"testalpha"
,"ofthe etiology and pathophysiology","NNP NN CC NN",4,1,1,16462406,"pubmed1",1.88E+017,"testalpha"
,"cases experienced skin graft","NNS VBN NN NN",4,1,1,17165594,2,6.72E+018,"testalpha"
,"size distribution and zeta","NN NN CC ",4,1,1,16584167,"pubmed1",6.37E+018,"testalpha"
,"suppress immediate hypersensitivity reactions","VB JJ NN NNS",4,1,1,16585982,2,8.64E+018,"testalpha"
,"mass screening for surface","NN NN IN NN",4,1,1,16414103,2,7.50E+018,"testalpha"
,"wereanalyzed using mtt test","VBN VBG  NN",4,1,1,16951739,"pubmed1",6.42E+018,"testalpha"
,"recklessness and driver drunkenness","NN CC NN NN",4,1,1,16112069,"pubmed1",1.09E+018,"testalpha"
,"palliative surgery in hips","JJ NN IN ",4,1,1,17438833,2,1.46E+018,"testalpha"
,"decrease ponv in breast","VB  IN NN",4,1,1,16451147,"pubmed1",8.14E+018,"testalpha"
,"negative binomial nb estimates","JJ JJ  NNS",4,1,1,16451795,"pubmed1",1.66E+018,"testalpha"
,"patient with recurrentaphthous stomatitis","NN IN JJ NN",4,1,1,16874419,2,3.78E+018,"testalpha"
,"coronary by passgrafting cabg","NN IN VBG ",4,1,1,17338197,2,1.29E+018,"testalpha"
,"flap safety and simplicity"," NN CC NN",4,1,1,16722345,2,5.38E+018,"testalpha"
,"thefunction of numerous cell","NN IN JJ NN",4,1,1,16770441,"pubmed1",7.66E+018,"testalpha"
,"symmetry of space groupr","NN IN NN ",4,1,1,16511283,2,2.16E+018,"testalpha"
,"monthly motor vehicle fatalities","JJ NN NN NNS",4,1,1,16169506,"pubmed1",5.49E+018,"testalpha"
,"authors identified published research","NNS VBN VBN NN",4,1,1,16474001,"pubmed1",8.33E+018,"testalpha"
,"more soluble fas ligand","JJR JJ  NN",4,1,1,16710577,2,1.30E+018,"testalpha"
,"ch o reveals thepresence","  VBZ NN",4,1,1,16456275,2,2.47E+018,"testalpha"
,"inconclusion atopy patch testing","NN  NN NN",4,1,1,16648919,2,7.44E+018,"testalpha"
,"facilitatebiocompatibility with biological tissue","NN IN JJ NN",4,1,1,16701857,"pubmed1",3.09E+018,"testalpha"
,"i of clinical trials"," IN JJ NNS",4,1,1,16951739,"pubmed1",3.61E+018,"testalpha"
,"eczema dermatitis syndrome aeds","NN NN NN ",4,1,1,17438830,2,2.49E+017,"testalpha"
,"high risk hr nhl","JJ NN  ",4,1,1,16424644,2,7.81E+018,"testalpha"
,"importance of introducing research","NN IN VBG NN",4,1,1,16473989,"pubmed1",4.56E+018,"testalpha"
,"region of low risk","NN IN JJ NN",4,1,1,17117605,2,8.92E+018,"testalpha"
,"positive correlation with plasma","JJ NN IN NNP",4,1,1,16585983,2,3.68E+018,"testalpha"
,"case of chilaiditi syndrome","NN IN NNP NN",4,1,1,16132430,"pubmed1",1.36E+018,"testalpha"
,"skin surveillance cultures swabs","NN NN NNS NNS",4,1,1,17311736,2,6.94E+018,"testalpha"
,"n and wild type"," CC JJ NN",4,1,1,16951742,"pubmed1",3.30E+018,"testalpha"
,"repeat vntr markers vwf","VB  NNS ",4,1,1,16424652,2,8.63E+018,"testalpha"
,"set of approximate parameters","NN IN NN NNS",4,1,1,16388314,"pubmed1",2.01E+018,"testalpha"
,"n or dilute iodinatedsolution"," CC VB NN",4,1,1,16252139,"pubmed1",6.62E+018,"testalpha"
,"minutes of selective liver","NNS IN JJ NN",4,1,1,17013507,2,4.01E+018,"testalpha"
,"psa with astandardized data"," IN VBN NNS",4,1,1,16365337,"pubmed1",5.27E+018,"testalpha"
,"sectionalstudies of hospital populations","NNS IN NN NNS",4,1,1,17106600,2,4.10E+018,"testalpha"
,"invaluable measurableshort term goals","JJ NN NN NNS",4,1,1,17139882,2,3.51E+018,"testalpha"
,"full thickness ala nasi","JJ NN  ",4,1,1,17165594,2,4.80E+018,"testalpha"
,"pursestring suture during revision","VBG NN IN NN",4,1,1,16612923,"pubmed1",7.69E+018,"testalpha"
,"kidney including tubular necrosis","NN VBG JJ NN",4,1,1,16999986,2,6.46E+018,"testalpha"
,"chills nausea vomiting arthralgias","NNS NNP VBG NNP",4,1,1,16696448,2,1.38E+018,"testalpha"
,"influence dui intensivesupervision program","NN  NN NN",4,1,1,16202465,"pubmed1",2.68E+018,"testalpha"
,"analog n n decylnicotinium","NN   NN",4,1,1,16594645,"pubmed1",8.95E+018,"testalpha"
,"percentage of degranulated mast","NN IN VBN ",4,1,1,16585982,2,2.07E+018,"testalpha"
,"mglu receptor antagonists ly"," NN NNS ",4,1,1,17265692,2,3.30E+018,"testalpha"
,"variation haveprovided valuable insight","NN VBN JJ NN",4,1,1,16411735,"pubmed1",4.25E+018,"testalpha"
,"n and knife n"," CC JJ ",4,1,1,16412373,"pubmed1",1.74E+018,"testalpha"
,"liver regeneration at mg","NN NN IN ",4,1,1,17013510,2,6.19E+018,"testalpha"
,"v iu t i","   ",4,1,1,16859614,2,8.76E+018,"testalpha"
,"repeated doses e g","VBN NNS  ",4,1,1,17133954,2,6.62E+018,"testalpha"
,"saver andthe median transfusion","NN NNP JJ NN",4,1,1,17013513,2,7.65E+017,"testalpha"
,"conducting research surrounding violence","VBG NN VBG NN",4,1,1,16209925,"pubmed1",4.12E+018,"testalpha"
,"active site amino acids","JJ NN NNP NNS",4,1,1,16511248,2,3.18E+018,"testalpha"
,"aga newborns mg dl"," NNS  ",4,1,1,17438837,2,5.11E+018,"testalpha"
,"patients with higher level","NNS IN JJR NN",4,1,1,17338197,2,7.87E+018,"testalpha"
,"degradation and subsequent gel","NN CC JJ ",4,1,1,17285741,"pubmed1",8.96E+018,"testalpha"
,"liver by peroxisome proliferator","NN IN NN NN",4,1,1,16951743,"pubmed1",8.01E+018,"testalpha"
,"information of cells isvery","NN IN NNS NN",4,1,1,17294912,2,2.90E+018,"testalpha"
,"pyrazolo d pyrimidinemonohydrate c","NNP  NN NN",4,1,1,16456292,2,2.26E+018,"testalpha"
,"bank of thefaculty hospital","NN IN NN NN",4,1,1,16999268,2,5.48E+018,"testalpha"
,"small bowel on sonoenteroclysis","JJ NN IN NN",4,1,1,16447095,"pubmed1",6.29E+018,"testalpha"
,"tothe thoracic wall pleura","NNP JJ NN NNP",4,1,1,16918062,"pubmed1",5.33E+018,"testalpha"
,"complications reoperations hospital stay","NNS NNS NN NN",4,1,1,17139896,2,6.69E+017,"testalpha"
,"cx cl fractalkine cxcl","  NN ",4,1,1,16594639,"pubmed1",6.47E+018,"testalpha"
,"clinicalconditions including transplant recipients","NNS IN JJ NNS",4,1,1,17119329,2,1.54E+018,"testalpha"
,"presence of strongelectromagnetic fields","NN IN JJ NNS",4,1,1,16365330,"pubmed1",3.39E+018,"testalpha"
,"level lymphocyte count age","NN NNP NN NN",4,1,1,16479024,2,5.40E+018,"testalpha"
,"policy and standards education","NN CC NNS NN",4,1,1,16770860,"pubmed1",3.98E+018,"testalpha"
,"hcii digene gaithersburg maryland"," NN NNP NN",4,1,1,16514835,2,5.77E+018,"testalpha"
,"beneficial effect of isp","JJ NN IN ",4,1,1,17438835,2,6.63E+018,"testalpha"
,"systemsuch as solid lipid","NN IN JJ NN",4,1,1,17285742,"pubmed1",4.80E+017,"testalpha"
,"weeks gestation with ahistory","NNS NN IN NN",4,1,1,16916187,"pubmed1",9.06E+018,"testalpha"
,"firm midline perineal mass","NN NN NN NN",4,1,1,16514847,2,5.67E+018,"testalpha"
,"cell interactions are rule","NN NNS VBP NN",4,1,1,16988903,"pubmed1",3.99E+018,"testalpha"
,"mgkg for days i"," IN NNS ",4,1,1,16764913,2,2.46E+018,"testalpha"
,"films with opposite protein","NNS IN JJ NN",4,1,1,16701874,"pubmed1",6.78E+018,"testalpha"
,"old youngadult and month","JJ NN CC NN",4,1,1,17046052,2,1.17E+018,"testalpha"
,"active enzyme in adenosine","JJ  IN NN",4,1,1,16421444,2,5.66E+018,"testalpha"
,"cells in normal thyroid","NNS IN JJ NN",4,1,1,16720036,2,7.63E+017,"testalpha"
,"tissues following acute blood","NNS VBG JJ NN",4,1,1,16762404,2,1.24E+017,"testalpha"
,"thestandards of breast care","NNS IN NN NN",4,1,1,16596895,"pubmed1",6.19E+018,"testalpha"
,"smears and chlamydia testing","NNS CC NNP NN",4,1,1,16514839,2,5.62E+018,"testalpha"
,"phone use among drivers","NN NN IN NNS",4,1,1,16157285,"pubmed1",6.78E+018,"testalpha"
,"results show thatprophylactic levocetirizine","NNS VBP JJ NN",4,1,1,16874418,2,4.36E+018,"testalpha"
,"erythematous papules onher chin","JJ NNS JJ NN",4,1,1,16874423,2,9.93E+017,"testalpha"
,"body for restoration body","NN IN NN NN",4,1,1,17294911,2,8.45E+018,"testalpha"
,"background hydroxyethyl starch hes","NN  NN ",4,1,1,16451158,"pubmed1",6.70E+018,"testalpha"
,"knowledge skill and ability","NN NN CC NN",4,1,1,16438092,"pubmed1",6.32E+018,"testalpha"
,"fl and phorbolmyristate acetate"," CC NN NN",4,1,1,16404477,"pubmed1",4.14E+018,"testalpha"
,"reduced head injury rates","VBD NN NN NNS",4,1,1,16223468,"pubmed1",6.73E+018,"testalpha"
,"genetic treatment for hccs","JJ NN IN ",4,1,1,16317488,"pubmed1",3.22E+017,"testalpha"
,"process of dealing withdui","NN IN VBG ",4,1,1,16112068,"pubmed1",9.16E+018,"testalpha"
,"attitudes and practices kap","NNS CC NNS ",4,1,1,16514839,2,8.46E+017,"testalpha"
,"empirical therapy with antibioticsand","JJ NN IN NN",4,1,1,16918064,"pubmed1",5.20E+018,"testalpha"
,"mediterranean diet containing oliveoil","JJ NN VBG NN",4,1,1,16696439,2,4.67E+018,"testalpha"
,"disp isan effective means","  JJ NNS",4,1,1,16202465,"pubmed1",6.64E+018,"testalpha"
,"blood stem cell pbsc","NN VB NN ",4,1,1,17119322,2,3.92E+017,"testalpha"
,"solvents for adversebiobehavioral outcomes","NNS IN JJ NNS",4,1,1,16808045,"pubmed1",4.12E+018,"testalpha"
,"opposite protein and cellrepellent","JJ NN CC NN",4,1,1,16701874,"pubmed1",2.02E+018,"testalpha"
,"sleepdeprivation and mood disturbances","NN CC NN NNS",4,1,1,16377826,"pubmed1",5.48E+018,"testalpha"
,"mean values of tgf","VBP NNS IN ",4,1,1,17293967,2,5.33E+018,"testalpha"
,"n or propofol remifentanil"," CC  ",4,1,1,16451145,"pubmed1",7.17E+018,"testalpha"
,"property with regard tobeta","NN IN NN NN",4,1,1,16701860,"pubmed1",1.38E+017,"testalpha"
,"operating time averaged min","VBG NN VBD ",4,1,1,16612912,"pubmed1",5.81E+018,"testalpha"
,"effects of topical morphine","NNS IN JJ NN",4,1,1,16955184,2,2.77E+018,"testalpha"
,"monoclonalanti methotrexate igg ami"," NN  ",4,1,1,16594642,"pubmed1",7.57E+017,"testalpha"
,"fordisease control and prevention","NN NN CC NN",4,1,1,16438095,"pubmed1",2.00E+018,"testalpha"
,"radical mediated lipid peroxidation","JJ VBN NN NN",4,1,1,16764913,2,5.69E+018,"testalpha"
,"course of work male","NN IN NN NN",4,1,1,16043107,"pubmed1",3.69E+018,"testalpha"
,"induced increase in right","VBN NN IN NN",4,1,1,16537087,2,6.13E+017,"testalpha"
,"expression of ts egfr","NN IN  ",4,1,1,17139902,2,7.57E+018,"testalpha"
,"acute gi bleeding contrast","JJ  VBG NN",4,1,1,16333701,"pubmed1",5.31E+017,"testalpha"
,"centred monoclinic space group","VBN JJ NN NN",4,1,1,16511275,2,2.10E+018,"testalpha"
,"fluid and thenonquiescent cell","NN CC NN NN",4,1,1,16988902,"pubmed1",7.84E+018,"testalpha"
,"understandwhether patients use ambulance","JJ NNS VB NN",4,1,1,16321535,"pubmed1",7.68E+018,"testalpha"
,"properties of composite skin","NNS IN JJ NN",4,1,1,16999269,2,2.88E+018,"testalpha"
,"viaepidural catheter sensory block","JJ NN NN NN",4,1,1,16916188,"pubmed1",8.52E+018,"testalpha"
,"twohuman erythroblastoid cell lines","NN VB NN NNS",4,1,1,17160143,"pubmed1",8.35E+018,"testalpha"
,"diagnosis cad in diagnosticinterpretation","NN  IN NN",4,1,1,16399036,"pubmed1",7.65E+018,"testalpha"
,"cells with mutated autophosphorylation","NNS IN VBN NN",4,1,1,16404475,"pubmed1",5.82E+018,"testalpha"
,"histopathological baseline for spontaneousatherosclerosis","JJ NN IN NN",4,1,1,17007910,2,7.38E+017,"testalpha"
,"reconceptualisation of deterrence theory","NN IN NN NN",4,1,1,16405859,"pubmed1",4.05E+017,"testalpha"
,"injury rates in san","NN NNS IN ",4,1,1,16223468,"pubmed1",5.36E+018,"testalpha"
,"marital status faculty discipline","JJ NN NN NN",4,1,1,16377815,"pubmed1",3.64E+018,"testalpha"
,"ofpruritus visual analogue scale","NN JJ NN NN",4,1,1,16874418,2,3.52E+018,"testalpha"
,"ligand on cd cd","NN IN  ",4,1,1,17016035,2,4.94E+018,"testalpha"
,"higher relative crash risks","JJR JJ NN NNS",4,1,1,16198299,"pubmed1",5.16E+018,"testalpha"
,"impact ofpositive outcome bias","NN JJ NN NN",4,1,1,16365332,"pubmed1",5.26E+017,"testalpha"
,"icu for extensive burn"," IN JJ NN",4,1,1,17294910,2,5.68E+018,"testalpha"
,"lesions thathave low risk","NNS VB JJ NN",4,1,1,17139888,2,5.31E+018,"testalpha"
,"distal stumps of spinalroots","NN NNS IN NNS",4,1,1,16414104,2,8.04E+018,"testalpha"
,"nurses improvingawareness and adoption","NNS NN CC NN",4,1,1,16330213,"pubmed1",5.92E+017,"testalpha"
,"different doses of dexamethasone","JJ NNS IN NN",4,1,1,17007911,2,6.73E+018,"testalpha"
,"training modelsfor medical students","NN JJ JJ NNS",4,1,1,16473989,"pubmed1",4.60E+018,"testalpha"
,"morphologicalchanges in treated cells","NNS IN VBN NNS",4,1,1,16956122,2,2.98E+018,"testalpha"
,"centers and secondary health","NNS CC JJ NN",4,1,1,16514839,2,5.09E+018,"testalpha"
,"tp technique cytyc corp"," NN  ",4,1,1,16514842,2,2.29E+018,"testalpha"
,"order of increasing risk","NN IN VBG NN",4,1,1,16236235,"pubmed1",2.39E+018,"testalpha"
,"higher total protein release","JJR NN NN NN",4,1,1,16594643,"pubmed1",8.85E+018,"testalpha"
,"components in amyloid deposits","NNS IN VB NNS",4,1,1,16542712,2,8.40E+018,"testalpha"
,"range of motion abduction","NN IN NN NN",4,1,1,17438833,2,6.62E+018,"testalpha"
,"type localization and extent","NN NN CC NN",4,1,1,17311739,2,9.01E+018,"testalpha"
,"moieties on theconformational behavior","NNS IN JJ NN",4,1,1,16496038,"pubmed1",2.57E+018,"testalpha"
,"diagnosis of aggressive nhl","NN IN JJ ",4,1,1,16424645,2,2.08E+018,"testalpha"
,"casualties majorinjuries and fatalities","NNS NNS CC NNS",4,1,1,16169506,"pubmed1",1.62E+017,"testalpha"
,"complex new phenotypes insingle","JJ JJ NNS NN",4,1,1,17347785,"pubmed1",4.74E+018,"testalpha"
,"selecting suitablesuites of indicators","VBG NNS IN NNS",4,1,1,16988904,"pubmed1",7.59E+018,"testalpha"
,"c h n v","NN   ",4,1,1,16456275,2,6.18E+018,"testalpha"
,"nothave serious head injury","VB JJ NN NN",4,1,1,16223468,"pubmed1",6.56E+018,"testalpha"
,"vein and middlehepatic vein","NN CC JJ NN",4,1,1,17438838,2,6.41E+018,"testalpha"
,"apoptosis of smooth muscle","NN IN JJ NN",4,1,1,16395522,"pubmed1",6.52E+018,"testalpha"
,"arterial haemoglobin and haematocrit","JJ NNP CC NN",4,1,1,16809888,2,1.86E+018,"testalpha"
,"acetylneuraminic acid cmp neuac","JJ NN  ",4,1,1,16511286,2,9.00E+017,"testalpha"
,"pcr were applied todiscriminate"," VBD VBN NN",4,1,1,17019440,"pubmed1",7.76E+018,"testalpha"
,"therepair defect in ly","NN NN IN ",4,1,1,16404475,"pubmed1",7.15E+018,"testalpha"
,"physical properties of saturatedphosphatidylcholine","JJ NNS IN NN",4,1,1,16964324,"pubmed1",5.42E+018,"testalpha"
,"efficacy and side effects","NN CC NN NNS",4,1,1,16955184,2,8.48E+018,"testalpha"
,"institution and societal factors","NN CC NN NNS",4,1,1,16473991,"pubmed1",3.54E+018,"testalpha"
,"using immunohistochemistry and immunofluorescence","VBG NN CC NN",4,1,1,16423381,2,6.18E+018,"testalpha"
,"results in bone pain","NNS IN NN NN",4,1,1,16714048,2,4.99E+018,"testalpha"
,"confirm previous research findings","VB JJ NN NNS",4,1,1,16426560,"pubmed1",6.15E+018,"testalpha"
,"challenges of controlling residents","NNS IN VBG NNS",4,1,1,16377820,"pubmed1",1.25E+018,"testalpha"
,"based treatment of theemergent","VBN NN IN NN",4,1,1,16462410,"pubmed1",6.99E+018,"testalpha"
,"improved protein expression characteristics","VBN NN NN NNS",4,1,1,16369090,2,8.75E+018,"testalpha"
,"form in atherosclerotic plaques","NN IN JJ NNS",4,1,1,17128291,"pubmed1",4.95E+018,"testalpha"
,"evaluation of treatment timeintervals","NN IN NN NNS",4,1,1,16365334,"pubmed1",3.34E+018,"testalpha"
,"squattersettlements in karachi pakistan","NNS IN NNP NNP",4,1,1,16412373,"pubmed1",3.04E+018,"testalpha"
,"cases of rare uterine","NNS IN JJ NN",4,1,1,17338203,2,5.54E+018,"testalpha"
,"new mechanisms of action","JJ NNS IN NN",4,1,1,17016040,2,5.95E+018,"testalpha"
,"sacs scfa treated sacs","  VBN ",4,1,1,16491218,2,7.45E+018,"testalpha"
,"survival forr resected patients","NN  VBN NNS",4,1,1,17139895,2,1.26E+018,"testalpha"
,"timing for antibiotic prophylaxis","NN IN JJ ",4,1,1,16673611,2,3.26E+018,"testalpha"
,"other derivatives of aminofluorene","JJ NNS IN NN",4,1,1,17143337,"pubmed1",1.72E+018,"testalpha"
,"test cognitive function participants","NN JJ NN NNS",4,1,1,16436796,"pubmed1",5.28E+018,"testalpha"
,"laser treatment quantitative energy","NN NN JJ NN",4,1,1,16648911,2,3.37E+018,"testalpha"
,"important therapeutic implications forthe","JJ JJ NNS NNP",4,1,1,16388313,"pubmed1",9.14E+018,"testalpha"
,"national cervical screening policy","JJ JJ NN NN",4,1,1,16514839,2,2.26E+018,"testalpha"
,"dihydroxyanthraquinone dihydroxyanthraquinone and benzo","NN NN CC NNP",4,1,1,16404478,"pubmed1",4.28E+018,"testalpha"
,"facilitate rapid clot resolution","VB JJ NN NN",4,1,1,16549898,2,3.38E+018,"testalpha"
,"structures of hca ii","NNS IN  ",4,1,1,16511248,2,1.75E+018,"testalpha"
,"renal i r injury","JJ  NN NN",4,1,1,16764913,2,7.54E+018,"testalpha"
,"preplacement screening preventive measures","NN NN JJ NNS",4,1,1,16438093,"pubmed1",7.80E+018,"testalpha"
,"operative myocardialischemia reperfusion injury","JJ NN NN NN",4,1,1,16451157,"pubmed1",7.15E+018,"testalpha"
,"analogous allergens hdm patients","JJ NNS  NNS",4,1,1,17328144,2,3.55E+017,"testalpha"
,"radiobiological enhancement of thisregimen","JJ NN IN NNS",4,1,1,17117605,2,2.04E+018,"testalpha"
,"incubationtemperature degrees c degrees","NN NNS NN NNS",4,1,1,16696441,2,8.99E+018,"testalpha"
,"corresponding n carbamylated beta","JJ  VBN NN",4,1,1,16511257,2,6.96E+018,"testalpha"
,"evaluation by thephysician endoscopist","NN IN JJ NN",4,1,1,16673611,2,3.30E+018,"testalpha"
,"vitalsigns intubation and intoxication","NNS NN CC NN",4,1,1,16365326,"pubmed1",9.07E+018,"testalpha"
,"high degree of similarity","JJ NN IN NN",4,1,1,16951743,"pubmed1",1.65E+018,"testalpha"
,"topical application bath puva","JJ NN NN ",4,1,1,16585984,2,6.15E+018,"testalpha"
,"riskfor developing anxiety symptoms","JJ VBG NN NNS",4,1,1,17236646,"pubmed1",2.76E+018,"testalpha"
,"erythema gyratum repens likelesions","NN NN NNS NNS",4,1,1,16955192,2,7.79E+018,"testalpha"
,"pelvic floor in case","JJ NN IN NN",4,1,1,17139889,2,1.75E+018,"testalpha"
,"sleepiness burnout empathy anddepression","NN NN JJ NN",4,1,1,16377826,"pubmed1",4.81E+017,"testalpha"
,"authors recorded resting pressure","NNS VBN VBG NN",4,1,1,17139884,2,6.53E+018,"testalpha"
,"underlying cathepsin c mutations","VBG NNP NN NNS",4,1,1,16585980,2,7.43E+018,"testalpha"
,"bupivacaine infusion serialarterial blood","NN NN JJ NN",4,1,1,17067137,"pubmed1",3.97E+018,"testalpha"
,"assessedfollowing standardized barrier removal","VBG VBN NN NN",4,1,1,16874414,2,1.76E+017,"testalpha"
,"atp levels in u"," NNS IN ",4,1,1,17128291,"pubmed1",3.08E+018,"testalpha"
,"receiving csav and n","VBG  CC ",4,1,1,16436788,"pubmed1",7.30E+018,"testalpha"
,"model ofmyocardial ischemia reperfusion","NN JJ NN NN",4,1,1,16566960,2,3.51E+018,"testalpha"
,"concentration of reactive oxygen","NN IN JJ NN",4,1,1,16410836,"pubmed1",6.27E+018,"testalpha"
,"cmh o cmh o","   ",4,1,1,16451155,"pubmed1",5.27E+018,"testalpha"
,"h o contacts stabilizethe","  NNS NNP",4,1,1,16456296,2,6.62E+018,"testalpha"
,"anpg mug and fpgglycosylases","  CC NNS",4,1,1,16582987,"pubmed1",9.57E+017,"testalpha"
,"serum ige than control","NN  IN NN",4,1,1,16859613,2,4.57E+018,"testalpha"
,"lactobacillus helveticus during pre","NN NN IN ",4,1,1,17293972,2,8.12E+018,"testalpha"
,"pollenand or food allergens","NN CC NN NNS",4,1,1,16648913,2,4.56E+017,"testalpha"
,"detectshemorrhagic lesions requiring neurosurgery","JJ NNS VBG NN",4,1,1,16436787,"pubmed1",3.27E+018,"testalpha"
,"indicate thatthe transferred models","VB NNP VBN NNS",4,1,1,16414003,"pubmed1",2.77E+018,"testalpha"
,"right branch of n","JJ NN IN ",4,1,1,17139884,2,4.29E+018,"testalpha"
,"wall visualization luminal distention","NN NN JJ NN",4,1,1,16252139,"pubmed1",7.83E+018,"testalpha"
,"diagnosis conclusions radiograph interpretations","NN NNS NN NNS",4,1,1,16436791,"pubmed1",1.52E+018,"testalpha"
,"pattern atpulmonary function tests","NN JJ NN NNS",4,1,1,16809886,2,8.58E+018,"testalpha"
,"inneutrophils sequestration between group","NNS NN IN NN",4,1,1,16491220,2,2.39E+018,"testalpha"
,"human operator lesion enhancement","JJ NN NN NN",4,1,1,16399033,"pubmed1",3.32E+018,"testalpha"
,"percent of new cases","NN IN JJ NNS",4,1,1,17010267,2,8.88E+018,"testalpha"
,"areas of acinic cell","NNS IN JJ NN",4,1,1,16514851,2,5.78E+018,"testalpha"
,"scaffold degradation in serum","JJ NN IN NN",4,1,1,16701855,"pubmed1",1.40E+018,"testalpha"
,"correlation with vegf ind","NN IN  ",4,1,1,16317488,"pubmed1",7.55E+018,"testalpha"
,"family history and signs","NN NN CC NNS",4,1,1,16859613,2,4.27E+018,"testalpha"
,"individuals and vwd patients","NNS CC  NNS",4,1,1,16424652,2,5.45E+018,"testalpha"
,"sphincters defect by anal","NNS NN IN ",4,1,1,17139884,2,2.13E+016,"testalpha"
,"classical lift off processes","JJ NN IN NNS",4,1,1,16701874,"pubmed1",4.10E+018,"testalpha"
,"annual person based school","JJ NN VBN NN",4,1,1,16236234,"pubmed1",7.54E+018,"testalpha"
,"abstracts and meta analysis","NNS CC  NN",4,1,1,16365335,"pubmed1",2.57E+018,"testalpha"
,"thatrecombinant stbetarii fc binds","JJ   NNS",4,1,1,16733563,"pubmed1",5.17E+018,"testalpha"
,"perspective for modern application","NN IN JJ NN",4,1,1,17013504,2,3.92E+016,"testalpha"
,"latent form of hcmv","JJ NN IN ",4,1,1,17019440,"pubmed1",3.61E+018,"testalpha"
,"dihydroxyanthraquinone dihydroxyanthraquinone dihydroxyanthraquinone dihydroxyanthraquinone","NN NN NN NN",4,1,1,16404478,"pubmed1",9.00E+018,"testalpha"
,"oral dose of escitalopram","JJ NN IN NN",4,1,1,16584121,"pubmed1",8.85E+018,"testalpha"
,"reactions was related toexposure","NNS VBD VBN NN",4,1,1,17106597,2,6.94E+018,"testalpha"
,"stained slides and cell","VBN NNS CC NN",4,1,1,16514837,2,5.38E+018,"testalpha"
,"importance ofincorporating organizational factors","NN VBG JJ NNS",4,1,1,16442068,"pubmed1",5.81E+018,"testalpha"
,"chlorohydrins from fatty acids","NNS IN JJ NNS",4,1,1,17128291,"pubmed1",7.57E+018,"testalpha"
,"retrospective study of cases","JJ NN IN NNS",4,1,1,17338203,2,6.96E+018,"testalpha"
,"component of metabolic syndrome","NN IN JJ NN",4,1,1,16479027,2,4.58E+018,"testalpha"
,"life or elimination rate","NN CC NN NN",4,1,1,17067137,"pubmed1",6.54E+018,"testalpha"
,"thrombocytopenic purpura itp developsin","JJ NNP  NNP",4,1,1,16424649,2,8.66E+018,"testalpha"
,"flt flt lg ndst","   ",4,1,1,16914901,2,6.27E+018,"testalpha"
,"study groups with study","NN NNS IN NN",4,1,1,16436796,"pubmed1",4.75E+018,"testalpha"
,"stiffness hydrophobic interactions ofthe","NN JJ NNS NNP",4,1,1,16365636,"pubmed1",9.04E+018,"testalpha"
,"awake sprague dawley rats","NN NN NNP NNS",4,1,1,17067137,"pubmed1",5.85E+018,"testalpha"
,"ectropion tumors cicatritial retraction","NN NNS JJ NN",4,1,1,17165595,2,8.38E+018,"testalpha"
,"cafe au lait spots","NN   NNS",4,1,1,17010267,2,5.41E+017,"testalpha"
,"inventory lajunen t summala","NN NN  NNP",4,1,1,16443186,"pubmed1",4.91E+018,"testalpha"
,"venom of black widow","NN IN JJ NN",4,1,1,16395521,"pubmed1",6.84E+018,"testalpha"
,"days groups ii iii","NNS NNS  ",4,1,1,16612918,"pubmed1",1.97E+018,"testalpha"
,"drug targets and complexes","NN NNS CC NNS",4,1,1,16369099,2,7.33E+018,"testalpha"
,"role in determining host","NN IN VBG NN",4,1,1,16951739,"pubmed1",7.43E+018,"testalpha"
,"acuteregulatory protein related lipid","NN NN VBN NN",4,1,1,16951743,"pubmed1",1.77E+018,"testalpha"
,"segments isolated fromc bl","NNS VBN  ",4,1,1,17128291,"pubmed1",4.45E+018,"testalpha"
,"firstsection discusses body composition","NN NNS NN NN",4,1,1,16918067,"pubmed1",2.94E+018,"testalpha"
,"review deals with i","NN NNS IN ",4,1,1,17013514,2,4.91E+018,"testalpha"
,"gender disease type duration","NN NN NN NN",4,1,1,16673554,2,6.45E+018,"testalpha"
,"theassessment of malabsorption syndromes","NN IN NN NNS",4,1,1,16673563,2,4.69E+018,"testalpha"
,"glycated lens proteins ofdiabetics","VBN NN NNS NNS",4,1,1,16696441,2,8.75E+018,"testalpha"
,"full length integral membrane","JJ NN JJ NN",4,1,1,16511288,2,1.41E+018,"testalpha"
,"transmission electron microscopy findings","NN NN  NNS",4,1,1,16874415,2,7.25E+018,"testalpha"
,"using immunohistochemistry for dyn","VBG NN IN ",4,1,1,17133952,2,1.93E+018,"testalpha"
,"clonal disorder of plasma","JJ NN IN NNP",4,1,1,16809883,2,2.52E+018,"testalpha"
,"redblood cells from patients","NN NNS IN NNS",4,1,1,17016037,2,6.56E+018,"testalpha"
,"hemodialysis hd patients andits","NN  NNS NNS",4,1,1,17119323,2,2.40E+018,"testalpha"
,"consisting ofliposomal amphotericin b","VBG JJ NNP NN",4,1,1,16918062,"pubmed1",3.64E+018,"testalpha"
,"initial andthe target inr","JJ NNP NN ",4,1,1,16916181,"pubmed1",6.02E+018,"testalpha"
,"conclusions aspiration liquid flow","NNS NN JJ NN",4,1,1,16491219,2,6.32E+018,"testalpha"
,"carcinomatosis pc in contrast","NN  IN NN",4,1,1,17139879,2,3.20E+018,"testalpha"
,"time period of hours","NN NN IN NNS",4,1,1,17285741,"pubmed1",4.92E+017,"testalpha"
,"gen induced acuterenal failure"," VBN JJ NN",4,1,1,16999986,2,5.64E+018,"testalpha"
,"differences in alginate composition","NNS IN NN NN",4,1,1,16701881,"pubmed1",7.76E+017,"testalpha"
,"traffic safety riskand consequence","NN NN NN NN",4,1,1,16406188,"pubmed1",3.89E+018,"testalpha"
,"procedural andperformance assessment problems","JJ NN NN NNS",4,1,1,16770857,"pubmed1",3.81E+018,"testalpha"
,"fos in aminopyridine ap"," IN NN ",4,1,1,17007911,2,7.28E+018,"testalpha"
,"rabbit anti rat beta","NN IN NN NN",4,1,1,16714054,2,2.70E+018,"testalpha"
,"preventive effect on radiation","JJ NN IN NN",4,1,1,16612919,"pubmed1",5.67E+018,"testalpha"
,"paraoxonase pon and binds","NN  CC NNS",4,1,1,16511265,2,1.27E+018,"testalpha"
,"treatment ofthe frozen shoulder","NN NNP VBN NN",4,1,1,16916183,"pubmed1",5.97E+018,"testalpha"
,"antibiotics extracts for desensitization","NNS NNS IN NN",4,1,1,17106600,2,4.16E+018,"testalpha"
,"disorder and acontrol group","NN CC NN NN",4,1,1,16733555,"pubmed1",2.40E+018,"testalpha"
,"b pyridoxine erythronate phosphate","NN NN NN NN",4,1,1,16511285,2,4.69E+018,"testalpha"
,"study inclusioncriteria were cabg","NN NNP VBD ",4,1,1,17338197,2,4.51E+018,"testalpha"
,"effect in cord plasma","NN IN NN NNP",4,1,1,16549888,2,8.73E+018,"testalpha"
,"was related toexposure intensity","VBD VBN NN NN",4,1,1,17106597,2,1.40E+017,"testalpha"
,"abnormal indicators and iron","JJ NNS CC NN",4,1,1,16809889,2,8.96E+018,"testalpha"
,"routine surgery and re","JJ NN CC ",4,1,1,16451159,"pubmed1",6.61E+018,"testalpha"
,"sores represent recurrent problem","NNS VBP NN NN",4,1,1,17165597,2,2.49E+018,"testalpha"
,"oftandem repeat vntr markers","NNP VB  NNS",4,1,1,16424652,2,1.23E+018,"testalpha"
,"sphincters and pathologic values","NNS CC JJ NNS",4,1,1,17139884,2,1.83E+018,"testalpha"
,"using n primers ttv","VBG  NNS ",4,1,1,16696442,2,8.34E+018,"testalpha"
,"liposomal amphotericin b l","JJ NNP NN ",4,1,1,16918060,"pubmed1",7.14E+017,"testalpha"
,"egf and tgf beta"," CC  NN",4,1,1,17115080,"pubmed1",2.46E+018,"testalpha"
,"depression anxiety and jobdissatisfaction","NN NN CC NN",4,1,1,16377815,"pubmed1",6.19E+018,"testalpha"
,"preliminary x raydiffraction data","JJ NN NN NNS",4,1,1,16511269,2,3.46E+018,"testalpha"
,"number of ageing drivers","NN IN VBG NNS",4,1,1,16198299,"pubmed1",2.46E+018,"testalpha"
,"organism with high density","NN IN JJ NN",4,1,1,17019438,"pubmed1",4.52E+018,"testalpha"
,"crash hospitalization ratesand death","NN NN NN NN",4,1,1,16139232,"pubmed1",5.68E+018,"testalpha"
,"responsive p waf gene","JJ   ",4,1,1,16733561,"pubmed1",5.97E+018,"testalpha"
,"distribution of pv immunoreactivity","NN IN  NN",4,1,1,17046052,2,1.74E+018,"testalpha"
,"records and workers compensation","NNS CC NNS NN",4,1,1,16043107,"pubmed1",3.09E+018,"testalpha"
,"cm free skin margins"," JJ NN NNS",4,1,1,16612932,"pubmed1",6.17E+017,"testalpha"
,"french cattle bse case","JJ NNS  NN",4,1,1,16770445,"pubmed1",6.15E+018,"testalpha"
,"reviewed literature address issues","VBD NN NN NNS",4,1,1,16596897,"pubmed1",2.14E+017,"testalpha"
,"plastic and cell surfaces","NN CC NN NNS",4,1,1,16549888,2,4.60E+018,"testalpha"
,"county level fb models","NN NN  NNS",4,1,1,16451795,"pubmed1",5.73E+018,"testalpha"
,"ofmicrowave dried sucralfate gel","VB VBD NN ",4,1,1,16584168,"pubmed1",7.15E+018,"testalpha"
,"family endo beta glucanase","NN  NN NN",4,1,1,16511252,2,3.23E+018,"testalpha"
,"workgroup of psychiatric educators","NN IN JJ NNS",4,1,1,16473991,"pubmed1",3.14E+017,"testalpha"
,"cases of high grade","NNS IN JJ NN",4,1,1,16514839,2,5.18E+018,"testalpha"
,"worldwide known health drug","VB VBN NN NN",4,1,1,17265697,2,4.47E+018,"testalpha"
,"scanning electronmicroscopy and transmission","VBG  CC NN",4,1,1,16874415,2,2.70E+017,"testalpha"
,"caseswith preserved atrx levels","NN VBN  NNS",4,1,1,16914901,2,7.40E+018,"testalpha"
,"cellular signals for muscle","JJ NNS IN NN",4,1,1,16410836,"pubmed1",1.26E+018,"testalpha"
,"hiv infection areindependent risk"," NN NN NN",4,1,1,16673613,2,1.73E+018,"testalpha"
,"antioxidant system of cirrhosis","JJ NN IN NN",4,1,1,16404476,"pubmed1",1.55E+018,"testalpha"
,"further diversity in moisturizer","JJ NN IN NNP",4,1,1,16859617,2,6.21E+018,"testalpha"
,"whetherintravascular time density course","JJ NN NN NN",4,1,1,16399037,"pubmed1",7.67E+018,"testalpha"
,"liver showed marginal moderatedirect","NN VBD JJ NN",4,1,1,16317488,"pubmed1",2.38E+018,"testalpha"
,"parenchyma oriented tissuesparing surgery"," VBN VBG NN",4,1,1,17139901,2,3.03E+018,"testalpha"
,"arr sheep years postinoculation"," NN NNS NN",4,1,1,16770445,"pubmed1",4.39E+018,"testalpha"
,"thr towardscopper ii ions"," NN  ",4,1,1,16496037,"pubmed1",8.95E+018,"testalpha"
,"non cancer colon cell"," NN NN NN",4,1,1,16414103,2,4.59E+018,"testalpha"
,"lox lipoxygenase cox cyclooxygenase"," NN  NN",4,1,1,16456296,2,5.24E+018,"testalpha"
,"control group of patients","NN NN IN NNS",4,1,1,16424643,2,2.42E+017,"testalpha"
,"allergic forms of ad","JJ NNS IN NN",4,1,1,16859611,2,6.79E+018,"testalpha"
,"co localized fluorescent dyes"," JJ NN ",4,1,1,16730369,2,6.52E+018,"testalpha"
,"uroepithelium showedsigns of disintegration","NN NNS IN NN",4,1,1,16253314,2,2.99E+018,"testalpha"
,"surveys of university integrity","NNS IN NN NN",4,1,1,16377817,"pubmed1",5.33E+018,"testalpha"
,"transient gfp gene expression","NN   NN",4,1,1,16582986,"pubmed1",4.90E+018,"testalpha"
,"dawley rats were dividedinto","NNP NNS VBD NNP",4,1,1,16612919,"pubmed1",5.75E+018,"testalpha"
,"fas fas l system","   NN",4,1,1,16330085,2,5.10E+018,"testalpha"
,"treatment of skin andrespiratory","NN IN NN NN",4,1,1,16365328,"pubmed1",1.63E+018,"testalpha"
,"increasedvolume and improve housestaff","NN CC VB NN",4,1,1,16377816,"pubmed1",8.07E+018,"testalpha"
,"k and hes k"," CC  ",4,1,1,17067137,"pubmed1",5.09E+018,"testalpha"
,"ais andpolice coded severity"," NN VBN NN",4,1,1,16426556,"pubmed1",7.46E+018,"testalpha"
,"diet changes in liver","NN NNS IN NN",4,1,1,16673555,2,4.62E+018,"testalpha"
,"accidents oftreatment of patients","NNS NN IN NNS",4,1,1,16236233,"pubmed1",6.93E+018,"testalpha"
,"controlled trial took place","VBN NN VBD NN",4,1,1,16365324,"pubmed1",7.26E+018,"testalpha"
,"crash type andenvironmental factors","NN NN NN NNS",4,1,1,16197912,"pubmed1",5.15E+018,"testalpha"
,"shift of routine work","NN IN JJ NN",4,1,1,16377820,"pubmed1",3.24E+016,"testalpha"
,"lymph node metastasis andsurvival","NN  NN NN",4,1,1,16530813,2,2.58E+018,"testalpha"
,"performed using chi square","VBN VBG  NN",4,1,1,16479026,2,6.17E+018,"testalpha"
,"adjuvant chemotherapy withfu leukovocin","JJ NN  NNP",4,1,1,17139902,2,2.55E+017,"testalpha"
,"computed tomography mdct ct","VBN NN  ",4,1,1,16333701,"pubmed1",7.03E+018,"testalpha"
,"formulations at various storage","NNS IN JJ NN",4,1,1,16584150,"pubmed1",1.68E+018,"testalpha"
,"placement on crash frequency","NN IN NN NN",4,1,1,16442487,"pubmed1",6.48E+018,"testalpha"
,"cd il t cells","   NNS",4,1,1,17016036,2,5.86E+017,"testalpha"
,"procedure used todetermine product","NN VBN NN NN",4,1,1,17285744,"pubmed1",6.45E+018,"testalpha"
,"urine levels of selectedeosinophil","NN NNS IN ",4,1,1,16859611,2,4.37E+018,"testalpha"
,"protect hpv positive persons","VB  JJ NNS",4,1,1,17010274,2,5.54E+018,"testalpha"
,"vivo dynamics ofthis pathway"," NNS NNP NN",4,1,1,17068636,"pubmed1",8.56E+018,"testalpha"
,"nitroaromatic compounds n increaseswith","JJ VBZ  NN",4,1,1,16929382,"pubmed1",1.82E+017,"testalpha"
,"was used forthe identification","VBD VBN NNP NN",4,1,1,17285740,"pubmed1",2.65E+018,"testalpha"
,"using logistic regression methodology","VBG JJ NN NN",4,1,1,16426559,"pubmed1",7.49E+018,"testalpha"
,"wait wereaustralian triage scale","VB JJ NN NN",4,1,1,16377190,"pubmed1",4.78E+018,"testalpha"
,"success in cda patientswith","NN IN  NN",4,1,1,17117609,2,3.72E+018,"testalpha"
,"use of control groups","NN IN NN NNS",4,1,1,16451151,"pubmed1",1.07E+018,"testalpha"
,"femoral medialcondylus and relocation","JJ NN CC NN",4,1,1,17293966,2,7.08E+018,"testalpha"
,"opposite effects on pituitary","JJ NNS IN NN",4,1,1,16714054,2,6.71E+018,"testalpha"
,"stromal capacity tosupport hematopoiesis","JJ NN NN NN",4,1,1,17016038,2,2.44E+018,"testalpha"
,"observed differences betweenthe properties","VBN NNS NNP NNS",4,1,1,16929383,"pubmed1",4.54E+018,"testalpha"
,"lsil n and hsil","  CC ",4,1,1,16514835,2,3.08E+018,"testalpha"
,"producing cells in rat","VBG NNS IN NN",4,1,1,16762403,2,8.53E+018,"testalpha"
,"c on chromosome q","NN IN NN ",4,1,1,17311740,2,8.09E+018,"testalpha"
,"patients tolerated repeated phlebotomies","NNS VBN VBN NNS",4,1,1,17117609,2,2.84E+017,"testalpha"
,"reference toits magnetic resonance","NN NNS JJ NN",4,1,1,16252140,"pubmed1",4.01E+018,"testalpha"
,"old woman with erythema","JJ NN IN NN",4,1,1,16955192,2,6.31E+018,"testalpha"
,"release of free radicals","NN IN JJ NNS",4,1,1,17265697,2,3.98E+018,"testalpha"
,"aspects of liverregeneration lr","NNS IN NN ",4,1,1,17013517,2,8.33E+018,"testalpha"
,"proteins exhibit significantantiviral activity","NNS NN JJ NN",4,1,1,17128290,"pubmed1",1.08E+018,"testalpha"
,"l vs mg dl","   ",4,1,1,17438837,2,5.84E+018,"testalpha"
,"umbilical cord blood derivedcd","JJ NN NN ",4,1,1,17265691,2,7.24E+018,"testalpha"
,"isolates retained inthe data","VBZ VBN NNP NNS",4,1,1,16365328,"pubmed1",4.29E+016,"testalpha"
,"acute generalizedexanthematous pustulosis days","JJ JJ NN NNS",4,1,1,16696448,2,5.19E+018,"testalpha"
,"concept in female reproduction","NN IN NN NN",4,1,1,16808046,"pubmed1",1.20E+018,"testalpha"
,"peripancreatic vessels and distal","JJ NNS CC NN",4,1,1,16333694,"pubmed1",4.67E+018,"testalpha"
,"small papillae cell ballsand","JJ NNS NN NN",4,1,1,16514838,2,4.73E+018,"testalpha"
,"lm pcr using anpg","  VBG ",4,1,1,16582987,"pubmed1",1.99E+018,"testalpha"
,"tothiuram mix on patch","NN NN IN NN",4,1,1,16710586,2,2.67E+018,"testalpha"
,"engineering thec h type","NN   NN",4,1,1,16411739,"pubmed1",2.24E+018,"testalpha"
,"accident rate for escalator","NN NN IN NN",4,1,1,16434013,"pubmed1",3.50E+018,"testalpha"
,"group n and ahypoxia","NN  CC ",4,1,1,16395522,"pubmed1",1.87E+018,"testalpha"
,"valence mnii mniii state","NN   NN",4,1,1,16456265,2,6.07E+018,"testalpha"
,"non producing yeastsaccharomyces cerevisiae"," VBG NNS ",4,1,1,17063209,"pubmed1",2.78E+018,"testalpha"
,"gradesquamous intraepithelial lesion lsils","JJ JJ NN NNS",4,1,1,16514839,2,5.11E+018,"testalpha"
,"findings onadmission were pancytopenia","NNS NN VBD NNP",4,1,1,16918063,"pubmed1",2.96E+018,"testalpha"
,"obtained using mtm software","VBN VBG  NN",4,1,1,17285744,"pubmed1",5.97E+018,"testalpha"
,"studied plasma gsh pxactivity","VBN NNP  NN",4,1,1,17160142,"pubmed1",3.25E+018,"testalpha"
,"clot resolution elevation compression","NN NN NN NN",4,1,1,16549898,2,4.75E+018,"testalpha"
,"itsnuclear receptors modify expression","JJ NNS VB NN",4,1,1,17115080,"pubmed1",3.55E+018,"testalpha"
,"urine and calculated inmmol","NN CC VBN ",4,1,1,16956119,2,2.34E+018,"testalpha"
,"sida and sida groups"," CC  NNS",4,1,1,17013511,2,2.28E+018,"testalpha"
,"molecular analysis showed thatthe","JJ NN VBD NNP",4,1,1,16424663,2,7.20E+018,"testalpha"
,"identified publications from theabstracts","VBN NNS IN NNS",4,1,1,16365332,"pubmed1",3.31E+018,"testalpha"
,"expression was confirmed onb","NN VBD VBN ",4,1,1,16424654,2,4.34E+018,"testalpha"
,"oflow sequence identity models","VB NN NN NNS",4,1,1,16421452,2,8.69E+018,"testalpha"
,"offractionated ala mediated pdt","VBN  VBN ",4,1,1,16955185,2,7.48E+018,"testalpha"
,"kinaseinhibitor imatinib in respect","NN  IN NN",4,1,1,16424660,2,4.86E+018,"testalpha"
,"task force on atopic","NN NN IN NN",4,1,1,17438830,2,3.97E+018,"testalpha"
,"ni ii complex ofac","  JJ ",4,1,1,17117212,"pubmed1",9.00E+018,"testalpha"
,"oxygen innitrogen and ondansetron","NN NN CC NNP",4,1,1,16451147,"pubmed1",7.42E+018,"testalpha"
,"variations in product temperature","NNS IN NN NN",4,1,1,17285744,"pubmed1",3.32E+018,"testalpha"
,"pediatrics disorders of energy","NNS NNS IN NN",4,1,1,16462411,"pubmed1",8.98E+018,"testalpha"
,"hamster kidney cells bhk","NN NN NNS ",4,1,1,16914903,2,6.06E+018,"testalpha"
,"patient developed recurrent fever","NN VBD NN NN",4,1,1,16918060,"pubmed1",3.63E+018,"testalpha"
,"tissue engineered biological dressings","NN VBN JJ NNS",4,1,1,17010268,2,2.83E+018,"testalpha"
,"academic structural biology groups","JJ JJ NN NNS",4,1,1,16369099,2,3.56E+017,"testalpha"
,"plaster castand early rehabilitation","NN NN JJ NN",4,1,1,16612914,"pubmed1",8.87E+018,"testalpha"
,"completed thequestionnaires at time","VBN NNS IN NN",4,1,1,16710574,2,8.24E+018,"testalpha"
,"determinewhether selective cox inhibitors","JJ JJ  NNS",4,1,1,16253314,2,1.83E+017,"testalpha"
,"scores and co morbidconditions","NNS CC  NNS",4,1,1,17117607,2,6.17E+018,"testalpha"
,"atopy patch testing scratchtests"," NN NN NNS",4,1,1,16648919,2,8.33E+018,"testalpha"
,"treatment method of choice","NN NN IN NN",4,1,1,17139890,2,3.74E+018,"testalpha"
,"indication of harmful effects","NN IN JJ NNS",4,1,1,16956116,2,1.74E+018,"testalpha"
,"diagnostic difficulties and treatment","JJ NNS CC NN",4,1,1,16424653,2,6.41E+018,"testalpha"
,"mmhg in group range"," IN NN NN",4,1,1,16612916,"pubmed1",6.17E+018,"testalpha"
,"thrombosis progression pulmonary embolism","NN NN JJ NN",4,1,1,16549899,2,9.65E+017,"testalpha"
,"possible role in thehistopathogenesis","JJ NN IN NN",4,1,1,16899283,2,3.22E+018,"testalpha"
,"photo activatedresin by mass","NN NNP IN NN",4,1,1,16701862,"pubmed1",3.13E+017,"testalpha"
,"ininfancy childhood and adolescence","NN NN CC NN",4,1,1,16549901,2,1.24E+018,"testalpha"
,"additional irrelevant amino acids","JJ JJ NNP NNS",4,1,1,16424663,2,7.12E+018,"testalpha"
,"nature that provides evidence","NN IN VBZ NN",4,1,1,16730054,2,1.48E+018,"testalpha"
,"varying points of view","VBG NNS IN NN",4,1,1,16722345,2,1.57E+018,"testalpha"
,"terminal sh domain ansh","NN  NN ",4,1,1,16511262,2,4.31E+018,"testalpha"
,"cancer than caucasian women","NN IN JJ NNS",4,1,1,16596899,"pubmed1",9.15E+018,"testalpha"
,"patients had timi riskscores","NNS VBD  NNS",4,1,1,16365321,"pubmed1",7.37E+018,"testalpha"
,"survival rates male sex","NN NNS NN NN",4,1,1,16451146,"pubmed1",9.32E+017,"testalpha"
,"risk stratification ofed patients","NN NN VBD NNS",4,1,1,16365321,"pubmed1",2.90E+018,"testalpha"
,"year with anaveraged rate","NN IN VBN NN",4,1,1,16223468,"pubmed1",8.59E+018,"testalpha"
,"particulate carrier havingcontrolled drug","NN NN VBN NN",4,1,1,17285742,"pubmed1",4.63E+018,"testalpha"
,"anddyastolic left ventricle dysfunction","JJ VBN NN NN",4,1,1,16479034,2,4.63E+018,"testalpha"
,"more frequent skill gaps","JJR JJ NN NNS",4,1,1,16377820,"pubmed1",8.89E+018,"testalpha"
,"area under curves auc","NN IN NNS ",4,1,1,17067137,"pubmed1",7.98E+018,"testalpha"
,"stroke volume sv ejection","NN NN  NN",4,1,1,16989140,2,5.63E+018,"testalpha"
,"andldl cholesterol p value"," NN  NN",4,1,1,16479028,2,6.73E+018,"testalpha"
,"acid ala and j","NN  CC ",4,1,1,16955185,2,5.61E+017,"testalpha"
,"absence of neuroendocrine antigens","NN IN NN NNS",4,1,1,16919707,2,3.56E+018,"testalpha"
,"nogeneration and increased gsh","NN CC VBD ",4,1,1,16999986,2,2.54E+018,"testalpha"
,"accuracy of tp endometrialcytology","NN IN  NN",4,1,1,16514842,2,9.22E+018,"testalpha"
,"induced enrichment of ecm","VBN NN IN ",4,1,1,16733556,"pubmed1",2.52E+018,"testalpha"
,"percent changes ofheart rate","NN NNS NN NN",4,1,1,17067136,"pubmed1",8.69E+018,"testalpha"
,"purple undermined edges anda","JJ VBN NNS ",4,1,1,16603100,2,2.78E+018,"testalpha"
,"desensitisers in cavity preparation","NNS IN NN NN",4,1,1,16701865,"pubmed1",9.16E+018,"testalpha"
,"therapy in high risk","NN IN JJ NN",4,1,1,16424644,2,4.15E+017,"testalpha"
,"lowerproportion of inadequate specimens","NN IN JJ NNS",4,1,1,16514836,2,3.23E+018,"testalpha"
,"increased level of gc","VBN NN IN ",4,1,1,16733554,"pubmed1",7.74E+018,"testalpha"
,"toproline change at amino","NN NN IN NNP",4,1,1,16585980,2,2.62E+018,"testalpha"
,"poor visualization or non","JJ NN CC ",4,1,1,16673610,2,2.49E+018,"testalpha"
,"andbiomerieux kit with pcr","NNP  IN ",4,1,1,17019441,"pubmed1",7.74E+018,"testalpha"
,"positive history of thromboembolism","JJ NN IN NN",4,1,1,16696443,2,8.29E+018,"testalpha"
,"activity against wehi cells","NN IN  NNS",4,1,1,17117211,"pubmed1",8.86E+018,"testalpha"
,"volume sv ejection fraction","NN  NN NN",4,1,1,16989140,2,7.40E+018,"testalpha"
,"acto myosin ii system"," NNP  NN",4,1,1,17115079,"pubmed1",2.81E+017,"testalpha"
,"stable complex formof cuh","JJ NN  ",4,1,1,16496037,"pubmed1",3.64E+018,"testalpha"
,"o gal c glc","  NN ",4,1,1,16456293,2,4.32E+018,"testalpha"
,"variety of dna sequences","NN IN  NNS",4,1,1,16411739,"pubmed1",9.05E+018,"testalpha"
,"g l phenol g","  NN ",4,1,1,17019438,"pubmed1",1.06E+018,"testalpha"
,"date of crash road","NN IN NN NN",4,1,1,16221468,"pubmed1",7.43E+018,"testalpha"
,"rejection level forthe nullity","NN NN NNP NN",4,1,1,17293969,2,2.75E+018,"testalpha"
,"academic physicians and basicscience","JJ NNS CC NN",4,1,1,16377815,"pubmed1",7.32E+018,"testalpha"
,"ddexma vinyl terminated polylactidemacromonomers"," NN VBD NNS",4,1,1,16701854,"pubmed1",6.64E+018,"testalpha"
,"brain development andheterologous desensitization","NN NN JJ NN",4,1,1,16594639,"pubmed1",7.94E+018,"testalpha"
,"study wereto examine attitudes","NN  VB NNS",4,1,1,17106601,2,1.76E+018,"testalpha"
,"effect on traffic accidents","NN IN NN NNS",4,1,1,16236233,"pubmed1",5.16E+018,"testalpha"
,"h o co c","   NN",4,1,1,16397335,2,1.11E+018,"testalpha"
,"patients with heart failure","NNS IN NN NN",4,1,1,16377816,"pubmed1",1.63E+018,"testalpha"
,"respiratory failure mechanical ventilation","NN NN JJ NN",4,1,1,16400088,"pubmed1",5.30E+018,"testalpha"
,"change in road width","NN IN NN NN",4,1,1,16426558,"pubmed1",5.34E+018,"testalpha"
,"theregulation of arginine metabolism","NN IN NN NN",4,1,1,16511254,2,7.38E+018,"testalpha"
,"x ray photoelectron spectroscopy","NN  NNP ",4,1,1,16701874,"pubmed1",1.73E+018,"testalpha"
,"existence ofmembrane bound delta","NN NN VBN NN",4,1,1,17063209,"pubmed1",5.51E+018,"testalpha"
,"issues in rectal cancer","NNS IN NN NN",4,1,1,17139882,2,7.28E+018,"testalpha"
,"cell survival encapsulated min","NN NN VBN ",4,1,1,16701853,"pubmed1",3.39E+018,"testalpha"
,"hydrogen bonds and c","NN NNS CC NN",4,1,1,16397328,2,6.52E+018,"testalpha"
,"whounderwent non abdominal surgery","NN  JJ NN",4,1,1,16451146,"pubmed1",3.64E+018,"testalpha"
,"topical aminolaevulinic acid ala","JJ JJ NN ",4,1,1,16955185,2,1.53E+018,"testalpha"
,"existing belgian healthcare system","VBG JJ NN NN",4,1,1,16612907,2,1.12E+018,"testalpha"
,"cause and neurological group","NN CC JJ NN",4,1,1,16111641,"pubmed1",7.06E+018,"testalpha"
,"role ofthe pharmaceutical industry","NN NNP JJ NN",4,1,1,16596744,"pubmed1",8.30E+018,"testalpha"
,"regression analysis for eachcondition","NN NN IN NN",4,1,1,16054104,"pubmed1",3.86E+018,"testalpha"
,"expression of transforming growth","NN IN VBG NN",4,1,1,17293967,2,9.04E+018,"testalpha"
,"ahas at higher concentrations"," IN JJR NNS",4,1,1,16574202,2,4.61E+018,"testalpha"
,"true matches andnonmatches confidence","JJ NNS NNS NN",4,1,1,16365326,"pubmed1",5.91E+018,"testalpha"
,"includedsociodemographic characteristics clinical presentation","JJ NNS JJ NN",4,1,1,16696444,2,2.14E+018,"testalpha"
,"important tool for structure","JJ NN IN NN",4,1,1,16369089,2,6.09E+018,"testalpha"
,"number of neutrophils p","NN IN NNS ",4,1,1,16491218,2,5.31E+018,"testalpha"
,"location and traveling direction","NN CC VBG NN",4,1,1,16434013,"pubmed1",1.82E+018,"testalpha"
,"ribofuranosyl h pyrazolo d","  NNP ",4,1,1,16456292,2,6.23E+018,"testalpha"
,"transplant patients characterizedas neutrophil","JJ NNS NNP ",4,1,1,17119329,2,4.63E+018,"testalpha"
,"malignanthematological disorders during disease","JJ NNS IN NN",4,1,1,16914909,2,1.83E+018,"testalpha"
,"thrombosis and pulmonary embolism","NN CC JJ NN",4,1,1,16549896,2,7.81E+018,"testalpha"
,"following days after puva","VBG NNS IN ",4,1,1,17016038,2,5.47E+017,"testalpha"
,"beta induced collagen deposition","NN VBN NN NN",4,1,1,16874413,2,2.04E+018,"testalpha"
,"agnor dots were quantifiedand","NN NNS VBD NN",4,1,1,17293964,2,4.92E+018,"testalpha"
,"types of programsreduced teen","NNS IN VBN ",4,1,1,16171767,"pubmed1",7.36E+018,"testalpha"
,"false aneurysm by stent","JJ  IN NN",4,1,1,16612926,"pubmed1",7.80E+018,"testalpha"
,"novel source of ctgf","NN NN IN ",4,1,1,16395527,"pubmed1",3.92E+018,"testalpha"
,"crucial c terminal region","JJ NN NN NN",4,1,1,16421451,2,4.80E+018,"testalpha"
,"thecatastrophic consequences of cirrhosis","JJ NNS IN NN",4,1,1,17013520,2,1.41E+018,"testalpha"
,"tumor of tendon sheath","NN IN NNP NN",4,1,1,16514850,2,8.28E+018,"testalpha"
,"funded public foundation industry","VBN JJ NN NN",4,1,1,16365335,"pubmed1",7.77E+018,"testalpha"
,"limited colocalisation of inhibin","JJ NN IN NNP",4,1,1,16423381,2,5.47E+018,"testalpha"
,"subsequent induction of antiinflammatory","JJ NN IN NN",4,1,1,16770444,"pubmed1",1.39E+018,"testalpha"
,"onset method and stage","VB NN CC NN",4,1,1,16696444,2,7.30E+018,"testalpha"
,"credentials andgraduate medical education","NNS NN JJ NN",4,1,1,16377812,"pubmed1",3.09E+018,"testalpha"
,"patient movements or electrodefailure","NN NNS CC NN",4,1,1,16365330,"pubmed1",6.92E+018,"testalpha"
,"high coordination lattice representation","JJ NN NN NN",4,1,1,16365636,"pubmed1",7.23E+018,"testalpha"
,"other institutions and hadcome","JJ NNS CC NN",4,1,1,16333710,"pubmed1",2.34E+018,"testalpha"
,"wehi cells and interleukin"," NNS CC NNP",4,1,1,17117211,"pubmed1",8.03E+018,"testalpha"
,"response of pfkfb mrna","NN IN  ",4,1,1,17143338,"pubmed1",6.48E+018,"testalpha"
,"affected persons inherit thedisorder","VBN NNS VB NN",4,1,1,17010267,2,7.08E+018,"testalpha"
,"registry cancer registry andcauses","NN NN NN NNS",4,1,1,16710578,2,4.54E+018,"testalpha"
,"health education and screening","NN NN CC NN",4,1,1,16596901,"pubmed1",1.54E+018,"testalpha"
,"tgf beta primary antibodies"," NN JJ NNS",4,1,1,17293967,2,6.06E+018,"testalpha"
,"effectiveness and systems enablers","NN CC NNS NNS",4,1,1,16377814,"pubmed1",4.91E+018,"testalpha"
,"seat position crash type","NN NN NN NN",4,1,1,16197912,"pubmed1",1.66E+018,"testalpha"
,"activity in c subtypes","NN IN NN NNS",4,1,1,17106510,"pubmed1",5.96E+018,"testalpha"
,"k dependantcoagulation factors ii"," NN NNS ",4,1,1,16916181,"pubmed1",8.01E+018,"testalpha"
,"wedgedvenography and transvenous liver","NN CC JJ NN",4,1,1,16447097,"pubmed1",7.10E+018,"testalpha"
,"showed non significant changes","VBD  JJ NNS",4,1,1,17133954,2,8.70E+017,"testalpha"
,"unsymmetrical dinucleating n o","JJ VBG  ",4,1,1,16456265,2,1.38E+018,"testalpha"
,"lasers and different techniques","NNS CC JJ NNS",4,1,1,16710582,2,3.80E+018,"testalpha"
,"effects of intravenous iron","NNS IN JJ NN",4,1,1,16809890,2,7.39E+017,"testalpha"
,"tremendous public health potential","JJ JJ NN NN",4,1,1,16365327,"pubmed1",8.48E+018,"testalpha"
,"neuronal nicotinic acetylcholine receptors","JJ JJ NN NNS",4,1,1,16594641,"pubmed1",2.37E+018,"testalpha"
,"product temperatures and sublimation","NN NNS CC NN",4,1,1,17285744,"pubmed1",4.00E+018,"testalpha"
,"poor long term survival","JJ JJ NN NN",4,1,1,16314992,"pubmed1",2.00E+018,"testalpha"
,"activated macrophages and bacteria","VBN NNS CC NNS",4,1,1,16701867,"pubmed1",3.87E+018,"testalpha"
,"impairment in thecontrol group","NN IN NN NN",4,1,1,16451151,"pubmed1",1.98E+018,"testalpha"
,"published cases reporting malignantmelanomas","VBN NNS VBG NNP",4,1,1,16585989,2,4.54E+018,"testalpha"
,"total rna isolated fromthe","JJ  VBN NNP",4,1,1,16505899,"pubmed1",8.66E+018,"testalpha"
,"evidence of adisturbed vascularisation","NN IN VBD NN",4,1,1,16613748,2,3.24E+018,"testalpha"
,"plant type l asparaginasesare","NN NN  NN",4,1,1,17143335,"pubmed1",4.98E+018,"testalpha"
,"acdcrgdcfcggklaklakklaklak binds selectivelyto alphavbeta","NNP NNS  NN",4,1,1,17143339,"pubmed1",3.31E+018,"testalpha"
,"fundamental importance for theinterpretation","JJ NN IN NN",4,1,1,16874422,2,2.56E+017,"testalpha"
,"leaflets and coresponding chordal","NNS CC VBG NN",4,1,1,16989140,2,6.53E+018,"testalpha"
,"thestart of acyclovir therapy","NN IN  NN",4,1,1,16809891,2,6.38E+018,"testalpha"
,"noise positive startle responses","NN JJ VB NNS",4,1,1,17133954,2,6.69E+018,"testalpha"
,"maneuver promoted neutrophils sequestration","NN VBN NNS NN",4,1,1,16491220,2,2.60E+018,"testalpha"
,"undetermined significance while theremainder","JJ NN IN NN",4,1,1,16514840,2,4.16E+018,"testalpha"
,"cavity liver abdominal lymph","NN NN JJ NN",4,1,1,17338205,2,6.70E+018,"testalpha"
,"number ofoccupants per vehicle","NN NNS IN NN",4,1,1,16126153,"pubmed1",4.19E+018,"testalpha"
,"main function of oxytocin","JJS NN IN NNP",4,1,1,16523218,"pubmed1",1.72E+018,"testalpha"
,"subsequent collisions with vehicles","JJ NNS IN NNS",4,1,1,16442487,"pubmed1",6.90E+018,"testalpha"
,"matrix wound dressing bmwd","NNP VBD VBG ",4,1,1,17010268,2,3.88E+018,"testalpha"
,"job required career needs","NN VBN NN NNS",4,1,1,16436795,"pubmed1",5.34E+018,"testalpha"
,"motor latency pn tml","NN NN  ",4,1,1,17139884,2,2.46E+018,"testalpha"
,"data collected usingsynchrotron radiation","NN VBN NNP NN",4,1,1,16511247,2,7.31E+018,"testalpha"
,"tumour thickness tumour thickness","JJ NN JJ NN",4,1,1,16585990,2,5.64E+018,"testalpha"
,"society foracademic emergency medicine","NN JJ NN NN",4,1,1,16365332,"pubmed1",4.31E+018,"testalpha"
,"care workers and controls","NN NNS CC NNS",4,1,1,16696442,2,1.55E+018,"testalpha"
,"evaluatedusing papanicolaou stained slides","VBG  VBN NNS",4,1,1,16514837,2,4.74E+018,"testalpha"
,"role in pollen germination","NN IN NN NN",4,1,1,16963110,2,4.38E+018,"testalpha"
,"directors ofmedical student education","NNS JJ NN NN",4,1,1,16473991,"pubmed1",6.52E+018,"testalpha"
,"n unaffected hs family"," JJ  NN",4,1,1,17016037,2,6.38E+018,"testalpha"
,"clinical implications of hiv","JJ NNS IN ",4,1,1,16462406,"pubmed1",9.06E+018,"testalpha"
,"glycinato mu thiosulfato dipotassium","NN  NN NN",4,1,1,16397335,2,8.84E+018,"testalpha"
,"lazaroid type protect organs","VB NN VB NNS",4,1,1,16365323,"pubmed1",8.24E+018,"testalpha"
,"phototherapy and systemic therapy","NN CC JJ NN",4,1,1,17010269,2,2.87E+018,"testalpha"
,"alower percentage of collagen","NN NN IN NN",4,1,1,16701880,"pubmed1",4.24E+018,"testalpha"
,"demonstrates deranged circulation andarrhythmias","VBZ VBN NN NNP",4,1,1,16451157,"pubmed1",9.03E+017,"testalpha"
,"scope spatial scales successionalseres","NN JJ NNS NNS",4,1,1,16988904,"pubmed1",5.33E+018,"testalpha"
,"treatment of chronic anal","NN IN JJ ",4,1,1,16612915,"pubmed1",8.56E+018,"testalpha"
,"glutamine micro andglutamine scfa","NN NNP NN ",4,1,1,17293957,2,4.16E+018,"testalpha"
,"ct during arterial portography"," IN JJ NN",4,1,1,16317488,"pubmed1",1.52E+018,"testalpha"
,"clinical trials and registries","JJ NNS CC NNS",4,1,1,16365321,"pubmed1",9.05E+017,"testalpha"
,"observation and x ray","NN CC NN ",4,1,1,16701860,"pubmed1",2.72E+018,"testalpha"
,"dephosphorylation of adenine nucleotides","NN IN NN NNS",4,1,1,16770441,"pubmed1",4.98E+018,"testalpha"
,"role in thewarburg effect","NN IN NNP NN",4,1,1,17143338,"pubmed1",1.32E+018,"testalpha"
,"basic life support units","JJ NN NN NNS",4,1,1,16491215,2,4.22E+018,"testalpha"
,"rate systolic blood pressure","NN JJ NN NN",4,1,1,17067136,"pubmed1",9.04E+018,"testalpha"
,"studya long term alteration"," JJ NN NN",4,1,1,17133952,2,8.10E+018,"testalpha"
,"immunodeficiency disorders altered regulation","NN NNS VBN NN",4,1,1,17068636,"pubmed1",2.90E+018,"testalpha"
,"pneumothorax in patients pneumonia"," IN NNS NNP",4,1,1,16956118,2,1.83E+018,"testalpha"
,"surrogates for particular purposes","NNS IN JJ NNS",4,1,1,16988904,"pubmed1",2.27E+018,"testalpha"
,"e followingthe highest increase"," NNP JJS NN",4,1,1,16733561,"pubmed1",8.29E+018,"testalpha"
,"genetic modification of thesecells","JJ NN IN NNS",4,1,1,17160143,"pubmed1",1.84E+017,"testalpha"
,"organ involvement after exposure","NN NN IN NN",4,1,1,16710584,2,2.15E+018,"testalpha"
,"treatment prolongssurvival and doubles","NN NN CC NNS",4,1,1,16436797,"pubmed1",8.49E+018,"testalpha"
,"essential toquality patient care","JJ NN NN NN",4,1,1,16596898,"pubmed1",7.47E+018,"testalpha"
,"house dust mites hdm","VB NN NNS ",4,1,1,17328144,2,5.23E+018,"testalpha"
,"ii bis sulfate co","  NN ",4,1,1,16397335,2,2.81E+018,"testalpha"
,"system tropism and perturbation","NN NN CC NN",4,1,1,17119328,2,6.28E+017,"testalpha"
,"tfam confirmed itshigh affinity"," VBN VB NN",4,1,1,17143337,"pubmed1",4.50E+018,"testalpha"
,"identification and optimizationprogram crystallizations","NN CC NN NNS",4,1,1,16511290,2,5.33E+018,"testalpha"
,"pathology breast cancer screeningguidelines","NN NN NN NNS",4,1,1,16596895,"pubmed1",6.48E+018,"testalpha"
,"treatment ofhepatic fibrotic diseases","NN JJ JJ NNS",4,1,1,16256175,2,3.40E+017,"testalpha"
,"improvement in hematocrit levels","NN IN NN NNS",4,1,1,16424651,2,7.69E+018,"testalpha"
,"subgroups of pediatric patients","NNS IN JJ NNS",4,1,1,16549896,2,3.72E+018,"testalpha"
,"particle fragmentation and deformation","NN NN CC NN",4,1,1,16584166,"pubmed1",8.21E+018,"testalpha"
,"conformational changes in bax","JJ NNS IN ",4,1,1,16424655,2,7.37E+018,"testalpha"
,"arteries in thehypoxic group","NNS IN JJ NN",4,1,1,16395522,"pubmed1",5.15E+018,"testalpha"
,"attendingselected primary care centers","VBN JJ NN NNS",4,1,1,16514839,2,3.48E+018,"testalpha"
,"uses dutch travel survey","VBZ NN NN NN",4,1,1,16426560,"pubmed1",4.44E+018,"testalpha"
,"andrepair of root resorption","NN IN NN NN",4,1,1,16956115,2,1.94E+018,"testalpha"
,"mileage and road density","NN CC NN NN",4,1,1,16451795,"pubmed1",4.64E+018,"testalpha"
,"urinary incontinent postmenopausal women","JJ NN NN NNS",4,1,1,16962646,2,5.00E+018,"testalpha"
,"nuclear factor kappab nf","JJ NN  ",4,1,1,17068636,"pubmed1",8.39E+018,"testalpha"
,"bcr abltyrosine kinase inhibitors"," NN NN NNS",4,1,1,16914906,2,1.81E+017,"testalpha"
,"compounds hexaaquacobalt ii tetraaquadiglycinatocobalt","VBZ NN  NN",4,1,1,16397335,2,3.83E+018,"testalpha"
,"reach good reactivation results","VB JJ NN NNS",4,1,1,17438836,2,5.42E+018,"testalpha"
,"terms of safetyeffects infrastructure","NNS IN NNS NN",4,1,1,16406188,"pubmed1",5.35E+018,"testalpha"
,"amphotericin b l amb","NNP NN  ",4,1,1,16918060,"pubmed1",3.23E+018,"testalpha"
,"resp of chronichepatitis c"," IN NN NN",4,1,1,16696442,2,1.12E+018,"testalpha"
,"month period before thesurvey","NN NN IN NN",4,1,1,16236234,"pubmed1",8.05E+018,"testalpha"
,"medicalcenters amcs teaching hospitals","NNS  VBG NNS",4,1,1,16377816,"pubmed1",7.05E+018,"testalpha"
,"normal testis until postoperation","JJ NN IN NN",4,1,1,16395525,"pubmed1",3.85E+018,"testalpha"
,"er and compare urgency"," CC VB NN",4,1,1,16321533,"pubmed1",2.72E+018,"testalpha"
,"satisfaction or physical health","NN CC JJ NN",4,1,1,16377815,"pubmed1",7.79E+018,"testalpha"
,"specific modes of receptor","JJ NNS IN NN",4,1,1,16594640,"pubmed1",4.26E+018,"testalpha"
,"was mg kg day","VBD   NN",4,1,1,16955187,2,3.41E+018,"testalpha"
,"hep cells exhibiting features"," NNS VBG NNS",4,1,1,16956122,2,4.96E+018,"testalpha"
,"clotocclusiveness clot persistence number","NN NN NN NN",4,1,1,16549898,2,8.73E+018,"testalpha"
,"sites of dna damage","NNS IN  NN",4,1,1,16582987,"pubmed1",7.17E+018,"testalpha"
,"convenient physico mechanical properties","JJ NNP JJ NNS",4,1,1,16970980,2,5.22E+018,"testalpha"
,"diabetes and stroke severity","NN CC NN NN",4,1,1,16436794,"pubmed1",3.25E+018,"testalpha"
,"human saposin c ora","JJ NNP NN ",4,1,1,16511279,2,4.71E+018,"testalpha"
,"viral vectors chemo viruses","JJ NNS  NNS",4,1,1,17285739,"pubmed1",1.14E+018,"testalpha"
,"catalysed oxidative demethylation mechanism","VBN JJ NN NN",4,1,1,16733554,"pubmed1",2.78E+018,"testalpha"
,"time initial setting time","NN JJ VBG NN",4,1,1,16701865,"pubmed1",4.27E+017,"testalpha"
,"total body surface area","NN NN NN NN",4,1,1,17165599,2,1.01E+018,"testalpha"
,"framework todesign novel dna","NN JJ NN ",4,1,1,16411739,"pubmed1",3.07E+018,"testalpha"
,"vasodilation proliferation and cell","NN NN CC NN",4,1,1,16770441,"pubmed1",5.99E+018,"testalpha"
,"pattern inni ii complexes","NN   NNS",4,1,1,17117212,"pubmed1",7.60E+018,"testalpha"
,"years completed neuropsychological assessmentpre","NNS VBN JJ ",4,1,1,16451151,"pubmed1",3.12E+018,"testalpha"
,"flt ligand fl togenerate"," NN  NN",4,1,1,16404477,"pubmed1",5.87E+018,"testalpha"
,"keratinocyte cytoarchitectural differentiation mitosesand","NNP JJ NN NN",4,1,1,17311737,2,2.24E+018,"testalpha"
,"known phenomenon in patients","VBN NN IN NNS",4,1,1,16914909,2,2.27E+018,"testalpha"
,"available atwww usp org","JJ   ",4,1,1,17285738,"pubmed1",7.40E+018,"testalpha"
,"celltransplantation pbsct in patients","NN  IN NNS",4,1,1,16914902,2,4.05E+017,"testalpha"
,"high prevalence indiabetic patients","JJ NN JJ NNS",4,1,1,16955188,2,4.09E+018,"testalpha"
,"group had good knowledge","NN VBD JJ NN",4,1,1,17106601,2,1.28E+017,"testalpha"
,"ofthe molecular replacement method","NNP JJ NN NN",4,1,1,16511279,2,1.24E+018,"testalpha"
,"twomulticopy suppressor genes yjl"," NN NNS ",4,1,1,17146497,"pubmed1",5.31E+018,"testalpha"
,"genes have important roles","NNS VBP JJ NNS",4,1,1,16325892,2,8.77E+018,"testalpha"
,"interval ci for paireddifferences","NN  IN NNS",4,1,1,16377828,"pubmed1",4.16E+018,"testalpha"
,"spectroscopy chemicaldenaturation and determination"," NN CC NN",4,1,1,17019437,"pubmed1",4.50E+018,"testalpha"
,"rfa procedures for supraventriculartachycardias"," NNS IN NNP",4,1,1,16696443,2,7.08E+018,"testalpha"
,"mycobacterium tuberculosis epoxide hydrolases","NN NN VB NNS",4,1,1,16511284,2,1.86E+018,"testalpha"
,"periappendicealtissue and mesenteric fat","NN CC JJ NN",4,1,1,16612913,"pubmed1",6.76E+018,"testalpha"
,"domain ofgads gads csh","NN NNS  ",4,1,1,16511262,2,4.08E+018,"testalpha"
,"hdl cholesterol in patients"," NN IN NNS",4,1,1,16479028,2,3.68E+018,"testalpha"
,"leadingexternal causes of injuries","JJ NNS IN NNS",4,1,1,16162331,"pubmed1",5.55E+018,"testalpha"
,"analysing data for radiation","VBG NNS IN NN",4,1,1,16369098,2,2.31E+018,"testalpha"
,"surveyed n sought treatment","VBN  VBD NN",4,1,1,16377190,"pubmed1",1.21E+018,"testalpha"
,"strong affinity for dna","JJ NN IN ",4,1,1,17143337,"pubmed1",5.37E+018,"testalpha"
,"analysis included maximal pg","NN VBD JJ ",4,1,1,16989140,2,2.51E+017,"testalpha"
,"theabsence of ppargamma ligands","NN IN NN NNS",4,1,1,16395520,"pubmed1",8.05E+017,"testalpha"
,"type mice lens cells","NN  NN NNS",4,1,1,16325892,2,1.01E+018,"testalpha"
,"significant difference in consumption","JJ NN IN NN",4,1,1,16916184,"pubmed1",2.66E+018,"testalpha"
,"downregulation of c mycexpression","NN IN NN NN",4,1,1,16809887,2,3.38E+018,"testalpha"
,"related spinal cord injury","VBN JJ NN NN",4,1,1,16111641,"pubmed1",3.64E+018,"testalpha"
,"new kind of light","JJ NN IN NN",4,1,1,16585984,2,6.06E+018,"testalpha"
,"obligate intracellular parasite toxoplasma","NN JJ JJ NNP",4,1,1,16421444,2,5.41E+018,"testalpha"
,"condylus leaving theempty standard","NN VBG JJ NN",4,1,1,17293966,2,2.60E+018,"testalpha"
,"life and job satisfaction","NN CC NN NN",4,1,1,16377815,"pubmed1",1.85E+018,"testalpha"
,"surgery performed undercardiopulmonary bypass","NN VBN JJ NN",4,1,1,16451153,"pubmed1",7.77E+018,"testalpha"
,"sequence identity with legionella","NN NN IN NNP",4,1,1,16511256,2,7.60E+017,"testalpha"
,"physician directed destination control","NN VBN NN NN",4,1,1,16365324,"pubmed1",7.38E+018,"testalpha"
,"median time of months","JJ NN IN NNS",4,1,1,16424648,2,7.38E+018,"testalpha"
,"pineal gland pinealectomy pnx","NN NN NN ",4,1,1,16491217,2,4.75E+018,"testalpha"
,"phenomenon isan inevitable consequence","NN  JJ NN",4,1,1,17106512,"pubmed1",1.73E+018,"testalpha"
,"method for assessing platelet","NN IN VBG NN",4,1,1,16549889,2,3.29E+018,"testalpha"
,"simulated french road crash","VBN JJ NN NN",4,1,1,16126153,"pubmed1",3.54E+018,"testalpha"
,"reduce thenumber of patrons","VB NN IN NNS",4,1,1,16169506,"pubmed1",7.59E+018,"testalpha"
,"transcription factors c fos","NN NNS NN ",4,1,1,17115080,"pubmed1",7.34E+018,"testalpha"
,"supply of theremaining rectum","NN IN VBG NN",4,1,1,16612911,2,8.50E+018,"testalpha"
,"cd p or p","  CC ",4,1,1,16809885,2,1.02E+017,"testalpha"
,"loss of balance cases","NN IN NN NNS",4,1,1,16434013,"pubmed1",3.34E+018,"testalpha"
,"sialic acid and sambucus","JJ NN CC NN",4,1,1,16720036,2,6.02E+018,"testalpha"
,"brain protection associatedorgan dysfunctions","NN NN VBD NNS",4,1,1,17067134,"pubmed1",2.42E+018,"testalpha"
,"allows rapid mass screening","VBZ JJ NN NN",4,1,1,16414103,2,6.65E+018,"testalpha"
,"choice tissue forthe construction","NN NN NNP NN",4,1,1,16714053,2,2.43E+018,"testalpha"
,"lvg containing bovine islet"," VBG NN NN",4,1,1,16701881,"pubmed1",1.74E+018,"testalpha"
,"adhesion molecules in atopic","NN NNS IN NN",4,1,1,16603095,2,2.09E+018,"testalpha"
,"effects of methylating agents","NNS IN VBG NNS",4,1,1,16733554,"pubmed1",1.84E+018,"testalpha"
,"deregulation on transport safety","NN IN NN NN",4,1,1,16427020,"pubmed1",7.48E+018,"testalpha"
,"modes of receptor activation","NNS IN NN NN",4,1,1,16594640,"pubmed1",1.22E+018,"testalpha"
,"finger peptides by re","NN NNS IN ",4,1,1,16411739,"pubmed1",1.68E+018,"testalpha"
,"extracellular localization of zea","JJ NN IN ",4,1,1,16963110,2,8.33E+018,"testalpha"
,"eosinophil protein x epx"," NN NN ",4,1,1,16859611,2,7.82E+018,"testalpha"
,"smad and p mapk"," CC  ",4,1,1,16874413,2,2.28E+018,"testalpha"
,"time of months months","NN IN NNS NNS",4,1,1,16914904,2,7.90E+017,"testalpha"
,"peripheral blood of patients","JJ NN IN NNS",4,1,1,17016036,2,2.10E+018,"testalpha"
,"traffic crashes with victims","NN NNS IN NNS",4,1,1,16426561,"pubmed1",7.41E+018,"testalpha"
,"kind of traffic problem","NN IN NN NN",4,1,1,16236233,"pubmed1",7.05E+018,"testalpha"
,"psba psbb psbc psbd","   ",4,1,1,17106511,"pubmed1",1.16E+018,"testalpha"
,"allergic contact dermatitis skin","JJ NN NN NN",4,1,1,16585981,2,6.55E+018,"testalpha"
,"ofdiverse late stage complications","NN JJ NN NNS",4,1,1,16462405,"pubmed1",1.41E+018,"testalpha"
,"theinstitutionalization of centralized systems","NN IN VBN NNS",4,1,1,16770859,"pubmed1",1.73E+018,"testalpha"
,"analysis showed thatthe patient","NN VBD NNP NN",4,1,1,16424663,2,2.36E+018,"testalpha"
,"tmv accumulation in tobacco"," NN IN NN",4,1,1,16395523,"pubmed1",5.79E+018,"testalpha"
,"t species in samples"," NN IN NNS",4,1,1,16710579,2,4.63E+018,"testalpha"
,"fromlimited complexity of work","VBN NN IN NN",4,1,1,16451152,"pubmed1",7.37E+018,"testalpha"
,"reperfusion after controlledhemorrhagic shock","NN IN JJ NN",4,1,1,16491220,2,4.08E+018,"testalpha"
,"routes in pepsinogen activation","NNS IN NN NN",4,1,1,16770446,"pubmed1",7.86E+018,"testalpha"
,"applications were investigated lung","NNS VBD VBD NN",4,1,1,16399029,"pubmed1",1.03E+018,"testalpha"
,"markers in thishemorrhagic shock","NNS IN JJ NN",4,1,1,16365323,"pubmed1",7.01E+018,"testalpha"
,"immunoreactivity for cspg tn","NN IN  ",4,1,1,16414104,2,8.86E+018,"testalpha"
,"radiologic examinations confirmed theexistence","JJ NNS VBD NN",4,1,1,16612927,"pubmed1",2.29E+018,"testalpha"
,"thepresence of mop inhibits","NN IN  NNS",4,1,1,17016038,2,7.44E+018,"testalpha"
,"conditions and crash risk","NNS CC NN NN",4,1,1,16054104,"pubmed1",8.45E+017,"testalpha"
,"reduced treatment related toxicity","VBD NN VBN NN",4,1,1,16424645,2,7.16E+018,"testalpha"
,"several days after thestart","JJ NNS IN NN",4,1,1,16809891,2,1.42E+018,"testalpha"
,"patients had proximal paresis","NNS VBD JJ NN",4,1,1,16479025,2,2.49E+018,"testalpha"
,"aha week n week"," NN  NN",4,1,1,16574202,2,1.59E+018,"testalpha"
,"large number of drug","JJ NN IN NN",4,1,1,16584115,"pubmed1",3.48E+018,"testalpha"
,"county level crash frequency","NN NN NN NN",4,1,1,16451795,"pubmed1",8.60E+018,"testalpha"
,"presence of viral dna","NN IN JJ ",4,1,1,17019440,"pubmed1",1.07E+018,"testalpha"
,"terms of neutralization rateand","NNS IN NN NN",4,1,1,16584168,"pubmed1",4.09E+018,"testalpha"
,"petroleum derivatives and phenol","NN NNS CC NN",4,1,1,17019438,"pubmed1",5.42E+018,"testalpha"
,"mu acetato kappao kappao"," NN  ",4,1,1,16456276,2,7.31E+018,"testalpha"
,"intestinal sites after days","JJ NNS IN NNS",4,1,1,17293957,2,5.43E+018,"testalpha"
,"organ manifestation of langerhans","NN NN IN NNS",4,1,1,16585988,2,4.44E+017,"testalpha"
,"hydroxybenzamido ethylammonioethyl aminocarbonyl phenolate","  NN NN",4,1,1,16456282,2,3.06E+018,"testalpha"
,"less severe liver disease","JJR JJ NN NN",4,1,1,17013512,2,4.85E+018,"testalpha"
,"patients with high titer","NNS IN JJ NN",4,1,1,16549892,2,2.62E+018,"testalpha"
,"infusion and min ng","NN CC  ",4,1,1,17067137,"pubmed1",8.33E+018,"testalpha"
,"method in semistructured interviews","NN IN VBN NNS",4,1,1,16377814,"pubmed1",6.38E+018,"testalpha"
,"greatest combination of sensitivity","JJT NN IN NN",4,1,1,16451151,"pubmed1",3.45E+018,"testalpha"
,"toprotect against ischaemia reperfusion","NN IN NN NN",4,1,1,16612918,"pubmed1",8.86E+018,"testalpha"
,"mma v and dimethylarsenate","  CC NN",4,1,1,17019444,"pubmed1",2.79E+018,"testalpha"
,"residue intramolecular hydrogen bond","NN JJ NN NN",4,1,1,16456293,2,4.99E+018,"testalpha"
,"hr hpv after treatment","  IN NN",4,1,1,16514834,2,3.11E+018,"testalpha"
,"novel polypeptide velvet antler","JJ VB NN NN",4,1,1,16770447,"pubmed1",9.15E+018,"testalpha"
,"studies ofprophylaxis for catheter","NNS  IN NN",4,1,1,16549897,2,8.39E+018,"testalpha"
,"group creceived saline ml","NN VBN NN ",4,1,1,17067136,"pubmed1",1.01E+018,"testalpha"
,"pain or related symptoms","NN CC VBN NNS",4,1,1,16365321,"pubmed1",3.17E+018,"testalpha"
,"ofphotochemical activity in c","JJ NN IN NN",4,1,1,17106510,"pubmed1",7.17E+018,"testalpha"
,"careers in academic psychiatry","NNS IN JJ NN",4,1,1,16473996,"pubmed1",5.62E+018,"testalpha"
,"model mimics theshort range","JJ VBZ NN NN",4,1,1,16365636,"pubmed1",8.01E+018,"testalpha"
,"be transient but canpersist","VB NN CC NN",4,1,1,17236646,"pubmed1",5.35E+018,"testalpha"
,"tissueschanges of wistar rats","NNS IN NN NNS",4,1,1,17293964,2,4.49E+018,"testalpha"
,"treatment modalities comorbid conditions","NN NNS VB NNS",4,1,1,16462405,"pubmed1",6.26E+018,"testalpha"
,"treatment of iron deficiency","NN IN NN NN",4,1,1,16809889,2,7.95E+018,"testalpha"
,"ige and specific ige"," CC JJ ",4,1,1,16648919,2,7.05E+018,"testalpha"
,"mniimniii c h n"," NN  ",4,1,1,16456265,2,5.47E+018,"testalpha"
,"pro inflammatory signals andhelp","JJ JJ NNS ",4,1,1,16648910,2,5.41E+018,"testalpha"
,"overlooked complication ofinflammatory bowel","VBN NN NN NN",4,1,1,16673554,2,6.79E+018,"testalpha"
,"ponv pain scores opioidconsumption"," NN NNS NN",4,1,1,16451147,"pubmed1",7.26E+018,"testalpha"
,"diseasecontrol and prevention cdc","NN CC NN ",4,1,1,16365331,"pubmed1",6.15E+018,"testalpha"
,"survival of ebv negativepatients","NN IN  NNS",4,1,1,16914904,2,4.60E+018,"testalpha"
,"relative numbers show specificdifferences","JJ NNS VB NNS",4,1,1,17165598,2,2.99E+018,"testalpha"
,"numerous amino acid side","JJ NNP NN NN",4,1,1,16421453,2,1.54E+018,"testalpha"
,"cellular migration andintercellular communication","JJ NN JJ NN",4,1,1,16594639,"pubmed1",3.76E+016,"testalpha"
,"leading cause of death","VBG NN IN NN",4,1,1,17139885,2,4.09E+017,"testalpha"
,"mediastinal germ cell tumor","JJ NN NN NN",4,1,1,16809892,2,8.42E+018,"testalpha"
,"secretory protein component ofsaliva","NN NN NN ",4,1,1,16511271,2,7.72E+018,"testalpha"
,"lymphatic stasis capillary stasis","JJ NN JJ NN",4,1,1,17294912,2,1.94E+018,"testalpha"
,"dynamical analyses of thesesubstrates","JJ NNS IN NNS",4,1,1,16397333,2,7.74E+018,"testalpha"
,"use available emergencyhealth care","VB JJ NN NN",4,1,1,16365324,"pubmed1",8.19E+018,"testalpha"
,"greater number of neutrophils","JJR NN IN NNS",4,1,1,16491218,2,1.67E+018,"testalpha"
,"ppdo plla b peg","  NN ",4,1,1,16701879,"pubmed1",7.09E+018,"testalpha"
,"ofthe evaluated biological samples","NNP VBN JJ NNS",4,1,1,17285740,"pubmed1",7.09E+018,"testalpha"
,"receptor antagonistmk and mglul","NN  CC ",4,1,1,17265692,2,6.02E+018,"testalpha"
,"aspiration fna ofthyroid gland","NN  VB NN",4,1,1,16514836,2,1.81E+018,"testalpha"
,"prevention of chronic diseases","NN IN JJ NNS",4,1,1,16918068,"pubmed1",1.23E+018,"testalpha"
,"receivedbupivacaine mg kg bolus","NN   NN",4,1,1,17067137,"pubmed1",4.65E+018,"testalpha"
,"fluorescence was fitted toexperimental","NN VBD VBN NN",4,1,1,16404478,"pubmed1",2.45E+018,"testalpha"
,"patients with orofacial clefts","NNS IN JJ NNS",4,1,1,17165598,2,1.83E+018,"testalpha"
,"pelvic sidewalls and orupper","JJ NNS CC NN",4,1,1,17139900,2,3.81E+018,"testalpha"
,"number of ito cells","NN IN  NNS",4,1,1,16256175,2,3.33E+018,"testalpha"
,"comparison with experimental data","NN IN JJ NN",4,1,1,16388314,"pubmed1",4.89E+018,"testalpha"
,"brain of mcao rats","NN IN  NNS",4,1,1,17265691,2,8.64E+018,"testalpha"
,"steroidal anti inflammatory drugs","NN IN JJ NNS",4,1,1,17106603,2,2.25E+018,"testalpha"
,"positive effect on plasma","JJ NN IN NNP",4,1,1,17160142,"pubmed1",8.44E+018,"testalpha"
,"bilateral lower limbacute ischemia","JJ JJR NN NN",4,1,1,16612926,"pubmed1",6.28E+018,"testalpha"
,"fingers have shown nuclease","NNS VBP VBN NN",4,1,1,16411739,"pubmed1",7.33E+018,"testalpha"
,"perceived risk low perceivedprevalence","VBN NN JJ NN",4,1,1,16191426,"pubmed1",9.16E+018,"testalpha"
,"solution were studied modifications","NN VBD VBN NNS",4,1,1,16996581,2,4.38E+017,"testalpha"
,"development calcification ofthe vessel","NN NN NNP NN",4,1,1,17007910,2,5.25E+018,"testalpha"
,"envelope and cover letter","NN CC VB NN",4,1,1,16377812,"pubmed1",5.98E+018,"testalpha"
,"cells and interleukin secretionby","NNS CC NNP ",4,1,1,17117211,"pubmed1",1.70E+018,"testalpha"
,"cellinteractions or cell matrix","NNS CC NN NNP",4,1,1,16511286,2,2.98E+018,"testalpha"
,"y r ly r"," NN  NN",4,1,1,16404475,"pubmed1",6.65E+018,"testalpha"
,"returned elevated blood calcium","VBD VBN NN NN",4,1,1,17016034,2,8.21E+018,"testalpha"
,"examine attitudes of psoriasis","VB NNS IN NN",4,1,1,17106601,2,3.00E+018,"testalpha"
,"ultrasound energy liquefies sweat","NN NN NNS NN",4,1,1,16710583,2,3.70E+018,"testalpha"
,"number of available positions","NN IN JJ NNS",4,1,1,16399040,"pubmed1",3.43E+018,"testalpha"
,"used toreanimation group pss","VBN NN NN ",4,1,1,16491220,2,5.44E+018,"testalpha"
,"collection of excellent data","NN IN JJ NN",4,1,1,16369095,2,5.86E+018,"testalpha"
,"victim task product andenvironment","NN NN NN NN",4,1,1,16434013,"pubmed1",5.65E+017,"testalpha"
,"presence of different sugars","NN IN JJ NNS",4,1,1,16730370,2,5.81E+018,"testalpha"
,"electronic searches identified publications","JJ NNS VBN NNS",4,1,1,16365332,"pubmed1",7.16E+018,"testalpha"
,"microginjection of oestrogen e","NN IN NN ",4,1,1,16584758,2,7.83E+018,"testalpha"
,"inhibition of mitochondrial translation","NN IN JJ NN",4,1,1,16389406,"pubmed1",4.67E+018,"testalpha"
,"service education influence theirattitudes","NN NN NN NNS",4,1,1,16330213,"pubmed1",2.13E+018,"testalpha"
,"australia canada new zealand","NNP NNP JJ NN",4,1,1,16770859,"pubmed1",4.39E+018,"testalpha"
,"st of december patients"," IN NN NNS",4,1,1,17139899,2,6.96E+018,"testalpha"
,"metabolic syndrome subjects hadat","JJ NN NNS NNP",4,1,1,16479027,2,5.27E+018,"testalpha"
,"scars directions of rotation","NNS NNS IN NN",4,1,1,17165597,2,6.44E+018,"testalpha"
,"induce transdifferentiation of fibroblasts","VB NN IN NNS",4,1,1,16395524,"pubmed1",8.04E+018,"testalpha"
,"interpreted mammograms containing clusteredmicrocalcifications","VBN NNS VBG NNS",4,1,1,16399036,"pubmed1",2.25E+018,"testalpha"
,"psoriatic drugs betamethasone calcipotriol","JJ NNS NN ",4,1,1,16874412,2,3.76E+018,"testalpha"
,"angstroms by molecular replacement","NNS IN JJ NN",4,1,1,16421443,2,2.29E+018,"testalpha"
,"energy balance body function","NN NN NN NN",4,1,1,16918067,"pubmed1",8.05E+018,"testalpha"
,"testing after night shifts","NN IN NN NNS",4,1,1,16436796,"pubmed1",6.11E+018,"testalpha"
,"volume or pressure limits","NN CC NN NNS",4,1,1,16451155,"pubmed1",7.63E+017,"testalpha"
,"cell types i e","NN NNS  ",4,1,1,16770441,"pubmed1",4.42E+018,"testalpha"
,"mathematical treatment of radiation","JJ NN IN NN",4,1,1,16369098,2,5.07E+018,"testalpha"
,"hypoxemia and lactic acidosis","NN CC JJ NN",4,1,1,16673614,2,3.18E+018,"testalpha"
,"validate thisclinical risk assessment","VB JJ NN NN",4,1,1,17236637,"pubmed1",7.54E+018,"testalpha"
,"bfs degree of vinyl"," NN IN NN",4,1,1,16701862,"pubmed1",8.54E+018,"testalpha"
,"mechanisms in signal transductions","NNS IN NN NNS",4,1,1,17016035,2,2.28E+018,"testalpha"
,"cells in transient mcao","NNS IN NN ",4,1,1,17265691,2,8.46E+018,"testalpha"
,"antigen in normal ejaculatedspermatozoa","NN IN JJ ",4,1,1,16919708,2,9.12E+018,"testalpha"
,"dilute iodinatedsolution di n","VB NN  ",4,1,1,16252139,"pubmed1",2.17E+018,"testalpha"
,"complexes ofac thr glu","NNS   ",4,1,1,17117212,"pubmed1",5.28E+018,"testalpha"
,"defects or aesthetic body","NNS CC JJ NN",4,1,1,17294911,2,7.86E+018,"testalpha"
,"presence ofits corepressor arginine","NN NNS NN NN",4,1,1,16511254,2,1.10E+018,"testalpha"
,"bcr abl gene variant","   NN",4,1,1,16914906,2,1.77E+018,"testalpha"
,"dimericcontrast agent in electron","JJS NN IN NN",4,1,1,16399037,"pubmed1",8.89E+018,"testalpha"
,"mtt test microscopic observation"," NN NN NN",4,1,1,16951739,"pubmed1",3.85E+018,"testalpha"
,"tuberculosis patients with aplacebo","NN NNS IN ",4,1,1,16479024,2,2.73E+018,"testalpha"
,"contraindications for salvage surgery","NNS IN NN NN",4,1,1,17139900,2,5.85E+018,"testalpha"
,"theinterpretation of test reactions","NN IN NN NNS",4,1,1,16874422,2,5.73E+018,"testalpha"
,"myocardium alongwith continuous measurements","NN NN JJ NNS",4,1,1,16451157,"pubmed1",7.11E+018,"testalpha"
,"novelty with increased timespent","NN IN VBN NN",4,1,1,17133955,2,7.86E+017,"testalpha"
,"family skillsinto existing programs","NN NNP VBG NNS",4,1,1,16473998,"pubmed1",7.79E+018,"testalpha"
,"dialectical behavior therapy dbt","JJ NN NN ",4,1,1,16473997,"pubmed1",2.55E+018,"testalpha"
,"crashes are necessary inorder","NNS VBP JJ NN",4,1,1,16126153,"pubmed1",9.01E+018,"testalpha"
,"complete unilateral cleft lip","JJ JJ NN NN",4,1,1,16722348,2,4.12E+017,"testalpha"
,"level malignancy abdominal surgery","NN NN JJ NN",4,1,1,16451146,"pubmed1",6.77E+018,"testalpha"
,"tools for genetic modification","NNS IN JJ NN",4,1,1,17160143,"pubmed1",3.42E+018,"testalpha"
,"centralfeatures include obesity hyperinsulinemia","NNS VBP NN NN",4,1,1,17013519,2,6.51E+018,"testalpha"
,"illumination using anumeric rating","NN VBG JJ NN",4,1,1,16955184,2,8.35E+018,"testalpha"
,"nitric oxide synthase enos","JJ VB NN ",4,1,1,16762404,2,4.22E+018,"testalpha"
,"pain induced byphotodynamic therapy","NN VBN JJ NN",4,1,1,16955184,2,8.27E+018,"testalpha"
,"new cases of colorectal","JJ NNS IN NN",4,1,1,17139892,2,6.01E+018,"testalpha"
,"pk activation hepatic glutathione"," NN JJ NN",4,1,1,17013507,2,4.57E+018,"testalpha"
,"atoms cis with respect","NNS  IN NN",4,1,1,16397330,2,1.94E+018,"testalpha"
,"good x ray sources","JJ NN  NNS",4,1,1,16369095,2,8.71E+018,"testalpha"
,"estimated using life table","VBN VBG NN NN",4,1,1,16451146,"pubmed1",7.82E+018,"testalpha"
,"toluidine blue abt reaction","NN JJ  NN",4,1,1,16714048,2,2.20E+018,"testalpha"
,"reviewed generalemergency medicine em","VBD NN NN ",4,1,1,16365335,"pubmed1",1.04E+018,"testalpha"
,"microscopy findings confirm earlierobservations"," NNS VBP NNS",4,1,1,16874415,2,5.02E+018,"testalpha"
,"group with similar unit","NN IN JJ NN",4,1,1,16511254,2,6.74E+018,"testalpha"
,"fluid and electrolyte balance","NN CC NNP NN",4,1,1,16462411,"pubmed1",5.72E+018,"testalpha"
,"dermatophytesequence was obtained t","NN VBD VBN ",4,1,1,16710579,2,8.00E+018,"testalpha"
,"education and job satisfaction","NN CC NN NN",4,1,1,16377823,"pubmed1",5.23E+017,"testalpha"
,"digene gaithersburg maryland u","NN NNP NN ",4,1,1,16514835,2,5.45E+018,"testalpha"
,"gst activity in cancer"," NN IN NN",4,1,1,16404476,"pubmed1",8.53E+018,"testalpha"
,"c h o interactions","NN   NNS",4,1,1,16456295,2,7.47E+018,"testalpha"
,"symptomssuch as decreased cell","NN IN VBD NN",4,1,1,16951739,"pubmed1",3.60E+018,"testalpha"
,"education and screening program","NN CC NN NN",4,1,1,16596901,"pubmed1",1.83E+018,"testalpha"
,"concentrated phase and tc","VBN NN CC ",4,1,1,17285745,"pubmed1",4.98E+018,"testalpha"
,"series of plasma donors","NN IN NNP NNS",4,1,1,16956121,2,3.67E+018,"testalpha"
,"tothe second calcium ion","NNP JJ NN ",4,1,1,16511247,2,2.86E+018,"testalpha"
,"overview of important issues","NN IN JJ NNS",4,1,1,16473991,"pubmed1",2.90E+018,"testalpha"
,"usp org aboutusp resolutions","   NNS",4,1,1,17285738,"pubmed1",3.81E+018,"testalpha"
,"malva branca on liver"," NNP IN NN",4,1,1,17013511,2,4.25E+018,"testalpha"
,"selected patients with pc","VBN NNS IN ",4,1,1,17139879,2,4.07E+018,"testalpha"
,"recurrence and side effectsof","NN CC NN ",4,1,1,16612915,"pubmed1",4.51E+018,"testalpha"
,"use ofcentral venous lines","NN JJ JJ NNS",4,1,1,16549897,2,2.94E+018,"testalpha"
,"roentgenograms by triage nurses","NNS IN NN NNS",4,1,1,16436790,"pubmed1",4.96E+018,"testalpha"
,"signs ofactivation of caspase","NNS NN IN NN",4,1,1,16956122,2,8.51E+018,"testalpha"
,"military personnel during peacetime","JJ NNS IN NN",4,1,1,16405857,"pubmed1",8.57E+018,"testalpha"
,"depth by massive technologies","NN IN JJ NNS",4,1,1,16914901,2,5.57E+018,"testalpha"
,"components of themediterranean diet","NNS IN JJ NN",4,1,1,16696439,2,8.22E+018,"testalpha"
,"withlower motorcyclist fatality rates","NN NN NN NNS",4,1,1,16202466,"pubmed1",6.53E+017,"testalpha"
,"lost fromthe epidermal surface","VBD NNP JJ NN",4,1,1,16733064,2,8.13E+018,"testalpha"
,"ie following ami pretreatment"," VBG  NN",4,1,1,16594642,"pubmed1",7.01E+018,"testalpha"
,"substratepool for nucleic acids","NN IN JJ NNS",4,1,1,16770441,"pubmed1",6.59E+018,"testalpha"
,"sources are umbilical cord","NNS VBP JJ NN",4,1,1,17269167,2,9.05E+018,"testalpha"
,"smears with normal n","NNS IN JJ ",4,1,1,17019439,"pubmed1",8.16E+018,"testalpha"
,"subsequent phases of neutropenia","JJ NNS IN NNP",4,1,1,16918066,"pubmed1",7.67E+018,"testalpha"
,"structures of drug targets","NNS IN NN NNS",4,1,1,16369099,2,3.83E+018,"testalpha"
,"developed recurrent severe life","VBD NN JJ NN",4,1,1,16673613,2,2.83E+018,"testalpha"
,"primaryanastomosis and colo rectal","NN CC  NN",4,1,1,17139896,2,3.95E+018,"testalpha"
,"celllines hl and k","NNS  CC ",4,1,1,16424655,2,4.99E+017,"testalpha"
,"leukocyte count in sepsis","NNP NN IN NN",4,1,1,17293958,2,3.93E+018,"testalpha"
,"distal common bile duct","NN JJ NN ",4,1,1,16333694,"pubmed1",5.38E+018,"testalpha"
,"innovative court based intervention","JJ NN VBN NN",4,1,1,16202465,"pubmed1",2.08E+017,"testalpha"
,"potential advantages over pet","JJ NNS IN NN",4,1,1,16333707,"pubmed1",2.09E+017,"testalpha"
,"oral form containing ferroglycine","JJ NN VBG NN",4,1,1,16809890,2,7.54E+018,"testalpha"
,"period advanced life support","NN VBD NN NN",4,1,1,16491215,2,1.58E+018,"testalpha"
,"libraries mitochondrion derived tags","NNS NN VBN NNS",4,1,1,16496041,"pubmed1",2.14E+018,"testalpha"
,"age standardised incidence rates","NN VBN NN NNS",4,1,1,16111641,"pubmed1",3.38E+018,"testalpha"
,"withlaser high insensitive nd","NN JJ JJ ",4,1,1,17293968,2,6.60E+018,"testalpha"
,"strand complemented variant ofcfae","NN VBN NN ",4,1,1,16511280,2,4.47E+018,"testalpha"
,"piece of glass n","NN IN NN ",4,1,1,16412373,"pubmed1",2.66E+018,"testalpha"
,"skin and inner ear","NN CC JJ NN",4,1,1,17106596,2,5.88E+018,"testalpha"
,"phaser revealing extensive pseudosymmetry","NN VBG JJ NN",4,1,1,16421452,2,6.98E+018,"testalpha"
,"low hdl cholesterol level","JJ  NN NN",4,1,1,16479026,2,5.20E+018,"testalpha"
,"mixed lymphocyte tumor cultures","VBN NNP NN NNS",4,1,1,17117211,"pubmed1",1.15E+018,"testalpha"
,"sample studies involving thinprep","NN NNS VBG ",4,1,1,16514841,2,3.86E+018,"testalpha"
,"planus graft versus host","NN NN IN NN",4,1,1,17311739,2,8.74E+018,"testalpha"
,"initial clinical diagnosis ofhistiocytomas","JJ JJ NN NNP",4,1,1,16874423,2,7.60E+018,"testalpha"
,"crypt cell population pnx","NN NN NN ",4,1,1,16491217,2,6.04E+017,"testalpha"
,"missed diagnosis conclusions radiograph","VBD NN NNS NN",4,1,1,16436791,"pubmed1",4.33E+018,"testalpha"
,"damage in white blood","NN IN JJ NN",4,1,1,16582984,"pubmed1",4.41E+018,"testalpha"
,"improvement nutritional status sputumconversion","NN JJ NN NN",4,1,1,16479024,2,8.08E+018,"testalpha"
,"combination ofprednisone and dapsone","NN NN CC NN",4,1,1,16955192,2,6.25E+017,"testalpha"
,"cytologic features in cases","JJ NNS IN NNS",4,1,1,16514838,2,8.31E+018,"testalpha"
,"efficacy and better patientcompliance","NN CC JJR NN",4,1,1,16584139,"pubmed1",8.65E+018,"testalpha"
,"invasion and extensive tumor","NN CC JJ NN",4,1,1,16314992,"pubmed1",2.00E+018,"testalpha"
,"inalbino rats revealed increase","NNP NNS VBD NN",4,1,1,17285742,"pubmed1",5.65E+018,"testalpha"
,"parallel artificial membrane permeability","JJ JJ NN NN",4,1,1,16584115,"pubmed1",1.94E+018,"testalpha"
,"identification of base pair","NN IN NN NN",4,1,1,16733554,"pubmed1",4.84E+018,"testalpha"
,"genetic engineering replication transcription","JJ NN NN NN",4,1,1,17347785,"pubmed1",1.03E+018,"testalpha"
,"group iii and group","NN  CC NN",4,1,1,16612918,"pubmed1",5.15E+018,"testalpha"
,"yearsurvival rates for patients","NN NNS IN NNS",4,1,1,17139879,2,6.03E+018,"testalpha"
,"containing oliveoil fish fruits","VBG NN NN NNS",4,1,1,16696439,2,6.61E+018,"testalpha"
,"aortic wall using anilino","JJ NN VBG NNP",4,1,1,16714053,2,2.41E+018,"testalpha"
,"fold in caucasian children","NN IN JJ NNS",4,1,1,16549894,2,4.73E+018,"testalpha"
,"activities are altered inblood","NNS VBP VBN NN",4,1,1,17160142,"pubmed1",4.86E+018,"testalpha"
,"lot of attention fromdental","NN IN NN NN",4,1,1,16696438,2,7.45E+018,"testalpha"
,"cell reactivity in patients","NN NN IN NNS",4,1,1,16511273,2,3.70E+017,"testalpha"
,"proposed algorithmfor breast lesion","VBN JJ NN NN",4,1,1,16399033,"pubmed1",1.12E+018,"testalpha"
,"enhanced computed tomography n","VBN VBN NN ",4,1,1,16333704,"pubmed1",2.79E+018,"testalpha"
,"thedifferences between tissue hydroxyproline","NNS IN NN NN",4,1,1,16612916,"pubmed1",3.39E+018,"testalpha"
,"r resectedpatients with colon","NN NNS IN NN",4,1,1,17139895,2,7.35E+018,"testalpha"
,"comparedstreet level advertisements slas","NNP NN NNS ",4,1,1,16427019,"pubmed1",5.02E+018,"testalpha"
,"beam apertures oscillation width","NN NNS NN NN",4,1,1,16369094,2,4.64E+018,"testalpha"
,"osseous palliative surgery transient","JJ JJ NN NN",4,1,1,17438833,2,8.49E+018,"testalpha"
,"deleterious effectsof x ray","JJ  NN ",4,1,1,16369092,2,1.11E+018,"testalpha"
,"typical immunophenotypecd cd fmc","JJ   ",4,1,1,16424654,2,2.07E+018,"testalpha"
,"generalrecommendations on antibiotic prophylaxis","NNS IN JJ ",4,1,1,16673611,2,6.50E+018,"testalpha"
,"cach induction in rat"," NN IN NN",4,1,1,16951743,"pubmed1",4.23E+018,"testalpha"
,"protein and high levels","NN CC JJ NNS",4,1,1,16496041,"pubmed1",8.27E+018,"testalpha"
,"differences between untreated cultures","NNS IN JJ NNS",4,1,1,16874415,2,4.98E+018,"testalpha"
,"proliferativeproperties in human epidermis","NNS IN JJ NN",4,1,1,16874412,2,6.31E+017,"testalpha"
,"study of fatal mvc","NN IN JJ ",4,1,1,16405857,"pubmed1",1.26E+018,"testalpha"
,"adhesion kinase p fak","NN NN  ",4,1,1,17106595,2,4.89E+018,"testalpha"
,"bloodclotting time calcium level","VBG NN NN NN",4,1,1,16479024,2,1.49E+018,"testalpha"
,"histiocytosis associatedwith mediastinal germ","NN NN JJ NN",4,1,1,16809892,2,6.26E+018,"testalpha"
,"food specific ige antibodies","NN JJ  NNS",4,1,1,16673562,2,7.87E+018,"testalpha"
,"proportions of psoriasis patients","NNS IN NN NNS",4,1,1,17106601,2,7.18E+018,"testalpha"
,"autosomal dominant skin disorder","JJ JJ NN NN",4,1,1,17311740,2,8.72E+017,"testalpha"
,"result of thecentral co","NN IN JJ ",4,1,1,16456276,2,3.56E+018,"testalpha"
,"subtotal colectomy with ira","NN NN IN ",4,1,1,17139890,2,2.17E+018,"testalpha"
,"therapy of various cutaneousdisorders","NN IN JJ NNS",4,1,1,16648912,2,4.81E+018,"testalpha"
,"tata and ccaat boxes"," CC  NNS",4,1,1,16951743,"pubmed1",4.92E+018,"testalpha"
,"containing timolol n metipranolol","VBG   ",4,1,1,17106597,2,3.99E+018,"testalpha"
,"term immunosuppressionprolong islet function","NN IN NN NN",4,1,1,16701881,"pubmed1",8.74E+018,"testalpha"
,"vs mmol l carvedilol","   ",4,1,1,17338197,2,7.87E+018,"testalpha"
,"arg tyr leupsi cn","  NNP ",4,1,1,16496037,"pubmed1",5.52E+018,"testalpha"
,"vegetative tumor measuring x","JJ NN VBG NN",4,1,1,16603102,2,7.99E+018,"testalpha"
,"jakarta from january st","NNP IN JJ ",4,1,1,16479024,2,6.55E+018,"testalpha"
,"essential step in theassessment","JJ NN IN NN",4,1,1,16673563,2,8.96E+017,"testalpha"
,"national formulary usp nf","JJ JJ  ",4,1,1,17285738,"pubmed1",8.80E+018,"testalpha"
,"malerat tibia and femur","NNP NNP CC ",4,1,1,16443258,2,7.74E+018,"testalpha"
,"l xaa l serinepeptides","   NNS",4,1,1,16397334,2,4.88E+018,"testalpha"
,"traffic safety measures basedon","NN NN NNS NNP",4,1,1,16406188,"pubmed1",2.10E+018,"testalpha"
,"ofprimordial germ cells pgc","JJ NN NNS ",4,1,1,17265694,2,8.67E+018,"testalpha"
,"screening newformulations of drug","NN NNS IN NN",4,1,1,16584164,"pubmed1",7.99E+018,"testalpha"
,"conventional times week haemodialysis","JJ NNS NN NN",4,1,1,17106603,2,2.78E+018,"testalpha"
,"major axes of cc","JJ NNS IN ",4,1,1,16399030,"pubmed1",7.75E+018,"testalpha"
,"test spt results serumconcentration","NN  NNS NN",4,1,1,16859611,2,8.50E+018,"testalpha"
,"hour urinary calcium excretion","NN JJ NN NN",4,1,1,16956119,2,6.93E+018,"testalpha"
,"infiltrationby trilineage extramedullary hematopoiesis"," NN JJ NN",4,1,1,17016039,2,5.83E+018,"testalpha"
,"process and perceptions ofthe","NN CC NNS NNP",4,1,1,16399040,"pubmed1",8.93E+018,"testalpha"
,"risk and thetotal fatalities","NN CC NN NNS",4,1,1,16061188,"pubmed1",6.61E+018,"testalpha"
,"affective disorder patients formutations","JJ NN NNS NNS",4,1,1,16733555,"pubmed1",7.85E+018,"testalpha"
,"total leukocytes neutrophils lymphocytes","JJ NNS NNS NNS",4,1,1,17293958,2,7.62E+018,"testalpha"
,"clinical efficiency and bed","JJ NN CC NN",4,1,1,16377816,"pubmed1",1.11E+017,"testalpha"
,"cytology findings of xanthomas","NN NNS IN NNP",4,1,1,16514844,2,5.55E+018,"testalpha"
,"combination therapy in children","NN NN IN NNS",4,1,1,16585987,2,2.97E+018,"testalpha"
,"injury prevention efforts methods","NN NN NNS NNS",4,1,1,16436798,"pubmed1",3.73E+018,"testalpha"
,"ofa major city hospital"," JJ NN NN",4,1,1,16330213,"pubmed1",5.90E+018,"testalpha"
,"apathogenic role in dress","JJ NN IN NN",4,1,1,16710584,2,2.67E+018,"testalpha"
,"nongenotoxic mechanisms for lymphomagenesis","JJ NNS IN NN",4,1,1,17016033,2,7.08E+018,"testalpha"
,"future studies such asthe","NN NNS JJ NNP",4,1,1,17016033,2,2.94E+018,"testalpha"
,"thediagnosis of retained stones","NN IN VBN NNS",4,1,1,16447096,"pubmed1",3.56E+018,"testalpha"
,"microns and wall thicknesses","NNS CC NN NNS",4,1,1,16701854,"pubmed1",9.10E+018,"testalpha"
,"resistance and colonicmucosal trophism","NN CC NN NN",4,1,1,17293972,2,2.61E+018,"testalpha"
,"patients experienced more application","NNS VBN JJR NN",4,1,1,16585986,2,3.50E+018,"testalpha"
,"induciblenitric oxide synthase inos","JJ VB NN ",4,1,1,16762404,2,4.98E+017,"testalpha"
,"expression of themitochondrial genome","NN IN JJ NN",4,1,1,16951738,"pubmed1",6.58E+018,"testalpha"
,"reconstruction of full thickness","NN IN JJ NN",4,1,1,17165594,2,1.20E+017,"testalpha"
,"oral bcr abltyrosine kinase","JJ  NN NN",4,1,1,16914906,2,6.79E+018,"testalpha"
,"asingle full scan acquisition","NN JJ VB NN",4,1,1,16399032,"pubmed1",5.01E+018,"testalpha"
,"proteins thatcan bind complement","NNS JJ NN NN",4,1,1,16964325,"pubmed1",5.36E+018,"testalpha"
,"outcome of stroke patients","NN IN NN NNS",4,1,1,16436794,"pubmed1",2.90E+018,"testalpha"
,"enhancementpatterns diffuse contrast enhancement","NNS IN NN NN",4,1,1,16333704,"pubmed1",2.20E+018,"testalpha"
,"effect on radiation inducedwound","NN IN NN NN",4,1,1,16612919,"pubmed1",1.25E+018,"testalpha"
,"l and l capsid"," CC  ",4,1,1,17010274,2,4.61E+018,"testalpha"
,"administration of l carnitine","NN IN  NN",4,1,1,16424656,2,3.36E+017,"testalpha"
,"ng ml at intubation","  IN NN",4,1,1,17067138,"pubmed1",4.05E+018,"testalpha"
,"patch testing positive sites","NN NN JJ NNS",4,1,1,16648919,2,1.37E+018,"testalpha"
,"pulmonary aspergillosis caused byaspergillus","JJ NN VBN NN",4,1,1,17370567,"pubmed1",7.60E+018,"testalpha"
,"immunoreactive nuclei per section","JJ  IN NN",4,1,1,17007911,2,7.45E+017,"testalpha"
,"enhancement preand postcontrast images","NN NN JJS NNS",4,1,1,16399029,"pubmed1",9.03E+018,"testalpha"
,"comparative analysis of tssr","JJ NN IN ",4,1,1,16733558,"pubmed1",6.12E+018,"testalpha"
,"origin of thyroid gland","NN IN NN NN",4,1,1,16514836,2,7.62E+018,"testalpha"
,"cancer colon cell line","NN NN NN NN",4,1,1,16414103,2,6.21E+018,"testalpha"
,"medicaleducation duty hour limitations","NN NN NN NNS",4,1,1,16377825,"pubmed1",8.79E+018,"testalpha"
,"future studies of duty","NN NNS IN NN",4,1,1,16377820,"pubmed1",8.19E+018,"testalpha"
,"acid dihydroxyanthraquinone dihydroxyanthraquinone dihydroxyanthraquinone","NN NN NN NN",4,1,1,16404478,"pubmed1",7.12E+018,"testalpha"
,"andsupramolecular chemistry of trivalent","JJ NN IN NN",4,1,1,16411740,"pubmed1",7.26E+018,"testalpha"
,"prostatic acid phosphatase structureas","JJ NN NN NNS",4,1,1,16511256,2,6.62E+018,"testalpha"
,"testis on postoperation day","NN IN NN NN",4,1,1,16395525,"pubmed1",4.35E+018,"testalpha"
,"based pan coating process","VBN NN NN NN",4,1,1,17285748,"pubmed1",4.34E+018,"testalpha"
,"using high pressure homogenization","VBG JJ NN NN",4,1,1,17285742,"pubmed1",8.32E+018,"testalpha"
,"range of spatial scales","NN IN JJ NNS",4,1,1,16823606,"pubmed1",2.35E+018,"testalpha"
,"glutamate receptors and nmda","NN NNS CC ",4,1,1,17265692,2,5.36E+018,"testalpha"
,"cause of morbidity andmortality","NN IN NN NN",4,1,1,16412373,"pubmed1",3.11E+018,"testalpha"
,"blood mononuclear cells pbmcs","NN JJ NNS ",4,1,1,16710577,2,9.14E+018,"testalpha"
,"identify high risk drivers","VB JJ NN NNS",4,1,1,16405858,"pubmed1",3.18E+018,"testalpha"
,"mean age was year","VB NN VBD NN",4,1,1,17139879,2,5.30E+018,"testalpha"
,"normalactivity of cytochrome c","NN IN NN NN",4,1,1,16951738,"pubmed1",2.13E+018,"testalpha"
,"defined volume of interest","VBN NN IN NN",4,1,1,16399031,"pubmed1",4.91E+018,"testalpha"
,"infarctionsand ischemic cerebrovascular accidents","NN JJ JJ NNS",4,1,1,16914907,2,3.08E+018,"testalpha"
,"multicentric involvement of bone","JJ NN IN NN",4,1,1,16514850,2,3.54E+018,"testalpha"
,"screening ph adjusted formulations","NN  VBN NNS",4,1,1,16584164,"pubmed1",7.91E+018,"testalpha"
,"option and promising results","NN CC JJ NNS",4,1,1,16710582,2,2.54E+018,"testalpha"
,"option for palmoplantar psoriasis","NN IN NN NN",4,1,1,16585984,2,5.77E+018,"testalpha"
,"research group icdrg rules","NN NN  NNS",4,1,1,17010264,2,8.61E+018,"testalpha"
,"younger faculty raise concerns","JJR NN VB NNS",4,1,1,16377815,"pubmed1",2.31E+018,"testalpha"
,"governmental industrial hygienists www","JJ JJ NNS ",4,1,1,16438095,"pubmed1",9.98E+017,"testalpha"
,"including hypoglycemicand hyperglycemic episodes","VBG NN JJ NNS",4,1,1,16918068,"pubmed1",5.70E+018,"testalpha"
,"reactions against amphotericin b","NNS IN NNP NN",4,1,1,17370567,"pubmed1",5.62E+017,"testalpha"
,"lower degree of aggregation","JJR NN IN NN",4,1,1,16511282,2,4.19E+018,"testalpha"
,"onsquare planar platinum ii","NN NN NN ",4,1,1,16397333,2,1.07E+018,"testalpha"
,"bis gma tegdma resin","  NN NNP",4,1,1,16701856,"pubmed1",1.51E+018,"testalpha"
,"rate without adding toxicity","NN IN VBG NN",4,1,1,16424645,2,4.40E+018,"testalpha"
,"percentage of pasi improvement","NN IN  NN",4,1,1,17311738,2,2.05E+017,"testalpha"
,"direct methods using theprogram","JJ NNS VBG NN",4,1,1,16421448,2,3.16E+018,"testalpha"
,"time of thecrash ci","NN IN NN ",4,1,1,16043107,"pubmed1",9.18E+018,"testalpha"
,"type acute lymphoblastic leukemia","NN JJ JJ NN",4,1,1,16918064,"pubmed1",8.46E+018,"testalpha"
,"treatment for actinic keratosis","NN IN JJ NN",4,1,1,16955183,2,8.79E+018,"testalpha"
,"nad p h quinoneoxidoreductase","   NN",4,1,1,16929382,"pubmed1",3.39E+018,"testalpha"
,"micrometastases werepresent complete lymphadenectomy","NNS NN JJ NN",4,1,1,16491216,2,5.06E+018,"testalpha"
,"national health and development","JJ NN CC NN",4,1,1,16412373,"pubmed1",4.84E+018,"testalpha"
,"baselineinformation on school injuries","NN IN NN NNS",4,1,1,16236234,"pubmed1",6.57E+018,"testalpha"
,"average length of hospital","JJ NN IN NN",4,1,1,16956118,2,4.08E+018,"testalpha"
,"colonicmucosal trophism in rats","NN NN IN NNS",4,1,1,17293972,2,2.63E+018,"testalpha"
,"fragments ofthe initial model","NNS NNP JJ NN",4,1,1,16421450,2,8.59E+018,"testalpha"
,"encapsulated min beta cells","VBN  NN NNS",4,1,1,16701853,"pubmed1",8.37E+018,"testalpha"
,"arteriography andpercutaneous transhepatic liver","NN JJ JJ NN",4,1,1,16447097,"pubmed1",8.21E+018,"testalpha"
,"consecutivepregnant women with anemia","JJ NNS IN NN",4,1,1,17119327,2,8.63E+018,"testalpha"
,"hepaticglycogen gh pyruvate kinase","NN  NN NN",4,1,1,17013507,2,6.83E+017,"testalpha"
,"immune deficiency and hepatotoxicity","JJ NN CC NN",4,1,1,17265697,2,2.75E+018,"testalpha"
,"treatment of rectal cancer","NN IN NN NN",4,1,1,16612911,2,1.11E+018,"testalpha"
,"synchrotron x ray studies","NNP NN  NNS",4,1,1,16456276,2,7.74E+018,"testalpha"
,"substitution of ferric heme","NN IN JJ ",4,1,1,16421446,2,8.61E+018,"testalpha"
,"andxenogeneic biological skin grafts","JJ JJ NN NNS",4,1,1,16999268,2,7.99E+018,"testalpha"
,"averageannual motor vehicle crash","JJ NN NN NN",4,1,1,16139232,"pubmed1",6.14E+018,"testalpha"
,"same period considerable strides","JJ NN JJ NNS",4,1,1,16596744,"pubmed1",2.20E+018,"testalpha"
,"cryosections brain kidney heart","NNS NN NN NN",4,1,1,16950501,2,2.19E+018,"testalpha"
,"cells overexpression of ppargamma","NNS NN IN NN",4,1,1,16395520,"pubmed1",3.08E+018,"testalpha"
,"situation following extensive haemorrhage","NN VBG JJ NN",4,1,1,16612920,"pubmed1",1.25E+018,"testalpha"
,"nh and h tyr"," CC  ",4,1,1,16496038,"pubmed1",8.57E+017,"testalpha"
,"thechest tube upon thoracostomy","NN NN IN NN",4,1,1,16365333,"pubmed1",3.09E+018,"testalpha"
,"structure solution and refinement","NN NN CC NN",4,1,1,16369097,2,3.78E+018,"testalpha"
,"discovered bycrystallization and x","VBD NN CC NN",4,1,1,16511265,2,3.75E+018,"testalpha"
,"prior history of cancer","JJ NN IN NN",4,1,1,16514846,2,6.54E+018,"testalpha"
,"establishments in ontario canada","NNS IN NNP NNP",4,1,1,16169506,"pubmed1",1.35E+018,"testalpha"
,"components of chronic kidney","NNS IN JJ NN",4,1,1,17160142,"pubmed1",4.08E+018,"testalpha"
,"anion via o h","NN IN  ",4,1,1,16456283,2,4.58E+018,"testalpha"
,"excessive deposition of collagen","JJ NN IN NN",4,1,1,16874413,2,5.99E+018,"testalpha"
,"mutation and childrenwith ais","NN CC NN ",4,1,1,16549893,2,4.02E+018,"testalpha"
,"inducibletranscription factor c fos","NN NN NN ",4,1,1,17007911,2,4.96E+017,"testalpha"
,"sumatriptan microemulsions sme sumatriptan","NNP NNS  NNP",4,1,1,16584167,"pubmed1",8.89E+018,"testalpha"
,"genetic code vector space","JJ NN NN NN",4,1,1,16823609,"pubmed1",6.77E+018,"testalpha"
,"development of amyloid tumors","NN IN VB NNS",4,1,1,16714048,2,1.12E+018,"testalpha"
,"victims of road traffic","NNS IN NN NN",4,1,1,16956123,2,280790484461108,"testalpha"
,"profile metabolicabnormality and immunostatus","NN NN CC NN",4,1,1,16710576,2,5.28E+018,"testalpha"
,"limit of cell divisions","NN IN NN NNS",4,1,1,17106513,"pubmed1",8.23E+018,"testalpha"
,"patients with suspected appendicitis","NNS IN VBN NN",4,1,1,16612913,"pubmed1",6.78E+018,"testalpha"
,"duct with frequent contrast"," IN JJ NN",4,1,1,16333694,"pubmed1",3.75E+017,"testalpha"
,"nmda glutamate receptor antagonist"," NN NN NN",4,1,1,17133953,2,4.05E+017,"testalpha"
,"mechanical properties ofamorphous calcium","JJ NNS JJ NN",4,1,1,16701862,"pubmed1",6.01E+018,"testalpha"
,"further interactions ofolder females","JJ NNS NN NNS",4,1,1,16197912,"pubmed1",5.64E+018,"testalpha"
,"efficiency lower thermal stabilityand","NN JJR JJ NN",4,1,1,16511268,2,2.04E+018,"testalpha"
,"asa i and ii","  CC ",4,1,1,17236635,"pubmed1",4.61E+018,"testalpha"
,"research laboratory test vdrl","NN NN NN ",4,1,1,16874420,2,5.84E+018,"testalpha"
,"normal animals treatedwith mhz","JJ NNS NN ",4,1,1,17293959,2,7.07E+018,"testalpha"
,"loss of hand movement","NN IN NN NN",4,1,1,17236636,"pubmed1",8.58E+018,"testalpha"
,"mtm vial heattransfer coefficients","  VB NNS",4,1,1,17285746,"pubmed1",9.90E+017,"testalpha"
,"infarcted transgenic mouse model","VBN JJ NN NN",4,1,1,17014894,2,2.76E+018,"testalpha"
,"low molecular weight heparins","JJ JJ NN NNS",4,1,1,16549901,2,9.22E+018,"testalpha"
,"significance of road accidentcauses","NN IN NN NNS",4,1,1,16191426,"pubmed1",2.53E+018,"testalpha"
,"dex mg kg day","   NN",4,1,1,17133953,2,3.83E+017,"testalpha"
,"crucial role inthe control","JJ NN NNP NN",4,1,1,16770444,"pubmed1",1.44E+018,"testalpha"
,"treatment of basal cellcarcinomas","NN IN NN NNP",4,1,1,17165596,2,3.62E+018,"testalpha"
,"colorectal and gastric tumors","NN CC JJ NNS",4,1,1,16430945,2,2.88E+018,"testalpha"
,"tissue glue tissucol duo","NN NN NN ",4,1,1,16696446,2,6.88E+018,"testalpha"
,"food allergies in children","NN NNS IN NNS",4,1,1,17438830,2,7.75E+018,"testalpha"
,"di mu acetato kappao","  NN ",4,1,1,16456276,2,3.08E+018,"testalpha"
,"resorbable bis gma tegdma","JJ   NN",4,1,1,16701856,"pubmed1",3.43E+018,"testalpha"
,"observed betweenatoms h oglc","VBN NNS  ",4,1,1,16456293,2,3.57E+018,"testalpha"
,"discipline and medical school","NN CC JJ NN",4,1,1,16377815,"pubmed1",9.02E+018,"testalpha"
,"changes in respiratory rate","NNS IN NN NN",4,1,1,17133957,2,5.82E+018,"testalpha"
,"cholesterol and phospholipids glycoproteins","NN CC NNS NNS",4,1,1,16523217,"pubmed1",1.93E+018,"testalpha"
,"rare malignant sweat gland","JJ JJ NN NN",4,1,1,16612934,"pubmed1",1.81E+018,"testalpha"
,"specific hydroxyacid dehydrogenase family","JJ NN NN NN",4,1,1,16511285,2,2.07E+018,"testalpha"
,"intensity ofpruritus visual analogue","NN NN JJ NN",4,1,1,16874418,2,1.09E+018,"testalpha"
,"folds deformedileocecal junction mass","NNS JJ NN NN",4,1,1,16447095,"pubmed1",9.22E+018,"testalpha"
,"lead identification and optimizationprogram","NN NN CC NN",4,1,1,16511290,2,7.87E+018,"testalpha"
,"necessitating effectiveantithrombotic treatment regimens","VBG JJ NN NNS",4,1,1,16549901,2,8.56E+018,"testalpha"
,"resource use and costs","NN NN CC NNS",4,1,1,16451154,"pubmed1",4.45E+018,"testalpha"
,"age fluorescence in lenses","NN NN IN NNS",4,1,1,16696441,2,4.09E+018,"testalpha"
,"showed mean particle size","VBD VB NN NN",4,1,1,17285742,"pubmed1",5.07E+018,"testalpha"
,"chains consecutive anion cation","NNS JJ NN NN",4,1,1,16456289,2,3.69E+018,"testalpha"
,"disorders therelation with symptoms","NNS NN IN NNS",4,1,1,17338194,2,6.15E+018,"testalpha"
,"failure patients reduced length","NN NNS VBD NN",4,1,1,16377816,"pubmed1",2.07E+018,"testalpha"
,"loss inmale sprague dawley","NN NN NN NNP",4,1,1,16762404,2,2.85E+018,"testalpha"
,"patients experience angioedema fromangiotensin","NNS NN NN NNP",4,1,1,16451161,"pubmed1",7.89E+018,"testalpha"
,"slighthepatic protection at mg","JJ NN IN ",4,1,1,17013510,2,4.77E+018,"testalpha"
,"attention of passing drivers","NN IN VBG NNS",4,1,1,16427019,"pubmed1",4.15E+018,"testalpha"
,"place in various compartments","NN IN JJ NNS",4,1,1,16770441,"pubmed1",6.28E+018,"testalpha"
,"cora from archaeoglobusfulgidus afcora"," IN NN NNP",4,1,1,16511288,2,9.00E+018,"testalpha"
,"provoked angioedema shares many","VBD NN NNS NN",4,1,1,16451161,"pubmed1",6.53E+018,"testalpha"
,"permanganate bisulfite toluidine pbt","NN JJ NN ",4,1,1,16714053,2,3.74E+017,"testalpha"
,"medical conditions and crash","JJ NNS CC NN",4,1,1,16054104,"pubmed1",6.29E+018,"testalpha"
,"cause of death inalcoholics","NN IN NN NNS",4,1,1,16859619,2,2.66E+017,"testalpha"
,"ranges in dio titles","NNS IN  NNS",4,1,1,16377812,"pubmed1",4.27E+018,"testalpha"
,"tumors such asmedullary thyroid","NNS JJ JJ NN",4,1,1,16514846,2,3.21E+018,"testalpha"
,"surface area burns survivors","NN NN NNS NNS",4,1,1,17165599,2,5.67E+018,"testalpha"
,"cells cannevertheless destroy hair","NNS NN VB NN",4,1,1,16983449,2,2.59E+018,"testalpha"
,"dsk and rad function"," CC  NN",4,1,1,16421449,2,8.68E+018,"testalpha"
,"conclusions intralipid treatment prolongssurvival","NNS JJ NN NN",4,1,1,16436797,"pubmed1",6.13E+018,"testalpha"
,"threat of global importance","NN IN JJ NN",4,1,1,16511280,2,2.78E+018,"testalpha"
,"control n with azoxymethaneadministration","NN  IN NN",4,1,1,17293962,2,2.59E+018,"testalpha"
,"influences health promoting practicessuch","NNS NN VBG NN",4,1,1,16596899,"pubmed1",1.88E+018,"testalpha"
,"subcutaneous desferrioxamine minimal liver","JJ NN JJ NN",4,1,1,16424659,2,1.45E+018,"testalpha"
,"establish normal tissue hemodynamics","VB JJ NN NNS",4,1,1,16762404,2,7.82E+018,"testalpha"
,"frompolyacrylic acid tartaric acid","JJ NN JJ NN",4,1,1,16701865,"pubmed1",2.42E+018,"testalpha"
,"yielded sensitivity and specificity","VBD NN CC NN",4,1,1,16399036,"pubmed1",4.38E+018,"testalpha"
,"health and stress profile","NN CC NN NN",4,1,1,16451152,"pubmed1",5.25E+018,"testalpha"
,"involving vehicles with uslicence","VBG NNS IN NN",4,1,1,16169506,"pubmed1",2.26E+018,"testalpha"
,"students gave asubjective evaluation","NNS VBD JJ NN",4,1,1,16451149,"pubmed1",5.19E+018,"testalpha"
,"stage of structure analysis","NN IN NN NN",4,1,1,16369097,2,8.15E+018,"testalpha"
,"determination by direct methods","NN IN JJ NNS",4,1,1,16421448,2,2.21E+018,"testalpha"
,"cpt vigilance complex task"," NN JJ NN",4,1,1,16479025,2,8.82E+018,"testalpha"
,"geneexpression in ins cells","NN IN  NNS",4,1,1,16395520,"pubmed1",5.34E+018,"testalpha"
,"modality employing nm uvb","NN VBG  ",4,1,1,16585984,2,7.68E+018,"testalpha"
,"increasing numbers of researchstudies","VBG NNS IN NNS",4,1,1,16770858,"pubmed1",6.83E+017,"testalpha"
,"were identified byhybridization analysis","VBD VBN NN NN",4,1,1,16365637,"pubmed1",8.00E+018,"testalpha"
,"silence or activate transcription","NN CC NN NN",4,1,1,16582985,"pubmed1",6.12E+018,"testalpha"
,"much volume of gas","NN NN IN NN",4,1,1,16491219,2,3.89E+018,"testalpha"
,"alcohol involved crash rates","NN VBD NN NNS",4,1,1,16423318,"pubmed1",4.54E+018,"testalpha"
,"more risk factors werepresent","JJR NN NNS NN",4,1,1,17338203,2,6.52E+018,"testalpha"
,"betab suggesting asubstantial function"," VBG JJ NN",4,1,1,16423381,2,7.90E+018,"testalpha"
,"extent by stabilized hsa","NN IN VBN ",4,1,1,17285745,"pubmed1",8.08E+018,"testalpha"
,"constitutional elevated plasmafactor viii","JJ VBN NN ",4,1,1,16673613,2,6.54E+018,"testalpha"
,"earlystage of microscopic polyangiitis","NN IN NN NN",4,1,1,16648918,2,8.65E+018,"testalpha"
,"solitary metastasesare pelvis liver","JJ NN NNP NN",4,1,1,17139900,2,3.15E+018,"testalpha"
,"kg min for minutes","  IN NNS",4,1,1,17067137,"pubmed1",6.43E+018,"testalpha"
,"microwave dried gel exhibitedantacid","NN VBD  NN",4,1,1,16584168,"pubmed1",4.26E+018,"testalpha"
,"use dosage and time","NN NN CC NN",4,1,1,16574202,2,3.92E+018,"testalpha"
,"tapered narrowing of thedistal","VBN NN IN NN",4,1,1,16333694,"pubmed1",7.07E+018,"testalpha"
,"diseaseand locoregional lymph node","NN JJ NN ",4,1,1,16673556,2,1.86E+018,"testalpha"
,"responders and public health","NNS CC JJ NN",4,1,1,16696436,2,3.00E+017,"testalpha"
,"large dermatological hospital initaly","JJ JJ NN NNP",4,1,1,17106601,2,6.18E+018,"testalpha"
,"afterthe intravenous iron therapy","NNP JJ NN NN",4,1,1,16809890,2,4.31E+017,"testalpha"
,"computerizedtomography sct in patients","NN  IN NNS",4,1,1,16612913,"pubmed1",6.12E+018,"testalpha"
,"andcauses of death registry","NNS IN NN NN",4,1,1,16710578,2,4.31E+018,"testalpha"
,"thecumulative rate of oxygen","JJ NN IN NN",4,1,1,16365337,"pubmed1",5.56E+018,"testalpha"
,"kinase catalytic subunit dna","NN JJ JJ ",4,1,1,16404475,"pubmed1",6.41E+018,"testalpha"
,"undergone surgery for nasalpolyposis","VBN NN IN NN",4,1,1,17370567,"pubmed1",9.52E+017,"testalpha"
,"serum pro inflammatory cytokines","NN JJ JJ NNS",4,1,1,17293958,2,2.44E+018,"testalpha"
,"peroxidation after hepatic ischemia","NN IN JJ NN",4,1,1,17013507,2,7.33E+018,"testalpha"
,"ac thr glu thr","   ",4,1,1,17117212,"pubmed1",8.18E+018,"testalpha"
,"beta erythroidine ic nmol","NN NN JJ ",4,1,1,16594645,"pubmed1",2.80E+018,"testalpha"
,"kinase c pkc activity","NN NN  NN",4,1,1,17016035,2,6.11E+018,"testalpha"
,"primary genital herpes oro","JJ NN NNS ",4,1,1,16648915,2,6.86E+018,"testalpha"
,"outcome of thai cml","NN IN  ",4,1,1,16914906,2,2.22E+018,"testalpha"
,"pu m pu rprimers","   NNS",4,1,1,17019439,"pubmed1",7.46E+018,"testalpha"
,"broadened themain phase transition","VBD VB NN NN",4,1,1,16964324,"pubmed1",2.89E+018,"testalpha"
,"dual lox lipoxygenase cox","JJ  NN ",4,1,1,16456296,2,7.64E+018,"testalpha"
,"variable association ofsystemic involvement","JJ NN JJ NN",4,1,1,16710585,2,2.16E+018,"testalpha"
,"shouldinclude assessment and prevention","VB NN CC NN",4,1,1,16412373,"pubmed1",4.15E+018,"testalpha"
,"simple statistical potentials andknowledge","JJ JJ NNS NN",4,1,1,16365636,"pubmed1",1.99E+018,"testalpha"
,"compared withthe cytologic diagnoses","VBN NNP JJ NNS",4,1,1,16514837,2,4.38E+018,"testalpha"
,"drug rash with eosinophilia","NN NN IN NNP",4,1,1,16710584,2,6.51E+018,"testalpha"
,"disparities culturalcompetence and diversity","NNS NN CC NN",4,1,1,16473988,"pubmed1",6.49E+018,"testalpha"
,"velvet antler of sika","NN NN IN ",4,1,1,16770447,"pubmed1",2.65E+018,"testalpha"
,"mug glycosylase excised basemodifications"," NN VBN NNS",4,1,1,16582987,"pubmed1",5.12E+018,"testalpha"
,"male and female patients","NN CC NN NNS",4,1,1,17688033,2,2.74E+018,"testalpha"
,"non gypsies nn gypsy"," NNS  NN",4,1,1,17165598,2,1.59E+018,"testalpha"
,"cell by aspecific ag","NN IN NNP ",4,1,1,16808043,"pubmed1",8.84E+018,"testalpha"
,"inhibition of tumor growth","NN IN NN NN",4,1,1,16733559,"pubmed1",7.56E+018,"testalpha"
,"seeds of dolichos lablab","NNS IN  ",4,1,1,16511291,2,6.98E+018,"testalpha"
,"conclusion gastric brushing cytology","NN JJ NN NN",4,1,1,16514844,2,4.86E+018,"testalpha"
,"synthase inos and tgf","NN  CC ",4,1,1,16762404,2,4.45E+018,"testalpha"
,"withlow levels of atrx","VB NNS IN ",4,1,1,16914901,2,4.51E+018,"testalpha"
,"performed using scar tissues","VBN VBG  NNS",4,1,1,16874413,2,2.12E+018,"testalpha"
,"irregularities orchanges in pigmentation","NNS NNS IN NN",4,1,1,16585990,2,1.85E+018,"testalpha"
,"anticoagulation for preventing catheter","NN IN VBG NN",4,1,1,16549897,2,8.41E+018,"testalpha"
,"tothe subcutaneous fat tissue","NNP JJ NN NN",4,1,1,16648918,2,8.27E+018,"testalpha"
,"suggesting effectivetransport of drug","VBG NN IN NN",4,1,1,16584167,"pubmed1",3.11E+018,"testalpha"
,"response and colonic weight","NN CC JJ NN",4,1,1,17293972,2,3.62E+018,"testalpha"
,"number of nf kappab","NN IN  ",4,1,1,17068636,"pubmed1",2.63E+018,"testalpha"
,"shelters with raised leveladvertisements","NNS IN VBN NNS",4,1,1,16427019,"pubmed1",7.13E+018,"testalpha"
,"crystals belong tospace group","NNS VB NN NN",4,1,1,16511256,2,3.69E+018,"testalpha"
,"safety and theirunsafe driving","NN CC NN NN",4,1,1,16061188,"pubmed1",9.15E+018,"testalpha"
,"metabolicsyndrome in elderly females","NN IN JJ NNS",4,1,1,16479027,2,7.85E+017,"testalpha"
,"interactions thatspecific thioredoxins form","NNS NNP NNS NN",4,1,1,16421453,2,1.30E+018,"testalpha"
,"simultaneous diagnosis of ttp","JJ NN IN ",4,1,1,16424653,2,4.56E+018,"testalpha"
,"changes among high risk","NNS IN JJ NN",4,1,1,16236235,"pubmed1",5.61E+018,"testalpha"
,"grade of primarytumors p","NN IN NNS ",4,1,1,16430945,2,3.60E+018,"testalpha"
,"extra cellularlocalization substrate affinity","JJ NN NN NN",4,1,1,17143335,"pubmed1",7.91E+018,"testalpha"
,"hierarchical crash car occupant","JJ NN NN NN",4,1,1,16126153,"pubmed1",7.75E+018,"testalpha"
,"bettermechanical properties than calf","JJ NNS IN NN",4,1,1,16701880,"pubmed1",4.02E+018,"testalpha"
,"hands free mobile phone","NNS JJ JJ NN",4,1,1,16226211,"pubmed1",2.69E+018,"testalpha"
,"pasi score clinical assessment"," NN JJ NN",4,1,1,16585984,2,1.17E+018,"testalpha"
,"contraction of uterussmooth muscle","NN IN JJ NN",4,1,1,16523218,"pubmed1",4.96E+018,"testalpha"
,"latent membrane protein lmp","JJ NN NN ",4,1,1,16914904,2,6.69E+018,"testalpha"
,"michigan monthly motor vehicle","VBD JJ NN NN",4,1,1,16169506,"pubmed1",1.35E+018,"testalpha"
,"crystal structure of dck","NN NN IN ",4,1,1,16421443,2,4.20E+018,"testalpha"
,"modafinil increased certain aspects"," VBN JJ NNS",4,1,1,16436796,"pubmed1",4.82E+018,"testalpha"
,"variabilityin dissolution rate measurements"," NN NN NNS",4,1,1,16594638,"pubmed1",4.04E+018,"testalpha"
,"risk factors for work","NN NNS IN NN",4,1,1,16438093,"pubmed1",6.72E+018,"testalpha"
,"detection ofthe y c","NN NNP  NN",4,1,1,16929381,"pubmed1",5.85E+018,"testalpha"
,"fresh frozenplasma ffp group","JJ NNP  NN",4,1,1,16451158,"pubmed1",7.65E+018,"testalpha"
,"lesions gavemore pain p","NNS IN NN ",4,1,1,16955183,2,1.15E+018,"testalpha"
,"mix on patch testing","NN IN NN NN",4,1,1,16710586,2,6.54E+018,"testalpha"
,"terminalhydroxyl groups of xanthophyll"," NNS IN NN",4,1,1,16964324,"pubmed1",1.72E+018,"testalpha"
,"patiens yearsafter composite skin","NNS NN JJ NN",4,1,1,16999269,2,1.90E+018,"testalpha"
,"quantum and classical degrees","NN CC JJ NNS",4,1,1,16411736,"pubmed1",3.13E+018,"testalpha"
,"methods of selective oxidation","NNS IN JJ NN",4,1,1,16411734,"pubmed1",2.86E+018,"testalpha"
,"normalization of lipid profile","NN IN NN NN",4,1,1,16918068,"pubmed1",4.71E+018,"testalpha"
,"linear regression analysis consideringage","JJ NN NN NN",4,1,1,17119323,2,1.77E+018,"testalpha"
,"increase in total provider","NN IN JJ NN",4,1,1,16365329,"pubmed1",1.78E+018,"testalpha"
,"radioresistantcounterpart l y r","NN   NN",4,1,1,16404475,"pubmed1",5.44E+018,"testalpha"
,"andamphetamine induced locomotor activity","NN VBN NN NN",4,1,1,16808045,"pubmed1",3.43E+018,"testalpha"
,"angiotensin converting enzyme inhibitors","NNP VBG  NNS",4,1,1,16377816,"pubmed1",1.49E+017,"testalpha"
,"ambulance destination control program","NN NN NN NN",4,1,1,16365324,"pubmed1",9.37E+017,"testalpha"
,"blue azure ii solution","JJ JJ  NN",4,1,1,16574202,2,6.57E+018,"testalpha"
,"expression of different genes","NN IN JJ NNS",4,1,1,17115080,"pubmed1",2.07E+018,"testalpha"
,"intranasal delivery of st","NN NN IN ",4,1,1,16584167,"pubmed1",4.12E+018,"testalpha"
,"were investigated lung nodule","VBD VBD NN NN",4,1,1,16399029,"pubmed1",2.67E+018,"testalpha"
,"lasers and leds light","NNS CC  NN",4,1,1,17013504,2,5.76E+018,"testalpha"
,"small bowel and occlusion","JJ NN CC NN",4,1,1,17293970,2,1.95E+018,"testalpha"
,"adrenal myelolipomas reported inassociation","NN NNP VBD NN",4,1,1,16245020,"pubmed1",8.85E+018,"testalpha"
,"scalp biopsy was consideredmandatory","NN NN VBD NN",4,1,1,17311739,2,3.91E+018,"testalpha"
,"pelvic computed tomography ct","JJ VBN NN ",4,1,1,16252139,"pubmed1",5.09E+017,"testalpha"
,"acid and phospholipid chlorohydrins","NN CC JJ NNS",4,1,1,17128291,"pubmed1",5.49E+018,"testalpha"
,"changes proportion of variouscomponents","NNS NN IN NNS",4,1,1,16918067,"pubmed1",4.16E+018,"testalpha"
,"total of volunteer individuals","NN IN NN NNS",4,1,1,16956116,2,3.16E+018,"testalpha"
,"conformation polymorphism andsequence analysis","NN NN NN NN",4,1,1,16733555,"pubmed1",2.25E+018,"testalpha"
,"study reports theimmunohistochemical localisation","NN NNS JJ NN",4,1,1,17034836,2,4.70E+018,"testalpha"
,"diagnoses onifs cb preparations","NNS   NNS",4,1,1,16514842,2,9.67E+017,"testalpha"
,"recapture method was usedto","NN NN VBD ",4,1,1,16221468,"pubmed1",3.48E+018,"testalpha"
,"malignant atrophic papulosis degos","JJ JJ NN NNS",4,1,1,16710585,2,7.99E+018,"testalpha"
,"release improved skin hydration","NN VBN NN NN",4,1,1,17285742,"pubmed1",7.01E+018,"testalpha"
,"retrospective case control study","JJ NN NN NN",4,1,1,16438093,"pubmed1",3.10E+018,"testalpha"
,"end of surgical procedure","NN IN JJ NN",4,1,1,17338197,2,4.75E+018,"testalpha"
,"receptor cd and serum","NN  CC NN",4,1,1,16809890,2,7.89E+018,"testalpha"
,"changes of lung tissues","NNS IN NN NNS",4,1,1,16395522,"pubmed1",3.55E+018,"testalpha"
,"changesof sodium chloride tablets"," NN NN NNS",4,1,1,16584166,"pubmed1",3.81E+018,"testalpha"
,"included type diabetic patients","VBD NN JJ NNS",4,1,1,16673610,2,3.16E+018,"testalpha"
,"examination showed early stagesof","NN VBD JJ ",4,1,1,16399028,"pubmed1",3.47E+018,"testalpha"
,"non thrombosed ulnar artery"," VBN NN NN",4,1,1,16612927,"pubmed1",6.01E+018,"testalpha"
,"concentration serum iron si","NN NN NN ",4,1,1,16809890,2,3.49E+018,"testalpha"
,"dinucleating n o donorligand","VBG   NN",4,1,1,16456265,2,1.25E+017,"testalpha"
,"cell tumors papillary carcinomas","NN NNS JJ NNP",4,1,1,16514836,2,3.83E+016,"testalpha"
,"washingtonuniversity school of medicine","NN NN IN NN",4,1,1,16377823,"pubmed1",7.78E+018,"testalpha"
,"complemented variant ofcfae dsccfae","VBN NN  ",4,1,1,16511280,2,1.04E+016,"testalpha"
,"neuraminidase and chemical extractions","NN CC NN NNS",4,1,1,16764914,2,7.17E+018,"testalpha"
,"undescribed mutation of hjv","VBD NN IN ",4,1,1,16424663,2,1.68E+017,"testalpha"
,"org aboutusp resolutions html","  NNS ",4,1,1,17285738,"pubmed1",8.66E+018,"testalpha"
,"high throughput screening methodologies","JJ NN NN NNS",4,1,1,16369090,2,5.90E+018,"testalpha"
,"dimension of ed quality","NN IN VBD NN",4,1,1,16365329,"pubmed1",5.47E+018,"testalpha"
,"ofthe histidine acid phosphatase","NNP NN NN NN",4,1,1,16511256,2,1.40E+018,"testalpha"
,"peg mme and mm","  CC ",4,1,1,16511255,2,1.27E+018,"testalpha"
,"impacts of transport deregulation","NNS IN NN NN",4,1,1,16427020,"pubmed1",5.80E+018,"testalpha"
,"global indicators of radiation","JJ NNS IN NN",4,1,1,16421442,2,4.01E+018,"testalpha"
,"magnitude andindicated low affinity","NN VBN JJ NN",4,1,1,16404478,"pubmed1",1.26E+018,"testalpha"
,"adhesion and activatory molecules","NN CC NN NNS",4,1,1,16733557,"pubmed1",7.71E+017,"testalpha"
,"auricular acupressurepoints for hip","JJ NNS IN NN",4,1,1,16365322,"pubmed1",3.16E+018,"testalpha"
,"phosphate dehydrogenase from pseudomonas","NN NN IN NNP",4,1,1,16511285,2,4.92E+018,"testalpha"
,"distances angles and eccentricities","NNS NNS CC NNS",4,1,1,16399030,"pubmed1",9.09E+018,"testalpha"
,"generated corneocytes containing beta","VBN NNS VBG NN",4,1,1,16733064,2,2.91E+018,"testalpha"
,"hypoxia response of pfkfb"," NN IN ",4,1,1,17143338,"pubmed1",1.98E+018,"testalpha"
,"items and thecalculated knowledge","NNS CC VBN NN",4,1,1,16377828,"pubmed1",6.18E+017,"testalpha"
,"nested case control study","VBN NN NN NN",4,1,1,16405857,"pubmed1",5.32E+018,"testalpha"
,"frozenplasma ffp group n","NNP  NN ",4,1,1,16451158,"pubmed1",6.02E+018,"testalpha"
,"increase in p waf","NN IN  ",4,1,1,16733561,"pubmed1",5.95E+018,"testalpha"
,"confirmedthe inefficiency of ac","NNP NN IN ",4,1,1,16950501,2,2.28E+018,"testalpha"
,"hazards and increased subjectiveworkload","NNS CC VBN NN",4,1,1,16226211,"pubmed1",5.58E+018,"testalpha"
,"school university of zagreb","NN NN IN ",4,1,1,16918061,"pubmed1",2.24E+018,"testalpha"
,"possibility of expressing diversity","NN IN VBG NN",4,1,1,16988905,"pubmed1",4.19E+018,"testalpha"
,"mast cellsand smooth muscle"," NN JJ NN",4,1,1,16770441,"pubmed1",4.29E+018,"testalpha"
,"lung overdistension throughout ards","NN NN IN ",4,1,1,16451155,"pubmed1",1.14E+018,"testalpha"
,"results bothresidents and interns","NNS NNS CC NNS",4,1,1,16377823,"pubmed1",6.57E+018,"testalpha"
,"i and ii patients"," CC  NNS",4,1,1,17236635,"pubmed1",2.36E+017,"testalpha"
,"assess differences and similarities","VB NNS CC NNS",4,1,1,16221468,"pubmed1",3.40E+018,"testalpha"
,"brain bone abdominal wall","NN NN JJ NN",4,1,1,17139900,2,7.89E+018,"testalpha"
,"digit forwardand backward repetition","JJ NN JJ NN",4,1,1,16479025,2,1.30E+018,"testalpha"
,"new problems and questions","JJ NNS CC NNS",4,1,1,17013518,2,6.30E+018,"testalpha"
,"substrate binding domain sbd","NN VBG NN ",4,1,1,16511258,2,7.83E+018,"testalpha"
,"key steps in computer","JJ NNS IN NN",4,1,1,16473991,"pubmed1",5.64E+018,"testalpha"
,"thickened folds deformedileocecal junction","VBN NNS JJ NN",4,1,1,16447095,"pubmed1",2.33E+018,"testalpha"
,"practiced candidate assessment approaches","VBN NN NN NNS",4,1,1,16399035,"pubmed1",6.40E+018,"testalpha"
,"quicktime vr apple computer","JJ  NNS NN",4,1,1,16399038,"pubmed1",4.78E+018,"testalpha"
,"binding andfilament forming proteins","VBG NN VBG NNS",4,1,1,16511282,2,3.39E+018,"testalpha"
,"activities ofmesophyll and bundle","NNS NN CC NN",4,1,1,17106510,"pubmed1",3.97E+018,"testalpha"
,"index of marked cells","NN IN VBN NNS",4,1,1,17013509,2,2.40E+018,"testalpha"
,"additional alterations of nascentproteins","JJ NNS IN NNS",4,1,1,16505901,"pubmed1",5.27E+018,"testalpha"
,"persons with hemolytic anemia","NNS IN JJ NN",4,1,1,17010266,2,8.04E+018,"testalpha"
,"bonds inproteins of e","NNS NNS IN ",4,1,1,17019443,"pubmed1",7.83E+018,"testalpha"
,"possible transmissionroutes in order","JJ NNS IN NN",4,1,1,16710581,2,1.67E+017,"testalpha"
,"auditors and compliance officers","NNS CC NN NNS",4,1,1,16770860,"pubmed1",3.80E+015,"testalpha"
,"summary of current safety","NN IN JJ NN",4,1,1,16999268,2,6.83E+018,"testalpha"
,"coronary arteries on axialscans","NN NNS IN NNS",4,1,1,16399037,"pubmed1",8.19E+018,"testalpha"
,"improvement of thegeneral infection","NN IN JJ NN",4,1,1,16710581,2,6.53E+018,"testalpha"
,"technique and intensive post","NN CC JJ NN",4,1,1,16999266,2,5.05E+018,"testalpha"
,"ofcases of high voltage","NNS IN JJ NN",4,1,1,17294910,2,9.06E+018,"testalpha"
,"evidence for intrafollicular mucin","NN IN JJ NNP",4,1,1,16859615,2,6.87E+017,"testalpha"
,"function compared withhypothermic cpb","NN VBN JJ ",4,1,1,16451153,"pubmed1",5.59E+018,"testalpha"
,"diagnosis of cancer willresult","NN IN NN NN",4,1,1,16596899,"pubmed1",4.05E+018,"testalpha"
,"psoriatic lesions and healthycontrol","JJ NNS CC NN",4,1,1,17034836,2,5.68E+018,"testalpha"
,"pminv egfp retroviral vector","  JJ NN",4,1,1,17160143,"pubmed1",8.85E+018,"testalpha"
,"cells by cell cellinteractions","NNS IN NN NNS",4,1,1,16511286,2,5.37E+018,"testalpha"
,"indication for laser treatment","NN IN NN NN",4,1,1,16585989,2,5.61E+018,"testalpha"
,"bis controlled desflurane fentanyl"," VBN NN NN",4,1,1,16451145,"pubmed1",9.06E+018,"testalpha"
,"results modafinil facilitated performance","NNS  VBN NN",4,1,1,16436796,"pubmed1",5.37E+018,"testalpha"
,"stress urinary incontinent postmenopausal","VB JJ NN NN",4,1,1,16962646,2,6.73E+018,"testalpha"
,"softer epidermis ofthe limbs","JJR NN NNP NNS",4,1,1,16733064,2,3.06E+018,"testalpha"
,"candidate forcurative surgical management","NN JJ JJ NN",4,1,1,16673565,2,4.14E+018,"testalpha"
,"cases high grade hg","NNS JJ NN ",4,1,1,17338203,2,4.54E+018,"testalpha"
,"iii scores and co"," NNS CC ",4,1,1,17117607,2,3.19E+018,"testalpha"
,"cases of severe sepsis","NNS IN JJ NN",4,1,1,16914908,2,3.96E+017,"testalpha"
,"high fidelity simulation laboratory","JJ NN NN NN",4,1,1,16365338,"pubmed1",7.88E+018,"testalpha"
,"data on cervical abnormalities","NN IN JJ NNS",4,1,1,16514839,2,1.05E+018,"testalpha"
,"skin of atopic individuals","NN IN NN NNS",4,1,1,16603095,2,2.26E+018,"testalpha"
,"fever examination of bone","NN NN IN NN",4,1,1,16809892,2,5.05E+018,"testalpha"
,"cspg tn c andtsp","  NN ",4,1,1,16414104,2,2.83E+018,"testalpha"
,"xy r xy r"," NN  NN",4,1,1,16914909,2,5.56E+018,"testalpha"
,"atarget for regulating female","NN IN VBG NN",4,1,1,16808046,"pubmed1",2.84E+018,"testalpha"
,"various medications e g","JJ NNS  ",4,1,1,17106603,2,8.09E+018,"testalpha"
,"obstruction pboo of rat","NN  IN NN",4,1,1,16253314,2,5.05E+018,"testalpha"
,"sln for topical application"," IN JJ NN",4,1,1,17285742,"pubmed1",1.89E+018,"testalpha"
,"cr and blood urea"," CC NN ",4,1,1,16999986,2,7.11E+018,"testalpha"
,"fluid resuscitation results pretreatment","NN NN NNS NN",4,1,1,16365323,"pubmed1",3.74E+018,"testalpha"
,"gene and clinical parameters"," CC JJ NNS",4,1,1,17139886,2,4.03E+017,"testalpha"
,"survival mature stromal layers","NN JJ JJ NNS",4,1,1,17016038,2,2.82E+018,"testalpha"
,"treatment ofsynchronous metastases significance","NN JJ NNS NN",4,1,1,17139901,2,4.12E+018,"testalpha"
,"sensitization of fusion machinery","NN IN NN NN",4,1,1,16395521,"pubmed1",3.80E+018,"testalpha"
,"bmp in bone defects"," IN NN NNS",4,1,1,17293969,2,3.11E+018,"testalpha"
,"treatment results and itis","NN NNS CC ",4,1,1,17438831,2,8.57E+018,"testalpha"
,"theclassical pathway c b","JJ NN NN NN",4,1,1,16964325,"pubmed1",7.22E+018,"testalpha"
,"oxalic acid at concentrations","JJ NN IN NNS",4,1,1,16701865,"pubmed1",3.44E+017,"testalpha"
,"preto facultyof medicine usp","  NN ",4,1,1,17013504,2,7.48E+018,"testalpha"
,"blastic crisis in e","JJ NN IN ",4,1,1,16914906,2,7.83E+018,"testalpha"
,"interns supported work hour","NNS VBD NN NN",4,1,1,16377823,"pubmed1",2.21E+018,"testalpha"
,"positive single stranded rna","JJ NN VBN ",4,1,1,16733562,"pubmed1",5.39E+018,"testalpha"
,"reduces platelet aggregation anddense","VBZ NN NN NN",4,1,1,17068635,"pubmed1",2.80E+018,"testalpha"
,"showed severe andintermediate neutropenia","VBD JJ NN NNP",4,1,1,17119324,2,6.49E+018,"testalpha"
,"metabolism and glycerol phosphate","NN CC NN NN",4,1,1,16919313,2,8.95E+018,"testalpha"
,"relative contribution of bothroutes","JJ NN IN NNS",4,1,1,16770446,"pubmed1",1.04E+018,"testalpha"
,"atrophic papular skin lesions","JJ JJ NN NNS",4,1,1,16710585,2,1.38E+017,"testalpha"
,"monomer per asymmetric unit","NN IN JJ NN",4,1,1,16511292,2,3.46E+018,"testalpha"
,"women median age range","NNS JJ NN NN",4,1,1,16612911,2,5.44E+018,"testalpha"
,"received treatment for weeks","VBD NN IN NNS",4,1,1,16253314,2,4.96E+018,"testalpha"
,"protection ofthe liver parenchyma","NN NNP NN ",4,1,1,17013514,2,3.64E+018,"testalpha"
,"aplastic crisis in persons","JJ NN IN NNS",4,1,1,17010266,2,2.03E+018,"testalpha"
,"earliestavailable pairs of serum","JJ NNS IN NN",4,1,1,16874420,2,5.52E+018,"testalpha"
,"excellent results in bothpatients","JJ NNS IN NNS",4,1,1,16603097,2,7.07E+018,"testalpha"
,"included results from september","VBD NNS IN NN",4,1,1,16436791,"pubmed1",1.42E+018,"testalpha"
,"mg andnucleotide free form"," VB JJ NN",4,1,1,17019437,"pubmed1",1.71E+018,"testalpha"
,"treatment or recurrent disease","NN CC NN NN",4,1,1,16955186,2,5.99E+018,"testalpha"
,"infective vector with ltr","JJ NN IN ",4,1,1,17160143,"pubmed1",8.81E+018,"testalpha"
,"correlation between apache iii","NN IN NNP ",4,1,1,17117607,2,2.66E+018,"testalpha"
,"academic pediatric emergency department","JJ JJ NN NN",4,1,1,16365328,"pubmed1",3.57E+018,"testalpha"
,"become beltusers in order","VB NNS IN NN",4,1,1,16236235,"pubmed1",2.28E+018,"testalpha"
,"quantities and clinical preparations","NNS CC JJ NNS",4,1,1,16594642,"pubmed1",8.41E+018,"testalpha"
,"pc encoded carboxylesterase frompyrobaculum"," VBN NN NN",4,1,1,16511287,2,6.97E+018,"testalpha"
,"treatment modality employing nm","NN NN VBG ",4,1,1,16585984,2,4.17E+018,"testalpha"
,"cells inatopic dermatitis skin","NNS NN NN NN",4,1,1,16955181,2,2.89E+018,"testalpha"
,"hpv infection lone l"," NN JJ ",4,1,1,17010274,2,4.17E+018,"testalpha"
,"bythe thinprep tp technique","NNP   NN",4,1,1,16514842,2,3.50E+018,"testalpha"
,"hyperglycemic bg or mg","JJ  CC ",4,1,1,16436794,"pubmed1",6.88E+018,"testalpha"
,"creatinine cr and blood","NN  CC NN",4,1,1,16999986,2,3.81E+018,"testalpha"
,"diphenylethanone ethylthiosemicarbazone c h","NN NN NN ",4,1,1,16397328,2,8.78E+018,"testalpha"
,"theimpacts of economic deregulation","NNS IN JJ NN",4,1,1,16427020,"pubmed1",2.41E+017,"testalpha"
,"stimulating factor g csf","JJ NN  ",4,1,1,16809884,2,8.63E+018,"testalpha"
,"goal of current research","NN IN JJ NN",4,1,1,16549892,2,8.24E+018,"testalpha"
,"cohorts of ibd patients","NNS IN  NNS",4,1,1,16673554,2,6.08E+018,"testalpha"
,"patientswith low tumor burden","NN JJ NN NN",4,1,1,17139879,2,5.29E+018,"testalpha"
,"abnormalities involving capillaries veinsand","NNS VBG NNS NN",4,1,1,16722347,2,7.51E+018,"testalpha"
,"patients normal chest good","NNS JJ NN NN",4,1,1,16956118,2,4.66E+018,"testalpha"
,"situ andunder cell culture"," NN NN NN",4,1,1,16713618,2,3.33E+018,"testalpha"
,"taken asa group pbmcs","VBN  NN ",4,1,1,16710577,2,2.28E+017,"testalpha"
,"distance between wild type","NN IN JJ NN",4,1,1,16823609,"pubmed1",2.80E+018,"testalpha"
,"rubrum in t mentagrophytes","NN IN  NNS",4,1,1,16710579,2,5.61E+018,"testalpha"
,"right thigh andsurgical dissection","JJ NN JJ NN",4,1,1,17293969,2,4.33E+018,"testalpha"
,"doubles median lethal dose","NNS JJ JJ NN",4,1,1,16436797,"pubmed1",5.80E+017,"testalpha"
,"protein adsorption and cell","NN NN CC NN",4,1,1,16701874,"pubmed1",4.76E+018,"testalpha"
,"x mm sec p","NN   ",4,1,1,16399034,"pubmed1",1.12E+018,"testalpha"
,"diagnostics and therapy selection","NNS CC NN NN",4,1,1,16596744,"pubmed1",4.34E+018,"testalpha"
,"potential ion binding sites","JJ  VBG NNS",4,1,1,16770442,"pubmed1",7.89E+018,"testalpha"
,"analysis consideringage inflammation iron","NN NN NN NN",4,1,1,17119323,2,9.13E+018,"testalpha"
,"moderatedirect correlation with vegf","NN NN IN ",4,1,1,16317488,"pubmed1",1.31E+018,"testalpha"
,"formeasurement of marp pain","NN IN  NN",4,1,1,16612915,"pubmed1",3.56E+018,"testalpha"
,"cerebral concentration of propofol","JJ NN IN ",4,1,1,17067138,"pubmed1",5.80E+017,"testalpha"
,"factors months after theacute","NNS NNS IN NN",4,1,1,16549894,2,2.05E+018,"testalpha"
,"dependent cellular fluid concentration","JJ JJ NN NN",4,1,1,16988902,"pubmed1",8.02E+018,"testalpha"
,"skills by facilitating candiddiscussion","NNS IN VBG NN",4,1,1,16377827,"pubmed1",3.30E+018,"testalpha"
,"governmental industrial hygienists guide","JJ JJ NNS NN",4,1,1,16438095,"pubmed1",7.61E+017,"testalpha"
,"indications forsplit thickness skin","NNS NN NN NN",4,1,1,17165596,2,2.78E+018,"testalpha"
,"role of oxidative stress","NN IN JJ NN",4,1,1,16696441,2,1.96E+018,"testalpha"
,"test results and treatment","NN NNS CC NN",4,1,1,16673554,2,4.51E+017,"testalpha"
,"self treatment at home","NN NN IN NN",4,1,1,16710573,2,6.62E+018,"testalpha"
,"representedmisdiagnoses of amyloid classes","NNS IN VB NNS",4,1,1,16790262,2,7.99E+018,"testalpha"
,"responsive cis acting elements","JJ  VBG NNS",4,1,1,16395526,"pubmed1",1.04E+018,"testalpha"
,"solution concentration and measuredfiber","NN NN CC NN",4,1,1,16701855,"pubmed1",1.07E+018,"testalpha"
,"cyclic tetrapeptide analogues h","JJ VB NNS ",4,1,1,16496038,"pubmed1",7.74E+018,"testalpha"
,"electron microscopy sem images","NN   NNS",4,1,1,16584166,"pubmed1",8.98E+018,"testalpha"
,"table analysis for patients","NN NN IN NNS",4,1,1,16451146,"pubmed1",5.16E+018,"testalpha"
,"calledpaget schroetter syndrome effort","NN NN NN NN",4,1,1,16549900,2,6.18E+018,"testalpha"
,"earlydetection of intestinal injury","NN IN JJ NN",4,1,1,16317496,"pubmed1",2.37E+018,"testalpha"
,"adult perineal soft tissue","NN NN JJ NN",4,1,1,16514847,2,9.08E+018,"testalpha"
,"cell and reticulocyte counts","NN CC NNP NNS",4,1,1,16424649,2,5.35E+018,"testalpha"
,"effects on thyrotrope morphology","NNS IN NNP NN",4,1,1,16714054,2,5.25E+018,"testalpha"
,"symmetry of space group","NN IN NN NN",4,1,1,16511280,2,3.21E+018,"testalpha"
,"preimplantation embryodevelopment and activation","NN NN CC NN",4,1,1,16808046,"pubmed1",6.13E+018,"testalpha"
,"university affiliated community hospital","NN VBN NN NN",4,1,1,16365324,"pubmed1",1.39E+018,"testalpha"
,"defecation with presentdefect od","NN IN NN ",4,1,1,17139884,2,2.48E+018,"testalpha"
,"colonystimulating factor gm csf","VBG NN  ",4,1,1,16404477,"pubmed1",3.00E+018,"testalpha"
,"theleading indication of liver","VBG NN IN NN",4,1,1,17013506,2,4.18E+018,"testalpha"
,"velocities studied withcolloidal silicon","NNS VBN NN NN",4,1,1,17285749,"pubmed1",5.42E+018,"testalpha"
,"mucosal cells withpyknotic nuclei","NN NNS JJ ",4,1,1,16514843,2,3.56E+018,"testalpha"
,"diet and nutrition exercise","NN CC NN NN",4,1,1,16596897,"pubmed1",1.24E+018,"testalpha"
,"adult acute myeloidleukemia aml","NN JJ NN ",4,1,1,17119322,2,8.87E+018,"testalpha"
,"disturbances during internship outcome","NNS IN NN NN",4,1,1,16377826,"pubmed1",3.70E+018,"testalpha"
,"patients type type type","NNS NN NN NN",4,1,1,16424652,2,4.91E+018,"testalpha"
,"binding site residue glu","VBG NN NN ",4,1,1,16511247,2,9.95E+017,"testalpha"
,"displaced fractures in patients","VBN NNS IN NNS",4,1,1,16613748,2,3.79E+018,"testalpha"
,"resp of healthcare workers"," IN NN NNS",4,1,1,16696442,2,6.51E+018,"testalpha"
,"oxidative stress and inflammation","JJ NN CC NN",4,1,1,16770444,"pubmed1",2.08E+018,"testalpha"
,"gre images and ct"," NNS CC ",4,1,1,16317488,"pubmed1",3.91E+018,"testalpha"
,"significant decrease of fn","JJ NN IN ",4,1,1,16430945,2,5.45E+017,"testalpha"
,"contraindications and scoring systems","NNS CC VBG NNS",4,1,1,17139901,2,7.77E+018,"testalpha"
,"photopheresis or extracorporeal photochemotherapy","NN CC NN NN",4,1,1,17016038,2,4.46E+018,"testalpha"
,"developed multiple lung metastases","VBD JJ NN NNS",4,1,1,16859616,2,8.73E+018,"testalpha"
,"efficiency in preventing dysplasiaand","NN IN VBG NN",4,1,1,17010274,2,8.19E+018,"testalpha"
,"treatment of human diseases","NN IN JJ NNS",4,1,1,17013511,2,9.10E+018,"testalpha"
,"inaccuratediagnoses and inappropriate treatments","NNS CC JJ NNS",4,1,1,16365325,"pubmed1",5.69E+018,"testalpha"
,"alternatives for drug administration","NNS IN NN NN",4,1,1,16617761,"pubmed1",6.20E+018,"testalpha"
,"ns d polylepsis venom","  NN NN",4,1,1,16436788,"pubmed1",6.15E+018,"testalpha"
,"session pei plus radiofrequency","NN  CC NN",4,1,1,16333710,"pubmed1",3.38E+018,"testalpha"
,"state examination mmse trail","NN NN  NN",4,1,1,16479025,2,8.96E+018,"testalpha"
,"stepcolorimetric sandwich elisa method","JJ NN  NN",4,1,1,16603096,2,6.57E+018,"testalpha"
,"thecollection of diffraction data","NN IN NN NNS",4,1,1,16369089,2,5.93E+018,"testalpha"
,"above types of frameshifts","JJ NNS IN NNS",4,1,1,16733554,"pubmed1",1.31E+018,"testalpha"
,"proliferative andsecretory phase p","JJ NN NN ",4,1,1,16423381,2,8.32E+018,"testalpha"
,"cannevertheless destroy hair follicles","NN VB NN NNS",4,1,1,16983449,2,3.95E+018,"testalpha"
,"epx leveland urine epx"," NN NN ",4,1,1,16859611,2,9.52E+017,"testalpha"
,"exposed skinsurfaces from age","VBN NNS IN NN",4,1,1,16859612,2,5.69E+018,"testalpha"
,"restricted work hour regulations","VBN NN NN NNS",4,1,1,16377822,"pubmed1",3.46E+018,"testalpha"
,"protect cells fromoxidative stress","VB NNS JJ NN",4,1,1,17160142,"pubmed1",8.80E+018,"testalpha"
,"cmh o and cmh","  CC ",4,1,1,16451155,"pubmed1",5.85E+017,"testalpha"
,"theextent that particular diets","NN IN JJ NNS",4,1,1,17318328,"pubmed1",6.69E+018,"testalpha"
,"themonoclinic space group p","JJ NN NN ",4,1,1,16511268,2,1.59E+017,"testalpha"
,"aggregation anddense granule secretion","NN NN NN NN",4,1,1,17068635,"pubmed1",3.19E+018,"testalpha"
,"data onthe review systems","NNS NNP NN NNS",4,1,1,16770859,"pubmed1",5.07E+018,"testalpha"
,"corneocytes containing beta keratinform","NNS VBG NN NN",4,1,1,16733064,2,3.60E+018,"testalpha"
,"current contents dissertation abstracts","JJ NNS NN NNS",4,1,1,16365334,"pubmed1",6.72E+018,"testalpha"
,"green fluorescent protein egfp","JJ NN NN ",4,1,1,16404477,"pubmed1",8.55E+018,"testalpha"
,"clinical presentation symptoms date","JJ NN NNS NN",4,1,1,16696444,2,6.15E+018,"testalpha"
,"part timethan full time","NN NNP JJ NN",4,1,1,16438093,"pubmed1",6.58E+017,"testalpha"
,"methods retrospective cohort study","NNS JJ NN NN",4,1,1,16365332,"pubmed1",1.28E+018,"testalpha"
,"stratified cox proportional hazards","VBN  JJ NNS",4,1,1,16202465,"pubmed1",7.91E+018,"testalpha"
,"diabetic patients ii form","JJ NNS  NN",4,1,1,16696441,2,5.91E+018,"testalpha"
,"pbscs in aml patients","NNS IN  NNS",4,1,1,17119322,2,1.11E+018,"testalpha"
,"mid spectrum threat agents","JJ NN NN NNS",4,1,1,16696436,2,7.38E+018,"testalpha"
,"bidentate carboxyl c o","NN  NN ",4,1,1,16456276,2,8.97E+017,"testalpha"
,"malignant b lineage cells","JJ NN NN NNS",4,1,1,16809887,2,1.99E+018,"testalpha"
,"using equations for largedeformation","VBG NNS IN NN",4,1,1,16399039,"pubmed1",6.46E+018,"testalpha"
,"article contains conclusions andproposals","NN VBZ NNS NNS",4,1,1,16999265,2,7.29E+018,"testalpha"
,"images and averagesurface roughness","NNS CC NN NN",4,1,1,16584166,"pubmed1",6.90E+018,"testalpha"
,"presence of mild epidermotropism","NN IN JJ NN",4,1,1,16859615,2,3.49E+018,"testalpha"
,"respective reporting period ateach","JJ VBG NN NN",4,1,1,16365337,"pubmed1",7.25E+018,"testalpha"
,"h after systemic hypothermia"," IN JJ NN",4,1,1,16451153,"pubmed1",1.65E+018,"testalpha"
,"serum at degrees c","NN IN NNS NN",4,1,1,17160143,"pubmed1",6.14E+018,"testalpha"
,"highest expression of ts","JJS NN IN ",4,1,1,17139902,2,3.91E+018,"testalpha"
,"functioning doctor patient interactionis","VBG NN NN NNP",4,1,1,16710573,2,6.03E+018,"testalpha"
,"ptclu and hepatosplenic t"," CC JJ ",4,1,1,16914902,2,3.41E+018,"testalpha"
,"patients with myocardial infarction","NNS IN JJ NN",4,1,1,16914907,2,7.66E+018,"testalpha"
,"simple reductionism orhard determinism","JJ NN NN NN",4,1,1,16505901,"pubmed1",6.78E+018,"testalpha"
,"myocardial infarction timi risk","JJ NN  NN",4,1,1,16365321,"pubmed1",1.62E+018,"testalpha"
,"use of medicinal plants","NN IN JJ NNS",4,1,1,17013511,2,4.36E+018,"testalpha"
,"years post orthodontic treatment","NNS NN JJ NN",4,1,1,17438832,2,6.17E+018,"testalpha"
,"degradation ina predictable fashion","NN  JJ NN",4,1,1,16701855,"pubmed1",7.97E+018,"testalpha"
,"american women breast cancer","JJ NNS NN NN",4,1,1,16596895,"pubmed1",2.73E+018,"testalpha"
,"analysiswas performed using chi"," VBN VBG ",4,1,1,16479026,2,3.50E+018,"testalpha"
,"possibility of domestic violence","NN IN JJ NN",4,1,1,16377192,"pubmed1",2.54E+018,"testalpha"
,"elective cesarean section patients","JJ JJ NN NNS",4,1,1,16617756,"pubmed1",8.31E+018,"testalpha"
,"differences indicating different genomesensitivity","NNS VBG JJ NN",4,1,1,16582984,"pubmed1",4.25E+018,"testalpha"
,"cases ofbenign papillary neoplasm","NNS JJ JJ NN",4,1,1,16514838,2,8.27E+018,"testalpha"
,"jejunum and ileum sites","NN CC NN NNS",4,1,1,17293957,2,8.14E+018,"testalpha"
,"kinase activation andlipid peroxidation","NN NN JJ NN",4,1,1,17013507,2,7.05E+018,"testalpha"
,"condition fromreactive sinusoidal lesions","NN JJ NN NNS",4,1,1,16256177,2,6.56E+018,"testalpha"
,"answering pages and tasks","VBG NNS CC NNS",4,1,1,16377825,"pubmed1",8.52E+018,"testalpha"
,"cirrhosis and liver ischemia","NN CC NN NN",4,1,1,17013508,2,5.75E+017,"testalpha"
,"chloroplasts of c subtypes","NNS IN NN NNS",4,1,1,17106510,"pubmed1",3.61E+018,"testalpha"
,"cells producing biogenic amines","NNS VBG JJ NNS",4,1,1,16997356,2,3.59E+018,"testalpha"
,"n and severe cases"," CC JJ NNS",4,1,1,16956117,2,7.90E+018,"testalpha"
,"root mean square error","NN VB NN NN",4,1,1,16399032,"pubmed1",3.27E+018,"testalpha"
,"post operativecognitive dysfunction pocd","NN JJ NN ",4,1,1,16451151,"pubmed1",2.58E+018,"testalpha"
,"age percentof postmenopausal patients","NN  NN NNS",4,1,1,17338203,2,5.08E+018,"testalpha"
,"increase in myocardial glycerol","NN IN JJ NN",4,1,1,16451157,"pubmed1",1.46E+018,"testalpha"
,"hyperglycemic effects maycause discouragement","JJ NNS IN NN",4,1,1,16918069,"pubmed1",8.80E+018,"testalpha"
,"patients presenting airborne ige","NNS VBG NNP ",4,1,1,16603103,2,8.30E+018,"testalpha"
,"colonic j pouch group","JJ  NN NN",4,1,1,17139896,2,5.22E+018,"testalpha"
,"theeffects of such agents","NNS IN JJ NNS",4,1,1,16696436,2,5.71E+018,"testalpha"
,"byzeta potential zp measurements","NN NN  NNS",4,1,1,16584150,"pubmed1",8.14E+018,"testalpha"
,"p dioxanone co l"," NN  ",4,1,1,16701879,"pubmed1",4.27E+018,"testalpha"
,"oral therapy in patients","JJ NN IN NNS",4,1,1,16809890,2,9.74E+016,"testalpha"
,"forthe development of novel","NNP NN IN NN",4,1,1,16388313,"pubmed1",1.30E+018,"testalpha"
,"groups of xanthophyll molecules","NNS IN NN NNS",4,1,1,16964324,"pubmed1",5.39E+018,"testalpha"
,"toformation of crystal contacts","NN IN NN NNS",4,1,1,16369101,2,4.81E+018,"testalpha"
,"field of thefour dna","NN IN JJ ",4,1,1,16823609,"pubmed1",8.39E+018,"testalpha"
,"ossuary th th century","JJ   NN",4,1,1,17438834,2,7.84E+018,"testalpha"
,"amyloid fibrils reveals thepresence","VB NNS VBZ NN",4,1,1,16764914,2,1.01E+018,"testalpha"
,"opioides and previous ponv","NNS CC JJ ",4,1,1,17236637,"pubmed1",3.44E+018,"testalpha"
,"vinyl terminated polylactidemacromonomers plam","NN VBD NNS ",4,1,1,16701854,"pubmed1",6.31E+018,"testalpha"
,"mild thrombocytopenia in addition","JJ NNP IN NN",4,1,1,17119324,2,2.35E+018,"testalpha"
,"ferric heme by mn","JJ  IN ",4,1,1,16421446,2,1.62E+018,"testalpha"
,"ebpadma tegdma molar ratios","NN NN JJ NNS",4,1,1,16701862,"pubmed1",1.88E+018,"testalpha"
,"potential impairment ofneonatal platelet","JJ NN NN NN",4,1,1,16549890,2,5.43E+018,"testalpha"
,"streak and give rise","NN CC VB NN",4,1,1,17265694,2,3.10E+018,"testalpha"
,"antler of sika deer","NN IN  NNS",4,1,1,16770447,"pubmed1",7.97E+018,"testalpha"
,"gold conjugated secondary antibodies","NN VBN JJ NNS",4,1,1,16828846,2,9.10E+018,"testalpha"
,"dc bfs or ws","  CC ",4,1,1,16701862,"pubmed1",8.39E+018,"testalpha"
,"b cll with aberrantexpression","NN  IN NN",4,1,1,16424654,2,4.95E+018,"testalpha"
,"lead todevelopment of colorectal","VB NN IN NN",4,1,1,17139886,2,6.45E+018,"testalpha"
,"treatment support from healthcare","NN NN IN NN",4,1,1,16710575,2,9.14E+018,"testalpha"
,"range from mg x","NN IN  NN",4,1,1,16770447,"pubmed1",4.52E+017,"testalpha"
,"outcome measuresinclude helmet use","NN VB VB NN",4,1,1,16223468,"pubmed1",7.45E+018,"testalpha"
,"bioadhesion using response surface","NN VBG NN NN",4,1,1,16584161,"pubmed1",3.73E+018,"testalpha"
,"knowledge attitudes and skills","NN NNS CC NNS",4,1,1,16473998,"pubmed1",8.31E+018,"testalpha"
,"dependantcoagulation factors ii vii","NN NNS  ",4,1,1,16916181,"pubmed1",3.26E+018,"testalpha"
,"mechanism of inositolhexaphosphate insp","NN IN NN ",4,1,1,16733561,"pubmed1",4.56E+018,"testalpha"
,"equilibrium betweendifferent tautomeric forms","NN NN JJ NNS",4,1,1,16434797,2,7.36E+018,"testalpha"
,"patients with plaque type","NNS IN JJ NN",4,1,1,17034836,2,3.57E+018,"testalpha"
,"week and months post","NN CC NNS NN",4,1,1,16451151,"pubmed1",2.37E+018,"testalpha"
,"participants were assigned toone","NNS VBD VBN NN",4,1,1,16436796,"pubmed1",4.97E+018,"testalpha"
,"development of contact hypersensitivity","NN IN NN NN",4,1,1,17010265,2,4.43E+018,"testalpha"
,"inhibit erythropoiesis in hd","VB NN IN ",4,1,1,17119323,2,2.48E+017,"testalpha"
,"patients with cc score","NNS IN  NN",4,1,1,17139879,2,5.28E+018,"testalpha"
,"brain acts in concert","NN NNS IN NN",4,1,1,16594639,"pubmed1",5.80E+017,"testalpha"
,"stafford m c warr","NN  NN ",4,1,1,16405859,"pubmed1",3.61E+018,"testalpha"
,"resident matching program radiology","NN VBG NN NN",4,1,1,16399040,"pubmed1",6.92E+018,"testalpha"
,"proteasomal degradation controls unc","JJ NN NNS ",4,1,1,16496042,"pubmed1",3.40E+018,"testalpha"
,"enzymes in liver tissue","NNS IN NN NN",4,1,1,16404476,"pubmed1",3.06E+018,"testalpha"
,"risks of transmissible diseases","NNS IN JJ NNS",4,1,1,17013513,2,3.48E+017,"testalpha"
,"mean levels of serum","NN NNS IN NN",4,1,1,16859611,2,5.27E+018,"testalpha"
,"schroetter syndrome or effort","NN NN CC NN",4,1,1,16549899,2,4.40E+018,"testalpha"
,"thepresence of different classes","NN IN JJ NNS",4,1,1,16764914,2,7.55E+018,"testalpha"
,"incidence of adverse reactions","NN IN JJ NNS",4,1,1,16585984,2,9.38E+016,"testalpha"
,"use of x rays","NN IN NN NNS",4,1,1,16421453,2,8.79E+015,"testalpha"
,"probability of success decreases","NN IN NN NNS",4,1,1,16823607,"pubmed1",1.28E+018,"testalpha"
,"group and aprotonated amino","NN CC VBN NNP",4,1,1,16456282,2,3.49E+018,"testalpha"
,"aretrospective study of patients","JJ NN IN NNS",4,1,1,16436794,"pubmed1",5.41E+018,"testalpha"
,"scutes and hinge regions","NNS CC NN NNS",4,1,1,16733064,2,3.70E+018,"testalpha"
,"ct orpet magnetic resonance"," NN JJ NN",4,1,1,17139879,2,8.42E+018,"testalpha"
,"scores blood pressure pulse","NNS NN NN NN",4,1,1,16612915,"pubmed1",4.65E+018,"testalpha"
,"temperature and ph dependence","NN CC  NN",4,1,1,17117212,"pubmed1",1.71E+018,"testalpha"
,"blsu alsu pre hospital","   NN",4,1,1,16491215,2,2.15E+018,"testalpha"
,"eachnewborn pathogen is drug","NNP NN VBZ NN",4,1,1,16823607,"pubmed1",6.67E+018,"testalpha"
,"typicalenhancement pattern of liver","NN NN IN NN",4,1,1,16333704,"pubmed1",2.83E+018,"testalpha"
,"severe injuries for females","JJ NNS IN NNS",4,1,1,16197912,"pubmed1",6.61E+018,"testalpha"
,"causing death or incapacitationthan","VBG NN CC NNP",4,1,1,16696436,2,1.81E+018,"testalpha"
,"product dry layer resistance","NN JJ NN NN",4,1,1,17285744,"pubmed1",3.42E+018,"testalpha"
,"protect activatedcd t cells","VB   NNS",4,1,1,16511253,2,3.21E+017,"testalpha"
,"conclusion although uncommon cepa","NN IN JJ ",4,1,1,16514848,2,3.94E+018,"testalpha"
,"oldfemale patient with nsmm","NN NN IN ",4,1,1,16714048,2,4.04E+018,"testalpha"
,"equal increase in bothinos","JJ NN IN NNP",4,1,1,16566960,2,1.68E+018,"testalpha"
,"animals receivedbupivacaine mg kg","NNS NN  ",4,1,1,17067137,"pubmed1",7.86E+018,"testalpha"
,"using police report data","VBG NN NN NNS",4,1,1,16139232,"pubmed1",7.41E+018,"testalpha"
,"biological age asa score","JJ NN  NN",4,1,1,16613748,2,5.11E+018,"testalpha"
,"p responsive p waf"," JJ  ",4,1,1,16733561,"pubmed1",3.36E+018,"testalpha"
,"response of eukaryotes todifferent","NN IN NNS NN",4,1,1,17063208,"pubmed1",8.27E+018,"testalpha"
,"clinical presentation histopathology immunofluorescence","JJ NN NN NN",4,1,1,16874424,2,1.98E+018,"testalpha"
,"monoquaternary pyridinium oximesto reactivate","JJ NN NNP NN",4,1,1,17438836,2,3.14E+018,"testalpha"
,"mg day or placebo"," NN CC ",4,1,1,16479024,2,7.23E+018,"testalpha"
,"fibrinolytic system interact togenerate","JJ NN NN NN",4,1,1,16549888,2,4.48E+018,"testalpha"
,"beta and tgf beta","NN CC  NN",4,1,1,16733563,"pubmed1",7.53E+018,"testalpha"
,"cancer detection and care","NN NN CC NN",4,1,1,16596900,"pubmed1",6.80E+017,"testalpha"
,"dilution in vial van","NN IN  NNP",4,1,1,16584164,"pubmed1",1.30E+018,"testalpha"
,"reactivators of inhibitedacetylcholinesterase oximes","NNS IN NN NNS",4,1,1,16956120,2,3.37E+018,"testalpha"
,"common types of injury","JJ NNS IN NN",4,1,1,16412373,"pubmed1",9.69E+016,"testalpha"
,"l arginine methyl ester"," NN  NN",4,1,1,16764913,2,7.14E+018,"testalpha"
,"developments in healthcare policy","NNS IN NN NN",4,1,1,16473988,"pubmed1",8.23E+018,"testalpha"
,"immunohistochemical analysis of e","JJ NN IN ",4,1,1,16253314,2,6.75E+018,"testalpha"
,"effect of cys gly","NN IN  ",4,1,1,16914903,2,1.70E+017,"testalpha"
,"dissociationrates and activation energy","NNS CC NN NN",4,1,1,16410837,"pubmed1",8.63E+018,"testalpha"
,"serum uric acid levels","NN JJ NN NNS",4,1,1,16514850,2,8.73E+018,"testalpha"
,"secondary analysis of medline","JJ NN IN NN",4,1,1,16365335,"pubmed1",1.88E+018,"testalpha"
,"levels and histopathological specimens","NNS CC JJ NNS",4,1,1,16612917,"pubmed1",4.00E+018,"testalpha"
,"correlated negativelywith humanistic values","VBN NN JJ NNS",4,1,1,16377814,"pubmed1",8.10E+017,"testalpha"
,"hepatitis c virus hcv","NN NN NN ",4,1,1,17119328,2,2.51E+018,"testalpha"
,"duration between date oftransplantation","NN IN NN NN",4,1,1,16710578,2,7.40E+018,"testalpha"
,"c cells with rock","NN NNS IN NN",4,1,1,17115079,"pubmed1",1.66E+018,"testalpha"
,"tissue and cellular organization","NN CC JJ NN",4,1,1,16950501,2,5.55E+018,"testalpha"
,"thehydrolysis of acyl coas","NN IN  ",4,1,1,16511283,2,8.30E+018,"testalpha"
,"anemia type ii cda","NN NN  ",4,1,1,17117609,2,8.75E+018,"testalpha"
,"phosphatidylcholine andstearoyl arachidonoyl phosphatidylcholine","NN   NN",4,1,1,17128291,"pubmed1",6.20E+018,"testalpha"
,"pp fad protein shows"," NN NN NNS",4,1,1,17063209,"pubmed1",2.06E+018,"testalpha"
,"criteria and stratifiedby county","NNS CC JJ NN",4,1,1,16202465,"pubmed1",4.30E+018,"testalpha"
,"included questions concerning demographics","VBD NNS IN NNS",4,1,1,16436795,"pubmed1",1.07E+018,"testalpha"
,"factors related tothe frequency","NNS VBN NNP NN",4,1,1,16122689,"pubmed1",4.92E+018,"testalpha"
,"thinprep tp technique cytyc","  NN ",4,1,1,16514842,2,1.84E+018,"testalpha"
,"adverse reactions and bettercompliance","JJ NNS CC NN",4,1,1,16585984,2,7.33E+018,"testalpha"
,"renal mda and nolevels","JJ  CC NNS",4,1,1,16999986,2,4.88E+018,"testalpha"
,"afterright nephrectomy i r","NN NN  NN",4,1,1,16764913,2,7.38E+017,"testalpha"
,"was usedto assess differences","VBD  VB NNS",4,1,1,16221468,"pubmed1",8.46E+017,"testalpha"
,"immunolabelled perivascular cell counts","VBN JJ NN NNS",4,1,1,17034836,2,5.60E+018,"testalpha"
,"c maf knockout mice","NN  NN ",4,1,1,16325892,2,7.43E+018,"testalpha"
,"variables fgf v e","NNS   ",4,1,1,16451150,"pubmed1",1.98E+018,"testalpha"
,"nih t cell line","  NN NN",4,1,1,16770447,"pubmed1",5.07E+018,"testalpha"
,"use while driving ofthe","NN IN VBG NNP",4,1,1,16157285,"pubmed1",4.14E+018,"testalpha"
,"endonuclease and oligonucleosomal dna","NN CC JJ ",4,1,1,16951739,"pubmed1",3.96E+018,"testalpha"
,"attracted theinterest of researchers","VBN NN IN NNS",4,1,1,16929383,"pubmed1",7.02E+018,"testalpha"
,"findpatients with possible drug","NNS IN JJ NN",4,1,1,17106599,2,1.63E+018,"testalpha"
,"medical education and technology","JJ NN CC NN",4,1,1,16473991,"pubmed1",5.45E+018,"testalpha"
,"c h o contacts","NN   NNS",4,1,1,16456296,2,3.26E+018,"testalpha"
,"modified viral vectors chemo","VBN JJ NNS ",4,1,1,17285739,"pubmed1",2.78E+017,"testalpha"
,"decliningrates in young males","NNS IN JJ NNS",4,1,1,16111641,"pubmed1",3.26E+017,"testalpha"
,"clinicalpre and postoperative status"," CC JJ NN",4,1,1,16989140,2,8.17E+018,"testalpha"
,"objective analysis of thepermeability","NN NN IN NN",4,1,1,16584115,"pubmed1",4.14E+018,"testalpha"
,"levels units of blood","NNS NNS IN NN",4,1,1,16424656,2,2.85E+018,"testalpha"
,"extent of glycolysis stimulation","NN IN NN NN",4,1,1,17068635,"pubmed1",2.31E+018,"testalpha"
,"groups benign indeterminate formalignancy","NNS JJ JJ NN",4,1,1,16514837,2,5.26E+018,"testalpha"
,"l ratskeletal muscle cells"," NN NN NNS",4,1,1,16964326,"pubmed1",3.78E+018,"testalpha"
,"fetal arterial cord blood","JJ JJ NN NN",4,1,1,16809888,2,3.78E+018,"testalpha"
,"accounting and understanding ofthis","NN CC VBG NNP",4,1,1,16983449,2,5.61E+018,"testalpha"
,"units g cfu g","NNS   ",4,1,1,17293960,2,3.18E+018,"testalpha"
,"oxygenationlevel dependent sequences dwi","NN JJ NNS ",4,1,1,16447077,"pubmed1",4.85E+018,"testalpha"
,"t wand spgr datasets","   NNS",4,1,1,16399031,"pubmed1",6.93E+018,"testalpha"
,"i mhc i molecules","   NNS",4,1,1,16511250,2,3.04E+018,"testalpha"
,"natural dye in phase","JJ  IN NN",4,1,1,16951739,"pubmed1",4.31E+018,"testalpha"
,"night shift didactic sessions","NN NN JJ NNS",4,1,1,16436796,"pubmed1",7.26E+018,"testalpha"
,"computed tomographic ct sign","VBN JJ  NN",4,1,1,16317492,"pubmed1",2.35E+018,"testalpha"
,"intranasal administration of microemulsions","NN NN IN NNS",4,1,1,16584167,"pubmed1",6.62E+018,"testalpha"
,"life among military personnel","NN IN JJ NNS",4,1,1,16405857,"pubmed1",5.97E+018,"testalpha"
,"patients after routineclinical practice","NNS IN JJ NN",4,1,1,17106601,2,7.16E+018,"testalpha"
,"ambulance is amajor decision","NN VBZ JJ NN",4,1,1,16321535,"pubmed1",1.98E+018,"testalpha"
,"u kg bodyweight treatment","  NN NN",4,1,1,17119327,2,3.20E+017,"testalpha"
,"impairment of respiratory mechanics","NN IN NN NNS",4,1,1,16451155,"pubmed1",1.94E+018,"testalpha"
,"body ofknowledge on m","NN NN IN ",4,1,1,16964325,"pubmed1",8.37E+018,"testalpha"
,"occurrence of opportunistic infections","NN IN JJ NNS",4,1,1,17106602,2,9.03E+018,"testalpha"
,"b time dbr dfr","NN NN  ",4,1,1,16479025,2,4.84E+018,"testalpha"
,"extent oftransport of microemulsion","NN NN IN NN",4,1,1,16584167,"pubmed1",4.20E+018,"testalpha"
,"merge police crash records","VB NN NN NNS",4,1,1,16043107,"pubmed1",2.36E+018,"testalpha"
,"primary targetpopulation for vaccination","NN NN IN NN",4,1,1,17010274,2,8.06E+018,"testalpha"
,"patients with suspected onychomycosis","NNS IN VBN NN",4,1,1,16710579,2,4.87E+018,"testalpha"
,"reduce opioid inducedbowel dysfunction","VB VB NN NN",4,1,1,16916180,"pubmed1",9.94E+017,"testalpha"
,"excessive amount of collagen","JJ NN IN NN",4,1,1,17294912,2,3.41E+018,"testalpha"
,"analyses urine and bloodanalysis","NNS NN CC NN",4,1,1,17688033,2,4.96E+017,"testalpha"
,"positive outcome biasor time","JJ NN NN NN",4,1,1,16365332,"pubmed1",3.94E+018,"testalpha"
,"higher total serum ige","JJR NN NN ",4,1,1,16859613,2,8.92E+018,"testalpha"
,"nos inhibited hypertensive rats","NNS VBN JJ NNS",4,1,1,16764913,2,1.76E+018,"testalpha"
,"confirmed ige mediated airborne","VBD  VBN NNP",4,1,1,17328144,2,6.80E+018,"testalpha"
,"c glc c glc","NN  NN ",4,1,1,16456293,2,9.02E+018,"testalpha"
,"method significantlyoverestimates fractal d","NN NNS NN ",4,1,1,16823606,"pubmed1",1.33E+018,"testalpha"
,"religion and spirituality onhealth","NN CC NN NN",4,1,1,16596897,"pubmed1",3.01E+018,"testalpha"
,"inhibition by pre pulsewas","NN IN  ",4,1,1,17133954,2,1.08E+018,"testalpha"
,"skill gaps at night","NN NNS IN NN",4,1,1,16377820,"pubmed1",8.83E+018,"testalpha"
,"transposition by increasing translationinfidelity","NN IN VBG NN",4,1,1,17106514,"pubmed1",5.33E+018,"testalpha"
,"asfas expression in pasmc","NNS NN IN ",4,1,1,16395522,"pubmed1",4.32E+018,"testalpha"
,"role of dermatophagoides d","NN IN NNS ",4,1,1,16859613,2,1.76E+018,"testalpha"
,"differentialexpression profile between ad","NN NN IN NN",4,1,1,16951744,"pubmed1",3.27E+018,"testalpha"
,"majorhaemoglobin clearing cells cd","NNP VBG NNS ",4,1,1,16770444,"pubmed1",2.16E+018,"testalpha"
,"endoscopy correlation of ultrasound"," NN IN NN",4,1,1,16399038,"pubmed1",7.54E+018,"testalpha"
,"bioactivity of thetetrazole peptides","NN IN JJ NNS",4,1,1,16496037,"pubmed1",1.18E+018,"testalpha"
,"total hysterectomywith bilateral salpingooophorectomy","JJ NN JJ NN",4,1,1,17338203,2,1.02E+018,"testalpha"
,"therapy combinedwith antiangiogenic chemotherapy","NN NN JJ NN",4,1,1,16388313,"pubmed1",6.87E+017,"testalpha"
,"ms and esi ms"," CC  ",4,1,1,16496039,"pubmed1",7.92E+018,"testalpha"
,"urinary sample from hour","JJ NN IN NN",4,1,1,16956119,2,2.25E+018,"testalpha"
,"decrease inalcohol related motor","NN NN VBN NN",4,1,1,16169506,"pubmed1",2.45E+018,"testalpha"
,"engineering designedto create patches","NN  VB NNS",4,1,1,16369101,2,4.22E+017,"testalpha"
,"brushite forming calcium phosphate","JJ VBG NN NN",4,1,1,16701863,"pubmed1",9.62E+017,"testalpha"
,"activated prothrombin complex concentrates","VBN NNP JJ NNS",4,1,1,16549892,2,3.50E+018,"testalpha"
,"score at ed presentation","NN IN VBD NN",4,1,1,16365321,"pubmed1",4.96E+018,"testalpha"
,"neurologic disorders of parkinson","JJ NNS IN NN",4,1,1,16594641,"pubmed1",1.70E+018,"testalpha"
,"protein coupled receptors gpcrs","NN VBN NNS ",4,1,1,16594640,"pubmed1",6.70E+018,"testalpha"
,"presence ofxenogenic islet tissue","NN JJ NN NN",4,1,1,16701881,"pubmed1",2.10E+018,"testalpha"
,"risk for traffic injury","NN IN NN NN",4,1,1,16112069,"pubmed1",7.52E+018,"testalpha"
,"efficacy of dm inpost","NN IN  NN",4,1,1,16451144,"pubmed1",4.40E+018,"testalpha"
,"changes in respiratory mechanics","NNS IN NN NNS",4,1,1,16451155,"pubmed1",4.72E+018,"testalpha"
,"percentages and t tests","NNS CC  NNS",4,1,1,16377820,"pubmed1",3.39E+018,"testalpha"
,"johnson syndrome with azithromycin","NN NN IN NNP",4,1,1,16603101,2,2.92E+018,"testalpha"
,"r injury in rats","NN NN IN NNS",4,1,1,16764913,2,4.40E+018,"testalpha"
,"values of hccs inverselyon","NNS IN  NNP",4,1,1,16317488,"pubmed1",5.94E+018,"testalpha"
,"highernumber of sexual partners","NN IN JJ NNS",4,1,1,16648915,2,1.10E+018,"testalpha"
,"control physician for patients","NN NN IN NNS",4,1,1,16365324,"pubmed1",4.25E+018,"testalpha"
,"containing astroglial andoligodendrogliallike elements","VBG JJ NN NNS",4,1,1,16514849,2,7.57E+017,"testalpha"
,"create case specific incidentmanagement","VB NN JJ NN",4,1,1,16426557,"pubmed1",5.91E+018,"testalpha"
,"interact and create value","NN CC VB NN",4,1,1,16596744,"pubmed1",3.14E+018,"testalpha"
,"enzymes serpins aspins andcystatins","NNS NNS NNS NNS",4,1,1,16410836,"pubmed1",6.38E+018,"testalpha"
,"administeredwith liposomal amphotericin b","NN JJ NNP NN",4,1,1,16918060,"pubmed1",6.04E+017,"testalpha"
,"peroxidase activity of cytochrome","NN NN IN NN",4,1,1,16951741,"pubmed1",7.82E+018,"testalpha"
,"subjects with radiological improvement","NNS IN JJ NN",4,1,1,16479024,2,9.09E+018,"testalpha"
,"toexocytotic rabs and facilitates","JJ  CC NNS",4,1,1,16511278,2,4.64E+018,"testalpha"
,"non visualizationof intrahepatic vessels","  JJ NNS",4,1,1,16673610,2,8.40E+018,"testalpha"
,"score and monthsin patients","NN CC NNP NNS",4,1,1,17139879,2,8.41E+018,"testalpha"
,"keratoses and other skinlesions","NNS CC JJ NNS",4,1,1,16585985,2,1.51E+018,"testalpha"
,"hours per week p","NNS IN NN ",4,1,1,16377825,"pubmed1",1.96E+018,"testalpha"
,"incomputational studies of protein","JJ NNS IN NN",4,1,1,16365636,"pubmed1",2.27E+018,"testalpha"
,"revealed casesof normal anal","VBD  JJ ",4,1,1,17139883,2,4.69E+018,"testalpha"
,"elevated level of mms","VBN NN IN ",4,1,1,16733554,"pubmed1",5.82E+018,"testalpha"
,"profiles f and p","NNS NN CC ",4,1,1,17285748,"pubmed1",1.98E+017,"testalpha"
,"totalquantity of residual monomers","NN IN JJ NNS",4,1,1,16701856,"pubmed1",6.64E+018,"testalpha"
,"treated cells was development","VBN NNS VBD NN",4,1,1,16956122,2,6.19E+018,"testalpha"
,"agrobacterium mediatedtransient gene expression","NN NN  NN",4,1,1,16582986,"pubmed1",2.44E+018,"testalpha"
,"pc k on day","  IN NN",4,1,1,16424649,2,1.47E+018,"testalpha"
,"centres in castilla y","NNS IN NNP ",4,1,1,16236233,"pubmed1",3.45E+018,"testalpha"
,"research productivity and decreasedcontrol","NN NN CC NN",4,1,1,16377815,"pubmed1",3.65E+017,"testalpha"
,"distinct ligand dependent receptorstates","JJ NN JJ NNS",4,1,1,16594640,"pubmed1",8.68E+018,"testalpha"
,"treatment of specific skin","NN IN JJ NN",4,1,1,16574202,2,8.28E+018,"testalpha"
,"ileo and coloanal anastomosis"," CC JJ NN",4,1,1,17139887,2,1.81E+018,"testalpha"
,"endoscopic retrograde cholangiopancreatography ercp","NN NN NN ",4,1,1,16673611,2,7.38E+018,"testalpha"
,"tdv and telesystolic tsv"," CC JJ ",4,1,1,16989140,2,3.36E+017,"testalpha"
,"operative blood loss inchildren","JJ NN NN NNS",4,1,1,16451158,"pubmed1",1.61E+018,"testalpha"
,"percentage ofchildren with ais","NN NNS IN ",4,1,1,16549893,2,5.37E+018,"testalpha"
,"purification detergent exchange protocol","NN NN NN NN",4,1,1,16511265,2,5.74E+018,"testalpha"
,"jack beans urease antibodies"," NNS NN NNS",4,1,1,16496040,"pubmed1",8.06E+018,"testalpha"
,"rats weeks old g","NNS NNS JJ ",4,1,1,17133954,2,7.76E+018,"testalpha"
,"background percutaneous dilatation tracheostomy","NN JJ NN NN",4,1,1,16451156,"pubmed1",3.59E+018,"testalpha"
,"adenosine and erythro hydroxy","NN CC  NN",4,1,1,16929383,"pubmed1",6.34E+018,"testalpha"
,"probed faculty work experiences","VBD NN NN NNS",4,1,1,16377820,"pubmed1",1.16E+018,"testalpha"
,"biophys acta in theiranalysis","  IN NN",4,1,1,17019442,"pubmed1",5.62E+018,"testalpha"
,"shaped structures onthe surface","VBN NNS NNP NN",4,1,1,16733562,"pubmed1",8.17E+018,"testalpha"
,"research on ageing drivers","NN IN VBG NNS",4,1,1,16198299,"pubmed1",5.06E+018,"testalpha"
,"red light nm light","JJ NN  NN",4,1,1,16585985,2,1.34E+018,"testalpha"
,"extractions using mild acid","NNS VBG JJ NN",4,1,1,16764914,2,2.12E+018,"testalpha"
,"true intervention group n","JJ NN NN ",4,1,1,16365322,"pubmed1",4.70E+018,"testalpha"
,"significant reduction in colony","JJ NN IN NN",4,1,1,17293963,2,7.14E+018,"testalpha"
,"importance of viral inducedgastritis","NN IN JJ NN",4,1,1,16809891,2,2.91E+018,"testalpha"
,"peer reviewed generalemergency medicine","NN VBD NN NN",4,1,1,16365335,"pubmed1",1.75E+018,"testalpha"
,"hepatic colocalization of nhl","JJ NN IN ",4,1,1,17119328,2,4.86E+018,"testalpha"
,"prevalence of pft abnormalities","NN IN  NNS",4,1,1,16809886,2,2.00E+018,"testalpha"
,"results in acute group","NNS IN JJ NN",4,1,1,16491217,2,6.99E+018,"testalpha"
,"lectins of algal origin","NNS IN JJ NN",4,1,1,17128290,"pubmed1",1.36E+018,"testalpha"
,"alteration in cell proliferation","NN IN NN NN",4,1,1,16491217,2,3.44E+018,"testalpha"
,"many years of use","JJ NNS IN NN",4,1,1,16451161,"pubmed1",6.37E+018,"testalpha"
,"lymphocyte count age sex","NNP NN NN NN",4,1,1,16479024,2,1.99E+018,"testalpha"
,"presence of diphosphoglycerate dpg","NN IN NN ",4,1,1,17019442,"pubmed1",7.83E+018,"testalpha"
,"method was used forthe","NN VBD VBN NNP",4,1,1,17285740,"pubmed1",3.17E+018,"testalpha"
,"product dry layer resistances","NN JJ NN NNS",4,1,1,17285744,"pubmed1",6.97E+018,"testalpha"
,"ofac thr glu thr","   ",4,1,1,17117212,"pubmed1",7.95E+018,"testalpha"
,"radiofrequency catheter ablation rfa","NN NN NN ",4,1,1,16696443,2,1.48E+018,"testalpha"
,"hypothalamus nucleusaccumbens limbic system","NN NNS JJ NN",4,1,1,16594639,"pubmed1",4.67E+018,"testalpha"
,"fordetermination of lower traces","NN IN JJR NNS",4,1,1,16700150,2,4.82E+018,"testalpha"
,"authors achieving publication insuch","NNS VBG NN NN",4,1,1,16399035,"pubmed1",2.96E+018,"testalpha"
,"quantitative study about alcohol","JJ NN IN NN",4,1,1,16112068,"pubmed1",6.62E+018,"testalpha"
,"deltaabu nme and ac","  CC ",4,1,1,16528413,"pubmed1",7.40E+018,"testalpha"
,"important roles for normalgametogenesis","JJ NNS IN NN",4,1,1,16325891,2,8.43E+018,"testalpha"
,"ina contact clinic women"," NN NN NNS",4,1,1,16710586,2,1.24E+018,"testalpha"
,"attenuation oral contrast agent","NN JJ NN NN",4,1,1,16252139,"pubmed1",4.81E+018,"testalpha"
,"thebirefringence of amyloid deposits","NN IN VB NNS",4,1,1,16714051,2,5.28E+018,"testalpha"
,"signsand symptoms of heart","NN NNS IN NN",4,1,1,16914907,2,5.12E+018,"testalpha"
,"effects in awide range","NNS IN VB NN",4,1,1,17265697,2,7.73E+018,"testalpha"
,"controland decision board group","NN NN NN NN",4,1,1,17106601,2,3.07E+018,"testalpha"
,"women are presented patients","NNS VBP VBN NNS",4,1,1,16424651,2,5.04E+018,"testalpha"
,"concentrations abovethe th age","NNS NNP  NN",4,1,1,16549894,2,8.07E+018,"testalpha"
,"partner inthe last months","NN NNP JJ NNS",4,1,1,16648915,2,1.40E+018,"testalpha"
,"blood pressure and rate","NN NN CC NN",4,1,1,17067136,"pubmed1",5.97E+018,"testalpha"
,"nafld and elevated liver"," CC VBN NN",4,1,1,16673555,2,8.86E+018,"testalpha"
,"large number of degrees","JJ NN IN NNS",4,1,1,16411736,"pubmed1",8.88E+018,"testalpha"
,"water maze examined cognitiveperformance","NN NN VBD NN",4,1,1,17265691,2,2.67E+018,"testalpha"
,"butyl methyl h dioxine","   NN",4,1,1,16456281,2,6.90E+018,"testalpha"
,"attracting lot of attention","VBG NN IN NN",4,1,1,16696438,2,8.22E+018,"testalpha"
,"translocation of labelled bacteria","NN IN VBN NNS",4,1,1,17293960,2,7.03E+018,"testalpha"
,"binding sites in theseallergens","VBG NNS IN NNS",4,1,1,16673562,2,3.54E+018,"testalpha"
,"nulliparous women with singletonpregnancies","JJ NNS IN NNS",4,1,1,16617757,"pubmed1",4.71E+018,"testalpha"
,"poor response hb increase","JJ NN  NN",4,1,1,17119327,2,7.71E+018,"testalpha"
,"ranks amongthe major health","NNS NNP JJ NN",4,1,1,16479029,2,4.19E+017,"testalpha"
,"rapid diagnostics ofrespiratory infections","JJ NNS NN NNS",4,1,1,17019441,"pubmed1",3.51E+018,"testalpha"
,"disubstituted tetrazole ring favours","VBN JJ NN NNS",4,1,1,16496037,"pubmed1",4.26E+018,"testalpha"
,"treatment of cutaneous t","NN IN JJ ",4,1,1,17016038,2,9.19E+018,"testalpha"
,"methods subjects were patients","NNS NNS VBD NNS",4,1,1,16451146,"pubmed1",7.60E+018,"testalpha"
,"contain sialicacids and glycosaminoglycans","VB NNS CC NNS",4,1,1,16764914,2,7.98E+018,"testalpha"
,"group n or hes","NN  CC ",4,1,1,16451158,"pubmed1",6.61E+018,"testalpha"
,"used anticancer drugs cladribine","VBN NN NNS NN",4,1,1,16421443,2,5.38E+018,"testalpha"
,"respiratory rate in rats","NN NN IN NNS",4,1,1,17133957,2,3.77E+018,"testalpha"
,"vigilance complex task vct","NN JJ NN ",4,1,1,16479025,2,2.38E+018,"testalpha"
,"dump trucks at asurface","NN NNS IN NN",4,1,1,16129405,"pubmed1",5.98E+018,"testalpha"
,"methods ast alt andgamma","NNS   NN",4,1,1,17013510,2,8.22E+018,"testalpha"
,"peripheral blood stem celltransplantation","JJ NN VB NN",4,1,1,16914902,2,7.22E+018,"testalpha"
,"thegreat majority of residents","JJ NN IN NNS",4,1,1,16377827,"pubmed1",1.78E+018,"testalpha"
,"cellular immune response againstvirus","JJ JJ NN NN",4,1,1,17010274,2,4.32E+017,"testalpha"
,"related organisms and theirpre","VBN NNS CC ",4,1,1,16770443,"pubmed1",9.40E+017,"testalpha"
,"likelihood tobe at fault","NN  IN NN",4,1,1,16405858,"pubmed1",6.19E+018,"testalpha"
,"mean age of diagnosis","NN NN IN NN",4,1,1,16696444,2,7.30E+017,"testalpha"
,"oflymph node cellular response","NN  JJ NN",4,1,1,16256177,2,6.05E+018,"testalpha"
,"review of current concepts","NN IN JJ NNS",4,1,1,17013518,2,6.59E+018,"testalpha"
,"inspiratory and end expiratoryvolumes","NN CC VB NNS",4,1,1,16399029,"pubmed1",1.42E+017,"testalpha"
,"gels with lactic acid"," IN JJ NN",4,1,1,17285750,"pubmed1",3.62E+018,"testalpha"
,"atopic eczema dermatitis syndrome","NN NN NN NN",4,1,1,17438830,2,9.03E+018,"testalpha"
,"cases of signet ring","NNS IN NN NN",4,1,1,16514844,2,1.88E+018,"testalpha"
,"existingmodels of research training","NNS IN NN NN",4,1,1,16473989,"pubmed1",8.73E+018,"testalpha"
,"factor v leiden mutation","NN  JJ NN",4,1,1,16696443,2,6.82E+018,"testalpha"
,"normal values of haptoglobin","JJ NNS IN NNP",4,1,1,17117609,2,6.84E+018,"testalpha"
,"success in local excision","NN IN JJ NN",4,1,1,17139888,2,8.98E+018,"testalpha"
,"method ofdetecting endometrial lesions","NN VBG JJ NNS",4,1,1,16514842,2,4.75E+018,"testalpha"
,"approach about probablecandidate mirnas","NN IN NN NNP",4,1,1,16770443,"pubmed1",1.25E+018,"testalpha"
,"andconsequent acute systemic toxicity","NN JJ JJ NN",4,1,1,17067137,"pubmed1",3.09E+018,"testalpha"
,"coating on thesize distribution","NN IN VB NN",4,1,1,16594643,"pubmed1",8.33E+018,"testalpha"
,"pathologicvalues of n pudendal","NNS IN  NN",4,1,1,17139884,2,9.22E+018,"testalpha"
,"patients with chronic dermatologicaldiseases","NNS IN JJ NNS",4,1,1,16710575,2,5.02E+017,"testalpha"
,"level results in increase","NN NNS IN NN",4,1,1,16505900,"pubmed1",1.98E+018,"testalpha"
,"ascertain journal manuscript rr","VB JJ NN ",4,1,1,16399035,"pubmed1",8.02E+018,"testalpha"
,"processes includinggrowth differentiation cell","NNS NN NN NN",4,1,1,16713618,2,1.88E+018,"testalpha"
,"red cellgsh px activity","JJ   NN",4,1,1,17160142,"pubmed1",1.87E+018,"testalpha"
,"relationship between electrospinning solution","NN IN VBG NN",4,1,1,16701855,"pubmed1",5.70E+018,"testalpha"
,"effect of oral glutamine","NN IN JJ NN",4,1,1,17293957,2,7.32E+018,"testalpha"
,"performed using confirmatory runs","VBN VBG NN NNS",4,1,1,16584161,"pubmed1",7.31E+018,"testalpha"
,"several other dump analogues","JJ JJ NN NNS",4,1,1,16505899,"pubmed1",3.42E+018,"testalpha"
,"activation and uterine differentiation","NN CC NN NN",4,1,1,16808046,"pubmed1",8.36E+018,"testalpha"
,"technique for mammalian cells","NN IN JJ NNS",4,1,1,16414103,2,8.20E+018,"testalpha"
,"better systolic blood pressures","JJR JJ NN NNS",4,1,1,16617756,"pubmed1",1.75E+018,"testalpha"
,"studied block copolymer mightbe","VBN NN NN ",4,1,1,16701879,"pubmed1",1.49E+018,"testalpha"
,"lesion contained similar cells","NN VBN JJ NNS",4,1,1,16514841,2,5.61E+018,"testalpha"
,"development of carbohydrate drugsand","NN IN NN NN",4,1,1,16730370,2,6.92E+018,"testalpha"
,"units was administered i","NNS VBD VBD ",4,1,1,16451161,"pubmed1",6.21E+018,"testalpha"
,"fibrous cap development calcification","JJ NN NN NN",4,1,1,17007910,2,2.70E+018,"testalpha"
,"casesincluded adenomatoid nodules cases","VBN VB NNS NNS",4,1,1,16514836,2,3.21E+018,"testalpha"
,"asymmetry inmelanocytic lesion images","NN JJ NN NNS",4,1,1,16648914,2,2.90E+017,"testalpha"
,"applicability of modifications onthe","NN IN NNS NNP",4,1,1,17293970,2,2.29E+018,"testalpha"
,"pressure bp andischemia reperfusion","NN  NN NN",4,1,1,16764913,2,3.08E+018,"testalpha"
,"group i andhealthy controls","NN  JJ NNS",4,1,1,16956117,2,5.09E+018,"testalpha"
,"bloodparameters in pediatric patients","NNS IN JJ NNS",4,1,1,16809890,2,8.45E+018,"testalpha"
,"initiation dose intervalbetween infusions","NN NN IN NNS",4,1,1,16549891,2,1.15E+018,"testalpha"
,"thatare below minimum inhibitory","NN IN JJ NN",4,1,1,17106514,"pubmed1",8.21E+018,"testalpha"
,"intravenous administration of cd","JJ NN IN ",4,1,1,17265691,2,8.03E+018,"testalpha"
,"plane by analyzing theirrelationships","NN IN VBG NNS",4,1,1,16399031,"pubmed1",6.93E+018,"testalpha"
,"conversion dc of glass","NN  IN NN",4,1,1,16701856,"pubmed1",4.05E+018,"testalpha"
,"lower extremity motor blockade","JJR NN NN NN",4,1,1,16617757,"pubmed1",8.60E+018,"testalpha"
,"n and acomparison group"," CC NN NN",4,1,1,16202465,"pubmed1",8.82E+018,"testalpha"
,"connections amongalgebraic relationships codon","NNS JJ NNS NNP",4,1,1,16823609,"pubmed1",4.47E+017,"testalpha"
,"ccl and cutaneous t"," CC JJ ",4,1,1,16955181,2,8.57E+018,"testalpha"
,"presenting airborne ige mediatedallergy","VBG NNP  NN",4,1,1,16603103,2,2.39E+018,"testalpha"
,"electroporation maturation of dc","NN NN IN ",4,1,1,16404477,"pubmed1",6.60E+018,"testalpha"
,"aha in appropriate dosages"," IN JJ NNS",4,1,1,16574202,2,1.86E+018,"testalpha"
,"ofmyocardial ischemia without st","JJ NN IN ",4,1,1,16365321,"pubmed1",3.02E+018,"testalpha"
,"repopulating capacity of pbscs","VBG NN IN NNS",4,1,1,17119322,2,4.01E+018,"testalpha"
,"rat bladdersusing ultrastructural morphometry","NN VBG JJ NN",4,1,1,16253314,2,6.49E+017,"testalpha"
,"h of immersion inwater"," IN NN NN",4,1,1,16701856,"pubmed1",6.37E+018,"testalpha"
,"oncology group toxicity scale","NN NN NN NN",4,1,1,17117605,2,5.92E+018,"testalpha"
,"hiv positive tanzanian sti"," JJ JJ ",4,1,1,16874417,2,1.35E+018,"testalpha"
,"blood loss postoperative complications","NN NN JJ NNS",4,1,1,17139896,2,3.11E+018,"testalpha"
,"ethics boards i e","NNS NNS  ",4,1,1,16770860,"pubmed1",6.48E+018,"testalpha"
,"impede recognition and repair","VB NN CC NN",4,1,1,17143337,"pubmed1",8.76E+018,"testalpha"
,"peroxisome proliferatorresponsive element ppre","NN JJ NN ",4,1,1,16951743,"pubmed1",8.01E+018,"testalpha"
,"dismutases catalases andglutathione peroxidases","NNS NNS NN NNS",4,1,1,17160142,"pubmed1",6.67E+018,"testalpha"
,"awareness of possiblecirculating neutrophil","NN IN VBG ",4,1,1,17119329,2,8.02E+018,"testalpha"
,"plant or animal food","NN CC NN NN",4,1,1,16673562,2,9.16E+018,"testalpha"
,"conditions instrument for stress","NNS NN IN NN",4,1,1,16451152,"pubmed1",6.12E+018,"testalpha"
,"blood serum humanpleural fluid","NN NN JJ NN",4,1,1,16929383,"pubmed1",4.57E+018,"testalpha"
,"properties of saturatedphosphatidylcholine pc","NNS IN NN ",4,1,1,16964324,"pubmed1",3.42E+018,"testalpha"
,"ofalternating anions and cations","VBG NNS CC NNS",4,1,1,16456289,2,1.06E+016,"testalpha"
,"prevalence of cervical abnormalities","NN IN JJ NNS",4,1,1,16514839,2,7.09E+018,"testalpha"
,"administration glucagon stimulated c","NN NNP VBN NN",4,1,1,16673610,2,2.98E+018,"testalpha"
,"mild orno radiological abnormalities","JJ  JJ NNS",4,1,1,16673614,2,4.84E+017,"testalpha"
,"actinic keratosesor basal cell","JJ NN NN NN",4,1,1,16955184,2,4.71E+018,"testalpha"
,"attitudes of psoriasis patients","NNS IN NN NNS",4,1,1,17106601,2,7.53E+018,"testalpha"
,"peaces were analyzed macro","NNS VBD VBD NNP",4,1,1,17293971,2,3.18E+018,"testalpha"
,"ultrasound and computed tomography","NN CC VBN NN",4,1,1,17013521,2,7.38E+018,"testalpha"
,"thetapping mode atomic force","VBG NN JJ NN",4,1,1,16701857,"pubmed1",2.51E+018,"testalpha"
,"therapeutic option for palmoplantar","JJ NN IN NN",4,1,1,16585984,2,2.03E+018,"testalpha"
,"influence of working conditions","NN IN VBG NNS",4,1,1,16451152,"pubmed1",8.47E+018,"testalpha"
,"acyl derivatives of length"," NNS IN NN",4,1,1,16511287,2,8.03E+018,"testalpha"
,"male sex primary school","NN NN JJ NN",4,1,1,16236234,"pubmed1",6.65E+017,"testalpha"
,"stabilizingagents glycerol and trimethylamine","NNS NN CC NN",4,1,1,16511258,2,3.85E+018,"testalpha"
,"symptoms of other atopic","NNS IN JJ NN",4,1,1,16859611,2,6.50E+018,"testalpha"
,"procedure was total hysterectomywith","NN VBD JJ NN",4,1,1,17338203,2,8.27E+018,"testalpha"
,"complications including thrombosis progression","NNS VBG NN NN",4,1,1,16549899,2,3.24E+018,"testalpha"
,"developmental changes in pvlocalization","NN NNS IN NN",4,1,1,17046052,2,6.90E+018,"testalpha"
,"patients ml of blood","NNS  IN NN",4,1,1,17117609,2,7.84E+018,"testalpha"
,"gastroenteritis antibiotic antihemetic vermifuge","NN JJ JJ NNP",4,1,1,17293961,2,5.52E+018,"testalpha"
,"c t r q","NN  NN ",4,1,1,16424658,2,6.86E+018,"testalpha"
,"glutamine glutamine group n","NN NN NN ",4,1,1,17293970,2,2.03E+018,"testalpha"
,"ctoffers several potential advantages","NNS JJ JJ NNS",4,1,1,16333707,"pubmed1",7.06E+018,"testalpha"
,"solutions salary and expenses","NNS NN CC NNS",4,1,1,16436795,"pubmed1",7.50E+018,"testalpha"
,"bonded sheet while theaminoquinoline","VBN NN IN NN",4,1,1,16456284,2,3.89E+018,"testalpha"
,"peripubertal femalerats after treatments","NN NNS IN NNS",4,1,1,16714054,2,2.96E+018,"testalpha"
,"leg of thesame patient","NN IN VBD NN",4,1,1,16919313,2,8.18E+018,"testalpha"
,"resp of hemodialysis patients"," IN NN NNS",4,1,1,16696442,2,7.05E+018,"testalpha"
,"gene therapy andcyclophosphamide administration"," NN VB NN",4,1,1,16388313,"pubmed1",3.82E+018,"testalpha"
,"gastric distention small bowel","JJ NN JJ NN",4,1,1,16252139,"pubmed1",3.50E+018,"testalpha"
,"ipc group cirrhotic rats"," NN JJ NNS",4,1,1,17013508,2,3.65E+018,"testalpha"
,"source of systematic error","NN IN JJ NN",4,1,1,16369098,2,6.14E+018,"testalpha"
,"myelosuppressive chemotherapy and underwent","JJ NN CC NN",4,1,1,16918066,"pubmed1",1.02E+018,"testalpha"
,"factorshemodialysis and transfusion count","NN CC NN NN",4,1,1,16696442,2,3.01E+018,"testalpha"
,"subjects were comparing durations","NNS VBD VBG NNS",4,1,1,17133956,2,2.94E+018,"testalpha"
,"responsibilities dio specific salaries","NNS  JJ NNS",4,1,1,16377812,"pubmed1",5.48E+018,"testalpha"
,"sdtf based ona multivariate"," VBN  NN",4,1,1,17133951,2,8.10E+018,"testalpha"
,"lower extremity arterial disease","JJR NN JJ NN",4,1,1,16955188,2,7.62E+018,"testalpha"
,"agglutinationtest and lipid profile","NN CC NN NN",4,1,1,16479028,2,1.81E+018,"testalpha"
,"level of surface activemethacryloxyethyl","NN IN NN ",4,1,1,16701862,"pubmed1",7.30E+018,"testalpha"
,"institutional financial stability colleague","JJ JJ NN NN",4,1,1,16377815,"pubmed1",3.68E+018,"testalpha"
,"national meetings lectures advice","JJ NNS NNS NN",4,1,1,16436795,"pubmed1",6.84E+018,"testalpha"
,"level of ifn g","NN IN  ",4,1,1,16603096,2,4.89E+018,"testalpha"
,"leaves ofstellera chamaejasme l","VBZ NN  ",4,1,1,16456294,2,7.10E+018,"testalpha"
,"ncs dimer crystal structure"," NN NN NN",4,1,1,16511271,2,7.64E+018,"testalpha"
,"uip lip and recruitment"," NN CC NN",4,1,1,16451155,"pubmed1",7.05E+018,"testalpha"
,"lower gastrointestinal tract symptoms","JJR JJ NN NNS",4,1,1,16333702,"pubmed1",7.68E+018,"testalpha"
,"anastomotic height perioperative blood","JJ NN JJ NN",4,1,1,17139896,2,7.61E+017,"testalpha"
,"iron overload by phlebotomies","NN NN IN NNS",4,1,1,17117609,2,5.42E+018,"testalpha"
,"markers of coeliac disease","NNS IN JJ NN",4,1,1,16874419,2,1.28E+018,"testalpha"
,"distribution and encapsulation efficiency","NN CC NN NN",4,1,1,16594643,"pubmed1",1.39E+018,"testalpha"
,"models postgraduate year pgy","NNS NN NN ",4,1,1,16377825,"pubmed1",3.23E+018,"testalpha"
,"myeloid leukemia cml patients","VB NN  NNS",4,1,1,16914906,2,5.96E+018,"testalpha"
,"aid for discussing treatmentoptions","NN IN VBG NNS",4,1,1,17106601,2,7.27E+018,"testalpha"
,"animals werekilled bursting pressure","NNS VBN VBG NN",4,1,1,16612916,"pubmed1",2.92E+018,"testalpha"
,"mechanisms ofbiomolecules on silicon","NNS NNS IN NN",4,1,1,16701857,"pubmed1",3.83E+018,"testalpha"
,"protein in intact plant","NN IN JJ NN",4,1,1,16395523,"pubmed1",8.06E+018,"testalpha"
,"melanocytes and p fak","NNS CC  ",4,1,1,17106595,2,8.01E+018,"testalpha"
,"o gal and h","  CC ",4,1,1,16456293,2,5.45E+018,"testalpha"
,"long term cognitive outcome","JJ NN JJ NN",4,1,1,16436787,"pubmed1",2.65E+018,"testalpha"
,"features in intraoperativeimprint smears","NNS IN NN NNS",4,1,1,16514849,2,2.51E+018,"testalpha"
,"applications ofthe atomic force","NNS NNP JJ NN",4,1,1,16411737,"pubmed1",2.27E+018,"testalpha"
,"methodology thirtywistar albino rats","NN NN NNP NNS",4,1,1,16612918,"pubmed1",2.17E+018,"testalpha"
,"type diabetic patients men","NN JJ NNS NNS",4,1,1,16673610,2,1.44E+018,"testalpha"
,"number oftandem repeat vntr","NN NNP VB ",4,1,1,16424652,2,1.49E+018,"testalpha"
,"values for comparing pre","NNS IN VBG ",4,1,1,16223468,"pubmed1",8.13E+018,"testalpha"
,"tails ofmitochondrial nd transcript","NNS JJ  NN",4,1,1,16505900,"pubmed1",8.57E+018,"testalpha"
,"n hydroxybenzamido ethylammonioethyl aminocarbonyl","   NN",4,1,1,16456282,2,1.46E+018,"testalpha"
,"lengths bp and sequence","NNS  CC NN",4,1,1,16365637,"pubmed1",4.52E+018,"testalpha"
,"fresh gas flow duringmaintenance","JJ NN NN NN",4,1,1,16451150,"pubmed1",6.51E+018,"testalpha"
,"felt patient care teaching","VBD NN NN NN",4,1,1,16377823,"pubmed1",7.77E+018,"testalpha"
,"serum of hemodialysis hd","NN IN NN ",4,1,1,17119323,2,4.15E+018,"testalpha"
,"motor vehicle crash hospitalization","NN NN NN NN",4,1,1,16139232,"pubmed1",8.39E+018,"testalpha"
,"drug abuse eg alcohol","NN NN  NN",4,1,1,16808045,"pubmed1",3.99E+018,"testalpha"
,"ofaspergillus niger and pseudomonas","NN NN CC NNP",4,1,1,17370569,"pubmed1",1.87E+015,"testalpha"
,"impairedvisualization of intrahepatic vessels","NN IN JJ NNS",4,1,1,16673610,2,6.77E+018,"testalpha"
,"cells in preparing pre","NNS IN VBG ",4,1,1,16730054,2,7.99E+017,"testalpha"
,"track record in tissue","NN NN IN NN",4,1,1,16701855,"pubmed1",7.21E+018,"testalpha"
,"glycol dimethacrylate tegdma hydroxyethylmethacrylate","NN NN NN NN",4,1,1,16701862,"pubmed1",4.13E+018,"testalpha"
,"stage chronic myelogenous leukaemia","NN JJ JJ NN",4,1,1,16809884,2,5.97E+017,"testalpha"
,"guards against genomic instability","NNS IN JJ NN",4,1,1,17139886,2,9.15E+018,"testalpha"
,"lymph nodes and liver","NN NNS CC NN",4,1,1,17139879,2,7.62E+018,"testalpha"
,"ofthe atomic force microscope","NNP JJ NN NN",4,1,1,16411737,"pubmed1",3.04E+018,"testalpha"
,"management of pati ents","NN IN  ",4,1,1,17139878,2,6.99E+018,"testalpha"
,"receiveddesflurane n o fentanyl","NN   NN",4,1,1,17236635,"pubmed1",8.60E+018,"testalpha"
,"radiologicalproperties of ac pc","NNS IN  ",4,1,1,16399031,"pubmed1",8.88E+018,"testalpha"
,"outburst of gamma activity","NN IN NN NN",4,1,1,17133951,2,2.99E+018,"testalpha"
,"b or th po","NN CC  ",4,1,1,17293972,2,5.21E+017,"testalpha"
,"microg ml culprit drug","NNP  NN NN",4,1,1,16710577,2,7.86E+018,"testalpha"
,"detection of ureaplasmasin endotracheal","NN IN NNP NN",4,1,1,17019441,"pubmed1",8.20E+017,"testalpha"
,"throughcomputer assisted image processing","NN VBN NN NN",4,1,1,17293967,2,3.18E+018,"testalpha"
,"epidemic and bioterroristagent illnesses","NN CC NN NNS",4,1,1,16400088,"pubmed1",4.08E+018,"testalpha"
,"palmitate from nanoparticulate dispersion","NN IN NN NN",4,1,1,17285742,"pubmed1",2.66E+018,"testalpha"
,"ofmesophyll and bundle sheath","NN CC NN NN",4,1,1,17106510,"pubmed1",8.84E+017,"testalpha"
,"sedimentation analyses on native","NN NNS IN NN",4,1,1,17019436,"pubmed1",2.05E+018,"testalpha"
,"monitoring antibiotics fluid resuscitation","NN NNS NN NN",4,1,1,16365336,"pubmed1",6.26E+018,"testalpha"
,"cardiovascular abnormalities in patients","JJ NNS IN NNS",4,1,1,16424656,2,6.43E+018,"testalpha"
,"aspect in treating hypovolemia","NN IN VBG NN",4,1,1,16762404,2,8.94E+018,"testalpha"
,"gene variant groups e"," NN NNS ",4,1,1,16914906,2,3.42E+017,"testalpha"
,"relevant changes in laboratory","JJ NNS IN NN",4,1,1,16585986,2,8.17E+018,"testalpha"
,"growing evidence thatnatural genome","VBG NN JJ NN",4,1,1,17347785,"pubmed1",8.10E+018,"testalpha"
,"key regulators of membrane","JJ NNS IN NN",4,1,1,16511278,2,7.88E+018,"testalpha"
,"amyloid deposits included reactions","VB NNS VBD NNS",4,1,1,16542712,2,6.44E+018,"testalpha"
,"wholefield of cancer management","NN IN NN NN",4,1,1,17139882,2,2.63E+018,"testalpha"
,"vs than bovine pericardium"," IN NN NN",4,1,1,16701880,"pubmed1",7.67E+018,"testalpha"
,"laboratory parameters acute physiology","NN NNS JJ NN",4,1,1,17117607,2,4.22E+017,"testalpha"
,"nutrition and blood products","NN CC NN NNS",4,1,1,16549897,2,8.61E+018,"testalpha"
,"treatment consisting ofliposomal amphotericin","NN VBG JJ NNP",4,1,1,16918062,"pubmed1",2.00E+018,"testalpha"
,"male rattus norvegicus albinus","NN NN NN NN",4,1,1,17293964,2,4.29E+018,"testalpha"
,"objectives to characterize propofol","NNS IN VB ",4,1,1,16365337,"pubmed1",1.65E+018,"testalpha"
,"survivability and resource utilization","NN CC NN NN",4,1,1,16400088,"pubmed1",8.21E+018,"testalpha"
,"biological tests and food","JJ NNS CC NN",4,1,1,16673561,2,1.57E+017,"testalpha"
,"induced fasciculation and subse","VBN NN CC ",4,1,1,17067136,"pubmed1",7.26E+016,"testalpha"
,"counts fibroblasts vessel neoformation","NNS NNS NN NN",4,1,1,17293959,2,1.61E+018,"testalpha"
,"bisphosphonate ibandronate for thetreatment","NN NN IN NN",4,1,1,17016034,2,6.93E+018,"testalpha"
,"applying dressings while others","VBG NNS IN NNS",4,1,1,16696446,2,2.51E+018,"testalpha"
,"isolated platelets by reversetranscription","VBN NNS IN NN",4,1,1,16733564,"pubmed1",7.97E+018,"testalpha"
,"concepts prototypical technology tools","NNS JJ NN NNS",4,1,1,16473991,"pubmed1",4.52E+018,"testalpha"
,"index bis controlled desflurane","NN  VBN NN",4,1,1,16451145,"pubmed1",6.97E+018,"testalpha"
,"situation and possible future","NN CC JJ NN",4,1,1,16369088,2,8.11E+018,"testalpha"
,"platelet function in neonates","NN NN IN NNS",4,1,1,16549889,2,5.97E+018,"testalpha"
,"dissertation abstracts cochrane library","NN NNS NN NN",4,1,1,16365334,"pubmed1",8.99E+017,"testalpha"
,"andadvanced glycation end products","VBN NN NN NNS",4,1,1,16696441,2,6.53E+018,"testalpha"
,"comparedto non treated rats","  VBN NNS",4,1,1,16537087,2,7.49E+018,"testalpha"
,"revisingthe united states pharmacopeia","NNP VBN NNS ",4,1,1,17285738,"pubmed1",7.57E+018,"testalpha"
,"pancreatic islets in alginate","JJ NNS IN NN",4,1,1,16701881,"pubmed1",5.62E+018,"testalpha"
,"housestaff education and practice","NN NN CC NN",4,1,1,16377816,"pubmed1",4.96E+018,"testalpha"
,"agadministration with gen injection","NN IN  NN",4,1,1,16999986,2,4.22E+018,"testalpha"
,"burnout inventory human services","NN NN JJ NNS",4,1,1,16377826,"pubmed1",8.82E+018,"testalpha"
,"variety of treatment strategies","NN IN NN NNS",4,1,1,16365334,"pubmed1",4.30E+018,"testalpha"
,"creb activation and creb"," NN CC ",4,1,1,17265688,2,3.07E+018,"testalpha"
,"isolated cleft palate cp","VBN NN NN ",4,1,1,17165598,2,2.02E+018,"testalpha"
,"therapeutic effect of lithium","JJ NN IN NN",4,1,1,16733555,"pubmed1",3.67E+018,"testalpha"
,"diffusion method and synchrotron","NN NN CC NNP",4,1,1,16511274,2,7.17E+018,"testalpha"
,"hemodynamic profiles and level","JJ NNS CC NN",4,1,1,16365322,"pubmed1",1.62E+018,"testalpha"
,"remifentanil predicted effect site"," VBD NN NN",4,1,1,17067138,"pubmed1",7.37E+017,"testalpha"
,"yeast open upnew possibilities","NN JJ VB NNS",4,1,1,17019438,"pubmed1",4.01E+017,"testalpha"
,"inthis view energy balance","NNP NN NN NN",4,1,1,16918067,"pubmed1",8.60E+018,"testalpha"
,"cellular processes includinggrowth differentiation","JJ NNS NN NN",4,1,1,16713618,2,7.26E+018,"testalpha"
,"presence of incomplete information","NN IN JJ NN",4,1,1,16426557,"pubmed1",6.10E+018,"testalpha"
,"conclusions institutional clinical practice","NNS JJ JJ NN",4,1,1,16617757,"pubmed1",8.67E+018,"testalpha"
,"lesions and variable association","NNS CC JJ NN",4,1,1,16710585,2,2.55E+018,"testalpha"
,"saline anddextran treated groups","NN NN VBN NNS",4,1,1,16762404,2,4.28E+018,"testalpha"
,"ankle and foot limits","NN CC NN NNS",4,1,1,17293973,2,1.97E+018,"testalpha"
,"examined sixhealthy adult volunteers","VBD JJ NN NNS",4,1,1,16399034,"pubmed1",2.35E+018,"testalpha"
,"themajor steps in evolution","JJ NNS IN NN",4,1,1,17347785,"pubmed1",1.59E+018,"testalpha"
,"differentiated acc with areas","VBN  IN NNS",4,1,1,16514851,2,3.21E+018,"testalpha"
,"infected material from skinulcers","VBN NN IN NNS",4,1,1,17293963,2,3.63E+018,"testalpha"
,"brain heart and lung","NN NN CC NN",4,1,1,16762404,2,3.04E+018,"testalpha"
,"related casualties in windsor","VBN NNS IN NN",4,1,1,16169506,"pubmed1",1.68E+018,"testalpha"
,"deletion ofthe long arm","NN NNP JJ NN",4,1,1,17016041,2,2.64E+018,"testalpha"
,"limited effect of steroids","JJ NN IN NNS",4,1,1,16451161,"pubmed1",3.92E+018,"testalpha"
,"impulses about insufficient firmness","NNS IN JJ NN",4,1,1,17294912,2,8.38E+018,"testalpha"
,"overview of current approaches","NN IN JJ NNS",4,1,1,16369099,2,3.35E+018,"testalpha"
,"available online inreal time","JJ NN NN NN",4,1,1,16770858,"pubmed1",3.44E+018,"testalpha"
,"ofselected cases of atopic","VBN NNS IN NN",4,1,1,16603103,2,7.35E+018,"testalpha"
,"foci of various size"," IN JJ NN",4,1,1,16603097,2,8.78E+018,"testalpha"
,"significant improvement in patients","JJ NN IN NNS",4,1,1,17311738,2,4.45E+018,"testalpha"
,"political culture and theefficiency","JJ NN CC NN",4,1,1,16423318,"pubmed1",1.89E+018,"testalpha"
,"emerging concept in female","VBG NN IN NN",4,1,1,16808046,"pubmed1",4.53E+018,"testalpha"
,"critical perinatalperiods of exposure","JJ NNS IN NN",4,1,1,16808045,"pubmed1",4.75E+018,"testalpha"
,"extractsfor desensitization and insulins","JJ NN CC NNS",4,1,1,17106600,2,8.12E+018,"testalpha"
,"tsp dependent tgfbeta activation"," JJ NN NN",4,1,1,16733556,"pubmed1",1.64E+018,"testalpha"
,"network or active site","NN CC JJ NN",4,1,1,16511248,2,2.01E+018,"testalpha"
,"poor adherenceto dermatological treatment","JJ  JJ NN",4,1,1,16710573,2,3.63E+018,"testalpha"
,"new resident work hour","JJ NN NN NN",4,1,1,16377822,"pubmed1",6.42E+018,"testalpha"
,"polyenoic fatty acid isomerase","JJ JJ NN NN",4,1,1,16511289,2,4.90E+018,"testalpha"
,"nd yag nm laser","   NN",4,1,1,16648911,2,8.15E+018,"testalpha"
,"alterations in transplant patients","NNS IN JJ NNS",4,1,1,17119329,2,8.11E+018,"testalpha"
,"related questions and taskstatements","VBN NNS CC NNS",4,1,1,16438092,"pubmed1",5.22E+018,"testalpha"
,"fluorescence labelledpolymerase binding protein","NN NN VBG NN",4,1,1,16421445,2,3.94E+018,"testalpha"
,"asn thr and thr","  CC ",4,1,1,16511248,2,8.85E+018,"testalpha"
,"benefits ofworking fewer hours","NNS VBG JJR NNS",4,1,1,16377823,"pubmed1",8.09E+018,"testalpha"
,"system revealed similar concerns","NN VBD JJ NNS",4,1,1,16596900,"pubmed1",8.43E+018,"testalpha"
,"limited time for treatmentsupport","JJ NN IN NN",4,1,1,16710575,2,5.79E+018,"testalpha"
,"unstable grade iii slippedcapital","JJ NN  NN",4,1,1,16696447,2,8.04E+018,"testalpha"
,"mucinosis perifolliculitis capitisabscedens lichen","NN NN NNS NNP",4,1,1,17311739,2,3.45E+018,"testalpha"
,"forclassification of systemic lupus","NN IN JJ NN",4,1,1,16479028,2,7.90E+018,"testalpha"
,"usefulness of selected eosinophil","NN IN VBN ",4,1,1,16859611,2,6.97E+018,"testalpha"
,"continuous renewal of cells","JJ NN IN NNS",4,1,1,16569423,2,3.21E+018,"testalpha"
,"study provides evidences thatthe","NN VBZ NNS NNP",4,1,1,17016038,2,6.18E+018,"testalpha"
,"cases withnegative spt results","NNS JJ  NNS",4,1,1,16859611,2,7.63E+017,"testalpha"
,"characterize emergency medicine em","VB NN NN ",4,1,1,16436795,"pubmed1",1.13E+018,"testalpha"
,"outcome mode of delivery","NN NN IN NN",4,1,1,16617757,"pubmed1",3.98E+018,"testalpha"
,"investigatethe potential protective effects","NNP JJ JJ NNS",4,1,1,16537087,2,3.66E+018,"testalpha"
,"element separation iii podates","NN NN  NNS",4,1,1,16411740,"pubmed1",3.56E+018,"testalpha"
,"mri scanning serum biomarkers"," VBG NN NNS",4,1,1,16436787,"pubmed1",3.57E+018,"testalpha"
,"cell structures including changes","NN NNS IN NNS",4,1,1,16720036,2,5.45E+018,"testalpha"
,"galactosidase gene and cytotoxicityevaluations","NN  CC NNS",4,1,1,16701879,"pubmed1",6.59E+018,"testalpha"
,"radiography ct mri emng","NN   ",4,1,1,17688033,2,6.52E+018,"testalpha"
,"histochemical analysis of gus","JJ NN IN ",4,1,1,16395526,"pubmed1",4.94E+018,"testalpha"
,"ph bicarbonate base deficit"," NN NN NN",4,1,1,16491220,2,9.04E+017,"testalpha"
,"injection rate acetate buffer","NN NN NN NN",4,1,1,16584164,"pubmed1",3.47E+018,"testalpha"
,"preparations withderivatives of adenosine","NNS NNS IN NN",4,1,1,16929383,"pubmed1",2.64E+018,"testalpha"
,"role in addressing disparities","NN IN VBG NNS",4,1,1,16473988,"pubmed1",2.58E+018,"testalpha"
,"reviews in emergency medicine","NNS IN NN NN",4,1,1,16365332,"pubmed1",8.80E+018,"testalpha"
,"medline embase current contents","NN NN JJ NNS",4,1,1,16365334,"pubmed1",7.48E+018,"testalpha"
,"andatherosclerosis but further study","NN CC JJ NN",4,1,1,16809885,2,2.90E+018,"testalpha"
,"was euglycemia odds ratio","VBD NN NNS NN",4,1,1,16436794,"pubmed1",5.22E+018,"testalpha"
,"grade iv mucositis duration","NN  NN NN",4,1,1,16424643,2,4.80E+018,"testalpha"
,"divisions ofcultured mammalian cells","NNS VBN JJ NNS",4,1,1,17106512,"pubmed1",1.78E+018,"testalpha"
,"evaluation apache ii score","NN NNP  NN",4,1,1,16365336,"pubmed1",7.46E+018,"testalpha"
,"px activity in patients"," NN IN NNS",4,1,1,17160142,"pubmed1",5.21E+018,"testalpha"
,"loss months after lc","NN NNS IN ",4,1,1,16447096,"pubmed1",6.35E+018,"testalpha"
,"childrenwith ais or cvt","NN  CC ",4,1,1,16549893,2,2.44E+018,"testalpha"
,"cardiovascular system and skin","JJ NN CC NN",4,1,1,17311736,2,8.83E+018,"testalpha"
,"mr images n ct"," NNS  ",4,1,1,16317488,"pubmed1",5.67E+018,"testalpha"
,"andone parent gypsy ng","NN NN NN ",4,1,1,17165598,2,1.75E+018,"testalpha"
,"definitive treatment of lesions","JJ NN IN NNS",4,1,1,17067135,"pubmed1",4.44E+018,"testalpha"
,"prehospital traumacare in sao","NN NN IN ",4,1,1,16491215,2,5.75E+018,"testalpha"
,"peri operative myocardialischemia reperfusion"," JJ NN NN",4,1,1,16451157,"pubmed1",4.17E+018,"testalpha"
,"acid residues vlsat dktnv","NN NNS  ",4,1,1,16770447,"pubmed1",4.69E+018,"testalpha"
,"renal function tests ultrasound","JJ NN NNS NN",4,1,1,16956119,2,2.00E+018,"testalpha"
,"hydration studies inalbino rats","NN NNS NNP NNS",4,1,1,17285742,"pubmed1",8.17E+018,"testalpha"
,"grea transcription factor gfh"," NN NN ",4,1,1,16511259,2,2.70E+018,"testalpha"
,"protein micro array technology","NN NNP NN NN",4,1,1,16714050,2,3.84E+018,"testalpha"
,"rna interference rnai silences"," NN  NNS",4,1,1,16395523,"pubmed1",8.57E+018,"testalpha"
,"bearing activatingtranscription factor camp","NN NN NN NN",4,1,1,16395528,"pubmed1",2.64E+018,"testalpha"
,"lives of mitochondrial mrnas","NNS IN JJ NNP",4,1,1,16389406,"pubmed1",1.47E+018,"testalpha"
,"cells pbmcs in patients","NNS  IN NNS",4,1,1,16710577,2,5.08E+018,"testalpha"
,"muscle of mammary glands","NN IN JJ NNS",4,1,1,16523218,"pubmed1",6.35E+018,"testalpha"
,"energy intake and energy","NN NN CC NN",4,1,1,16479031,2,1.03E+018,"testalpha"
,"betweeninduction of hpnpase mrna","NN IN NN ",4,1,1,16505900,"pubmed1",4.08E+018,"testalpha"
,"resuscitation mechanicalventilation vasopressors inotropes","NN NN NNS NNS",4,1,1,16365336,"pubmed1",9.27E+017,"testalpha"
,"high risk for endocarditis","JJ NN IN NN",4,1,1,16673611,2,4.74E+018,"testalpha"
,"larger lesions gavemore pain","JJR NNS IN NN",4,1,1,16955183,2,5.91E+017,"testalpha"
,"order of magnitude moreefficient","NN IN NN NN",4,1,1,17019436,"pubmed1",1.96E+018,"testalpha"
,"agent in b allwith","NN IN NN NN",4,1,1,16809887,2,6.86E+017,"testalpha"
,"intensive care unit icu","JJ NN NN ",4,1,1,16451156,"pubmed1",3.28E+018,"testalpha"
,"several microns and wall","JJ NNS CC NN",4,1,1,16701854,"pubmed1",2.67E+018,"testalpha"
,"using atomic force microscopy","VBG JJ NN ",4,1,1,16410837,"pubmed1",6.50E+018,"testalpha"
,"necrolysis stevens johnson syndrome","NN NNS NN NN",4,1,1,16710577,2,5.01E+018,"testalpha"
,"preconditioned groups underwent min","VBN NNS NN ",4,1,1,17438835,2,7.08E+018,"testalpha"
,"placebo controlled murine model"," VBN NN NN",4,1,1,16436788,"pubmed1",8.05E+017,"testalpha"
,"harvested tissues proofof product","VBN NNS  NN",4,1,1,16999268,2,6.16E+018,"testalpha"
,"b type hca precipitates","NN NN  NNS",4,1,1,16701876,"pubmed1",9.03E+018,"testalpha"
,"prognostic significance with respect","JJ NN IN NN",4,1,1,17139902,2,5.18E+018,"testalpha"
,"patients under yearsof age","NNS IN  NN",4,1,1,16613748,2,8.50E+018,"testalpha"
,"monitoredfor psa related events","JJ  VBN NNS",4,1,1,16365337,"pubmed1",6.83E+018,"testalpha"
,"occureach year in surface","NN NN IN NN",4,1,1,16129405,"pubmed1",5.82E+018,"testalpha"
,"skin lesions from ad","NN NNS IN NN",4,1,1,16603095,2,2.75E+018,"testalpha"
,"antiproliferative drugs or therapies","JJ NNS CC NNS",4,1,1,16988902,"pubmed1",1.31E+018,"testalpha"
,"board for occupational health","NN IN JJ NN",4,1,1,16438092,"pubmed1",3.25E+018,"testalpha"
,"effectiveness of using flinders","NN IN VBG NNS",4,1,1,16951742,"pubmed1",8.08E+018,"testalpha"
,"andnuclear magnetic resonance spectroscopy","JJ JJ NN ",4,1,1,16700150,2,2.20E+018,"testalpha"
,"childhood isthe optimal time","NN NNP JJ NN",4,1,1,17438833,2,3.79E+018,"testalpha"
,"surfaces by polar hydroxyl","NNS IN JJ ",4,1,1,16964324,"pubmed1",4.50E+018,"testalpha"
,"bortezomib dexamethasone of patients"," NN IN NNS",4,1,1,17119326,2,4.79E+018,"testalpha"
,"functional impairment of platelets","JJ NN IN NNS",4,1,1,16523217,"pubmed1",3.97E+018,"testalpha"
,"costs of apropofol remifentanil","NNS IN  ",4,1,1,16451145,"pubmed1",7.40E+017,"testalpha"
,"understanding of howhigh dose","NN IN VB NN",4,1,1,16808044,"pubmed1",3.50E+018,"testalpha"
,"v leiden mutation inone"," JJ NN NN",4,1,1,16696443,2,9.17E+017,"testalpha"
,"thickness ala nasi defects","NN   NNS",4,1,1,17165594,2,4.19E+018,"testalpha"
,"factor during cabg procedure","NN IN  NN",4,1,1,17338197,2,1.13E+018,"testalpha"
,"rate of lipid peroxidation","NN IN NN NN",4,1,1,16404476,"pubmed1",1.76E+018,"testalpha"
,"aggregation andbetter structural homogeneity","NN NN JJ NN",4,1,1,16511282,2,7.37E+018,"testalpha"
,"ear reconstruction after cancer","NN NN IN NN",4,1,1,16722346,2,2.77E+018,"testalpha"
,"i r group minute"," NN NN NN",4,1,1,17013508,2,1.92E+018,"testalpha"
,"cases with extensive involvement","NNS IN JJ NN",4,1,1,16956117,2,1.65E+018,"testalpha"
,"differentbcr abl gene variants","   NNS",4,1,1,16914906,2,3.06E+018,"testalpha"
,"represent appropriate analytes toassess","VB JJ NNS NN",4,1,1,16714050,2,2.50E+018,"testalpha"
,"incidence in certain countries","NN IN JJ NNS",4,1,1,17016033,2,6.23E+017,"testalpha"
,"adsorption and cell culture","NN CC NN NN",4,1,1,16701874,"pubmed1",2.20E+018,"testalpha"
,"identifying true matches andnonmatches","VBG JJ NNS NNS",4,1,1,16365326,"pubmed1",7.43E+018,"testalpha"
,"various transcription factors c","JJ NN NNS NN",4,1,1,17115080,"pubmed1",4.05E+018,"testalpha"
,"t cell lat protein"," NN  NN",4,1,1,16511262,2,8.41E+018,"testalpha"
,"human activated protein c","JJ VBN NN NN",4,1,1,16365336,"pubmed1",5.51E+017,"testalpha"
,"including exonuclease enzyme solutions","VBG NN  NNS",4,1,1,17285740,"pubmed1",8.53E+018,"testalpha"
,"non caseating granulomatous lymphadenitis"," VBG JJ NN",4,1,1,16256177,2,2.74E+018,"testalpha"
,"isolation of bundle sheath","NN IN NN NN",4,1,1,17106510,"pubmed1",6.81E+018,"testalpha"
,"showed significantsoluble fas ligand","VBD JJ  NN",4,1,1,16710577,2,9.09E+018,"testalpha"
,"factor vii fvii deficiency","NN   NN",4,1,1,16914903,2,4.04E+018,"testalpha"
,"drug administration for treatment","NN NN IN NN",4,1,1,16365328,"pubmed1",1.85E+018,"testalpha"
,"suppressive effect of imatinib","JJ NN IN ",4,1,1,16809884,2,6.15E+018,"testalpha"
,"number of isolated cp","NN IN VBN ",4,1,1,17165598,2,4.17E+018,"testalpha"
,"utilization fluid and electrolyte","NN NN CC NNP",4,1,1,16462411,"pubmed1",2.89E+018,"testalpha"
,"neededless top up medication","NN NN IN NN",4,1,1,16617757,"pubmed1",1.91E+018,"testalpha"
,"sputumconversion complete blood counts","NN JJ NN NNS",4,1,1,16479024,2,1.75E+018,"testalpha"
,"glycol as precipitant diffraction","NN IN JJ NN",4,1,1,16511269,2,4.40E+018,"testalpha"
,"study identified multiple resources","NN VBD JJ NNS",4,1,1,16436795,"pubmed1",1.08E+017,"testalpha"
,"climate likely influences injury","NN JJ NNS NN",4,1,1,16442068,"pubmed1",4.93E+018,"testalpha"
,"planar platinum ii complexes","NN NN  NNS",4,1,1,16397333,2,6.03E+018,"testalpha"
,"modern hospital requires consultants","JJ NN VBZ NNS",4,1,1,17139882,2,6.14E+018,"testalpha"
,"manganesecomplex di mu acetato","JJ   NN",4,1,1,16456265,2,7.11E+018,"testalpha"
,"adjunctive agent in post","JJ NN IN NN",4,1,1,16451144,"pubmed1",1.67E+018,"testalpha"
,"finalmodel including water molecules","NN VBG NN NNS",4,1,1,16421450,2,4.17E+018,"testalpha"
,"byintra arterial nmda challenge","JJ JJ  NN",4,1,1,17133957,2,3.25E+018,"testalpha"
,"inhibited rats by l","VBN NNS IN ",4,1,1,16764913,2,1.19E+018,"testalpha"
,"activation hepatic glutathione gsh","NN JJ NN ",4,1,1,17013507,2,4.10E+018,"testalpha"
,"gal c gal o"," NN  ",4,1,1,16456293,2,8.65E+017,"testalpha"
,"induced dsb but show","VBN  CC NN",4,1,1,16404475,"pubmed1",8.35E+018,"testalpha"
,"performance on longinterstimulus interval","NN IN NN NN",4,1,1,16436796,"pubmed1",8.08E+018,"testalpha"
,"psychological evaluation including assessmentof","JJ NN IN ",4,1,1,17013512,2,7.19E+018,"testalpha"
,"preventivetreatment against new skin","NN IN JJ NN",4,1,1,16585985,2,2.92E+018,"testalpha"
,"vital statistics and mortality","JJ NNS CC NN",4,1,1,16236235,"pubmed1",3.40E+018,"testalpha"
,"use of thereverse flow","NN IN NN NN",4,1,1,16722345,2,3.06E+018,"testalpha"
,"individuals after applying par","NNS IN VBG NN",4,1,1,17438832,2,2.84E+018,"testalpha"
,"patients using retrospectivelyassigned icd","NNS VBG VBN ",4,1,1,16365331,"pubmed1",6.90E+018,"testalpha"
,"total ige and asige","JJ  CC NN",4,1,1,16603096,2,8.11E+018,"testalpha"
,"associatedwith poorer cardiac function","NN JJR JJ NN",4,1,1,16566960,2,3.85E+018,"testalpha"
,"questionnairecontaining closed answer questions","VBG VBD NN NNS",4,1,1,16191426,"pubmed1",2.09E+018,"testalpha"
,"scan reconstruction for use","VB NN IN NN",4,1,1,16399032,"pubmed1",6.17E+018,"testalpha"
,"gelation and chitosan coating","NN CC JJ NN",4,1,1,16594643,"pubmed1",5.20E+018,"testalpha"
,"ml at intubation incision"," IN NN NN",4,1,1,17067138,"pubmed1",6.00E+018,"testalpha"
,"startle response and pre","VB NN CC ",4,1,1,17133954,2,5.94E+017,"testalpha"
,"directtreatment by proteinase k","NN IN NN ",4,1,1,16514835,2,4.24E+018,"testalpha"
,"program for cooperative irb","NN IN JJ ",4,1,1,16770857,"pubmed1",3.72E+018,"testalpha"
,"different grades of colloidal","JJ NNS IN NN",4,1,1,17285749,"pubmed1",7.21E+018,"testalpha"
,"complex class i mhc","JJ NN  ",4,1,1,16511250,2,4.82E+018,"testalpha"
,"stacks of msu crystals","NNS IN  NNS",4,1,1,16514850,2,4.49E+018,"testalpha"
,"dose of m f","NN IN  NN",4,1,1,16436788,"pubmed1",6.09E+018,"testalpha"
,"liquid chromatography mass spectrometry","JJ NN NN NN",4,1,1,17285740,"pubmed1",6.61E+018,"testalpha"
,"inin depth qualitative interviews"," NN JJ NNS",4,1,1,16377827,"pubmed1",9.02E+018,"testalpha"
,"required corticosteroids and ivig","VBN NNS CC ",4,1,1,16424648,2,3.64E+018,"testalpha"
,"t g mutation codon","  NN NNP",4,1,1,17139886,2,7.82E+018,"testalpha"
,"exploration andamphetamine induced locomotor","NN NN VBN NN",4,1,1,16808045,"pubmed1",5.06E+018,"testalpha"
,"thetypical criteria of housekeeping","JJ NNS IN NN",4,1,1,16951743,"pubmed1",6.48E+018,"testalpha"
,"zonula occludens junctional complexes","NN NNS JJ NNS",4,1,1,16253314,2,1.13E+018,"testalpha"
,"carboxylate c h n","NN NN  ",4,1,1,16456283,2,9.24E+017,"testalpha"
,"estimates of displacement showedexcellent","NNS IN NN NN",4,1,1,16399029,"pubmed1",3.64E+018,"testalpha"
,"hours after hp procedure","NNS IN  NN",4,1,1,17013509,2,2.46E+018,"testalpha"
,"ans and dansyl chloride"," CC  NN",4,1,1,16714053,2,7.31E+018,"testalpha"
,"cabg patients mean age"," NNS VBP NN",4,1,1,16451151,"pubmed1",1.36E+018,"testalpha"
,"adrenergic receptors andarteriolar walls","JJ NNS JJ NNS",4,1,1,16874421,2,4.07E+018,"testalpha"
,"epidermal water loss p","JJ NN NN ",4,1,1,16874414,2,2.20E+018,"testalpha"
,"cell carcinomas received topicalala","NN NNP VBD NNP",4,1,1,16955185,2,7.50E+018,"testalpha"
,"found individuals with differentshapes","VBD NNS IN NNS",4,1,1,16722348,2,4.43E+018,"testalpha"
,"was administered i v","VBD VBD  ",4,1,1,16451161,"pubmed1",4.67E+018,"testalpha"
,"groups and watched video","NNS CC VBN NN",4,1,1,16427019,"pubmed1",1.03E+018,"testalpha"
,"patientsreceiving chemotherapy for indolent","VBG NN IN NN",4,1,1,16424646,2,7.82E+018,"testalpha"
,"tert butyl methyl tolylsulfonyl","   NN",4,1,1,16456281,2,7.04E+018,"testalpha"
,"c glc and psi","NN  CC ",4,1,1,16456293,2,3.22E+018,"testalpha"
,"neutrophils sequestration in theinterstitium","NNS NN IN NN",4,1,1,16491220,2,6.16E+018,"testalpha"
,"incrystals of macromolecular complexes","NNS IN JJ NNS",4,1,1,16421445,2,1.73E+018,"testalpha"
,"risk for tumor lysis","NN IN NN NN",4,1,1,16424647,2,8.23E+018,"testalpha"
,"relevant traffic safety issue","JJ NN NN NN",4,1,1,16157285,"pubmed1",7.26E+018,"testalpha"
,"consider specific safety requirements","VB JJ NN NNS",4,1,1,16365330,"pubmed1",5.06E+018,"testalpha"
,"professional apcs by cd","JJ  IN ",4,1,1,16733557,"pubmed1",3.57E+018,"testalpha"
,"coat weight uniformity andmembrane","NN NN NN NN",4,1,1,17285748,"pubmed1",4.03E+018,"testalpha"
,"o and maximum squeezepressure"," CC JJ NN",4,1,1,17139884,2,5.04E+018,"testalpha"
,"significant decrease in tgf","JJ NN IN ",4,1,1,17293967,2,6.30E+018,"testalpha"
,"effects for humanbeing health","NNS IN VBG NN",4,1,1,16956116,2,7.07E+018,"testalpha"
,"isoforms of nitric oxidase","NNS IN JJ NN",4,1,1,16824585,2,8.49E+018,"testalpha"
,"greater risk for hyperglycemia","JJR NN IN NN",4,1,1,16462409,"pubmed1",1.49E+018,"testalpha"
,"time spent obtaining approval","NN VBN VBG NN",4,1,1,16770858,"pubmed1",5.77E+018,"testalpha"
,"theproximal jejunum or distal","JJ NN CC NN",4,1,1,16673563,2,6.23E+018,"testalpha"
,"onthe original assay method","NNP JJ NN NN",4,1,1,17293970,2,7.54E+018,"testalpha"
,"active researchers and inspection","JJ NNS CC NN",4,1,1,16377817,"pubmed1",9.09E+016,"testalpha"
,"telesystolic tsv lv volume","JJ   NN",4,1,1,16989140,2,9.07E+017,"testalpha"
,"m f fulvius venom"," NN NNP NN",4,1,1,16436788,"pubmed1",5.42E+018,"testalpha"
,"bothinos and enos immunoreactivity","NNP CC  NN",4,1,1,16566960,2,1.99E+018,"testalpha"
,"based ed chest painpopulation","VBN VBD NN NN",4,1,1,16365321,"pubmed1",2.81E+018,"testalpha"
,"arterial ischemic stroke ais","JJ JJ NN ",4,1,1,16549893,2,5.29E+018,"testalpha"
,"tracheal resection through mediansternotomy","NN NN IN NN",4,1,1,16612923,"pubmed1",4.92E+018,"testalpha"
,"departmentalclinical risk management committee","JJ NN NN NN",4,1,1,16321534,"pubmed1",5.76E+018,"testalpha"
,"biml transfected ad cells"," VBN NN NNS",4,1,1,16951744,"pubmed1",7.16E+018,"testalpha"
,"bypassing agents recombinant factor","VBG NNS JJ NN",4,1,1,16549892,2,5.31E+018,"testalpha"
,"endothelial dysfunction in diabetes","JJ NN IN NN",4,1,1,16479030,2,5.42E+018,"testalpha"
,"stable lesions group i","JJ NNS VBP ",4,1,1,16956117,2,2.05E+018,"testalpha"
,"ofpositive outcome bias time","JJ NN NN NN",4,1,1,16365332,"pubmed1",6.69E+018,"testalpha"
,"application of d l","NN IN  ",4,1,1,17265692,2,4.15E+018,"testalpha"
,"thisunselected cohort of chest","VBN NN IN NN",4,1,1,16365321,"pubmed1",2.81E+018,"testalpha"
,"oxygen hydrogen sulfurand nitrogen","NN NN NN NN",4,1,1,17143336,"pubmed1",3.86E+017,"testalpha"
,"levels and histopathological liver","NNS CC JJ NN",4,1,1,16612918,"pubmed1",6.87E+018,"testalpha"
,"observed mean hb increase","VBN VB  NN",4,1,1,17119327,2,6.25E+017,"testalpha"
,"adverse effects of cannabinoids","JJ NNS IN NNS",4,1,1,16808046,"pubmed1",2.89E+017,"testalpha"
,"amino acid sequence similarity","NNP NN NN NN",4,1,1,16511287,2,9.10E+018,"testalpha"
,"cell line during hours","NN NN IN NNS",4,1,1,17117608,2,1.92E+017,"testalpha"
,"carbamylated beta amino acids","VBN NN NNP NNS",4,1,1,16511257,2,8.36E+018,"testalpha"
,"isoformsin cortical neuronal culture","NNP JJ JJ NN",4,1,1,17265688,2,3.47E+018,"testalpha"
,"course of thrombocytopenia p","NN IN NNP ",4,1,1,16594642,"pubmed1",2.18E+018,"testalpha"
,"decreased gsh px sod","VBD   ",4,1,1,16999986,2,8.04E+018,"testalpha"
,"patients with pc ofcrc","NNS IN  ",4,1,1,17139879,2,2.59E+018,"testalpha"
,"peripheral blood stem cell","JJ NN VB NN",4,1,1,16809891,2,8.91E+017,"testalpha"
,"addition monocyte cd hbsr","NN NNP  ",4,1,1,16770444,"pubmed1",6.07E+018,"testalpha"
,"using univariate andmultivariate analysis","VBG NN NN NN",4,1,1,16451146,"pubmed1",5.43E+018,"testalpha"
,"cirrhotic rats i r","JJ NNS  NN",4,1,1,17013508,2,1.22E+017,"testalpha"
,"min of bowelischemia min"," IN NN ",4,1,1,17293960,2,2.38E+018,"testalpha"
,"competence and diversity inhealthcare","NN CC NN NN",4,1,1,16473988,"pubmed1",2.32E+018,"testalpha"
,"nitric oxide synthase nnos","JJ VB NN ",4,1,1,16325891,2,3.22E+018,"testalpha"
,"changes in opioid activity","NNS IN VB NN",4,1,1,16496038,"pubmed1",3.35E+018,"testalpha"
,"andclear description of incident","JJ NN IN NN",4,1,1,16426557,"pubmed1",2.54E+018,"testalpha"
,"areduced coronary artery diameter","VBN JJ NN NN",4,1,1,16479030,2,3.75E+018,"testalpha"
,"repair kinetics of caa","NN NNS IN ",4,1,1,16582987,"pubmed1",2.90E+018,"testalpha"
,"rupture force isabout pn","NN NN IN ",4,1,1,16410837,"pubmed1",1.26E+018,"testalpha"
,"anca titres of mpo"," NNS IN ",4,1,1,16648918,2,4.47E+018,"testalpha"
,"done soft tissuerelease procedures","VBN JJ NN NNS",4,1,1,17438833,2,8.66E+018,"testalpha"
,"ornonisolated ankle or foot","VBN NN CC NN",4,1,1,16436790,"pubmed1",7.09E+018,"testalpha"
,"decreases in capacitance p","NNS IN NN ",4,1,1,16874414,2,6.36E+018,"testalpha"
,"oftyrosine at various phs","NN IN JJ ",4,1,1,16951741,"pubmed1",3.45E+018,"testalpha"
,"normal saline venom groups","JJ NN NN NNS",4,1,1,16436788,"pubmed1",2.78E+018,"testalpha"
,"cortex were made thetests","NNP VBD VBN NNS",4,1,1,16491220,2,8.30E+018,"testalpha"
,"analysis of follicular architecture","NN IN JJ NN",4,1,1,17311739,2,2.71E+015,"testalpha"
,"manitoba andon site video","NNP NNP NN NN",4,1,1,16438094,"pubmed1",6.03E+018,"testalpha"
,"side chains tyr asn","NN NNS  ",4,1,1,16511248,2,2.39E+018,"testalpha"
,"aeroallergens and food allergens","NNS CC NN NNS",4,1,1,17438830,2,7.18E+018,"testalpha"
,"lazaroid pretreatment increased expression","VB NN VBN NN",4,1,1,16365323,"pubmed1",2.99E+018,"testalpha"
,"c cells and lung","NN NNS CC NN",4,1,1,16762403,2,1.27E+018,"testalpha"
,"subpopulation of embryonic likestem","NN IN JJ NN",4,1,1,17265690,2,4.75E+018,"testalpha"
,"elevation compression moderate exercise","NN NN JJ NN",4,1,1,16549898,2,8.39E+018,"testalpha"
,"females with other factors","NNS IN JJ NNS",4,1,1,16197912,"pubmed1",3.81E+018,"testalpha"
,"novel zinc finger peptides","NN NN NN NNS",4,1,1,16411739,"pubmed1",6.11E+018,"testalpha"
,"time of supervened group","NN IN VBN NN",4,1,1,16491220,2,8.00E+018,"testalpha"
,"designers and maintenance people","NNS CC NN NNS",4,1,1,16054101,"pubmed1",1.14E+018,"testalpha"
,"withpyknotic nuclei extensive karyorrhexis","JJ  JJ ",4,1,1,16514843,2,1.87E+018,"testalpha"
,"regeneration at mg kg","NN IN  ",4,1,1,17013510,2,2.09E+017,"testalpha"
,"increased serum tsa levels","VBN NN  NNS",4,1,1,16956116,2,2.75E+018,"testalpha"
,"day ld l d","NN   ",4,1,1,17133952,2,5.60E+018,"testalpha"
,"patients were included ina","NNS VBD VBN ",4,1,1,16451159,"pubmed1",3.18E+018,"testalpha"
,"occupational health nurses inc","JJ NN NNS ",4,1,1,16438092,"pubmed1",8.87E+018,"testalpha"
,"ofnovoseven novo nordisk denmark","VBN  JJ NN",4,1,1,16914908,2,5.85E+018,"testalpha"
,"cardinal mutations and inthe","JJ NNS CC NNP",4,1,1,16585980,2,4.91E+018,"testalpha"
,"brown norway rat andnevirapine","JJ NN NN NN",4,1,1,16594644,"pubmed1",6.51E+017,"testalpha"
,"ring chromosome xy r","NN NN  NN",4,1,1,16914909,2,2.39E+018,"testalpha"
,"narrow band uvb photochemotherapy","JJ NN  NN",4,1,1,17311742,2,9.22E+017,"testalpha"
,"means of standard yeast","NNS IN JJ NN",4,1,1,17019438,"pubmed1",7.40E+018,"testalpha"
,"times mechanism penetrating injury","NNS NN JJ NN",4,1,1,16365326,"pubmed1",2.71E+018,"testalpha"
,"mice with lyme arthritis"," IN  NN",4,1,1,16399028,"pubmed1",8.50E+018,"testalpha"
,"results with cell death","NNS IN NN NN",4,1,1,17139880,2,2.78E+018,"testalpha"
,"t treatment or t"," NN CC ",4,1,1,17115080,"pubmed1",1.33E+018,"testalpha"
,"drop vapor diffusion technique","NN  NN NN",4,1,1,16511259,2,6.62E+018,"testalpha"
,"graduated drivers license programs","VBN NNS NN NNS",4,1,1,16171767,"pubmed1",4.55E+018,"testalpha"
,"new treatment modalities e","JJ NN NNS ",4,1,1,16733557,"pubmed1",9.08E+018,"testalpha"
,"experience with centralized review","NN IN VBN NN",4,1,1,16770857,"pubmed1",3.97E+018,"testalpha"
,"antioxidant enzymes superoxide dismutases","JJ NNS VB NNS",4,1,1,17160142,"pubmed1",6.54E+018,"testalpha"
,"counterions and increasingionic strength","NNS CC JJ NN",4,1,1,17285750,"pubmed1",8.00E+018,"testalpha"
,"exon homozygotes t t"," NNS  ",4,1,1,16733564,"pubmed1",2.86E+018,"testalpha"
,"late phase min afterinjection","JJ NN  NN",4,1,1,16333704,"pubmed1",8.29E+018,"testalpha"
,"dios reportedconfusion or overlap"," NN CC ",4,1,1,16377812,"pubmed1",6.09E+018,"testalpha"
,"sil r il il"," NN  ",4,1,1,16603096,2,8.18E+018,"testalpha"
,"treatment dilemmas for healthcareproviders","NN NNS IN NNS",4,1,1,16462411,"pubmed1",1.48E+017,"testalpha"
,"hyperplasias and high grade","NNP CC JJ NN",4,1,1,16514840,2,5.16E+018,"testalpha"
,"dose yields unsatisfactorylong term","NN NNS IN NN",4,1,1,16955185,2,1.23E+018,"testalpha"
,"score reduction nm uvb","NN NN  ",4,1,1,16585984,2,3.61E+017,"testalpha"
,"extended drinking hour policy","VBN NN NN NN",4,1,1,16169506,"pubmed1",4.09E+017,"testalpha"
,"forboth doses investigated p","JJ NNS VBD ",4,1,1,16399028,"pubmed1",1.44E+018,"testalpha"
,"width resolution limit redundancy","NN NN NN NN",4,1,1,16369094,2,4.58E+018,"testalpha"
,"perceived control on safety","VBN NN IN NN",4,1,1,16442068,"pubmed1",1.85E+018,"testalpha"
,"state on enzymatic properties","NN IN JJ NNS",4,1,1,16505899,"pubmed1",4.85E+018,"testalpha"
,"isomerase from propionibacterium acnes","NN IN NN NNS",4,1,1,16511289,2,2.76E+018,"testalpha"
,"superoxide dismutases catalases andglutathione","VB NNS NNS NN",4,1,1,17160142,"pubmed1",3.58E+018,"testalpha"
,"self reported psychiatric morbidity","NN VBD JJ NN",4,1,1,16710573,2,3.79E+018,"testalpha"
,"household in fivesquatter settlements","NN IN NN NNS",4,1,1,16412373,"pubmed1",7.13E+018,"testalpha"
,"target for gene therapy","NN IN  NN",4,1,1,17160143,"pubmed1",7.24E+018,"testalpha"
,"subjects male and female","NNS NN CC NN",4,1,1,16859613,2,3.33E+018,"testalpha"
,"bymtm assuming fixed temperature"," VBG VBN NN",4,1,1,17285744,"pubmed1",7.71E+018,"testalpha"
,"responsive element binding protein","JJ NN VBG NN",4,1,1,16395528,"pubmed1",6.16E+018,"testalpha"
,"leadingcauses of traffic injuries","NNS IN NN NNS",4,1,1,16112069,"pubmed1",8.02E+018,"testalpha"
,"type and diabetic patients","NN CC JJ NNS",4,1,1,16955188,2,2.04E+018,"testalpha"
,"pattern of liver hemangiomas","NN IN NN NNP",4,1,1,16333704,"pubmed1",8.18E+017,"testalpha"
,"controlpresented expression of sod","VBN NN IN ",4,1,1,17293962,2,4.40E+018,"testalpha"
,"precipitate or exacerbate comorbidconditions","NN CC NN NNS",4,1,1,16462404,"pubmed1",1.09E+018,"testalpha"
,"liverhomogenates of ud rats","NNS IN  NNS",4,1,1,16714049,2,2.77E+017,"testalpha"
,"oxygen and ornitrogen species","NN CC NN NN",4,1,1,16808044,"pubmed1",1.16E+018,"testalpha"
,"identifying hereditary spherocytosis hs","VBG JJ NN ",4,1,1,17016037,2,8.81E+018,"testalpha"
,"trends by em investigators","NNS IN  NNS",4,1,1,16365335,"pubmed1",6.94E+018,"testalpha"
,"cases of atopic dermatitis","NNS IN NN NN",4,1,1,16603103,2,7.68E+018,"testalpha"
,"structurecompatibility of short fragments","NN IN JJ NNS",4,1,1,16365636,"pubmed1",8.30E+018,"testalpha"
,"effectsof electrical ear acupuncture"," JJ NN NN",4,1,1,16955182,2,4.57E+017,"testalpha"
,"completeblood cell and reticulocyte","NN NN CC NNP",4,1,1,16424649,2,1.83E+018,"testalpha"
,"delta fatty acid desaturases","NN JJ NN NNS",4,1,1,17063209,"pubmed1",6.50E+018,"testalpha"
,"enlarged lymph nodes andascites","VBD NN NNS NNS",4,1,1,16447095,"pubmed1",8.81E+018,"testalpha"
,"mechanism of tssr instability","NN IN  NN",4,1,1,16733558,"pubmed1",8.51E+018,"testalpha"
,"use of ambulance transport","NN IN NN NN",4,1,1,16321535,"pubmed1",5.12E+018,"testalpha"
,"armpit groinsand intravenous catheter","NN NN JJ NN",4,1,1,17311736,2,8.48E+018,"testalpha"
,"insignificant impact onthe number","JJ NN NNP NN",4,1,1,16198299,"pubmed1",1.95E+018,"testalpha"
,"womenwith known risk factors","NN VBN NN NNS",4,1,1,17338203,2,8.82E+018,"testalpha"
,"mesodermal progenitor cells mpcs","JJ NN NNS ",4,1,1,16696440,2,5.57E+018,"testalpha"
,"patients witha thromboembolic complication","NNS NN JJ NN",4,1,1,16696443,2,2.78E+018,"testalpha"
,"following age gender race","VBG NN NN NN",4,1,1,16365326,"pubmed1",5.58E+017,"testalpha"
,"common map d transport","JJ NN  NN",4,1,1,16451150,"pubmed1",6.86E+018,"testalpha"
,"cells transcription factor oct","NNS NN NN ",4,1,1,17265694,2,2.05E+017,"testalpha"
,"theconsequences of median barrier","NNS IN JJ NN",4,1,1,16442487,"pubmed1",1.30E+018,"testalpha"
,"carvedilol by decreasing level"," IN VBG NN",4,1,1,17338197,2,5.90E+018,"testalpha"
,"fab subtype raeb t"," JJ  ",4,1,1,16914909,2,7.21E+018,"testalpha"
,"patients with intermediate beta","NNS IN JJ NN",4,1,1,16809886,2,5.84E+017,"testalpha"
,"trianglesimilarity matrices per country","NN NNS IN NN",4,1,1,16191426,"pubmed1",8.63E+018,"testalpha"
,"near infrared nir emission","JJ VBN  NN",4,1,1,16411740,"pubmed1",7.75E+018,"testalpha"
,"usingperformance indicators lr expression","NN NNS  NN",4,1,1,16514834,2,8.68E+018,"testalpha"
,"emergency department ed visits","NN NN VBD NNS",4,1,1,16436798,"pubmed1",4.85E+018,"testalpha"
,"solvent tetrahydrofuran for days","NN NN IN NNS",4,1,1,16701856,"pubmed1",7.86E+018,"testalpha"
,"cushing syndrome and congenital","VBG NN CC NN",4,1,1,16245020,"pubmed1",1.90E+018,"testalpha"
,"pathology of thyroid cancer","NN IN NN NN",4,1,1,17046053,2,4.00E+018,"testalpha"
,"f box proteinsbind proteins","NN NN IN NNS",4,1,1,16496042,"pubmed1",7.25E+018,"testalpha"
,"growth of horny scutes","NN IN JJ NNS",4,1,1,16733064,2,1.56E+018,"testalpha"
,"risk high perceived prevalence","NN JJ VBN NN",4,1,1,16191426,"pubmed1",6.52E+017,"testalpha"
,"blood brain barrier endothelia","NN NN NN NNP",4,1,1,16828846,2,5.41E+018,"testalpha"
,"pathologic values of pn","JJ NNS IN ",4,1,1,17139884,2,3.85E+018,"testalpha"
,"squamous cell carcinomas sccs","JJ NN NNP ",4,1,1,16514834,2,3.29E+018,"testalpha"
,"medium by transfected bhk","NN IN VBN ",4,1,1,16914903,2,3.66E+017,"testalpha"
,"ray powder diffraction ltxrd"," NN NN ",4,1,1,17285745,"pubmed1",2.13E+018,"testalpha"
,"stbetarii fc in ns","  IN ",4,1,1,16733563,"pubmed1",8.51E+018,"testalpha"
,"average intake of proteins","NN NN IN NNS",4,1,1,16999267,2,8.35E+018,"testalpha"
,"patients withtype diabetes t","NNS JJ NN ",4,1,1,16918068,"pubmed1",8.57E+018,"testalpha"
,"thirdsof motor vehicle crashes"," NN NN NNS",4,1,1,16236233,"pubmed1",6.20E+018,"testalpha"
,"l and l proteins"," CC  NNS",4,1,1,17010274,2,2.52E+018,"testalpha"
,"alanine aminotransferase alt glycemia","NN NN  NN",4,1,1,17013507,2,7.63E+018,"testalpha"
,"autumn fall thin corneocytes","NN NN JJ NNS",4,1,1,16733064,2,7.49E+018,"testalpha"
,"awide variety of diseases","VB NN IN NNS",4,1,1,17068636,"pubmed1",6.14E+018,"testalpha"
,"court actions and treatments","NN NNS CC NNS",4,1,1,16112068,"pubmed1",4.67E+018,"testalpha"
,"temperaturesduring months of investigation","VBG NNS IN NN",4,1,1,16584150,"pubmed1",1.65E+018,"testalpha"
,"lymphocytic group e g","JJ NN  ",4,1,1,17311739,2,7.87E+018,"testalpha"
,"water molecules forman r","NN NNS NN NN",4,1,1,16456284,2,7.64E+018,"testalpha"
,"using polymerase chain reaction","VBG NN NN NN",4,1,1,16514834,2,8.91E+018,"testalpha"
,"pancreas soft tissue breast","NNS JJ NN NN",4,1,1,16514845,2,8.86E+018,"testalpha"
,"augmented hpnpase mrna level","VBD NN  NN",4,1,1,16505900,"pubmed1",2.54E+018,"testalpha"
,"serious risk for road","JJ NN IN NN",4,1,1,16443186,"pubmed1",8.82E+017,"testalpha"
,"consecutive adultpatients with ankle","JJ NNS IN NN",4,1,1,16436790,"pubmed1",2.19E+018,"testalpha"
,"fii fvii or fx","  CC ",4,1,1,16424651,2,8.63E+017,"testalpha"
,"patients needed re intervention","NNS VBD  NN",4,1,1,16612911,2,3.12E+018,"testalpha"
,"protection from reperfusion injury","NN IN NN NN",4,1,1,17338197,2,7.21E+018,"testalpha"
,"forthe identification of gti","NNP NN IN ",4,1,1,17285740,"pubmed1",4.64E+018,"testalpha"
,"transferrinsaturation ts and serum","NN  CC NN",4,1,1,16809889,2,1.46E+018,"testalpha"
,"increased theresponse of cells","VBD NN IN NNS",4,1,1,16395521,"pubmed1",7.23E+018,"testalpha"
,"minimize wri andassociated costs","VB  VBN NNS",4,1,1,16438093,"pubmed1",1.94E+017,"testalpha"
,"errors on ay trials","NNS IN  NNS",4,1,1,16436796,"pubmed1",1.55E+018,"testalpha"
,"lacking individual time control","VBG JJ NN NN",4,1,1,16451152,"pubmed1",8.87E+018,"testalpha"
,"k i nmol l","   ",4,1,1,16594645,"pubmed1",8.35E+018,"testalpha"
,"context of dynamic morphology","NN IN JJ NN",4,1,1,17486414,"pubmed1",7.33E+018,"testalpha"
,"show active eczema lesions","NN JJ NN NNS",4,1,1,16648913,2,1.36E+018,"testalpha"
,"hydroxy nonyl adenine ehna","NN NN NN ",4,1,1,16929383,"pubmed1",7.06E+018,"testalpha"
,"liver abdominal lymph nodes","NN JJ NN NNS",4,1,1,17338205,2,1.12E+018,"testalpha"
,"escitalopram mg and bloodwas","NN  CC ",4,1,1,16584121,"pubmed1",4.93E+018,"testalpha"
,"trichomes andatypical structures phylloclades","NNS JJ NNS NNS",4,1,1,17486414,"pubmed1",4.82E+017,"testalpha"
,"measured consumptionof inhaled anaesthetics","VBN  VBN NNS",4,1,1,16916184,"pubmed1",8.93E+018,"testalpha"
,"assessment evaluation ofpulmonary enhancement","NN NN JJ NN",4,1,1,16399029,"pubmed1",8.59E+018,"testalpha"
,"activity acoustic startle response","NN JJ VB NN",4,1,1,17133954,2,5.97E+017,"testalpha"
,"ast alt andgamma gt","  NN ",4,1,1,17013510,2,7.64E+018,"testalpha"
,"dr cells lacking lineage"," NNS VBG NN",4,1,1,16404477,"pubmed1",6.15E+018,"testalpha"
,"bicyclehelmet law on bicycle","VB NN IN NN",4,1,1,16223468,"pubmed1",6.98E+018,"testalpha"
,"serum concentration of escitalopramwas","NN NN IN ",4,1,1,16584121,"pubmed1",1.24E+018,"testalpha"
,"avoid problems and errors","VB NNS CC NNS",4,1,1,16126153,"pubmed1",1.95E+018,"testalpha"
,"changes of experimental arthritis","NNS IN JJ NN",4,1,1,16399028,"pubmed1",8.31E+017,"testalpha"
,"diffusionmethod using ammonium sulfate","NN VBG NN NN",4,1,1,16511268,2,1.71E+018,"testalpha"
,"been identified inthe gene","VBN VBN NNP ",4,1,1,17311740,2,7.25E+018,"testalpha"
,"initial week of tb","JJ NN IN ",4,1,1,16479024,2,2.15E+018,"testalpha"
,"associated pigment protein complexes","VBN NN NN NNS",4,1,1,17106511,"pubmed1",3.75E+018,"testalpha"
,"instances of rule violations","NNS IN NN NNS",4,1,1,16399040,"pubmed1",1.70E+018,"testalpha"
,"inincreasing numbers of thromboses","VBG NNS IN NNS",4,1,1,16549901,2,3.59E+018,"testalpha"
,"e oncoproteines on june"," NNS IN ",4,1,1,17010274,2,5.99E+018,"testalpha"
,"cells with physiological stresses","NNS IN JJ NNS",4,1,1,16395528,"pubmed1",2.85E+018,"testalpha"
,"j cm in fivedifferent","  IN NN",4,1,1,17013509,2,3.09E+017,"testalpha"
,"cells and cultured plant","NNS CC VBN NN",4,1,1,16395523,"pubmed1",4.40E+017,"testalpha"
,"self immune system orthe","NN JJ NN NNP",4,1,1,16919708,2,5.66E+018,"testalpha"
,"historyand physical examination determination","NN JJ NN NN",4,1,1,16479028,2,4.98E+018,"testalpha"
,"mild tomoderate plaque psoriasis","JJ NN JJ NN",4,1,1,16585986,2,8.53E+018,"testalpha"
,"glutamine scfa group n","NN  NN ",4,1,1,17293957,2,1.89E+018,"testalpha"
,"ratiocan give contradictory results","JJ NN JJ NNS",4,1,1,16823608,"pubmed1",2.98E+018,"testalpha"
,"male and female meanage","NN CC NN NN",4,1,1,16859613,2,4.26E+018,"testalpha"
,"binds with theprotonated pyrimidine","NNS IN VBN NN",4,1,1,16456283,2,2.27E+018,"testalpha"
,"non glycosylated hca ii"," VBN  ",4,1,1,16511271,2,2.19E+018,"testalpha"
,"following pulse therapy mg","VBG NN NN ",4,1,1,16955189,2,1.77E+018,"testalpha"
,"catheter thrombosis in children","NN NN IN NNS",4,1,1,16549897,2,2.07E+018,"testalpha"
,"isi listed radiology journals"," VBN NN NNS",4,1,1,16399035,"pubmed1",7.56E+017,"testalpha"
,"irritation with intense headaches","NN IN JJ NNS",4,1,1,17294913,2,6.78E+017,"testalpha"
,"monomers in space group","NNS IN NN NN",4,1,1,16511271,2,3.66E+017,"testalpha"
,"mutational surface engineering designedto","JJ NN NN ",4,1,1,16369101,2,2.19E+017,"testalpha"
,"cytoplasmic granules papillary clusters","JJ NNS JJ NNS",4,1,1,16514838,2,7.51E+018,"testalpha"
,"post radiation injuri es","NN NN NNP ",4,1,1,17139883,2,6.03E+018,"testalpha"
,"presence of inhibitors ofphosphatases","NN IN NNS NNS",4,1,1,16505899,"pubmed1",6.88E+018,"testalpha"
,"uc patients and lowrectal"," NNS CC NN",4,1,1,17139887,2,6.98E+018,"testalpha"
,"maintenance and custodial staff","NN CC JJ NN",4,1,1,16438093,"pubmed1",3.52E+018,"testalpha"
,"cl and mm mgcl"," CC  ",4,1,1,16648912,2,3.47E+018,"testalpha"
,"biodiversity surrogates atcandidate sites","NN NNS NN NNS",4,1,1,16988906,"pubmed1",4.97E+018,"testalpha"
,"yield substantial variabilityin dissolution","VB JJ  NN",4,1,1,16594638,"pubmed1",2.68E+018,"testalpha"
,"rate of oxygen desaturation","NN IN NN NN",4,1,1,16365337,"pubmed1",1.14E+018,"testalpha"
,"city of anhui province","NN IN  NN",4,1,1,16236234,"pubmed1",8.13E+018,"testalpha"
,"levels of endogenous glucocorticoids","NNS IN JJ NNS",4,1,1,17133953,2,6.96E+018,"testalpha"
,"fasting c peptide fcp","VBG NN VB ",4,1,1,16673610,2,5.89E+018,"testalpha"
,"post anaesthetic care unit","NN JJ NN NN",4,1,1,16451145,"pubmed1",5.19E+018,"testalpha"
,"client with cardiac disease","NN IN JJ NN",4,1,1,16462405,"pubmed1",8.95E+018,"testalpha"
,"treatment of bone defects","NN IN NN NNS",4,1,1,17293965,2,2.93E+018,"testalpha"
,"length recombinant vp protein","NN JJ  NN",4,1,1,16733562,"pubmed1",1.21E+018,"testalpha"
,"trial of abivalent hpv","NN IN NN ",4,1,1,17010274,2,8.58E+018,"testalpha"
,"k or normal saline"," CC JJ NN",4,1,1,17067137,"pubmed1",4.95E+018,"testalpha"
,"internationational contact dermatitis research","JJ NN NN NN",4,1,1,17010264,2,2.12E+018,"testalpha"
,"overall certain platelet response","JJ JJ NN NN",4,1,1,16809885,2,1.60E+018,"testalpha"
,"initials date ofbirth gender","NNS NN JJ NN",4,1,1,16221468,"pubmed1",1.22E+018,"testalpha"
,"crash by maximum injury","NN IN JJ NN",4,1,1,16426556,"pubmed1",3.63E+018,"testalpha"
,"andcardiovascular events during propofol","JJ NNS IN ",4,1,1,16365337,"pubmed1",2.44E+018,"testalpha"
,"cells protein kinase b","NNS NN NN NN",4,1,1,16964326,"pubmed1",8.42E+018,"testalpha"
,"thickness and relativemedial area","NN CC JJ NN",4,1,1,16395522,"pubmed1",1.02E+018,"testalpha"
,"material in various parts","NN IN JJ NNS",4,1,1,17294911,2,3.06E+018,"testalpha"
,"chain reaction for ebv","NN NN IN ",4,1,1,16955191,2,6.84E+017,"testalpha"
,"criteria of housekeeping genes","NNS IN NN NNS",4,1,1,16951743,"pubmed1",8.68E+018,"testalpha"
,"processing during stable propofol","NN IN JJ ",4,1,1,17236636,"pubmed1",9.12E+018,"testalpha"
,"investigate novel particulate carrier","VB NN NN NN",4,1,1,17285742,"pubmed1",2.75E+018,"testalpha"
,"forall other traffic offenses","JJ JJ NN NNS",4,1,1,16202465,"pubmed1",7.55E+018,"testalpha"
,"part of thehpv pathogenlss","NN IN  ",4,1,1,16514834,2,6.09E+018,"testalpha"
,"newer localanesthetics in equipotent","JJR NNS IN NN",4,1,1,16617756,"pubmed1",7.11E+018,"testalpha"
,"proteinexpression in gastric cancers","NN IN JJ NNS",4,1,1,17143338,"pubmed1",4.56E+018,"testalpha"
,"date of last evaluation","NN IN JJ NN",4,1,1,16696444,2,5.79E+018,"testalpha"
,"frequentsymptom and erythema nodosum","NN CC NN NN",4,1,1,16696444,2,9.12E+017,"testalpha"
,"gh pyruvate kinase pk"," NN NN ",4,1,1,17013507,2,5.68E+018,"testalpha"
,"glucuronidase gus reporter gene","NN  NN ",4,1,1,16395526,"pubmed1",7.10E+018,"testalpha"
,"mniii state of manganese"," NN IN NN",4,1,1,16456265,2,2.90E+018,"testalpha"
,"kg confidence interval ci"," NN NN ",4,1,1,16436797,"pubmed1",4.57E+018,"testalpha"
,"probability p eachnewborn pathogen","NN  NNP NN",4,1,1,16823607,"pubmed1",2.59E+018,"testalpha"
,"scf fl and phorbolmyristate","  CC NN",4,1,1,16404477,"pubmed1",3.70E+018,"testalpha"
,"gypsy andone parent gypsy","NN NN NN NN",4,1,1,17165598,2,9.07E+018,"testalpha"
,"phosphokinase cpk in male","NN  IN NN",4,1,1,17338197,2,8.75E+018,"testalpha"
,"protein like conformational stiffness","NN IN JJ NN",4,1,1,16365636,"pubmed1",2.51E+018,"testalpha"
,"atherogenic properties of hdls","JJ NNS IN ",4,1,1,17106515,"pubmed1",5.98E+017,"testalpha"
,"dependent sequences dwi diffusion","JJ NNS  NN",4,1,1,16447077,"pubmed1",7.44E+018,"testalpha"
,"were used toassess sensorimotor","VBD VBN NN NN",4,1,1,17265691,2,5.75E+018,"testalpha"
,"tissue isolated amyloid fibrils","NN VBN VB NNS",4,1,1,16764914,2,2.16E+018,"testalpha"
,"named mesodermal progenitor cells","VBN JJ NN NNS",4,1,1,16696440,2,6.10E+017,"testalpha"
,"grade squamous intraepitheliallesion lsil","NN JJ NN ",4,1,1,16514835,2,8.12E+018,"testalpha"
,"relationships of living organisms","NNS IN VBG NNS",4,1,1,16505901,"pubmed1",8.72E+018,"testalpha"
,"congenital abnormalities involving capillaries","NN NNS VBG NNS",4,1,1,16722347,2,5.14E+018,"testalpha"
,"licensesuspensions and traffic school","NNS CC NN NN",4,1,1,16405858,"pubmed1",8.99E+017,"testalpha"
,"genetic basis of thepatient","JJ NN IN NN",4,1,1,16424663,2,7.19E+018,"testalpha"
,"absorption spectroscopy and hplc","NN  CC ",4,1,1,17117212,"pubmed1",7.45E+018,"testalpha"
,"cartilaginous degeneration and detachment","JJ NN CC NN",4,1,1,17293966,2,7.77E+018,"testalpha"
,"paintreatment treatment of nausea","NN NN IN NNP",4,1,1,16916184,"pubmed1",8.44E+018,"testalpha"
,"ofamorphous calcium phosphate acp","JJ NN NN ",4,1,1,16701862,"pubmed1",5.33E+018,"testalpha"
,"distinct cyclooxygenase and peroxidase","JJ NN CC NN",4,1,1,16421446,2,7.49E+018,"testalpha"
,"studies revealed thatrecombinant stbetarii","NNS VBD JJ ",4,1,1,16733563,"pubmed1",4.82E+018,"testalpha"
,"physical examination and thorax","JJ NN CC ",4,1,1,16696444,2,4.33E+017,"testalpha"
,"importance of dose concentration","NN IN NN NN",4,1,1,16808045,"pubmed1",2.34E+018,"testalpha"
,"complete heavy atom substructure","JJ JJ NN NN",4,1,1,16421448,2,8.79E+018,"testalpha"
,"tumor growth following atherapy","NN NN VBG NN",4,1,1,16733559,"pubmed1",8.55E+018,"testalpha"
,"oncologists and general surgeons","NNS CC JJ NNS",4,1,1,17139901,2,5.40E+018,"testalpha"
,"detectedasymptomatic thrombosis in children","JJ NN IN NNS",4,1,1,16549897,2,5.96E+018,"testalpha"
,"microg kg i v","NNP   ",4,1,1,16424649,2,5.94E+018,"testalpha"
,"cases without invasive investigation","NNS IN JJ NN",4,1,1,16673560,2,7.48E+017,"testalpha"
,"vehicle crashes involving alcohol","NN NNS VBG NN",4,1,1,16236233,"pubmed1",1.25E+017,"testalpha"
,"activates glucocerebrosidase andbeta galactosylceramidase","NNS NN NN NN",4,1,1,16511279,2,4.37E+018,"testalpha"
,"nicotine nic affords n","NN JJ NNS ",4,1,1,16594645,"pubmed1",4.69E+018,"testalpha"
,"accepted oral ct agents","VBN JJ  NNS",4,1,1,16252139,"pubmed1",3.43E+018,"testalpha"
,"appropriate analytes toassess health","JJ NNS NN NN",4,1,1,16714050,2,4.12E+018,"testalpha"
,"mu and delta agonist"," CC NN NN",4,1,1,16496038,"pubmed1",7.29E+018,"testalpha"
,"cd and slight decrease"," CC JJ NN",4,1,1,16256177,2,2.61E+018,"testalpha"
,"shares many clinical features","NNS NN JJ NNS",4,1,1,16451161,"pubmed1",7.16E+018,"testalpha"
,"protein complexes photophosphorylation efficiency","NN NNS NN NN",4,1,1,17106510,"pubmed1",2.98E+018,"testalpha"
,"facilitated differentiation of bmscs","VBN NN IN NNS",4,1,1,16443258,2,6.81E+018,"testalpha"
,"dilation of native coarctation","NN IN NN NN",4,1,1,16612929,"pubmed1",5.69E+018,"testalpha"
,"forms of small bowel","NNS IN JJ NN",4,1,1,16673560,2,5.36E+018,"testalpha"
,"chain atoms from residues","NN NNS IN NNS",4,1,1,16511247,2,5.67E+018,"testalpha"
,"children with type diabetes","NNS IN NN NN",4,1,1,16918071,"pubmed1",8.89E+016,"testalpha"
,"bronchi and vasculature myocytes","NNP CC NN NNS",4,1,1,16770441,"pubmed1",4.19E+018,"testalpha"
,"brain blood uptake ratios","NN NN NN NNS",4,1,1,16584167,"pubmed1",1.97E+017,"testalpha"
,"pcr using anpg mug"," VBG  ",4,1,1,16582987,"pubmed1",4.53E+018,"testalpha"
,"cell differentiation and highgrade","NN NN CC NN",4,1,1,16514851,2,5.32E+018,"testalpha"
,"substantial amount of zea","JJ NN IN ",4,1,1,16963110,2,5.76E+018,"testalpha"
,"groups disclosedhigher liver regeneration","NNS JJ NN NN",4,1,1,17013511,2,2.36E+018,"testalpha"
,"administration improved therapeutic effects","NN VBN JJ NNS",4,1,1,16388313,"pubmed1",3.33E+016,"testalpha"
,"data on motor vehicle","NNS IN NN NN",4,1,1,16171767,"pubmed1",2.94E+018,"testalpha"
,"form of male pseudohermaphroditism","NN IN NN NN",4,1,1,16612933,"pubmed1",8.64E+018,"testalpha"
,"underestimation of heavy vehicle","NN IN JJ NN",4,1,1,16221468,"pubmed1",7.33E+018,"testalpha"
,"useful baselineinformation on school","JJ NN IN NN",4,1,1,16236234,"pubmed1",6.93E+018,"testalpha"
,"effective valve area area","JJ NN NN NN",4,1,1,16989140,2,8.30E+018,"testalpha"
,"helmet studies and review","VB NNS CC NN",4,1,1,16417901,"pubmed1",2.19E+018,"testalpha"
,"ua levels andcreatine phosphokinase"," NNS NN NN",4,1,1,17338197,2,7.56E+018,"testalpha"
,"interpersonal relationships among minority","JJ NNS IN NN",4,1,1,16596898,"pubmed1",8.24E+018,"testalpha"
,"protein egfp asa reporter","NN   NN",4,1,1,16404477,"pubmed1",2.27E+018,"testalpha"
,"formal cognitive andbalance tests","JJ JJ NN NNS",4,1,1,16436787,"pubmed1",9.11E+018,"testalpha"
,"patients undergoing coronary artery","NNS VBG NN NN",4,1,1,16451153,"pubmed1",5.24E+018,"testalpha"
,"justification of such usage","NN IN JJ NN",4,1,1,16988903,"pubmed1",3.33E+018,"testalpha"
,"analysis and parameter distribution","NN CC NN NN",4,1,1,16399030,"pubmed1",3.50E+018,"testalpha"
,"pkc activity inperipheral blood"," NN JJ NN",4,1,1,17016035,2,8.35E+018,"testalpha"
,"asan indicator of merit"," NN IN NN",4,1,1,16399035,"pubmed1",6.41E+017,"testalpha"
,"blinded placebo controlled murine","VBN  VBN NN",4,1,1,16436788,"pubmed1",4.04E+018,"testalpha"
,"sex is themain risk","NN VBZ VB NN",4,1,1,16648915,2,4.42E+018,"testalpha"
,"papillomavirus hpv dna detection","NN   NN",4,1,1,16514835,2,6.51E+018,"testalpha"
,"ischemicbrain damage and tolerance","VB NN CC NN",4,1,1,17265693,2,3.41E+017,"testalpha"
,"eudragit rlpo and rspo","JJ  CC ",4,1,1,16584139,"pubmed1",4.94E+018,"testalpha"
,"surgical resection by histologicexamination","JJ NN IN NN",4,1,1,16514847,2,7.21E+018,"testalpha"
,"review systems in place","NN NNS IN NN",4,1,1,16770859,"pubmed1",6.84E+018,"testalpha"
,"cellular response tooxidative stress","JJ NN JJ NN",4,1,1,17143336,"pubmed1",4.00E+018,"testalpha"
,"knowledge of various aspects","NN IN JJ NNS",4,1,1,16369088,2,1.69E+018,"testalpha"
,"cell acute lymphoblastic leukemia","NN JJ JJ NN",4,1,1,16809887,2,6.11E+018,"testalpha"
,"reactive species with neurotoxicconsequences","JJ NN IN NNS",4,1,1,16808044,"pubmed1",3.35E+018,"testalpha"
,"injectionand aspiration of saline","NN NN IN NN",4,1,1,16447096,"pubmed1",8.59E+018,"testalpha"
,"sequence arg tyr leupsi","NN   NNP",4,1,1,16496037,"pubmed1",8.36E+018,"testalpha"
,"soluble calcium channel blocker","JJ NN NN NN",4,1,1,16436797,"pubmed1",6.38E+018,"testalpha"
,"cpk in male patients"," IN NN NNS",4,1,1,17338197,2,9.00E+018,"testalpha"
,"thrombocytopenic purpura itp children","JJ NNP  NNS",4,1,1,17016035,2,6.14E+018,"testalpha"
,"theexistence of spatial correlation","NN IN JJ NN",4,1,1,16451795,"pubmed1",7.73E+018,"testalpha"
,"th and st days"," CC  NNS",4,1,1,17293969,2,7.04E+018,"testalpha"
,"corrections regarding pahs fluorescence","NNS IN  NN",4,1,1,16404478,"pubmed1",1.74E+018,"testalpha"
,"increase was found foralcohol","NN VBD VBN NN",4,1,1,16169506,"pubmed1",2.23E+018,"testalpha"
,"rugous roughness and homogeneity","JJ NN CC NN",4,1,1,17293968,2,6.92E+018,"testalpha"
,"olf family member amassin"," NN NN NNP",4,1,1,16511251,2,8.93E+018,"testalpha"
,"conserved role forthis enzyme","VBN NN NNP ",4,1,1,16951743,"pubmed1",3.91E+018,"testalpha"
,"c c single bond","NN NN NN NN",4,1,1,16456295,2,3.71E+018,"testalpha"
,"oral saline group sham","JJ NN NN ",4,1,1,17293958,2,5.20E+018,"testalpha"
,"spectrometry lc ms method","NN   NN",4,1,1,17285740,"pubmed1",8.55E+018,"testalpha"
,"characteristic ofthe histidine acid","NN NNP NN NN",4,1,1,16511256,2,9.85E+017,"testalpha"
,"average cost per patient","JJ NN IN NN",4,1,1,16451154,"pubmed1",2.29E+018,"testalpha"
,"membranephase transition fluidity order","NN NN NN NN",4,1,1,16964324,"pubmed1",3.76E+018,"testalpha"
,"lutrol and xanthan gum","NN CC NNP NN",4,1,1,17285742,"pubmed1",1.68E+018,"testalpha"
,"clinical manifestations of svc","JJ NNS IN ",4,1,1,16617761,"pubmed1",8.41E+017,"testalpha"
,"qol of norwegian patients"," IN JJ NNS",4,1,1,16710574,2,8.96E+018,"testalpha"
,"crashes in severe weather","NNS IN JJ NN",4,1,1,16197912,"pubmed1",3.58E+018,"testalpha"
,"cells and cell cycle","NNS CC NN NN",4,1,1,16733561,"pubmed1",4.85E+018,"testalpha"
,"hour incubation with galn","NN NN IN ",4,1,1,16696445,2,6.21E+018,"testalpha"
,"dimensional hydrogen bonded sheet","JJ NN VBN NN",4,1,1,16456284,2,6.22E+018,"testalpha"
,"including tubular necrosis intracellularedema","VBG JJ NN NN",4,1,1,16999986,2,3.31E+017,"testalpha"
,"kg body weight b"," NN NN NN",4,1,1,16549901,2,3.75E+018,"testalpha"
,"rheumatic stenosis posterior leafletpreservation","JJ NN JJ NN",4,1,1,16989140,2,1.46E+018,"testalpha"
,"weight management and cancer","NN NN CC NN",4,1,1,16596897,"pubmed1",6.74E+018,"testalpha"
,"medical colleagues and supervisory","JJ NNS CC NN",4,1,1,16377827,"pubmed1",2.67E+018,"testalpha"
,"membranes with different thickness","NNS IN JJ NN",4,1,1,16964324,"pubmed1",1.17E+018,"testalpha"
,"renal failure in mm","JJ NN IN ",4,1,1,17119326,2,4.50E+018,"testalpha"
,"endogyn endometrial device biogyn"," JJ NN ",4,1,1,16514842,2,8.57E+018,"testalpha"
,"patients complete remission rate","NNS JJ NN NN",4,1,1,16424644,2,7.67E+018,"testalpha"
,"metastasis of cancer cells","NN IN NN NNS",4,1,1,16511286,2,2.70E+018,"testalpha"
,"proliferation and cell death","NN CC NN NN",4,1,1,16770441,"pubmed1",6.23E+018,"testalpha"
,"treatment of bleeding episodes","NN IN VBG NNS",4,1,1,16549892,2,3.63E+018,"testalpha"
,"host cell surface receptors","NN NN NN NNS",4,1,1,16511280,2,4.35E+018,"testalpha"
,"effects of depsipeptide fk","NNS IN VB ",4,1,1,16424655,2,9.15E+018,"testalpha"
,"number of published reports","NN IN VBN NNS",4,1,1,16369091,2,7.54E+018,"testalpha"
,"importance of several causes","NN IN JJ NNS",4,1,1,16191426,"pubmed1",6.97E+018,"testalpha"
,"ofadherent hematopoietic cell survival","NN JJ NN NN",4,1,1,17016038,2,1.56E+018,"testalpha"
,"performance based core values","NN VBN NN NNS",4,1,1,16377814,"pubmed1",9.04E+018,"testalpha"
,"volume mean erythrocyte hb","NN VB NNP ",4,1,1,16809890,2,7.09E+018,"testalpha"
,"own police reporting time","JJ NN NN NN",4,1,1,16430844,"pubmed1",9.15E+018,"testalpha"
,"refining various detectorand crystal","NN JJ NN NN",4,1,1,16369093,2,5.06E+018,"testalpha"
,"day ip for weeks","NN  IN NNS",4,1,1,16714049,2,5.70E+018,"testalpha"
,"part of hischest wall","NN IN NN NN",4,1,1,16612932,"pubmed1",8.51E+018,"testalpha"
,"rats increased renal mda","NNS VBN JJ ",4,1,1,16999986,2,2.26E+018,"testalpha"
,"hold tentimes as much","VB NNS IN NN",4,1,1,16491219,2,3.79E+018,"testalpha"
,"oftotal hip arthroplasty marks","NN NN JJ NNS",4,1,1,16613741,2,6.58E+018,"testalpha"
,"reconstructions were includedand data","NNS VBD NN NNS",4,1,1,17165596,2,6.93E+018,"testalpha"
,"possibility of diabetic ketoacidosis","NN IN JJ NN",4,1,1,16462410,"pubmed1",2.77E+018,"testalpha"
,"il il and il","  CC ",4,1,1,16603096,2,8.57E+018,"testalpha"
,"involving activation ofphagocytic cells","VBG NN JJ NNS",4,1,1,17128291,"pubmed1",2.92E+018,"testalpha"
,"show anadditional cell target","VB JJ NN NN",4,1,1,17016038,2,1.82E+018,"testalpha"
,"kinases and phosphatases endonucleases","NNS CC NNS NNS",4,1,1,16410836,"pubmed1",6.93E+018,"testalpha"
,"strands beta and beta","NNS NN CC NN",4,1,1,16421453,2,3.06E+018,"testalpha"
,"n fiber solution n"," NN NN ",4,1,1,16252139,"pubmed1",4.10E+018,"testalpha"
,"amphotericin b deoxycholate ambd","NNP NN NN ",4,1,1,17370566,"pubmed1",7.63E+018,"testalpha"
,"having previous driver licensesuspensions","VBG JJ NN NNS",4,1,1,16405858,"pubmed1",4.02E+018,"testalpha"
,"results are insemiquantitative agreement","NNS VBP JJ NN",4,1,1,16365636,"pubmed1",7.65E+017,"testalpha"
,"complication of pat procedures","NN IN  NNS",4,1,1,16333710,"pubmed1",8.77E+018,"testalpha"
,"reperfusion injury in rat","NN NN IN NN",4,1,1,16612918,"pubmed1",4.37E+018,"testalpha"
,"dihydrogenphosphate phosphoric acid c","NN JJ NN NN",4,1,1,16456284,2,4.10E+018,"testalpha"
,"dedifferentiation of acinic cell","NN IN JJ NN",4,1,1,16514851,2,9.33E+017,"testalpha"
,"combination ofantagonists of group","NN NNS IN NN",4,1,1,17265692,2,2.04E+018,"testalpha"
,"protein precursors theyeast tim","NN NNS JJS ",4,1,1,16511294,2,7.12E+018,"testalpha"
,"venom csav d polylepsisvenom","NN   NN",4,1,1,16436788,"pubmed1",5.02E+018,"testalpha"
,"bupivacaine and fentanyl microg","NN CC NN NNP",4,1,1,16916188,"pubmed1",5.96E+018,"testalpha"
,"elected date second dose","VBN NN JJ NN",4,1,1,17010274,2,7.92E+018,"testalpha"
,"evaluatedby recording video images","JJ NN NN NNS",4,1,1,16129405,"pubmed1",9.10E+018,"testalpha"
,"b glucuronidase gus reporter","NN NN  NN",4,1,1,16395526,"pubmed1",8.11E+018,"testalpha"
,"fall related spinal cord","NN VBN JJ NN",4,1,1,16111641,"pubmed1",8.66E+018,"testalpha"
,"adescending aorta anastomotic aneurysm","VBG NNP JJ ",4,1,1,16612926,"pubmed1",6.09E+018,"testalpha"
,"residues on human skin","NNS IN JJ NN",4,1,1,16603097,2,2.84E+018,"testalpha"
,"sources and crystallized ina","NNS CC VBN ",4,1,1,16511249,2,5.45E+018,"testalpha"
,"presence of neuroendocrine ne","NN IN NN ",4,1,1,16997356,2,6.36E+018,"testalpha"
,"morbidity after major surgicalprocedures","NN IN JJ NNS",4,1,1,17236639,"pubmed1",7.10E+018,"testalpha"
,"cys phe d cys","   ",4,1,1,16496038,"pubmed1",6.02E+017,"testalpha"
,"ofbleeding location on hand","VBG NN IN NN",4,1,1,16585990,2,4.38E+018,"testalpha"
,"boar testis and epididymis"," NN CC NN",4,1,1,17084885,2,7.83E+018,"testalpha"
,"transmission of human immunodeficiency","NN IN JJ NN",4,1,1,17128290,"pubmed1",2.11E+018,"testalpha"
,"normal brain ct thisevidence","JJ NN  NN",4,1,1,16436787,"pubmed1",2.55E+018,"testalpha"
,"model of intraperitoneal venom","NN IN NN NN",4,1,1,16436788,"pubmed1",2.68E+017,"testalpha"
,"resp of acutehepatitis b"," IN NN NN",4,1,1,16696442,2,2.41E+018,"testalpha"
,"organizations and b irbnet","NNS CC NN NN",4,1,1,16770857,"pubmed1",5.16E+018,"testalpha"
,"evidence based guidelines treatment","NN VBN NNS NN",4,1,1,16549899,2,6.34E+018,"testalpha"
,"introduction of noveltytook place","NN IN NN NN",4,1,1,17133955,2,4.37E+018,"testalpha"
,"pfkfb and pfkfb mrna"," CC  ",4,1,1,17143338,"pubmed1",3.01E+018,"testalpha"
,"triethylene glycol dimethacrylate tegdma","NN NN NN NN",4,1,1,16701862,"pubmed1",7.19E+018,"testalpha"
,"severe complicationsof anastomotic failure","JJ  JJ NN",4,1,1,16612911,2,5.87E+018,"testalpha"
,"cam ii mrna populations","   NNS",4,1,1,16949651,2,5.32E+018,"testalpha"
,"image mri scanning serum","NN  VBG NN",4,1,1,16436787,"pubmed1",8.56E+018,"testalpha"
,"evolution ofischemic brain damage","NN JJ NN NN",4,1,1,17265689,2,3.51E+018,"testalpha"
,"succinate dehydrogenaseand cytochrome oxidase","NN NN NN NN",4,1,1,17068635,"pubmed1",4.98E+018,"testalpha"
,"h quinoneoxidoreductase nqo dt"," NN  ",4,1,1,16929382,"pubmed1",1.62E+018,"testalpha"
,"c bp and uspa","NN  CC ",4,1,1,16964325,"pubmed1",4.46E+018,"testalpha"
,"ofunenhanced sct in patients","VBN  IN NNS",4,1,1,16612913,"pubmed1",1.69E+018,"testalpha"
,"inventories of biodiversity surrogates","NNS IN NN NNS",4,1,1,16988906,"pubmed1",7.26E+018,"testalpha"
,"authors surveyed internal medicine","NNS VBN JJ NN",4,1,1,16377825,"pubmed1",7.65E+018,"testalpha"
,"patientswith atopic dermatitis patients","NN NN NN NNS",4,1,1,16648919,2,1.36E+018,"testalpha"
,"patients with concurrent chemotherapy","NNS IN JJ NN",4,1,1,17117605,2,5.30E+018,"testalpha"
,"arrival volume of patients","NN NN IN NNS",4,1,1,16365329,"pubmed1",4.56E+018,"testalpha"
,"conditions or b people","NNS CC NN NNS",4,1,1,16423319,"pubmed1",2.01E+018,"testalpha"
,"increased levels of uamay","VBN NNS IN NN",4,1,1,17338197,2,3.38E+018,"testalpha"
,"modulation of toxicnucleoside neutralization","NN IN VB NN",4,1,1,16929383,"pubmed1",2.19E+018,"testalpha"
,"skin barriers high carrier","NN NNS JJ NN",4,1,1,16710581,2,8.99E+018,"testalpha"
,"effect against serious head","NN IN JJ NN",4,1,1,16223468,"pubmed1",4.91E+018,"testalpha"
,"complete remission withbreast cancer","JJ NN JJS NN",4,1,1,17016036,2,5.46E+018,"testalpha"
,"such asarthralgias and myalgias","JJ NNP CC NNP",4,1,1,16648918,2,8.69E+018,"testalpha"
,"development of neutralizing antibodies","NN IN VBG NNS",4,1,1,16549892,2,1.24E+018,"testalpha"
,"riding accidents in terms","NN NNS IN NNS",4,1,1,16434013,"pubmed1",4.70E+018,"testalpha"
,"treatment of childhood itp","NN IN NN ",4,1,1,16424649,2,8.40E+017,"testalpha"
,"normal homozygotes g g","JJ NNS  ",4,1,1,16733564,"pubmed1",6.26E+018,"testalpha"
,"beckdepression inventory short form","NN NN JJ NN",4,1,1,16377826,"pubmed1",9.11E+018,"testalpha"
,"increased gsh px sod","VBD   ",4,1,1,16999986,2,1.43E+018,"testalpha"
,"majority of myocardialinfarctions mis","NN IN NNS ",4,1,1,16914907,2,8.11E+018,"testalpha"
,"prevent injury and death","VB NN CC NN",4,1,1,16426561,"pubmed1",2.31E+017,"testalpha"
,"thiosemicarbazone moiety is planar","NN NN VBZ NN",4,1,1,16397328,2,3.02E+018,"testalpha"
,"newformulations of drug products","NNS IN NN NNS",4,1,1,16584164,"pubmed1",1.02E+017,"testalpha"
,"inhibin b inmalignant endometrium","NNP NN JJ NN",4,1,1,16423381,2,2.96E+018,"testalpha"
,"thatimposing rigid work hour","VBG JJ NN NN",4,1,1,16377823,"pubmed1",1.70E+018,"testalpha"
,"members n and patients","NNS  CC NNS",4,1,1,17016037,2,8.59E+018,"testalpha"
,"antigens while further research","NNS IN JJR NN",4,1,1,16919707,2,8.44E+018,"testalpha"
,"body of literature describesoutcomes","NN IN NN NNS",4,1,1,16596897,"pubmed1",1.10E+018,"testalpha"
,"deficiency or fx deficiency","NN CC  NN",4,1,1,16424651,2,8.95E+018,"testalpha"
,"limited number of divisions","JJ NN IN NNS",4,1,1,17106512,"pubmed1",6.35E+018,"testalpha"
,"gains and affected thechanges","NNS CC VBN NNS",4,1,1,16377828,"pubmed1",2.28E+018,"testalpha"
,"eosinophil proteins in serum"," NNS IN NN",4,1,1,16859611,2,4.51E+018,"testalpha"
,"cleavage of trna precursors","NN IN  NNS",4,1,1,16648912,2,5.33E+018,"testalpha"
,"bound solvent h o","VBN NN  ",4,1,1,16511248,2,7.33E+018,"testalpha"
,"studiedthe effects of h","NNP NNS IN ",4,1,1,17046053,2,4.27E+018,"testalpha"
,"x ray diffraction analysis","NN  NN NN",4,1,1,16701860,"pubmed1",7.51E+016,"testalpha"
,"sida sida and sida","  CC ",4,1,1,17013511,2,4.23E+018,"testalpha"
,"sputumconversion and radiological improvement","NN CC JJ NN",4,1,1,16479024,2,4.27E+018,"testalpha"
,"hospital canprovide special interest","NN VB JJ NN",4,1,1,17139882,2,4.57E+018,"testalpha"
,"fentanyl or propofol n","NN CC  ",4,1,1,17236635,"pubmed1",6.21E+018,"testalpha"
,"treatment option for cirrhosis","NN NN IN NN",4,1,1,17013520,2,7.27E+018,"testalpha"
,"byenzyme linked immunosorbent assay"," VBN NN NN",4,1,1,16549888,2,7.46E+018,"testalpha"
,"measuring depression anxiety work","VBG NN NN NN",4,1,1,16377815,"pubmed1",8.59E+018,"testalpha"
,"treatedgroup vs minutes p","NN  NNS ",4,1,1,16436797,"pubmed1",3.06E+018,"testalpha"
,"investigated theeffects of mop","VBD NNS IN ",4,1,1,17016038,2,1.35E+018,"testalpha"
,"symptoms with higher levels","NNS IN JJR NNS",4,1,1,16377815,"pubmed1",2.53E+018,"testalpha"
,"antipneumococcal vaccination and antibioticprophylaxis","JJ NN CC ",4,1,1,16424648,2,9.18E+018,"testalpha"
,"method for minimisingthe truncation","NN IN NNP NN",4,1,1,16823606,"pubmed1",1.12E+018,"testalpha"
,"general mean was p","JJ NN VBD ",4,1,1,17293963,2,5.54E+018,"testalpha"
,"kit culture with pcr"," NN IN ",4,1,1,17019441,"pubmed1",9.12E+016,"testalpha"
,"significant differences in perception","JJ NNS IN NN",4,1,1,16399040,"pubmed1",6.52E+018,"testalpha"
,"clinical symptoms prp d","JJ NNS  ",4,1,1,16770445,"pubmed1",8.11E+018,"testalpha"
,"well studied unicellulareukaryotic organism","NN VBN JJ NN",4,1,1,17063208,"pubmed1",1.54E+018,"testalpha"
,"demonstrated immune system tropism","VBN JJ NN NN",4,1,1,17119328,2,1.54E+017,"testalpha"
,"being asked family history","VBG VBN NN NN",4,1,1,16436792,"pubmed1",4.44E+018,"testalpha"
,"co ordination of resources"," NN IN NNS",4,1,1,16377191,"pubmed1",4.95E+018,"testalpha"
,"key enzyme in trna","NN  IN ",4,1,1,16648912,2,3.49E+018,"testalpha"
,"sentinel node sn biopsy","NN   NN",4,1,1,16491216,2,7.20E+018,"testalpha"
,"primary analysis identified articles","NN NN VBD NNS",4,1,1,16365335,"pubmed1",8.62E+018,"testalpha"
,"application of standardized strain","NN IN VBN NN",4,1,1,16874414,2,3.76E+018,"testalpha"
,"blood transfusions in order","NN NNS IN NN",4,1,1,16809890,2,1.93E+018,"testalpha"
,"affected t lymphocyte proliferation","VBN  NNP NN",4,1,1,17016035,2,7.84E+017,"testalpha"
,"fluid and bovine kidney","NN CC NN NN",4,1,1,16929383,"pubmed1",3.23E+018,"testalpha"
,"fragmentation wereanalyzed using mtt","NN VBN VBG ",4,1,1,16951739,"pubmed1",6.15E+018,"testalpha"
,"traditional divider method significantlyoverestimates","JJ NN NN NNS",4,1,1,16823606,"pubmed1",2.89E+018,"testalpha"
,"free survival of hl","JJ NN IN ",4,1,1,16914904,2,8.45E+018,"testalpha"
,"problem waspositive breath tests","NN JJ NN NNS",4,1,1,16236233,"pubmed1",6.60E+018,"testalpha"
,"sampling devices used tocollect","VBG NNS VBN NN",4,1,1,16514841,2,6.02E+018,"testalpha"
,"biodistribution of sme ssme","NN IN  ",4,1,1,16584167,"pubmed1",2.46E+018,"testalpha"
,"disease factor xi fxi","NN NN  ",4,1,1,16424651,2,8.61E+018,"testalpha"
,"spinalcord injury register ascir","NN NN NN ",4,1,1,16111641,"pubmed1",8.47E+018,"testalpha"
,"inclusive averageannual motor vehicle","JJ JJ NN NN",4,1,1,16139232,"pubmed1",4.47E+018,"testalpha"
,"spectroscopy pcs andlaser diffraction","  NN NN",4,1,1,16584150,"pubmed1",2.62E+016,"testalpha"
,"auditor providing circumferential margin","NN VBG JJ NN",4,1,1,17139882,2,7.82E+017,"testalpha"
,"conclusions in type diabeticpatients","NNS IN NN NNS",4,1,1,16673610,2,2.66E+018,"testalpha"
,"features of basal cell","NNS IN NN NN",4,1,1,16603102,2,5.41E+018,"testalpha"
,"patch testing in eczema","NN NN IN NN",4,1,1,17438830,2,1.36E+018,"testalpha"
,"sensitivity of hpv testing","NN IN  NN",4,1,1,16514835,2,9.14E+018,"testalpha"
,"history of blistering eruptions","NN IN VBG NNS",4,1,1,17311740,2,7.15E+018,"testalpha"
,"female patientwithout clinical manifestations","NN IN JJ NNS",4,1,1,16617761,"pubmed1",1.31E+018,"testalpha"
,"tanzanian sti groupmight question","JJ  NN NN",4,1,1,16874417,2,2.91E+017,"testalpha"
,"cd cells cd cd"," NNS  ",4,1,1,17119322,2,8.53E+018,"testalpha"
,"mechanismsindependent of hr hpv","NN IN  ",4,1,1,16514834,2,7.96E+018,"testalpha"
,"atopic dermatitis ad skinlesions","NN NN NN NNS",4,1,1,16603095,2,2.09E+017,"testalpha"
,"average annual conviction rates","JJ JJ NN NNS",4,1,1,16423318,"pubmed1",8.78E+018,"testalpha"
,"values of bursting pressures","NNS IN VBG NNS",4,1,1,16612917,"pubmed1",8.64E+018,"testalpha"
,"sulfated gags inamyloid deposits","VBN  VB NNS",4,1,1,16714048,2,4.77E+018,"testalpha"
,"concentrations for days induces","NNS IN NNS NNS",4,1,1,17265692,2,6.90E+018,"testalpha"
,"likelihood for negative experiences","NN IN JJ NNS",4,1,1,17236646,"pubmed1",1.22E+018,"testalpha"
,"adults with atopic dermatitis","NNS IN NN NN",4,1,1,16648916,2,4.71E+018,"testalpha"
,"rural manitoba andon site","JJ NNP NNP NN",4,1,1,16438094,"pubmed1",2.92E+016,"testalpha"
,"toinfinity auc inf values","NN   NNS",4,1,1,16584121,"pubmed1",1.47E+018,"testalpha"
,"drugallergy including blood tests","NN IN NN NNS",4,1,1,17106599,2,1.12E+018,"testalpha"
,"sacrificedsome traditional resident education","NN JJ NN NN",4,1,1,16377824,"pubmed1",1.65E+018,"testalpha"
,"toinvestigate patients with atopic","NN NNS IN NN",4,1,1,16648919,2,1.71E+018,"testalpha"
,"morbidity and good success","NN CC JJ NN",4,1,1,17139891,2,5.44E+018,"testalpha"
,"intra extra cellularlocalization substrate","JJ JJ NN NN",4,1,1,17143335,"pubmed1",7.64E+018,"testalpha"
,"dynamic surface tension measurements","JJ NN NN NNS",4,1,1,17285747,"pubmed1",2.46E+018,"testalpha"
,"time overproduction of protein","NN NN IN NN",4,1,1,17294912,2,4.06E+018,"testalpha"
,"angioedema fromangiotensin converting enzyme","NN NNP VBG ",4,1,1,16451161,"pubmed1",6.63E+018,"testalpha"
,"reduction cardioversion fracture reduction","NN NN NN NN",4,1,1,16365337,"pubmed1",1.50E+018,"testalpha"
,"aromatic ring of catechol","JJ NN IN NN",4,1,1,16511281,2,6.02E+017,"testalpha"
,"expansion maycause coagulation abnormalities","NN IN NN NNS",4,1,1,16451158,"pubmed1",8.99E+018,"testalpha"
,"candidiasis in early pregnancy","NN IN JJ NN",4,1,1,16603098,2,7.37E+018,"testalpha"
,"block potentiatesrocuronium during maintenance","NN NN IN NN",4,1,1,17236635,"pubmed1",1.01E+018,"testalpha"
,"advantage of thebipolar system","NN IN JJ NN",4,1,1,16613748,2,3.72E+018,"testalpha"
,"comparing patients with diabetes","VBG NNS IN NN",4,1,1,16989147,2,1.09E+018,"testalpha"
,"subtle neuropathic changes gastresophageal","JJ JJ NNS NN",4,1,1,17338194,2,5.92E+018,"testalpha"
,"intralipid treatedgroup vs minutes","JJ NN  NNS",4,1,1,16436797,"pubmed1",4.79E+018,"testalpha"
,"cells naked bipolar nuclei","NNS JJ JJ ",4,1,1,16514838,2,4.21E+018,"testalpha"
,"increased cd cd ratio","VBN   NN",4,1,1,16256177,2,3.20E+018,"testalpha"
,"expression and lung tissueschanges","NN CC NN NNS",4,1,1,17293964,2,6.50E+018,"testalpha"
,"performance by cd cells","NN IN  NNS",4,1,1,17265691,2,7.02E+018,"testalpha"
,"increase of sialic acid","NN IN JJ NN",4,1,1,16720036,2,4.95E+018,"testalpha"
,"regarding handsor periodontal condition","VBG NN NN NN",4,1,1,16585980,2,4.14E+018,"testalpha"
,"tissue inhibitor ofmetalloproteinase timp","NN NN NN ",4,1,1,16585983,2,7.92E+018,"testalpha"
,"immunopositive forct in lungs","JJ NN IN NNS",4,1,1,16762403,2,3.27E+017,"testalpha"
,"theperiod st of june","NN  IN ",4,1,1,17139899,2,8.60E+018,"testalpha"
,"moderate forms of psoriasis","JJ NNS IN NN",4,1,1,17010269,2,2.28E+018,"testalpha"
,"possess good stability againstcoagulation","VB JJ NN NN",4,1,1,16701854,"pubmed1",7.19E+018,"testalpha"
,"pc and surrounding structures"," CC VBG NNS",4,1,1,16399031,"pubmed1",2.55E+018,"testalpha"
,"internal iliac artery aneurysm","JJ JJ NN ",4,1,1,16612928,"pubmed1",4.26E+018,"testalpha"
,"driver recklessness and driver","NN NN CC NN",4,1,1,16112069,"pubmed1",6.13E+018,"testalpha"
,"standardize treatment among criticalcare","VB NN IN NN",4,1,1,16462409,"pubmed1",1.64E+018,"testalpha"
,"studies with public government","NNS IN JJ NN",4,1,1,16365335,"pubmed1",3.41E+018,"testalpha"
,"immunostimulating agent in april","VBG NN IN NNP",4,1,1,16914909,2,9.15E+018,"testalpha"
,"g csfadministration in combination"," NN IN NN",4,1,1,16809884,2,6.76E+018,"testalpha"
,"immunosuppressive drug and infliximab","JJ NN CC ",4,1,1,16673554,2,2.64E+017,"testalpha"
,"calcipotriol dithranol and tazarotene"," NN CC NN",4,1,1,16874412,2,3.24E+016,"testalpha"
,"lactic acidosis andcardiopulmonary arrest","JJ NN JJ NN",4,1,1,16673614,2,4.38E+018,"testalpha"
,"carboxyl or amine groups"," CC NN NNS",4,1,1,16456289,2,8.34E+017,"testalpha"
,"experiencing aceinhibitor provoked angioedema","VBG NN VBD NN",4,1,1,16451161,"pubmed1",4.98E+018,"testalpha"
,"endoneurium for early andlater","NN IN JJ NN",4,1,1,16414104,2,6.15E+018,"testalpha"
,"cycle arrest and apoptosis","NN NN CC NN",4,1,1,16809887,2,1.13E+018,"testalpha"
,"examined motor vehicle crash","VBD NN NN NN",4,1,1,16139232,"pubmed1",1.55E+017,"testalpha"
,"number of multifocal cases","NN IN JJ NNS",4,1,1,16612935,"pubmed1",8.50E+018,"testalpha"
,"superior point of cc","JJ NN IN ",4,1,1,16399030,"pubmed1",6.63E+017,"testalpha"
,"contrast in thecrystal structure","NN IN NN NN",4,1,1,16456293,2,5.71E+018,"testalpha"
,"peri operative days mortality"," JJ NNS NN",4,1,1,16612914,"pubmed1",8.05E+018,"testalpha"
,"medicinal exposure and smoking","JJ NN CC NN",4,1,1,16582984,"pubmed1",2.12E+018,"testalpha"
,"surgeon gynaecologist and urologist","NN NN CC NN",4,1,1,17139877,2,1.38E+018,"testalpha"
,"main cause of cirrhosis","JJ NN IN NN",4,1,1,17013506,2,6.07E+018,"testalpha"
,"pi kinase inhibitor ly"," NN NN ",4,1,1,16964326,"pubmed1",4.40E+018,"testalpha"
,"setbacks in recent yearswith","NNS IN JJ NN",4,1,1,17010268,2,6.38E+018,"testalpha"
,"blood plus equal amounts","NN CC JJ NNS",4,1,1,16365323,"pubmed1",1.64E+018,"testalpha"
,"normal vascular relationship andportal","JJ JJ NN NN",4,1,1,17013515,2,5.25E+018,"testalpha"
,"ppargamma antagonists failed toreverse","NN NNS VBD NN",4,1,1,16809887,2,5.23E+018,"testalpha"
,"diversity in thehealthcare workforce","NN IN NN NN",4,1,1,16473988,"pubmed1",7.07E+018,"testalpha"
,"collected fromthe community leaders","VBN NNP NN NNS",4,1,1,16596901,"pubmed1",2.12E+018,"testalpha"
,"process and symptomatic therapy","NN CC JJ NN",4,1,1,16956113,2,3.54E+018,"testalpha"
,"nuclear atypia nuclear grade","JJ NNP JJ NN",4,1,1,16514838,2,8.58E+018,"testalpha"
,"rate of macromolecular crystallization","NN IN JJ NN",4,1,1,16369101,2,8.21E+018,"testalpha"
,"external anal sphincters defect","JJ  NNS NN",4,1,1,17139884,2,7.10E+018,"testalpha"
,"dyspnea without obvious cause","NNP IN JJ NN",4,1,1,16673614,2,9.14E+018,"testalpha"
,"gypsies nn gypsy children","NNS  NN NNS",4,1,1,17165598,2,8.02E+017,"testalpha"
,"nifedipine retard patients mg","NN NN NNS ",4,1,1,16612915,"pubmed1",8.74E+018,"testalpha"
,"acids non producing yeastsaccharomyces","NNS  VBG NNS",4,1,1,17063209,"pubmed1",4.26E+018,"testalpha"
,"haveallergic contact dermatitis acd","JJ NN NN ",4,1,1,17010264,2,8.63E+017,"testalpha"
,"thegene named pp fad","NN VBN  NN",4,1,1,17063209,"pubmed1",4.56E+018,"testalpha"
,"heel tendon and crush","NN NNP CC NN",4,1,1,17293959,2,3.49E+018,"testalpha"
,"pfkfb and pfkfb genes"," CC  NNS",4,1,1,17143338,"pubmed1",8.82E+018,"testalpha"
,"methods using theprogram sir","NNS VBG NN NN",4,1,1,16421448,2,3.92E+018,"testalpha"
,"ac and posterior commissure"," CC JJ NN",4,1,1,16399031,"pubmed1",3.23E+018,"testalpha"
,"incise excise or coagulate","NN NN CC NN",4,1,1,17139880,2,4.35E+018,"testalpha"
,"andatypical structures phylloclades cladodes","JJ NNS NNS NNS",4,1,1,17486414,"pubmed1",7.45E+018,"testalpha"
,"co drug abuse eg"," NN NN ",4,1,1,16808045,"pubmed1",3.48E+018,"testalpha"
,"analyses of arrival patterns","NNS IN NN NNS",4,1,1,16365329,"pubmed1",8.98E+016,"testalpha"
,"severityand prognosis of sarcoidosis","NN NN IN NN",4,1,1,16696444,2,5.47E+018,"testalpha"
,"fractalkine cxcl ip ccl","NN   ",4,1,1,16594639,"pubmed1",1.80E+018,"testalpha"
,"clinical presentation of uterine","JJ NN IN NN",4,1,1,17338203,2,4.64E+018,"testalpha"
,"studies of maritime transport","NNS IN JJ NN",4,1,1,16427020,"pubmed1",6.64E+018,"testalpha"
,"vas score forperceived exaggeration"," NN VBN NN",4,1,1,16436793,"pubmed1",5.28E+017,"testalpha"
,"hasserious implications for road","JJ NNS IN NN",4,1,1,16426558,"pubmed1",5.30E+018,"testalpha"
,"evaluatethe results of ruby","NNP NNS IN ",4,1,1,16710582,2,1.52E+018,"testalpha"
,"units per virion particle","NNS IN NN NN",4,1,1,16733562,"pubmed1",1.67E+018,"testalpha"
,"receptors and nmda receptors","NNS CC  NNS",4,1,1,17265692,2,6.60E+018,"testalpha"
,"injuries in malnourished rats","NNS IN VBN NNS",4,1,1,17293959,2,8.60E+018,"testalpha"
,"mask ilma laryngeal tube","  NN NN",4,1,1,16451149,"pubmed1",3.92E+018,"testalpha"
,"arteries are rare causes","NNS VBP JJ NNS",4,1,1,16333706,"pubmed1",2.50E+018,"testalpha"
,"activated protein kinase ampk","VBN NN NN ",4,1,1,16964326,"pubmed1",5.80E+018,"testalpha"
,"average diameter of artemisiaarborescens","NN NN IN NNS",4,1,1,16584150,"pubmed1",2.72E+018,"testalpha"
,"grass pollen allergens patients","NN NN NNS NNS",4,1,1,17328144,2,5.84E+018,"testalpha"
,"radiologicalsigns were appendiceal enlargement","NNS VBD NN NN",4,1,1,16612913,"pubmed1",4.93E+018,"testalpha"
,"viral vectors on theone","JJ NNS IN NN",4,1,1,17285739,"pubmed1",5.63E+018,"testalpha"
,"likestem cells of pluripotent","NN NNS IN NN",4,1,1,17265690,2,6.52E+018,"testalpha"
,"oftraining programs that offer","VBG NNS IN NN",4,1,1,16473998,"pubmed1",3.01E+017,"testalpha"
,"lt and cobrapla cob"," CC  ",4,1,1,16451149,"pubmed1",8.12E+018,"testalpha"
,"cell death after treatment","NN NN IN NN",4,1,1,16956122,2,5.85E+017,"testalpha"
,"including pharmacotherapy andbehavior modification","VBG NN JJ NN",4,1,1,16436789,"pubmed1",5.55E+018,"testalpha"
,"administration of beta d","NN IN NN ",4,1,1,16612917,"pubmed1",1.95E+018,"testalpha"
,"work related traffic crashes","NN VBN NN NNS",4,1,1,16043107,"pubmed1",8.84E+018,"testalpha"
,"performance of emergency physicians","NN IN NN NNS",4,1,1,16436796,"pubmed1",6.01E+018,"testalpha"
,"number ofdiverse late stage","NN NN JJ NN",4,1,1,16462405,"pubmed1",1.27E+018,"testalpha"
,"n rectal tumor resection"," NN NN NN",4,1,1,17139887,2,6.52E+018,"testalpha"
,"idealfor initial screening studies","JJ JJ NN NNS",4,1,1,16414103,2,3.68E+018,"testalpha"
,"e improved outcome markers"," VBN NN NNS",4,1,1,16365323,"pubmed1",5.82E+018,"testalpha"
,"ketoacidosis and hyperosmolar hyperglycemicstates","NN CC JJ NNS",4,1,1,16462410,"pubmed1",3.12E+018,"testalpha"
,"leveland accuracy of information","NN NN IN NN",4,1,1,16321534,"pubmed1",8.75E+018,"testalpha"
,"editing competences of viruses","NN NNS IN NNS",4,1,1,17347785,"pubmed1",3.44E+018,"testalpha"
,"incapable ofsynthesizing purine nucleotides","JJ VBG NN NNS",4,1,1,16421444,2,2.91E+018,"testalpha"
,"time of caesarean delivery","NN IN JJ NN",4,1,1,16809888,2,8.86E+018,"testalpha"
,"prpc prik cpga genes","   NNS",4,1,1,16964327,"pubmed1",1.12E+018,"testalpha"
,"afm and scanning electron"," CC VBG NN",4,1,1,16701867,"pubmed1",8.28E+018,"testalpha"
,"wash brieflybloodstained fta filter","NN VBN  NN",4,1,1,16951742,"pubmed1",4.59E+018,"testalpha"
,"lys glu asp val","   ",4,1,1,16496040,"pubmed1",3.53E+018,"testalpha"
,"allfull length protein crystals","NN NN NN NNS",4,1,1,16511288,2,3.88E+018,"testalpha"
,"general medicinal product safetyprinciples","JJ JJ NN NNS",4,1,1,16999268,2,2.65E+018,"testalpha"
,"area in psoriatic lesions","NN IN JJ NNS",4,1,1,17034836,2,7.65E+018,"testalpha"
,"ups was yearsafter surgery","NNS VBD NN NN",4,1,1,17438833,2,9.20E+017,"testalpha"
,"expansionand survival of cd","NN NN IN ",4,1,1,16511253,2,3.80E+017,"testalpha"
,"patients were enrolled males","NNS VBD VBD NNS",4,1,1,16955188,2,4.29E+018,"testalpha"
,"program for africanamerican elderly","NN IN JJ NN",4,1,1,16596901,"pubmed1",1.28E+018,"testalpha"
,"lymph node biopsy tissue","NN  NN NN",4,1,1,16256177,2,8.16E+017,"testalpha"
,"gene exons using dna"," NNS VBG ",4,1,1,16582987,"pubmed1",7.96E+018,"testalpha"
,"plasma fromatopic dermatitis patients","NNP NN NN NNS",4,1,1,16955181,2,2.72E+018,"testalpha"
,"histology water content amino","NN NN JJ NNP",4,1,1,16701880,"pubmed1",5.32E+017,"testalpha"
,"months after thestudy period","NNS IN NN NN",4,1,1,17106599,2,1.27E+018,"testalpha"
,"therapy strategies and definition","NN NNS CC NN",4,1,1,17117607,2,3.74E+018,"testalpha"
,"shows uniquedna binding features","VBZ  VBG NNS",4,1,1,16511254,2,6.30E+018,"testalpha"
,"immune response in mice","JJ NN IN ",4,1,1,16733559,"pubmed1",7.74E+018,"testalpha"
,"human saposin c activates","JJ NNP NN NNS",4,1,1,16511279,2,7.64E+018,"testalpha"
,"were reproduciblewith relative standard","VBD NN JJ NN",4,1,1,17285749,"pubmed1",8.76E+018,"testalpha"
,"analogs produced maximal inhibition","NNS VBN JJ NN",4,1,1,16594645,"pubmed1",3.85E+017,"testalpha"
,"sub clusters per cluster","NN NNS IN NN",4,1,1,16126153,"pubmed1",3.11E+017,"testalpha"
,"technological changes inacademic research","JJ NNS JJ NN",4,1,1,16377817,"pubmed1",6.48E+018,"testalpha"
,"bythe residency review committee","NNP NN NN NN",4,1,1,16473998,"pubmed1",3.07E+018,"testalpha"
,"inalcohol related motor vehicle","NN VBN NN NN",4,1,1,16169506,"pubmed1",2.32E+018,"testalpha"
,"myc mrna and c","  CC NN",4,1,1,16809887,2,1.79E+018,"testalpha"
,"row computed tomography mdct","VB VBN NN ",4,1,1,16333701,"pubmed1",5.54E+018,"testalpha"
,"size of platelet aggregates","NN IN NN NNS",4,1,1,16549890,2,4.61E+018,"testalpha"
,"abundance and specificity foraaaf","NN CC NN ",4,1,1,17143337,"pubmed1",1.80E+018,"testalpha"
,"events during propofol psa","NNS IN  ",4,1,1,16365337,"pubmed1",8.60E+018,"testalpha"
,"rate effect relates todifferences","NN NN NNS NNS",4,1,1,16421442,2,5.58E+017,"testalpha"
,"phase and tc collapse","NN CC  NN",4,1,1,17285745,"pubmed1",8.76E+018,"testalpha"
,"assessed pressure volume pv","VBN NN NN ",4,1,1,16451155,"pubmed1",7.19E+018,"testalpha"
,"pulsed field gel electrophoresis","VBN NN  NN",4,1,1,16710581,2,7.40E+018,"testalpha"
,"rate of hepatocyte injury","NN IN NNP NN",4,1,1,16696445,2,3.54E+018,"testalpha"
,"gtn and oral nifedipine"," CC JJ NN",4,1,1,16612915,"pubmed1",7.29E+018,"testalpha"
,"maximum pep ck type","JJ   NN",4,1,1,17106510,"pubmed1",2.21E+018,"testalpha"
,"min beta cells priorto"," NN NNS NNP",4,1,1,16701853,"pubmed1",1.31E+018,"testalpha"
,"years group ii years","NNS VBP  NNS",4,1,1,16809889,2,8.28E+018,"testalpha"
,"mucous extravasation phenomenon similarity","JJ NN NN NN",4,1,1,16899283,2,2.69E+018,"testalpha"
,"magnitude moreefficient than chloride","NN NN IN NN",4,1,1,17019436,"pubmed1",9.21E+018,"testalpha"
,"accessibilityof breast care resources"," NN NN NNS",4,1,1,16596895,"pubmed1",8.24E+018,"testalpha"
,"effects and space timeinteractions","NNS CC NN NNS",4,1,1,16451795,"pubmed1",4.21E+018,"testalpha"
,"levels change withbiological effects","NNS VB JJ NNS",4,1,1,16714050,2,1.14E+018,"testalpha"
,"unknown bacteriophage p lysozyme","JJ NN  ",4,1,1,16421448,2,4.49E+018,"testalpha"
,"fortnight formeasurement of marp","NN NN IN ",4,1,1,16612915,"pubmed1",8.72E+018,"testalpha"
,"phaset weighted gre images","VB JJ  NNS",4,1,1,16317488,"pubmed1",2.41E+018,"testalpha"
,"broumov ossuary th th"," JJ  ",4,1,1,17438834,2,1.24E+018,"testalpha"
,"efforts toimprove organizational safety","NNS VB JJ NN",4,1,1,16442068,"pubmed1",8.35E+018,"testalpha"
,"increased risk standardized mortality","VBD NN VBN NN",4,1,1,16710578,2,6.03E+018,"testalpha"
,"gtp binding consensus sequences"," VBG NN NNS",4,1,1,16365637,"pubmed1",6.04E+017,"testalpha"
,"value of release rate","NN IN NN NN",4,1,1,16584161,"pubmed1",2.06E+018,"testalpha"
,"hadaffected first degree relatives","VBN JJ NN NNS",4,1,1,17010267,2,6.09E+018,"testalpha"
,"chronic hepatitis b resp","JJ NN NN ",4,1,1,16696442,2,5.85E+018,"testalpha"
,"properties of ac delta","NNS IN  NN",4,1,1,16528414,"pubmed1",4.29E+018,"testalpha"
,"c activity on clearance","NN NN IN NN",4,1,1,16584121,"pubmed1",5.43E+018,"testalpha"
,"x u of rhepo","NN  IN ",4,1,1,17119327,2,6.52E+018,"testalpha"
,"requirements for further research","NNS IN JJR NN",4,1,1,16474001,"pubmed1",4.95E+018,"testalpha"
,"treatment at normaldosage levels","NN IN NN NNS",4,1,1,17370566,"pubmed1",4.25E+018,"testalpha"
,"stress oriented task analysis","NN VBN NN NN",4,1,1,16451152,"pubmed1",8.05E+018,"testalpha"
,"dental implantology and orthopaedics","JJ NN CC NNS",4,1,1,16701867,"pubmed1",3.61E+018,"testalpha"
,"spinal cord injury sci","JJ NN NN ",4,1,1,16916187,"pubmed1",6.12E+018,"testalpha"
,"skin andrespiratory tract infections","NN NN NN NNS",4,1,1,16365328,"pubmed1",5.66E+018,"testalpha"
,"proteinsin serum or blood","NNP NN CC NN",4,1,1,16714050,2,6.68E+018,"testalpha"
,"pbs washing and i"," NN CC ",4,1,1,16514835,2,1.15E+018,"testalpha"
,"phenotypes insingle evolutionary events","NNS NN JJ NNS",4,1,1,17347785,"pubmed1",4.97E+018,"testalpha"
,"number of othercellular processes","NN IN JJ NNS",4,1,1,16410835,"pubmed1",2.99E+018,"testalpha"
,"hb hematocrit erythrocyte indices"," NN NNP NNS",4,1,1,16809890,2,2.54E+018,"testalpha"
,"administration of cd cells","NN IN  NNS",4,1,1,17265691,2,8.87E+018,"testalpha"
,"intravenous infusion of hes","JJ NN IN ",4,1,1,17067137,"pubmed1",5.00E+018,"testalpha"
,"employment of therapeutic strategies","NN IN JJ NNS",4,1,1,17013514,2,9.15E+018,"testalpha"
,"contributing pathogenic factor inthe","VBG JJ NN NNP",4,1,1,16874416,2,3.94E+018,"testalpha"
,"pbsct and underwentallogenic bone"," CC JJ NN",4,1,1,16914902,2,6.61E+018,"testalpha"
,"change in clinical routines","NN IN JJ NNS",4,1,1,16710573,2,6.48E+018,"testalpha"
,"postoperative morbidityafter extended laryngeal","JJ NN VBD NN",4,1,1,16989147,2,8.80E+018,"testalpha"
,"andinflamed human dental pulp","VBN NN JJ NN",4,1,1,16919707,2,2.48E+018,"testalpha"
,"receptors for tumor proliferation","NNS IN NN NN",4,1,1,17117604,2,4.15E+018,"testalpha"
,"thesea urchin strongylocentrotus purpuratus","NNP IN NN NN",4,1,1,16511251,2,4.58E+018,"testalpha"
,"cells isolated fromcord blood","NNS VBN NN NN",4,1,1,17160143,"pubmed1",5.71E+018,"testalpha"
,"patients with acute gi","NNS IN JJ ",4,1,1,16333701,"pubmed1",1.39E+018,"testalpha"
,"bonds are observed betweenatoms","NNS VBP VBN NNS",4,1,1,16456293,2,6.59E+018,"testalpha"
,"packed red blood cells","VBN JJ NN NNS",4,1,1,17013513,2,1.97E+018,"testalpha"
,"endometrial cells and candida","JJ NNS CC NNP",4,1,1,16514841,2,7.29E+018,"testalpha"
,"importance of ada adenosine","NN IN  NN",4,1,1,16929383,"pubmed1",4.55E+018,"testalpha"
,"important target for gene","JJ NN IN ",4,1,1,17160143,"pubmed1",7.77E+017,"testalpha"
,"technology tools and model","NN NNS CC NN",4,1,1,16473991,"pubmed1",7.30E+018,"testalpha"
,"linker foractivation of t","NN NN IN ",4,1,1,16511262,2,1.82E+018,"testalpha"
,"hypertension abdominal obesity highblood","NN JJ NN NN",4,1,1,16462412,"pubmed1",6.65E+018,"testalpha"
,"groups including designers andtesters","NNS IN NNS NNS",4,1,1,16054101,"pubmed1",1.56E+018,"testalpha"
,"c with co centrifugationof","NN IN  ",4,1,1,17160143,"pubmed1",1.40E+018,"testalpha"
,"localization of immune deposits","NN IN JJ NNS",4,1,1,16430945,2,2.38E+018,"testalpha"
,"indecreased activities of nadh","VBN NNS IN ",4,1,1,17068635,"pubmed1",9.15E+017,"testalpha"
,"thin forl phenylalanyl l","JJ  NN ",4,1,1,16397334,2,2.19E+018,"testalpha"
,"c and strong inhibition","NN CC JJ NN",4,1,1,17019438,"pubmed1",1.97E+018,"testalpha"
,"cochrane library and index","NN NN CC NN",4,1,1,16365334,"pubmed1",2.18E+018,"testalpha"
,"composite design for factors","JJ NN IN NNS",4,1,1,16584161,"pubmed1",5.46E+018,"testalpha"
,"liquid extraction and derivatization","JJ NN CC NN",4,1,1,16700150,2,6.62E+018,"testalpha"
,"urine of ad patients","NN IN NN NNS",4,1,1,16859611,2,2.33E+018,"testalpha"
,"were bled ml min","VBD VBD  ",4,1,1,16762404,2,5.32E+018,"testalpha"
,"methods by selected examples","NNS IN VBN NNS",4,1,1,16411740,"pubmed1",8.34E+018,"testalpha"
,"cecal ligation and puncture","JJ NN CC NN",4,1,1,17293958,2,8.75E+017,"testalpha"
,"anastomoses material and methods","NNS NN CC NNS",4,1,1,16612916,"pubmed1",6.75E+018,"testalpha"
,"allergens aeroallergens or foods","NNS NNS CC NNS",4,1,1,17438830,2,4.74E+017,"testalpha"
,"heat and mass flow","NN CC NN NN",4,1,1,17285746,"pubmed1",7.27E+018,"testalpha"
,"thenumber of mast cells","NN IN  NNS",4,1,1,16585982,2,6.74E+018,"testalpha"
,"burncentre of brno university","NN IN  NN",4,1,1,17294910,2,7.18E+018,"testalpha"
,"ofreported incidences of pocd","VBN NNS IN ",4,1,1,16451151,"pubmed1",1.69E+018,"testalpha"
,"boards i e rebs","NNS   ",4,1,1,16770860,"pubmed1",6.22E+018,"testalpha"
,"immersion in different testsolutions","NN IN JJ NNS",4,1,1,16701867,"pubmed1",4.69E+018,"testalpha"
,"cad sensitivity and specificity"," NN CC NN",4,1,1,16399036,"pubmed1",4.64E+018,"testalpha"
,"hb release profile wasalso"," NN NN ",4,1,1,16594643,"pubmed1",1.71E+018,"testalpha"
,"mental state examination mmse","JJ NN NN ",4,1,1,16479025,2,8.02E+018,"testalpha"
,"intracellular il t cells","JJ   NNS",4,1,1,17016036,2,9.13E+016,"testalpha"
,"brain and inone case","NN CC NN NN",4,1,1,17338205,2,1.97E+018,"testalpha"
,"development of pft abnormalities","NN IN  NNS",4,1,1,16809886,2,1.03E+017,"testalpha"
,"pyridine n n alkylation","NN   NN",4,1,1,16594645,"pubmed1",3.72E+018,"testalpha"
,"gels were applied min"," VBD VBN ",4,1,1,16955184,2,8.27E+018,"testalpha"
,"infusion of ringer acetate","NN IN NN NN",4,1,1,16365323,"pubmed1",3.71E+018,"testalpha"
,"create novel zinc finger","VB NN NN NN",4,1,1,16411739,"pubmed1",4.50E+018,"testalpha"
,"including rare primary tumors","VBG JJ NN NNS",4,1,1,16514847,2,5.74E+018,"testalpha"
,"polyethylene oxide groups inthe","NN VB NNS NNP",4,1,1,16701874,"pubmed1",1.99E+018,"testalpha"
,"field of body compositionand","NN IN NN NN",4,1,1,16918067,"pubmed1",6.94E+018,"testalpha"
,"cytoplasm of round spermatids","NN IN NN NNS",4,1,1,16395525,"pubmed1",2.62E+018,"testalpha"
,"molecular weigh polyethylene cup","JJ VB NN NN",4,1,1,16613741,2,5.59E+018,"testalpha"
,"combination of clinical examination","NN IN JJ NN",4,1,1,16514838,2,5.66E+018,"testalpha"
,"national electronic injury surveillance","JJ JJ NN NN",4,1,1,16436798,"pubmed1",4.98E+018,"testalpha"
,"immune response inflammation proliferation","JJ NN NN NN",4,1,1,17068636,"pubmed1",4.74E+018,"testalpha"
,"numerous cell types i","JJ NN NNS ",4,1,1,16770441,"pubmed1",5.41E+018,"testalpha"
,"ch ch and ch","  CC ",4,1,1,16496038,"pubmed1",1.13E+018,"testalpha"
,"ameliorate specific dermatological problemswith","NN JJ JJ NN",4,1,1,16574202,2,5.49E+018,"testalpha"
,"bsa adsorption on znhap"," NN IN NN",4,1,1,16701860,"pubmed1",3.35E+017,"testalpha"
,"control and prevention www","NN CC NN ",4,1,1,16438095,"pubmed1",7.79E+018,"testalpha"
,"musculocutaneousflap and free split"," CC JJ NN",4,1,1,16612932,"pubmed1",2.18E+018,"testalpha"
,"real time allelic discrimination","JJ NN JJ NN",4,1,1,16929381,"pubmed1",3.80E+018,"testalpha"
,"ns b ns protease"," NN  NN",4,1,1,16511290,2,6.53E+018,"testalpha"
,"patients hadaffected first degree","NNS VBN JJ NN",4,1,1,17010267,2,4.96E+018,"testalpha"
,"rat skin using light","NN NN VBG NN",4,1,1,16574202,2,3.39E+018,"testalpha"
,"pathogenesis of hypertrophic scars","NN IN JJ NNS",4,1,1,16874413,2,5.78E+018,"testalpha"
,"tetanus toxin and ricin","NN  CC NNP",4,1,1,16696436,2,4.95E+018,"testalpha"
,"remodeling byupregulating fas expression","VBG VBG  NN",4,1,1,16395522,"pubmed1",1.34E+018,"testalpha"
,"parenchymal soft tissue mechanics","JJ JJ NN NNS",4,1,1,16399039,"pubmed1",5.25E+018,"testalpha"
,"nbd and iii use"," CC  NN",4,1,1,16511258,2,9.08E+017,"testalpha"
,"favourable long term outcome","JJ JJ NN NN",4,1,1,16451156,"pubmed1",6.14E+018,"testalpha"
,"colon cancer and withrectal","NN NN CC NN",4,1,1,17139895,2,5.51E+016,"testalpha"
,"differential diagnosis of patients","JJ NN IN NNS",4,1,1,16612930,"pubmed1",5.20E+018,"testalpha"
,"erythrocyte indices mean erythrocyte","NNP NNS VBP NNP",4,1,1,16809890,2,3.87E+018,"testalpha"
,"related motor vehicle casualties","VBN NN NN NNS",4,1,1,16169506,"pubmed1",9.04E+016,"testalpha"
,"atopic dermatitis in children","NN NN IN NNS",4,1,1,16648916,2,8.43E+018,"testalpha"
,"donor recipient route prevention","NN NN NN NN",4,1,1,16999268,2,6.28E+018,"testalpha"
,"significant impact on safety","JJ NN IN NN",4,1,1,16236232,"pubmed1",9.02E+018,"testalpha"
,"objective changes i e","NN NNS  ",4,1,1,17236639,"pubmed1",7.65E+018,"testalpha"
,"registry andcauses of death","NN NNS IN NN",4,1,1,16710578,2,5.14E+018,"testalpha"
,"based proximity warning system","VBD NN NN NN",4,1,1,16129405,"pubmed1",6.22E+018,"testalpha"
,"form complexes withother transcription","VB NNS JJ NN",4,1,1,17115080,"pubmed1",5.47E+018,"testalpha"
,"identification of cannabinoid receptors","NN IN VB NNS",4,1,1,16808046,"pubmed1",2.79E+018,"testalpha"
,"atomic level conformational transitions","JJ NN JJ NNS",4,1,1,16388314,"pubmed1",4.42E+018,"testalpha"
,"groups of active researchers","NNS IN JJ NNS",4,1,1,16377817,"pubmed1",8.54E+018,"testalpha"
,"characterization ofthe atomic structures","NN NNP JJ NNS",4,1,1,16369101,2,3.48E+018,"testalpha"
,"distribution of various types","NN IN JJ NNS",4,1,1,17016036,2,7.21E+018,"testalpha"
,"dihydrate cimetidine grades ofcolloidal","NN NN NNS NN",4,1,1,17285749,"pubmed1",6.47E+018,"testalpha"
,"majority ofthe residual monomers","NN NNP JJ NNS",4,1,1,16701856,"pubmed1",1.45E+018,"testalpha"
,"financial stability colleague attrition","JJ NN NN NN",4,1,1,16377815,"pubmed1",3.17E+018,"testalpha"
,"week n week n","NN  NN ",4,1,1,16574202,2,7.46E+018,"testalpha"
,"study period patch testing","NN NN NN NN",4,1,1,17010264,2,5.30E+018,"testalpha"
,"important event in re","JJ NN IN ",4,1,1,17106595,2,8.10E+018,"testalpha"
,"age without co morbidity","NN IN  NN",4,1,1,16613748,2,4.51E+018,"testalpha"
,"situ reverse transcription pcr"," VB NN ",4,1,1,17019440,"pubmed1",3.45E+018,"testalpha"
,"guide fine needleaspiration fna","NN JJ NN ",4,1,1,16514848,2,2.41E+018,"testalpha"
,"protein cora from thermotoga","NN  IN NNP",4,1,1,16511288,2,2.68E+018,"testalpha"
,"absence of physiological data","NN IN JJ NN",4,1,1,16824585,2,2.53E+018,"testalpha"
,"additive topo optical reaction","JJ  JJ NN",4,1,1,16714051,2,4.34E+018,"testalpha"
,"fordetection of sialylated glycoconjugates","NN IN VBN NNS",4,1,1,16720036,2,4.66E+018,"testalpha"
,"sensitization and hencereduces cpsp","NN CC NNS ",4,1,1,17236639,"pubmed1",5.86E+018,"testalpha"
,"sheet while theaminoquinoline cations","NN IN NN NNS",4,1,1,16456284,2,5.02E+018,"testalpha"
,"change or difference incrash","NN CC NN NN",4,1,1,16122689,"pubmed1",4.62E+018,"testalpha"
,"aged years because recentstudies","VBN NNS IN NNS",4,1,1,17106515,"pubmed1",8.35E+018,"testalpha"
,"timely identification ofsuch attacks","JJ NN NN NNS",4,1,1,16696436,2,6.43E+017,"testalpha"
,"c reactive protein levels","NN JJ NN NNS",4,1,1,16809889,2,2.45E+018,"testalpha"
,"peripheral blood stem cells","JJ NN VB NNS",4,1,1,16914909,2,1.30E+018,"testalpha"
,"diffraction data were collectedto","NN NNS VBD ",4,1,1,16511285,2,4.96E+018,"testalpha"
,"oleoyl phosphatidylcholine andstearoyl arachidonoyl"," NN  ",4,1,1,17128291,"pubmed1",8.46E+018,"testalpha"
,"transplant chemotherapy mobilization chemotherapy","JJ NN NN NN",4,1,1,17119322,2,6.43E+018,"testalpha"
,"t cells in hl"," NNS IN ",4,1,1,17016036,2,5.59E+018,"testalpha"
,"expression vector andglutamine synthetase","NN NN NN NN",4,1,1,16733563,"pubmed1",9.13E+018,"testalpha"
,"wild type yeast strain","JJ NN NN NN",4,1,1,17146497,"pubmed1",7.21E+017,"testalpha"
,"use of spf primers","NN IN  NNS",4,1,1,17019439,"pubmed1",8.88E+018,"testalpha"
,"astroglial elements in imprint","JJ NNS IN NN",4,1,1,16514849,2,7.89E+018,"testalpha"
,"mini mental state examination"," JJ NN NN",4,1,1,16479025,2,8.31E+018,"testalpha"
,"o n ii andpoly","   NN",4,1,1,16397335,2,3.94E+018,"testalpha"
,"thymidylate synthase coding sequence","NN NN VBG NN",4,1,1,16505899,"pubmed1",2.39E+018,"testalpha"
,"sucralfate gel and sucralfate","NN  CC NN",4,1,1,16584168,"pubmed1",2.22E+018,"testalpha"
,"e human phenylalanine hydroxylase"," JJ NN NN",4,1,1,16823609,"pubmed1",2.20E+018,"testalpha"
,"factor for ischemic stroke","NN IN JJ NN",4,1,1,16479026,2,2.98E+017,"testalpha"
,"structure of clofarabine andadp","NN IN NN ",4,1,1,16421443,2,2.83E+018,"testalpha"
,"scanning microscopy and transmission","VBG  CC NN",4,1,1,16701854,"pubmed1",7.15E+018,"testalpha"
,"tyr leupsi cn ala"," NNP  ",4,1,1,16496037,"pubmed1",8.44E+018,"testalpha"
,"emotional challenges facing residentphysicians","JJ NNS VBG NNS",4,1,1,16377827,"pubmed1",1.20E+018,"testalpha"
,"thiosulfato dipotassium i k","NN NN  ",4,1,1,16397335,2,3.37E+018,"testalpha"
,"created using incident data","VBN VBG NN NNS",4,1,1,16426557,"pubmed1",1.17E+018,"testalpha"
,"face of human medicine","NN IN JJ NN",4,1,1,17269167,2,2.29E+018,"testalpha"
,"tension free repair offering","NN JJ NN NN",4,1,1,16612912,"pubmed1",5.19E+018,"testalpha"
,"perception of financial instability","NN IN JJ NN",4,1,1,16377815,"pubmed1",1.85E+018,"testalpha"
,"stromal precursors and mature","JJ NNS CC NNP",4,1,1,17016038,2,6.83E+018,"testalpha"
,"disorders during disease progression","NNS IN NN NN",4,1,1,16914909,2,6.70E+018,"testalpha"
,"os rate was slightlybetter"," NN VBD NN",4,1,1,16914906,2,8.36E+018,"testalpha"
,"aggregation of hen egg","NN IN NN NN",4,1,1,16770442,"pubmed1",7.29E+016,"testalpha"
,"detectorcomputed tomogra phy mdct","VBN NN  ",4,1,1,17067135,"pubmed1",8.63E+017,"testalpha"
,"magnetic resonance image mri","JJ NN NN ",4,1,1,16436787,"pubmed1",4.82E+018,"testalpha"
,"hasa binds free haem"," NNS JJ ",4,1,1,16511263,2,7.59E+018,"testalpha"
,"recalled echo gre images","VBD   NNS",4,1,1,16317488,"pubmed1",2.67E+018,"testalpha"
,"map heat rate cardiacindex","NN NN NN NN",4,1,1,16491220,2,4.83E+018,"testalpha"
,"map activation of glycid","NN NN IN NN",4,1,1,17013507,2,8.68E+018,"testalpha"
,"factor xi fxi deficiency","NN   NN",4,1,1,16424651,2,6.57E+018,"testalpha"
,"was received fromthe summit","VBD VBN NNP NN",4,1,1,16473991,"pubmed1",6.66E+018,"testalpha"
,"proliferation of allogeneic t","NN IN JJ ",4,1,1,16733557,"pubmed1",4.85E+018,"testalpha"
,"phototherapy narrow band uvb","NN JJ NN ",4,1,1,17311742,2,1.88E+018,"testalpha"
,"protein substrate binding domain","NN NN VBG NN",4,1,1,16511258,2,3.90E+018,"testalpha"
,"respiratory distress syndrome ards","NN NN NN ",4,1,1,16451155,"pubmed1",8.85E+018,"testalpha"
,"identification of individual allergens","NN IN JJ NNS",4,1,1,16673562,2,4.80E+018,"testalpha"
,"cells on fha discs","NNS IN  NNS",4,1,1,16701866,"pubmed1",7.66E+018,"testalpha"
,"major histocompatibility complex class","JJ NN JJ NN",4,1,1,16511250,2,1.69E+018,"testalpha"
,"total motorvehicle casualty data","JJ NN NN NNS",4,1,1,16169506,"pubmed1",1.47E+018,"testalpha"
,"slight decrease of ngfat","JJ NN IN NNP",4,1,1,16325891,2,8.62E+018,"testalpha"
,"group metabotropic glutamate receptors","NN NN NN NNS",4,1,1,17265692,2,1.35E+018,"testalpha"
,"characteristics were selected age","NNS VBD VBN NN",4,1,1,16585990,2,5.72E+018,"testalpha"
,"oxidation ofnadh by quinone","NN  IN NN",4,1,1,16511277,2,8.75E+018,"testalpha"
,"themean values of hydroxyproline","JJ NNS IN NN",4,1,1,16612917,"pubmed1",5.56E+018,"testalpha"
,"andcoworkers full sequence acdcrgdcfcggklaklakklaklak","NNS JJ NN NNP",4,1,1,17143339,"pubmed1",1.39E+017,"testalpha"
,"stimulating factors g csf","JJ NNS  ",4,1,1,16424645,2,3.62E+018,"testalpha"
,"controls andarthritic animals p","NNS JJ NNS ",4,1,1,16399028,"pubmed1",6.12E+018,"testalpha"
,"case of pituitary apoplexy","NN IN NN ",4,1,1,16612920,"pubmed1",8.29E+018,"testalpha"
,"transcription cleavage factor greb","NN NN NN ",4,1,1,16511259,2,7.30E+018,"testalpha"
,"national resident matching program","JJ NN VBG NN",4,1,1,16399040,"pubmed1",5.83E+018,"testalpha"
,"presence of low grade","NN IN JJ NN",4,1,1,16514848,2,8.02E+018,"testalpha"
,"thepresumptive absence of neuroendocrine","JJ NN IN NN",4,1,1,16919707,2,3.79E+018,"testalpha"
,"children with b cell","NNS IN NN NN",4,1,1,16733557,"pubmed1",2.30E+018,"testalpha"
,"females youngs and patients","NNS NNS CC NNS",4,1,1,16696444,2,2.40E+018,"testalpha"
,"remitting multiple sclerosis ms","VBG JJ NN ",4,1,1,17016041,2,4.32E+018,"testalpha"
,"future emergency medicine research","NN NN NN NN",4,1,1,16436787,"pubmed1",4.56E+018,"testalpha"
,"habitat indicated lack ofpathogenicity","NN VBD NN NN",4,1,1,17019438,"pubmed1",7.39E+018,"testalpha"
,"thefissure and adverse effects","NN CC JJ NNS",4,1,1,16612915,"pubmed1",7.21E+017,"testalpha"
,"bleeding manifestations completeblood cell","VBG NNS NN NN",4,1,1,16424649,2,5.33E+018,"testalpha"
,"give data of sufficientquality","VB NNS IN NN",4,1,1,16369100,2,2.83E+018,"testalpha"
,"amyloid fibrils periodate reactivecarbohydrates","VB NNS NN NNS",4,1,1,16542712,2,5.21E+018,"testalpha"
,"distribution of theadministered tracer","NN IN VBN NN",4,1,1,16333707,"pubmed1",2.28E+018,"testalpha"
,"preparation of diffraction qualitycrystals","NN IN NN NNS",4,1,1,16511258,2,5.41E+018,"testalpha"
,"ophthalmological complications in children","JJ NNS IN NNS",4,1,1,17106598,2,5.09E+017,"testalpha"
,"events in order sport","NNS IN NN NN",4,1,1,16918068,"pubmed1",2.58E+018,"testalpha"
,"theregenerative process originating cells","JJ NN VBG NNS",4,1,1,17013517,2,3.31E+018,"testalpha"
,"maturationalarrest of muscle fibers","NN IN NN NNS",4,1,1,16893562,2,6.42E+018,"testalpha"
,"growing rings of scutes","VBG NNS IN NNS",4,1,1,16733064,2,5.93E+018,"testalpha"
,"clinical improvement nutritional status","JJ NN JJ NN",4,1,1,16479024,2,3.21E+018,"testalpha"
,"difference inproperties of hallucinogens","NN NNS IN NNS",4,1,1,16594640,"pubmed1",3.23E+018,"testalpha"
,"hyperthyroid patients hadsignificant decrease","VB NNS JJ NN",4,1,1,16479025,2,7.62E+017,"testalpha"
,"ray castingvisualization with subvoxel"," NN IN NNP",4,1,1,16399038,"pubmed1",5.26E+018,"testalpha"
,"unit ain shams university","NN  NNS NN",4,1,1,16424649,2,3.83E+018,"testalpha"
,"diversity in medical student","NN IN JJ NN",4,1,1,16473988,"pubmed1",6.07E+018,"testalpha"
,"using united states pharmacopeia","VBG VBN NNS ",4,1,1,16584139,"pubmed1",3.83E+018,"testalpha"
,"treatment stabilityand healing chances","NN NN VBG NNS",4,1,1,16613748,2,4.94E+018,"testalpha"
,"inflammation in atopic dermatitis","NN IN NN NN",4,1,1,16648910,2,8.38E+018,"testalpha"
,"high grade squamous intraepitheliallesion","JJ NN JJ NN",4,1,1,16514839,2,2.49E+018,"testalpha"
,"olf domain from amassin"," NN IN NNP",4,1,1,16511251,2,5.86E+018,"testalpha"
,"therapeutic use of ace","JJ NN IN NN",4,1,1,16479034,2,6.46E+018,"testalpha"
,"acp filler by mass"," NN IN NN",4,1,1,16701862,"pubmed1",4.95E+018,"testalpha"
,"injected glutamine glutamine group","VBD NN NN NN",4,1,1,17293970,2,1.61E+018,"testalpha"
,"different clinical studies report","JJ JJ NNS NN",4,1,1,16859616,2,5.88E+018,"testalpha"
,"cells with viral supernatants","NNS IN JJ NNS",4,1,1,17160143,"pubmed1",1.82E+018,"testalpha"
,"homogeneous distribution of animals","JJ NN IN NNS",4,1,1,17318329,"pubmed1",8.79E+018,"testalpha"
,"connective tissue growth factor","JJ NN NN NN",4,1,1,16395527,"pubmed1",5.34E+018,"testalpha"
,"ofpulmonary artery smooth muscle","JJ NN JJ NN",4,1,1,16395522,"pubmed1",5.65E+018,"testalpha"
,"suchthey are integral components","NNP VBP JJ NNS",4,1,1,17143336,"pubmed1",4.10E+018,"testalpha"
,"interact with lung fibroblasts","NN IN NN NNS",4,1,1,16395527,"pubmed1",5.22E+018,"testalpha"
,"highest level of transient","JJT NN IN NN",4,1,1,16582986,"pubmed1",2.91E+017,"testalpha"
,"shape of skeletal profile","NN IN NN NN",4,1,1,16722348,2,8.74E+017,"testalpha"
,"wild type n mice","JJ NN  ",4,1,1,16951742,"pubmed1",2.92E+018,"testalpha"
,"exposure and smoking habit","NN CC NN NN",4,1,1,16582984,"pubmed1",5.22E+018,"testalpha"
,"assessed methods retrospective cohort","VBN NNS JJ NN",4,1,1,16365332,"pubmed1",6.82E+018,"testalpha"
,"o c h b"," NN  NN",4,1,1,16456265,2,4.82E+018,"testalpha"
,"motivatingsedentary type diabetic subjects","JJ NN JJ NNS",4,1,1,16921608,"pubmed1",8.53E+018,"testalpha"
,"carbonyl and hydroxyl groups","NN CC  NNS",4,1,1,16404478,"pubmed1",5.67E+018,"testalpha"
,"primary thyroid neuroendocrine tumors","JJ NN NN NNS",4,1,1,16514846,2,7.79E+018,"testalpha"
,"hazards model was usedto","NNS NN VBD ",4,1,1,16202465,"pubmed1",3.17E+018,"testalpha"
,"typical case of gloves","JJ NN IN NNS",4,1,1,17010266,2,9.00E+018,"testalpha"
,"curricular reform in medicalstudent","JJ NN IN NN",4,1,1,16473990,"pubmed1",1.12E+018,"testalpha"
,"availablefor hepatitis virus b","JJ NN NN NN",4,1,1,17013520,2,5.01E+018,"testalpha"
,"life of t dm","NN IN  ",4,1,1,16918069,"pubmed1",3.06E+018,"testalpha"
,"radiological evaluation monitoring intracranialpressure","JJ NN NN NN",4,1,1,17067134,"pubmed1",6.80E+018,"testalpha"
,"electron reduction by nad","NN NN IN ",4,1,1,16929382,"pubmed1",2.59E+018,"testalpha"
,"search for general methods","NN IN JJ NNS",4,1,1,16411734,"pubmed1",6.26E+018,"testalpha"
,"preventive nature in termsof","JJ NN IN ",4,1,1,16603103,2,8.07E+018,"testalpha"
,"musculus mm and rattus","NN  CC NN",4,1,1,16733558,"pubmed1",4.32E+018,"testalpha"
,"properties into elaborate mono","NNS IN VB ",4,1,1,16411740,"pubmed1",3.87E+018,"testalpha"
,"skill and safety motive","NN CC NN NN",4,1,1,16443186,"pubmed1",6.10E+018,"testalpha"
,"ethylthiosemicarbazone c h n","NN NN  ",4,1,1,16397328,2,3.77E+018,"testalpha"
,"theimpact of driver education","NN IN NN NN",4,1,1,16112070,"pubmed1",3.37E+018,"testalpha"
,"causedby loss of balance","JJ NN IN NN",4,1,1,16434013,"pubmed1",7.80E+017,"testalpha"
,"adriamycin vincristine and prednisolone","NNP NN CC NN",4,1,1,17119328,2,3.96E+018,"testalpha"
,"cost per patient day","NN IN NN NN",4,1,1,16451154,"pubmed1",8.99E+018,"testalpha"
,"disease andtime dependent fashion","NN JJ JJ NN",4,1,1,17285739,"pubmed1",5.95E+018,"testalpha"
,"representation and alsoin regions","NN CC VB NNS",4,1,1,17133958,2,4.32E+018,"testalpha"
,"collection ofreviews of children","NN NNS IN NNS",4,1,1,16474001,"pubmed1",3.69E+018,"testalpha"
,"potential complications including thrombosis","JJ NNS VBG NN",4,1,1,16549899,2,2.29E+018,"testalpha"
,"disease themean serum ada","NN JJ NN ",4,1,1,16956117,2,1.89E+018,"testalpha"
,"radio chemotherapy and tmeresection","NN NN CC NN",4,1,1,16612911,2,4.09E+018,"testalpha"
,"evolution of theoperative technique","NN IN JJ NN",4,1,1,17165595,2,2.96E+018,"testalpha"
,"functional impact on vision","JJ NN IN NN",4,1,1,16955189,2,5.37E+018,"testalpha"
,"contained highamounts of titanium","VBD NNS IN NN",4,1,1,16648911,2,4.88E+018,"testalpha"
,"trial based ed chest","NN VBN VBD NN",4,1,1,16365321,"pubmed1",9.17E+018,"testalpha"
,"n tricobalt ii bis"," NN  ",4,1,1,16456276,2,3.61E+018,"testalpha"
,"combined effect of imatinib","VBN NN IN ",4,1,1,16809884,2,8.23E+018,"testalpha"
,"prognostic factor for time","JJ NN IN NN",4,1,1,17139902,2,2.73E+018,"testalpha"
,"epidermalgrowth factor receptors egfr","NN NN NNS ",4,1,1,17139902,2,7.29E+018,"testalpha"
,"use of intraoperative multimodal","NN IN JJ NN",4,1,1,17236639,"pubmed1",7.39E+018,"testalpha"
,"nic binding sites k","JJ VBG NNS ",4,1,1,16594645,"pubmed1",1.74E+017,"testalpha"
,"triamcinoloneacetonide ointment in patients","VB NN IN NNS",4,1,1,16710580,2,6.76E+018,"testalpha"
,"patients and healthy non","NNS CC JJ ",4,1,1,16451151,"pubmed1",4.92E+018,"testalpha"
,"control mortality and morbidity","NN NN CC NN",4,1,1,17236639,"pubmed1",2.82E+018,"testalpha"
,"triglyceride hdl andldl cholesterol","VB   NN",4,1,1,16479028,2,3.21E+018,"testalpha"
,"h o conclusions state","  NNS NN",4,1,1,16399039,"pubmed1",1.61E+018,"testalpha"
,"identified twomulticopy suppressor genes","VBN  NN NNS",4,1,1,17146497,"pubmed1",1.41E+018,"testalpha"
,"galn induced hepatocyte injury"," VBN NNP NN",4,1,1,16696445,2,3.10E+018,"testalpha"
,"mean duration between date","JJ NN IN NN",4,1,1,16710578,2,3.38E+018,"testalpha"
,"treatment olanzapine and valproate","NN NN CC NN",4,1,1,16696448,2,5.78E+018,"testalpha"
,"hada total of pregnancies"," NN IN NNS",4,1,1,16424651,2,5.05E+018,"testalpha"
,"queueing model inidentifying provider","VBG NN VBG NN",4,1,1,16365329,"pubmed1",7.36E+018,"testalpha"
,"lower drugconcentration enos immunoreactivity","JJR NN  NN",4,1,1,16566960,2,1.81E+018,"testalpha"
,"adherens and zonula occludens","NNS CC NN NNS",4,1,1,16253314,2,7.46E+018,"testalpha"
,"cationic protein level epx","JJ NN NN ",4,1,1,16859611,2,1.42E+018,"testalpha"
,"lesionsand presence of mucin","NN NN IN NNP",4,1,1,16859615,2,4.25E+017,"testalpha"
,"centers for disease control","NNS IN NN NN",4,1,1,16511256,2,1.03E+018,"testalpha"
,"october in anurban level","NN IN JJ NN",4,1,1,16365333,"pubmed1",6.61E+017,"testalpha"
,"multilevel logistic models mlm","NN JJ NNS ",4,1,1,16126153,"pubmed1",2.56E+018,"testalpha"
,"ampk in l skeletalmuscle"," IN  NN",4,1,1,16964326,"pubmed1",7.42E+018,"testalpha"
,"c were lower thanthe","NN VBD JJR NNP",4,1,1,17285744,"pubmed1",8.23E+018,"testalpha"
,"pancreatic beta cells lbetat","JJ NN NNS NN",4,1,1,16395521,"pubmed1",2.29E+017,"testalpha"
,"cellular aspects of liverregeneration","JJ NNS IN NN",4,1,1,17013517,2,2.53E+018,"testalpha"
,"alsodifferentiate into chondrocytes adipocytes","NN IN NNS NNS",4,1,1,16696440,2,3.74E+018,"testalpha"
,"operate ina constructive manner","VB  JJ NN",4,1,1,17139882,2,9.03E+018,"testalpha"
,"continued biphosphonates and hip","VBD NNS CC NN",4,1,1,16613748,2,8.73E+017,"testalpha"
,"vascular malformations are congenital","JJ NNS VBP NN",4,1,1,16722347,2,7.87E+018,"testalpha"
,"d ribofuranosyl h pyrazolo","   NNP",4,1,1,16456292,2,3.51E+018,"testalpha"
,"sepsis or septic shock","NN CC JJ NN",4,1,1,16365336,"pubmed1",6.90E+018,"testalpha"
,"series for disease pre","NN IN NN ",4,1,1,17119322,2,6.02E+017,"testalpha"
,"sika deer cervus nippon"," NNS  NN",4,1,1,16770447,"pubmed1",2.56E+018,"testalpha"
,"high prevalence of mi","JJ NN IN ",4,1,1,16914907,2,6.24E+018,"testalpha"
,"equations for airway flow","NNS IN NN NN",4,1,1,16399039,"pubmed1",4.34E+018,"testalpha"
,"uptake and reduced toxicity","NN CC VBN NN",4,1,1,17285739,"pubmed1",6.32E+018,"testalpha"
,"n decylnicotinium iodide ndni"," NN VB ",4,1,1,16594645,"pubmed1",2.86E+018,"testalpha"
,"wall cells induce atherosclerosis","NN NNS VB NN",4,1,1,17106515,"pubmed1",6.26E+018,"testalpha"
,"stem cell transplant recipient","VB NN JJ NN",4,1,1,16918062,"pubmed1",8.37E+018,"testalpha"
,"function and body composition","NN CC NN NN",4,1,1,16918067,"pubmed1",8.88E+018,"testalpha"
,"tacsimate hepes and peg","NN NNS CC ",4,1,1,16511256,2,3.34E+018,"testalpha"
,"interleukin b il b","NNP NN  NN",4,1,1,17019444,"pubmed1",5.28E+017,"testalpha"
,"smooth muscle cells pasmc","JJ NN NNS ",4,1,1,16395522,"pubmed1",7.50E+018,"testalpha"
,"vehicle fatalities among year","NN NNS IN NN",4,1,1,16171767,"pubmed1",6.39E+018,"testalpha"
,"cm h o p","   ",4,1,1,16612915,"pubmed1",5.80E+018,"testalpha"
,"authorreport of extramural funding","NN IN JJ NN",4,1,1,16365335,"pubmed1",4.14E+018,"testalpha"
,"identify thosepatients with nste","VB NNS IN ",4,1,1,16365321,"pubmed1",4.91E+018,"testalpha"
,"sequence motifs and association","NN  CC NN",4,1,1,16733558,"pubmed1",4.18E+018,"testalpha"
,"dose dependent hepatocyte injurywas","NN JJ NNP ",4,1,1,16696445,2,3.26E+018,"testalpha"
,"using affinity column chromatographicmethods","VBG NN NN NNS",4,1,1,16511286,2,5.72E+018,"testalpha"
,"determinates in secondary scars","NNS IN JJ NNS",4,1,1,17293973,2,1.57E+018,"testalpha"
,"pituitary thyroidstimulating hormone tsh","NN VBG NN ",4,1,1,16714054,2,5.20E+018,"testalpha"
,"research training models conclusion","NN NN NNS NN",4,1,1,16473989,"pubmed1",8.91E+018,"testalpha"
,"understaffed analyses of arrival","VBN NNS IN NN",4,1,1,16365329,"pubmed1",1.07E+018,"testalpha"
,"residue glu adopts twoalternate","NN  VBZ NN",4,1,1,16511247,2,2.46E+018,"testalpha"
,"reticulocyte counts reticulocyte index","NNP NNS NNP NN",4,1,1,17117609,2,1.70E+018,"testalpha"
,"mortality or treatmenttime intervals","NN CC JJ NNS",4,1,1,16365334,"pubmed1",7.33E+018,"testalpha"
,"incidence of early recurrence","NN IN JJ NN",4,1,1,16612915,"pubmed1",8.75E+018,"testalpha"
,"perfusion fluid min beforeocclusion","NN NN  NN",4,1,1,16566960,2,8.12E+018,"testalpha"
,"min before induction group"," IN NN NN",4,1,1,17067136,"pubmed1",6.86E+018,"testalpha"
,"c analog n n","NN NN  ",4,1,1,16594645,"pubmed1",7.92E+018,"testalpha"
,"anastomsois andthe dentate line","NNP NNP NN NN",4,1,1,17139887,2,4.52E+018,"testalpha"
,"glutathione level and activities","NN NN CC NNS",4,1,1,16404476,"pubmed1",5.28E+018,"testalpha"
,"effect on iron absorption","NN IN NN NN",4,1,1,17119325,2,4.48E+017,"testalpha"
,"mean square rms error","VB NN  NN",4,1,1,16399039,"pubmed1",5.47E+018,"testalpha"
,"graduate medicaleducation duty hour","NN NN NN NN",4,1,1,16377825,"pubmed1",9.98E+017,"testalpha"
,"association with occupational exposure","NN IN JJ NN",4,1,1,17016033,2,5.71E+018,"testalpha"
,"ssri exposedfull term neonates"," NN NN NNS",4,1,1,16549890,2,3.79E+017,"testalpha"
,"complication and abnormal platelet","NN CC JJ NN",4,1,1,16523217,"pubmed1",1.34E+017,"testalpha"
,"outcome elective cesarean delivery","NN JJ JJ NN",4,1,1,16424651,2,6.67E+018,"testalpha"
,"tshs were done patients"," VBD VBN NNS",4,1,1,16479025,2,2.06E+018,"testalpha"
,"spectrophotometry andnuclear magnetic resonance","NN JJ JJ NN",4,1,1,16700150,2,5.52E+018,"testalpha"
,"life style and prevention","NN NN CC NN",4,1,1,16918068,"pubmed1",3.86E+018,"testalpha"
,"adult and child populations","NN CC NN NNS",4,1,1,16223468,"pubmed1",8.95E+018,"testalpha"
,"cancer and immunodeficiency disorders","NN CC NN NNS",4,1,1,17068636,"pubmed1",6.75E+018,"testalpha"
,"bortezomib includes gastrointestinal symptoms"," VBZ JJ NNS",4,1,1,17016040,2,6.31E+018,"testalpha"
,"consequences of dna modification","NNS IN  NN",4,1,1,16582987,"pubmed1",5.88E+018,"testalpha"
,"procedures and monograph specifications","NNS CC NN NNS",4,1,1,17285738,"pubmed1",7.45E+018,"testalpha"
,"tumours in other areas","NNS IN JJ NNS",4,1,1,16722346,2,5.80E+018,"testalpha"
,"african americans withinthe faith","JJ NNS NNP NN",4,1,1,16596897,"pubmed1",3.45E+018,"testalpha"
,"mri positron emission tomography"," NNP NN NN",4,1,1,16436787,"pubmed1",5.69E+018,"testalpha"
,"free survival of ebv","JJ NN IN ",4,1,1,16914904,2,5.64E+018,"testalpha"
,"serum eosinophil cationic protein","NN  JJ NN",4,1,1,16859611,2,4.91E+018,"testalpha"
,"reduces post operative lung","VBZ NN JJ NN",4,1,1,16451153,"pubmed1",4.57E+018,"testalpha"
,"epidermal cells and nih","JJ NNS CC ",4,1,1,16770447,"pubmed1",4.64E+018,"testalpha"
,"giant cells in cases","NN NNS IN NNS",4,1,1,16514850,2,7.54E+018,"testalpha"
,"marked reduction in apoptosis","VBN NN IN NN",4,1,1,16566960,2,7.36E+018,"testalpha"
,"signals were observed toinvestigate","NNS VBD VBN NN",4,1,1,16061188,"pubmed1",3.62E+017,"testalpha"
,"precursor peptide containing allylglycine","NN VB VBG NN",4,1,1,16496038,"pubmed1",1.64E+018,"testalpha"
,"bacterial vaginosis in earlypregnancy","JJ NN IN NN",4,1,1,16603098,2,8.56E+017,"testalpha"
,"concept ofglycation glycoxidation pathway","NN NN NN NN",4,1,1,16696441,2,8.25E+018,"testalpha"
,"tabun induced cognitive impairment","NNP VBN JJ NN",4,1,1,16956120,2,5.93E+018,"testalpha"
,"improvement in several quality","NN IN JJ NN",4,1,1,16377816,"pubmed1",4.68E+018,"testalpha"
,"csav and n naja"," CC  ",4,1,1,16436788,"pubmed1",6.59E+018,"testalpha"
,"l but lowerincrease p"," CC NN ",4,1,1,17338197,2,1.54E+018,"testalpha"
,"highest number of injuries","JJT NN IN NNS",4,1,1,16436798,"pubmed1",3.99E+018,"testalpha"
,"specificity of food sigetests","NN IN NN NNS",4,1,1,16673562,2,8.70E+018,"testalpha"
,"ppargamma ligands inhibit cell","NN NNS VB NN",4,1,1,16809887,2,4.85E+018,"testalpha"
,"icu hospital and yearmortality"," NN CC NN",4,1,1,16451156,"pubmed1",9.96E+017,"testalpha"
,"ilma lt or cob","  CC ",4,1,1,16451149,"pubmed1",4.68E+018,"testalpha"
,"surface coating of cementspecimens","NN NN IN NNS",4,1,1,16701863,"pubmed1",7.73E+017,"testalpha"
,"care was sought months","NN VBD VBN NNS",4,1,1,16412373,"pubmed1",5.77E+018,"testalpha"
,"laboratory data nursing notes","NN NNS VBG NNS",4,1,1,16365338,"pubmed1",1.17E+018,"testalpha"
,"sinuses and nasal bones","NNS CC NN NNS",4,1,1,17370565,"pubmed1",1.08E+018,"testalpha"
,"left branch msec right","VBN NN  NN",4,1,1,17139884,2,2.32E+018,"testalpha"
,"re engineering thec h"," NN  ",4,1,1,16411739,"pubmed1",7.16E+018,"testalpha"
,"usedvarious rating scales residents","JJ NN NNS NNS",4,1,1,16377825,"pubmed1",6.42E+018,"testalpha"
,"proteases from other retroviruses","NNS IN JJ NNS",4,1,1,16421452,2,2.83E+018,"testalpha"
,"experimentalresins with different ebpadma","NNS IN JJ NN",4,1,1,16701862,"pubmed1",3.87E+018,"testalpha"
,"preceding thestart of treatment","VBG NN IN NN",4,1,1,16236233,"pubmed1",7.99E+018,"testalpha"
,"risk of lung overdistension","NN IN NN NN",4,1,1,16451155,"pubmed1",6.33E+018,"testalpha"
,"mg kg beta d","  NN ",4,1,1,16612917,"pubmed1",8.91E+018,"testalpha"
,"theonoo effects on glycolysis"," NNS IN NN",4,1,1,17068635,"pubmed1",6.85E+018,"testalpha"
,"levels and leukocyte count","NNS CC NNP NN",4,1,1,17293958,2,5.54E+018,"testalpha"
,"median barrier warrant criteria","JJ NN NN NNS",4,1,1,16442487,"pubmed1",8.82E+017,"testalpha"
,"aspyrexial disease meningeal irritation","JJ NN NN NN",4,1,1,17294913,2,7.46E+018,"testalpha"
,"nh cl and mm","  CC ",4,1,1,16648912,2,5.24E+018,"testalpha"
,"index ai total cholesterol","NN  NN NN",4,1,1,17106515,"pubmed1",6.41E+018,"testalpha"
,"undergoing total mesorectal excision","VBG JJ NN NN",4,1,1,17139896,2,5.24E+018,"testalpha"
,"groups oxygen in nitrogen","NNS NN IN NN",4,1,1,16451147,"pubmed1",9.63E+017,"testalpha"
,"grade squamous intraepithelial lesionalso","NN JJ JJ ",4,1,1,16514841,2,5.83E+018,"testalpha"
,"living human tissuesand data","VBG JJ NN NNS",4,1,1,16648912,2,1.79E+018,"testalpha"
,"g n malnourished rats","  VBN NNS",4,1,1,17293959,2,4.72E+018,"testalpha"
,"stacked pi pi interactions","VBN   NNS",4,1,1,16456296,2,1.58E+018,"testalpha"
,"patients with positive crp","NNS IN JJ ",4,1,1,16479028,2,4.49E+018,"testalpha"
,"r and group i","NN CC NN ",4,1,1,17293960,2,7.50E+018,"testalpha"
,"generation of reactive species","NN IN JJ NN",4,1,1,16808044,"pubmed1",3.20E+018,"testalpha"
,"using theempirical bayes method","VBG JJ NNS NN",4,1,1,16236232,"pubmed1",6.55E+018,"testalpha"
,"sites of crystal contacts","NNS IN NN NNS",4,1,1,16369101,2,6.70E+018,"testalpha"
,"human embryos whilst cord","JJ   NN",4,1,1,17269167,2,3.83E+018,"testalpha"
,"changes and ancillary findings","NNS CC JJ NNS",4,1,1,16333694,"pubmed1",9.19E+018,"testalpha"
,"types of peripheral t","NNS IN JJ ",4,1,1,16914902,2,4.82E+018,"testalpha"
,"altered lipid and enzyme","VBN NN CC ",4,1,1,16523217,"pubmed1",2.44E+018,"testalpha"
,"values at various temperatures","NNS IN JJ NNS",4,1,1,17019442,"pubmed1",1.81E+017,"testalpha"
,"completecytoreduction cc score months","NN  NN NNS",4,1,1,17139879,2,3.83E+018,"testalpha"
,"deficiencies dental prostheses medicaments","NNS JJ NNS NNS",4,1,1,17010270,2,5.29E+018,"testalpha"
,"non fickian drug release"," JJ NN NN",4,1,1,16584161,"pubmed1",3.50E+018,"testalpha"
,"alonger period of time","NN NN IN NN",4,1,1,16436795,"pubmed1",1.92E+018,"testalpha"
,"jack bean urease antibodies"," NN NN NNS",4,1,1,16496040,"pubmed1",6.47E+017,"testalpha"
,"limbs tail and neck","NNS NN CC NN",4,1,1,16733064,2,5.81E+018,"testalpha"
,"dried gel exhibitedantacid effectiveness","VBD  NN NN",4,1,1,16584168,"pubmed1",2.97E+018,"testalpha"
,"combined orsequential immunomodulatory therapies","VBN JJ NN NNS",4,1,1,17016041,2,3.39E+018,"testalpha"
,"developmental disordersinvolving chromosome instabilities","NN VBG NN NNS",4,1,1,16582985,"pubmed1",1.78E+018,"testalpha"
,"induce neuronal dysfunction butthey","VB JJ NN NNP",4,1,1,17265695,2,3.77E+018,"testalpha"
,"online survey was e","NN NN VBD ",4,1,1,16436795,"pubmed1",7.98E+018,"testalpha"
,"positive reaction with masson","JJ NN IN NN",4,1,1,16514844,2,9.79E+017,"testalpha"
,"iii for fe iii"," IN  ",4,1,1,16421446,2,6.41E+018,"testalpha"
,"history of diabetes mellitus","NN IN NN NN",4,1,1,16462409,"pubmed1",7.40E+018,"testalpha"
,"nerve agent poisoned men","NN NN VBN NNS",4,1,1,16956120,2,2.28E+018,"testalpha"
,"ipc on rat liver"," IN NN NN",4,1,1,17013508,2,1.14E+018,"testalpha"
,"positivecorrelations between pkc activity","NNS IN  NN",4,1,1,17016035,2,2.89E+018,"testalpha"
,"regulation of testosterone release","NN IN NN NN",4,1,1,16325891,2,2.15E+017,"testalpha"
,"microbubble injection typical centripetal","JJ NN JJ NN",4,1,1,16333704,"pubmed1",9.50E+017,"testalpha"
,"gambiae usingknown d melanogaster"," VBN  NN",4,1,1,16770443,"pubmed1",3.22E+018,"testalpha"
,"sk fad from saccharomyces"," NN IN NNS",4,1,1,17063209,"pubmed1",4.42E+018,"testalpha"
,"milled zirconia acp filler","VBN NNP  NN",4,1,1,16701862,"pubmed1",2.16E+018,"testalpha"
,"retinoic acid conditioned group","JJ NN VBN NN",4,1,1,16612919,"pubmed1",5.59E+018,"testalpha"
,"pattern showing prominent sclerosis","NN VBG JJ NN",4,1,1,17311737,2,2.63E+018,"testalpha"
,"bupivacaine viaepidural catheter sensory","NN JJ NN NN",4,1,1,16916188,"pubmed1",2.61E+018,"testalpha"
,"cytotoxic activity of leukocytes","JJ NN IN NNS",4,1,1,16919708,2,2.04E+018,"testalpha"
,"activation regulated chemokine ccl","NN VBN NN ",4,1,1,16955181,2,7.00E+018,"testalpha"
,"central venous catheter tunnel","JJ JJ NN NN",4,1,1,16918062,"pubmed1",2.05E+017,"testalpha"
,"truncation fragmentation or point","NN NN CC NN",4,1,1,16369090,2,1.73E+018,"testalpha"
,"integral components of respiratory","JJ NNS IN NN",4,1,1,17143336,"pubmed1",2.84E+018,"testalpha"
,"return ofcognitive function post","NN JJ NN NN",4,1,1,16451145,"pubmed1",1.66E+018,"testalpha"
,"cases of primary genital","NNS IN JJ NN",4,1,1,16648915,2,5.66E+018,"testalpha"
,"board for human subject","NN IN JJ NN",4,1,1,16399034,"pubmed1",4.69E+018,"testalpha"
,"report levels of serum","NN NNS IN NN",4,1,1,17338197,2,8.99E+018,"testalpha"
,"athigher dosages of aha","JJ NNS IN ",4,1,1,16574202,2,7.65E+018,"testalpha"
,"j cm light dose","  NN NN",4,1,1,16955185,2,1.69E+017,"testalpha"
,"mosaic virus tmv rna","JJ NN  ",4,1,1,16395523,"pubmed1",8.24E+018,"testalpha"
,"underlying components of traffic","VBG NNS IN NN",4,1,1,16406188,"pubmed1",5.87E+018,"testalpha"
,"transduction of human cd","NN IN JJ ",4,1,1,17160143,"pubmed1",7.26E+018,"testalpha"
,"university of california san","NN IN NNP ",4,1,1,16377825,"pubmed1",1.25E+018,"testalpha"
,"regrowth of regenerating axons","NN IN VBG NNS",4,1,1,16414104,2,8.08E+018,"testalpha"
,"light dose j cm","NN NN  ",4,1,1,16585985,2,3.74E+018,"testalpha"
,"discrimination assay enabling detection","NN NN VBG NN",4,1,1,16929381,"pubmed1",3.40E+018,"testalpha"
,"fordifferentiation during skeletal muscle","NN IN NN NN",4,1,1,16965805,2,1.72E+017,"testalpha"
,"temporal scope spatial scales","JJ NN JJ NNS",4,1,1,16988904,"pubmed1",3.70E+018,"testalpha"
,"products usp expectsthe plan","NNS  NNP NN",4,1,1,17285738,"pubmed1",6.80E+018,"testalpha"
,"data from patients females","NNS IN NNS NNS",4,1,1,16696443,2,7.27E+018,"testalpha"
,"terminal extension of amino","NN NN IN NNP",4,1,1,16421447,2,4.96E+018,"testalpha"
,"hdl decreased blood pressure"," VBD NN NN",4,1,1,16918068,"pubmed1",8.35E+018,"testalpha"
,"vegf andglut mrna expression","   NN",4,1,1,17143338,"pubmed1",7.97E+018,"testalpha"
,"source of health care","NN IN NN NN",4,1,1,16365327,"pubmed1",3.61E+017,"testalpha"
,"preparation and asbonding agents","NN CC VBG NNS",4,1,1,16701865,"pubmed1",3.78E+018,"testalpha"
,"n or distilled water"," CC VBN NN",4,1,1,17293970,2,1.14E+018,"testalpha"
,"complications after endoscopic retrograde","NNS IN NN NN",4,1,1,16673611,2,6.25E+018,"testalpha"
,"induce dimerization ofhuman growth","VB NN NN NN",4,1,1,16565748,"pubmed1",3.69E+018,"testalpha"
,"treatment of bone wound","NN IN NN NN",4,1,1,16443258,2,8.60E+017,"testalpha"
,"chemistry projects crystal structures","NN NNS NN NNS",4,1,1,16369099,2,7.77E+018,"testalpha"
,"wheezing dyspnea and non","VBG NNP CC ",4,1,1,16612936,"pubmed1",1.00E+018,"testalpha"
,"outgrowth rate and fraction","NN NN CC NN",4,1,1,16874412,2,7.34E+018,"testalpha"
,"receive neo adjuvantradio chemotherapy","VB  NN NN",4,1,1,16612911,2,1.18E+018,"testalpha"
,"cholesterol triglyceride hdl andldl","NN VB  ",4,1,1,16479028,2,3.62E+018,"testalpha"
,"efflux from rat thalamicsynaptosomes","NN IN NN NNS",4,1,1,16594645,"pubmed1",5.25E+018,"testalpha"
,"normal uterine epithelial cells","JJ NN JJ NNS",4,1,1,16564564,2,8.61E+018,"testalpha"
,"u e improved outcome","  VBN NN",4,1,1,16365323,"pubmed1",4.36E+018,"testalpha"
,"bodyweight b i d","NN NN  ",4,1,1,16549901,2,7.81E+018,"testalpha"
,"perimenopausal and postmenopausal women","NN CC NN NNS",4,1,1,16514842,2,6.11E+018,"testalpha"
,"catalyses thehydrolysis of acyl","NNS NN IN ",4,1,1,16511283,2,9.17E+018,"testalpha"
,"il tr and cd","  CC ",4,1,1,17016036,2,9.10E+018,"testalpha"
,"development and cellular differentiation","NN CC JJ NN",4,1,1,16325892,2,7.01E+018,"testalpha"
,"defects with neighboring skin","NNS IN VBG NN",4,1,1,17165599,2,5.29E+018,"testalpha"
,"substantial variabilityin dissolution rate","JJ  NN NN",4,1,1,16594638,"pubmed1",1.61E+017,"testalpha"
,"oxidation and containedstoichiometric amounts","NN CC JJ NNS",4,1,1,16511277,2,3.74E+018,"testalpha"
,"intra common carotid artery","JJ JJ  NN",4,1,1,17133957,2,8.27E+018,"testalpha"
,"studied byzeta potential zp","VBN NN NN ",4,1,1,16584150,"pubmed1",6.40E+018,"testalpha"
,"crystals with variable number","NNS IN JJ NN",4,1,1,16514850,2,2.81E+018,"testalpha"
,"activities methods bibliographic research","NNS NNS JJ NN",4,1,1,16918069,"pubmed1",5.07E+018,"testalpha"
,"luminal narrowing intestinaldilatation peristalsis","JJ NN NN NN",4,1,1,16447095,"pubmed1",1.02E+018,"testalpha"
,"services towards primary prevention","NNS IN JJ NN",4,1,1,16859619,2,2.14E+018,"testalpha"
,"beneficial effects on skin","JJ NNS IN NN",4,1,1,17285742,"pubmed1",7.71E+018,"testalpha"
,"anastomotic leakage or failure","JJ NN CC NN",4,1,1,16612911,2,8.73E+018,"testalpha"
,"questions about behavioral factors","NNS IN JJ NNS",4,1,1,16436792,"pubmed1",2.80E+018,"testalpha"
,"orct evidence of invasion"," NN IN NN",4,1,1,17139900,2,2.98E+018,"testalpha"
,"data provide candidate genes","NNS VB NN NNS",4,1,1,16951744,"pubmed1",8.35E+018,"testalpha"
,"moiety fromcytidine monophospho n","NN NN  ",4,1,1,16511286,2,9.03E+018,"testalpha"
,"data about reported crashes","NNS IN VBN NNS",4,1,1,16122689,"pubmed1",2.18E+018,"testalpha"
,"riskmodel of behavioural adaptation","NN IN JJ NN",4,1,1,16426558,"pubmed1",1.54E+018,"testalpha"
,"low flux tohigh flux","JJ NN VB NN",4,1,1,17106603,2,7.51E+018,"testalpha"
,"values were range mmhg","NNS VBD NN ",4,1,1,16612916,"pubmed1",8.45E+017,"testalpha"
,"owing toembedment of drug","VBG NN IN NN",4,1,1,17285742,"pubmed1",3.44E+018,"testalpha"
,"sexual maturation energy production","JJ NN NN NN",4,1,1,16462411,"pubmed1",3.47E+018,"testalpha"
,"alertness during thesimulated patient","NN IN VBN NN",4,1,1,16436796,"pubmed1",8.31E+018,"testalpha"
,"hada combined prothrombotic state"," VBN JJ NN",4,1,1,16549900,2,3.32E+018,"testalpha"
,"infections in atopic dermatitis","NNS IN NN NN",4,1,1,16648910,2,8.70E+018,"testalpha"
,"atp dependent autophosphorylation andinactivation"," JJ NN NN",4,1,1,16404475,"pubmed1",6.61E+018,"testalpha"
,"animal models of huntington'sdisease","NN NNS IN NN",4,1,1,17133954,2,4.73E+018,"testalpha"
,"operation without medial incision","NN IN JJ NN",4,1,1,16956118,2,8.54E+018,"testalpha"
,"based monolayers surepath tripath","VBN NNS NN NN",4,1,1,16514840,2,7.02E+018,"testalpha"
,"interviews in dar es","NNS IN  ",4,1,1,16112069,"pubmed1",2.68E+018,"testalpha"
,"model ofthe adult testis","NN NNP NN NN",4,1,1,16395525,"pubmed1",4.11E+018,"testalpha"
,"similar ph profile ofadenosine","JJ  NN NN",4,1,1,16929383,"pubmed1",3.71E+018,"testalpha"
,"general principles of quality","JJ NNS IN NN",4,1,1,16999268,2,8.59E+018,"testalpha"
,"periocular haemangiomas of infancy","JJ NNP IN NN",4,1,1,16955189,2,4.70E+018,"testalpha"
,"ofdeath acute myocardial infarction","NN JJ JJ NN",4,1,1,16365321,"pubmed1",9.11E+018,"testalpha"
,"duty and commuting trafficcrashes","NN CC VBG NNS",4,1,1,16043107,"pubmed1",4.37E+018,"testalpha"
,"liver ischemia andreperfusion group","NN NN NN NN",4,1,1,17013507,2,1.18E+018,"testalpha"
,"analyzethe escalator riding accidents","NNP NN NN NNS",4,1,1,16434013,"pubmed1",4.62E+017,"testalpha"
,"known inbrazil as malva","VBN NNP IN ",4,1,1,17013511,2,8.48E+018,"testalpha"
,"prevention of secondary stroke","NN IN JJ NN",4,1,1,16436789,"pubmed1",7.27E+018,"testalpha"
,"levels of eosinophil proteins","NNS IN  NNS",4,1,1,16859611,2,3.98E+017,"testalpha"
,"finest expressions inoculoplastic surgery","JJS NNS JJ NN",4,1,1,16722343,2,3.19E+017,"testalpha"
,"transposition of insertion sequences","NN IN NN NNS",4,1,1,17106514,"pubmed1",1.68E+018,"testalpha"
,"staining patterns and anisotropic","VBG NNS CC NN",4,1,1,16542712,2,7.86E+017,"testalpha"
,"user type and vehicle","NN NN CC NN",4,1,1,16221468,"pubmed1",6.93E+017,"testalpha"
,"low tomoderate occupational solvent","JJ NN JJ NN",4,1,1,16808045,"pubmed1",2.61E+018,"testalpha"
,"changes inacademic research groups","NNS JJ NN NNS",4,1,1,16377817,"pubmed1",5.31E+018,"testalpha"
,"link between chronic infections","NN IN JJ NNS",4,1,1,16809885,2,7.44E+018,"testalpha"
,"major axis of cc","JJ  IN ",4,1,1,16399030,"pubmed1",5.31E+017,"testalpha"
,"asmassive hepatic resections sepsis","JJ JJ NNS NN",4,1,1,17013514,2,4.50E+018,"testalpha"
,"ofprivacy and clinical history","NN CC JJ NN",4,1,1,16710575,2,8.23E+018,"testalpha"
,"thedistribution of free air","NN IN JJ NN",4,1,1,16317496,"pubmed1",6.32E+018,"testalpha"
,"effect of various substances","NN IN JJ NNS",4,1,1,16696445,2,7.59E+017,"testalpha"
,"oflaryngeal and pulmonary tuberculosis","NN CC JJ NN",4,1,1,16479029,2,7.42E+018,"testalpha"
,"relatedstressors in academic medicine","NNS IN JJ NN",4,1,1,16377815,"pubmed1",3.58E+018,"testalpha"
,"treatment with ambisome ciprofloxacin","NN IN NN NNP",4,1,1,17370569,"pubmed1",2.56E+018,"testalpha"
,"crystallographic symmetry ncs dimer","JJ NN  NN",4,1,1,16511271,2,2.67E+018,"testalpha"
,"x l and mg","NN  CC ",4,1,1,16770447,"pubmed1",6.31E+018,"testalpha"
,"study included patients male","NN VBD NNS NN",4,1,1,16859613,2,6.56E+018,"testalpha"
,"wistar rats rattus norvegicus","NN NNS NN NN",4,1,1,17293969,2,1.62E+018,"testalpha"
,"cpk were measured spectrophotometricaly"," VBD VBN NNP",4,1,1,17338197,2,8.26E+018,"testalpha"
,"complete historyand physical examination","JJ NN JJ NN",4,1,1,16479028,2,4.43E+018,"testalpha"
,"hydrocarbon receptor nuclear translocator","NN NN JJ NN",4,1,1,16411738,"pubmed1",4.59E+018,"testalpha"
,"perioperative probiotics enhanced theimmune","JJ NNS VBN NN",4,1,1,17293972,2,3.18E+018,"testalpha"
,"patients showed stimulationof erythropoiesis","NNS VBD  NN",4,1,1,17119327,2,8.44E+017,"testalpha"
,"multicenter nonrandomized open label","NN VBN JJ NN",4,1,1,16424647,2,8.23E+018,"testalpha"
,"role in hiv vaccine","NN IN  NN",4,1,1,16511250,2,4.89E+018,"testalpha"
,"pg ml in clp","  IN ",4,1,1,17293958,2,6.14E+018,"testalpha"
,"theinfluence of mechanical bowel","NN IN JJ NN",4,1,1,16612916,"pubmed1",7.18E+018,"testalpha"
,"normal anal epithelium granulomas","JJ  NN NNP",4,1,1,17139883,2,2.01E+018,"testalpha"
,"show thatprophylactic levocetirizine mg","VBP JJ NN ",4,1,1,16874418,2,5.27E+018,"testalpha"
,"clinical outcomes afterischemic stroke","JJ NNS JJ NN",4,1,1,16436789,"pubmed1",1.81E+018,"testalpha"
,"diet containing oliveoil fish","NN VBG NN NN",4,1,1,16696439,2,6.07E+018,"testalpha"
,"agents with new mechanisms","NNS IN JJ NNS",4,1,1,17016040,2,5.63E+018,"testalpha"
,"infusion serialarterial blood samples","NN JJ NN NNS",4,1,1,17067137,"pubmed1",2.38E+018,"testalpha"
,"effect invarious cardiovascular diseases","NN JJ JJ NNS",4,1,1,16479034,2,3.02E+018,"testalpha"
,"specific ige rast tod","JJ   ",4,1,1,16859613,2,3.71E+018,"testalpha"
,"field performance showed dose","NN NN VBD NN",4,1,1,17133954,2,4.68E+018,"testalpha"
,"serology was positive days","NN VBD JJ NNS",4,1,1,16955191,2,2.79E+018,"testalpha"
,"number of case reports","NN IN NN NNS",4,1,1,16612924,"pubmed1",3.81E+018,"testalpha"
,"fluorescent protein egfp asa","NN NN  ",4,1,1,16404477,"pubmed1",7.67E+018,"testalpha"
,"others loss of balance","NNS NN IN NN",4,1,1,16434013,"pubmed1",5.88E+018,"testalpha"
,"highway environment compared withyounger","NN NN VBN NN",4,1,1,16226211,"pubmed1",4.27E+018,"testalpha"
,"cell leukemia virus protease","NN NN NN NN",4,1,1,16421452,2,5.91E+018,"testalpha"
,"platelet counts at r","NN NNS IN NN",4,1,1,17119322,2,1.09E+018,"testalpha"
,"body foreducation in anatomy","NN NN IN NN",4,1,1,16399038,"pubmed1",4.33E+018,"testalpha"
,"tc labeled st formulations"," VBD  NNS",4,1,1,16584167,"pubmed1",9.80E+017,"testalpha"
,"viii or ix replacement"," CC  NN",4,1,1,16549891,2,3.50E+018,"testalpha"
,"injection ofn methyl d","NN   ",4,1,1,17133957,2,5.28E+018,"testalpha"
,"inducedagranulocytosis hepatotoxicity and halothane","NN NN CC NN",4,1,1,16594644,"pubmed1",8.95E+018,"testalpha"
,"cxcl ip ccl mip","   ",4,1,1,16594639,"pubmed1",4.27E+017,"testalpha"
,"correction of radiation damage","NN IN NN NN",4,1,1,16369098,2,3.93E+018,"testalpha"
,"contrast and water ninety","NN CC NN NN",4,1,1,16252139,"pubmed1",6.18E+018,"testalpha"
,"modification rnatranscription mrna translation","NN NN  NN",4,1,1,16505901,"pubmed1",4.18E+018,"testalpha"
,"hearts from newborn month","NNS IN NNP NN",4,1,1,17046052,2,4.75E+018,"testalpha"
,"immunomodulatory effects known aspleiotropic","NN NNS VBN NN",4,1,1,17293958,2,7.63E+018,"testalpha"
,"department withvarious thyroid disorders","NN JJ NN NNS",4,1,1,16514836,2,4.95E+018,"testalpha"
,"velocity of sedimentation analyses","NN IN NN NNS",4,1,1,17019436,"pubmed1",6.35E+018,"testalpha"
,"review summarizes current views","NN VBZ JJ NNS",4,1,1,16951740,"pubmed1",1.76E+018,"testalpha"
,"dimer and temperature dependence","NN CC NN NN",4,1,1,16505899,"pubmed1",2.59E+018,"testalpha"
,"vwd in indian patients"," IN JJ NNS",4,1,1,16424652,2,9.81E+017,"testalpha"
,"cp and yjr cp"," CC  ",4,1,1,17146497,"pubmed1",3.21E+018,"testalpha"
,"nd and trna arg"," CC  ",4,1,1,16389406,"pubmed1",5.65E+018,"testalpha"
,"categories lymphocytic group e","NNS JJ NN ",4,1,1,17311739,2,2.48E+018,"testalpha"
,"d pteronyssinus in atopic"," NN IN NN",4,1,1,16859613,2,9.02E+018,"testalpha"
,"withoutsignificant increases over time","JJ NNS IN NN",4,1,1,16809886,2,7.62E+018,"testalpha"
,"patients showeddyslipidaemia in patients","NNS NN IN NNS",4,1,1,16479028,2,8.58E+017,"testalpha"
,"effect site concentrations remice","NN NN NNS NN",4,1,1,17067138,"pubmed1",8.64E+018,"testalpha"
,"arteryinjection of nmda mg","NN IN  ",4,1,1,17133957,2,2.50E+018,"testalpha"
,"thisregimen by concurrent chemotherapy","NNS IN JJ NN",4,1,1,17117605,2,2.24E+018,"testalpha"
,"morphological analyse trough micrographics","JJ  NN NNS",4,1,1,17293968,2,3.45E+018,"testalpha"
,"postoperative complications reoperations hospital","JJ NNS NNS NN",4,1,1,17139896,2,4.76E+018,"testalpha"
,"p acnes in vivo"," NNS IN ",4,1,1,16874416,2,3.99E+018,"testalpha"
,"including small tissue fragmentsand","VBG JJ NN NN",4,1,1,16514842,2,1.73E+018,"testalpha"
,"mentoring nurses and improvingattitudes","VBG NNS CC NNS",4,1,1,16330213,"pubmed1",8.78E+018,"testalpha"
,"cobalt chloride in fragrance","NN NN IN NN",4,1,1,17010264,2,8.03E+018,"testalpha"
,"health and development agenda","NN CC NN NN",4,1,1,16412373,"pubmed1",4.13E+018,"testalpha"
,"matched non surgical controls","VBN  JJ NNS",4,1,1,16451151,"pubmed1",2.71E+018,"testalpha"
,"withelevated serum tsa levels","VBN NN  NNS",4,1,1,16956116,2,9.03E+017,"testalpha"
,"ora liver trunk cell"," NN NN NN",4,1,1,17013517,2,7.64E+018,"testalpha"
,"lower heart rate f","JJR NN NN NN",4,1,1,16365322,"pubmed1",2.86E+018,"testalpha"
,"patients healed showed improvement","NNS VBD VBD NN",4,1,1,16710580,2,1.03E+018,"testalpha"
,"neuropathic changes gastresophageal refluxand","JJ NNS NN NN",4,1,1,17338194,2,4.17E+018,"testalpha"
,"degree of conversion glass","NN IN NN NN",4,1,1,16701856,"pubmed1",2.80E+018,"testalpha"
,"use of concentrated solutions","NN IN VBN NNS",4,1,1,16701876,"pubmed1",7.23E+018,"testalpha"
,"clinicalfeatures management and outcome","NNS NN CC NN",4,1,1,16549900,2,4.69E+018,"testalpha"
,"improvedblood pressure and normalization","NN NN CC NN",4,1,1,16918068,"pubmed1",6.38E+018,"testalpha"
,"volume horizontal alignment interchange","NN NN NN NN",4,1,1,16442487,"pubmed1",9.11E+018,"testalpha"
,"thinprep medium preparation cytyc"," NN NN ",4,1,1,16514835,2,4.69E+018,"testalpha"
,"concentrations were determined viaenzyme","NNS VBD VBN ",4,1,1,16594642,"pubmed1",2.27E+018,"testalpha"
,"optical flow method ofm","JJ NN NN ",4,1,1,16399029,"pubmed1",6.42E+018,"testalpha"
,"degree of vinyl conversion","NN IN NN NN",4,1,1,16701862,"pubmed1",1.61E+018,"testalpha"
,"cimetidine grades ofcolloidal silicon","NN NNS NN NN",4,1,1,17285749,"pubmed1",6.44E+018,"testalpha"
,"noassociations between factor v","NNS IN NN ",4,1,1,16549893,2,4.75E+018,"testalpha"
,"prp d in sheep","  IN NN",4,1,1,16770445,"pubmed1",4.24E+018,"testalpha"
,"stroke or tiaencounter eps","NN CC NN ",4,1,1,16436789,"pubmed1",3.52E+018,"testalpha"
,"sptcl patients achieved cr"," NNS VBN ",4,1,1,16914902,2,7.41E+018,"testalpha"
,"large randomized phase iiitrials","JJ VBN NN NNS",4,1,1,16673565,2,8.33E+018,"testalpha"
,"spectrum of contact allergy","NN IN NN NN",4,1,1,17106597,2,7.75E+018,"testalpha"
,"hygienists www acgih org","NNS   ",4,1,1,16438095,"pubmed1",4.47E+018,"testalpha"
,"phospholipids glycoproteins and membrane","NNS NNS CC NN",4,1,1,16523217,"pubmed1",8.47E+018,"testalpha"
,"protein level epx leveland","NN NN  NN",4,1,1,16859611,2,5.39E+018,"testalpha"
,"killed conditional poisson regression","VBN JJ NN NN",4,1,1,16426561,"pubmed1",8.76E+018,"testalpha"
,"demographics weather conditions transportation","NNS NN NNS NN",4,1,1,16451795,"pubmed1",2.84E+017,"testalpha"
,"induces neurodegeneration in primarycultures","NNS NN IN NNS",4,1,1,17265692,2,4.80E+018,"testalpha"
,"groups of antioxidant enzymes","NNS IN JJ NNS",4,1,1,17160142,"pubmed1",6.04E+017,"testalpha"
,"comprised patientswho underwent organ","VBN  NN NN",4,1,1,16710578,2,8.98E+018,"testalpha"
,"healthcare environmentsclinical incident reporting","NN JJ NN NN",4,1,1,16321534,"pubmed1",7.45E+018,"testalpha"
,"results hps developed days","NNS  VBN NNS",4,1,1,16914905,2,6.39E+018,"testalpha"
,"attention concentration verbal memory","NN NN JJ NN",4,1,1,16479025,2,1.10E+018,"testalpha"
,"infection of human cytomegalovirus","NN IN JJ NN",4,1,1,17019440,"pubmed1",6.25E+018,"testalpha"
,"current research and currenttreatments","JJ NN CC NNS",4,1,1,17318328,"pubmed1",1.03E+018,"testalpha"
,"manner on plasmid pact","NN IN JJ NN",4,1,1,16395528,"pubmed1",7.42E+018,"testalpha"
,"ifn g sil r","   NN",4,1,1,16603096,2,6.37E+018,"testalpha"
,"constitute comparable collectives whereasdifferent","VB JJ NNS NN",4,1,1,16988904,"pubmed1",3.32E+018,"testalpha"
,"crystal structure of clofarabine","NN NN IN NN",4,1,1,16421443,2,2.20E+018,"testalpha"
,"related morbidity and mortality","VBN NN CC NN",4,1,1,16918068,"pubmed1",2.08E+018,"testalpha"
,"prothrombin deficiency or fx","NNP NN CC ",4,1,1,16424651,2,6.03E+018,"testalpha"
,"livinglonger and developing conditions","NN CC VBG NNS",4,1,1,16462404,"pubmed1",1.58E+018,"testalpha"
,"prokaryotic proteins yield x","JJ NNS NN NN",4,1,1,16369101,2,3.66E+018,"testalpha"
,"phenomenon of stem cell","NN IN VB NN",4,1,1,17265694,2,7.93E+018,"testalpha"
,"dimensional model on prevalence","JJ NN IN NN",4,1,1,16191426,"pubmed1",2.24E+018,"testalpha"
,"accreditation council of graduate","NN NN IN NN",4,1,1,16436795,"pubmed1",6.44E+018,"testalpha"
,"nonpolar beta carotene carotenoids","JJ NN NN NNS",4,1,1,16964324,"pubmed1",3.40E+018,"testalpha"
,"secretes among others protein","NNS IN NNS NN",4,1,1,16410836,"pubmed1",8.77E+018,"testalpha"
,"regimen of aml patients","NN IN  NNS",4,1,1,17119322,2,6.95E+018,"testalpha"
,"gtpase ii nucleotide exchange","NN  VB NN",4,1,1,17019437,"pubmed1",5.19E+018,"testalpha"
,"fn tenascin c tn"," NNP NN ",4,1,1,16414104,2,2.28E+018,"testalpha"
,"cases of glandular abnormalities","NNS IN JJ NNS",4,1,1,16514839,2,3.63E+018,"testalpha"
,"hepatic relapse of non","JJ NN IN ",4,1,1,17119328,2,5.94E+018,"testalpha"
,"andthe severity of pruritus","NNP NN IN NN",4,1,1,16585987,2,3.06E+018,"testalpha"
,"successful use of q","JJ NN IN ",4,1,1,16859612,2,2.91E+018,"testalpha"
,"anatomic features of theslip","JJ NNS IN NNP",4,1,1,16696447,2,4.13E+018,"testalpha"
,"tools several geometric modifications","NNS JJ JJ NNS",4,1,1,16594638,"pubmed1",7.83E+018,"testalpha"
,"skin and compares itwith","NN CC VBZ NN",4,1,1,17034836,2,6.01E+018,"testalpha"
,"inferior vena cava involvement","JJ   NN",4,1,1,16314992,"pubmed1",7.43E+018,"testalpha"
,"maturation spontaneous exploration andamphetamine","NN JJ NN NN",4,1,1,16808045,"pubmed1",7.54E+017,"testalpha"
,"promoter expression vector andglutamine","NN NN NN NN",4,1,1,16733563,"pubmed1",8.40E+018,"testalpha"
,"active structural genomics initiatives","JJ JJ NNS NNS",4,1,1,16369088,2,9.06E+018,"testalpha"
,"potential pitfall in medicaldecision","JJ NN IN NN",4,1,1,16365325,"pubmed1",7.06E+018,"testalpha"
,"role releasing neuronal growth","NN VBG JJ NN",4,1,1,17265695,2,7.25E+018,"testalpha"
,"solid organ transplant recipients","JJ NN JJ NNS",4,1,1,16710578,2,6.43E+018,"testalpha"
,"expression of ctgf transcripts","NN IN  NNS",4,1,1,16395527,"pubmed1",8.44E+018,"testalpha"
,"element in poor response","NN IN JJ NN",4,1,1,16648911,2,5.02E+018,"testalpha"
,"annelid worm chaetopterus variopedatus","JJ  NN NN",4,1,1,17019436,"pubmed1",8.31E+017,"testalpha"
,"atotal of treatment periods","NN IN NN NNS",4,1,1,16424646,2,4.54E+018,"testalpha"
,"evaluation of hydroxyapatite formation","NN IN JJ NN",4,1,1,16701876,"pubmed1",4.22E+017,"testalpha"
,"natural genetic engineering replication","JJ JJ NN NN",4,1,1,17347785,"pubmed1",1.94E+018,"testalpha"
,"months of therapy withl","NNS IN NN ",4,1,1,16424656,2,3.45E+018,"testalpha"
,"effects of good fair","NNS IN JJ NN",4,1,1,16171767,"pubmed1",4.86E+018,"testalpha"
,"serious complication following thoracicprocedures","JJ NN VBG NNS",4,1,1,16612923,"pubmed1",5.03E+018,"testalpha"
,"patients received anantimycotic agent","NNS VBD JJ NN",4,1,1,16603098,2,6.66E+015,"testalpha"
,"multivariate analysis using logisticregression","NN NN VBG NN",4,1,1,16479026,2,8.86E+018,"testalpha"
,"following intranasal andintravenous iv","VBG NN JJ ",4,1,1,16584167,"pubmed1",2.21E+018,"testalpha"
,"conclusion in cervical carcinogenesis","NN IN JJ NN",4,1,1,16514834,2,7.22E+018,"testalpha"
,"patients and healthy volunteers","NNS CC JJ NNS",4,1,1,17119323,2,5.44E+018,"testalpha"
,"l methanol g l"," NN  ",4,1,1,17019438,"pubmed1",6.60E+018,"testalpha"
,"years regarding clinical stages","NNS IN JJ NNS",4,1,1,16914904,2,3.64E+018,"testalpha"
,"chitosan coated alginate microspheres","JJ VBN NN NNS",4,1,1,16594643,"pubmed1",4.21E+018,"testalpha"
,"junction incompetence with correctionof","NN NN IN ",4,1,1,16612909,2,6.55E+018,"testalpha"
,"comorbidity was females male","NN VBD NNS NN",4,1,1,16696444,2,5.98E+018,"testalpha"
,"tumors and vascular malformations","NNS CC JJ NNS",4,1,1,16722347,2,4.13E+018,"testalpha"
,"indication of range eclipses","NN IN NN NNS",4,1,1,17318329,"pubmed1",3.97E+018,"testalpha"
,"achieve beneficial effects inthe","VB JJ NNS NNP",4,1,1,16594642,"pubmed1",8.02E+017,"testalpha"
,"ii complex ofac thr"," JJ  ",4,1,1,17117212,"pubmed1",6.02E+018,"testalpha"
,"physicians following overnight shifts","NNS VBG JJ NNS",4,1,1,16436796,"pubmed1",3.79E+018,"testalpha"
,"hdl cholesterol andldl cholesterol"," NN  NN",4,1,1,16479026,2,8.04E+018,"testalpha"
,"duringtimes of ground combat","NNS IN NN NN",4,1,1,16405857,"pubmed1",4.57E+017,"testalpha"
,"knowledge attitudes and practices","NN NNS CC NNS",4,1,1,16514839,2,6.53E+018,"testalpha"
,"urinary calcium excretion u","JJ NN NN ",4,1,1,16956119,2,1.72E+018,"testalpha"
,"excision of basal cellcarcinomas","NN IN NN NNP",4,1,1,17165594,2,2.21E+018,"testalpha"
,"fluid resuscitation mechanicalventilation vasopressors","NN NN NN NNS",4,1,1,16365336,"pubmed1",3.06E+018,"testalpha"
,"determined temperature and resistance","VBN NN CC NN",4,1,1,17285746,"pubmed1",4.92E+018,"testalpha"
,"studies of medical conditions","NNS IN JJ NNS",4,1,1,16054104,"pubmed1",7.70E+018,"testalpha"
,"karyorrhexis and numerous bacteria"," CC JJ NNS",4,1,1,16514843,2,6.70E+017,"testalpha"
,"paleopathological asymmetrical skull deformitiesis","JJ JJ NN NN",4,1,1,17438834,2,7.79E+018,"testalpha"
,"study about alcohol impaireddrivers","NN IN NN NNS",4,1,1,16112068,"pubmed1",2.38E+018,"testalpha"
,"lung nodule assessment evaluation","NN NN NN NN",4,1,1,16399029,"pubmed1",8.31E+017,"testalpha"
,"recombinant urate oxidase rasburicase","JJ NN NN NN",4,1,1,16424647,2,1.85E+018,"testalpha"
,"direct drug transport dtp","JJ NN NN ",4,1,1,16584167,"pubmed1",7.67E+018,"testalpha"
,"disease research laboratory test","NN NN NN NN",4,1,1,16874420,2,9.06E+017,"testalpha"
,"colon mucosal weight dna","NN NN NN ",4,1,1,17293972,2,2.41E+018,"testalpha"
,"surgery timing of treatment","NN NN IN NN",4,1,1,17139901,2,3.04E+018,"testalpha"
,"search identified cervicovaginal smears","NN VBD JJ NNS",4,1,1,16514840,2,1.50E+018,"testalpha"
,"intestinal permeability and transport","JJ NN CC NN",4,1,1,16584115,"pubmed1",2.54E+018,"testalpha"
,"theconcequence of diminished destruction","NN IN VBN NN",4,1,1,17117609,2,5.88E+018,"testalpha"
,"counties witha higher percentage","NNS NN JJR NN",4,1,1,16451795,"pubmed1",3.13E+018,"testalpha"
,"changes in skin mechanics","NNS IN NN NNS",4,1,1,16874414,2,4.27E+018,"testalpha"
,"total of surveys web","NN IN NNS ",4,1,1,16438092,"pubmed1",3.45E+017,"testalpha"
,"blood pressure bp andischemia","NN NN  NN",4,1,1,16764913,2,2.43E+018,"testalpha"
,"sideeffects of iron prophylaxis","NNS IN NN ",4,1,1,16424650,2,6.41E+018,"testalpha"
,"name i r lead","NN  NN NN",4,1,1,16764913,2,7.56E+018,"testalpha"
,"risk factors for vte","NN NNS IN ",4,1,1,16549896,2,6.24E+018,"testalpha"
,"andnevirapine induced skin rash","NN VBN NN NN",4,1,1,16594644,"pubmed1",7.19E+018,"testalpha"
,"forthe characterization of crystal","NNP NN IN NN",4,1,1,16421445,2,2.79E+018,"testalpha"
,"desferrioxamine minimal liver iron","NN JJ NN NN",4,1,1,16424659,2,2.75E+018,"testalpha"
,"derived stromal cells mdsc","VBN JJ NNS ",4,1,1,16713618,2,2.25E+018,"testalpha"
,"atomic force microscopy afm","JJ NN  ",4,1,1,16410837,"pubmed1",5.95E+017,"testalpha"
,"congenital heart defect inadulthood","NN NN NN NN",4,1,1,16612922,"pubmed1",1.39E+018,"testalpha"
,"high expression of adhesion","JJ NN IN NN",4,1,1,16603095,2,6.00E+018,"testalpha"
,"theobtained crystal was p","VBN NN VBD ",4,1,1,16511281,2,2.95E+016,"testalpha"
,"factor beta and des","NN NN CC NNP",4,1,1,16395527,"pubmed1",1.42E+018,"testalpha"
,"pretreatment with u e","NN IN  ",4,1,1,16365323,"pubmed1",1.40E+018,"testalpha"
,"ischemia atp sensitive k","NN  JJ ",4,1,1,16566960,2,6.23E+018,"testalpha"
,"fresh gasflow rate fgf","JJ VB NN ",4,1,1,16451150,"pubmed1",5.52E+018,"testalpha"
,"oxygen saturation monitoring antibiotics","NN NN NN NNS",4,1,1,16365336,"pubmed1",7.66E+018,"testalpha"
,"circle of cutaneous inflammation","NN IN JJ NN",4,1,1,16648910,2,8.51E+018,"testalpha"
,"mutation codon in exon","NN NNP IN ",4,1,1,17139886,2,3.07E+018,"testalpha"
,"itshigh affinity for dna","VB NN IN ",4,1,1,17143337,"pubmed1",2.76E+018,"testalpha"
,"estimate of thecrystal unit","NN IN NN NN",4,1,1,16369093,2,1.11E+018,"testalpha"
,"blood counts revealed pancytopenia","NN NNS VBD NNP",4,1,1,16809892,2,7.41E+018,"testalpha"
,"view of new concepts","NN IN JJ NNS",4,1,1,17013519,2,5.31E+018,"testalpha"
,"problem of skin replacement","NN IN NN NN",4,1,1,16999270,2,2.81E+018,"testalpha"
,"changes of protein kinase","NNS IN NN NN",4,1,1,17016035,2,9.02E+018,"testalpha"
,"enable integration of information","VB NN IN NN",4,1,1,16714050,2,5.73E+018,"testalpha"
,"temperature for fluid phasemembranes","NN IN NN NNS",4,1,1,16964324,"pubmed1",7.66E+018,"testalpha"
,"d aspartate nmda receptor"," NN  NN",4,1,1,16451144,"pubmed1",2.48E+018,"testalpha"
,"repair shows apronounced g","NN VBZ VBN ",4,1,1,16404475,"pubmed1",6.30E+018,"testalpha"
,"averaged days range days","VBD NNS VBP NNS",4,1,1,16701881,"pubmed1",8.28E+018,"testalpha"
,"complications of human immunodeficiencyvirus","NNS IN JJ NN",4,1,1,16462406,"pubmed1",3.36E+018,"testalpha"
,"n and burns n"," CC NNS ",4,1,1,16412373,"pubmed1",2.24E+018,"testalpha"
,"rise in mitochondrial oxygen","NN IN JJ NN",4,1,1,17068635,"pubmed1",6.40E+018,"testalpha"
,"tolerate oral iron therapy","VB JJ NN NN",4,1,1,16809890,2,5.12E+018,"testalpha"
,"analysis was performed bydirect","NN VBD VBN NN",4,1,1,16424663,2,8.26E+018,"testalpha"
,"several inhibitors of dna","JJ NNS IN ",4,1,1,16582985,"pubmed1",7.31E+018,"testalpha"
,"residency program duty hour","NN NN NN NN",4,1,1,16377825,"pubmed1",5.62E+017,"testalpha"
,"channel blocker with significantmortality","NN NN IN NN",4,1,1,16436797,"pubmed1",2.91E+018,"testalpha"
,"mutation p asp asn","NN   ",4,1,1,17106596,2,3.36E+018,"testalpha"
,"inflammatory cytokines andleukocytes count","JJ NNS NNS NN",4,1,1,17293958,2,5.91E+018,"testalpha"
,"gender date of crash","NN NN IN NN",4,1,1,16221468,"pubmed1",6.28E+018,"testalpha"
,"oglc and o gal"," CC  ",4,1,1,16456293,2,4.16E+018,"testalpha"
,"structure determination bymad methods","NN NN NNP NNS",4,1,1,16511294,2,5.37E+018,"testalpha"
,"inpatient diagnosis of substance","NN NN IN NN",4,1,1,16405857,"pubmed1",2.40E+018,"testalpha"
,"introduction of systematic changes","NN IN JJ NNS",4,1,1,16701853,"pubmed1",5.91E+018,"testalpha"
,"lip and palate clp","NN CC NN ",4,1,1,17165598,2,7.73E+018,"testalpha"
,"incident durations and tohelp","NN NNS CC ",4,1,1,16426557,"pubmed1",6.18E+018,"testalpha"
,"was assessed inthe patients","VBD VBN NNP NNS",4,1,1,17106600,2,3.32E+018,"testalpha"
,"women men mean age","NNS NNS VBP NN",4,1,1,16874420,2,8.45E+017,"testalpha"
,"cause of allergic contactdermatitis","NN IN JJ NN",4,1,1,17106597,2,4.56E+018,"testalpha"
,"derivatives of length c","NNS IN NN NN",4,1,1,16511287,2,6.08E+018,"testalpha"
,"d polylepsis venom csav"," NN NN ",4,1,1,16436788,"pubmed1",4.63E+018,"testalpha"
,"pro inflammatory cytokines andleukocytes","JJ JJ NNS NNS",4,1,1,17293958,2,8.99E+018,"testalpha"
,"immunohistochemistry andwestern blot assay","NN JJ NN NN",4,1,1,17046052,2,6.81E+018,"testalpha"
,"cicatricial pemphigoid porphyria cutanea","JJ VB NNP NNP",4,1,1,17311739,2,8.36E+018,"testalpha"
,"concentrations of w w","NNS IN  ",4,1,1,16701865,"pubmed1",1.71E+018,"testalpha"
,"methods in aprospective study","NNS IN JJ NN",4,1,1,17236637,"pubmed1",4.56E+018,"testalpha"
,"withdecreased survival rates male","VBN NN NNS NN",4,1,1,16451146,"pubmed1",7.88E+017,"testalpha"
,"element binding protein atf","NN VBG NN ",4,1,1,16395528,"pubmed1",1.48E+018,"testalpha"
,"sem images and averagesurface"," NNS CC NN",4,1,1,16584166,"pubmed1",3.30E+018,"testalpha"
,"allergens patients and grass","NNS NNS CC NN",4,1,1,17328144,2,6.52E+018,"testalpha"
,"biotoxins producedby animals plants","NNS JJ NNS NNS",4,1,1,16696436,2,4.52E+018,"testalpha"
,"relocation of phosphorylated myosin","NN IN VBN NNP",4,1,1,17115079,"pubmed1",8.42E+017,"testalpha"
,"climate measureshave considerable promise","NN VB JJ NN",4,1,1,16202466,"pubmed1",4.26E+018,"testalpha"
,"less lower extremity motor","JJR JJR NN NN",4,1,1,16617757,"pubmed1",1.74E+018,"testalpha"
,"spinal analgesics andantihyperalgesic drugs","JJ NNS NN NNS",4,1,1,17236639,"pubmed1",2.79E+018,"testalpha"
,"activated mouse t lymphocytes","VBN NN  NNS",4,1,1,17117211,"pubmed1",4.16E+017,"testalpha"
,"stains byportal blood flow","NNS NN NN NN",4,1,1,16317494,"pubmed1",6.43E+018,"testalpha"
,"vii ix and x","  CC NN",4,1,1,16916181,"pubmed1",4.26E+018,"testalpha"
,"non equilibrium phase transitions"," NN NN NNS",4,1,1,16988902,"pubmed1",6.95E+018,"testalpha"
,"injuries wri amongcavhs employees","NNS   NNS",4,1,1,16438093,"pubmed1",8.79E+018,"testalpha"
,"discoveryof specific antiangiogenic inhibitors"," JJ JJ NNS",4,1,1,16388313,"pubmed1",9.05E+018,"testalpha"
,"dose of escitalopram mg","NN IN NN ",4,1,1,16584121,"pubmed1",8.73E+017,"testalpha"
,"ct guided lung biopsy"," VBD NN NN",4,1,1,16918065,"pubmed1",4.10E+018,"testalpha"
,"cyclins cip kip family","NNS   NN",4,1,1,17115080,"pubmed1",9.38E+017,"testalpha"
,"creatinine ratio u nag","NN NN  ",4,1,1,16956119,2,1.80E+018,"testalpha"
,"thepresence of age fluorescence","NN IN NN NN",4,1,1,16696441,2,9.06E+018,"testalpha"
,"detailed analysis of unidentifiedgenes","VBN NN IN NNS",4,1,1,16582986,"pubmed1",7.11E+018,"testalpha"
,"tothe frequency of crash","NNP NN IN NN",4,1,1,16122689,"pubmed1",3.24E+018,"testalpha"
,"diamine dihydrate c h","NN NN NN ",4,1,1,16456284,2,6.77E+018,"testalpha"
,"experimental group of rats","JJ NN IN NNS",4,1,1,17133955,2,7.55E+018,"testalpha"
,"cell surfaces inthe presence","NN NNS NNP NN",4,1,1,16549888,2,8.07E+018,"testalpha"
,"collected data ofall patients","VBN NNS JJ NNS",4,1,1,16612911,2,3.44E+018,"testalpha"
,"ionization ip rp esi","NN   ",4,1,1,17285740,"pubmed1",1.09E+017,"testalpha"
,"days of treatment olanzapine","NNS IN NN NN",4,1,1,16696448,2,8.80E+018,"testalpha"
,"osteoclastomalike giant cell tumor","NN NN NN NN",4,1,1,16514845,2,7.57E+018,"testalpha"
,"pressure control lipid profile","NN NN NN NN",4,1,1,16921608,"pubmed1",6.34E+018,"testalpha"
,"dermal sclerosis and pattern","JJ NN CC NN",4,1,1,17311737,2,9.80E+017,"testalpha"
,"median barrier placement decisions","JJ NN NN NNS",4,1,1,16442487,"pubmed1",7.79E+018,"testalpha"
,"license holders with driver","NN NNS IN NN",4,1,1,16112070,"pubmed1",6.98E+018,"testalpha"
,"cm laser light nm"," NN JJ ",4,1,1,16955185,2,1.32E+018,"testalpha"
,"application of calibration factors","NN IN NN NNS",4,1,1,16414003,"pubmed1",5.74E+018,"testalpha"
,"patients andduring standard acne","NNS VBG JJ ",4,1,1,16874416,2,7.58E+018,"testalpha"
,"using dna polymerase fingerprint","VBG  NN NN",4,1,1,16582987,"pubmed1",8.84E+018,"testalpha"
,"profound impact onresident physicians","JJ NN NN NNS",4,1,1,16377827,"pubmed1",1.47E+018,"testalpha"
,"stringent graduated drivers license","JJ VBN NNS NN",4,1,1,16171767,"pubmed1",8.66E+018,"testalpha"
,"non specific t cell"," JJ  NN",4,1,1,16956117,2,2.62E+018,"testalpha"
,"possibility of enhancing theimmunogenicity","NN IN VBG NN",4,1,1,16733557,"pubmed1",8.99E+018,"testalpha"
,"fused withthe b glucuronidase","VBN NNP NN NN",4,1,1,16395526,"pubmed1",7.72E+018,"testalpha"
,"nitrogen square planar ni","NN NN NN ",4,1,1,17117212,"pubmed1",4.39E+018,"testalpha"
,"assessment and therapy side","NN CC NN NN",4,1,1,16955182,2,5.84E+018,"testalpha"
,"prehospital lead electrocardiogram phecg","NN NN NN ",4,1,1,16365334,"pubmed1",3.49E+018,"testalpha"
,"diagnostic modalities asdiagnostic peritoneal","NN NNS JJ NN",4,1,1,17013521,2,5.16E+018,"testalpha"
,"native conformations in spite","JJ NNS IN NN",4,1,1,16365636,"pubmed1",7.86E+018,"testalpha"
,"metallic synthesis or technique","JJ NN CC NN",4,1,1,17293966,2,1.83E+018,"testalpha"
,"structures of unliganded ak","NNS IN VBN ",4,1,1,16421444,2,6.73E+018,"testalpha"
,"cd hbsr andsoluble cd","  JJ ",4,1,1,16770444,"pubmed1",1.59E+017,"testalpha"
,"cancer morbidity and mortality","NN NN CC NN",4,1,1,16596895,"pubmed1",8.87E+018,"testalpha"
,"grade normal liver texture","NN JJ NN NN",4,1,1,16673610,2,7.39E+018,"testalpha"
,"r and d systems","NN CC  NNS",4,1,1,16603096,2,5.79E+017,"testalpha"
,"rb efflux from rat"," NN IN NN",4,1,1,16594645,"pubmed1",1.99E+018,"testalpha"
,"anticoagulants andantihypertensives for prevention","NNS NNS IN NN",4,1,1,16436789,"pubmed1",7.09E+018,"testalpha"
,"were expressed asz scores","VBD VBN  NNS",4,1,1,16956119,2,9.13E+017,"testalpha"
,"psi c gal o"," NN  ",4,1,1,16456293,2,3.33E+018,"testalpha"
,"selenium concentrations and gsh","NN NNS CC ",4,1,1,17160142,"pubmed1",8.38E+018,"testalpha"
,"beta d glucosaminidase u","NN  NN ",4,1,1,16956119,2,8.76E+018,"testalpha"
,"ppargamma and retinoid xreceptor","NN CC VB NN",4,1,1,16395520,"pubmed1",5.52E+018,"testalpha"
,"cytoskeletal changes in hep","NN NNS IN ",4,1,1,16956122,2,2.75E+018,"testalpha"
,"weak institutionalalignment staffing problems","JJ NN NN NNS",4,1,1,16377814,"pubmed1",4.56E+018,"testalpha"
,"receivedplasmapheresis as initial treatment","NN IN JJ NN",4,1,1,16424653,2,2.66E+018,"testalpha"
,"mechanisms compensating limited expression","NNS VBG JJ NN",4,1,1,16951738,"pubmed1",5.30E+017,"testalpha"
,"inhalational anesthetic desfluraneand rocuronium","JJ JJ NN NN",4,1,1,17236635,"pubmed1",3.06E+018,"testalpha"
,"usinghuman embryonic stem cells","NN JJ VB NNS",4,1,1,17269167,2,1.30E+018,"testalpha"
,"qualitative evaluation of coronary","JJ NN IN NN",4,1,1,16399037,"pubmed1",7.79E+018,"testalpha"
,"form of rhoa mg","NN IN  ",4,1,1,17019437,"pubmed1",4.68E+018,"testalpha"
,"circumstances of occupational roadcrashes","NNS IN JJ NNS",4,1,1,16043107,"pubmed1",4.31E+018,"testalpha"
,"data on aconsistent scale","NNS IN NN NN",4,1,1,16369096,2,5.52E+017,"testalpha"
,"binding assay in sea","VBG NN IN NN",4,1,1,16414103,2,3.76E+018,"testalpha"
,"programs reduce night time","NNS VB NN NN",4,1,1,16171767,"pubmed1",1.88E+018,"testalpha"
,"transfusion requirements and blood","NN NNS CC NN",4,1,1,16451158,"pubmed1",3.72E+018,"testalpha"
,"ts epidermalgrowth factor receptors"," NN NN NNS",4,1,1,17139902,2,1.99E+018,"testalpha"
,"systemic form of therapy","JJ NN IN NN",4,1,1,16955187,2,2.54E+018,"testalpha"
,"organs fromischemia reperfusion damage","NNS NN NN NN",4,1,1,16365323,"pubmed1",4.27E+018,"testalpha"
,"glucan rats had enhancement","JJ NNS VBD NN",4,1,1,17293960,2,9.09E+018,"testalpha"
,"mg kg min p","   ",4,1,1,17236635,"pubmed1",3.55E+018,"testalpha"
,"event but transposition frequency","NN CC NN NN",4,1,1,17106514,"pubmed1",2.12E+018,"testalpha"
,"ligands inhibit cell proliferation","NNS VB NN NN",4,1,1,16809887,2,3.08E+017,"testalpha"
,"periods consecutive medical records","NNS JJ JJ NNS",4,1,1,16436791,"pubmed1",7.45E+017,"testalpha"
,"sources years versus year","NNS NNS IN NN",4,1,1,16221468,"pubmed1",2.21E+018,"testalpha"
,"single or multi organ","NN CC  NN",4,1,1,16585988,2,2.96E+018,"testalpha"
,"families as mandated bythe","NNS IN VBN NNP",4,1,1,16473998,"pubmed1",9.11E+018,"testalpha"
,"posttreatment pain vas scores","NN NN  NNS",4,1,1,16436793,"pubmed1",3.43E+018,"testalpha"
,"quantitative decline of ctgf","JJ NN IN ",4,1,1,16395527,"pubmed1",3.58E+018,"testalpha"
,"increased liver regeneration index","VBN NN NN NN",4,1,1,17013510,2,4.05E+018,"testalpha"
,"crucial role in hiv","JJ NN IN ",4,1,1,16511250,2,6.83E+018,"testalpha"
,"pci and cc score"," CC  NN",4,1,1,17139879,2,5.30E+018,"testalpha"
,"liquid soap preserved withmdbgn","JJ NN VBN ",4,1,1,16585981,2,3.93E+017,"testalpha"
,"studying themechanisms and risk","VBG NNS CC NN",4,1,1,16808045,"pubmed1",2.13E+018,"testalpha"
,"rate for escalator riding","NN IN NN NN",4,1,1,16434013,"pubmed1",5.58E+018,"testalpha"
,"changes in facial shape","NNS IN JJ NN",4,1,1,16722348,2,6.49E+018,"testalpha"
,"pseudo pelger huet patients","JJ NN  NNS",4,1,1,17119329,2,8.22E+018,"testalpha"
,"hepatic arterial vascularity andheterogeneity","JJ JJ NN NN",4,1,1,16317488,"pubmed1",7.18E+018,"testalpha"
,"numbers of orofacial cleft","NNS IN JJ NN",4,1,1,17165598,2,3.39E+018,"testalpha"
,"b deoxycholate ambd fungizone","NN NN  NN",4,1,1,17370566,"pubmed1",7.35E+018,"testalpha"
,"human carbonic anhydrase ii","JJ JJ NN ",4,1,1,16511248,2,4.04E+018,"testalpha"
,"cabg with equal intensity"," IN JJ NN",4,1,1,16451153,"pubmed1",2.23E+018,"testalpha"
,"wild type human enzyme","JJ NN JJ ",4,1,1,16421451,2,6.81E+018,"testalpha"
,"demonstrated ahigher alkaline phosphatase","VBN JJ NN NN",4,1,1,16701866,"pubmed1",1.49E+018,"testalpha"
,"viral causes hepatitis virus","JJ NNS NN NN",4,1,1,17013520,2,3.71E+018,"testalpha"
,"elaborate mono and polymetallicedifices","VB  CC NNS",4,1,1,16411740,"pubmed1",5.46E+018,"testalpha"
,"occurrence oflate mechanical complications","NN NN JJ NNS",4,1,1,16613748,2,7.83E+018,"testalpha"
,"ischemia and minutes ofreperfusion","NN CC NNS NN",4,1,1,17013507,2,6.06E+018,"testalpha"
,"levels in pesticide exposure","NNS IN VB NN",4,1,1,16956116,2,2.21E+018,"testalpha"
,"syndrome in elderly women","NN IN JJ NNS",4,1,1,16479027,2,2.66E+018,"testalpha"
,"scaling effectsof wet adhesion","VBG  JJ NN",4,1,1,16701858,"pubmed1",8.87E+018,"testalpha"
,"uncompetitive nmda receptor antagonistmk","JJ  NN ",4,1,1,17265692,2,4.34E+018,"testalpha"
,"majority of iron deficiency","NN IN NN NN",4,1,1,16673554,2,1.23E+018,"testalpha"
,"diabetes related microvascular complications","NN VBN JJ NNS",4,1,1,16918068,"pubmed1",3.65E+018,"testalpha"
,"calcification ofthe vessel wall","NN NNP NN NN",4,1,1,17007910,2,3.28E+018,"testalpha"
,"tracheal intubation inducedhemodynamic changes","NN NN JJ NNS",4,1,1,17067136,"pubmed1",3.47E+018,"testalpha"
,"final extrinsic conditions stimulatingthe","JJ NN NNS NNP",4,1,1,16414104,2,1.91E+018,"testalpha"
,"traumacenter with pediatric patients","NN IN JJ NNS",4,1,1,16549896,2,3.57E+018,"testalpha"
,"defect by endoanal ultrasound","NN IN JJ NN",4,1,1,17139884,2,6.42E+017,"testalpha"
,"fatal head on crashes","JJ NN IN NNS",4,1,1,16423319,"pubmed1",5.16E+018,"testalpha"
,"thediagnosis of latex allergy","NN IN NNP NN",4,1,1,16916182,"pubmed1",6.73E+017,"testalpha"
,"measuredusing fluoroenzyme immunoassay techniques","VBG  NN NNS",4,1,1,17010262,2,9.11E+018,"testalpha"
,"participation in risky behaviors","NN IN JJ NNS",4,1,1,16426559,"pubmed1",5.53E+018,"testalpha"
,"burden upon local irbs","NN IN JJ ",4,1,1,16770858,"pubmed1",5.94E+018,"testalpha"
,"increase in tgf beta","NN IN  NN",4,1,1,17293967,2,2.16E+018,"testalpha"
,"same adjuvant chemotherapy withfu","JJ JJ NN ",4,1,1,17139902,2,4.31E+018,"testalpha"
,"testing hours post recovery","NN NNS NN NN",4,1,1,17236636,"pubmed1",7.70E+017,"testalpha"
,"cipto mangunkusumo hospital jakarta","  NN NNP",4,1,1,16479024,2,6.46E+018,"testalpha"
,"early recurrence and side","JJ NN CC NN",4,1,1,16612915,"pubmed1",8.26E+018,"testalpha"
,"july emergency medical services"," NN JJ NNS",4,1,1,16365324,"pubmed1",2.87E+018,"testalpha"
,"thorough understanding ofthe etiology","JJ NN NNP NN",4,1,1,16462406,"pubmed1",9.88E+017,"testalpha"
,"dependent effect of toluene","JJ NN IN NN",4,1,1,16808045,"pubmed1",2.82E+018,"testalpha"
,"diagnostic range for gout","JJ NN IN ",4,1,1,16514850,2,7.55E+018,"testalpha"
,"mechanical ventilation in epidemicsituations","JJ NN IN NNS",4,1,1,16400088,"pubmed1",1.54E+018,"testalpha"
,"breaches ininfection control procedures","NNS NN NN NNS",4,1,1,16710581,2,9.19E+018,"testalpha"
,"aftermany years of use","NN NNS IN NN",4,1,1,16451161,"pubmed1",3.87E+018,"testalpha"
,"procedures at other institutions","NNS IN JJ NNS",4,1,1,16333710,"pubmed1",8.21E+018,"testalpha"
,"restingpressure cm h o","NN   ",4,1,1,17139884,2,4.76E+018,"testalpha"
,"case of rib tb","NN IN  ",4,1,1,16612935,"pubmed1",7.91E+018,"testalpha"
,"drinking and driving riding","NN CC VBG NN",4,1,1,16426559,"pubmed1",4.71E+018,"testalpha"
,"relationship between ox ldland","NN IN  NN",4,1,1,17106515,"pubmed1",6.06E+018,"testalpha"
,"patients after modifyingthe sct","NNS IN NNP ",4,1,1,16612913,"pubmed1",5.50E+018,"testalpha"
,"riskfactors for risky behaviors","NNS IN JJ NNS",4,1,1,16426559,"pubmed1",7.38E+018,"testalpha"
,"underlying principles advantages disadvantages","VBG NNS NNS NNS",4,1,1,16918067,"pubmed1",6.10E+018,"testalpha"
,"middle cerebral artery mcao","NN JJ NN ",4,1,1,17265691,2,4.20E+018,"testalpha"
,"clock protein per vertebrate","NN NN IN NN",4,1,1,16411738,"pubmed1",8.31E+018,"testalpha"
,"fentanyl than using tiva","NN IN VBG ",4,1,1,16451145,"pubmed1",7.32E+016,"testalpha"
,"oesophageal varices as aconsequence","NN NNS IN NN",4,1,1,16673613,2,2.46E+018,"testalpha"
,"application of statistical rules","NN IN JJ NNS",4,1,1,16451151,"pubmed1",6.04E+018,"testalpha"
,"witha consequent increased risk","NN NN VBN NN",4,1,1,16451155,"pubmed1",3.69E+018,"testalpha"
,"c cyp c activity","NN  NN NN",4,1,1,16584121,"pubmed1",7.85E+018,"testalpha"
,"general environment of humanbeings","JJ NN IN NNS",4,1,1,16603097,2,4.86E+017,"testalpha"
,"available technology and makeinformation","JJ NN CC NN",4,1,1,16770858,"pubmed1",3.01E+018,"testalpha"
,"earlydevelopment epiblast germ line","NN JJS NN NN",4,1,1,17265694,2,8.90E+018,"testalpha"
,"patient developed lethal cytomegalovirus","NN VBD JJ NN",4,1,1,16918065,"pubmed1",6.21E+017,"testalpha"
,"normal healthy control skin","JJ JJ NN NN",4,1,1,17034836,2,5.24E+018,"testalpha"
,"form chains via hydrogen","NN NNS IN NN",4,1,1,16456294,2,7.60E+018,"testalpha"
,"chronic hepatic diseases andit","JJ JJ NNS NN",4,1,1,17013515,2,4.92E+018,"testalpha"
,"lipidparameters examined ox ldl","NNS VBD  ",4,1,1,17106515,"pubmed1",3.17E+018,"testalpha"
,"find values for thecoefficients","VB NNS IN NNS",4,1,1,16406188,"pubmed1",6.82E+018,"testalpha"
,"practices for research record","NNS IN NN NN",4,1,1,16377817,"pubmed1",1.98E+018,"testalpha"
,"antithrombotic agents i e","JJ NNS  ",4,1,1,16549893,2,8.40E+018,"testalpha"
,"recent years overallsurvival rates","JJ NNS NN NNS",4,1,1,16451146,"pubmed1",5.93E+017,"testalpha"
,"cytotoxic dna lesions methyladenine","JJ  NNS NN",4,1,1,16733554,"pubmed1",7.01E+018,"testalpha"
,"traffic volumes and operatingspeeds","NN NNS CC NNS",4,1,1,16442487,"pubmed1",8.56E+018,"testalpha"
,"gene products yjl cp"," NNS  ",4,1,1,17146497,"pubmed1",4.05E+018,"testalpha"
,"nqo dt diaphorase ec","  NN ",4,1,1,16929382,"pubmed1",7.96E+018,"testalpha"
,"ancillary techniques insuspicious cases","JJ NNS JJ NNS",4,1,1,16514836,2,7.33E+018,"testalpha"
,"reduced collagen induced aggregation","VBN NN VBN NN",4,1,1,17068635,"pubmed1",6.31E+018,"testalpha"
,"absorption potential in humans","NN NN IN NNS",4,1,1,16584115,"pubmed1",6.70E+018,"testalpha"
,"rate cardiacindex vascular resistance","NN NN JJ NN",4,1,1,16491220,2,1.07E+018,"testalpha"
,"h po h po","   ",4,1,1,16456284,2,1.57E+018,"testalpha"
,"value of performanceimprovement programs","NN IN NN NNS",4,1,1,16377816,"pubmed1",2.85E+018,"testalpha"
,"amount of created proteins","NN IN VBN NNS",4,1,1,17294912,2,1.70E+017,"testalpha"
,"sm and associated examination"," CC VBN NN",4,1,1,16438092,"pubmed1",3.72E+018,"testalpha"
,"acids into target cells","NNS IN NN NNS",4,1,1,17285739,"pubmed1",3.89E+018,"testalpha"
,"wistar rats atdifferent ages","NN NNS NN NNS",4,1,1,17046052,2,7.66E+018,"testalpha"
,"immunoreactivity of low density","NN IN JJ NN",4,1,1,16965805,2,3.90E+018,"testalpha"
,"glycemiccontrol normalization of bg","NN NN IN ",4,1,1,16436794,"pubmed1",4.85E+018,"testalpha"
,"structure distribution and location","NN NN CC NN",4,1,1,16542712,2,7.95E+017,"testalpha"
,"patient positioning errors andnodule","NN VBG NNS NN",4,1,1,16399029,"pubmed1",2.91E+018,"testalpha"
,"process of conducting research","NN IN VBG NN",4,1,1,16209925,"pubmed1",4.18E+018,"testalpha"
,"findings of osteoclastomalike giant","NNS IN NN NN",4,1,1,16514845,2,4.98E+018,"testalpha"
,"sequences gdsgvgkt wdtagq nkld","NNS   ",4,1,1,16365637,"pubmed1",1.41E+018,"testalpha"
,"response hb increase g","NN  NN ",4,1,1,17119327,2,1.79E+018,"testalpha"
,"cytometric analysis of eosin","JJ NN IN NNP",4,1,1,17016037,2,4.76E+018,"testalpha"
,"anincrease in arrival volume","NN IN NN NN",4,1,1,16365329,"pubmed1",1.31E+018,"testalpha"
,"hospital mortality of patients","NN NN IN NNS",4,1,1,16365336,"pubmed1",3.59E+018,"testalpha"
,"european parliament and council","JJ NN CC NN",4,1,1,16999268,2,7.37E+018,"testalpha"
,"patientswith chronic itp boys","NN JJ  NNS",4,1,1,16424649,2,2.08E+018,"testalpha"
,"facilitated performance on longinterstimulus","VBN NN IN NN",4,1,1,16436796,"pubmed1",5.14E+018,"testalpha"
,"ethics training inpsychiatric education","NNS NN JJ NN",4,1,1,16473995,"pubmed1",6.81E+018,"testalpha"
,"xanthan gum for convenientapplication","NNP NN IN NN",4,1,1,17285742,"pubmed1",8.02E+018,"testalpha"
,"mortality amongafrican american women","NN JJ JJ NNS",4,1,1,16596895,"pubmed1",2.51E+018,"testalpha"
,"different os between e","JJ  IN ",4,1,1,16914906,2,3.01E+018,"testalpha"
,"attract moreattention and research","VB NN CC NN",4,1,1,17311739,2,2.91E+018,"testalpha"
,"review skin replacement options","NN NN NN NNS",4,1,1,16999270,2,7.20E+018,"testalpha"
,"model for short term","NN IN JJ NN",4,1,1,16696445,2,1.83E+018,"testalpha"
,"metabolism in t gondii","NN IN  ",4,1,1,16421444,2,1.25E+018,"testalpha"
,"cases in group i","NNS IN NN ",4,1,1,16809889,2,5.50E+018,"testalpha"
,"water and oxalic acid","NN CC JJ NN",4,1,1,16701865,"pubmed1",4.53E+018,"testalpha"
,"secretion by inhibiting energy","NN IN VBG NN",4,1,1,17068635,"pubmed1",1.38E+018,"testalpha"
,"dependent inhibition of g","JJ NN IN ",4,1,1,17046053,2,2.99E+018,"testalpha"
,"study comparedstreet level advertisements","NN NNP NN NNS",4,1,1,16427019,"pubmed1",6.61E+018,"testalpha"
,"caspase positive cell fraction","NN JJ NN NN",4,1,1,17034836,2,6.96E+018,"testalpha"
,"cfa i fimbrial assembly","  JJ NN",4,1,1,16511280,2,8.01E+018,"testalpha"
,"producing system in vertebrates","VBG NN IN NNS",4,1,1,16770441,"pubmed1",6.84E+017,"testalpha"
,"salivacontaining f h o","VBG NN  ",4,1,1,16701867,"pubmed1",5.30E+018,"testalpha"
,"does notimpair whole blood","VBZ NN JJ NN",4,1,1,16549890,2,2.73E+018,"testalpha"
,"asvisible spectrum of cytochrome","JJ NN IN NN",4,1,1,16951741,"pubmed1",3.51E+018,"testalpha"
,"involved inthe birch pollen","VBN NNP NN NN",4,1,1,16673562,2,3.60E+016,"testalpha"
,"limb deformities open fractures","NN NNS JJ NNS",4,1,1,16436790,"pubmed1",3.39E+017,"testalpha"
,"medical school faculty method","JJ NN NN NN",4,1,1,16377815,"pubmed1",7.60E+018,"testalpha"
,"association between psoriasis severityand","NN IN NN NN",4,1,1,16585983,2,3.28E+018,"testalpha"
,"skin grafts after years","NN NNS IN NNS",4,1,1,16999269,2,7.98E+017,"testalpha"
,"trans epidermal water lossand","NNS JJ NN NN",4,1,1,16874414,2,6.98E+018,"testalpha"
,"month intravenous iron dose","NN JJ NN NN",4,1,1,17119323,2,5.66E+018,"testalpha"
,"novel oral bcr abltyrosine","NN JJ  NN",4,1,1,16914906,2,1.84E+018,"testalpha"
,"cases of hemophilia b","NNS IN NNP NN",4,1,1,16424651,2,3.00E+018,"testalpha"
,"kg body weight h"," NN NN ",4,1,1,17007911,2,3.75E+018,"testalpha"
,"yield x ray diffraction","NN NN  NN",4,1,1,16369101,2,7.27E+018,"testalpha"
,"increase inthe cell volume","NN NNP NN NN",4,1,1,17106513,"pubmed1",8.50E+018,"testalpha"
,"i suggest anevenness formula"," VB NN NN",4,1,1,16988905,"pubmed1",3.50E+018,"testalpha"
,"clinical features of basal","JJ NNS IN NN",4,1,1,16603102,2,1.10E+018,"testalpha"
,"medicine usp in cooperation","NN  IN NN",4,1,1,17013504,2,1.84E+018,"testalpha"
,"inevitable stage of formation","JJ NN IN NN",4,1,1,16988902,"pubmed1",1.07E+018,"testalpha"
,"significance incausing road accidents","NN VBG NN NNS",4,1,1,16191426,"pubmed1",3.61E+018,"testalpha"
,"possible symmetry of thediffraction","JJ NN IN NN",4,1,1,16369096,2,5.96E+018,"testalpha"
,"improvement of cognitive performance","NN IN JJ NN",4,1,1,16956120,2,8.85E+018,"testalpha"
,"assessments andtreatments patient teaching","NNS NNS NN NN",4,1,1,16462405,"pubmed1",4.22E+018,"testalpha"
,"influences cell metabolic response","NNS NN JJ NN",4,1,1,16733556,"pubmed1",7.56E+018,"testalpha"
,"weight chitosan edta conjugates","NN JJ  NNS",4,1,1,17285741,"pubmed1",4.56E+018,"testalpha"
,"committee on medical education","NN IN JJ NN",4,1,1,16473988,"pubmed1",6.24E+018,"testalpha"
,"heterogeneousdeposition of tn fn","NN IN  ",4,1,1,16430945,2,6.06E+017,"testalpha"
,"program duty hour reduction","NN NN NN NN",4,1,1,16377825,"pubmed1",6.39E+017,"testalpha"
,"motor block but thatropivacaine","NN NN CC NN",4,1,1,16617756,"pubmed1",7.28E+018,"testalpha"
,"authors review recent developments","NNS NN JJ NNS",4,1,1,16473988,"pubmed1",5.78E+018,"testalpha"
,"ad into respiratory allergy","NN IN NN NN",4,1,1,17328144,2,8.40E+018,"testalpha"
,"newlygenerated corneocytes containing beta","VBN NNS VBG NN",4,1,1,16733064,2,3.86E+018,"testalpha"
,"inter residue intramolecular hydrogen","NN NN JJ NN",4,1,1,16456293,2,5.11E+018,"testalpha"
,"h expression of ctgf"," NN IN ",4,1,1,16395527,"pubmed1",8.26E+018,"testalpha"
,"range days in manugel","VBP NNS IN NNP",4,1,1,16701881,"pubmed1",3.68E+018,"testalpha"
,"biopsy recommendations and receiver","NN NNS CC NN",4,1,1,16399036,"pubmed1",4.91E+018,"testalpha"
,"energyexpenditure and physical activity","NN CC JJ NN",4,1,1,16918067,"pubmed1",8.60E+018,"testalpha"
,"protocol was followed results","NN VBD VBN NNS",4,1,1,16451150,"pubmed1",8.24E+017,"testalpha"
,"prepare microemulsions containingsumatriptan st","VB NNS NNP ",4,1,1,16584167,"pubmed1",7.51E+018,"testalpha"
,"symptoms of abdominal sarcomaare","NNS IN JJ NN",4,1,1,16314988,"pubmed1",2.03E+018,"testalpha"
,"ofanemia among ibd patients","NN IN  NNS",4,1,1,16673554,2,3.68E+018,"testalpha"
,"glutathione gsh content serum","NN  JJ NN",4,1,1,16999986,2,4.31E+018,"testalpha"
,"role in sa inductionof","NN IN  ",4,1,1,16395526,"pubmed1",6.55E+018,"testalpha"
,"method for screening ph","NN IN NN ",4,1,1,16584164,"pubmed1",1.54E+018,"testalpha"
,"fromthe mtm determined temperature","NNP  VBN NN",4,1,1,17285746,"pubmed1",6.81E+018,"testalpha"
,"lung were demonstrated usingimages","NN VBD VBN NNS",4,1,1,16399029,"pubmed1",6.90E+018,"testalpha"
,"including national meetings lectures","VBG JJ NNS NNS",4,1,1,16436795,"pubmed1",6.31E+018,"testalpha"
,"surgical treatment of pc","JJ NN IN ",4,1,1,17139879,2,3.80E+017,"testalpha"
,"time pcr thatof ppargamma","NN   NN",4,1,1,16809887,2,5.40E+018,"testalpha"
,"forchronic itp in children","JJ  IN NNS",4,1,1,16424648,2,5.14E+018,"testalpha"
,"fx defects hada total"," NNS  NN",4,1,1,16424651,2,2.13E+018,"testalpha"
,"quantitative determination of lesion","JJ NN IN NN",4,1,1,17007910,2,6.75E+018,"testalpha"
,"anaplastic carcinomas increased membrane","JJ NNP VBD NN",4,1,1,16720036,2,4.61E+018,"testalpha"
,"pp pe tissue hadshort","  NN NN",4,1,1,16584758,2,3.27E+017,"testalpha"
,"study included ad patients","NN VBD NN NNS",4,1,1,16859611,2,5.22E+018,"testalpha"
,"conclusion mechanical bowel preparation","NN JJ NN NN",4,1,1,16612916,"pubmed1",6.36E+018,"testalpha"
,"fatalism influence breast cancer","NN NN NN NN",4,1,1,16596899,"pubmed1",8.28E+018,"testalpha"
,"tape with pendant hydrogen","NN IN JJ NN",4,1,1,16456284,2,3.49E+018,"testalpha"
,"surface methodology with meanpercentage","NN NN IN NN",4,1,1,16584161,"pubmed1",4.08E+018,"testalpha"
,"augmentsneurotransmitter and hormone release","NN CC NN NN",4,1,1,16395521,"pubmed1",1.30E+018,"testalpha"
,"leukemias and otherhematological malignancies","NNP CC JJ NNS",4,1,1,16421443,2,4.36E+018,"testalpha"
,"thecortical representation of vibrissae","JJ NN IN ",4,1,1,17133958,2,4.78E+018,"testalpha"
,"normative standards for research","JJ NNS IN NN",4,1,1,16377817,"pubmed1",1.87E+018,"testalpha"
,"fibromas cafe au lait","NNP NN  ",4,1,1,17010267,2,8.61E+018,"testalpha"
,"inhibition of tumour growth","NN IN JJ NN",4,1,1,16388313,"pubmed1",2.83E+018,"testalpha"
,"total provider hours areallocation","JJ NN NNS NN",4,1,1,16365329,"pubmed1",3.68E+018,"testalpha"
,"t rubrum in t"," NN IN ",4,1,1,16710579,2,6.12E+018,"testalpha"
,"inthe pe case enhancement","NNP  NN NN",4,1,1,16399029,"pubmed1",3.23E+018,"testalpha"
,"raman and x ray","NN CC NN ",4,1,1,16701876,"pubmed1",8.41E+017,"testalpha"
,"cirrhotic group simulated operation","JJ NN VBN NN",4,1,1,17013508,2,1.50E+018,"testalpha"
,"outcome in various fields","NN IN JJ NNS",4,1,1,17139892,2,2.62E+018,"testalpha"
,"ventilation and pulmonary shunt","NN CC JJ NN",4,1,1,16451155,"pubmed1",8.92E+018,"testalpha"
,"adequate diagnosis and treatment","JJ NN CC NN",4,1,1,17338203,2,4.49E+017,"testalpha"
,"orfewer hours worked coincident","NN NNS VBD NN",4,1,1,16377826,"pubmed1",3.37E+018,"testalpha"
,"effects allow adjusting risks","NNS VBP VBG NNS",4,1,1,16126153,"pubmed1",2.48E+018,"testalpha"
,"costs while simultaneouslyimproving patient","NNS IN VBG NN",4,1,1,16462412,"pubmed1",1.61E+018,"testalpha"
,"assesspsychological distress in patients","JJ NN IN NNS",4,1,1,17013512,2,9.17E+018,"testalpha"
,"rats were dividedinto groups","NNS VBD NNP NNS",4,1,1,16612919,"pubmed1",2.87E+018,"testalpha"
,"treatment of radiation damage","NN IN NN NN",4,1,1,16369098,2,2.80E+018,"testalpha"
,"study period h vs","NN NN  ",4,1,1,16451147,"pubmed1",3.30E+017,"testalpha"
,"associated withmutations in connexin","VBN NNS IN ",4,1,1,17106596,2,4.44E+018,"testalpha"
,"providers in dermatological treatment","NNS IN JJ NN",4,1,1,16710575,2,4.00E+018,"testalpha"
,"baseline demographic information anxietylevel","NN JJ NN NN",4,1,1,16365322,"pubmed1",6.86E+018,"testalpha"
,"researchers at thespokane research","NNS IN NN NN",4,1,1,16129405,"pubmed1",1.97E+018,"testalpha"
,"hsa non crystallographic symmetry","  JJ NN",4,1,1,16511271,2,2.67E+017,"testalpha"
,"recurrent attacks and complications","NN NNS CC NNS",4,1,1,17338195,2,7.45E+018,"testalpha"
,"x linked recessive form","NN VBN JJ NN",4,1,1,16893562,2,4.20E+017,"testalpha"
,"official guidelines on proctology","JJ NNS IN NN",4,1,1,16673559,2,2.82E+018,"testalpha"
,"non fluid resuscitated group"," NN VBN NN",4,1,1,16762404,2,2.01E+018,"testalpha"
,"andcorresponding nonmalignant tissue counterparts","VBG JJ NN NNS",4,1,1,17143338,"pubmed1",8.91E+018,"testalpha"
,"institutional review board irb","JJ NN NN ",4,1,1,16770858,"pubmed1",9.12E+018,"testalpha"
,"measures of ventilation distribution","NNS IN NN NN",4,1,1,16399039,"pubmed1",2.78E+017,"testalpha"
,"expression of superoxide dismutase","NN IN VB NN",4,1,1,17293962,2,3.54E+018,"testalpha"
,"pretreated patients in respect","VBN NNS IN NN",4,1,1,17338197,2,4.35E+018,"testalpha"
,"frequency of neonatal hypoglycemia","NN IN JJ NN",4,1,1,17438837,2,7.44E+018,"testalpha"
,"rate constants andinitial conditions","NN NNS JJ NNS",4,1,1,16770446,"pubmed1",5.81E+018,"testalpha"
,"right atrium flail thrombus","JJ NN NN NNP",4,1,1,16696443,2,4.40E+018,"testalpha"
,"days after photothrombotic stroke","NNS IN JJ NN",4,1,1,17133958,2,1.71E+018,"testalpha"
,"outcome in acutemyocardial infarction","NN IN JJ NN",4,1,1,16365334,"pubmed1",6.64E+018,"testalpha"
,"investigate therelationships between placental","VB NNS IN NN",4,1,1,16809888,2,6.05E+018,"testalpha"
,"role of endocannabinoids agroup","NN IN NNS NN",4,1,1,16808046,"pubmed1",5.04E+018,"testalpha"
,"diabetes mellitus is atherosclerosis","NN NN VBZ NN",4,1,1,16479030,2,4.34E+018,"testalpha"
,"aretrospective case file evaluation","JJ NN NN NN",4,1,1,16112068,"pubmed1",1.92E+018,"testalpha"
,"dry layer resistance ie","JJ NN NN ",4,1,1,17285746,"pubmed1",3.57E+018,"testalpha"
,"pathological characteristics of uterinesarcomas","JJ NNS IN NNP",4,1,1,17338203,2,2.06E+018,"testalpha"
,"highdefinition improved quality video","NN VBN NN NN",4,1,1,17139882,2,6.67E+018,"testalpha"
,"allowunlimited freedom of movement","VBN NN IN NN",4,1,1,16722347,2,4.79E+018,"testalpha"
,"had enhancement of il","VBD NN IN ",4,1,1,17293960,2,5.86E+018,"testalpha"
,"incident duration estimation trees","NN NN NN NNS",4,1,1,16426557,"pubmed1",8.19E+018,"testalpha"
,"kda form of caenorhabditis"," NN IN NN",4,1,1,16496042,"pubmed1",7.29E+018,"testalpha"
,"bmscs from adult malerat","NNS IN NN NNP",4,1,1,16443258,2,3.44E+018,"testalpha"
,"malignancy abdominal surgery emergencysurgery","NN JJ NN NN",4,1,1,16451146,"pubmed1",8.62E+018,"testalpha"
,"type breslow thickness presence","NN VB NN NN",4,1,1,16585990,2,6.50E+018,"testalpha"
,"vegfr positive haematopoietic bone"," JJ JJ NN",4,1,1,16730054,2,5.21E+018,"testalpha"
,"ofpretreat ment with magnesium","JJ NN IN NN",4,1,1,17067136,"pubmed1",2.67E+018,"testalpha"
,"helmet use compliance site","VB NN NN NN",4,1,1,16223468,"pubmed1",5.11E+017,"testalpha"
,"options for childhood psoriasis","NNS IN NN NN",4,1,1,17311742,2,1.84E+018,"testalpha"
,"solution containing scfa glutamine","NN VBG  NN",4,1,1,17293957,2,6.07E+018,"testalpha"
,"immunotherapy with specific airborne","NN IN JJ NNP",4,1,1,16603103,2,4.52E+018,"testalpha"
,"seeding nodule allowsdefinitive diagnosis","VBG NN JJ NN",4,1,1,16333710,"pubmed1",3.61E+018,"testalpha"
,"crashes highway planners designers","NNS NN NNS NNS",4,1,1,16054101,"pubmed1",2.91E+017,"testalpha"
,"disks after days immersion","NNS IN NNS NN",4,1,1,16701867,"pubmed1",7.06E+018,"testalpha"
,"metihigh fidelity patient simulator","VB NN NN NN",4,1,1,16365338,"pubmed1",2.05E+018,"testalpha"
,"glycol ppdo plla b","NN   NN",4,1,1,16701879,"pubmed1",5.35E+018,"testalpha"
,"surgeryis indicated subtotal colectomy"," VBD NN NN",4,1,1,17139890,2,5.22E+018,"testalpha"
,"nd nd co co","   ",4,1,1,16389406,"pubmed1",7.40E+017,"testalpha"
,"bad risk taking behavior","JJ NN VBG NN",4,1,1,16236234,"pubmed1",5.96E+017,"testalpha"
,"age ethnicity and time","NN NN CC NN",4,1,1,16223468,"pubmed1",2.49E+018,"testalpha"
,"combined group in patients","VBN NN IN NNS",4,1,1,16451159,"pubmed1",6.20E+018,"testalpha"
,"able todiscriminate among substrates","JJ NN IN NNS",4,1,1,17143335,"pubmed1",3.77E+018,"testalpha"
,"containing different beta blockers","VBG JJ NN NNS",4,1,1,17106597,2,7.75E+018,"testalpha"
,"physicians toafrican american couples","NNS JJ JJ NNS",4,1,1,16596898,"pubmed1",3.30E+017,"testalpha"
,"subjects with largestbite lesions","NNS IN JJ NNS",4,1,1,16874418,2,2.70E+018,"testalpha"
,"p c cyp c"," NN  NN",4,1,1,16584121,"pubmed1",3.07E+018,"testalpha"
,"orthorhombic space group p","JJ NN NN ",4,1,1,16511285,2,5.48E+018,"testalpha"
,"amount of road safety","NN IN NN NN",4,1,1,16112069,"pubmed1",5.81E+018,"testalpha"
,"dermal side of salt","JJ NN IN NN",4,1,1,16955192,2,3.63E+018,"testalpha"
,"aceinhibitor provoked angioedema shares","NN VBD NN NNS",4,1,1,16451161,"pubmed1",4.67E+018,"testalpha"
,"binders for specific molecules","NNS IN JJ NNS",4,1,1,16414103,2,6.62E+018,"testalpha"
,"q type in patients"," NN IN NNS",4,1,1,16914907,2,3.83E+018,"testalpha"
,"patients received short term","NNS VBD NN NN",4,1,1,17139896,2,2.34E+018,"testalpha"
,"case of atopic dermatitis","NN IN NN NN",4,1,1,16603103,2,8.18E+018,"testalpha"
,"profile of dipeptidyl peptidase","NN IN  NN",4,1,1,16929383,"pubmed1",4.06E+018,"testalpha"
,"threonineresidues and permit predictions","NNS CC VB NNS",4,1,1,17117212,"pubmed1",7.97E+018,"testalpha"
,"immunosorbent assay and platelet","NN NN CC NN",4,1,1,16594642,"pubmed1",1.91E+018,"testalpha"
,"durationof observation following dvt"," NN VBG ",4,1,1,16549898,2,3.37E+018,"testalpha"
,"lane rural roads inmaine","NN JJ NNS NN",4,1,1,16423319,"pubmed1",5.86E+018,"testalpha"
,"inhibitor h of pkc","NN  IN ",4,1,1,17016035,2,6.69E+018,"testalpha"
,"evolved fibrillar attachment devices","VBD JJ NN NNS",4,1,1,16701858,"pubmed1",2.52E+017,"testalpha"
,"drosophilamelanogaster proteasomal degradation controls","NN JJ NN NNS",4,1,1,16496042,"pubmed1",3.21E+018,"testalpha"
,"accurate calculations of heat","JJ NNS IN NN",4,1,1,17285746,"pubmed1",9.21E+018,"testalpha"
,"pathogenesis and gene therapy","NN CC  NN",4,1,1,16648912,2,3.87E+018,"testalpha"
,"essentialingredient for obtaining diffraction","NN IN VBG NN",4,1,1,16511266,2,6.20E+017,"testalpha"
,"reorganization formation ofstress fibers","NN NN NN NNS",4,1,1,17115079,"pubmed1",2.45E+018,"testalpha"
,"function and full donor","NN CC JJ NN",4,1,1,16918062,"pubmed1",4.61E+018,"testalpha"
,"common disease in children","JJ NN IN NNS",4,1,1,17311742,2,4.35E+017,"testalpha"
,"palliative managementof inoperative patients","JJ  JJ NNS",4,1,1,17139878,2,7.37E+018,"testalpha"
,"itp children increasing theexpressions"," NNS VBG NNS",4,1,1,17016035,2,6.12E+018,"testalpha"
,"incision and resection cartilages","NN CC NN NNS",4,1,1,16956118,2,2.83E+018,"testalpha"
,"caspase in psoriatic skin","NN IN JJ NN",4,1,1,17034836,2,1.60E+018,"testalpha"
,"institute for orthopedic surgery","NN IN JJ NN",4,1,1,17688033,2,4.69E+018,"testalpha"
,"increase of serum il","NN IN NN ",4,1,1,16603096,2,2.46E+018,"testalpha"
,"canreceive women aged years","JJ NNS VBN NNS",4,1,1,17010274,2,6.05E+018,"testalpha"
,"current illness known tointeract","JJ NN VBN NN",4,1,1,16809889,2,2.80E+018,"testalpha"
,"noted mean hb increase","VBD VB  NN",4,1,1,17119327,2,5.56E+018,"testalpha"
,"expression after eradication therapy","NN IN NN NN",4,1,1,16809885,2,3.31E+018,"testalpha"
,"high activity against themalassezia","JJ NN IN NNP",4,1,1,16874415,2,8.35E+018,"testalpha"
,"byconfocal laser scanning microscopy","JJ NN VBG ",4,1,1,16701854,"pubmed1",6.36E+017,"testalpha"
,"derived fromartery wall cells","VBN NN NN NNS",4,1,1,17106515,"pubmed1",2.53E+018,"testalpha"
,"tools and model programs","NNS CC NN NNS",4,1,1,16473991,"pubmed1",3.00E+018,"testalpha"
,"year year and year","NN NN CC NN",4,1,1,17139879,2,4.42E+018,"testalpha"
,"potential role in pollen","JJ NN IN NN",4,1,1,16963110,2,3.07E+018,"testalpha"
,"scavenger of free radicals","NN IN JJ NNS",4,1,1,16999986,2,7.91E+018,"testalpha"
,"proxies of motorcycling activityin","NNS IN VBG ",4,1,1,16202466,"pubmed1",6.72E+018,"testalpha"
,"arecurrent mutation p asp","NN NN  ",4,1,1,17106596,2,6.66E+018,"testalpha"
,"anticipated cessation related health","VBN NN VBN NN",4,1,1,16365327,"pubmed1",2.99E+018,"testalpha"
,"onone side and nm","NN NN CC ",4,1,1,16585984,2,6.68E+018,"testalpha"
,"absence ofxenogenic islet tissue","NN JJ NN NN",4,1,1,16701881,"pubmed1",4.38E+018,"testalpha"
,"polymerase ii and crystals","NN  CC NNS",4,1,1,16421445,2,9.15E+018,"testalpha"
,"tool for detecting safetyissues","NN IN VBG NNS",4,1,1,16321534,"pubmed1",4.16E+018,"testalpha"
,"lesions from ad patients","NNS IN NN NNS",4,1,1,16603095,2,4.99E+018,"testalpha"
,"therespiratory control ratio rcr","NN NN NN ",4,1,1,17013508,2,2.53E+018,"testalpha"
,"chin with aesthetical purpose","NN IN JJ NN",4,1,1,17294911,2,9.22E+018,"testalpha"
,"institute for scientific information","NN IN JJ NN",4,1,1,16399035,"pubmed1",4.30E+018,"testalpha"
,"r hydrogen bonded ring","NN NN VBN NN",4,1,1,16456284,2,3.23E+018,"testalpha"
,"secondary health care facilities","JJ NN NN NNS",4,1,1,16514839,2,5.22E+018,"testalpha"
,"proteins or other oncoproteins","NNS CC JJ NNS",4,1,1,17117604,2,4.05E+018,"testalpha"
,"alginate with predominantlyguluronic acid","NN IN JJ NN",4,1,1,16701881,"pubmed1",5.54E+018,"testalpha"
,"surgery residency programs method","NN NN NNS NN",4,1,1,16377820,"pubmed1",1.68E+018,"testalpha"
,"amongalgebraic relationships codon assignment","JJ NNS NNP NN",4,1,1,16823609,"pubmed1",2.41E+018,"testalpha"
,"papillomatosis index andepithelial thickness","NN NN JJ NN",4,1,1,16874412,2,1.34E+018,"testalpha"
,"section and immediate anastomosis","NN CC JJ NN",4,1,1,17293972,2,2.28E+018,"testalpha"
,"mucinous component clinical orct","JJ NN JJ ",4,1,1,17139900,2,5.16E+017,"testalpha"
,"group with unit cell","NN IN NN NN",4,1,1,16511254,2,6.47E+018,"testalpha"
,"response and pre pulseinhibition","NN CC  NN",4,1,1,17133954,2,6.45E+016,"testalpha"
,"containingsumatriptan st and sumatriptan","NNP  CC NNP",4,1,1,16584167,"pubmed1",6.03E+018,"testalpha"
,"pre cellular viral life"," JJ JJ NN",4,1,1,17347785,"pubmed1",2.03E+018,"testalpha"
